PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Patel, V; Carrion, K; Hollands, A; Hinton, A; Gallegos, T; Dyo, J; Sasik, R; Leire, E; Hardiman, G; Mohamed, SA; Nigam, S; King, CC; Nizet, V; Nigam, V				Patel, Vishal; Carrion, Katrina; Hollands, Andrew; Hinton, Andrew; Gallegos, Thomas; Dyo, Jeffrey; Sasik, Roman; Leire, Emma; Hardiman, Gary; Mohamed, Salah A.; Nigam, Sanjay; King, Charles C.; Nizet, Victor; Nigam, Vishal			The stretch responsive microRNA miR-148a-3p is a novel repressor of IKBKB, NF-kappa B signaling, and inflammatory gene expression in human aortic valve cells	FASEB JOURNAL			English	Article						inflammation; aortic valve calcification; mechanotransduction	MATRIX-METALLOPROTEINASE EXPRESSION; INTERSTITIAL-CELLS; TARGET PREDICTION; ENDOTHELIAL-CELLS; VALVULAR LESIONS; SMOOTH-MUSCLE; IKK-BETA; STENOSIS; DISEASE; CALCIFICATION	Bicuspid aortic valves calcify at a significantly higher rate than normal aortic valves, a process that involves increased inflammation. Because we have previously found that bicuspid aortic valve experience greater stretch, we investigated the potential connection between stretch and inflammation in human aortic valve interstitial cells (AVICs). Microarray, quantitative PCR (qPCR), and protein assays performed on AVICs exposed to cyclic stretch showed that stretch was sufficient to increase expression of interleukin and metalloproteinase family members by more than 1.5-fold. Conditioned medium from stretched AVICs was sufficient to activate leukocytes. microRNA sequencing and qPCR experiments demonstrated that miR-148a-3p was repressed in both stretched AVICs (43% repression) and, as a clinical correlate, human bicuspid aortic valves (63% reduction). miR-148a-3p was found to be a novel repressor of IKBKB based on data from qPCR, luciferase, and Western blot experiments. Furthermore, increasing miR-148a-3p levels in AVICs was sufficient to decrease NF-kappa B (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling and NF-kappa B target gene expression. Our data demonstrate that stretch-mediated activation of inflammatory pathways is at least partly the result of stretch-repression of miR-148a-3p and a consequent failure to repress IKBKB. To our knowledge, we are the first to report that cyclic stretch of human AVICs activates inflammatory genes in a tissue-autonomous manner via a microRNA that regulates a central inflammatory pathway.	[Patel, Vishal; Carrion, Katrina; Dyo, Jeffrey; Nigam, Vishal] Univ Calif San Diego, Dept Pediat Cardiol, La Jolla, CA 92093 USA; [Hollands, Andrew; Gallegos, Thomas; Leire, Emma; Nigam, Sanjay; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Hollands, Andrew; Leire, Emma; Nizet, Victor] Univ Calif San Diego, Sch Pharm, La Jolla, CA 92093 USA; [Hinton, Andrew; King, Charles C.] Univ Calif San Diego, Pediat Diabet Res Ctr, La Jolla, CA 92093 USA; [Gallegos, Thomas; Nigam, Sanjay] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Sasik, Roman] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hardiman, Gary] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Hardiman, Gary] San Diego State Univ, Biomed Informat Res Ctr, San Diego, CA 92182 USA; [Hardiman, Gary] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Mohamed, Salah A.] Univ Clin Schleswig Holstein, Dept Cardiac Surg, Lubeck, Germany; [Nigam, Vishal] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University; Medical University of South Carolina; University of Kiel; Schleswig Holstein University Hospital; Rady Childrens Hospital San Diego	Nigam, V (corresponding author), Univ Calif San Diego, Dept Pediat Cardiol, 9500 Gilman Dr Box 0731, La Jolla, CA 92093 USA.	vnigam@ucsd.edu	Nizet, Victor/AAF-3190-2019; Mohamed, Salah A./O-2955-2018; Leire, Emma/B-8026-2016	Nigam, Vishal/0000-0002-9652-8146; Leire, Emma/0000-0001-9161-0442; Hardiman, Gary/0000-0003-4558-0400; Nizet, Victor/0000-0003-3847-0422	Australian National Health and Medical Research Council; Larry L. Hillblom Foundation; U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grant [K08 HL086775-01]; UCSD Department of Pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL086775] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Larry L. Hillblom Foundation; U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grant; UCSD Department of Pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Lifesharing for their assistance in obtaining the human valve tissue. The authors also thank Drs. I. Banerjee and S. Lange for technical assistance. They also acknowledge the University of California, San Diego (UCSD) Microarray and Biomedical Genomics Microarray Core Facilities for their assistance with the miRNA-Seq and microarray experiments. A.H. was funded by a CJ Martin-Biomedical Overseas fellowship from the Australian National Health and Medical Research Council. A.H. was funded by the Larry L. Hillblom Foundation. V.N. was supported by U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grant K08 HL086775-01 and the UCSD Department of Pediatrics.	Aggarwal A, 2014, ANN BIOMED ENG, V42, P986, DOI 10.1007/s10439-014-0973-0; *AM HEART ASS, 2004, HEART DIS STROK STAT; Balachandran K, 2009, AM J PHYSIOL-HEART C, V296, pH756, DOI 10.1152/ajpheart.00900.2008; BEPPU S, 1993, AM J CARDIOL, V71, P322, DOI 10.1016/0002-9149(93)90799-I; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Davies MJ, 1996, HEART, V75, P174, DOI 10.1136/hrt.75.2.174; Du W, 1995, J BIOMECH, V28, P1485, DOI 10.1016/0021-9290(95)00096-8; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Edep ME, 2000, CARDIOVASC PATHOL, V9, P281, DOI 10.1016/S1054-8807(00)00043-0; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Fondard O, 2005, EUR HEART J, V26, P1333, DOI 10.1093/eurheartj/ehi248; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Gould RA, 2012, ACTA BIOMATER, V8, P1710, DOI 10.1016/j.actbio.2012.01.006; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hishikawa K, 1997, CIRC RES, V81, P797; Holliday CJ, 2011, AM J PHYSIOL-HEART C, V301, pH856, DOI 10.1152/ajpheart.00117.2011; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kaden JJ, 2005, CARDIOVASC PATHOL, V14, P80, DOI 10.1016/j.carpath.2005.01.002; Kaden JJ, 2003, ATHEROSCLEROSIS, V170, P205, DOI 10.1016/S0021-9150(03)00284-3; Kang HB, 2007, STEM CELLS DEV, V16, P615, DOI 10.1089/scd.2007.0014; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Meng XZ, 2008, AM J PHYSIOL-CELL PH, V294, pC29, DOI 10.1152/ajpcell.00137.2007; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Mohler ER, 1997, ARTERIOSCL THROM VAS, V17, P547, DOI 10.1161/01.ATV.17.3.547; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; Naito Y, 2010, INT J CARDIOL, V144, P260, DOI 10.1016/j.ijcard.2009.01.022; Nigam V, 2010, J HEART VALVE DIS, V19, P459; OBRIEN KD, 1995, CIRCULATION, V92, P2163, DOI 10.1161/01.CIR.92.8.2163; OLSSON M, 1994, J AM COLL CARDIOL, V23, P1162, DOI 10.1016/0735-1097(94)90606-8; Osman L, 2006, CIRCULATION, V114, pI547, DOI 10.1161/CIRCULATIONAHA.105.001115; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Panda H, 2012, REPROD SCI, V19, P786, DOI 10.1177/1933719112438448; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Robicsek F, 2004, ANN THORAC SURG, V77, P177, DOI 10.1016/S0003-4975(03)01249-9; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Satta J, 2003, ANN THORAC SURG, V76, P681, DOI 10.1016/S0003-4975(03)00529-0; Smith KE, 2010, BIOMECH MODEL MECHAN, V9, P117, DOI 10.1007/s10237-009-0165-2; Soini Y, 2001, J PATHOL, V194, P225, DOI 10.1002/path.850; Song LB, 2013, CELL RES, V23, P274, DOI 10.1038/cr.2012.174; Song LB, 2010, BIOCHEM BIOPH RES CO, V402, P135, DOI 10.1016/j.bbrc.2010.10.003; Steinmetz M, 2008, J HEART VALVE DIS, V17, P187; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Szeto K, 2013, WORLD J PEDIATR CONG, V4, P362, DOI 10.1177/2150135113501901; Tanaka K, 2005, J AM COLL CARDIOL, V46, P134, DOI 10.1016/j.jacc.2005.03.058; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Wallby L, 2002, HEART, V88, P348, DOI 10.1136/heart.88.4.348; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Yanagawa B, 2012, J THORAC CARDIOV SUR, V144, P256, DOI 10.1016/j.jtcvs.2011.10.097; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200	57	58	59	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1859	1868		10.1096/fj.14-257808	http://dx.doi.org/10.1096/fj.14-257808			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25630970	Green Published			2022-12-26	WOS:000354114600021
J	Li, SM; Bhave, D; Chow, JM; Riera, TV; Schlee, S; Rauch, S; Atanasova, M; Cate, RL; Whitty, A				Li, Simin; Bhave, Devayani; Chow, Jennifer M.; Riera, Thomas V.; Schlee, Sandra; Rauch, Simone; Atanasova, Mariya; Cate, Richard L.; Whitty, Adrian			Quantitative Analysis of Receptor Tyrosine Kinase-Effector Coupling at Functionally Relevant Stimulus Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Extracellular Signal-regulated Kinase (ERK); Kinetics; Mitogen-activated Protein Kinase (MAPK); Neurite Outgrowth; Signal Transduction; Systems Biology; RET; Artemin; Signal Gain	SIGNAL-REGULATED KINASE; GDNF FAMILY; IN-VIVO; GROWTH; RET; DYNAMICS; ARTEMIN; ERK; TRANSIENT; CELLS	A major goal of current signaling research is to develop a quantitative understanding of how receptor activation is coupled to downstream signaling events and to functional cellular responses. Here, we measure how activation of the RET receptor tyrosine kinase on mouse neuroblastoma cells by the neurotrophin artemin (ART) is quantitatively coupled to key downstream effectors. We show that the efficiency of RET coupling to ERK and Akt depends strongly on ART concentration, and it is highest at the low (approximate to 100 pm) ART levels required for neurite outgrowth. Quantitative discrimination between ERK and Akt pathway signaling similarly is highest at this low ART concentration. Stimulation of the cells with 100 pm ART activated RET at the rate of approximate to 10 molecules/cell/min, leading at 5-10 min to a transient peak of approximate to 150 phospho-ERK (pERK) molecules and approximate to 50 pAkt molecules per pRET, after which time the levels of these two signaling effectors fell by 25-50% while the pRET levels continued to slowly rise. Kinetic experiments showed that signaling effectors in different pathways respond to RET activation with different lag times, such that the balance of signal flux among the different pathways evolves over time. Our results illustrate that measurements using high, super-physiological growth factor levels can be misleading about quantitative features of receptor signaling. We propose a quantitative model describing how receptor-effector coupling efficiency links signal amplification to signal sensitization between receptor and effector, thereby providing insight into design principles underlying how receptors and their associated signaling machinery decode an extracellular signal to trigger a functional cellular outcome.	[Li, Simin; Bhave, Devayani; Chow, Jennifer M.; Riera, Thomas V.; Schlee, Sandra; Rauch, Simone; Atanasova, Mariya; Cate, Richard L.; Whitty, Adrian] Boston Univ, Dept Chem, Boston, MA 02215 USA	Boston University	Whitty, A (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.	whitty@bu.edu	Bhave, Devayani/D-1915-2017	Bhave, Devayani/0000-0002-0773-9962; Riera, Thomas/0000-0001-7427-2728; Atanasova, Mariya/0000-0002-4707-6833	National Institutes of Health [GM087469]; F31 Predoctoral Fellowship [CA177224]; NATIONAL CANCER INSTITUTE [F31CA177224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F31 Predoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087469 (to A. W.) and F31 Predoctoral Fellowship CA177224 (to J. M. C.).	Adachi T, 2002, J CELL PHYSIOL, V192, P151, DOI 10.1002/jcp.10124; Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Andres R, 2001, DEVELOPMENT, V128, P3685; Androulakis IP, 2013, ANNU REV BIOMED ENG, V15, P1, DOI 10.1146/annurev-bioeng-071812-152425; [Anonymous], MAN DAT SHEET PDF PA; Awais M, 2011, MOL BIOSYST, V7, P1376, DOI 10.1039/c0mb00328j; Bakstad D, 2012, CURR OPIN BIOTECH, V23, P103, DOI 10.1016/j.copbio.2011.11.007; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; Birtwistle MR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-109; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Carmillo P, 2005, BIOCHEMISTRY-US, V44, P2545, DOI 10.1021/bi049247p; Carter Y, 2013, NEUROENDOCRINOLOGY, V97, P57, DOI 10.1159/000335136; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Cheong R, 2008, TRENDS CELL BIOL, V18, P112, DOI 10.1016/j.tcb.2008.01.005; Chew YH, 2014, PLANT CELL, V26, P5, DOI 10.1105/tpc.113.120006; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Fujita KA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000810; Ganesan A, 2012, PROTEIN SCI, V21, P918, DOI 10.1002/pro.2089; Gardell LR, 2003, NAT MED, V9, P1383, DOI 10.1038/nm944; Gattelli A, 2013, EMBO MOL MED, V5, P1335, DOI 10.1002/emmm.201302625; Gherardini PF, 2013, NEW BIOTECHNOL, V30, P327, DOI 10.1016/j.nbt.2012.11.007; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Haugh JM, 2012, BIOESSAYS, V34, P528, DOI 10.1002/bies.201200077; Houser B, 2012, ARCH PHYSIOL BIOCHEM, V118, P192, DOI 10.3109/13813455.2012.705301; Huang PH, 2008, MOL CELL, V31, P777, DOI 10.1016/j.molcel.2008.09.001; Hughey JJ, 2010, WIRES SYST BIOL MED, V2, P194, DOI 10.1002/wsbm.52; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Ibanez CF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009134; Janes KA, 2013, J CELL SCI, V126, P1913, DOI 10.1242/jcs.112045; Kawamoto Y, 2004, J BIOL CHEM, V279, P14213, DOI 10.1074/jbc.M312600200; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kolitz SE, 2012, BIOCHEMISTRY-US, V51, P7433, DOI 10.1021/bi300846p; Lee HW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2507; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marunaka Y, 2005, J MEMBRANE BIOL, V203, P31, DOI 10.1007/s00232-004-0729-0; Masure S, 1999, EUR J BIOCHEM, V266, P892, DOI 10.1046/j.1432-1327.1999.00925.x; Meyer R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00451; Morandi A, 2013, CANCER RES, V73, P3783, DOI 10.1158/0008-5472.CAN-12-4265; Nandagopal K, 2001, J CELL BIOCHEM, V83, P326, DOI 10.1002/jcb.1222; Park CS, 2003, J BIOL CHEM, V278, P37064, DOI 10.1074/jbc.M304968200; Paveliev M, 2004, MOL CELL NEUROSCI, V25, P453, DOI 10.1016/j.mcn.2003.11.010; Perrett RM, 2013, J BIOL CHEM, V288, P21001, DOI 10.1074/jbc.M113.455345; Phay JE, 2010, CLIN CANCER RES, V16, P5936, DOI 10.1158/1078-0432.CCR-09-0786; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Plaza-Menacho I, 2010, ONCOGENE, V29, P4648, DOI 10.1038/onc.2010.209; Prazeres H, 2011, J THROID RES, V2011, DOI 10.4061/2011/678357; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Rogne M, 2013, NEW BIOTECHNOL, V30, P333, DOI 10.1016/j.nbt.2013.01.003; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Runeberg-Roos P, 2007, ANN MED, V39, P572, DOI 10.1080/07853890701646256; Runkel L, 2000, BIOCHEMISTRY-US, V39, P2538, DOI 10.1021/bi991631c; Salehian B, 2013, J CLIN RES PEDIATR E, V5, P70, DOI 10.4274/Jcrpe.870; Samaga R, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-43; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schlee S, 2006, NAT CHEM BIOL, V2, P636, DOI 10.1038/nchembio823; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Shankaran H, 2007, PLOS COMPUT BIOL, V3, P986, DOI 10.1371/journal.pcbi.0030101; Shankaran H, 2010, CURR OPIN GENET DEV, V20, P650, DOI 10.1016/j.gde.2010.08.002; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Slusarczyk AL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003092; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Warnecke A, 2010, NEUROREPORT, V21, P517, DOI 10.1097/WNR.0b013e328339045b; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yosef N, 2011, CELL, V144, P886, DOI 10.1016/j.cell.2011.02.015; ZHU BT, 1993, J PHARMACOL TOXICOL, V29, P85, DOI 10.1016/1056-8719(93)90055-J; Zi ZK, 2012, FEBS LETT, V586, P1921, DOI 10.1016/j.febslet.2012.03.063; Zi ZK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.22; Zihlmann KB, 2005, BRAIN RES BULL, V68, P42, DOI 10.1016/j.brainresbull.2004.10.012	76	2	2	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10018	10036		10.1074/jbc.M114.602268	http://dx.doi.org/10.1074/jbc.M114.602268			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25635057	Green Published, hybrid			2022-12-26	WOS:000353241100010
J	Yang, YB; Gu, LH; Xiao, Y; Liu, Q; Hu, HJ; Wang, ZT; Chen, KX				Yang, Yingbo; Gu, Lihua; Xiao, Ying; Liu, Qing; Hu, Haijun; Wang, Zhengtao; Chen, Kaixian			Rapid Identification of alpha-Glucosidase Inhibitors from Phlomis tuberosa by Sepbox Chromatography and Thin-Layer Chromatography Bioautography	PLOS ONE			English	Article							IRIDOID GLUCOSIDES; GLYCOSIDES; DERIVATIVES; FLAVONOIDS; EXTRACTS	Alpha-glucosidase inhibitors currently form an important basis for developing novel drugs for diabetes treatment. In our preliminary tests, the ethyl acetate fraction of Phlomis tuberosa extracts showed significant alpha-glucosidase inhibitory activity (IC50 = 100 mu g/mL). In the present study, a combined method using Sepbox chromatography and thin-layer chromatography (TLC) bioautography was developed to probe alpha-glucosidase inhibitors further. The ethyl acetate fraction of P. tuberosa extracts was separated into 150 individual subfractions within 20 h using Sepbox chromatography. Then, under the guidance of TLC bioautography, 20 compounds were successfully isolated from these fractions, including four new diterpenoids [14-hydroxyabieta-8,11,13-triene-11-carbaldehyde-18-oic-12-carboxy-13-(1-hydroxy-1-methylethyl)-lactone (1), 14-hydroxyabieta-8,11,13-triene-17-oic-12-carboxy-13-(1-hydroxy-1-methylethyl)-lactone (2), 14,16-dihydroxyabieta-8,11,13-triene-15,17-dioic acid (3), and phlomisol (15,16-eposy-8,13(16),14-labdatrien-19-ol) (4)], and 16 known compounds. Activity estimation indicated that 15 compounds showed more potent alpha-glucosidase inhibitory effects (with IC50 values in the range 0.067-1.203 mM) than the positive control, acarbose (IC50 = 3.72 +/- 0.113 mM). This is the first report of separation of alpha-glucosidase inhibitors from P. tuberosa.	[Yang, Yingbo; Gu, Lihua; Xiao, Ying; Liu, Qing; Hu, Haijun; Wang, Zhengtao; Chen, Kaixian] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China; [Liu, Qing; Wang, Zhengtao] Shanghai R&D Ctr Standardizat Chinese Med, Shanghai, Peoples R China; [Xiao, Ying] Second Mil Med Univ, Changzheng Hosp, Dept Pharm, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Naval Medical University	Wang, ZT (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China.	ztwang@shutcm.edu.cn	Wang, Zhengtao/AAH-7360-2019	Wang, Zhengtao/0000-0003-2797-4625	Program for Changjiang Scholars and Innovative Research Team in University [IRT1071]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	The authors gratefully acknowledge the Program for Changjiang Scholars and Innovative Research Team in University (IRT1071) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari M, 2011, J YOUNG PHARM, V3, P226, DOI 10.4103/0975-1483.83771; Calis I, 2005, Z NATURFORSCH B, V60, P1295, DOI 10.1515/znb-2005-1214; CALIS I, 1992, PHYTOCHEMISTRY, V31, P3624, DOI 10.1016/0031-9422(92)83740-P; Cheng ZH, 2013, COMB CHEM HIGH T SCR, V16, P531, DOI 10.2174/1386207311316070004; Gao JT, 2011, J NAT PROD, V74, P1636, DOI 10.1021/np200147c; Hanamura T, 2008, J FOOD SCI, V73, pT55, DOI 10.1111/j.1750-3841.2008.00708.x; Hanefeld M, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-20; Kanchanapoom T, 2002, PHYTOCHEMISTRY, V59, P557, DOI 10.1016/S0031-9422(01)00466-6; KATAGIRI M, 1994, PHYTOCHEMISTRY, V35, P439, DOI 10.1016/S0031-9422(00)94777-0; Kim JS, 2011, FOOD CHEM, V124, P1647, DOI 10.1016/j.foodchem.2010.08.020; Kwon HC, 2011, BIOMOL THER, V19, P90, DOI 10.4062/biomolther.2011.19.1.090; Li DL, 2008, CHEM PHARM BULL, V56, P1282, DOI 10.1248/cpb.56.1282; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li YL, 2008, MOLECULES, V13, P1931, DOI 10.3390/molecules13081931; Liu YL, 2013, J ETHNOPHARMACOL, V149, P431, DOI 10.1016/j.jep.2013.06.042; Mahmoud IN, 2009, PHARMACOGN RES, V1, P342; Misbah H, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-118; Modaressi M, 2009, PHYTOTHER RES, V23, P99, DOI 10.1002/ptr.2568; NISHIZAWA M, 1987, J ORG CHEM, V52, P4878, DOI 10.1021/jo00231a011; Simoes-Pires CA, 2009, PHYTOCHEM ANALYSIS, V20, P511, DOI 10.1002/pca.1154; Standl E, 2012, DIABETES VASC DIS RE, V9, P163, DOI 10.1177/1479164112441524; Takeda Y, 2000, PHYTOCHEMISTRY, V53, P931, DOI 10.1016/S0031-9422(99)00431-8; Xu MF, 2009, FITOTERAPIA, V80, P461, DOI 10.1016/j.fitote.2009.06.006; ZHANG CZ, 1991, PHYTOCHEMISTRY, V30, P4156, DOI 10.1016/0031-9422(91)83486-5; Zhang TT, 2007, BIOCHEM SYST ECOL, V35, P801, DOI 10.1016/j.bse.2007.03.023	25	26	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116922	10.1371/journal.pone.0116922	http://dx.doi.org/10.1371/journal.pone.0116922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658100	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900079
J	Zhang, YY; Jiang, WJ; Teng, ZE; Wu, JF; Hu, YY; Lu, TL; Wu, H; Sun, W; Wang, XR; Bi, HS; Jonas, JB				Zhang, Yue Ying; Jiang, Wen Jun; Teng, Zhao E.; Wu, Jian Feng; Hu, Yuan Yuan; Lu, Tai Liang; Wu, Hui; Sun, Wei; Wang, Xing Rong; Bi, Hong Sheng; Jonas, Jost B.			Corneal Curvature Radius and Associated Factors in Chinese Children: The Shandong Children Eye Study	PLOS ONE			English	Article							OCULAR BIOMETRIC PARAMETERS; POPULATION-BASED SAMPLE; AUSTRALIAN CHILDREN; INTRAOCULAR-PRESSURE; PRESCHOOL-CHILDREN; ETHNIC-DIFFERENCES; ADULT-POPULATION; REYKJAVIK EYE; REFRACTION; STATURE	Purpose To investigate the distribution of the (CCR) and its associated factors in children. Methods Using a random cluster sampling method, the school-based, cross-sectional Shandong Children Eye Study included children aged 4 to 18 years from the rural county of Guanxian and the city of Weihai in the province of Shandong in East China. CCR was measured by ocular biometry. Results CCR measurements were available for 5913 (92.9%) out of 6364 eligible children. Mean age was 10.0 +/- 3.3 years, and mean CCR was 7.84 +/- 0.27 mm (range: 6.98 to 9.35 mm). In multivariate linear regression analysis, longer CCR (i. e. flatter cornea) was significantly associated with the systemic parameters of male sex (P<0001; standardized regression coefficient beta: -0.08; regression coefficient B:-0.04; 95% Confidence Interval (CI):-0.05,-0.03), younger age (P<0.001; beta:-0.37; B:-0.03; 95% CI:-0.04,-0.03), taller body height (P = 0.002; beta: 0.06; B: 0.001; 95% CI:0.000,0.001), lower level of education of the father (P = 0.001; beta:-0.04; B:-0.01; 95% CI:-0.02,-0.01) and maternal myopia (P< 0.001; beta:0.07; B:-0.04; 95% CI:-0.06,-0.03), and with the ocular parameters of longer ocular axial length (P< 0.001; beta: 0.59; B:0.13; 95% CI:0.12,0.14), larger horizontal corneal diameter (P< 0.001; beta:0.19; B:0.13; 95% CI:0.11,0.14), and smaller amount of cylindrical refractive error (P = 0.001; beta:-0.09; B:-0.05; 95% CI:-0.06,-0.04). Conclusions Longer CCR (i.e., flatter corneas) (mean: 7.84 +/- 0.27mm) was correlated with male sex, younger age, taller body height, lower paternal educational level, maternal myopia, longer axial length, larger corneas (i.e., longer horizontal corneal diameter), and smaller amount of cylindrical refractive error. These findings may be of interest for elucidation of the process of emmetropization and myopization and for corneal refractive surgery.	[Zhang, Yue Ying] Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan, Shandong, Peoples R China; [Zhang, Yue Ying] Shandong Acad Med Sci, Inst Basic Med, Jinan, Shandong, Peoples R China; [Jiang, Wen Jun; Wu, Hui; Wang, Xing Rong; Bi, Hong Sheng] Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China; [Teng, Zhao E.] Wulian Peoples Hosp, Dept Ophthalmol, Rizhao, Shandong, Peoples R China; [Wu, Jian Feng] Shandong Univ Tradit Chinese Med, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Hu, Yuan Yuan; Lu, Tai Liang; Sun, Wei; Wang, Xing Rong; Bi, Hong Sheng] Shandong Univ Tradit Chinese Med, Affiliated Hosp Shandong 2, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-69115 Heidelberg, Germany	Shandong University of Traditional Chinese Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Ruprecht Karls University Heidelberg	Bi, HS (corresponding author), Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China.	hongshengbi@126.com						ABRAHAMSSON M, 1990, ACTA OPHTHALMOL, V68, P435; Chang SW, 2001, BRIT J OPHTHALMOL, V85, P916, DOI 10.1136/bjo.85.8.916; Eysteinsson T, 2005, ACTA OPHTHALMOL SCAN, V83, P734, DOI 10.1111/j.1600-0420.2005.00540.x; Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x; Fan DSP, 2004, BRIT J OPHTHALMOL, V88, P938, DOI 10.1136/bjo.2003.030338; Fotedar R, 2010, OPHTHALMOLOGY, V117, P417, DOI 10.1016/j.ophtha.2009.07.028; GARNER LF, 1995, OPTOMETRY VISION SCI, V72, P266, DOI 10.1097/00006324-199504000-00007; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; Blanco FG, 2008, OPTOMETRY VISION SCI, V85, P89, DOI 10.1097/OPX.0b013e3181622602; Goto T, 2001, CORNEA, V20, P270, DOI 10.1097/00003226-200104000-00007; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; Ip JM, 2008, EYE, V22, P649, DOI 10.1038/sj.eye.6702701; Jiang WJ, 2014, INVEST OPHTH VIS SCI, V55, P4128, DOI 10.1167/iovs.14-14244; Jonas J B, 1994, Ger J Ophthalmol, V3, P179; Jonas JB, 2011, OPHTHALMOLOGY, V118, P1805, DOI 10.1016/j.ophtha.2011.02.001; Lee KE, 2009, ARCH OPHTHALMOL-CHIC, V127, P88, DOI 10.1001/archophthalmol.2008.521; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P103, DOI 10.1167/iovs.09-3553; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Logan NS, 2011, OPHTHAL PHYSL OPT, V31, P550, DOI 10.1111/j.1475-1313.2011.00862.x; McKean-Cowdin R, 2013, OPHTHALMOLOGY, V120, P2117, DOI 10.1016/j.ophtha.2013.03.001; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Mutti DO, 2005, INVEST OPHTH VIS SCI, V46, P3074, DOI 10.1167/iovs.04-1040; Nangia V, 2010, OPHTHALMOLOGY, V117, P705, DOI 10.1016/j.ophtha.2009.09.003; Nieto-Bona A, 2009, GRAEF ARCH CLIN EXP, V247, P815, DOI 10.1007/s00417-008-1013-2; Northstone K, 2013, OPHTHALMOLOGY, V120, P1064, DOI 10.1016/j.ophtha.2012.11.004; O'Donoghue L, 2011, INVEST OPHTH VIS SCI, V52, P4048, DOI 10.1167/iovs.10-6100; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P4424, DOI 10.1167/iovs.05-0077; Ojaimi E, 2005, INVEST OPHTH VIS SCI, V46, P2748, DOI 10.1167/iovs.04-1324; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; PANDAJONAS S, 1994, OPHTHALMOLOGY, V101, P519; PAPASTATHOPOULOS KI, 1995, EXP EYE RES, V60, P459, DOI 10.1016/S0014-4835(05)80102-2; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P1408; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Scholz K, 2009, J CATARACT REFR SURG, V35, P1046, DOI 10.1016/j.jcrs.2009.01.019; Shufelt C, 2005, INVEST OPHTH VIS SCI, V46, P4450, DOI 10.1167/iovs.05-0435; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P73; Wu HM, 2007, CLIN EXP OPHTHALMOL, V35, P834, DOI 10.1111/j.1442-9071.2007.01638.x; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Yuen LH, 2010, INVEST OPHTH VIS SCI, V51, P3433, DOI 10.1167/iovs.09-4307	40	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117481	10.1371/journal.pone.0117481	http://dx.doi.org/10.1371/journal.pone.0117481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658095	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900160
J	Kanaani, J; Cianciaruso, C; Phelps, EA; Pasquier, M; Brioudes, E; Billestrup, N; Baekkeskov, S				Kanaani, Jamil; Cianciaruso, Chiara; Phelps, Edward A.; Pasquier, Miriella; Brioudes, Estelle; Billestrup, Nils; Baekkeskov, Steinunn			Compartmentalization of GABA Synthesis by GAD67 Differs between Pancreatic Beta Cells and Neurons	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; 65-KDA ISOFORM; DIFFERENTIAL EXPRESSION; MONOCLONAL-ANTIBODIES; GLUCOSE-INHIBITION; GLUCAGON-SECRETION; INSULIN-SECRETION; MICE DEFICIENT; ENZYME GAD65	The inhibitory neurotransmitter GABA is synthesized by the enzyme glutamic acid decarboxylase (GAD) in neurons and in pancreatic beta-cells in islets of Langerhans where it functions as a paracrine and autocrine signaling molecule regulating the function of islet endocrine cells. The localization of the two non-allelic isoforms GAD65 and GAD67 to vesicular membranes is important for rapid delivery and accumulation of GABA for regulated secretion. While the membrane anchoring and trafficking of GAD65 are mediated by intrinsic hydrophobic modifications, GAD67 remains hydrophilic, and yet is targeted to vesicular membrane pathways and synaptic clusters in neurons by both a GAD65-dependent and a distinct GAD65-independent mechanism. Herein we have investigated the membrane association and targeting of GAD67 and GAD65 in monolayer cultures of primary rat, human, and mouse islets and in insulinoma cells. GAD65 is primarily detected in Golgi membranes and in peripheral vesicles distinct from insulin vesicles in beta-cells. In the absence of GAD65, GAD67 is in contrast primarily cytosolic in beta-cells; its co-expression with GAD65 is necessary for targeting to Golgi membranes and vesicular compartments. Thus, the GAD65-independent mechanism for targeting of GAD67 to synaptic vesicles in neurons is not functional in islet beta-cells. Therefore, only GAD65:GAD65 homodimers and GAD67:GAD65 heterodimers, but not the GAD67:GAD67 homodimer gain access to vesicular compartments in beta-cells to facilitate rapid accumulation of newly synthesized GABA for regulated secretion and fine tuning of GABA-signaling in islets of Langerhans.	[Kanaani, Jamil; Baekkeskov, Steinunn] Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA; [Kanaani, Jamil; Baekkeskov, Steinunn] Univ Calif San Francisco, Ctr Diabet, Dept Microbiol Immunol, San Francisco, CA 94143 USA; [Cianciaruso, Chiara; Phelps, Edward A.; Pasquier, Miriella; Baekkeskov, Steinunn] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [Brioudes, Estelle] Univ Hosp Geneva, Dept Surg, Cell Isolat & Transplantat Ctr, Geneva, Switzerland; [Brioudes, Estelle] Univ Geneva, Geneva, Switzerland; [Billestrup, Nils] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; University of Copenhagen	Baekkeskov, S (corresponding author), Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA.	steinunn.baekkeskov@epfl.ch	Phelps, Edward A/Q-1302-2016	Phelps, Edward A/0000-0001-8666-805X; Billestrup, Nils/0000-0002-4968-8067; Baekkeskov, Steinunn/0000-0003-0878-3188; Cianciaruso, Chiara/0000-0002-5635-5404	Nora Eccles Treadwell Foundation; International Network Program from the Danish Ministry of Science, Innovation and Higher Education [INP-2010-0102]; National Institute of Health Diabetes Education and Research Center grant [P30 DK063720]; Microscopy Core and Islet Isolation Core [31-2012-783]; JFRF Advanced Postdoctoral Fellowship [3-APF-2014-208-A-N]; JDRF award	Nora Eccles Treadwell Foundation; International Network Program from the Danish Ministry of Science, Innovation and Higher Education; National Institute of Health Diabetes Education and Research Center grant; Microscopy Core and Islet Isolation Core; JFRF Advanced Postdoctoral Fellowship; JDRF award	This study was supported by the Nora Eccles Treadwell Foundation (S. B., J. K.), by an International Network Program from the Danish Ministry of Science, Innovation and Higher Education (INP-2010-0102) (N. B., S. B.), by a National Institute of Health Diabetes Education and Research Center grant (P30 DK063720) Microscopy Core and Islet Isolation Core, a JDRF award (31-2012-783) (E. B.) to the ECIT Islets for Basic Research Program, and by a JFRF Advanced Postdoctoral Fellowship (3-APF-2014-208-A-N) (E. A. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Baekkeskov S, 2009, MOL MEMBR BIOL, V26, P42, DOI 10.1080/09687680802680108; Bailey SJ, 2007, DIABETES, V56, P320, DOI 10.2337/db06-0712; Bonaventura MM, 2012, EUR J PHARMACOL, V677, P188, DOI 10.1016/j.ejphar.2011.12.013; Braun M, 2004, J GEN PHYSIOL, V123, P191, DOI 10.1085/jgp.200308966; Braun M, 2012, DIABETES OBES METAB, V14, P143, DOI 10.1111/j.1463-1326.2012.01642.x; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brice NL, 2002, DIABETOLOGIA, V45, P242, DOI 10.1007/s00125-001-0750-0; Bridgett M, 1998, DIABETES, V47, P1848, DOI 10.2337/diabetes.47.12.1848; Brunstedt J, 1984, METHODS DIABETES R C, P245; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; CHANG YC, 1988, J NEUROSCI, V8, P2123; Chessler SD, 2002, DIABETES, V51, P1763, DOI 10.2337/diabetes.51.6.1763; CHRISTGAU S, 1991, J BIOL CHEM, V266, P21257; CHRISTGAU S, 1992, J CELL BIOL, V118, P309, DOI 10.1083/jcb.118.2.309; Codazzi F, 2006, J NEUROSCI, V26, P3404, DOI 10.1523/JNEUROSCI.0478-06.2006; DIRKX R, 1995, J BIOL CHEM, V270, P2241, DOI 10.1074/jbc.270.5.2241; Durst MA, 2012, CAN J DIABETES, V36, P100, DOI 10.1016/j.jcjd.2012.06.002; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Gammelsaeter R, 2004, J CELL SCI, V117, P3749, DOI 10.1242/jcs.01209; GILON P, 1991, ENDOCRINOLOGY, V129, P2521, DOI 10.1210/endo-129-5-2521; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067228; Kanaani J, 1999, J BIOL CHEM, V274, P37200, DOI 10.1074/jbc.274.52.37200; Kanaani J, 2004, J CELL SCI, V117, P2001, DOI 10.1242/jcs.01030; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Kanaani J, 2008, J CELL SCI, V121, P437, DOI 10.1242/jcs.011916; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Kass I, 2014, P NATL ACAD SCI USA, V111, pE2524, DOI 10.1073/pnas.1403182111; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Maekawa S, 2013, NEUROSCI LETT, V537, P50, DOI 10.1016/j.neulet.2013.01.030; Minami K, 2000, AM J PHYSIOL-ENDOC M, V279, pE773, DOI 10.1152/ajpendo.2000.279.4.E773; Obata K, 1999, NEUROSCIENCE, V93, P1475, DOI 10.1016/S0306-4522(99)00274-2; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Owens DF, 2002, NEURON, V36, P989, DOI 10.1016/S0896-6273(02)01136-4; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; PETERSEN JS, 1993, DIABETES, V42, P484, DOI 10.2337/diabetes.42.3.484; RICHTER W, 1993, P NATL ACAD SCI USA, V90, P2832, DOI 10.1073/pnas.90.7.2832; ROBBINS MS, 1981, DIABETES, V30, P168, DOI 10.2337/diabetes.30.2.168; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Sheikh SN, 1998, J NEUROSCI RES, V52, P736, DOI 10.1002/(SICI)1097-4547(19980615)52:6<736::AID-JNR12>3.0.CO;2-X; Shi YG, 2000, AM J PHYSIOL-ENDOC M, V279, pE684, DOI 10.1152/ajpendo.2000.279.3.E684; SHI YG, 1994, J CELL BIOL, V124, P927, DOI 10.1083/jcb.124.6.927; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; SORENSON RL, 1991, DIABETES, V40, P1365, DOI 10.2337/diabetes.40.11.1365; Szot GL, 2007, JOVE-J VIS EXP, V7, P255, DOI DOI 10.3791/255; Taneera J, 2012, DIABETOLOGIA, V55, P1985, DOI 10.1007/s00125-012-2548-7; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; VELLOSO LA, 1994, CLIN EXP IMMUNOL, V96, P129; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	59	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117130	10.1371/journal.pone.0117130	http://dx.doi.org/10.1371/journal.pone.0117130			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647668	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600056
J	Lee, S; Yang, G; Bushman, W				Lee, Sanghee; Yang, Guang; Bushman, Wade			Prostatic Inflammation Induces Urinary Frequency in Adult Mice	PLOS ONE			English	Article							COLONIC INFLAMMATION; SENSORY INNERVATION; OVERACTIVE BLADDER; CROSS-TALK; NITROFURANTOIN; IRRITATION; NEURONS; SENSITIZATION; CONVERGENCE; HYPERPLASIA	Lower urinary tract symptoms (LUTS) including urinary frequency and nocturia are common in aging men. Recent studies have revealed a strong association of prostatic inflammation with LUTS. We developed an animal model of bacterial induced, isolated prostatic inflammation and examined the effect of prostatic inflammation on voiding behavior in adult C57BL/6J mice. Prostatic inflammation was induced by transurethral inoculation of uropathogenic E. coli-1677. Bacterial cystitis was prevented by continuous administration of nitrofurantoin. Hematoxylin and eosin (H& E) staining and bacterial culture were preformed to validate our animal model. Voiding behavior was examined by metabolic cage testing on post-instillation day 1 (PID 1), PID 4, PID 7 and PID 14 and both voiding frequency and volume per void were determined. Mice with prostatic inflammation showed significantly increased voiding frequency at PID 1, 7 and 14, and decreased volume per void at all time points, as compared to mice instilled with saline and receiving nitrofurantoin (NTF). Linked analysis of voiding frequency and voided volumes revealed an overwhelming preponderance of high frequency, low volume voiding in mice with prostatic inflammation. These observations suggest that prostatic inflammation may be causal for symptoms of urinary frequency and nocturia.	[Lee, Sanghee; Yang, Guang; Bushman, Wade] Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA; [Bushman, Wade] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA; [Lee, Sanghee] Univ Wisconsin, Sch Med & Publ Hlth, Cellular & Mol Biol Program, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bushman, W (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA.	bushman@urology.wisc.edu		Lee, Sanghee/0000-0002-6574-8656	National Institutes of Health (NIH) [R01DK075700]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075700] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health (NIH), R01DK075700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Andreu A, 1997, J INFECT DIS, V176, P464, DOI 10.1086/514065; Bautista OM, 2003, CONTROL CLIN TRIALS, V24, P224, DOI 10.1016/S0197-2456(02)00263-5; Bielefeldt K, 2006, AM J PHYSIOL-GASTR L, V291, pG658, DOI 10.1152/ajpgi.00585.2005; Birder LA, 2013, INT J UROL, V20, P4, DOI 10.1111/j.1442-2042.2012.03210.x; Bjorling DE, 2011, NEUROUROL URODYNAM, V30, P673, DOI 10.1002/nau.21078; Boehm BJ, 2012, PROSTATE, V72, P307, DOI 10.1002/pros.21433; Burris MB, 2014, UROLOGY, V83, P186, DOI 10.1016/j.urology.2013.07.080; BUZARD JA, 1961, J PHARMACOL EXP THER, V131, P38; CERVERO F, 1994, PHYSIOL REV, V74, P95, DOI 10.1152/physrev.1994.74.1.95; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Christianson JA, 2007, PAIN, V128, P235, DOI 10.1016/j.pain.2006.09.023; CUNHA BA, 1988, UROLOGY, V32, P67, DOI 10.1016/0090-4295(88)90460-8; de Groat William C, 2009, Handb Exp Pharmacol, P91, DOI 10.1007/978-3-540-79090-7_4; De Wachter SG, 2011, NEUROUROL URODYNAM, V30, P1220, DOI 10.1002/nau.21038; Delongchamps NB, 2008, J UROLOGY, V179, P1736, DOI 10.1016/j.juro.2008.01.034; Dmochowski Roger, 2006, Curr Urol Rep, V7, P462, DOI 10.1007/s11934-006-0055-4; Elkahwaji JE, 2007, PROSTATE, V67, P14, DOI 10.1002/pros.20445; Guerios SD, 2006, NEUROSCI LETT, V392, P193, DOI 10.1016/j.neulet.2005.09.026; Guerios SD, 2008, AM J PHYSIOL-REG I, V295, pR111, DOI 10.1152/ajpregu.00728.2007; Hochreiter WW, 2000, J UROLOGY, V163, P127, DOI 10.1016/S0022-5347(05)67987-6; Jerde TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000338; Kanasaki K, 2013, FASEB J, V27, P1950, DOI 10.1096/fj.12-223404; KEAST JR, 1992, J COMP NEUROL, V319, P615, DOI 10.1002/cne.903190411; KIRBY RS, 1982, BRIT J UROL, V54, P729, DOI 10.1111/j.1464-410X.1982.tb13635.x; Knutson T, 2001, NEUROUROL URODYNAM, V20, P237, DOI 10.1002/nau.1001; Krieger JN, 2002, INT J ANTIMICROB AG, V19, P475, DOI 10.1016/S0924-8579(02)00086-9; Levine M, 1943, J BACTERIOL, V45, P471, DOI 10.1128/JB.45.5.471-475.1943; Malykhina AP, 2006, NEUROGASTROENT MOTIL, V18, P936, DOI 10.1111/j.1365-2982.2006.00807.x; Malykhina AP, 2004, NEUROREPORT, V15, P2601, DOI 10.1097/00001756-200412030-00008; Mirone V, 2007, EUR UROL, V51, P57, DOI 10.1016/j.eururo.2006.07.050; Nazif O, 2007, UROLOGY, V69, P24, DOI 10.1016/j.urology.2006.08.1108; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Nomiya M, 2012, NEUROUROL URODYNAM, V31, P195, DOI 10.1002/nau.21073; Pan XQ, 2010, EXP NEUROL, V225, P262, DOI 10.1016/j.expneurol.2010.05.012; PANG X, 1995, BRIT J UROL, V75, P744, DOI 10.1111/j.1464-410X.1995.tb07384.x; Pezzone MA, 2005, GASTROENTEROLOGY, V128, P1953, DOI 10.1053/j.gastro.2005.03.008; Qin C, 2005, GASTROENTEROLOGY, V129, P1967, DOI 10.1053/j.gastro.2005.09.013; Rudick CN, 2007, AM J PHYSIOL-REG I, V293, pR1191, DOI 10.1152/ajpregu.00411.2007; Sauver JLS, 2008, UROLOGY, V71, P475, DOI 10.1016/j.urology.2007.11.155; Schnegelsberg B, 2010, AM J PHYSIOL-REG I, V298, pR534, DOI 10.1152/ajpregu.00367.2009; Smith AL, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.06.041; Sugino Y, 2008, NEUROUROL URODYNAM, V27, P548, DOI 10.1002/nau.20552; Ustinova EE, 2006, AM J PHYSIOL-RENAL, V290, pF1478, DOI 10.1152/ajprenal.00395.2005; Ustinova EE, 2007, AM J PHYSIOL-RENAL, V292, pF123, DOI 10.1152/ajprenal.00162.2006; WEISS J, 1983, J UROLOGY, V130, P479, DOI 10.1016/S0022-5347(17)51258-6; Wong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100770	47	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116827	10.1371/journal.pone.0116827	http://dx.doi.org/10.1371/journal.pone.0116827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647072	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600039
J	Scumaci, D; Trimboli, F; Dell'Aquila, L; Concolino, A; Pappaianni, G; Tamme, L; Vignola, G; Luciani, A; Morelli, D; Cuda, G; Boari, A; Britti, D				Scumaci, Domenica; Trimboli, Francesca; Dell'Aquila, Ludovica; Concolino, Antonio; Pappaianni, Giusi; Tamme, Laura; Vignola, Giorgio; Luciani, Alessia; Morelli, Daniela; Cuda, Giovanni; Boari, Andrea; Britti, Domenico			Proteomics-Driven Analysis of Ovine Whey Colostrum	PLOS ONE			English	Article							PASSIVE TRANSFER STATUS; HEAT-SHOCK PROTEINS; MILK-FAT GLOBULE; MASS-SPECTROMETRY; NEONATAL LAMB; BOVINE WHEY; IDENTIFICATION; SHEEP; IMMUNOGLOBULINS; SECRETION	The aim of this study was to shed light in to the complexity of the ovine colostrum proteome, with a specific focus on the low abundance proteins. The ovine colostrum is characterized by a few dominating proteins, as the immunoglobulins, but it also contains less represented protein species, equally important for the correct development of neonates. Ovine colostrum, collected immediately after lambing, was separated by 1D SDS-PAGE. Proteins bands were digested with trypsin and the resulting peptides were analyzed by LC-MS/MS. On the basis of the Swiss-Prot database, a total of 343 unique proteins were identified. To our knowledge, this study represents the most comprehensive analysis of ovine colostrum proteome.	[Scumaci, Domenica; Concolino, Antonio; Pappaianni, Giusi; Tamme, Laura; Cuda, Giovanni] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Trimboli, Francesca; Britti, Domenico] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Dell'Aquila, Ludovica; Vignola, Giorgio; Luciani, Alessia; Boari, Andrea] Univ Teramo, Fac Vet Med, Teramo, Italy; [Morelli, Daniela] Ist Zooprofilatt Sperimentale Abruzzo & Molise IZ, Teramo, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; University of Teramo; IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Cuda, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	cuda@unicz.it	Scumaci, Domenica/AAH-1493-2019; Cuda, Giovanni/F-5359-2012; Trimboli, Francesca/Y-1143-2019; Cuda, Giovanni/AAC-2821-2019; Britti, Domenico/O-3275-2015	Cuda, Giovanni/0000-0001-6313-1866; Trimboli, Francesca/0000-0002-1766-9179; Cuda, Giovanni/0000-0001-6313-1866; Scumaci, Domenica/0000-0002-8117-834X; LUCIANI, ALESSIA/0000-0002-0536-0916; Britti, Domenico/0000-0001-7355-8791	progetto special "ricerca di eccellenza anno 2011" Fondazione cassa di risparmio della provincial di Teramo	progetto special "ricerca di eccellenza anno 2011" Fondazione cassa di risparmio della provincial di Teramo	This work was supported by progetto special "ricerca di eccellenza anno 2011" Fondazione cassa di risparmio della provincial di Teramo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2011, INFECT IMMUN, V79, P3833, DOI 10.1128/IAI.00040-11; Andrews MH, 2000, BRAIN RES, V878, P174, DOI 10.1016/S0006-8993(00)02735-9; Bauman DE, 2006, J DAIRY SCI, V89, P1235, DOI 10.3168/jds.S0022-0302(06)72192-0; Britti D, 2005, JAVMA-J AM VET MED A, V226, P951, DOI 10.2460/javma.2005.226.951; CAMPBELL SG, 1977, NEW ZEAL VET J, V25, P361, DOI 10.1080/00480169.1977.34458; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen JX, 2013, MOL ENDOCRINOL, V27, P1065, DOI 10.1210/me.2012-1277; Chiaradia E, 2013, J PROTEOMICS, V83, P144, DOI 10.1016/j.jprot.2013.03.017; Delana R, 2007, MATRIX BIOL, V26, P508; Galvani M, 2001, RAPID COMMUN MASS SP, V15, P258, DOI 10.1002/rcm.220; Gu HM, 2013, BBA-MOL CELL BIOL L, V1831, P1067, DOI 10.1016/j.bbalip.2013.01.019; HALLIDAY R, 1974, ANIM PROD, V19, P301, DOI 10.1017/S000335610002287X; HALLIDAY R, 1978, VET REC, V103, P489, DOI 10.1136/vr.103.22.489; Hernandez-Castellano LE, 2014, CURR PROTEIN PEPT SC, V15, P64, DOI 10.2174/1389203715666140221124622; Hogarth CJ, 2004, PROTEOMICS, V4, P2094, DOI 10.1002/pmic.200300723; HUNTER AG, 1977, J ANIM SCI, V45, P1146, DOI 10.2527/jas1977.4551146x; Kelly D, 2000, LIVEST PROD SCI, V66, P161, DOI 10.1016/S0301-6226(00)00223-2; Korhonen H, 2007, CURR PHARM DESIGN, V13, P829, DOI 10.2174/138161207780363112; Korhonen H, 2000, BRIT J NUTR, V84, pS75; Kramer BW, 2002, AM J PHYSIOL-LUNG C, V283, pL452, DOI 10.1152/ajplung.00407.2001; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahov E, 1996, FOOD CHEM TOXICOL, V34, P131, DOI 10.1016/0278-6915(95)00097-6; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; LEVIEUX D, 1982, PHYSL PATHOLOGIE PER, P345, DOI DOI 10.1016/J.EJVS.2014.10.022; Liao YL, 2011, J PROTEOME RES, V10, P1746, DOI 10.1021/pr101028k; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Massimini G, 2007, JAVMA-J AM VET MED A, V231, P1873, DOI 10.2460/javma.231.12.1873; McManaman L, 2002, J PHYSL, V545, P567; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Morelli M, 2014, INT J GYNECOL CANCER, V103, P550; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; Napolitano F, 2014, SMALL RUMINANT RES, V116, P21, DOI 10.1016/j.smallrumres.2013.10.007; Natale M, 2004, MOL NUTR FOOD RES, V48, P363, DOI 10.1002/mnfr.200400011; Nissen A, 2012, PROTEOMICS, V12, P2866, DOI 10.1002/pmic.201200231; Ogawa S, 2014, ANIM SCI J, V85, P440, DOI 10.1111/asj.12165; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Oshima K, 2002, EUR J BIOCHEM, V269, P1209, DOI 10.1046/j.1432-1033.2002.02758.x; Palmer DJ, 2006, PROTEOMICS, V6, P2208, DOI 10.1002/pmic.200500558; Parodi PW, 2007, CURR PHARM DESIGN, V13, P813, DOI 10.2174/138161207780363059; PATUREAU MIRAND P, 1990, BIOL NEONATE, V57, P30, DOI 10.1159/000243156; Pecka E, 2012, ANIM SCI J, V83, P162, DOI 10.1111/j.1740-0929.2011.00930.x; Petrof Elaine O, 2004, Chin J Dig Dis, V5, P45, DOI 10.1111/j.1443-9573.2004.00154.x; Picariello G, 2008, PROTEOMICS, V8, P3833, DOI 10.1002/pmic.200701057; Pujia A, 2010, INT J NANOMED, V5, P1005, DOI 10.2147/IJN.S12865; Robenek H, 2006, P NATL ACAD SCI USA, V103, P10385, DOI 10.1073/pnas.0600795103; SAWYER M, 1977, J AM VET MED ASSOC, V171, P1255; Scharte M, 2001, J NUTR, V131, P1433, DOI 10.1093/jn/131.5.1433; Senda A, 2011, ANIM SCI J, V82, P698, DOI 10.1111/j.1740-0929.2011.00886.x; Sozmen M, 2012, J COMP PATHOL, V147, P441, DOI 10.1016/j.jcpa.2012.04.004; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Welch WJ, 1990, STRESS PROTEINS BIOL, P223; Wu CC, 2000, TRAFFIC, V1, P769, DOI 10.1034/j.1600-0854.2000.011004.x; Wu WX, 1996, ENDOCRINOLOGY, V137, P5685, DOI 10.1210/en.137.12.5685; Yamada M, 2002, ELECTROPHORESIS, V23, P1153, DOI 10.1002/1522-2683(200204)23:7/8&lt;1153::AID-ELPS1153&gt;3.0.CO;2-Y; Yekta MA, 2011, VET MICROBIOL, V150, P373, DOI 10.1016/j.vetmic.2011.02.052	56	17	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117433	10.1371/journal.pone.0117433	http://dx.doi.org/10.1371/journal.pone.0117433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643159	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821200037
J	Bhan, U; Podsiad, AB; Kovach, MA; Ballinger, MN; Keshamouni, V; Standiford, TJ				Bhan, Urvashi; Podsiad, Amy B.; Kovach, Melissa A.; Ballinger, Megan N.; Keshamouni, Venkateshwar; Standiford, Theodore J.			Linezolid Has Unique Immunomodulatory Effects in Post-Influenza Community Acquired MRSA Pneumonia	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; TUMOR-NECROSIS-FACTOR; 2 DOUBLE-BLIND; BACTERIAL PNEUMONIA; CYTOKINE PRODUCTION; BINDING PROTEINS; EPITHELIAL-CELLS; VIRUS; INFECTION	Introduction Post influenza pneumonia is a leading cause of mortality and morbidity, with mortality rates approaching 60% when bacterial infections are secondary to multi-drug resistant (MDR) pathogens. Staphylococcus aureus, in particular community acquired MRSA (cMRSA), has emerged as a leading cause of post influenza pneumonia. Hypothesis Linezolid (LZD) prevents acute lung injury in murine model of post influenza bacterial pneumonia Methods Mice were infected with HINI strain of influenza and then challenged with cMRSA at day 7, treated with antibiotics (LZD or Vanco) or vehicle 6 hours post bacterial challenge and lungs and bronchoalveolar lavage fluid (BAL) harvested at 24 hours for bacterial clearance, inflammatory cell influx, cytokine/chemokine analysis and assessment of lung injury. Results Mice treated with LZD or Vanco had lower bacterial burden in the lung and no systemic dissemination, as compared to the control (no antibiotic) group at 24 hours post bacterial challenge. As compared to animals receiving Vanco, LZD group had significantly lower numbers of neutrophils in the BAL (9x10(3) vs. 2.3x10(4), p < 0.01), which was associated with reduced levels of chemotactic chemokines and inflammatory cytokines KC, MIP-2, IFN-gamma, TNF-alpha and IL-1 beta in the BAL. Interestingly, LZD treatment also protected mice from lung injury, as assessed by albumin concentration in the BAL post treatment with H1N1 and cMRSA when compared to vanco treatment. Moreover, treatment with LZD was associated with significantly lower levels of PVL toxin in lungs. Conclusion Linezolid has unique immunomodulatory effects on host inflammatory response and lung injury in a murine model of post-viral cMRSA pneumonia.	[Bhan, Urvashi; Podsiad, Amy B.; Kovach, Melissa A.; Keshamouni, Venkateshwar; Standiford, Theodore J.] Univ Michigan, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Ballinger, Megan N.] Ohio State Univ, Dept Med, Div Pulm & Crit Care Med, Columbus, OH 43210 USA	University of Michigan System; University of Michigan; University System of Ohio; Ohio State University	Bhan, U (corresponding author), Univ Michigan, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	ubhan@umich.edu		Keshamouni, Venkateshwar/0000-0003-1947-791X; Ballinger, Megan/0000-0002-2202-3049	Pfizer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123515, R01HL097564, R01HL119682, K08HL121089] Funding Source: NIH RePORTER	Pfizer(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study was funded by a grant through Pfizer but this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; ABRAMSON JS, 1982, J CLIN INVEST, V69, P1393, DOI 10.1172/JCI110580; ABRAMSON JS, 1982, INFECT IMMUN, V36, P289, DOI 10.1128/IAI.36.1.289-296.1982; Araujo FG, 2002, ANTIMICROB AGENTS CH, V46, P3327, DOI 10.1128/AAC.46.10.3327-3330.2002; Bhan U, 2008, INFECT IMMUN, V76, P2895, DOI 10.1128/IAI.01489-07; Bhan U, 2007, J IMMUNOL, V179, P3937, DOI 10.4049/jimmunol.179.6.3937; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Breslow-Deckman JM, 2013, J IMMUNOL, V191, P1792, DOI 10.4049/jimmunol.1300180; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chavanet P, 2013, MED MALADIES INFECT, V43, P451, DOI 10.1016/j.medmal.2013.09.011; COLIN DA, 1994, INFECT IMMUN, V62, P3184, DOI 10.1128/IAI.62.8.3184-3188.1994; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P1475, DOI 10.1128/AAC.46.5.1475-1480.2002; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; DAVISON VE, 1981, INFECT IMMUN, V32, P118, DOI 10.1128/IAI.32.1.118-126.1981; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Estes KS, 2010, EUR J MED RES, V15, P533, DOI 10.1186/2047-783X-15-12-533; Finelli L, 2008, PEDIATRICS, V122, P805, DOI 10.1542/peds.2008-1336; Garcia-Roca P, 2006, ARCH MED RES, V37, P31, DOI 10.1016/j.arcmed.2005.05.022; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; HENSLER T, 1994, INFECT IMMUN, V62, P5281, DOI 10.1128/IAI.62.12.5281-5289.1994; HENSLER T, 1994, INFECT IMMUN, V62, P2529, DOI 10.1128/IAI.62.6.2529-2535.1994; Holzinger D, 2012, J LEUKOCYTE BIOL, V92, P1069, DOI 10.1189/jlb.0112014; Honeybourne D, 2003, J ANTIMICROB CHEMOTH, V51, P1431, DOI 10.1093/jac/dkg262; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Keel RA, 2012, ANTIMICROB AGENTS CH, V56, P3420, DOI 10.1128/AAC.06121-11; Khan AA, 1999, INT J ANTIMICROB AG, V11, P121, DOI 10.1016/S0924-8579(98)00091-0; KLEIN B, 1995, IMMUNOL TODAY, V16, P216, DOI 10.1016/0167-5699(95)80161-8; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kollef MH, 2004, INTENS CARE MED, V30, P388, DOI 10.1007/s00134-003-2088-1; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; Liu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057483; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Mandell LA, 2012, CLIN INFECT DIS, V54, P1134, DOI 10.1093/cid/cis045; Manzer R, 2008, AM J RESP CELL MOL, V38, P318, DOI 10.1165/rcmb.2007-0250OC; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; MARTIN CM, 1959, ARCH INTERN MED, V103, P532, DOI 10.1001/archinte.1959.00270040018002; MATTHAY MA, 1984, J CLIN IMMUNOL, V4, P479, DOI 10.1007/BF00916578; McNamee LA, 2006, INFECT IMMUN, V74, P6707, DOI 10.1128/IAI.00789-06; Melles DC, 2006, EMERG INFECT DIS, V12, P1174, DOI 10.3201/eid1207.050865; MEUNIER O, 1995, CYTOMETRY, V21, P241, DOI 10.1002/cyto.990210304; Morikawa K, 1996, ANTIMICROB AGENTS CH, V40, P1366, DOI 10.1128/AAC.40.6.1366; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Murray RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008705; NICKERSON CL, 1990, INFECT IMMUN, V58, P2809, DOI 10.1128/IAI.58.9.2809-2814.1990; Niemann S, 2012, J INFECT DIS, V206, P1138, DOI 10.1093/infdis/jis468; PARSONS PE, 1985, AM REV RESPIR DIS, V132, P490; Patel BV, 2013, J IMMUNOL, V190, P4274, DOI 10.4049/jimmunol.1202437; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594; SCHWARZMANN SW, 1971, ARCH INTERN MED, V127, P1037, DOI 10.1001/archinte.127.6.1037; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Sun K, 2014, J IMMUNOL, V192, P3301, DOI 10.4049/jimmunol.1303049; SUTER PM, 1992, AM REV RESPIR DIS, V145, P1016, DOI 10.1164/ajrccm/145.5.1016; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; TASHIRO M, 1987, J GEN VIROL, V68, P2039, DOI 10.1099/0022-1317-68-7-2039; TASHIRO M, 1987, NATURE, V325, P536, DOI 10.1038/325536a0; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Ware LB, 2006, SEMIN RESP CRIT CARE, V27, P337, DOI 10.1055/s-2006-948288; Wunderink RG, 2003, CHEST, V124, P1789, DOI 10.1378/chest.124.5.1789; Wunderink RG, 2013, INFECT DIS CLIN N AM, V27, P177, DOI 10.1016/j.idc.2012.11.006; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Yoshizawa S, 2012, ANTIMICROB AGENTS CH, V56, P1744, DOI 10.1128/AAC.05430-11	65	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0114574	10.1371/journal.pone.0114574	http://dx.doi.org/10.1371/journal.pone.0114574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635685	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700003
J	Oscherwitz, J; Cease, KB				Oscherwitz, Jon; Cease, Kemp B.			Identification and Validation of a Linear Protective Neutralizing Epitope in the beta-Pore Domain of Alpha Toxin	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SITE-DIRECTED MUTAGENESIS; HUMAN-ANTIBODY RESPONSE; T-CELL EPITOPES; MONOCLONAL-ANTIBODIES; IN-VIVO; PASSIVE-IMMUNIZATION; LETHAL TOXIN; HEMOLYSIN; VIRULENCE	The plethora of virulence factors associated with Staphylococcus aureus make this bacterium an attractive candidate for a molecularly-designed epitope-focused vaccine. This approach, which necessitates the identification of neutralizing epitopes for incorporation into a vaccine construct, is being evaluated for pathogens where conventional approaches have failed to elicit protective humoral responses, like HIV-1 and malaria, but may also hold promise for pathogens like S. aureus, where the elicitation of humoral immunity against multiple virulence factors may be required for development of an effective vaccine. Among the virulence factors employed by S. aureus, animal model and epidemiological data suggest that alpha toxin, a multimeric beta-pore forming toxin like protective antigen from Bacillus anthracis, is particularly critical, yet no candidate neutralizing epitopes have been delineated in alpha toxin to date. We have previously shown that a linear determinant in the 2 beta 2-2 beta 3 loop of the pore forming domain of B. anthracis protective antigen is a linear neutralizing epitope. Antibody against this site is highly potent for neutralizing anthrax lethal toxin in vitro and for protection of rabbits in vivo from virulent B. anthracis. We hypothesized that sequences in the beta-pore of S. aureus alpha toxin that share structural and functional homology to beta-pore sequences in protective antigen would contain a similarly critical neutralizing epitope. Using an in vivo mapping strategy employing peptide immunogens, an optimized in vitro toxin neutralization assay, and an in vivo dermonecrosis model, we have now confirmed the presence of this epitope in alpha toxin, termed the pore neutralizing determinant. Antibody specific for this determinant neutralizes alpha toxin in vitro, and is highly effective for mitigating dermonecrosis and bacterial growth in a mouse model of S. aureus USA300 skin infection. The delineation of this linear neutralizing determinant in alpha toxin could facilitate the development of an epitope-focused vaccine against S. aureus.	[Oscherwitz, Jon; Cease, Kemp B.] Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48105 USA; [Oscherwitz, Jon; Cease, Kemp B.] VA Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Oscherwitz, J (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48105 USA.	joscher@umich.edu			Department of Veterans Affairs Merit Award [I01BX000429]	Department of Veterans Affairs Merit Award(US Department of Veterans Affairs)	This work was supported by Department of Veterans Affairs Merit Award I01BX000429 (to KBC) and by resources and the use of facilities at the Veterans Administration Ann Arbor Healthcare System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Bartlett AH, 2008, J INFECT DIS, V198, P1529, DOI 10.1086/592758; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BHAKDI S, 1984, INFECT IMMUN, V46, P318, DOI 10.1128/IAI.46.2.318-323.1984; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Brady RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063040; Brandt S, 2003, CLIN DIAGN LAB IMMUN, V10, P903, DOI 10.1128/CDLI.10.5.903-909.2003; Calvo-Calle JM, 2006, INFECT IMMUN, V74, P6929, DOI 10.1128/IAI.01151-06; CalvoCalle JM, 1997, J IMMUNOL, V159, P1362; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Correia BE, 2014, NATURE, DOI [10.1038/nature14135, DOI 10.1038/NATURE14135]; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2008, J EXP MED, V205, P271, DOI 10.1084/jem.20080167; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deresinski S, 2005, CLIN INFECT DIS, V40, P562, DOI 10.1086/427701; Dormitzer PR, 2012, NAT REV MICROBIOL, V10, P807, DOI 10.1038/nrmicro2893; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Hering D, 2004, BIOLOGICALS, V32, P17, DOI 10.1016/j.biologicals.2003.09.003; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; Karginov VA, 2007, BIOORGAN MED CHEM, V15, P5424, DOI 10.1016/j.bmc.2007.05.058; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lattar SM, 2014, INFECT IMMUN, V82, P83, DOI 10.1128/IAI.01050-13; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Little SF, 2004, VACCINE, V22, P422, DOI 10.1016/j.vaccine.2003.07.004; Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110; Menzies BE, 1996, INFECT IMMUN, V64, P1839, DOI 10.1128/IAI.64.5.1839-1841.1996; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Mocca CP, 2014, CLIN VACCINE IMMUNOL; Molne L, 2003, CLIN EXP IMMUNOL, V132, P209, DOI 10.1046/j.1365-2249.2003.02151.x; MORENO A, 1991, INT IMMUNOL, V3, P997, DOI 10.1093/intimm/3.10.997; Moyle PM, 2013, CHEMMEDCHEM, V8, P360, DOI 10.1002/cmdc.201200487; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Nygaard TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036532; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; OREILLY M, 1986, MICROB PATHOGENESIS, V1, P125, DOI 10.1016/0882-4010(86)90015-X; Oscherwitz J, 2014, MOL IMMUNOL, V60, P62, DOI 10.1016/j.molimm.2014.03.012; Oscherwitz J, 2013, CLIN VACCINE IMMUNOL, V20, P341, DOI 10.1128/CVI.00612-12; Oscherwitz J, 2010, J IMMUNOL, V185, P3661, DOI 10.4049/jimmunol.1001749; Oscherwitz J, 2009, INFECT IMMUN, V77, P5509, DOI 10.1128/IAI.00899-09; Oscherwitz J, 2009, INFECT IMMUN, V77, P3380, DOI 10.1128/IAI.00358-09; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; Plaut RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059232; Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09; Powers ME, 2012, J INFECT DIS, V206, P352, DOI 10.1093/infdis/jis192; Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rauch S, 2012, INFECT IMMUN, V80, P3721, DOI 10.1128/IAI.00442-12; Reason D, 2009, INFECT IMMUN, V77, P2030, DOI 10.1128/IAI.01254-08; Reason DC, 2008, VACCINE, V26, P4041, DOI 10.1016/j.vaccine.2008.05.023; SCHMIDT MA, 1991, INFECT IMMUN, V59, P1402, DOI 10.1128/IAI.59.4.1402-1408.1991; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Spaulding A. R, 2014, J INFECT DIS; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Tkaczyk C, 2012, CLIN VACCINE IMMUNOL, V19, P377, DOI 10.1128/CVI.05589-11; Tkaczyk C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075103; Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Zuo QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081212	72	11	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116882	10.1371/journal.pone.0116882	http://dx.doi.org/10.1371/journal.pone.0116882			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635901	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700063
J	Stein, GY; Alon, D; Korenfeld, R; Fuchs, S				Stein, Gideon Y.; Alon, Danny; Korenfeld, Roman; Fuchs, Shmuel			Clinical Implications of High-Sensitivity Cardiac Troponin Measurements in Hospitalized Medical Patients	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; MYOCARDIAL-INFARCTION; HEART-FAILURE; MORTALITY; ASSAY; ASSOCIATION; POPULATION; RISK; AGE	Background The increased use of high sensitivity cardiac troponins (hs-cTn), have made the diagnosis of non-ST elevation myocardial infarction (MI) challenging, especially in complex medical patients, in whom the clinical presentation of MI is nonspecific and multiple comorbidities as well as non-ischemic acute conditions may account for elevated hs-cTn levels. The aim of this study was to assess the frequency of both elevated hs-cTn levels and dynamic changes in hospitalized patients. Methods and Findings We conducted a retrospective study identifying all patients hospitalized in the Internal Medicine Division of Rabin Medical Center, Israel between January 2011 to December 2011, for whom at least one hs-cTn T (hs-cTnT) measurement was obtained. Collected data included patient demographics, acute and chronic diagnosis, hs-cTnT and creatinine levels and date of death. Hs-cTnT levels were obtained in 5,696 admissions and was above the 99th percentile (> = 13 ng/L) in 61.6% of the measurements. A relative change of 50% or higher was observed in 24% of the admissions. Among those with elevated hs-cTnT levels, acute coronary syndromes (ACS) accounted for only 6.1% of acute diagnoses. Maximal hs-cTnT levels above 100 ng/L but not dynamic changes discriminated between ACS and non-ACS conditions (positive and negative predictive values of 12% and 96% respectively). The frequency of elevated hs-cTnT levels was age-dependent and over 75% of patients aged >70 yearsold had levels above the 99th percentile. Multivariate analysis identified hs-cTnT levels higher than the 99th percentile, as an independent, strong predictor for 30-day mortality (OR 4.58 [2.8, 7.49], p<0.0001). Conclusions Elevated hs-cTnT levels together with dynamic changes are frequent findings among hospitalized patients and in most cases, are not related to the ACS diagnosis. These findings highlight the diagnostic challenge of ACS in this complex population. Further studies are needed in order to optimize the use of hs-cTnT measurements in hospitalized patients.	[Fuchs, Shmuel] Beilinson Med Ctr, Rabin Med Ctr, Dept Internal Med B, Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Fuchs, S (corresponding author), Beilinson Med Ctr, Rabin Med Ctr, Dept Internal Med B, Petah Tiqwa, Israel.	shmuelf@clalit.org.il						Baron JM, 2014, AM J CLIN PATHOL, V141, P488, DOI 10.1309/AJCPLVQQY35XTFVN; de Lemos JA, 2011, CLIN CHEM, V57, P826, DOI 10.1373/clinchem.2011.163758; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Eggers KM, 2013, J AM COLL CARDIOL, V61, P1906, DOI 10.1016/j.jacc.2012.12.048; Gore MO, 2014, J AM COLL CARDIOL, V63, P1441, DOI 10.1016/j.jacc.2013.12.032; Haaf P, 2012, CIRCULATION, V126, P31, DOI 10.1161/CIRCULATIONAHA.112.100867; Hammarsten O, 2012, CLIN CHEM, V58, P628, DOI 10.1373/clinchem.2011.171496; Hijazi Z, 2013, CIRCULATION, DOI [10.1161/CIRCULATIONAHA.113.007747, DOI 10.1161/CIRCULATIONAHA.113.007747]; Irfan A, 2012, AM J MED, V125, P491, DOI 10.1016/j.amjmed.2011.10.031; Kelley WE, 2009, CLIN CHEM, V55, P2098, DOI 10.1373/clinchem.2009.130799; Korley FK, 2013, J AM COLL CARDIOL, V61, P1753, DOI 10.1016/j.jacc.2012.09.069; Masson S, 2013, J INTERN MED, V273, P306, DOI 10.1111/joim.12023; McFalls EO, 2011, AM J MED, V124, P630, DOI 10.1016/j.amjmed.2011.02.024; Mishra RK, 2013, AM J KIDNEY DIS, V61, P701, DOI 10.1053/j.ajkd.2012.11.034; Mueller M, 2012, CLIN CHEM, V58, P209, DOI 10.1373/clinchem.2011.171827; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; Normann J, 2012, AM HEART J, V164, P698, DOI 10.1016/j.ahj.2012.08.003; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Sandoval Y, 2014, J AM COLL CARDIOL, V63, P2079, DOI 10.1016/j.jacc.2014.02.541; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Stein GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084285; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117162	10.1371/journal.pone.0117162	http://dx.doi.org/10.1371/journal.pone.0117162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25636061	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700073
J	Xue, F; Zhang, N; Feng, XW; Zheng, XG; Kan, JG				Xue, Fei; Zhang, Nong; Feng, Xiaowei; Zheng, Xigui; Kan, Jiaguang			Strengthening Borehole Configuration from the Retaining Roadway for Greenhouse Gas Reduction: A Case Study	PLOS ONE			English	Article							COALBED METHANE; EMISSIONS; OPTIMIZATION; STABILITY; WELL	A monitoring trial was carried out to investigate the effect of boreholes configuration on the stability and gas production rate. These boreholes were drilled from the retaining roadway at longwall mining panel 1111(1) of the Zhuji Coalmine, in China. A borehole camera exploration device and multiple gas parameter measuring device were adopted to monitor the stability and gas production rate. Research results show that boreholes 1 similar to 8 with low intensity and thin casing thickness were broken at the depth of 5 similar to 10m along the casing and with a distance of 2 similar to 14 m behind the coal face, while boreholes 9 similar to 11 with a special thick-walled high-strength oil casing did not fracture during the whole extraction period. The gas extraction volume is closely related to the boreholes stability. After the stability of boreholes 9 similar to 11 being improved, the average gas flow rate increased dramatically 16-fold from 0.13 to 2.21 m(3)/min, and the maximum gas flow rate reached 4.9 m(3)/min. Strengthening boreholes configuration is demonstrated to be a good option to improve gas extraction effect. These findings can make a significant contribution to the reduction of greenhouse gas emissions from the coal mining industry.	[Xue, Fei; Zhang, Nong; Feng, Xiaowei; Zheng, Xigui; Kan, Jiaguang] China Univ Min & Technol, Sch Mines, Key Lab Deep Coal Resource Min, Minist Educ China, Xuzhou 221116, Jiangsu, Peoples R China; [Zhang, Nong] Hunan Univ Sci & Technol, Hunan Key Lab Safe Min Tech Coal Mines, Xiangtan 411201, Peoples R China	China University of Mining & Technology; Ministry of Education, China; Hunan University of Science & Technology	Zhang, N (corresponding author), China Univ Min & Technol, Sch Mines, Key Lab Deep Coal Resource Min, Minist Educ China, Xuzhou 221116, Jiangsu, Peoples R China.	zhangnong@126.com	Feng, Xiaowei/P-8126-2019; 冯, 晓巍/E-7039-2015	冯, 晓巍/0000-0002-9348-9874; Zhang, Nong/0000-0001-6961-0729	Program for Changjiang Scholars and Innovative Research Team in University [IRT_14R55]; Fundamental Research Funds for the Central Universities [2014XT01]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was sponsored by Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT_14R55) and the Fundamental Research Funds for the Central Universities (Grant No. 2014XT01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibler CJ, 1998, INT J COAL GEOL, V35, P283, DOI 10.1016/S0166-5162(97)00038-4; Chen JH, 2012, INT J COAL GEOL, V90, P135, DOI 10.1016/j.coal.2011.11.007; Cheng Y., 2009, J MIN SAF ENG, V26, P127, DOI DOI 10.1016/J.TIV.2014.12.011; Feng QH, 2012, INT J COAL GEOL, V104, P34, DOI 10.1016/j.coal.2012.09.004; Flores RM, 1998, INT J COAL GEOL, V35, P3, DOI 10.1016/S0166-5162(97)00043-8; Gentzis T, 2009, INT J COAL GEOL, V78, P149, DOI 10.1016/j.coal.2008.11.001; Gentzis T, 2009, INT J COAL GEOL, V77, P328, DOI 10.1016/j.coal.2008.05.016; Huang H.Z, 2010, MIN SCI TECHNOL, V20, P230; Jellison MJ, 2000, SPE DRILL COMPLETION, V15, P241, DOI 10.2118/67608-PA; Karacan CO, 2007, INT J COAL GEOL, V72, P15, DOI 10.1016/j.coal.2006.12.007; Karacan CO, 2007, INT J COAL GEOL, V71, P225, DOI 10.1016/j.coal.2006.08.003; Karacan CO, 2011, INT J COAL GEOL, V86, P121, DOI 10.1016/j.coal.2011.02.009; Keim SA, 2011, INT J COAL GEOL, V86, P306, DOI 10.1016/j.coal.2011.03.004; Tan YL, 2012, INT J ROCK MECH MIN, V49, P113, DOI 10.1016/j.ijrmms.2011.11.015; Wang FT, 2012, INT J GREENH GAS CON, V11, P290, DOI 10.1016/j.ijggc.2012.09.006; Warmuzinski K, 2008, PROCESS SAF ENVIRON, V86, P315, DOI 10.1016/j.psep.2008.04.003; Whittles DN, 2007, INT J COAL GEOL, V71, P313, DOI 10.1016/j.coal.2006.11.004; Whittles DN, 2006, INT J ROCK MECH MIN, V43, P369, DOI 10.1016/j.ijrmms.2005.07.006; Yuan L, 2008, INT J COAL SCI TECHN, V31, P174, DOI [10.1016/j.envres.2014.08.017, DOI 10.1016/J.ENVRES.2014.08.017]; Yuan L, 2008, INT J COAL SCI TECHN, V33, P898, DOI [10.1097/BRS.0b013e31816b1f83, DOI 10.1097/BRS.0B013E31816B1F83]	20	6	6	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0115874	10.1371/journal.pone.0115874	http://dx.doi.org/10.1371/journal.pone.0115874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633368	gold, Green Published, Green Submitted			2022-12-26	WOS:000348609800004
J	Dutta-Roy, R; Rosenmund, C; Edelstein, SJ; Le Novere, N				Dutta-Roy, Ranjita; Rosenmund, Christian; Edelstein, Stuart J.; Le Novere, Nicolas			Ligand-Dependent Opening of the Multiple AMPA Receptor Conductance States: A Concerted Model	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR; ALLOSTERIC TRANSITIONS; QUANTAL TRANSMISSION; HIPPOCAMPAL-NEURONS; MARKUP LANGUAGE; PYRAMIDAL CELLS; CHANNELS; BINDING; ACTIVATION; ACETYLCHOLINE	Modulation of the properties of AMPA receptors at the post-synaptic membrane is one of the main suggested mechanisms underlying fast synaptic transmission in the central nervous system of vertebrates. Electrophysiological recordings of single channels stimulated with agonists showed that both recombinant and native AMPA receptors visit multiple conductance states in an agonist concentration dependent manner. We propose an allosteric model of the multiple conductance states based on concerted conformational transitions of the four subunits, as an iris diaphragm. Our model predicts that the thermodynamic behaviour of the conductance states upon full and partial agonist stimulations can be described with increased affinity of receptors as they progress to higher conductance states. The model also predicts the existence of AMPA receptors in non-liganded conductive substates. However, the probability of spontaneous openings decreases with increasing conductances. Finally, we predict that the large conductance states are stabilized within the rise phase of a whole-cell EPSC in glutamatergic hippocampal neurons. Our model provides a mechanistic link between ligand concentration and conductance states that can explain thermodynamic and kinetic features of AMPA receptor gating.	[Dutta-Roy, Ranjita] Karolinska Inst, Dept Med Solna, S-17176 Stockholm, Sweden; [Dutta-Roy, Ranjita; Rosenmund, Christian] Charite, NWFZ, D-10117 Berlin, Germany; [Dutta-Roy, Ranjita; Le Novere, Nicolas] EBI, EMBL, Hinxton CB10 1SD, Cambs, England; [Edelstein, Stuart J.; Le Novere, Nicolas] Babraham Inst, Babraham CB22 3AT, Cambs, England	Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Le Novere, N (corresponding author), EBI, EMBL, Wellcome Trust Genome Campus, Hinxton CB10 1SD, Cambs, England.	lenov@babraham.ac.uk	Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444	BBSRC [BBS/E/B/000C0419] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0419] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; Diamond JS, 1997, J NEUROSCI, V17, P4672; Edelstein SJ, 1997, BIOCHEMISTRY-US, V36, P13755, DOI 10.1021/bi9718301; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; Gebhardt C, 2006, J PHYSIOL-LONDON, V573, P371, DOI 10.1113/jphysiol.2005.102723; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; JACKSON MB, 1984, P NATL ACAD SCI-BIOL, V81, P3901, DOI 10.1073/pnas.81.12.3901; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; Lu M, 2010, NEUROSCI RES, V66, P92, DOI 10.1016/j.neures.2009.09.1713; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Prince RJ, 1999, J BIOL CHEM, V274, P19623, DOI 10.1074/jbc.274.28.19623; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Ruiz M, 1999, J GEN PHYSIOL, V113, P873, DOI 10.1085/jgp.113.6.873; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Smith TC, 2000, J NEUROSCI, V20, P2073; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stern-Bach Y, 2004, NEURON, V41, P309, DOI 10.1016/S0896-6273(04)00040-6; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Tigerholm J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044388; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turecek R, 1997, EUR J NEUROSCI, V9, P1999, DOI 10.1111/j.1460-9568.1997.tb01368.x; Waltemath D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-198; Wang QJ, 1997, ENVIRON MODELL SOFTW, V12, P27, DOI 10.1016/S1364-8152(96)00030-8	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116616	10.1371/journal.pone.0116616	http://dx.doi.org/10.1371/journal.pone.0116616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629405	Green Submitted, Green Published, gold			2022-12-26	WOS:000348732100043
J	Nelson, N; Xiang, SY; Zhang, XH; Gilvary, D; Djeu, J; Husain, K; Malafa, M; Vohra, N; Pilon-Thomas, S; Ghansah, T				Nelson, Nadine; Xiang, Shengyan; Zhang, Xiaohong; Gilvary, Danielle; Djeu, Julie; Husain, Kazim; Malafa, Mokenge; Vohra, Nasreen; Pilon-Thomas, Shari; Ghansah, Tomar			Murine Pancreatic Adenocarcinoma Reduces Ikaros Expression and Disrupts T Cell Homeostasis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR IKAROS; IL2 GENE-EXPRESSION; HELIOS; DIFFERENTIATION; IMMUNOTHERAPY; LENALIDOMIDE; INDUCTION; ISOFORMS; CANCER	Background Maintenance of T cell immune homeostasis is critical for adequate anti-tumor immunity. The transcription factor Ikaros is essential for lymphocyte development including T cells. Alterations in Ikaros expression occur in blood malignancies in humans and mice. In this study, we investigated the role of Ikaros in regulating T cell immune balance in pancreatic cancer mouse models. Methodology and Principal Findings Using our Panc02 tumor-bearing (TB) mouse model, western blot analysis revealed a reduction in Ikaros proteins while qRT-PCR showed no differences in Ikaros mRNA levels in TB splenocytes compared to control. Treatment of naive splenocytes with the proteasomal inhibitor, MG132, stabilized Ikaros expression and prevented Ikaros downregulation by Panc02 cells, in vitro. Western blot analyses showed a reduction in protein phosphatase 1 (PP1) and protein kinase CK2 expression in TB splenocytes while CK2 activity was increased. Immunofluorescence microscopy revealed altered punctate staining of Ikaros in TB splenocytes. Flow cytometry revealed a significant decrease in effector CD4(+) and CD8(+) T cell percentages but increased CD4(+)CD25(+) regulatory T cells in TB splenocytes. Similar alterations in T cell percentages, as well as reduced Ikaros and CK2 but not PP1 expression, were observed in a transgenic, triple mutant (TrM) pancreatic cancer model. Ikaros expression was also reduced in enriched TB CD3(+)T cells. MG132 treatment of naive CD3(+)T cells stabilized Ikaros expression in the presence of Panc02 cells. Western blots showed reduced PP1 and CK2 expression in TB CD3(+)T cells. Conclusions/Significance The results of this study suggest that the pancreatic tumor microenvironment may cause proteasomal degradation of Ikaros, possibly via dysregulation of PP1 and CK2 expression and activity, respectively. This loss of Ikaros expression may contribute to an imbalance in T cell percentages. Ikaros may potentially be a therapeutic target to restore T cell homeostasis in pancreatic cancer hosts, which may be critical for effective anti-tumor immunity.	[Nelson, Nadine; Ghansah, Tomar] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA; [Xiang, Shengyan; Zhang, Xiaohong] Univ S Florida, Dept Pathol & Cell Biol, Morsani Coll Med, Tampa, FL USA; [Gilvary, Danielle; Djeu, Julie; Pilon-Thomas, Shari; Ghansah, Tomar] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA; [Husain, Kazim; Malafa, Mokenge] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Gastrointestinal Oncol, Tampa, FL 33682 USA; [Vohra, Nasreen] E Carolina Univ, Dept Surg, Brody Sch Med, Greenville, NC USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of North Carolina; East Carolina University	Ghansah, T (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA.	Tghansah@health.usf.edu	Vohra, Nasreen/AAW-3454-2021; XIANG, SHENGYAN/C-3176-2013	Vohra, Nasreen/0000-0002-6411-3042; XIANG, SHENGYAN/0000-0002-6940-3559	American Cancer Society [93-032-13]; National Cancer Institute; Center to Reduce Cancer Health Disparities [1R21 CA179668-01A1, R01CA164147]; National Science Foundation Bridge to Doctorate Fellowship; Florida Education Fund McKnight Dissertation Completion Fellowship; NATIONAL CANCER INSTITUTE [R21CA179668, P30CA076292, R01CA164147, R25CA174664] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center to Reduce Cancer Health Disparities; National Science Foundation Bridge to Doctorate Fellowship(National Science Foundation (NSF)); Florida Education Fund McKnight Dissertation Completion Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by an Institutional Research Grant #93-032-13 from the American Cancer Society, National Cancer Institute, Center to Reduce Cancer Health Disparities, 1R21 CA179668-01A1 grants awarded to TG and R01CA164147 grant awarded to XZ. NN graduate training supported in part, by the National Science Foundation Bridge to Doctorate Fellowship and the Florida Education Fund McKnight Dissertation Completion Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Antica M, 2008, BLOOD, V111, P3296, DOI 10.1182/blood-2007-12-125682; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Baine I, 2013, J IMMUNOL, V190, P1008, DOI 10.4049/jimmunol.1200792; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Bazhin AV, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25736; Bazhin AV, 2014, CANCER IMMUNOL IMMUN, V63, P59, DOI 10.1007/s00262-013-1485-8; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; CORBETT TH, 1984, CANCER RES, V44, P717; Dovat S, 2011, MOL CELL BIOCHEM, V356, P201, DOI 10.1007/s11010-011-0964-5; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Gerloni M, 2005, SPRINGER SEMIN IMMUN, V27, P37, DOI 10.1007/s00281-004-0193-z; Ghansah T, 2013, CANCER IMMUNOL IMMUN, V62, P1083, DOI 10.1007/s00262-013-1407-9; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; Gurel Z, 2008, J BIOL CHEM, V283, P8291, DOI 10.1074/jbc.M707906200; Hadrup S, 2013, CANCER MICROENVIRON, V6, P123, DOI 10.1007/s12307-012-0127-6; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; He LC, 2011, BIOCHEM BIOPH RES CO, V406, P430, DOI 10.1016/j.bbrc.2011.02.062; Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Husain K, 2013, CANCER PREV RES, V6, P1074, DOI 10.1158/1940-6207.CAPR-13-0157; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Kastner Philippe, 2011, World J Biol Chem, V2, P108, DOI 10.4331/wjbc.v2.i6.108; Kathrein KL, 2008, J BIOL CHEM, V283, P10476, DOI 10.1074/jbc.M709643200; Kathrein KL, 2005, MOL CELL BIOL, V25, P1645, DOI 10.1128/MCB.25.5.1645-1654.2005; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Payne Kimberly J., 2011, Critical Reviews in Oncogenesis, V16, P3; Payne KJ, 2003, J IMMUNOL, V170, P3091, DOI 10.4049/jimmunol.170.6.3091; Payne KJ, 2001, J IMMUNOL, V167, P1867, DOI 10.4049/jimmunol.167.4.1867; Pilon-Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027729; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Sun L, 1999, CLIN CANCER RES, V5, P2112; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Sun L, 1999, J CLIN ONCOL, V17, P3753, DOI 10.1200/JCO.1999.17.12.3753; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Thomas RM, 2010, J BIOL CHEM, V285, P2545, DOI 10.1074/jbc.M109.038794; Tinsley KW, 2013, BLOOD, V122, P2358, DOI 10.1182/blood-2012-12-472076; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wei S, 2000, J IMMUNOL, V165, P3811, DOI 10.4049/jimmunol.165.7.3811; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yap WH, 2005, FEBS LETT, V579, P4470, DOI 10.1016/j.febslet.2005.07.018; Zhang L, 2011, CELL CYCLE, V10, P3515, DOI 10.4161/cc.10.20.17789	50	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115546	10.1371/journal.pone.0115546	http://dx.doi.org/10.1371/journal.pone.0115546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629611	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100022
J	Sanchez, S; Llorente, MT; Echeita, MA; Herrera-Leon, S				Sanchez, Sergio; Teresa Llorente, Maria; Aurora Echeita, Maria; Herrera-Leon, Silvia			Development of Three Multiplex PCR Assays Targeting the 21 Most Clinically Relevant Serogroups Associated with Shiga Toxin-Producing E-coli Infection in Humans	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ANTIGEN GENE-CLUSTER; O-ANTIGEN; IDENTIFICATION; PREVALENCE; SEROTYPES; OUTBREAK; SEQUENCE; DIARRHEA	Escherichia coli serogroups O5, O15, O26, O45, O55, O76, O91, O103, O104, O111, O113, O118, O121, O123, O128, O145, O146, O157, O165, O172, and O177 are the O-antigen forms of the most clinically relevant Shiga toxin-producing E. coli (STEC) serotypes. In this study, three multiplex PCR assays able to specifically detect these 21 serogroups were developed and validated. For this purpose, the O-antigen gene clusters of E. coli O5 and O76 were fully sequenced, their associated genes were identified on the basis of homology, and serogroup-specific primers were designed. After preliminary evaluation, these two primer pairs were proven to be highly specific and suitable for the development of PCR assays for O5 and O76 serogroup identification. Specific primers were also designed for serogroups O15, O45, O55, O91, O104, O113, O118, O123, O128, O146, O157, O165, O172, and O177 based on previously published sequences, and previously published specific primers for serogroups O26, O103, O111, O121, and O145 were also included. These 21 primer pairs were shown to be specific for their target serogroup when tested against E. coli type strains representing 169 known O-antigen forms of E. coli and Shigella and therefore suitable for being used in PCR assays for serogroup identification. In order to validate the three multiplex PCR assays, 22 E. coli strains belonging to the 21 covered serogroups and 18 E. coli strains belonging to other serogroups were screened in a double-blind test and their sensitivity was determined as 1 ng chromosomal DNA. The PCR assays developed in this study could be a faster, simpler, and less expensive strategy for serotyping of the most clinically relevant STEC strains in both clinical microbiology and public health laboratories, and so their development could benefit for clinical diagnosis, epidemiological investigations, surveillance, and control of STEC infections.	[Sanchez, Sergio; Teresa Llorente, Maria; Aurora Echeita, Maria; Herrera-Leon, Silvia] Inst Hlth Carlos III, Natl Ctr Microbiol, Serv Bacteriol, Lab Enterobacteriaceae, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Sanchez, S (corresponding author), Inst Hlth Carlos III, Natl Ctr Microbiol, Serv Bacteriol, Lab Enterobacteriaceae, Madrid, Spain.	sergio.sanchez@isciii.es	Sanchez, Sergio/N-2756-2015	Sanchez, Sergio/0000-0001-9903-6203	Madrid Regional Government [P2009/AGR-1489]	Madrid Regional Government	This study was supported by the Madrid Regional Government (P2009/AGR-1489). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelheim KA, 2007, CRIT REV MICROBIOL, V33, P67, DOI 10.1080/10408410601172172; Beutin L, 2005, J CLIN MICROBIOL, V43, P5143, DOI 10.1128/JCM.43.10.5143-5149.2005; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bugarel M, 2010, INT J FOOD MICROBIOL, V142, P318, DOI 10.1016/j.ijfoodmicro.2010.07.010; Diaz-Sanchez S, 2013, VET MICROBIOL, V163, P274, DOI 10.1016/j.vetmic.2012.12.026; Eklund M, 2001, J CLIN MICROBIOL, V39, P2829, DOI 10.1128/JCM.39.8.2829-2834.2001; Guinee P. A. M., 1981, Laboratory diagnosis in neonatal calf and pig diarrhoea, P126; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; LEVINE MM, 1987, J INFECT DIS, V155, P377, DOI 10.1093/infdis/155.3.377; Liu B, 2010, FEMS IMMUNOL MED MIC, V60, P199, DOI 10.1111/j.1574-695X.2010.00738.x; Liu YH, 2007, MOL CELL PROBE, V21, P295, DOI 10.1016/j.mcp.2007.03.002; Maidhof H, 2002, APPL ENVIRON MICROB, V68, P5834, DOI 10.1128/AEM.68.12.5834-5842.2002; McLean C, 2005, J MED MICROBIOL, V54, P605, DOI 10.1099/jmm.0.45938-0; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Monday SR, 2007, MOL CELL PROBE, V21, P308, DOI 10.1016/j.mcp.2007.02.002; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Rey J, 2006, INT J FOOD MICROBIOL, V107, P212, DOI 10.1016/j.ijfoodmicro.2005.08.025; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Sanchez S, 2014, EPIDEMIOL INFECT, V142, P1029, DOI 10.1017/S0950268813001842; Sanchez S, 2010, SMALL RUMINANT RES, V93, P144, DOI 10.1016/j.smallrumres.2010.05.014; Schimmer B, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-41; Stritt A, 2013, CLIN INFECT DIS, V56, P114, DOI 10.1093/cid/cis851; Tarr PI, 2000, J BACTERIOL, V182, P6183, DOI 10.1128/JB.182.21.6183-6191.2000; Wang L, 2001, GENE, V270, P231, DOI 10.1016/S0378-1119(01)00471-1; Wang L, 2000, J BACTERIOL, V182, P5256, DOI 10.1128/JB.182.18.5256-5261.2000; Wang L, 1998, INFECT IMMUN, V66, P3545, DOI 10.1128/IAI.66.8.3545-3551.1998; Wang QA, 2010, MOL CELL PROBE, V24, P286, DOI 10.1016/j.mcp.2010.06.002; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x	30	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117660	10.1371/journal.pone.0117660	http://dx.doi.org/10.1371/journal.pone.0117660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629697	Green Published, gold			2022-12-26	WOS:000348732100094
J	Layne, JD; Shridas, P; Webb, NR				Layne, Joseph D.; Shridas, Preetha; Webb, Nancy R.			Ectopically Expressed Pro-group X Secretory Phospholipase A(2) Is Proteolytically Activated in Mouse Adrenal Cells by Furin-like Proprotein Convertases IMPLICATIONS FOR THE REGULATION OF ADRENAL STEROIDOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adrenal; Glucocorticoid; Nuclear Receptor; Phospholipase; Proprotein Convertase Subtilisin; Kexin Type 9 (PCSK9)	GROUP-V; ARACHIDONIC-ACID; RECEPTOR; PROTEIN; MACROPHAGES; INFLAMMATION; HYDROLYSIS; GLANDS; ASTHMA; PACE4	Background: GX sPLA(2) is expressed as an inactive pro-enzyme; the protease(s) responsible for pro-GX sPLA(2) processing are unknown. Results: Epitope-tagged pro-GX sPLA(2) is proteolytically activated by furin and PCSK6 in adrenal cells. Conclusion: Furin-like proprotein convertases regulate GX sPLA(2) activity. Significance: Identifying the factors involved in activating GX sPLA(2) provides novel insight into the mechanisms surrounding its regulation. Group X secretory phospholipase A(2) (GX sPLA(2)) hydrolyzes mammalian cell membranes, liberating free fatty acids and lysophospholipids. GX sPLA(2) is produced as a pro-enzyme (pro-GX sPLA(2)) that contains an N-terminal 11-amino acid propeptide ending in a dibasic motif, suggesting cleavage by a furin-like proprotein convertase (PC). Although propeptide cleavage is clearly required for enzymatic activity, the protease(s) responsible for pro-GX sPLA(2) activation have not been identified. We previously reported that GX sPLA(2) negatively regulates adrenal glucocorticoid production, likely by suppressing liver X receptor-mediated activation of steroidogenic acute regulatory protein expression. In this study, using a FLAG epitope-tagged pro-GX sPLA(2) expression construct (FLAG-pro-GX sPLA(2)), we determined that adrenocorticotropic hormone (ACTH) enhanced FLAG-pro-GX sPLA(2) processing and phospholipase activity secreted by Y1 adrenal cells. ACTH increased the expression of furin and PCSK6, but not other members of the PC family, in Y1 cells. Overexpression of furin and PCSK6 in HEK 293 cells significantly enhanced FLAG-pro-GX sPLA(2) processing, whereas siRNA-mediated knockdown of both PCs almost completely abolished FLAG-pro-GX sPLA(2) processing in Y1 cells. Expression of either furin or PCSK6 enhanced the ability of GX sPLA(2) to suppress liver X receptor reporter activity. The PC inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethyl ketone significantly suppressed FLAG-pro-GX sPLA(2) processing and sPLA(2) activity in Y1 cells, and it significantly attenuated GX sPLA(2)-dependent inhibition of steroidogenic acute regulatory protein expression and progesterone production. These findings provide strong evidence that pro-GX sPLA(2) is a substrate for furin and PCSK6 proteolytic processing and define a novel mechanism for regulating corticosteroid production in adrenal cells.	[Layne, Joseph D.] Univ Kentucky, Med Ctr, Dept Pharmacol & Nutr Sci, Div Nutr Sci,Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Shridas, Preetha; Webb, Nancy R.] Univ Kentucky, Med Ctr, Dept Internal Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Webb, NR (corresponding author), Dept Pharmacol & Nutr Sci, 535 CT Wethington Bldg,900 S Limestone St, Lexington, KY 40536 USA.	nrwebb1@uky.edu	Webb, Nancy/AAL-7030-2021		National Institutes of Health [R01 DK082419]; T32 Training Grant [2T32DK007778-11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007778, R01DK082419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK082419 (to N.R.W.) and T32 Training Grant 2T32DK007778-11 (to J.L.).	Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Boyanovsky BB, 2009, CARDIOVASC DRUG THER, V23, P61, DOI 10.1007/s10557-008-6134-7; Cherradi N, 2001, ENDOCRINOLOGY, V142, P3302, DOI 10.1210/en.142.8.3302; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Fon WP, 2007, ENDOCRINE, V32, P155, DOI 10.1007/s12020-007-9030-1; Fujioka D, 2008, CIRCULATION, V117, P2977, DOI 10.1161/CIRCULATIONAHA.107.743997; Guillemot J, 2013, HEPATOLOGY, V57, P2514, DOI 10.1002/hep.26297; Hallstrand TS, 2013, AM J RESP CRIT CARE, V188, P42, DOI 10.1164/rccm.201301-0084OC; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Higashino K, 2002, J BIOL CHEM, V277, P13583, DOI 10.1074/jbc.M108752200; Jemel I, 2011, J BIOL CHEM, V286, P36509, DOI 10.1074/jbc.M111.268540; Karabina SA, 2006, FASEB J, V20, P2547, DOI 10.1096/fj.06-6018fje; Li X, 2010, FASEB J, V24, P4313, DOI 10.1096/fj.10-154716; Mesnard D, 2011, GENE DEV, V25, P1871, DOI 10.1101/gad.16738711; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; Morioka Y, 2000, FEBS LETT, V487, P262, DOI 10.1016/S0014-5793(00)02350-4; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; PARKER KL, 1985, P NATL ACAD SCI USA, V82, P7860, DOI 10.1073/pnas.82.23.7860; Pruzanski W, 2005, BBA-MOL CELL BIOL L, V1736, P38, DOI 10.1016/j.bbalip.2005.07.005; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Saiga A, 2001, BBA-MOL CELL BIOL L, V1530, P67, DOI 10.1016/S1388-1981(00)00167-0; Shridas P, 2011, J IMMUNOL, V187, P482, DOI 10.4049/jimmunol.1003552; Shridas P, 2010, ARTERIOSCL THROM VAS, V30, P2014, DOI 10.1161/ATVBAHA.110.210237; Shridas P, 2010, J BIOL CHEM, V285, P20031, DOI 10.1074/jbc.M109.090423; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Tamaru S, 2013, J IMMUNOL, V191, P1021, DOI 10.4049/jimmunol.1300738; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Wooton-Kee CR, 2004, ARTERIOSCL THROM VAS, V24, P762, DOI 10.1161/01.ATV.0000122363.02961.c1; Yokota Y, 2001, FEBS LETT, V509, P250, DOI 10.1016/S0014-5793(01)03173-8	33	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7851	7860		10.1074/jbc.M114.634667	http://dx.doi.org/10.1074/jbc.M114.634667			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25623068	Green Published, hybrid			2022-12-26	WOS:000351613600043
J	Yamak, A; Georges, RO; Sheikh-Hassani, M; Morin, M; Komati, H; Nemer, M				Yamak, Abir; Georges, Romain O.; Sheikh-Hassani, Massomeh; Morin, Martin; Komati, Hiba; Nemer, Mona			Novel Exons in the Tbx5 Gene Locus Generate Protein Isoforms with Distinct Expression Domains and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLT-ORAM-SYNDROME; TRANSCRIPTION FACTOR; NUCLEAR-LOCALIZATION; MUTATIONS; GATA4; DIFFERENTIATION; HEART; CARDIOGENESIS; MORPHOGENESIS; NKX2-5	TBX5 is the gene mutated in Holt-Oran syndrome, an autosomal dominant disorder with complex heart and limb deformities. Its protein product is a member of the T-box family of transcription factors and an evolutionarily conserved dosage-sensitive regulator of heart and limb development. Understanding TBX5 regulation is therefore of paramount importance. Here we uncover the existence of novel exons and provide evidence that TBX5 activity may be extensively regulated through alternative splicing to produce protein isoforms with differing N- and C-terminal domains. These isoforms are also present in human heart, indicative of an evolutionarily conserved regulatory mechanism. The newly identified isoforms have different transcriptional properties and can antagonize TBX5a target gene activation. Droplet Digital PCI1 as well as immunohistochemistry with isoform-specific antibodies reveal differential as well as overlapping expression domains. In particular, we find that the predominant isoform in skeletal myoblasts is Tbx5c, and we show that it is dramatically up-regulated in differentiating myotubes and is essential for myotube formation. Mechanistically, TBX5c antagonizes TBX5a activation of pro-proliferative signals such as IGF-1, FGF-10, and BMP4. The results provide new insight into Tbx5 regulation and function that will further our understanding of its role in health and disease. The finding of new exons in the Tbx5 locus may also be relevant to mutational screening especially in the 30% of Holt-Oram syndrome patients with no mutations in the known TBX5a exons.	[Yamak, Abir; Sheikh-Hassani, Massomeh; Komati, Hiba; Nemer, Mona] Univ Ottawa, Dept Biochem Microbiol & Immunol, Lab Mol Genet & Cardiac Regenerat, Ottawa, ON K1N 6N5, Canada; [Georges, Romain O.; Morin, Martin; Nemer, Mona] Univ Montreal, Inst Rech Clin Montreal, Grad Program Mol Biol, Montreal, PQ H2W 1R7, Canada	University of Ottawa; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Nemer, M (corresponding author), Univ Ottawa, 550 Cumberland,Rm 246, Ottawa, ON K1N 6N5, Canada.	mona.nemer@uottawa.ca			Canadian Heart and Stroke Foundation; McCain Foundation	Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); McCain Foundation	This work was supported by a grant from the Canadian Heart and Stroke Foundation and the McCain Foundation.	Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Borozdin W, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9396; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Camarata T, 2006, J CELL BIOL, V174, P339, DOI 10.1083/jcb.200511109; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Collavoli A, 2003, J MOL CELL CARDIOL, V35, P1191, DOI 10.1016/S0022-2828(03)00231-1; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Georges R, 2008, MOL CELL BIOL, V28, P4052, DOI 10.1128/MCB.02100-07; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Hariri F, 2012, ANN MED, V44, P680, DOI 10.3109/07853890.2011.607468; Heinritz Wolfram, 2005, Hum Mutat, V26, P397, DOI 10.1002/humu.9375; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Kulisz A, 2008, MOL CELL BIOL, V28, P1553, DOI 10.1128/MCB.00935-07; Lavallee G, 2006, EMBO J, V25, P5201, DOI 10.1038/sj.emboj.7601379; Li QY, 1997, NAT GENET, V15, P21; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Nadeau M, 2010, P NATL ACAD SCI USA, V107, P19356, DOI 10.1073/pnas.0914888107; Nemer G, 2003, DEV BIOL, V254, P131, DOI 10.1016/S0012-1606(02)00026-X; Plageman TF, 2004, J BIOL CHEM, V279, P19026, DOI 10.1074/jbc.M314041200; Rochais F, 2014, CARDIOVASC RES, V104, P432, DOI 10.1093/cvr/cvu232; Sato M, 2011, J BIOSCI BIOENG, V112, P273, DOI 10.1016/j.jbiosc.2011.05.007; Stirnimann CU, 2010, J MOL BIOL, V400, P71, DOI 10.1016/j.jmb.2010.04.052; Yamak A, 2014, P NATL ACAD SCI USA, V111, P1415, DOI 10.1073/pnas.1312993111; Yamak A, 2012, AM J PHYSIOL-HEART C, V303, pH1057, DOI 10.1152/ajpheart.00250.2012; Zaragoza MV, 2004, GENE, V330, P9, DOI 10.1016/j.gene.2004.01.017	31	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6844	6856		10.1074/jbc.M114.634451	http://dx.doi.org/10.1074/jbc.M114.634451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25623069	Green Published, hybrid			2022-12-26	WOS:000350991500020
J	Hansen, GJA; Carey, CC				Hansen, Gretchen J. A.; Carey, Cayelan C.			Fish and Phytoplankton Exhibit Contrasting Temporal Species Abundance Patterns in a Dynamic North Temperate Lake	PLOS ONE			English	Article							INTERANNUAL VARIABILITY; COMMUNITY; DIVERSITY; CORE; DISTRIBUTIONS; MACROECOLOGY; ZOOPLANKTON; ASSEMBLAGES; TURNOVER; INSIGHTS	Temporal patterns of species abundance, although less well-studied than spatial patterns, provide valuable insight to the processes governing community assembly. We compared temporal abundance distributions of two communities, phytoplankton and fish, in a north temperate lake. We used both 17 years of observed relative abundance data as well as resampled data from Monte Carlo simulations to account for the possible effects of non-detection of rare species. Similar to what has been found in other communities, phytoplankton and fish species that appeared more frequently were generally more abundant than rare species. However, neither community exhibited two distinct groups of "core" (common occurrence and high abundance) and "occasional" (rare occurrence and low abundance) species. Both observed and resampled data show that the phytoplankton community was dominated by occasional species appearing in only one year that exhibited large variation in their abundances, while the fish community was dominated by core species occurring in all 17 years at high abundances. We hypothesize that the life-history traits that enable phytoplankton to persist in highly dynamic environments may result in communities dominated by occasional species capable of reaching high abundances when conditions allow. Conversely, longer turnover times and broad environmental tolerances of fish may result in communities dominated by core species structured primarily by competitive interactions.	[Hansen, Gretchen J. A.] Wisconsin Dept Nat Resources, Sci Serv, Madison, WI USA; [Carey, Cayelan C.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Carey, CC (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	cayelan@vt.edu	Carey, Cayelan/D-4874-2016	Carey, Cayelan/0000-0001-8835-4476; Hansen, Gretchen/0000-0003-0241-7048	U.S. National Science Foundation through the Riparian Land, People, and Lakes Biocomplexity Project [DEB-083545]; North Temperate Lakes Long-Term Ecological Research Program [DEB-9632853]; NSF [CDI-0941510]; Virginia Tech Department of Biological Sciences; Virginia Tech's Open Access Subvention Fund	U.S. National Science Foundation through the Riparian Land, People, and Lakes Biocomplexity Project(National Science Foundation (NSF)); North Temperate Lakes Long-Term Ecological Research Program; NSF(National Science Foundation (NSF)); Virginia Tech Department of Biological Sciences; Virginia Tech's Open Access Subvention Fund	The data collection for this study was supported by the U.S. National Science Foundation through the Riparian Land, People, and Lakes Biocomplexity Project (DEB-083545) and the North Temperate Lakes Long-Term Ecological Research Program (DEB-9632853). CCC was funded by NSF CDI-0941510 and the Virginia Tech Department of Biological Sciences. Virginia Tech's Open Access Subvention Fund provided funds for publication. The funders had no role in the study design, analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, FOOD WEB MANAGEMENT; Arnott SE, 1999, CAN J FISH AQUAT SCI, V56, P162, DOI 10.1139/cjfas-56-1-162; Becker G. C., 1983, FISHES WISCONSIN; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; BENSON BJ, 1992, CAN J FISH AQUAT SCI, V49, P1493, DOI 10.1139/f92-165; Blackburn TM, 1998, ECOL LETT, V1, P47, DOI 10.1046/j.1461-0248.1998.00005.x; Brock T.D., 1985, EUTROPHIC LAKE LAKE; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Carey CC, 2008, J PLANKTON RES, V30, P893, DOI 10.1093/plankt/fbn055; Chesson PL., 1986, COMMUNITY ECOL; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; COLLINS SL, 1991, ECOLOGY, V72, P654, DOI 10.2307/2937205; Dakos V, 2009, P ROY SOC B-BIOL SCI, V276, P2871, DOI 10.1098/rspb.2009.0584; Dolan JR, 2009, J BIOGEOGR, V36, P887, DOI 10.1111/j.1365-2699.2008.02046.x; Fisher JAD, 2010, GLOBAL ECOL BIOGEOGR, V19, P1, DOI 10.1111/j.1466-8238.2009.00482.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; GAEDKE U, 1992, LIMNOL OCEANOGR, V37, P1202, DOI 10.4319/lo.1992.37.6.1202; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; GASTON KJ, 1989, AM NAT, V134, P761, DOI 10.1086/285010; Genner MJ, 2004, P ROY SOC B-BIOL SCI, V271, P655, DOI 10.1098/rspb.2003.2651; Gibson DJ, 1999, J ECOL, V87, P1064, DOI 10.1046/j.1365-2745.1999.00424.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Guo QF, 2000, J ECOL, V88, P551, DOI 10.1046/j.1365-2745.2000.00466.x; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Hanski I, 1996, J ANIM ECOL, V65, P274, DOI 10.2307/5874; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jackson DA, 2001, CAN J FISH AQUAT SCI, V58, P157, DOI 10.1139/f00-239; Karlsson-Elfgren I, 2003, J PHYCOL, V39, P1050, DOI 10.1111/j.0022-3646.2003.03-030.x; Kitchell JF, 1992, FOOD WEB MANAGEMENTS; LATHROP RC, 1992, FOOD WEB MANAGEMENT, P99; LYONS J, 1987, T AM FISH SOC, V116, P29, DOI 10.1577/1548-8659(1987)116<29:EOWPOT>2.0.CO;2; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; MAGNUSON JJ, 1994, AM ZOOL, V34, P437; Magurran A., 2010, BIOL DIVERSITY FRONT, P85; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Magurran AE, 2007, ECOL LETT, V10, P347, DOI 10.1111/j.1461-0248.2007.01024.x; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; May R.M., 1975, P81; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; NEE S, 1991, P ROY SOC B-BIOL SCI, V243, P161, DOI 10.1098/rspb.1991.0026; Oksanen J., 2020, VEGAN COMMUNITY ECOL; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; Raybaud V, 2008, BIOGEOSCIENCES, V5, P1765, DOI 10.5194/bg-5-1765-2008; Reynolds CS, 1995, NATO ADV SCI INST SE, V38, P115; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Rigosi A, 2014, LIMNOL OCEANOGR, V59, P99, DOI 10.4319/lo.2014.59.1.0099; Scheffer M, 2003, HYDROBIOLOGIA, V491, P9, DOI 10.1023/A:1024404804748; Scrosati RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018982; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Ulrich W, 2004, DIVERS DISTRIB, V10, P263, DOI 10.1111/j.1366-9516.2004.00082.x; Uthermol H., 1958, MITTEILINGEN INTERNA, V9, P1, DOI [10.1080/0 5384680.1958.11904091, DOI 10.1080/05384680.1958.11904091]; Vergnon R, 2009, ECOL LETT, V12, P1079, DOI 10.1111/j.1461-0248.2009.01364.x; Waters T.F., 1977, Advances in Ecological Research, V10, P91, DOI 10.1016/S0065-2504(08)60235-4; WEAVER MJ, 1993, T AM FISH SOC, V122, P1111, DOI 10.1577/1548-8659(1993)122<1111:AFDLFA>2.3.CO;2; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Williams C. B., 1964, PATTERNS BALANCE NAT; WILLIAMS CB, 1953, J ANIM ECOL, V22, P14, DOI 10.2307/1687	59	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0115414	10.1371/journal.pone.0115414	http://dx.doi.org/10.1371/journal.pone.0115414			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651399	Green Published, gold, Green Submitted			2022-12-26	WOS:000349250700001
J	Li, YQ; Yang, HZ; Liu, N; Luo, JX; Wang, Q; Wang, L				Li, Yongquan; Yang, Huizhen; Liu, Na; Luo, Jixian; Wang, Qian; Wang, Lan			Cadmium Accumulation and Metallothionein Biosynthesis in Cadmium-Treated Freshwater Mussel Anodonta woodiana	PLOS ONE			English	Article							TISSUE-SPECIFIC CADMIUM; DIGESTIVE GLAND; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; METAL EXPOSURE; MYTILUS-EDULIS; PROTEIN-LEVELS; INDUCTION; BIOMARKER; BIVALVES	This study investigated the distribution of cadmium (Cd) and the protein level of metallothionein (MT) and examined the relationship of Cd accumulation and the MT concentration in different tissues of freshwater mussel Anodonta woodiana following Cd treatment. The mussels were exposed to Cd (4.21, 8.43, 16.86, 33.72 and 67.45 mg L-1) for 24, 48, 72 and 96 h, respectively. After Cd treatment, the gills, mantle, foot, visceral mass and digestive gland tissues were collected for analysis. We found that, in the controls, Cd distributed in all tissues in the concentration order of gills>mantle>foot>visceral mass>digestive gland. Upon Cd treatment, Cd concentration significantly increased in all tissues. The highest Cd accumulation was found in the digestive gland, which was 0.142 mg g(-1) (P< 0.05). MT levels in the gills and mantle of the mussels increased significantly (P< 0.05), which were in positive correlation with Cd accumulation in the tissues (P< 0.05). In conclusion, our results demonstrated a correlation between Cd accumulation and MT up-regulation in gills and mantle of the mussels after Cd treatment. It is suggested that the protein level of MT in gills and mantle of Anodonta woodiana is a good biomarker for Cd contamination.	[Li, Yongquan; Yang, Huizhen; Liu, Na; Luo, Jixian; Wang, Qian; Wang, Lan] Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China	Shanxi University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China.	cnlanwang@sxu.edu.cn			Doctor Subject Foundation of the Ministry of Education of China [20111401110010]; Youth Science Foundation Project of Shanxi, China [2013021022-4]	Doctor Subject Foundation of the Ministry of Education of China(Ministry of Education, China); Youth Science Foundation Project of Shanxi, China	This research was supported by the Doctor Subject Foundation of the Ministry of Education of China (No. 20111401110010) and the Youth Science Foundation Project of Shanxi, China (No. 2013021022-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; AMIARD JC, 1987, WATER RES, V21, P693, DOI 10.1016/0043-1354(87)90081-9; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Barka S, 2001, COMP BIOCHEM PHYS C, V128, P479, DOI 10.1016/S1532-0456(00)00198-8; BEBIANNO MJ, 1993, AQUAT TOXICOL, V27, P315, DOI 10.1016/0166-445X(93)90061-5; BEBIANNO MJ, 1991, MAR BIOL, V108, P91, DOI 10.1007/BF01313475; BEBIANNO MJ, 1992, COMP BIOCHEM PHYS C, V103, P79, DOI 10.1016/0742-8413(92)90231-U; Berthet B, 2003, ARCH ENVIRON CON TOX, V45, P468, DOI 10.1007/s00244-003-0135-0; Blaise C, 2002, ENVIRON TOXICOL, V17, P170, DOI 10.1002/tox.10048; Boening DW, 1999, ENVIRON MONIT ASSESS, V55, P459, DOI 10.1023/A:1005995217901; Bourdineaud JP, 2006, BIOCHIMIE, V88, P1787, DOI 10.1016/j.biochi.2006.07.021; Burger J, 2008, SCI TOTAL ENVIRON, V389, P37, DOI 10.1016/j.scitotenv.2007.08.037; Bustamante P, 2002, MAR ENVIRON RES, V53, P227, DOI 10.1016/S0141-1136(01)00108-8; Cajaraville MP, 2000, SCI TOTAL ENVIRON, V247, P295, DOI 10.1016/S0048-9697(99)00499-4; Campbell PGC, 2006, ENVIRON CHEM, V3, P387, DOI 10.1071/EN06075; Campbell PGC, 2005, AQUAT TOXICOL, V72, P83, DOI 10.1016/j.aquatox.2004.11.023; Clements William H., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P113, DOI 10.1023/A:1009927612391; Corsi I, 2007, COMP BIOCHEM PHYS C, V145, P413, DOI 10.1016/j.cbpc.2007.01.011; Cosson RP, 2000, CELL MOL BIOL, V46, P295; Cossu C, 1997, ECOTOX ENVIRON SAFE, V38, P122, DOI 10.1006/eesa.1997.1582; COUILLARD Y, 1993, LIMNOL OCEANOGR, V38, P299, DOI 10.4319/lo.1993.38.2.0299; Dallinger R, 1995, MECH METAL INCORPORA, P135; Dalton T, 1997, COMP BIOCHEM PHYS B, V116, P75, DOI 10.1016/S0305-0491(96)00224-6; DALTON T, 1994, NUCLEIC ACIDS RES, V22, P5016, DOI 10.1093/nar/22.23.5016; Enshaei M, 2010, IRAN J ENVIRON HEALT, V7, P287; Fingerman M, 1996, ZOOL STUD, V35, P1; Geffard A, 2001, BIOMARKERS, V6, P91, DOI 10.1080/13547500010000860; Geret F, 2000, OCEANOL ACTA, V23, P261, DOI 10.1016/S0399-1784(00)00118-3; Giamberini L, 2005, ENVIRON RES, V98, P210, DOI 10.1016/j.envres.2004.11.003; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; Isani G, 2000, CELL MOL BIOL, V46, P311; Kalman J, 2010, ECOTOX ENVIRON SAFE, V73, P306, DOI 10.1016/j.ecoenv.2009.10.013; Kim BH, 2011, ECOL ENG, V37, P1957, DOI 10.1016/j.ecoleng.2011.08.008; Ladhar-Chaabouni R, 2012, ENVIRON MONIT ASSESS, V184, P2177, DOI 10.1007/s10661-011-2108-5; Langston William J., 1998, Chapman & Hall Ecotoxicology Series, V7, P219; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080475; Liu LY, 2009, GEN ZOOLOGY, P208, DOI [10.1016/j.mrgentox.2009.07.012, DOI 10.1016/J.MRGENTOX.2009.07.012]; Ma WL, 2009, ARCH ENVIRON CON TOX, V56, P747, DOI 10.1007/s00244-008-9224-4; Ma WL, 2008, ENVIRON TOXICOL, V23, P393, DOI 10.1002/tox.20339; Mao H, 2012, AQUAT TOXICOL, V110, P208, DOI 10.1016/j.aquatox.2012.01.018; Marie V, 2006, BIOMETALS, V19, P399, DOI 10.1007/s10534-005-4064-4; MOORE MN, 1990, HISTOCHEM J, V22, P187, DOI 10.1007/BF02386003; Novelli JLVB, 2000, INT J ENVIRON HEAL R, V10, P125, DOI 10.1080/09603120050021128; ONOSAKA S, 1982, TOXICOL APPL PHARM, V63, P270, DOI 10.1016/0041-008X(82)90049-7; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Pedersen SN, 1996, MAR ENVIRON RES, V42, P241, DOI 10.1016/0141-1136(96)00077-3; Pellerin J, 2009, COMP BIOCHEM PHYS C, V150, P186, DOI 10.1016/j.cbpc.2009.04.008; Perceval O, 2002, ENVIRON POLLUT, V118, P5, DOI 10.1016/S0269-7491(01)00282-2; Rajalakshmi S, 2005, ECOTOX ENVIRON SAFE, V62, P140, DOI 10.1016/j.ecoenv.2005.01.003; Roesijadi G, 1996, COMP BIOCHEM PHYS C, V113, P117, DOI 10.1016/0742-8413(95)02077-2; Siegel A., 2009, METAL IONS LIFE SCI, V5, P51; Silvestre F, 2005, COMP BIOCHEM PHYS C, V140, P39, DOI 10.1016/j.cca.2005.01.004; STUART GW, 1984, P NATL ACAD SCI-BIOL, V81, P7318, DOI 10.1073/pnas.81.23.7318; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Viarengo A, 1997, MAR ENVIRON RES, V44, P69, DOI 10.1016/S0141-1136(96)00103-1; VIARENGO A, 1993, COMP BIOCHEM PHYS C, V104, P355, DOI 10.1016/0742-8413(93)90001-2; VIARENGO A, 1985, MAR ENVIRON RES, V16, P23, DOI 10.1016/0141-1136(85)90018-2; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064020; Wu JP, 2005, COMP BIOCHEM PHYS C, V140, P383, DOI 10.1016/j.cca.2005.03.006; [邢慧芳 Xing Huifang], 2013, [环境科学学报, Acta Scientiae Circumstantiae], V33, P856; Zhou QF, 2003, ENVIRON POLLUT, V125, P301, DOI 10.1016/S0269-7491(03)00145-3; Zorita I, 2007, TOXICOL APPL PHARM, V220, P186, DOI 10.1016/j.taap.2007.01.003; Zorita I, 2005, BIOMARKERS, V10, P342, DOI 10.1080/13547500500264645	64	45	50	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117037	10.1371/journal.pone.0117037	http://dx.doi.org/10.1371/journal.pone.0117037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647043	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600050
J	Wiggers, N; Nauwelaerts, SLP; Hobbs, SJ; Bool, S; Wolschrijn, CF; Back, W				Wiggers, Nathan; Nauwelaerts, Sandra L. P.; Hobbs, Sarah Jane; Bool, Sophie; Wolschrijn, Claudia F.; Back, Willem			Functional Locomotor Consequences of Uneven Forefeet for Trot Symmetry in Individual Riding Horses	PLOS ONE			English	Article							GROUND REACTION FORCES; SWEDISH WARMBLOOD; 3D KINEMATICS; 3-DIMENSIONAL KINEMATICS; FOOT CONFORMATION; DISTAL FORELIMB; HOOF ANGLE; FRONT FEET; LAMENESS; PERFORMANCE	Left-right symmetrical distal limb conformation can be an important prerequisite for a successful performance, and it is often hypothesized that asymmetric or uneven feet are important enhancing factors for the development of lameness. On a population level, it has been demonstrated that uneven footed horses are retiring earlier from elite level competition, but the biomechanical consequences are not yet known. The objectives of this study were to compare the functional locomotor asymmetries of horses with uneven to those with even feet. Hoof kinetics and distal limb kinematics were collected from horses (n = 34) at trot. Dorsal hoof wall angle was used to classify horses as even or uneven (< 1.5 and > 1.5 degrees difference between forefeet respectively) and individual feet as flat (< 50 degrees), medium (between 50 degrees and 55 degrees) or upright (> 55 degrees). Functional kinetic parameters were compared between even and uneven forefeet using MANOVA followed by ANOVA. The relative influences of differences in hoof angle between the forefeet and of absolute hoof angle on functional parameters were analysed using multiple regression analysis (P<0.05). In horses with uneven feet, the side with the flatter foot showed a significantly larger maximal horizontal braking and vertical ground reaction force, a larger vertical fetlock displacement and a suppler fetlock spring. The foot with a steeper hoof angle was linearly correlated with an earlier braking-propulsion transition. The conformational differences between both forefeet were more important for loading characteristics than the individual foot conformation of each individual horse. The differences in vertical force and braking force between uneven forefeet could imply either an asymmetrical loading pattern without a pathological component or a subclinical lameness as a result of a pathological development in the steeper foot.	[Wiggers, Nathan; Bool, Sophie; Back, Willem] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Nauwelaerts, Sandra L. P.] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [Hobbs, Sarah Jane] Univ Cent Lancashire, Ctr Appl Sport & Exercise Sci, Preston PR1 2HE, Lancs, England; [Wolschrijn, Claudia F.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Back, Willem] Univ Ghent, Fac Vet Med, Dept Surg & Anaesthesiol, Merelbeke, Belgium	Utrecht University; University of Antwerp; University of Central Lancashire; Utrecht University; Ghent University	Hobbs, SJ (corresponding author), Univ Cent Lancashire, Ctr Appl Sport & Exercise Sci, Preston PR1 2HE, Lancs, England.	sjhobbs1@uclan.ac.uk		Hobbs, Sarah Jane/0000-0002-1552-8647	University of Central Lancashire; Utrecht University; University of Antwerp	University of Central Lancashire; Utrecht University; University of Antwerp	This work was funded by the the University of Central Lancashire, Utrecht University and the University of Antwerp in relation to resources needed to undertake the study. In addition, Qualisys AB kindly provided 1000 pound towards costs and Kistler Instrument Corp loaned equipment FOC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TM, 2004, EQUINE VET J, V36, P571, DOI 10.2746/0425164044864462; Back W, 2007, J EQUINE VET SCI, V27, P123, DOI 10.1016/j.jevs.2007.01.007; Back W., 2013, EQUINE LOCOMOTION, P175; BALCH O, 1995, COMP CONT EDUC PRACT, V17, P1275; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chateau H, 2006, EQUINE VET J, V38, P164, DOI 10.2746/042516406776563260; Chateau H, 2004, EQUINE VET J, V36, P649, DOI 10.2746/0425164044848217; Chateau H, 2013, VET J, V198, pE20, DOI 10.1016/j.tvjl.2013.09.028; Clayton HM, 2007, VET COMP ORTHOPAED, V20, P86, DOI 10.1160/VCOT-07-01-0011; Clayton HM, 2007, VET COMP ORTHOPAED, V20, P1; Clayton H M, 1990, Equine Vet J Suppl, P86; Clayton HM, 2000, AM J VET RES, V61, P191, DOI 10.2460/ajvr.2000.61.191; CLAYTON HM, 1988, PROC ANN CONV AM ASS, V33, P289; Ducro BJ, 2009, EQUINE VET J, V41, P139, DOI 10.2746/042516409X366130; Ducro BJ, 2009, EQUINE VET J, V41, P144, DOI 10.2746/042516408X363800; DYCE KM, 2009, TXB VET ANATOMY, P586; FARLEY CT, 1993, J EXP BIOL, V185, P71; Gustas P, 2001, Equine Vet J Suppl, P11; Hobbs SJ, 2006, AM J VET RES, V67, P1511, DOI 10.2460/ajvr.67.9.1511; Jonsson L, 2014, LIVEST SCI, V163, P12, DOI 10.1016/j.livsci.2014.02.010; Jonsson L, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-34; Kane AJ, 1998, AM J VET RES, V59, P1545; Kaneene JB, 1997, PREV VET MED, V29, P277, DOI 10.1016/S0167-5877(96)01080-X; Keegan KG, 2010, EQUINE VET J, V42, P92, DOI 10.2746/042516409X479568; KEELING LK, 2001, SOCIAL BEHAV FARM AN, P59; Kroekenstoel AM, 2006, EQUINE VET J, V38, P652, DOI 10.2746/042516406X159089; Kummer M, 2006, VET J, V172, P58, DOI 10.1016/j.tvjl.2005.03.008; McGuigan MP, 2003, J EXP BIOL, V206, P1325, DOI 10.1242/jeb.00254; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; Moleman M, 2006, EQUINE VET J, V38, P170, DOI 10.2746/042516406776563242; Moleman M, 2005, EQUINE VET EDUC, V17, P319, DOI 10.1111/j.2042-3292.2005.tb00401.x; Morris E., 1987, EQUINE EXERC PHYSL, V2, P553; Parkes RSV, 2009, EQUINE VET J, V41, P112, DOI 10.2746/042516408X343000; Parks A.H., 2003, DIAGNOSIS MANAGEMENT, P250; Robertson DGE, 2003, J ELECTROMYOGR KINES, V13, P569, DOI 10.1016/S1050-6411(03)00080-4; Scheffer CJW, 2001, VET QUART, V23, P191, DOI 10.1080/01652176.2001.9695111; Starke SD, 2012, VET J, V193, P73, DOI 10.1016/j.tvjl.2011.10.019; Stashak TS, 2002, ADAMS LAMENESS HORSE, V6th, P1081; van Heel MCV, 2006, EQUINE VET J, V38, P646, DOI 10.2746/042516406X159070; van Heel MCV, 2010, EQUINE VET J, V42, P444, DOI 10.1111/j.2042-3306.2010.00064.x; VELLEMAN PF, 1981, APPL BASICS COMPUTIN, P48; Wallin L, 2000, LIVEST PROD SCI, V63, P275, DOI 10.1016/S0301-6226(99)00126-8; Wallin L, 2001, LIVEST PROD SCI, V68, P97, DOI 10.1016/S0301-6226(00)00244-X; Weishaupt MA, 2006, VET J, V171, P135, DOI 10.1016/j.tvjl.2004.09.004; Willemen MA, 1999, EQUINE VET J, V31, P25, DOI 10.1111/j.2042-3306.1999.tb03787.x; Wilson AM, 1998, EQUINE VET J, V30, P540, DOI 10.1111/j.2042-3306.1998.tb04531.x	47	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0114836	10.1371/journal.pone.0114836	http://dx.doi.org/10.1371/journal.pone.0114836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646752	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600007
J	Zhang, ZH; Yin, JY; Chen, JDZ				Zhang, Zhaohui; Yin, Jieyun; Chen, Jiande D. Z.			Ameliorating Effects of Auricular Electroacupuncture on Rectal Distention-Induced Gastric Dysrhythmias in Rats	PLOS ONE			English	Article							IMPROVES DYSPEPTIC SYMPTOMS; MYOELECTRICAL ACTIVITY; ELECTRICAL-STIMULATION; SLOW WAVES; ACUPUNCTURE; MECHANISMS; MOTILITY; IMPAIRMENT	Gastric slow waves (GSW) are known to regulate gastric motility and are impaired with rectal distention (RD). Electroacupuncture (EA) at body acupoints, such as ST 36, has been shown to improve gastric dysrhythmias; however, little is known about the possible effects of auricular electroacupuncture (AEA) on GSW. To study effects and possible mechanisms of AEA on RD-induced gastric dysrhythmias in rats, ten male Sprague-Dawley (SD) rats implanted with gastric serosal electrodes were studied in two different experiments in fed state. Four sessions were performed in experiment 1 as follows: control (RD, no stimulation), RD+AEA, RD+EA at body points and RD+sham AEA. Two sessions were included in experiment 2 to study mechanisms of AEA: RD + atropine and RD + atropine + AEA. It was found that 1) RD significantly decreased the percentage of normal GSW from 89.8 +/- 3.5% to 76.0 +/- 3.3% (P<0.05); 2) AEA increased the percentage of normal GSW during RD to 94.0 +/- 2.1% (P<0.05 vs. RD) via a reduction in the percentages of tachygastria and arrhythmia (P<0.05 vs. RD); 3) atropine blocked the ameliorating effect of AEA on RD-induced gastric dysrhythmias. Our results demonstrated that RD induces gastric dysrhythmias in fed state in rats. AEA improves RD-induced gastric dysrhythmias via the vagal pathway. AEA may have a therapeutic potential in treating gastric dysrhythmias.	[Zhang, Zhaohui; Yin, Jieyun; Chen, Jiande D. Z.] Nanjing Med Univ, Affiliated Hosp 1, Dept Acupuncture, Nanjing, Jiangsu, Peoples R China; [Chen, Jiande D. Z.] Ningbo Pace Translat Med Res Ctr, Ningbo, Zhejiang, Peoples R China	Nanjing Medical University	Chen, JDZ (corresponding author), Univ Texas Med Branch, Div Gastroenterol, Galveston, TX 77555 USA.	Jiandedzchen@gmail.com	zhang, zh/GWV-4677-2022		National Institutes of Health (NIH) Program [CA149956]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [JX10231801]; NATIONAL CANCER INSTITUTE [R21CA149956] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support was received from the National Institutes of Health (NIH) Program (CA149956) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo M, 2000, DIGEST DIS SCI, V45, P1731, DOI 10.1023/A:1005590413490; Abramochkin DV, 2012, J COMP PHYSIOL B, V182, P101, DOI 10.1007/s00360-011-0602-2; Arrighi N, 2011, PHARMACOL RES, V64, P420, DOI 10.1016/j.phrs.2011.06.009; Browning KN, 2006, AUTON NEUROSCI-BASIC, V126, P2, DOI 10.1016/j.autneu.2006.01.019; Chang FY, 2005, J GASTROEN HEPATOL, V20, P502, DOI 10.1111/j.1440-1746.2004.03751.x; Chen DD, 2008, J GASTROEN HEPATOL, V23, P141, DOI 10.1111/j.1440-1746.2007.05123.x; Chen JDZ, 1998, DIGEST DIS SCI, V43, P80, DOI 10.1023/A:1018876021156; Chen JDZ, 1996, DIGEST DIS SCI, V41, P1538, DOI 10.1007/BF02087897; Chen JDZ, 2003, GASTROENTEROLOGY, V124, P401, DOI 10.1053/gast.2003.50048; Chen JDZ, 2000, ALIMENT PHARM THERAP, V14, P1041, DOI 10.1046/j.1365-2036.2000.00801.x; Chen J, 2008, AM J PHYSIOL-GASTR L, V295, pG614, DOI 10.1152/ajpgi.90322.2008; Choy DSJ, 1998, J ALTERN COMPLEM MED, V4, P399, DOI 10.1089/acm.1998.4.399; Gao XY, 2011, BRAIN RES, V1397, P19, DOI 10.1016/j.brainres.2011.04.034; Gao XY, 2008, AUTON NEUROSCI-BASIC, V138, P50, DOI 10.1016/j.autneu.2007.10.003; Gori L, 2007, EVID-BASED COMPL ALT, V4, P13, DOI 10.1093/ecam/nem106; Guzik Przemyslaw, 2002, Card Electrophysiol Rev, V6, P256, DOI 10.1023/A:1016333109829; Hirsch DP, 2002, ALIMENT PHARM THER, V16, P17, DOI 10.1046/j.1365-2036.2002.01153.x; Hirst GDS, 2004, J PHARMACOL SCI, V96, P1, DOI 10.1254/jphs.CRJ04002X; Inui A, 2004, FASEB J, V18, P439, DOI 10.1096/fj.03-0641rev; Iwa M, 2007, AUTON NEUROSCI-BASIC, V137, P67, DOI 10.1016/j.autneu.2007.08.001; Kima EH, 2001, NEUROSCI LETT, V307, P113, DOI 10.1016/S0304-3940(01)01948-6; Kraus T, 2007, J NEURAL TRANSM, V114, P1485, DOI 10.1007/s00702-007-0755-z; Li H, 2013, ACUPUNCT MED, V31, P57, DOI 10.1136/acupmed-2012-010173; Li MK, 2010, J ALTERN COMPLEM MED, V16, P435, DOI 10.1089/acm.2009.0348; Liu JS, 2012, AM J PHYSIOL-REG I, V303, pR209, DOI 10.1152/ajpregu.00301.2010; Liu S, 2008, NEUROGASTROENT MOTIL, V20, P1204, DOI 10.1111/j.1365-2982.2008.01164.x; Olsson C, 2011, AUTON NEUROSCI-BASIC, V165, P80, DOI 10.1016/j.autneu.2010.07.002; ORGAN AN, 2009, VOPR KURORTOL FIZIOT, V5, P12; Qian L, 2002, DIGEST DIS SCI, V47, P2473, DOI 10.1023/A:1020551824234; Qian LW, 2003, DIGEST DIS SCI, V48, P508, DOI 10.1023/A:1022532515172; Sallam HS, 2010, AM J PHYSIOL-REG I, V299, pR298, DOI 10.1152/ajpregu.00135.2010; Schukro RP, 2014, COMPLEMENT THER MED, V22, P21, DOI 10.1016/j.ctim.2013.10.002; Shi X., 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/894096; SHIRAISHI T, 1995, BRAIN RES BULL, V36, P141, DOI 10.1016/0361-9230(94)00179-5; Sima Lei, 2009, Zhongguo Zhen Jiu, V29, P3; Sun Y, 2010, NEUROGASTROENT MOTIL, V22, P1217, DOI 10.1111/j.1365-2982.2010.01565.x; Takahashi T, 2011, NEUROMODULATION, V14, P8, DOI 10.1111/j.1525-1403.2010.00295.x; Takahashi T, 2006, J GASTROENTEROL, V41, P408, DOI 10.1007/s00535-006-1773-6; Wang J, 2010, J CLIN GASTROENTEROL, V44, P335, DOI 10.1097/MCG.0b013e3181d34572; Wang Yan-Gang, 2007, Zhongguo Zhen Jiu, V27, P245; Xu SP, 2006, DIGEST DIS SCI, V51, P2154, DOI 10.1007/s10620-006-9412-x; Xu XH, 2002, DIGEST DIS SCI, V47, P365, DOI 10.1023/A:1013726223531; Xu XH, 2002, DIGEST DIS SCI, V47, P1746, DOI 10.1023/A:1016484226110; Yang AC, 2011, MED HYPOTHESES, V77, P244, DOI 10.1016/j.mehy.2011.04.021; Yin JY, 2011, AM J PHYSIOL-REG I, V301, pR465, DOI 10.1152/ajpregu.00271.2010; Yin JY, 2010, AM J PHYSIOL-GASTR L, V298, pG563, DOI 10.1152/ajpgi.00252.2009	46	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0114226	10.1371/journal.pone.0114226	http://dx.doi.org/10.1371/journal.pone.0114226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643282	gold, Green Submitted, Green Published			2022-12-26	WOS:000348821200003
J	Bach, JN; Bramkamp, M				Bach, Juri Nino; Bramkamp, Marc			Dissecting the Molecular Properties of Prokaryotic Flotillins	PLOS ONE			English	Article							SPFH DOMAIN; MEMBRANE TOPOLOGY; IN-VITRO; PROTEINS; IDENTIFICATION; OLIGOMERIZATION; ASSOCIATION; REGGIE-1; REGGIE-1/FLOTILLIN-2; PALMITOYLATION	Flotillins are universally conserved proteins that are present in all kingdoms of life. Recently it was demonstrated that the B. subtilis flotillin YuaG (FloT) has a direct influence on membrane domain formation by orchestrating lipid domains. Thereby it allocates a proper environment for diverse cellular machineries. YuaG creates platforms for signal transduction, processes crucial for biofilm formation, sporulation, competence, secretion, and others. Even though, flotillins are an emerging topic of research in the field of microbiology little is known about the molecular architecture of prokaryotic flotillins. All flotillins share common structural elements and are tethered to the membrane N'-terminally, followed by a so called PHB domain and a flotillin domain. We show here that prokaryotic flotillins are, similarly to eukaryotic flotillins, tethered to the membrane via a hairpin loop. Further it is demonstrated by sedimentation assays that B. subtilis flotillins do not bind to the membrane via their PHB domain contrary to eukaryotic flotillins. Size exclusion chromatography experiments, blue native PAGE and cross linking experiments revealed that B. subtilis YuaG can oligomerize into large clusters via the PHB domain. This illustrates an important difference in the setup of prokaryotic flotillins compared to the organization of eukaryotic flotillins.	[Bach, Juri Nino; Bramkamp, Marc] Univ Munich, Dept Biol 1, Munich, Germany	University of Munich	Bramkamp, M (corresponding author), Univ Munich, Dept Biol 1, Munich, Germany.	marc.bramkamp@lmu.de		Bramkamp, Marc/0000-0002-7704-3266	Deutsche Forschungsgemeinschaft [DFG BR 2915/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge financial support from the Deutsche Forschungsgemeinschaft (DFG BR 2915/2-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Bach JN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00059; Bach JN, 2013, MOL MICROBIOL, V88, P1205, DOI 10.1111/mmi.12252; Banning A, 2011, CURR PROTEIN PEPT SC, V12, P725, DOI 10.2174/138920311798841708; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bramkamp M, 2012, BIOL CHEM, V393, P1203, DOI 10.1515/hsz-2012-0185; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Burmann F, 2011, MOL MICROBIOL, V79, P1294, DOI 10.1111/j.1365-2958.2011.07523.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Donovan C, 2009, MICROBIOL-SGM, V155, P1786, DOI 10.1099/mic.0.025312-0; Feng XX, 2014, CHEM BIOL, V21, P1557, DOI 10.1016/j.chembiol.2014.08.018; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hinderhofer M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-10; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kadurin I, 2009, BIOCHEM J, V418, P587, DOI 10.1042/BJ20081662; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kuwahara Y, 2009, BIOPHYS J, V97, P2034, DOI 10.1016/j.bpj.2009.07.034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Monier S, 1996, FEBS LETT, V388, P143, DOI 10.1016/0014-5793(96)00519-4; Monne M, 1999, J MOL BIOL, V293, P807, DOI 10.1006/jmbi.1999.3183; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; PARTRIDGE SR, 1991, MOL MICROBIOL, V5, P757, DOI 10.1111/j.1365-2958.1991.tb00746.x; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; SALZER U, 1993, BIOCHIM BIOPHYS ACTA, V1151, P149, DOI 10.1016/0005-2736(93)90098-K; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schurek EM, 2014, J BIOL CHEM, V289, P11262, DOI 10.1074/jbc.M113.521773; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Snyers L, 1999, FEBS LETT, V449, P101, DOI 10.1016/S0014-5793(99)00417-2; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Stuermer CAO, 2011, BBA-MOL BASIS DIS, V1812, P415, DOI 10.1016/j.bbadis.2010.12.004; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Vitrac H, 2013, P NATL ACAD SCI USA, V110, P9338, DOI 10.1073/pnas.1304375110; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yepes A, 2012, MOL MICROBIOL, V86, P457, DOI 10.1111/j.1365-2958.2012.08205.x	53	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116750	10.1371/journal.pone.0116750	http://dx.doi.org/10.1371/journal.pone.0116750			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635948	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700057
J	Hofmann, F; Blasche, R; Kasper, M; Barth, K				Hofmann, Falk; Blaesche, Robert; Kasper, Michael; Barth, Kathrin			A Co-Culture System with an Organotypic Lung Slice and an Immortal Alveolar Macrophage Cell Line to Quantify Silica-Induced Inflammation	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; EPITHELIAL-CELLS; IN-VITRO; IMMUNOHISTOCHEMICAL EVIDENCE; INTRATRACHEAL INSTILLATION; DECREASED EXPRESSION; CAVEOLIN-1 PROTECTS; CRITICAL REGULATOR; BLEOMYCIN; NANOPARTICLES	There is growing evidence that amorphous silica nanoparticles cause toxic effects on lung cells in vivo as well as in vitro and induce inflammatory processes. The phagocytosis of silica by alveolar macrophages potentiates these effects. To understand the underlying molecular mechanisms of silica toxicity, we applied a co-culture system including the immortal alveolar epithelial mouse cell line E10 and the macrophage cell line AMJ2-C11. In parallel we exposed precision-cut lung slices (lacking any blood cells as well as residual alveolar macrophages) of wild type and P2rx7(-/-) mice with or without AMJ2-C11 cells to silica nanoparticles. Exposure of E10 cells as well as slices of wild type mice resulted in an increase of typical alveolar epithelial type 1 cell proteins like T1 alpha, caveolin-1 and -2 and PKC-beta 1, whereas the co-culture with AMJ2-C11 showed mostly a slightly lesser increase of these proteins. In P2rx7(-/-) mice most of these proteins were slightly decreased. ELISA analysis of the supernatant of wild type and P2rx7(-/-) mice precision-cut lung slices showed decreased amounts of IL-6 and TNF-alpha when incubated with nano-silica. Our findings indicate that alveolar macrophages influence the early inflammation of the lung and also that cell damaging reagents e.g. silica have a smaller impact on P2rx7(-/-) mice than on wild type mice. The co-culture system with an organotypic lung slice is a useful tool to study the role of alveolar macrophages during lung injury at the organoid level.	[Hofmann, Falk; Blaesche, Robert; Kasper, Michael; Barth, Kathrin] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Anat, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Barth, K (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Anat, Dresden, Germany.	kathrin.barth@tu-dresden.de	Barth, Kathrin/AGX-6107-2022					Antonini JM, 2000, LUNG, V178, P341, DOI 10.1007/s004080000038; Barth K, 2008, INT J BIOCHEM CELL B, V40, P2230, DOI 10.1016/j.biocel.2008.03.001; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; Blasche R, 2012, INT J BIOCHEM CELL B, V44, P514, DOI 10.1016/j.biocel.2011.12.003; Chen M, 2005, EXP CELL RES, V305, P51, DOI 10.1016/j.yexcr.2004.12.021; DieckmannSchuppert A, 1997, CELL TISSUE RES, V288, P119, DOI 10.1007/s004410050799; Ebeling G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100282; Englert JM, 2008, AM J PATHOL, V172, P583, DOI 10.2353/ajpath.2008.070569; Eom HJ, 2009, TOXICOL IN VITRO, V23, P1326, DOI 10.1016/j.tiv.2009.07.010; Fujimura N, 2000, Curr Opin Pulm Med, V6, P140, DOI 10.1097/00063198-200003000-00010; Gabazza EC, 2004, PATHOL INT, V54, P774, DOI 10.1111/j.1440-1827.2004.01754.x; Gilberti RM, 2008, AM J RESP CELL MOL, V39, P619, DOI 10.1165/rcmb.2008-0046OC; Green FHY, 2007, TOXICOL PATHOL, V35, P136, DOI 10.1080/01926230601132055; Held HD, 1999, BRIT J PHARMACOL, V126, P1191, DOI 10.1038/sj.bjp.0702394; Herold S, 2013, AM J PHYSIOL-LUNG C, V305, pL665, DOI 10.1152/ajplung.00232.2013; Herzog CR, 1996, ONCOGENE, V13, P1885; Huaux F, 2007, CURR OPIN ALLERGY CL, V7, P168, DOI 10.1097/ACI.0b013e32802bf8a5; Jin Y, 2008, AM J RESP CELL MOL, V39, P171, DOI 10.1165/rcmb.2007-0323OC; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; Jin Y, 2009, FASEB J, V23, P341, DOI 10.1096/fj.08-108423; Kasper M, 2000, INT J RADIAT BIOL, V76, P493; KASPER M, 1995, HISTOCHEM CELL BIOL, V104, P397, DOI 10.1007/BF01458134; Kasper M, 2004, HISTOCHEM CELL BIOL, V121, P131, DOI 10.1007/s00418-003-0612-6; Kasper M, 1998, HISTOCHEM CELL BIOL, V109, P41; Kasper M, 2009, CURR CANCER DRUG TAR, V9, P341, DOI 10.2174/156800909788166501; Kojima S, 2014, TOXICOLOGY, V321, P13, DOI 10.1016/j.tox.2014.03.008; Koslowski R, 1998, EUR RESPIR J, V12, P1397, DOI 10.1183/09031936.98.12061397; Li XY, 1999, INHAL TOXICOL, V11, P709; Lin WS, 2006, TOXICOL APPL PHARM, V217, P252, DOI 10.1016/j.taap.2006.10.004; Linge A, 2007, ANTICANCER RES, V27, P1343; McElroy MC, 2004, EUR RESPIR J, V24, P664, DOI 10.1183/09031936.04.00096003; Moncao-Ribeiro LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110185; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mungunsukh O, 2010, AM J PHYSIOL-LUNG C, V298, pL696, DOI 10.1152/ajplung.00322.2009; Nabeshi H, 2010, PHARMAZIE, V65, P199, DOI 10.1691/ph.2010.9268; Nemmar A, 2003, TOXICOL APPL PHARM, V186, P38, DOI 10.1016/S0041-008X(02)00024-8; Odajima N, 2007, J HISTOCHEM CYTOCHEM, V55, P899, DOI 10.1369/jhc.7A7203.2007; PALLERONI AV, 1991, INT J CANCER, V49, P296, DOI 10.1002/ijc.2910490226; Rao KMK, 2004, ENVIRON HEALTH PERSP, V112, P1679, DOI 10.1289/ehp.7295; Rastrick J, 2014, MINERVA MED, V105, P9; Riteau N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.144; Shi YL, 2010, J TOXICOL ENV HEAL A, V73, P748, DOI 10.1080/15287391003614042; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; VANHEE D, 1995, EUR RESPIR J, V8, P834; Wallach-Dayan SB, 2006, AM J PHYSIOL-LUNG C, V290, pL790, DOI 10.1152/ajplung.00300.2004; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wiley JS, 2012, PURINERG SIGNAL, V8, P579, DOI 10.1007/s11302-012-9308-5; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wottrich R, 2004, INT J HYG ENVIR HEAL, V207, P353, DOI 10.1078/1438-4639-00300; Ye YY, 2010, TOXICOL IN VITRO, V24, P751, DOI 10.1016/j.tiv.2010.01.001; Ye YY, 2010, ENVIRON TOXICOL PHAR, V29, P131, DOI 10.1016/j.etap.2009.12.002; Yu KO, 2009, J NANOPART RES, V11, P15, DOI 10.1007/s11051-008-9417-9; Zhang M, 2009, AM J PHYSIOL-LUNG C, V297, pL945, DOI 10.1152/ajplung.00081.2009; Zhang QW, 2003, J OCCUP HEALTH, V45, P23, DOI 10.1539/joh.45.23	55	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117056	10.1371/journal.pone.0117056	http://dx.doi.org/10.1371/journal.pone.0117056			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635824	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700069
J	Zhong, YF; Wang, K; Zhang, XW; Cai, XF; Chen, YP; Deng, YY				Zhong, Yifei; Wang, Ke; Zhang, Xianwen; Cai, Xiaofan; Chen, Yiping; Deng, Yueyi			Nephrokeli, a Chinese Herbal Formula, May Improve IgA Nephropathy through Regulation of the Sphingosine-1-Phosphate Pathway	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; PROTEIN-COUPLED RECEPTORS; SPHINGOSINE 1-PHOSPHATE; CELL-PROLIFERATION; CANCER CELLS; KINASE; ACTIVATION; EXPRESSION; APIGENIN; FRUITS	Nephrokeli (NPKL) is a Chinese herbal formula that has been used to treat patients with IgA nephropathy (IgAN) for improvement of proteinuria and kidney injury. However, the mechanism remains unclear. Sphingosine-1-phosphate (S1P) and its receptors S1PR2 and S1PR3 are known to play an important role in kidney disease. Here, we tested whether NPKL is able to regulate the S1P pathway in the kidney of IgAN rats. Four groups of rats were included in the study: Control, IgAN, IgAN treated with losartan, and IgAN treated with NPKL. The IgAN model was generated by injection of bovine serum albumin and staphylococcus enterotoxin B. We found that IgAN rats had increased staining for proliferating cell nuclear antigen (PCNA) in the mesangial area and increased mRNA and protein levels of S1PR2 and S1PR3 in the kidney compared to control rats. Connective tissue growth factor (CTGF), a downstream growth factor in the S1P pathway, was also elevated in the kidney of IgAN rats. Treatment with either NPKL or losartan was able to reduce PCNA staining and the expression of both S1PR2 and S1PR3 in the kidney of IgAN rats. However, NPKL (but not losartan treatment) reduced the expression of CTGF in the kidney of IgAN rats. In addition, we treated rat mesangial cells with sera collected from either NPKL-treated rats or control rats and found that NPKL-serum was able to reduce S1P-induced mesangial cell proliferation and the expression of S1PR2/S1PR3 and CTGF. NPKL also attenuates expression of fibrosis, inflammation, and oxidative stress markers in the kidney of IgAN rats. Our studies provide the mechanism by which NPKL attenuates kidney injury in IgAN rats.	[Zhong, Yifei; Zhang, Xianwen; Cai, Xiaofan; Chen, Yiping; Deng, Yueyi] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Nephrol, Shanghai, Peoples R China; [Wang, Ke] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Surg Res Inst Tradit Chinese Med Combined Western, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Zhong, YF (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Nephrol, Shanghai, Peoples R China.	yifeilily@126.com; dengyueyi@medmail.com.cn	Chen, Yi/HIR-2608-2022; zhang, xian/GYA-0290-2022		National Natural Science Foundation of China [1999-30901944]; Shanghai Bureau of Science and Technology [2000-10QA1406500]; Shanghai Bureau of Health [2011-XYQ2011059]; Shanghai Pujiang Program [14PJ1408000]; Shanghai Three-Years Development Program for Traditional Chinese Medicine [ZYSNXD-CC-HPGC-JD-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Bureau of Science and Technology; Shanghai Bureau of Health; Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Three-Years Development Program for Traditional Chinese Medicine	The research conducted in this manuscript was supported by the grants to Dr. Yifei Zhong from the National Natural Science Foundation of China for Young Investigators (1999-30901944), the Shanghai Bureau of Science and Technology for Young Investigator (2000-10QA1406500), and the Shanghai Bureau of Health for Young Investigators (2011-XYQ2011059). Shanghai Pujiang Program (14PJ1408000), Shanghai Three-Years Development Program for Traditional Chinese Medicine (ZYSNXD-CC-HPGC-JD-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 1999, J BIOL CHEM, V274, P3994, DOI 10.1074/jbc.274.7.3994; Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Brizuela L, 2007, J LIPID RES, V48, P2264, DOI 10.1194/jlr.M700291-JLR200; Coppo R, 2010, J NEPHROL, V23, P626; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; EMANCIPATOR SN, 1987, LAB INVEST, V57, P269; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Geoffroy K, 2004, J BIOL CHEM, V279, P34343, DOI 10.1074/jbc.M403273200; Harrison ME, 2014, EXP MOL PATHOL, V97, P211, DOI 10.1016/j.yexmp.2014.07.006; He ZD, 2001, CHEM PHARM BULL, V49, P780, DOI 10.1248/cpb.49.780; Heringdorf DM, 1999, FEBS LETT, V461, P217, DOI 10.1016/S0014-5793(99)01463-5; Huwiler A, 2006, CURR PHARM DESIGN, V12, P4625, DOI 10.2174/138161206779010422; Jin D, 2015, CELL BIOCHEM BIOPHYS, V71, P1349, DOI 10.1007/s12013-014-0355-0; Katsuma S, 2005, FEBS LETT, V579, P2576, DOI 10.1016/j.febslet.2005.03.073; Katsuma S, 2002, GENES CELLS, V7, P1217, DOI 10.1046/j.1365-2443.2002.00594.x; Katsuma S., 2001, Pharmacogenomics Journal, V1, P211; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Li LS, 2004, KIDNEY INT, V66, P920, DOI 10.1111/j.1523-1755.2004.00837.x; Liu RJ, 2014, DIABETES, V63, P2440, DOI 10.2337/db13-1810; Liu Yi, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1308; Liu ZH., 1989, CHINESE J NEPHROL, V5, P6; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Olivera A, 2001, PROSTAG OTH LIPID M, V64, P123, DOI 10.1016/S0090-6980(01)00108-3; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Rithidech KN, 2012, MUTAT RES-GEN TOX EN, V749, P29, DOI 10.1016/j.mrgentox.2012.08.001; Shi LF, 1998, BIOMED CHROMATOGR, V12, P27; Wahab NA, 2001, BIOCHEM J, V359, P77, DOI 10.1042/0264-6021:3590077; Weston BS, 2003, J AM SOC NEPHROL, V14, P601, DOI 10.1097/01.ASN.0000051600.53134.B9; WIDSTAMATTORPS U, 1992, CLIN NEPHROL, V38, P245; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Xiao WQ, 2014, INT J MOL SCI, V15, P11957, DOI 10.3390/ijms150711957; XU B, 2011, CHINESE J INTEGRATED, V12, P333; Yamashita H, 2006, J SURG RES, V130, P80, DOI 10.1016/j.jss.2005.08.004; Zhang GF, 1999, GENE, V227, P89, DOI 10.1016/S0378-1119(98)00589-7; Zhang XX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0107072, 10.1371/journal.pone.0110243]; ZHANG Y, 2007, J GUANGZHOU U TRADIT, V24, P231; Zhong YF, 2013, KIDNEY INT, V84, P1108, DOI 10.1038/ki.2013.276; [周玲 ZHOU Ling], 2008, [中药新药与临床药理, Traditional Chinese Drug Research and Clinical Plarmacology], V19, P259; Zhu WJ, 2012, LIFE SCI, V91, P369, DOI 10.1016/j.lfs.2012.08.013	42	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116873	10.1371/journal.pone.0116873	http://dx.doi.org/10.1371/journal.pone.0116873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633986	Green Published, Green Submitted, gold			2022-12-26	WOS:000348609800011
J	Yamada, H; Yamaguchi, M; Chikamatsu, K; Aono, A; Mitarai, S				Yamada, Hiroyuki; Yamaguchi, Masashi; Chikamatsu, Kinuyo; Aono, Akio; Mitarai, Satoshi			Structome Analysis of Virulent Mycobacterium tuberculosis, Which Survives with Only 700 Ribosomes per 0.1 fl of Cytoplasm	PLOS ONE			English	Article							FREEZE-SUBSTITUTION; ELECTRON-MICROSCOPY; EXOPHIALA-DERMATITIDIS; OUTER-MEMBRANE; YEAST-CELLS; GROWTH; SUSCEPTIBILITY; RESISTANCE; SEQUENCE; RNA	We previously reported the exquisite preservation of the ultrastructures of virulent Mycobacterium tuberculosis cells processed through cryofixation and rapid freeze substitution. Here, we report the "structome" analysis (i.e., the quantitative three-dimensional structural analysis of a whole cell at the electron microscopic level) of virulent M. tuberculosis using serial ultrathin sections prepared after cryofixation and rapid freeze substitution and analyzed by transmission electron microscopy. Five M. tuberculosis cells, which were contained in the serial ultrathin cross sections encompassing from one end to the other, were cut into 24, 36, 69, 55, and 63 serial ultrathin sections, respectively. On average, the cells were 2.71 +/- 1.05 mu m in length, and the average diameter of the cell was 0.345 +/- 0.029 mu m. The outer membrane and plasma membrane surface areas were 3.04 +/- 1.33 mu m(2) and 2.67 +/- 1.19 mu m(2), respectively. The cell, outer membrane, periplasm, plasma membrane, and cytoplasm volumes were 0.293 +/- 0.113 fl (= mu m(3)), 0.006 +/- 0.003 fl, 0.060 +/- 0.021 fl, 0.019 +/- 0.008 fl, and 0.210 +/- 0.091 fl, respectively. The average total ribosome number was 1,672 +/- 568, and the ribosome density was 716.5 +/- 171.4/0.1 fl. This is the first report of a structome analysis of M. tuberculosis cells prepared as serial ultrathin sections following cryofixation and rapid freeze substitution and examined by transmission electron microscopy. These data are based on the direct measurement and enumeration of exquisitely preserved single-cell structures in transmission electron microscopy images rather than calculations or assumptions from indirect biochemical or molecular biological data. In addition, these data may explain the slow growth of M. tuberculosis and enhance understanding of the structural properties related to the expression of antigenicity, acid-fastness, and the mechanism of drug resistance, particularly in regard to the ratio of target to drug concentrations.	[Yamada, Hiroyuki; Chikamatsu, Kinuyo; Aono, Akio; Mitarai, Satoshi] Japan Anti TB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Kiyose, Tokyo, Japan; [Yamaguchi, Masashi] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan	Chiba University	Yamada, H (corresponding author), Japan Anti TB Assoc, Res Inst TB, Dept Mycobacterium Reference & Res, Kiyose, Tokyo, Japan.	hyamada@jata.or.jp		Yamada, Hiroyuki/0000-0002-2720-9125	Ministry of Health, Labour and Welfare of Japan [H24-SHINKO-IPPAN-011]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Health Science Research grant (H24-SHINKO-IPPAN-011) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Ardito F, 2001, J CLIN MICROBIOL, V39, P4440, DOI 10.1128/JCM.39.12.4440-4444.2001; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Biswas SK, 2003, J ELECTRON MICROSC, V52, P133, DOI 10.1093/jmicro/52.2.133; Calder N, 1976, THE HUMAN CONSPIRACY, P75; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox RA, 2003, MICROBIOL-SGM, V149, P729, DOI 10.1099/mic.0.25645-0; Cox RA, 2003, MICROBIOLOGY, V150, P1413; Cox RA, 2007, MICROBIOL-SGM, V153, P3337, DOI 10.1099/mic.0.2007/005868-0; Cox RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059883; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jagielski T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100078; Ohta K, 2012, MICRON, V43, P612, DOI 10.1016/j.micron.2011.11.001; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Pelchovich G, 2013, INT J ANTIMICROB AG, V42, P129, DOI 10.1016/j.ijantimicag.2013.04.001; Santi I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3470; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Tekwu EM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-113; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Yamada H, 2014, J MICROBIOL METH, V96, P50, DOI 10.1016/j.mimet.2013.10.019; Yamada H, 2012, TUBERCULOSIS, V92, P351, DOI 10.1016/j.tube.2012.02.006; Yamada H, 2010, J MICROBIOL METH, V80, P14, DOI 10.1016/j.mimet.2009.09.022; Yamaguchi M, 2002, EXP CELL RES, V279, P71, DOI 10.1006/excr.2002.5578; Yamaguchi M., 2006, Current trends in microbiology, Volume 2, P1; Yamaguchi M, 2011, J ELECTRON MICROSC, V60, P321, DOI 10.1093/jmicro/dfr052; Yamaguchi M, 2009, J ELECTRON MICROSC, V58, P261, DOI 10.1093/jmicro/dfp013; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	28	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117109	10.1371/journal.pone.0117109	http://dx.doi.org/10.1371/journal.pone.0117109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629354	gold, Green Submitted, Green Published			2022-12-26	WOS:000348732100066
J	Mather, KA; Armstrong, NJ; Wen, W; Kwok, JB; Assareh, AA; Thalamuthu, A; Reppermund, S; Duesing, K; Wright, MJ; Ames, D; Trollor, JN; Brodaty, H; Schofield, PR; Sachdev, PS				Mather, Karen A.; Armstrong, Nicola J.; Wen, Wei; Kwok, John B.; Assareh, Amelia A.; Thalamuthu, Anbupalam; Reppermund, Simone; Duesing, Konsta; Wright, Margaret J.; Ames, David; Trollor, Julian N.; Brodaty, Henry; Schofield, Peter R.; Sachdev, Perminder S.			Investigating the Genetics of Hippocampal Volume in Older Adults without Dementia	PLOS ONE			English	Article							COMMON VARIANTS; ASSOCIATION; GENOTYPE; HERITABILITY; METAANALYSIS; PERSPECTIVE	Hippocampal atrophy is observed with ageing and age-related neurodegenerative disease. Identification of the genetic correlates of hippocampal volume (HV) and atrophy may assist in elucidating the mechanisms of ageing and age-related neurodegeneration. Using two community cohorts of older Caucasians we estimated the heritability of HV and examined associations of HV with previously identified single nucleotide polymorphisms (SNPs). In addition we undertook genome-association studies (GWAS) examining HV and HV atrophy. Participants were community-dwelling non-demented older adults from the longitudinal Sydney Memory and Ageing Study (Sydney MAS) (N = 498) and the Older Australian Twins Study (OATS) (N = 351) aged 65 and over. HV was measured using T1-weighted magnetic resonance images. Heritability of HV was estimated in OATS. Genome-wide genotyping was imputed using the 1K Genomes reference set. Associations with HV-candidate and Alzheimer's disease (AD)-related SNPs were investigated. A GWAS examining HV (in both cohorts) and an exploratory GWAS of HV atrophy over two years (in Sydney MAS only) were also undertaken. HV heritability was estimated at 62-65%. The previously identified GWAS HV SNP (rs6581612) and the candidate BDNF SNP (rs6265) were nominally significant (p = 0.047 and p = 0.041 respectively). No AD-related SNPs, including the APOE epsilon 4 polymorphism, were significant. No significant results were observed for either of the GWAS undertaken. Despite our estimate of a high heritability of HV, our results are consistent with a highly polygenic model suggesting that SNPs identified from prior studies, including GWAS meta-analyses, can be difficult to replicate in smaller samples of older adults.	[Mather, Karen A.; Armstrong, Nicola J.; Wen, Wei; Assareh, Amelia A.; Thalamuthu, Anbupalam; Reppermund, Simone; Trollor, Julian N.; Brodaty, Henry; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Armstrong, Nicola J.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Armstrong, Nicola J.] UNSW, Sch Math & Stat, Sydney, NSW, Australia; [Kwok, John B.; Schofield, Peter R.] Neurosci Res Australia, Sydney, NSW, Australia; [Kwok, John B.; Schofield, Peter R.] UNSW, Sch Med Sci, Sydney, NSW, Australia; [Duesing, Konsta] CSIRO, Anim Food & Hlth Sci Div, Sydney, NSW, Australia; [Wright, Margaret J.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Ames, David] Royal Melbourne Hosp, Natl Ageing Res Inst, Melbourne, Vic, Australia; [Ames, David] Univ Melbourne, Acad Unit Psychiat Old Age, Melbourne, Vic, Australia; [Trollor, Julian N.] UNSW, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia; [Brodaty, Henry] UNSW, Primary Dementia Collaborat Res Ctr, Sydney, NSW, Australia; [Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO); QIMR Berghofer Medical Research Institute; National Ageing Research Institute; Royal Melbourne Hospital; University of Melbourne; University of New South Wales Sydney; University of New South Wales Sydney	Mather, KA (corresponding author), Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia.	karen.mather@unsw.edu.au	Wright, Margaret Jane/A-4560-2016; Karen, Mather A/O-9795-2016; Duesing, Konsta/H-2802-2013; Armstrong, Nicola J./AAF-3045-2021; Thalamuthu, Anbupalam/Z-5545-2019; Sachdev, Perminder/ABC-1137-2020; Schofield, Peter/C-9669-2011	Wright, Margaret Jane/0000-0001-7133-4970; Karen, Mather A/0000-0003-4143-8941; Duesing, Konsta/0000-0003-3103-0600; Armstrong, Nicola J./0000-0002-4477-293X; Thalamuthu, Anbupalam/0000-0002-7114-1260; Sachdev, Perminder/0000-0002-9595-3220; Kwok, John/0000-0001-9574-6195; Wen, Wei/0000-0003-2753-3870; Trollor, Julian/0000-0002-7685-2977; Schofield, Peter/0000-0003-2967-9662	Australian National Health and Medical Research Council (NHMRC) [350833, 568969]; NHMRC/Australian Research Council Strategic Award [401162]; NHMRC Project Grant [1045325, 525453]; NHMRC Enabling Grant [310667]; Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund Grant; NHMRC Grant [401184]; Australian Government - Dementia Collaborative Research Centre (DCRC), UNSW; DCRC; Alzheimer's Australia Dementia Research Foundation Postdoctoral Fellowship; NHMRC Capacity Building Grant [568940]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020403] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC/Australian Research Council Strategic Award(Australian Research Council); NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Enabling Grant(National Health and Medical Research Council (NHMRC) of Australia); Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund Grant; NHMRC Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Government - Dementia Collaborative Research Centre (DCRC), UNSW(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); DCRC; Alzheimer's Australia Dementia Research Foundation Postdoctoral Fellowship; NHMRC Capacity Building Grant(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a number of sources. Sydney MAS was supported by the Australian National Health and Medical Research Council (NHMRC) Program Grants 350833 and 568969. OATS is supported by the NHMRC/Australian Research Council Strategic Award 401162 and NHMRC Project Grant 1045325. OATS was facilitated through access to the Australian Twin Registry, a national research resource supported by the NHMRC Enabling Grant 310667, administered by the University of Melbourne. OATS genotyping was partly funded by a Commonwealth Scientific and Industrial Research Organisation Flagship Collaboration Fund Grant. DNA was extracted by Genetic Repositories Australia, an Enabling Facility supported by the NHMRC Grant 401184. Henry Brodaty is supported by the Australian Government funded Dementia Collaborative Research Centre (DCRC), UNSW. Amelia Assareh was supported by a PhD scholarship from the DCRC. Nicola Armstrong is supported by the NHMRC Project Grant 525453 and Karen Mather is supported by an Alzheimer's Australia Dementia Research Foundation Postdoctoral Fellowship. Both Simone Reppermund and Karen Mather are supported by the NHMRC Capacity Building Grant 568940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Batouli SAH, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.10.079; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Blokland GAM, 2012, TWIN RES HUM GENET, V15, P351, DOI 10.1017/thg.2012.11; Boker S.M., 2012, OPENMX 1 3 USER GUID; den Braber A, 2013, NEUROIMAGE, V83, P98, DOI 10.1016/j.neuroimage.2013.06.027; Ferencz B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00198; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Jak AJ, 2007, DEMENT GERIATR COGN, V23, P382, DOI 10.1159/000101340; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang JY, 2014, NEUROIMAGE, V86, P203, DOI 10.1016/j.neuroimage.2013.08.022; Kim H, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.013; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Melville SA, 2012, ANN NEUROL, V72, P65, DOI 10.1002/ana.23644; Molendijk ML, 2012, AM J MED GENET B, V159B, P731, DOI 10.1002/ajmg.b.32078; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Mueller SG, 2009, HIPPOCAMPUS, V19, P558, DOI 10.1002/hipo.20614; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Sachdev PS, 2009, TWIN RES HUM GENET, V12, P573, DOI 10.1375/twin.12.6.573; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034078; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Sullivan EV, 2001, HIPPOCAMPUS, V11, P754, DOI 10.1002/hipo.1091; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	32	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116920	10.1371/journal.pone.0116920	http://dx.doi.org/10.1371/journal.pone.0116920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625606	Green Published, gold			2022-12-26	WOS:000348821400023
J	Balan, M; Teran, EMY; Waaga-Gasser, AM; Gasser, M; Choueiri, TK; Freeman, G; Pal, S				Balan, Murugabaskar; Mier y Teran, Eduardo; Waaga-Gasser, Ana Maria; Gasser, Martin; Choueiri, Toni K.; Freeman, Gordon; Pal, Soumitro			Novel Roles of c-Met in the Survival of Renal Cancer Cells through the Regulation of HO-1 and PD-L1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; HEME OXYGENASE-1; TYROSINE KINASE; CARCINOMA PATIENTS; T-CELLS; RECEPTOR; RAS; PROTEIN; B7-H1; ACTIVATION	The receptor tyrosine kinase c-Met is overexpressed in renal cancer cells and can play major role in the growth and survival of tumor. We investigated how the c-Met-mediated signaling through binding to its ligand hepatocyte growth factor (HGF) can modulate the apoptosis and immune escape mechanism(s) of renal cancer cells by the regulations of novel molecules heme oxygenase-1 (HO-1) and programmed death-1 ligand 1 (PD-L1). We found that HGF/c-Met-mediated signaling activated the Ras/Raf pathway and down-regulated cancer cell apoptosis; and it was associated with the overexpression of cytoprotective HO-1 and anti-apoptotic Bcl-2/Bcl-xL. c-Met-induced HO-1 overexpression was regulated at the transcriptional level. Next, we observed that c-Met induction markedly up-regulated the expression of the negative co-stimulatory molecule PD-L1, and this can be prevented following treatment of the cells with pharmacological inhibitors of c-Met. Interestingly, HGF/c-Met-mediated signaling could not induce PD-L1 at the optimum level when either Ras or HO-1 was knocked down. To study the functional significance of c-Met-induced PD-L1 expression, we performed a co-culture assay using mouse splenocytes (expressing PD-L1 receptor PD-1) and murine renal cancer cells (RENCA, expressing high PD-L1). We observed that the splenocyte-mediated apoptosis of cancer cells during co-culture was markedly increased in the presence of either c-Met inhibitor or PD-L1 neutralizing antibody. Finally, we found that both c-Met and PD-L1 are significantly up-regulated and co-localized in human renal cancer tissues. Together, our study suggests a novel mechanism(s) by which c-Met can promote increased survival of renal cancer cells through the regulation of HO-1 and PD-L1.	[Balan, Murugabaskar; Mier y Teran, Eduardo; Pal, Soumitro] Boston Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Balan, Murugabaskar; Choueiri, Toni K.; Freeman, Gordon; Pal, Soumitro] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Choueiri, Toni K.; Freeman, Gordon] Dana Farber Canc Inst, Boston, MA 02115 USA; [Waaga-Gasser, Ana Maria; Gasser, Martin] Univ Wurzburg, Dept Surg Mol Oncol & Immunol, D-97080 Wurzburg, Germany	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Wurzburg	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu	Freeman, Gordon/AAC-5380-2019; Choueiri, Toni/K-5238-2019	Freeman, Gordon/0000-0002-7210-5616; Choueiri, Toni/0000-0002-9201-3217	National Institutes of Health [R01 CA131145, R21 CA172946]; NATIONAL CANCER INSTITUTE [R21CA172946, R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01 CA131145 and R21 CA172946 (to S. P.).	Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Baek JH, 2012, J IMMUNOL, V189, P1699, DOI 10.4049/jimmunol.1200729; Balan M, 2014, J BIOL CHEM, V289, P3126, DOI 10.1074/jbc.M113.508044; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Benkhoucha M, 2010, P NATL ACAD SCI USA, V107, P6424, DOI 10.1073/pnas.0912437107; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Datta D, 2009, CANCER RES, V69, P8902, DOI 10.1158/0008-5472.CAN-09-1404; FUJITA J, 1988, CANCER RES, V48, P5251; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gibney GT, 2013, ANN ONCOL, V24, P343, DOI 10.1093/annonc/mds463; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.396; Hirano F, 2005, CANCER RES, V65, P1089; Kamimoto M, 2009, BIOCHEM BIOPH RES CO, V380, P333, DOI 10.1016/j.bbrc.2009.01.080; Ke BB, 2012, J HEPATOL, V56, P359, DOI 10.1016/j.jhep.2011.05.023; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kuroda N, 2010, PATHOL INT, V60, P9, DOI 10.1111/j.1440-1827.2009.02467.x; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; MARGOLIS B, 1994, J AM SOC NEPHROL, V5, P1288; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Mizuno S, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/909350; Nakaigawa N, 2006, CANCER RES, V66, P3699, DOI 10.1158/0008-5472.CAN-05-0617; Natali PG, 1996, INT J CANCER, V69, P212, DOI 10.1002/(SICI)1097-0215(19960621)69:3<212::AID-IJC11>3.0.CO;2-9; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rayman P, 2004, CLIN CANCER RES, V10, p6360S, DOI 10.1158/1078-0432.CCR-050011; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Singhal E, 2011, J BIOL CHEM, V286, P32054, DOI 10.1074/jbc.M111.271247; Skibinski G, 2003, ARCH IMMUNOL THER EX, V51, P277; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tanimoto S, 2008, J MED INVESTIG, V55, P106, DOI 10.2152/jmi.55.106; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Tzima S, 2009, J EXP MED, V206, P1167, DOI 10.1084/jem.20081582; Uzzo RG, 1999, CLIN CANCER RES, V5, P1219; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686	49	108	114	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8110	8120		10.1074/jbc.M114.612689	http://dx.doi.org/10.1074/jbc.M114.612689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645920	Green Published, hybrid			2022-12-26	WOS:000351662600009
J	Hesketh, EL; Parker-Manuel, RP; Chaban, Y; Satti, R; Coverley, D; Orlova, EV; Chong, JPJ				Hesketh, Emma L.; Parker-Manuel, Richard P.; Chaban, Yuriy; Satti, Rabab; Coverley, Dawn; Orlova, Elena V.; Chong, James P. J.			DNA Induces Conformational Changes in a Recombinant Human Minichromosome Maintenance Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; DNA Helicase; DNA Replication; Electron Microscopy (EM); Recombinant Protein Expression; MCM; Minichromosome Maintenance	REPLICATIVE HELICASE; SACCHAROMYCES-CEREVISIAE; MCM2-7 COMPLEX; ATP HYDROLYSIS; HUMAN-CELLS; CYCLIN-E; PROTEIN; FORK; ORGANIZATION; ACTIVATION	Background: The human minichromosome maintenance (hMCM) complex is an important component of the DNA replication apparatus. Results: After being produced in Escherichia coli, hMCM has ATPase and DNA helicase activity and undergoes a conformational change when bound to DNA. Conclusion: Recombinant hMCM is functional in vitro. Significance: hMCM provides an important tool for the biochemical reconstitution of the human replicative helicase. ATP-dependent DNA unwinding activity has been demonstrated for recombinant archaeal homohexameric minichromosome maintenance (MCM) complexes and their yeast heterohexameric counterparts, but in higher eukaryotes such as Drosophila, MCM-associated DNA helicase activity has been observed only in the context of a co-purified Cdc45-MCM-GINS complex. Here, we describe the production of the recombinant human MCM (hMCM) complex in Escherichia coli. This protein displays ATP hydrolysis activity and is capable of unwinding duplex DNA. Using single-particle asymmetric EM reconstruction, we demonstrate that recombinant hMCM forms a hexamer that undergoes a conformational change when bound to DNA. Recombinant hMCM produced without post-translational modifications is functional in vitro and provides an important tool for biochemical reconstitution of the human replicative helicase.	[Hesketh, Emma L.; Parker-Manuel, Richard P.; Satti, Rabab; Coverley, Dawn; Chong, James P. J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Chaban, Yuriy; Orlova, Elena V.] Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England	University of York - UK; University of London; Birkbeck University London	Chong, JPJ (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	james.chong@york.ac.uk	Chong, James/AAC-4957-2019; Orlova, Elena/CAF-8290-2022	Coverley, Dawn/0000-0001-8262-7023; Chong, James/0000-0001-9447-7421; Orlova, Elena/0000-0003-3371-415X	Cancer Research UK [A7771, A10945]; Wellcome VIP funds; Yorkshire Cancer Research Grant [Y002PhD]; BBSRC [BB/J006920/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J006920/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome VIP funds; Yorkshire Cancer Research Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Cancer Research UK Grants A7771 and A10945; Wellcome VIP funds administered by the Department of Biology, University of York; and Yorkshire Cancer Research Grant Y002PhD.	Biswas-Fiss EE, 2005, BIOCHEMISTRY-US, V44, P2916, DOI 10.1021/bi0491649; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Coster G, 2014, MOL CELL, V55, P666, DOI 10.1016/j.molcel.2014.06.034; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 1998, J BIOL CHEM, V273, P8369, DOI 10.1074/jbc.273.14.8369; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jenkinson ER, 2006, P NATL ACAD SCI USA, V103, P7613, DOI 10.1073/pnas.0509297103; Kang S, 2014, MOL CELL, V55, P655, DOI 10.1016/j.molcel.2014.06.033; Kim JH, 2010, ANN VASC SURG, V24, P538, DOI 10.1016/j.avsg.2010.01.007; Lyubimov AY, 2012, P NATL ACAD SCI USA, V109, P11999, DOI 10.1073/pnas.1209406109; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Munkley J, 2011, NUCLEIC ACIDS RES, V39, P2671, DOI 10.1093/nar/gkq1190; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Stead BE, 2011, NUCLEIC ACIDS RES, V39, P6998, DOI 10.1093/nar/gkr371; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Poh WT, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130138; You ZY, 2003, EMBO J, V22, P6148, DOI 10.1093/emboj/cdg576	36	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7973	7979		10.1074/jbc.M114.622738	http://dx.doi.org/10.1074/jbc.M114.622738			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648893	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000351613600054
J	de Miranda, ML; Pereira, SJ; Santos, AOMT; Villela, NR; Kraemer-Aguiar, LG; Bouskela, E				de Miranda, Marcos Lopes; Pereira, Sandra J.; Santos, Ana O. M. T.; Villela, Nivaldo R.; Kraemer-Aguiar, Luiz Guilherme; Bouskela, Eliete			Milrinone Attenuates Arteriolar Vasoconstriction and Capillary Perfusion Deficits on Endotoxemic Hamsters	PLOS ONE			English	Article							MICROCIRCULATORY BLOOD-FLOW; ISCHEMIA-REPERFUSION INJURY; ACTIVATED PROTEIN-C; SEPTIC SHOCK; INTESTINAL MICROCIRCULATION; SEPSIS; NOREPINEPHRINE; LACTATE; NITROGLYCERIN; VASODILATORS	Background and Objective Apart from its inotropic property, milrinone has vasodilator, anti-inflammatory and antithrombotic effects that could assist in the reversal of septic microcirculatory changes. This paper investigates the effects of milrinone on endotoxemia-related microcirculatory changes and compares them to those observed with the use of norepinephrine. Materials and Methods After skinfold chamber implantation procedures and endotoxemia induction by intravenous Escherichia coli lipopolysaccharide administration (2 mg. kg-1), male golden Syrian hamsters were treated with two regimens of intravenous milrinone (0.25 or 0.5 mu g. kg-1. min-1). Intravital microscopy of skinfold chamber preparations allowed quantitative analysis of microvascular variables. Macro-hemodynamic, biochemical, and hematological parameters and survival rate were also analyzed. Endotoxemic non-treated animals, endotoxemic animals treated with norepinephrine (0.2 mu g. kg-1. min-1), and non-endotoxemic hamsters served as controls. Results Milrinone (0.5 mu g. kg-1. min-1) was effective in reducing lipopolysaccharide-induced arteriolar vasoconstriction, capillary perfusion deficits, and inflammatory response, and in increasing survival. Norepinephrine treated animals showed the best mean arterial pressure levels but the worst functional capillary density values among all endotoxemic groups. Conclusion Our data suggests that milrinone yielded protective effects on endotoxemic animals' microcirculation, showed anti-inflammatory properties, and improved survival. Norepinephrine did not recruit the microcirculation nor demonstrated anti-inflammatory effects.	[de Miranda, Marcos Lopes] Univ Estado Rio De Janeiro, Fac Med Sci, Dept Internal Med, Div Crit Care, Rio De Janeiro, RJ, Brazil; [Pereira, Sandra J.] Perinatal Barra, Pediat Cardiac Intens Care Unit, Rio De Janeiro, RJ, Brazil; [Santos, Ana O. M. T.] Oswaldo Cruz Fdn FIOCRUZ, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil; [Villela, Nivaldo R.] Univ Estado Rio De Janeiro, Fac Med Sci, Dept Surg, Div Anesthesiol, Rio De Janeiro, RJ, Brazil; [Kraemer-Aguiar, Luiz Guilherme] Univ Estado Rio De Janeiro, Fac Med Sci, Dept Internal Med, Div Endocrinol, Rio De Janeiro, RJ, Brazil; [Bouskela, Eliete] Univ Estado Rio De Janeiro, Biomed Ctr, Lab Clin & Expt Res Vasc Biol BioVasc, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	de Miranda, ML (corresponding author), Univ Estado Rio De Janeiro, Fac Med Sci, Dept Internal Med, Div Crit Care, Rio De Janeiro, RJ, Brazil.	marcoslmiranda@gmail.com		Kraemer-Aguiar, Luiz Guilherme/0000-0002-3528-5881	CNPq (National Council for Scientific and Technological Development, Brasilia, Brazil) [303836/2010-5]; FAPERJ (State of Rio de Janeiro Agency for Research Support, Rio de Janeiro, Brazil) [E26/110.754/2012]	CNPq (National Council for Scientific and Technological Development, Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (State of Rio de Janeiro Agency for Research Support, Rio de Janeiro, Brazil)	This study was supported by grants from CNPq (National Council for Scientific and Technological Development, Brasilia, Brazil, http:// www.cnpq.br/; grant number 303836/2010-5) and FAPERJ (State of Rio de Janeiro Agency for Research Support, Rio de Janeiro, Brazil, http://www. faperj.br/; grant number E26/110.754/2012).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker J, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-12; Barton P, 1996, CHEST, V109, P1302, DOI 10.1378/chest.109.5.1302; Brierley J, 2009, CRIT CARE MED, V37, P666, DOI 10.1097/CCM.0b013e31819323c6; Buwalda M, 2002, INTENS CARE MED, V28, P1208, DOI 10.1007/s00134-002-1407-2; Cabrales P, 2005, AM J PHYSIOL-HEART C, V288, pH2146, DOI 10.1152/ajpheart.00749.2004; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; De Backer D, 2010, CURR OPIN CRIT CARE, V16, P250, DOI 10.1097/MCC.0b013e3283383621; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Donati A, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/892710; Dubin A, 2009, CRIT CARE, V13, DOI 10.1186/cc7922; ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841; FINK MP, 1990, J SURG RES, V49, P186, DOI 10.1016/0022-4804(90)90260-9; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; Hangai-Hoger N, 2007, CRIT CARE MED, V35, P1123, DOI 10.1097/01.CCM.0000259533.84180.C7; Hayashida N, 1999, ANN THORAC SURG, V68, P1661, DOI 10.1016/S0003-4975(99)00716-X; Hoffmann JN, 1999, SHOCK, V12, P355, DOI 10.1097/00024382-199911000-00005; Hoffmann JN, 2005, CRIT CARE, V9, pS33, DOI 10.1186/cc3758; Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42; Hofstetter C, 2007, INT J MOL MED, V20, P597; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; Jung HS, 2014, KOREAN J ANESTHESIOL, V66, P136, DOI 10.4097/kjae.2014.66.2.136; Jutkowitz LA, 2005, VET CLIN N AM-SMALL, V35, P397, DOI 10.1016/j.cvsm.2004.10.006; Klyscz T, 1997, BIOMED TECH, V42, P168, DOI 10.1515/bmte.1997.42.6.168; Krejci V, 2006, CRIT CARE MED, V34, P1456, DOI 10.1097/01.CCM.0000215834.48023.57; Kume M, 2006, J SURG RES, V136, P209, DOI 10.1016/j.jss.2006.05.038; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946; Li X, 2004, BRIT J PHARMACOL, V141, P709, DOI 10.1038/sj.bjp.0705634; Liet Jean-Michel, 2005, Pediatr Crit Care Med, V6, P195, DOI 10.1097/01.PCC.0000155636.53455.96; Mariscalco MM, 2006, CRIT CARE MED, V34, P561, DOI 10.1097/01.CCM.0000199075.70631.B8; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mollhoff T, 1999, ANESTHESIOLOGY, V90, P72, DOI 10.1097/00000542-199901000-00012; Nacul FE, 2010, ANESTH ANALG, V110, P547, DOI 10.1213/ANE.0b013e3181c88af1; Nakajima Y, 2006, CRIT CARE MED, V34, P1752, DOI 10.1097/01.CCM.0000218812.73741.6C; Nishiki T, 2011, TRANSPL P, V43, P1489, DOI 10.1016/j.transproceed.2011.03.009; Preiser JC, 2003, LANCET, V361, P880, DOI 10.1016/S0140-6736(03)12691-8; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Rich Naomi, 2003, Pediatr Crit Care Med, V4, P394, DOI 10.1097/01.PCC.0000074278.30462.73; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Sales Júnior João Andrade L., 2006, Rev. bras. ter. intensiva, V18, P9, DOI 10.1590/S0103-507X2006000100003; Santos AOMT, 2011, CLIN HEMORHEOL MICRO, V47, P1, DOI 10.3233/CH-2010-1358; Schafer A, 2003, BIOCHEM PHARMACOL, V65, P397, DOI 10.1016/S0006-2952(02)01523-X; Shipley JB, 1996, AM J MED SCI, V311, P286, DOI 10.1097/00000441-199606000-00011; Spronk PE, 2002, LANCET, V360, P1395, DOI 10.1016/S0140-6736(02)11393-6; Trzeciak S, 2008, ACAD EMERG MED, V15, P399, DOI 10.1111/j.1553-2712.2008.00109.x; Tsai AG, 2003, AM J PHYSIOL-HEART C, V285, pH1537, DOI 10.1152/ajpheart.00176.2003; Wesley MC, 2009, ANESTH ANALG, V108, P1425, DOI 10.1213/ane.0b013e3181981fbe; Wettstein R, 2003, CRIT CARE MED, V31, P1824, DOI 10.1097/01.CCM.0000069340.16319.F2; Yeh YC, 2012, ANESTH ANALG, V115, P46, DOI 10.1213/ANE.0b013e318253631c; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026	52	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117004	10.1371/journal.pone.0117004	http://dx.doi.org/10.1371/journal.pone.0117004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646813	gold, Green Submitted, Green Published			2022-12-26	WOS:000348822600048
J	Korzeniewski, B				Korzeniewski, Bernard			'Idealized' State 4 and State 3 in Mitochondria vs. Rest and Work in Skeletal Muscle	PLOS ONE			English	Article							METABOLIC CONTROL-THEORY; TOP-DOWN APPROACH; OXIDATIVE-PHOSPHORYLATION; PROTON LEAK; INTENSITY EXERCISE; RESPIRATION RATE; HEART; MODEL; CALCIUM; CELLS	A computer model of oxidative phosphorylation (OXPHOS) in skeletal muscle is used to compare state 3, intermediate state and state 4 in mitochondria with rest and work in skeletal muscle. 'Idealized' state 4 and 3 in relation to various 'experimental' states 4 and 3 are defined. Theoretical simulations show, in accordance with experimental data, that oxygen consumption (V'O-2), ADP and P-i are higher, while ATP/ADP and Delta p are lower in rest than in state 4, because of the presence of basal ATP consuming reactions in the former. It is postulated that moderate and intensive work in skeletal muscle is very different from state 3 in isolated mitochondria. V'O-2, ATP/ADP, Delta p and the control of ATP usage over V'O-2 are much higher, while ADP and Pi are much lower in the former. The slope of the phenomenological V'O-2-ADP relationship is much steeper during the rest-work transition than during the state 4-state 3 transition. The work state in intact muscle is much more similar to intermediate state than to state 3 in isolated mitochondria in terms of ADP, ATP/ADP, Delta p and metabolic control pattern, but not in terms of V'O-2. The huge differences between intact muscle and isolated mitochondria are proposed to be caused by the presence of the eachstep activation (ESA) mechanism of the regulation of OXPHOS in intact skeletal muscle. Generally, the present study suggests that isolated mitochondria (at least in the absence of Ca2+) cannot serve as a good model of OXPHOS regulation in intact skeletal muscle.	Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland	Jagiellonian University	Korzeniewski, B (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	bernard.korzeniewski@gmail.com						ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BROWN GC, 1990, EUR J BIOCHEM, V188, P321, DOI 10.1111/j.1432-1033.1990.tb15406.x; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; CHANCE B, 1955, J BIOL CHEM, V217, P383; CHANCE B, 1985, P NATL ACAD SCI USA, V82, P8384, DOI 10.1073/pnas.82.24.8384; CHANCE B, 1982, P NATL ACAD SCI-BIOL, V79, P7714, DOI 10.1073/pnas.79.24.7714; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Cieslar JH, 2000, J BIOL CHEM, V275, P6129, DOI 10.1074/jbc.275.9.6129; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035; Fernstrom M, 2004, J PHYSIOL-LONDON, V554, P755, DOI 10.1113/jphysiol.2003.055202; Gellerich FN, 2012, BIOCHEM J, V443, P747, DOI 10.1042/BJ20110765; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; GROEN AK, 1982, J BIOL CHEM, V257, P2754; HAFNER RP, 1990, EUR J BIOCHEM, V188, P313, DOI 10.1111/j.1432-1033.1990.tb15405.x; Hansford R.G., 1980, CURR TOP BIOENERG, VVolume 10, P217, DOI 10.1016/B978-0-12-152510-1.50012-2; Hochachka P, 1994, MUSCLES METABOLIC ME; HOPPELER H, 1985, J EXP BIOL, V115, P355; HOPPELER H, 1973, PFLUG ARCH EUR J PHY, V344, P217, DOI 10.1007/BF00588462; Kavanagh NI, 2000, BBA-BIOENERGETICS, V1457, P57, DOI 10.1016/S0005-2728(00)00054-2; Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Korzeniewski B, 2004, BIOPHYS CHEM, V110, P147, DOI 10.1016/j.bpc.2004.01.011; Korzeniewski B, 1996, BIOCHEM J, V319, P143, DOI 10.1042/bj3190143; Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013; Korzeniewski B, 2014, J APPL PHYSIOL, V116, P83, DOI 10.1152/japplphysiol.00759.2013; KUSHMERICK MJ, 1985, AM J PHYSIOL, V248, pC542, DOI 10.1152/ajpcell.1985.248.5.C542; LETELLIER T, 1993, BIOCHIM BIOPHYS ACTA, V1141, P58, DOI 10.1016/0005-2728(93)90189-M; Li YJ, 2012, CELL MOL BIOENG, V5, P92, DOI 10.1007/s12195-011-0210-y; Li YJ, 2009, AM J PHYSIOL-CELL PH, V296, pC25, DOI 10.1152/ajpcell.00094.2008; MEYER RA, 1988, AM J PHYSIOL, V254, pC548, DOI 10.1152/ajpcell.1988.254.4.C548; Mildaziene V, 1996, BIOCHEM J, V320, P329, DOI 10.1042/bj3200329; RICHARDSON RS, 1995, AM J PHYSIOL-HEART C, V268, pH1453, DOI 10.1152/ajpheart.1995.268.4.H1453; Rolfe DFS, 1996, BBA-BIOENERGETICS, V1276, P45, DOI 10.1016/0005-2728(96)00029-1; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Schild L, 1988, EUR J BIOCHEM, V252, P508; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Tonkonogi M, 2000, J PHYSIOL-LONDON, V528, P379, DOI 10.1111/j.1469-7793.2000.00379.x; Tonkonogi M, 1997, ACTA PHYSIOL SCAND, V161, P345, DOI 10.1046/j.1365-201X.1997.00222.x; Vendelin M, 2000, AM J PHYSIOL-CELL PH, V278, pC747, DOI 10.1152/ajpcell.2000.278.4.C747; WANDERS RJA, 1984, EUR J BIOCHEM, V142, P417, DOI 10.1111/j.1432-1033.1984.tb08303.x; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006; Zoladz JA, 2010, J PHYSIOL SCI, V60, P331, DOI 10.1007/s12576-010-0101-3	50	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117145	10.1371/journal.pone.0117145	http://dx.doi.org/10.1371/journal.pone.0117145			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647747	gold, Green Published, Green Submitted			2022-12-26	WOS:000348822600057
J	Zeng, Q; Zhang, YM; Sun, GQ; Duo, HR; Wen, L; Lei, GC				Zeng, Qing; Zhang, Yamian; Sun, Gongqi; Duo, Hairui; Wen, Li; Lei, Guangchun			Using Species Distribution Model to Estimate the Wintering Population Size of the Endangered Scaly-Sided Merganser in China	PLOS ONE			English	Article							MERGUS-SQUAMATUS; PREDICTION; BIAS; DISTURBANCE; ACCURACY; RANGE; RISK	Scaly-sided Merganser is a globally endangered species restricted to eastern Asia. Estimating its population is difficult and considerable gap exists between populations at its breeding grounds and wintering sites. In this study, we built a species distribution model (SDM) using Maxent with presence-only data to predict the potential wintering habitat for Scaly-sided Merganser in China. Area under the receiver operating characteristic curve (AUC) method suggests high predictive power of the model (training and testing AUC were 0.97 and 0.96 respectively). The most significant environmental variables included annual mean temperature, mean temperature of coldest quarter, minimum temperature of coldest month and precipitation of driest quarter. Suitable conditions for Scaly-sided Merganser are predicted in the middle and lower reaches of the Yangtze River, especially in Jiangxi, Hunan and Hubei Provinces. The predicted suitable habitat embraces 6,984 km of river. Based on survey results from three consecutive winters (2010-2012) and previous studies, we estimated that the entire wintering population of Scaly-sided Merganser in China to be 3,561 +/- 478 individuals, which is consistent with estimate in its breeding ground.	[Zeng, Qing; Zhang, Yamian; Sun, Gongqi; Duo, Hairui; Wen, Li; Lei, Guangchun] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Wen, Li] Off Environm & Heritage, Sydney, NSW, Australia	Beijing Forestry University; Office of Environment & Heritage - New South Wales	Lei, GC (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	guangchun8099@gmail.com	ZENG, Qing/V-9563-2019; Guangchun, Lei/ABC-8081-2021	Zeng, Qing/0000-0002-7471-4941; WEN, LI/0000-0003-3783-3826	National Basic Research Program of China (973 Program) [2009CB421103]; National Basic Research Program of China [2012CB417005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 Program) (No. 2009CB421103) http://www.973.gov.cn and National Basic Research Program of China (No. 2012CB417005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, WATERBIRD POPULATION; Barre N, 2010, J ORNITHOL, V151, P695, DOI 10.1007/s10336-010-0499-7; Barter M, 2014, BIRD CONSERV INT, V24, P406, DOI 10.1017/S0959270913000622; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; BirdLife International, 2013, SPEC FACTSH MERG SQU; BirdLife International, 2001, THREAT BIRDS AS BIRD; Birdskorea, 2013, SCAL SID MERG REP KO; Birtsas P, 2013, ITAL J ZOOL, V80, P392, DOI 10.1080/11250003.2013.805827; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Cumming GS, 2000, J BIOGEOGR, V27, P425, DOI 10.1046/j.1365-2699.2000.00419.x; Dennis RLH, 2001, BIODIVERS CONSERV, V10, P483, DOI 10.1023/A:1016602309983; Duckworth J. W., 2005, Wildfowl, V55, P133; EAAFW, 2012, SCAL SID MERG; Elith J, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P39; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frid A, 2002, CONSERV ECOL, V6; Funk VA, 2002, SYST BIOL, V51, P303, DOI 10.1080/10635150252899789; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; *GLC, 2003, GLOB LAND COV 2000 D; Harcourt AH, 2005, SCIENCE, V310, P1276; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; He Fen-Qi, 2006, Chinese Journal of Zoology, V41, P52; He FQ, 2002, WATERBIRDS, V25, P462, DOI 10.1675/1524-4695(2002)025[0462:SOTSMW]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hochachka WM, 2000, CAN J ZOOL, V78, P521, DOI 10.1139/cjz-78-4-521; Hu JH, 2010, OECOLOGIA, V164, P555, DOI 10.1007/s00442-010-1732-z; Hughes B, 1994, THREATENED WATERFOWL; Jamieson IG, 2012, TRENDS ECOL EVOL, V27, P578, DOI 10.1016/j.tree.2012.07.001; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Katzner TE, 2011, ANIM CONSERV, V14, P328, DOI 10.1111/j.1469-1795.2011.00444.x; Kauffman MJ, 2003, ECOL APPL, V13, P1802, DOI 10.1890/01-5324; Legault A, 2013, BIOL CONSERV, V167, P149, DOI 10.1016/j.biocon.2013.07.041; Lisi PJ, 2013, GEOMORPHOLOGY, V185, P78, DOI 10.1016/j.geomorph.2012.12.013; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu Yu, 2008, Dongbei Shida Xuebao (Ziran Kexue Ban), V40, P111; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Manel S, 1999, ECOL MODEL, V120, P337, DOI 10.1016/S0304-3800(99)00113-1; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026784; Meffert PJ, 2012, BIOL CONSERV, V153, P87, DOI 10.1016/j.biocon.2012.04.018; Negro JJ, 2011, ANIM CONSERV, V14, P338, DOI 10.1111/j.1469-1795.2011.00484.x; Nilsson ALK, 2011, J ANIM ECOL, V80, P235, DOI 10.1111/j.1365-2656.2010.01755.x; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; Pearce J, 2000, ECOL MODEL, V128, P127, DOI 10.1016/S0304-3800(99)00227-6; Penteriani V, 2011, ANIM CONSERV, V14, P233, DOI 10.1111/j.1469-1795.2010.00433.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Robertson M. P., 2001, Diversity and Distributions, V7, P15, DOI 10.1046/j.1472-4642.2001.00094.x; Robinet O, 1996, EMU, V96, P151, DOI 10.1071/MU9960151; Shao MQ, 2012, PAK J ZOOL, V44, P503; Shokhrin Valeri, 2003, TWSG News, V14, P43; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Solovieva Diana, 2006, TWSG News, V15, P60; Solovyeva DV, 2014, BIRD CONSERV INT, V24, P393, DOI 10.1017/S0959270913000610; Solovyeva Diana V., 2012, Endangered Species Research, V17, P217, DOI 10.3354/esr00429; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Underwood J, 2013, WILSON J ORNITHOL, V125, P159, DOI 10.1676/11-176.1; Vanagas Giedrius, 2004, Interact Cardiovasc Thorac Surg, V3, P319, DOI 10.1016/j.icvts.2004.01.008; Zhang J, 2012, J BIOGEOGRAPHY; Zhiru W, 2010, SICHUAN J ZOOLOGY, V29, P597	64	21	25	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117307	10.1371/journal.pone.0117307	http://dx.doi.org/10.1371/journal.pone.0117307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646969	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600064
J	Pham, N; Akonasu, H; Shishkin, R; Taghibiglou, C				Nam Pham; Akonasu, Hungbo; Shishkin, Rhonda; Taghibiglou, Changiz			Plasma Soluble Prion Protein, a Potential Biomarker for Sport-Related Concussions: A Pilot Study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; CELLULAR ISOFORM; EXPRESSION; EPIDEMIOLOGY; PRPC; PATHOPHYSIOLOGY; DIAGNOSIS; HEALTHY	Sport-related mild traumatic brain injury (mTBI) or concussion is a significant health concern to athletes with potential long-term consequences. The diagnosis of sport concussion and return to sport decision making is one of the greatest challenges facing health care clinicians working in sports. Blood biomarkers have recently demonstrated their potential in assisting the detection of brain injury particularly, in those cases with no obvious physical injury. We have recently discovered plasma soluble cellular prion protein (PrPC) as a potential reliable biomarker for blast induced TBI (bTBI) in a rodent animal model. In order to explore the application of this novel TBI biomarker to sport-related concussion, we conducted a pilot study at the University of Saskatchewan (U of S) by recruiting athlete and non-athlete 18 to 30 year-old students. Using a modified quantitative ELISA method, we first established normal values for the plasma soluble PrPC in male and female students. The measured plasma soluble PrPC in confirmed concussion cases demonstrated a significant elevation of this analyte in post-concussion samples. Data collected from our pilot study indicates that the plasma soluble PrPC is a potential biomarker for sport-related concussion, which may be further developed into a clinical diagnostic tool to assist clinicians in the assessment of sport concussion and return-to-play decision making.	[Nam Pham; Akonasu, Hungbo; Taghibiglou, Changiz] Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada; [Shishkin, Rhonda] Univ Saskatchewan, Coll Kinesiol & Huskies Athlet, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Taghibiglou, C (corresponding author), Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada.	changiz.taghibiglou@usask.ca	Taghibiglou, Changiz/H-4590-2019					Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Breitling LP, 2012, EXP GERONTOL, V47, P919, DOI 10.1016/j.exger.2012.08.001; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Haddon DJ, 2009, J INFECT DIS, V200, P827, DOI 10.1086/605022; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Jeon Jae-Won, 2013, Immune Netw, V13, P148, DOI 10.4110/in.2013.13.4.148; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Krupinski J, 2008, ACTA NEUROPATHOL, V116, P537, DOI 10.1007/s00401-008-0427-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2011, CLIN SPORT MED, V30, pXVII, DOI 10.1016/j.csm.2010.09.008; Megra B, 2013, J NEUROIMMUNE PHARM, V8, P1159, DOI 10.1007/s11481-013-9458-4; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Meyne F, 2009, J ALZHEIMERS DIS, V17, P863, DOI 10.3233/JAD-2009-1110; Mitsios N, 2007, J NEUROSCI RES, V85, P602, DOI 10.1002/jnr.21142; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Pham N, 2015, J NEUROTRAUM, V32, P58, DOI 10.1089/neu.2014.3471; Pham N, 2014, BIOCHEM BIOPH RES CO, V448, P151, DOI 10.1016/j.bbrc.2014.04.071; Picard-Hagen N, 2006, J GEN VIROL, V87, P3723, DOI 10.1099/vir.0.81859-0; Politopoulou G, 2000, HAEMATOLOGICA, V85, P580; Ritchie AJ, 2013, BRIT J HAEMATOL, V163, P678, DOI 10.1111/bjh.12543; Roberts TK, 2010, AM J PATHOL, V177, P1848, DOI 10.2353/ajpath.2010.091006; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; Starke R, 2002, BRIT J HAEMATOL, V119, P863, DOI 10.1046/j.1365-2141.2002.03847.x; Stewart TC, 2013, J TRAUMA ACUTE CARE, V76, P736; Strathmann FG, 2014, CLIN BIOCHEM, DOI [10.1016/j.clinbiochem.2014.12.017, DOI 10.1016/J.CLINBIOCHEM.2014.12.017]; Torres M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036159; Volkel D, 2001, TRANSFUSION, V41, P441, DOI 10.1046/j.1537-2995.2001.41040441.x; Wang Kevin K W, 2012, Front Neurol, V3, P147, DOI 10.3389/fneur.2012.00147; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Yusa S, 2012, VIRUSES-BASEL, V4, P3109, DOI 10.3390/v4113109; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	48	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117286	10.1371/journal.pone.0117286	http://dx.doi.org/10.1371/journal.pone.0117286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643046	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821200036
J	Schwarting, T; Lechler, P; Struewer, J; Ambrock, M; Frangen, TM; Ruchholtz, S; Ziring, E; Frink, M				Schwarting, Tim; Lechler, Philipp; Struewer, Johannes; Ambrock, Marius; Frangen, Thomas Manfred; Ruchholtz, Steffen; Ziring, Ewgeni; Frink, Michael			Bone Morphogenetic Protein 7 (BMP-7) Influences Tendon-Bone Integration In Vitro	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; OSTEOGENIC PROTEIN-1; DIFFERENTIATION; RECONSTRUCTION; ANTAGONISTS; FIBROBLAST; EXPRESSION	Introduction Successful graft ingrowth following reconstruction of the anterior cruciate ligament is governed by complex biological processes at the tendon-bone interface. The aim of this study was to investigate in an in vitro study the effects of bone morphogenetic protein 7 (BMP-7) on tendon-bone integration. Materials and Methods To study the biological effects of BMP-7 on the process of tendon-bone-integration, two independent in vitro models were used. The first model involved the mono-and coculture of bovine tendon specimens and primary bovine osteoblasts with and without BMP-7 exposure. The second model comprised the mono-and coculture of primary bovine osteoblasts and fibroblasts. Alkaline phosphatase (ALP), lactate dehydrogenase (LDH), lactate and osteocalcin (OCN) were analyzed by ELISA. Histological analysis and electron microscopy of the tendon specimens were performed. Results In both models, positive effects of BMP-7 on ALP enzyme activity were observed (p<0.001). Additionally, similar results were noted for LDH activity and lactate concentration. BMP-7 stimulation led to a significant increase in OCN expression. Whereas the effects of BMP-7 on tendon monoculture peaked during an early phase of the experiment (p<0.001), the cocultures showed a maximal increase during the later stages (p<0.001). The histological analysis showed a stimulating effect of BMP-7 on extracellular matrix formation. Organized ossification zones and calcium carbonate-like structures were only observed in the BMP-stimulated cell cultures. Discussion This study showed the positive effects of BMP-7 on the biological process of tendon-bone integration in vitro. Histological signs of improved mineralization were paralleled by increased rates of osteoblast-specific protein levels in primary bovine osteoblasts and fibroblasts. Conclusion Our findings indicated a role for BMP-7 as an adjuvant therapeutic agent in the treatment of ligamentous injuries, and they emphasized the importance of the transdifferentiation process of tendinous fibroblasts at the tendon-bone interface.	[Schwarting, Tim; Lechler, Philipp; Ambrock, Marius; Frangen, Thomas Manfred; Ruchholtz, Steffen; Ziring, Ewgeni; Frink, Michael] Univ Hosp Giessen & Marburg, Dept Trauma Hand & Reconstruct Surg, Marburg, Germany; [Struewer, Johannes] Univ Hosp Giessen & Marburg, Dept Orthopaed & Rheumatol, Marburg, Germany	University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg	Frink, M (corresponding author), Univ Hosp Giessen & Marburg, Dept Trauma Hand & Reconstruct Surg, Marburg, Germany.	frink@med.uni-marburg.de						Ali IHA, 2014, BRIT J PHARMACOL, V171, P3620, DOI 10.1111/bph.12724; AMIEL D, 1986, J ORTHOPAED RES, V4, P162, DOI 10.1002/jor.1100040204; Aspenberg P, 2001, J BONE MINER RES, V16, P497, DOI 10.1359/jbmr.2001.16.3.497; Biau DJ, 2009, AM J SPORT MED, V37, P2470, DOI 10.1177/0363546509333006; Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Cook SD, 1996, CLIN ORTHOP RELAT R, P29, DOI 10.1097/00003086-199603000-00005; Cox S, 2004, BRAIN RES, V1010, P55, DOI 10.1016/j.brainres.2004.02.068; Curtze S, 2004, J CELL SCI, V117, P2721, DOI 10.1242/jcs.01119; de Jong DS, 2004, J BONE MINER RES, V19, P947, DOI 10.1359/JBMR.040216; Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Griffin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072978; Hashimoto Y, 2007, J ORTHOP RES, V25, P1415, DOI 10.1002/jor.20447; Jang WG, 2012, J BIOL CHEM, V287, P905, DOI 10.1074/jbc.M111.253187; JONES DB, 1991, CELL MATER, V1, P329; Lavery K, 2009, BONE, V45, P27, DOI 10.1016/j.bone.2009.03.656; Lovric V, 2012, AM J SPORT MED, V40, P2365, DOI 10.1177/0363546512457648; Martinek V, 2002, J BONE JOINT SURG AM, V84A, P1123, DOI 10.2106/00004623-200207000-00005; Menetrey J, 2008, KNEE SURG SPORT TR A, V16, P224, DOI 10.1007/s00167-007-0474-x; Mihelic R, 2004, AM J SPORT MED, V32, P1619, DOI 10.1177/0363546504263703; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Moon JS, 2014, J BONE MINER RES, V29, P1586, DOI 10.1002/jbmr.2197; Myllyla RM, 2014, CELL TISSUE RES, V355, P463, DOI 10.1007/s00441-013-1745-0; NICKLIN S, 2000, T ORTHOP RES SOC, V25, P155; Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2250, DOI 10.2106/JBJS.F.00409; Salkeld SL, 2001, J BONE JOINT SURG AM, V83A, P803, DOI 10.2106/00004623-200106000-00001; Scheffler SU, 2008, KNEE SURG SPORT TR A, V16, P834, DOI 10.1007/s00167-008-0560-8; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w; Spector JA, 2001, AM J PHYSIOL-CELL PH, V280, pC72, DOI 10.1152/ajpcell.2001.280.1.C72; Struewer J, 2013, ORTHOPEDICS, V36, pE200, DOI 10.3928/01477447-20130122-23; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Umehara K, 2012, ANAT REC, V295, P1327, DOI 10.1002/ar.22510; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018	38	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116833	10.1371/journal.pone.0116833	http://dx.doi.org/10.1371/journal.pone.0116833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643349	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821200025
J	Barrios, YV; Gelaye, B; Zhong, QY; Nicolaidis, C; Rondon, MB; Garcia, PJ; Sanchez, PAM; Sanchez, SE; Williams, MA				Barrios, Yasmin V.; Gelaye, Bizu; Zhong, Qiuyue; Nicolaidis, Christina; Rondon, Marta B.; Garcia, Pedro J.; Sanchez, Pedro A. Mascaro; Sanchez, Sixto E.; Williams, Michelle A.			Association of Childhood Physical and Sexual Abuse with Intimate Partner Violence, Poor General Health and Depressive Symptoms among Pregnant Women	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH; DOMESTIC VIOLENCE; SUICIDE ATTEMPTS; HOUSEHOLD DYSFUNCTION; PERUVIAN WOMEN; RISK-FACTOR; PREVALENCE; IMPACT; MALTREATMENT	Objective We examined associations of childhood physical and sexual abuse with risk of intimate partner violence (IPV). We also evaluated the extent to which childhood abuse was associated with self-reported general health status and symptoms of antepartum depression in a cohort of pregnant Peruvian women. Methods In-person interviews were conducted to collect information regarding history of childhood abuse and IPV from 1,521 women during early pregnancy. Antepartum depressive symptomatology was evaluated using the Patient Health Questionnaire-9. Multivariable logistic regression procedures were used to estimate adjusted odds ratios (aOR) and 95%Confidence intervals (95%CI). Results Any childhood abuse was associated with 2.2-fold increased odds of lifetime IPV (95%CI: 1.72-2.83). Compared with women who reported no childhood abuse, those who reported both, childhood physical and sexual abuse had a 7.14-fold lifetime risk of physical and sexual IPV (95%CI: 4.15-12.26). The odds of experiencing physical and sexual abuse by an intimate partner in the past year was 3.33-fold higher among women with a history of childhood physical and sexual abuse as compared to women who were not abused as children (95%CI 1.60-6.89). Childhood abuse was associated with higher odds of self-reported poor health status during early pregnancy (aOR = 1.32, 95%CI: 1.04-1.68) and with symptoms of antepartum depression (aOR = 2.07, 95%CI: 1.58-2.71). Conclusion These data indicate that childhood sexual and physical abuse is associated with IPV, poor general health and depressive symptoms in early pregnancy. The high prevalence of childhood trauma and its enduring effects of on women's health warrant concerted global health efforts in preventing violence.	[Barrios, Yasmin V.; Gelaye, Bizu; Zhong, Qiuyue; Williams, Michelle A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Nicolaidis, Christina] Portland State Univ, Sch Social Work, Portland, OR 97207 USA; [Rondon, Marta B.] Cayetano Heredia Peruvian Univ, Sect Psychiat & Mental Hlth, Dept Med, Lima, Peru; [Garcia, Pedro J.; Sanchez, Pedro A. Mascaro] Inst Nacl Materno Perinatal, Lima, Peru; [Sanchez, Sixto E.] Univ Peruana Ciencias Aplicadas, Lima, Peru; [Sanchez, Sixto E.] Asociac Civil PROESA, Lima, Peru	Harvard University; Harvard T.H. Chan School of Public Health; Portland State University; Universidad Peruana Cayetano Heredia; Universidad Peruana de Ciencias Aplicadas (UPC)	Gelaye, B (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	bgelaye@hsph.harvard.edu	Nicolaidis, Christina/CAC-0028-2022; Nicolaidis, Christina/X-6468-2019	Nicolaidis, Christina/0000-0002-9394-5956; Nicolaidis, Christina/0000-0002-9394-5956; Mascaro Sanchez, Pedro Arnaldo/0000-0001-7868-771X; Gelaye, Bizu/0000-0001-7934-548X; Rondon, Marta/0000-0001-8459-6785; Sanchez, Sixto/0000-0003-0354-0523	National Institutes of Health (NIH), the Eunice Kennedy Shriver Institute of Child Health and Human Development [R01-HD-059835]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052468, R01HD059835] Funding Source: NIH RePORTER	National Institutes of Health (NIH), the Eunice Kennedy Shriver Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by an award from the National Institutes of Health (NIH), the Eunice Kennedy Shriver Institute of Child Health and Human Development (R01-HD-059835). The NIH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Aquino Nicole Moraes Rego de, 2009, Rev Saude Publica, V43, P954, DOI 10.1590/S0034-89102009005000068; Arata C M, 2000, Child Maltreat, V5, P28, DOI 10.1177/1077559500005001004; Banducci AN, 2014, CHILD ABUSE NEGLECT, V38, P928, DOI 10.1016/j.chiabu.2013.12.007; Barnes JE, 2009, CHILD ABUSE NEGLECT, V33, P412, DOI 10.1016/j.chiabu.2008.09.013; Barth J, 2013, INT J PUBLIC HEALTH, V58, P469, DOI 10.1007/s00038-012-0426-1; Benedict MI, 1999, CHILD ABUSE NEGLECT, V23, P659, DOI 10.1016/S0145-2134(99)00040-X; Bensley L, 2003, AM J PREV MED, V25, P38, DOI 10.1016/S0749-3797(03)00094-1; BERGMAN B, 1991, ACTA PSYCHIAT SCAND, V83, P380, DOI 10.1111/j.1600-0447.1991.tb05560.x; Bertone-Johnson ER, 2012, AM J PREV MED, V43, P611, DOI 10.1016/j.amepre.2012.08.014; Bonomi AE, 2008, CHILD ABUSE NEGLECT, V32, P693, DOI 10.1016/j.chiabu.2007.10.004; BRIERE J, 1990, CHILD ABUSE NEGLECT, V14, P357, DOI 10.1016/0145-2134(90)90007-G; Brodsky BS, 2008, J CLIN PSYCHIAT, V69, P584, DOI 10.4088/JCP.v69n0410; Brown DW, 2009, AM J PREV MED, V37, P389, DOI 10.1016/j.amepre.2009.06.021; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Clark DB, 2003, DRUG ALCOHOL DEPEN, V69, P51, DOI 10.1016/S0376-8716(02)00254-5; Coid J, 2001, LANCET, V358, P450, DOI 10.1016/S0140-6736(01)05622-7; Coogan PF, 2013, J ALLERGY CLIN IMMUN, V131, P1058, DOI 10.1016/j.jaci.2012.10.023; Cripe SM, 2011, HEADACHE, V51, P208, DOI 10.1111/j.1526-4610.2010.01777.x; Cripe SM, 2010, J INTERPERS VIOLENCE, V25, P2054, DOI 10.1177/0886260509354517; Cyr K, 2014, J INTERPERS VIOLENCE, V29, P616, DOI 10.1177/0886260513505220; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; de Paz NC, 2011, J AFFECT DISORDERS, V130, P280, DOI 10.1016/j.jad.2010.07.024; DELLAFEMINA D, 1990, CHILD ABUSE NEGLECT, V14, P227; Devries KM, 2014, PEDIATRICS; DHS, 2005, DEMOGRAPHIC HEALTH S; Dinwiddie S, 2000, PSYCHOL MED, V30, P41, DOI 10.1017/S0033291799001373; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Dunkle KL, 2004, AM J EPIDEMIOL, V160, P230, DOI 10.1093/aje/kwh194; Easton SD, 2013, CHILD ABUSE NEGLECT, V37, P380, DOI 10.1016/j.chiabu.2012.11.007; Ellsberg MC, 2001, J EPIDEMIOL COMMUN H, V55, P547, DOI 10.1136/jech.55.8.547; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finkelhor D, 2013, JAMA PEDIATR, V167, P614, DOI 10.1001/jamapediatrics.2013.42; Frank JB, 1999, EMERG MED CLIN N AM, V17, P657, DOI 10.1016/S0733-8627(05)70089-4; Fraser JA, 2000, CHILD ABUSE NEGLECT, V24, P1399, DOI 10.1016/S0145-2134(00)00193-9; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gelaye B, 2010, J INTERPERS VIOLENCE, V25, P136, DOI 10.1177/0886260508329127; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Gomez-Beloz A, 2009, VIOLENCE VICTIMS, V24, P380, DOI 10.1891/0886-6708.24.3.380; Gonzalez A, 2012, J PSYCHIATR RES, V46, P1475, DOI 10.1016/j.jpsychires.2012.08.004; Harrison PA, 2008, J HEALTH CARE POOR U, V19, P258, DOI 10.1353/hpu.2008.0003; Hart C, 2012, SOC PSYCH PSYCH EPID, V47, P1581, DOI 10.1007/s00127-011-0464-7; Hedin LW, 1999, ACTA OBSTET GYN SCAN, V78, P310, DOI 10.1034/j.1600-0412.1999.780407.x; Heffernan K, 2000, J NERV MENT DIS, V188, P589, DOI 10.1097/00005053-200009000-00005; Hornor G, 2010, J PEDIATR HEALTH CAR, V24, P358, DOI 10.1016/j.pedhc.2009.07.003; Hotaling G. T., 1990, J FAM VIOLENCE, V5, P1, DOI DOI 10.1007/BF00979135; Irish L, 2010, J PEDIATR PSYCHOL, V35, P450, DOI 10.1093/jpepsy/jsp118; Miranda JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099662; KENDALLTACKETT KA, 1988, CHILD ABUSE NEGLECT, V12, P73, DOI 10.1016/0145-2134(88)90009-9; KENDALLTACKETT KA, 1993, PSYCHOL BULL, V113, P164, DOI 10.1037/0033-2909.113.1.164; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P953, DOI 10.1001/archpsyc.57.10.953; Kernic MA, 2000, AM J PUBLIC HEALTH, V90, P1416, DOI 10.2105/AJPH.90.9.1416; Kessler RC, 1997, AM J PSYCHIAT, V154, P1405; Knox M, 2013, J COMMUNITY PSYCHOL, V41, P395, DOI 10.1002/jcop.21543; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leeners B, 2014, J PERINAT MED, V42, P171, DOI 10.1515/jpm-2013-0003; Lindert J, 2014, INT J PUBLIC HEALTH, V59, P359, DOI 10.1007/s00038-013-0519-5; Molnar BE, 2001, PSYCHOL MED, V31, P965, DOI 10.1017/S0033291701004329; Nelson DB, 2010, J WOMENS HEALTH, V19, P1177, DOI 10.1089/jwh.2009.1539; Nicolaidis C, 2004, J GEN INTERN MED, V19, P819, DOI 10.1111/j.1525-1497.2004.30382.x; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Perales MT, 2009, VIOLENCE AGAINST WOM, V15, P224, DOI 10.1177/1077801208329387; Pereda N, 2009, CLIN PSYCHOL REV, V29, P328, DOI 10.1016/j.cpr.2009.02.007; Pico-Alfonso MA, 2006, J WOMENS HEALTH, V15, P599, DOI 10.1089/jwh.2006.15.599; Pineda-Lucatero AG, 2009, CHILD CARE HLTH DEV, V35, P184, DOI 10.1111/j.1365-2214.2008.00888.x; Roberts GL, 1997, GEN HOSP PSYCHIAT, V19, P5, DOI 10.1016/S0163-8343(96)00119-3; Runtz MG, 1997, CHILD ABUSE NEGLECT, V21, P211, DOI 10.1016/S0145-2134(96)00147-0; Russell D E, 1983, Child Abuse Negl, V7, P133, DOI 10.1016/0145-2134(83)90065-0; Sachs-Ericsson N, 2005, HEALTH PSYCHOL, V24, P32, DOI 10.1037/0278-6133.24.1.32; Sanders MR, 2000, J CHILD PSYCHOL PSYC, V41, P939, DOI 10.1111/1469-7610.00681; Sarkar NN, 2008, J OBSTET GYNAECOL, V28, P266, DOI 10.1080/01443610802042415; Schaaf KK, 1998, CHILD ABUSE NEGLECT, V22, P1119, DOI 10.1016/S0145-2134(98)00090-8; Seng JS, 2008, J MIDWIFERY WOM HEAL, V53, P511, DOI 10.1016/j.jmwh.2008.04.013; SIEGEL JM, 1987, AM J EPIDEMIOL, V126, P1141, DOI 10.1093/oxfordjournals.aje.a114752; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; STERN AE, 1995, J CHILD PSYCHOL PSYC, V36, P1077, DOI 10.1111/j.1469-7610.1995.tb01352.x; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Teicher MH, 2006, AM J PSYCHIAT, V163, P993, DOI 10.1176/appi.ajp.163.6.993; Thompson Martie P, 2002, Violence Vict, V17, P283; Trickett PK, 2011, DEV PSYCHOPATHOL, V23, P453, DOI 10.1017/S0954579411000174; Watts-English T, 2006, J SOC ISSUES, V62, P717, DOI 10.1111/j.1540-4560.2006.00484.x; WILLIAMS LM, 1995, J TRAUMA STRESS, V8, P649, DOI 10.1007/BF02102893; Wise LA, 2009, AM J PUBLIC HEALTH, V99, pS460, DOI 10.2105/AJPH.2008.149005; Woods S J, 2000, Issues Ment Health Nurs, V21, P309, DOI 10.1080/016128400248112; World Health Organization (WHO), 2005, PROMOTING MENTAL HEA; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; Yampolsky L, 2010, J ADV NURS, V66, P2025, DOI 10.1111/j.1365-2648.2010.05387.x; Zhang TH, 2013, COMPR PSYCHIAT, V54, P856, DOI 10.1016/j.comppsych.2013.03.014; Zhong QY, 2014, J AFFECT DISORDERS, V162, P1, DOI 10.1016/j.jad.2014.03.028; Zhong QY, 2014, J AFFECT DISORDERS, V158, P148, DOI 10.1016/j.jad.2014.02.012	91	85	88	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116609	10.1371/journal.pone.0116609	http://dx.doi.org/10.1371/journal.pone.0116609			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HX	25635902	Green Published, gold			2022-12-26	WOS:000350680700047
J	Daivajna, S; Bajwa, A; Villar, R				Daivajna, Sachin; Bajwa, Ali; Villar, Richard			Outcome of Arthroscopy in Patients with Advanced Osteoarthritis of the Hip	PLOS ONE			English	Article							FEMOROACETABULAR IMPINGEMENT; FEMORAL OSTEOCHONDROPLASTY; LABRAL DEBRIDEMENT; PAIN; OSTEOPLASTY; ATHLETE	Hip arthroscopy has continued to expand its horizons in treating many conditions other than femoroacetabular impingement (FAI). However, the results of hip arthroscopy are known to be poor if the degree of articular cartilage damage is significant. We wanted to assess, whether the procedure might have a role in the management of young and active patients with advanced osteoarthritis (OA) and whether it should be offered as a treatment modality. 77 consecutive patients with Tonnis grade 2 and 3 osteoarthritis of the hip who had undergone hip arthroscopy were included in the study. Patients' medical notes, plain radiographs and outcome scores (modified Harris hip score (mHHS), non-arthritic hip score (NAHS)) preoperatively and postoperatively at six weeks, six months, one year and annually thereafter, were analysed. 77 patients consisted of 63 men and 14 women with mean follow-up of 2.8 years (2.2 to 4.2) and mean age at surgery of 43 years (19 to 64). The mean preoperative mHHS and NAHS scores were 58 (28 to 87) and 64 (27 to 93) respectively. The mean improvements in both the mHHS and NAHS scores were significant (p = 0.003 and p = 0.0001 for mHHS at one and two years, p = 0.002 and p = 0.0003 for NAHS at one and two years, respectively). There were 34 patients (44%) who required a total hip replacement at mean of 18 months (6 to 48) after hip arthroscopy. We conclude that hip arthroscopy improves outcome scores in 56% of patients with severe OA of the hip (Tonnis grade 2 and 3) for at least two years after surgery. We thus consider the procedure to be a reasonable option for patients with hip OA, although success of the procedure will be less than if undertaken for certain other conditions.	[Daivajna, Sachin; Bajwa, Ali; Villar, Richard] Spire Cambridge Lea Hosp, Cambridge CB24 9EL, England		Daivajna, S (corresponding author), Spire Cambridge Lea Hosp, Cambridge CB24 9EL, England.	sachin.daivajna@gmail.com						Bardakos NV, 2008, J BONE JOINT SURG BR, V90B, P1570, DOI 10.1302/0301-620X.90B12.21012; Bozic KJ, 2013, J ARTHROPLASTY, V28, P140, DOI 10.1016/j.arth.2013.02.039; Byrd JWT, 2009, ARTHROSCOPY, V25, P365, DOI 10.1016/j.arthro.2009.02.001; Byrd JWT, 2000, ARTHROSCOPY, V16, P578, DOI 10.1053/jars.2000.7683; Christensen CP, 2003, CLIN ORTHOP RELAT R, P75, DOI 10.1097/01.blo.0000043047.84315.4b; Dienst M, 1999, ORTHOPADE, V28, P812, DOI 10.1007/PL00003671; Gomberawalla MM, 2014, SPORTS HEALTH, V6, P70, DOI 10.1177/1941738113497678; Hassouna H, 2007, ACTA ORTHOP BELG, V73, P737; Haviv B, 2010, J BONE JOINT SURG BR, V92B, P629, DOI 10.1302/0301-620X.92B5.23667; Haviv B, 2010, BMC SPORTS SCI MED R, V2, DOI 10.1186/1758-2555-2-18; Helenius I, 2001, ANN CHIR GYNAECOL, V90, P28; Sanchez VMI, 2007, REUMATOL CLIN, V3, P50; Javed A, 2011, J BONE JOINT SURG BR, V93B, P326, DOI 10.1302/0301-620X.93B3.25262; Kim KC, 2007, CLIN ORTHOP RELAT R, P128, DOI 10.1097/01.blo.0000246542.49575.2c; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Krych AJ, 2013, SPORTS MED ARTHROSC, V21, P23, DOI 10.1097/JSA.0b013e318270d1bd; Larson CM, 2011, CLIN ORTHOP RELAT R, V469, P1667, DOI 10.1007/s11999-010-1741-6; Malviya A, 2012, J BONE JOINT SURG BR, V94B, P466, DOI 10.1302/0301-620X.94B4.28023; Margheritini F, 1999, Chir Organi Mov, V84, P257; McCarthy JC, 2011, CLIN ORTHOP RELAT R, V469, P362, DOI 10.1007/s11999-010-1559-2; Meftah M, 2011, ORTHOPEDICS, V34, pE588, DOI 10.3928/01477447-20110826-04; Philippon MJ, 2007, AM J SPORT MED, V35, P1571, DOI 10.1177/0363546507300258; Philippon MJ, 2012, ARTHROSCOPY, V28, P59, DOI 10.1016/j.arthro.2011.07.004; Simpson J, 2010, ORTHOP TRAUMATOL-SUR, V96, pS68, DOI 10.1016/j.otsr.2010.09.010; TONNIS D, 1979, Z ORTHOP GRENZGEB, V117, P808; Wilkin G, 2014, J BONE JOINT SURG AM, V96A, P113, DOI 10.2106/JBJS.L.01710	26	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0113970	10.1371/journal.pone.0113970	http://dx.doi.org/10.1371/journal.pone.0113970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635392	gold, Green Submitted, Green Published			2022-12-26	WOS:000350680700002
J	Hite, RK; Chiu, PL; Schuller, JM; Walz, T				Hite, Richard Kevin; Chiu, Po-Lin; Schuller, Jan Michael; Walz, Thomas			Effect of Lipid Head Groups on Double-Layered Two-Dimensional Crystals Formed by Aquaporin-0	PLOS ONE			English	Article							PROTEIN INTERACTIONS; PHOSPHATIDIC-ACID; 2D CRYSTALS; MICROSCOPY; MEMBRANES; IMAGES	Aquaporin-0 (AQP0) is a lens-specific water channel that also forms membrane junctions. Reconstitution of AQP0 with dimyristoyl phosphatidylcholine (DMPC) and E. coli polar lipids (EPL) yielded well-ordered, double-layered two-dimensional (2D) crystals that allowed electron crystallographic structure determination of the AQP0-mediated membrane junction. The interacting tetramers in the two crystalline layers are exactly in register, resulting in crystals with p422 symmetry. The high-resolution density maps also allowed modeling of the annular lipids surrounding the tetramers. Comparison of the DMPC and EPL bilayers suggested that the lipid head groups do not play an important role in the interaction of annular lipids with AQP0. We now reconstituted AQP0 with the anionic lipid dimyristoyl phosphatidylglycerol (DMPG), which yielded a mixture of 2D crystals with different symmetries. The different crystal symmetries result from shifts between the two crystalline layers, suggesting that the negatively charged PG head group destabilizes the interaction between the extracellular AQP0 surfaces. Reconstitution of AQP0 with dimyristoyl phosphatidylserine (DMPS), another anionic lipid, yielded crystals that had the usual p422 symmetry, but the crystals showed a pH-dependent tendency to stack through their cytoplasmic surfaces. Finally, AQP0 failed to reconstitute into membranes that were composed of more than 40% dimyristoyl phosphatidic acid (DMPA). Hence, although DMPG, DMPS, and DMPA are all negatively charged lipids, they have very different effects on AQP0 2D crystals, illustrating the importance of the specific lipid head group chemistry beyond its mere charge.	[Hite, Richard Kevin; Chiu, Po-Lin; Schuller, Jan Michael; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Walz, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	twalz@hms.harvard.edu	Chiu, Po-Lin/D-2762-2013; Chiu, Po-Lin/ABB-7848-2021; Chiu, Po-Lin/GWV-6758-2022	Chiu, Po-Lin/0000-0001-8608-7650; Chiu, Po-Lin/0000-0001-8608-7650; Walz, Thomas/0000-0003-2606-2835; Schuller, Jan Michael/0000-0002-9121-1764	National Institutes of Health [R01 EY015107, P01 GM62580]; NATIONAL EYE INSTITUTE [R01EY015107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 EY015107 (to TW). TW is an investigator with the Howard Hughes Medical Institute. The molecular electron microscopy facility at Harvard Medical School was established with a generous donation from the Giovanni Armenise Harvard Center for Structural Biology and is maintained with funds from NIH grant P01 GM62580 (to Stephen C. Harrison). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzhynskyy N, 2007, EMBO REP, V8, P51, DOI 10.1038/sj.embor.7400858; ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9; Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920; Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012; HARLOS K, 1984, CHEM PHYS LIPIDS, V34, P115, DOI 10.1016/0009-3084(84)90037-9; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Hite RK, 2010, METHOD ENZYMOL, V481, P251, DOI 10.1016/S0076-6879(10)81011-0; Hite RK, 2010, EMBO J, V29, P1652, DOI 10.1038/emboj.2010.68; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Marsh D., 1990, CRC HDB LIPID BILAYE; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Peterson E, 2011, BBA-BIOMEMBRANES, V1808, P516, DOI 10.1016/j.bbamem.2010.10.010; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Tani K, 2009, J MOL BIOL, V389, P694, DOI 10.1016/j.jmb.2009.04.049; VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Zampighi G, 1982, J CELL BIOL, V93, P172, DOI 1016/j.jmb.2009.04.049; ZELENKA PS, 1984, CURR EYE RES, V3, P1337, DOI 10.3109/02713688409007421	24	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117371	10.1371/journal.pone.0117371	http://dx.doi.org/10.1371/journal.pone.0117371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635393	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700082
J	Meziane, HB; Moisello, C; Perfetti, B; Kvint, S; Isaias, IU; Quartarone, A; Di Rocco, A; Ghilardi, MF				Meziane, Hadj Boumediene; Moisello, Clara; Perfetti, Bernardo; Kvint, Svetlana; Isaias, Ioannis Ugo; Quartarone, Angelo; Di Rocco, Alessandro; Ghilardi, Maria Felice			Movement Preparation and Bilateral Modulation of Beta Activity in Aging and Parkinson's Disease	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; OSCILLATORY ACTIVITY; CORTICAL RHYTHMS; EEG DATA; L-DOPA; TIME; COHERENCE; BRADYKINESIA; ACTIVATION; PARADIGMS	In previous studies of young subjects performing a reaction-time reaching task, we found that faster reaction times are associated with increased suppression of beta power over primary sensorimotor areas just before target presentation. Here we ascertain whether such beta decrease similarly occurs in normally aging subjects and also in patients with Parkinson's disease (PD), where deficits in movement execution and abnormalities of beta power are usually present. We found that in both groups, beta power decreased during the motor task in the electrodes over the two primary sensorimotor areas. However, before target presentation, beta decreases in PD were significantly smaller over the right than over the left areas, while they were symmetrical in controls. In both groups, functional connectivity between the two regions, measured with imaginary coherence, increased before the target appearance; however, in PD, it decreased immediately after, while in controls, it remained elevated throughout motor planning. As in previous studies with young subjects, the degree of beta power before target appearance correlated with reaction time. The values of coherence during motor planning, instead, correlated with movement time, peak velocity and acceleration. We conclude that planning of prompt and fast movements partially depends on coordinated beta activity of both sensorimotor areas, already at the time of target presentation. The delayed onset of beta decreases over the right region observed in PD is possibly related to a decreased functional connectivity between the two areas, and this might account for deficits in force programming, movement duration and velocity modulation.	[Meziane, Hadj Boumediene; Moisello, Clara; Perfetti, Bernardo; Kvint, Svetlana; Ghilardi, Maria Felice] CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA; [Isaias, Ioannis Ugo] Univ Hosp Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany; [Quartarone, Angelo] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol Sci, Messina, Italy; [Quartarone, Angelo; Di Rocco, Alessandro; Ghilardi, Maria Felice] NYU, Langone Sch Med, Movement Disorders Ctr, Dept Neurol, New York, NY USA	City University of New York (CUNY) System; University of Wurzburg; University of Messina; New York University; NYU Langone Medical Center	Ghilardi, MF (corresponding author), CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, New York, NY 10031 USA.	lice.mg79@gmail.com	Isaias, Ioannis Ugo/F-4492-2014	Isaias, Ioannis Ugo/0000-0002-3552-5144; Meziane, Hadj Boumediene/0000-0001-9284-5016; Di Rocco (also publications under DiRocco), Alessandro/0000-0002-5508-5043	McDonnell Foundation; National Parkinson Foundation; National Institute of Health [NS-054864]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054864] Funding Source: NIH RePORTER	McDonnell Foundation; National Parkinson Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the McDonnell Foundation to MFG, the National Parkinson Foundation to MFG & ADR, and the National Institute of Health (NS-054864 to MFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2003, EXP BRAIN RES, V148, P17, DOI 10.1007/s00221-002-1255-x; Babiloni C, 2004, BEHAV BRAIN RES, V153, P261, DOI 10.1016/j.bbr.2003.12.012; Beaule V, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/627816; Brown P, 1999, MOVEMENT DISORD, V14, P423, DOI 10.1002/1531-8257(199905)14:3<423::AID-MDS1006>3.0.CO;2-V; Defebvre L, 1998, ELECTROMYOGR MOTOR C, V109, P161, DOI 10.1016/S0924-980X(97)00085-4; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DERAMBURE P, 1993, ELECTROEN CLIN NEURO, V89, P197, DOI 10.1016/0168-5597(93)90133-A; Doyle LMF, 2005, CLIN NEUROPHYSIOL, V116, P1879, DOI 10.1016/j.clinph.2005.03.017; Formaggio E, BRAIN TOPOGR; Freyer F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00144; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Ghilardi MF, 2003, NEUROLOGY, V60, P1313, DOI 10.1212/01.WNL.0000059545.69089.EE; Ghilardi MF, 2000, BRAIN RES, V876, P112, DOI 10.1016/S0006-8993(00)02635-4; Giannicola G, 2010, EXP NEUROL, V226, P120, DOI 10.1016/j.expneurol.2010.08.011; Gross J, 2005, NEUROIMAGE, V26, P91, DOI 10.1016/j.neuroimage.2005.01.025; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Heinrichs-Graham E, 2013, CEREB CORTEX; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Koeda T, 1995, ELECTROEN CLIN NEURO, V95, P397, DOI 10.1016/0013-4694(95)00171-9; Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x; Kuhn AA, 2006, BRAIN, V129, P695, DOI 10.1093/brain/awh715; Kvint S, 2011, ARCH ITAL BIOL, V149, P303, DOI 10.4449/aib.v149i3.1244; Labyt E, 2005, J CLIN NEUROPHYSIOL, V22, P192; Leocani L, 2001, CLIN NEUROPHYSIOL, V112, P923, DOI 10.1016/S1388-2457(01)00530-2; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Magnani G, 1998, MOVEMENT DISORD, V13, P653, DOI 10.1002/mds.870130408; Magnani G, 2002, NEUROL SCI, V23, P91, DOI 10.1007/s100720200033; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Manganotti P, 1998, ELECTROMYOGR MOTOR C, V109, P50, DOI 10.1016/S0924-980X(97)00074-X; Mani S, 2013, BRAIN, V136, P1288, DOI 10.1093/brain/aws283; Marinelli L, 2010, MOVEMENT DISORD, V25, P1498, DOI 10.1002/mds.23156; Mima T, 2000, NEUROSCI LETT, V287, P93, DOI 10.1016/S0304-3940(00)01165-4; MONTPLAISIR J, 1990, CLIN ELECTROENCEPHAL, V21, P42, DOI 10.1177/155005949002100114; Mutha PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058582; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onton J, 2006, PROG BRAIN RES, V159, P99, DOI 10.1016/S0079-6123(06)59007-7; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Priori A, 2004, EXP NEUROL, V189, P369, DOI 10.1016/j.expneurol.2004.06.001; Sailer A, 2000, NEUROLOGY, V55, P979, DOI 10.1212/WNL.55.7.979; Salmelin R, 1995, ELECTROEN CLIN NEURO, V95, P444, DOI 10.1016/0013-4694(95)00193-X; Schaefer SY, 2012, CEREB CORTEX, V22, P1407, DOI 10.1093/cercor/bhr237; Tan HL, 2013, EXP NEUROL, V240, P122, DOI 10.1016/j.expneurol.2012.11.011; Tombini M, 2009, NEUROIMAGE, V47, P1735, DOI 10.1016/j.neuroimage.2009.04.046; Vallesi A, 2010, BIOL PSYCHOL, V85, P213, DOI 10.1016/j.biopsycho.2010.07.003; Zaepffel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060060; Zhang Y, 2008, J COGNITIVE NEUROSCI, V20, P1915, DOI 10.1162/jocn.2008.20132	53	21	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0114817	10.1371/journal.pone.0114817	http://dx.doi.org/10.1371/journal.pone.0114817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635777	Green Published, gold			2022-12-26	WOS:000350680700004
J	Oba, Y; Ohira, H; Murase, Y; Moriyama, A; Kumazawa, Y				Oba, Yuichi; Ohira, Hitoo; Murase, Yukio; Moriyama, Akihiko; Kumazawa, Yoshinori			DNA Barcoding of Japanese Click Beetles (Coleoptera, Elateridae)	PLOS ONE			English	Article								Click beetles (Coleoptera: Elateridae) represent one of the largest groups of beetle insects. Some click beetles in larval form, known as wireworms, are destructive agricultural pests. Morphological identification of click beetles is generally difficult and requires taxonomic expertise. This study reports on the DNA barcoding of Japanese click beetles to enable their rapid and accurate identification. We collected and assembled 762 cytochrome oxidase subunit I barcode sequences from 275 species, which cover approximately 75% of the common species found on the Japanese main island, Honshu. This barcode library also contains 20 out of the 21 potential pest species recorded in Japan. Our analysis shows that most morphologically identified species form distinct phylogenetic clusters separated from each other by large molecular distances. This supports the general usefulness of the DNA barcoding approach for quick and reliable identification of Japanese elaterid species for environmental impact assessment, agricultural pest control, and biodiversity analysis. On the other hand, the taxonomic boundary in dozens of species did not agree with the boundary of barcode index numbers (a criterion for sequence-based species delimitation). These findings urge taxonomic reinvestigation of these mismatched taxa.	[Oba, Yuichi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ohira, Hitoo] Kitsuneyama, Okazaki, Aichi 4443511, Japan; [Murase, Yukio; Moriyama, Akihiko; Kumazawa, Yoshinori] Nagoya City Univ, Grad Sch Nat Sci, Res Ctr Biol Divers, Nagoya, Aichi 4678501, Japan	Nagoya University; Nagoya City University	Oba, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	oba@agr.nagoya-u.ac.jp; kuma@nsc.nagoya-cu.ac.jp	Oba, Yuichi/AAZ-7796-2021		Nagoya City University [42]; Japan Society for the Promotion of Science [258041]	Nagoya City University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Research in Nagoya City University (no. 42) and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (258041). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki N, 2008, J ECON ENTOMOL, V101, P1568, DOI 10.1603/0022-0493(2008)101[1568:MDFCOM]2.0.CO;2; Asahida T, 1996, FISHERIES SCI, V62, P727, DOI 10.2331/fishsci.62.727; Azuma S, 2002, CHECK LIST INSECT RY, P203; Chujo M, 1973, MEMOIRS FACULTY LIBE, P17; Costa C, 2010, HBK ZOOL, P75; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hayakawa H, 1987, ANN REPT PLANT PROT, V38, P107; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HIRAI Y, 1991, JARQ-JPN AGR RES Q, V25, P12; Hirano Y., 2004, INSECT FAUNA KANAGAW, VII, P335; Inaizumi M, 2003, INSECTS TOCHIGI PREF, P177; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Jinnouchi Hiroaki, 1997, Proceedings of the Association for Plant Protection of Kyushu, V43, P91; Johnson PJ, 2001, AM BEETLES, V2, P160; Kishii T, 1996, B HEIAN HIGH SCH KYO, V39, P1; Kishii T., 1999, B HEIAN HIGH SCH KYO, V42, P1; Kishii T, 1966, ELATERIDAE KYOTO ITS, P1; MATSUI M, 1980, J FOREST, V78, P96; Mendel H, 2012, CHECKLIST BEETLES BR, P62; Mittermeier RA, 2005, HOTSPOTS REVISITED; Oba Yuichi, 2007, Coleopterists' News, V157, P7; Ohira H., 1986, New Entomologist, V35, P17; Ohira H., 1989, Gekkan-Mushi, P23; Ohira H., 1988, Edaphologia, P27; Ohira H, 1988, T ESSA ENT SOC NIIGA, V65, P19; Ohira H, 2004, MISC REPT HIWA MUS N, V43; Ohira H., 1962, MORPHOLOGICAL TAXONO; Ohira H, 1999, B SOUNKYO MUS NAT HI, V19, P1; Ohira H, 2001, ANN REPT AOMORI PREF, V25, P77; Ohira H, 2002, THREATENED WILDLIFE; Ohira H, 1993, HIBAKAGAKU, V154, P11; Ohira H, 1984, B SOUNKYO MUS NAT HI, V4, P13; Ohira H, 1989, T ESSA ENT SOC NIIGA, V68, P59; Ohira H, 1968, KONCHU SHIZEN, V3, P30; Ohira H, 1989, GEKKAN MUSHI, V217, P9; Ohira H, 1990, INSECTS IN AICHI, V1, P367; Ohira H, 2013, ILLUSTRATED GUIDE ID, P227; Ohira H, 1985, COLEOPTERA JAPAN COL, VIII, P53; Ohira H, 1969, KONCHU SHIZEN, V4, P22; Ohira H, 1996, ENT J FUKUI, V19, P33; Ohira Hitoo, 1997, Miscellaneous Reports of the Hiwa Museum for Natural History, V35, P1; Ohira Hitoo, 1992, Transactions Essa Entomological Society Niigata, V74, P23; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Sagegami-Oba R, 2008, ELYTRA, V36, P79; Sagegami-Oba R, 2007, MOL PHYLOGENET EVOL, V42, P410, DOI 10.1016/j.ympev.2006.07.017; Sakurai K, 1942, KONCHU, V16, P1; Sasaji H, 1998, INSECT FAUNA FUKUI P; Staudacher K, 2011, B ENTOMOL RES, V101, P201, DOI 10.1017/S0007485310000337; SUZUKI W, 1985, Transactions of the Shikoku Entomological Society, V17, P79; Suzuki W, 1989, CHECK LIST JAPANESE, P327; Taira A, 1989, EVOLUTION PACIFIC OC, P100; Tarnawski Dariusz, 2001, Genus (Wroclaw), V12, P277; The Association for Geological Collaboration of Japan, 1965, GEOL DEV JAP ISL; Vernon RS, 2007, J CHEM ECOL, V33, P345, DOI 10.1007/s10886-006-9217-6; Watanabe T, 1989, COLEOPTERA MIYAGI PR; Yamaji O, 2012, LIST COLEOPTERA OKAY; YOSHIDA M., 1951, OYO KONTYU, V7, P145	59	32	33	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116612	10.1371/journal.pone.0116612	http://dx.doi.org/10.1371/journal.pone.0116612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25636000	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700049
J	Ohsumi, T; Takenaka, S; Wakamatsu, R; Sakaue, Y; Narisawa, N; Senpuku, H; Ohshima, H; Terao, Y; Okiji, T				Ohsumi, Tatsuya; Takenaka, Shoji; Wakamatsu, Rika; Sakaue, Yuuki; Narisawa, Naoki; Senpuku, Hidenobu; Ohshima, Hayato; Terao, Yutaka; Okiji, Takashi			Residual Structure of Streptococcus mutans Biofilm following Complete Disinfection Favors Secondary Bacterial Adhesion and Biofilm Re-Development	PLOS ONE			English	Article							SUBMINIMAL INHIBITORY CONCENTRATIONS; STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS; PORPHYROMONAS-GINGIVALIS; ANTIMICROBIAL AGENTS; SUPRAGINGIVAL PLAQUE; TEMPORAL PATTERNS; DENTAL BIOFILMS; ORAL BIOFILM; MODEL; ANTIBIOTICS	Chemical disinfection of oral biofilms often leaves biofilm structures intact. This study aimed to examine whether the residual structure promotes secondary bacterial adhesion. Streptococcus mutans biofilms generated on resin-composite disks in a rotating disc reactor were disinfected completely with 70% isopropyl alcohol, and were again cultured in the same reactor after resupplying with the same bacterial solution. Specimens were subjected to fluorescence confocal laser scanning microscopy, viable cell counts and PCR-Invader assay in order to observe and quantify secondarily adhered cells. Fluorescence microscopic analysis, particularly after longitudinal cryosectioning, demonstrated stratified patterns of viable cells on the disinfected biofilm structure. Viable cell counts of test specimens were significantly higher than those of controls, and increased according to the amount of residual structure and culture period. Linear regression analysis exhibited a high correlation between viable and total cell counts. It was concluded that disinfected biofilm structures favored secondary bacterial adhesion.	[Ohsumi, Tatsuya; Takenaka, Shoji; Wakamatsu, Rika; Sakaue, Yuuki; Okiji, Takashi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Div Cariol Operat Dent & Endodont, Niigata, Japan; [Narisawa, Naoki] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan; [Senpuku, Hidenobu] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Ohshima, Hayato] Niigata Univ, Grad Sch Med & Dent Sci, Dept Tissue Regenerat & Reconstruct, Div Anat & Cell Biol Hard Tissue, Niigata, Japan; [Terao, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Div Microbiol & Infect Dis, Niigata, Japan	Niigata University; Nihon University; National Institute of Infectious Diseases (NIID); Niigata University; Niigata University	Takenaka, S (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Div Cariol Operat Dent & Endodont, Niigata, Japan.	takenaka@dent.niigata-u.ac.jp	Ohshima, Hayato/AAW-5545-2020; narisawa, naoki/GQZ-2781-2022; SENPUKU, HIDENOBU/ABC-6160-2021; Okiji, Takashi/W-3841-2019; Takenaka, Shoji/AAM-2347-2020	Ohshima, Hayato/0000-0001-8571-9900; Okiji, Takashi/0000-0002-9791-4508; Terao, Yutaka/0000-0002-4450-5583; Narisawa, Naoki/0000-0002-5932-497X	Japan Society for the Promotion of Science (JSPS) [23592795]; Grants-in-Aid for Scientific Research [26462876] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (no. 23592795) from the Japan Society for the Promotion of Science (JSPS); and the JSPS Institutional Program for Young Researcher Overseas Visits. ST received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaker RP, 2009, INT J ANTIMICROB AG, V33, P8, DOI 10.1016/j.ijantimicag.2008.07.014; Augustin P, 2013, INFECT IMMUN, V81, P1721, DOI 10.1128/IAI.00775-12; Baehni PC, 2003, ORAL DIS, V9, P23, DOI 10.1034/j.1601-0825.9.s1.5.x; Bales PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067950; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Bonito AJ, 2005, J PERIODONTOL, V76, P1227, DOI 10.1902/jop.2005.76.8.1227; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brading MG, 2003, INT DENT J, V53, P353, DOI 10.1111/j.1875-595X.2003.tb00910.x; Compagnoni MA, 2014, GERODONTOLOGY, V31, P220, DOI 10.1111/ger.12031; Corbin A, 2011, ANTIMICROB AGENTS CH, V55, P3338, DOI 10.1128/AAC.00206-11; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cotter JJ, 2010, J APPL MICROBIOL, V109, P2105, DOI 10.1111/j.1365-2672.2010.04842.x; Davison WM, 2010, ANTIMICROB AGENTS CH, V54, P2920, DOI 10.1128/AAC.01734-09; Dong LP, 2012, INT J ANTIMICROB AG, V39, P390, DOI 10.1016/j.ijantimicag.2012.01.009; Frank KL, 2007, ANTIMICROB AGENTS CH, V51, P888, DOI 10.1128/AAC.01052-06; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Guggenheim B, 2004, CARIES RES, V38, P212, DOI 10.1159/000077757; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Haddadin RNS, 2010, J APPL MICROBIOL, V108, P1281, DOI 10.1111/j.1365-2672.2009.04529.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Ishihara K, 1999, FEMS MICROBIOL LETT, V181, P199; Jepsen S, 2011, PERIODONTOL 2000, V55, P167, DOI 10.1111/j.1600-0757.2010.00382.x; Jin Y, 2002, CRIT REV ORAL BIOL M, V13, P426, DOI 10.1177/154411130201300506; Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12; Kaplan JB, 2011, INT J ARTIF ORGANS, V34, P737, DOI 10.5301/ijao.5000027; Kaplan JB, 2011, RES MICROBIOL, V162, P535, DOI 10.1016/j.resmic.2011.03.008; KOGA T, 1990, INFECT IMMUN, V58, P289, DOI 10.1128/IAI.58.2.289-296.1990; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lyons SR, 2000, J CLIN MICROBIOL, V38, P2362; Marra J, 2012, J APPL ORAL SCI, V20, P643, DOI 10.1590/S1678-77572012000600009; Marsh PD, 2010, J DENT, V38, pS11, DOI 10.1016/S0300-5712(10)70005-1; Matesanz-Perez P, 2013, J CLIN PERIODONTOL, V40, P227, DOI 10.1111/jcpe.12026; O'Brien-Simpson NM, 2004, PERIODONTOL 2000, V35, P101, DOI 10.1111/j.0906-6713.2004.003559.x; Pratten J, 1999, ANTIMICROB AGENTS CH, V43, P1595, DOI 10.1128/AAC.43.7.1595; Quirynen M, 2002, PERIODONTOL 2000, V28, P72, DOI 10.1034/j.1600-0757.2002.280104.x; Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07; Samaranayake YH, 2009, ARCH ORAL BIOL, V54, P115, DOI 10.1016/j.archoralbio.2008.09.015; Sato Y, 1997, INFECT IMMUN, V65, P668, DOI 10.1128/IAI.65.2.668-675.1997; Sedlacek MJ, 2007, ORAL MICROBIOL IMMUN, V22, P333, DOI 10.1111/j.1399-302X.2007.00366.x; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Stoodley P, 2008, J AM DENT ASSOC, V139, P1182, DOI 10.14219/jada.archive.2008.0333; Strydonck DAC, 2012, J CLIN PERIODONTOL, V39, P1042, DOI 10.1111/j.1600-051X.2012.01883.x; Tada A, 2012, JPN J INFECT DIS, V65, P415, DOI 10.7883/yoken.65.415; Tadokoro K, 2010, MICROBIOL RES, V165, P43, DOI 10.1016/j.micres.2008.06.001; Takenaka S, 2008, APPL ENVIRON MICROB, V74, P1869, DOI 10.1128/AEM.02218-07; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; Terao Y, 2009, ORAL MICROBIOL IMMUN, V24, P211, DOI 10.1111/j.1399-302X.2008.00497.x; Thurnheer T, 2003, APPL ENVIRON MICROB, V69, P1702, DOI 10.1128/AEM.69.3.1702-1709.2003; von Ohle C, 2010, APPL ENVIRON MICROB, V76, P2326, DOI 10.1128/AEM.02090-09; Wakamatsu R, 2014, CLIN ORAL INVEST, V18, P625, DOI 10.1007/s00784-013-1002-7; Watson PS, 2005, J DENT RES, V84, P451, DOI 10.1177/154405910508400510; Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13; Yamaguchi M, 2013, EUR J ORAL SCI, V121, P162, DOI 10.1111/eos.12050	57	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116647	10.1371/journal.pone.0116647	http://dx.doi.org/10.1371/journal.pone.0116647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635770	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700052
J	Aoyagi, Y; Kawakami, R; Osanai, H; Hibi, T; Nemoto, T				Aoyagi, Yuka; Kawakami, Ryosuke; Osanai, Hisayuki; Hibi, Terumasa; Nemoto, Tomomi			A Rapid Optical Clearing Protocol Using 2,2'-Thiodiethanol for Microscopic Observation of Fixed Mouse Brain	PLOS ONE			English	Article							MULTIPHOTON MICROSCOPY; TISSUE	Elucidation of neural circuit functions requires visualization of the fine structure of neurons in the inner regions of thick brain specimens. However, the tissue penetration depth of laser scanning microscopy is limited by light scattering and/or absorption by the tissue. Recently, several optical clearing reagents have been proposed for visualization in fixed specimens. However, they require complicated protocols or long treatment times. Here we report the effects of 2,2'-thiodiethanol (TDE) solutions as an optical clearing reagent for fixed mouse brains expressing a yellow fluorescent protein. Immersion of fixed brains in TDE solutions rapidly (within 30 min in the case of 400-mu m-thick fixed brain slices) increased their transparency and enhanced the penetration depth in both confocal and two-photon microscopy. In addition, we succeeded in visualizing dendritic spines along single dendrites at deep positions in fixed thick brain slices. These results suggest that our proposed protocol using TDE solution is a rapid and useful method for optical clearing of fixed specimens expressing fluorescent proteins.	[Aoyagi, Yuka; Kawakami, Ryosuke; Osanai, Hisayuki; Hibi, Terumasa; Nemoto, Tomomi] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Aoyagi, Yuka; Kawakami, Ryosuke; Osanai, Hisayuki; Hibi, Terumasa; Nemoto, Tomomi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan; [Kawakami, Ryosuke; Hibi, Terumasa; Nemoto, Tomomi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama, Japan	Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Nemoto, T (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan.	tn@es.hokudai.ac.jp	Nemoto, Tomomi/B-4412-2012; Kawakami, Ryosuke/AAU-6087-2020; Hibi, Terumasa/I-3407-2013	Nemoto, Tomomi/0000-0001-6102-1495; Hibi, Terumasa/0000-0001-9373-9602; Osanai, Hisayuki/0000-0002-0920-8428	JSPS KAKENHI grants of the Ministry of Education, Culture, Sports, Science and Technology, Japan [26242082, 22113005]; Nano-Macro Materials, Devices and System Research Alliance; Network Joint Research Center for Materials and Devices;  [26-1533]; Grants-in-Aid for Scientific Research [14J01533] Funding Source: KAKEN	JSPS KAKENHI grants of the Ministry of Education, Culture, Sports, Science and Technology, Japan; Nano-Macro Materials, Devices and System Research Alliance; Network Joint Research Center for Materials and Devices; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for JSPS Fellows (No. 26-1533 for YA) (http://www.jsps.go. jp/english/), by JSPS KAKENHI grants of the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 26242082 and 22113005 for TN) (MEXT;http://www.mext.go.jp/english/), by the Nano-Macro Materials, Devices and System Research Alliance (MEXT; http://www.mext.go.jp/english/) and by the Network Joint Research Center for Materials and Devices (MEXT; http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024695; Appleton PL, 2009, J MICROSC-OXFORD, V234, P196, DOI 10.1111/j.1365-2818.2009.03163.x; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DeFelipe J, 2010, SCIENCE, V330, P1198, DOI 10.1126/science.1193378; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/nphoton.2012.336, 10.1038/NPHOTON.2012.336]; Jung Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094054; Kawakami R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01014; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Parra SG, 2012, JOVE-J VIS EXP, DOI 10.3791/3848; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Reddy G, 2005, INT J TOXICOL, V24, P435, DOI 10.1080/10915810500368878; Sakhalkar HS, 2007, PHYS MED BIOL, V52, P2035, DOI 10.1088/0031-9155/52/8/001; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	27	94	101	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116280	10.1371/journal.pone.0116280	http://dx.doi.org/10.1371/journal.pone.0116280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633541	Green Published, Green Submitted, gold			2022-12-26	WOS:000348609800007
J	Raikwar, SP; Kim, EM; Sivitz, WI; Allamargot, C; Thedens, DR; Zavazava, N				Raikwar, Sudhanshu P.; Kim, Eun-Mi; Sivitz, William I.; Allamargot, Chantal; Thedens, Daniel R.; Zavazava, Nicholas			Human iPS Cell-Derived Insulin Producing Cells Form Vascularized Organoids under the Kidney Capsules of Diabetic Mice	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MOUSE; GENERATION; DIFFERENTIATION; TRANSPLANTATION; HYPERGLYCEMIA	Type 1 diabetes (T1D) is caused by autoimmune disease that leads to the destruction of pancreatic beta-cells. Transplantation of cadaveric pancreatic organs or pancreatic islets can restore normal physiology. However, there is a chronic shortage of cadaveric organs, limiting the treatment of the majority of patients on the pancreas transplantation waiting list. Here, we hypothesized that human iPS cells can be directly differentiated into insulin producing cells (IPCs) capable of secreting insulin. Using a series of pancreatic growth factors, we successfully generated iPS cells derived IPCs. Furthermore, to investigate the capability of these cells to secrete insulin in vivo, the differentiated cells were transplanted under the kidney capsules of diabetic immunodeficient mice. Serum glucose levels gradually declined to either normal or near normal levels over 150 days, suggesting that the IPCs were secreting insulin. In addition, using MRI, a 3D organoid appeared as a white patch on the transplanted kidneys but not on the control kidneys. These organoids showed neovascularization and stained positive for insulin and glucagon. All together, these data show that a pancreatic organ can be created in vivo providing evidence that iPS cells might be a novel option for the treatment of T1D.	[Raikwar, Sudhanshu P.; Kim, Eun-Mi; Zavazava, Nicholas] Univ Iowa, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA; [Sivitz, William I.] Univ Iowa, Div Endocrinol & Metab, Iowa City, IA 52242 USA; [Allamargot, Chantal] Univ Iowa, Cent Microscopy Res Facil, Iowa City, IA 52242 USA; [Thedens, Daniel R.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Raikwar, Sudhanshu P.; Kim, Eun-Mi; Zavazava, Nicholas] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Zavazava, N (corresponding author), Univ Iowa, Dept Internal Med, Div Immunol, Iowa City, IA 52242 USA.	nicholas-zavazava@uiowa.edu	Raikwar, Sudhanshu/AAT-5128-2021	Raikwar, Sudhanshu/0000-0001-8549-8570; Sivitz, William/0000-0002-7829-0189	Veterans Affairs [1I01BX001125-01A1]; NIH/NHLBI [R01 HLO73015]; NIH/NIDDK [P30 DK054759]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000285] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs (http://www.iowacity.va.gov/) Award #1I01BX001125-01A1 to NZ, NIH/NHLBI Award Number NIH/NHLBI #R01 HLO73015 (http://NIH.gov) to NZ, and NIH/NIDDK #P30 DK054759 to SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIHANNA D, 1988, TRANSPLANTATION, V45, P610, DOI 10.1097/00007890-198803000-00021; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Ben Nasr M, 2014, THE RISE FALL AND RE; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Bonde S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003212; D'Addio F, 2014, DIABETES, V63, P3041, DOI 10.2337/db14-0295; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dao LT, 2014, TRANSPLANTATION OF I; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Guo TX, 2013, DIABETES, V62, P1581, DOI 10.2337/db12-0167; Hua XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102198; Kelly OG, 2011, NAT BIOTECHNOL, V29, P750, DOI 10.1038/nbt.1931; Kim EM, 2013, BLOOD, V121, P5167, DOI 10.1182/blood-2012-11-467753; Luo J, 2013, METABOLISM, V62, P90, DOI 10.1016/j.metabol.2012.07.010; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Raikwar SP, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-19; Raikwar SP, 2011, TRANSPLANTATION, V91, P11, DOI 10.1097/TP.0b013e3181fdd98b; Raikwar SP, 2009, METHODS MOL BIOL, V590, P317, DOI 10.1007/978-1-60327-378-7_21; Rezania A, 2014, NAT BIOTECHNOL; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep04488	29	32	37	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116582	10.1371/journal.pone.0116582	http://dx.doi.org/10.1371/journal.pone.0116582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629318	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100042
J	Yost, EA; Hynes, TR; Hartle, CM; Ott, BJ; Berlot, CH				Yost, Evan A.; Hynes, Thomas R.; Hartle, Cassandra M.; Ott, Braden J.; Berlot, Catherine H.			Inhibition of G-Protein beta gamma Signaling Enhances T Cell Receptor-Stimulated Interleukin 2 Transcription in CD4(+) T Helper Cells	PLOS ONE			English	Article							SMALL-MOLECULE DISRUPTION; PHOSPHOLIPASE-C-BETA; IN-VIVO; RHEUMATOID-ARTHRITIS; GLUCOCORTICOID-RECEPTOR; DIFFERENTIAL REGULATION; SYNOVIAL FIBROBLASTS; NUCLEAR-LOCALIZATION; FLUORESCENT PROTEIN; CALCIUM-CHANNELS	G-protein-coupled receptor (GPCR) signaling modulates the expression of cytokines that are drug targets for immune disorders. However, although GPCRs are common targets for other diseases, there are few GPCR-based pharmaceuticals for inflammation. The purpose of this study was to determine whether targeting G-protein beta gamma (G beta gamma) complexes could provide a useful new approach for modulating interleukin 2 (IL-2) levels in CD4(+) T helper cells. Gallein, a small molecule inhibitor of G beta gamma, increased levels of T cell receptor (TCR)-stimulated IL-2 mRNA in primary human naive and memory CD4(+) T helper cells and in Jurkat human CD4(+) leukemia T cells. G beta(1) and G beta(2) mRNA accounted for > 99% of G beta mRNA, and small interfering RNA (siRNA)-mediated silencing of G beta(1) but not G beta(2) enhanced TCR-stimulated IL-2 mRNA increases. Blocking G beta gamma enhanced TCR-stimulated increases in IL-2 transcription without affecting IL-2 mRNA stability. Blocking G beta gamma also enhanced TCR-stimulated increases in nuclear localization of nuclear factor of activated T cells 1 (NFAT1), NFAT transcriptional activity, and levels of intracellular Ca2+. Potentiation of IL-2 transcription required continuous G beta gamma inhibition during at least two days of TCR stimulation, suggesting that induction or repression of additional signaling proteins during T cell activation and differentiation might be involved. The potentiation of TCR-stimulated IL-2 transcription that results from blocking G beta gamma in CD4(+) T helper cells could have applications for autoimmune diseases.	[Yost, Evan A.; Hynes, Thomas R.; Hartle, Cassandra M.; Ott, Braden J.; Berlot, Catherine H.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Berlot, CH (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.	chberlot@geisinger.edu			National Institutes of Health [GM050369]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050369, R29GM050369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health Grant GM050369 (to CHB) http://www.nigms.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bach TL, 2007, J IMMUNOL, V179, P2223, DOI 10.4049/jimmunol.179.4.2223; Badou A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00243; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Bhatnagar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052689; Bluestone JA, 2011, NEW ENGL J MED, V365, P2129, DOI 10.1056/NEJMe1110900; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Borner C, 2009, J BIOL CHEM, V284, P35450, DOI 10.1074/jbc.M109.006338; Borner C, 2009, J IMMUNOL, V183, P882, DOI 10.4049/jimmunol.0802763; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Boularan C, 2014, CELL SIGNAL, V26, P1269, DOI 10.1016/j.cellsig.2014.02.010; Bunting K, 2006, VITAM HORM, V74, P105, DOI 10.1016/S0083-6729(06)74005-5; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Fan J, 1998, CLIN DIAGN LAB IMMUN, V5, P335, DOI 10.1128/CDLI.5.3.335-340.1998; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; Harada K, 2011, CLIN EXP NEPHROL, V15, P966, DOI 10.1007/s10157-011-0518-x; Harris SJ, 2012, EUR J IMMUNOL, V42, P3394, DOI 10.1002/eji.201242463; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Insel PA, 2007, BBA-BIOMEMBRANES, V1768, P994, DOI 10.1016/j.bbamem.2006.09.029; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; Jenabian MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003319; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Kawakami Toshiaki, 2013, Advances in Biological Regulation, V53, P249, DOI 10.1016/j.jbior.2013.08.001; Kerppola TK, 1998, STRUCT FOLD DES, V6, P549, DOI 10.1016/S0969-2126(98)00057-4; Kerr JS, 2013, CELL SIGNAL, V25, P729, DOI 10.1016/j.cellsig.2012.12.015; Kershaw MH, 2013, NAT REV CANCER, V13, P525, DOI 10.1038/nrc3565; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kino T, 2005, EUR J CLIN INVEST, V35, P508, DOI 10.1111/j.1365-2362.2005.01539.x; Kino T, 2005, J CELL BIOL, V169, P885, DOI 10.1083/jcb.200409150; Kotturi MF, 2003, J BIOL CHEM, V278, P46949, DOI 10.1074/jbc.M309268200; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Ladygina N, 2013, EUR J IMMUNOL, V43, P3183, DOI 10.1002/eji.201343812; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; LOTZE MT, 1985, J IMMUNOL, V135, P2865; Lyakh L, 1997, MOL CELL BIOL, V17, P2475, DOI 10.1128/MCB.17.5.2475; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Matsuoka K, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005265; Medina R, 1996, J BIOL CHEM, V271, P24720, DOI 10.1074/jbc.271.40.24720; Molloy MJ, 2009, J IMMUNOL, V182, P4512, DOI 10.4049/jimmunol.0804175; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Norii M, 2006, ACTA MED OKAYAMA, V60, P149; Park JG, 1999, EMBO J, V18, P4004, DOI 10.1093/emboj/18.14.4004; Pease J, 2012, J MED CHEM, V55, P9363, DOI 10.1021/jm300682j; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Riether C, 2011, BRAIN BEHAV IMMUN, V25, P59, DOI 10.1016/j.bbi.2010.07.248; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Robitaille M, 2010, CELL SIGNAL, V22, P1254, DOI 10.1016/j.cellsig.2010.04.005; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; SALMON M, 1994, EUR J IMMUNOL, V24, P892, DOI 10.1002/eji.1830240417; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Seneviratne AMPB, 2011, BBA-PROTEINS PROTEOM, V1814, P1210, DOI 10.1016/j.bbapap.2011.05.010; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHAW J, 1988, J IMMUNOL, V140, P2243; Simmons DL, 2006, DRUG DISCOV TODAY, V11, P210, DOI 10.1016/S1359-6446(05)03721-9; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Smrcka AV, 2008, COMB CHEM HIGH T SCR, V11, P382, DOI 10.2174/138620708784534761; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Spiegelberg BD, 2005, J BIOL CHEM, V280, P41769, DOI 10.1074/jbc.M504066200; Srinivasan M, 2007, J IMMUNOL, V179, P3734, DOI 10.4049/jimmunol.179.6.3734; Steinman L, 2012, J CELL BIOL, V199, P413, DOI 10.1083/jcb.201207175; Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Tsubaki T, 2005, CLIN EXP IMMUNOL, V141, P363, DOI 10.1111/j.1365-2249.2005.02850.x; Ueno A, 2005, RHEUMATOL INT, V25, P361, DOI 10.1007/s00296-004-0449-x; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Weiss N, 2010, J PHYSIOL-LONDON, V588, P2945, DOI 10.1113/jphysiol.2010.191593; Zhang CH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001501; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zheng YH, 2000, FASEB J, V14, P2387	88	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116575	10.1371/journal.pone.0116575	http://dx.doi.org/10.1371/journal.pone.0116575			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629163	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100041
J	Paiva, I; da Costa, RMG; Ribeiro, J; Sousa, H; Bastos, M; Rocha, AFC; Oliveira, PA; Medeiros, R				Paiva, Isabel; da Costa, Rui M. Gil; Ribeiro, Joana; Sousa, Hugo; Bastos, Margarida; Rocha, Ana Faustino Carlos; Oliveira, Paula A.; Medeiros, Rui			A Role for MicroRNA-155 Expression in Microenvironment Associated to HPV-Induced Carcinogenesis in K14-HPV16 Transgenic Mice	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; B-CELL; DOWN-REGULATION; CANCER; MIR-155; GENE; PROLIFERATION; HEAD	Human Papillomavirus cause a number of diseases most notably cervical cancer. K14-HPV16 transgenic mice expressing the HPV16 early genes in squamous epithelial cells provide a suitable experimental model for studying these diseases. MicroRNAs are small non-coding RNAs that play an important role in regulating gene expression and have been suggested to play an important role in cancer development. The role of miR-155 in cancer remains controversial and there is limited evidence linking this miRNA to HPV-associated diseases. We hypothesized that miR-155 expression modulates each tissue's susceptibility to develop HPV-associated carcinogenesis. In this study, we analyzed miR-155 expression in ear and chest skin samples from 22-26 weeks old, female K14-HPV16 transgenic (HPV16+/-) and wild-type (HPV-/-) mice. Among wild-type mice the expression of miR-155 was lower in ear skin compared with chest skin (p = 0.028). In transgenic animals, in situ carcinoma was present in all ear samples whereas chest tissues only showed epidermal hyperplasia. Furthermore, in hyperplastic chest skin samples, miR-155 expression was lower than in normal chest skin (p = 0,026). These results suggest that miR-155 expression may modulate the microenvironmental susceptibility to cancer development and that high miR155 levels may be protective against the carcinogenesis induced by HPV16.	[Paiva, Isabel; Ribeiro, Joana; Sousa, Hugo; Medeiros, Rui] CI IPOP, Portuguese Inst Oncol Porto, Mol Oncol & Viral Pathol Grp, P-4200072 Porto, Portugal; [Paiva, Isabel; Medeiros, Rui] Univ Porto, Abel Salazar Inst Biomed Sci, ICBAS, P-4050313 Porto, Portugal; [da Costa, Rui M. Gil; Bastos, Margarida] Univ Porto, Fac Engn, LEPABE, P-4200465 Porto, Portugal; [da Costa, Rui M. Gil; Rocha, Ana Faustino Carlos] CI IPOP, Portuguese Inst Oncol, Expt Pathol & Therapeut Grp, P-4200072 Porto, Portugal; [Ribeiro, Joana; Sousa, Hugo; Medeiros, Rui] Portuguese Inst Oncol Porto, Virol Serv, P-4200072 Porto, Portugal; [Oliveira, Paula A.] Univ Tras Os Montes & Alto Douro UTAD, Dept Vet Sci, P-5001801 Vila Real, Portugal; [Rocha, Ana Faustino Carlos; Oliveira, Paula A.] Univ Tras Os Montes & Alto Douro UTAD, Ctr Res & Technol Agro Environm & Biol Sci CITAB, P-5001911 Vila Real, Portugal; [Medeiros, Rui] Fernando Pessoa Univ, Fac Hlth Sci, CEBIMED, Porto, Portugal; [Medeiros, Rui] Portuguese League Againt Canc Liga Portuguesa Can, P-4200177 Porto, Portugal	Universidade de Coimbra; Universidade do Porto; Universidade do Porto; Universidade de Coimbra; Universidade de Coimbra; University of Tras-os-Montes & Alto Douro; University of Tras-os-Montes & Alto Douro; Universidade Fernando Pessoa	Medeiros, R (corresponding author), CI IPOP, Portuguese Inst Oncol Porto, Mol Oncol & Viral Pathol Grp, Rua Dr Antonio Bernardino Almeida, P-4200072 Porto, Portugal.	ruimedei@ipoporto.min-saude.pt	Bastos, Margarida/O-4945-2018; Oliveira, Paula Alexandra/F-2510-2013; Sousa, Hugo/B-7714-2011; Paiva, Isabel/GNP-7941-2022; Medeiros, Rui/C-7938-2009; Gil da Costa, Rui/O-5029-2018	Bastos, Margarida/0000-0002-8605-0054; Oliveira, Paula Alexandra/0000-0001-9519-4044; Sousa, Hugo/0000-0001-5795-2131; Paiva, Isabel/0000-0001-7607-9390; Medeiros, Rui/0000-0003-3010-8373; Ribeiro, Joana/0000-0002-8431-9718; Gil da Costa, Rui/0000-0002-2151-2449	Liga Portuguesa Contra o Cancro; Portuguese Foundation for Science and Technology - Portuguese Government [SFRH/BPD/85462/2012]; Social European Fund	Liga Portuguesa Contra o Cancro; Portuguese Foundation for Science and Technology - Portuguese Government; Social European Fund(European Social Fund (ESF))	This study was supported by Liga Portuguesa Contra o Cancro. Rui M. Gil da Costa is supported by grant SFRH/BPD/85462/2012 from the Portuguese Foundation for Science and Technology, financed by the Portuguese Government and the Social European Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Bosch FX, 2007, DIS MARKERS, V23, P213, DOI 10.1155/2007/914823; Canadas MP, 2010, CLIN MICROBIOL INFEC, V16, P836, DOI 10.1111/j.1469-0691.2009.02964.x; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cheung ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071336; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Coussens LM, 1996, AM J PATHOL, V149, P1899; Das LM, 2013, MUCOSAL IMMUNOL, V6, P167, DOI 10.1038/mi.2012.60; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fan XL, 2005, APOPTOSIS, V10, P63, DOI 10.1007/s10495-005-6062-y; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Huffaker TB, 2012, CELL REP, V2, P1697, DOI 10.1016/j.celrep.2012.10.025; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kjaer SK, 2001, CANCER EPIDEM BIOMAR, V10, P101; KONKEL DA, 1978, CELL, V15, P1125, DOI 10.1016/0092-8674(78)90040-5; Lei C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052310; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Major T, 2005, J CLIN PATHOL, V58, P51, DOI 10.1136/jcp.2004.016634; Masset A, 2011, INT J CANCER, V128, P283, DOI 10.1002/ijc.25326; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Paranjape T, 2009, GUT, V58, P1546, DOI 10.1136/gut.2009.179531; Ribeiro J, 2014, INT J GYNECOL OBSTET, V125, P107, DOI 10.1016/j.ijgo.2013.10.011; Stanczuk GA, 2001, INT J CANCER, V94, P792, DOI 10.1002/ijc.1543; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Street D, 1997, GYNECOL ONCOL, V65, P265, DOI 10.1006/gyno.1997.4667; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Turner M, 2008, BIOCHEM SOC T, V36, P531, DOI 10.1042/BST0360531; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wald AI, 2011, HEAD NECK-J SCI SPEC, V33, P504, DOI 10.1002/hed.21475; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Willimott S, 2012, J BIOL CHEM, V287, P2608, DOI 10.1074/jbc.M111.285718; Wong TS, 2008, INT J CANCER, V123, P251, DOI 10.1002/ijc.23583; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Zonari E, 2013, BLOOD, V122, P243, DOI 10.1182/blood-2012-08-449306; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116868	10.1371/journal.pone.0116868	http://dx.doi.org/10.1371/journal.pone.0116868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625305	Green Published, gold			2022-12-26	WOS:000348821400020
J	Pascoe, SJS; Langhaug, LF; Mavhu, W; Hargreaves, J; Jaffar, S; Hayes, R; Cowan, FM				Pascoe, Sophie J. S.; Langhaug, Lisa F.; Mavhu, Webster; Hargreaves, James; Jaffar, Shabbar; Hayes, Richard; Cowan, Frances M.			Poverty, Food Insufficiency and HIV Infection and Sexual Behaviour among Young Rural Zimbabwean Women	PLOS ONE			English	Article							INTIMATE-PARTNER VIOLENCE; COMMON MENTAL-DISORDERS; DZIVE SHIRI PROJECT; RISK-FACTORS; PREVENTION INTERVENTION; EDUCATIONAL-ATTAINMENT; SOUTH-AFRICA; 4 CITIES; POPULATION; ASSOCIATION	Background Despite a recent decline, Zimbabwe still has the fifth highest adult HIV prevalence in the world at 14.7%; 56% of the population are currently living in extreme poverty. Design Cross-sectional population-based survey of 18-22 year olds, conducted in 30 communities in south-eastern Zimbabwe in 2007. Objective To examine whether the risk of HIV infection among young rural Zimbabwean women is associated with socio-economic position and whether different socio-economic domains, including food sufficiency, might be associated with HIV risk in different ways. Methods Eligible participants completed a structured questionnaire and provided a finger-prick blood sample tested for antibodies to HIV and HSV-2. The relationship between poverty and HIV was explored for three socio-economic domains: ability to afford essential items; asset wealth; food sufficiency. Analyses were performed to examine whether these domains were associated with HIV infection or risk factors for infection among young women, and to explore which factors might mediate the relationship between poverty and HIV. Results 2593 eligible females participated in the survey and were included in the analyses. Overall HIV prevalence among these young females was 7.7% (95% CI: 6.7-8.7); HSV-2 prevalence was 11.2% (95% CI: 9.9-12.4). Lower socio-economic position was associated with lower educational attainment, earlier marriage, increased risk of depression and anxiety disorders and increased reporting of higher risk sexual behaviours such as earlier sexual debut, more and older sexual partners and transactional sex. Young women reporting insufficient food were at increased risk of HIV infection and HSV-2. Conclusions This study provides evidence from Zimbabwe that among young poor women, economic need and food insufficiency are associated with the adoption of unsafe behaviours. Targeted structural interventions that aim to tackle social and economic constraints including insufficient food should be developed and evaluated alongside behaviour and biomedical interventions, as a component of HIV prevention programming and policy.	[Pascoe, Sophie J. S.; Hargreaves, James; Jaffar, Shabbar; Hayes, Richard] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Langhaug, Lisa F.; Cowan, Frances M.] Royal Free & Univ Coll, Sch Med, Ctr Sexual Hlth & HIV Res, London, England; [Mavhu, Webster; Cowan, Frances M.] Ctr Sexual Hlth & HIV AIDS Res CeSHHAR Zimbabw, Harare, Zimbabwe	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School	Cowan, FM (corresponding author), Royal Free & Univ Coll, Sch Med, Ctr Sexual Hlth & HIV Res, London, England.	f.cowan@ucl.ac.uk		Mavhu, Webster/0000-0003-1881-4398; Hargreaves, James/0000-0002-3509-3572; Jaffar, Shabbar/0000-0002-9615-1588; Cowan, Frances/0000-0003-3087-4422; Pascoe, Sophie/0000-0002-9199-8333; Langhaug, Lisa/0000-0002-9131-8158; Hayes, Richard/0000-0002-1729-9892	National Institute of Mental Health [RO1 MH66570]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066570] Funding Source: NIH RePORTER; Medical Research Council [MR/K012126/1] Funding Source: researchfish	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded through the National Institute of Mental Health (RO1 MH66570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REP GLOB AIDS EP 200; [Anonymous], AIDS EP UPD DEC 2007; Auerbach JD, 2006, WHO TECH REP SER, V938, P43; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Bachmann MO, 2006, AIDS, V20, P1861, DOI 10.1097/01.aids.0000244205.03382.84; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Barnett T, 2008, AIDS, V22, pS27, DOI 10.1097/01.aids.0000327434.28538.51; Booysen FL, 2002, J HEALTH POPUL NUTR, V20, P285; Brook DW, 2006, AIDS EDUC PREV, V18, P259, DOI 10.1521/aeap.2006.18.3.259; Bryceson D. F., 2006, AIDS, poverty, and hunger: challenges and responses. Highlights of the International Conference on HIV/AIDS and Food and Nutrition Security, Durban, South Africa, 14-16 April, 2005, P97; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Cohen-Or D, 1998, GRAPHICS INTERFACE '98 - PROCEEDINGS, P1; COWAN F, 2005, 16 INT SOC SEX TRANS, P42331; Cowan FM, 2008, TROP MED INT HEALTH, V13, P1235, DOI 10.1111/j.1365-3156.2008.02137.x; Cowan FM, 2010, AIDS, V24, P2533, DOI 10.1097/QAD.0b013e32833e77c9; de Walque D, 2005, TROP MED INT HEALTH, V10, P993, DOI 10.1111/j.1365-3156.2005.01475.x; Dinkelman T, 2007, AIDS, V21, pS49, DOI 10.1097/01.aids.0000300535.05226.a9; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; Freeman EE, 2004, AIDS, V18, P1715, DOI 10.1097/01.aids.0000139075.13906.2f; Gillespie S. R., 2006, AIDS POVERTY HUNGER; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Gillespie S, 2007, AIDS, V21, pS1, DOI 10.1097/01.aids.0000300530.67107.45; Glynn JR, 2004, TROP MED INT HEALTH, V9, P4, DOI 10.1046/j.1365-3156.2003.01168.x; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Gregson S, 2009, SEX TRANSM INFECT, V85, pI1, DOI 10.1136/sti.2009.036053; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x; Hewett PC, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2004.013250; *INT DISPL MON CTR, 2008, MAN FAC DISPL IDPS Z, P42331; *IPPF, 2007, UN POP FUND YOUNG PO, P42331; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Johnson K, 2006, JAIDS-J ACQ IMM DEF, V42, P627, DOI 10.1097/01.qai.0000225870.87456.ae; Kaufman CE, 2004, STUD FAMILY PLANN, V35, P261, DOI 10.1111/j.0039-3665.2004.00030.x; Kim J, 2008, AIDS, V22, pS57, DOI 10.1097/01.aids.0000341777.78876.40; Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; Lopman B, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000300536.82354.52; [Macro International Inc Central Statistical Office (CSO) [Zimbabwe]], 2007, ZIMB DEM HLTH SURV 2; Madise Nyovani, 2007, Afr J Reprod Health, V11, P83, DOI 10.2307/25549733; Mahomva A, 2006, SEX TRANSM INFECT, V82, pI42, DOI 10.1136/sti.2005.019174; MCCOY S, 2013, 7 IAS C HIV PATH TRE, P42331; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; Miller CL, 2011, AIDS BEHAV, V15, P1512, DOI 10.1007/s10461-010-9693-0; *MIN HLTH CHILD WE, 2004, ZIMB NAT FAM PLANN, P42331; MISHRA V, 2007, DHS WORKING PAPERS S, V31, P42331; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; Morrow RA, 2006, J CLIN VIROL, V36, P141, DOI 10.1016/j.jcv.2006.02.006; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; O'Farrell N, 2001, LANCET, V357, P636, DOI 10.1016/S0140-6736(05)71428-8; Pascoe SJS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074977; Patel V, 1997, ACTA PSYCHIAT SCAND, V95, P469, DOI 10.1111/j.1600-0447.1997.tb10134.x; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Pettifor AE, 2008, INT J EPIDEMIOL, V37, P1266, DOI 10.1093/ije/dyn131; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Pronyk PM, 2008, AIDS, V22, P1659, DOI 10.1097/QAD.0b013e328307a040; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Rollins N, 2007, PLOS MED, V4, P1576, DOI 10.1371/journal.pmed.0040301; Shelton JD, 2007, LANCET, V370, P1809, DOI 10.1016/S0140-6736(07)61755-3; Shelton JD, 2005, LANCET, V366, P1057, DOI 10.1016/S0140-6736(05)67401-6; The World Bank, 2007, HIV AIDS NUTR FOOD S; Todd J, 2004, SEX TRANSM INFECT, V80, P35, DOI 10.1136/sti.2003.005413; Tsai AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001557; Tsai AC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001203; *UN FAO WFP, 2009, FAO WFP CROP FOOD SE, P42331; *UNAIDS, 2008, HIV FOOD SEC NUTR PO, P42331; *UNAIDS, 2005, EV HIV DECL ZIMB COM; UNICEF, 2003, STAT WORLDS CHILDR 2; *UNICEF, 2005, GUIDE TO MONITORING, P42331; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; United nations Development Programme (UNDP), 2007, NAT HUM DEV REP RUSS; US Department of Health and Human Services, 2000, SER ASS HUM IMM VIR; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2; *ZIMSTAT, 2012, ZIMB POP CENS 2012 N, P42331	90	59	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115290	10.1371/journal.pone.0115290	http://dx.doi.org/10.1371/journal.pone.0115290			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QM	25625868	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000348821400007
J	Guyer, RA; Macara, IG				Guyer, Richard A.; Macara, Ian G.			Loss of the Polarity Protein PAR3 Activates STAT3 Signaling via an Atypical Protein Kinase C (aPKC)/NF-kappa B/Interleukin-6 (IL-6) Axis in Mouse Mammary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR; ONCOGENIC RAS; ZETA; TUMORIGENESIS; INTERLEUKIN-6; IOTA; PHOSPHORYLATION; EXPRESSION; GROWTH	PAR3suppresses tumor growth and metastasis in vivo and cell invasion through matrix in vitro. We propose that PAR3 organizes and limits multiple signaling pathways and that inappropriate activation of these pathways occurs without PAR3. Silencing Pard3 in conjunction with oncogenic activation promotes invasion and metastasis via constitutiveSTAT3activity in mouse models, but the mechanism for this is unknown. Wenow show that loss of PAR3 triggers increased production of interleukin- 6, which induces STAT3 signaling in an autocrine manner. Activation of atypical protein kinase C iota/lambda (aPKC iota/lambda) mediates this effect by stimulating NF-kappa B signaling and IL-6 expression. Our results suggest that PAR3 restrains aPKC iota/lambda activity and thus prevents aPKC iota/lambda from activating an oncogenic signaling network.	[Guyer, Richard A.; Macara, Ian G.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Guyer, Richard A.] Vanderbilt Univ, Med Scientist Training Program, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Macara, IG (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, U 3209 MRB 3,465 21st Ave S, Nashville, TN 37232 USA.	ian.g.macara@vanderbilt.edu	Guyer, Richard A./AAC-3850-2022	Guyer, Richard A./0000-0001-5075-1767	National Institutes of Health [CA132898, T32-GM07347]; NATIONAL CANCER INSTITUTE [R01CA132898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902, T32GM007347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA132898 to Ian Macara, and T32-GM07347 to the Vanderbilt Medical-Scientist Training Program.	AGRAWAL N, 1995, DEV BIOL, V172, P218, DOI 10.1006/dbio.1995.0017; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Chatterjee SJ, 2014, BREAST CANCER-TARGET, V6, P15, DOI 10.2147/BCTT.S43764; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; DOMINGUEZ I, 1993, MOL CELL BIOL, V13, P1290, DOI 10.1128/MCB.13.2.1290; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Forteza R, 2013, BIOL OPEN, V2, P1263; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hammacher A, 1998, J BIOL CHEM, V273, P22701, DOI 10.1074/jbc.273.35.22701; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Ishiguro H, 2009, P NATL ACAD SCI USA, V106, P16369, DOI 10.1073/pnas.0907044106; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kim E, 2013, CANCER CELL, V23, P839, DOI 10.1016/j.ccr.2013.04.008; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kusne Y, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005196; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Lee AM, 2013, NATURE, V493, P416, DOI 10.1038/nature11803; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Linch M, 2014, CARCINOGENESIS, V35, P396, DOI 10.1093/carcin/bgt313; Ling C, 2012, CANCER DISCOV, V2, P68, DOI 10.1158/2159-8290.CD-11-0189; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Maeda S, 2009, HEPATOLOGY, V50, P1851, DOI 10.1002/hep.23199; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Rothenberg SM, 2010, CANCER RES, V70, P2158, DOI 10.1158/0008-5472.CAN-09-3458; Russ A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047734; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; STARNES HF, 1990, J IMMUNOL, V145, P4185; Takagawa R, 2010, ANN SURG ONCOL, V17, P81, DOI 10.1245/s10434-009-0708-x; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; TIMMONS L, 1993, DEV BIOL, V158, P364, DOI 10.1006/dbio.1993.1195; Tran CS, 2014, CELL HOST MICROBE, V15, P636, DOI 10.1016/j.chom.2014.04.007; Uberall F, 1999, J CELL BIOL, V144, P413, DOI 10.1083/jcb.144.3.413; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802; Win HY, 2008, CANCER LETT, V270, P302, DOI 10.1016/j.canlet.2008.05.023; Wooten MW, 1999, J NEUROSCI RES, V58, P607, DOI 10.1002/(SICI)1097-4547(19991201)58:5<607::AID-JNR1>3.0.CO;2-M; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zen K, 2009, ONCOGENE, V28, P2910, DOI 10.1038/onc.2009.148; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhuang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067431	56	23	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8457	8468		10.1074/jbc.M114.621011	http://dx.doi.org/10.1074/jbc.M114.621011			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25657002	hybrid, Green Published			2022-12-26	WOS:000351662600038
J	Bolte, C; Ren, XM; Tomley, T; Ustiyan, V; Pradhan, A; Hoggatt, A; Kalin, TV; Herring, BP; Kalinichenko, VV				Bolte, Craig; Ren, Xiaomeng; Tomley, Tatiana; Ustiyan, Vladimir; Pradhan, Arun; Hoggatt, April; Kalin, Tanya V.; Herring, B. Paul; Kalinichenko, Vladimir V.			Forkhead Box F2 Regulation of Platelet-derived Growth Factor and Myocardin/Serum Response Factor Signaling Is Essential for Intestinal Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Knockout; Intestine; Myocardin; Smooth Muscle; Transcription Factor; Transgenic Mice; Forkhead Protein; Foxf2	M1 TRANSCRIPTION FACTOR; SMOOTH-MUSCLE-CELLS; MOUSE EMBRYONIC GUT; GASTROINTESTINAL-TRACT; PULMONARY VASCULATURE; EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; FACTOR FOXF1; DIFFERENTIATION	Background: Transcriptional regulation of smooth muscle cells is an understudied component of intestinal development and physiology. Results: Foxf2 deletion from smooth muscle causes intestinal malformations and colon remodeling. Conclusion: Foxf2 regulation of PDGF and myocardin/SRF signaling is essential for intestinal development and homeostasis. Significance: Better understanding of transcriptional mechanisms regulating postnatal intestine development and homeostasis may provide therapeutic approaches for congenital and acquired gastrointestinal diseases. Alterations in the forkhead box F2 gene expression have been reported in numerous pathologies, and Foxf2(-/-) mice are perinatal lethal with multiple malformations; however, molecular mechanisms pertaining to Foxf2 signaling are severely lacking. In this study, Foxf2 requirements in murine smooth muscle cells were examined using a conditional knock-out approach. We generated novel Foxf2-floxed mice, which we bred to smMHC-Cre-eGFP mice to generate a mouse line with Foxf2 deleted specifically from smooth muscle. These mice exhibited growth retardation due to reduced intestinal length as well as inflammation and remodeling of the small intestine. Colons of Tg(smMHC-Cre-eGFP(+/-));Foxf2(-/-) mice had expansion of the myenteric nerve plexus and increased proliferation of smooth muscle cells leading to thickening of the longitudinal smooth muscle layer. Foxf2 deficiency in colonic smooth muscle was associated with increased expression of Foxf1, PDGFa, PDGFb, PDGF receptor , and myocardin. FOXF2 bound to promoter regions of these genes indicating direct transcriptional regulation. Foxf2 repressed Foxf1 promoter activity in co-transfection experiments. We also show that knockdown of Foxf2 in colonic smooth muscle cells in vitro and in transgenic mice increased myocardin/serum response factor signaling and increased expression of contractile proteins. Foxf2 attenuated myocardin/serum response factor signaling in smooth muscle cells through direct binding to the N-terminal region of myocardin. Our results indicate that Foxf2 signaling in smooth muscle cells is essential for intestinal development and serum response factor signaling.	[Bolte, Craig; Ren, Xiaomeng; Tomley, Tatiana; Ustiyan, Vladimir; Pradhan, Arun; Kalin, Tanya V.; Kalinichenko, Vladimir V.] Cincinnati Childrens Res Fdn, Dept Pediat, Perinatal Inst, Cincinnati, OH 45229 USA; [Hoggatt, April; Herring, B. Paul] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Indiana University System; Indiana University Bloomington	Bolte, C (corresponding author), Cincinnati Childrens Res Fdn, Dept Pediat, Perinatal Inst, 3333 Burnet Ave,MLC 7009, Cincinnati, OH 45229 USA.	Craig.Bolte@cchmc.org; Vladimir.Kalinichenko@cchmc.org	Ren, Xiaomeng/U-1751-2019		National Institutes of Health [HL84151, HL123490, CA142724, DK061130]; NATIONAL CANCER INSTITUTE [R01CA142724] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151, R01HL123490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL84151 (to V. V. K.), HL123490 (to V. V. K.), CA142724 (to T. V. K.), and DK061130 (to B. P. H.).	Aitola M, 2000, DEV DYNAM, V218, P136, DOI 10.1002/(SICI)1097-0177(200005)218:1<136::AID-DVDY12>3.0.CO;2-U; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Balli D, 2013, EMBO J, V32, P231, DOI 10.1038/emboj.2012.336; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Barbara PD, 2005, DEV DYNAM, V234, P312, DOI 10.1002/dvdy.20554; Blair PJ, 2012, NEUROGASTROENT MOTIL, V24, pe437, DOI 10.1111/j.1365-2982.2012.01975.x; Bolte C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022217; Bolte C, 2009, AM J PHYSIOL-HEART C, V296, pH967, DOI 10.1152/ajpheart.00909.2008; Cai YQ, 2013, J BIOL CHEM, V288, P22527, DOI 10.1074/jbc.M113.455089; Cheng XH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004656; ECCLESTON PA, 1993, DEV BIOL, V155, P459, DOI 10.1006/dbio.1993.1044; Flynn RS, 2009, AM J PHYSIOL-GASTR L, V297, pG1232, DOI 10.1152/ajpgi.00323.2009; Fruttiger M, 2000, CURR BIOL, V10, P1283, DOI 10.1016/S0960-9822(00)00757-0; Graham MF, 1996, GASTROENTEROLOGY, V110, P344, DOI 10.1053/gast.1996.v110.pm8566579; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hazelgrove KB, 2009, AM J PHYSIOL-GASTR L, V296, pG1230, DOI 10.1152/ajpgi.90508.2008; Hellqvist M, 1996, J BIOL CHEM, V271, P4482; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Hoggatt AM, 2000, J BIOL CHEM, V275, P31162, DOI 10.1074/jbc.M005595200; Hoggatt AM, 2013, J BIOL CHEM, V288, P28477, DOI 10.1074/jbc.M113.478974; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kalinichenko VV, 2001, DEV BIOL, V235, P489, DOI 10.1006/dbio.2001.0322; KEDINGER M, 1990, DIFFERENTIATION, V43, P87, DOI 10.1111/j.1432-0436.1990.tb00434.x; Kim IM, 2005, J BIOL CHEM, V280, P37908, DOI 10.1074/jbc.M506531200; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Kurahashi M, 2008, NEUROGASTROENT MOTIL, V20, P521, DOI 10.1111/j.1365-2982.2007.01055.x; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lobsiger CS, 2000, GLIA, V30, P290, DOI 10.1002/(SICI)1098-1136(200005)30:3<290::AID-GLIA8>3.0.CO;2-6; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; McKeone R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025489; Mclin VA, 2010, INT J DEV BIOL, V54, P919, DOI 10.1387/ijdb.092916vm; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Nik AM, 2013, GASTROENTEROLOGY, V144, P1001, DOI 10.1053/j.gastro.2013.01.045; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Ormestad M, 2004, DEV DYNAM, V229, P328, DOI 10.1002/dvdy.10426; Peterson RS, 1997, MECH DEVELOP, V69, P53, DOI 10.1016/S0925-4773(97)00153-6; Philip-Couderc P, 2008, CIRC RES, V102, pE20, DOI 10.1161/CIRCRESAHA.107.166744; Ramakrishna S, 2007, DEV DYNAM, V236, P1000, DOI 10.1002/dvdy.21113; Ren XM, 2014, CIRC RES, V115, P709, DOI 10.1161/CIRCRESAHA.115.304382; Ren XM, 2013, MOL CELL BIOL, V33, P371, DOI 10.1128/MCB.00934-12; Ren XM, 2010, MOL CELL BIOL, V30, P5381, DOI 10.1128/MCB.00876-10; Reneker LW, 1996, INVEST OPHTH VIS SCI, V37, P2455; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Spence JR, 2011, DEV DYNAM, V240, P501, DOI 10.1002/dvdy.22540; Stanzel RDP, 2010, AM J PHYSIOL-CELL PH, V299, pC805, DOI 10.1152/ajpcell.00086.2010; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Theodosiou NA, 2003, DEV BIOL, V259, P258, DOI 10.1016/S0012-1606(03)00185-4; Torihashi S, 2009, DIFFERENTIATION, V77, P277, DOI 10.1016/j.diff.2008.10.003; Ustiyan V, 2009, DEV BIOL, V336, P266, DOI 10.1016/j.ydbio.2009.10.007; van der Heul-Nieuwenhuijsen L, 2009, PROSTATE, V69, P1538, DOI 10.1002/pros.20996; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wang IC, 2014, ONCOGENE, V33, P5391, DOI 10.1038/onc.2013.475; Wang IC, 2012, MOL CELL BIOL, V32, P3838, DOI 10.1128/MCB.00355-12; Wang IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006609; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Young HM, 2005, CELL TISSUE RES, V320, P1, DOI 10.1007/s00441-004-1057-5; Zhang M, 2007, J BIOL CHEM, V282, P25708, DOI 10.1074/jbc.M701925200; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005; Zhou JL, 2004, J BIOL CHEM, V279, P15929, DOI 10.1074/jbc.M313822200	63	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7563	7575		10.1074/jbc.M114.609487	http://dx.doi.org/10.1074/jbc.M114.609487			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25631042	Green Published, hybrid			2022-12-26	WOS:000351613600021
J	Mantilla, BS; Paes, LS; Pral, EMF; Martil, DE; Thiemann, OH; Fernandez-Silva, P; Bastos, EL; Silber, AM				Mantilla, Brian S.; Paes, Lisvane S.; Pral, Elizabeth M. F.; Martil, Daiana E.; Thiemann, Otavio H.; Fernandez-Silva, Patricio; Bastos, Erick L.; Silber, Ariel M.			Role of Delta(1)-Pyrroline-5-Carboxylate Dehydrogenase Supports Mitochondrial Metabolism and Host-Cell Invasion of Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Enzyme Mechanism; Host-Pathogen Interaction; Mitochondrial Metabolism; Parasite Metabolism; Trypanosoma cruzi	GLUTAMIC-GAMMA-SEMIALDEHYDE; YEAST SACCHAROMYCES-CEREVISIAE; RAY SOLUTION SCATTERING; DELTA-1-PYRROLINE-5-CARBOXYLIC ACID; BIOCHEMICAL-CHARACTERIZATION; II HYPERPROLINEMIA; PROLINE CATABOLISM; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; MAMMALIAN STAGES	Background: The enzyme, (1)-pyrroline-5-carboxylate dehydrogenase (P5CDH), is a key enzyme involved in proline catabolism. Results: The parasite Trypanosoma cruzi up-regulates P5CDH during host infection. Conclusion:T. cruzi uses P5C to produce energy, resist metabolic stress, and invade host cells through this mitochondrion-bound enzyme. Significance: The oxidation of P5C is sufficient to supply energy and enhance the pathogenicity of T. cruzi. Proline is crucial for energizing critical events throughout the life cycle of Trypanosoma cruzi, the etiological agent of Chagas disease. The proline breakdown pathway consists of two oxidation steps, both of which produce reducing equivalents as follows: the conversion of proline to (1)-pyrroline-5-carboxylate (P5C), and the subsequent conversion of P5C to glutamate. We have identified and characterized the (1)-pyrroline-5-carboxylate dehydrogenase from T. cruzi (TcP5CDH) and report here on how this enzyme contributes to a central metabolic pathway in this parasite. Size-exclusion chromatography, two-dimensional gel electrophoresis, and small angle x-ray scattering analysis of TcP5CDH revealed an oligomeric state composed of two subunits of six protomers. TcP5CDH was found to complement a yeast strain deficient in PUT2 activity, confirming the enzyme's functional role; and the biochemical parameters (K-m, k(cat), and k(cat)/K-m) of the recombinant TcP5CDH were determined, exhibiting values comparable with those from T. cruzi lysates. In addition, TcP5CDH exhibited mitochondrial staining during the main stages of the T. cruzi life cycle. mRNA and enzymatic activity levels indicated the up-regulation (6-fold change) of TcP5CDH during the infective stages of the parasite. The participation of P5C as an energy source was also demonstrated. Overall, we propose that this enzymatic step is crucial for the viability of both replicative and infective forms of T. cruzi.	[Mantilla, Brian S.; Paes, Lisvane S.; Pral, Elizabeth M. F.; Silber, Ariel M.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508000 Sao Paulo, Brazil; [Martil, Daiana E.; Thiemann, Otavio H.] Univ Sao Paulo, Inst Fis Sao Carlos, Lab Biol Estrutural, BR-13560590 Sao Paulo, Brazil; [Bastos, Erick L.] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, BR-13560590 Sao Paulo, Brazil; [Fernandez-Silva, Patricio] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, E-50013 Zaragoza, Spain	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Zaragoza	Silber, AM (corresponding author), Inst Ciencias Biomed, Dept Parasitol, Ave Lineu Prestes 1374,Sala 24,Cidade Univ, BR-05508900 Sao Paulo, Brazil.	asilber@usp.br	Silva, Patricio Fernandez/U-2256-2017; Vieira, Lisvane Paes/AAI-6761-2020; Thiemann, Otavio H/D-9767-2012; Bastos, Erick L/F-8746-2012; Silber, Ariel/O-6951-2015	Silva, Patricio Fernandez/0000-0001-8971-7355; Vieira, Lisvane Paes/0000-0001-8589-5939; Bastos, Erick L/0000-0002-0592-9455; Suarez Mantilla, Brian/0000-0001-7839-1222; Silber, Ariel/0000-0003-4528-4732	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [13/18970-6]; Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [475741/2013-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 13/18970-6 (to A. M. S.), Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant 475741/2013-7 (to A. M. S.).	Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Acestor N, 2009, PROTEOMICS, V9, P5497, DOI 10.1002/pmic.200900354; ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Auxiliadora de Sousa M., 1983, Memorias do Instituto Oswaldo Cruz, V78, P317, DOI 10.1590/S0074-02761983000300009; Avilan L., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/932549; Balana-Fouce R, 2012, MOL BIOCHEM PARASIT, V181, P85, DOI 10.1016/j.molbiopara.2011.10.007; BARRETT FM, 1975, COMP BIOCHEM PHYS B, V52, P427; Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711; Bastos IMD, 2005, BIOCHEM J, V388, P29, DOI 10.1042/BJ20041049; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bayer-Santos E, 2013, J PROTEOME RES, V12, P883, DOI 10.1021/pr300947g; BEARNE SL, 1995, BIOCHEMISTRY-US, V34, P11515, DOI 10.1021/bi00036a026; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bookout A. L., 2003, CURRENT PROTOCOLS MO; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDRISS MC, 1986, MOL CELL BIOL, V6, P3502, DOI 10.1128/MCB.6.10.3502; BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023; BRENER Z, 1971, Revista do Instituto de Medicina Tropical de Sao Paulo, V13, P171; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Carranza JC, 2009, J BIOENERG BIOMEMBR, V41, P299, DOI 10.1007/s10863-009-9228-4; CAZZULO JJ, 1994, J BIOENERG BIOMEMBR, V26, P157, DOI 10.1007/BF00763064; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Christmas PB, 2000, FEMS MICROBIOL LETT, V183, P225, DOI 10.1111/j.1574-6968.2000.tb08962.x; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cooper H. M., 2000, CURRENT PROTOCOLS MO; Covarrubias C, 2007, INT J PARASITOL, V37, P1609, DOI 10.1016/j.ijpara.2007.05.013; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; de Souza W, 2009, INT J BIOCHEM CELL B, V41, P2069, DOI 10.1016/j.biocel.2009.04.007; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; DENICOLASEOANE A, 1992, MOL BIOCHEM PARASIT, V54, P43, DOI 10.1016/0166-6851(92)90093-Y; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; ELTHON TE, 1981, PLANT PHYSIOL, V67, P780, DOI 10.1104/pp.67.4.780; Emmer BT, 2011, EUKARYOT CELL, V10, P455, DOI 10.1128/EC.00248-10; Ernster L., 1970, MEMBRANES MITOCHONDR, P175; Farrant RD, 2001, J BIOL CHEM, V276, P15107, DOI 10.1074/jbc.M010860200; Fernandes MP, 2010, J BIOENERG BIOMEMBR, V42, P69, DOI 10.1007/s10863-010-9268-9; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; FLEMING GA, 1984, METABOLISM, V33, P739, DOI 10.1016/0026-0495(84)90215-4; FORTEMCROBBIE C, 1989, BIOCHEM J, V261, P935, DOI 10.1042/bj2610935; FORTEMCROBBIE CM, 1986, J BIOL CHEM, V261, P2154; Geraghty MT, 1998, HUM MOL GENET, V7, P1411, DOI 10.1093/hmg/7.9.1411; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Haslett MR, 2004, BBA-GEN SUBJECTS, V1675, P81, DOI 10.1016/j.bbagen.2004.08.008; He F, 2011, MITOCHONDRION, V11, P397, DOI 10.1016/j.mito.2010.12.001; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOMSY JJ, 1989, J PROTOZOOL, V36, P150, DOI 10.1111/j.1550-7408.1989.tb01063.x; Inagaki E, 2006, J MOL BIOL, V362, P490, DOI 10.1016/j.jmb.2006.07.048; JOCKERSSCHERUBL MC, 1989, EUR J BIOCHEM, V180, P267, DOI 10.1111/j.1432-1033.1989.tb14643.x; JUAN SM, 1978, INT J BIOCHEM, V9, P395, DOI 10.1016/0020-711X(78)90052-6; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krnacova K, 2012, J MOL EVOL, V75, P119, DOI 10.1007/s00239-012-9523-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lee IR, 2013, GENETICS, V194, P421, DOI 10.1534/genetics.113.150326; LEWIS ML, 1993, BIOORG MED CHEM LETT, V3, P1193, DOI 10.1016/S0960-894X(00)80313-3; Lijek RS, 2012, P NATL ACAD SCI USA, V109, P13823, DOI 10.1073/pnas.1208075109; Lisvane Silva Paes, 2011, Curr Pharm Des, V17, P2074; Lundblad V., 2003, CURRENT PROTOCOLS MO; Luo M, 2013, J MOL BIOL, V425, P3106, DOI 10.1016/j.jmb.2013.05.027; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Magdaleno Anahi, 2011, Enzyme Res, V2011, P486928, DOI 10.4061/2011/486928; Magdaleno A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004534; Marciano D, 2008, MOL BIOCHEM PARASIT, V161, P12, DOI 10.1016/j.molbiopara.2008.05.005; Marciano D, 2009, MOL BIOCHEM PARASIT, V166, P172, DOI 10.1016/j.molbiopara.2009.04.001; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; MIXSON AJ, 1988, J BIOL CHEM, V263, P10720; MONTEMARTINI M, 1993, BIOCHEM J, V292, P901, DOI 10.1042/bj2920901; Monzote L, 2010, CURR CLIN PHARMACOL, V5, P55, DOI 10.2174/157488410790410605; Nomura M, 2004, P NATL ACAD SCI USA, V101, P12616, DOI 10.1073/pnas.0403349101; ODALY JA, 1983, INT J PARASITOL, V13, P433, DOI 10.1016/S0020-7519(83)80005-8; Paes LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069419; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Sambrook P. M., 2001, MOL CLONING LAB MANU; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Schagger H, 2002, BBA-BIOENERGETICS, V1555, P154, DOI 10.1016/S0005-2728(02)00271-2; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneider A., 2007, METHOD MOL BIOL, P379; SEMON BA, 1991, IN VITRO CELL DEV B, V27, P665, DOI 10.1007/BF02631111; Silber AM, 2006, INT J PARASITOL, V36, P157, DOI 10.1016/j.ijpara.2005.10.006; Silber AM, 2009, MOL BIOCHEM PARASIT, V168, P102, DOI 10.1016/j.molbiopara.2009.07.006; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; SILVIUS JR, 1981, J THEOR BIOL, V88, P135, DOI 10.1016/0022-5193(81)90332-5; Souza DHF, 1998, FEBS LETT, V424, P131, DOI 10.1016/S0014-5793(98)00154-9; Srivastava D, 2012, J MOL BIOL, V420, P176, DOI 10.1016/j.jmb.2012.04.010; Srivastava D, 2010, P NATL ACAD SCI USA, V107, P2878, DOI 10.1073/pnas.0906101107; STRECKER HJ, 1960, J BIOL CHEM, V235, P2045; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; SYLVESTER D, 1976, COMP BIOCHEM PHYS B, V55, P443, DOI 10.1016/0305-0491(76)90318-7; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; Truhlar DG, 2001, P NATL ACAD SCI USA, V98, P848, DOI 10.1073/pnas.98.3.848; TSCHUDI C, 1985, P NATL ACAD SCI USA, V82, P3998, DOI 10.1073/pnas.82.12.3998; TURRENS JF, 1989, BIOCHEM J, V259, P363, DOI 10.1042/bj2590363; Van Der Heyden N, 2000, MOL BIOCHEM PARASIT, V105, P237, DOI 10.1016/S0166-6851(99)00184-X; VOGEL HJ, 1952, J AM CHEM SOC, V74, P109, DOI 10.1021/ja01121a025; WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X; World Health Organization, 2012, EP BURD DIS	108	33	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7767	7790		10.1074/jbc.M114.574525	http://dx.doi.org/10.1074/jbc.M114.574525			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25623067	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000351613600037
J	Lienard, J; Florescu, I; Strigul, N				Lienard, Jean; Florescu, Ionut; Strigul, Nikolay			An Appraisal of the Classic Forest Succession Paradigm with the Shade Tolerance Index	PLOS ONE			English	Article							COMMUNITY STABILITY; CONTINUUM CONCEPT; MARKOV-MODELS; DISTURBANCE; GROWTH; TREES; DYNAMICS; ECOLOGY; SIZE; ARCHITECTURE	In this paper we revisit the classic theory of forest succession that relates shade tolerance and species replacement and assess its validity to understand patch-mosaic patterns of forested ecosystems of the USA. We introduce a macroscopic parameter called the "shade tolerance index" and compare it to the classic continuum index in southern Wisconsin forests. We exemplify shade tolerance driven succession in White Pine-Eastern Hemlock forests using computer simulations and analyzing approximated chronosequence data from the USDA FIA forest inventory. We describe this parameter across the last 50 years in the ecoregions of mainland USA, and demonstrate that it does not correlate with the usual macroscopic characteristics of stand age, biomass, basal area, and biodiversity measures. We characterize the dynamics of shade tolerance index using transition matrices and delimit geographical areas based on the relevance of shade tolerance to explain forest succession. We conclude that shade tolerance driven succession is linked to climatic variables and can be considered as a primary driving factor of forest dynamics mostly in central-north and northeastern areas in the USA. Overall, the shade tolerance index constitutes a new quantitative approach that can be used to understand and predict succession of forested ecosystems and biogeographic patterns.	[Lienard, Jean; Strigul, Nikolay] Washington State Univ, Dept Math, Vancouver, WA 98686 USA; [Lienard, Jean; Strigul, Nikolay] Washington State Univ Vancouver, Sch Art & Sci, Washington, DC USA; [Florescu, Ionut] Stevens Inst Technol, Financial Engn Div, Hoboken, NJ 07030 USA; [Florescu, Ionut] Stevens Inst Technol, Hanlon Financial Syst Lab, Hoboken, NJ 07030 USA	Washington State University; Washington State University; Stevens Institute of Technology; Stevens Institute of Technology	Strigul, N (corresponding author), Washington State Univ, Dept Math, Vancouver, WA 98686 USA.	nick.strigul@wsu.edu	Strigul, Nick/C-3987-2016; Florescu, Ionut/Y-7008-2018	Florescu, Ionut/0000-0002-4225-9008; Lienard, Jean/0000-0003-4279-4980	Simons Foundation [283770]; Washington State University New Faculty SEED grant	Simons Foundation; Washington State University New Faculty SEED grant	This work was partially supported by a grant from the Simons Foundation, simonsfoundation.org (283770 to NS) and a Washington State University New Faculty SEED grant (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVEDO MF, 1995, ECOL APPL, V5, P1040, DOI 10.2307/2269353; Ashton MPS, 1992, ECOLOGY SILVICULTURE, P101; Ashton MS, 2001, FOREST ECOL MANAG, V154, P409, DOI 10.1016/S0378-1127(01)00512-6; AUSTIN MP, 1985, ANNU REV ECOL SYST, V16, P39, DOI 10.1146/annurev.es.16.110185.000351; AUSTIN MP, 1977, VEGETATIO, V35, P165, DOI 10.1007/BF02097067; Bailey R.G., 1995, DESCRIPTION ECOREGIO; Bailey RG, 2004, ENVIRON MANAGE, V34, pS14, DOI 10.1007/s00267-003-0163-6; BAKER F. S., 1949, JOUR FOREST, V47, P179; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; BORMANN FH, 1979, AM SCI, V67, P660; Bostock J., 1855, NAT HIST; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bromley S.W., 1935, ECOL MONOGR, V5, P61, DOI DOI 10.2307/1943098; BUELL MF, 1966, ECOLOGY, V47, P416, DOI 10.2307/1932981; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Burns R. M., 1990, SILVICS N AM, V2; Burns RM., 1990, SILVICS N AM; Busing RT, 2004, J VEG SCI, V15, P831, DOI 10.1111/j.1654-1103.2004.tb02326.x; BUSING RT, 1991, VEGETATIO, V92, P167; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; Chen HYH, 2012, GLOBAL ECOL BIOGEOGR, V21, P441, DOI 10.1111/j.1466-8238.2011.00689.x; Clements F.E, 1916, PLANT SUCCESSION ANA, DOI [10.5962/bhl.title.56234, DOI 10.5962/BHL.TITLE.56234]; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cowles HC, 1911, ANN ASSOC AM GEOGR, V1, P3, DOI 10.2307/2560843; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Deutschman DH, 1999, ECOLOGY, V80, P1927, DOI 10.2307/176669; Dube P, 2001, ECOL MODEL, V142, P39, DOI 10.1016/S0304-3800(01)00238-1; Franklin JF, 2007, NRS19 USDA FOR SERV; Frelich LE, 1999, ECOSYSTEMS, V2, P151, DOI 10.1007/s100219900066; FRELICH LE, 1988, FOREST SCI, V34, P530; GALE MR, 1987, CAN J FOREST RES, V17, P829, DOI 10.1139/x87-131; Hallik L, 2009, NEW PHYTOL, V184, P257, DOI 10.1111/j.1469-8137.2009.02918.x; Hewitt N, 1998, OECOLOGIA, V114, P432, DOI 10.1007/s004420050467; Heyer G, 1852, VERHALTEN WALDBAUME; Horn H. S., 1974, Annual Review of Ecology and Systematics, V5, P25, DOI 10.1146/annurev.es.05.110174.000325; Horn H. S., 1981, FOREST SUCCESSION CO, P24; Humbert L, 2007, ECOL INDIC, V7, P195, DOI 10.1016/j.ecolind.2005.12.002; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; Johnstone JF, 2006, ECOSYSTEMS, V9, P268, DOI 10.1007/s10021-005-0061-2; KESSELL SR, 1980, ENVIRON MANAGE, V4, P227, DOI 10.1007/BF01866456; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Kohyama T, 2006, ECOL RES, V21, P346, DOI 10.1007/s11284-006-0168-8; Korotkov VN, 2001, ECOL MODEL, V142, P25, DOI 10.1016/S0304-3800(01)00247-2; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Laska G, 2001, PLANT ECOL, V157, P77, DOI 10.1023/A:1013760320805; LEPS J, 1988, FOLIA GEOBOT PHYTOTX, V23, P79, DOI 10.1007/BF02853297; LEVIN D. A., 2009, MARKOV CHAINS MIXING; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Lienard J, 2014, DATA INTENSIVE MULTI; Lin J, 2001, CAN J FOREST RES, V31, P345, DOI 10.1139/cjfr-31-2-345; Logofet DO, 2000, ECOL MODEL, V126, P285, DOI 10.1016/S0304-3800(00)00269-6; LORIMER CG, 1983, CAN J BOT, V61, P1595, DOI 10.1139/b83-172; McCarthy John, 2001, Environmental Reviews, V9, P1, DOI 10.1139/a00-012; MCINTOSH RP, 1967, BOT REV, V33, P130, DOI 10.1007/BF02858667; Messier C, 1999, CAN J FOREST RES, V29, P812, DOI 10.1139/cjfr-29-6-812; Morozov GF, 1908, ENCY RUSSIAN FORESTR, P1286; Morozov GF, 1912, THEORY OF FOREST; NAKAMURA T, 1985, VEGETATIO, V64, P15, DOI 10.1007/BF00033450; Nichols GE, 1935, ECOLOGY, V16, P403, DOI 10.2307/1930077; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Oliver C.D., 1996, FOREST STAND DYNAMIC; PACALA SW, 1993, CAN J FOREST RES, V23, P1980, DOI 10.1139/x93-249; Pacala SW, 1995, OIKOS, V74, P357, DOI 10.2307/3545980; PARRISH JAD, 1982, B TORREY BOT CLUB, V109, P451, DOI 10.2307/2996486; PICKETT STA, 1987, BOT REV, V53, P335, DOI 10.1007/BF02858321; PICKETT STA, 1989, OIKOS, V54, P129, DOI 10.2307/3565258; Platt WJ, 2003, ECOL MONOGR, V73, P507, DOI 10.1890/01-0552; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Rogers DA, 2008, ECOLOGY, V89, P2482, DOI 10.1890/07-1129.1; RUNKLE JR, 1982, ECOLOGY, V63, P1533, DOI 10.2307/1938878; Shirley Hardy L., 1943, JOUR FOREST, V41, P339; Shugart H.H., 1984, THEORY FOREST DYNAMI; Smith D.M., 1997, PRACTICE SILVICULTUR; Spurr S.H., 1980, FOREST ECOLOGY; Stephens GR, 1980, B CONNECTICUT AGR EX; Strigul, 2012, SUSTAINABLE FOREST M, DOI DOI 10.5772/29590; Strigul N, 2008, ECOL MONOGR, V78, P523, DOI 10.1890/08-0082.1; Strigul N, 2012, ENVIRON MODELL SOFTW, V31, P64, DOI 10.1016/j.envsoft.2011.12.004; Sukatschew W, 1928, PLANT COMMUNITIES IN; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Thoreau HD, 1992, MASTERWORKS LIT SERI, P164; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; USHER MB, 1979, J ANIM ECOL, V48, P413, DOI 10.2307/4170; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; WAGGONER PE, 1970, NATURE, V225, P1160, DOI 10.1038/2251160a0; Walters MB, 1996, ECOLOGY, V77, P841, DOI 10.2307/2265505; WHITE PS, 1979, BOT REV, V45, P229, DOI 10.1007/BF02860857; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172; Yamamoto S.I., 2000, J FORESTRY RES, V5, P223, DOI DOI 10.1007/BF02767114; Zon R, 1911, LIGHT RELATION TREE, DOI [10.5962/bhl.title.66218, DOI 10.5962/BHL.TITLE.66218]	93	32	33	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117138	10.1371/journal.pone.0117138	http://dx.doi.org/10.1371/journal.pone.0117138			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658092	gold, Green Submitted, Green Published			2022-12-26	WOS:000349444900106
J	Dongiovanni, P; Lanti, C; Gatti, S; Rametta, R; Recalcati, S; Maggioni, M; Fracanzani, AL; Riso, P; Cairo, G; Fargion, S; Valenti, L				Dongiovanni, Paola; Lanti, Claudia; Gatti, Stefano; Rametta, Raffaela; Recalcati, Stefania; Maggioni, Marco; Fracanzani, Anna Ludovica; Riso, Patrizia; Cairo, Gaetano; Fargion, Silvia; Valenti, Luca			High Fat Diet Subverts Hepatocellular Iron Uptake Determining Dysmetabolic Iron Overload	PLOS ONE			English	Article							INSULIN-RESISTANCE; LIVER-DISEASE; METABOLIC SYNDROME; SERUM FERRITIN; HEPCIDIN; RISK; HYPERFERRITINEMIA; MACROPHAGES; DEPLETION	Increased serum ferritin associated with mild hepatic iron accumulation, despite preserved upregulation of the iron hormone hepcidin, is frequently observed in patients with dysmetabolic overload syndrome (DIOS). Genetic factors and Western diet represent predisposing conditions, but the mechanisms favoring iron accumulation in DIOS are still unclear. Aims of this study were to assess the effect a high-fat diet (HFD) on hepatic iron metabolismin an experimental model in rats, to further characterize the effect of free fatty acids on iron metabolismin HepG2 hepatocytes in vitro, and to assess the translational relevance in patients with fatty liver with and without iron accumulation. Despite decreased uptake of dietary iron, rats fed HFD accumulated more hepatic iron than those fed regular diet, which was associated with steatosis development. Hepatic iron accumulation was paralleled by induction of ferritin, in the presence of preserved upregulation of hepcidin, recapitulating the features of DIOS. HFD was associated with increased expression of the major iron uptake protein Transferrin receptor-1 (TfR-1), consistently with upregulation of the intracellular iron sensor Iron regulated protein-1 (IRP1). Supplementation with fatty acids induced TfR-1 and IRP1 in HepG2 hepatocytes, favoring intracellular iron accumulation following exposure to iron salts. IRP1 silencing completely abrogated TfR-1 induction and the facilitation of intracellular iron accumulation induced by fatty acids. Hepatic TfR-1 mRNA levels were upregulated in patients with fatty liver and DIOS, whereas they were not associated with liver fat nor with inflammation. In conclusion, increased exposure to fatty acids subverts hepatic iron metabolism, favoring the induction of an iron uptake program despite hepatocellular iron accumulation.	[Dongiovanni, Paola; Maggioni, Marco; Fracanzani, Anna Ludovica; Fargion, Silvia; Valenti, Luca] Fdn IRCCS Ca Granda, Osped Policlin, Milan, Italy; [Lanti, Claudia; Riso, Patrizia] Univ Milan, Dept Food Environm & Nutrit Sci, Milan, Italy; [Gatti, Stefano] Fdn IRCCS Ca Granda, Osped Policlin, Preclin Surg Res Ctr & Surg, Milan, Italy; [Rametta, Raffaela; Fracanzani, Anna Ludovica; Fargion, Silvia; Valenti, Luca] Univ Milan, Metab Liver Dis Res Ctr, Dept Pathophysiol & Transplantat, Milan, Italy; [Recalcati, Stefania; Cairo, Gaetano] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan	Dongiovanni, P (corresponding author), Fdn IRCCS Ca Granda, Osped Policlin, Milan, Italy.	paola.dongiovanni@policlinico.mi.it; luca.valenti@unimi.it	Gatti, Stefano/M-1780-2015; Dongiovanni, Paola/AAC-9965-2019; Gatti, Stefano/AAE-3281-2022; Fracanzani, Anna Ludovica/J-8986-2018; Maggioni, Marco/AAC-4617-2022; Riso, Patrizia/AAC-2072-2019; Valenti, Luca/B-3695-2009; Cairo, Gaetano/M-5104-2016; recalcati, stefania/M-5045-2016	Gatti, Stefano/0000-0003-2209-4338; Dongiovanni, Paola/0000-0003-4343-7213; Gatti, Stefano/0000-0003-2209-4338; Fracanzani, Anna Ludovica/0000-0001-5918-0171; Maggioni, Marco/0000-0001-8603-8998; Riso, Patrizia/0000-0002-9204-7257; Valenti, Luca/0000-0001-8909-0345; Cairo, Gaetano/0000-0002-8147-4720; recalcati, stefania/0000-0002-2115-8283; rametta, raffaela/0000-0003-0091-9394	Bando Giovani Ricercatori Ricerca Finalizzata; Ministero della Salute e delle Politiche Sociali (Italian ministry of Health grant) [GR-2007-683265]	Bando Giovani Ricercatori Ricerca Finalizzata; Ministero della Salute e delle Politiche Sociali (Italian ministry of Health grant)	This paper was supported by the following grants: Bando Giovani Ricercatori Ricerca Finalizzata 2007, Ministero della Salute e delle Politiche Sociali (Italian ministry of Health grant; GR-2007-683265) to LV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed U, 2013, NUTR RES, V33, P126, DOI 10.1016/j.nutres.2012.11.012; Aigner E, 2008, GASTROENTEROLOGY, V135, P680, DOI 10.1053/j.gastro.2008.04.007; Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Barisani D, 2008, J HEPATOL, V49, P123, DOI 10.1016/j.jhep.2008.03.011; BARRY M, 1971, LANCET, V1, P100; Bu WM, 2012, FASEB J, V26, P2394, DOI 10.1096/fj.11-198853; Cairo G, 2000, BIOCHEM J, V352, P241, DOI 10.1042/0264-6021:3520241; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; Camaschella C, 2011, THESCIENTIFICWORLDJO, V11, P1357, DOI 10.1100/tsw.2011.130; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Dongiovanni P, 2011, J HEPATOL, V54, pS505, DOI 10.1016/S0168-8278(11)61282-8; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Dongiovanni P, 2010, AM J PATHOL, V176, P1006, DOI 10.2353/ajpath.2010.090249; Edgren G, 2008, J NATL CANCER I, V100, P572, DOI 10.1093/jnci/djn084; Facchini FS, 2002, GASTROENTEROLOGY, V122, P931, DOI 10.1053/gast.2002.32403; Fargion S, 2001, AM J GASTROENTEROL, V96, P2448, DOI 10.1111/j.1572-0241.2001.04052.x; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohgo Y, 2005, ALCOHOL CLIN EXP RES, V29, p189S, DOI 10.1097/01.alc.0000189274.00479.62; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Martinelli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048250; Meli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066570; Montosi G, 2005, HEPATOLOGY, V41, P545, DOI 10.1002/hep.20620; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Ramos P, 2011, BLOOD, V117, P1379, DOI 10.1182/blood-2010-09-307462; Riva A, 2008, WORLD J GASTROENTERO, V14, P4745, DOI 10.3748/wjg.14.4745; SCHEUER PJ, 1962, J PATHOL BACTERIOL, V84, P53, DOI 10.1002/path.1700840107; Sonnweber T, 2012, J NUTR BIOCHEM, V23, P1600, DOI 10.1016/j.jnutbio.2011.10.013; Svegliati-Baroni G, 2006, AM J PATHOL, V169, P846, DOI 10.2353/ajpath.2006.050953; VALENTI L, 2010, NUTR METAB IN PRESS; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Valenti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048804; Valenti L, 2011, ARTERIOSCL THROM VAS, V31, P683, DOI 10.1161/ATVBAHA.110.214858; Valenti L, 2010, J HEPATOL, V53, P927, DOI 10.1016/j.jhep.2010.05.023; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; WLAZLO N, 2012, DIABETES CARE, P28669	40	32	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116855	10.1371/journal.pone.0116855	http://dx.doi.org/10.1371/journal.pone.0116855			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647178	Green Published, gold			2022-12-26	WOS:000348822600040
J	Maier, IL; Karch, A; Mikolajczyk, R; Bahr, M; Liman, J				Maier, Ilko L.; Karch, Andre; Mikolajczyk, Rafael; Bahr, Mathias; Liman, Jan			Effect of Beta-Blocker Therapy on the Risk of Infections and Death after Acute Stroke - A Historical Cohort Study	PLOS ONE			English	Article							IMMUNE; IMMUNODEPRESSION; INFLAMMATION; IMMUNOLOGY; ACTIVATION; MORTALITY; STATINS; SEPSIS; INJURY; CELLS	Background Infections are a frequent cause for prolonged hospitalization and increased mortality after stroke. Recent studies revealed a stroke-induced depression of the peripheral immune system associated with an increased susceptibility for infections. In a mice model for stroke, this immunosuppressive effect was reversible after beta-blocker administration. The aim of our study was to investigate the effect of beta-blocker therapy on the risk of infections and death after stroke in humans. Methods 625 consecutive patients with ischemic or hemorrhagic stroke, admitted to a university hospital stroke unit, were included in this historical cohort study. The effect of beta-blocker therapy on post-stroke pneumonia, urinary tract infections and death was investigated using multivariable Poisson and Cox regression models. Results 553 (88.3%) patients were admitted with ischemic stroke, the remaining 72 (11.7%) had a hemorrhagic stroke. Median baseline NIHSS was 8 (IQR 5-16) points. 301 (48.2%) patients received beta-blocker therapy. There was no difference in the risk of post-stroke pneumonia between patients with and without beta-blocker therapy (Rate Ratio = 1.00, 95% CI 0.77-1.30, p = 0.995). Patients with beta-blocker therapy showed a decreased risk for urinary tract infections (RR = 0.65, 95% CI 0.43-0.98, p = 0.040). 7-days mortality did not differ between groups (Hazard Ratio = 1.36, 95% CI 0.65-2.77, p = 0.425), while patients with beta-blocker therapy showed a higher 30-days mortality (HR = 1.93, 95% CI 1.20-3.10, p = 0.006). Conclusions Beta-blocker therapy did not reduce the risk for post-stroke pneumonia, but significantly reduced the risk for urinary tract infections. Different immune mechanisms underlying both diseases might explain these findings that need to be confirmed in future studies.	[Maier, Ilko L.; Bahr, Mathias; Liman, Jan] Univ Med Gottingen, Dept Neurol, Gottingen, Germany; [Karch, Andre; Mikolajczyk, Rafael] Helmholtz Ctr Infect Res, Dept Epidemiol, Res Grp Epidemiol & Stat Methods ESME, Braunschweig, Germany; [Karch, Andre; Mikolajczyk, Rafael] German Ctr Infect Res DZIF, Braunschweig, Germany; [Mikolajczyk, Rafael] Hannover Med Sch, Hannover, Germany	University of Gottingen; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Hannover Medical School	Maier, IL (corresponding author), Univ Med Gottingen, Dept Neurol, Gottingen, Germany.	ilko.maier@med.uni-goettingen.de	Karch, André/D-6973-2017; Mikolajczyk, Rafael/ABB-5259-2021; Baehr, Mathias/K-2188-2014	Karch, André/0000-0003-3014-8543; Mikolajczyk, Rafael/0000-0003-1271-7204	German Research Foundation; Open Access Publication Funds of the Gottingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland GL, 2010, CRIT CARE MED, V38, P388, DOI 10.1097/CCM.0b013e3181c03dfa; Ay H, 2006, NEUROLOGY, V66, P1325, DOI 10.1212/01.wnl.0000206077.13705.6d; BARER DH, 1988, BRIT MED J, V296, P737, DOI 10.1136/bmj.296.6624.737; Brossay L, 1998, J IMMUNOL, V161, P5124; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dziedzic T, 2007, J NEUROL SCI, V252, P53, DOI 10.1016/j.jns.2006.10.007; Fehr T, 2004, ATHEROSCLEROSIS, V175, P83, DOI 10.1016/j.atherosclerosis.2004.02.016; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Harms H, 2011, CEREBROVASC DIS, V32, P552, DOI 10.1159/000331922; Herz J, 2014, NEUROBIOL DIS, V62, P456, DOI 10.1016/j.nbd.2013.10.022; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Laowattana S, 2007, NEUROLOGY, V68, P509, DOI 10.1212/01.wnl.0000253186.23949.fd; Macchia A, 2012, CRIT CARE MED, V40, P2768, DOI 10.1097/CCM.0b013e31825b9509; Miida Takashi, 2004, J Atheroscler Thromb, V11, P253; Muthu K, 2009, J BURN CARE RES, V30, P8, DOI 10.1097/BCR.0b013e3181921f22; Oberbeck R, 2009, CURR MED CHEM, V16, P1082, DOI 10.2174/092986709787581770; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Platzer C, 2000, J NEUROIMMUNOL, V105, P31, DOI 10.1016/S0165-5728(00)00205-8; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; Seki Y, 2010, J CLIN NEUROSCI, V17, P187, DOI 10.1016/j.jocn.2009.04.020; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Weber MS, 2005, NAT CLIN PRACT NEURO, V1, P106, DOI 10.1038/ncpneuro0047; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	31	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116836	10.1371/journal.pone.0116836	http://dx.doi.org/10.1371/journal.pone.0116836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643360	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821200026
J	Lindholm, B; Hagell, P; Hansson, O; Nilsson, MH				Lindholm, Beata; Hagell, Peter; Hansson, Oskar; Nilsson, Maria H.			Prediction of Falls and/or Near Falls in People with Mild Parkinson's Disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTURAL INSTABILITY; GAIT QUESTIONNAIRE; SYDNEY MULTICENTER; MEASURING FATIGUE; FEAR; SCALE; RISK; PROGRESSION; MORTALITY	Objective To determine factors associated with future falls and/or near falls in people with mild PD. Methods The study included 141 participants with PD. Mean (SD) age and PD-duration were 68 (9.7) and 4 years (3.9), respectively. Their median (q1-q3) UPDRS III score was 13 (8-18). Those >80 years of age, requiring support in standing or unable to understand instructions were excluded. Self-administered questionnaires targeted freezing of gait, turning hesitations, walking difficulties in daily life, fatigue, fear of falling, independence in activities of daily living, dyskinesia, demographics, falls/near falls history, balance problems while dual tasking and pain. Clinical assessments addressed functional balance performance, retropulsion, comfortable gait speed, motor symptoms and cognition. All falls and near falls were subsequently registered in a diary during a six-month period. Risk factors for prospective falls and/or near falls were determined using logistic regression. Results Sixty-three participants (45%) experienced >= 1 fall and/or near fall. Three factors were independent predictors of falls and/or near falls: fear of falling (OR = 1.032, p<0.001) history of near falls (OR = 3.475, p = 0.009) and retropulsion (OR = 2.813, p = 0.035). The strongest contributing factor was fear of falling, followed by a history of near falls and retropulsion. Conclusions Fear of falling seems to be an important issue to address already in mild PD as well as asking about prior near falls.	[Lindholm, Beata] Skane Univ Hosp, Dept Neurol, Malmo, Sweden; [Hagell, Peter] Kristianstad Univ, PRO CARE Grp, Sch Hlth & Soc, Kristianstad, Sweden; [Lindholm, Beata; Hansson, Oskar] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Hansson, Oskar] Skane Univ Hosp, Memory Clin, Malmo, Sweden; [Nilsson, Maria H.] Lund Univ, Dept Hlth Sci, Lund, Sweden	Lund University; Skane University Hospital; Kristianstad University; Lund University; Lund University; Skane University Hospital; Lund University	Lindholm, B (corresponding author), Skane Univ Hosp, Dept Neurol, Malmo, Sweden.	Beata.Lindholm@med.lu.se	Nilsson, Maria H/AAQ-6987-2020; Hansson, Oskar/A-7134-2013; Lindholm, Bengt/P-1334-2017	Nilsson, Maria H/0000-0002-6580-6721; Hansson, Oskar/0000-0001-8467-7286; Lindholm, Bengt/0000-0003-4269-4293	Swedish Parkinson Academy; Stoltz fund (Department of Neurology, Malmo, Skane University Hospital, Sweden); Academy of Caring Sciences (Skane University Hospital, Sweden); Skane county council's research and development foundation; strategic research area for neuroscience at Lund University (MultiPark), Sweden; Swedish Council for Working Life, Public Health and Welfare (Forte)	Swedish Parkinson Academy; Stoltz fund (Department of Neurology, Malmo, Skane University Hospital, Sweden); Academy of Caring Sciences (Skane University Hospital, Sweden); Skane county council's research and development foundation; strategic research area for neuroscience at Lund University (MultiPark), Sweden; Swedish Council for Working Life, Public Health and Welfare (Forte)	This work was supported by grants from the Swedish Parkinson Academy, the Stoltz fund (Department of Neurology, Malmo, Skane University Hospital, Sweden), the Academy of Caring Sciences (Skane University Hospital, Sweden), Skane county council's research and development foundation, and the strategic research area for neuroscience at Lund University (MultiPark), Sweden. None of the funders had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was accomplished within BAGADILICO (the Basal Ganglia Disorders Linnaeus Consortium) research consortium at Lund University, Sweden, and within the context of the Centre for Ageing and Supportive Environments (CASE) at Lund University, financed by the Swedish Council for Working Life, Public Health and Welfare (Forte).	Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; Allcock LM, 2009, PARKINSONISM RELAT D, V15, P110, DOI 10.1016/j.parkreldis.2008.03.010; Allen NE, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/906274; Ashburn A, 2001, GERONTOLOGY, V47, P277, DOI 10.1159/000052812; Ashburn A, 2001, AGE AGEING, V30, P47, DOI 10.1093/ageing/30.1.47; Ashburn A, 2007, J NEUROL NEUROSUR PS, V78, P678, DOI 10.1136/jnnp.2006.099333; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bladh S, 2012, J NEUROL, V259, P729, DOI 10.1007/s00415-011-6254-z; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Brozova H, 2009, NEUROENDOCRINOL LETT, V30, P453; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; Cole MH, 2010, MOVEMENT DISORD, V25, P2369, DOI 10.1002/mds.23292; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Ellis T, 2013, PHYS THER, V93, P628, DOI 10.2522/ptj.20120279; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Gray P, 2000, J Neurosci Nurs, V32, P222; Grimbergen YAM, 2013, J PARKINSON DIS, V3, P409, DOI 10.3233/JPD-120113; Hagell P, 2009, PARKINSONISM RELAT D, V15, pS62, DOI 10.1016/S1353-8020(09)70253-6; Hagell P, 2006, J PAIN SYMPTOM MANAG, V32, P420, DOI 10.1016/j.jpainsymman.2006.05.021; Hariz GM, 2011, ACTA NEUROL SCAND, V123, P20, DOI 10.1111/j.1600-0404.2010.01344.x; HELY MA, 1989, J NEUROL NEUROSUR PS, V52, P324, DOI 10.1136/jnnp.52.3.324; Hely MA, 1999, J NEUROL NEUROSUR PS, V67, P300, DOI 10.1136/jnnp.67.3.300; Hobson JP, 2001, CLIN REHABIL, V15, P241, DOI 10.1191/026921501666767060; Hoehn MM, 2001, NEUROLOGY, V57, pS11; Horak FB, 2005, EXP NEUROL, V193, P504, DOI 10.1016/j.expneurol.2004.12.008; Jonasson SB, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-66; Kelly VE, 2012, PARKINSONS DIS-US, V2012, DOI [10.1155/2012/918719, 10.1073/pnas.1207553109]; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Lessig S, 2012, MOVEMENT DISORD, V27, P1125, DOI 10.1002/mds.25070; Lindholm B, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-19; Nieuwboer A, 1998, DISABIL REHABIL, V20, P142, DOI 10.3109/09638289809166074; Nilsson MH, 2011, ACTA NEUROL SCAND, V123, P424, DOI 10.1111/j.1600-0404.2010.01418.x; Nilsson MH, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/713236; Nilsson MH, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-78; Nilsson MH, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-85; Nutt J, 1992, DIAGNOSIS IS IT PARK, P3, DOI DOI 10.1111/JVH.12392; Sipp AR, 2008, IEEE ENG MED BIO, P1262, DOI 10.1109/IEMBS.2008.4649393; Stack E, 1999, Physiother Res Int, V4, P190, DOI 10.1002/pri.165; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; TENO J, 1990, J AM GERIATR SOC, V38, P1321, DOI 10.1111/j.1532-5415.1990.tb03455.x; Thordardottir B, 2014, DISABIL REHABIL; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Visser M, 2003, ARCH PHYS MED REHAB, V84, P1669, DOI 10.1053/S0003-9993(03)00348-4; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721; Yellen SB, 1997, J PAIN SYMPTOM MANAG, V13, P63, DOI 10.1016/S0885-3924(96)00274-6	51	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117018	10.1371/journal.pone.0117018	http://dx.doi.org/10.1371/journal.pone.0117018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HX	25635687	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700067
J	McEwan, P; Ward, T; Bennett, H; Kalsekar, A; Webster, S; Brenner, M; Yuan, Y				McEwan, Phil; Ward, Thomas; Bennett, Hayley; Kalsekar, Anupama; Webster, Samantha; Brenner, Michael; Yuan, Yong			Estimating the Clinical and Economic Benefit Associated with Incremental Improvements in Sustained Virologic Response in Chronic Hepatitis C	PLOS ONE			English	Article							COST-EFFECTIVENESS; GENOTYPE 1; PEGYLATED INTERFERON; PEGINTERFERON ALPHA-2A; VIRUS-INFECTION; PLUS RIBAVIRIN; THERAPY; CIRRHOSIS; RISK; COMBINATION	Introduction Hepatitis C virus (HCV) infection is one of the principle causes of chronic liver disease. Successful treatment significantly decreases the risk of hepatic morbidity and mortality. Current standard of care achieves sustained virologic response (SVR) rates of 40-80%; however, the HCV therapy landscape is rapidly evolving. The objective of this study was to quantify the clinical and economic benefit associated with increasing levels of SVR. Methods A published Markov model (MONARCH) that simulates the natural history of hepatitis C over a lifetime horizon was used. Discounted and non-discounted life-years (LYs), quality-adjusted life-years (QALYs) and cost of complication management were estimated for various plausible SVR rates. To demonstrate the robustness of projections obtained, the model was validated to ten UK-specific HCV studies. Results QALY estimates ranged from 18.0 years for those treated successfully in fibrosis stage F0 to 7.5 years (discounted) for patients in fibrosis stage F4 who remain untreated. Predicted QALY gains per 10% improvement in SVR ranged from 0.23 (F0) to 0.64 (F4) and 0.58 (F0) to 1.35 (F4) in 40 year old patients (discounted and non-discounted results respectively). In those aged 40, projected discounted HCV-related costs are minimised with successful treatment in F0/F1 (at approximately 300) pound, increasing to 49,300 pound in F4 patients who remain untreated. Validation of the model to published UK cost-effectiveness studies produce R2 goodness of fit statistics of 0.988, 0.978 and of 0.973 for total costs, QALYs and incremental cost effectiveness ratios, respectively. Conclusion Projecting the long-term clinical and economic consequences associated with chronic hepatitis C is a necessary requirement for the evaluation of new treatments. The principle analysis demonstrates the significant impact on expected costs, LYs and QALYs associated with increasing SVR. A validation analysis demonstrated the robustness of the results reported.	[McEwan, Phil; Ward, Thomas; Bennett, Hayley; Webster, Samantha] HEOR Ltd, Monmouth, Wales; [McEwan, Phil; Ward, Thomas] Swansea Univ, Sch Human & Hlth Sci, Swansea Ctr Hlth Econ, Swansea, W Glam, Wales; [Kalsekar, Anupama; Yuan, Yong] Bristol Myers Squibb Co, Global Hlth Econ & Outcomes Res, Princeton, NJ USA; [Brenner, Michael] Bristol Myers Squibb Co, Uxbridge, Middx, England	Swansea University; Bristol-Myers Squibb; Bristol-Myers Squibb	McEwan, P (corresponding author), HEOR Ltd, Singleton Court Business Pk, Monmouth, Wales.	phil.mcewan@heor.co.uk			BMS Pharmaceuticals Ltd.	BMS Pharmaceuticals Ltd.	PM, TW, SW and HB are employed by HEOR Ltd., which received funding support in the form of a grant from BMS Pharmaceuticals Ltd. The funding agreement ensured PM, TW, SW and HB's independence in designing the study, interpreting the data, writing, and publishing the report. Authors YY, AK and MB are employed by BMS Pharmaceuticals Ltd. and critically reviewed the manuscript for intellectual content and appropriate interpretation of findings. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Coon JT, 2008, BRIT J CANCER, V98, P1166, DOI 10.1038/sj.bjc.6604301; Cooper C, 2013, QJM-INT J MED, V106, P153, DOI 10.1093/qjmed/hcs214; Cooper CL, 2012, THER CLIN RISK MANAG, V8, P105, DOI 10.2147/TCRM.S29830; Dore GJ, 2012, MED J AUSTRALIA, V196, P629, DOI 10.5694/mja11.11531; Druyts E, 2012, CLIN EXP GASTROENTER, V5, P11, DOI 10.2147/CEG.S28253; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Grieve R, 2002, ACTA GASTRO-ENT BELG, V65, P104; Grishchenko M, 2009, INT J TECHNOL ASSESS, V25, P171, DOI 10.1017/S0266462309090229; Harris HE, 2006, EPIDEMIOL INFECT, V134, P472, DOI 10.1017/S0950268805005340; Harris HE, 2002, BMJ-BRIT MED J, V324, P450, DOI 10.1136/bmj.324.7335.450; Huang YW, 2014, HEPATOLOGY, V60, P807, DOI 10.1002/hep.27212; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Law AM., 1991, SIMULATION MODELING, V2nd; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; McCombs J, 2014, JAMA INTERN MED, V174, P204, DOI 10.1001/jamainternmed.2013.12505; McEwan P, 2013, VALUE HLTH REGIONAL, V3, P5; McEwan P, 2013, HEPATOLOGY, V58, P54, DOI 10.1002/hep.26304; McEwan P, 2013, APPL HEALTH ECON HEA, V11, P53, DOI 10.1007/s40258-012-0002-0; Miller MH, 2014, ALIMENT PHARM THER, V39, P1363, DOI 10.1111/apt.12764; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2012, JANSS SUBM TEL TREAT; National Institute for Health and Care Excellence, 2012, TECHN APPR TA253 BOC; National Institute for Health and Care Excellence, 2010, TECHN ASS TA200 HEP; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Public Health England, 2014, COMM TEMPL EST HCV P; Public Health England, 2014, HEP C UK 2014 REP; Saab S, 2010, LIVER TRANSPLANT, V16, P748, DOI 10.1002/lt.22072; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Shepherd J, 2004, HEALTH TECHNOL ASSES, V8, P1; Shepherd J, 2000, Health Technol Assess, V4, P1; Stein K, 2002, GUT, V50, P253, DOI 10.1136/gut.50.2.253; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Townsend R, 2011, VALUE HEALTH, V14, P1068, DOI 10.1016/j.jval.2011.06.006	44	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117334	10.1371/journal.pone.0117334	http://dx.doi.org/10.1371/journal.pone.0117334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635922	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700081
J	Wanzirah, H; Tusting, LS; Arinaitwe, E; Katureebe, A; Maxwell, K; Rek, J; Bottomley, C; Staedke, SG; Kamya, M; Dorsey, G; Lindsay, SW				Wanzirah, Humphrey; Tusting, Lucy S.; Arinaitwe, Emmanuel; Katureebe, Agaba; Maxwell, Kilama; Rek, John; Bottomley, Christian; Staedke, Sarah G.; Kamya, Moses; Dorsey, Grant; Lindsay, Steve W.			Mind the Gap: House Structure and the Risk of Malaria in Uganda	PLOS ONE			English	Article							TRANSMISSION; CHILDREN; ENTRY; VECTORS; DISEASE; AREA	Background Good house construction may reduce the risk of malaria by limiting the entry of mosquito vectors. We assessed how house design may affect mosquito house entry and malaria risk in Uganda. Methods 100 households were enrolled in each of three sub-counties: Walukuba, Jinja district; Kihihi, Kanungu district; and Nagongera, Tororo district. CDC light trap collections of mosquitoes were done monthly in all homes. All children aged six months to ten years (n = 878) were followed prospectively for a total of 24 months to measure parasite prevalence every three months and malaria incidence. Homes were classified as modern (cement, wood or metal walls; and tiled or metal roof; and closed eaves) or traditional (all other homes). Results A total of 113,618 female Anopheles were collected over 6,765 nights. 6,816 routine blood smears were taken of which 1,061 (15.6%) were malaria parasite positive. 2,582 episodes of uncomplicated malaria were diagnosed after 1,569 person years of follow-up, giving an overall incidence of 1.6 episodes per person year at risk. The human biting rate was lower in modern homes than in traditional homes (adjusted incidence rate ratio (IRR) 0.48, 95% confidence interval (CI) 0.37-0.64, p < 0.001). The odds of malaria infection were lower in modern homes across all the sub-counties (adjusted odds ratio 0.44, 95%CI 0.30-0.65, p < 0.001), while malaria incidence was lower in modern homes in Kihihi (adjusted IRR 0.61, 95%CI 0.40-0.91, p = 0.02) but not in Walukuba or Nagongera. Conclusions House design is likely to explain some of the heterogeneity of malaria transmission in and represents a promising target for future interventions, even in highly endemic areas.	[Wanzirah, Humphrey; Arinaitwe, Emmanuel; Katureebe, Agaba; Maxwell, Kilama; Rek, John] Infect Dis Res Collaborat, Kampala, Uganda; [Tusting, Lucy S.; Lindsay, Steve W.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Bottomley, Christian] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Staedke, Sarah G.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Kamya, Moses] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Makerere University; University of California System; University of California San Francisco; Durham University	Tusting, LS (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	lucy.tusting@lshtm.ac.uk	Wanzira, Humphrey/AAF-1373-2020	Wanzira, Humphrey/0000-0003-1074-5340; Bottomley, Christian/0000-0002-5241-8412; Tusting, Lucy/0000-0002-6897-8625; Lindsay, Steve/0000-0002-3461-9050	National Institutes of Health, International Centers of Excellence in Malaria Research (ICMER) program [U19AI089674]; Global Health Trials (MRC-DfID-Wellcome Trust) [MR/M007383/1]; Leverhulme Centre for Integrative Research in Agriculture and Health; Medical Research Council [MR/K012126/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER	National Institutes of Health, International Centers of Excellence in Malaria Research (ICMER) program; Global Health Trials (MRC-DfID-Wellcome Trust); Leverhulme Centre for Integrative Research in Agriculture and Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National Institutes of Health as part of the International Centers of Excellence in Malaria Research (ICMER) program (U19AI089674). SWL received support from the Global Health Trials (MRC-DfID-Wellcome Trust; MR/M007383/1). LST was supported by the Leverhulme Centre for Integrative Research in Agriculture and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIAMAH JH, 1993, ANN TROP MED PARASIT, V87, P491, DOI 10.1080/00034983.1993.11812801; Al-Taiar A, 2008, TROP MED INT HEALTH, V13, P762, DOI 10.1111/j.1365-3156.2008.02066.x; Anderson L, 2014, DURABLE HOUSING IMPR, DOI [10.1016/j.aca.2014.12.042, DOI 10.1016/J.ACA.2014.12.042]; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Barat LM, 2004, AM J TROP MED HYG, V71, P174, DOI 10.4269/ajtmh.2004.71.174; Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Habitat UN, 2010, STAT AFR CIT 2010 GO, DOI [10.2174/157340310793566145, DOI 10.2174/157340310793566145]; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Huho B, 2013, INT J EPIDEMIOL, V42, P235, DOI 10.1093/ije/dys214; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087358; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Mmbando BP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-145; Njie M, 2009, J MED ENTOMOL, V46, P977; Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773; RBM/UNDP, 2013, MULT ACT FRAM MAL, DOI [10.1007/s13224-012-0272-3, DOI 10.1007/S13224-012-0272-3]; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Somi MF, 2007, AM J TROP MED HYG, V77, P1020, DOI 10.4269/ajtmh.2007.77.1020; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	29	71	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117396	10.1371/journal.pone.0117396	http://dx.doi.org/10.1371/journal.pone.0117396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635688	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700083
J	Awad, AI; Alsaleh, FM				Awad, Abdelmoneim Ismail; Alsaleh, Fatemah Mohammad			10-Year Risk Estimation for Type 2 Diabetes Mellitus and Coronary Heart Disease in Kuwait: A Cross-Sectional Population-Based Study	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; LIFE-STYLE INTERVENTION; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; IDENTIFY INDIVIDUALS; INSULIN-RESISTANCE; NATIONAL-HEALTH; PRIMARY-CARE; PREVALENCE	Background Type 2 diabetes mellitus (T2DM), coronary heart disease (CHD) and metabolic syndrome (MetS) are major healthcare problems in Kuwait. The present study was designed to determine the prevalence of MetS, and to estimate the 10-year risk for developing T2DM and CHD among the general population in Kuwait. Methods A descriptive, cross-sectional survey was undertaken in 1800 individuals without diabetes or a history of cardiovascular disease (CVD). They were selected from six governorates using two stage convenience sampling. The questionnaire was developed using the Finnish Diabetes Risk Score (FINDRISK), Framingham Risk Score [FRS] and the 2009 Joint Statement criteria for diagnosis of MetS as a framework. Descriptive and multivariate logistic regression analyses were used. Results The response rate was 89.4%. More than half (60.8%; 95% CI: 58.4-63.2) of responders were either overweight or obese. One hundred and ninety seven (12.2%) subjects had blood pressure (BP) >= 140/90 mm Hg. Almost three-in-ten (28.3%: 26.2-30.6) subjects had fasting plasma glucose (FPG) levels >= 5.6 mmol/l, of whom 86.0% and 14.0% had impaired fasting glucose (IFG) and screen detected T2DM, respectively. MetS was present in 512 (31.8%; 29.5-34.2) respondents. Just under one third (n = 481; 29.9%; 27.7-32.2) of participants were at moderate, high, or very high risk of developing T2DM, while 283 (17.6%: 15.8-19.6) were at moderate/high 10-year risk of developing CHD. Approximately one-in-ten (8.5%; 7.2-9.9) subjects were at moderate/high/very high 10-year risk of developing both T2DM/CHD. T2DM risk was higher for females compared to males (p < 0.001); however, the pattern was reversed in terms of the risk of developing CHD or T2DM/CHD. The risk of developing T2DM, CHD, or T2DM/CHD was greater among those aged >= 45 years, and those having MetS (p<0.001). Conclusions The current findings highlight the need for multifaceted interventions for prevention.	[Awad, Abdelmoneim Ismail; Alsaleh, Fatemah Mohammad] Kuwait Univ, Fac Pharm, Dept Pharm Practice, Kuwait, Kuwait	Kuwait University	Awad, AI (corresponding author), Kuwait Univ, Fac Pharm, Dept Pharm Practice, Kuwait, Kuwait.	amoneim@hsc.edu.kw	Awad, Abdelmoneim Ismail/AAU-1963-2020	Awad, Abdelmoneim Ismail/0000-0002-2266-3687				Abduelkarem A. R., 2009, Practical Diabetes International, V26, P148, DOI 10.1002/pdi.1359; Ahmed F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-103; Ajani UA, 2006, J AM COLL CARDIOL, V48, P1177, DOI 10.1016/j.jacc.2006.05.055; Al Khalaf M. M., 2010, Eastern Mediterranean Health Journal, V16, P725; Al Rashdan I, 2010, ANGIOLOGY, V61, P42, DOI 10.1177/0003319709333226; Al Zenki S, 2012, INT J ENV RES PUB HE, V9, P1984, DOI 10.3390/ijerph9051984; Al-Dahi S, 2013, MIL MED, V178, P299, DOI 10.7205/MILMED-D-12-00079; Al-Shaibani H, 2004, FAM MED, V36, P540; Al-Taweel DM, 2013, INT J CLIN PHARM-NET, V35, P244, DOI 10.1007/s11096-012-9738-8; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alzohairy MA, 2011, GLOB J HEAL SCI, V3, P123; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Blenkinsopp A, 2003, J PUBLIC HEALTH MED, V25, P144, DOI 10.1093/pubmed/fdg030; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Dupront WD, 2011, POWER SAMPLE SIZE CA; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Garca-Alcala H, 2012, DIABET METAB SYND OB, V5, P403, DOI 10.2147/DMSO.S35545; George J, 2011, AUSTRALAS MED J, V4, P266, DOI 10.4066/AMJ.2011.698; Golagiuri S, 2002, DIABETES CARE, V25, P1410; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Hjellset VT, 2011, J IMMIGR MINOR HEALT, V13, P101, DOI 10.1007/s10903-009-9290-3; Hu G, 2007, EUR HEART J, V28, P492, DOI 10.1093/eurheartj/ehl475; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Ismail M N, 2002, Obes Rev, V3, P203, DOI 10.1046/j.1467-789X.2002.00074.x; Jaber LA, 2004, DIABETES CARE, V27, P234, DOI 10.2337/diacare.27.1.234; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kuwait Central Statistical Bureau, 2011, GEN POP CENS; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Memon A, 2000, B WORLD HEALTH ORGAN, V78, P1306; Menon VU, 2006, DIABETES RES CLIN PR, V74, P289, DOI 10.1016/j.diabres.2006.03.025; Musaiger AO, 2002, MED PRIN PRACT, V11, P9, DOI 10.1159/000066415; Dominguez AAN, 2013, MEDICC REV, V15, P16, DOI 10.37757/MR2013V15.N2.4; Nestle M, 2005, AM J PUBLIC HEALTH, V95, P1497, DOI 10.2105/AJPH.2005.069120; Olusi SO, 2003, ANN SAUDI MED, V23, P162, DOI 10.5144/0256-4947.2003.162; Organization WH, 2009, GLOB HLTH RISKS MORT; Rajala U, 1998, DIABETES CARE, V21, P1664, DOI 10.2337/diacare.21.10.1664; Rice Virginia Hill, 2013, Cochrane Database Syst Rev, pCD001188, DOI 10.1002/14651858.CD001188.pub4; Rodondi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034287; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Schwarz PEH, 2009, J CLIN ENDOCR METAB, V94, P920, DOI 10.1210/jc.2007-2427; Sorkhou EI, 2004, MED PRIN PRACT, V13, P39, DOI 10.1159/000074050; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Vermunt PWA, 2010, FAM PRACT, V27, P312, DOI 10.1093/fampra/cmp100; WHO, 2014, GLOB DAT BOD MASS IN; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Winkler G, 2013, MED SCI MONITOR, V19, P67, DOI 10.12659/MSM.883747; World Health Organization, 2013, WORLD HLTH STAT KUW; World Health Organization, 2004, WHO TECHN REP SER, V894; World Health Organization, 2017, CARD DIS CVDS; Xie J, 2010, J EPIDEMIOL COMMUN H, V64, P236, DOI 10.1136/jech.2009.087544; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zubaid M, 2004, CAN J CARDIOL, V20, P783	60	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116742	10.1371/journal.pone.0116742	http://dx.doi.org/10.1371/journal.pone.0116742			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629920	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100047
J	Dallmeier, D; Pencina, MJ; Rajman, I; Koenig, W; Rothenbacher, D; Brenner, H				Dallmeier, Dhayana; Pencina, Michael J.; Rajman, Iris; Koenig, Wolfgang; Rothenbacher, Dietrich; Brenner, Hermann			Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR EVENTS; PROGNOSTIC VALUE; FOLLOW-UP; PREDICTION; RISK; MORTALITY; BIOMARKERS; FAILURE; ISCHEMIA	Objective To assess the prognostic value of 12-months N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) levels on adverse cardiovascular events in patients with stable coronary heart disease. Methods NT-proBNP concentrations were measured at baseline and at 12-months follow-up in participants of cardiac rehabilitation (median follow-up 8.96 years). Cox-proportional hazards models evaluated the prognostic value of log-transformed NT-proBNP levels, and of 12-months NT-proBNP relative changes on adverse cardiovascular events adjusting for established risk factors measured at baseline. Results Among 798 participants (84.7% men, mean age 59 years) there were 114 adverse cardiovascular events. 12-months NT-proBNP levels were higher than baseline levels in 60 patients (7.5%) and numerically more strongly associated with the outcome in multivariable analysis (HR 1.65 [95% CI 1.33-2.05] vs. HR 1.41 [95% CI 1.12-1.78], with a net reclassification improvement (NRI) of 0.098 [95% CI 0.002-0.194] compared to NRI of 0.047 [95% CI -0.0004-0.133] for baseline NT-proBNP levels. A 12-month 10% increment of NTproBNP was associated with a HR of 1.35 [95% CI 1.12-1.63] for the onset of an adverse cardiovascular event. Subjects with a 12-month increment of NT-proBNP had a HR of 2.56 [95% CI 1.10-5.95] compared to those with the highest 12-months reduction. Conclusions Twelve-months NT-proBNP levels after an acute cardiovascular event are strongly associated with a subsequent event and may provide numerically better reclassification of patients at risk for an adverse cardiovascular event compared to NT-proBNP baseline levels after adjustment for established risk factors.	[Dallmeier, Dhayana; Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Dallmeier, Dhayana] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Dallmeier, Dhayana; Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Pencina, Michael J.] Duke Univ, Duke Clin Res Inst, Dept Biostat & Bioinformat, Durham, NC USA; [Rajman, Iris] Novartis Inst Biomed Res, Basel, Switzerland; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany	Ulm University; Boston University; Ulm University; Duke University; Novartis; Helmholtz Association; German Cancer Research Center (DKFZ)	Koenig, W (corresponding author), Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany.	wolfgang.koenig@uniklinik-ulm.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017; Dallmeier, Dhayana/A-1169-2015	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Dallmeier, Dhayana/0000-0003-3665-7023; Koenig, Wolfgang/0000-0002-2064-9603; Rothenbacher, Dietrich/0000-0002-3563-2791	German Federal Ministry of Education and Research [01GD9820/0]; Pitzer Foundation (Bad Nauheim, Germany); Novartis Institute of Biomedical Research (NIBR) (Basel, Switzerland) [PRSUPPC 1050213]; University of Ulm	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Pitzer Foundation (Bad Nauheim, Germany); Novartis Institute of Biomedical Research (NIBR) (Basel, Switzerland); University of Ulm	This work was supported in part by the German Federal Ministry of Education and Research [#01GD9820/0] and the Pitzer Foundation (Bad Nauheim, Germany). Part of this work was financed by Novartis Institute of Biomedical Research (NIBR) (Basel, Switzerland) [by an unrestricted grant, PRSUPPC 1050213], and by additional funds from the University of Ulm. Dr. Rajman is a full-time employee of Novartis at their Institute of Biomedical Research. Novartis, as one of the funders of this work, provided support in the form of salary for Dr. Rajman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bibbins-Domingo K, 2003, CIRCULATION, V108, P2987, DOI 10.1161/01.CIR.0000103681.04726.9C; Bibbins-Domingo K, 2007, JAMA-J AM MED ASSOC, V297, P169, DOI 10.1001/jama.297.2.169; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; deFilippi CR, 2010, J AM COLL CARDIOL, V55, P441, DOI 10.1016/j.jacc.2009.07.069; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Franke J, 2011, CLIN RES CARDIOL, V100, P1059, DOI 10.1007/s00392-011-0340-1; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Linssen GCM, 2010, EUR HEART J, V31, P120, DOI 10.1093/eurheartj/ehp420; Masson S, 2008, J AM COLL CARDIOL, V52, P997, DOI 10.1016/j.jacc.2008.04.069; Morrow DA, 2005, JAMA-J AM MED ASSOC, V294, P2866, DOI 10.1001/jama.294.22.2866; Noveanu M, 2011, CRIT CARE, V15, DOI 10.1186/cc9398; O'Donoghue ML, 2011, AM HEART J, V162, P613, DOI 10.1016/j.ahj.2011.07.018; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Omland T, 2008, AM J CARDIOL, V101, p61A, DOI 10.1016/j.amjcard.2007.11.025; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Richards M, 2006, J AM COLL CARDIOL, V47, P52, DOI 10.1016/j.jacc.2005.06.085; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rothenbacher D, 2006, ARCH INTERN MED, V166, P2455, DOI 10.1001/archinte.166.22.2455; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Singh HS, 2009, CLIN CARDIOL, V32, P447, DOI 10.1002/clc.20569; Steyerberg EW, 2014, BIOMETRICAL J; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Thygesen K, 2012, EUR HEART J, V33, P2001, DOI 10.1093/eurheartj/ehq509; Toggweiler S, 2011, CLIN CARDIOL, V34, P183, DOI 10.1002/clc.20894; Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P56, DOI 10.1016/j.jacc.2011.02.041; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Health Organization, 2011, CARDIOVASCULAR DISEA; Wu AHB, 2006, AM HEART J, V152, P828, DOI 10.1016/j.ahj.2006.08.021	31	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117143	10.1371/journal.pone.0117143	http://dx.doi.org/10.1371/journal.pone.0117143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629613	gold, Green Submitted, Green Published			2022-12-26	WOS:000348732100069
J	Rao, MY; Li, JB; Qin, J; Zhang, JH; Gao, XB; Yu, SY; Yu, J; Chen, GZ; Xu, BD; Li, HJ; Rao, RS; Huang, L; Jin, J				Rao, Mingyue; Li, Jiabei; Qin, Jun; Zhang, Jihang; Gao, Xubin; Yu, Shiyong; Yu, Jie; Chen, Guozhu; Xu, Baida; Li, Huijie; Rao, Rongsheng; Huang, Lan; Jin, Jun			Left Ventricular Function during Acute High-Altitude Exposure in a Large Group of Healthy Young Chinese Men	PLOS ONE			English	Article							MYOCARDIAL PERFORMANCE INDEX; ACUTE MOUNTAIN-SICKNESS; OPERATION EVEREST-II; CARDIAC-FUNCTION; PULMONARY-EDEMA; DIASTOLIC FUNCTION; ACUTE-HYPOXIA; DOPPLER; EXERCISE; ECHOCARDIOGRAPHY	Objective The purpose of this study was to observe left ventricular function during acute high-altitude exposure in a large group of healthy young males. Methods A prospective trial was conducted in Szechwan and Tibet from June to August, 2012. By Doppler echocardiography, left ventricular function was examined in 139 healthy young Chinese men at sea level; within 24 hours after arrival in Lhasa, Tibet, at 3700 m; and on day 7 following an ascent to Yangbajing at 4400 m after 7 days of acclimatization at 3700 m. The resting oxygen saturation (SaO2), heart rate (HR) and blood pressure (BP) were also measured at the above mentioned three time points. Results Within 24 hours of arrival at 3700 m, the HR, ejection fraction (EF), fractional shortening (FS), stroke volume (SV), cardiac output (CO), and left ventricular (LV) Tei index were significantly increased, but the LV end-systolic dimension (ESD), end-systolic volume (ESV), SaO2, E/A ratio, and ejection time (ET) were significantly decreased compared to the baseline levels in all subjects. On day 7 at 4400 m, the SV and CO were significantly decreased; the EF and FS Tei were not decreased compared with the values at 3700 m; the HR was further elevated; and the SaO2, ESV, ESD, and ET were further reduced. Additionally, the E/A ratio was significantly increased on day 7 but was still lower than it was at low altitude. Conclusion Upon acute high-altitude exposure, left ventricular systolic function was elevated with increased stroke volume, but diastolic function was decreased in healthy young males. With higher altitude exposure and prolonged acclimatization, the left ventricular systolic function was preserved with reduced stroke volume and improved diastolic function.	[Rao, Mingyue; Li, Jiabei; Qin, Jun; Zhang, Jihang; Gao, Xubin; Yu, Shiyong; Yu, Jie; Chen, Guozhu; Xu, Baida; Huang, Lan; Jin, Jun] Third Mil Med Univ, Inst Cardiovasc Dis PLA, Chongqing 400037, Peoples R China; [Rao, Mingyue; Li, Jiabei; Qin, Jun; Yu, Shiyong; Chen, Guozhu; Xu, Baida; Li, Huijie; Huang, Lan; Jin, Jun] Third Mil Med Univ, Xinqiao Hosp, Dept Cardiol, Chongqing 400037, Peoples R China; [Rao, Rongsheng] Third Mil Med Univ, Xinqiao Hosp, Dept Med Ultrason, Chongqing 400037, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Huang, L (corresponding author), Third Mil Med Univ, Inst Cardiovasc Dis PLA, Chongqing 400037, Peoples R China.	huanglan260@126.com; jjxqyy@163.com			Special Health Research Project, Ministry of Health of PR China [201002012]	Special Health Research Project, Ministry of Health of PR China	This work was supported by grants from the Special Health Research Project, Ministry of Health of PR China (no. 201002012) and was conducted by Professor Huang Lan and team members, whose work on the Tibet trek allowed the authors' research to be conducted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemann Y, 2004, AM J PHYSIOL-HEART C, V286, pH856, DOI 10.1152/ajpheart.00518.2003; Allemann Y, 2012, AM J PHYSIOL-HEART C, V302, pH2646, DOI 10.1152/ajpheart.00053.2012; Asmussen E, 1941, AM J PHYSIOL, V132, P0555, DOI 10.1152/ajplegacy.1941.132.2.555; BALASUBRAMANIAN V, 1978, BRIT HEART J, V40, P276; Boos CJ, 2014, CLIN RES CARDIOL, V103, P291, DOI 10.1007/s00392-013-0654-2; Boussuges A, 2000, AM J RESP CRIT CARE, V161, P264, DOI 10.1164/ajrccm.161.1.9902096; Bouzat P, 2013, RESP PHYSIOL NEUROBI, V186, P16, DOI 10.1016/j.resp.2012.12.009; Cheung MMH, 2004, EUR HEART J, V25, P2238, DOI 10.1016/j.ehj.2004.07.034; Duplain H, 1999, CIRCULATION, V99, P1713, DOI 10.1161/01.CIR.99.13.1713; FOWLES RE, 1983, AM J CARDIOL, V52, P862, DOI 10.1016/0002-9149(83)90429-0; GOMEZ A, 1992, AM REV RESPIR DIS, V146, P313, DOI 10.1164/ajrccm/146.2.313; Grollman A, 1930, AM J PHYSIOL, V93, P19, DOI 10.1152/ajplegacy.1930.93.1.19; Grunig E, 2000, J AM COLL CARDIOL, V35, P980, DOI 10.1016/S0735-1097(99)00633-6; Hanaoka M, 2011, INTERNAL MED, V50, P2967, DOI 10.2169/internalmedicine.50.5942; Holloway C, 2011, FASEB J, V25, P3130, DOI 10.1096/fj.11-183426; Holloway CJ, 2011, FASEB J, V25, P792, DOI 10.1096/fj.10-172999; Huez S, 2005, AM J PHYSIOL-HEART C, V289, pH1391, DOI 10.1152/ajpheart.00332.2005; Huez S, 2009, AM J CARDIOL, V103, P1605, DOI 10.1016/j.amjcard.2009.02.006; JUNG RC, 1971, J APPL PHYSIOL, V31, P593, DOI 10.1152/jappl.1971.31.4.593; Kjaergaard J, 2006, EUR J APPL PHYSIOL, V98, P411, DOI 10.1007/s00421-006-0299-1; Misumi Ikuo, 2002, J Cardiol, V39, P85; OLIVER RM, 1991, INT J CARDIOL, V31, P235, DOI 10.1016/0167-5273(91)90221-A; OLSEN N, 1992, J APPL PHYSIOL, V73, P2036, DOI 10.1152/jappl.1992.73.5.2036; Poulsen SH, 2000, J AM SOC ECHOCARDIOG, V13, P379, DOI 10.1016/S0894-7317(00)70007-1; REEVES JT, 1987, J APPL PHYSIOL, V63, P531, DOI 10.1152/jappl.1987.63.2.531; Riepl RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044445; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Sawka MN, 1996, J APPL PHYSIOL, V81, P636, DOI 10.1152/jappl.1996.81.2.636; Shave RE, 2004, BRIT J SPORT MED, V38, P86, DOI 10.1136/bjsm.2002.002832; Strobel G, 1996, EUR J APPL PHYSIOL, V73, P82, DOI 10.1007/BF00262813; SUAREZ J, 1987, AM J CARDIOL, V60, P137, DOI 10.1016/0002-9149(87)91000-9; SURKS MI, 1966, J APPL PHYSIOL, V21, P1741, DOI 10.1152/jappl.1966.21.6.1741; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Tei C, 1995, J Cardiol, V26, P135; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tian R, 1997, CIRCULATION, V96, P1313, DOI 10.1161/01.CIR.96.4.1313; Vallecilla C, 2014, J BIOMECH, DOI [10.1016/j.jbiomech.2014.12.037, DOI 10.1016/J.JBIOMECH.2014.12.037]; Westerterp KR, 1996, J APPL PHYSIOL, V80, P1968, DOI 10.1152/jappl.1996.80.6.1968; Wu TY, 2012, THORAX, V67, P914, DOI 10.1136/thoraxjnl-2011-200623; Yakabe K, 2008, CLIN NEPHROL, V70, P41; Zhou QQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031097	41	24	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116936	10.1371/journal.pone.0116936	http://dx.doi.org/10.1371/journal.pone.0116936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629435	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100051
J	Relevy, NZ; Bechor, S; Harari, A; Ben-Amotz, A; Kamari, Y; Harats, D; Shaish, A				Relevy, Noa Zolberg; Bechor, Sapir; Harari, Ayelet; Ben-Amotz, Ami; Kamari, Yehuda; Harats, Dror; Shaish, Aviv			The Inhibition of Macrophage Foam Cell Formation by 9-Cis beta-Carotene Is Driven by BCMO1 Activity	PLOS ONE			English	Article							ALGA DUNALIELLA-BARDAWIL; CARDIOVASCULAR-DISEASE; RETINOIC ACID; 9-CIS-RETINOIC ACID; GENE-EXPRESSION; VITAMIN-A; ATHEROSCLEROSIS; MICE; ALPHA; RISK	Atherosclerosis is a major cause of morbidity and mortality in developed societies, and begins when activated endothelial cells recruit monocytes and T-cells from the bloodstream into the arterial wall. Macrophages that accumulate cholesterol and other fatty materials are transformed into foam cells. Several epidemiological studies have demonstrated that a diet rich in carotenoids is associated with a reduced risk of heart disease; while previous work in our laboratory has shown that the 9-cis beta-carotene rich alga Dunaliella inhibits atherogenesis in mice. The effect of 9-cis beta-carotene on macrophage foam cell formation has not yet been investigated. In the present work, we sought to study whether the 9-cis eta-carotene isomer, isolated from the alga Dunaliella, can inhibit macrophage foam cell formation upon its conversion to retinoids. The 9-cis beta-carotene and Dunaliella lipid extract inhibited foam cell formation in the RAW264.7 cell line, similar to 9-cis retinoic acid. Furthermore, dietary enrichment with the algal powder in mice resulted in carotenoid accumulation in the peritoneal macrophages and in the inhibition of foam cell formation ex-vivo and in-vivo. We also found that the beta-carotene cleavage enzyme beta-carotene 15,15'-monooxygenase (BCMO1) is expressed and active in macrophages. Finally, 9-cis beta-carotene, as well as the Dunaliella extract, activated the nuclear receptor RXR in hepa1-6 cells. These results indicate that dietary carotenoids, such as 9-cis beta-carotene, accumulate in macrophages and can be locally cleaved by endogenous BCMO1 to form 9-cis retinoic acid and other retinoids. Subsequently, these retinoids activate the nuclear receptor RXR that, along with additional nuclear receptors, can affect various metabolic pathways, including those involved in foam cell formation and atherosclerosis.	[Relevy, Noa Zolberg; Bechor, Sapir; Harari, Ayelet; Kamari, Yehuda; Harats, Dror; Shaish, Aviv] Sheba Med Ctr, Bert W Strassburger Lipid Ctr, IL-5265601 Ramat Gan, Israel; [Relevy, Noa Zolberg; Bechor, Sapir; Kamari, Yehuda; Harats, Dror] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ben-Amotz, Ami] NBT, Elat, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Shaish, A (corresponding author), Sheba Med Ctr, Bert W Strassburger Lipid Ctr, IL-5265601 Ramat Gan, Israel.	Aviv.Shaish@sheba.health.gov.il			Nikken Sohonsha Corporation, Japan	Nikken Sohonsha Corporation, Japan	This work was supported by Nikken Sohonsha Corporation, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. N.B.T. Israel provided support in the form of a salary for author ABA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions' section.	BENAMOTZ A, 1988, PLANT PHYSIOL, V86, P1286, DOI 10.1104/pp.86.4.1286; BENAMOTZ A, 1983, PLANT PHYSIOL, V72, P593, DOI 10.1104/pp.72.3.593; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Chichili GR, 2005, INVEST OPHTH VIS SCI, V46, P3562, DOI 10.1167/iovs.05-0089; Cui YX, 2009, J BIOL CHEM, V284, P24925, DOI 10.1074/jbc.M109.026609; D'Odorico A, 2000, ATHEROSCLEROSIS, V153, P231, DOI 10.1016/S0021-9150(00)00403-2; Dushkin MI, 2007, B EXP BIOL MED+, V144, P713, DOI 10.1007/s10517-007-0413-3; Erdman JW, 1998, J NUTR, V128, P2009, DOI 10.1093/jn/128.11.2009; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Glise D, 1998, IN VIVO, V12, P447; Harari A, 2008, J NUTR, V138, P1923, DOI 10.1093/jn/138.10.1923; Harari A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/169517; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HEBUTERNE X, 1995, J LIPID RES, V36, P1264; Helmersson J, 2009, BRIT J NUTR, V101, P1775, DOI 10.1017/S0007114508147377; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENRIKSEN T, 1983, ARTERIOSCLEROSIS, V3, P149, DOI 10.1161/01.ATV.3.2.149; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Iizuka M, 2012, J NUTR SCI VITAMINOL, V58, P96, DOI 10.3177/jnsv.58.96; Iyama T, 1996, INT J VITAM NUTR RES, V66, P301; Jung WJ, 2004, BIOFACTORS, V21, P113, DOI 10.1002/biof.552210122; Karppi J, 2012, NUTR METAB CARDIOVAS, V22, P921, DOI 10.1016/j.numecd.2012.01.008; Karppi J, 2013, INT J CARDIOL, V168, P1841, DOI 10.1016/j.ijcard.2012.12.072; Karppi J, 2013, ATHEROSCLEROSIS, V226, P172, DOI 10.1016/j.atherosclerosis.2012.10.077; Katsuura S, 2009, MOL NUTR FOOD RES, V53, P1396, DOI 10.1002/mnfr.200800566; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; KRAEMER FB, 1985, J CLIN ENDOCR METAB, V61, P335, DOI 10.1210/jcem-61-2-335; Langmann T, 2005, BBA-MOL BASIS DIS, V1740, P155, DOI 10.1016/j.bbadis.2004.11.016; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lo HM, 2014, FOOD FUNCT, V5, P140, DOI 10.1039/c3fo60309a; Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACCREHAN WA, 1987, J CHROMATOGR-BIOMED, V417, P65, DOI 10.1016/0378-4347(87)80092-0; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Napolitano M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1820, DOI 10.1152/ajpendo.00315.2007; Palozza P, 2011, J NUTR BIOCHEM, V22, P971, DOI 10.1016/j.jnutbio.2010.08.010; Park CS, 2008, BIOTECHNOL LETT, V30, P735, DOI 10.1007/s10529-007-9598-9; Rhee EJ, 2012, BBA-MOL CELL BIOL L, V1821, P230, DOI 10.1016/j.bbalip.2011.07.001; Scott J, 2004, CURR OPIN GENET DEV, V14, P271, DOI 10.1016/j.gde.2004.04.012; Shaish A, 2006, ATHEROSCLEROSIS, V189, P215, DOI 10.1016/j.atherosclerosis.2005.12.004; Takeda N, 2006, ARTERIOSCL THROM VAS, V26, P1177, DOI 10.1161/01.ATV.0000214296.94849.1c; WANG XD, 1994, ARCH BIOCHEM BIOPHYS, V313, P150, DOI 10.1006/abbi.1994.1371; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yan WM, 2001, GENOMICS, V72, P193, DOI 10.1006/geno.2000.6476; Yeum KJ, 1996, AM J CLIN NUTR, V64, P594, DOI 10.1093/ajcn/64.4.594	48	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115272	10.1371/journal.pone.0115272	http://dx.doi.org/10.1371/journal.pone.0115272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629601	Green Submitted, Green Published, gold			2022-12-26	WOS:000348732100014
J	Ahn, J; Konno, H; Barber, GN				Ahn, J.; Konno, H.; Barber, G. N.			Diverse roles of STING-dependent signaling on the development of cancer	ONCOGENE			English	Article							INNATE; TUMORIGENESIS; INFLAMMATION; ADAPTER; CELLS; TOLL	Stimulator of interferon genes (STING) is a cellular sensor that controls cytosolic DNA-activated innate immune signaling. We have previously demonstrated that STING-deficient mice are resistant to carcinogen-induced skin cancer, similar to myeloid differentiation primary response gene 88 (MyD88) deficient mice, since the production of STING-dependent DNA-damage-induced proinflammatory cytokines, that likely require MyD88 signaling to exert their growth-promoting activity, are prevented. In contrast, MyD88-deficient mice are sensitive to colitis-associated cancer (CAC), since selected cytokines generated following DNA-damage also activate repair pathways, which can help prevent tumor development. Here, we demonstrate that STING signaling facilitates wound repair processes and that analogous to MyD88-deficient mice, STING-deficient mice (SKO) are prone to CAC induced by DNA-damaging agents. SKO mice harboring tumors exhibited low levels of tumor-suppressive interleukin-22 binding protein (IL-22BP) compared to normal mice, a cytokine considered critical for preventing colon-related cancer. Our data indicate that STING constitutes a critical component of the host early response to intestinal damage and is essential for invigorating tissue repair pathways that may help prevent tumorigenesis.	[Barber, G. N.] Univ Miami, Sch Med, Dept Cell Biol, Miami, FL 33136 USA; [Barber, G. N.] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami	Barber, GN (corresponding author), Univ Miami, Sch Med, Dept Cell Biol, 511 Papanicolaou Bldg,1550 NW 10th Ave, Miami, FL 33136 USA.	gbarber@med.miami.edu			NATIONAL CANCER INSTITUTE [R01CA194404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079336] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA194404] Funding Source: Medline; NIAID NIH HHS [R01 AI079336] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn J, 2014, J IMMUNOL, V193, P4634, DOI 10.4049/jimmunol.1401337; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6166; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cataisson C, 2012, J EXP MED, V209, P1689, DOI 10.1084/jem.20101355; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Goldszmid RS, 2012, NAT IMMUNOL, V13, P932, DOI 10.1038/ni.2422; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; JACOBY RF, 1991, J CLIN INVEST, V87, P624, DOI 10.1172/JCI115039; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Nowarski R, 2013, CANCER IMMUNOL RES, V1, P77, DOI 10.1158/2326-6066.CIR-13-0081; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Salcedo R, 2013, TRENDS IMMUNOL, V34, P379, DOI 10.1016/j.it.2013.03.008; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051	26	83	87	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2015	34	41					5302	5308		10.1038/onc.2014.457	http://dx.doi.org/10.1038/onc.2014.457			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CT1QL	25639870	Green Accepted			2022-12-26	WOS:000362575400010
J	Jung, SA; Park, YM; Hong, SW; Moon, JH; Shin, JS; Lee, HR; Ha, SH; Lee, DH; Kim, JH; Kim, SM; Kim, JE; Kim, KP; Hong, YS; Choi, EK; Lee, JS; Jin, DH; Kim, T				Jung, Soo-A; Park, Yong-Man; Hong, Seung-Woo; Moon, Jai-Hee; Shin, Jae-Sik; Lee, Ha-Reum; Ha, Seung-Hee; Lee, Dae-Hee; Kim, Jeong Hee; Kim, Seung-Mi; Kim, Jeong Eun; Kim, Kyu-pyo; Hong, Yong Sang; Choi, Eun Kyung; Lee, Jung Shin; Jin, Dong-Hoon; Kim, TaeWon			Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) Stability Contributes to YM155 Resistance in Human Gastric Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Apoptosis; Gastric Cancer; Survivin; Ubiquitylation (Ubiquitination); YM155; cIAP1	SYNERGISTIC ANTITUMOR ACTIVITIES; SEPANTRONIUM BROMIDE YM155; MCL-1 DOWN-REGULATION; TARGETED THERAPIES; CISPLATIN RESISTANCE; SURVIVIN SUPPRESSANT	YM155, which blocks the expression of survivin, a member of the inhibitor of apoptosis (IAP) family, induces cell death in a variety of cancer types, including prostate, bladder, breast, leukemia, and non-small lung cancer. However, the mechanism underlying gastric cancer susceptibility and resistance to YM155 is yet to be specified. Here, we demonstrate that cIAP1 stability dictates resistance to YM155 in human gastric cancer cells. Treatment of human gastric cancer cells with YM155 differentially induced cell death dependent on the stability of cIAP1 as well as survivin. Transfection with cIAP1 expression plasmids decreased cell sensitivity to YM155, whereas knockdown of endogenous cIAP1 using RNA interference enhanced sensitivity to YM155. In addition, double knockdown of survivin and cIAP1 significantly induced cell death in the YM155-resistant cell line, MKN45. We also showed that YM155 induced autoubiquitination and proteasome-dependent degradation of cIAP1. Surprisingly, survivin affected the stability of cIAP1 through binding, contributing to cell sensitivity to YM155. Thus, our findings reveal that YM155 sensitizes human gastric cancer cells to apoptotic cell death by degrading cIAP1, and furthermore, cIAP1 in gastric cancer cells may act as a PD marker for YM155 treatment.	[Jung, Soo-A; Park, Yong-Man; Hong, Seung-Woo; Moon, Jai-Hee; Shin, Jae-Sik; Lee, Ha-Reum; Ha, Seung-Hee; Lee, Dae-Hee; Kim, Jeong Hee; Kim, Seung-Mi; Kim, Jeong Eun; Kim, Kyu-pyo; Hong, Yong Sang; Choi, Eun Kyung; Lee, Jung Shin; Jin, Dong-Hoon; Kim, TaeWon] Univ Ulsan, Coll Med, Asan Med Ctr, Innovat Canc Res,Asan Inst Life Sci, Seoul, South Korea; [Jung, Soo-A; Park, Yong-Man; Hong, Seung-Woo; Moon, Jai-Hee; Shin, Jae-Sik; Lee, Ha-Reum; Ha, Seung-Hee; Lee, Dae-Hee; Kim, Jeong Hee; Kim, Seung-Mi; Kim, Jeong Eun; Kim, Kyu-pyo; Hong, Yong Sang; Lee, Jung Shin; Jin, Dong-Hoon; Kim, TaeWon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Choi, Eun Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Jin, Dong-Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea; [Lee, Ha-Reum] Sookmyung Womens Univ, Dept Life Sci, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Sookmyung Women's University	Jin, DH (corresponding author), Asan Med Ctr, Dept Oncol, 88 Olympicro 43gil, Seoul 138736, South Korea.	inno183@amc.seoul.kr		Lee, Ha-Reum/0000-0001-9200-4372	Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs Grant, Republic of Korea [HI06C0868]; National Research Foundation of Korea (NRF) - Korea government (MEST) [2013R1A2A2A01067394]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1420030]	Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs Grant, Republic of Korea; National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Health 21 R&D Project, Ministry of Health and Welfare and Family Affairs Grant HI06C0868, Republic of Korea, the National Research Foundation of Korea (NRF) funded by Korea government (MEST) Grant 2013R1A2A2A01067394, and National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea Grant 1420030.	Aspe JR, 2010, ONCOTARGETS THER, V3, P247, DOI 10.2147/OTT.S15293; Cheng Qiuying, 2012, Int J Biochem Mol Biol, V3, P179; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Custodio A, 2012, CANCER TREAT REV, V38, P36, DOI 10.1016/j.ctrv.2011.04.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaneko N, 2013, BIOL PHARM BULL, V36, P1921, DOI 10.1248/bpb.b13-00515; Kasper S, 2014, EUR J CANCER, V50, P1247, DOI 10.1016/j.ejca.2014.01.009; Kumar B, 2012, MOL CANCER THER, V11, P1988, DOI 10.1158/1535-7163.MCT-12-0167; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Mohamed A, 2013, AM J PATHOL, V183, P1096, DOI 10.1016/j.ajpath.2013.07.005; Na Y. S., 2012, PLOS ONE, V7; Nakahara T, 2011, ANTI-CANCER DRUG, V22, P454, DOI 10.1097/CAD.0b013e328344ac68; Premkumar DR, 2013, J PHARMACOL EXP THER, V346, P201, DOI 10.1124/jpet.113.204743; Rauch A, 2014, BBA-REV CANCER, V1845, P202, DOI 10.1016/j.bbcan.2014.01.003; Singer EA, 2012, CURR OPIN ONCOL, V24, P284, DOI 10.1097/CCO.0b013e328351c646; Sun XP, 2014, FEBS J, V281, P115, DOI 10.1111/febs.12577; Tabernero J, 2004, ANN ONCOL, V15, P55, DOI 10.1093/annonc/mdh905; Tang HK, 2011, BIOCHEM PHARMACOL, V82, P1066, DOI 10.1016/j.bcp.2011.07.064; Yamauchi T, 2012, BIOCHEM BIOPH RES CO, V425, P711, DOI 10.1016/j.bbrc.2012.07.103; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yoon DH, 2012, ANTICANCER RES, V32, P1681; Yoong J, 2011, DRUGS, V71, P1367, DOI 10.2165/11592530-000000000-00000	22	9	9	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					9974	9985		10.1074/jbc.M114.600874	http://dx.doi.org/10.1074/jbc.M114.600874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25635055	Green Published, hybrid			2022-12-26	WOS:000353241100007
J	Scholer, J; Ferralli, J; Thiry, S; Chiquet-Ehrismann, R				Schoeler, Jonas; Ferralli, Jacqueline; Thiry, Stephane; Chiquet-Ehrismann, Ruth			The Intracellular Domain of Teneurin-1 Induces the Activity of Microphthalmia-associated Transcription Factor (MITF) by Binding to Transcriptional Repressor HINT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIR-RULE GENE; RNA-POLYMERASE-II; FIBROBLAST-GROWTH-FACTOR; IN-VITRO; TRANSMEMBRANE PROTEIN; PHYLOGENETIC ANALYSIS; NEURITE OUTGROWTH; CELL-ADHESION; EXPRESSION; FAMILY	Teneurins are large type II transmembrane proteins that are necessary for the normal development of the CNS. Although many studies highlight the significance of teneurins, especially during development, there is only limited information known about the molecular mechanisms of function. Previous studies have shown that the N-terminal intracellular domain (ICD) of teneurins can be cleaved at the membrane and subsequently translocates to the nucleus, where it can influence gene transcription. Because teneurin ICDs do not contain any intrinsic DNA binding sequences, interaction partners are required to affect transcription. Here, we identified histidine triad nucleotide binding protein 1 (HINT1) as a human teneurin-1 ICD interaction partner in a yeast two-hybrid screen. This interaction was confirmed in human cells, where HINT1 is known to inhibit the transcription of target genes by directly binding to transcription factors at the promoter. In a whole transcriptome analysis of BS149 glioblastoma cells overexpressing the teneurin- 1 ICD, several microphthalmia-associated transcription factor (MITF) target genes were found to be up-regulated. Directly comparing the transcriptomes of MITF versus TEN1-ICD-overexpressing BS149 cells revealed 42 co-regulated genes, including glycoprotein non-metastatic b (GPNMB). Using real-time quantitative PCR to detect endogenous GPNMB expression upon overexpression of MITF and HINT1 as well as promoter reporter assays using GPNMB promoter constructs, we could demonstrate that the teneurin-1 ICD binds HINT1, thus switching on MITF-dependent transcription of GPNMB.	[Schoeler, Jonas; Ferralli, Jacqueline; Thiry, Stephane; Chiquet-Ehrismann, Ruth] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Schoeler, Jonas; Chiquet-Ehrismann, Ruth] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Basel	Chiquet-Ehrismann, R (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	ruth.chiquet@fmi.ch						Abdelmagid SM, 2010, J CELL BIOCHEM, V111, P295, DOI 10.1002/jcb.22702; Adijanto J, 2012, J BIOL CHEM, V287, P20491, DOI 10.1074/jbc.M112.354761; Anastassiadis K, 2002, GENE, V298, P159, DOI 10.1016/S0378-1119(02)00979-4; Bagutti C, 2003, J CELL SCI, V116, P2957, DOI 10.1242/jcs.00603; BAUMGARTNER S, 1993, MECH DEVELOP, V40, P165, DOI 10.1016/0925-4773(93)90074-8; BAUMGARTNER S, 1994, EMBO J, V13, P3728, DOI 10.1002/j.1460-2075.1994.tb06682.x; Beckmann J, 2013, NANO LETT, V13, P2937, DOI 10.1021/nl4013248; Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532; Boucard AA, 2014, J BIOL CHEM, V289, P387, DOI 10.1074/jbc.M113.504779; Broz DK, 2010, INT J DEV BIOL, V54, P1509, DOI 10.1387/ijdb.103139dk; Busby JN, 2013, NATURE, V501, P547, DOI 10.1038/nature12465; Cao JY, 2014, MOL CELL BIOL, V34, P246, DOI 10.1128/MCB.00968-13; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Carter BD, 2006, EMBO REP, V7, P382, DOI 10.1038/sj.embor.7400675; Cheung HNM, 2014, FASEB J, V28, P337, DOI 10.1096/fj.13-232694; Drabikowski K, 2005, DEV BIOL, V282, P27, DOI 10.1016/j.ydbio.2005.02.017; Dui Y, 2014, BIOCHEM BIOPH RES CO, V445, P58, DOI 10.1016/j.bbrc.2014.01.119; Durrin LK, 2002, GENOMICS, V79, P809, DOI 10.1006/geno.2002.6772; Enneking EM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001537; Fanciulli M, 2000, FASEB J, V14, P904, DOI 10.1096/fasebj.14.7.904; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Genovese G, 2012, CELL CYCLE, V11, P2206, DOI 10.4161/cc.20765; Gharesouran J, 2014, J MOL NEUROSCI, V54, P780, DOI 10.1007/s12031-014-0377-5; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Huang JJ, 2012, BRAIN BEHAV, V2, P85, DOI 10.1002/brb3.39; Kenzelmann D, 2007, CELL MOL LIFE SCI, V64, P1452, DOI 10.1007/s00018-007-7108-9; Kenzelmann D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-30; Kolpakova E, 1998, BIOCHEM J, V336, P213, DOI 10.1042/bj3360213; Kypri E, 2014, CELL MOL LIFE SCI, V71, P517, DOI 10.1007/s00018-013-1401-6; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Li WM, 2009, ARCH OTOLARYNGOL, V135, P896, DOI 10.1001/archoto.2009.121; Liu Q, 2008, NEUROCHEM RES, V33, P1263, DOI 10.1007/s11064-007-9578-4; Lovejoy DA, 2006, GEN COMP ENDOCR, V148, P299, DOI 10.1016/j.ygcen.2006.01.012; Margaron Y, 2013, J BIOL CHEM, V288, P1184, DOI 10.1074/jbc.M112.431825; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Minet AD, 1999, J CELL SCI, V112, P2019; Minet AD, 2000, GENE, V257, P87, DOI 10.1016/S0378-1119(00)00388-7; Morck C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-55; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Murakami T, 2010, J ANAT, V217, P236, DOI 10.1111/j.1469-7580.2010.01267.x; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Proshkin SA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P976, DOI 10.1134/S0006297911080141; Razin E, 1999, J BIOL CHEM, V274, P34272, DOI 10.1074/jbc.274.48.34272; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sanchez-Soriano N, 2009, J CELL SCI, V122, P2534, DOI 10.1242/jcs.046268; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Suzuki N, 2014, J ORTHOP RES, V32, P915, DOI 10.1002/jor.22616; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Tian Y, 2013, P NATL ACAD SCI USA, V110, P17071, DOI 10.1073/pnas.1315110110; Tucker RP, 2012, MOL BIOL EVOL, V29, P1019, DOI 10.1093/molbev/msr271; Tucker RP, 2000, MECH DEVELOP, V98, P187, DOI 10.1016/S0925-4773(00)00444-5; Tucker RP, 2006, DEV BIOL, V290, P237, DOI 10.1016/j.ydbio.2005.11.038; Tucker RP, 2001, DEV DYNAM, V220, P27, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1084>3.0.CO;2-B; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Wang L, 2009, INT J CANCER, V124, P1526, DOI 10.1002/ijc.24072; Wang LQ, 2005, MOL BRAIN RES, V133, P253, DOI 10.1016/j.molbrainres.2004.10.019; Young TR, 2013, J NEUROSCI, V33, P12490, DOI 10.1523/JNEUROSCI.4708-12.2013; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022956; Zheng YH, 2013, CHIN J CANCER, V32, P75, DOI [10.5732/cjc.012.10084, 10.5732/cjc.012.1008]; Zhou XH, 2003, GENE EXPR PATTERNS, V3, P397, DOI 10.1016/S1567-133X(03)00087-5; Ziegler A, 2012, CANCER LETT, V326, P1, DOI 10.1016/j.canlet.2012.07.021	70	23	24	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8154	8165		10.1074/jbc.M114.615922	http://dx.doi.org/10.1074/jbc.M114.615922			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25648896	Green Published, hybrid			2022-12-26	WOS:000351662600013
J	Koo, CX; Kobiyama, K; Shen, YJ; LeBert, N; Ahmad, S; Khatoo, M; Aoshi, T; Gasser, S; Ishii, KJ				Koo, Christine Xing'er; Kobiyama, Kouji; Shen, Yu J.; LeBert, Nina; Ahmad, Shandar; Khatoo, Muznah; Aoshi, Taiki; Gasser, Stephan; Ishii, Ken J.			RNA Polymerase III Regulates Cytosolic RNA:DNA Hybrids and Intracellular MicroRNA Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; DNA Damage; Innate Immunity; MicroRNA (miRNA); RNA Polymerase III; RNA Transport; RNA:DNA Hybrid; RNase H; Antibody S9.6	DNA-DAMAGE RESPONSE; GENOME INSTABILITY; ELONGATION COMPLEX; RNA/DNA HYBRIDS; HUMAN-CELLS; R-LOOPS; TRANSCRIPTION; TERMINATION; SUBCOMPLEX; STABILITY	Background: RNA:DNA hybrids exist in the nucleus and mitochondria but not in the cytosol, except in viral infection. Results: RNA:DNA hybrids exist in the cytosol of various human cells and are mediated by RNA polymerase III (Pol III), which regulates the microRNA machinery. Conclusion: Cytosolic RNA:DNA hybrids are regulated by Pol III. Significance: Previous unknown cytosolic RNA:DNA hybrids may have physiological relevance to miRNA machinery and RNA transport. RNA:DNA hybrids form in the nuclei and mitochondria of cells as transcription-induced R-loops or G-quadruplexes, but exist only in the cytosol of virus-infected cells. Little is known about the existence of RNA:DNA hybrids in the cytosol of virus-free cells, in particular cancer or transformed cells. Here, we show that cytosolic RNA:DNA hybrids are present in various human cell lines, including transformed cells. Inhibition of RNA polymerase III (Pol III), but not DNA polymerase, abrogated cytosolic RNA:DNA hybrids. Cytosolic RNA:DNA hybrids bind to several components of the microRNA (miRNA) machinery-related proteins, including AGO2 and DDX17. Furthermore, we identified miRNAs that are specifically regulated by Pol III, providing a potential link between RNA:DNA hybrids and the miRNA machinery. One of the target genes, exportin-1, is shown to regulate cytosolic RNA:DNA hybrids. Taken together, we reveal previously unknown mechanism by which Pol III regulates the presence of cytosolic RNA:DNA hybrids and miRNA biogenesis in various human cells.	[Koo, Christine Xing'er; Shen, Yu J.; LeBert, Nina; Khatoo, Muznah; Gasser, Stephan] Natl Univ Singapore, Immunol Programme, Ctr Life Sci, Singapore 117456, Singapore; [Koo, Christine Xing'er; Shen, Yu J.; LeBert, Nina; Khatoo, Muznah; Gasser, Stephan] Natl Univ Singapore, Dept Microbiol, Ctr Life Sci, Singapore 117456, Singapore; [Koo, Christine Xing'er; Shen, Yu J.; Gasser, Stephan] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Koo, Christine Xing'er; Kobiyama, Kouji; Aoshi, Taiki; Ishii, Ken J.] Natl Inst Biomed Innovat NIBIO, Lab Adjuvant Innovat, Osaka 5670085, Japan; [Ahmad, Shandar] Natl Inst Biomed Innovat NIBIO, Lab Bioinformat, Osaka 5670085, Japan; [Kobiyama, Kouji; Aoshi, Taiki; Ishii, Ken J.] Osaka Univ, Lab Vaccine Sci, World Premier Int Immunol Frontier Res Ctr iFREC, Suita, Osaka 5650871, Japan	National University of Singapore; National University of Singapore; National University of Singapore; Osaka University	Gasser, S (corresponding author), Natl Univ Singapore, Immunol Programme, Ctr Life Sci, Singapore 117456, Singapore.	stephan_gasser@nuhs.edu.sg; kenishii@biken.osaka-u.ac.jp	Ishii, Ken J/B-1685-2012; Shen, Yujia/L-2407-2018	Ishii, Ken J/0000-0002-6728-3872; Le Bert, Nina/0000-0003-0502-2527; Gasser, Stephan/0000-0002-5616-0914	Health and Labour Sciences Research Grant Adjuvant Database Project from the Japanese Ministry of Health, Labour and Welfare; National Research Foundation Grant HUJ-CREATE-Cellular and Molecular Mechanisms of Inflammation	Health and Labour Sciences Research Grant Adjuvant Database Project from the Japanese Ministry of Health, Labour and Welfare; National Research Foundation Grant HUJ-CREATE-Cellular and Molecular Mechanisms of Inflammation	This work was supported by the Health and Labour Sciences Research Grant Adjuvant Database Project from the Japanese Ministry of Health, Labour and Welfare and by the National Research Foundation Grant HUJ-CREATE-Cellular and Molecular Mechanisms of Inflammation (to S. G.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brown TA, 2008, J BIOL CHEM, V283, P36743, DOI 10.1074/jbc.M806174200; Bussing I, 2010, EMBO J, V29, P1830, DOI 10.1038/emboj.2010.82; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Chan YA, 2014, TRENDS GENET, V30, P245, DOI 10.1016/j.tig.2014.03.005; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P296, DOI 10.1016/j.bbagrm.2012.09.010; Dragan AI, 2010, BIOPHYS J, V99, P3010, DOI 10.1016/j.bpj.2010.09.012; FRANK P, 1994, NUCLEIC ACIDS RES, V22, P5247, DOI 10.1093/nar/22.24.5247; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gao M, 2014, CELL RES, V24, P532, DOI 10.1038/cr.2014.36; Gjidoda A, 2013, BBA-GENE REGUL MECH, V1829, P385, DOI 10.1016/j.bbagrm.2012.09.011; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Haugland R. P., 2005, MOL PROBES HDB GUIDE; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; JAEHNING JA, 1977, J BIOL CHEM, V252, P8753; Jounai N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00168; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Lam AR, 2014, CANCER RES, V74, P2193, DOI 10.1158/0008-5472.CAN-13-1703; Lorenzen K, 2007, STRUCTURE, V15, P1237, DOI 10.1016/j.str.2007.07.016; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Nakama M, 2012, GENES CELLS, V17, P218, DOI 10.1111/j.1365-2443.2012.01583.x; PEDRALINOY G, 1979, BIOCHEM BIOPH RES CO, V88, P1194, DOI 10.1016/0006-291X(79)91106-9; Pothof J, 2009, CELL CYCLE, V8, P3462, DOI 10.4161/cc.8.21.9835; Rigby RE, 2014, EMBO J, V33, P542, DOI 10.1002/embj.201386117; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; SCHWARTZ LB, 1974, J BIOL CHEM, V249, P5889; Shaw NN, 2008, BIOCHIMIE, V90, P1026, DOI 10.1016/j.biochi.2008.04.011; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; TAKANO T, 1974, COLD SPRING HARB SYM, V39, P1009, DOI 10.1101/SQB.1974.039.01.116; Theofilopoulos AN, 2011, J INTERF CYTOK RES, V31, P867, DOI 10.1089/jir.2011.0092; Valentine R, 2010, J GEN VIROL, V91, P2221, DOI 10.1099/vir.0.021998-0; Vanaja SK, 2014, P NATL ACAD SCI USA, V111, P7765, DOI 10.1073/pnas.1400075111; Veras L, 2009, J MOL BIOL, V387, P523, DOI 10.1016/j.jmb.2009.02.008; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wahba L, 2013, ELIFE, V2, DOI 10.7554/eLife.00505; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wang YM, 2013, CELL CYCLE, V12, P32, DOI 10.4161/cc.23051; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; Wu LP, 2003, EUKARYOT CELL, V2, P256, DOI 10.1128/EC.2.2.256-264.2003; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x	53	28	28	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7463	7473		10.1074/jbc.M115.636365	http://dx.doi.org/10.1074/jbc.M115.636365			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25623070	hybrid, Green Published			2022-12-26	WOS:000351613600015
J	Tsitoura, P; Koussis, K; Iatrou, K				Tsitoura, Panagiota; Koussis, Konstantinos; Iatrou, Kostas			Inhibition of Anopheles gambiae Odorant Receptor Function by Mosquito Repellents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosensor; Chemical Biology; High-throughput Screening (HTS); Insect; Recombinant Protein Expression; Orco Co-receptor Antagonism; Lepidopteran Insect Cells; Mosquito Olfaction; Olfactory Receptors	THROUGHPUT SCREENING PLATFORMS; INSECT-CELL-LINES; ION CHANNELS; AMILORIDE DERIVATIVES; OLFACTORY RECEPTORS; OPIOID RECEPTORS; MOLECULAR-BASIS; BOMBYX-MORI; IN-VITRO; DEET	Background: The mode of action of insect repellents on odorant receptor (OR) function remains unclear. Results:Anopheles gambiae OR function in vitro is inhibited by specific repellents. Conclusion: The identified inhibitory effects are due to functional blocking of Orco, the common subunit of OR heteromers. Significance: The specific mechanism of action is distinct from the proposed modes of DEET function. The identification of molecular targets of insect repellents has been a challenging task, with their effects on odorant receptors (ORs) remaining a debatable issue. Here, we describe a study on the effects of selected mosquito repellents, including the widely used repellent N,N-diethyl-meta-toluamide (DEET), on the function of specific ORs of the African malaria vector Anopheles gambiae. This study, which has been based on quantitative measurements of a Ca2+-activated photoprotein biosensor of recombinant OR function in an insect cell-based expression platform and a sequential compound addition protocol, revealed that heteromeric OR (ORx/Orco) function was susceptible to strong inhibition by all tested mosquito repellents except DEET. Moreover, our results demonstrated that the observed inhibition was due to efficient blocking of Orco (olfactory receptor coreceptor) function. This mechanism of repellent action, which is reported for the first time, is distinct from the mode of action of other characterized insect repellents including DEET.	[Tsitoura, Panagiota; Iatrou, Kostas] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Insect Mol Genet & Biotechnol Grp, Athens 15310, Greece; [Koussis, Konstantinos] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 70013, Crete, Greece	National Centre of Scientific Research "Demokritos"; Foundation for Research & Technology - Hellas (FORTH)	Iatrou, K (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens 15310, Greece.	iatrou@bio.demokritos.gr	Kousis, Konstantinos/K-7371-2019	Kousis, Konstantinos/0000-0002-6737-8724	European Union (ENAROMaTIC - European Network for Advanced Research on Olfaction for Malaria Transmitting Insect Control) [FP7-222927]	European Union (ENAROMaTIC - European Network for Advanced Research on Olfaction for Malaria Transmitting Insect Control)	This work was supported by a grant from the European Union (FP7-222927, ENAROMaTIC - European Network for Advanced Research on Olfaction for Malaria Transmitting Insect Control).	AMANN R, 1991, LIFE SCI, V49, P849, DOI 10.1016/0024-3205(91)90169-C; AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bovolenta S, 2007, J BIOMOL SCREEN, V12, P694, DOI 10.1177/1087057107301497; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chen SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084575; Chen Sisi, 2014, F1000Res, V3, P84, DOI 10.12688/f1000research.3825.1; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; CHRISTOPHERS SR, 1947, J HYG-CAMBRIDGE, V45, P176, DOI 10.1017/S0022172400013863; Corcoran JA, 2014, INSECT BIOCHEM MOLEC, V54, P22, DOI 10.1016/j.ibmb.2014.08.005; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Douris V, 2006, ADV VIRUS RES, V68, P113, DOI 10.1016/S0065-3527(06)68004-4; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Hall S. A., 1945, U.S. Patent, Patent No. [2,390,249A, 2390249]; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Kiely A, 2007, J NEUROSCI METH, V159, P189, DOI 10.1016/j.jneumeth.2006.07.005; King W. V., 1954, CHEM EVALUATED INSEC; Krober T, 2010, J AM MOSQUITO CONTR, V26, P381, DOI 10.2987/10-6044.1; Kwon HW, 2011, J MED ENTOMOL, V48, P61, DOI 10.1603/ME10042; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2010, NATURE, V464, P37, DOI 10.1038/464037a; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; Lu ML, 1996, VIROLOGY, V218, P103, DOI 10.1006/viro.1996.0170; Molokanova M, 2008, DRUG DISCOV TODAY, V13, P14, DOI 10.1016/j.drudis.2007.11.009; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Pask GM, 2013, CHEM SENSES, V38, P221, DOI 10.1093/chemse/bjs100; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Rinker DC, 2012, PHYSIOL ENTOMOL, V37, P33, DOI 10.1111/j.1365-3032.2011.00821.x; Rollecke K, 2013, CHEM SENSES, V38, P231, DOI 10.1093/chemse/bjs140; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Suh E, 2014, CURR OPIN INSECT SCI, V6, P86, DOI 10.1016/j.cois.2014.10.006; Swevers L, 2005, CELL MOL LIFE SCI, V62, P919, DOI 10.1007/s00018-005-4537-1; Swevers L, 2004, FASEB J, V18, P134, DOI 10.1096/fj.03-0627fje; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Tabanca N, 2013, J AGR FOOD CHEM, V61, P8573, DOI 10.1021/jf402182h; Thompson AJ, 2010, BIOTECHNIQUES, V49, P822, DOI 10.2144/000113538; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WICKHAM TJ, 1992, BIOTECHNOL PROGR, V8, P391, DOI 10.1021/bp00017a003; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111; YASUDA K, 1993, P NATL ACAD SCI USA, V90, P6736, DOI 10.1073/pnas.90.14.6736	64	22	22	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7961	7972		10.1074/jbc.M114.632299	http://dx.doi.org/10.1074/jbc.M114.632299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25657000	Green Published, hybrid			2022-12-26	WOS:000351613600053
J	Eisenberger, T; Decker, C; Hiersche, M; Hamann, RC; Decker, E; Neuber, S; Frank, V; Bolz, HJ; Fehrenbach, H; Pape, L; Toenshoff, B; Mache, C; Latta, K; Bergmann, C				Eisenberger, Tobias; Decker, Christian; Hiersche, Milan; Hamann, Ruben C.; Decker, Eva; Neuber, Steffen; Frank, Valeska; Bolz, Hanno J.; Fehrenbach, Henry; Pape, Lars; Toenshoff, Burkhard; Mache, Christoph; Latta, Kay; Bergmann, Carsten			An Efficient and Comprehensive Strategy for Genetic Diagnostics of Polycystic Kidney Disease	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT; PRIMARY CILIUM; MUTATIONS; CILIOPATHIES; ALIGNMENT; PKD1; NEK8	Renal cysts are clinically and genetically heterogeneous conditions. Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent life-threatening genetic disease and mainly caused by mutations in PKD1. The presence of six PKD1 pseudogenes and tremendous allelic heterogeneity make molecular genetic testing challenging requiring laborious locus-specific amplification. Increasing evidence suggests a major role for PKD1 in early and severe cases of ADPKD and some patients with a recessive form. Furthermore it is becoming obvious that clinical manifestations can be mimicked by mutations in a number of other genes with the necessity for broader genetic testing. We established and validated a sequence capture based NGS testing approach for all genes known for cystic and polycystic kidney disease including PKD1. Thereby, we demonstrate that the applied standard mapping algorithm specifically aligns reads to the PKD1 locus and overcomes the complication of unspecific capture of pseudogenes. Employing careful and experienced assessment of NGS data, the method is shown to be very specific and equally sensitive as established methods. An additional advantage over conventional Sanger sequencing is the detection of copy number variations (CNVs). Sophisticated bioinformatic read simulation increased the high analytical depth of the validation study and further demonstrated the strength of the approach. We further raise some awareness of limitations and pitfalls of common NGS work-flows when applied in complex regions like PKD1 demonstrating that quality of NGS needs more than high coverage of the target region. By this, we propose a time- and cost-efficient diagnostic strategy for comprehensive molecular genetic testing of polycystic kidney disease which is highly automatable and will be of particular value when therapeutic options for PKD emerge and genetic testing is needed for larger numbers of patients.	[Eisenberger, Tobias; Decker, Christian; Hiersche, Milan; Hamann, Ruben C.; Decker, Eva; Neuber, Steffen; Frank, Valeska; Bolz, Hanno J.; Bergmann, Carsten] Bioscientia Ctr Human Genet, Ingelheim, Germany; [Fehrenbach, Henry] Childrens Hosp Memmingen, Dept Pediat, Memmingen, Germany; [Pape, Lars] MHH Hannover, Clin Pediat Kidney Liver & Metab Dis, Hannover, Germany; [Toenshoff, Burkhard] Univ Childrens Hosp Heidelberg, Dept Pediat 1, Heidelberg, Germany; [Mache, Christoph] Med Univ Graz, Dept Pediat, Graz, Austria; [Latta, Kay] Clementine Childrens Hosp, Frankfurt, Germany; [Bergmann, Carsten] Univ Freiburg, Med Ctr, Dept Med, Div Renal, D-79106 Freiburg, Germany	Hannover Medical School; Ruprecht Karls University Heidelberg; Medical University of Graz; University of Freiburg	Bergmann, C (corresponding author), Bioscientia Ctr Human Genet, Ingelheim, Germany.	carsten.bergmann@bioscientia.de	Pape, Lars/AAF-1477-2021	Pape, Lars/0000-0002-3635-6418				Arts HH, 2013, PEDIATR NEPHROL, V28, P863, DOI 10.1007/s00467-012-2259-9; Audrezet MP, 2012, HUM MUTAT, V33, P1239, DOI 10.1002/humu.22103; Bergmann C, 2014, AUTOSOMAL RECESSIVE; Bergmann C., 2014, PEDIAT NEPHROL; Bergmann C, 2008, NEW ENGL J MED, V359, P318, DOI 10.1056/NEJMc0801868; Bergmann C, 2011, J AM SOC NEPHROL, V22, P2047, DOI 10.1681/ASN.2010101080; Bogdanova N, 2001, GENOMICS, V74, P333, DOI 10.1006/geno.2001.6568; Consugar MB, 2008, KIDNEY INT, V74, P1468, DOI 10.1038/ki.2008.485; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Eisenberger T, 2014, HUM MUTAT, V35, P565, DOI 10.1002/humu.22532; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; Fehrenbach H., 2014, PEDIAT NEPHROL; Frank V, 2013, HUM MOL GENET, V22, P2177, DOI 10.1093/hmg/ddt070; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Landsverk ML, 2012, GENET MED, V14, P877, DOI 10.1038/gim.2012.58; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nix DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-9; OTT E, 2014, J MED GENET, P91; Rossetti S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/j.1523-1755.2002.00326.x; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Rossetti S, 2007, J AM SOC NEPHROL, V18, P1374, DOI 10.1681/ASN.2007010125; Rossetti S, 2012, J AM SOC NEPHROL, V23, P915, DOI 10.1681/ASN.2011101032; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Salomon R, 2009, PEDIATR NEPHROL, V24, P2333, DOI 10.1007/s00467-008-0840-z; Schmidts M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/humu.22294; Suzuki S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S7; Symmons O, 2008, MOL BIOL EVOL, V25, P2601, DOI 10.1093/molbev/msn202; TRUJILLANO D, 2014, MOL GENETIC GENETIC, V5, P28669, DOI DOI 10.1093/BRAIN/AWQ331; Turner EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/annurev-genom-082908-150112; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789	35	51	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116680	10.1371/journal.pone.0116680	http://dx.doi.org/10.1371/journal.pone.0116680			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646624	Green Submitted, gold, Green Published			2022-12-26	WOS:000348822600032
J	Pasqualim, G; Baldo, G; de Carvalho, TG; Tavares, AMV; Giugliani, R; Matte, U				Pasqualim, Gabriela; Baldo, Guilherme; de Carvalho, Talita Giacomet; Tavares, Angela Maria Vicente; Giugliani, Roberto; Matte, Ursula			Effects of Enzyme Replacement Therapy Started Late in a Murine Model of Mucopolysaccharidosis Type I	PLOS ONE			English	Article							RECOMBINANT ENCAPSULATED CELLS; MPS-I; AORTIC DILATATION; UP-REGULATION; TRANSPLANTATION; LARONIDASE; EFFICACY; IMPROVES; GUIDELINES; MANAGEMENT	Mucopolysaccharidosis type I (MPS I) is a progressive disorder caused by deficiency of alpha L- iduronidase (IDUA), which leads to storage of heparan and dermatan sulphate. It is suggested that early enzyme replacement therapy (ERT) leads to better outcomes, although many patients are diagnosed late and don't receive immediate treatment. This study aims to evaluate the effects of late onset ERT in a MPS I murine model. MPS I mice received treatment from 6 to 8 months of age (ERT 6-8mo) with 1.2mg laronidase/kg every 2 weeks and were compared to 8 months-old wild-type (Normal) and untreated animals (MPS I). ERT was effective in reducing urinary and visceral GAG to normal levels. Heart GAG levels and left ventricular (LV) shortening fraction were normalized but cardiac function was not completely improved. While no significant improvements were found on aortic wall width, treatment was able to significantly reduce heart valves thickening. High variability was found in behavior tests, with treated animals presenting intermediate results between normal and affected mice, without correlation with cerebral cortex GAG levels. Cathepsin D activity in cerebral cortex also did not correlate with behavior heterogeneity. All treated animals developed anti-laronidase antibodies but no correlation was found with any parameters analyzed. However, intermediary results from locomotion parameters analyzed are in accordance with intermediary levels of heart function, cathepsin D, activated glia and reduction of TNF-alpha expression in the cerebral cortex. In conclusion, even if started late, ERT can have beneficial effects on many aspects of the disease and should be considered whenever possible.	[Pasqualim, Gabriela; de Carvalho, Talita Giacomet; Giugliani, Roberto; Matte, Ursula] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol PPGBM, Porto Alegre, RS, Brazil; [Pasqualim, Gabriela; Baldo, Guilherme; de Carvalho, Talita Giacomet; Giugliani, Roberto; Matte, Ursula] Hosp Clin Porto Alegre, Expt Res Ctr, Gene Therapy Ctr, Porto Alegre, RS, Brazil; [Baldo, Guilherme] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Physiol, Porto Alegre, RS, Brazil; [Tavares, Angela Maria Vicente] Uniritter Laureate Int Univ, Dept Hlth Sci, Porto Alegre, RS, Brazil; [Giugliani, Roberto] Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil; [Giugliani, Roberto; Matte, Ursula] INAGEMP, Porto Alegre, RS, Brazil; [Giugliani, Roberto; Matte, Ursula] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Matte, U (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol PPGBM, Porto Alegre, RS, Brazil.	umatte@hcpa.ufrgs.br	Baldo, Guilherme/U-9104-2019; Da Silveira Matte umatte, Ursula/U-3912-2019; Pasqualim, Gabriela/E-5219-2018; Baldo, Guilherme/AAR-5677-2020; Giugliani, Roberto/G-4790-2015; Tavares, Angela Maria Vicente/F-6539-2010	Baldo, Guilherme/0000-0003-1598-5861; Da Silveira Matte umatte, Ursula/0000-0003-4977-6662; Pasqualim, Gabriela/0000-0002-6250-9609; Giugliani, Roberto/0000-0001-9655-3686; Vicente Tavares, Angela Maria/0000-0002-3402-0523	Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)/Ministerio da Saude (MS)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Secretaria de Estado da Saude do RS [1151-2551/13-3]	Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)/Ministerio da Saude (MS)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Secretaria de Estado da Saude do RS	This work was supported by Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (FIPE-HCPA) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)/Ministerio da Saude (MS)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Secretaria de Estado da Saude do RS (process #1151-2551/13-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer LD, 2014, J INHERIT METAB DIS, V37, P1, DOI 10.1007/s10545-013-9613-3; Arfi A, 2011, MOL GENET METAB, V103, P18, DOI 10.1016/j.ymgme.2011.01.015; Baldo G, 2014, MED HYPOTHESES, V82, P478, DOI 10.1016/j.mehy.2014.01.029; Baldo G, 2013, MOL GENET METAB, V109, P33, DOI 10.1016/j.ymgme.2013.03.005; Baldo G, 2012, CYTOTHERAPY, V14, P860, DOI 10.3109/14653249.2012.672730; Baldo G, 2012, BEHAV BRAIN RES, V233, P169, DOI 10.1016/j.bbr.2012.04.051; Baldo G, 2012, CELLS TISSUES ORGANS, V195, P323, DOI 10.1159/000327532; Baldo G, 2011, MOL GENET METAB, V104, P608, DOI 10.1016/j.ymgme.2011.08.018; Beck M, 2014, GENET MED, V16, P759, DOI 10.1038/gim.2014.25; Boelens JJ, 2010, PEDIATR CLIN N AM, V57, P123, DOI 10.1016/j.pcl.2009.11.004; Brands MMMG, 2013, J INHERIT METAB DIS, V36, P227, DOI 10.1007/s10545-011-9444-z; Braunlin EA, 2003, AM J CARDIOL, V92, P882, DOI 10.1016/S0002-9149(03)00909-3; Braunlin EA, 2006, AM J CARDIOL, V98, P416, DOI 10.1016/j.amjcard.2006.02.047; Clarke LA, 2009, PEDIATRICS, V123, P229, DOI 10.1542/peds.2007-3847; D'Aco K, 2012, EUR J PEDIATR, V171, P911, DOI 10.1007/s00431-011-1644-x; de Ru MH, 2013, J INHERIT METAB DIS, V36, P247, DOI 10.1007/s10545-012-9538-2; de Ru MH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-22; de Ru MH, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-55; Dickson P, 2008, J CLIN INVEST, V118, P2868, DOI 10.1172/JCI34676; Dierenfeld AD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001380; Gabrielli O, 2010, PEDIATRICS, V125, pE183, DOI 10.1542/peds.2009-1728; Giugliani R, 2009, MOL GENET METAB, V96, P13, DOI 10.1016/j.ymgme.2008.10.009; Giugliani R, 2012, J INHERIT METAB DIS, V35, P871, DOI 10.1007/s10545-011-9436-z; Giugliani R, 2010, GENET MOL BIOL, V33, P589, DOI 10.1590/S1415-47572010005000093; Harada H, 2011, MOL GENET METAB, V103, P215, DOI 10.1016/j.ymgme.2011.03.016; Jones JE, 2002, AM J PHYSIOL-HEART C, V283, pH364, DOI 10.1152/ajpheart.00979.2001; Kakkis ED, 2001, NEW ENGL J MED, V344, P182, DOI 10.1056/NEJM200101183440304; Lyons JA, 2011, LAB INVEST, V91, P665, DOI 10.1038/labinvest.2011.7; Ma X, 2008, MOL GENET METAB, V94, P298, DOI 10.1016/j.ymgme.2008.03.018; Martins AM, 2009, J PEDIATR-US, V155, pS32, DOI 10.1016/j.jpeds.2009.07.005; Matthes F, 2012, HUM MOL GENET, V21, P2599, DOI 10.1093/hmg/dds086; Metcalf JA, 2010, MOL GENET METAB, V99, P396, DOI 10.1016/j.ymgme.2009.12.003; Muenzer J, 2011, RHEUMATOLOGY, V50, pV4, DOI 10.1093/rheumatology/ker394; Muenzer J, 2009, PEDIATRICS, V123, P19, DOI 10.1542/peds.2008-0416; Munoz-Rojas MV, 2011, J INHERIT METAB DIS, V34, P1029, DOI 10.1007/s10545-011-9336-2; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Ou L, 2014, MOL GENET METAB, V111, P116, DOI 10.1016/j.ymgme.2013.09.008; Pan D, 2008, BRAIN RES, V1188, P241, DOI 10.1016/j.brainres.2007.10.036; Sifuentes M, 2007, MOL GENET METAB, V90, P171, DOI 10.1016/j.ymgme.2006.08.007; Tokic V, 2007, EUR J PEDIATR, V166, P727, DOI 10.1007/s00431-006-0316-8; Valayannopoulos V, 2011, RHEUMATOLOGY, V50, pV49, DOI 10.1093/rheumatology/ker396; Vieira T, 2008, AM J MED GENET A, V146A, P1741, DOI 10.1002/ajmg.a.32320; Wilkinson FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035787; Wolf DA, 2012, BONE MARROW TRANSPL, V47, P1235, DOI 10.1038/bmt.2011.239; Wraith JE, 2007, PEDIATRICS, V120, pE37, DOI 10.1542/peds.2006-2156; Wraith JE, 2004, J PEDIATR-US, V144, P581, DOI 10.1016/j.jpeds.2004.01.046	47	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117271	10.1371/journal.pone.0117271	http://dx.doi.org/10.1371/journal.pone.0117271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646802	gold, Green Submitted, Green Published			2022-12-26	WOS:000348822600062
J	Zhang, H; Huang, PF; Meng, E; Li, WY; Zhou, L; Zhu, LY; Wu, L; Li, MJ; Liang, SP; Zhang, DY				Zhang, Hui; Huang, Peng-Fei; Meng, Er; Li, Wen-Ying; Zhou, Lu; Zhu, Ling-Yun; Wu, Lei; Li, Meng-Jie; Liang, Song-Ping; Zhang, Dong-Yi			An Efficient Strategy for Heterologous Expression and Purification of Active Peptide Hainantoxin-IV	PLOS ONE			English	Article							SPIDER-VENOM PEPTIDES; GATED SODIUM-CHANNEL; TOXINS; PROTEINS	Hainantoxin-IV (HNTX-IV) from the venom of the spider Selenocosmia hainana is a potent antagonist that specifically inhibits the tetrodotoxin-sensitive (TTX-S) sodium channels. The toxin peptide consists of 35 amino acids and adopts a typical inhibitory cystine knot (ICK) motif. To obtain adequate HNTX-IV peptides for further insight into the structure-activity relationships of the toxin, a novel strategy including cloning, expression and purification was developed in an E. coli expression system. For this purpose, a seamless restriction-free (RF) cloning method was employed for the construction of an expression vector to avoid introducing unwanted sequences into the target gene. Furthermore, the solubility of recombinant HNTX-IV could be promoted efficiently by the combination of a glutathione S-transferase (GST) tag and a small ubiquitin-related modifier (SUMO) tag. Finally, an affinity-chromatography-free purification strategy was developed by cut-off dialysis tubing combined with trichloroacetic acid (TCA) extraction. Further HPLC purification yielded recombinant, tag-free HNTX-IV with high yield and purity. The molecular weight of recombinant HNTX-IV (rHNTX-IV) is identical to its theoretical value according to Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF-MS) analysis. The recombinant toxin has similar activity (IC50 value of 120 nM) on the tetrodotoxin-sensitive (TTX-S) sodium channels in adult rat dorsal root ganglion (DRG) neurons to native toxins. In the report, an efficient and cost-effective strategy for producing rHNTX-IV was developed, which paved the way for the further study of structure-activity relationships of rHNTX-IV and its pharmaceutical applications.	[Zhang, Hui; Huang, Peng-Fei; Zhou, Lu; Li, Meng-Jie; Liang, Song-Ping] Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, Minist Educ, Changsha 410081, Hunan, Peoples R China; [Meng, Er; Zhu, Ling-Yun; Wu, Lei; Zhang, Dong-Yi] Natl Univ Def Technol, Res Ctr Biol Informat, Coll Sci, Changsha 410073, Hunan, Peoples R China	Hunan Normal University; National University of Defense Technology - China	Liang, SP (corresponding author), Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, Minist Educ, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; dongyizhang@nudt.edu.cn	li, mengjie/GRS-3931-2022	/0000-0002-0420-4508; zhang, hui/0000-0003-4513-5606	Ministry of Science and Technology of China "973" Project [2010CB529800]; National University of Defense Technology Project [JC2006-02-01, JC13-02-16]; National Natural Science Foundation of China [31100609]	Ministry of Science and Technology of China "973" Project(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National University of Defense Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China "973" Project, No. 2010CB529800 to Prof. S.P. Liang; National University of Defense Technology Project, No. JC2006-02-01 to Prof. D.Y. Zhang, and JC13-02-16 to Dr. Lei Wu; and National Natural Science Foundation of China, No. 31100609 to Dr. L.Y. Zhu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051516; Bommarius B, 2010, PEPTIDES, V31, P1957, DOI 10.1016/j.peptides.2010.08.008; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Cain CC, 1997, PLANT MOL BIOL, V35, P377, DOI 10.1023/A:1005846620791; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Garcia F, 2013, J ANTIBIOT, V66, P3, DOI 10.1038/ja.2012.87; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Kumar P, 2014, PROTEIN EXPRES PURIF, V95, P129, DOI 10.1016/j.pep.2013.12.004; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; Liang S, 1998, LIFE SCI RES HUMAN N, V3, P299; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liu XJ, 2012, APPL MICROBIOL BIOT, V96, P103, DOI 10.1007/s00253-011-3864-4; Liu Z, 2003, CELL MOL LIFE SCI, V60, P972, DOI 10.1007/s00018-003-2354-x; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Prakash A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-92; Rabhi-Essafi I, 2007, PROTEIN ENG DES SEL, V20, P201, DOI 10.1093/protein/gzm012; Rowe AH, 2013, SCIENCE, V342, P441, DOI 10.1126/science.1236451; Sermadiras I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083202; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Windley MJ, 2012, TOXINS, V4, P191, DOI 10.3390/toxins4030191	24	7	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117099	10.1371/journal.pone.0117099	http://dx.doi.org/10.1371/journal.pone.0117099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647561	gold, Green Submitted, Green Published			2022-12-26	WOS:000348822600055
J	Bhakta, MS; Jones, VA; Vallejos, CE				Bhakta, Mehul S.; Jones, Valerie A.; Vallejos, C. Eduardo			Punctuated Distribution of Recombination Hotspots and Demarcation of Pericentromeric Regions in Phaseolus vulgaris L.	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; LINKAGE MAP; DNA; GENOME; CROSSOVERS; DISCOVERY; SEQUENCE; MARKERS; GENERATION; CONVERSION	High density genetic maps are a reliable tool for genetic dissection of complex plant traits. Mapping resolution is often hampered by the variable crossover and non-crossover events occurring across the genome, with pericentromeric regions (pCENR) showing highly suppressed recombination rates. The efficiency of linkage mapping can further be improved by characterizing and understanding the distribution of recombinational activity along individual chromosomes. In order to evaluate the genome wide recombination rate in common beans (Phaseolus vulgaris L.) we developed a SNP-based linkage map using the genotype-by-sequencing approach with a 188 recombinant inbred line family generated from an inter gene pool cross (Andean x Mesoamerican). We identified 1,112 SNPs that were subsequently used to construct a robust linkage map with 11 groups, comprising 513 recombinationally unique marker loci spanning 943 cM (LOD 3.0). Comparative analysis showed that the linkage map spanned >95% of the physical map, indicating that the map is almost saturated. Evaluation of genome-wide recombination rate indicated that at least 45% of the genome is highly recombinationally suppressed, and allowed us to estimate locations of pCENRs. We observed an average recombination rate of 0.25 cM/Mb in pCENRs as compared to the rest of genome that showed 3.72 cM/Mb. However, several hot spots of recombination were also detected with recombination rates reaching as high as 34 cM/Mb. Hotspots were mostly found towards the end of chromosomes, which also happened to be gene-rich regions. Analyzing relationships between linkage and physical map indicated a punctuated distribution of recombinational hot spots across the genome.	[Bhakta, Mehul S.; Jones, Valerie A.; Vallejos, C. Eduardo] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Vallejos, C. Eduardo] Univ Florida, Plant Mol & Cellular Biol Program, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Vallejos, CE (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.	vallejos@ufl.edu		Vallejos, Carlos/0000-0001-8936-7885	National Science Foundation [DBI/PGRP-0923975]; University of Florida Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); University of Florida Agricultural Experiment Station	This work was funded in part by a grant from the National Science Foundation (DBI/PGRP-0923975), and by the University of Florida Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Basten C. J., 2003, QTL CARTOGRAPHER VER; Basu-Roy S, 2013, GENETICS, V195, P769, DOI 10.1534/genetics.113.155549; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Blair MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049488; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; CHASE CD, 1991, THEOR APPL GENET, V81, P806, DOI 10.1007/BF00224994; Choi K, 2013, NAT GENET, V45, P1; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cole F, 2012, ANN NY ACAD SCI, V1267, P95, DOI 10.1111/j.1749-6632.2012.06595.x; Da Ines O, 2013, PLANT J, V74, P959, DOI 10.1111/tpj.12182; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DOBRITSA AP, 1980, GENE, V10, P105, DOI 10.1016/0378-1119(80)90128-6; Drouaud J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003922; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Freyre R, 1998, THEOR APPL GENET, V97, P847, DOI 10.1007/s001220050964; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; GRUENBAUM Y, 1981, NUCLEIC ACIDS RES, V9, P2509, DOI 10.1093/nar/9.11.2509; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Harushima Y, 1998, GENETICS, V148, P479; Hellsten U, 2013, P NATL ACAD SCI USA, V110, P19478, DOI 10.1073/pnas.1319032110; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Huang BE, 2014, GENETICS, V197, P401, DOI 10.1534/genetics.113.158014; Jung G, 1997, J AM SOC HORTIC SCI, V122, P329, DOI 10.21273/JASHS.122.3.329; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kozik A, 2006, P PLANT AN GEN 14 C; LAMPRECHT HERBERT, 1936, HEREDITAS, V21, P129; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lhuissier FGP, 2007, PLANT CELL, V19, P862, DOI 10.1105/tpc.106.049106; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin JY, 2005, GENETICS, V170, P1221, DOI 10.1534/genetics.105.041616; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Ma JX, 2007, TRENDS GENET, V23, P134, DOI 10.1016/j.tig.2007.01.004; Mamidi S, 2013, HEREDITY, V110, P267, DOI 10.1038/hdy.2012.82; Matos J, 2014, DNA REPAIR, V19, P176, DOI 10.1016/j.dnarep.2014.03.013; Matsubara K, 2011, MOL GENET GENOMICS, V286, P307, DOI 10.1007/s00438-011-0648-6; Murray J, 2002, GENOME, V45, P1013, DOI 10.1139/G02-069; NELSON M, 1984, NUCLEIC ACIDS RES, V12, P5165, DOI 10.1093/nar/12.13.5165; NELSON PS, 1993, NUCLEIC ACIDS RES, V21, P681, DOI 10.1093/nar/21.3.681; Palhares AC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-51; Pedrosa A, 2003, THEOR APPL GENET, V106, P205, DOI 10.1007/s00122-002-1138-3; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Pradillo M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00023; Prakken R, 1974, MEDEDLANDBOUWHOGESCH, V24, P1; Repinski SL, 2012, THEOR APPL GENET, V124, P1539, DOI 10.1007/s00122-012-1808-8; Sagawa H, 1995, NUCLEIC ACIDS RES, V23, P2; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Stange M, 2013, THEOR APPL GENET, V126, P2563, DOI 10.1007/s00122-013-2155-0; Topp CN, 2006, CURR OPIN PLANT BIOL, V9, P647, DOI 10.1016/j.pbi.2006.09.008; Vallejos C, 2001, DNA BASED MARKERS PL; Vallejos C Eduardo, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4765; VALLEJOS CE, 1992, GENETICS, V131, P733; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; Yuste-Lisbona FJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-136	63	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116822	10.1371/journal.pone.0116822	http://dx.doi.org/10.1371/journal.pone.0116822			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629314	gold, Green Submitted, Green Published			2022-12-26	WOS:000348732100050
J	Vaidya, S; Vundinti, BR; Shanmukhaiah, C; Chakrabarti, P; Ghosh, K				Vaidya, Shantashri; Vundinti, Babu Rao; Shanmukhaiah, Chandrakala; Chakrabarti, Prantar; Ghosh, Kanjaksha			Evolution of BCR/ABL Gene Mutation in CML Is Time Dependent and Dependent on the Pressure Exerted by Tyrosine Kinase Inhibitor	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; IMATINIB MESYLATE; DOMAIN MUTATIONS; RESISTANCE; DISCONTINUATION	Background Mutations in the ABL kinase domain and SH3-SH2 domain of the BCR/ABL gene and amplification of the Philadelphia chromosome are the two important BCR/ABL dependent mechanisms of imatinib resistance. Here, we intended to study the role played by TKI, imatinib, in selection of gene mutations and development of chromosomal abnormalities in Indian CML patients. Methods Direct sequencing methodology was employed to detect mutations and conventional cytogenetics was done to identify Philadelphia duplication. Results Among the different mechanisms of imatinib resistance, kinase domain mutations (39%) of the BCR/ABL gene were seen to be more prevalent, followed by mutations in the SH3-SH2 domain (4%) and then BCR/ABL amplification with the least frequency (1%). The median duration of occurrence of mutation was significantly shorter for patients with front line imatinib than those pre-treated with hydroxyurea. Patients with high Sokal score (p = 0.003) showed significantly higher incidence of mutations, as compared to patients with low/intermediate score. Impact of mutations on the clinical outcome in AP and BC was observed to be insignificant. Of the 94 imatinib resistant patients, only 1 patient exhibited duplication of Philadelphia chromosome, suggesting a less frequent occurrence of this abnormality in Indian CML patients. Conclusion C lose monitoring at regular intervals and proper analysis of the disease resistance would facilitate early detection of resistance and thus aid in the selection of the most appropriate therapy.	[Vaidya, Shantashri; Vundinti, Babu Rao; Ghosh, Kanjaksha] Natl Inst Immunohaematol, Dept Cytogenet, Bombay 400012, Maharashtra, India; [Shanmukhaiah, Chandrakala] King Edward Mem Hosp, Dept Haematol, Bombay 400012, Maharashtra, India; [Chakrabarti, Prantar] Inst Haematol & Transfus Med, Kolkata 700073, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Ghosh, K (corresponding author), Natl Inst Immunohaematol, Dept Cytogenet, 13th Floor,New Multistoried Bldg,KEM Hosp Campus, Bombay 400012, Maharashtra, India.	kanjakshaghosh@hotmail.com	Ghosh, Kanjaksha/D-7621-2015; Chakrabarti, Prantar/G-3440-2010	Ghosh, Kanjaksha/0000-0002-0645-6565; Chakrabarti, Prantar/0000-0003-1026-5427	Indian Council of Medical Research [53/8/2006-BMS]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by Indian Council of Medical Research, Grant no. 53/8/2006-BMS (KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1996, J BIOL CHEM, V271, P19585, DOI 10.1074/jbc.271.32.19585; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; CAIRNS J, 1981, NATURE, V289, P353, DOI 10.1038/289353a0; Ghanima W, 2004, EUR J HAEMATOL, V72, P441, DOI 10.1111/j.1600-0609.2004.00257.x; Jabbour E, 2008, BLOOD, V112, P53, DOI 10.1182/blood-2007-11-123950; Kim SH, 2009, HEMATOL ONCOL, V27, P190, DOI 10.1002/hon.894; LOEB LA, 1991, CANCER RES, V51, P3075; Merante S, 2005, HAEMATOLOGICA, V90, P979; Qin YZ, 2011, ANN HEMATOL, V90, P47, DOI 10.1007/s00277-010-1039-5; Quintas-Cardama A, 2009, CANCER-AM CANCER SOC, V115, P5382, DOI 10.1002/cncr.24601; Razga F, 2012, MOL DIAGN THER, V16, P251, DOI 10.2165/11635340-000000000-00000; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Shaffer LG, 2009, ISCN INT SYSTEM HUMA; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sherbenou DW, 2008, LEUKEMIA, V22, P1184, DOI 10.1038/leu.2008.65; Sherbenou DW, 2010, BLOOD, V116, P3278, DOI 10.1182/blood-2008-10-183665; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Vaidya S, 2012, LEUKEMIA RES, V36, pE110, DOI 10.1016/j.leukres.2012.02.005; Wang LH, 2006, HAEMATOL-HEMATOL J, V91, P235	22	17	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0114828	10.1371/journal.pone.0114828	http://dx.doi.org/10.1371/journal.pone.0114828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629972	gold, Green Published, Green Submitted			2022-12-26	WOS:000348732100009
J	van der Post, DJ; Verbrugge, R; Hemelrijk, CK				van der Post, Daniel J.; Verbrugge, Rineke; Hemelrijk, Charlotte K.			The Evolution of Different Forms of Sociality: Behavioral Mechanisms and Eco-Evolutionary Feedback	PLOS ONE			English	Article							GROUP-SIZE; VIGILANCE; EMERGENCE; DIET; INDIVIDUALS; PRIMATE; BRAIN; MODEL	Different forms of sociality have evolved via unique evolutionary trajectories. However, it remains unknown to what extent trajectories of social evolution depend on the specific characteristics of different species. Our approach to studying such trajectories is to use evolutionary case-studies, so that we can investigate how grouping co-evolves with a multitude of individual characteristics. Here we focus on anti-predator vigilance and foraging. We use an individual-based model, where behavioral mechanisms are specified, and costs and benefits are not predefined. We show that evolutionary changes in grouping alter selection pressures on vigilance, and vice versa. This eco-evolutionary feedback generates an evolutionary progression from "leader-follower" societies to "fission-fusion" societies, where cooperative vigilance in groups is maintained via a balance between within-and between-group selection. Group-level selection is generated from an assortment that arises spontaneously when vigilant and non-vigilant foragers have different grouping tendencies. The evolutionary maintenance of small groups, and cooperative vigilance in those groups, is therefore achieved simultaneously. The evolutionary phases, and the transitions between them, depend strongly on behavioral mechanisms. Thus, integrating behavioral mechanisms and eco-evolutionary feedback is critical for understanding what kinds of intermediate stages are involved during the evolution of particular forms of sociality.	[van der Post, Daniel J.; Verbrugge, Rineke] Univ Groningen, Inst Artificial Intelligence, Groningen, Netherlands; [van der Post, Daniel J.; Hemelrijk, Charlotte K.] Univ Groningen, Groningen, Netherlands; [van der Post, Daniel J.] Univ St Andrews, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland	University of Groningen; University of Groningen; University of St Andrews	van der Post, DJ (corresponding author), Univ Groningen, Inst Artificial Intelligence, Groningen, Netherlands.	d.j.vanderpost@gmail.com	Verbrugge, Rineke/D-3781-2012; Hemelrijk, Charlotte/E-4828-2013	Verbrugge, Rineke/0000-0003-3829-0106; Hemelrijk, Charlotte/0000-0001-6160-077X	Netherlands Organization for Scientific Research [NWO-277-80-001]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was funded by the Netherlands Organization for Scientific Research (http://www.nwo.nl/en): Vici grant NWO-277-80-001 awarded to Rineke Verbrugge (in the project Cognitive systems in interaction: Logical and computational models of higher-order social cognition). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Aviles L, 2002, P NATL ACAD SCI USA, V99, P14268, DOI 10.1073/pnas.212408299; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Beauchamp G, 2003, AM NAT, V161, P672, DOI 10.1086/368225; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Brashares JS, 2000, BEHAV ECOL, V11, P452, DOI 10.1093/beheco/11.4.452; Byrne RW, 2010, NEURON, V65, P815, DOI 10.1016/j.neuron.2010.03.010; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; Fawcett TW, 2013, BEHAV ECOL, V24, P2, DOI 10.1093/beheco/ars085; GIRALDEAU LA, 1993, EVOL ECOL, V7, P429, DOI 10.1007/BF01237874; Grafen A., 1984, BEHAV ECOLOGY EVOLUT, V2, P62; Hamilton IM, 2000, AM NAT, V155, P684, DOI 10.1086/303349; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; Hemelrijk CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037271; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; HIGASHI M, 1993, AM NAT, V142, P553, DOI 10.1086/285555; HOGEWEG P, 1989, BIOSYSTEMS, V23, P231, DOI 10.1016/0303-2647(89)90029-4; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; HOGEWEG P, 1985, J THEOR BIOL, V113, P311, DOI 10.1016/S0022-5193(85)80230-7; Hogeweg Paulien, 2005, P166; Hogeweg P, 2012, ADV EXP MED BIOL, V751, P195, DOI 10.1007/978-1-4614-3567-9_10; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Laland KN, 2011, SCIENCE, V334, P1512, DOI 10.1126/science.1210879; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; MCNAMARA JM, 1992, ANIM BEHAV, V43, P641, DOI 10.1016/0003-3472(92)90086-O; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Powers ST, 2011, EVOLUTION, V65, P1527, DOI 10.1111/j.1558-5646.2011.01250.x; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; PULLIAM HR, 1982, J THEOR BIOL, V95, P89, DOI 10.1016/0022-5193(82)90289-2; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Reed Kaye E., 1999, P116, DOI 10.1017/CBO9780511542381.008; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Sanchez A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001547; Shultz S, 2007, P ROY SOC B-BIOL SCI, V274, P2429, DOI 10.1098/rspb.2007.0693; SIBLY RM, 1983, ANIM BEHAV, V31, P947, DOI 10.1016/S0003-3472(83)80250-4; Sirot Etienne, 2012, Proceedings of the Royal Society Biological Sciences Series B, V279, P2862; Smith J. M., 1997, MAJOR TRANSITIONS EV; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Van der Post DJ, 2008, ANIM BEHAV, V75, P133, DOI 10.1016/j.anbehav.2007.04.021; van der Post DJ, 2013, AM NAT, V182, P682, DOI 10.1086/673298; van der Post DJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-335; van der Post DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002186; van der Post DJ, 2009, ANIM BEHAV, V78, P155, DOI 10.1016/j.anbehav.2009.04.009; van Schaik CP, 2012, TRENDS COGN SCI, V16, P277, DOI 10.1016/j.tics.2012.04.004; VANDERLAAN JD, 1995, P ROY SOC B-BIOL SCI, V259, P35, DOI 10.1098/rspb.1995.0006; Wood AJ, 2007, P R SOC B, V274, P1637, DOI 10.1098/rspb.2007.0306; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	54	12	12	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117027	10.1371/journal.pone.0117027	http://dx.doi.org/10.1371/journal.pone.0117027			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629313	Green Submitted, Green Published, gold			2022-12-26	WOS:000348732100058
J	Jeansonne, D; DeLuca, M; Marrero, L; Lassak, A; Pacifici, M; Wyczechowska, D; Wilk, A; Reiss, K; Peruzzi, F				Jeansonne, Duane; DeLuca, Mariacristina; Marrero, Luis; Lassak, Adam; Pacifici, Marco; Wyczechowska, Dorota; Wilk, Anna; Reiss, Krzysztof; Peruzzi, Francesca			Anti-tumoral Effects of miR-3189-3p in Glioblastoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED GENE NAG-1/GDF15; EXPRESSION; GROWTH; TEMOZOLOMIDE; INHIBITION; MICRORNAS; RECEPTOR; PATHWAY; TARGETS; NAG-1	Glioblastoma is one of the most aggressive brain tumors. We have previously found up-regulation of growth differentiation factor 15 (GDF15) in glioblastoma cells treated with the anticancer agent fenofibrate. Sequence analysis of GDF15 revealed the presence of a microRNA, miR-3189, in the single intron. We then asked whether miR-3189 was expressed in clinical samples and whether it was functional in glioblastoma cells. We found that expression of miR-3189-3p was down-regulated in astrocytoma and glioblastoma clinical samples compared with control brain tissue. In vitro, the functionality of miR-3189-3p was tested by RNA-binding protein immunoprecipitation, and miR3189- 3p coimmunoprecipitated with Argonaute 2 together with two of its major predicted gene targets, the SF3B2 splicing factor and the guanine nucleotide exchange factor p63RhoGEF. Overexpression of miR-3189-3p resulted in a significant inhibition of cell proliferation and migration through direct targeting of SF3B2 and p63RhoGEF, respectively. Interestingly, miR3189- 3p levels were increased by treatment of glioblastoma cells with fenofibrate, a lipid-lowering drug with multiple anticancer activities. The attenuated expression of miR-3189-3p in clinical samples paralleled the elevated expression of SF3B2, which could contribute to the activation of SF3B2 growth-promoting pathways in these tumors. Finally, miR-3189-3p-mediated inhibition of tumor growth in vivo further supported the function of this microRNA as a tumor suppressor.	[Wyczechowska, Dorota; Wilk, Anna; Reiss, Krzysztof; Peruzzi, Francesca] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA; [Jeansonne, Duane; DeLuca, Mariacristina; Lassak, Adam; Pacifici, Marco; Wyczechowska, Dorota; Wilk, Anna; Reiss, Krzysztof; Peruzzi, Francesca] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Peruzzi, F (corresponding author), LSU Hlth Sci Ctr, Dept Med, 1700 Tulane Ave, New Orleans, LA USA.	fperuz@lsuhsc.edu			NIGMS/National Institutes of Health [1U54 GM104940]; National Institutes of Health [P20 GM103501, RO1 CA095518]; Stanley S Scott Cancer Research Center, LSUHSC, Louisiana Cancer Research Center; Department of Biological and Clinical Sciences, University of Milan, Italy; NATIONAL CANCER INSTITUTE [R01CA095518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940, P20GM103501] Funding Source: NIH RePORTER	NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley S Scott Cancer Research Center, LSUHSC, Louisiana Cancer Research Center; Department of Biological and Clinical Sciences, University of Milan, Italy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMS/National Institutes of Health Grant 1U54 GM104940, which funds the Louisiana Clinical and Translational Science Center, and by National Institutes of Health Grants P20 GM103501 (to F.P. and K.R.) and RO1 CA095518 (to K.R.). This work was also supported by the Stanley S Scott Cancer Research Center, LSUHSC, Louisiana Cancer Research Center.; Supported by the Department of Biological and Clinical Sciences, University of Milan, Italy.	Araki H, 2009, ANGIOGENESIS, V12, P221, DOI 10.1007/s10456-009-9142-8; Chiu SC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-146; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Drukala J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-159; Eletto D, 2008, J CELL PHYSIOL, V216, P764, DOI 10.1002/jcp.21452; Eling TE, 2006, J BIOCHEM MOL BIOL, V39, P649; Hayashi A, 2013, FEBS LETT, V587, P698, DOI 10.1016/j.febslet.2013.01.043; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jeansonne D, 2013, GENES-BASEL, V4, P46, DOI 10.3390/genes4010046; Kim JM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/641851; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Marrero L, 2014, NEOPLASIA, V16, P874, DOI 10.1016/j.neo.2014.08.015; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Nagasawa DT, 2012, NEUROSURG CLIN N AM, V23, P307, DOI 10.1016/j.nec.2012.01.007; Nakada M, 2007, CELL MOL LIFE SCI, V64, P458, DOI 10.1007/s00018-007-6342-5; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Orr SJ, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.5; Pacifici M, 2013, J CELL PHYSIOL, V228, P1070, DOI 10.1002/jcp.24254; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Rom S, 2010, FASEB J, V24, P2292, DOI 10.1096/fj.09-143503; Shimizu S, 2013, BIOCHEM BIOPH RES CO, V430, P1277, DOI 10.1016/j.bbrc.2012.11.137; Sivadas VP, 2013, GENE CHROMOSOME CANC, V52, P1042, DOI 10.1002/gcc.22099; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Swenson-Fields KI, 2008, MOL CELL, V32, P43, DOI 10.1016/j.molcel.2008.09.007; Tang XL, 2013, CANCER RES, V73, P6206, DOI 10.1158/0008-5472.CAN-13-1049; Urbanska K, 2008, INT J CANCER, V123, P1015, DOI 10.1002/ijc.23588; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Wilk A, 2015, MOL CELL BIOL, V35, P182, DOI 10.1128/MCB.00562-14; Wilk A, 2012, CELL CYCLE, V11, P2660, DOI 10.4161/cc.21015; Yoshioka H, 2008, J BIOL CHEM, V283, P33129, DOI 10.1074/jbc.M805248200	33	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8067	8080		10.1074/jbc.M114.633081	http://dx.doi.org/10.1074/jbc.M114.633081			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645911	hybrid, Green Published			2022-12-26	WOS:000351662600006
J	Moonens, K; Van den Broeck, I; De Kerpel, M; Deboeck, F; Raymaekers, H; Remaut, H; De Greve, H				Moonens, Kristof; Van den Broeck, Imke; De Kerpel, Maia; Deboeck, Francine; Raymaekers, Hanne; Remaut, Han; De Greve, Henri			Structural and Functional Insight into the Carbohydrate Receptor Binding of F4 Fimbriae-producing Enterotoxigenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; ADHESIN VARIANTS; MAJOR SUBUNIT; K88 FIMBRIAE; PSA FIMBRIAE; IDENTIFICATION; FIMH; ANTIGEN; BIOSYNTHESIS	Enterotoxigenic Escherichia coli (ETEC) strains are important causes of intestinal disease in humans and lead to severe production losses in animal farming. A range of fimbrial adhesins in ETEC strains determines host and tissue tropism. ETEC strains expressing F4 fimbriae are associated with neonatal and post-weaning diarrhea in piglets. Three naturally occurring variants of F4 fimbriae (F4(ab), F4(ac), and F4(ad)) exist that differ in the primary sequence of their major adhesive subunit FaeG, and each features a related yet distinct receptor binding profile. Here the x-ray structure of FaeGad bound to lactose provides the first structural insight into the receptor specificity and mode of binding by the poly-adhesive F4 fimbriae. A small D'-D''-alpha 1-alpha 2 subdomain grafted on the immunoglobulin-like core of FaeG hosts the carbohydrate binding site. Two short amino acid stretches Phe(150)-Glu(152) and Val(166)-Glu(170) of FaeG(ad) bind the terminal galactose in the lactosyl unit and provide affinity and specificity to the interaction. A hemagglutination-based assay with E. coli expressing mutant F4(ad) fimbriae confirmed the elucidated co-complex structure. Interestingly, the crucial D'-alpha 1 loop that borders the FaeG(ad) binding site adopts a different conformation in the two other FaeG variants and hints at a heterogeneous binding pocket among the FaeG serotypes.	[Moonens, Kristof; Van den Broeck, Imke; De Kerpel, Maia; Raymaekers, Hanne; Remaut, Han; De Greve, Henri] VIB Struct Biol Res Ctr, Struct & Mol Microbiol, B-1050 Brussels, Belgium; [Moonens, Kristof; Van den Broeck, Imke; De Kerpel, Maia; Raymaekers, Hanne; Remaut, Han; De Greve, Henri] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Deboeck, Francine] Vrije Univ Brussel, Viral Genet Lab, B-1050 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel	De Greve, H (corresponding author), Vrije Univ Brussel, Struct Biol Res Ctr, Pl Laan 2, B-1050 Brussels, Belgium.	hdegreve@vub.ac.be		Remaut, Han/0000-0002-9775-4102	Hercules Foundation [UABR/09/005]	Hercules Foundation	We are grateful to the beamline staff of the Proxima1 beamline (Soleil, France) for support with data collection and processing. This work was supported by Equipment Grant UABR/09/005 from the Hercules Foundation.	AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; BAKKER D, 1991, MOL MICROBIOL, V5, P875, DOI 10.1111/j.1365-2958.1991.tb00761.x; BAKKER D, 1992, J BACTERIOL, V174, P6350, DOI 10.1128/JB.174.20.6350-6358.1992; BAKKER D, 1992, MOL MICROBIOL, V6, P247, DOI 10.1111/j.1365-2958.1992.tb02006.x; Bao R, 2013, P NATL ACAD SCI USA, V110, P1065, DOI 10.1073/pnas.1212431110; BIJLSMA IGW, 1982, INFECT IMMUN, V37, P891, DOI 10.1128/IAI.37.3.891-894.1982; Billey LO, 1998, VET MICROBIOL, V59, P203, DOI 10.1016/S0378-1135(97)00193-4; Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Busch A, 2012, PHILOS T R SOC B, V367, P1112, DOI 10.1098/rstb.2011.0206; Buts L, 2003, MOL MICROBIOL, V49, P705, DOI 10.1046/j.1365-2958.2003.03600.x; Coddens A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023309; De Greve H, 2007, CURR OPIN STRUC BIOL, V17, P506, DOI 10.1016/j.sbi.2007.06.011; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Erickson AK, 1997, ADV EXP MED BIOL, V412, P167; ERICKSON AK, 1992, INFECT IMMUN, V60, P983, DOI 10.1128/IAI.60.3.983-988.1992; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Francis DH, 1999, ADV EXP MED BIOL, V473, P147; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Galvan EM, 2007, INFECT IMMUN, V75, P1272, DOI 10.1128/IAI.01153-06; GIBBONS RA, 1975, J GEN MICROBIOL, V86, P228, DOI 10.1099/00221287-86-2-228; Grange PA, 1996, INFECT IMMUN, V64, P606, DOI 10.1128/IAI.64.2.606-610.1996; Grange PA, 1999, INFECT IMMUN, V67, P165, DOI 10.1128/IAI.67.1.165-172.1999; Grange PA, 1998, INFECT IMMUN, V66, P1613, DOI 10.1128/IAI.66.4.1613-1621.1998; Grange PA, 2002, INFECT IMMUN, V70, P2336, DOI 10.1128/IAI.70.5.2336-2343.2002; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Jones G. W., 1977, MICROBIAL INTERACTIO, P141; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Larsson A, 2003, BIOORGAN MED CHEM, V11, P2255, DOI 10.1016/S0968-0896(03)00114-7; LAUX DC, 1986, INFECT IMMUN, V52, P18, DOI 10.1128/IAI.52.1.18-25.1986; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Meng Q, 1998, J ANIM SCI, V76, P551; Mol O, 1996, FEMS MICROBIOL REV, V19, P25, DOI 10.1016/0168-6445(96)00022-8; Moonens K, 2012, MOL MICROBIOL, V86, P82, DOI 10.1111/j.1365-2958.2012.08174.x; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nagy B, 1999, VET RES, V30, P259; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; Nilsson LM, 2006, APPL ENVIRON MICROB, V72, P3005, DOI 10.1128/AEM.72.4.3005-3010.2006; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; ORSKOV I, 1964, ACTA PATHOL MIC SC, V62, P439, DOI 10.1111/apm.1964.62.3.439; OUDEGA B, 1989, MOL MICROBIOL, V3, P645, DOI 10.1111/j.1365-2958.1989.tb00212.x; PAYNE D, 1993, INFECT IMMUN, V61, P3673, DOI 10.1128/IAI.61.9.3673-3677.1993; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; SELLWOOD R, 1980, BIOCHIM BIOPHYS ACTA, V632, P326, DOI 10.1016/0304-4165(80)90090-2; Sujatha MS, 2007, J MOL STRUC-THEOCHEM, V814, P11, DOI 10.1016/j.theochem.2007.02.032; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; VALENT QA, 1995, MOL MICROBIOL, V16, P1243, DOI 10.1111/j.1365-2958.1995.tb02346.x; Van Molle I, 2007, J MOL BIOL, V368, P791, DOI 10.1016/j.jmb.2007.02.051; Van Molle I, 2009, J MOL BIOL, V394, P957, DOI 10.1016/j.jmb.2009.09.059; Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370; WILLEMSEN PTJ, 1992, MICROB PATHOGENESIS, V12, P367, DOI 10.1016/0882-4010(92)90099-A; Zhang WP, 2009, INFECT IMMUN, V77, P699, DOI 10.1128/IAI.01165-08	59	22	22	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8409	8419		10.1074/jbc.M114.618595	http://dx.doi.org/10.1074/jbc.M114.618595			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25631050	Green Published, hybrid			2022-12-26	WOS:000351662600034
J	Zhu, K; Yi, JX; Xiao, YJ; Lai, YM; Song, PP; Zheng, W; Jiao, HL; Fan, J; Wu, CY; Chen, D; Zhou, JS; Xiao, GZ				Zhu, Ke; Yi, Jianxun; Xiao, Yajuan; Lai, Yumei; Song, Pingping; Zheng, Wei; Jiao, Hongli; Fan, Jie; Wu, Chuanyue; Chen, Di; Zhou, Jingsong; Xiao, Guozhi			Impaired Bone Homeostasis in Amyotrophic Lateral Sclerosis Mice with Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; MUSCULAR-DYSTROPHY; WNT; DIFFERENTIATION; EXPRESSION; OSTEOCYTES; OSTEOBLAST; DENSITY; PROTEIN; CELLS	There is an intimate relationship between muscle and bone throughout life. However, how alterations in muscle functions indiseaseimpactbonehomeostasisispoorlyunderstood. Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease characterized by progressive muscle atrophy. In this study we analyzed the effects of ALS on bone using the well established G93A transgenic mouse model, which harbors an ALS-causing mutation in the gene encoding superoxide dismutase 1. We found that 4-month-old G93A mice with severe muscle atrophy had dramatically reduced trabecular and cortical bone mass compared with their sex-matched wild type (WT) control littermates. Mechanically, we found that multiple osteoblast properties, such as the formation of osteoprogenitors, activation of Akt and Erk1/2 pathways, and osteoblast differentiation capacity, were severely impaired in primary cultures and bones from G93A relative to WT mice; this could contribute to reduced bone formation in the mutant mice. Conversely, osteoclast formation and bone resorption were strikingly enhanced in primary bone marrow cultures and bones of G93A mice compared withWTmice. Furthermore, sclerostin and RANKL expression in osteocytes embedded in the bone matrix were greatly up-regulated, and beta-catenin was down-regulated in osteoblasts from G93A mice when compared with those of WT mice. Interestingly, calvarial bone that does not load and long bones from 2-month-old G93A mice without muscle atrophy displayed no detectable changes in parameters for osteoblast and osteoclast functions. Thus, for the first time to our knowledge, we have demonstrated that ALS causes abnormal bone remodeling and defined the underlying molecular and cellular mechanisms.	[Zhu, Ke; Lai, Yumei; Song, Pingping; Zheng, Wei; Jiao, Hongli; Chen, Di; Xiao, Guozhi] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Yi, Jianxun; Xiao, Yajuan; Zhou, Jingsong] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Fan, Jie] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15261 USA; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Xiao, Guozhi] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China; [Xiao, Guozhi] South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China	Rush University; Rush University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Southern University of Science & Technology; Southern University of Science & Technology	Zhou, JS (corresponding author), Kansas City Univ Med & Biosci, Dept Physiol, Kansas City, MO 64106 USA.	Guozhi_Xiao@rush.edu	Chen, Di/AAJ-3665-2021	Jiao, Hongli/0000-0001-8005-8496	National Institutes of Health [AR059647, GM65188, AR057404]; National Natural Science Foundation of China [81472049]; Muscular Dystrophy Association [MDA-4351]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054465, R01AR059647, R01AR057404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR059647 (to G. X.), GM65188 (to C. W.), and AR057404 (to J. Z.). This work was in part supported by National Natural Science Foundation of China Grant 81472049 (to G. X.) and Muscular Dystrophy Association Research Grant MDA-4351 (to J. Z.).	Ausk BJ, 2013, BONE, V57, P413, DOI 10.1016/j.bone.2013.09.009; Bikle Daniel D, 2003, Gravit Space Biol Bull, V16, P45; Bivi N, 2013, J ORTHOP RES, V31, P1075, DOI 10.1002/jor.22341; Bonewald LF, 2013, J BONE MINER RES, V28, P1857, DOI 10.1002/jbmr.1980; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Cao HL, 2013, J BIOL CHEM, V288, P30399, DOI 10.1074/jbc.M113.469973; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; de Aguilar JLG, 2008, PHYSIOL GENOMICS, V32, P207, DOI 10.1152/physiolgenomics.00017.2007; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Di Monaco M, 2011, ARCH GERONTOL GERIAT, V52, P71, DOI 10.1016/j.archger.2010.02.002; Edwards MH, 2013, J BONE MINER RES, V28, P2295, DOI 10.1002/jbmr.1972; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Galli C, 2010, J DENT RES, V89, P331, DOI 10.1177/0022034510363963; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hamrick M, 2010, J MUSCULOSKEL NEURON, V10, P1; Hamrick MW, 2010, J MUSCULOSKEL NEURON, V10, P64; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jansen JHW, 2004, J CELL BIOCHEM, V93, P542, DOI 10.1002/jcb.20162; Javaheri B, 2014, J BONE MINER RES, V29, P705, DOI 10.1002/jbmr.2064; Kaji Hiroshi, 2014, [Journal of Bone Metabolism, 대한골대사학회지], V21, P29; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Khatri Ismail A, 2008, J Clin Neuromuscul Dis, V10, P11, DOI 10.1097/CND.0b013e318183e0fa; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kostenuik PJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE1133; Lang TF, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/702735; Larson CM, 2000, J PEDIATR ORTHOPED, V20, P71, DOI 10.1097/00004694-200001000-00016; LeBrasseur NK, 2012, J BONE MINER RES, V27, P2159, DOI 10.1002/jbmr.1666; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Lloyd SA, 2014, J BONE MINER RES, V29, P1118, DOI 10.1002/jbmr.2113; McGoldrick P, 2013, BBA-MOL BASIS DIS, V1832, P1421, DOI 10.1016/j.bbadis.2013.03.012; Morikawa D, 2013, J BONE MINER RES, V28, P2368, DOI 10.1002/jbmr.1981; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rufo A, 2011, J BONE MINER RES, V26, P1891, DOI 10.1002/jbmr.410; Sato K, 2007, J BIOMECH, V40, P1246, DOI 10.1016/j.jbiomech.2006.05.028; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Sbrocchi AM, 2012, OSTEOPOROSIS INT, V23, P2703, DOI 10.1007/s00198-012-1911-3; Shackelford LC, 2004, J APPL PHYSIOL, V97, P119, DOI 10.1152/japplphysiol.00741.2003; Sudkamp N P, 1993, Aktuelle Traumatol, V23, P59; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Vestergaard P, 2001, J REHABIL MED, V33, P150, DOI 10.1080/165019701750300609; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Xiao GZ, 2012, J BIOL CHEM, V287, P21450, DOI 10.1074/jbc.M111.331249; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang SY, 2011, J BIOL CHEM, V286, P19149, DOI 10.1074/jbc.M110.197905; Yu SB, 2013, INT J BIOL SCI, V9, P256, DOI 10.7150/ijbs.5898; Zhang XY, 2008, J CELL BIOCHEM, V105, P885, DOI 10.1002/jcb.21888; Zhao LM, 2013, BONE, V54, P35, DOI 10.1016/j.bone.2013.01.033; Zhu K, 2013, J BONE MINER RES, V28, P1870, DOI 10.1002/jbmr.1958	62	24	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8081	8094		10.1074/jbc.M114.603985	http://dx.doi.org/10.1074/jbc.M114.603985			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25648889	Green Published, hybrid			2022-12-26	WOS:000351662600007
J	Mao, XM; Luo, S; Zhou, RC; Wang, F; Yu, P; Sun, N; Chen, XX; Tang, Y; Li, YQ				Mao, Xu-Ming; Luo, Shuai; Zhou, Ri-Cheng; Wang, Feng; Yu, Pin; Sun, Ning; Chen, Xiao-Xia; Tang, Yi; Li, Yong-Quan			Transcriptional Regulation of the Daptomycin Gene Cluster in Streptomyces roseosporus by an Autoregulator, AtrA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotics; Bacterial Genetics; Gene Regulation; Protein-DNA Interaction; Secondary Metabolism	SECONDARY METABOLISM; TETR-FAMILY; ADPA; COELICOLOR; BIOSYNTHESIS; GRISEUS; CLONING; IMPROVEMENT; EXPRESSION; ACTIVATOR	Background: No investigation on daptomycin production at the transcriptional regulatory level has been reported. Results: The autoregulator AtrA directly regulates daptomycin gene cluster expression, and atrA is the transcriptional target of AdpA. Conclusion: The AtrA-mediated transcriptional signaling pathway directly regulates daptomycin production. Significance: We reveal for the first time the transcriptional regulatory mechanism of daptomycin production for its potential rational genetic engineering. Daptomycin is a cyclic lipopeptide antibiotic produced by Streptomyces roseosporus. To reveal the transcriptional regulatory mechanism of daptomycin biosynthesis, we used the biotinylated dptE promoter (dptEp) as a probe to affinity isolate the dptEp-interactive protein AtrA, a TetR family transcriptional regulator, from the proteome of mycelia. AtrA bound directly to dptEp to positively regulate gene cluster expression and daptomycin production. Meanwhile, both atrA and adpA mutants showed bald phenotype and null production of daptomycin. AdpA positively regulated atrA expression by direct interaction with atrA promoter (atrAp), and removal of ArpA in S. roseosporus, a homolog of the A-factor receptor, resulted in accelerated morphological development and increased daptomycin production, suggesting that atrA was the target of AdpA to mediate the A-factor signaling pathway. Furthermore, AtrA was positively autoregulated by binding to its own promoter atrAp. Thus, for the first time at the transcriptional level, we have identified an autoregulator, AtrA, that directly mediates the A-factor signaling pathway to regulate the proper production of daptomycin.	[Mao, Xu-Ming; Luo, Shuai; Zhou, Ri-Cheng; Wang, Feng; Yu, Pin; Sun, Ning; Li, Yong-Quan] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Mao, Xu-Ming; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Mao, Xu-Ming; Luo, Shuai; Zhou, Ri-Cheng; Wang, Feng; Yu, Pin; Sun, Ning; Chen, Xiao-Xia; Li, Yong-Quan] Key Lab Microbial Biochem & Metab Engn Zhejiang P, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Xiao-Xia] Hangzhou Huadong Med Grp Biotechnol Inst Co Ltd, Hangzhou 310011, Zhejiang, Peoples R China	Zhejiang University; University of California System; University of California Los Angeles	Mao, XM (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xmmao@zju.edu.cn; lyq@zju.edu.cn	Mao, Xu-Ming/AAI-4212-2020		National Basic Research Program of China (973 Program) [2012CB721005]; National Natural Science Foundation of China [31370103]; National High Technology Research and Development Program of China (863 Program) [2012AA02A706]; Key Program of Zhejiang Provincial Natural Science Foundation of China [LZ12C01001]; New Star Project from Zhejiang University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Key Program of Zhejiang Provincial Natural Science Foundation of China; New Star Project from Zhejiang University	This work was supported by Grants 2012CB721005 from the National Basic Research Program of China (973 Program), 31370103 from the National Natural Science Foundation of China, 2012AA02A706 from the National High Technology Research and Development Program of China (863 Program), and LZ12C01001 from the Key Program of Zhejiang Provincial Natural Science Foundation of China and by fellowships from the New Star Project from Zhejiang University. The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession number(s) KM091937, KM091938, KM091939, and KM091940.	Ahn SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050562; Arbeit RD, 2004, CLIN INFECT DIS, V38, P1673, DOI 10.1086/420818; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Chen L, 2008, APPL MICROBIOL BIOT, V80, P277, DOI 10.1007/s00253-008-1545-8; Higo A, 2012, DNA RES, V19, P259, DOI 10.1093/dnares/dss010; Hirano S, 2008, MICROBIOL-SGM, V154, P905, DOI 10.1099/mic.0.2007/014381-0; Huang D, 2012, APPL MICROBIOL BIOT, V94, P637, DOI 10.1007/s00253-011-3773-6; Huang D, 2011, APPL BIOCHEM BIOTECH, V165, P1725, DOI 10.1007/s12010-011-9390-0; INGRAM C, 1989, J BACTERIOL, V171, P6617, DOI 10.1128/jb.171.12.6617-6624.1989; Jones GH, 2011, PLASMID, V65, P219, DOI 10.1016/j.plasmid.2011.02.002; Kieser T., 2000, PRACTICAL STREPTOMYC, P125; Lee HN, 2013, APPL ENVIRON MICROB, V79, P4159, DOI 10.1128/AEM.00546-13; Li LL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/479742; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Mao XM, 2013, J BACTERIOL, V195, P2072, DOI 10.1128/JB.00040-13; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431; ONAKA H, 1995, J BACTERIOL, V177, P6083, DOI 10.1128/jb.177.21.6083-6092.1995; Pan YY, 2009, MOL MICROBIOL, V72, P710, DOI 10.1111/j.1365-2958.2009.06681.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Sader HS, 2013, ANTIMICROB AGENTS CH, V57, P6378, DOI 10.1128/AAC.01906-13; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; Wang F, 2014, GENE, V544, P208, DOI 10.1016/j.gene.2014.04.044; Wang L, 2012, J APPL MICROBIOL, V112, P1095, DOI 10.1111/j.1365-2672.2012.05302.x; Wolanski M, 2011, J BACTERIOL, V193, P6358, DOI 10.1128/JB.05734-11; Yamazaki H, 2004, MOL MICROBIOL, V53, P555, DOI 10.1111/j.1365-2958.2004.04153.x; Yang YH, 2012, APPL MICROBIOL BIOT, V96, P113, DOI 10.1007/s00253-011-3803-4; Yu GH, 2011, APPL BIOCHEM BIOTECH, V163, P729, DOI 10.1007/s12010-010-9078-x	28	50	52	0	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7992	8001		10.1074/jbc.M114.608273	http://dx.doi.org/10.1074/jbc.M114.608273			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648897	Green Published, hybrid			2022-12-26	WOS:000351613600056
J	Sahay, S; Ghosh, D; Dwivedi, S; Anoop, A; Mohite, GM; Kombrabail, M; Krishnamoorthy, G; Maji, SK				Sahay, Shruti; Ghosh, Dhiman; Dwivedi, Saumya; Anoop, Arunagiri; Mohite, Ganesh Maruti; Kombrabail, Mamata; Krishnamoorthy, Guruswamy; Maji, Samir K.			Familial Parkinson Disease-associated Mutations Alter the Site-specific Microenvironment and Dynamics of alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Synuclein; Amyloid; Fluorescence Anisotropy; Parkinson Disease; Protein Aggregation; Protein Misfolding	TIME-RESOLVED FLUORESCENCE; PHOTOINDUCED CROSS-LINKING; AMYLOID FIBRIL FORMATION; FREE-ENERGY LANDSCAPES; IN-VITRO; TRYPTOPHAN FLUORESCENCE; E46K MUTATION; LEWY BODIES; WILD-TYPE; NEURON DEATH	Background: Aggregation of -Syn is associated with PD pathogenesis. Results: Despite being natively unfolded, a site-specific structure exists in -Syn that is significantly altered by familial PD-associated E46K, A53T, and A30P mutations. Conclusion: Altered site-specific structure of the PD-associated mutants may attribute to their different aggregation propensity. Significance: This study contributes to understanding the relationship between structure and aggregation of -Syn. Human -synuclein (-Syn) is a natively unstructured protein whose aggregation into amyloid fibrils is associated with Parkinson disease (PD) pathogenesis. Mutations of -Syn, E46K, A53T, and A30P, have been linked to the familial form of PD. In vitro aggregation studies suggest that increased propensity to form non-fibrillar oligomers is the shared property of these familial PD-associated mutants. However, the structural basis of the altered aggregation propensities of these PD-associated mutants is not yet clear. To understand this, we studied the site-specific structural dynamics of wild type (WT) -Syn and its three PD mutants (A53T, E46K, and A30P). Tryptophan (Trp) was substituted at the N terminus, central hydrophobic region, and C terminus of all -Syns. Using various biophysical techniques including time-resolved fluorescence studies, we show that irrespective of similar secondary structure and early oligomerization propensities, familial PD-associated mutations alter the site-specific microenvironment, solvent exposure, and conformational flexibility of the protein. Our results further show that the common structural feature of the three PD-associated mutants is more compact and rigid sites at their N and C termini compared with WT -Syn that may facilitate the formation of a partially folded intermediate that eventually leads to their increased oligomerization propensities.	[Sahay, Shruti; Ghosh, Dhiman; Dwivedi, Saumya; Anoop, Arunagiri; Mohite, Ganesh Maruti; Maji, Samir K.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Kombrabail, Mamata; Krishnamoorthy, Guruswamy] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tata Institute of Fundamental Research (TIFR)	Krishnamoorthy, G (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	gk@tifr.res.in; samirmaji@iitb.ac.in	Maji, Samir K. K./B-9640-2019; Arunagiri, Anoop/P-2528-2018	Maji, Samir K. K./0000-0002-9110-1565; Arunagiri, Anoop/0000-0001-9839-1860	Department of Biotechnology, Government of India [BT/PR14344Med/30/501/2010, BT/PR13359/BRB/10/752/2009]; Council of Scientific and Industrial Research, Government of India; Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Government of India	This work was supported in part by Department of Biotechnology, Government of India Grants BT/PR14344Med/30/501/2010 and BT/PR13359/BRB/10/752/2009.; Supported by a Shyama Prasad Mukherjee fellowship from the Council of Scientific and Industrial Research, Government of India.; Recipient of a J.C. Bose fellowship of the Government of India.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Anoop A, 2014, J BIOL CHEM, V289, P16884, DOI 10.1074/jbc.M114.548354; Ariesandi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053487; Baba M, 1998, AM J PATHOL, V152, P879; BEECHEM JM, 1985, ANNU REV BIOCHEM, V54, P43, DOI 10.1146/annurev.biochem.54.1.43; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bevington PR, 1969, DATA REDUCTION ERROR; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Coskuner O, 2013, ACS CHEM NEUROSCI, V4, P1101, DOI 10.1021/cn400041j; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dusa A, 2006, BIOCHEMISTRY-US, V45, P2752, DOI 10.1021/bi051426z; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fujioka S, 2014, PARKINSONISM RELAT D, V20, P1129, DOI [10.1016/S1353-8020(13)70010-5, 10.1016/j.parkreldis.2014.07.014]; Garzon-Rodriguez W, 2000, J BIOL CHEM, V275, P22645, DOI 10.1074/jbc.M000756200; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jha A, 2009, J MOL BIOL, V393, P735, DOI 10.1016/j.jmb.2009.08.053; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Krishnamoorthy G, 2012, CURR SCI INDIA, V102, P266; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lakshmikanth GS, 2001, NAT STRUCT BIOL, V8, P799, DOI 10.1038/nsb0901-799; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Lee JC, 2004, P NATL ACAD SCI USA, V101, P16466, DOI 10.1073/pnas.0407307101; Lee SJ, 2008, ACTA NEUROBIOL EXP, V68, P509; Li HT, 2006, PROTEIN PEPTIDE LETT, V13, P385, DOI 10.2174/092986606775974384; Li J, 2002, NEUROTOXICOLOGY, V23, P553, DOI 10.1016/S0161-813X(02)00066-9; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maji SK, 2005, BIOCHEMISTRY-US, V44, P13365, DOI 10.1021/bi0508284; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Ono K, 2012, NEUROBIOL AGING, V33, P2172, DOI 10.1016/j.neurobiolaging.2011.10.015; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Recchia A, 2004, FASEB J, V18, P617, DOI 10.1096/fj.03-0338rev; Rospigliosi CC, 2009, J MOL BIOL, V388, P1022, DOI 10.1016/j.jmb.2009.03.065; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sahay S, 2014, BIOCHEMISTRY-US, V53, P807, DOI 10.1021/bi401543z; Sambrook J., 2001, MOL CLONING LAB MANU; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; Singh TS, 2012, BIOCHEMISTRY-US, V51, P9260, DOI 10.1021/bi301110u; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wise-Scira O, 2013, ACS CHEM NEUROSCI, V4, P486, DOI 10.1021/cn300198q; Wise-Scira O, 2013, ACS CHEM NEUROSCI, V4, P498, DOI 10.1021/cn3002027; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhang L, 2008, BRAIN RES, V1244, P40, DOI 10.1016/j.brainres.2008.08.067; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	76	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7804	7822		10.1074/jbc.M114.598607	http://dx.doi.org/10.1074/jbc.M114.598607			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25635052	Green Published, hybrid			2022-12-26	WOS:000351613600039
J	Torr, EE; Ngam, CR; Bernau, K; Tomasini-Johansson, B; Acton, B; Sandbo, N				Torr, Elizabeth E.; Ngam, Caitlyn R.; Bernau, Ksenija; Tomasini-Johansson, Bianca; Acton, Benjamin; Sandbo, Nathan			Myofibroblasts Exhibit Enhanced Fibronectin Assembly That Is Intrinsic to Their Contractile Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; SMOOTH MUSCLE ACTIN; STRESS FIBER FORMATION; EXTRACELLULAR-MATRIX; GRANULATION-TISSUE; PULMONARY-FIBROSIS; STREPTOCOCCUS-PYOGENES; MURINE MODEL; TGF-BETA; DIFFERENTIATION	Myofibroblasts have increased expression of contractile proteins and display augmented contractility. It is not known if the augmented contractile gene expression characterizing the myofibroblast phenotype impacts its intrinsic ability to assemble fibronectin (FN) and extracellular matrix. In this study we investigated whether myofibroblasts displayed increased rates of EN fibril assembly when compared with their undifferentiated counterparts. Freshly plated myofibroblasts assemble exogenous FN (488-FN) into a fibrillar matrix more rapidly than fibroblasts that have not undergone myofibroblast differentiation. The augmented rate of FN matrix formation by myofibroblasts was dependent on intact Rho/Rho kinase (ROCK) and myosin signals inasmuch as treatment with Y27632 or blebbistatin attenuated 488-EN assembly. Inhibiting contractile gene expression by pharmacologic disruption of the transcription factors megakaryoblastic leukemia-1 (MKL1)/serum response factor (SRE) during myofibroblast differentiation resulted in decreased contractile force generation and attenuated 488-EN incorporation although not FN expression. Furthermore, disruption of the MKL1/SRF target gene, smooth muscle alpha-actin (alpha-SMA) via siRNA knockdown resulted in attenuation of 488-EN assembly. In conclusion, this study demonstrates a linkage between increased contractile gene expression, most importantly a-SMA, and the intrinsic capacity of myofibroblasts to assemble exogenous EN into fibrillar extracellular matrix.	[Torr, Elizabeth E.; Ngam, Caitlyn R.; Bernau, Ksenija; Acton, Benjamin; Sandbo, Nathan] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53792 USA; [Tomasini-Johansson, Bianca] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sandbo, N (corresponding author), Univ Wisconsin, Dept Med, Div Allergy Pulm & Crit Care Med, H4-620,600 Highland Ave, Madison, WI 53792 USA.	nsandbo@medicine.wisc.edu			National Institutes of Health (NCI) [5K08HL093367, P30 CA014520]; University of Wisconsin; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093367] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Wisconsin; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 5K08HL093367 (to N. S.) and P30 CA014520 (NCI; to the University of Wisconsin Comprehensive Cancer Center). This work was also supported by University of Wisconsin Development Funding (to N. S.).	Altrock E., 2014, J HEPATOL, DOI [10.1016/j.j-hep.2014.06.010, DOI 10.1016/J.J-HEP.2014.06.010]; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Cho J, 2006, J THROMB HAEMOST, V4, P943, DOI 10.1111/j.1538-7836.2006.01862.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Haak AJ, 2014, J PHARMACOL EXP THER, V349, P480, DOI 10.1124/jpet.114.213520; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089016; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Holtz ML, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-18; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; KUHN C, 1991, AM J PATHOL, V138, P1257; Lemmon CA, 2009, BIOPHYS J, V96, P729, DOI 10.1016/j.bpj.2008.10.009; Lockman K, 2004, J BIOL CHEM, V279, P42422, DOI 10.1074/jbc.M405432200; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Pankov Roumen, 2009, V522, P261, DOI 10.1007/978-1-59745-413-1_18; Pereira M, 2002, J CELL SCI, V115, P609; PETERS DMP, 1987, J CELL BIOL, V104, P121, DOI 10.1083/jcb.104.1.121; Phan SH, 1996, KIDNEY INT, V49, pS46; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Sandbo N, 2005, MOL PHARMACOL, V67, P789, DOI 10.1124/mol.104.006874; Sandbo N, 2013, J BIOL CHEM, V288, P15466, DOI 10.1074/jbc.M113.464461; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimizu Y, 2001, AM J RESP CRIT CARE, V163, P210, DOI 10.1164/ajrccm.163.1.2001089; SINGER II, 1984, J CELL BIOL, V98, P2091, DOI 10.1083/jcb.98.6.2091; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2012, MATRIX BIOL, V31, P360, DOI 10.1016/j.matbio.2012.07.003; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	49	45	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6951	6961		10.1074/jbc.M114.606186	http://dx.doi.org/10.1074/jbc.M114.606186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627685	Green Published, hybrid			2022-12-26	WOS:000350991500029
J	Zhang, XT; Ni, ZH; Duan, ZP; Xin, ZY; Wang, HD; Tan, JY; Wang, GQ; Li, F				Zhang, XiaoTian; Ni, ZhaoHui; Duan, ZiPeng; Xin, ZhuoYuan; Wang, HuaiDong; Tan, JiaYi; Wang, GuoQing; Li, Fan			Overexpression of E2F mRNAs Associated with Gastric Cancer Progression Identified by the Transcription Factor and miRNA Co-Regulatory Network Analysis	PLOS ONE			English	Article							MICRORNA TARGET PREDICTION; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; EXPRESSION; CELL; PROLIFERATION; ACTIVATION; RESISTANCE; PATTERNS; BIOLOGY	Gene expression is regulated at the transcription and translation levels; thus, both transcription factors (TFs) and microRNAs (miRNA) play roles in regulation of gene expression. This study profiled differentially expressed mRNAs and miRNAs in gastric cancer tissues to construct a TF and miRNA co-regulatory network in order to identify altered genes in gastric cancer progression. A total of 70 cases gastric cancer and paired adjacent normal tissues were subjected to cDNA and miRNA microarray analyses. We obtained 887 up-regulated and 93 down-regulated genes and 41 down-regulated and 4 up-regulated miRNAs in gastric cancer tissues. Using the Transcriptional Regulatory Element Database, we obtained 105 genes that are regulated by the E2F family of genes and using Targetscan, miRanda, miRDB and miRWalk tools, we predicted potential targeting genes of these 45 miRNAs. We then built up the E2F-related TF and miRNA co-regulatory gene network and identified 9 hub-genes. Furthermore, we found that levels of E2F1, 2, 3, 4, 5, and 7 mRNAs associated with gastric cancer cell invasion capacity, and has associated with tumor differentiation. These data showed Overexpression of E2F mRNAs associated with gastric cancer progression.	[Zhang, XiaoTian; Ni, ZhaoHui; Duan, ZiPeng; Xin, ZhuoYuan; Wang, HuaiDong; Tan, JiaYi; Wang, GuoQing; Li, Fan] Jilin Univ, Coll Basic Med, Dept Pathogenobiol, Key Lab Zoonosis,Chinese Minist Educ, Changchun 130023, Jilin, Peoples R China	Jilin University	Wang, GQ (corresponding author), Jilin Univ, Coll Basic Med, Dept Pathogenobiol, Key Lab Zoonosis,Chinese Minist Educ, Changchun 130023, Jilin, Peoples R China.	qing@jlu.edu.cn; lifan@jlu.edu.cn		Tan, Jiayi/0000-0001-5938-7471	National Natural Science Foundation of China [81320108025, 81472662]; Foundation of Jilin Province Science and Technology Department [20130522013JH, 20140414048GH]; Norman Bethune Program of Jilin University [2012219]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Jilin Province Science and Technology Department; Norman Bethune Program of Jilin University	This work was supported in part by grants from National Natural Science Foundation of China (#81320108025 and #81472662), Foundation of Jilin Province Science and Technology Department (#20130522013JH and #20140414048GH) and the Norman Bethune Program of Jilin University (#2012219). The authors also thank the Medjaden Bioscience Limited (Hong Kong, China) for editing and proofreading this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Emmrich S, 2010, CELL CYCLE, V9, P2555, DOI 10.4161/cc.9.13.12061; Gao CP, 2010, CANCER-AM CANCER SOC, V116, P41, DOI 10.1002/cncr.24743; Golan T, 2014, BRIT J CANCER, DOI [10.1038/bjc.2014.626, DOI 10.1038/BJC.2014.626]; Greten FR, 2014, CELL, V158, P11, DOI 10.1016/j.cell.2014.06.021; Guo XB, 2010, BIOCHEM BIOPH RES CO, V398, P1, DOI 10.1016/j.bbrc.2010.05.082; Hsu KW, 2012, CARCINOGENESIS, V33, P1459, DOI 10.1093/carcin/bgs165; Huang SL, 2012, CANCER LETT, V315, P198, DOI 10.1016/j.canlet.2011.10.011; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jiang DF, 2014, BLOOD, V123, P86, DOI 10.1182/blood-2013-07-515254; Kubota E, 2014, CELL CYCLE, V13, P2129, DOI 10.4161/cc.29212; Lee JS, 2010, J CLIN ONCOL, V28, P2660, DOI 10.1200/JCO.2009.25.0977; Li GJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp491; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Okamoto W, 2011, BRIT J CANCER, V105, P407, DOI 10.1038/bjc.2011.246; Park D, 2014, PATHOL INT, V64, P309, DOI 10.1111/pin.12178; Peterson SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00023; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Reimer D, 2011, ONCOGENE, V30, P4038, DOI 10.1038/onc.2011.119; Ren ZJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.327; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vauhkonen M, 2006, BEST PRACT RES CL GA, V20, P651, DOI 10.1016/j.bpg.2006.03.016; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Wilting SM, 2013, ONCOGENE, V32, P106, DOI 10.1038/onc.2012.20; Wong HL, 2011, CANCER SCI, V102, P1911, DOI 10.1111/j.1349-7006.2011.02033.x; Wu Q, 2013, J CELL SCI, V126, P4220, DOI 10.1242/jcs.127944; Wu Q, 2010, BIOCHEM BIOPH RES CO, V392, P340, DOI 10.1016/j.bbrc.2009.12.182; Xu YJ, 2014, MOL MED REP, V10, P2601, DOI 10.3892/mmr.2014.2567; Yao YL, 2013, ASIAN PAC J CANCER P, V14, P2839, DOI 10.7314/APJCP.2013.14.5.2839; Zhang YY, 2010, MED ONCOL, V27, P685, DOI 10.1007/s12032-009-9269-x; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	47	29	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116979	10.1371/journal.pone.0116979	http://dx.doi.org/10.1371/journal.pone.0116979			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646628	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600045
J	Kellar, NM; Catelani, KN; Robbins, MN; Trego, ML; Allen, CD; Danil, K; Chivers, SJ				Kellar, Nicholas M.; Catelani, Krista N.; Robbins, Michelle N.; Trego, Marisa L.; Allen, Camryn D.; Danil, Kerri; Chivers, Susan J.			Blubber Cortisol: A Potential Tool for Assessing Stress Response in Free-Ranging Dolphins without Effects due to Sampling	PLOS ONE			English	Article							FECAL GLUCOCORTICOIDS; TURSIOPS-TRUNCATUS; THYROID-HORMONES; SEASONAL-CHANGES; BIOPSY SYSTEM; BLOOD-OXYGEN; PREGNANCY; CAPTURE; INDICATORS; CALIFORNIA	When paired with dart biopsying, quantifying cortisol in blubber tissue may provide an index of relative stress levels (i.e., activation of the hypothalamus-pituitary-adrenal axis) in free-ranging cetacean populations while minimizing the effects of the act of sampling. To validate this approach, cortisol was extracted from blubber samples collected from beach-stranded and bycaught short-beaked common dolphins using a modified blubber steroid isolation technique and measured via commercially available enzyme immunoassays. The measurements exhibited appropriate quality characteristics when analyzed via a bootstraped stepwise parallelism analysis (observed/expected = 1.03, 95%CI: 99.6-1.08) and showed no evidence of matrix interference with increasing sample size across typical biopsy tissue masses (75-150mg; r(2) = 0.012, p = 0.78, slope = 0.022ng(cortisol) (deviation)/ul(tissue) (extract added)). The relationships between blubber cortisol and eight potential cofactors namely, 1) fatality type (e.g., stranded or bycaught), 2) specimen condition (state of decomposition), 3) total body length, 4) sex, 5) sexual maturity state, 6) pregnancy status, 7) lactation state, and 8) adrenal mass, were assessed using a Bayesian generalized linear model averaging technique. Fatality type was the only factor correlated with blubber cortisol, and the magnitude of the effect size was substantial: beach-stranded individuals had on average 6.1-fold higher cortisol levels than those of bycaught individuals. Because of the difference in conditions surrounding these two fatality types, we interpret this relationship as evidence that blubber cortisol is indicative of stress response. We found no evidence of seasonal variation or a relationship between cortisol and the remaining cofactors.	[Kellar, Nicholas M.; Catelani, Krista N.; Robbins, Michelle N.; Trego, Marisa L.; Allen, Camryn D.; Danil, Kerri; Chivers, Susan J.] Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Southwest Fisheries Sci Ctr, Protected Resources Div, La Jolla, CA 92038 USA; [Catelani, Krista N.; Robbins, Michelle N.; Trego, Marisa L.] Ocean Associates Inc, Arlington, VA USA	National Oceanic Atmospheric Admin (NOAA) - USA	Kellar, NM (corresponding author), Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm, Southwest Fisheries Sci Ctr, Protected Resources Div, La Jolla, CA 92038 USA.	Nick.Kellar@noaa.gov	Kellar, Nicholas/AAA-4606-2021	Danil, Kerri/0000-0001-6985-4678	Office of Naval Research [N0001411IP20080]; National Marine Fisheries Service	Office of Naval Research(Office of Naval Research); National Marine Fisheries Service	The Office of Naval Research, award N0001411IP20080, was the primary funding source for this research with additional support from the National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON HC, 1995, ENDOCRINOLOGY, V136, P512, DOI 10.1210/en.136.2.512; BarrettLennard LG, 1996, MAR MAMMAL SCI, V12, P14, DOI 10.1111/j.1748-7692.1996.tb00302.x; Bennett KA, 2012, COMP BIOCHEM PHYS A, V161, P69, DOI 10.1016/j.cbpa.2011.09.003; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Blasius ME, 2008, MAR POLLUT BULL, V56, P1973, DOI 10.1016/j.marpolbul.2008.08.011; Boonstra R, 2001, CAN J ZOOL, V79, P49, DOI 10.1139/cjz-79-1-49; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Caretta J.V., 2004, MAR FISH REV, V66, P21; CARLIN BP, 1995, J ROY STAT SOC B MET, V57, P473; Cash WB, 1997, GEN COMP ENDOCR, V108, P427, DOI 10.1006/gcen.1997.6999; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Danil Kerri, 2010, Journal of Cetacean Research and Management, V11, P163; Delehanty B, 2009, GEN COMP ENDOCR, V160, P176, DOI 10.1016/j.ygcen.2008.11.011; DESLYPERE JP, 1985, J CLIN ENDOCR METAB, V61, P564, DOI 10.1210/jcem-61-3-564; Douyon L, 2002, ENDOCRIN METAB CLIN, V31, P173, DOI 10.1016/S0889-8529(01)00023-8; du Dot TJ, 2009, COMP BIOCHEM PHYS A, V152, P524, DOI 10.1016/j.cbpa.2008.12.010; Fair PA, 2014, GEN COMP ENDOCR, V206, P203, DOI 10.1016/j.ygcen.2014.07.002; Falk RT, 2008, CANCER EPIDEM BIOMAR, V17, P1891, DOI 10.1158/1055-9965.EPI-08-0119; Ferin M, 1999, J CLIN ENDOCR METAB, V84, P1768, DOI 10.1210/jc.84.6.1768; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Heyning John E., 1994, Contributions in Science (Los Angeles), V442, P1; Hunt KE, 2006, GEN COMP ENDOCR, V148, P260, DOI 10.1016/j.ygcen.2006.03.012; Hunt KE, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot006; JOHNSON EO, 1992, NEUROSCI BIOBEHAV R, V16, P115, DOI 10.1016/S0149-7634(05)80175-7; Keay JM, 2006, J ZOO WILDLIFE MED, V37, P234, DOI 10.1638/05-050.1; Kellar NM, 2013, ENDANGER SPECIES RES, V22, P61, DOI 10.3354/esr00537; Kellar NM, 2013, MAR BIOL, V160, P3113, DOI 10.1007/s00227-013-2299-0; Kellar NM, 2013, MAR MAMMAL SCI, V29, pE366, DOI 10.1111/mms.12014; Kellar NM, 2009, MAR MAMMAL SCI, V25, P507, DOI 10.1111/j.1748-7692.2009.00291.x; Kellar NM, 2006, MAR MAMMAL SCI, V22, P1, DOI 10.1111/j.1748-7692.2006.00001.x; Knieriem A., 2001, Aquatic Mammals, V27, P73; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Le Boeuf Burney J, 2002, BMC Ecol, V2, P11, DOI 10.1186/1472-6785-2-11; LOCKYER C, 1976, J CONSEIL, V36, P259, DOI 10.1093/icesjms/36.3.259; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Mansour AAH, 2002, MAR MAMMAL SCI, V18, P112, DOI 10.1111/j.1748-7692.2002.tb01022.x; Martin P. A., 2003, McDonald's veterinary endocrinology and reproduction, P165; Mashburn KL, 2004, GEN COMP ENDOCR, V136, P371, DOI 10.1016/j.ygcen.2004.01.016; Mead J. F., 1986, LIPIDS CHEM BIOCH NU; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Noren DP, 2012, MAR MAMMAL SCI, V28, P154, DOI 10.1111/j.1748-7692.2011.00469.x; Noren SR, 2002, J ZOOL, V258, P105, DOI 10.1017/S0952836902001243; Ortiz RM, 2000, COMP BIOCHEM PHYS A, V125, P317, DOI 10.1016/S1095-6433(00)00158-6; PEARN J, 1985, MED J AUSTRALIA, V142, P586, DOI 10.5694/j.1326-5377.1985.tb113523.x; Perez S, 2011, MAR BIOL, V158, P1677, DOI 10.1007/s00227-011-1676-9; PROTHERO JW, 1980, COMP BIOCHEM PHYS A, V67, P649, DOI 10.1016/0300-9629(80)90255-8; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; RIDGWAY SH, 1966, SCIENCE, V151, P456, DOI 10.1126/science.151.3709.456; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Romero LM, 2008, AM J PHYSIOL-REG I, V294, pR614, DOI 10.1152/ajpregu.00752.2007; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Ryan C, 2013, MAR MAMMAL SCI, V29, P542, DOI 10.1111/j.1748-7692.2012.00578.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Southall BL, 2012, MAR TECHNOL SOC J, V46, P48, DOI 10.4031/MTSJ.46.4.1; Szymczak J, 1998, STEROIDS, V63, P319, DOI 10.1016/S0039-128X(98)00019-1; TAYLOR KM, 1978, J THORAC CARDIOV SUR, V75, P574; Trego ML, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082806, DOI 10.1371/JOURNAL.PONE.0082806]; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]	64	51	52	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115257	10.1371/journal.pone.0115257	http://dx.doi.org/10.1371/journal.pone.0115257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643144	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821200009
J	Ghose, S; Min, YF; Lin, PC				Ghose, Sampa; Min, Yongfen; Lin, P. Charles			delta-Catenin Activates Rho GTPase, Promotes Lymphangiogenesis and Growth of Tumor Metastases	PLOS ONE			English	Article								delta-catenin, an adherens junctions protein, is not only involved in early development, cell-cell adhesion and cell motility in neuronal cells, but it also plays an important role in vascular endothelial cell motility and pathological angiogenesis. In this study, we report a new function of delta-catenin in lymphangiogenesis. Consistent with expression of delta-catenin in vascular endothelial cells, we detected expression of the gene in lymphatic endothelial cells (LECs). Ectopic expression of delta-catenin in LECs increased cell motility and lymphatic vascular network formation in vitro and lymphangiogenesis in vivo in a Matrigel plug assay. Conversely, knockdown of delta-catenin in LECs impaired lymphangiogenesis in vitro and in vivo. Biochemical analysis shows that delta-catenin regulates activation of Rho family small GTPases, key mediators in cell motility. delta-catenin activates Rac1 and Cdc42 but inhibits RhoA in LECs. Notably, blocking of Rac1 activation impaired delta-catenin mediated lymphangiogenesis in a Matrigel assay. Consistently, loss of delta-catenin in mice inhibited the growth of tumor metastases. Taken together, these findings identify a new function of delta-catenin in lymphangiogenesis and tumor growth/metastasis, likely through modulation of small Rho GTPase activation. Targeting delta-catenin may offer a new way to control tumor metastasis.	[Ghose, Sampa] Jawaharlal Nehru Univ, Ctr Mol Med, New Delhi 110067, India; [Min, Yongfen; Lin, P. Charles] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA	Jawaharlal Nehru University, New Delhi; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lin, PC (corresponding author), NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA.	p.lin@NIH.gov			Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH); NIH [CA108856, NS45888, AR053718]; NATIONAL CANCER INSTITUTE [R01CA108856, ZIABC011390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045888] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH) and by the grants from NIH (CA108856, NS45888 and AR053718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; DeBusk LM, 2010, J EXP MED, V207, P77, DOI 10.1084/jem.20091097; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jones CA, 2007, CURR OPIN GENET DEV, V17, P332, DOI 10.1016/j.gde.2007.07.004; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019	12	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116338	10.1371/journal.pone.0116338	http://dx.doi.org/10.1371/journal.pone.0116338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635825	gold, Green Submitted, Green Published			2022-12-26	WOS:000350680700029
J	Grigson, ER; Ozerova, M; Pisklakova, A; Liu, H; Sullivan, DM; Nefedova, Y				Grigson, Eileen R.; Ozerova, Maria; Pisklakova, Alexandra; Liu, Hao; Sullivan, Daniel M.; Nefedova, Yulia			Canonical Wnt Pathway Inhibitor ICG-001 Induces Cytotoxicity of Multiple Myeloma Cells in Wnt-Independent Manner	PLOS ONE			English	Article							NOVO DRUG-RESISTANCE; APOPTOSIS; PROLIFERATION	Canonical Wnt signaling has been implicated in the regulation of multiple myeloma ( MM) growth. Here, we investigated whether the targeting of this pathway with a novel pharmacological inhibitor ICG-001 would result in an anti-tumor effect and improvement of chemosensitivity in MM. As expected, ICG-001 specifically down-regulated beta-catenin/TCF-mediated transcription in MM cells. Treatment with ICG-001 resulted in growth arrest and apoptosis in MM cell lines and primary MM cells. Moreover, ICG-001 enhanced the cytotoxic effects of doxorubicin and melphalan and abrogated chemoresistance of MM cells to these chemotherapeutics induced by bone marrow stroma. The cytotoxic effect of ICG-001 was caspase-dependent and mediated through transcriptional up-regulation of BH3-only proapoptotic members of the Bcl-2 family Noxa and Puma but not through inhibition of canonical Wnt signaling. ICG-001 selectively induced apoptosis in primary MM cells but did not affect non-MM cells of the bone marrow microenvironment. Experiments using a xenograft model of MM showed substantial anti-tumor effects of this compound in vivo. Thus, our study demonstrated that the small molecule inhibitor ICG-001 has strong anti-MM effects and could be developed further for therapeutic intervention in this disease.	[Grigson, Eileen R.; Pisklakova, Alexandra; Liu, Hao; Sullivan, Daniel M.; Nefedova, Yulia] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Grigson, Eileen R.; Ozerova, Maria; Nefedova, Yulia] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; The Wistar Institute	Nefedova, Y (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	ynefedova@wistar.org		Nefedova, Yulia/0000-0002-5121-9294	Multiple Myeloma Research Foundation Senior Award; National Cancer Institute of the National Institutes of Health [R01CA130923]; Cancer Center Support Grant (CCSG) [P30-CA76292, CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815, R25CA174664, R01CA130923, P30CA076292] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation Senior Award; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the Multiple Myeloma Research Foundation (http://www.themmrf.org) Senior Award (to YN) and by the National Cancer Institute of the National Institutes of Health under award number R01CA130923 (to YN). Support for Shared Resources utilized in the study was provided by Cancer Center Support Grant (CCSG) P30-CA76292 to the Moffitt Cancer Center and Research Institute and CA010815 to The Wistar Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Ashihara E, 2009, CLIN CANCER RES, V15, P2731, DOI 10.1158/1078-0432.CCR-08-1350; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Colla S, 2007, BLOOD, V109, P4470, DOI 10.1182/blood-2006-11-056747; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Gang E.J., 2013, ONCOGENE; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Huang ML, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-221; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Khin ZP, 2014, CANCER RES, V74, P56, DOI 10.1158/0008-5472.CAN-13-2397; Lento W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008011; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Qiang YW, 2008, BLOOD, V112, P374, DOI 10.1182/blood-2007-10-120253; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Qiang YW, 2003, ONCOGENE, V22, P1536, DOI 10.1038/sj.onc.1206239; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Shibue T, 2006, INT J CANC; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Sun P, 2006, MOL PHARMACOL, V69, P520, DOI 10.1124/mol.105.019620; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Veeramachaneni NK, 2004, J THORAC CARDIOV SUR, V127, P92, DOI 10.1016/j.jtcvs.2003.06.008; Wend P, 2013, EMBO J, V32, P1977, DOI 10.1038/emboj.2013.127; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	31	36	36	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117693	10.1371/journal.pone.0117693	http://dx.doi.org/10.1371/journal.pone.0117693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635944	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700097
J	Lanza, D; Perna, AF; Oliva, A; Vanholder, R; Pletinck, A; Guastafierro, S; Di Nunzio, A; Vigorito, C; Capasso, G; Jankowski, V; Jankowski, J; Ingrosso, D				Lanza, Diana; Perna, Alessandra F.; Oliva, Adriana; Vanholder, Raymond; Pletinck, Anneleen; Guastafierro, Salvatore; Di Nunzio, Annarita; Vigorito, Carmela; Capasso, Giovambattista; Jankowski, Vera; Jankowski, Joachim; Ingrosso, Diego			Impact of the Uremic Milieu on the Osteogenic Potential of Mesenchymal Stem Cells	PLOS ONE			English	Article							ALIZARIN RED-S; HYDROGEN-SULFIDE; MINERAL METABOLISM; SECONDARY HYPERPARATHYROIDISM; HEMODIALYSIS-PATIENTS; BONE; MARKERS; CALCIFICATION; EXPRESSION; CINACALCET	Human mesenchymal stem cells (hMSCs), the precursors of osteoblasts during osteogenesis, play a role in the balance of bone formation and resorption, but their functioning in uremia has not been well defined. To study the effects of the uremic milieu on osteogenic properties, we applied an in vitro assay culturing hMSCs in osteogenic medium supplemented with serum from healthy donors and from uremic patients on hemodialysis. Compared to control, serum from uremic patients induces, in hMSC cultures, a modification of several key regulators of bone remodeling, in particular a reduction of the ratio Receptor Activator of Nuclear factor Kappa B Receptor (RANKL) over osteoprotegerin, indicating an adaptive response of the system to favor osteogenesis over osteoclastosis. However, the levels of osteopontin, osteocalcin, and collagen type I, are increased in cell medium, while BMP-2, and alizarin red staining were decreased, pointing to a reduction of bone formation favoring resorption. Selected uremic toxins, such as p-cresylsulfate, p-cresylglucuronide, parathyroid hormone, indoxyl sulfate, asymmetric dimethylarginine, homocysteine, were able to mimic some of the effects of whole serum from uremic patients. Serum from cinacalcet-treated patients antagonizes these effects. Hydrogen sulfide (H2S) donors as well as hemodialysis treatment are able to induce beneficial effects. In conclusion, bone modifications in uremia are influenced by the capability of the uremic milieu to alter hMSC osteogenic differentiation. Cinacalcet, H2S donors and a hemodialysis session can ameliorate the hampered calcium deposition.	[Lanza, Diana; Perna, Alessandra F.; Di Nunzio, Annarita; Capasso, Giovambattista] Univ Naples 2, Sch Med, Dept Cardiothorac & Resp Sci, Div Nephrol 1, Naples, Italy; [Oliva, Adriana; Vigorito, Carmela; Ingrosso, Diego] Univ Naples 2, Sch Med, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Vanholder, Raymond; Pletinck, Anneleen] Ghent Univ Hosp, Dept Internal Med, Nephrol Sect, Ghent, Belgium; [Guastafierro, Salvatore] Univ Naples 2, Sch Med, Dept Clin & Expt Med, Div Hematol & Med Oncol, Naples, Italy; [Jankowski, Vera; Jankowski, Joachim] Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res IMCAR, Aachen, Germany	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Ghent University; Ghent University Hospital; Universita della Campania Vanvitelli; RWTH Aachen University	Perna, AF (corresponding author), Univ Naples 2, Sch Med, Dept Cardiothorac & Resp Sci, Div Nephrol 1, Naples, Italy.	alessandra.perna@unina2.it	Ingrosso, Diego/AHE-4980-2022; Perna, Alessandra F/AAC-3952-2022	Capasso, Giovambattista/0000-0003-3469-8614; PERNA, Alessandra/0000-0003-4048-9392	Italian Society of Nephrology (SIN), GRANT "Ricercando"	Italian Society of Nephrology (SIN), GRANT "Ricercando"	This work was supported by the Italian Society of Nephrology (SIN), http://www.sin-italy.org, GRANT "Ricercando 2011" to AFP. Project name: "Exploring the osteogenic properties of mesenchymal stem cells for bone structural -functional repair in hemodialysis patients: role of uremic toxins." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeras C, 2009, SEMIN DIALYSIS, V22, P329, DOI 10.1111/j.1525-139X.2009.00575.x; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Boncler M, 2014, J PHARMACOL TOX MET, V69, P9, DOI 10.1016/j.vascn.2013.09.003; Bordia A, 1998, PROSTAG LEUKOTR ESS, V58, P257, DOI 10.1016/S0952-3278(98)90034-5; Borriello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028555; Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333; Chen NX, 2006, KIDNEY INT, V70, P1046, DOI 10.1038/sj.ki.5001663; Cook DA, 2014, STEM CELL RES, V12, P415, DOI 10.1016/j.scr.2013.10.002; Costa E, 2012, RENAL FAILURE, V34, P1355, DOI 10.3109/0886022X.2012.725289; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; Dalfino G, 2010, ATHEROSCLEROSIS, V211, P418, DOI 10.1016/j.atherosclerosis.2010.04.023; DAWSONSAUNDERS B, 1990, BASIC CLIN BIOSTATIS; Doumouchtsis KK, 2007, J ENDOCRINOL INVEST, V30, P762, DOI 10.1007/BF03350814; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Feigenbaum J, 1941, J AM CHEM SOC, V63, P3529, DOI 10.1021/ja01857a508; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Graneli C, 2014, STEM CELL RES, V12, P153, DOI 10.1016/j.scr.2013.09.009; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Guida L, 2010, CLIN ORAL IMPLAN RES, V21, P1234, DOI 10.1111/j.1600-0501.2010.01929.x; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Huang YT, 2013, J APPL PHYSIOL, V114, P402, DOI 10.1152/japplphysiol.00672.2012; Iwasaki Y, 2006, J BONE MINER METAB, V24, P172, DOI 10.1007/s00774-005-0667-7; Jankowski J, 2003, J CLIN INVEST, V112, P256, DOI 10.1172/JCI200315524; Kawata T, 2008, KIDNEY INT, V74, P1270, DOI 10.1038/ki.2008.407; Kazama JJ, 2004, CURR OPIN NEPHROL HY, V13, P411, DOI 10.1097/01.mnh.0000133982.40182.8a; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kolluru GK, 2013, NITRIC OXIDE-BIOL CH, V35, P5, DOI 10.1016/j.niox.2013.07.002; Kramann R, 2011, ARTERIOSCL THROM VAS, V31, pE45, DOI 10.1161/ATVBAHA.111.228601; Lall Namrita, 2013, Int J Microbiol, V2013, P420601, DOI 10.1155/2013/420601; Lesaffer G, 2000, NEPHROL DIAL TRANSPL, V15, P50, DOI 10.1093/ndt/15.1.50; Li D, 2013, ENDOCRINE, V43, P68, DOI 10.1007/s12020-012-9711-2; Liabeuf S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067168; Liao CS, 2013, ARCH ORAL BIOL, V58, P1784, DOI 10.1016/j.archoralbio.2013.08.004; LIEVREMONT M, 1982, ACTA ANAT, V114, P268; Liu Y, 2014, CELL STEM CELL, V15, P66, DOI 10.1016/j.stem.2014.03.005; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Meert N, 2012, NEPHROL DIAL TRANSPL, V27, P2388, DOI 10.1093/ndt/gfr672; Nemcsik Janos, 2012, World J Nephrol, V1, P25, DOI 10.5527/wjn.v1.i1.25; Nii-Kono T, 2007, KIDNEY INT, V71, P738, DOI 10.1038/sj.ki.5002097; Nitta K, 2001, NEPHRON, V89, P455, DOI 10.1159/000046119; Oliva A, 2005, Int J Immunopathol Pharmacol, V18, P47; Perna AF, 2004, J AM SOC NEPHROL, V15, P2747, DOI 10.1097/01.ASN.0000141041.71717.11; Perna AF, 2013, J CELL BIOCHEM, V114, P1536, DOI 10.1002/jcb.24495; Perna AF, 2009, NEPHROL DIAL TRANSPL, V24, P3756, DOI 10.1093/ndt/gfp378; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Takano M, 2011, CLIN INVEST MED, V34, pE267; Tanaka H, 2011, BIOCHEM BIOPH RES CO, V411, P690, DOI 10.1016/j.bbrc.2011.07.001; Tanaka H, 2013, BONE, V56, P347, DOI 10.1016/j.bone.2013.07.002; Urena P, 1996, J AM SOC NEPHROL, V7, P506; Urena P, 2009, NEPHROL DIAL TRANSPL, V24, P2852, DOI 10.1093/ndt/gfp144; Van der Eycken E, 2000, PLANT CELL REP, V19, P966, DOI 10.1007/s002990000219; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Xiao ZS, 2001, KIDNEY INT, V60, P1699, DOI 10.1046/j.1523-1755.2001.00011.x; Xu ZS, 2011, FREE RADICAL BIO MED, V50, P1314, DOI 10.1016/j.freeradbiomed.2011.02.016; Yang J, 2012, BONE, V51, P376, DOI 10.1016/j.bone.2012.05.024	61	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116468	10.1371/journal.pone.0116468	http://dx.doi.org/10.1371/journal.pone.0116468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635832	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700038
J	Liu, TY; Chen, YS; Hsieh, JC; Chen, LF				Liu, Tai-Ying; Chen, Yong-Sheng; Hsieh, Jen-Chuen; Chen, Li-Fen			Asymmetric Engagement of Amygdala and Its Gamma Connectivity in Early Emotional Face Processing	PLOS ONE			English	Article							GRANGER CAUSALITY ANALYSIS; FACIAL EXPRESSIONS; BIPOLAR DISORDER; PERCEPTION; SYNCHRONIZATION; RESPONSES; NEUROBIOLOGY; METAANALYSIS; ACTIVATION; DYNAMICS	The amygdala has been regarded as a key substrate for emotion processing. However, the engagement of the left and right amygdala during the early perceptual processing of different emotional faces remains unclear. We investigated the temporal profiles of oscillatory gamma activity in the amygdala and effective connectivity of the amygdala with the thalamus and cortical areas during implicit emotion-perceptual tasks using event-related magnetoencephalography (MEG). We found that within 100 ms after stimulus onset the right amygdala habituated to emotional faces rapidly (with duration around 20-30 ms), whereas activity in the left amygdala (with duration around 50-60 ms) sustained longer than that in the right. Our data suggest that the right amygdala could be linked to autonomic arousal generated by facial emotions and the left amygdala might be involved in decoding or evaluating expressive faces in the early perceptual emotion processing. The results of effective connectivity provide evidence that only negative emotional processing engages both cortical and subcortical pathways connected to the right amygdala, representing its evolutional significance (survival). These findings demonstrate the asymmetric engagement of bilateral amygdala in emotional face processing as well as the capability of MEG for assessing tha-lamo-cortico-limbic circuitry.	[Liu, Tai-Ying; Hsieh, Jen-Chuen; Chen, Li-Fen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Liu, Tai-Ying; Hsieh, Jen-Chuen; Chen, Li-Fen] Taipei Vet Gen Hosp, Dept Med Res, Integrated Brain Res Unit, Taipei, Taiwan; [Liu, Tai-Ying; Chen, Li-Fen] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chen, Yong-Sheng] Natl Chiao Tung Univ, Dept Comp Sci, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, LF (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan.	lfchen@ym.edu.tw	Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019		National Science Council [NSC100-2628-E-010-001, NSC 97-2752-B-010-003-PAE]; Taipei Veterans General Hospital [V97ER1-001]; Brain Research Center, National Yang-Ming University	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Brain Research Center, National Yang-Ming University	This study was supported in part by National Science Council (NSC100-2628-E-010-001, NSC 97-2752-B-010-003-PAE) and Taipei Veterans General Hospital (V97ER1-001) and Brain Research Center, National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P396, DOI 10.1037//0894-4105.15.3.396; Adolphs R, 1997, BILATERAL DAMAGE TO, P1582; Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amaral DG, 1992, ANATOMICAL ORGANIZAT; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Braeutigam S, 2001, NEUROREPORT, V12, P1531, DOI 10.1097/00001756-200105250-00046; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; Chen YS, 2006, IEEE T BIO-MED ENG, V53, P1765, DOI 10.1109/TBME.2006.878115; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; Csibra G, 2000, SCIENCE, V290, P1582, DOI 10.1126/science.290.5496.1582; Davidson RJ, 1995, BRAIN ASYMMETRY; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Freese JL, 2005, J COMP NEUROL, V486, P295, DOI 10.1002/cne.20520; Fusar-Poli P, 2009, NEUROSCI LETT, V452, P262, DOI 10.1016/j.neulet.2009.01.065; Garrido MI, 2012, CURR BIOL, V22, P129, DOI 10.1016/j.cub.2011.11.056; Glascher J, 2003, J NEUROSCI, V23, P10274; Gow DW, 2008, NEUROIMAGE, V43, P614, DOI 10.1016/j.neuroimage.2008.07.027; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grossman ED, 2005, VISION RES, V45, P2847, DOI 10.1016/j.visres.2005.05.027; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Im CH, 2010, OPT EXPRESS, V18, P5730, DOI 10.1364/OE.18.005730; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kujala J, 2012, CEREB CORTEX, V22, P2305, DOI 10.1093/cercor/bhr307; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; LeDoux J. E., 1996, EMOTIONAL BRAIN; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Liu JX, 2010, ANN BIOMED ENG, V38, P138, DOI 10.1007/s10439-009-9840-9; Liu LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009790; Liu TY, 2012, NEUROPSYCHOLOGIA, V50, P1514, DOI 10.1016/j.neuropsychologia.2012.03.004; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Luo Q, 2009, CEREB CORTEX, V19, P1896, DOI 10.1093/cercor/bhn216; Maior RS, 2010, BEHAV BRAIN RES, V215, P129, DOI 10.1016/j.bbr.2010.07.009; Maldonado PE, 2000, CEREB CORTEX, V10, P1117, DOI 10.1093/cercor/10.11.1117; Markowitsch HJ, 1998, BEHAV NEUROL, V11, P233; Martin A, 2003, COGN NEUROPSYCHOL, V20, P575, DOI 10.1080/02643290342000005; Morel S, 2012, NEUROIMAGE, V61, P1461, DOI 10.1016/j.neuroimage.2012.04.016; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Santos A, 2011, NEUROIMAGE, V54, P3111, DOI 10.1016/j.neuroimage.2010.11.024; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Stangor C, 2010, INTRODUCTION TO PSYC; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Williams LM, 2001, NEUROIMAGE, V14, P1070, DOI 10.1006/nimg.2001.0904; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5	65	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115677	10.1371/journal.pone.0115677	http://dx.doi.org/10.1371/journal.pone.0115677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629899	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100024
J	Harms, RZ; Lorenzo, KM; Corley, KP; Cabrera, MS; Sarvetnick, NE				Harms, Robert Z.; Lorenzo, Kristina M.; Corley, Kevin P.; Cabrera, Monina S.; Sarvetnick, Nora E.			Altered CD161(bright) CD8(+) Mucosal Associated Invariant T (MAIT)-Like Cell Dynamics and Increased Differentiation States among Juvenile Type 1 Diabetics	PLOS ONE			English	Article							INCREASED INTESTINAL PERMEABILITY; GENOME-WIDE ASSOCIATION; GUT MICROBIOTA; HEALTHY-CHILDREN; MAIT CELLS; RISK; INSULIN; AUTOIMMUNITY; ACTIVATION; POPULATION	Type 1A diabetes (T1D) is believed to be caused by immune-mediated destruction of beta-cells, but the immunological basis for T1D remains controversial. Microbial diversity promotes the maturation and activation of certain immune subsets, including CD161(bright) CD8(+) mucosal associated invariant T (MAIT) cells, and alterations in gut mucosal responses have been reported in type 1 diabetics (T1Ds). We analyzed T cell populations in peripheral blood leukocytes from juvenile T1Ds and healthy controls. We found that proportion and absolute number of MAIT cells were similar between T1Ds and controls. Furthermore, while MAIT cell proportions increased with age among healthy controls, this trend was not observed among long-standing T1Ds. Additionally, the CD27-MAIT cell subset is significantly increased in T1Ds and positively correlated with HbA1c levels. However, after T1Ds are stratified by age, the younger group has significantly increased proportions of CD27-MAIT cells compared to age-matched controls, and this proportional increase appears to be independent of HbA1c levels. Finally, we analyzed function of the CD27-MAIT cells and observed that IL-17A production is increased in CD27-compared to CD27(+) MAIT cells. Overall, our data reveal disparate MAIT cell dynamics between T1Ds and controls, as well as signs of increased MAIT cell activation in T1Ds. These changes may be linked to hyperglycemia and increased mucosal challenge among T1Ds.	[Harms, Robert Z.; Lorenzo, Kristina M.; Sarvetnick, Nora E.] Univ Nebraska Med Ctr, Dept Surg Transplant, Omaha, NE 68198 USA; [Corley, Kevin P.; Cabrera, Monina S.] Childrens Hosp & Med Ctr, Omaha, NE USA; [Sarvetnick, Nora E.] Univ Nebraska Med Ctr, Nebraska Regenerat Med Program, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Harms, RZ (corresponding author), Univ Nebraska Med Ctr, Dept Surg Transplant, Omaha, NE 68198 USA.	rharms@unmc.edu			National Institute of Diabetes and Digestive and Kidney Diseases [5 U01 AI102012-02]; J.W. Kieckhefer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI102012] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); J.W. Kieckhefer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding to NES from the National Institute of Diabetes and Digestive and Kidney Diseases (5 U01 AI102012-02) and the J.W. Kieckhefer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNER T, 1987, DIABETES CARE, V10, P164, DOI 10.2337/diacare.10.2.164; Altinova AE, 2008, CYTOKINE, V42, P217, DOI 10.1016/j.cyto.2008.02.006; Altobelli E, 2005, CLIN EXP MED, V5, P72, DOI 10.1007/s10238-005-0069-0; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Borchers AT, 2010, AUTOIMMUN REV, V9, pA355, DOI 10.1016/j.autrev.2009.12.003; Bosi E, 2006, DIABETOLOGIA, V49, P2824, DOI 10.1007/s00125-006-0465-3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Campbell-Thompson M, 2012, JAMA-J AM MED ASSOC, V308, P2337, DOI 10.1001/jama.2012.15008; Canivell S, 2014, AUTOIMMUN REV, V13, P403, DOI 10.1016/j.autrev.2014.01.020; Cengiz E, 2014, PEDIATR DIABETES, V15, P287, DOI 10.1111/pedi.12068; Charlton M, 2000, GASTROENTEROLOGY, V118, P299, DOI 10.1016/S0016-5085(00)70212-5; Chillaron JJ, 2014, METABOLISM, V63, P181, DOI 10.1016/j.metabol.2013.10.002; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Costa VS, 2010, DIABETES RES CLIN PR, V88, P222, DOI 10.1016/j.diabres.2010.03.014; Damci T, 2003, EUR J CLIN INVEST, V33, P397, DOI 10.1046/j.1365-2362.2003.01161.x; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Donath MY, 2014, DIABETOLOGIA, V57, P653, DOI 10.1007/s00125-013-3153-0; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Endesfelder D, 2014, DIABETES, V63, P2006, DOI 10.2337/db13-1676; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Mejia-Leon ME, 2014, SCI REP-UK, V4, DOI 10.1038/srep03814; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Goto Y, 2013, IMMUNOL CELL BIOL, V91, P204, DOI 10.1038/icb.2012.80; Heptulla RA, 2008, PEDIATR DIABETES, V9, P561, DOI 10.1111/j.1399-5448.2008.00430.x; Huber S, 2012, EUR J IMMUNOL, V42, P2238, DOI 10.1002/eji.201242619; Ilonen J, 2002, AM J MED GENET, V115, P30, DOI 10.1002/ajmg.10341; Katakami N, 2007, DIABETES CARE, V30, P159, DOI 10.2337/dc06-1768; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Korsgren S, 2012, AM J PATHOL, V181, P1735, DOI 10.1016/j.ajpath.2012.07.022; Le Bourhis L, 2013, CURR OPIN IMMUNOL, V25, P174, DOI 10.1016/j.coi.2013.01.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lee OJ, 2014, EXP GERONTOL, V49, P47, DOI 10.1016/j.exger.2013.11.003; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; McCarthy NE, 2013, J IMMUNOL, V191, P2752, DOI 10.4049/jimmunol.1202959; Mortensen HB, 2010, PEDIATR DIABETES, V11, P218, DOI 10.1111/j.1399-5448.2009.00566.x; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Reutens AT, 2013, MED CLIN N AM, V97, P1, DOI 10.1016/j.mcna.2012.10.001; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Sapone A, 2006, DIABETES, V55, P1443, DOI 10.2337/db05-1593; Savilahti E, 1999, CLIN EXP IMMUNOL, V116, P70; Secondulfo M, 2004, DIGEST LIVER DIS, V36, P35, DOI 10.1016/j.dld.2003.09.016; Skog O, 2013, CURR OPIN ENDOCRINOL, V20, P118, DOI 10.1097/MED.0b013e32835edb89; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; Sorini C, 2013, AM J CLIN EXP IMMUNO, V2, P156; Soyucen E, 2014, PEDIATR INT, V56, P336, DOI 10.1111/ped.12243; Thaiss CA, 2014, CURR OPIN IMMUNOL, V26, P41, DOI 10.1016/j.coi.2013.10.016; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Westerholm-Ormio M, 2003, DIABETES, V52, P2287, DOI 10.2337/diabetes.52.9.2287	58	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117335	10.1371/journal.pone.0117335	http://dx.doi.org/10.1371/journal.pone.0117335			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625430	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821400031
J	Langaee, T; Hamadeh, I; Chapman, AB; Gums, JG; Johnson, JA				Langaee, Taimour; Hamadeh, Issam; Chapman, Arlene B.; Gums, John G.; Johnson, Julie A.			A Novel Simple Method for Determining CYP2D6 Gene Copy Number and Identifying Allele(s) with Duplication/Multiplication	PLOS ONE			English	Article							DELETION; STRATEGY; LOCUS	Background Cytochrome P450 2D6 (CYP2D6) gene duplication and multiplication can result in ultrarapid drug metabolism and therapeutic failure or excessive response in patients. Long range polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP) and sequencing are usually used for genotyping CYP2D6 duplication/multiplications and identification, but are labor intensive, time consuming, and costly. Methods We developed a simple allele quantification-based Pyrosequencing genotyping method that facilitates CYP2D6 copy number variation (CNV) genotyping while also identifying allele-specific CYP2D6 CNV in heterozygous samples. Most routine assays do not identify the allele containing a CNV. A total of 237 clinical and Coriell DNA samples with different known CYP2D6 gene copy numbers were genotyped for CYP2D6 *2, *3, *4, *6, *10, *17, *41 polymorphisms and CNV determination. Results The CYP2D6 gene allele quantification/identification were determined simultaneously with CYP2D6*2, *3, *4, *6, *10, *17, *41 genotyping. We determined the exact CYP2D6 gene copy number, identified which allele had the duplication or multiplication, and assigned the correct phenotype and activity score for all samples. Conclusions Our method can efficiently identify the duplicated CYP2D6 allele in heterozygous samples, determine its copy number in a fraction of time compared to conventional methods and prevent incorrect ultrarapid phenotype calls. It also greatly reduces the cost, effort and time associated with CYP2D6 CNV genotyping.	[Langaee, Taimour; Hamadeh, Issam; Gums, John G.; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA; [Langaee, Taimour; Hamadeh, Issam; Gums, John G.; Johnson, Julie A.] Univ Florida, Coll Pharm, Ctr Pharmacogen, Gainesville, FL USA; [Chapman, Arlene B.] Emory Univ, Sch Med, Dept Med, Div Renal, Atlanta, GA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Emory University	Johnson, JA (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32611 USA.	Johnson@cop.ufl.edu			National Institute of General Medical Sciences (NIGMS) [U01 GM074492]; National Institutes of Health; National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trial Implementation Cooperative Agreement [U01, U01 HG007269]; NIH [UL1 TR000064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trial Implementation Cooperative Agreement; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Sciences (NIGMS) U01 GM074492, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) Clinical Trial Implementation (U01) Cooperative Agreement, U01 HG007269 and the UL1 administratively linked to another project or projects to support clinical and translational research, NIH award UL1 TR000064.	Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287; Dorado P, 2005, BIOTECHNIQUES, V39, P571, DOI 10.2144/000112044; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; Gaedigk A, 2008, CLIN PHARMACOL THER, V83, P234, DOI 10.1038/sj.clpt.6100406; Gaedigk A, 2007, CLIN PHARMACOL THER, V81, P242, DOI 10.1038/sj.clpt.6100033; GAEDIGK A, 1991, AM J HUM GENET, V48, P943; Gaedigk A, 2012, PHARMACOGENOMICS, V13, P91, DOI [10.2217/PGS.11.135, 10.2217/pgs.11.135]; GONZALEZ F J, 1988, Genomics, V2, P174, DOI 10.1016/0888-7543(88)90100-0; HAMADEH IS, 2014, CLIN PHARM THER, P42331; Hosono N, 2009, CLIN CHEM, V55, P1546, DOI 10.1373/clinchem.2009.123620; KIMURA S, 1989, AM J HUM GENET, V45, P889; Kramer WE, 2009, PHARMACOGENET GENOM, V19, P813, DOI 10.1097/FPC.0b013e3283317b95; Langaee T, 2005, MUTAT RES-FUND MOL M, V573, P96, DOI 10.1016/j.mrfmmm.2004.07.023; Leandro-Garcia LJ, 2009, ANAL BIOCHEM, V389, P74, DOI 10.1016/j.ab.2009.03.021; Meijerman I, 2007, DRUG METAB REV, V39, P45, DOI 10.1080/03602530600952206; Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090; Ramamoorthy A, 2010, PHARMACOGENET GENOM, V20, P451, DOI 10.1097/FPC.0b013e32833a1083; Schaeffeler E, 2003, HUM MUTAT, V22, P476, DOI 10.1002/humu.10280; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soderback E, 2005, CLIN CHEM, V51, P522, DOI 10.1373/clinchem.2004.043182	20	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0113808	10.1371/journal.pone.0113808	http://dx.doi.org/10.1371/journal.pone.0113808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625348	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821400002
J	Stoler-Barak, L; Petrovich, E; Aychek, T; Gurevich, I; Tal, O; Hatzav, M; Ilan, N; Feigelson, SW; Shakhar, G; Vlodavsky, I; Alon, R				Stoler-Barak, Liat; Petrovich, Ekaterina; Aychek, Tegest; Gurevich, Irina; Tal, Orna; Hatzav, Miki; Ilan, Neta; Feigelson, Sara W.; Shakhar, Guy; Vlodavsky, Israel; Alon, Ronen			Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation	FASEB JOURNAL			English	Article						extracellular matrix; extravasation; heparan sulfate; leukocytes; postcapillary venules	SUBENDOTHELIAL EXTRACELLULAR-MATRIX; REACTIVE LYMPH-NODES; SULFATE PROTEOGLYCANS; MAMMALIAN HEPARANASE; DENDRITIC CELLS; T-CELLS; REGULATES DEGRADATION; ENZYME HEPARANASE; CANCER METASTASIS; BASEMENT-MEMBRANE	Heparanase, the exclusive mammalian heparan sulfate-degrading enzyme, has been suggested to be utilized by leukocytes to penetrate through the dense basement membranes surrounding blood venules. Despite its established role in tumor cell invasion, heparanase function in leukocyte extravasation has never been demonstrated. We found that T(H)1/T(C)1-type effector T cells are highly enriched for this enzyme, with a 3.6-fold higher heparanase mRNA expression compared with naive lymphocytes. Using adoptive transfer of wild-type and heparanase-deficient effector T cells into inflamed mice, we show that T-cell heparanase was not required for extravasation inside inflamed lymph nodes or skin. Leukocyte extravasation through acute inflamed skin vessels was also heparanase independent. Furthermore, neutrophils emigrated to the inflamed peritoneal cavity independently of heparanase expression on either the leukocytes or on the endothelial and mesothelial barriers, and overexpression of the enzyme on neutrophils did not facilitate their emigration. However, heparanase absence significantly reduced monocyte emigration into the inflamed peritoneal cavity. These results collectively suggest that neither leukocyte nor endothelial heparanase is required for T-cell and neutrophil extravasation through inflamed vascular barriers, whereas this enzyme is required for optimal monocyte recruitment to inflamed peritoneum.	[Stoler-Barak, Liat; Petrovich, Ekaterina; Aychek, Tegest; Gurevich, Irina; Tal, Orna; Hatzav, Miki; Feigelson, Sara W.; Shakhar, Guy; Alon, Ronen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Alon, R (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ronen.alon@weizmann.ac.il	ALON, RONEN/GRX-6987-2022	Kopitman, Ekaterina/0000-0002-6050-6404; Alon, Ronen/0000-0001-9161-6369	German-Israeli Foundation; Israel Science Foundation; Flight Attendant Medical Research Institute Foundation; Minerva Foundation, Germany	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Flight Attendant Medical Research Institute Foundation; Minerva Foundation, Germany	The authors thank Dr. Jin-Ping Li (Department of Medical Biochemistry and Microbiology, University of Uppsala, Uppsala, Sweden) for generating the heparanase-knockout mice. The authors also thank Yochai Wolf for intellectual assistance. R.A. is an incumbent of the Linda Jacobs Chair in Immune and Stem Cell Research, and his research is supported by the German-Israeli Foundation, the Israel Science Foundation, the U.S.-Israel Binational Science Foundation, the Flight Attendant Medical Research Institute Foundation, and the Minerva Foundation, Germany. The authors declare no conflicts of interest.	Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; Arvatz G, 2011, CANCER METAST REV, V30, P253, DOI 10.1007/s10555-011-9288-x; BARTLETT MR, 1995, IMMUNOL CELL BIOL, V73, P113, DOI 10.1038/icb.1995.19; Benhamron S, 2006, J IMMUNOL, V176, P6417, DOI 10.4049/jimmunol.176.11.6417; Benhamron S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035602; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Cohen SJ, 2013, BLOOD, V122, P2609, DOI 10.1182/blood-2013-04-495036; Cunha TM, 2006, J LEUKOCYTE BIOL, V80, P727, DOI 10.1189/jlb.0406244; Davis DAS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00470; de Mestre AM, 2007, J LEUKOCYTE BIOL, V82, P1289, DOI 10.1189/jlb.0507315; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; FRIDMAN R, 1987, J CELL PHYSIOL, V130, P85, DOI 10.1002/jcp.1041300113; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; Goode KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109596; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; He YQ, 2012, TRANSCR-AUSTIN, V3, P130, DOI 10.4161/trns.19998; Hermano E, 2012, CELL MOL LIFE SCI, V69, P2501, DOI 10.1007/s00018-012-0930-8; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; LIDER O, 1990, EUR J IMMUNOL, V20, P493, DOI 10.1002/eji.1830200306; LIDER O, 1995, P NATL ACAD SCI USA, V92, P5037, DOI 10.1073/pnas.92.11.5037; Lu CL, 2010, BLOOD, V115, P221, DOI 10.1182/blood-2009-06-228494; Maletto BA, 2006, BLOOD, V108, P3094, DOI 10.1182/blood-2006-04-016659; Martin-Fontecha A, 2008, J EXP MED, V205, P2561, DOI 10.1084/jem.20081212; MATZNER Y, 1985, J CLIN INVEST, V76, P1306, DOI 10.1172/JCI112104; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; MULLIGAN MS, 1992, J IMMUNOL, V148, P1847; Nadir Y, 2014, THROMB RES, V133, pS90, DOI 10.1016/S0049-3848(14)50015-1; NAPARSTEK Y, 1984, NATURE, V310, P241, DOI 10.1038/310241a0; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Parish CR, 1998, IMMUNOL CELL BIOL, V76, P104, DOI 10.1046/j.1440-1711.1998.00722.x; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Poon IKH, 2014, EUR J IMMUNOL, V44, P1016, DOI 10.1002/eji.201343645; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Sanderson RD, 2005, J CELL BIOCHEM, V96, P897, DOI 10.1002/jcb.20602; Sasaki N, 2004, J IMMUNOL, V172, P3830, DOI 10.4049/jimmunol.172.6.3830; SEWELL RF, 1989, BIOCHEM J, V264, P777, DOI 10.1042/bj2640777; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Sotnikov I, 2004, J IMMUNOL, V172, P5185, DOI 10.4049/jimmunol.172.9.5185; Spiegel A, 2008, BLOOD, V111, P4934, DOI 10.1182/blood-2007-10-116145; Stoler-Barak L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085699; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2013, MATRIX BIOL, V32, P220, DOI 10.1016/j.matbio.2013.03.001; Zcharia E, 2005, FASEB J, V19, P211, DOI 10.1096/fj.04-1970com; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181; Zhang JH, 2005, CELL MOL IMMUNOL, V2, P271	56	22	23	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2010	2021		10.1096/fj.14-265447	http://dx.doi.org/10.1096/fj.14-265447			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25634957				2022-12-26	WOS:000354114600034
J	Wadhwa, R; Ryu, J; Ahn, HM; Saxena, N; Chaudhary, A; Yun, CO; Kaul, SC				Wadhwa, Renu; Ryu, Jihoon; Ahn, Hyo Min; Saxena, Nishant; Chaudhary, Anupama; Yun, Chae-Ok; Kaul, Sunil C.			Functional Significance of Point Mutations in Stress Chaperone Mortalin and Their Relevance to Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEIN L11; CELLULAR SENESCENCE; INDUCED APOPTOSIS; CANCER-CELLS; MOLECULAR CHAPERONES; HUMAN FIBROBLASTS; OXIDATIVE STRESS; HSP70 FAMILY; MOUSE MOT-1; IN-VITRO	Mortalin/mtHsp70/Grp75 (mot-2), a heat shock protein 70 family member, is an essential chaperone, enriched in cancers, and has been shown to possess pro-proliferative and anti-apoptosis functions. An allelic form of mouse mortalin (mot-1) that differs by two amino acids, M618V and G624R, in the C terminus substrate-binding domain has been reported. Furthermore, genome sequencing of mortalin from Parkinson disease patients identified two missense mutants, R126W and P509S. In the present study, we investigated the significance of these mutations in survival, proliferation, and oxidative stress tolerance in human cells. Using mot-1 and mot-2 recombinant proteins and specific antibodies, we performed screening to find their binding proteins and then identified ribosomal protein L-7 (RPL-7) and elongation factor-1 alpha (EF-1 alpha), which differentially bind to mot-1 and mot-2, respectively. We demonstrate that mot-1, R126W, or P509S mutant (i) lacks mot-2 functions involved in carcinogenesis, such as p53 inactivation and hTERT/hnRNP-K (heterogeneous nuclear ribonucleoprotein K) activation; (ii) causes increased level of endogenous oxidative stress; (iii) results in decreased tolerance of cells to exogenous oxidative stress; and (iv) shows differential binding and impact on the RPL-7 and EF-1 alpha proteins. These factors may mediate the transformation of longevity/pro-proliferative function of mot-2 to the premature aging/anti-proliferative effect of mutants, and hence may have significance in cellular aging, Parkinson disease pathology, and prognosis.	[Wadhwa, Renu; Ryu, Jihoon; Ahn, Hyo Min; Saxena, Nishant; Chaudhary, Anupama; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Int Lab Adv Biomedicine DAILAB, Cell Proliferat Res Grp, Tsukuba, Ibaraki 3058562, Japan; [Wadhwa, Renu; Ryu, Jihoon; Ahn, Hyo Min; Saxena, Nishant; Chaudhary, Anupama; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Int Lab Adv Biomedicine DAILAB, Dept Biotechnol DBT India, Tsukuba, Ibaraki 3058562, Japan; [Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Hanyang University	Yun, CO (corresponding author), Hanyang Univ, Coll Engn, Dept Bioengn, 222 Wangsimni Ro, Seoul 133791, South Korea.	chaeok@hanyang.ac.kr; s-kaul@aist.go.jp	Wadhwa, Renu/L-8898-2018; Yun, Chae-Ok/P-3698-2015; Chaudhary, Anupama/AAF-8156-2020; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Chaudhary, Anupama/0000-0001-9619-8813; Kaul, Sunil C/0000-0002-0046-3916; Yun, Chae-Ok/0000-0002-9466-4531	Japanese Society for the Promotion of Science, Japan; Korea Food and Drug Administration [13172KFDA306]; Korea Science, Engineering Foundation [2010-0029220, 2013K1A1A2A02050188, 2013M3A9D3045879]	Japanese Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Korea Science, Engineering Foundation(Korea Science and Engineering Foundation)	This study was partly supported by grants-in-aid for scientific research (Kakenhi) from the Japanese Society for the Promotion of Science, Japan (to S. C. K.) and grants from the Korea Food and Drug Administration (13172KFDA306) and the Korea Science, Engineering Foundation (2010-0029220, 2013K1A1A2A02050188, 2013M3A9D3045879, brain Korea 21 plus) (to C. O. Y.)	Banerjee S, 2014, INT J BIOCHEM CELL B, V54, P36, DOI 10.1016/j.biocel.2014.05.041; Berghofer-Hochheimer Y, 1998, J CELL BIOCHEM, V69, P1, DOI 10.1002/(SICI)1097-4644(19980401)69:1<1::AID-JCB1>3.0.CO;2-X; Blanch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066436; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Burbulla LF, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.103; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cheung CT, 2010, ANN NY ACAD SCI, V1197, P129, DOI 10.1111/j.1749-6632.2009.05392.x; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Dai MS, 2012, J BIOL CHEM, V287, P17120, DOI 10.1074/jbc.M111.311902; De Mena L, 2009, J NEURAL TRANSM, V116, P1289, DOI 10.1007/s00702-009-0273-2; Deocaris CC, 2006, ANN NY ACAD SCI, V1067, P220, DOI 10.1196/annals.1354.027; Gaweda-Walerych K, 2013, CURR GENOMICS, V14, P543, DOI 10.2174/1389202914666131210211033; Giffard RG, 2013, J CLIN INVEST, V123, P3206, DOI 10.1172/JCI70799; GRANT AG, 1992, INT J CANCER, V50, P740, DOI 10.1002/ijc.2910500513; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hayflick L, 1998, EXP GERONTOL, V33, P639, DOI 10.1016/S0531-5565(98)00023-0; HEMMERICH P, 1993, NUCLEIC ACIDS RES, V21, P223, DOI 10.1093/nar/21.2.223; Kaul SC, 1998, ONCOGENE, V17, P907, DOI 10.1038/sj.onc.1202017; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2003, EXP CELL RES, V286, P96, DOI 10.1016/S0014-4827(03)00101-0; Kaul SC, 2000, BIOCHEM BIOPH RES CO, V279, P602, DOI 10.1006/bbrc.2000.3986; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nakabayashi K, 1997, EXP CELL RES, V235, P345, DOI 10.1006/excr.1997.3678; Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Pecorari L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-58; Qu MY, 2012, NEUROSCI RES, V72, P94, DOI 10.1016/j.neures.2011.09.009; Ryu J, 2014, J BIOL CHEM, V289, P24832, DOI 10.1074/jbc.M114.565929; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Shi YQ, 2004, EXP CELL RES, V296, P337, DOI 10.1016/j.yexcr.2004.02.009; Shibata Y, 2014, CURR BIOL, V24, pR463, DOI 10.1016/j.cub.2014.03.033; Shih YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026236; Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v; Soti C, 2003, EXP GERONTOL, V38, P1037, DOI 10.1016/S0531-5565(03)00185-2; Soti C, 2003, AGING CELL, V2, P39, DOI 10.1046/j.1474-9728.2003.00031.x; Strub A, 2003, J MOL BIOL, V334, P1087, DOI 10.1016/j.jmb.2003.10.023; Tai-Nagara I, 2014, BLOOD, V123, P41, DOI 10.1182/blood-2013-06-508333; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; Verbeke P, 2001, FREE RADICAL BIO MED, V31, P1593, DOI 10.1016/S0891-5849(01)00752-3; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; WADHWA R, 1993, J BIOL CHEM, V268, P22239; WADHWA R, 1993, J BIOL CHEM, V268, P6615; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Yang LM, 2011, C IND ELECT APPL, P2011, DOI 10.1109/ICIEA.2011.5975922; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; Zhu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083714	54	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8447	8456		10.1074/jbc.M114.627463	http://dx.doi.org/10.1074/jbc.M114.627463			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645922	Green Published, hybrid			2022-12-26	WOS:000351662600037
J	Liu, MX; Allegood, J; Zhu, XW; Seo, J; Gebre, AK; Boudyguina, E; Cheng, DM; Chuang, CC; Shelness, GS; Spiegel, S; Parks, JS				Liu, Mingxia; Allegood, Jeremy; Zhu, Xuewei; Seo, Jeongmin; Gebre, Abraham K.; Boudyguina, Elena; Cheng, Dongmei; Chuang, Chia-Chi; Shelness, Gregory S.; Spiegel, Sarah; Parks, John S.			Uncleaved ApoM Signal Peptide Is Required for Formation of Large ApoM/Sphingosine 1-Phosphate (S1P)-enriched HDL Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ceramide; Cholesterol; Liver; Sphingolipid; Sphingosine 1-Phosphate (S1P); Apolipoprotein M; Fumonisin B1; High Density Lipoproteins; Myriocin	HIGH-DENSITY-LIPOPROTEIN; PRE-BETA-HDL; PLASMA-MEMBRANE MICROSOLUBILIZATION; REVERSE CHOLESTEROL TRANSPORT; APOLIPOPROTEIN-M; CELLULAR CHOLESTEROL; NASCENT HDL; SPHINGOSINE-1-PHOSPHATE; SECRETION; EFFLUX	Background: ApoM overexpression generates larger nascent and plasma HDLs. Results: ApoM(Q22A) overexpression generates smaller nascent and plasma HDL and enhances apoM and S1P secretion as compared with apoM(WT). Conclusion: ApoM secretion regulates hepatocyte S1P secretion, and its uncleaved signal peptide delays apoM secretion, promoting larger nascent and plasma HDL particle formation. Significance: ApoM signal peptide is required for large apoM/S1P-enriched HDL formation. Apolipoprotein M (apoM), a plasma sphingosine 1-phosphate (S1P) carrier, associates with plasma HDL via its uncleaved signal peptide. Hepatocyte-specific apoM overexpression in mice stimulates formation of both larger nascent HDL in hepatocytes and larger mature apoM/S1P-enriched HDL particles in plasma by enhancing hepatic S1P synthesis and secretion. Mutagenesis of apoM glutamine 22 to alanine (apoM(Q22A)) introduces a functional signal peptidase cleavage site. Expression of apoM(Q22A) in ABCA1-expressing HEK293 cells resulted in the formation of smaller nascent HDL particles compared with wild type apoM (apoM(WT)). When apoM(Q22A) was expressed in vivo, using recombinant adenoviruses, smaller plasma HDL particles and decreased plasma S1P and apoM were observed relative to expression of apoM(WT). Hepatocytes isolated from both apoM(WT)- and apoM(Q22A)-expressing mice displayed an equivalent increase in cellular levels of S1P, relative to LacZ controls; however, relative to apoM(WT), apoM(Q22A) hepatocytes displayed more rapid apoM and S1P secretion but minimal apoM(Q22A) bound to nascent lipoproteins. Pharmacologic inhibition of ceramide synthesis increased cellular sphingosine and S1P but not medium S1P in both apoM(WT) and apoM(Q22A) hepatocytes. We conclude that apoM secretion is rate-limiting for hepatocyte S1P secretion and that its uncleaved signal peptide delays apoM trafficking out of the cell, promoting formation of larger nascent apoM- and S1P-enriched HDL particles that are probably precursors of larger apoM/S1P-enriched plasma HDL.	[Liu, Mingxia; Zhu, Xuewei; Seo, Jeongmin; Gebre, Abraham K.; Boudyguina, Elena; Cheng, Dongmei; Chuang, Chia-Chi; Shelness, Gregory S.; Parks, John S.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Shelness, Gregory S.; Parks, John S.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Allegood, Jeremy; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	Wake Forest University; Wake Forest University; Virginia Commonwealth University	Parks, JS (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jparks@wakehealth.edu		Key, Chia-Chi/0000-0003-0669-2936	National Institutes of Health [P01HL49373, R01HL119962, R37GM043880]; American Heart Association [12PRE12040309]; RJR-Leon Golberg postdoctoral fellowship; National Institutes of Health, NCI, Cancer Center Support Grant [P30 CA016059]; NATIONAL CANCER INSTITUTE [R01CA061774, P30CA016059, P30CA012197] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373, R01HL119962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880, R01GM043880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); RJR-Leon Golberg postdoctoral fellowship; National Institutes of Health, NCI, Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL49373 (to J. S. P. and G. S. S.), R01HL119962 (to J. S. P.), and R37GM043880 (to S. S.). This work was also supported by American Heart Association Predoctoral Fellowship 12PRE12040309 and an RJR-Leon Golberg postdoctoral fellowship (to M. L.). The Lipidomics Core Facility in the Virginia Commonwealth University Biochemistry and Molecular Biology Department is supported in part by funding to the Massey Cancer Center from National Institutes of Health, NCI, Cancer Center Support Grant P30 CA016059.	Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; Ahnstrom J, 2010, PROTEIN PEPTIDE LETT, V17, P1285, DOI 10.2174/092986610792231410; Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bi X, 2013, ARTERIOSCL THROM VAS, V33, P2288, DOI 10.1161/ATVBAHA.112.301110; Boadu E, 2008, CURR OPIN LIPIDOL, V19, P270, DOI 10.1097/MOL.0b013e3282feea99; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; Chisholm JW, 2002, J LIPID RES, V43, P36; Christoffersen C, 2008, J BIOL CHEM, V283, P18765, DOI 10.1074/jbc.M800695200; Christoffersen C, 2008, J BIOL CHEM, V283, P1839, DOI 10.1074/jbc.M704576200; Christoffersen C, 2011, P NATL ACAD SCI USA, V108, P9613, DOI 10.1073/pnas.1103187108; Chung Soonkyu, 2010, J Biol Chem, V285, P12197, DOI 10.1074/jbc.M109.096933; Elsoe S, 2012, ATHEROSCLEROSIS, V221, P91, DOI 10.1016/j.atherosclerosis.2011.11.031; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Gallagher JW, 2004, J LIPID RES, V45, P1826, DOI 10.1194/jlr.M400188-JLR200; Gillotte KL, 1998, J LIPID RES, V39, P1918; Gillotte KL, 1999, J BIOL CHEM, V274, P2021, DOI 10.1074/jbc.274.4.2021; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Karuna R, 2011, ATHEROSCLEROSIS, V219, P855, DOI 10.1016/j.atherosclerosis.2011.08.049; Kontush A, 2010, CURR OPIN LIPIDOL, V21, P312, DOI 10.1097/MOL.0b013e32833bcdc1; Kurano M, 2013, ATHEROSCLEROSIS, V229, P102, DOI 10.1016/j.atherosclerosis.2013.04.024; Liu MX, 2014, J BIOL CHEM, V289, P2801, DOI 10.1074/jbc.M113.499913; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Mulya A, 2008, J LIPID RES, V49, P2390, DOI 10.1194/jlr.M800241-JLR200; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Mulya A, 2010, J LIPID RES, V51, P514, DOI 10.1194/jlr.M002162; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Sorenson RC, 1999, ARTERIOSCL THROM VAS, V19, P2214, DOI 10.1161/01.ATV.19.9.2214; Sutter I, 2014, J LIPID RES, V55, P1730, DOI 10.1194/jlr.M050021; VerHague MA, 2013, ARTERIOSCL THROM VAS, V33, P2501, DOI 10.1161/ATVBAHA.113.301948; WANG E, 1991, J BIOL CHEM, V266, P14486; Weinberg RB, 2012, J LIPID RES, V53, P736, DOI 10.1194/jlr.M019992; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286	38	21	27	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7861	7870		10.1074/jbc.M114.631101	http://dx.doi.org/10.1074/jbc.M114.631101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25627684	Green Published, hybrid			2022-12-26	WOS:000351613600044
J	Cao, XY; Cronan, JE				Cao, Xinyun; Cronan, John E.			The Streptomyces coelicolor Lipoate-protein Ligase Is a Circularly Permuted Version of the Escherichia coli Enzyme Composed of Discrete Interacting Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; LIPOIC ACID; THERMOPLASMA-ACIDOPHILUM; POSTTRANSLATIONAL MODIFICATION; MULTIENZYME COMPLEX; FLUOROPHORE LIGASE; CRYSTAL-STRUCTURE; SWINGING ARMS; LPLA; IDENTIFICATION	Lipoate-protein ligases are used to scavenge lipoic acid from the environment and attach the coenzyme to its cognate proteins, which are generally the E2 components of the 2-oxoacid dehydrogenases. The enzymes use ATP to activate lipoate to its adenylate, lipoyl-AMP, which remains tightly bound in the active site. This mixed anhydride is attacked by the epsilon-amino group of a specific lysine present on a highly conserved acceptor protein domain, resulting in the amide-linked coenzyme. The Streptomyces coelicolor genome encodes only a single putative lipoate ligase. However, this protein had only low sequence identity (<25%) to the lipoate ligases of demonstrated activity and appears to be a circularly permuted version of the known lipoate ligase proteins in that the canonical C-terminal domain seems to have been transposed to the N terminus We tested the activity of this protein both by in vivo complementation of an Escherichia coli ligase-deficient strain and by in vitro assays. Moreover, when the domains were rearranged into a protein that mimicked the arrangement found in the canonical lipoate ligases, the enzyme retained complementation activity. Finally, when the two domains were separated into two proteins, both domain-containing proteins were required for complementation and catalysis of the overall ligase reaction in vitro. However, only the large domain-containing protein was required for transfer of lipoate from the lipoyl-AMP intermediate to the acceptor proteins, whereas both domain-containing proteins were required to form lipoyl-AM	[Cao, Xinyun; Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019		National Institutes of Health from NIAID [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015650, R37AI015650] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650 from NIAID.	ALI ST, 1990, MOL MICROBIOL, V4, P943, DOI 10.1111/j.1365-2958.1990.tb00667.x; ALI ST, 1990, BIOCHEM J, V271, P139, DOI 10.1042/bj2710139; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baruah H, 2008, ANGEW CHEM INT EDIT, V47, P7018, DOI 10.1002/anie.200802088; BERG A, 1994, EUR J BIOCHEM, V221, P87, DOI 10.1111/j.1432-1033.1994.tb18717.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Christensen QH, 2011, J BIOL CHEM, V286, P31447, DOI 10.1074/jbc.M111.273607; Christensen QH, 2011, MOL MICROBIOL, V80, P350, DOI 10.1111/j.1365-2958.2011.07598.x; Christensen QH, 2009, J BIOL CHEM, V284, P21317, DOI 10.1074/jbc.M109.015016; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Cohen JD, 2012, CHEMBIOCHEM, V13, P888, DOI 10.1002/cbic.201100764; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Cronan JE., 2014, ECOSAL PLUS, V6, P1, DOI [10.1128/ecosalplus.ESP-0001-2012, DOI 10.1128/ECOSALPLUS.ESP-0001-2012]; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Fujino T, 2001, J BIOL CHEM, V276, P35961, DOI 10.1074/jbc.M106651200; Fujiwara K, 2001, J BIOL CHEM, V276, P28819, DOI 10.1074/jbc.M101748200; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; Fujiwara K, 2010, J BIOL CHEM, V285, P9971, DOI 10.1074/jbc.M109.078717; Gueguen V, 1999, J BIOL CHEM, V274, P26344, DOI 10.1074/jbc.274.37.26344; GUEST JR, 1985, J MOL BIOL, V185, P743, DOI 10.1016/0022-2836(85)90059-2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HERBERT AA, 1968, J GEN MICROBIOL, V53, P363, DOI 10.1099/00221287-53-3-363; Hermes FAM, 2009, J BACTERIOL, V191, P6796, DOI 10.1128/JB.00798-09; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim DJ, 2005, J BIOL CHEM, V280, P38081, DOI 10.1074/jbc.M507284200; Liu DS, 2014, P NATL ACAD SCI USA, V111, pE4551, DOI 10.1073/pnas.1404736111; Martin N, 2011, MOL MICROBIOL, V80, P335, DOI 10.1111/j.1365-2958.2011.07597.x; McManus E, 2006, J MOL BIOL, V356, P625, DOI 10.1016/j.jmb.2005.11.057; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posner MG, 2013, BIOCHEM J, V449, P415, DOI 10.1042/BJ20121150; Posner MG, 2009, FEBS J, V276, P4012, DOI 10.1111/j.1742-4658.2009.07110.x; Reche P, 1999, EMBO J, V18, P2673, DOI 10.1093/emboj/18.10.2673; REED LJ, 1958, J BIOL CHEM, V232, P143; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Uttamapinant C, 2010, P NATL ACAD SCI USA, V107, P10914, DOI 10.1073/pnas.0914067107; Vessey DA, 2003, J BIOCHEM MOL TOXIC, V17, P1, DOI 10.1002/jbt.10056; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	44	10	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7280	7290		10.1074/jbc.M114.626879	http://dx.doi.org/10.1074/jbc.M114.626879			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631049	hybrid, Green Published			2022-12-26	WOS:000350991500056
J	Sanchez-Casalongue, ME; Lee, J; Diamond, A; Shuldiner, S; Moir, RD; Willis, IM				Sanchez-Casalongue, Manuel E.; Lee, Jaehoon; Diamond, Aviva; Shuldiner, Scott; Moir, Robyn D.; Willis, Ian M.			Differential Phosphorylation of a Regulatory Subunit of Protein Kinase CK2 by Target of Rapamycin Complex 1 Signaling and the Cdc-like Kinase Kns1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-III; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; BETA-SUBUNIT; CRYSTAL-STRUCTURE; GLOBAL ANALYSIS; TRANSCRIPTION; YEAST; ACTIVATION; CELL	Transcriptional regulation of ribosome and tRNA synthesis plays a central role in determining protein synthetic capacity and is tightly controlled in response to nutrient availability and cellular stress. In Saccharomyces cerevisiae, the regulation of ribosome and tRNA synthesis was recently shown to involve the Cdc-like kinase Kns1 and the GSK-3 kinase Mck1. In this study, we explored additional roles for these conserved kinases in processes connected to the target of rapamycin complex 1 (TORC1). We conducted a synthetic chemical-genetic screen in a kns1 Delta mck1 Delta strain and identified many novel rapamycin-hypersensitive genes. Gene ontology analysis showed enrichment for TORC1-regulated processes (vesicle-mediated transport, autophagy, and regulation of cell size) and identified new connections to protein complexes including the protein kinase CK2. CK2 is considered to be a constitutively active kinase and in budding yeast, the holoenzyme comprises two regulatory subunits, Ckb1 and Ckb2, and two catalytic subunits, Cka1 and Cka2. We show that Ckb1 is differentially phosphorylated in vivo and that Kns1 mediates this phosphorylation when nutrients are limiting and under all tested stress conditions. We determined that the phosphorylation of Ckb1 does not detectably affect the stability of the CK2 holoenzyme but correlates with the reduced occupancy of Ckb1 on tRNA genes after rapamycin treatment. Thus, the differential occupancy of tRNA genes by CK2 is likely to modulate its activation of RNA polymerase III transcription. Our data suggest that TORC1, via its effector kinase Kns1, may regulate the association of CK2 with some of its substrates by phosphorylating Ckb1.	[Sanchez-Casalongue, Manuel E.; Lee, Jaehoon; Diamond, Aviva; Shuldiner, Scott; Moir, Robyn D.; Willis, Ian M.] Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Sanchez-Casalongue, Manuel E.; Lee, Jaehoon; Diamond, Aviva; Shuldiner, Scott; Moir, Robyn D.; Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Willis, IM (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ian.willis@einstein.yu.edu		Willis, Ian/0000-0001-6599-2395	National Institutes of Health [RO1 GM085177]; Albert Einstein College of Medicine; Medical Scientist Training Program from National Institutes of Health, NIGMS [T32-GM007288]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, R01GM085177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; Medical Scientist Training Program from National Institutes of Health, NIGMS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM085177 (to I. M. W.) and the Albert Einstein College of Medicine.; Supported by the Medical Scientist Training Program Grant T32-GM007288 from the National Institutes of Health, NIGMS.	Acker J, 2013, BBA-GENE REGUL MECH, V1829, P283, DOI 10.1016/j.bbagrm.2012.10.002; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Bibby AC, 2005, INT J BIOL SCI, V1, P67; BIDWAI AP, 1994, ARCH BIOCHEM BIOPHYS, V309, P348, DOI 10.1006/abbi.1994.1123; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; BOLDYREFF B, 1994, J BIOL CHEM, V269, P4827; Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Campbell KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018408; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cho BR, 2014, MOL MICROBIOL, V93, P306, DOI 10.1111/mmi.12660; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Faresse NJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003028; Farley AR, 2011, J PROTEOME RES, V10, P1481, DOI 10.1021/pr100877m; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghavidel A, 2001, CELL, V106, P575, DOI 10.1016/S0092-8674(01)00473-1; Ghavidel A, 1997, GENE DEV, V11, P2780, DOI 10.1101/gad.11.21.2780; Gjidoda A, 2013, BBA-GENE REGUL MECH, V1829, P385, DOI 10.1016/j.bbagrm.2012.09.011; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Graczyk D, 2011, P NATL ACAD SCI USA, V108, P4926, DOI 10.1073/pnas.1010010108; Graham KC, 2000, J BIOL CHEM, V275, P5003, DOI 10.1074/jbc.275.7.5003; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; Hannan KM, 2013, BBA-GENE REGUL MECH, V1829, P342, DOI 10.1016/j.bbagrm.2012.10.014; Hockman DJ, 1996, MOL CELL BIOL, V16, P892; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hu P, 2004, MOL CELL, V16, P81, DOI 10.1016/j.molcel.2004.09.008; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Johnston IM, 2002, MOL CELL BIOL, V22, P3757, DOI 10.1128/MCB.22.11.3757-3768.2002; Kim HS, 2014, CELL REP, V6, P892, DOI 10.1016/j.celrep.2014.01.029; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee J, 2012, MOL CELL, V45, P836, DOI 10.1016/j.molcel.2012.01.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Moir RD, 2012, J BIOL CHEM, V287, P30833, DOI 10.1074/jbc.M112.378828; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; PADMANABHA R, 1987, J BIOL CHEM, V262, P1829; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Rudra D, 2007, MOL CELL BIOL, V27, P4815, DOI 10.1128/MCB.02062-06; Sanchez-Casalongue M., 2014, THESIS A EINSTEIN CO; Silva AC, 2012, J BIOL CHEM, V287, P1709, DOI 10.1074/jbc.M111.316489; Soragni E, 2008, J BIOL CHEM, V283, P26568, DOI 10.1074/jbc.M803769200; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; Tong AHY, 2007, METHOD MICROBIOL, V36, P369, DOI 10.1016/S0580-9517(06)36016-3; Tripodi F, 2011, MOL CELL BIOCHEM, V356, P269, DOI 10.1007/s11010-011-0958-3; Umekawa M., 2012, INT J CELL BIOL, V2012, DOI [DOI 10.1155/2012/142634, 10.1155/ 2012/142634]; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; White RJ, 2008, TRENDS GENET, V24, P622, DOI 10.1016/j.tig.2008.10.003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Young BP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-354; Zhang CJ, 2002, ONCOGENE, V21, P3754, DOI 10.1038/sj.onc.1205467	62	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7221	7233		10.1074/jbc.M114.626523	http://dx.doi.org/10.1074/jbc.M114.626523			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631054	Green Published, hybrid			2022-12-26	WOS:000350991500051
J	Sakurai, A; Takayama, K; Nomura, N; Kajiwara, N; Okamatsu, MS; Yamamoto, N; Tamura, T; Yamada, J; Hashimoto, M; Sakoda, Y; Suda, Y; Kobayashi, Y; Kida, H; Shibasaki, F				Sakurai, Akira; Takayama, Katsuyoshi; Nomura, Namiko; Kajiwara, Naoki; Okamatsu, Masatoshi; Yamamoto, Naoki; Tamura, Tsuruki; Yamada, Jitsuho; Hashimoto, Masako; Sakoda, Yoshihiro; Suda, Yoshihiko; Kobayashi, Yukuharu; Kida, Hiroshi; Shibasaki, Futoshi			Fluorescent Immunochromatography for Rapid and Sensitive Typing of Seasonal Influenza Viruses	PLOS ONE			English	Article							A H7N9 VIRUS; HUMAN INFECTION; H5N1 VIRUS; EVOLUTIONARY PATTERN; UNITED-STATES; B VIRUS; ORIGIN; LINEAGES; HUMANS; TRANSMISSION	Lateral flow tests also known as Immunochromatography (IC) is an antigen-detection method conducted on a nitrocellulose membrane that can be completed in less than 20 min. IC has been used as an important rapid test for clinical diagnosis and surveillance of influenza viruses, but the IC sensitivity is relatively low (approximately 60%) and the limit of detection (LOD) is as low as 10(3) pfu per reaction. Recently, we reported an improved IC assay using antibodies conjugated with fluorescent beads (fluorescent immunochromatography; FLIC) for subtyping H5 influenza viruses (FLIC-H5). Although the FLIC strip must be scanned using a fluorescent reader, the sensitivity (LOD) is significantly improved over that of conventional IC methods. In addition, the antibodies which are specific against the subtypes of influenza viruses cannot be available for the detection of other subtypes when the major antigenicity will be changed. In this study, we established the use of FLIC to type seasonal influenza A and B viruses (FLIC-AB). This method has improved sensitivity to 100-fold higher than that of conventional IC methods when we used several strains of influenza viruses. In addition, FLIC-AB demonstrated the ability to detect influenza type A and influenza type B viruses from clinical samples with high sensitivity and specificity (Type A: sensitivity 98.7% (74/75), specificity 100% (54/54), Type B: sensitivity 100% (90/90), specificity 98.2% (54/55) in nasal swab samples) in comparison to the results of qRT-PCR. And furthermore, FLIC-AB performs better in the detection of early stage infection (under 13h) than other conventional IC methods. Our results provide new strategies to prevent the early-stage transmission of influenza viruses in humans during both seasonal outbreaks and pandemics.	[Sakurai, Akira; Nomura, Namiko; Kajiwara, Naoki; Hashimoto, Masako; Kobayashi, Yukuharu; Shibasaki, Futoshi] Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, Tokyo 113, Japan; [Takayama, Katsuyoshi; Kobayashi, Yukuharu] ADTEC Co LTD, Oita, Japan; [Okamatsu, Masatoshi; Yamamoto, Naoki; Sakoda, Yoshihiro; Kida, Hiroshi] Hokkaido Univ, Microbiol Lab, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Yamamoto, Naoki] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Tamura, Tsuruki; Yamada, Jitsuho; Suda, Yoshihiko] Konica Minolta Inc, Tokyo, Japan; [Sakoda, Yoshihiro; Kida, Hiroshi] Hokkaido Univ, Global Stn Zoonosis Control, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan	Tokyo Metropolitan Institute of Medical Science; Hokkaido University; Tokyo Metropolitan Institute of Medical Science; Konica Minolta Inc.; Hokkaido University	Shibasaki, F (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Mol Med Res, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 113, Japan.	shibasaki-ft@igakuken.or.jp			Ministry of Economy, Trade, and Industry, Japan [2010FY]; Japan Society for the Promotion of Science KAKENHI [23659069, 23659314, 25860420]; Ministry of Education, Culture, Sports, Science; Tokyo Metropolitan Government	Ministry of Economy, Trade, and Industry, Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Metropolitan Government(Tokyo Metropolitan Government)	This work was supported by grants from Ministry of Economy, Trade, and Industry, Japan as a part of "Program to support collaboration between hospitals and businesses for development and improvement of medical equipment and devices to solve unmet medical needs" (supplementary budget, 2010FY), Japan Society for the Promotion of Science KAKENHI (Grant Numbers 23659069 [FS], 23659314 [AS] and 25860420 [AS]), a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and by some part of the special grant from Tokyo Metropolitan Government (FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Bowman AS, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.33; Centers for Disease Control and Preventation, 2013, 1 H3N2V OUTBR 2013 R; Chan KH, 2007, J CLIN VIROL, V38, P169, DOI 10.1016/j.jcv.2006.11.010; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Cruz AT, 2006, ANN EMERG MED, V47, P250, DOI 10.1016/j.annemergmed.2005.10.019; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; DiOrio Mary, 2012, Morbidity and Mortality Weekly Report, V61, P764; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Indiana State Department of Health, 2013, HLTH OFF ENC HOOS PR; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Kamigaki T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1139; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Keitel K, 2011, EUR J PEDIATR, V170, P511, DOI 10.1007/s00431-010-1326-0; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Mok C. K., 2013, MBIO, V4, P4, DOI DOI 10.1128/MBIO.01006-13; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Sakai-Tagawa Y, 2010, J CLIN MICROBIOL, V48, P2872, DOI 10.1128/JCM.00439-10; Sakurai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076753; Sakurai A, 2012, VIRUSES-BASEL, V4, P1235, DOI 10.3390/v4081235; Sakurai A, 2011, J VIROL METHODS, V178, P75, DOI 10.1016/j.jviromet.2011.08.015; Sasaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050670; Shichinohe S, 2013, VET MICROBIOL, V164, P39, DOI 10.1016/j.vetmic.2013.01.041; Shu B, 2012, VIROLOGY, V422, P151, DOI 10.1016/j.virol.2011.10.016; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Wada A, 2011, J VIROL METHODS, V178, P82, DOI 10.1016/j.jviromet.2011.08.017; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Webster RG, 1997, ARCH VIROL, P105; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; WHO, 2013, CUM NUMB CONF HUM CA; WHO, 2020, PAND INFL RISK MAN W; World Health Organization, 2010, H1N1 IN POSTP PER; World Health Organization, 2010, PAND H1N1 2009 UPD 1; World Health Organization, 2013, 9 WHO, V14, P45; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3	44	13	14	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116715	10.1371/journal.pone.0116715	http://dx.doi.org/10.1371/journal.pone.0116715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25650570	Green Published, Green Submitted, gold			2022-12-26	WOS:000349250700005
J	Sussan, TE; Gajghate, S; Thimmulappa, RK; Ma, JF; Kim, JH; Sudini, K; Consolini, N; Cormier, SA; Lomnicki, S; Hasan, F; Pekosz, A; Biswal, S				Sussan, Thomas E.; Gajghate, Sachin; Thimmulappa, Rajesh K.; Ma, Jinfang; Kim, Jung-Hyun; Sudini, Kuladeep; Consolini, Nicola; Cormier, Stephania A.; Lomnicki, Slawo; Hasan, Farhana; Pekosz, Andrew; Biswal, Shyam			Exposure to Electronic Cigarettes Impairs Pulmonary Anti-Bacterial and Anti-Viral Defenses in a Mouse Model	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; VIRUS M2 PROTEIN; ACETYLCHOLINE-RECEPTORS; ALVEOLAR MACROPHAGES; INFLUENZA-VIRUS; CELL RESPONSE; IMPACT; SUSCEPTIBILITY; PHAGOCYTOSIS; INFLAMMATION	Electronic cigarettes (E-cigs) have experienced sharp increases in popularity over the past five years due to many factors, including aggressive marketing, increased restrictions on conventional cigarettes, and a perception that E-cigs are healthy alternatives to cigarettes. Despite this perception, studies on health effects in humans are extremely limited and in vivo animal models have not been generated. Presently, we determined that E-cig vapor contains 7x10(11) free radicals per puff. To determine whether E-cig exposure impacts pulmonary responses in mice, we developed an inhalation chamber for E-cig exposure. Mice that were exposed to E-cig vapor contained serum cotinine concentrations that are comparable to human E-cig users. E-cig exposure for 2 weeks produced a significant increase in oxidative stress and moderate macrophage-mediated inflammation. Since, COPD patients are susceptible to bacterial and viral infections, we tested effects of E-cigs on immune response. Mice that were exposed to E-cig vapor showed significantly impaired pulmonary bacterial clearance, compared to air-exposed mice, following an intranasal infection with Streptococcus pneumonia. This defective bacterial clearance was partially due to reduced phagocytosis by alveolar macrophages from E-cig exposed mice. In response to Influenza A virus infection, E-cig exposed mice displayed increased lung viral titers and enhanced virus-induced illness and mortality. In summary, this study reports a murine model of E-cig exposure and demonstrates that E-cig exposure elicits impaired pulmonary anti-microbial defenses. Hence, E-cig exposure as an alternative to cigarette smoking must be rigorously tested in users for their effects on immune response and susceptibility to bacterial and viral infections.	[Sussan, Thomas E.; Gajghate, Sachin; Thimmulappa, Rajesh K.; Ma, Jinfang; Kim, Jung-Hyun; Sudini, Kuladeep; Consolini, Nicola] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Cormier, Stephania A.] Univ Tennessee, Childrens Res Fdn Inst, Hlth Sci Ctr, Memphis, TN 37996 USA; [Lomnicki, Slawo] Louisiana State Univ, Dept Environm Sci, Baton Rouge, LA 70803 USA; [Hasan, Farhana] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [Pekosz, Andrew] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Tennessee System; University of Tennessee Health Science Center; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sussan, TE (corresponding author), Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	tsussan1@jhu.edu; sbiswal@jhu.edu	Thimmulappa, Rajesh/AAW-5013-2021; Cormier, Stephania A/I-7382-2017	Thimmulappa, Rajesh/0000-0001-6050-1323; Cormier, Stephania A/0000-0002-6050-6172; Pekosz, Andrew/0000-0003-3248-1761; Sussan, Thomas/0000-0002-5240-4299	Young Clinical Scientist Awards from Flight Attendant Medical Research Institute (FAMRI); Clinical Innovator Award from FAMRI; National Institutes of Health (NIH) [R01CA140492, P50CA058184]; NATIONAL CANCER INSTITUTE [R01CA140492, P50CA058184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015050] Funding Source: NIH RePORTER	Young Clinical Scientist Awards from Flight Attendant Medical Research Institute (FAMRI); Clinical Innovator Award from FAMRI; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	TES and RKTare supported in part by Young Clinical Scientist Awards from Flight Attendant Medical Research Institute (FAMRI). SB is supported by a Clinical Innovator Award from FAMRI and National Institutes of Health (NIH) grants R01CA140492 and P50CA058184. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Benowitz NL, 2004, J PHARMACOL EXP THER, V310, P1208, DOI 10.1124/jpet.104.066902; Berenson CS, 2006, J INFECT DIS, V194, P1375, DOI 10.1086/508428; Bertholon JF, 2013, RESPIRATION, V86, P433, DOI 10.1159/000353253; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Etter JF, 2014, ADDICTION, V109, P825, DOI 10.1111/add.12475; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Flouris AD, 2013, INHAL TOXICOL, V25, P91, DOI 10.3109/08958378.2012.758197; Giebelen IAJ, 2009, EUR RESPIR J, V33, P375, DOI 10.1183/09031936.00103408; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Grantham ML, 2010, J VIROL, V84, P8765, DOI 10.1128/JVI.00853-10; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Kim HJ, 2013, J CHROMATOGR A, V1291, P48, DOI 10.1016/j.chroma.2013.03.035; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Mahapatra SK, 2011, INT IMMUNOPHARMACOL, V11, P485, DOI 10.1016/j.intimp.2010.12.020; Manani Madhu, 2013, Perm J, V17, P8, DOI 10.7812/TPP/12-130; Matsunaga K, 2001, J IMMUNOL, V167, P6518, DOI 10.4049/jimmunol.167.11.6518; Matt U, 2013, J CLIN INVEST, V123, P3014, DOI 10.1172/JCI60681; McAuley TR, 2012, INHAL TOXICOL, V24, P850, DOI 10.3109/08958378.2012.724728; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334; Park S, 2014, THE EFFECT OF E CIGA, pB16; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; PRYOR WA, 1976, ENVIRON HEALTH PERSP, V16, P161, DOI 10.2307/3428597; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Radek KA, 2010, CELL HOST MICROBE, V7, P277, DOI 10.1016/j.chom.2010.03.009; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; Regan AK, 2013, TOB CONTROL, V22, P19, DOI 10.1136/tobaccocontrol-2011-050044; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Romagna G, 2013, INHAL TOXICOL, V25, P354, DOI 10.3109/08958378.2013.793439; Saini A, 2013, INDIAN J MED RES, V137, P1193; Schober W, 2014, INT J HYG ENVIR HEAL, V217, P628, DOI 10.1016/j.ijheh.2013.11.003; Schripp T, 2013, INDOOR AIR, V23, P25, DOI 10.1111/j.1600-0668.2012.00792.x; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Stewart SM, 2010, VIROLOGY, V405, P530, DOI 10.1016/j.virol.2010.06.035; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Taut K, 2008, AM J RESP CELL MOL, V38, P105, DOI 10.1165/rcmb.2007-0132OC; Thimmulappa RK, 2012, BIOCHEM BIOPH RES CO, V426, P253, DOI 10.1016/j.bbrc.2012.08.076; Vardavas CI, 2012, CHEST, V141, P1400, DOI 10.1378/chest.11-2443; Varughese S, 2005, AM J IND MED, V47, P411, DOI 10.1002/ajim.20151; Wang XH, 2011, CELL MOL IMMUNOL, V8, P462, DOI 10.1038/cmi.2011.38; Wieslander G, 2001, OCCUP ENVIRON MED, V58, P649, DOI 10.1136/oem.58.10.649; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Wongtrakool C, 2012, PEDIATR RES, V72, P147, DOI 10.1038/pr.2012.55	45	258	266	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116861	10.1371/journal.pone.0116861	http://dx.doi.org/10.1371/journal.pone.0116861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651083	Green Submitted, Green Published, gold			2022-12-26	WOS:000349250700008
J	Barn, R; Waaijman, R; Nollet, F; Woodburn, J; Bus, SA				Barn, Ruth; Waaijman, Roelof; Nollet, Frans; Woodburn, James; Bus, Sicco A.			Predictors of Barefoot Plantar Pressure during Walking in Patients with Diabetes, Peripheral Neuropathy and a History of Ulceration	PLOS ONE			English	Article							LIMITED JOINT MOBILITY; FOOT ULCERATION; HIGH-RISK; TOE DEFORMITY; ULCERS; PEOPLE; MELLITUS; TRIAL; DETERMINANTS; RECURRENCE	Objective Elevated dynamic plantar foot pressures significantly increase the risk of foot ulceration in diabetes mellitus. The aim was to determine which factors predict plantar pressures in a population of diabetic patients who are at high-risk of foot ulceration. Methods Patients with diabetes, peripheral neuropathy and a history of ulceration were eligible for inclusion in this cross sectional study. Demographic data, foot structure and function, and disease-related factors were recorded and used as potential predictor variables in the analyses. Barefoot peak pressures during walking were calculated for the heel, midfoot, forefoot, lesser toes, and hallux regions. Potential predictors were investigated using multivariate linear regression analyses. 167 participants with mean age of 63 years contributed 329 feet to the analyses. Results The regression models were able to predict between 6% (heel) and 41% (midfoot) of the variation in peak plantar pressures. The largest contributing factor in the heel model was glycosylated haemoglobin concentration, in the midfoot Charcot deformity, in the forefoot prominent metatarsal heads, in the lesser toes hammer toe deformity and in the hallux previous ulceration. Variables with local effects (e.g. foot deformity) were stronger predictors of plantar pressure than global features (e.g. body mass, age, gender, or diabetes duration). Conclusion The presence of local deformity was the largest contributing factor to barefoot dynamic plantar pressure in high-risk diabetic patients and should therefore be adequately managed to reduce plantar pressure and ulcer risk. However, a significant amount of variance is unexplained by the models, which advocates the quantitative measurement of plantar pressures in the clinical risk assessment of the patient.	[Barn, Ruth; Waaijman, Roelof; Nollet, Frans; Bus, Sicco A.] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands; [Barn, Ruth; Woodburn, James] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Inst Appl Hlth Res, Glasgow G4 0BA, Lanark, Scotland	University of Amsterdam; Academic Medical Center Amsterdam; Glasgow Caledonian University	Bus, SA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Rehabil, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.a.bus@amc.uva.nl		Bus, Sicco/0000-0002-8357-9163; Woodburn, James/0000-0002-5497-8739	Dutch Diabetes Research Foundation [2007.00.067]; Dutch Foundation for the Development of Orthopaedic Footwear; Dutch Organization for Health Research and Development [14350054]	Dutch Diabetes Research Foundation; Dutch Foundation for the Development of Orthopaedic Footwear; Dutch Organization for Health Research and Development	The study was supported by project grants from the Dutch Diabetes Research Foundation project 2007.00.067) www.diabetesfonds.nl; the Dutch Foundation for the Development of Orthopaedic Footwear, and the Dutch Organization for Health Research and Development (project 14350054) www.zonmw.nl/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouaesha F, 2001, DIABETES CARE, V24, P1270, DOI 10.2337/diacare.24.7.1270; Ahroni JH, 1999, DIABETES CARE, V22, P965, DOI 10.2337/diacare.22.6.965; Armstrong D G, 1998, J Foot Ankle Surg, V37, P303; Arts MLJ, 2012, DIABETIC MED, V29, P1534, DOI 10.1111/j.1464-5491.2012.03770.x; Bus SA, 2005, CLIN BIOMECH, V20, P892, DOI 10.1016/j.clinbiomech.2005.05.004; Bus SA, 2005, J BIOMECH, V38, P1918, DOI 10.1016/j.jbiomech.2004.07.034; Bus SA, 2002, DIABETES CARE, V25, P1444, DOI 10.2337/diacare.25.8.1444; Bus SA, 2013, DIABETES CARE, V36, P4109, DOI 10.2337/dc13-0996; Bus SA, 2012, DIABETES-METAB RES, V28, P54, DOI 10.1002/dmrr.2240; CAVANAGH PR, 1991, DIABETES CARE, V14, P750, DOI 10.2337/diacare.14.8.750; Cavanagh PR, 2005, LANCET, V366, P1725, DOI 10.1016/S0140-6736(05)67699-4; Crawford F, 2007, QJM-INT J MED, V100, P65; FERNANDO DJS, 1991, DIABETES CARE, V14, P8, DOI 10.2337/diacare.14.1.8; Frykberg RG, 1998, DIABETES CARE, V21, P1714, DOI 10.2337/diacare.21.10.1714; GRIMSTON SK, 1993, FOOT ANKLE, V14, P215, DOI 10.1177/107110079301400407; Guldemond Nick A, 2008, BMC Endocr Disord, V8, P16, DOI 10.1186/1472-6823-8-16; HAMILL J, 1989, CLIN BIOMECH, V4, P217, DOI 10.1016/0268-0033(89)90006-5; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Kastenbauer T, 2001, J AM PODIAT MED ASSN, V91, P343; Kwan RLC, 2010, CLIN BIOMECH, V25, P601, DOI 10.1016/j.clinbiomech.2010.04.003; Lavery LA, 2003, DIABETES CARE, V26, P1069, DOI 10.2337/diacare.26.4.1069; Melai T, 2013, HUM MOVEMENT SCI, V32, P785, DOI 10.1016/j.humov.2013.05.001; Menz HB, 2006, GAIT POSTURE, V24, P229, DOI 10.1016/j.gaitpost.2005.09.002; Monteiro-Soares M, 2012, DIABETES-METAB RES, V28, P574, DOI 10.1002/dmrr.2319; Morag E, 1999, J BIOMECH, V32, P359, DOI 10.1016/S0021-9290(98)00188-2; Mueller MJ, 2003, J BONE JOINT SURG AM, V85A, P1436, DOI 10.2106/00004623-200308000-00003; Mueller MJ, 2003, J BIOMECH, V36, P1009, DOI 10.1016/S0021-9290(03)00078-2; MUELLER MJ, 1989, PHYS THER, V69, P453, DOI 10.1093/ptj/69.6.453; Payne C, 2002, J DIABETES COMPLICAT, V16, P277, DOI 10.1016/S1056-8727(01)00187-8; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Pound N, 2005, DIABETIC MED, V22, P1306, DOI 10.1111/j.1464-5491.2005.01640.x; Rasmussen A, 2013, J TISSUE VIABILITY, V22, P68, DOI 10.1016/j.jtv.2013.04.001; Rosenbloom AL, 1996, ENDOCRIN METAB CLIN, V25, P473, DOI 10.1016/S0889-8529(05)70335-2; Segal A, 2004, FOOT ANKLE INT, V25, P926, DOI 10.1177/107110070402501215; Turner DE, 2007, DIABETIC MED, V24, P1240, DOI 10.1111/j.1464-5491.2007.02233.x; VEVES A, 1992, DIABETOLOGIA, V35, P660, DOI 10.1007/BF00400259; Waaijman R, 2014, DIABETES CARE, V37, P1697, DOI 10.2337/dc13-2470; Wrobel JS, 2003, J AM PODIAT MED ASSN, V93, P367, DOI 10.7547/87507315-93-5-367; Zimny S, 2004, DIABETES CARE, V27, P942, DOI 10.2337/diacare.27.4.942	39	40	40	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117443	10.1371/journal.pone.0117443	http://dx.doi.org/10.1371/journal.pone.0117443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647421	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600068
J	Hart, CE; Blanco, GS; Coyne, MS; Delgado-Trejo, C; Godley, BJ; Jones, TT; Resendiz, A; Seminoff, JA; Witt, MJ; Nichols, WJ				Hart, Catherine E.; Blanco, Gabriela S.; Coyne, Michael S.; Delgado-Trejo, Carlos; Godley, Brendan J.; Jones, T. Todd; Resendiz, Antonio; Seminoff, Jeffrey A.; Witt, Matthew J.; Nichols, Wallace J.			Multinational Tagging Efforts Illustrate Regional Scale of Distribution and Threats for East Pacific Green Turtles (Chelonia mydas agassizii)	PLOS ONE			English	Article							POST-NESTING MIGRATIONS; GULF-OF-CALIFORNIA; SATELLITE TRACKING; SEA-TURTLES; LEATHERBACK TURTLES; DERMOCHELYS-CORIACEA; FORAGING AREA; NATIONAL-PARK; GLOBAL PATTERNS; MOVEMENTS	To further describe movement patterns and distribution of East Pacific green turtles (Chelonia mydas agassizii) and to determine threat levels for this species within the Eastern Pacific. In order to do this we combined published data from existing flipper tagging and early satellite tracking studies with data from an additional 12 satellite tracked green turtles (1996-2006). Three of these were tracked from their foraging grounds in the Gulf of California along the east coast of the Baja California peninsula to their breeding grounds in Michoacan (1337-2928 km). In addition, three post-nesting females were satellite tracked from Colola beach, Michoacan to their foraging grounds in southern Mexico and Central America (941.3-3020 km). A further six turtles were tracked in the Gulf of California within their foraging grounds giving insights into the scale of ranging behaviour. Turtles undertaking long-distance migrations showed a tendency to follow the coastline. Turtles tracked within foraging grounds showed that foraging individuals typically ranged up to 691.6 km (maximum) from release site location. Additionally, we carried out threat analysis (using the cumulative global human impact in the Eastern Pacific) clustering pre-existing satellite tracking studies from Galapagos, Costa Rica, and data obtained from this study; this indicated that turtles foraging and nesting in Central American waters are subject to the highest anthropogenic impact. Considering that turtles from all three rookeries were found to migrate towards Central America, it is highly important to implement conservation plans in Central American coastal areas to ensure the survival of the remaining green turtles in the Eastern Pacific. Finally, by combining satellite tracking data from this and previous studies, and data of tag returns we created the best available distributional patterns for this particular sea turtle species, which emphasized that conservation measures in key areas may have positive consequences on a regional scale.	[Hart, Catherine E.; Coyne, Michael S.; Godley, Brendan J.; Witt, Matthew J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Blanco, Gabriela S.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Coyne, Michael S.] SEATURTLE Org, Durham, NC USA; [Delgado-Trejo, Carlos] Univ Michoacana, Inst Invest Recursos Nat, Morelia, Michoacan, Mexico; [Jones, T. Todd] NOAA Fisheries, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Resendiz, Antonio] Inst Nacl Ecol, Direcc Gen Vida Silvestre, Secretaria Medio Ambiente Recursos Natur, Ensenada, Baja California, Mexico; [Seminoff, Jeffrey A.] NOAA, Southwest Fisheries Sci Ctr, La Jolla, CA USA; [Nichols, Wallace J.] Calif Acad Sci, San Francisco, CA 94118 USA	University of Exeter; Drexel University; Universidad Michoacana de San Nicolas de Hidalgo; National Oceanic Atmospheric Admin (NOAA) - USA; Instituto de Ecologia - Mexico; National Oceanic Atmospheric Admin (NOAA) - USA; California Academy of Sciences	Nichols, WJ (corresponding author), Calif Acad Sci, Golden Gate Pk, San Francisco, CA 94118 USA.	wallacejnichols@me.com	Hart, Catherine E./AAD-5944-2022; godley, brendan j/A-6139-2009; Witt, Matthew/V-3318-2018; godley, brendan/O-1959-2019	Hart, Catherine E./0000-0002-0833-2523; godley, brendan j/0000-0003-3845-0034; Witt, Matthew/0000-0002-9498-5378; godley, brendan/0000-0003-3845-0034; Blanco, Gabriela S./0000-0001-6794-4207	Earthwatch Institute; David and Lucile Packard Foundation; Wallace Research Foundation; PADI Foundation; Arizona-Sonora Desert Museum; Unversity of Exeter; European Social Fund; Consejo Nacional de Ciencia y Tecnologia (iMexico); Fulbright Fellowship; Marshall Fellowship; Darwin Initiative; Natural Environment Research Council	Earthwatch Institute; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Wallace Research Foundation; PADI Foundation; Arizona-Sonora Desert Museum; Unversity of Exeter; European Social Fund(European Social Fund (ESF)); Consejo Nacional de Ciencia y Tecnologia (iMexico); Fulbright Fellowship; Marshall Fellowship; Darwin Initiative; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by Earthwatch Institute, David and Lucile Packard Foundation, Wallace Research Foundation, PADI Foundation and the Arizona-Sonora Desert Museum. C. E. H. received a Masters degree bursary from the Unversity of Exeter and the European Social Fund and would like to thank Consejo Nacional de Ciencia y Tecnologia (iMexico) for support through a PhD scholarship. W. J. N. was supported by a Fulbright Fellowship and a Marshall Fellowship during the period field research in Baja California was conducted. B. J. G. is supported by the Darwin Initiative, European Social Fund and The Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO J, 1992, BIOTROPICA, V24, P560, DOI 10.2307/2389020; Alvarado-Diaz J, 2003, P 22 ANN S SEA TURTL, P69; Alvarado-Diaz Javier, 2001, Marine Turtle Newsletter, V92, P4; Amorocho Diego F., 2007, Endangered Species Research, V3, P43, DOI 10.3354/esr003043; Amorocho DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031486; Arthur KE, 2008, PAC SCI, V62, P205, DOI 10.2984/1534-6188(2008)62[205:ACOIGT]2.0.CO;2; AWBREY F T, 1984, Bulletin Southern California Academy of Sciences, V83, P69; Balazs G.H., 1996, P 15 ANN S SEA TURTL, P21; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Benson SR, 2007, CHELONIAN CONSERV BI, V6, P150, DOI 10.2744/1071-8443(2007)6[150:PMOLTD]2.0.CO;2; BJORNDAL K.A, 2003, BIOL SEA TURTLES, V2; Blanco Gabriela S., 2012, Endangered Species Research, V18, P233, DOI 10.3354/esr00451; Blanco GS, 2012, J WILDLIFE MANAGE, V76, P841, DOI 10.1002/jwmg.304; Blanco GS, 2010, THESIS DREXEL U PHIL; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Blumenthal Janice M., 2006, Endangered Species Research, V7, P1; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Brooks LB, 2009, MAR ECOL PROG SER, V386, P263, DOI 10.3354/meps08061; Byles R, 1995, P 12 ANN WORKSH SEA, P12; Cardona L, 2009, MAR BIOL, V156, P2621, DOI 10.1007/s00227-009-1288-9; Cheng IJ, 2000, MAR BIOL, V137, P747, DOI 10.1007/s002270000375; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Dutton PH, 2014, ECOL EVOL, V4, P4317, DOI 10.1002/ece3.1269; Eguchi T, 2010, MAR BIOL, V157, P1869, DOI 10.1007/s00227-010-1458-9; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; Fonseca LG, 2014, ANIDACION TORTUGAS M; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Godley BJ, 2003, MAR ECOL PROG SER, V253, P279, DOI 10.3354/meps253279; Godley BJ, 2002, ECOGRAPHY, V25, P352, DOI 10.1034/j.1600-0587.2002.250312.x; GREEN D, 1984, J HERPETOL, V18, P121, DOI 10.2307/1563739; Guerra-Correa C, 2008, NOAA TECH MEMO NMFS, P211; Guerra-Correa C, 2007, SEA TURTLES SI UNPUB; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hart KA, 2013, MAR POLICY, V42, P236, DOI 10.1016/j.marpol.2013.03.008; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; Holroyd GL, 2010, CHELONIAN CONSERV BI, V9, P305, DOI 10.2744/CCB-0831.1; Hueter R, 2007, HIGHLY MIGRATORY SHA, P91; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Inter-American Tropical Tuna Commission, 2003, WORK GROUP BYC 4 M K; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; Jones TT, 2013, METHODS ECOL EVOL, V4, P1178, DOI 10.1111/2041-210X.12109; Jones TT, 2011, NMFSSWFSC480 NOAA; Juarez-Ceron JA, 2002, P 22 ANN S SEA TURTL, P70; Kelez S, 2011, THESIS DUKE U; Keller JM, 2014, ENVIRON SCI TECHNOL, V48, P7807, DOI 10.1021/es5014054; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; Koch V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056776; Lewison RL, 2014, P NATL ACAD SCI USA, V111, P5271, DOI 10.1073/pnas.1318960111; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Lopez E, 2002, P 22 ANN S SEA TURTL, P84; MacDonald BD, 2012, MAR ECOL PROG SER, V461, P211, DOI 10.3354/meps09820; Marquez-Millan, 2002, P 22 ANN S SEA TURTL, P80; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; McCarthy AL, 2010, PROG OCEANOGR, V86, P224, DOI 10.1016/j.pocean.2010.04.009; Nichols WJ, 2003, THESIS U ARIZONA MEX; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Pritchard PCH, 1999, CONSERV BIOL, V13, P1000, DOI 10.1046/j.1523-1739.1999.98432.x; Quinones J, 2010, DEV HYDROBIOL, V212, P69, DOI 10.1007/s10750-010-0225-8; Raygadas-Torres BS, 2008, THESIS U MICHOACANA, DOI [10.1038/tp.2014.91, DOI 10.1038/TP.2014.91]; Tomillo PS, 2015, MAR ECOL-EVOL PERSP, V36, P506, DOI 10.1111/maec.12159; Santos RG, 2011, MAR POLLUT BULL, V62, P1297, DOI 10.1016/j.marpolbul.2011.03.004; Scott R, 2014, ECOLOGY, V95, P2840, DOI 10.1890/13-2164.1; Scott R, 2012, GLOBAL ECOL BIOGEOGR, V21, P1053, DOI 10.1111/j.1466-8238.2011.00757.x; Seminoff JA, 2002, SOUTHWEST NAT, V47, P314, DOI 10.2307/3672922; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Seminoff JA, 2002, J HERPETOL, V36, P447, DOI 10.2307/1566189; Seminoff JA, 2007, GREEN SEA TURTLE CHE; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Seminoff JA, 2006, HERPETOL CONSERV BIO, V1, P81; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Southall EJ, 2006, BIOL CONSERV, V132, P33, DOI 10.1016/j.biocon.2006.03.011; Tomillo PS, 2008, CONSERV BIOL, V22, P1216, DOI 10.1111/j.1523-1739.2008.00987.x; Tomillo PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037602; Troeng S, 2005, BIOL CONSERV, V121, P111, DOI 10.1016/j.biocon.2004.04.014; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Watson KP, 1998, J EXP BIOL, V201, P2497; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; Witt MJ, 2008, ORYX, V42, P296, DOI 10.1017/S0030605308006947; Zarate P, 2002, P 22 ANN S SEA TURTL, P70	83	15	16	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116225	10.1371/journal.pone.0116225	http://dx.doi.org/10.1371/journal.pone.0116225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646803	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600023
J	Kim, SC; Kim, S; Lee, DH; Choi, SR; Kim, JS				Kim, Seong Chun; Kim, Sunjoo; Lee, Dong-Hyun; Choi, Sae-Rom; Kim, Jeong-Sook			Effect of Blood Volume in Standard Anaerobic Blood Culture Bottles of the BacT/ALERT 3D System Used for the Detection of Pathogens and Time to Detection	PLOS ONE			English	Article								Background Blood volume may profoundly affect the isolation of microorganisms in blood cultures. The effect of blood volume in standard anaerobic bottles of the BacT/ALERT 3D system was investigated. Methods Adult patients who visited the emergency department and referred for blood culture (n = 824) were enrolled from June to September 2013. Two sets of blood cultures were obtained from each patient. One set consisted of 5 mL that was collected in a standard aerobic bottle (SA5), 5 mL that was collected in a standard anaerobic bottle (SN5), and 10 mL that was collected in a standard anaerobic bottle (SN10). The growth of clinically significant pathogens and the time to detection (TTD) were compared between the SN5 and SN10 samples. Results Increasing the volume of blood collected from 5 to 10 mL yielded a 14.7% improvement in the isolation of microorganisms. There was a statistically significant difference in the isolation of pathogens (14 vs. 30, P = 0.023) between the SN5 and SN10 samples. Gram-positive microorganisms were detected earlier in the SN10 samples than the SN5 samples (P = 0.052). The mean TTD of all pathogens was 13.5 h for the SN5 samples and 12.9 h for the SN10 samples (P = 0.099). Conclusion Increased blood volume in the SN bottle yielded a significantly higher pathogen detection rate. However, there was no difference in the frequency of earlier detection or TTD between the SN5 and SN10 samples.	[Kim, Seong Chun] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Emergency Med, Jinju, South Korea; [Kim, Sunjoo; Lee, Dong-Hyun; Choi, Sae-Rom] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Lab Med, Jinju, South Korea; [Kim, Jeong-Sook] Jinju Hlth Coll, Dept Nursing, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University	Kim, S (corresponding author), Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Lab Med, Jinju, South Korea.	sjkim8239@hanmail.net		Kim, Sunjoo/0000-0001-8099-8891; Lee, Donghyun/0000-0001-5880-4528	National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology [2011-0008757]	National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science, and Technology (2011-0008757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFA M, 1995, J CLIN MICROBIOL, V33, P1185, DOI 10.1128/JCM.33.5.1185-1191.1995; Bouza E, 2007, J CLIN MICROBIOL, V45, P2765, DOI 10.1128/JCM.00140-07; BROWN DFJ, 1990, J CLIN PATHOL, V43, P777, DOI 10.1136/jcp.43.9.777; Clinical and Laboratory Standards Institute, 2007, M47A CLSI; Kellogg JA, 2000, J CLIN MICROBIOL, V38, P2181; LI J, 1994, J CLIN MICROBIOL, V32, P2829, DOI 10.1128/JCM.32.11.2829-2831.1994; Riedel S, 2010, J INFECT CHEMOTHER, V16, P301, DOI 10.1007/s10156-010-0069-1; Shin JH, 2011, KOREAN J CLIN MICROB, V14, P91; Vitrat-Hincky V, 2011, EUR J CLIN MICROBIOL, V30, P533, DOI 10.1007/s10096-010-1115-8; WEINSTEIN MP, 1994, J CLIN MICROBIOL, V32, P2103, DOI 10.1128/JCM.32.9.2103-2106.1994; Weinstein MP, 2003, J CLIN MICROBIOL, V41, P2275, DOI 10.1128/JCM.41.6.2275-2278.2003	11	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116728	10.1371/journal.pone.0116728	http://dx.doi.org/10.1371/journal.pone.0116728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646758	Green Submitted, Green Published, gold			2022-12-26	WOS:000348822600033
J	Noda, T; Murakami, K; Etoh, Y; Okamoto, F; Yatsuyanagi, J; Sera, N; Furuta, M; Onozuka, D; Oda, T; Asai, T; Fujimoto, S				Noda, Tamie; Murakami, Koichi; Etoh, Yoshiki; Okamoto, Fuyuki; Yatsuyanagi, Jun; Sera, Nobuyuki; Furuta, Munenori; Onozuka, Daisuke; Oda, Takahiro; Asai, Tetsuo; Fujimoto, Shuji			Increase in Resistance to Extended-Spectrum Cephalosporins in Salmonella Isolated from Retail Chicken Products in Japan	PLOS ONE			English	Article							AMPC BETA-LACTAMASES; FOOD-PRODUCING ANIMALS; ESCHERICHIA-COLI; CTX-M; SEROVAR INFANTIS; MOLECULAR CHARACTERIZATION; KLEBSIELLA-PNEUMONIAE; SOUTHERN TAIWAN; FARM-ANIMALS; ENTERICA	Extended-spectrum beta-lactamase (ESBL)-producing Salmonella are one of the most important public health problems in developed countries. ESBL-producing Salmonella strains have been isolated from humans in Asian countries neighboring Japan, along with strains harboring the plasmid-mediated extended-spectrum cephalosporin (ESC)-resistance gene, ampC (pAmpC). However, only a few studies have investigated the prevalence of ESC-resistant Salmonella in chicken products in Japan, which are the main vehicle of Salmonella transmission. The aim of this study was to investigate the prevalence of ESBL-producing, pAmpC-harboring, or carbapenem-resistant Salmonella in chicken products in Japan. In total, 355 out of 779 (45.6%) chicken product samples collected from 1996-2010 contained Salmonella, resulting in 378 distinct isolates. Of these isolates, 373 were tested for resistance to ESCs, cephamycins, or carbapenems. Isolates that showed resistance to one or more of these antimicrobials were then examined by PCR and DNA sequence analysis for the presence of the bla(CMY), bla(CTX-M), bla(TEM), and bla(SHV) resistance genes. Thirty-five resistant isolates were detected, including 26 isolates that contained pAmpC (bla(CMY-2)), and nine ESBL-producing isolates harboring bla(CTX-M) (n = 4, consisting of two bla(CTX-M-2) and two bla(CTX-M-15) genes), bla(TEM) (n = 4, consisting of one bla(TEM-20) and three bla(TEM-52) genes), and bla(SHV) (n = 1, bla(SHV-12)). All pAmpC-harboring and ESBL-producing Salmonella isolates were obtained from samples collected after 2005, and the percentage of resistant isolates increased significantly from 0% in 2004 to 27.9% in 2010 (P for trend = 0.006). This increase was caused in part by an increase in the number of Salmonella enterica subsp. enterica serovar Infantis strains harboring an approximately 280-kb plasmid containing bla(CMY-2) in proximity to ISEcp1. The dissemination of ESC-resistant Salmonella containing plasmid-mediated bla(CMY-2) in chicken products indicates the need for the development of continuous monitoring strategies in the interests of public health.	[Noda, Tamie; Fujimoto, Shuji] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka 8128582, Japan; [Noda, Tamie; Murakami, Koichi; Etoh, Yoshiki; Okamoto, Fuyuki; Sera, Nobuyuki] Fukuoka Inst Hlth & Environm Sci, Dept Hlth Sci, Div Pathol & Bacteriol, Dazaifu, Fukuoka 8180135, Japan; [Yatsuyanagi, Jun] Akita Prefectural Inst Publ Hlth, Akita 0100874, Japan; [Furuta, Munenori; Oda, Takahiro] Nakamura Gakuen Univ, Jr Coll, Jonan Ku, Fukuoka 8140198, Japan; [Onozuka, Daisuke] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Higashi Ku, Fukuoka 8128582, Japan; [Asai, Tetsuo] Gifu Univ, United Grad Sch Vet Sci, Anim Infect Dis Control, Gifu 5011193, Japan	Kyushu University; Kyushu University; Gifu University	Murakami, K (corresponding author), Fukuoka Inst Hlth & Environm Sci, Dept Hlth Sci, Div Pathol & Bacteriol, 39 Mukaizano, Dazaifu, Fukuoka 8180135, Japan.	murakami@fihes.pref.fukuoka.jp	Asai, Tetsuo/F-3402-2014; Onozuka, Daisuke/F-5067-2014	Asai, Tetsuo/0000-0002-6556-9674; Onozuka, Daisuke/0000-0001-9596-9188	Japan Society for the Promotion of Sciences [24590846]; Daido Life Welfare Foundation, Osaka, Japan	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Daido Life Welfare Foundation, Osaka, Japan	This work was supported by the Japan Society for the Promotion of Sciences KAKENHI, Grant No. 24590846 and the Daido Life Welfare Foundation, Osaka, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2009, J FOOD SCI, V74, pM405, DOI 10.1111/j.1750-3841.2009.01291.x; Allen KJ, 2002, CAN J VET RES, V66, P137; Aviv G, 2014, ENVIRON MICROBIOL, V16, P977, DOI 10.1111/1462-2920.12351; Clinical and Laboratory Standards Institute, 2009, M02A10 CLSI; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI; CLSI, 2012, PERFORMANCE STANDARD, V7th; Colom K, 2003, FEMS MICROBIOL LETT, V223, P147, DOI 10.1016/S0378-1097(03)00306-9; Fernandez-Alarcon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023415; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Fujita Takuji, 2011, Kansenshogaku Zasshi, V85, P355; Furuta M, 2010, JPN J FOOD MICROBIOL, V27, P200; Giles WP, 2004, ANTIMICROB AGENTS CH, V48, P2845, DOI 10.1128/AAC.48.8.2845-2852.2004; Hamidian M, 2009, JPN J INFECT DIS, V62, P368; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Hiki M, 2013, FOODBORNE PATHOG DIS, V10, P243, DOI 10.1089/fpd.2012.1306; Hiroi M, 2011, JPN J INFECT DIS, V64, P153; Ishihara K, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-35; Izumiya H, 2005, ANTIMICROB AGENTS CH, V49, P2568, DOI 10.1128/AAC.49.6.2568-2570.2005; Jacoby G, 2014, BETA LACTAMASE CLASS; Leinberger DM, 2010, J CLIN MICROBIOL, V48, P460, DOI 10.1128/JCM.00765-09; Li Y, 2008, J CLIN MICROBIOL, V46, P1317, DOI 10.1128/JCM.00073-07; Liu JH, 2007, INT J ANTIMICROB AG, V29, P576, DOI 10.1016/j.ijantimicag.2006.12.015; Mataseje LE, 2009, J ANTIMICROB CHEMOTH, V64, P723, DOI 10.1093/jac/dkp249; Matsumoto Y, 2007, JPN J INFECT DIS, V60, P236; Morita M, 2010, ANTIMICROB AGENTS CH, V54, P3991, DOI 10.1128/AAC.00225-10; Murakami K, 2001, EPIDEMIOL INFECT, V126, P159, DOI 10.1017/S0950268801005283; Murakami Koichi, 2013, Int J Microbiol, V2013, P463095, DOI 10.1155/2013/463095; Murakami K, 2014, J MICROBIOL METH, V101, P67, DOI 10.1016/j.mimet.2014.04.001; Nakaya H, 2001, Kansenshogaku Zasshi, V75, P815; National Institute of Genetics, 2014, DNA DAT BANK JAP; Noda T, 2010, FOODBORNE PATHOG DIS, V7, P727, DOI 10.1089/fpd.2009.0438; Pagani L, 2003, J CLIN MICROBIOL, V41, P4264, DOI 10.1128/JCM.41.9.4264-4269.2003; Perilli M, 2002, J CLIN MICROBIOL, V40, P611, DOI 10.1128/JCM.40.2.611-614.2002; Riano I, 2006, J ANTIMICROB CHEMOTH, V58, P844, DOI 10.1093/jac/dkl337; Rodriguez I, 2009, J ANTIMICROB CHEMOTH, V64, P301, DOI 10.1093/jac/dkp195; Shahada F, 2013, POULTRY SCI, V92, P1641, DOI 10.3382/ps.2012-02934; Shahada F, 2011, ANTIMICROB AGENTS CH, V55, P4114, DOI 10.1128/AAC.00560-11; Su LH, 2006, J ANTIMICROB CHEMOTH, V57, P424, DOI 10.1093/jac/dki478; Su LH, 2005, J ANTIMICROB CHEMOTH, V55, P846, DOI 10.1093/jac/dki116; Sun Y, 2010, CLIN MICROBIOL INFEC, V16, P1475, DOI 10.1111/j.1469-0691.2010.03127.x; Taguchi M, 2006, JPN J INFECT DIS, V59, P144; Tamang MD, 2011, J CLIN MICROBIOL, V49, P2671, DOI 10.1128/JCM.00754-11; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Yamasaki K, 2010, J CLIN MICROBIOL, V48, P3267, DOI 10.1128/JCM.02111-09; Yan JJ, 2003, EMERG INFECT DIS, V9, P323; Yan JJ, 2004, J CLIN MICROBIOL, V42, P5337, DOI 10.1128/JCM.42.11.5337-5340.2004; Yan JJ, 2004, ANTIMICROB AGENTS CH, V48, P1353, DOI 10.1128/AAC.48.4.1353-1356.2004; Yan JJ, 2000, J CLIN MICROBIOL, V38, P4320, DOI 10.1128/JCM.38.12.4320-4325.2000; Yum JH, 2005, J KOREAN MED SCI, V20, P961, DOI 10.3346/jkms.2005.20.6.961; Zhao S, 2003, J CLIN MICROBIOL, V41, P5366, DOI 10.1128/JCM.41.12.5366-5371.2003	50	38	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116927	10.1371/journal.pone.0116927	http://dx.doi.org/10.1371/journal.pone.0116927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642944	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000348821200028
J	Zhang, LY; Chen, SY; Deng, AW; Liu, XY; Liang, Y; Shao, XF; Sun, MX; Zou, HQ				Zhang, Liying; Chen, Shanying; Deng, Aiwen; Liu, Xinyu; Liang, Yan; Shao, Xiaofei; Sun, Mingxia; Zou, Hequn			Association between Lipid Ratios and Insulin Resistance in a Chinese Population	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; METABOLIC SYNDROME; RISK; TRIGLYCERIDE; DISEASE; INDIVIDUALS; SENSITIVITY; KIDNEY; OBESE; INDEX	Aim To explore the association of lipid ratios and triglyceride (TG) with insulin resistance (IR) in a Chinese population. We also provide the clinical utility of lipid ratios to identify men and women with IR. Methods This cross-sectional study included 614 men and 1055 women without diabetes. Insulin resistance was defined by homeostatic model assessment of IR > 2.69. Lipid ratios included the TG/high density lipoprotein cholesterol (HDL-C), the total cholesterol (TC)/HDL-C and the low density lipoprotein cholesterol (LDL-C)/HDL-C. Logistic regression models and accurate estimates of the area under the receiver operating characteristic (AUROC) curves were obtained. Results In normal-weight men, none of lipid ratios nor TG was associated with IR. In overweight/obese men, normal-weight women and overweight/obese women, the TG/HDL-C, the TC/HDL-C and TG were significantly associated with IR, and the associations were independent of waist circumference. All of the AUROCs for the TG/HDL-C and TG were > 0.7. The AUROCs for TC/HDL-C ratio were 0.69-0.77. The optimal cut-offs for TG/HDL-C were 1.51 in men and 0.84 in women. The optimal cut-offs for TG were 1.78 mmol/L in men and 1.49 mmol/L in women, respectively. In men, the optimal cut-off for LDL-C/HDL-C is 3.80. In women, the optimal cut-off for LDL-C/HDL-C is 3.82. Conclusion The TG/HDL-C, the TC/HDL-C and TG are associated with IR in overweight/obese men, normal-weight and overweight/obese women. The LDL-C/HDL-C is only associated with IR in normal-weight women. The TG/HDL-C and TG might be used as surrogate markers for assessing IR.	[Zhang, Liying; Chen, Shanying; Liu, Xinyu; Liang, Yan; Shao, Xiaofei; Sun, Mingxia; Zou, Hequn] Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Zhang, Liying] Inner Mongolia Med Univ, Affiliated Hosp 1, Dept Nephrol, Hohhot, Peoples R China; [Chen, Shanying] Fujian Med Univ, Zhangzhou Affiliated Hosp, Dept Nephrol, Zhangzhou, Fujian, Peoples R China; [Deng, Aiwen] Southern Med Univ, Affiliated Hosp 3, Dept Rehabil, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Inner Mongolia Medical University; Fujian Medical University; Southern Medical University - China	Zou, HQ (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	hequnzou@hotmail.com	Zou, He/GXH-0280-2022		EU FP7 Program, UroSense; ISN Research Committee grant; Guangdong Provincial Science and Technique Program [2011B031800386]	EU FP7 Program, UroSense; ISN Research Committee grant; Guangdong Provincial Science and Technique Program	This study was supported by the following Science Foundations: 1. EU FP7 Program, UroSense, 2011; 2. ISN Research Committee grant, 2007; 3. ISN Research Committee grant, 2004; 4. Guangdong Provincial Science and Technique Program (No. 2011B031800386), 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault BJ, 2011, NAT REV CARDIOL, V8, P197, DOI 10.1038/nrcardio.2010.223; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Chen SY, 2014, ENDOCRINE, V46, P496, DOI 10.1007/s12020-013-0079-8; Chen SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074058; Chiang JK, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-93; Elahl D, 1996, DIABETES CARE, V19, P278, DOI 10.2337/diacare.19.3.278; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gasevic D, 2012, METABOLISM, V61, P583, DOI 10.1016/j.metabol.2011.09.009; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hanley AJG, 2003, DIABETES, V52, P463, DOI 10.2337/diabetes.52.2.463; He JY, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/105168; HOSMER DW, 2000, WILEY PS TX, P1; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kawamoto R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-138; Kim-Dorner SJ, 2010, METABOLISM, V59, P299, DOI 10.1016/j.metabol.2009.07.027; Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685; Li CY, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-4; Li GW, 1996, CHINESE J CARDIOLOGY, V24, P57; McLaughlin T, 2005, AM J CARDIOL, V96, P399, DOI 10.1016/j.amjcard.2005.03.085; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Molarius A, 1999, INT J OBESITY, V23, P116, DOI 10.1038/sj.ijo.0800772; Mostafa SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050931; Ray Sayantan, 2012, Indian J Endocrinol Metab, V16, pS460, DOI 10.4103/2230-8210.104132; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; Xiang SK, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/173281; [邢小燕 Xing Xiaoyan], 2004, [中华糖尿病杂志, Chinese Journal of Diabetes], V12, P182; Zhang LY, 2014, INT J ENV RES PUB HE, V11, P7622, DOI 10.3390/ijerph110807622	33	21	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116110	10.1371/journal.pone.0116110	http://dx.doi.org/10.1371/journal.pone.0116110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635876	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700024
J	Zhang, ZK; Lei, ZR				Zhang, Zhi-Ke; Lei, Zhong-Ren			Identification, Expression Profiling and Fluorescence-Based Binding Assays of a Chemosensory Protein Gene from the Western Flower Thrips, Frankliniella occidentalis	PLOS ONE			English	Article							LOCUSTA-MIGRATORIA ORTHOPTERA; ODORANT-BINDING; MOLECULAR-CLONING; SOLUBLE-PROTEINS; REGENERATING LEGS; MOTH; PURIFICATION; PATTERN; GENOME; FAMILY	Using RT-PCR and RACE-PCR strategies, we cloned and identified a new chemosensory protein (FoccCSP) from the Western flower thrips, Frankliniella occidentalis, a species for which no chemosensory protein (CSP) has yet been identified. The FoccCSP gene contains a 387 bp open-reading frame encoding a putative protein of 128 amino acids with a molecular weight of 14.51 kDa and an isoelectric point of 5.41. The deduced amino acid sequence contains a putative signal peptide of 19 amino acid residues at the N-terminus, as well as the typical four-cysteine signature found in other insect CSPs. As FoccCSP is from a different order of insect than other known CSPs, the GenBank FoccCSP homolog showed only 31-50% sequence identity with them. A neighbor-joining tree was constructed and revealed that FoccCSP is in a group with CSPs from Homopteran insects (e.g., AgosCSP4, AgosCSP10, ApisCSP, and NlugCSP9), suggesting that these genes likely developed from a common ancestral gene. The FoccCSP gene expression profile of different tissues and development stages was measured by quantitative real-time PCR. The results of this analysis revealed this gene is predominantly expressed in the antennae and also highly expressed in the first instar nymph, suggesting a function for FoccCSP in olfactory reception and in particular life activities during the first instar nymph stage. We expressed recombinant FoccCSP protein in a prokaryotic expression system and purified FoccCSP protein by affinity chromatography using a Ni-NTA-Sepharose column. Using N-phenyl-1-naphthylamine (1-NPN) as a fluorescent probe in fluorescence-based competitive binding assay, we determined the binding affinities of 19 volatile substances for FoccCSP protein. This analysis revealed that anisic aldehyde, geraniol and methyl salicylate have high binding affinities for FoccCSP, with KD values of 10.50, 15.35 and 35.24 mu M, respectively. Thus, our study indicates that FoccCSP may play an important role in regulating the development of the first instar nymph and mediate F. occidentalis host recognition.	[Zhang, Zhi-Ke; Lei, Zhong-Ren] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Zhang, Zhi-Ke] Ningxia Acad Agr & Forestry Sci, Inst Plant Protect, Yinchuan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhang, ZK (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	zhangzhike98@163.com; zrlei@ippcaas.cn			China Agriculture Research System [CARS-25-B-07]; National Modern Agricultural Science and Technology City Industry of Beijing [Z121100001212006]	China Agriculture Research System; National Modern Agricultural Science and Technology City Industry of Beijing	This research is partially funded by the China Agriculture Research System (CARS-25-B-07) and the National Modern Agricultural Science and Technology City Industry of Beijing (Z121100001212006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Benton R, 2008, CURR OPIN NEUROBIOL, V18, P357, DOI 10.1016/j.conb.2008.08.012; Bohbot J, 1998, BIOCHEM BIOPH RES CO, V253, P489, DOI 10.1006/bbrc.1998.9806; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Calvello M, 2005, INSECT BIOCHEM MOLEC, V35, P297, DOI 10.1016/j.ibmb.2005.01.002; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Deng YP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-264; Du Yu-zhou, 2005, Scientia Agricultura Sinica, V38, P2360; DYANOV HM, 1995, BIOTECHNIQUES, V18, P822; FELLAND CM, 1995, J ECON ENTOMOL, V88, P1004, DOI 10.1093/jee/88.4.1004; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gu SH, 2012, PLOS ONE, V7, P1; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Hagen-Larsen H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-171; Ishida Y, 2002, NATURWISSENSCHAFTEN, V89, P505, DOI 10.1007/s00114-002-0368-1; Jacobs SP, 2005, INSECT MOL BIOL, V14, P423, DOI 10.1111/j.1365-2583.2005.00573.x; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; Li XR, 2011, INT J BIOL SCI, V7, P848, DOI 10.7150/ijbs.7.848; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Liu XL, 2010, J BIOCHEM, V148, P189, DOI 10.1093/jb/mvq050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DG, 2007, J CHEM ECOL, V33, P1359, DOI 10.1007/s10886-007-9310-5; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mameli M, 1996, INSECT BIOCHEM MOLEC, V26, P875, DOI 10.1016/S0965-1748(96)00055-0; Marchese S, 2000, INSECT BIOCHEM MOLEC, V30, P1091, DOI 10.1016/S0965-1748(00)00084-9; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Oduol F, 2000, P NATL ACAD SCI USA, V97, P11397, DOI 10.1073/pnas.180060997; Ozaki K, 2008, INSECT BIOCHEM MOLEC, V38, P969, DOI 10.1016/j.ibmb.2008.07.010; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Picimbon JF, 2000, ARCH INSECT BIOCHEM, V44, P120, DOI 10.1002/1520-6327(200007)44:3&lt;120::AID-ARCH3&gt;3.0.CO;2-H; Picimbon JF, 1999, INSECT BIOCHEM MOLEC, V29, P973, DOI 10.1016/S0965-1748(99)00073-9; Picimbon JF, 2000, INSECT BIOCHEM MOLEC, V30, P233, DOI 10.1016/S0965-1748(99)00121-6; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Ronderos DS, 2009, FLY, V3, P290, DOI 10.4161/fly.9801; Sabatier L, 2003, EUR J BIOCHEM, V270, P3398, DOI 10.1046/j.1432-1033.2003.03725.x; SCHNEIDER D, 1969, SCIENCE, V163, P1031, DOI 10.1126/science.163.3871.1031; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Steinbrecht RA, 1996, ENTOMOL EXP APPL, V80, P15, DOI 10.1007/BF00194714; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang JL, 2012, THESIS SHAANXI NORMA, P22; Wanner KW, 2005, INSECT MOL BIOL, V14, P289, DOI 10.1111/j.1365-2583.2005.00559.x; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Yoshizawa Y, 2011, INSECT BIOCHEM MOLEC, V41, P545, DOI 10.1016/j.ibmb.2011.03.006; Zhang GF, 2012, J APPL ENTOMOL, V136, P410, DOI 10.1111/j.1439-0418.2011.01661.x; Zhang SA, 2011, J CHEM ECOL, V37, P189, DOI 10.1007/s10886-010-9902-3; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x	63	10	16	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117726	10.1371/journal.pone.0117726	http://dx.doi.org/10.1371/journal.pone.0117726			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635391	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700098
J	Zhu, Y; Lei, Y; Du, BC; Zheng, YB; Lu, XF; Tan, T; Kang, JT; Sun, L; Liang, QJ				Zhu, Yan; Lei, Yan; Du, Baochen; Zheng, Yanbo; Lu, Xiangfeng; Tan, Tan; Kang, Jingting; Sun, Le; Liang, Qianjin			INMAP Overexpression Inhibits Cell Proliferation, Induces Genomic Instability and Functions through p53/p21 Pathways	PLOS ONE			English	Article							P53 TRANSCRIPTIONAL ACTIVITY; STRAND BREAK REPAIR; COLORECTAL-CANCER; POOR-PROGNOSIS; TUMOR ANGIOGENESIS; GASTRIC-CANCER; STROMAL CELLS; TARGET GENES; LUNG-CANCER; HYPOXIA	INMAP is a spindle protein that plays essential role for mitosis, by ensuring spindle and centromere integrality. The aim of this study was to investigate the relevant functions of INMAP for genomic stability and its functional pathway. We overexpressed INMAP in HeLa cells, resulting in growth inhibition in monolayer cell cultures, anchorage-independent growth in soft agar and xenograft growth in nude mice. In this system caused micronuclei (MNi) formation, chromosome distortion and gamma H2AX expression upregulation, suggesting DNA damage induction and genomic stability impairment. As a tumour biochemical marker, lactate dehydrogenase (LDH) isoenzymes were detected to evaluate cell metabolic activity, the results confirming that total activity of LDH, as well as that of its LDH5 isoform, is significantly decreased in INMAP-overexpressing HeLa cells. The levels of p53 and p21 were upregulated, and however, that of PCNA and Bcl-2, downregulated. Indirect immunofluorescence (IIF) and coimmunoprecipitation (CoIP) analyses revealed the interaction between INMAP and p21. These results suggest that INMAP might function through p53/p21 pathways.	[Zhu, Yan; Du, Baochen; Tan, Tan; Liang, Qianjin] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Zhu, Yan; Lei, Yan; Kang, Jingting; Liang, Qianjin] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Zheng, Yanbo] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Lu, Xiangfeng] Beijing Univ Chinese Tradit Med, Dongzhimen Hosp, Beijing 100700, Peoples R China; [Sun, Le] AbMax Biotechnol Co, Beijing 100085, Peoples R China	Beijing Normal University; Beijing Normal University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Beijing University of Chinese Medicine	Liang, QJ (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China.	lqj@bnu.edu.cn			Beijing Natural Science Foundation [5122017]; National Natural Science Foundation of China [30971470]; open fund of Beijing Key Laboratory of Gene Resource and Molecular Development [201204]; Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education of China [201307]; Fund for the Doctoral Innovative Research of Science & Technology Review [kjdb2012003]; AbMax Biotechnology Co	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open fund of Beijing Key Laboratory of Gene Resource and Molecular Development; Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education of China(Ministry of Education, China); Fund for the Doctoral Innovative Research of Science & Technology Review; AbMax Biotechnology Co	This study was supported by the Beijing Natural Science Foundation (no. 5122017 to QL), the National Natural Science Foundation of China (no. 30971470 to QL), the open fund of Beijing Key Laboratory of Gene Resource and Molecular Development (no. 201204 to YZ), the Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education of China (no. 201307 to YZ), and the Fund for the Doctoral Innovative Research of Science & Technology Review (no. kjdb2012003 to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AbMax Biotechnology Co provided support in the form of a salary for LS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors are articulated in the 'author contributions' section.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chuang JY, 2009, INT J CANCER, V125, P2066, DOI 10.1002/ijc.24563; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Giatromanolaki A, 2012, CLIN EXP METASTAS, V29, P11, DOI 10.1007/s10585-011-9424-6; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Grimm M, 2013, CLIN EXP METASTAS, V30, P529, DOI 10.1007/s10585-012-9557-2; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hill R, 2008, CELL CYCLE, V7, P2535; Kennedy BWC, 2012, J AM CHEM SOC, V134, P4969, DOI 10.1021/ja300222e; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Koukourakis MI, 2003, TUMOR BIOL, V24, P199, DOI 10.1159/000074430; Koukourakis MI, 2003, BRIT J CANCER, V89, P877, DOI 10.1038/sj.bjc.6601205; Koukourakis MI, 2006, J CLIN ONCOL, V24, P4301, DOI 10.1200/JCO.2006.05.9501; Koukourakis MI, 2011, CLIN CANCER RES, V17, P4892, DOI 10.1158/1078-0432.CCR-10-2918; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liu WL, 2011, HEPATOLOGY, V53, P843, DOI 10.1002/hep.24124; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Mauro M, 2012, NUCLEIC ACIDS RES, V40, P8348, DOI 10.1093/nar/gks612; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Neal JL, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-128; Ohata H, 2013, MOL CELL BIOL, V33, P2447, DOI 10.1128/MCB.01221-12; Rao XT, 2008, MUTAT RES-FUND MOL M, V646, P41, DOI 10.1016/j.mrfmmm.2008.09.004; Salnikow K, 2000, CANCER RES, V60, P5630; Shao SJ, 2010, J CLIN INVEST, V120, P498, DOI 10.1172/JCI39447; Shen EZ, 2009, EXP CELL RES, V315, P1100, DOI 10.1016/j.yexcr.2009.01.022; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Tan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091937; Trempus CS, 2011, MOL CARCINOGEN, V50, P981, DOI 10.1002/mc.20768; Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Xu RH, 2005, CANCER RES, V65, P613; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zhou YL, 2013, MOL CELL BIOCHEM, V374, P81, DOI 10.1007/s11010-012-1507-4	46	0	0	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115704	10.1371/journal.pone.0115704	http://dx.doi.org/10.1371/journal.pone.0115704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635878	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700017
J	Guo, AL; Daniels, NA; Thuma, J; McCall, KD; Malgor, R; Schwartz, FL				Guo, Aili; Daniels, Nigel A.; Thuma, Jean; McCall, Kelly D.; Malgor, Ramiro; Schwartz, Frank L.			Diet Is Critical for Prolonged Glycemic Control after Short-Term Insulin Treatment in High-Fat Diet-Induced Type 2 Diabetic Male Mice	PLOS ONE			English	Article							BETA-CELL FUNCTION; HOMEOSTASIS MODEL ASSESSMENT; LONG-TERM; MOUSE MODEL; THERAPY; RESISTANCE; REMISSION; INFUSION; MELLITUS; GLUCOSE	Background Clinical studies suggest that short-term insulin treatment in new-onset type 2 diabetes (T2DM) can promote prolonged glycemic control. The purpose of this study was to establish an animal model to examine such a "legacy" effect of early insulin therapy (EIT) in long-term glycemic control in new-onset T2DM. The objective of the study was to investigate the role of diet following onset of diabetes in the favorable outcomes of EIT. Methodology As such, C57BL6/J male mice were fed a high-fat diet (HFD) for 21 weeks to induce diabetes and then received 4 weeks of daily insulin glargine or sham subcutaneous injections. Subsequently, mice were either kept on the HFD or switched to a low-fat diet (LFD) for 4 additional weeks. Principal Findings Mice fed a HFD gained significant fat mass and displayed increased leptin levels, increasing insulin resistance (poor HOMA-IR) and worse glucose tolerance test (GTT) performance in comparison to mice fed a LFD, as expected. Insulin-treated diabetic mice but maintained on the HFD demonstrated even greater weight gain and insulin resistance compared to shamtreated mice. However, insulin-treated mice switched to the LFD exhibited a better HOMA-IR compared to those mice left on a HFD. Further, between the insulin-treated and sham control mice, in spite of similar HOMA-IR values, the insulin-treated mice switched to a LFD following insulin therapy did demonstrate significantly better HOMA-B% values than sham control and insulin-treated HFD mice. Conclusion/Interpretation Early insulin treatment in HFD-induced T2DM in C57BL6/J mice was only beneficial in animals that were switched to a LFD after insulin treatment which may explain why a similar legacy effect in humans is achieved clinically in only a portion of cases studied, emphasizing a vital role for diet adherence in diabetes control.	[Guo, Aili; Daniels, Nigel A.; Thuma, Jean; McCall, Kelly D.; Malgor, Ramiro; Schwartz, Frank L.] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Guo, Aili; Daniels, Nigel A.; Thuma, Jean; McCall, Kelly D.; Malgor, Ramiro; Schwartz, Frank L.] Ohio Univ, Inst Diabet, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Guo, AL (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA.	guoa@ohio.edu	McCall, Kelly D/T-3251-2018; Daniels, Nigel/HIA-0660-2022		Ohio University Heritage College of Osteopathic Medicine	Ohio University Heritage College of Osteopathic Medicine	This work was supported by start-up funding for Aili Guo from the Ohio University Heritage College of Osteopathic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen AL, 2012, DIABETES CARE, V35, P474, DOI 10.2337/dc11-1638; Chen HB, 2007, DIABETES RES CLIN PR, V75, P327, DOI 10.1016/j.diabres.2006.07.001; Chen HS, 2008, DIABETES CARE, V31, P1927, DOI 10.2337/dc08-0075; Dandona P, 2005, J CLIN INVEST, V115, P2069, DOI 10.1172/JCI26045; Dandona P, 2007, CURR OPIN CLIN NUTR, V10, P511, DOI 10.1097/MCO.0b013e3281e38774; Dandona P, 2007, AM J CARDIOL, V99, p15B, DOI 10.1016/j.amjcard.2006.11.003; DEFRONZO RA, 1981, DIABETOLOGIA, V21, P165, DOI 10.1007/BF00252649; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Ghanim H, 2010, DIABETES CARE, V33, P1103, DOI 10.2337/dc09-2193; Hu Y, 2011, DIABETES CARE, V34, P1848, DOI 10.2337/dc10-2105; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Klaus S, 2005, PHYSIOL GENOMICS, V21, P193, DOI 10.1152/physiolgenomics.00299.2004; Kramer CK, 2013, LANCET DIABETES ENDO, V1, P28, DOI 10.1016/S2213-8587(13)70006-8; Leahy JL, 2010, J CLIN ENDOCR METAB, V95, P4206, DOI 10.1210/jc.2010-0668; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Li HQ, 2011, METABOLISM, V60, P1566, DOI 10.1016/j.metabol.2011.01.018; Li YB, 2004, DIABETES CARE, V27, P2597, DOI 10.2337/diacare.27.11.2597; Liu LH, 2012, DIABETES TECHNOL THE, V14, P756, DOI 10.1089/dia.2012.0055; Makimattila S, 1999, DIABETOLOGIA, V42, P406, DOI 10.1007/s001250051172; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meneghini LF, 2009, DIABETES CARE, V32, pS266, DOI 10.2337/dc09-S320; Nagel Jutta M., 2010, Hormones & Cancer, V1, P320, DOI 10.1007/s12672-010-0020-z; Omar BA, 2013, DIABETOLOGIA, V56, P1752, DOI 10.1007/s00125-013-2927-8; Son JW, 2013, ENDOCR RES, V38, P160, DOI 10.3109/07435800.2012.745870; Suzuki Jun, 2004, Nihon Yakurigaku Zasshi, V123, P281; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Viberti G, 2002, DIABETES CARE, V25, P1737, DOI 10.2337/diacare.25.10.1737; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Zhao Qing-bin, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1878	37	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0117556	10.1371/journal.pone.0117556	http://dx.doi.org/10.1371/journal.pone.0117556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633992	gold, Green Published, Green Submitted			2022-12-26	WOS:000348609800012
J	Cruz, ICS; Loiola, M; Albuquerque, T; Reis, R; Nunes, JDCC; Reimer, JD; Mizuyama, M; Kikuchi, RKP; Creed, JC				Cruz, Igor C. S.; Loiola, Miguel; Albuquerque, Tiago; Reis, Rodrigo; Nunes, Jose de Anchieta C. C.; Reimer, James D.; Mizuyama, Masaru; Kikuchi, Ruy K. P.; Creed, Joel C.			Effect of Phase Shift from Corals to Zoantharia on Reef Fish Assemblages	PLOS ONE			English	Article							HABITAT COMPLEXITY; COMMUNITY STRUCTURE; DIVERSITY; COMPETITION; CNIDARIA; PATTERNS; MACROALGAE; FISHERIES; ABUNDANCE; ANTHOZOA	Consequences of reef phase shifts on fish communities remain poorly understood. Studies on the causes, effects and consequences of phase shifts on reef fish communities have only been considered for coral-to-macroalgae shifts. Therefore, there is a large information gap regarding the consequences of novel phase shifts and how these kinds of phase shifts impact on fish assemblages. This study aimed to compare the fish assemblages on reefs under normal conditions (relatively high cover of corals) to those which have shifted to a dominance of the zoantharian Palythoa cf. variabilis on coral reefs in Todos os Santos Bay (TSB), Brazilian eastern coast. We examined eight reefs, where we estimated cover of corals and P. cf. variabilis and coral reef fish richness, abundance and body size. Fish richness differed significantly between normal reefs (48 species) and phase-shift reefs (38 species), a 20% reduction in species. However there was no difference in fish abundance between normal and phase shift reefs. One fish species, Chaetodon striatus, was significantly less abundant on normal reefs. The differences in fish assemblages between different reef phases was due to differences in trophic groups of fish; on normal reefs carnivorous fishes were more abundant, while on phase shift reefs mobile invertivores dominated.	[Cruz, Igor C. S.] Univ Estado Rio de Janeiro, Programa Pos Grad Ecol, BR-20550011 Rio De Janeiro, RJ, Brazil; [Cruz, Igor C. S.; Loiola, Miguel; Albuquerque, Tiago; Reis, Rodrigo; Kikuchi, Ruy K. P.] Univ Fed Bahia, Inst Geociencias, Lab Recifes Corais & Mudancas Globais, Salvador, BA, Brazil; [Loiola, Miguel; Reis, Rodrigo; Nunes, Jose de Anchieta C. C.] Univ Fed Bahia, Programa Pos Grad Ecol & Biomonitoramento, Salvador, BA, Brazil; [Nunes, Jose de Anchieta C. C.] Univ Fed Bahia, Inst Biol, Lab Ecol Benton, Salvador, BA, Brazil; [Reimer, James D.; Mizuyama, Masaru] Univ Ryukyus, Grad Sch Engn & Sci, Mol Invertebrate Systemat & Ecol Lab, Nishihara, Okinawa 90301, Japan; [Cruz, Igor C. S.; Creed, Joel C.] Univ Estado Rio de Janeiro UERJ, Dept Ecol, Inst Biol Roberto Alcantara Gomes, Lab Ecol Marinha Bent, BR-20550011 Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; University of the Ryukyus; Universidade do Estado do Rio de Janeiro	Cruz, ICS (corresponding author), Univ Estado Rio de Janeiro, Programa Pos Grad Ecol, BR-20550011 Rio De Janeiro, RJ, Brazil.	igorcruz@gmail.com	Reimer, James Davis/AAP-1331-2020; Cruz, Igor Cristino Silva/O-9525-2014; Creed, Joel Christopher/C-4764-2013; Cruz, Igor Cristino Silva/H-3292-2019; Mizuyama, Masaru/AAP-9920-2020; Kikuchi, Ruy K P/I-4884-2013	Cruz, Igor Cristino Silva/0000-0002-7475-533X; Creed, Joel Christopher/0000-0002-1722-0806; Cruz, Igor Cristino Silva/0000-0002-7475-533X; Mizuyama, Masaru/0000-0002-1671-4046; Kikuchi, Ruy K P/0000-0002-6271-7491; C. C. Nunes, Jose de Anchieta/0000-0002-2743-797X	Conselho Nacional de Pesquisa [556755/2010-3, PQ 1D]; Fundacao de Amparo a Pesquisa do Estado da Bahia [6935/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Programa de Incentivo a Producao Cientifica, Tecnica e Artistica; UERJ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico from the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-25/170669/2004]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1137/2010]; International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus	Conselho Nacional de Pesquisa; Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Incentivo a Producao Cientifica, Tecnica e Artistica; UERJ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico from the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus	I. C. S. C. is supported by PhD scholarships of Conselho Nacional de Pesquisa (No 556755/2010-3). M. L. by PhD scholarships OF Fundacao de Amparo a Pesquisa do Estado da Bahia (No 6935/2014). J.A.C.C.N. by PhD scholarships of Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. R. K. P. K. by Grant of Conselho Nacional de Pesquisa (PQ 1D). J.C.C. by Financial support of the Programa de Incentivo a Producao Cientifica, Tecnica e Artistica, UERJ and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grants from the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (No. E-25/170669/2004) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Ciencias do Mar 1137/2010). J.D.R.and M. M. were funded in part by the International Research Hub Project for Climate Change and Coral Reef/Island Dynamics at the University of the Ryukyus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta C, 2014, MAR ECOL; Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bo M, 2012, PAC SCI, V66, P63, DOI 10.2984/66.1.4; Bonaldo R. M., 2005, Braz. J. Biol., V65, P211, DOI 10.1590/S1519-69842005000200004; Bonaldo RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085786; Caley MJ, 1996, J ANIM ECOL, V65, P414, DOI 10.2307/5777; CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070; Carpenter K.E., 1982, Proceedings of the International Coral Reef Symposium, P497; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Chaves LDT, 2010, BRAZ J OCEANOGR, V58, P33, DOI 10.1590/S1679-87592010000800006; Cirano M., 2007, REVIS BRASILEIRA GEO, V25, P363, DOI DOI 10.1590/S0102-261X2007000400002; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; COX EF, 1994, B MAR SCI, V54, P535; Cruz ICS, 2014, MAR ECOL; Cruz ICS, 2009, GEST COSTEIRA INTEG, V9, P3, DOI DOI 10.5894/RGCI150; Cruz ICS, 2008, BRAZ J OCEANOGR, V56, P271, DOI 10.1590/S1679-87592008000400002; den Hartog J.C., 1991, Zoologische Mededelingen (Leiden), V65, P209; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Done TJ, 1999, AM ZOOL, V39, P66; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Dustan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057386; Dutra LXC, 2008, J SUSTAIN DEV, V1, P13, DOI DOI 10.5539/JSD.V1N1P13; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Ferreira CEL, 2006, J FISH BIOL, V69, P1533, DOI 10.1111/j.1095-8649.2006.01220.x; Ferreira CEL, 2004, J BIOGEOGR, V31, P1093, DOI 10.1111/j.1365-2699.2004.01044.x; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; FOWLER AJ, 1990, MAR ECOL PROG SER, V64, P39, DOI 10.3354/meps064039; GLADFELTER WB, 1978, REV BIOL TROP, V26, P65; Gotelli NJ, 2013, ECOSIMR 1 00; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Graham NAJ, 2014, CURR BIOL, V24, pR359, DOI 10.1016/j.cub.2014.03.069; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Grutter AS, 2003, CURR BIOL, V13, P64, DOI 10.1016/S0960-9822(02)01393-3; Harborne AR, 2011, ENV BIOL FISHES; Hoegh-Guldberg O, 2006, SCIENCE, V311, P42, DOI 10.1126/science.1122951; Holt BG, 2013, METHODS ECOL EVOL, V4, P383, DOI 10.1111/2041-210X.12031; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; JONES GP, 1988, J EXP MAR BIOL ECOL, V123, P115, DOI 10.1016/0022-0981(88)90164-5; Khalaf MA, 2002, MAR ECOL PROG SER, V239, P287, DOI 10.3354/meps239287; Knowlton N, 2001, MARINE COMMUNITY ECOLOGY, P395; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Krajewski JP, 2011, ENV BIOL FISHES; Laborel J. L., 1970, MADREPORAIRES HYDROC; LADD HS, 1961, SCIENCE, V134, P703, DOI 10.1126/science.134.3481.703; Lang JC, 2010, AGRRA PROTOCOLS VERS, P1; Leao Z.M.A.N., 2010, Pan-American Journal of Aquatic Sciences, V5, P224; Leao ZMAN, 2003, LATIN AMERICAN CORAL REEFS, P9, DOI 10.1016/B978-044451388-5/50003-5; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Medeiros PR, 2010, ENVIRON BIOL FISH, V87, P237, DOI 10.1007/s10641-010-9593-1; Medeiros Paulo R., 2007, Pan-American Journal of Aquatic Sciences, V2, P288; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Niendonca-Neto JP, 2008, AN ACAD BRAS CIENC, V80, P495, DOI 10.1590/S0001-37652008000300010; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Page C, 2001, SURVERYS BENTHIC REE; Pereira PHC, 2013, J FISH BIOL, V82, P1226, DOI 10.1111/jfb.12054; Perez CD, 2005, HYDROBIOLOGIA, V548, P207, DOI 10.1007/s10750-005-5441-2; Reimer JD, 2007, CORAL REEFS, V26, P399, DOI 10.1007/s00338-007-0210-5; Reimer J. D., 2012, J MAR BIOL, DOI 10.1155/2012/856079; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; Rocha LA, 2008, MOL PHYLOGENET EVOL, V48, P918, DOI 10.1016/j.ympev.2008.05.024; Rogers A, 2014, CURR BIOL, V24, P1000, DOI 10.1016/j.cub.2014.03.026; Sampaio CLS, 2008, GUIA IDENTIFICACAO P, P205, DOI [10.1039/b815601h, DOI 10.1039/B815601H]; Sazima I, 2000, ENV BIOL FISHES; Silva M, 2005, CONSERV BIOL, V19, P608, DOI 10.1111/j.1523-1739.2005.00707.x; Sinniger F, 2005, MAR BIOL, V147, P1121, DOI 10.1007/s00227-005-0016-3; Sinniger F, 2008, ZOOL SCI, V25, P1253, DOI 10.2108/zsj.25.1253; Smith JE, 2010, OECOLOGIA, V163, P497, DOI 10.1007/s00442-009-1546-z; Sorokin Y., 1993, CORAL REEF ECOLOGY; Swain TD, 2010, MOL ECOL, V19, P2587, DOI 10.1111/j.1365-294X.2010.04672.x; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Taylor MS, 2002, COPEIA, P1134, DOI 10.1643/0045-8511(2002)002[1134:OOMUBT]2.0.CO;2; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Verges A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017115; Vermeij MJA, 2010, MAR ECOL-EVOL PERSP, V31, P291, DOI 10.1111/j.1439-0485.2009.00343.x; Vila-Nova DA, 2014, OCEAN COAST MANAGE, V102, P88, DOI 10.1016/j.ocecoaman.2014.09.005; WELLINGTON GM, 1985, OECOLOGIA, V68, P15, DOI 10.1007/BF00379466; Wilkinson C, 2008, STATUS CORAL REEFS W; Willis SC, 2005, OECOLOGIA, V142, P284, DOI 10.1007/s00442-004-1723-z; Work TM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002989; Yang SY, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-39; Zar JH., 2010, BIOSTAT ANAL, V5th	94	34	36	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116944	10.1371/journal.pone.0116944	http://dx.doi.org/10.1371/journal.pone.0116944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629532	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100052
J	Han, XB; Patters, AB; Ito, T; Azuma, J; Schaffer, SW; Chesney, RW				Han, Xiaobin; Patters, Andrea B.; Ito, Takashi; Azuma, Junichi; Schaffer, Stephen W.; Chesney, Russell W.			Knockout of the TauT Gene Predisposes C57BL/6 Mice to Streptozotocin-Induced Diabetic Nephropathy	PLOS ONE			English	Article							TAURINE-TRANSPORTER GENE; DOWN-REGULATION; KIDNEY INJURY; CELLS; COMPLICATIONS; NEUROPATHY; EXCRETION; MELLITUS; GLUCOSE; OBESITY	Diabetic nephropathy is the leading cause of end stage renal disease in the world. Although tremendous efforts have been made, scientists have yet to identify an ideal animal model that can reproduce the characteristics of human diabetic nephropathy. In this study, we hypothesize that taurine insufficiency is a critical risk factor for development of diabetic nephropathy associated with diabetes mellitus. This hypothesis was tested in vivo in TauT heterozygous (TauT(+/-)) and homozygous (TauT(-/-)) knockout in C57BL/6 background mice. We have shown that alteration of the TauT gene (also known as SLC6A6) has a substantial effect on the susceptibility to development of extensive diabetic kidney disease in both TauT(+/-) and TauT(-/-)mouse models of diabetes. These animals developed histological changes characteristic of human diabetic nephropathy that included glomerulosclerosis, nodular lesions, arteriosclerosis, arteriolar dilation, and tubulointerstitial fibrosis. Immunohistochemical staining of molecular markers of smooth muscle actin, CD34, Ki67 and collagen IV further confirmed these observations. Our results demonstrated that both homozygous and heterozygous TauT gene deletion predispose C57BL/6 mice to develop end-stage diabetic kidney disease, which closely replicates the pathological features of diabetic nephropathy in human diabetic patients.	[Han, Xiaobin; Patters, Andrea B.; Chesney, Russell W.] Univ Tennessee, Dept Pediat, Hlth Sci Ctr, Memphis, TN 38163 USA; [Han, Xiaobin; Patters, Andrea B.; Chesney, Russell W.] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Ito, Takashi; Azuma, Junichi] Univ Hyogo, Coll Pharm, Dept Pharm, Kobe, Hyogo 6500044, Japan; [Schaffer, Stephen W.] Univ S Alabama, Dept Pharmacol, Mobile, AL 36688 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Hyogo; University of South Alabama	Han, XB (corresponding author), Univ Tennessee, Dept Pediat, Hlth Sci Ctr, Memphis, TN 38163 USA.	xhan@uthsc.edu						Askwith T, 2009, AM J PHYSIOL-ENDOC M, V297, pE620, DOI 10.1152/ajpendo.00287.2009; Astorri E, 1997, CARDIOLOGY, V88, P152, DOI 10.1159/000177322; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Cefalu WT, 2014, DIABETES CARE, V37, P5, DOI 10.2337/dc13-2369; Chertow GM, 2006, J AM SOC NEPHROL, V17, P1501, DOI 10.1681/ASN.2006040327; Emanuela F, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/476380; Fiordaliso F, 2001, DIABETES, V50, P2363, DOI 10.2337/diabetes.50.10.2363; Fiorina P, 2014, J AM SOC NEPHROL, V25, P1415, DOI 10.1681/ASN.2013050518; Folli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009923; FRANCONI F, 1995, AM J CLIN NUTR, V61, P1115, DOI 10.1093/ajcn/61.5.1115; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Han X, 2000, AMINO ACIDS, V19, P499, DOI 10.1007/s007260070002; Han XB, 2002, J BIOL CHEM, V277, P39266, DOI 10.1074/jbc.M205939200; Han XB, 2009, J AM SOC NEPHROL, V20, P1323, DOI 10.1681/ASN.2008050465; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Huang DY, 2006, PFLUG ARCH EUR J PHY, V451, P668, DOI 10.1007/s00424-005-1499-y; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001; Ito T, 2012, AMINO ACIDS, V42, P1529, DOI 10.1007/s00726-011-0883-5; Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107; Merheb M, 2007, DIABETES CARE, V30, P2652, DOI 10.2337/dc07-0872; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Renier G, 2007, CURR DIABETES REV, V3, P103, DOI 10.2174/157339907780598225; Schlondorff D, 2010, KIDNEY INT, V77, P749, DOI 10.1038/ki.2009.545; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stevens MJ, 1999, AM J PHYSIOL-ENDOC M, V277, pE760, DOI 10.1152/ajpendo.1999.277.4.E760; Wang LJ, 2008, EUR J PHARMACOL, V597, P75, DOI 10.1016/j.ejphar.2008.08.031	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117718	10.1371/journal.pone.0117718	http://dx.doi.org/10.1371/journal.pone.0117718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629817	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100095
J	Waqas, A; Raza, N; Lodhi, HW; Muhammad, Z; Jamal, M; Rehman, A				Waqas, Ahmed; Raza, Nahal; Lodhi, Haneen Wajid; Muhammad, Zerwah; Jamal, Mehak; Rehman, Abdul			Psychosocial Factors of Antenatal Anxiety and Depression in Pakistan: Is Social Support a Mediator?	PLOS ONE			English	Article							PREGNANT-WOMEN; PERINATAL DEPRESSION; GENDER PREFERENCES; PRENATAL ANXIETY; RISK-FACTORS; STRESS; SYMPTOMS; PREVALENCE; PREDICTORS; ASSOCIATION	Introduction Pregnancy is generally viewed as a time of fulfillment and joy; however, for many women it can be a stressful event. In South Asia it is associated with cultural stigmas revolving around gender discrimination, abnormal births and genetic abnormalities. Methodology This cross-sectional study was done at four teaching hospitals in Lahore from February, 2014 to June, 2014. A total of 500 pregnant women seen at hospital obstetrics and gynecology departments were interviewed with a questionnaire consisting of three sections: demographics, the Hospital Anxiety and Depression Scale (HADS) and the Social Provisions Scale (SPS). Pearson's chi-squared test, bivariate correlations and multiple linear regression were used to analyze associations between the independent variables and scores on the HADS and SPS. Results Mean age among the 500 respondents was 27.41 years (5.65). Anxiety levels in participants were categorized as normal (145 women, 29%), borderline (110, 22%) or anxious (245, 49%). Depression levels were categorized as normal (218 women, 43.6%), borderline (123, 24.6%) or depressed (159, 31.8%). Inferential analysis revealed that higher HADS scores were significantly associated with lower scores on the SPS, rural background, history of harassment, abortion, cesarean delivery and unplanned pregnancies (P < .05). Social support (SPS score) mediated the relationship between the total number of children, gender of previous children and HADS score. Women with more daughters were significantly more likely to score higher on the HADS and lower on the SPS, whereas higher numbers of sons were associated with the opposite trends in the scores (P < .05). Conclusion Because of the predominantly patriarchal sociocultural context in Pakistan, the predictors of antenatal anxiety and depression may differ from those in developed countries. We therefore suggest that interventions designed and implemented to reduce antenatal anxiety and depression should take into account these unique factors.	[Waqas, Ahmed; Raza, Nahal; Lodhi, Haneen Wajid; Muhammad, Zerwah; Jamal, Mehak] CMH Lahore Med Coll & Inst Dent, Lahore Cantt, Pakistan; [Rehman, Abdul] Allama Iqbal Med Coll, Lahore, Pakistan		Waqas, A (corresponding author), CMH Lahore Med Coll & Inst Dent, Shami Rd, Lahore Cantt, Pakistan.	ahmedwaqas1990@hotmail.com	Waqas, Ahmed/V-6682-2019	Waqas, Ahmed/0000-0002-3772-194X				Abrejo FG, 2009, EUR J CONTRACEP REPR, V14, P10, DOI 10.1080/13625180802518231; Ahmer S, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-59; Ali NS, 2012, SCIENTIFICWORLDJOURN, V2012; Anwar Alam, 2011, Sarhad Journal of Agriculture, V27, P329; Atta-ur-Rahman, 2011, Sarhad Journal of Agriculture, V27, P477; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; Bhutta Shereen, 2003, J PAKISTAN MED ASS, V53, P286; Blackmore ER, 2011, BRIT J PSYCHIAT, V198, P373, DOI 10.1192/bjp.bp.110.083105; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Casterline J, 2004, UNWANTED PREGNANCY A; Chan CY, 2013, OJPSYCH, V2013, P301; Cougle JR, 2005, J ANXIETY DISORD, V19, P137, DOI 10.1016/j.janxdis.2003.12.003; Dayan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012942; Faisal-Cury A, 2007, ARCH WOMEN MENT HLTH, V10, P25, DOI 10.1007/s00737-006-0164-6; Fall A, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-201; Fergusson DM, 2006, J CHILD PSYCHOL PSYC, V47, P16, DOI 10.1111/j.1469-7610.2005.01538.x; Fuse K, 2010, DEMOGR RES, V23, P1031, DOI 10.4054/DemRes.2010.23.36; Gaynes B N, 2005, Evid Rep Technol Assess (Summ), P1; Grav S, 2012, J CLIN NURS, V21, P111, DOI 10.1111/j.1365-2702.2011.03868.x; Gurung RAR, 2005, J SOC CLIN PSYCHOL, V24, P497, DOI 10.1521/jscp.2005.24.4.497; Hamirani MM, 2006, J LIAQUAT UNIV MED H, V5, P106; Hashemieh C, 2013, IRAN RED CRESCENT ME, V15, DOI 10.5812/ircmj.14465; Humayun A, 2013, E MEDITERR HEALTH J, V19, P327, DOI 10.26719/2013.19.4.327; Husain N, 2000, PSYCHOL MED, V30, P395, DOI 10.1017/S0033291700001707; Husain N, 2011, ARCH WOMEN MENT HLTH, V14, P395, DOI 10.1007/s00737-011-0233-3; Ilyas Muhammad, 2009, Hum Reprod Genet Ethics, V15, P55; Karmaliani R, 2009, INT J SOC PSYCHIATR, V55, P414, DOI 10.1177/0020764008094645; Kazi A, 2006, SOC SCI MED, V63, P1466, DOI 10.1016/j.socscimed.2006.05.019; Kinsella MT, 2009, CLIN OBSTET GYNECOL, V52, P425, DOI 10.1097/GRF.0b013e3181b52df1; Koleva H, 2011, ARCH WOMEN MENT HLTH, V14, P99, DOI 10.1007/s00737-010-0184-0; Kuo SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086653; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Melchior M, 2007, PSYCHOL MED, V37, P1119, DOI 10.1017/S0033291707000414; Mezey G, 2005, BJOG-INT J OBSTET GY, V112, P197, DOI 10.1111/j.1471-0528.2004.00307.x; MUMFORD DB, 1991, ACTA PSYCHIAT SCAND, V83, P81, DOI 10.1111/j.1600-0447.1991.tb07370.x; Nasreen HE, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-22; Nisar N, 2009, J LIAQUAT UNIV MED H, V8, P228; O'Connor TG, 2005, BIOL PSYCHIAT, V58, P211, DOI 10.1016/j.biopsych.2005.03.032; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Qadir F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-745; Rahman A, 2007, ARCH WOMEN MENT HLTH, V10, P211, DOI 10.1007/s00737-007-0193-9; Rahman A, 2007, ACTA PSYCHIAT SCAND, V115, P481, DOI 10.1111/j.1600-0447.2006.00950.x; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Rizwan M., 2010, INT J ED PSYCHOL ASS, V4, P33; Rodriguez MA, 2008, ANN FAM MED, V6, P44, DOI 10.1370/afm.743; Saleem S, 2001, J Pak Med Assoc, V51, P275; Sanchez SE, 2013, J REPROD MED, V58, P25; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Shah SMA, 2011, J PAK MED ASSOC, V61, P242; Soomro RH, 2012, IJCRB, V3, P354; Stewart RC, 2014, ARCH WOMEN MENT HLTH, V17, P145, DOI 10.1007/s00737-013-0387-2; Tohid O, 2004, PAKISTANS NOVEL ATTA; Westdahl C, 2007, OBSTET GYNECOL, V110, P134, DOI 10.1097/01.AOG.0000265352.61822.1b; Witt WP, 2010, ARCH WOMEN MENT HLTH, V13, P425, DOI 10.1007/s00737-010-0176-0; Zahidie A, 2011, J PAK MED ASSOC, V61, P1183; Zubair F, 2007, HUM REPROD, V22, P605, DOI 10.1093/humrep/del409	58	74	74	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116510	10.1371/journal.pone.0116510	http://dx.doi.org/10.1371/journal.pone.0116510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629925	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100039
J	Liu, ZS; Yan, CW; Kang, C; Zhang, B; Li, Y				Liu, Zhongshuang; Yan, Chengwei; Kang, Chen; Zhang, Bin; Li, Ying			Distributional Variations in Trabecular Architecture of the Mandibular Bone: An In Vivo Micro-CT Analysis in Rats	PLOS ONE			English	Article							MINERAL DENSITY; MORPHOMETRIC-ANALYSIS; POSTMENOPAUSAL WOMEN; OVARIECTOMIZED RATS; SKELETAL BONE; ALVEOLAR BONE; OSTEOPOROSIS; MICROSTRUCTURE; OSTEOPENIA; ESTROGEN	Purpose To evaluate the effect of trabecular thickness and trabecular separation on modulating the trabecular architecture of the mandibular bone in ovariectomized rats. Materials and Methods Fourteen 12-week-old adult female Wistar rats were divided into an ovariectomy group (OVX) and a sham-ovariectomy group (sham). Five months after the surgery, the mandibles from 14 rats (seven OVX and seven sham) were analyzed by micro-CT. Images of inter-radicular alveolar bone of the mandibular first molars underwent three-dimensional reconstruction and were analyzed. Results Compared to the sham group, trabecular thickness in OVX alveolar bone decreased by 27% (P = 0.012), but trabecular separation in OVX alveolar bone increased by 59% (P = 0.005). A thickness and separation map showed that trabeculae of less than 100 mu m increased by 46%, whereas trabeculae of more than 200 mu m decreased by more than 40% in the OVX group compared to those in the sham group. Furthermore, the OVX separation of those trabecular of more than 200 mu m was 65% higher compared to the sham group. Bone mineral density (P = 0.028) and bone volume fraction (p = 0.001) were also significantly decreased in the OVX group compared to the sham group. Conclusions Ovariectomy-induced bone loss in mandibular bone may be related to the distributional variations in trabecular thickness and separation which profoundly impact the modulation of the trabecular architecture.	[Liu, Zhongshuang; Kang, Chen; Zhang, Bin; Li, Ying] Harbin Med Univ, Affiliated Hosp 2, Sino Russian Inst Hard Tissue Dev & Regenerat, Harbin 150001, Heilongjiang, Peoples R China; [Yan, Chengwei] Harbin Med Univ, Affiliated Hosp 1, Dept Pediat Dent, Harbin 150001, Heilongjiang, Peoples R China; [Zhang, Bin] Heilongjiang Acad Med Sci, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Zhang, B (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Sino Russian Inst Hard Tissue Dev & Regenerat, Harbin 150001, Heilongjiang, Peoples R China.	zhangbhyd@126.com; bonnieli1122@gmail.com	liu, shuang/O-5181-2015	liu, zhongshuang/0000-0002-8137-7349	Heilongjiang postgraduate innovation science foundation [YJSCX2012-240HLJ]; Natural Science Foundation of China [81170960]; National Key Science Instrument and Equipment Development Project [2011YQ04008708]; Specialized Research Fund for the Doctoral Program of Higher Education [20102307110006]	Heilongjiang postgraduate innovation science foundation; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Science Instrument and Equipment Development Project; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the Heilongjiang postgraduate innovation science foundation (Grant No. YJSCX2012-240HLJ) and Natural Science Foundation of China (Grant No. 81170960), the National Key Science Instrument and Equipment Development Project (Grant No. 2011YQ04008708), and Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20102307110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brouwers JEM, 2008, CALCIFIED TISSUE INT, V82, P202, DOI 10.1007/s00223-007-9084-3; Cardoso L, 2013, J BIOMECH, V46, P253, DOI 10.1016/j.jbiomech.2012.10.025; Cui GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082815; Dai QG, 2013, ORAL DIS; Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6; Ejiri S, 2008, J BONE MINER METAB, V26, P409, DOI 10.1007/s00774-008-0870-4; ELOVIC RP, 1995, CALCIFIED TISSUE INT, V56, P305, DOI 10.1007/BF00318051; Frost HM, 1999, J BONE MINER RES, V14, P1473, DOI 10.1359/jbmr.1999.14.9.1473; Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307; Genant HK, 2008, RHEUMATOLOGY, V47, P9, DOI 10.1093/rheumatology/ken180; Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224; Gonzalez-Garcia R, 2013, CLIN ORAL IMPLAN RES, V24, P730, DOI 10.1111/j.1600-0501.2012.02478.x; Hanson NA, 2004, BONE, V35, P326, DOI 10.1016/j.bone.2004.02.019; Heshmati HM, 2002, J BONE MINER RES, V17, P172, DOI 10.1359/jbmr.2002.17.1.172; Hildebolt CF, 1997, DENTOMAXILLOFAC RAD, V26, P3, DOI 10.1038/sj.dmfr.4600226; Jeffcoat M K, 1998, Ann Periodontol, V3, P312, DOI 10.1902/annals.1998.3.1.312; Jeffcoat MK, 2000, PERIODONTOL 2000, V23, P94, DOI 10.1034/j.1600-0757.2000.2230109.x; Jiang GZ, 2008, J BONE MINER METAB, V26, P130, DOI 10.1007/s00774-007-0811-7; Jiang Guizhen, 2004, J Oral Sci, V46, P75, DOI 10.2334/josnusd.46.75; Jiang GZ, 2003, J BONE MINER METAB, V21, P388, DOI 10.1007/s00774-003-0433-7; Jiang YB, 2005, J BONE MINER METAB, V23, P122, DOI 10.1007/BF03026336; Jonasson G, 2001, ORAL SURG ORAL MED O, V92, P346, DOI 10.1067/moe.2001.116494; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; KRIBBS PJ, 1989, J PROSTHET DENT, V62, P703, DOI 10.1016/0022-3913(89)90596-9; Kuroda S, 2003, ORAL DIS, V9, P24, DOI 10.1034/j.1601-0825.2003.01810.x; Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022; Legrand E, 2000, J BONE MINER RES, V15, P13, DOI 10.1359/jbmr.2000.15.1.13; Leppanen OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002540; Lerouxel E, 2004, OSTEOPOROSIS INT, V15, P814, DOI 10.1007/s00198-004-1611-8; Litzlbauer HD, 2006, AM J PHYSIOL-LUNG C, V291, pL535, DOI 10.1152/ajplung.00088.2005; MAJESKA RJ, 1994, J BONE JOINT SURG AM, V76A, P713, DOI 10.2106/00004623-199405000-00013; Moon HS, 2004, SURG RADIOL ANAT, V26, P466, DOI 10.1007/s00276-004-0247-x; Moriya Y, 1998, J Oral Sci, V40, P171; Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4; OMI N, 1995, BONE, V17, pS163, DOI 10.1016/8756-3282(95)00329-C; Orrico SRP, 2007, J PERIODONTOL, V78, P164, DOI 10.1902/jop.2007.060136; Rawlinson SCF, 2009, J DENT RES, V88, P615, DOI 10.1177/0022034509340132; RIGGS BL, 1991, WESTERN J MED, V154, P63; Shimizu Y, 2013, ARCH ORAL BIOL, V58, P907, DOI 10.1016/j.archoralbio.2013.02.003; Sornay-Rendu E, 2007, J BONE MINER RES, V22, P425, DOI 10.1359/JBMR.061206; Tanaka M, 2003, ORAL SURG ORAL MED O, V95, P495, DOI 10.1067/moe.2003.135; WactawskiWende J, 1996, J PERIODONTOL, V67, P1076, DOI 10.1902/jop.1996.67.10s.1076; WRONSKI TJ, 1987, CALCIFIED TISSUE INT, V40, P155, DOI 10.1007/BF02555700	44	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116194	10.1371/journal.pone.0116194	http://dx.doi.org/10.1371/journal.pone.0116194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625431	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821400012
J	Suzuki, R; Okamoto, T; Arita, T				Suzuki, Reiji; Okamoto, Tomoko; Arita, Takaya			Emergent Dynamics of Fairness in the Spatial Coevolution of Proposer and Responder Species in the Ultimatum Game	PLOS ONE			English	Article							OBLIGATE POLLINATION MUTUALISM; EVOLUTION	While spatially local interactions are ubiquitous between coevolving species sharing recourses (e.g., plant-insect interactions), their effects on such coevolution processes of strategies involving the share of a resource are still not clearly understood. We construct a two-dimensional spatial model of the coevolution of the proposer and responder species in the ultimatum game (UG), in which a pair of proposer and responder individuals at each site plays the UG. We investigate the effects of the locality of interactions and the intensity of selection on the emergence of fairness between these species. We show that the lower intensity of selection favors fair strategies in general, and there are no significant differences in the evolution of fairness between the cases with local and global interactions when the intensity of selection is low. However, as the intensity of selection becomes higher, the spatially local interactions contribute to the evolution of fairer strategies more than the global interactions, even though fair strategies become more difficult to evolve. This positive effect of spatial interactions is expected to be due to the mutual benefit of fairness for both proposer and responder species in future generations, which brings about a dynamic evolution process of fairness.	[Suzuki, Reiji; Arita, Takaya] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Okamoto, Tomoko] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 305, Japan	Nagoya University; Forestry & Forest Products Research Institute - Japan	Suzuki, R (corresponding author), Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan.	reiji@nagoya-u.jp	Suzuki, Reiji/M-5038-2014; Arita, Takaya/GLU-7953-2022; Okamoto, Tomoko/L-8550-2013	Suzuki, Reiji/0000-0002-1953-2926; Okamoto, Tomoko/0000-0001-8135-481X	JSPS KAKENHI [23500176, 24500168]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 23500176 (TA), 24500168 (RS) (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciampaglia GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099039; Gao J, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/48003; Goto R, 2010, ECOL LETT, V13, P321, DOI 10.1111/j.1461-0248.2009.01425.x; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Henrich J, 2000, AM ECON REV, V90, P973, DOI 10.1257/aer.90.4.973; Ichinose G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05104; Iranzo J, 2011, J THEOR BIOL, V278, P1, DOI 10.1016/j.jtbi.2011.02.020; Kato M, 2003, P NATL ACAD SCI USA, V100, P5264, DOI 10.1073/pnas.0837153100; Kawakita A, 2004, AM J BOT, V91, P410, DOI 10.3732/ajb.91.3.410; Okamoto T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2280; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104	14	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116901	10.1371/journal.pone.0116901	http://dx.doi.org/10.1371/journal.pone.0116901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625524	Green Submitted, gold, Green Published			2022-12-26	WOS:000348821400022
J	Liou, JW; Hung, YJ; Yang, CH; Chen, YC				Liou, Je-Wen; Hung, Yu-Jiun; Yang, Chin-Hao; Chen, Yi-Cheng			The Antimicrobial Activity of Gramicidin A Is Associated with Hydroxyl Radical Formation	PLOS ONE			English	Article							PHOSPHOLIPID-MEMBRANES; STAPHYLOCOCCUS-AUREUS; STRUCTURAL FEATURES; CELL-MEMBRANE; BUFORIN II; PEPTIDES; ANTIBIOTICS; MECHANISM; CHANNELS; CONFORMATION	Gramicidin A is an antimicrobial peptide that destroys gram-positive bacteria. The bactericidal mechanism of antimicrobial peptides has been linked to membrane permeation and metabolism disruption as well as interruption of DNA and protein functions. However, the exact bacterial killing mechanism of gramicidin A is not clearly understood. In the present study, we examined the antimicrobial activity of gramicidin A on Staphylococcus aureus using biochemical and biophysical methods, including hydroxyl radical and NAD(+)/NADH cycling assays, atomic force microscopy, and Fourier transform infrared spectroscopy. Gramicidin A induced membrane permeabilization and changed the composition of the membrane. The morphology of Staphylococcus aureus during gramicidin A destruction was divided into four stages: pore formation, water permeability, bacterial flattening, and lysis. Changes in membrane composition included the destruction of membrane lipids, proteins, and carbohydrates. Most interestingly, we demonstrated that gramicidin A not only caused membrane permeabilization but also induced the formation of hydroxyl radicals, which are a possible end product of the transient depletion of NADH from the tricarboxylic acid cycle. The latter may be the main cause of complete Staphylococcus aureus killing. This new finding may provide insight into the underlying bactericidal mechanism of gA.	[Liou, Je-Wen; Hung, Yu-Jiun] Tzu Chi Univ, Inst Biochem, Hualien 970, Taiwan; [Yang, Chin-Hao] Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan; [Chen, Yi-Cheng] MacKay Med Coll, Dept Med, New Taipei City 252, Taiwan	Tzu Chi University; Tzu Chi University; Mackay Medical College	Chen, YC (corresponding author), MacKay Med Coll, Dept Med, New Taipei City 252, Taiwan.	chen15@mmc.edu.tw	Liou, Je-Wen/ABB-2157-2020	Liou, Je-Wen/0000-0002-6181-7263	Tzu Chi University [TCIRP96004-01]; National Science Council of Taiwan [NSC101-2627-M-715-001, NSC102-2627-M-715-002]	Tzu Chi University; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Tzu Chi University (TCIRP96004-01 to JWL) and the National Science Council of Taiwan (NSC101-2627-M-715-001 and NSC102-2627-M-715-002 to YCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN OS, 1984, ANNU REV PHYSIOL, V46, P531; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; BIERBAUM G, 1987, J BACTERIOL, V169, P5452, DOI 10.1128/jb.169.12.5452-5458.1987; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Cheng FC, 2002, J CHROMATOGR B, V781, P481, DOI 10.1016/S1570-0232(02)00620-7; Choi H, 2012, BBA-GEN SUBJECTS, V1820, P1831, DOI 10.1016/j.bbagen.2012.08.012; DECALEYA RF, 1972, APPL MICROBIOL, V23, P998, DOI 10.1128/AEM.23.5.998-1000.1972; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Gue M, 2001, BIOCHEMISTRY-US, V40, P11938; HENDERSO.PJ, 1969, BIOCHEM J, V111, P521, DOI 10.1042/bj1110521; HLADKY SB, 1972, BIOCHIM BIOPHYS ACTA, V274, P294, DOI 10.1016/0005-2736(72)90178-2; Hotchkiss RD, 1940, J BIOL CHEM, V132, P791; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Kacurakova M, 1996, CARBOHYD RES, V284, P145, DOI 10.1016/0008-6215(95)00412-2; KILLIAN JA, 1992, BIOCHIM BIOPHYS ACTA, V1113, P391; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; MILLER RJ, 1970, PLANT PHYSIOL, V46, P471, DOI 10.1104/pp.46.3.471; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12; SARGES R, 1965, J AM CHEM SOC, V87, P2011, DOI 10.1021/ja01087a027; SHAI Y, 1995, TRENDS BIOCHEM SCI, V20, P460, DOI 10.1016/S0968-0004(00)89101-X; Shea KM, 2003, PEDIATRICS, V112, P253; STADTMAN ER, 1991, J BIOL CHEM, V266, P17201; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; Tossi A, 2000, BIOPOLYMERS, V55, P4; Vizioli J, 2002, TRENDS PHARMACOL SCI, V23, P494, DOI 10.1016/S0165-6147(02)02105-3; Wallace BA, 2000, BIOESSAYS, V22, P227, DOI 10.1002/(SICI)1521-1878(200003)22:3<227::AID-BIES4>3.0.CO;2-6; Wallace BA, 1998, J STRUCT BIOL, V121, P123, DOI 10.1006/jsbi.1997.3948; WEINSTEIN S, 1980, J MOL BIOL, V143, P1, DOI 10.1016/0022-2836(80)90121-7; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P3114, DOI 10.1128/AAC.49.8.3114-3121.2005; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zoumpopoulou G, 2010, INT J FOOD MICROBIOL, V144, P202, DOI 10.1016/j.ijfoodmicro.2010.09.023	41	45	46	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117065	10.1371/journal.pone.0117065	http://dx.doi.org/10.1371/journal.pone.0117065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622083	Green Submitted, Green Published, gold			2022-12-26	WOS:000348470400017
J	Hedgepeth, SC; Garcia, MI; Wagner, LE; Rodriguez, AM; Chintapalli, SV; Snyder, RR; Hankins, GDV; Henderson, BR; Brodie, KM; Yule, DI; van Rossum, DB; Boehning, D				Hedgepeth, Serena C.; Garcia, M. Iveth; Wagner, Larry E., II; Rodriguez, Ana M.; Chintapalli, Sree V.; Snyder, Russell R.; Hankins, Gary D. V.; Henderson, Beric R.; Brodie, Kirsty M.; Yule, David I.; van Rossum, Damian B.; Boehning, Darren			The BRCA1 Tumor Suppressor Binds to Inositol 1,4,5-Trisphosphate Receptors to Stimulate Apoptotic Calcium Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID-BINDING; SPORADIC BREAST-CANCER; ENDOPLASMIC-RETICULUM; CA2+ OSCILLATIONS; HELA-CELLS; IDENTIFICATION; MITOCHONDRIA; EXPRESSION; PROTEINS; TYPE-1	The inositol 1,4,5-trisphosphate receptor (IP3R) is a ubiquitously expressed endoplasmic reticulum (ER)-resident calcium channel. Calcium release mediated by IP(3)Rs influences many signaling pathways, including those regulating apoptosis. IP3R activity is regulated by protein-protein interactions, including binding to proto-oncogenes and tumor suppressors to regulate cell death. Here we show that the IP3R binds to the tumor suppressor BRCA1. BRCA1 binding directly sensitizes the IP3R to its ligand, IP3. BRCA1 is recruited to the ER during apoptosis in an IP3R-dependent manner, and, in addition, a pool of BRCA1 protein is constitutively associated with the ER under non-apoptotic conditions. This is likely mediated by a novel lipid binding activity of the first BRCA1 C terminus domain of BRCA1 These findings provide a mechanistic explanation by which BRCA1 can act as a proapoptotic protein.	[Hedgepeth, Serena C.; Garcia, M. Iveth; Boehning, Darren] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Hedgepeth, Serena C.; Garcia, M. Iveth] Univ Texas Med Branch, Cell Biol Grad Program, Galveston, TX 77555 USA; [Rodriguez, Ana M.; Snyder, Russell R.; Hankins, Gary D. V.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Wagner, Larry E., II; Yule, David I.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Chintapalli, Sree V.; van Rossum, Damian B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Henderson, Beric R.; Brodie, Kirsty M.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Ctr Canc Res, Westmead, NSW 2145, Australia	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Sydney; Westmead Institute for Medical Research	Boehning, D (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, 6431 Fannin St,MSB Suite 6-161, Houston, TX 77030 USA.	Darren.F.Boehning@uth.tmc.edu	; Boehning, Darren/I-8539-2015	van Rossum, Damian/0000-0003-1011-2586; Boehning, Darren/0000-0001-7920-6922	National Institutes of Health [GM081685, DE014756]; Department of Obstetrics and Gynecology, University of Texas Medical Branch (Galveston, TX); Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston (Houston, TX); Cancer Institute of New South Wales, Australia [12/CDF/2-12]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014756, R01DE019245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE014756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology, University of Texas Medical Branch (Galveston, TX); Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston (Houston, TX); Cancer Institute of New South Wales, Australia; Pennsylvania Department of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081685 (to D. B.) and by National Institutes of Health Grant DE014756 (to D. I. Y.). This work was also supported by seed funds provided by the Department of Obstetrics and Gynecology, University of Texas Medical Branch (Galveston, TX) and startup funds provided by the Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston (Houston, TX) (to D. B.); by Cancer Institute of New South Wales, Australia Grant 12/CDF/2-12 (to B. R. H.); and by a grant from the Pennsylvania Department of Health using tobacco settlement funds (to D. V. R.).	Akimzhanov AM, 2013, CELL CALCIUM, V53, P152, DOI 10.1016/j.ceca.2012.10.002; Akl H, 2013, BBA-REV CANCER, V1835, P180, DOI 10.1016/j.bbcan.2012.12.001; BERNIER I, 1987, BIOCHIMIE, V69, P1127, DOI 10.1016/0300-9084(87)90140-4; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Bootman M, 1997, J PHYSIOL-LONDON, V499, P307, DOI 10.1113/jphysiol.1997.sp021928; Borahay MA, 2014, J BIOL CHEM, V289, P35075, DOI 10.1074/jbc.M114.583575; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Churchill GC, 1999, AM J PHYSIOL-CELL PH, V276, pC426, DOI 10.1152/ajpcell.1999.276.2.C426; Clark SL, 2012, COMPUT STRUCT BIOTEC, V1, DOI 10.5936/csbj.201204005; Coene ED, 2005, MOL BIOL CELL, V16, P997, DOI 10.1091/mbc.E04-10-0895; Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023; DIARRA A, 1994, PFLUG ARCH EUR J PHY, V426, P129, DOI 10.1007/BF00374680; Fabbro M, 2004, EXP CELL RES, V298, P661, DOI 10.1016/j.yexcr.2004.05.004; Fabbro M, 2002, J BIOL CHEM, V277, P21315, DOI 10.1074/jbc.M200769200; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; GLATZ JFC, 1990, MOL CELL BIOCHEM, V98, P237, DOI 10.1007/BF00231390; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Henderson BR, 2012, SCIENTIFICA, V2012, P1; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hong Y., 2011, J INTEGR OMICS, V1, P88; Hong Yoojin, 2009, J Proteomics Bioinform, V2, P139; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; Kennedy RD, 2004, JNCI-J NATL CANCER I, V96, P1659, DOI 10.1093/jnci/djh312; Ko KD, 2011, IEEE INT C BIO BIO W, P374, DOI 10.1109/BIBMW.2011.6112401; Lee LF, 1998, J BIOL CHEM, V273, P28253, DOI 10.1074/jbc.273.43.28253; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Magdinier F, 1998, ONCOGENE, V17, P3169, DOI 10.1038/sj.onc.1202248; Michaud M, 2011, INT J ONCOL, V38, P169, DOI 10.3892/ijo_00000836; Milner R, 2013, VIRCHOWS ARCH, V462, P269, DOI 10.1007/s00428-012-1368-y; Mylona E, 2014, PATHOL RES PRACT, V210, P533, DOI 10.1016/j.prp.2014.05.009; OCKNER RK, 1990, MOL CELL BIOCHEM, V98, P3; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Quinn JE, 2003, CANCER RES, V63, P6221; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Rodriguez JA, 2004, EXP CELL RES, V293, P14, DOI 10.1016/j.yexcr.2003.09.027; Rong YP, 2009, BBA-MOL CELL RES, V1793, P971, DOI 10.1016/j.bbamcr.2008.10.015; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; SAUVE R, 1991, CELL CALCIUM, V12, P165, DOI 10.1016/0143-4160(91)90018-A; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; Shao NS, 1996, ONCOGENE, V13, P1; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tembe V, 2007, J BIOL CHEM, V282, P20513, DOI 10.1074/jbc.M702627200; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Wagner LE, 2012, J PHYSIOL-LONDON, V590, P3245, DOI 10.1113/jphysiol.2012.228320; Wozniak AL, 2006, J CELL BIOL, V175, P709, DOI 10.1083/jcb.200608035; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541	51	49	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7304	7313		10.1074/jbc.M114.611186	http://dx.doi.org/10.1074/jbc.M114.611186			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25645916	hybrid, Green Published			2022-12-26	WOS:000350991500058
J	Obrochta, KM; Krois, CR; Campos, B; Napoli, JL				Obrochta, Kristin M.; Krois, Charles R.; Campos, Benito; Napoli, Joseph L.			Insulin Regulates Retinol Dehydrogenase Expression and All-trans-retinoic Acid Biosynthesis through FoxO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; TRANSCRIPTION FACTOR FOXO1; HEPATIC GLUCOSE-UPTAKE; SHORT-CHAIN DEHYDROGENASE/REDUCTASE; VITAMIN-A; IN-VIVO; INTRAPORTAL GLUCOSE; ACTIVATED RECEPTOR; RESPONSE ELEMENT; BINDING-PROTEIN	All-trans-retinoic acid (atRA), an autacoid derived from retinol (vitamin A), regulates energy balance and reduces adiposity. We show that energy status regulates atRA biosynthesis at the rate-limiting step, catalyzed by retinol dehydrogenases (RDH). Six h after re-feeding, Rdh1 expression decreased 80-90% in liver and brown adipose tissue and Rdh10 expression was decreased 45 63% in liver, pancreas, and kidney, all relative to mice fasted 16 h. atRA in the liver was decreased 44% 3 h after reduced Rdh expression. Oral gavage with glucose or injection with insulin decreased Rdh1 and Rdh10 mRNA 50% or greater in mouse liver. Removing serum from the medium of the human hepatoma cell line HepG2 increased Rdh10 and Rdh16 (human Rdh1 ortholog) mRNA expression 2-3-fold by 4 h, by increasing transcription and stabilizing mRNA. Insulin decreased Rdh10 and Rdh16 mRNA in HepG2 cells incubated in serum-free medium by inhibiting transcription and destabilizing mRNA. Insulin action required PI3K and Akt, which suppress FoxO1. Serum removal increased atRA biosynthesis 4-fold from retinol in HepG2 cells, whereas dominant-negative FoxO1 prevented the increase. Thus, energy status via insulin and FoxO1 regulate Rdh expression and atRA biosynthesis. These results reveal mechanisms for regulating atRA biosynthesis and the opposing effects of atRA and insulin on gluconeogenesis, and also suggest an interaction between atRA and insulin signaling related diseases, such as type II diabetes and cancer.	[Obrochta, Kristin M.; Krois, Charles R.; Campos, Benito; Napoli, Joseph L.] Univ Calif Berkeley, Grad Program Metab Biol, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Napoli, JL (corresponding author), Univ Calif Berkeley, Grad Program Metab Biol, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	jna@berkeley.edu			National Institutes of Health [DK090522, AA017927]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061918, R01DK090522, R01DK036870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK090522 and AA017927 (to J. L. N.).	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; BERGMAN RN, 1982, DIABETES, V31, P27, DOI 10.2337/diabetes.31.1.27; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Calmon MF, 2009, NEOPLASIA, V11, P1329, DOI 10.1593/neo.91110; Campos B, 2012, INT J CANCER, V131, P1963, DOI 10.1002/ijc.27446; Chakravarti N, 2007, CLIN CANCER RES, V13, P4817, DOI 10.1158/1078-0432.CCR-06-3026; CHERTOW BS, 1987, J CLIN INVEST, V79, P163, DOI 10.1172/JCI112778; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; ENG J, 1992, J BIOL CHEM, V267, P7402; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Frey SK, 2011, NUTRIENTS, V3, P27, DOI 10.3390/nu3010027; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; ISHIDA T, 1983, J CLIN INVEST, V72, P590, DOI 10.1172/JCI111007; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2011, MOL CELL BIOL, V31, P3277, DOI 10.1128/MCB.05516-11; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kido Y, 2001, J CLIN ENDOCR METAB, V86, P972, DOI 10.1210/jc.86.3.972; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; LUCAS PC, 1991, P NATL ACAD SCI USA, V88, P2184, DOI 10.1073/pnas.88.6.2184; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; MATSUURA T, 1993, ARCH BIOCHEM BIOPHYS, V301, P221, DOI 10.1006/abbi.1993.1137; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Mercader J, 2010, OBESITY, V18, P655, DOI 10.1038/oby.2009.330; Mira-y-Lopez R, 2000, J CELL PHYSIOL, V185, P302, DOI 10.1002/1097-4652(200011)185:2<302::AID-JCP15>3.0.CO;2-#; Mithieux G, 1996, DIABETES, V45, P891, DOI 10.2337/diabetes.45.7.891; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; MYERS SR, 1991, J CLIN INVEST, V88, P158, DOI 10.1172/JCI115273; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Noy N, 2013, ADIPOCYTE, V2, P184, DOI 10.4161/adip.23489; Ohlsson L, 2014, REGUL PEPTIDES, V189, P40, DOI 10.1016/j.regpep.2014.02.001; Perez RJ, 2013, EXP CELL RES, V319, P2196, DOI 10.1016/j.yexcr.2013.05.032; Pierzchalski K, 2013, FASEB J, V27, P1904, DOI 10.1096/fj.12-219410; Pino-Lagos K, 2010, BIOFACTORS, V36, P430, DOI 10.1002/biof.117; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ross AC, 2007, VITAM HORM, V75, P197, DOI 10.1016/S0083-6729(06)75008-7; Ross AC, 2011, PHYSIOL GENOMICS, V43, P57, DOI 10.1152/physiolgenomics.00182.2010; Rossi E, 2007, CANCER BIOL THER, V6, P238, DOI 10.4161/cbt.6.2.3625; Sancho P, 2010, J BIOL CHEM, V285, P24815, DOI 10.1074/jbc.M110.114280; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Scott DK, 1996, J BIOL CHEM, V271, P6260, DOI 10.1074/jbc.271.11.6260; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shin DJ, 2002, MOL CELL ENDOCRINOL, V195, P39, DOI 10.1016/S0303-7207(02)00215-0; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Sugiyama T, 1998, MOL ENDOCRINOL, V12, P1487, DOI 10.1210/me.12.10.1487; Tanabe K, 2008, CANCER SCI, V99, P267, DOI 10.1111/j.1349-7006.2007.00684.x; TOBE K, 1992, J BIOL CHEM, V267, P21089; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; WOLF G, 1958, Prog Nucl Energy 6 Biol Sci, V2, P457; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Yamamoto Y, 2000, FASEB J, V14, P2119, DOI 10.1096/fj.00-0061com; Zarrinpar A, 2012, ALIMENT PHARM THER, V36, P909, DOI 10.1111/apt.12084; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Zhao S, 2012, BIOCHEM CELL BIOL, V90, P142, DOI [10.1139/O11-079, 10.1139/o11-079]; Zizola CF, 2010, MOL CELL BIOL, V30, P3412, DOI 10.1128/MCB.00014-10	77	30	33	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7259	7268		10.1074/jbc.M114.609313	http://dx.doi.org/10.1074/jbc.M114.609313			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627686	Green Published, hybrid			2022-12-26	WOS:000350991500054
J	Kenerson, HL; Subramanian, S; McIntyre, R; Kazami, M; Yeung, RS				Kenerson, Heidi L.; Subramanian, Savitha; McIntyre, Rebecca; Kazami, Machiko; Yeung, Raymond S.			Livers with Constitutive mTORC1 Activity Resist Steatosis Independent of Feedback Suppression of Akt	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; CELL-SURVIVAL; FATTY LIVER; LIPOGENESIS; COMPLEX; NRF2; INHIBITION; ACTIVATION; SUBSTRATE; SREBP-1C	Insulin resistance is an important contributing factor in non-alcoholic fatty liver disease. AKT and mTORC1 are key components of the insulin pathway, and play a role in promoting de novo lipogenesis. However, mTORC1 hyperactivity per se does not induce steatosis in mouse livers, but instead, protects against high-fat diet induced steatosis. Here, we investigate the in vivo mechanism of steatosis-resistance secondary to mTORC1 activation, with emphasis on the role of S6K1-mediated feedback inhibition of AKT. Mice with single or double deletion of Tsc1 and/ or S6k1 in a liver-specific or whole-body manner were generated to study glucose and hepatic lipid metabolism between the ages of 6-14 weeks. Following 8 weeks of high- fat diet, the Tsc1-/-; S6k1-/- mice had lower body weights but higher liver TG levels compared to that of the Tsc1-/- mice. However, the loss of S6k1 did not relieve feedback inhibition of Akt activity in the Tsc1-/- livers. To overcome Akt suppression, Pten was deleted in Tsc1-/- livers, and the resultant mice showed improved glucose tolerance compared with the Tsc1-/- mice. However, liver TG levels were significantly reduced in the Tsc1-/-; Pten-/- mice compared to the Pten-/- mice, which was restored with rapamycin. We found no correlation between liver TG and serum NEFA levels. Expression of lipogenic genes (Srebp1c, Fasn) were elevated in the Tsc1-/-; Pten-/- livers, but this was counterbalanced by an up-regulation of Cpt1a involved in fatty acid oxidation and the anti-oxidant protein, Nrf2. In summary, our in vivo models showed that mTORC1-induced resistance to steatosis was dependent on S6K1 activity, but not secondary to AKT suppression. These findings confirm that AKT and mTORC1 have opposing effects on hepatic lipid metabolism in vivo.	[Kenerson, Heidi L.; McIntyre, Rebecca; Kazami, Machiko; Yeung, Raymond S.] Univ Washington, Dept Surg, Northwest Liver Res Program, Seattle, WA 98195 USA; [Subramanian, Savitha] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Yeung, RS (corresponding author), Univ Washington, Dept Surg, Northwest Liver Res Program, Seattle, WA 98195 USA.	ryeung@uw.edu		Subramanian, Savitha/0000-0002-4866-2009; McIntyre, Rebecca L./0000-0002-2863-8132	National Institutes of Health [CA102662]; University of Washington Department of Surgery Reinvestment Fund; NATIONAL CANCER INSTITUTE [R01CA102662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Department of Surgery Reinvestment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health CA102662 (RSY), University of Washington Department of Surgery Reinvestment Fund (RSY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chowdhry S, 2010, FREE RADICAL BIO MED, V48, P357, DOI 10.1016/j.freeradbiomed.2009.11.007; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kay HY, 2011, ANTIOXID REDOX SIGN, V15, P2135, DOI 10.1089/ars.2010.3834; Kenerson HL, 2013, GASTROENTEROLOGY, V144, P1055, DOI 10.1053/j.gastro.2013.01.053; Kenerson HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018075; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; McCullough AJ, 2011, J DIGEST DIS, V12, P333, DOI 10.1111/j.1751-2980.2010.00469.x; Miyake T, 2012, INTERNAL MED, V51, P2151, DOI 10.2169/internalmedicine.51.7578; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Quinn WJ, 2012, P NATL ACAD SCI USA, V109, P15974, DOI 10.1073/pnas.1214113109; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schieren G, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-22; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	36	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117000	10.1371/journal.pone.0117000	http://dx.doi.org/10.1371/journal.pone.0117000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646773	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600047
J	Tark, D; Kim, H; Neale, MH; Kim, M; Sohn, H; Lee, Y; Cho, I; Joo, Y; Windl, O				Tark, Dongseob; Kim, Hyojin; Neale, Michael H.; Kim, Minjeong; Sohn, Hyunjoo; Lee, Yoonhee; Cho, Insoo; Joo, Yiseok; Windl, Otto			Generation of a Persistently Infected MDBK Cell Line with Natural Bovine Spongiform Encephalopathy (BSE)	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; ENDOGENOUS PROTEOLYTIC CLEAVAGE; PRION PROTEIN-FORMATION; NEUROBLASTOMA-CELLS; SCRAPIE STRAINS; PRP; TISSUES; TRANSMISSION; PROPAGATION; EXPRESSION	Bovine spongiform encephalopathy (BSE) is a zoonotic transmissible spongiform encephalopathy (TSE) thought to be caused by the same prion strain as variant Creutzfeldt-Jakob disease (vCJD). Unlike scrapie and chronic wasting disease there is no cell culture model allowing the replication of proteinase K resistant BSE (PrPBSE) and the further in vitro study of this disease. We have generated a cell line based on the Madin-Darby Bovine Kidney (MDBK) cell line over-expressing the bovine prion protein. After exposure to naturally BSE infected bovine brain homogenate this cell line has shown to replicate and accumulate Pr-PBSE and maintain infection up to passage 83 after initial challenge. Collectively, we demonstrate, for the first time, that the BSE agent can infect cell lines over-expressing the bovine prion protein similar to other prion diseases. These BSE infected cells will provide a useful tool to facilitate the study of potential therapeutic agents and the diagnosis of BSE.	[Tark, Dongseob; Kim, Minjeong; Sohn, Hyunjoo; Lee, Yoonhee; Cho, Insoo] Anim & Plant Quarantine Agcy, Dept Anim & Plant Hlth Res, Anyang Si, Gyeonggi Do, South Korea; [Kim, Hyojin; Joo, Yiseok] Anim & Plant Quarantine Agcy, Dept Anim Dis Control & Quarantine, Anyang Si, Gyeonggi Do, South Korea; [Neale, Michael H.; Windl, Otto] Anim Hlth & Vet Labs Agcy, Pathol & Host Susceptibil Dept, Addlestone KT15 3NB, Surrey, England	Animal & Plant Quarantine Agency; Animal & Plant Quarantine Agency; Veterinary Laboratories Agency	Tark, D (corresponding author), Anim & Plant Quarantine Agcy, Dept Anim & Plant Hlth Res, 175 Anyang Ro, Anyang Si, Gyeonggi Do, South Korea.	tarkds@korea.kr			Veterinary Science Technical Development project of the Animal, Plant and Fisheries Quarantine and Inspection Agency [M-AD16-2006-09-09]	Veterinary Science Technical Development project of the Animal, Plant and Fisheries Quarantine and Inspection Agency	This work was supported by a fund of the Veterinary Science Technical Development project of the Animal, Plant and Fisheries Quarantine and Inspection Agency (project no. M-AD16-2006-09-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonia F, 2000, NAT GENET, V25, P217; Arima K, 2005, J VIROL, V79, P7104, DOI 10.1128/JVI.79.11.7104-7112.2005; Baron T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015839; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Dron M, 2010, J BIOL CHEM, V285, P10252, DOI 10.1074/jbc.M109.083857; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; HADLOW WJ, 1987, J VIROL, V61, P3235, DOI 10.1128/JVI.61.10.3235-3240.1987; Heinig L, 2010, PROTEIN EXPRES PURIF, V70, P129, DOI 10.1016/j.pep.2009.09.015; Iwamaru Y, 2008, J NEUROCHEM, V107, P636, DOI 10.1111/j.1471-4159.2008.05628.x; Iwamaru Y, 2007, J VIROL, V81, P1524, DOI 10.1128/JVI.01379-06; Jha KK, 1998, EXP CELL RES, V245, P1, DOI 10.1006/excr.1998.4272; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kim HJ, 2012, J VET MED SCI, V74, P1377, DOI 10.1292/jvms.12-0061; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; LADOGANA A, 1995, LANCET, V345, P594, DOI 10.1016/S0140-6736(95)90508-1; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Manuelidis L, 2007, P NATL ACAD SCI USA, V104, P1965, DOI 10.1073/pnas.0610999104; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Paquet S, 2007, J VIROL, V81, P10786, DOI 10.1128/JVI.01137-07; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Raymond GJ, 2006, J VIROL, V80, P596, DOI 10.1128/JVI.80.2.596-604.2006; Ryder SJ, 2001, VET REC, V148, P437, DOI 10.1136/vr.148.14.437; Stack MJ, 2011, J COMP PATHOL, V145, P289, DOI 10.1016/j.jcpa.2011.01.010; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9	38	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115939	10.1371/journal.pone.0115939	http://dx.doi.org/10.1371/journal.pone.0115939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647616	gold, Green Submitted, Green Published			2022-12-26	WOS:000348822600017
J	Yang, QC; Chen, LN; Hu, XL; Zhao, L; Yin, PH; Li, Q				Yang, Qiuchan; Chen, Lina; Hu, Xiaoli; Zhao, Ling; Yin, Pinghe; Li, Qiang			Toxic Effect of a Marine Bacterium on Aquatic Organisms and Its Algicidal Substances against Phaeocystis globosa	PLOS ONE			English	Article							RED TIDE; HYPOXANTHINE; BLOOMS; DINOFLAGELLATE; COMPOUND; EXTRACTS; INOSINE; OXIDASE	Harmful algal blooms have caused enormous damage to the marine ecosystem and the coastal economy in China. In this paper, a bacterial strain B1, which had strong algicidal activity against Phaeocystis globosa, was isolated from the coastal waters of Zhuhai in China. The strain B1 was identified as Bacillus sp. on the basis of 16S rDNA gene sequence and morphological characteristics. To evaluate the ecological safety of the algicidal substances produced by strain B1, their toxic effects on marine organisms were tested. Results showed that there were no adverse effects observed in the growth of Chlorella vulgaris, Chaetoceros muelleri, and Isochrystis galbana after exposure to the algicidal substances at a concentration of 1.0% (v/v) for 96 h. The 48h LC50 values for Brachionus plicatilis, Moina mongolica Daday and Paralichthys olivaceus were 5.7, 9.0 and 12.1%(v/v), respectively. Subsequently, the algicidal substances from strain B1 culture were isolated and purified by silica gel column, Sephadex G-15 column and high-performance liquid chromatography. Based on quadrupole time-of-flight mass spectrometry and PeakView Software, the purified substances were identified as prolyl-methionine and hypoxanthine. Algicidal mechanism indicated that prolyl-methionine and hypoxanthine inhibited the growth of P. globosa by disrupting the antioxidant systems. In the acute toxicity assessment using M. mongolica, 24h LC50 values of prolyl-methionine and hypoxanthine were 7.0 and 13.8 g/L, respectively. The active substances produced by strain B1 can be considered as ecologically and environmentally biological agents for controlling harmful algal blooms.	[Yang, Qiuchan; Chen, Lina; Zhao, Ling] Jinan Univ, Key Lab Water Soil Tox Pollutants Control & Biore, Guangdong Higher Educ Inst, Sch Environm, Guangzhou 510632, Guangdong, Peoples R China; [Hu, Xiaoli; Yin, Pinghe; Li, Qiang] Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China	Jinan University; Jinan University	Zhao, L (corresponding author), Jinan Univ, Key Lab Water Soil Tox Pollutants Control & Biore, Guangdong Higher Educ Inst, Sch Environm, Guangzhou 510632, Guangdong, Peoples R China.	zhaoling@jnu.edu.cn; tyinph@jnu.edu.cn			National Natural Science Foundation of China [41076068]; United Fund Project of National Natural Science Foundation of China-Guangdong [U1133003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United Fund Project of National Natural Science Foundation of China-Guangdong	This research was supported by the National Natural Science Foundation of China (No. 41076068) and the United Fund Project of National Natural Science Foundation of China-Guangdong (No. U1133003)(http://www.nsfc.gov.cn/publish/portal0/default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CY, 2003, BIOTECHNOL LETT, V25, P1137, DOI 10.1023/A:1024508927361; Alamri SA, 2013, SAUDI J BIOL SCI, V20, P357, DOI 10.1016/j.sjbs.2013.04.002; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Balladin DA, 1997, APPL BIOCHEM BIOTECH, V62, P317, DOI 10.1007/BF02788006; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; Blauw AN, 2010, J MARINE SYST, V83, P115, DOI 10.1016/j.jmarsys.2010.05.003; Chen WM, 2011, ENZYME MICROB TECH, V49, P372, DOI 10.1016/j.enzmictec.2011.06.016; Cho JY, 2012, BIOSCI BIOTECH BIOCH, V76, P1452, DOI 10.1271/bbb.120102; Farthing D, 2007, J CHROMATOGR B, V854, P158, DOI 10.1016/j.jchromb.2007.04.013; Farthing DE, 2011, LUMINESCENCE, V26, P65, DOI 10.1002/bio.1187; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gillespie KM, 2011, J EXP BOT, V62, P2667, DOI 10.1093/jxb/erq435; Imamura N, 2000, J ANTIBIOT, V53, P1317, DOI 10.7164/antibiotics.53.1317; Jancula D, 2007, ENVIRON TOXICOL, V22, P480, DOI 10.1002/tox.20290; Jeong SY, 2003, TETRAHEDRON LETT, V44, P8005, DOI 10.1016/j.tetlet.2003.08.115; Kim MJ, 2008, J APPL PHYCOL, V20, P1069, DOI 10.1007/s10811-008-9312-x; Kim SJ, 2011, ENVIRON TOXICOL CHEM, V30, P2810, DOI 10.1002/etc.691; Lee SO, 2002, BIOSCI BIOTECH BIOCH, V66, P1366, DOI 10.1271/bbb.66.1366; Li HS, 2006, EXPT PRINCIPLES TECH; Lovejoy C, 1998, APPL ENVIRON MICROB, V64, P2806; Luo JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076444, 10.1371/journal.pone.0049231]; Mayali X, 2002, HARMFUL ALGAE, V1, P277, DOI 10.1016/S1568-9883(02)00032-X; Nakashima T, 2006, APPL MICROBIOL BIOT, V73, P684, DOI 10.1007/s00253-006-0507-2; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pierce RH, 2008, ECOTOXICOLOGY, V17, P623, DOI 10.1007/s10646-008-0241-x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Shao J, 2014, INT J ENVIRON SCI TE, V11, P469, DOI 10.1007/s13762-013-0205-4; Shao JH, 2013, J ENVIRON MANAGE, V125, P149, DOI 10.1016/j.jenvman.2013.04.001; Somdee T, 2013, J APPL PHYCOL, V25, P1587, DOI 10.1007/s10811-013-9999-1; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Valentine JS, 1998, CURR OPIN CHEM BIOL, V2, P253, DOI 10.1016/S1367-5931(98)80067-7; van Rijssel M, 2000, J SEA RES, V43, P297, DOI 10.1016/S1385-1101(00)00013-7; VANHAECKE P, 1981, ECOTOX ENVIRON SAFE, V5, P382, DOI 10.1016/0147-6513(81)90012-9; Wang BX, 2010, LETT APPL MICROBIOL, V51, P552, DOI 10.1111/j.1472-765X.2010.02936.x; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Yang L, 2012, BIOCONTROL SCI, V17, P107, DOI 10.4265/bio.17.107; Yoshikawa K, 2000, APPL ENVIRON MICROB, V66, P718, DOI 10.1128/AEM.66.2.718-722.2000; Zhang HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065277, 10.1371/journal.pone.0054510, 10.1371/journal.pone.0068634, 10.1371/journal.pone.0079454]; Zheng XW, 2013, APPL MICROBIOL BIOT, V97, P9207, DOI 10.1007/s00253-012-4617-8; Zhou LH, 2010, J APPL PHYCOL, V22, P803, DOI 10.1007/s10811-010-9522-x	45	47	52	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0114933	10.1371/journal.pone.0114933	http://dx.doi.org/10.1371/journal.pone.0114933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646807	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600009
J	Gengler, S; Laudisoit, A; Batoko, H; Wattiau, P				Gengler, Samuel; Laudisoit, Anne; Batoko, Henri; Wattiau, Pierre			Long-Term Persistence of Yersinia pseudotuberculosis in Entomopathogenic Nematodes	PLOS ONE			English	Article							MUSCA-DOMESTICA DIPTERA; GRAM-NEGATIVE BACTERIA; TOXIN COMPLEX PROTEINS; PHOTORHABDUS-LUMINESCENS; CAENORHABDITIS-ELEGANS; SUICIDE VECTOR; VI SECRETION; XENORHABDUS; PESTIS; ENTEROCOLITICA	Entomopathogenic nematodes (EPNs) are small worms whose ecological behaviour consists to invade, kill insects and feed on their cadavers thanks to a species-specific symbiotic bacterium belonging to any of the genera Xenorhabdus or Photorhabdus hosted in the gastro-intestinal tract of EPNs. The symbiont provides a number of biological functions that are essential for its EPN host including the production of entomotoxins, of enzymes able to degrade the insect constitutive macromolecules and of antimicrobial compounds able to prevent the growth of competitors in the insect cadaver. The question addressed in this study was to investigate whether a mammalian pathogen taxonomically related to Xenorhabdus was able to substitute for or "hijack" the symbiotic relationship associating Xenorhabdus and Steinernema EPNs. To deal with this question, a laboratory experimental model was developed consisting in Galleria mellonella insect larvae, Steinernema EPNs with or without their natural Xenorhabdus symbiont and Yersinia pseudotuberculosis brought artificially either in the gut of EPNs or in the haemocoel of the insect larva prior to infection. The developed model demonstrated the capacity of EPNs to act as an efficient reservoir ensuring exponential multiplication, maintenance and dissemination of Y. pseudotuberculosis.	[Gengler, Samuel; Wattiau, Pierre] Vet & Agrochem Res Ctr VAR, Brussels, Belgium; [Gengler, Samuel; Batoko, Henri] Catholic Univ Louvain, Inst Life Sci, Louvain, Belgium; [Laudisoit, Anne] Univ Antwerp, Evolutionary Biol, B-2020 Antwerp, Belgium; [Laudisoit, Anne] Univ Liverpool, Sch Biol Sci, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	Universite Catholique Louvain; University of Antwerp; University of Liverpool	Wattiau, P (corresponding author), Vet & Agrochem Res Ctr VAR, Brussels, Belgium.	Pierre.Wattiau@coda-cerva.be	Batoko, Henri/Y-4238-2019; LAUDISOIT, Anne/O-5773-2019	Batoko, Henri/0000-0002-8256-519X; LAUDISOIT, Anne/0000-0001-7626-9426	Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture	Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture(Fonds de la Recherche Scientifique - FNRS)	This study was funded by the "Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture"; http://www.fnrs.be/. SG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; Ayyadurai S, 2008, MICROBIOL-SGM, V154, P2865, DOI 10.1099/mic.0.2007/016154-0; Babic I, 2000, MICROBIOL-UK, V146, P709, DOI 10.1099/00221287-146-3-709; Bari ML, 2011, J PATHOG, V2011, DOI 10.4061/2011/420732; Bertherat E, 2007, EMERG INFECT DIS, V13, P1459, DOI 10.3201/eid1310.070284; Brusselman E, 2006, Commun Agric Appl Biol Sci, V71, P701; Buzoleva LS, 2003, B EXP BIOL MED+, V135, P456, DOI 10.1023/A:1024915409187; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Collyn F, 2002, INFECT IMMUN, V70, P6196, DOI 10.1128/IAI.70.11.6196-6205.2002; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Derbise A, 2013, J INFECT DIS, V207, P1535, DOI 10.1093/infdis/jit057; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; Emelianoff V, 2008, EVOLUTION, V62, P932, DOI 10.1111/j.1558-5646.2008.00319.x; FARMER JJ, 1989, J CLIN MICROBIOL, V27, P1594, DOI 10.1128/JCM.27.7.1594-1600.1989; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Hatab Moeen Abu, 1998, Journal of Parasitology, V84, P215, DOI 10.2307/3284473; Heermann R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-40; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Jalava K, 2006, J INFECT DIS, V194, P1209, DOI 10.1086/508191; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Lambrecht E, 2013, APPL ENVIRON MICROB, V79, P6407, DOI 10.1128/AEM.01915-13; Lancaster Jeremiah D, 2012, BMC Res Notes, V5, P688, DOI 10.1186/1756-0500-5-688; Li JX, 1997, CAN J MICROBIOL, V43, P770, DOI 10.1139/m97-110; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; MCFARLANE GJB, 1987, J MICROBIOL METH, V6, P301, DOI 10.1016/0167-7012(87)90067-4; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Mwaitulo S., 2011, International Journal of Tropical Insect Science, V31, P154, DOI 10.1017/S1742758411000294; NIKULSHIN SV, 1992, ZH MIKROB EPID IMMUN, P2; Pinheiro VB, 2007, CELL MICROBIOL, V9, P2372, DOI 10.1111/j.1462-5822.2007.00966.x; POINER GO, 1966, PARASITOLOGY, V56, P385, DOI 10.1017/S0031182000070980; Rahuma N, 2005, ANN TROP MED PARASIT, V99, P795, DOI 10.1179/136485905X65134; Reznikoff WS, 2008, ANNU REV GENET, V42, P269, DOI 10.1146/annurev.genet.42.110807.091656; Schmiel DH, 1998, INFECT IMMUN, V66, P3941, DOI 10.1128/IAI.66.8.3941-3951.1998; Schubert S, 2004, INT J MED MICROBIOL, V294, P83, DOI 10.1016/j.ijmm.2004.06.026; Sheets JJ, 2011, J BIOL CHEM, V286, P22742, DOI 10.1074/jbc.M111.227009; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Tan L, 2004, J BACTERIOL, V186, P5087, DOI 10.1128/jb.186.15.5087-5092.2004; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Wilkinson P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-302; Wilson M, 2004, BIOTECHNOL LETT, V26, P1167, DOI 10.1023/B:BILE.0000035492.25214.3b; WOUTS WM, 1981, J NEMATOL, V13, P467; Zhang CX, 2009, INT J SYST EVOL MICR, V59, P1603, DOI 10.1099/ijs.0.65718-0; Zhang CX, 2008, J INVERTEBR PATHOL, V98, P153, DOI 10.1016/j.jip.2008.02.011; Zurek L, 2000, J MED ENTOMOL, V37, P924, DOI 10.1603/0022-2585-37.6.924; Zurek L, 2001, J MED ENTOMOL, V38, P333, DOI 10.1603/0022-2585-38.2.333	54	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116818	10.1371/journal.pone.0116818	http://dx.doi.org/10.1371/journal.pone.0116818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635766	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700060
J	Jennings, WB; Berry, KH				Jennings, W. Bryan; Berry, Kristin H.			Desert Tortoises (Gopherus agassizii) Are Selective Herbivores that Track the Flowering Phenology of Their Preferred Food Plants	PLOS ONE			English	Article							FREE-RANGING DESERT; MOJAVE-DESERT; NUTRITIONAL QUALITY; GEOCHELONE-PARDALIS; XEROBATES-AGASSIZII; SOUTHERN NEVADA; FEEDING ECOLOGY; GIANT TORTOISES; NATURAL FOODS; DIET	Previous studies of desert tortoise foraging ecology in the western Mojave Desert suggest that these animals are selective herbivores, which alter their diet according to the temporal availability of preferred food plants. These studies, however, did not estimate availability of potential food plants by taking into account the spatial and temporal variability in ephemeral plant abundance that occurs within the spring season. In this study, we observed 18 free-ranging adult tortoises take 35,388 bites during the spring foraging season. We also estimated the relative abundance of potential food plants by stratifying our sampling across different phenological periods of the 3-month long spring season and by different habitats and microhabitats. This methodology allowed us to conduct statistical tests comparing tortoise diet against plant abundance. Our results show that tortoises choose food plants non-randomly throughout the foraging season, a finding that corroborates the hypothesis that desert tortoises rely on key plants during different phenological periods of spring. Moreover, tortoises only consumed plants in a succulent state until the last few weeks of spring, at which time most annuals and herbaceous perennials had dried and most tortoises had ceased foraging. Many species of food plants-including several frequently eaten species-were not detected in our plant surveys, yet tortoises located these rare plants in their home ranges. Over 50% of bites consumed were in the group of undetected species. Interestingly, tortoises focused heavily on several leguminous species, which could be nutritious foods owing to their presumably high nitrogen contents. We suggest that herbaceous perennials, which were rare on our study area but represented similar to 30% of tortoise diet, may be important in sustaining tortoise populations during droughts when native annuals are absent. These findings highlight the vulnerability of desert tortoises to climate change if such changes alter the availability of their preferred food plants.	[Jennings, W. Bryan] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, BR-20940040 Rio De Janeiro, RJ, Brazil; [Berry, Kristin H.] US Geol Survey, Western Ecol Res Ctr, Riverside, CA 92518 USA	Universidade Federal do Rio de Janeiro; United States Department of the Interior; United States Geological Survey	Jennings, WB (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, BR-20940040 Rio De Janeiro, RJ, Brazil.	wbjenn@gmail.com	Jennings, Bryan/ABE-9193-2020	Jennings, Bryan/0000-0001-7700-8981	U.S. Bureau of Land Management [B950-C2-0014]	U.S. Bureau of Land Management	This study was funded by the U.S. Bureau of Land Management (Contract No. B950-C2-0014 awarded to WBJ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin B.G., 2012, JEPSON MANUAL VASCUL, V2nd ed.; BEATLEY JC, 1974, ECOLOGY, V55, P856, DOI 10.2307/1934421; BEATLEY JC, 1976, OECOLOGIA, V24, P21, DOI 10.1007/BF00545485; Bedford DR, 2009, MOJAVE DESERT, P252; Berry K.H., 1978, Transactions of the North American Wildlife and Natural Resources Conference, P505; Bolling JD, 2002, WEST N AM NATURALIST, V62, P88; Bourn D, 1999, P ROY SOC B-BIOL SCI, V266, P1091, DOI 10.1098/rspb.1999.0748; Brooks ML, 2006, J ARID ENVIRON, V67, P148, DOI 10.1016/j.jaridenv.2006.09.027; Brooks ML, 2006, J ARID ENVIRON, V67, P100, DOI 10.1016/j.jaridenv.2006.09.021; Brooks ML, 2006, J ARID ENVIRON, V67, P125, DOI 10.1016/j.jaridenv.2006.09.022; Brooks Matthew L., 2002, Chelonian Conservation and Biology, V4, P330; Brooks ML, 2009, MOJAVE DESERT, P168; Brooks ML, 2009, MOJAVE DESERT, P101; Brooks Matthew L., 1999, Madrono, V46, P13; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; BROOKS ML, 1995, ENVIRON MANAGE, V19, P65, DOI 10.1007/BF02472004; Brooks ML, 2000, AM MIDL NAT, V144, P92, DOI 10.1674/0003-0031(2000)144[0092:CBAAGA]2.0.CO;2; Brossard CC, 2000, INVASIVE PLANTS CALI; Burge BL, 1978, DES TORT COUNC S P, P80; Christopher MM, 1999, J WILDLIFE DIS, V35, P212, DOI 10.7589/0090-3558-35.2.212; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Del Vecchio S, 2011, HERPETOLOGICA, V67, P236, DOI 10.1655/HERPETOLOGICA-D-10-00064.1; El Mouden EH, 2006, J ARID ENVIRON, V64, P422, DOI 10.1016/j.jaridenv.2005.06.010; Fish and Wildlife Service, 1990, FED REG, V55, P12178; GIBSON CWD, 1983, OECOLOGIA, V56, P84, DOI 10.1007/BF00378221; GRUBB P, 1971, PHILOS T ROY SOC B, V260, P327, DOI 10.1098/rstb.1971.0018; Hailey A, 1998, FUNCT ECOL, V12, P373, DOI 10.1046/j.1365-2435.1998.00203.x; Hazard LC, 2010, J HERPETOL, V44, P135, DOI 10.1670/08-134.1; Hazard LC, 2009, J HERPETOL, V43, P38, DOI 10.1670/07-160R1.1; Henen BT, 1998, OECOLOGIA, V117, P365, DOI 10.1007/s004420050669; HNATIUK R J, 1976, Biological Conservation, V9, P305, DOI 10.1016/0006-3207(76)90052-5; JACOBSON ER, 1991, J WILDLIFE DIS, V27, P296, DOI 10.7589/0090-3558-27.2.296; Jennings W. Bryan, 2001, Madrono, V48, P162; Jennings W. Bryan, 2002, Chelonian Conservation and Biology, V4, P353; Jennings WB, 1993, P DES TORT COUNC 199, P69; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Joshua QI, 2010, J HERPETOL, V44, P124, DOI 10.1670/08-306R1.1; Kabigumila J, 2001, AFR J ECOL, V39, P276, DOI 10.1046/j.1365-2028.2001.00316.x; Krebs C. J, 1989, ECOLOGICAL METHODOLO; Lagarde FR, 2003, ECOGRAPHY, V26, P236, DOI 10.1034/j.1600-0587.2003.03365.x; MACDONALD LA, 1988, HERPETOLOGICA, V44, P345; Mason Mervyn C., 1999, Chelonian Conservation and Biology, V3, P435; MEIENBERGER C, 1993, PHYSIOL ZOOL, V66, P847, DOI 10.1086/physzool.66.5.30163827; MERTON L F H, 1976, Biological Conservation, V9, P293, DOI 10.1016/0006-3207(76)90051-3; MINNICH JE, 1972, COMP BIOCHEM PHYSIOL, V41, P535, DOI 10.1016/0300-9629(72)90011-4; Minnich JE, 1977, P DESERT TORTOISE CO, V1977, P102; MOSKOVITS DK, 1990, HERPETOLOGICA, V46, P207; Mushinsky HR, 2003, HERPETOLOGICA, V59, P475, DOI 10.1655/02-50; NAGY KA, 1986, HERPETOLOGICA, V42, P73; Oftedal Olav T., 2002, Chelonian Conservation and Biology, V4, P341; Oftedal Olav T., 2002, P194; OWENSMITH N, 1982, AM NAT, V119, P151, DOI 10.1086/283902; Peterson CC, 1996, PHYSIOL ZOOL, V69, P1324, DOI 10.1086/physzool.69.6.30164263; Peterson CC, 1996, ECOLOGY, V77, P1831, DOI 10.2307/2265787; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RALL M, 1993, S AFR J WILDL RES, V23, P63; Raven PH., 1992, BIOL PLANTS, V5th, P791; ROWLANDS P. G., 1978, THESIS U CALIFORNIA; Rowlands PG, 1986, P DES TORT COUNC 199, P41; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Sokol R.R., 1981, BIOMETRY, P859; U. S. Fish and Wildlife Service, 1994, DES TORT MOJ POP REC, P73; US Fish and Wildlife Service, 2010, MOJ POP DES TORT GOP; US Fish and Wildlife Service, 1994, FED REG, V59, P5820; WEBB RH, 1979, ENVIRON MANAGE, V3, P517, DOI 10.1007/BF01866321; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921	66	24	25	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116716	10.1371/journal.pone.0116716	http://dx.doi.org/10.1371/journal.pone.0116716			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635840	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700054
J	Nelson, LE; Wilton, L; Agyarko-Poku, T; Zhang, NH; Zou, YS; Aluoch, M; Apea, V; Hanson, SO; Adu-Sarkodie, Y				Nelson, LaRon E.; Wilton, Leo; Agyarko-Poku, Thomas; Zhang, Nanhua; Zou, Yuanshu; Aluoch, Marilyn; Apea, Vanessa; Hanson, Samuel Owiredu; Adu-Sarkodie, Yaw			Predictors of Condom Use among Peer Social Networks of Men Who Have Sex with Men in Ghana, West Africa	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; HIV-RELATED STIGMA; DETERMINATION THEORY PERSPECTIVE; BLACK-MEN; PREVENTION INTERVENTIONS; STRUCTURAL INTERVENTION; PSYCHOMETRIC EVALUATION; MEDICATION ADHERENCE; GENDER NONCONFORMITY; NEED SATISFACTION	Ghanaian men who have sex with men (MSM) have high rates of HIV infection. A first step in designing culturally relevant prevention interventions for MSM in Ghana is to understand the influence that peer social networks have on their attitudes and behaviors. We aimed to examine whether, in a sample of Ghanaian MSM, mean scores on psychosocial variables theorized to influence HIV/STI risk differed between peer social networks and to examine whether these variables were associated with condom use. We conducted a formative, cross-sectional survey with 22 peer social networks of MSM (n = 137) in Ghana. We assessed basic psychological- needs satisfaction, HIV/STI knowledge, sense of community, HIV and gender non-conformity stigmas, gender equitable norms, sexual behavior and condom use. Data were analyzed using analysis of variance, generalized estimating equations, and Wilcoxon two sample tests. All models were adjusted for age and income, ethnicity, education, housing and community of residence. Mean scores for all psychosocial variables differed significantly by social network. Men who reported experiencing more autonomy support by their healthcare providers had higher odds of condom use for anal (AOR = 3.29, p < 0.01), oral (AOR = 5.06, p < 0.01) and vaginal (AOR = 1.8, p < 0.05) sex. Those with a stronger sense of community also had higher odds of condom use for anal sex (AOR = 1.26, p < 0.001). Compared to networks with low prevalence of consistent condom users, networks with higher prevalence of consistent condom users had higher STD and HIV knowledge, had norms that were more supportive of gender equity, and experienced more autonomy support in their healthcare encounters. Healthcare providers and peer social networks can have an important influence on safer-sex behaviors in Ghanaian MSM. More research with Ghanaian MSM is needed that considers knowledge, attitudes, and norms of their social networks in the development and implementation of culturally relevant HIV/STI prevention intervention strategies.	[Nelson, LaRon E.] Univ Rochester, Sch Nursing, Rochester, NY 14627 USA; [Nelson, LaRon E.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Wilton, Leo] SUNY Binghamton, Coll Community & Publ Affairs, Dept Human Dev, Binghamton, NY USA; [Wilton, Leo] Univ Johannesburg, Fac Humanities, Johannesburg, South Africa; [Agyarko-Poku, Thomas] Ashanti Reg Hlth Directorate, Ghana Hlth Serv, Kumasi, Ghana; [Zhang, Nanhua; Zou, Yuanshu] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Aluoch, Marilyn] Univ S Florida, Coll Nursing, Tampa, FL USA; [Apea, Vanessa] Barts & Royal London Hosp, Dept Genitourinary Med, London, England; [Hanson, Samuel Owiredu] Ctr Popular Educ & Human Rights Ghana, Accra, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana	University of Rochester; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Johannesburg; Ghana Health Service; Cincinnati Children's Hospital Medical Center; State University System of Florida; University of South Florida; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; Kwame Nkrumah University Science & Technology	Nelson, LE (corresponding author), Univ Rochester, Sch Nursing, Rochester, NY 14627 USA.	laron_nelson@urmc.rochester.edu	AGYARKO-POKU, THOMAS/AAM-2462-2021; Zhang, Nanhua/L-7606-2015	Nelson, LaRon/0000-0002-2630-602X; Zhang, Nanhua/0000-0001-5796-3404	Grand Challenges Canada [CRS0024-0101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER	Grand Challenges Canada(CGIAR); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was supported by Grand Challenges Canada CRS0024-0101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Airhihenbuwa CO, 2012, J HEALTH COMMUN, V17, P629, DOI 10.1080/10810730.2012.703913; Alvergne A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022515; Auerbach J, 2009, HEALTH AFFAIR, V28, P1655, DOI 10.1377/hlthaff.28.6.1655; Baral S, 2012, AIDS BEHAV; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Berg R, 2009, EURO SURVEILL, V14; Bosu WK., 2009, MODES HIV TRANSMISSI; Boulay M, 2008, AJAR-AFR J AIDS RES, V7, P133, DOI 10.2989/AJAR.2008.7.1.13.441; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Carey M.P., 1997, AIDS BEHAV, V1, P61, DOI [DOI 10.1023/A:1026218005943, 10.1023/A:1026218005943]; Carey MP, 2010, AIDS BEHAV, V14, P504, DOI 10.1007/s10461-009-9587-1; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Chirkov V, 2003, J PERS SOC PSYCHOL, V84, P97, DOI 10.1037/0022-3514.84.1.97; Chirkov VI, 2005, J CROSS CULT PSYCHOL, V36, P423, DOI 10.1177/0022022105275960; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Clark AE, 2007, J HEALTH ECON, V26, P763, DOI 10.1016/j.jhealeco.2006.11.005; Commission GA, 2012, RESULTS FROM A NATIO; Deci EL, 2001, PERS SOC PSYCHOL B, V27, P930, DOI 10.1177/0146167201278002; Diaz Rafael M, 2004, Cultur Divers Ethnic Minor Psychol, V10, P255, DOI 10.1037/1099-9809.10.3.255; Drame F. M., 2012, CULT HEALTH SEX; El-Sayed AM, 2013, AM J EPIDEMIOL, V178, P287, DOI 10.1093/aje/kws455; FESTINGER L, 1959, J ABNORM SOC PSYCH, V58, P203, DOI 10.1037/h0041593; Fowler JH, 2008, J HEALTH ECON, V27, P1400, DOI 10.1016/j.jhealeco.2008.07.001; Geibel S, 2012, SEX TRANSM INFECT, V88, P357, DOI 10.1136/sextrans-2011-050224; Gillet N, 2013, J ADV NURS, V69, P2560, DOI 10.1111/jan.12144; Gordon Allegra R, 2007, J LGBT Health Res, V3, P55; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Gurnani V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-755; Harawa N, 2014, AIDS BEHAV; Hatzenbuehler ML, 2014, SOC SCI MED, V103, P33, DOI 10.1016/j.socscimed.2013.06.005; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Hatzenbuehler ML, 2009, PSYCHOL BULL, V135, P707, DOI 10.1037/a0016441; Herbst JH, 2007, AM J PREV MED, V32, pS38, DOI 10.1016/j.amepre.2006.12.006; Huang GC, 2013, J ADOLESC HLTH; Hurt CB, 2012, JAIDS-J ACQ IMM DEF, V61, P515, DOI 10.1097/QAI.0b013e31827076a4; Irvin R, 2014, AIDS BEHAV IN PRESS; Jaworski BC, 2007, AIDS BEHAV, V11, P557, DOI 10.1007/s10461-006-9168-5; Jeffries WL, 2013, AIDS BEHAV, V17, P1442, DOI 10.1007/s10461-012-0189-y; Johnson BT, 2010, AIDS BEHAV, V14, pS204, DOI 10.1007/s10461-010-9803-z; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Jones KT, 2008, AM J PUBLIC HEALTH, V98, P1043, DOI 10.2105/AJPH.2007.120337; Kang DM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-717; Kelly JA, 2013, AIDS EDUC PREV, V25, P49, DOI 10.1521/aeap.2013.25.1.49; Kennedy S, 2004, COGNITIVE THER RES, V28, P611, DOI 10.1023/B:COTR.0000045568.95219.e2; Kidder DP, 2007, AIDS BEHAV, V11, pS149, DOI 10.1007/s10461-007-9249-0; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; La Guardia JG, 2000, J PERS SOC PSYCHOL, V79, P367, DOI 10.1037//0022-3514.79.3.367; Latkin Carl, 2011, Am J Public Health, V101, pe18, DOI 10.2105/AJPH.2011.300281; Laumann EO, 1999, SEX TRANSM DIS, V26, P250, DOI 10.1097/00007435-199905000-00003; Levy ME, 2014, AIDS BEHAV; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Logie C, 2009, AIDS CARE, V21, P742, DOI 10.1080/09540120802511877; Logie CH, 2012, SOC SCI MED, V74, P1261, DOI 10.1016/j.socscimed.2012.01.008; Logie CH, 2011, EXPLORING EXPERIENCE; Lorimer K, 2013, AIDS CARE, V25, P133, DOI 10.1080/09540121.2012.699672; Lorway R, 2010, SEX TRANSM INFECT, V86, P70, DOI 10.1136/sti.2010.044909; Lynch MF, 2009, J POSIT PSYCHOL, V4, P290, DOI 10.1080/17439760902933765; Malebranche DJ, 2012, GAY LESBIAN MED ASS; Marks G, 2009, AIDS BEHAV, V13, P682, DOI 10.1007/s10461-008-9380-6; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Merrigan M, 2011, SEX TRANSM INFECT, V87, P65, DOI 10.1136/sti.2008.034991; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Millett GA, 2012, LANCET, V380, P411, DOI 10.1016/S0140-6736(12)60722-3; Mimiaga MJ, 2009, J URBAN HEALTH, V86, P602, DOI 10.1007/s11524-009-9363-6; Minkler M, 2008, COMMUNITY BASED PART; Moller AC, 2006, J PUBLIC POLICY MARK, V25, P104, DOI 10.1509/jppm.25.1.104; Mwinituo PP, 2006, WESTERN J NURS RES, V28, P369, DOI 10.1177/0193945906286602; Neilands TB, 2008, ARCH SEX BEHAV, V37, P838, DOI 10.1007/s10508-007-9305-x; Nelson LE, 2014, NURSING INQUIRY; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Ory MG, 2010, AM J HEALTH BEHAV, V34, P647, DOI 10.5993/AJHB.34.6.2; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Pachankis JE, 2014, SOC SCI MED, V103, P67, DOI 10.1016/j.socscimed.2013.10.005; Peterson JL, 2009, HEALTH EDUC RES, V24, P119, DOI 10.1093/her/cyn003; Peterson JL, 1996, AM J COMMUN PSYCHOL, V24, P461, DOI 10.1007/BF02506793; Peterson NA, 2008, J COMMUNITY PSYCHOL, V36, P61, DOI 10.1002/jcop.20217; Petty RD, 1992, IMPACT ADVERTISING L; Phelan JC, 2014, SOC SCI MED, V103, P15, DOI 10.1016/j.socscimed.2013.10.004; Poku Kwabena A, 2005, SAHARA J, V2, P344; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; Reeve J, 2002, MOTIV EMOTION, V26, P183, DOI 10.1023/A:1021711629417; Reid AE, 2014, SOC SCI MED, V103, P118, DOI 10.1016/j.socscimed.2013.06.028; Risher K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18715; Ryan R.M., 2005, HDB COMPETENCE MOTIV, P354; Ryan R. M., 2008, EUROPEAN HLTH PSYCHO, V10, P2, DOI DOI 10.1080/17509840701827437; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sabin L., 2013, EXPLORING BELIEFS AT; Sandfort TGM, 2007, J SEX RES, V44, P181, DOI 10.1080/00224490701263819; Sayegh M Aaron, 2005, J Adolesc Health, V37, P163, DOI 10.1016/j.jadohealth.2004.08.018; Schimmack U, 2005, PERS SOC PSYCHOL REV, V9, P17, DOI 10.1207/s15327957pspr0901_2; Schneider J, 2012, JAIDS-J ACQ IMM DEF, V61, P627, DOI 10.1097/QAI.0b013e318270d3cb; Schneider J, 2012, AIDS PATIENT CARE ST, V26, P631, DOI 10.1089/apc.2012.0188; Schneider John A, 2013, Am J Public Health, V103, pe28, DOI 10.2105/AJPH.2012.301003; Sheldon KM, 2012, WORLD PSYCHIATRY, V11, P101, DOI 10.1016/j.wpsyc.2012.05.017; Sheldon KM, 2009, INT J BEHAV DEV, V33, P451, DOI 10.1177/0165025409340095; Smit PJ, 2012, AIDS CARE, V24, P405, DOI 10.1080/09540121.2011.613910; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Stephenson R, 2009, AIDS CARE, V21, P403, DOI 10.1080/09540120802290365; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Stuber J, 2008, SOC SCI MED, V67, P351, DOI 10.1016/j.socscimed.2008.03.023; Ulasi CI, 2009, HEALTH PLACE, V15, P255, DOI 10.1016/j.healthplace.2008.05.006; Williams GC, 2000, J APPL SOC PSYCHOL, V30, P1756, DOI 10.1111/j.1559-1816.2000.tb02466.x; Williams GC, 1998, HEALTH PSYCHOL, V17, P269, DOI 10.1037/0278-6133.17.3.269; Williams GC, 1999, ARCH PEDIAT ADOL MED, V153, P959, DOI 10.1001/archpedi.153.9.959; Williams GC, 2006, J GEN INTERN MED, V21, P1288, DOI 10.1111/j.1525-1497.2006.00621.x; Williams GC, 2009, ANN BEHAV MED, V37, P315, DOI 10.1007/s12160-009-9090-y; Williams GC, 2009, DIABETES EDUCATOR, V35, P484, DOI 10.1177/0145721709333856; Williams JK, 2013, AM J PUBLIC HEALTH, V103, P1476, DOI 10.2105/AJPH.2012.301121; Williams M, 2001, SEX TRANSM INFECT, V77, P433, DOI 10.1136/sti.77.6.433; Wilton L, 2009, AIDS BEHAV, V13, P532, DOI 10.1007/s10461-009-9529-y	114	27	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115504	10.1371/journal.pone.0115504	http://dx.doi.org/10.1371/journal.pone.0115504			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HX	25635774	Green Submitted, gold, Green Published			2022-12-26	WOS:000350680700012
J	Welleweerd, JC; Nelissen, BGL; Koole, D; de Vries, JPPM; Moll, FL; Pasterkamp, G; Vink, A; de Borst, GJ				Welleweerd, Janna C.; Nelissen, Bastiaan G. L.; Koole, Dave; de Vries, Jean-Paul P. M.; Moll, Frans L.; Pasterkamp, Gerard; Vink, Aryan; de Borst, Gert Jan			Histological Analysis of Extracranial Carotid Artery Aneurysms	PLOS ONE			English	Article								Introduction Extracranial carotid artery aneurysms (ECAA) are rare but may be accompanied with significant morbidity. Previous studies mostly focused on diagnostic imaging and treatment. In contrast, the pathophysiological mechanisms and natural course of ECAA are largely unknown. Understanding the pathophysiological background may add to prediction of risk for adverse outcome and need for surgical exclusion. The aim of this study was to investigate the histopathological characteristics of ECAA in patients who underwent complete surgical ECAA resection. Material and Methods From March 2004 till June 2013, 13 patients were treated with open ECAA repair. During surgery the aneurysm sac was resected and processed for standardized histological analysis. Sections were stained with routine hematoxylin and eosin and special stains to detect elastin, collagen, different types of inflammatory cells, vascular smooth muscle cells and endothelial cells. Results Histopathological characterization revealed two distinct categories: dissection (abrupt interruption of the media; n = 3) and degeneration (general loss of elastin fibers in the media; n = 10). In the degenerative samples the elastin fibers in the media were fragmented and were partly absent. Inflammatory cells were observed in the vessel wall of the aneurysms. Conclusion Histological analysis in this small sample size revealed dissection and degeneration as the two distinct underlying mechanisms in ECAA formation.	[Welleweerd, Janna C.; Nelissen, Bastiaan G. L.; Koole, Dave; Moll, Frans L.; de Borst, Gert Jan] Univ Med Ctr Utrecht, Vasc Surg, NL-3584 CX Utrecht, Netherlands; [Nelissen, Bastiaan G. L.; Koole, Dave; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Expt Cardiol Lab, NL-3584 CX Utrecht, Netherlands; [de Vries, Jean-Paul P. M.] St Antonius Hosp, Vasc Surg, NL-3435 CM Nieuwegein, Netherlands; [Vink, Aryan] Univ Med Ctr Utrecht, Pathol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	de Borst, GJ (corresponding author), Univ Med Ctr Utrecht, Vasc Surg, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	G.J.deBorst-2@umcutrecht.nl						Burdorf A, 2011, HUMAN TISSUE MED RES; Chedgy ECP, 2010, ANN VASC SURG, V24, DOI 10.1016/j.avsg.2010.02.040; Dawson I, 1997, BRIT J SURG, V84, P293; de Jong K P, 1989, Eur J Vasc Surg, V3, P557, DOI 10.1016/S0950-821X(89)80132-X; Dobrin PB, 2000, MED INTELL UNIT, V17, P42; Donas KP, 2009, J VASC SURG, V49, P93, DOI 10.1016/j.jvs.2008.08.006; El-Sabrout R, 2000, J VASC SURG, V31, P702, DOI 10.1067/mva.2000.104101; Guillon B, 1999, NEUROLOGY, V53, P117, DOI 10.1212/WNL.53.1.117; Hanabusa K, 2010, NEUROL MED-CHIR, V50, P917, DOI 10.2176/nmc.50.917; James AL, 1999, J LARYNGOL OTOL, V113, P373, DOI 10.1017/S0022215100144020; Longo G Matthew, 2005, Semin Vasc Surg, V18, P178, DOI 10.1053/j.semvascsurg.2005.09.002; MCCOLLUM CH, 1979, AM J SURG, V137, P196, DOI 10.1016/0002-9610(79)90144-2; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Radak D, 2007, ANN VASC SURG, V21, P23, DOI 10.1016/j.avsg.2006.10.004; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; SAKALIHASAN N, 1993, EUR J VASCULAR SURG, V7, P633, DOI 10.1016/S0950-821X(05)80708-X; Troisi N, 2010, J VASC SURG, V51, P225, DOI 10.1016/j.jvs.2009.08.057; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Welleweerd JC, 2012, EXPERT REV CARDIOVAS, V10, P925, DOI [10.1586/ERC.12.61, 10.1586/erc.12.61]; Welleweerd JC, 2014, TREATMENT EXTR UNPUB; ZWOLAK RM, 1984, J VASC SURG, V1, P415, DOI 10.1067/mva.1984.avs0010415	21	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117915	10.1371/journal.pone.0117915	http://dx.doi.org/10.1371/journal.pone.0117915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635813	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700109
J	Choi, SC; Lee, H; Choi, JH; Kim, JH; Park, CY; Joo, HJ; Park, JH; Hong, SJ; Yu, CW; Lim, DS				Choi, Seung-Cheol; Lee, Hyunjoo; Choi, Ji-Hyun; Kim, Jong-Ho; Park, Chi-Yeon; Joo, Hyung-Joon; Park, Jae-Hyoung; Hong, Soon-Jun; Yu, Cheol-Woong; Lim, Do-Sun			Cyclosporin A Induces Cardiac Differentiation but Inhibits Hemato-Endothelial Differentiation of P19 Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CARDIOMYOCYTE DIFFERENTIATION; PROGENITOR SPECIFICATION; SIGNALING PATHWAY; MOUSE; PROLIFERATION; NFAT; EXPRESSION; MESODERM; NANOG	Little is known about the mechanisms underlying the effects of Cyclosporin A (CsA) on the fate of stem cells, including cardiomyogenic differentiation. Therefore, we investigated the effects and the molecular mechanisms behind the actions of CsA on cell lineage determination of P19 cells. CsA induced cardiomyocyte-specific differentiation of P19 cells, with the highest efficiency at a concentration of 0.32 mu M during embryoid body (EB) formation via activation of the Wnt signaling pathway molecules, Wnt3a, Wnt5a, and Wnt8a, and the cardiac mesoderm markers, Mixl1, Mesp1, and Mesp2. Interestingly, cotreatment of P19 cells with CsA plus dimethyl sulfoxide (DMSO) during EB formation significantly increases cardiac differentiation. In contrast, mRNA expression levels of hematopoietic and endothelial lineage markers, including Flk1 and Er71, were severely reduced in CsA-treated P19 cells. Furthermore, expression of Flk1 protein and the percentage of Flk1+ cells were severely reduced in 0.32 mu M CsA-treated P19 cells compared to control cells. CsA significantly modulated mRNA expression levels of the cell cycle molecules, p53 and Cyclins D1, D2, and E2 in P19 cells during EB formation. Moreover, CsA significantly increased cell death and reduced cell number in P19 cells during EB formation. These results demonstrate that CsA induces cardiac differentiation but inhibits hemato-endothelial differentiation via activation of the Wnt signaling pathway, followed by modulation of cell lineage-determining genes in P19 cells during EB formation.	[Choi, Seung-Cheol; Lee, Hyunjoo; Choi, Ji-Hyun; Kim, Jong-Ho; Park, Chi-Yeon; Joo, Hyung-Joon; Park, Jae-Hyoung; Hong, Soon-Jun; Yu, Cheol-Woong; Lim, Do-Sun] Korea Univ, Anam Hosp, Ctr Cardiovasc, Dept Cardiol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Lim, DS (corresponding author), Korea Univ, Anam Hosp, Ctr Cardiovasc, Dept Cardiol, Seoul, South Korea.	dslmd@kumc.or.kr	Park, Chi-Yeon/ABH-9980-2020; Joo, Hyung Joon/Q-4875-2016	Joo, Hyung Joon/0000-0003-1846-8464; Kim, Jong-Ho/0000-0002-1309-0821; Park, Chi-Yeon/0000-0002-9400-9078	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2012R1A1A2004485]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2012R1A1A2004485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Beyer TA, 2013, BBA-GEN SUBJECTS, V1830, P2268, DOI 10.1016/j.bbagen.2012.08.025; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Bryja V, 2008, CELL PROLIFERAT, V41, P875, DOI 10.1111/j.1365-2184.2008.00556.x; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Chen TL, 2008, SCAND J CLIN LAB INV, V68, P585, DOI 10.1080/00365510801918761; Choi SC, 2004, EXP MOL MED, V36, P515, DOI 10.1038/emm.2004.66; Choi SC, 2012, J CELL PHYSIOL, V227, P3678, DOI 10.1002/jcp.24076; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Fric J, 2012, BLOOD, V120, P1380, DOI 10.1182/blood-2012-02-404475; Fujiwara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016734; Gertow K, 2013, STEM CELL REP, V1, P53, DOI 10.1016/j.stemcr.2013.04.002; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Guo JS, 2007, NEUROREPORT, V18, P863, DOI 10.1097/WNR.0b013e32811d6d36; Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246; Hart AH, 2002, DEVELOPMENT, V129, P3597; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Huang T, 2011, J BIOL CHEM, V286, P37399, DOI 10.1074/jbc.M111.251165; Hunt J, 2010, J NEUROSCI, V30, P2888, DOI 10.1523/JNEUROSCI.5991-09.2010; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Li XA, 2011, CELL STEM CELL, V8, P46, DOI 10.1016/j.stem.2010.11.027; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Liu F, 2012, BLOOD, V119, P3295, DOI 10.1182/blood-2012-01-403766; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Nakamura T, 2003, P NATL ACAD SCI USA, V100, P5834, DOI 10.1073/pnas.0935626100; Pal R, 2006, STEM CELLS DEV, V15, P29, DOI 10.1089/scd.2006.15.29; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Paslaru L, 2007, J CELL MOL MED, V11, P369, DOI 10.1111/j.1582-4934.2007.00029.x; Pereira LA, 2012, DEV BIOL, V367, P163, DOI 10.1016/j.ydbio.2012.04.033; Preclikova H, 2002, CELL GROWTH DIFFER, V13, P421; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Sachinidis A, 2006, CELL PHYSIOL BIOCHEM, V18, P303, DOI 10.1159/000097608; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Solozobova Valeriya, 2011, World J Biol Chem, V2, P202, DOI 10.4331/wjbc.v2.i9.202; Song LH, 2006, TOXICOL IN VITRO, V20, P915, DOI 10.1016/j.tiv.2006.01.016; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X; Verma MK, 2010, J CELL MOL MED, V14, P2094, DOI 10.1111/j.1582-4934.2009.00774.x; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Yan P, 2009, BIOCHEM BIOPH RES CO, V379, P115, DOI 10.1016/j.bbrc.2008.12.019; Yang L, 2008, INTERNAL MED, V47, P1457, DOI 10.2169/internalmedicine.47.1042; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009; Zhu DY, 2005, EUR J PHARMACOL, V514, P99, DOI 10.1016/j.ejphar.2005.03.031	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117410	10.1371/journal.pone.0117410	http://dx.doi.org/10.1371/journal.pone.0117410			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629977	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100080
J	Kuo, CF; Tsao, N; Cheng, MH; Yang, HC; Wang, YC; Chen, YP; Lin, KJ				Kuo, Chih-Feng; Tsao, Nina; Cheng, Miao-Hui; Yang, Hsiu-Chen; Wang, Yu-Chieh; Chen, Ying-Pin; Lin, Kai-Jen			Application of the C3-Binding Motif of Streptococcal Pyrogenic Exotoxin B to Protect Mice from Invasive Group A Streptococcal Infection	PLOS ONE			English	Article							EXTRACELLULAR CYSTEINE PROTEASE; STAPHYLOCOCCUS-AUREUS; POSTSTREPTOCOCCAL GLOMERULONEPHRITIS; ENDOTHELIAL-CELLS; BINDING PROTEIN; INNATE IMMUNITY; MOUSE MODEL; COMPLEMENT; PYOGENES; SPEB	Group A streptococcus (GAS) is an important human pathogen that produces several extracellular exotoxins to facilitate invasion and infection. Streptococcal pyrogenic exotoxin B (SPE B) has been demonstrated to be an important virulence factor of GAS. Our previous studies indicate that SPE B cleaves complement 3 (C3) and inhibits the activation of complement pathways. In this study, we constructed and expressed recombinant fragments of SPE B to examine the C3-binding site of SPE B. Using enzyme-linked immunosorbent assays and pull-down assays, we found that the C-terminal domain, containing amino-acid residues 345-398, of SPE B was the major binding site of human serum C3. We further identified a major, Ala(376)-Pro(398), and a minor C3-binding motif, Gly(346)-Gly(360), that both mediated the binding of C3 complement. Immunization with the C3-binding motifs protected mice against challenge with a lethal dose of non-invasive M49 strain GAS but not invasive M1 strains. To achieve higher efficiency against invasive M1 GAS infection, a combination of synthetic peptides derived from C-terminal epitope of streptolysin S (SLSpp) and from the major C3-binding motif of SPE B (PP6, Ala(376)-Pro(398)) was used to elicit specific immune response to those two important streptococcal exotoxins. Death rates and the severity of skin lesions decreased significantly in PP6/SLSpp-immunized mice that were infected with invasive M1 strains of GAS. These results indicate a combination of the C3-binding motif of SPE B and the protective epitope of SLS could be used as a subunit vaccine against invasive M1 strains group A streptococcal infection.	[Kuo, Chih-Feng] I Shou Univ, Dept Nursing, Kaohsiung, Taiwan; [Tsao, Nina; Cheng, Miao-Hui; Yang, Hsiu-Chen; Wang, Yu-Chieh; Chen, Ying-Pin] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Lin, Kai-Jen] E DA Hosp, Dept Pathol, Kaohsiung, Taiwan	I Shou University; I Shou University; E-Da Hospital	Kuo, CF (corresponding author), I Shou Univ, Dept Nursing, Kaohsiung, Taiwan.	kuo@isu.edu.tw			Ministry of Science and Technology [MOST97-2320-B214-001-MY3, MOST100-2320-B214-007, MOST 103-2320-B-214-006]; I-Shou University, Taiwan [ISU102-07-07]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); I-Shou University, Taiwan	This work was supported by grants MOST97-2320-B214-001-MY3, MOST100-2320-B214-007, and MOST 103-2320-B-214-006 from the Ministry of Science and Technology, and ISU102-07-07 from I-Shou University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batsford SR, 2005, KIDNEY INT, V68, P1120, DOI 10.1111/j.1523-1755.2005.00504.x; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Burns EH, 1996, INFECT IMMUN, V64, P4744, DOI 10.1128/IAI.64.11.4744-4750.1996; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Chen CY, 2003, J BIOL CHEM, V278, P17336, DOI 10.1074/jbc.M209038200; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Cu GA, 1998, KIDNEY INT, V54, P819, DOI 10.1046/j.1523-1755.1998.00052.x; Dale JB, 2002, INFECT IMMUN, V70, P2166, DOI 10.1128/IAI.70.4.2166-2170.2002; Ender M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081298; Eriksson A, 2003, INFECT IMMUN, V71, P211, DOI 10.1128/IAI.71.1.211-217.2003; Ermert D, 2013, J BIOL CHEM, V288, P32172, DOI 10.1074/jbc.M113.502955; Fernie-King BA, 2001, IMMUNOLOGY, V103, P390, DOI 10.1046/j.1365-2567.2001.01249.x; Gonzalez-Paez GE, 2012, J BIOL CHEM, V287, P24412, DOI 10.1074/jbc.M112.361576; Haapasalo K, 2012, J IMMUNOL, V188, P426, DOI 10.4049/jimmunol.1102545; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Henningham A, 2012, DISCOV MED, V13, P329; Honda-Ogawa M, 2013, J BIOL CHEM, V288, P15854, DOI 10.1074/jbc.M113.469106; Hung CH, 2012, MED MICROBIOL IMMUN, V201, P357, DOI 10.1007/s00430-012-0241-6; Jackson SJ, 2011, TROP MED INT HEALTH, V16, P2, DOI 10.1111/j.1365-3156.2010.02670.x; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Kuo CF, 2004, MICROB PATHOGENESIS, V36, P273, DOI 10.1016/j.micpath.2004.01.003; Kuo CF, 2008, INFECT IMMUN, V76, P1163, DOI 10.1128/IAI.01116-07; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Luo YH, 2007, KIDNEY INT, V72, P716, DOI 10.1038/sj.ki.5002407; Luo YH, 2010, LAB INVEST, V90, P1492, DOI 10.1038/labinvest.2010.93; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Olsen JG, 2009, J MOL BIOL, V393, P693, DOI 10.1016/j.jmb.2009.08.046; Parra G, 1998, KIDNEY INT, V54, P509, DOI 10.1046/j.1523-1755.1998.00012.x; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Steer AC, 2012, DRUGS, V72, P1213, DOI 10.2165/11634180-000000000-00000; Steer AC, 2009, CURR OPIN INFECT DIS, V22, P544, DOI 10.1097/QCO.0b013e328332bbfe; Sumitomo T, 2013, J BIOL CHEM, V288, P13317, DOI 10.1074/jbc.M113.459875; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Tsao N, 2006, BIOCHEM BIOPH RES CO, V339, P779, DOI 10.1016/j.bbrc.2005.11.078; Tsao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055028; Upadhyay A, 2008, J BIOL CHEM, V283, P22113, DOI 10.1074/jbc.M802636200	42	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117268	10.1371/journal.pone.0117268	http://dx.doi.org/10.1371/journal.pone.0117268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629609	gold, Green Submitted, Green Published			2022-12-26	WOS:000348732100077
J	Long, Y; Wang, YY; Wu, SS; Wang, J; Tian, XJ; Pei, XW				Long, Yan; Wang, Yanyan; Wu, Shanshan; Wang, Jiao; Tian, Xinjie; Pei, Xinwu			De Novo Assembly of Transcriptome Sequencing in Caragana korshinskii Kom. and Characterization of EST-SSR Markers	PLOS ONE			English	Article							MICROSATELLITE MARKERS; GENETIC DIVERSITY; ANNOTATION; TOLERANCE; DISCOVERY; REPEATS; BARLEY; RICE; TOOL; MAP	Caragana korshinskii Kom. is widely distributed in various habitats, including gravel desert, clay desert, fixed and semi-fixed sand, and saline land in the Asian and African deserts. To date, no previous genomic information or EST-SSR marker has been reported in Caragana Fabr. genus. In this study, more than two billion bases of high-quality sequence of C. korshinskii were generated by using illumina sequencing technology and demonstrated the de novo assembly and annotation of genes without prior genome information. These reads were assembled into 86,265 unigenes (mean length = 709 bp). The similarity search indicated that 33,955 and 21,978 unigenes showed significant similarities to known proteins from NCBI non-redundant and Swissprot protein databases, respectively. Among these annotated unigenes, 26,232 a unigenes were separately assigned to Gene Ontology (GO) database. When 22,756 unigenes searched against the Kyoto Encyclopedia of Genes and Genomes Pathway (KEGG) database, 5,598 unigenes were assigned to 5 main categories including 32 KEGG pathways. Among the main KEGG categories, metabolism was the biggest category (2,862, 43.7%), suggesting the active metabolic processes in the desert tree. In addition, a total of 19,150 EST-SSRs were identified from 15,484 unigenes, and the characterizations of EST-SSRs were further compared with other four species in Fabraceae. 126 potential marker sites were randomly selected to validate the assembly quality and develop EST-SSR markers. Among the 9 germplasms in Caranaga Fabr. genus, PCR success rate were 93.7% and the phylogenic tree was constructed based on the genotypic data. This research generated a substantial fraction of transcriptome sequences, which were very useful resources for gene annotation and discovery, molecular markers development, genome assembly and annotation. The EST-SSR markers identified and developed in this study will facilitate marker-assisted selection breeding.	[Long, Yan; Wang, Jiao; Tian, Xinjie; Pei, Xinwu] Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100081, Peoples R China; [Wang, Yanyan; Wu, Shanshan] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China	Chinese Academy of Agricultural Sciences; Huazhong Agricultural University	Pei, XW (corresponding author), Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100081, Peoples R China.	peixinwu@caas.cn	pei, xinwu/O-7083-2019; Wang, Yanbo/HFZ-8018-2022; Pei, Xinwu/AAI-1736-2019; wang, yan/GSE-6489-2022	Pei, Xinwu/0000-0001-7828-3037; 	National Special Program for Transgenic Research [2014ZX08011-001]	National Special Program for Transgenic Research	This work is financially supported by the National Special Program for Transgenic Research (Nos. 2014ZX08011-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2014, MOL BIOL REP, V41, P6755, DOI 10.1007/s11033-014-3561-3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuadrado A, 2008, CYTOGENET GENOME RES, V120, P210, DOI 10.1159/000121069; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; Durand J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-570; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Qiang, 2008, Acta Agrestia Sinica, V16, P227; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Hyun TK, 2012, PLANT MOL BIOL, V79, P413, DOI 10.1007/s11103-012-9919-9; Jung Sook, 2005, Functional & Integrative Genomics, V5, P136, DOI 10.1007/s10142-005-0139-0; [康红梅 KANG Hongmei], 2011, [西南农业学报, Southwest China Journal of Agricultural Sciences], V24, P1099; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; [李彦瑾 LI Yanjin], 2008, [西北林学院学报, Journal of Northwest Forestry College], V23, P1; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Ma CC, 2003, ACTA BOT SIN, V45, P1218; Miah G, 2013, INT J MOL SCI, V14, P22499, DOI 10.3390/ijms141122499; Mogea JP, 1999, MEM NEW YORK BOTAN G, V83, P169; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naegele R, 2014, PHYTOPATHOLOGY; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Nunome T, 2009, THEOR APPL GENET, V119, P1143, DOI 10.1007/s00122-009-1116-0; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Talukder ZI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098628; Ting NC, 2010, J GENET, V89, P135, DOI 10.1007/s12041-010-0053-7; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang BH, 2014, GENET MOL RES, V13, P3732, DOI 10.4238/2014.May.13.1; Wang CB, 2006, CHINESE SCI BULL, V51, P557, DOI 10.1007/s11434-006-0557-y; Wang XM, 2011, MOL BIOL REP, V38, P2801, DOI 10.1007/s11033-010-0425-3; Wang Z, 2007, CROP SCI, V47, P1737, DOI 10.2135/cropsci2006.09.0562; [王赞 WANG Zan], 2008, [植物遗传资源学报, Journal of Plant Genetic Resources], V9, P397; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Xu P, 2013, GENE, V525, P26, DOI 10.1016/j.gene.2013.04.066; Yan DW, 2014, PLANT CELL PHYSIOL, V55, P1521, DOI 10.1093/pcp/pcu089; Yang DH, 2012, BIOCHEM BIOPH RES CO, V417, P732, DOI 10.1016/j.bbrc.2011.12.023; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zhang HY, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-591, DOI 10.1186/1471-2164-13-591]; Zhang ML, 2009, MOL PHYLOGENET EVOL, V50, P547, DOI 10.1016/j.ympev.2008.12.001; Zhou A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00413	48	14	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115805	10.1371/journal.pone.0115805	http://dx.doi.org/10.1371/journal.pone.0115805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629164	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100025
J	Mantani, PT; Duner, P; Bengtsson, E; Alm, R; Ljungcrantz, I; Soderberg, I; Sundius, L; To, F; Nilsson, J; Bjorkbacka, H; Fredrikson, GN				Mantani, Polyxeni T.; Duner, Pontus; Bengtsson, Eva; Alm, Ragnar; Ljungcrantz, Irena; Soderberg, Ingrid; Sundius, Lena; To, Fong; Nilsson, Jan; Bjorkbacka, Harry; Fredrikson, Gunilla Nordin			IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; INNATE LYMPHOID-CELLS; TYPE-2 IMMUNITY; REDUCES ATHEROSCLEROSIS; OXIDIZED LDL; NATURAL IGM; IMMUNIZATION; EXPRESSION; ANTIBODIES; CYTOKINES	Objective IL-25 has been implicated in the initiation of type 2 immunity and in the protection against autoimmune inflammatory diseases. Recent studies have identified the novel innate lymphoid type 2 cells (ILC2s) as an IL-25 target cell population. The purpose of this study was to evaluate if IL-25 has any influence on atherosclerosis development in mice. Methods and Results Administration of 1 mu g IL-25 per day for one week to atherosclerosis-prone apolipoprotein (apo) E deficient mice, had limited effect on the frequency of T cell populations, but resulted in a large expansion of ILC2s in the spleen. The expansion was accompanied by increased levels of anti-phosphorylcholine (PC) natural IgM antibodies in plasma and elevated levels of IL-5 in plasma and spleen. Transfer of ILC2s to apoE deficient mice elevated the natural antibody-producing B1a cell population in the spleen. Treatment of apoE/Rag-1 deficient mice with IL-25 was also associated with extensive expansion of splenic ILC2s and increased plasma IL-5, suggesting ILC2s to be the source of IL-5. Administration of IL-25 in IL-5 deficient mice resulted in an expanded ILC2 population, but did not stimulate generation of anti-PC IgM, indicating that IL-5 is not required for ILC2 expansion but for the downstream production of natural antibodies. Additionally, administration of 1 mu g IL-25 per day for 4 weeks in apoE deficient mice reduced atherosclerosis in the aorta both during initiation and progression of the disease. Conclusions The present findings demonstrate that IL-25 has a protective role in atherosclerosis mediated by innate responses, including ILC2 expansion, increased IL-5 secretion, B1a expansion and natural anti-PC IgM generation, rather than adaptive Th2 responses.	[Mantani, Polyxeni T.; Duner, Pontus; Bengtsson, Eva; Alm, Ragnar; Ljungcrantz, Irena; Soderberg, Ingrid; Sundius, Lena; To, Fong; Nilsson, Jan; Bjorkbacka, Harry; Fredrikson, Gunilla Nordin] Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci, Malmo, Sweden; [Fredrikson, Gunilla Nordin] Malmo Univ, Fac Hlth & Soc, Malmo, Sweden	Lund University; Skane University Hospital; Malmo University	Fredrikson, GN (corresponding author), Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci, Malmo, Sweden.	gunilla.nordin_fredrikson@med.lu.se	Bengtsson, Eva/AAA-1968-2019; Björkbacka, Harry/I-7157-2019; Bengtsson, Eva/AGH-2754-2022	Björkbacka, Harry/0000-0003-3918-0857; Bengtsson, Eva/0000-0001-7075-1772; Duner, Pontus/0000-0003-4171-5646				Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ameli S, 1996, ARTERIOSCL THROM VAS, V16, P1074, DOI 10.1161/01.ATV.16.8.1074; Barlow JL, 2011, J LEUKOCYTE BIOL, V90, P867, DOI 10.1189/jlb.0311160; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Buono C, 2003, ARTERIOSCL THROM VAS, V23, P454, DOI 10.1161/01.ATV.0000059419.11002.6E; Caligiuri G, 2007, J AM COLL CARDIOL, V50, P540, DOI 10.1016/j.jacc.2006.11.054; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Foks AC, 2013, J IMMUNOL, V191, P4573, DOI 10.4049/jimmunol.1200708; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gronlund H, 2009, EUR J CARDIOV PREV R, V16, P382, DOI 10.1097/HJR.0b013e32832a05df; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kyaw T, 2012, TRENDS CARDIOVAS MED, V22, P48, DOI 10.1016/j.tcm.2012.06.011; Kyaw T, 2011, CIRC RES, V109, P830, DOI 10.1161/CIRCRESAHA.111.248542; Lajoie-Kadoch S, 2006, AM J PHYSIOL-LUNG C, V290, pL1238, DOI 10.1152/ajplung.00301.2005; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Mallat Z, 2007, TRENDS CARDIOVAS MED, V17, P113, DOI 10.1016/j.tcm.2007.03.001; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Monteleone G, 2010, CYTOKINE GROWTH F R, V21, P471, DOI 10.1016/j.cytogfr.2010.05.001; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Perry HM, 2013, ARTERIOSCL THROM VAS, V33, P2771, DOI 10.1161/ATVBAHA.113.302571; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Sampi M, 2008, J AM COLL CARDIOL, V52, P1370, DOI 10.1016/j.jacc.2008.06.047; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349	35	39	41	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117255	10.1371/journal.pone.0117255	http://dx.doi.org/10.1371/journal.pone.0117255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629516	gold, Green Published, Green Submitted			2022-12-26	WOS:000348732100076
J	Mista, D; Kroliczewska, B; Marounek, M; Pecka, E; Zawadzki, W; Nicpon, J				Mista, Dorota; Kroliczewska, Bozena; Marounek, Milan; Pecka, Ewa; Zawadzki, Wojciech; Nicpon, Jzef			In Vitro Study and Comparison of Caecal Methanogenesis and Fermentation Pattern in the Brown Hare (Lepus europaeus) and Domestic Rabbit (Oryctolagus cuniculus)	PLOS ONE			English	Article							METHANE PRODUCTION; FATTY-ACIDS; DIET; AGE; IDENTIFICATION; DIGESTIBILITY; COMPETITION; COPROPHAGY; BACTERIA; HYDROGEN	The brown hare and the domestic rabbit are mid-sized herbivorous mammals and hindgut fermenters, though their digestive physiologies differ in some traits. The objective of this study was to estimate and compare the caecal microbial activity in hares and rabbits via an analysis of the following end-products of in vitro caecal fermentation: methane, total gas production, short chain fatty acids and ammonia concentration. Hare caecal methanogenesis occurred at a much lower level (0.25 mmol/kg for samples incubated without substrate and 0.22 mmol/kg for samples incubated with substrate) than that of the rabbit (15.49 and 11.73 mmol/kg, respectively) (P<0.001). The impact of the substrate's presence on caecal methanogenesis was not significant, though its presence increased the total gas production during fermentation (P<0.001). Hare caecal microflora produced a lower short chain fatty acids concentration than did rabbit microorganisms (P<0.05). In unincubated hare samples, the short chain fatty acids concentration was 28.4 mmol/kg, whereas in unincubated rabbit samples, the short chain fatty acids concentration was 51.8 mmol/kg. The caecal fermentation pattern of the hare was characterised by higher propionate and isobutyrate molar proportions compared with those observed in rabbit caecum (P<0.01). No significant changes in the ammonia concentration in either rabbit or hare caecum were found. The results obtained indicate some differences in the activity of the microbial populations colonising the hare and rabbit caecum, particularly in regards to methanogenic Archaea.	[Mista, Dorota; Kroliczewska, Bozena; Pecka, Ewa; Zawadzki, Wojciech] Wroclaw Univ Environm & Life Sci, Dept Biostruct & Anim Physiol, Wroclaw, Poland; [Marounek, Milan] Inst Anim Sci, Prague, Czech Republic; [Nicpon, Jzef] Wroclaw Univ Environm & Life Sci, Dept Internal Med & Clin Dis Horses, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Czech Research Institute of Animal Science; Wroclaw University of Environmental & Life Sciences	Mista, D (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Biostruct & Anim Physiol, Wroclaw, Poland.	dorota.mista@up.wroc.pl	Króliczewska, Bożena/AAO-5730-2021; Kroliczewska, Bozena/A-8324-2017; Miśta, Dorota/AAD-5644-2020	Króliczewska, Bożena/0000-0002-0291-3562; Kroliczewska, Bozena/0000-0002-0291-3562; Miśta, Dorota/0000-0002-0147-3681	Ministry of Science and Higher Education of the Republic of Poland [R1207003]; Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center)	Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland); Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center)	This research was supported by the Ministry of Science and Higher Education of the Republic of Poland http://www.nauka.gov.pl/en/grant number R1207003, author who received the funding: JN. The publication fee was paid by the Wroclaw Center for Biotechnology program KNOW (National Scientific Leadership Center) 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADJIRI D, 1992, REPROD NUTR DEV, V32, P351, DOI 10.1051/rnd:19920405; AOAC Association of Official Analytical Chemists, 2005, AOAC OFF METH AN; Belenguer A, 2011, WORLD RABBIT SCI, V19, P75, DOI 10.4995/wrs.2011.826; BELLIER R, 1995, J ANIM SCI, V73, P128; Bennegadi Nadia, 2003, Microbial Ecology in Health and Disease, V15, P23, DOI 10.1080/08910600310015574; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bernalier A, 1993, P NUTR SOC, V52, p118A; Carabano R., 1998, P1; CARABANO R, 1988, J ANIM SCI, V66, P901; Chapuis JL, 1990, MAMM BIOL, V55, P176; Cheeke PR., 1987, RABBIT FEEDING NUTR; De Blas C., 1998, NUTR RABBIT, P3441; DEGRAEVE KG, 1994, J APPL BACTERIOL, V76, P55; Drake H.L., 1994, ACETOGENESIS, P3; Falcao-e-Cunha L, 2004, ANIM FEED SCI TECH, V117, P131, DOI 10.1016/j.anifeedsci.2004.07.014; Fortun-Lamothe L, 2007, LIVEST SCI, V107, P1, DOI 10.1016/j.livsci.2006.09.005; Fraga M. J., 1998, P39; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P177, DOI 10.1016/j.cbpa.2010.10.019; Garcia J, 2002, ANIM RES, V51, P165, DOI 10.1051/animres:2002011; Garcia J, 2000, J ANIM SCI, V78, P638; GIBSON GR, 1990, GUT, V31, P679, DOI 10.1136/gut.31.6.679; Hacklander K, 2002, PHYSIOL BIOCHEM ZOOL, V75, P19, DOI 10.1086/324770; Hackstein JHP, 1996, EVOLUTION, V50, P559, DOI [10.2307/2410831, 10.1111/j.1558-5646.1996.tb03868.x]; HIRAKAWA H, 1994, J ZOOL, V232, P447, DOI 10.1111/j.1469-7998.1994.tb01585.x; Hirakawa H, 2001, MAMMAL REV, V31, P61, DOI 10.1046/j.1365-2907.2001.00079.x; Hirakawa Hirofumi, 1995, Journal of the Mammalogical Society of Japan, V20, P89; HOMOLKA M, 1987, FOLIA ZOOL, V36, P103; JARRELL KF, 1981, CAN J MICROBIOL, V27, P720, DOI 10.1139/m81-110; Kuijper DPJ, 2004, J ZOOL, V264, P171, DOI 10.1017/S0952836904005722; Kusar D, 2010, FEMS MICROBIOL ECOL, V74, P623, DOI 10.1111/j.1574-6941.2010.00980.x; Levitt MD, 2006, CLIN GASTROENTEROL H, V4, P123, DOI 10.1016/j.cgh.2005.11.006; Macfarlane G. T., 1995, P87; Marounek M, 1998, PHYSIOL RES, V47, P259; Marounek M, 1999, ARCH ANIM NUTR, V52, P195, DOI 10.1080/17450399909386162; Marounek M, 2000, ARCH ANIM NUTR, V53, P241, DOI 10.1080/17450390009381950; Marounek M, 2005, ACTA VET BRNO, V74, P3, DOI 10.2754/avb200574010003; Marounek M, 2013, ANIMAL BIOL, V15, P94; MILLER TL, 1982, ARCH MICROBIOL, V131, P14, DOI 10.1007/BF00451492; Mista D, 2011, POL J VET SCI, V14, P557, DOI 10.2478/v10181-011-0083-y; Morvan B, 1996, CURR MICROBIOL, V32, P129, DOI 10.1007/s002849900023; Piattoni F, 1996, REPROD NUTR DEV, V36, P253, DOI 10.1051/rnd:19960303; Remesy C., 1995, P171; Saemann MD, 2002, WIEN KLIN WOCHENSCHR, V114, P289; Smith RK, 2005, ACTA THERIOL, V50, P391, DOI 10.1007/BF03192634; Stott P, 2008, MAMM BIOL, V73, P276, DOI 10.1016/j.mambio.2007.07.002; STROCCHI A, 1991, GUT, V32, P1498, DOI 10.1136/gut.32.12.1498; VanNevel CJ, 1996, ENVIRON MONIT ASSESS, V42, P73, DOI 10.1007/BF00394043; Wolski K., 2009, Alternative functions of grassland. Proceedings of the 15th European Grassland Federation Symposium, Brno, Czech Republic, 7-9 September 2009, P277; WOLSTRUP J, 1979, ANN RECH VET, V10, P283; Yang HJ, 2010, ANIM FEED SCI TECH, V162, P149, DOI 10.1016/j.anifeedsci.2010.09.008	50	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117117	10.1371/journal.pone.0117117	http://dx.doi.org/10.1371/journal.pone.0117117			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629411	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100067
J	Barker, B; Xu, L; Gu, ZL				Barker, Brandon; Xu, Lin; Gu, Zhenglong			Dynamic Epistasis under Varying Environmental Perturbations	PLOS ONE			English	Article							CONSTRAINT-BASED MODELS; FLUX BALANCE MODELS; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; QUANTITATIVE PREDICTION; SPONTANEOUS MUTATIONS; CELLULAR-METABOLISM; FITNESS; LOAD; BIOLOGY	Epistasis describes the phenomenon that mutations at different loci do not have independent effects with regard to certain phenotypes. Understanding the global epistatic landscape is vital for many genetic and evolutionary theories. Current knowledge for epistatic dynamics under multiple conditions is limited by the technological difficulties in experimentally screening epistatic relations among genes. We explored this issue by applying flux balance analysis to simulate epistatic landscapes under various environmental perturbations. Specifically, we looked at gene-gene epistatic interactions, where the mutations were assumed to occur in different genes. We predicted that epistasis tends to become more positive from glucose-abundant to nutrient-limiting conditions, indicating that selection might be less effective in removing deleterious mutations in the latter. We also observed a stable core of epistatic interactions in all tested conditions, as well as many epistatic interactions unique to each condition. Interestingly, genes in the stable epistatic interaction network are directly linked to most other genes whereas genes with condition-specific epistasis form a scale-free network. Furthermore, genes with stable epistasis tend to have similar evolutionary rates, whereas this co-evolving relationship does not hold for genes with condition-specific epistasis. Our findings provide a novel genome-wide picture about epistatic dynamics under environmental perturbations.	[Barker, Brandon] Cornell Univ, Ctr Adv Comp, Ithaca, NY 14853 USA; [Xu, Lin] Univ Texas SW Med Ctr Dallas, Dept Pediat, Div Hematol Oncol, Dallas, TX 75390 USA; [Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Gu, Zhenglong] Tri Inst Training Program Computat Biol & Med, New York, NY USA	Cornell University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University	Gu, ZL (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	zg27@cornell.edu	xu, lin/H-8560-2016	Barker, Brandon/0000-0001-5732-9550	NSF [DEB-0949556]; NIH [1R01AI085286]; Direct For Biological Sciences [1243588] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083937] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF DEB-0949556 and NIH 1R01AI085286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2010, TRENDS ECOL EVOL, V25, P450, DOI 10.1016/j.tree.2010.05.003; Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Baer CF, 2006, GENETICS, V174, P1387, DOI 10.1534/genetics.106.061200; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Brochado AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002758; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cooper TF, 2005, P ROY SOC B-BIOL SCI, V272, P311, DOI 10.1098/rspb.2004.2975; CORNELIUS SP, 2011, CONTROLLING COMPLEX; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Fry JD, 2002, GENETICS, V161, P1155; Hansen TF, 2001, GENETICS, V158, P477; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Jakubowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033132; Jasnos L, 2008, GENETICS, V178, P2105, DOI 10.1534/genetics.107.084533; Kishony Roy, 2003, J Biol, V2, P14, DOI 10.1186/1475-4924-2-14; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Korona R, 1999, EVOLUTION, V53, P1966, DOI 10.1111/j.1558-5646.1999.tb04577.x; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Measday V, 2005, P NATL ACAD SCI USA, V102, P13956, DOI 10.1073/pnas.0503504102; Measday V, 2002, METHOD ENZYMOL, V350, P316, DOI 10.1016/S0076-6879(02)50971-X; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Otto SP, 2007, GENET RES, V89, P447, DOI 10.1017/S001667230800966X; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Perez-Figueroa A, 2009, GENETICS, V183, P299, DOI 10.1534/genetics.109.104893; Presgraves DC, 2007, CURR BIOL, V17, pR125, DOI 10.1016/j.cub.2006.12.030; Remold SK, 2001, P NATL ACAD SCI USA, V98, P11388, DOI 10.1073/pnas.201140198; Sanjuan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002663; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Smallbone K, 2009, J THEOR BIOL, V258, P311, DOI 10.1016/j.jtbi.2009.01.027; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Szafraniec K, 2001, P NATL ACAD SCI USA, V98, P1107, DOI 10.1073/pnas.021390798; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang AD, 2009, AM NAT, V174, P863, DOI 10.1086/645088; Xu L, 2012, P NATL ACAD SCI USA, V109, P10420, DOI 10.1073/pnas.1121507109; Xu L, 2011, GENOME BIOL EVOL, V3, P909, DOI 10.1093/gbe/evr065; Yang HP, 2001, GENETICS, V157, P1257; Young JA, 2009, J EVOLUTION BIOL, V22, P2125, DOI 10.1111/j.1420-9101.2009.01830.x	58	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0114911	10.1371/journal.pone.0114911	http://dx.doi.org/10.1371/journal.pone.0114911			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625594	gold, Green Submitted, Green Published			2022-12-26	WOS:000348821400004
J	Kakehi, JI; Kawano, E; Yoshimoto, K; Cai, QQ; Imai, A; Takahashi, T				Kakehi, Jun-Ichi; Kawano, Eri; Yoshimoto, Kaori; Cai, Qingqing; Imai, Akihiro; Takahashi, Taku			Mutations in Ribosomal Proteins, RPL4 and RACK1, Suppress the Phenotype of a Thermospermine-Deficient Mutant of Arabidopsis thaliana	PLOS ONE			English	Article							MESSENGER-RNA DECAY; OPEN READING FRAME; TRANSCRIPTION FACTOR; SCAFFOLD PROTEIN; STEM ELONGATION; DWARF PHENOTYPE; ACL5 MUTANT; TRANSLATION; AUXIN; POLYAMINE	Thermospermine acts in negative regulation of xylem differentiation and its deficient mutant of Arabidopsis thaliana, acaulis5 (acl5), shows excessive xylem formation and severe dwarfism. Studies of two dominant suppressors of acl5, sac51-d and sac52-d, have revealed that SAC51 and SAC52 encode a transcription factor and a ribosomal protein L10 (RPL10), respectively, and these mutations enhance translation of the SAC51 mRNA, which contains conserved upstream open reading frames in the 5' leader. Here we report identification of SAC53 and SAC56 responsible for additional suppressors of acl5. sac53-d is a semi-dominant allele of the gene encoding a receptor for activated C kinase 1 (RACK1) homolog, a component of the 40S ribosomal subunit. sac56-d represents a semi-dominant allele of the gene for RPL4. We show that the GUS reporter activity driven by the CaMV 35S promoter plus the SAC51 5' leader is reduced in acl5 and restored by sac52-d, sac53-d, and sac56-d as well as thermospermine. Furthermore, the SAC51 mRNA, which may be a target of nonsense-mediated mRNA decay, was found to be stabilized in these ribosomal mutants and by thermospermine. These ribosomal proteins are suggested to act in the control of uORF-mediated translation repression of SAC51, which is derepressed by thermospermine.	[Kakehi, Jun-Ichi; Kawano, Eri; Yoshimoto, Kaori; Cai, Qingqing; Imai, Akihiro; Takahashi, Taku] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan	Okayama University	Takahashi, T (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan.	perfect@cc.okayama-u.ac.jp	TAKAHASHI, Taku/B-1462-2011	TAKAHASHI, Taku/0000-0002-8879-0718	Japan Society for the Promotion of Science (JSPS) [22370021, 26113516]; Ryobi-Teien Memorial Foundation; JSPS research fellowship; Grants-in-Aid for Scientific Research [26113516] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ryobi-Teien Memorial Foundation; JSPS research fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research No. 22370021 and No. 26113516 from the Japan Society for the Promotion of Science (JSPS) and a grant from the Ryobi-Teien Memorial Foundation to TT. JIK was a recipient of a JSPS research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Atkinson GC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-290; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Baima S, 2014, MOL PLANT, V7, P1006, DOI 10.1093/mp/ssu051; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Chen JG, 2006, J EXP BOT, V57, P2697, DOI 10.1093/jxb/erl035; Clay NK, 2005, PLANT PHYSIOL, V138, P767, DOI 10.1104/pp.104.055756; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Dick FA, 1998, NUCLEIC ACIDS RES, V26, P2442, DOI 10.1093/nar/26.10.2442; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Ferreyra MLF, 2013, PLANT PHYSIOL, V163, P378, DOI 10.1104/pp.113.223222; Ferreyra MLF, 2010, PLANT PHYSIOL, V153, P1878, DOI 10.1104/pp.110.157057; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Guo JJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-108; Hanfrey C, 2005, J BIOL CHEM, V280, P39229, DOI 10.1074/jbc.M509340200; Hanzawa Y, 2000, EMBO J, V19, P4248, DOI 10.1093/emboj/19.16.4248; Hanzawa Y, 1997, PLANT J, V12, P863, DOI 10.1046/j.1365-313X.1997.12040863.x; Hayden CA, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-32; Hori K, 2005, PLANT J, V43, P530, DOI 10.1111/j.1365-313X.2005.02473.x; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Imai A, 2004, FEBS LETT, V556, P148, DOI 10.1016/S0014-5793(03)01395-4; Imai A, 2008, PLANT J, V56, P881, DOI 10.1111/j.1365-313X.2008.03647.x; Imai A, 2006, DEVELOPMENT, V133, P3575, DOI 10.1242/dev.02535; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jorgensen RA, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00191; Kakehi JI, 2008, PLANT CELL PHYSIOL, V49, P1342, DOI 10.1093/pcp/pcn109; Kim BH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r60; Knott JM, 2007, FEBS LETT, V581, P3081, DOI 10.1016/j.febslet.2007.05.074; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Law GL, 2001, J BIOL CHEM, V276, P38036; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Milhinhos A, 2013, PLANT J, V75, P685, DOI 10.1111/tpj.12231; Muniz L, 2008, DEVELOPMENT, V135, P2573, DOI 10.1242/dev.019349; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Naka Y, 2010, PLANT PHYSIOL BIOCH, V48, P527, DOI 10.1016/j.plaphy.2010.01.013; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nyiko T, 2009, PLANT MOL BIOL, V71, P367, DOI 10.1007/s11103-009-9528-4; OSHIMA T, 1979, J BIOL CHEM, V254, P8720; Pachler K, 2004, FEMS YEAST RES, V5, P271, DOI 10.1016/j.femsyr.2004.07.009; Rahmani F, 2009, PLANT PHYSIOL, V150, P1356, DOI 10.1104/pp.109.136036; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; Rosado A, 2012, P NATL ACAD SCI USA, V109, P19537, DOI 10.1073/pnas.1214774109; Rosado A, 2010, PLANT CELL, V22, P143, DOI 10.1105/tpc.109.068320; Saul H, 2009, PLANT J, V60, P1031, DOI 10.1111/j.1365-313X.2009.04021.x; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Takano A, 2012, PLANT CELL PHYSIOL, V53, P606, DOI 10.1093/pcp/pcs019; Tiruneh BS, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-123; Tong WRN, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00094; von Arnim AG, 2014, PLANT SCI, V214, P1, DOI 10.1016/j.plantsci.2013.09.006; Wu C, 2012, J MOL BIOL, V416, P518, DOI 10.1016/j.jmb.2011.12.064; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Yoine M, 2006, PLANT J, V47, P49, DOI 10.1111/j.1365-313X.2006.02771.x; Yoshimoto K, 2012, PLANT CELL PHYSIOL, V53, P635, DOI 10.1093/pcp/pcs017; ZHOU F, 2010, BMC PLANT BIOL, V10, P178, DOI DOI 10.1186/1471-2229-10-178	64	27	28	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117309	10.1371/journal.pone.0117309	http://dx.doi.org/10.1371/journal.pone.0117309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625317	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821400030
J	Kern, D; Regl, G; Hofbauer, SW; Altenhofer, P; Achatz, G; Dlugosz, A; Schnidar, H; Greil, R; Hartmann, TN; Aberger, F				Kern, D.; Regl, G.; Hofbauer, S. W.; Altenhofer, P.; Achatz, G.; Dlugosz, A.; Schnidar, H.; Greil, R.; Hartmann, T. N.; Aberger, F.			Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia	ONCOGENE			English	Article							BASAL-CELL CARCINOMAS; PATHWAY INHIBITOR; GLI ACTIVATION; STEM-CELLS; BCR-ABL; CANCER; GROWTH; AKT; MECHANISMS; PROTEIN	The initiation and maintenance of a malignant phenotype requires complex and synergistic interactions of multiple oncogenic signals. The Hedgehog (HH)/GLI pathway has been implicated in a variety of cancer entities and targeted pathway inhibition is of therapeutic relevance. Signal cross-talk with other cancer pathways including PI3K/AKT modulates HH/GLI signal strength and its oncogenicity. In this study, we addressed the role of HH/GLI and its putative interaction with the PI3K/AKT cascade in the initiation and maintenance of chronic lymphocytic leukemia (CLL). Using transgenic mouse models, we show that B-cell-specific constitutive activation of HH/GLI signaling either at the level of the HH effector and drug target Smoothened or at the level of the GLI transcription factors does not suffice to initiate a CLL-like phenotype characterized by the accumulation of CD5(+) B cells in the lymphatic system and peripheral blood. Furthermore, Hh/Gli activation in Pten-deficient B cells with activated Pi3K/Akt signaling failed to enhance the expansion of leukemic CD5(+) B cells, suggesting that genetic or epigenetic alterations leading to aberrant HH/GLI signaling in B cells do not suffice to elicit a CLL-like phenotype in mice. By contrast, we identify a critical role of GLI and PI3K signaling for the survival of human primary CLL cells. We show that combined targeting of GLI and PI3K/AKT/mTOR signaling can have a synergistic therapeutic effect in cells from a subgroup of CLL patients, thereby providing a basis for the evaluation of future combination therapies targeting HH/GLI and PI3K signaling in this common hematopoietic malignancy.	[Kern, D.; Regl, G.; Achatz, G.; Schnidar, H.; Aberger, F.] Paris Lodron Univ Salzburg, Dept Mol Biol, Salzburg, Austria; [Hofbauer, S. W.; Altenhofer, P.; Greil, R.; Hartmann, T. N.] Paracelsus Med Univ, Ctr Oncol, Lab Immunol & Mol Canc Res, Med Dept Haematol Med Oncol Haemostaseol Infect D, Salzburg, Austria; [Hofbauer, S. W.; Altenhofer, P.; Greil, R.; Hartmann, T. N.] Salzburg Canc Res Inst, Salzburg, Austria; [Dlugosz, A.] Univ Michigan, Dermatol & Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; [Schnidar, H.] APEIRON Biol AG, Vienna, Austria	Salzburg University; Paracelsus Private Medical University; University of Michigan System; University of Michigan	Aberger, F (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	Fritz.Aberger@sbg.ac.at	Aberger, Fritz/B-6357-2012; Hartmann, Tanja Nicole/AAA-6735-2020; Hartmann, Tanja Nicole/C-9345-2017; Greil, Richard F/C-7673-2017; Hartmann, Tanja Nicole/C-9345-2017	Aberger, Fritz/0000-0003-2009-6305; Hartmann, Tanja Nicole/0000-0002-0377-7179; Hartmann, Tanja Nicole/0000-0002-0377-7179; Greil, Richard F/0000-0002-4462-3694; Hartmann, Tanja Nicole/0000-0002-2633-7301	Austrian Science Fund FWF [W1213, SFB-P021]; Austrian Genome Project GEN-AU; priority program Biosciences and Health of the Paris-Lodron University of Salzburg; SCRI-LIMCR GmbH; province of Salzburg; NATIONAL CANCER INSTITUTE [P30CA046592, R01CA087837] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Genome Project GEN-AU; priority program Biosciences and Health of the Paris-Lodron University of Salzburg; SCRI-LIMCR GmbH; province of Salzburg; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Professors Tak Mak and Josef Penninger for providing transgenic mouse strains, and Dr Sandrine Tonon and Professor Christoph Binder for help with B-cell analysis. Work of FA has been supported by the Austrian Science Fund FWF (project W1213), the Austrian Genome Project GEN-AU and the priority program Biosciences and Health of the Paris-Lodron University of Salzburg. Work of RG, TNH, SWH and PA was supported by the Austrian Science Fund FWF (SFB-P021 and W1213 to RG), the SCRI-LIMCR GmbH and the province of Salzburg. We dedicate this study to Gernot Achatz who tragically passed away during the course of this study.	Aberger F, 2014, SEMIN CELL DEV BIOL, V33, P93, DOI 10.1016/j.semcdb.2014.05.003; Aberger F, 2012, VITAM HORM, V88, P25, DOI 10.1016/B978-0-12-394622-5.00002-X; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Atwood SX, 2013, NATURE, V494, P484, DOI 10.1038/nature11889; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Brennan D, 2012, VITAM HORM, V88, P55, DOI 10.1016/B978-0-12-394622-5.00003-1; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dao KHT, 2013, CLIN CANCER RES, V19, P1309, DOI 10.1158/1078-0432.CCR-12-3934; de Frias M, 2009, HAEMATOL-HEMATOL J, V94, P1698, DOI 10.3324/haematol.2008.004028; Decker S, 2012, BLOOD, V119, P997, DOI 10.1182/blood-2011-06-359075; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Desch P, 2010, ONCOGENE, V29, P4885, DOI 10.1038/onc.2010.243; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Filbin MG, 2013, NAT MED, V19, P1518, DOI 10.1038/nm.3328; Finetti F, 2011, TRENDS IMMUNOL, V32, P139, DOI 10.1016/j.it.2011.02.001; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gold MR, 2003, TRENDS IMMUNOL, V24, P104, DOI 10.1016/S1471-4906(03)00022-X; Grachtchouk V, 2003, EMBO J, V22, P2741, DOI 10.1093/emboj/cdg271; Gulino A, 2007, PSYCHONEUROENDOCRINO, V32, pS52, DOI 10.1016/j.psyneuen.2007.03.017; Hegde GV, 2008, MOL CANCER RES, V6, P1928, DOI 10.1158/1541-7786.MCR-08-0142; Herman SEM, 2010, BLOOD, V116, P2078, DOI 10.1182/blood-2010-02-271171; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Ju BS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-40; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kasper Maria, 2007, V397, P67; Katagiri S, 2013, CLIN CANCER RES, V19, P1422, DOI 10.1158/1078-0432.CCR-12-1777; Kim JE, 2009, MODERN PATHOL, V22, P1312, DOI 10.1038/modpathol.2009.98; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Lauth M, 2007, ONCOGENE, V26, P5163, DOI 10.1038/sj.onc.1210321; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Mangelberger D, 2012, FRONT BIOSCI-LANDMRK, V17, P90, DOI 10.2741/3917; Mann KK, 2008, MOL CANCER THER, V7, P1680, DOI 10.1158/1535-7163.MCT-07-2164; Merchant A, 2010, BLOOD, V115, P2391, DOI 10.1182/blood-2009-09-241703; Merkel O, 2008, J MOL MED-JMM, V86, P541, DOI 10.1007/s00109-008-0314-6; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Pelczar P, 2013, GASTROENTEROLOGY, V144, P134, DOI 10.1053/j.gastro.2012.09.061; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Ruiz I, 2007, TRENDS CELL BIOL, V17, P438, DOI DOI 10.1016/J.TCB.2007.06.007; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Skvara H, 2011, J INVEST DERMATOL, V131, P1735, DOI 10.1038/jid.2011.48; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tsimberidou AM, 2005, CANCER-AM CANCER SOC, V103, P216, DOI 10.1002/cncr.20773; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Wu M, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-36; Xue P, 2011, BIOCHEM BIOPH RES CO, V407, P360, DOI 10.1016/j.bbrc.2011.03.024; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zahreddine HA, 2014, NATURE, V511, P90, DOI 10.1038/nature13283; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	85	43	47	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2015	34	42					5341	5351		10.1038/onc.2014.450	http://dx.doi.org/10.1038/onc.2014.450			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EI	25639866	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000363479200004
J	Kaur, J; Tikoo, K				Kaur, J.; Tikoo, K.			Ets1 identified as a novel molecular target of RNA aptamer selected against metastatic cells for targeted delivery of nano-formulation	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; CANCER; EXPRESSION; NANOPARTICLES	Nanomedicine era is not far from its realization, but a major concern of targeted delivery still stands tall in its way. Herein we demonstrate the mechanism underlying the anticancer activity of an RNA aptamer (Apt) conjugated to gefitinib-loaded poly (lactic co-glycolic acid) nanoparticles (GNPs). Apt was selected through Cell-SELEX (systemic evolution of ligands by exponential enrichment) process against gefitinib-resistant H1975 lung cancer cells. The selected aptamer exhibited high specificity toward H1975 cells, both qualitatively as well as quantitatively. Software analysis using the MATCH tool predicted Ets1, a proto-oncoprotein, to be the target of the selected aptamer. Interestingly, the localization of identified aptamer varied in descending order of Ets1 expression, wherein maximum localization was observed in H1975 cells than in MDA-MB231, DU-145, H23, H460, A431, A549 and MCF-7 cells, and minimum in L132 cells. Furthermore, Apt-GNP bio-conjugate showed augmented anticancer activity specifically in Ets1-overexpressing cells. In addition, partial depletion of Ets1 in H1975 cells and overexpression of Ets1 in L132 cells reversed the targeting efficacy of the aptamer. Notably, a single intratumoral injection of the Apt-GNP bio-conjugate abrogated the growth of tumor in H1975 xenograft nude mice. Altogether, we present a pioneering platform, involving aptamers, which can be clinically used as a diagnostic marker for metastasis as well as an effective delivery system to escort the pharmaceutical cargo specifically to Ets1-overexpressing highly progressive tumors.	[Kaur, J.; Tikoo, K.] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Lab Epigenet & Dis, Sas Nagar 160062, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Tikoo, K (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Lab Epigenet & Dis, Phase 10, Sas Nagar 160062, Punjab, India.	tikoo.k@gmail.com		Tikoo, Kulbhushan/0000-0003-3061-9739				Arteaga CL, 2001, CURR OPIN ONCOL, V13, P491, DOI 10.1097/00001622-200111000-00012; Buggy Y, 2004, BRIT J CANCER, V91, P1308, DOI 10.1038/sj.bjc.6602128; Chu TC, 2006, CANCER RES, V66, P5989, DOI 10.1158/0008-5472.CAN-05-4583; Dassie JP, 2014, MOL THER, V22, P1910, DOI 10.1038/mt.2014.117; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Guo KT, 2008, INT J MOL SCI, V9, P668, DOI 10.3390/ijms9040668; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kaur J, 2013, BBA-MOL CELL RES, V1833, P1028, DOI 10.1016/j.bbamcr.2013.01.029; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim Y, 2013, CANCER RES, V73, P4923, DOI 10.1158/0008-5472.CAN-12-4556; Li N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020299; Li R, 2000, ONCOGENE, V19, P55; Lupold SE, 2002, CANCER RES, V62, P4029; Meert AP, 2002, EUR RESPIR J, V20, P975, DOI 10.1183/09031936.02.00296502; Mi J, 2010, NAT CHEM BIOL, V6, P22, DOI [10.1038/NCHEMBIO.277, 10.1038/nchembio.277]; Nakayama T, 2001, MODERN PATHOL, V14, P415, DOI 10.1038/modpathol.3880328; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; SACCHI N, 1988, LEUKEMIA, V2, P12; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Valter MM, 1999, CANCER RES, V59, P5608; Van Simaeys D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013770; Xiao ZY, 2012, ACS NANO, V6, P696, DOI 10.1021/nn204165v	30	20	22	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2015	34	41					5216	5228		10.1038/onc.2014.447	http://dx.doi.org/10.1038/onc.2014.447			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CT1QL	25639877	Green Published			2022-12-26	WOS:000362575400002
J	Shaw, JJ; Berbasova, T; Sasaki, T; Jefferson-George, K; Spakowicz, DJ; Dunican, BF; Portero, CE; Narvaez-Trujillo, A; Strobel, SA				Shaw, Jeffrey J.; Berbasova, Tetyana; Sasaki, Tomoaki; Jefferson-George, Kyra; Spakowicz, Daniel J.; Dunican, Brian F.; Portero, Carolina E.; Narvaez-Trujillo, Alexandra; Strobel, Scott A.			Identification of a Fungal 1,8-Cineole Synthase from Hypoxylon sp with Specificity Determinants in Common with the Plant Synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE RESIDUE SWITCH; ACTIVE-SITE RESIDUES; ARISTOLOCHENE SYNTHASE; ESCHERICHIA-COLI; TRICHODIENE SYNTHASE; MECHANISTIC INSIGHTS; CRYSTAL-STRUCTURE; BIOSYNTHESIS; EVOLUTION; GENE	Terpenes are an important and diverse class of secondary metabolites widely produced by fungi. Volatile compound screening of a fungal endophyte collection revealed a number of isolates in the family Xylariaceae, producing a series of terpene molecules, including 1,8-cineole. This compound is a commercially important component of eucalyptus oil used in pharmaceutical applications and has been explored as a potential biofuel additive. The genes that produce terpene molecules, such as 1,8-cineole, have been little explored in fungi, providing an opportunity to explore the biosynthetic origin of these compounds. Through genome sequencing of cineole-producing isolate E7406B, we were able to identify 11 new terpene synthase genes. Expressing a subset of these genes in Escherichia coli allowed identification of the hyp3 gene, responsible for 1,8-cineole biosynthesis, the first monoterpene synthase discovered in fungi. In a striking example of convergent evolution, mutational analysis of this terpene synthase revealed an active site asparagine critical for water capture and specificity during cineole synthesis, the same mechanism used in an unrelated plant homologue. These studies have provided insight into the evolutionary relationship of fungal terpene synthases to those in plants and bacteria and further established fungi as a relatively untapped source of this important and diverse class of compounds.	[Shaw, Jeffrey J.; Berbasova, Tetyana; Sasaki, Tomoaki; Spakowicz, Daniel J.; Dunican, Brian F.; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Jefferson-George, Kyra] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Portero, Carolina E.; Narvaez-Trujillo, Alexandra] Pontificia Univ Catolica Ecuador, Lab Biotecnol Vegetal, Quito 17012184, Ecuador	Yale University; University of Pennsylvania; Pennsylvania Medicine; Pontificia Universidad Catolica del Ecuador	Strobel, SA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	scott.strobel@yale.edu	Spakowicz, Dan/E-5233-2012	Spakowicz, Dan/0000-0003-2314-6435	Office of Assistant Secretary of Defense for Research and Engineering NSSEFF [N00244-09-1-0070]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER	Office of Assistant Secretary of Defense for Research and Engineering NSSEFF; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Office of Assistant Secretary of Defense for Research and Engineering NSSEFF Grant N00244-09-1-0070 and a Howard Hughes Medical Institute Professorship (to S.A.S.).	Agger S, 2009, MOL MICROBIOL, V72, P1181, DOI 10.1111/j.1365-2958.2009.06717.x; Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; BARTON AFM, 1989, FUEL, V68, P11, DOI 10.1016/0016-2361(89)90004-5; BENEDICT CR, 1995, PHYTOCHEMISTRY, V39, P327, DOI 10.1016/0031-9422(95)00066-G; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Cane DE, 2012, ACCOUNTS CHEM RES, V45, P463, DOI 10.1021/ar200198d; CANE DE, 1995, BIOCHEMISTRY-US, V34, P2480, DOI 10.1021/bi00008a011; Carter OA, 2003, PHYTOCHEMISTRY, V64, P425, DOI 10.1016/S0031-9422(03)00204-8; Chen MB, 2013, BIOCHEMISTRY-US, V52, P5441, DOI 10.1021/bi400691v; Chen XY, 1995, ARCH BIOCHEM BIOPHYS, V324, P255, DOI 10.1006/abbi.1995.0038; Christianson DW, 2008, CURR OPIN CHEM BIOL, V12, P141, DOI 10.1016/j.cbpa.2007.12.008; CROTEAU R, 1994, ARCH BIOCHEM BIOPHYS, V309, P184, DOI 10.1006/abbi.1994.1101; Davis EM, 2000, TOP CURR CHEM, V209, P53; Degenhardt J, 2000, PLANTA, V210, P815, DOI 10.1007/s004250050684; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Engels B, 2011, J BIOL CHEM, V286, P6871, DOI 10.1074/jbc.M110.165845; Ezra D, 2004, MICROBIOL-SGM, V150, P4023, DOI 10.1099/mic.0.27334-0; Fahnrich A, 2012, PLANT MOL BIOL, V79, P537, DOI 10.1007/s11103-012-9933-y; Fahnrich A, 2011, MOL PLANT, V4, P965, DOI 10.1093/mp/ssr021; Felicetti B, 2004, J AM CHEM SOC, V126, P7212, DOI 10.1021/ja0499593; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Gianoulis TA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002558; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Griffin MA, 2010, MICROBIOL-SGM, V156, P3814, DOI 10.1099/mic.0.041327-0; Harvey BG, 2010, ENERG FUEL, V24, P267, DOI 10.1021/ef900799c; Haynes RK, 2001, CURR OPIN INFECT DIS, V14, P719, DOI 10.1097/00001432-200112000-00010; HOHN TM, 1989, GENE, V79, P131, DOI 10.1016/0378-1119(89)90098-X; HOHN TM, 1989, ARCH BIOCHEM BIOPHYS, V272, P137, DOI 10.1016/0003-9861(89)90204-X; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hsieh HM, 2005, MYCOLOGIA, V97, P844, DOI 10.3852/mycologia.97.4.844; Inoue Y, 2004, FEMS MICROBIOL LETT, V237, P325, DOI 10.1016/j.femsle.2004.06.049; Jennewein S, 2001, APPL MICROBIOL BIOT, V57, P13; Kampranis SC, 2007, PLANT CELL, V19, P1994, DOI 10.1105/tpc.106.047779; Katoh S, 2004, ARCH BIOCHEM BIOPHYS, V425, P65, DOI 10.1016/j.abb.2004.02.015; Keeling CI, 2008, P NATL ACAD SCI USA, V105, P1085, DOI 10.1073/pnas.0709466105; KLOCKE JA, 1987, J CHEM ECOL, V13, P2131, DOI 10.1007/BF01012562; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kumeta Y, 2010, PLANT PHYSIOL, V154, P1998, DOI 10.1104/pp.110.161828; Lauchli R, 2013, ANGEW CHEM INT EDIT, V52, P5571, DOI 10.1002/anie.201301362; Leita BA, 2011, CATAL TODAY, V178, P98, DOI 10.1016/j.cattod.2011.05.037; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mends M. T., 2012, J PET ENV BIOTECHNOL, V3, P117, DOI [10.4172, DOI 10.4172/2157-7463.1000117]; Nakano C, 2011, CHEMBIOCHEM, V12, P1988, DOI 10.1002/cbic.201100330; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Pinedo C, 2008, ACS CHEM BIOL, V3, P791, DOI 10.1021/cb800225v; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Riyaz-Ul-Hassan S, 2013, J MICROBIOL BIOTECHN, V23, P29, DOI 10.4014/jmb.1208.04062; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schulz B, 2002, MYCOL RES, V106, P996, DOI 10.1017/S0953756202006342; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; Shaw JJ, 2015, APPL MICROBIOL BIOT, V99, P3715, DOI 10.1007/s00253-014-6206-5; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Silvestre AJD, 2000, IND CROP PROD, V12, P53, DOI 10.1016/S0926-6690(99)00067-9; Silvestre AJD, 1999, MONATSH CHEM, V130, P589, DOI 10.1007/s007060050218; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel GA, 2008, MICROBIOL-SGM, V154, P3319, DOI 10.1099/mic.0.2008/022186-0; Suwannasai N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054529; Tomsheck AR, 2010, MICROB ECOL, V60, P903, DOI 10.1007/s00248-010-9759-6; Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005; TURNER WB, 1983, FUNGAL METABOLITES; van Zeijl CMJ, 1998, J BIOTECHNOL, V59, P221, DOI 10.1016/S0168-1656(97)00170-3; Vedula LS, 2008, ARCH BIOCHEM BIOPHYS, V469, P184, DOI 10.1016/j.abb.2007.10.015; Wang JL, 2009, NAT PROD RES, V23, P1080, DOI 10.1080/14786410802267759; Wawrzyn GT, 2012, METHOD ENZYMOL, V515, P83, DOI 10.1016/B978-0-12-394290-6.00005-7; Wawrzyn GT, 2012, CHEM BIOL, V19, P772, DOI 10.1016/j.chembiol.2012.05.012; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; Xu MM, 2007, P NATL ACAD SCI USA, V104, P7397, DOI 10.1073/pnas.0611454104; Yang JM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-60; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607	81	52	59	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8511	8526		10.1074/jbc.M114.636159	http://dx.doi.org/10.1074/jbc.M114.636159			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25648891	Green Published, hybrid			2022-12-26	WOS:000351662600042
J	Mayor, R; Izquierdo-Bouldstridge, A; Millan-Arino, L; Bustillos, A; Sampaio, C; Luque, N; Jordan, A				Mayor, Regina; Izquierdo-Bouldstridge, Andrea; Millan-Arino, Lluis; Bustillos, Alberto; Sampaio, Cristina; Luque, Neus; Jordan, Albert			Genome Distribution of Replication-independent Histone H1 Variants Shows H1.0 Associated with Nucleolar Domains and H1X Associated with RNA Polymerase II-enriched Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Epigenetics; Histone; Nucleolus; RNA Polymerase II; H1; 0; H1X; Histone H1; Variants	NUCLEAR LAMINA INTERACTIONS; DNA METHYLATION; GENE-EXPRESSION; BREAST-CANCER; CHROMOSOME TERRITORIES; CHROMATIN-STRUCTURE; HUMAN-CELLS; IN-VIVO; TRANSCRIPTION; PHOSPHORYLATION	Background: There are seven histone H1 variants in somatic mammalian cells, two of which are replication-independent, H1.0 and H1X. Results: In breast cancer cells, H1.0 is enriched at nucleolus-associated domains, whereas H1X is associated with RNA polymerase II-enriched regions. Conclusion: Most H1 variants show great redundancy across the genome, but there is also some specificity. Significance: Some H1 variants may have specific functions. Unlike core histones, the linker histone H1 family is more evolutionarily diverse, and many organisms have multiple H1 variants or subtypes. In mammals, the H1 family includes seven somatic H1 variants; H1.1 to H1.5 are expressed in a replication-dependent manner, whereas H1.0 and H1X are replication-independent. Using ChIP-sequencing data and cell fractionation, we have compared the genomic distribution of H1.0 and H1X in human breast cancer cells, in which we previously observed differential distribution of H1.2 compared with the other subtypes. We have found H1.0 to be enriched at nucleolus-associated DNA repeats and chromatin domains, whereas H1X is associated with coding regions, RNA polymerase II-enriched regions, and hypomethylated CpG islands. Further, H1X accumulates within constitutive or included exons and retained introns and toward the 3 end of expressed genes. Inducible H1X knockdown does not affect cell proliferation but dysregulates a subset of genes related to cell movement and transport. In H1X-depleted cells, the promoters of up-regulated genes are not occupied specifically by this variant, have a lower than average H1 content, and, unexpectedly, do not form an H1 valley upon induction. We conclude that H1 variants are not distributed evenly across the genome and may participate with some specificity in chromatin domain organization or gene regulation.	[Mayor, Regina; Izquierdo-Bouldstridge, Andrea; Millan-Arino, Lluis; Bustillos, Alberto; Sampaio, Cristina; Luque, Neus; Jordan, Albert] CSIC, IBMB, E-08028 Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Jordan, A (corresponding author), CSIC, IBMB, C Baldiri Reixac 4, E-08028 Barcelona, Catalonia, Spain.	albert.jordan@ibmb.csic.es	jordan, albert/ABC-8229-2020; jordan, albert/K-4678-2014; Bustillos, Alberto/AAQ-5390-2021	jordan, albert/0000-0002-3970-8693; jordan, albert/0000-0002-3970-8693; Bustillos, Alberto/0000-0002-4409-8113; Izquierdo Bouldstridge, Andrea/0000-0001-6169-936X; Sampaio, Cristina/0000-0002-2974-210X	Spanish Ministry of Science and Innovation (MICINN); European Regional Development Fund [BFU2011-23057]; Generalitat de Catalunya [2009-SGR-1222]; Consejo Superior de Investigaciones Cientificas-MICINN; MICINN	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Consejo Superior de Investigaciones Cientificas-MICINN; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by funding from the Spanish Ministry of Science and Innovation (MICINN), European Regional Development Fund Grant BFU2011-23057, and Generalitat de Catalunya Grant 2009-SGR-1222.; Recipient of a Tecnico de Apoyo contract from Consejo Superior de Investigaciones Cientificas-MICINN.; Recipient of a Formacion de Personal Universitario predoctoral fellowship from MICINN.	Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Ballare C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Braunschweig U, 2013, CELL, V152, P1252, DOI 10.1016/j.cell.2013.02.034; Cao Kaixiang, 2013, PLoS Genet, V9, pe1003417, DOI 10.1371/journal.pgen.1003417; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Acuna LIG, 2013, WIRES RNA, V4, P77, DOI 10.1002/wrna.1142; GORKA C, 1993, EXP CELL RES, V205, P152, DOI 10.1006/excr.1993.1069; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hale TK, 2006, MOL CELL, V22, P693, DOI 10.1016/j.molcel.2006.04.016; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Happel N, 2005, BIOL CHEM, V386, P541, DOI 10.1515/BC.2005.064; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hergeth SP, 2011, J CELL SCI, V124, P1623, DOI 10.1242/jcs.084947; Hnilicova J, 2011, NUCLEUS-PHILA, V2, P182, DOI 10.4161/nucl.2.3.15876; Hodl M, 2012, CURR BIOL, V22, P2253, DOI 10.1016/j.cub.2012.10.008; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Izzo A, 2013, CELL REP, V3, P2142, DOI 10.1016/j.celrep.2013.05.003; Jarboui MA, 2011, MOL IMMUNOL, V49, P441, DOI 10.1016/j.molimm.2011.09.005; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalashnikova AA, 2013, NUCLEIC ACIDS RES, V41, P4026, DOI 10.1093/nar/gkt104; Kamieniarz K, 2012, GENE DEV, V26, P797, DOI 10.1101/gad.182014.111; Kim K, 2012, ONCOGENE, V31, P4290, DOI 10.1038/onc.2011.605; Kim KJ, 2013, BIOMIMETIC ROBOTIC ARTIFICIAL MUSCLES, P1; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; LENNOX RW, 1983, J BIOL CHEM, V258, P262; Lin QC, 2004, J BIOL CHEM, V279, P23525, DOI 10.1074/jbc.M400925200; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Medrzycki M, 2012, FRONT BIOSCI-LANDMRK, V17, P396, DOI 10.2741/3934; Meergans T, 1997, DNA CELL BIOL, V16, P1041, DOI 10.1089/dna.1997.16.1041; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; Orthaus S, 2009, NUCLEIC ACIDS RES, V37, P3391, DOI 10.1093/nar/gkp199; Parseghian MH, 2000, CHROMOSOME RES, V8, P405, DOI 10.1023/A:1009262819961; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; PINA B, 1987, EUR J BIOCHEM, V164, P71, DOI 10.1111/j.1432-1033.1987.tb10994.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Sato S, 2012, PATHOL INT, V62, P84, DOI 10.1111/j.1440-1827.2011.02755.x; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stoldt S, 2007, BIOL CELL, V99, P541, DOI 10.1042/BC20060117; Takata H, 2007, FEBS LETT, V581, P3783, DOI 10.1016/j.febslet.2007.06.076; Telu KH, 2013, J PROTEOME RES, V12, P3317, DOI 10.1021/pr400143x; Terme JM, 2014, FEBS LETT, V588, P2353, DOI 10.1016/j.febslet.2014.05.035; Terme JM, 2011, J BIOL CHEM, V286, P35347, DOI 10.1074/jbc.M111.281923; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; VanderKraats ND, 2013, NUCLEIC ACIDS RES, V41, P6816, DOI 10.1093/nar/gkt482; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Weiss T, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-7; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yamamoto T, 1996, GENE, V173, P281, DOI 10.1016/0378-1119(96)00020-0; Yang SM, 2013, P NATL ACAD SCI USA, V110, P1708, DOI 10.1073/pnas.1213266110; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zhang HS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004202; Zhang YZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002691; Zheng YP, 2010, J CELL BIOL, V189, P407, DOI 10.1083/jcb.201001148	78	45	45	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7474	7491		10.1074/jbc.M114.617324	http://dx.doi.org/10.1074/jbc.M114.617324			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25645921	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000351613600016
J	Sliepen, K; van Montfort, T; Melchers, M; Isik, G; Sanders, RW				Sliepen, Kwinten; van Montfort, Thijs; Melchers, Mark; Isik, Goezde; Sanders, Rogier W.			Immunosilencing a Highly Immunogenic Protein Trimerization Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); humoral response; influenza; protein engineering; vaccine	ENVELOPE GLYCOPROTEIN TRIMERS; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSE; CELL RESPONSES; COILED-COIL; CD40 LIGAND; ANTIGENICITY; POTENT; HEMAGGLUTININ; GLYCOSYLATION	Background: Trimerization domains are commonly used to stabilize trimeric protein vaccines and therapeutics. Results: The GCN4-based isoleucine zipper domain induces strong antibody responses in vivo but this can be overcome by introducing glycans. Conclusion: Appropriately positioned glycans can effectively immunosilence the GCN4-based trimerization domain. Significance: Immunosilencing trimerization domains could be important for the exploitation of trimerization domains in protein vaccines and therapeutics. Many therapeutic proteins and protein subunit vaccines contain heterologous trimerization domains, such as the widely used GCN4-based isoleucine zipper (IZ) and the T4 bacteriophage fibritin foldon (Fd) trimerization domains. We found that these domains induced potent anti-IZ or anti-Fd antibody responses in animals when fused to an HIV-1 envelope glycoprotein (Env) immunogen. To dampen IZ-induced responses, we constructed an IZ domain containing four N-linked glycans (IZN4) to shield the underlying protein surface. When fused to two different vaccine antigens, HIV-1 Env and influenza hemagglutinin (HA), IZN4 strongly reduced the antibody responses against the IZ, but did not affect the antibody titers against Env or HA. Silencing of immunogenic multimerization domains with glycans might be relevant for therapeutic proteins and protein vaccines.	[Sliepen, Kwinten; van Montfort, Thijs; Melchers, Mark; Isik, Goezde; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Sanders, Rogier W.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	rws2002@med.cornell.edu		Isik, Gozde/0000-0002-1329-6782	Aids fonds Netherlands [2009012]; Vidi fellowship from the Netherlands Organization for Scientific Research; European Research Council [ERC-StG-2011-280829-SHEV]	Aids fonds Netherlands; Vidi fellowship from the Netherlands Organization for Scientific Research; European Research Council(European Research Council (ERC)European Commission)	This work was supported by Aids fonds Netherlands, Grant 2009012.; Recipient of a Vidi fellowship from the Netherlands Organization for Scientific Research and a Starting Investigator Grant from the European Research Council (ERC-StG-2011-280829-SHEV).	Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Chakrabarti BK, 2013, J VIROL, V87, P13239, DOI 10.1128/JVI.01247-13; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555; Du SX, 2009, VIROLOGY, V395, P33, DOI 10.1016/j.virol.2009.07.042; Eggink D, 2014, J VIROL, V88, P699, DOI 10.1128/JVI.02608-13; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Forsell MNE, 2013, J IMMUNOL, V191, P44, DOI 10.4049/jimmunol.1203087; Forsell MNE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000171; Garrity RR, 1997, J IMMUNOL, V159, P279; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hemmer B, 2005, LANCET NEUROL, V4, P403, DOI 10.1016/S1474-4422(05)70117-4; Isik G, 2014, J IMMUNOL, V192, P4628, DOI 10.4049/jimmunol.1303401; Jain A, 2011, BLOOD, V118, P3811, DOI 10.1182/blood-2011-04-351254; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; King C, 2014, P NATL ACAD SCI USA, V111, P8577, DOI 10.1073/pnas.1321126111; Kovacs JM, 2014, P NATL ACAD SCI USA, V111, P18542, DOI 10.1073/pnas.1422269112; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Loeffen WLA, 2011, VACCINE, V29, P1545, DOI 10.1016/j.vaccine.2010.12.096; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Melchers M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-48; Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418; Morris NP, 2007, MOL IMMUNOL, V44, P3112, DOI 10.1016/j.molimm.2007.02.004; Nimmerjahn F, 2010, IMMUNOL REV, V236, P265, DOI 10.1111/j.1600-065X.2010.00910.x; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Onda M, 2008, P NATL ACAD SCI USA, V105, P11311, DOI 10.1073/pnas.0804851105; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Rigter A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071072; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozanov DV, 2009, MOL CANCER THER, V8, P1515, DOI 10.1158/1535-7163.MCT-09-0202; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Selvarajah S, 2005, J VIROL, V79, P12148, DOI 10.1128/JVI.79.19.12148-12163.2005; Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; van der Laken CJ, 2007, ANN RHEUM DIS, V66, P253, DOI 10.1136/ard.2006.057406; Van Montfort T, 2011, J BIOL CHEM, V286, P22250, DOI 10.1074/jbc.M111.229625; Vonderheide RH, 2001, J CLIN ONCOL, V19, P3280, DOI 10.1200/JCO.2001.19.13.3280; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; Wu XF, 2001, MOL THER, V3, P368, DOI 10.1006/mthe.2001.0280; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001	51	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7436	7442		10.1074/jbc.M114.620534	http://dx.doi.org/10.1074/jbc.M114.620534			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25635058	Green Published, hybrid			2022-12-26	WOS:000351613600012
J	Damgaard, AL; Hansen, BM; Mathiasen, R; Buchvald, F; Lange, T; Greisen, G				Damgaard, Anne Louise; Hansen, Bo Molholm; Mathiasen, Rene; Buchvald, Frederik; Lange, Theis; Greisen, Gorm			Prematurity and Prescription Asthma Medication from Childhood to Young Adulthood: A Danish National Cohort Study	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; LUNG-FUNCTION; PRETERM BIRTH; CHILDREN BORN; DISEASE; INFANTS; ASSOCIATION; PATHOLOGY; REGISTERS; PATTERNS	Introduction Preterm birth is associated with increased risk of asthma-like symptoms and purchase of prescription asthma medication in childhood. We investigated whether this association persists into adulthood and whether it is affected by accounting for neonatal respiratory morbidity (acute respiratory disease and bronchopulmonary dysplasia). Methods A national cohort of all infants born in Denmark in the period 1980-2009 was included in this register study. Data on purchase of asthma medication (combination of inhaled beta-2 agonists and other drugs for obstructive airway disease) in 2010-2011 were obtained from the Danish National Prescription Registry. Associations between gestational age (GA), neonatal respiratory morbidity and a cross-sectional evaluation of asthma medication purchase were explored by multivariate logistic regressions. Results A full dataset was obtained on 1,790,241 individuals, 84.6% of all infants born in the period. Odds-ratios (95% CI) for the association between GA and purchase of asthma medication during infancy were: 3.86 (2.46-6.04) in GA 23-27 weeks, 2.37 (1.84-3.04) in GA 28-31 weeks and 1.59 (1.43-1.77) in GA 32-36 weeks compared to term infants with GA 37-42 weeks. Associations weakened in older age groups and became insignificant in young adults born extremely and very preterm with odds-ratios: 1.41 (0.63-3.19) and 1.15 (0.83-1.60) in GA 23-27 and 28-31 respectively. When adjusting for neonatal respiratory morbidity, the associations weakened but persisted both in childhood and adolescence. Conclusion There was a strong dose-response association between gestational age and the purchase of prescription asthma medication in infancy and childhood. This association weakened during adolescence and was mostly non-significant in young adulthood. The increased risk of prescription asthma medication purchase in ex-preterm children could only partly be explained by neonatal respiratory morbidity.	[Damgaard, Anne Louise; Hansen, Bo Molholm; Greisen, Gorm] Rigshosp, Copenhagen Univ Hosp, Dept Neonatol, DK-2100 Copenhagen, Denmark; [Mathiasen, Rene] Rigshosp, Copenhagen Univ Hosp, Dept Pediat & Adolescent Med, DK-2100 Copenhagen, Denmark; [Buchvald, Frederik] Rigshosp, Copenhagen Univ Hosp, Dept Pediat & Adolescent Med, Pulm Serv, DK-2100 Copenhagen, Denmark; [Lange, Theis] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Damgaard, AL (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Neonatol, DK-2100 Copenhagen, Denmark.	aldamgaard@me.com	Greisen, Gorm/AAA-6463-2022; de Barros Garioud, Anne Louise/AAQ-3868-2021	Greisen, Gorm/0000-0001-8042-3262; de Barros Garioud, Anne Louise/0000-0003-1149-9946; Hansen, Bo Molholm/0000-0002-3087-3983; Lange, Theis/0000-0001-6807-8347	Rigshospitalet Research Funds	Rigshospitalet Research Funds	The study was funded by Rigshospitalet Research Funds and internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2012, CLIN EXP ALLERGY, V42, P1369, DOI 10.1111/j.1365-2222.2012.04021.x; Bancalari E, 2006, SEMIN PERINATOL, V30, P164, DOI 10.1053/j.semperi.2006.05.002; Baraldi E, 2005, AM J RESP CRIT CARE, V171, P68, DOI 10.1164/rccm.200403-298Oc; Bhatia Jatinder, 2009, Neonatology, V95, P362, DOI 10.1159/000209302; Bonnelykke Klaus, 2013, Ugeskr Laeger, V175, P1863; Brostrom EB, 2010, RESP MED, V104, P362, DOI 10.1016/j.rmed.2009.10.008; Crump C, 2011, PEDIATRICS, V127, pE913, DOI 10.1542/peds.2010-2603; Dishop MK, 2010, PEDIAT ALLER IMM PUL, V23, P69, DOI 10.1089/ped.2010.0007; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; Fakhoury KF, 2010, PEDIATRICS, V125, pE1441, DOI 10.1542/peds.2009-0668; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; Filippone M, 2010, EUR RESPIR J, V35, P1419, DOI 10.1183/09031936.00013310; Goyal NK, 2011, PEDIATRICS, V128, pE830, DOI 10.1542/peds.2011-0809; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hjalmarson O, 2002, AM J RESP CRIT CARE, V165, P83, DOI 10.1164/ajrccm.165.1.2107093; Jensen KE, 2008, ACTA OBSTET GYN SCAN, V87, P760, DOI 10.1080/00016340802179814; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Kallen B, 2012, ARCH DIS CHILD; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kindlund K, 2010, THORAX, V65, P146, DOI 10.1136/thx.2009.117101; Larsen CG, 2013, CLIN RESPIR J, V7, P354, DOI 10.1111/crj.12015; Laughon M, 2009, PEDIATRICS, V123, P1124, DOI 10.1542/peds.2008-0862; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McEvoy C, 2013, J PEDIATR-US, V162, P464, DOI 10.1016/j.jpeds.2012.09.042; Moth G, 2007, EUR J CLIN PHARMACOL, V63, P605, DOI 10.1007/s00228-007-0286-4; Narang I, 2006, PEDIATR PULM, V41, P497, DOI 10.1002/ppul.20385; Narayanan M, 2013, AM J RESP CRIT CARE, V187, P1104, DOI 10.1164/rccm.201210-1850OC; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; Ortqvist AK, 2009, PEDIATRICS, V124, pE737, DOI 10.1542/peds.2009-0305; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pelkonen AS, 1997, AM J RESP CRIT CARE, V156, P1178, DOI 10.1164/ajrccm.156.4.9610028; Porsbjerg C, 2009, ASTMA BEHANDLING, P1; Rogvi RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016668; Stensballe LG, 2012, J PEDIAT; THURLBECK WM, 1982, THORAX, V37, P564, DOI 10.1136/thx.37.8.564; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Tollanes MC, 2008, J PEDIATR-US, V153, P112, DOI 10.1016/j.jpeds.2008.01.029; Vinding GR, 2013, ACTA DERMATO VENEREO; Vogt H, 2011, PEDIATRICS, V127, P1052, DOI 10.1542/peds.2010-3083; Vrijlandt EJLE, 2007, J PEDIATR-US, V150, P256, DOI 10.1016/j.jpeds.2006.12.007; Wang Lei, 2008, Birth Defects Research, V84, P54, DOI 10.1002/bdrc.20114; Zilmer M, 2011, ACTA PAEDIATR, V100, P385, DOI 10.1111/j.1651-2227.2010.02036.x	43	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0117253	10.1371/journal.pone.0117253	http://dx.doi.org/10.1371/journal.pone.0117253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651521	Green Published, Green Submitted, gold			2022-12-26	WOS:000349250700011
J	Starlard-Davenport, A; Orloff, MS; Dhakal, I; Penney, RB; Kadlubar, SA				Starlard-Davenport, Athena; Orloff, Mohammed S.; Dhakal, Ishwori; Penney, Rosalind B.; Kadlubar, Susan A.			Genotypic and Allelic Variability in CYP19A1 among Populations of African and European Ancestry	PLOS ONE			English	Article							BREAST-CANCER RISK; ENDOMETRIAL CANCER; GENETIC-VARIATION; LINKAGE DISEQUILIBRIUM; HORMONE-LEVELS; AROMATASE; POLYMORPHISMS; ASSOCIATION; VARIANTS	CYP19A1 facilitates the bioconversion of estrogens from androgens. CYP19A1 intron single nucleotide polymorphisms (SNPs) may alter mRNA splicing, resulting in altered CYP19A1 activity, and potentially influencing disease susceptibility. Genetic studies of CYP19A1 SNPs have been well documented in populations of European ancestry; however, studies in populations of African ancestry are limited. In the present study, ten 'candidate' intronic SNPs in CYP19A1 from 125 African Americans (AA) and 277 European Americans (EA) were genotyped and their frequencies compared. Allele frequencies were also compared with HapMap and ASW 1000 Genomes populations. We observed significant differences in the minor allele frequencies between AA and EA in six of the ten SNPs including rs10459592 (p < 0.0001), rs12908960 (p < 0.0001), rs1902584 (p = 0.016), rs2470144 (p < 0.0001), rs1961177 (p < 0.0001), and rs6493497 (p = 0.003). While there were no significant differences in allele frequencies between EA and CEU in the HapMap population, a 1.2- to 19-fold difference in allele frequency for rs10459592 (p = 0.004), rs12908960 (p = 0.0006), rs1902584 (p < 0.0001), rs2470144 (p = 0.0006), rs1961177 (p < 0.0001), and rs6493497 (p = 0.0092) was observed between AA and the Yoruba (YRI) population. Linkage disequilibrium (LD) blocks and haplotype clusters that is unique to the EA population but not AA was also observed. In summary, we demonstrate that differences in the allele frequencies of CYP19A1 intron SNPs are not consistent between populations of African and European ancestry. Thus, investigations into whether CYP19A1 intron SNPs contribute to variations in cancer incidence, outcomes and pharmacological response seen in populations of different ancestry may prove beneficial.	[Starlard-Davenport, Athena; Kadlubar, Susan A.] Univ Arkansas Med Sci, Dept Med Genet, Little Rock, AR 72205 USA; [Orloff, Mohammed S.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Epidemiol, Little Rock, AR 72205 USA; [Dhakal, Ishwori] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Penney, Rosalind B.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Environm & Occupat Hlth, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Kadlubar, SA (corresponding author), Univ Arkansas Med Sci, Dept Med Genet, Little Rock, AR 72205 USA.	SAKadlubar@uams.edu	Starlard-Davenport, Athena/Q-3866-2017	Starlard-Davenport, Athena/0000-0002-8938-237X	UAMS Winthrop P. Rockefeller Cancer Institute; Arkansas Breast Cancer Research Program (ABCRP)	UAMS Winthrop P. Rockefeller Cancer Institute; Arkansas Breast Cancer Research Program (ABCRP)	This work was supported by generous funds from the UAMS Winthrop P. Rockefeller Cancer Institute to AS-D and funding from the Arkansas Breast Cancer Research Program (ABCRP) to MSO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai QY, 2008, CANCER EPIDEM BIOMAR, V17, P27, DOI 10.1158/1055-9965.EPI-07-0688; Chace C, 2012, J ALZHEIMERS DIS, V28, P601, DOI 10.3233/JAD-2011-110860; Chattopadhyay S., 2014, TUMOUR BIOL; Choudhury A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-437; Cooper David N, 2010, Hum Genomics, V4, P284; Czajka-Oraniec I, 2010, ENDOKRYNOL POL, V61, P126; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Golledge J, 2011, EUR J HUM GENET, V19, P363, DOI 10.1038/ejhg.2010.182; Haiman CA, 2003, HUM MOL GENET, V12, P2679, DOI 10.1093/hmg/ddg294; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; He SS, 2012, AM J ORTHOD DENTOFAC, V142, P662, DOI 10.1016/j.ajodo.2012.06.014; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Ikeda K, 2014, ANN SURG ONCOL, V21, P939, DOI 10.1245/s10434-013-3362-2; Kado N, 2002, HUM REPROD, V17, P897, DOI 10.1093/humrep/17.4.897; Kohno T, 2010, CARCINOGENESIS, V31, P1794, DOI 10.1093/carcin/bgq159; Lee SJ, 2010, J HUM GENET, V55, P189, DOI 10.1038/jhg.2010.6; Lin JH, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-78; Lonjou C, 2003, P NATL ACAD SCI USA, V100, P6069, DOI 10.1073/pnas.1031521100; Millar David S., 2010, Human Genomics, V4, P289; Olson SH, 2007, AM J EPIDEMIOL, V165, P235, DOI 10.1093/aje/kwk015; Park IH, 2011, CANCER CHEMOTH PHARM, V68, P1263, DOI 10.1007/s00280-011-1615-y; Paynter RA, 2005, INT J CANCER, V116, P267, DOI 10.1002/ijc.21041; Pietranera L, 2011, NEUROSCIENCE, V174, P151, DOI 10.1016/j.neuroscience.2010.11.044; Setiawan VW, 2009, CANCER EPIDEM BIOMAR, V18, P242, DOI 10.1158/1055-9965.EPI-08-0689; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Slattery ML, 2011, CANCER CAUSE CONTROL, V22, P955, DOI 10.1007/s10552-011-9768-x; Travis RC, 2009, CANCER EPIDEM BIOMAR, V18, P2734, DOI 10.1158/1055-9965.EPI-09-0496; Umamaheswaran G, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0665-x; Wang LW, 2010, CANCER RES, V70, P319, DOI 10.1158/0008-5472.CAN-09-3224; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Zhang XL, 2012, MOL MED REP, V5, P245, DOI 10.3892/mmr.2011.616	34	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117347	10.1371/journal.pone.0117347	http://dx.doi.org/10.1371/journal.pone.0117347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647083	gold, Green Published, Green Submitted			2022-12-26	WOS:000348822600065
J	Li, YY; Ma, XL; Zhao, JL; Xu, JJ; Shi, JF; Zhu, XG; Zhao, YX; Zhang, H				Li, Yuanyuan; Ma, Xiuling; Zhao, Jialei; Xu, Jiajia; Shi, Junfeng; Zhu, Xin-Guang; Zhao, Yanxiu; Zhang, Hui			Developmental Genetic Mechanisms of C-4 Syndrome Based on Transcriptome Analysis of C-3 Cotyledons and C-4 Assimilating Shoots in Haloxylon ammodendron	PLOS ONE			English	Article							AMPHIBIOUS PLANT; LEAF DEVELOPMENT; KRANZ ANATOMY; PHOTOSYNTHESIS; EVOLUTION; DIFFERENTIATION; EXPRESSION; RECRUITMENT; CO2; DISCRIMINATION	It is believed that transferring the C-4 engine into C-3 crops will greatly increase the yields of major C-3 crops. Many efforts have been made since the 1960s, but relatively little success has been achieved because C(4)plant traits, referred to collectively as C-4 syndrome, are very complex, and little is known about the genetic mechanisms involved. Unfortunately, there exists no ideal genetic model system to study C-4 syndrome. It was previously reported that the Haloxylon species have different photosynthetic pathways in different photosynthetic organs, cotyledons and assimilating shoots. Here, we took advantage of the developmental switch from the C-3 to the C-4 pathway to study the genetic mechanisms behind this natural transition. We compared the transcriptomes of cotyledons and assimilating shoots using mRNA-Seq to gain insight into the molecular and cellular events associated with C-4 syndrome. A total of 2959 differentially expressed genes [FDR <= 0.001 and abs (vertical bar log2(Fold change)vertical bar >= 1)] were identified, revealing that the transcriptomes of cotyledons and assimilating shoots are considerably different. We further identified a set of putative regulators of C-4 syndrome. This study expands our understanding of the development of C-4 syndrome and provides a new model system for future studies on the C-3-to- C-4 switch mechanism.	[Li, Yuanyuan] Shandong Normal Univ, Key Lab Syst Biol, Jinan, Shandong, Peoples R China; [Ma, Xiuling; Zhao, Jialei; Shi, Junfeng; Zhao, Yanxiu; Zhang, Hui] Shandong Normal Univ, Key Lab Plant Stress Res, Jinan, Shandong, Peoples R China; [Li, Yuanyuan; Xu, Jiajia; Zhu, Xin-Guang] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Shandong Normal University; Shandong Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Li, YY (corresponding author), Shandong Normal Univ, Key Lab Syst Biol, Jinan, Shandong, Peoples R China.	yuanyuan_li@outlook.com	xu, jia/GSD-6347-2022	Zhang, Hui/0000-0002-4819-6482; LI, YUANYUAN/0000-0003-3332-8128	China Postdoctoral Science Foundation [2013T60468]; National Basic Research Program of China [2012CB114204]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the China Postdoctoral Science Foundation (Grant No. 2013T60468) and the National Basic Research Program of China (Grant No. 2012CB114204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004365; Aubry S, 2011, J EXP BOT, V62, P3049, DOI 10.1093/jxb/err012; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; BENDER MM, 1968, RADIOCARBON, V10, P468, DOI 10.1017/S0033822200011103; BJORKMAN O, 1970, YEAR B CARNEGIE I WA, V69, P640; BJORKMAN O, 1971, YEAR B CARNEGIE I WA, V70, P507; Bju┬rkman O., 1969, YB CARNEGIE I WASHIN, V68, P620; BOYNTON JE, 1970, YEAR B CARNEGIE I WA, V69, P629; Brautigam A, 2011, PLANT PHYSIOL, V155, P142, DOI 10.1104/pp.110.159442; Brown NJ, 2011, SCIENCE, V331, P1436, DOI 10.1126/science.1201248; BROWN RH, 1993, ANNU REV PLANT PHYS, V44, P435, DOI 10.1146/annurev.pp.44.060193.002251; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Gowik U, 2011, PLANT CELL, V23, P2087, DOI 10.1105/tpc.111.086264; Hatch MD, 1976, TRANSPORT PLANTS 3 E, V3, P144, DOI DOI 10.1007/978-3-642-66417-5_5; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; John CR, 2014, PLANT PHYSIOL, V165, P62, DOI 10.1104/pp.114.238667; Kajala K, 2012, PLANT J, V69, P47, DOI 10.1111/j.1365-313X.2011.04769.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kulahoglu C, 2014, PLANT CELL, V26, P3243, DOI 10.1105/tpc.114.123752; LAETSCH WM, 1974, ANNU REV PLANT PHYS, V25, P27, DOI 10.1146/annurev.pp.25.060174.000331; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li YY, 2014, J EXP BOT, V65, P3657, DOI 10.1093/jxb/eru193; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; Majeran W, 2010, PLANT CELL, V22, P3509, DOI 10.1105/tpc.110.079764; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; NOBS MA, 1970, YEAR B CARNEGIE I WA, V69, P625; Osborne CP, 2006, PHILOS T R SOC B, V361, P173, DOI 10.1098/rstb.2005.1737; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; PEARCY RW, 1970, YEAR B CARNEGIE I WA, V69, P632; Pyankov VI, 1999, PLANT CELL PHYSIOL, V40, P125, DOI 10.1093/oxfordjournals.pcp.a029519; Pyankov VI, 2000, PHOTOSYNTH RES, V63, P69, DOI 10.1023/A:1006377708156; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sage RF, 2012, ANNU REV PLANT BIOL, V63, P19, DOI 10.1146/annurev-arplant-042811-105511; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Sawers RJH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-12; Slewinski TL, 2012, PLANT CELL PHYSIOL, V53, P2030, DOI 10.1093/pcp/pcs147; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Su PX, 2010, DESERT PLANTS: BIOLOGY AND BIOTECHNOLOGY, P243, DOI 10.1007/978-3-642-02550-1_12; Tolley BJ, 2012, PLANT PHYSIOL, V159, P1418, DOI 10.1104/pp.112.200584; Ueno O, 2001, PLANT PHYSIOL, V127, P1524, DOI 10.1104/pp.010704; Ueno O, 1998, PLANT CELL, V10, P571; UENO O, 1988, P NATL ACAD SCI USA, V85, P6733, DOI 10.1073/pnas.85.18.6733; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wang P, 2013, PLANT J, V75, P656, DOI 10.1111/tpj.12229; Westhoff P, 2010, PLANT PHYSIOL, V154, P598, DOI 10.1104/pp.110.161729; Xu JJ, 2013, PLANT MOL BIOL, V83, P77, DOI 10.1007/s11103-013-0025-4	53	27	28	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117175	10.1371/journal.pone.0117175	http://dx.doi.org/10.1371/journal.pone.0117175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643361	gold, Green Published, Green Submitted			2022-12-26	WOS:000348821200033
J	Seipke, RF				Seipke, Ryan F.			Strain-Level Diversity of Secondary Metabolism in Streptomyces albus	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; HETEROLOGOUS EXPRESSION; HOMOLOGOUS RECOMBINATION; MARINE ACTINOMYCETE; DIRECT CLONING; OPEN SOFTWARE; SIGMA-FACTOR; SEQUENCE; PRODUCT; IDENTIFICATION	Streptomyces spp. are robust producers of medicinally-, industrially- and agriculturally-important small molecules. Increased resistance to antibacterial agents and the lack of new antibiotics in the pipeline have led to a renaissance in natural product discovery. This endeavor has benefited from inexpensive high quality DNA sequencing technology, which has generated more than 140 genome sequences for taxonomic type strains and environmental Streptomyces spp. isolates. Many of the sequenced streptomycetes belong to the same species. For instance, Streptomyces albus has been isolated from diverse environmental niches and seven strains have been sequenced, consequently this species has been sequenced more than any other streptomycete, allowing valuable analyses of strain-level diversity in secondary metabolism. Bioinformatics analyses identified a total of 48 unique biosynthetic gene clusters harboured by Streptomyces albus strains. Eighteen of these gene clusters specify the core secondary metabolome of the species. Fourteen of the gene clusters are contained by one or more strain and are considered auxiliary, while 16 of the gene clusters encode the production of putative strain-specific secondary metabolites. Analysis of Streptomyces albus strains suggests that each strain of a Streptomyces species likely harbours at least one strain-specific biosynthetic gene cluster. Importantly, this implies that deep sequencing of a species will not exhaust gene cluster diversity and will continue to yield novelty.	Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Seipke, RF (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	r.seipke@leeds.ac.uk		Seipke, Ryan/0000-0002-6156-8498	University of Leeds	University of Leeds	The New Lecturer Startup Fund provided by the University of Leeds financially supported this work. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Brana AF, 2014, ARCH MICROBIOL, V196, P345, DOI 10.1007/s00203-014-0977-z; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; CHATER KF, 1976, J BACTERIOL, V128, P644, DOI 10.1128/JB.128.2.644-650.1976; Craney A, 2013, J ANTIBIOT, V66, P387, DOI 10.1038/ja.2013.25; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/NCHEMBIO.1659, 10.1038/nchembio.1659]; Doroghazi JR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-611; Doroghazi JR, 2010, ISME J, V4, P1136, DOI 10.1038/ismej.2010.45; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fan LJ, 2011, J BACTERIOL, V193, P3691, DOI 10.1128/JB.05097-11; Feng ZY, 2009, BIOORGAN MED CHEM, V17, P2147, DOI 10.1016/j.bmc.2008.10.074; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; GERBER NN, 1965, APPL MICROBIOL, V13, P935, DOI 10.1128/AEM.13.6.935-938.1965; Gullon S, 2006, APPL ENVIRON MICROB, V72, P4172, DOI 10.1128/AEM.00734-06; Guo YP, 2008, INT J SYST EVOL MICR, V58, P149, DOI 10.1099/ijs.0.65224-0; GURTLER H, 1994, J ANTIBIOT, V47, P434; Hanshew AS, 2015, MICROB ECOL, V69, P192, DOI 10.1007/s00248-014-0469-3; Ian E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096719; IMBERT M, 1995, CURR MICROBIOL, V31, P129, DOI 10.1007/BF00294289; Izumikawa M, 2003, J IND MICROBIOL BIOT, V30, P510, DOI 10.1007/s10295-003-0075-8; Kaltenpoth M, 2012, APPL ENVIRON MICROB, V78, P822, DOI 10.1128/AEM.06809-11; Kim SY, 2009, CHEM BIOL, V16, P736, DOI 10.1016/j.chembiol.2009.06.007; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Labeda DP, 2012, ANTON LEEUW INT J G, V101, P73, DOI 10.1007/s10482-011-9656-0; Lombo F, 2006, CHEMBIOCHEM, V7, P366, DOI 10.1002/cbic.200500325; Makitrynskyy R, 2010, J IND MICROBIOL BIOT, V37, P559, DOI 10.1007/s10295-010-0701-1; Malin G, 1996, J BACTERIOL, V178, P385, DOI 10.1128/jb.178.2.385-395.1996; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Medema MH, 2011, NAT REV MICROBIOL, V9, P131, DOI 10.1038/nrmicro2478; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Olano C, 2014, MICROB BIOTECHNOL, V7, P242, DOI 10.1111/1751-7915.12116; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schoenian I, 2011, P NATL ACAD SCI USA, V108, P1955, DOI 10.1073/pnas.1008441108; Seipke RF, 2014, PEERJ, V2, DOI 10.7717/peerj.253; Seipke RF, 2013, BEILSTEIN J ORG CHEM, V9, P2556, DOI 10.3762/bjoc.9.290; Seipke RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022028; Seipke RF, 2009, J BACTERIOL, V191, P5216, DOI 10.1128/JB.00390-09; Shao ZY, 2011, MOL BIOSYST, V7, P1056, DOI 10.1039/c0mb00338g; SHIGEMORI H, 1992, J ORG CHEM, V57, P4317, DOI 10.1021/jo00041a053; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Takano H, 2005, J BACTERIOL, V187, P1825, DOI 10.1128/JB.187.5.1825-1832.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Viegelmann C, 2014, MAR DRUGS, V12, P3323, DOI 10.3390/md12063323; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Winter JM, 2007, J BIOL CHEM, V282, P16362, DOI 10.1074/jbc.M611046200; Yamanaka K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/pnas.1319584111; Zaburannyi N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-97; Ziemert N, 2014, P NATL ACAD SCI USA, V111, pE1130, DOI 10.1073/pnas.1324161111; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	58	65	65	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116457	10.1371/journal.pone.0116457	http://dx.doi.org/10.1371/journal.pone.0116457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635820	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700037
J	Starzyk, EJ; Kelley, MA; Caskey, RN; Schwartz, A; Kennelly, JF; Bailey, RC				Starzyk, Erin J.; Kelley, Michele A.; Caskey, Rachel N.; Schwartz, Alan; Kennelly, Joan F.; Bailey, Robert C.			Infant Male Circumcision: Healthcare Provider Knowledge and Associated Factors	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; URINARY-TRACT-INFECTIONS; NEWBORN CIRCUMCISION; YOUNG MEN; HIV PREVENTION; UNITED-STATES; ORANGE FARM; RATES; RISK; PHYSICIANS	Background and Objectives The emerging science demonstrates various health benefits associated with infant male circumcision and adult male circumcision; yet rates are declining in the United States. The American Academy of Pediatrics and the Centers for Disease Control and Prevention recommend that healthcare providers present evidence-based risk and benefit information for infant male circumcision to parent(s) and guardian(s). The purpose of this study was to assess providers' level of infant male circumcision knowledge and to identify the associated characteristics. Methods An online survey was administered to healthcare providers in the family medicine, obstetrics, and pediatrics medical specialties at an urban academic health center. To assess infant male circumcision knowledge, a 17 point summary score was constructed to identify level of provider knowledge within the survey. Results Ninety-two providers completed the survey. Providers scored high for the following knowledge items: adverse event rates, protects against phimosis and urinary tract infections, and does not prevent hypospadias. Providers scored lower for items related to more recent research: protection against cervical cancer, genital ulcer disease, bacterial vaginosis, and reduction in HIV acquisition. Two models were constructed looking at (1) overall knowledge about male circumcision, and (2) knowledge about male circumcision reduction in HIV acquisition. Pediatricians demonstrated greater overall infant male circumcision knowledge, while obstetricians exhibited significantly greater knowledge for the HIV acquisition item. Conclusion Providers' knowledge levels regarding the risks and benefits of infant male circumcision are highly variable, indicating the need for system-based educational interventions.	[Starzyk, Erin J.; Kelley, Michele A.; Kennelly, Joan F.] Univ Illinois, Sch Publ Hlth, Div Community Hlth Sci, Chicago, IL 60607 USA; [Caskey, Rachel N.] Univ Illinois, Coll Med, Dept Internal Med & Pediat, Chicago, IL USA; [Schwartz, Alan] Univ Illinois, Coll Med, Dept Med Educ, Chicago, IL USA; [Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Starzyk, EJ (corresponding author), Univ Illinois, Sch Publ Hlth, Div Community Hlth Sci, Chicago, IL 60607 USA.	ecloherty@gmail.com		Schwartz, Alan/0000-0003-3809-6637	CDC-funded Illinois Public Health Research Fellowship [5T01CD000189-05]; Health Professions Student/Fellow Grant Awards [HRSA U76HP20207]; OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION [T01CD000189] Funding Source: NIH RePORTER	CDC-funded Illinois Public Health Research Fellowship; Health Professions Student/Fellow Grant Awards; OFFICE OF THE DIRECTOR, CENTERS FOR DISEASE CONTROL &PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was supported by funding from the CDC-funded Illinois Public Health Research Fellowship (5T01CD000189-05) and Health Professions Student/Fellow Grant Awards 2011 (HRSA U76HP20207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.2.e20; American Academy of Pediatrics, 2005, PEDIATRICS, V116, P796; American College of Obstetricians, 2012, NEW EVIDENCE POINTS; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey R C, 2001, Lancet Infect Dis, V1, P223, DOI 10.1016/S1473-3099(01)00117-7; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bauchner H, 2001, ARCH DIS CHILD, V84, P459, DOI 10.1136/adc.84.6.459; Bisono GM, 2012, CLIN PEDIATR, V51, P956, DOI 10.1177/0009922812441662; Blank S, 2012, PEDIATRICS, V130, P585, DOI 10.1542/peds.2012-1989; Carbery B, 2012, AIDS EDUC PREV, V24, P377, DOI 10.1521/aeap.2012.24.4.377; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Castro JG, 2010, INT J STD AIDS, V21, P591, DOI 10.1258/ijsa.2010.010201; Cherpes TL, 2003, SEX TRANSM DIS, V30, P405, DOI 10.1097/00007435-200305000-00006; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Diekema DS, 2010, ATTITUDES AND EXPERI; Donaldson GW, 1999, EVAL HEALTH PROF, V22, P427, DOI 10.1177/01632789922034392; El Bcheraoui C, 2010, 8TH INTERNATIONAL AI; Elashoff J.D., 2007, NQUERY ADVISOR VERSI; Field TS, 2002, MED CARE, V40, P596, DOI 10.1097/00005650-200207000-00006; Gore-Felton C, 2002, EVAL HEALTH PROF, V25, P152, DOI 10.1177/01678702025002002; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kahn JA, 2007, AMBUL PEDIATR, V7, P367, DOI 10.1016/j.ambp.2007.05.010; Kasprzyk D, 2001, EVAL HEALTH PROF, V24, P3, DOI 10.1177/01632780122034740; Lannon CM, 1999, PEDIATRICS, V103, P686; Larke NL, 2011, CANCER CAUSE CONTROL, V22, P1097, DOI 10.1007/s10552-011-9785-9; Leung GM, 2002, J CLIN EPIDEMIOL, V55, P801, DOI 10.1016/S0895-4356(02)00442-0; Mavis BE, 1998, EVAL HEALTH PROF, V21, P395, DOI 10.1177/016327879802100306; Mor Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000861; Morris BJ, 2014, MAYO CLIN PROC, V89, P677, DOI 10.1016/j.mayocp.2014.01.001; Nelson CP, 2005, J UROLOGY, V173, P978, DOI 10.1097/01.ju.0000145758.80937.7d; Nielson CM, 2009, J INFECT DIS, V199, P7, DOI 10.1086/595567; RIMM EB, 1990, AM J EPIDEMIOL, V131, P1068, DOI 10.1093/oxfordjournals.aje.a115598; Schleyer TKL, 2000, J AM MED INFORM ASSN, V7, P416, DOI 10.1136/jamia.2000.0070416; Schoen EJ, 2006, PEDIATRICS, V118, P385, DOI 10.1542/peds.2005-2881; Schoen EJ, 2000, PEDIATRICS, V105, P789, DOI 10.1542/peds.105.4.789; Schoen EJ, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e36; Smith DK, 2010, PUBLIC HEALTH REP, V125, P72, DOI 10.1177/00333549101250S110; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Straus SE, 2011, J CLIN EPIDEMIOL, V64, P6, DOI 10.1016/j.jclinepi.2009.08.016; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; WISWELL TE, 1987, PEDIATRICS, V79, P338; Wright JL, 2012, CANCER-AM CANCER SOC, V118, P4437, DOI 10.1002/cncr.26653	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115891	10.1371/journal.pone.0115891	http://dx.doi.org/10.1371/journal.pone.0115891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CC9HX	25635664	Green Published, gold			2022-12-26	WOS:000350680700019
J	Zhu, LX; Di, PYP; Wu, R; Pinkerton, KE; Chen, Y				Zhu, Lingxiang; Di, Peter Y. P.; Wu, Reen; Pinkerton, Kent E.; Chen, Yin			Repression of CC16 by Cigarette Smoke (CS) Exposure	PLOS ONE			English	Article							CELL SECRETORY PROTEIN; OBSTRUCTIVE PULMONARY-DISEASE; RETINOIC ACID; SYSTEMIC INFLAMMATION; ALVEOLAR REGENERATION; LUNG EPITHELIUM; VIRUS-INFECTION; 10-KD PROTEIN; CLARA CELLS; UTEROGLOBIN	Club (Clara) Cell Secretory Protein (CCSP, or CC16) is produced mainly by non-ciliated airway epithelial cells including bronchiolar club cells and the change of its expression has been shown to associate with the progress and severity of Chronic Obstructive Pulmonary Disease (COPD). In an animal model, the lack of CC16 renders the animal susceptible to the tumorigenic effect of a major CS carcinogen. A recent population-based Tucson Epidemiological Study of Airway Obstructive Diseases (TESAOD) has indicated that the low serum CC16 concentration is closely linked with the smoke-related mortality, particularly that driven by the lung cancer. However, the study of CC16 expression in well-defined smoke exposure models has been lacking, and there is no experimental support for the potential causal link between CC16 and CS-induced pathophysiological changes in the lung. In the present study, we have found that airway CC16 expression was significantly repressed in COPD patients, in monkey CS exposure model, and in CS-induced mouse model of COPD. Additionally, the lack of CC16 exacerbated airway inflammation and alveolar loss in the mouse model. Therefore, CC16 may play an important protective role in CS-related diseases.	[Zhu, Lingxiang; Chen, Yin] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Di, Peter Y. P.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Wu, Reen] Univ Calif Davis, Ctr Comparat Resp Biol & Med, Davis, CA 95616 USA; [Pinkerton, Kent E.] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA	University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California Davis	Chen, Y (corresponding author), Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	ychen@pharmacy.arizona.edu	Di, Yuanpu Peter/H-4191-2016	Di, Yuanpu Peter/0000-0003-2028-2087	Flight Attendant Medical Research Institute [123055_CIA]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091938] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by a grant (123055_CIA) from Flight Attendant Medical Research Institute (http://www.famri.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif ME, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008308.pub2; Antico G, 2006, J CELL PHYSIOL, V207, P553, DOI 10.1002/jcp.20604; Belloni PN, 2000, CHEST, V117, p235S, DOI 10.1378/chest.117.5_suppl_1.235S; BERNARD A, 1992, EUR RESPIR J, V5, P1231; Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; Braido F, 2007, RESP MED, V101, P2119, DOI 10.1016/j.rmed.2007.05.023; Broeckaert F, 2000, CLIN EXP ALLERGY, V30, P469; Buro-Auriemma LJ, 2013, HUM MOL GENET, V22, P4726, DOI 10.1093/hmg/ddt326; Coppens JT, 2007, AM J PHYSIOL-LUNG C, V292, pL1155, DOI 10.1152/ajplung.00454.2006; DIERYNCK I, 1995, AM J RESP CELL MOL, V12, P205, DOI 10.1165/ajrcmb.12.2.7865218; ENGELHARDT JF, 1994, J CLIN INVEST, V93, P737, DOI 10.1172/JCI117028; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Ganesan S, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24997; Geerts L, 2001, CRIT CARE MED, V29, P1920, DOI 10.1097/00003246-200110000-00012; Guerra S, 2013, LANCET RESP MED, V1, P779, DOI 10.1016/S2213-2600(13)70220-0; Harrod KS, 1998, AM J PHYSIOL-LUNG C, V275, pL924, DOI 10.1152/ajplung.1998.275.5.L924; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Hind M, 2004, EUR RESPIR J, V23, P20, DOI 10.1183/09031936.03.00119103; Hung CH, 2004, J ALLERGY CLIN IMMUN, V114, P664, DOI 10.1016/j.jaci.2004.05.042; Johnston CJ, 1997, AM J RESP CELL MOL, V17, P147, DOI 10.1165/ajrcmb.17.2.2676; Lakind JS, 2007, BIOMARKERS, V12, P445, DOI 10.1080/13547500701359327; LESUR O, 1995, AM J RESP CRIT CARE, V152, P290, DOI 10.1164/ajrccm.152.1.7541278; LEVIN SW, 1986, LIFE SCI, V38, P1813, DOI 10.1016/0024-3205(86)90135-9; Levine CR, 2005, PEDIATR RES, V58, P15, DOI 10.1203/01.PDR.0000156371.89952.35; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Mandal AK, 2005, J BIOL CHEM, V280, P32897, DOI 10.1074/jbc.M502375200; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Mango GW, 1998, AM J PHYSIOL-LUNG C, V275, pL348, DOI 10.1152/ajplung.1998.275.2.L348; Massaro GD, 1997, NAT MED, V3, P675, DOI 10.1038/nm0697-675; Massaro GD, 2000, AM J PHYSIOL-LUNG C, V278, pL955, DOI 10.1152/ajplung.2000.278.5.L955; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Park HY, 2013, AM J RESP CRIT CARE, V188, P1413, DOI 10.1164/rccm.201305-0892OC; Pilette C, 2001, AM J RESP CRIT CARE, V163, P185, DOI 10.1164/ajrccm.163.1.9912137; Pilon AL, 2000, ANN NY ACAD SCI, V923, P280; Plopper CG, 2006, TOXICOL APPL PHARM, V213, P74, DOI 10.1016/j.taap.2005.09.003; Ray R, 2006, FEBS LETT, V580, P6022, DOI 10.1016/j.febslet.2006.09.059; Sin Don D, 2007, BMC Pulm Med, V7, P13, DOI 10.1186/1471-2466-7-13; Sin DD, 2007, CAN J PHYSIOL PHARM, V85, P141, DOI 10.1139/Y06-093; SINGH G, 1988, J HISTOCHEM CYTOCHEM, V36, P73, DOI 10.1177/36.1.3275712; Singh G, 1992, COMP BIOL NORMAL LUN, P93; Snyder JC, 2010, AM J RESP CELL MOL, V42, P161, DOI 10.1165/rcmb.2008-0353OC; Stinchcombe SV, 2008, AM J RESP CELL MOL, V38, P185, DOI 10.1165/rcmb.2007-0252OC; Stripp BR, 1996, AM J PHYSIOL-LUNG C, V271, pL656, DOI 10.1152/ajplung.1996.271.4.L656; Tepper J, 2000, CHEST, V117, p242S, DOI 10.1378/chest.117.5_suppl_1.242S; Tsoumakidou M, 2010, EXP LUNG RES, V36, P373, DOI 10.3109/01902141003690389; VASANTHAKUMAR G, 1988, BIOCHEM PHARMACOL, V37, P389, DOI 10.1016/0006-2952(88)90204-3; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Wang L, 2008, J ALLERGY CLIN IMMUN, V122, P400, DOI 10.1016/j.jaci.2008.04.011; Wang SZ, 2003, J IMMUNOL, V171, P1051, DOI 10.4049/jimmunol.171.2.1051; Wang SZ, 2001, AM J PHYSIOL-LUNG C, V281, pL1303, DOI 10.1152/ajplung.2001.281.5.L1303; Wendt CH, 2013, AM J PHYSIOL LUNG CE; Widegren H, 2009, ANN ALLERG ASTHMA IM, V102, P51, DOI 10.1016/S1081-1206(10)60108-1; Yang YP, 2004, J BIOL CHEM, V279, P29336, DOI 10.1074/jbc.C400162200; Ye Q, 2004, RESPIRATION, V71, P505, DOI 10.1159/000080636	56	37	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116159	10.1371/journal.pone.0116159	http://dx.doi.org/10.1371/journal.pone.0116159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635997	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000350680700025
J	McClelland, KS; Wainwright, EN; Bowles, J; Koopman, P				McClelland, Kathryn S.; Wainwright, Elanor N.; Bowles, Josephine; Koopman, Peter			Rapid Screening of Gene Function by Systemic Delivery of Morpholino Oligonucleotides to Live Mouse Embryos	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; BRANCHING-MORPHOGENESIS; TESTIS DEVELOPMENT; KIDNEY DEVELOPMENT; SEX DETERMINATION; VIVO-MORPHOLINOS; CELL FATE; IN-VIVO; SOX9; EXPRESSION	Traditional gene targeting methods in mice are complex and time consuming, especially when conditional deletion methods are required. Here, we describe a novel technique for assessing gene function by injection of modified antisense morpholino oligonucleotides (MOs) into the heart of mid-gestation mouse embryos. After allowing MOs to circulate through the embryonic vasculature, target tissues were explanted, cultured and analysed for expression of key markers. We established proof-of-principle by partially phenocopying known gene knockout phenotypes in the fetal gonads (Stra8, Sox9) and pancreas (Sox9). We also generated a novel double knockdown of Gli1 and Gli2, revealing defects in Leydig cell differentiation in the fetal testis. Finally, we gained insight into the roles of Adamts19 and Ctrb1, genes of unknown function in sex determination and gonadal development. These studies reveal the utility of this method as a means of first-pass analysis of gene function during organogenesis before committing to detailed genetic analysis.	[McClelland, Kathryn S.; Wainwright, Elanor N.; Bowles, Josephine; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland	Bowles, J (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	j.bowles@imb.uq.edu.au	Koopman, Peter A/C-9416-2009; Bowles, Josephine/B-6583-2013; Bowles, Josephine/AAG-4903-2020	Koopman, Peter A/0000-0001-6939-0914; Bowles, Josephine/0000-0003-2867-7438; Bowles, Josephine/0000-0003-2867-7438; Wainwright, Elanor/0000-0001-6409-3881; McClelland, Kathryn S/0000-0003-2845-5448	Australian Research Council; National Health and Medical Research Council (NHMRC) of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council and the National Health and Medical Research Council (NHMRC) of Australia. P. K. is a Senior Principal Research Fellow of the NHMRC.	Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Barsoum I, 2011, BIOL REPROD, V84, P894, DOI 10.1095/biolreprod.110.088997; Beverdam A, 2006, HUM MOL GENET, V15, P417, DOI 10.1093/hmg/ddi463; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Combes AN, 2009, DEV DYNAM, V238, P1033, DOI 10.1002/dvdy.21925; Cool J, 2011, P NATL ACAD SCI USA, V108, P167, DOI 10.1073/pnas.1010299108; Coveney D, 2008, GENE EXPR PATTERNS, V8, P529, DOI 10.1016/j.gep.2008.05.006; Dean CH, 2005, DEV BIOL, V286, P270, DOI 10.1016/j.ydbio.2005.07.034; Dubois CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023131; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Feng CW, 2014, MOL CELL ENDOCRINOL, V382, P488, DOI 10.1016/j.mce.2013.09.026; Gao LY, 2011, BIOL REPROD, V84, P422, DOI 10.1095/biolreprod.110.084590; Gross I, 2003, J BIOL CHEM, V278, P41420, DOI 10.1074/jbc.M306425200; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Knauff EAH, 2009, HUM REPROD, V24, P2372, DOI 10.1093/humrep/dep197; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Menke Douglas B., 2002, Gene Expression Patterns, V2, P359, DOI 10.1016/S1567-133X(02)00022-4; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Moulton JD, 2009, MOLECULES, V14, P1304, DOI 10.3390/molecules14031304; Nagy Andras, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5371; Nakamura Y, 2002, REPROD FERT DEVELOP, V14, P259, DOI 10.1071/RD01130; Pyun JA, 2013, HUM REPROD, V28, P3146, DOI 10.1093/humrep/det365; Quaggin SE, 1998, MECH DEVELOP, V71, P37, DOI 10.1016/S0925-4773(97)00201-3; Ryan J, 2011, SEX DEV, V5, P7, DOI 10.1159/000322162; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Svingen T, 2009, DEV DYNAM, V238, P956, DOI 10.1002/dvdy.21919; Wainwright EN, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110155; Wainwright EN, 2010, CURR TOP DEV BIOL, V90, P231, DOI 10.1016/S0070-2153(10)90006-9; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wu B, 2009, MOL THER, V17, P864, DOI 10.1038/mt.2009.38; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Yates LL, 2010, HUM MOL GENET, V19, P2251, DOI 10.1093/hmg/ddq104; Zhao L, 2008, BLOOD CELL MOL DIS, V41, P188, DOI 10.1016/j.bcmd.2008.03.006	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0114932	10.1371/journal.pone.0114932	http://dx.doi.org/10.1371/journal.pone.0114932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629157	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100010
J	Schmeisser, F; Vasudevan, A; Verma, S; Wang, W; Alvarado, E; Weiss, C; Atukorale, V; Meseda, C; Weir, JP				Schmeisser, Falko; Vasudevan, Anupama; Verma, Swati; Wang, Wei; Alvarado, Esmeralda; Weiss, Carol; Atukorale, Vajini; Meseda, Clement; Weir, Jerry P.			Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge	PLOS ONE			English	Article							A VIRUS; CANDIDATE	Identifying major antigenic and protective epitopes of the H7 hemagglutinin (HA) will be important for understanding the antibody response to vaccines developed against the novel influenza H7N9 viruses that emerged in China in 2013. To facilitate antigenic characterization of the H7N9 HA and to develop reagents for evaluation of H7N9 candidate vaccines, we generated a panel of murine monoclonal antibodies (mAbs) to the HA of A/Shanghai/2/2013 using mammalian cell-derived virus-like particles (VLP) containing the H7 HA. Neutralizing antibodies identified an HA epitope corresponding to antigenic site A on the structurally similar influenza H3 hemagglutinin. Importantly, the neutralizing antibodies protect against A/Shanghai/2/2013 challenge. This antigenic site is conserved among many H7 viruses, including strains of both Eurasian and North American lineage, and the isolated neutralizing antibodies are cross-reactive with older H7 vaccine strains. The results indicate that the identified antigenic site is a potentially important protective epitope and suggest the potential benefit of cross-reactive antibody responses to vaccination with H7 candidate vaccines.	[Schmeisser, Falko; Vasudevan, Anupama; Verma, Swati; Wang, Wei; Alvarado, Esmeralda; Weiss, Carol; Atukorale, Vajini; Meseda, Clement; Weir, Jerry P.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Weir, JP (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	jerry.weir@fda.hhs.gov	Weiss, Carol D./F-6438-2011; Meseda, Clement/I-6336-2019	Weiss, Carol D./0000-0002-9965-1289; 	U.S. Food and Drug Administration; Biomedical Advanced Research and Development Authority, Department of Health and Human Services	U.S. Food and Drug Administration; Biomedical Advanced Research and Development Authority, Department of Health and Human Services	This work was supported by the U.S. Food and Drug Administration and by the Biomedical Advanced Research and Development Authority, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008761; Belser JA, 2013, J VIROL, V87, P5746, DOI 10.1128/JVI.00154-13; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Goff PH, 2013, J VIROL, V87, P8235, DOI 10.1128/JVI.01085-13; Guo L, 2014, EMERG INFECT DIS, V20, P192, DOI 10.3201/eid2002.131094; Jadhao SJ, 2008, VACCINE, V26, P1742, DOI 10.1016/j.vaccine.2008.01.036; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Palmer DF, 1975, ADV LAB TECHNINQUES; Pappas C, 2007, CLIN VACCINE IMMUNOL, V14, P1425, DOI 10.1128/CVI.00174-07; Schmeisser F, 2013, INFLUENZA OTHER RESP, V7, P480, DOI 10.1111/irv.12029; Schmeisser F, 2012, VACCINE, V30, P3413, DOI 10.1016/j.vaccine.2012.03.033; Wang W, 2008, J VIROL METHODS, V153, P111, DOI 10.1016/j.jviromet.2008.07.015; Wang W, 2010, J VIROL METHODS, V165, P305, DOI 10.1016/j.jviromet.2010.02.009; Whiteley A, 2007, INFLUENZA OTHER RESP, V1, P157, DOI 10.1111/j.1750-2659.2007.00022.x; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0	25	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117108	10.1371/journal.pone.0117108	http://dx.doi.org/10.1371/journal.pone.0117108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629172	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100065
J	Adams, MP; Mallet, DG; Pettet, GJ				Adams, Matthew P.; Mallet, Daniel G.; Pettet, Graeme J.			Towards a Quantitative Theory of Epidermal Calcium Profile Formation in Unwounded Skin	PLOS ONE			English	Article							TRANSEPIDERMAL WATER-LOSS; KERATINOCYTE STEM-CELLS; STRATUM-CORNEUM; PERMEABILITY BARRIER; TIGHT JUNCTIONS; ULTRASTRUCTURAL-LOCALIZATION; ELECTRON-MICROPROBE; MURINE EPIDERMIS; PROGENITOR CELLS; TUMOR DYNAMICS	We propose and mathematically examine a theory of calcium profile formation in unwounded mammalian epidermis based on: changes in keratinocyte proliferation, fluid and calcium exchange with the extracellular fluid during these cells' passage through the epidermal sublayers, and the barrier functions of both the stratum corneum and tight junctions localised in the stratum granulosum. Using this theory, we develop a mathematical model that predicts epidermal sublayer transit times, partitioning of the epidermal calcium gradient between intracellular and extracellular domains, and the permeability of the tight junction barrier to calcium ions. Comparison of our model's predictions of epidermal transit times with experimental data indicates that keratinocytes lose at least 87% of their volume during their disintegration to become corneocytes. Intracellular calcium is suggested as the main contributor to the epidermal calcium gradient, with its distribution actively regulated by a phenotypic switch in calcium exchange between keratinocytes and extracellular fluid present at the boundary between the stratum spinosum and the stratum granulosum. Formation of the extracellular calcium distribution, which rises in concentration through the stratum granulosum towards the skin surface, is attributed to a tight junction barrier in this sublayer possessing permeability to calcium ions that is less than 15 nm s(-1) in human epidermis and less than 37 nm s(-1) in murine epidermis. Future experimental work may refine the presented theory and reduce the mathematical uncertainty present in the model predictions.	[Adams, Matthew P.] Univ Queensland, Sch Math Sci, Brisbane, Qld, Australia; [Adams, Matthew P.] Univ Queensland, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Adams, Matthew P.] Univ Queensland, Sch Chem Engn, Brisbane, Qld, Australia; [Mallet, Daniel G.; Pettet, Graeme J.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Mallet, Daniel G.; Pettet, Graeme J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	University of Queensland; University of Queensland; University of Queensland; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Adams, MP (corresponding author), Univ Queensland, Sch Math Sci, Brisbane, Qld, Australia.	mp.adams@qut.edu.au	Pettet, Graeme/ABC-5209-2020; Adams, Matthew/C-5589-2018; Adams, Matthew Philip P/C-8870-2018	Adams, Matthew/0000-0003-4875-0225; Adams, Matthew Philip P/0000-0003-4875-0225; Mallet, Dann/0000-0003-4125-9900	Mathematical Sciences School, Queensland University of Technology	Mathematical Sciences School, Queensland University of Technology	Matthew P. Adams received a scholarship from the Mathematical Sciences School, Queensland University of Technology, to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MP, 2011, ANZIAM J, V53, pC90; Adams MP, 2012, J THEOR BIOL, V301, P112, DOI 10.1016/j.jtbi.2012.02.017; ADAMS MP, 2012, P 4 INT C COMP METH, P42331; Agren J, 2003, PEDIATR RES, V53, P558, DOI 10.1203/01.PDR.0000055777.25933.98; Ahn SK, 1999, J INVEST DERMATOL, V113, P189, DOI 10.1046/j.1523-1747.1999.00650.x; ALLEN TD, 1976, J CELL SCI, V21, P341; Baek JH, 2013, YONSEI MED J, V54, P523, DOI 10.3349/ymj.2013.54.2.523; BAKER H, 1967, ARCH DERMATOL, V95, P408, DOI 10.1001/archderm.95.4.408; Bashir SJ, 2001, SKIN RES TECHNOL, V7, P40, DOI 10.1034/j.1600-0846.2001.007001040.x; Behne MJ, 2011, ARCH DERMATOL RES, V303, P103, DOI 10.1007/s00403-010-1113-9; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; BERGSTRESSER PR, 1978, J INVEST DERMATOL, V70, P280, DOI 10.1111/1523-1747.ep12541516; BERNSTAM LI, 1986, IN VITRO CELL DEV B, V22, P695; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BLANK IH, 1984, J INVEST DERMATOL, V82, P188, DOI 10.1111/1523-1747.ep12259835; Bleich M, 2012, ANN NY ACAD SCI, V1258, P93, DOI 10.1111/j.1749-6632.2012.06539.x; Bloksgaard M, 2013, EUR J PHARM SCI, V50, P586, DOI 10.1016/j.ejps.2013.04.010; BORGERS M, 1981, ACTA HISTOCHEMICA S, V24, pS327; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Castelijns FACM, 1998, HISTOCHEM J, V30, P869, DOI 10.1023/A:1003457709690; Celli A, 2010, BIOPHYS J, V98, P911, DOI 10.1016/j.bpj.2009.10.055; CELLI A, 2012, EXPT DERMATOLOGY, V21, P783; Cho JK, 1997, J CELL PHYSIOL, V172, P146, DOI 10.1002/(SICI)1097-4652(199708)172:2<146::AID-JCP2>3.0.CO;2-O; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; CORCUFF P, 1993, ARCH DERMATOL RES, V285, P475, DOI 10.1007/BF00376820; Cornelissen LH, 2007, SKIN RES TECHNOL, V13, P369, DOI 10.1111/j.1600-0846.2007.00239.x; Denda M, 2000, BIOCHEM BIOPH RES CO, V272, P134, DOI 10.1006/bbrc.2000.2739; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; DOWNES AM, 1967, J INVEST DERMATOL, V49, P400, DOI 10.1038/jid.1967.156; ELIAS P, 1979, CLIN RES, V27, pA525; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; Elias PM, 2002, J INVEST DERMATOL, V119, P1269, DOI 10.1046/j.1523-1747.2002.19622.x; EPSTEIN WL, 1965, ARCH DERMATOL, V92, P462, DOI 10.1001/archderm.92.4.462; Feingold K. R., 2006, SKIN BARRIER; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; FORSLIND B, 1984, SCAN ELECTRON MICROS, P755; FORSLIND B, 2004, SKIN HAIR NAILS STRU, P42331; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gandolfi A, 2011, J MATH BIOL, V62, P111, DOI 10.1007/s00285-010-0330-3; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Grabe N, 2005, BIOINFORMATICS, V21, P3541, DOI 10.1093/bioinformatics/bti585; Gunzel D, 2010, CURR TOP MEMBR, V65, P39, DOI 10.1016/S1063-5823(10)65003-X; Haftek M, 2011, EXP DERMATOL, V20, P617, DOI 10.1111/j.1600-0625.2011.01315.x; HALPRIN KM, 1967, J INVEST DERMATOL, V49, P561, DOI 10.1038/jid.1967.181; HALPRIN KM, 1972, BRIT J DERMATOL, V86, P14, DOI 10.1111/j.1365-2133.1972.tb01886.x; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Houben E, 2007, SKIN PHARMACOL PHYS, V20, P122, DOI 10.1159/000098163; Iizuka Hajime, 1994, Journal of Dermatological Science, V8, P215; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Kalia YN, 2000, PHARMACEUT RES, V17, P1148, DOI 10.1023/A:1026474200575; KAMPMEYER PM, 1952, J APPL PHYS, V23, P99, DOI 10.1063/1.1701986; Kirschner N, 2013, J INVEST DERMATOL, V133, P1161, DOI 10.1038/jid.2012.507; Kirschner N, 2010, EUR J CELL BIOL, V89, P839, DOI 10.1016/j.ejcb.2010.07.010; Kitson N, 2000, ACTA DERM-VENEREOL, P12; KU HH, 1966, J RES NBS C ENG INST, VC 70, P263, DOI 10.6028/jres.070C.025; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kurasawa M, 2011, BIOCHEM BIOPH RES CO, V406, P506, DOI 10.1016/j.bbrc.2011.02.057; Landman KA, 2001, IMA J MATH APPL MED, V18, P131; Lemon G, 2007, MATH MED BIOL, V24, P57, DOI 10.1093/imammb/dql020; Lemon G, 2006, J MATH BIOL, V52, P571, DOI 10.1007/s00285-005-0363-1; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143; MALMQVIST KG, 1984, NUCL INSTRUM METH B, V3, P611, DOI 10.1016/0168-583X(84)90447-6; Mandel J., 1964, STAT ANAL EXPT DATA; MARKOVA NG, 1993, MOL CELL BIOL, V13, P613, DOI 10.1128/MCB.13.1.613; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Mauro T, 1998, J INVEST DERMATOL, V111, P1198, DOI 10.1046/j.1523-1747.1998.00421.x; MAURO TM, 2013, COMMUNICATION, P42331; Meldolesi J, 2001, CELL CALCIUM, V30, P1, DOI 10.1054/ceca.2001.0216; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; MENON GK, 1994, BRIT J DERMATOL, V130, P139, DOI 10.1111/j.1365-2133.1994.tb02892.x; MENON GK, 1992, CELL TISSUE RES, V270, P503, DOI 10.1007/BF00645052; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Norlen L, 2004, J INVEST DERMATOL, V123, P715, DOI 10.1111/j.0022-202X.2004.23213.x; Pallon J, 1996, CELL MOL BIOL, V42, P111; Petrova A, 2014, STEM CELL REP, V2, P675, DOI 10.1016/j.stemcr.2014.03.009; PETTET GJ, 2014, COMMUNICATION, P42331; Pierard GE, 2000, INT J MOL MED, V6, P217; Please CP, 1998, APPL MATH LETT, V11, P89, DOI 10.1016/S0893-9659(98)00038-X; Please CP, 1999, MATH MOD METH APPL S, V9, P569, DOI 10.1142/S0218202599000294; POTTEN CS, 1987, CELL TISSUE KINET, V20, P461, DOI 10.1111/j.1365-2184.1987.tb01355.x; Potten CS, 2002, J INVEST DERMATOL, V119, P888, DOI 10.1046/j.1523-1747.2002.00020.x; POTTEN CS, 1975, BRIT J DERMATOL, V93, P649, DOI 10.1111/j.1365-2133.1975.tb05115.x; POTTEN CS, 1975, J INVEST DERMATOL, V65, P488, DOI 10.1111/1523-1747.ep12610194; POTTS RO, 1992, PHARMACEUT RES, V9, P663, DOI 10.1023/A:1015810312465; REEMPTS JV, 1982, HISTOCHEM J, V14, P517, DOI DOI 10.1007/BF01011861; Rodrigues LHT, 2002, J COSMET SCI, V53, P269; ROTHBERG S, 1961, J INVEST DERMATOL, V37, P497, DOI 10.1038/jid.1961.150; ROWDEN G, 1975, J INVEST DERMATOL, V64, P1, DOI 10.1111/1523-1747.ep12540840; Schluter H, 2004, EUR J CELL BIOL, V83, P655, DOI 10.1078/0171-9335-00434; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Sougrat R, 2002, J INVEST DERMATOL, V118, P678, DOI 10.1046/j.1523-1747.2002.01710.x; Sun R, 2015, TISSUE ENG PART C-ME, V21, P15, DOI [10.1089/ten.tec.2014.0065, 10.1089/ten.TEC.2014.0065]; Sun T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008515; Tsutsumi M, 2009, CELL TISSUE RES, V338, P99, DOI 10.1007/s00441-009-0848-0; Vicanova J, 1998, J INVEST DERMATOL, V111, P97, DOI 10.1046/j.1523-1747.1998.00251.x; Watt FM, 2001, CURR OPIN GENET DEV, V11, P410, DOI 10.1016/S0959-437X(00)00211-2; Williams EM, 2008, PHYSIOL MEAS, V29, P341, DOI 10.1088/0967-3334/29/3/005; Yow HN, 2009, EUR J PHARM BIOPHARM, V72, P62, DOI 10.1016/j.ejpb.2008.11.004	104	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116751	10.1371/journal.pone.0116751	http://dx.doi.org/10.1371/journal.pone.0116751			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625723	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821400015
J	Palomares-Rius, JE; Castillo, P; Montes-Borrego, M; Navas-Cortes, JA; Landa, BB				Palomares-Rius, Juan E.; Castillo, Pablo; Montes-Borrego, Miguel; Navas-Cortes, Juan A.; Landa, Blanca B.			Soil Properties and Olive Cultivar Determine the Structure and Diversity of Plant-Parasitic Nematode Communities Infesting Olive Orchards Soils in Southern Spain	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; HETERODERA-MEDITERRANEA; MATURITY INDEX; MANAGEMENT; TREES; AGROECOSYSTEMS; RHIZOSPHERE; INDICATORS; TILLAGE; ECOLOGY	This work has studied for the first time the structure and diversity of plant-parasitic nematodes (PPNs) infesting olive orchard soils in a wide-region in Spain that included 92 locations. It aims at determining which agronomical or environmental factors associated to the olive orchards are the main drivers of the PPNs community structure and diversity. Classical morphological and morphometric identification methods were used to determine the frequency and densities of PPNs. Thirteen families, 34 genera and 77 species of PPNs were identified. The highest diversity was found in Helicotylenchus genus, with six species previously reported in Spain and with H. oleae being a first report. Neodolichorhynchus microphasmis and Diptenchus sp., Diphtherophora sp., and Discotylenchus sp., usually considered fungal feeders, were also reported for the first time associated to olive rhizosphere. PPNs abundance ranged from 66 to 16,288 individuals/500-cm(3) of soil with Helicotylenchus digonicus being the most prevalent species, followed by Filenchus sp., Merlinius brevidens and Xiphinema pachtaicum. Nematode abundance and diversity indexes were influenced by olive cultivar, and orchard and soil management practices; while olive variety and soil texture were the main factors driving PPN community composition. Soil physicochemical properties and climatic characteristics most strongly associated to the PPN community composition included pH, sand content and exchangeable K, and maximum and minimum average temperature of the sampled locations. Our data suggests that there is a high diversity of PPNs associated to olive in Southern Spain that can exert different damage to olive roots depending on the olive variety and their abundance. Further analysis to determine the resistance levels of most common olive varieties to the prevalent PPNs in Spain will help to choose the most appropriate ones for the establishment of new plantations. This choice will take into consideration the specific soils and environments where those olive varieties will be established.	[Palomares-Rius, Juan E.; Castillo, Pablo; Montes-Borrego, Miguel; Navas-Cortes, Juan A.; Landa, Blanca B.] CSIC, Inst Agr Sostenible, Cordoba 14080, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Landa, BB (corresponding author), CSIC, Inst Agr Sostenible, Apartado 4084, Cordoba 14080, Spain.	blanca.landa@csic.es	Navas-Cortes, Juan A./M-2060-2019; Navas-Cortes, Juan A/H-3381-2014; Palomares-Rius, Juan/K-8004-2015; Castillo, Pablo/A-1445-2011; Castillo, Pablo/L-3397-2019; Landa, Blanca B/K-9629-2014	Navas-Cortes, Juan A/0000-0001-6480-1104; Palomares-Rius, Juan/0000-0003-1776-8131; Castillo, Pablo/0000-0003-0256-876X; Castillo, Pablo/0000-0001-6657-6385; Landa, Blanca B/0000-0002-9511-3731	Ministerio de Ciencia e Innovacion [AGL2008-00344/AGR]; 'Ministerio de Economia y Competitividad' of Spain [AGL-2012-37521]; 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia [P10-AGR-5908, P12-AGR-1486]; European Union; ArimNET ERANET FP7 from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [219262]; 'Internacional del Aceite de Oliva Espanol-Citoliva'	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); 'Ministerio de Economia y Competitividad' of Spain(Spanish Government); 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia; European Union(European Commission); ArimNET ERANET FP7 from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); 'Internacional del Aceite de Oliva Espanol-Citoliva'	Financial support was received by Projects AGL2008-00344/AGR from 'Ministerio de Ciencia e Innovacion', Project AGL-2012-37521 from 'Ministerio de Economia y Competitividad' of Spain and Projects P10-AGR-5908 and P12-AGR-1486 from 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia, and FEDER financial support from the European Union is gratefully acknowledged. The grant 219262 ArimNET ERANET FP7 2012-2015 Project PESTOLIVE 'Contribution of olive history for the management of soilborne parasites in the Mediterranean basin' from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA), and the 'Internacional del Aceite de Oliva Espanol-Citoliva' also provided partial financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar FJ, 2014, HELMINTHOLOGIA, V51, P46, DOI 10.2478/s11687-014-0207-x; Ali N, 2014, CR BIOL, V337, P423, DOI 10.1016/j.crvi.2014.05.006; [Anonymous], EST AGR; Bongers T, 1997, APPL SOIL ECOL, V6, P195, DOI 10.1016/S0929-1393(96)00136-9; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Briar SS, 2007, APPL SOIL ECOL, V37, P256, DOI 10.1016/j.apsoil.2007.08.004; Brown D.J.F., 1994, Nematologia Mediterranea, V22, P253; CAP-JA, 2014, EST AGR; Castillo P, 2006, PLANT PATHOL, V55, P705, DOI 10.1111/j.1365-3059.2006.01400.x; Castillo P, 2002, J NEMATOL, V34, P146; Castillo P, 1999, PLANT DIS, V83, P710, DOI 10.1094/PDIS.1999.83.8.710; Castillo P, 2010, PLANT DIS, V94, P148, DOI 10.1094/PDIS-94-2-0148; Chen SY, 2012, J NEMATOL, V44, P361; Coll P, 2012, NEMATOLOGY, V14, P665, DOI 10.1163/156854112X624195; Cooler W.A., 1979, P317; Davis E. E., 2004, MINIRISK ASSESSMENT; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; DIAB K. A., 1968, PLANT DIS REPORT, V52, P150; DuPont ST, 2009, APPL SOIL ECOL, V41, P157, DOI 10.1016/j.apsoil.2008.10.004; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; Ferris JM, 1998, AGRONOMY, P21; FRECKMAN DW, 1993, AGR ECOSYST ENVIRON, V45, P239, DOI 10.1016/0167-8809(93)90074-Y; Garcia-Ruiz R, 2009, APPL SOIL ECOL, V41, P305, DOI 10.1016/j.apsoil.2008.12.004; Gardner CMK, 1999, SOIL PHYS CONSTRAINT, P51; Gomez JA, 2008, J ENVIRON MANAGE, V89, P99, DOI 10.1016/j.jenvman.2007.04.025; HASHIM Z, 1982, Revue de Nematologie, V5, P169; INSERRA RN, 1979, J NEMATOL, V11, P56; International Olive Council (IOC), 2014, WORLD EUR UN OL OIL; Khodakaramian N, 2012, INT C EC BIOL SCI ID, P51; Koenning SR, 1999, J NEMATOL, V31, P587; Kruger DHM, 2013, S AFR J ENOL VITIC, V34, P287; Lamberti F., 2001, Nematologia Mediterranea, V29, P3; LAMBERTI F, 1969, Plant Disease Reporter, V53, P557; Lamberti F., 1993, EPPO B, V23, P481, DOI DOI 10.1111/J.1365-2338.1993.TB01356.X; Landa BB, 2014, ENV MICROBIOL REP, V6, P196, DOI 10.1111/1758-2229.12148; Lodolini E. M., 2013, African Journal of Agricultural Research, V8, P6426; Maechler M, 2014, CLUSTER CLUSTER ANAL; McKenry MV, 1994, U CALIFORNIA PUBL, V3353, P97; Milgroom J, 2007, RENEW AGR FOOD SYST, V22, P1, DOI 10.1017/S1742170507001500; Montes-Borrego M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096397; Montes-Borrego M, 2013, AGR ECOSYST ENVIRON, V181, P169, DOI 10.1016/j.agee.2013.09.021; Mulder C, 2003, FUNCT ECOL, V17, P516, DOI 10.1046/j.1365-2435.2003.00755.x; NAVAS A, 1988, NEMATOLOGICA, V34, P314, DOI 10.1163/002825988X00170; Neher DA, 1999, J NEMATOL, V31, P142; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Nico AI, 2003, J NEMATOL, V35, P29; Nico AI, 2002, PLANT DIS, V86, P1075, DOI 10.1094/PDIS.2002.86.10.1075; Nielsen UN, 2014, GLOBAL ECOL BIOGEOGR, V23, P968, DOI 10.1111/geb.12177; NORTON DC, 1989, J NEMATOL, V21, P299; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Palomares-Rius JE, 2014, EUR J PLANT PATHOL, V140, P53, DOI 10.1007/s10658-014-0443-4; Palomares-Rius JE, 2012, SOIL BIOL BIOCHEM, V45, P168, DOI 10.1016/j.soilbio.2011.11.009; PARMELEE RW, 1986, J NEMATOL, V18, P403; Pena-Santiago R, 2004, TYLENCHID SPECIES NE; Perez B. A., 2001, Phytopathology, V91, pS71; Sasanelli Nicola, 2009, V4, P275, DOI 10.1007/978-1-4020-9858-1_12; SEINHORST J. W., 1962, NEMATOLOGICA, V8, P29; Siddiqui I. A., 2003, Nematologia Mediterranea, V31, P111; Soriano MA, 2014, RENEW AGR FOOD SYST, V29, P83, DOI 10.1017/S1742170512000361; Stirling G. R., 2010, Proceedings of the 2010 Conference of the Australian Society of Sugar Cane Technologists held at Bundaberg, Queensland, Australia, 11-14 May 2010, P152; Todd TC, 1999, APPL SOIL ECOL, V13, P45, DOI 10.1016/S0929-1393(99)00022-0; Ugarte CM, 2013, SOIL BIOL BIOCHEM, V64, P103, DOI 10.1016/j.soilbio.2013.03.035; van Bruggen AHC, 2000, APPL SOIL ECOL, V15, P13, DOI 10.1016/S0929-1393(00)00068-8; van Diepeningen AD, 2006, APPL SOIL ECOL, V31, P120, DOI 10.1016/j.apsoil.2005.03.003; VOVLAS N, 1983, J NEMATOL, V15, P571; WALLACE MK, 1993, J NEMATOL, V25, P642; Wang KH, 2004, NEMATROPICA, V34, P83; Wardle D.A., 1995, Advances in Ecological Research, V26, P105, DOI 10.1016/S0065-2504(08)60065-3; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1997, J APPL ECOL, V34, P453, DOI 10.2307/2404890; Zhang XK, 2012, ECOL INDIC, V13, P75, DOI 10.1016/j.ecolind.2011.05.009	72	33	33	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116890	10.1371/journal.pone.0116890	http://dx.doi.org/10.1371/journal.pone.0116890			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625375	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821400021
J	Peng, C; Yu, JY; Zhao, ZJ; Dai, J; Fu, JY; Zhao, ML; Wang, W				Peng, Chao; Yu, Jianying; Zhao, Zhijie; Dai, Jing; Fu, Jingyi; Zhao, Meiling; Wang, Wei			Synthesis and Properties of a Clean and Sustainable Deicing Additive for Asphalt Mixture	PLOS ONE			English	Article							LAYERED DOUBLE HYDROXIDES; CATALYTIC-PROPERTIES; MIXED OXIDES; ICE CONTROL; INTERCALATION; ACCUMULATION; DEICERS; SURFACE; SOILS; WATER	A clean and sustainable deicing additive was prepared via the adsorption of acetate anions (Ac-) by magnesium (Mg) and aluminum (Al) calcined layered double hydroxide (Mg/Al-CLDH). Fourier transform infrared spectroscopy spectrums proved that Ac- had intercalated into LDH structure. X-ray diffraction patterns, scanning electron microscopy and transmission electron microscopy images showed that the intercalation spacing and platelet thickness of Mg and Al layered double hydroxide containing Ac- anions (Mg/Al-Ac- LDH) had been enlarged due to substitution of divalent CO32- anions by a larger quantity of monovalent Ac- anions. Differential scanning calorimetry tests testified that the insoluble Mg2/Al-Ac- LDH evidently decreased the freeze point (FP) of water to -10.68 degrees C. X-ray photoelectron spectroscopy analyses confirmed that the Ac- were strongly confined by the metal layers of LDHs. FP test of asphalt mixtures confirmed that Mg/Al-Ac- LDHs reduced FP to -5.5 degrees C. Immersion test results indicated that Mg/Al-Ac- LDH had a good deicing durability and Ac- did not released from asphalt mixture. Snow melting observation was conducted further testified that Mg/Al-Ac- LDH melted snow or ice sustainably.	[Peng, Chao; Yu, Jianying; Zhao, Zhijie; Fu, Jingyi; Zhao, Meiling; Wang, Wei] Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan 430070, Peoples R China; [Zhao, Zhijie; Zhao, Meiling] Minist Transport, Res Inst Highway, Beijing 100088, Peoples R China; [Dai, Jing] Minist Educ, Key Lab Adv Technol Special Funct Mat, Wuhan 430070, Peoples R China	Wuhan University of Technology; Ministry of Transport of the People's Republic of China	Yu, JY (corresponding author), Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan 430070, Peoples R China.	jyyu@whut.edu.cn	Fu, JY/GRR-6179-2022		Ministry of Transport of the People's Republic of China [2013 318 800 020]; Independent Innovation Foundation of Wuhan University of Technology [145201016]	Ministry of Transport of the People's Republic of China; Independent Innovation Foundation of Wuhan University of Technology	This work is financially supported by the Ministry of Transport of the People's Republic of China (grant No. 2013 318 800 020, URL: http://www.moc.gov.cn/ and the Independent Innovation Foundation of Wuhan University of Technology (grant No: 145201016, URL: http://cxjj.whut.edu.cn/).	Bang SS, 1998, ARCH ENVIRON CON TOX, V35, P580, DOI 10.1007/s002449900419; Bryson GM, 2002, COMMUN SOIL SCI PLAN, V33, P67, DOI 10.1081/CSS-120002378; Cairon O, 2007, J PHYS CHEM C, V111, P8015, DOI 10.1021/jp0673011; Cavani F, 1991, CATAL TODAY, V11, P173, DOI 10.1016/0920-5861(91)80068-K; Chuang YH, 2010, COLLOID SURFACE A, V366, P170, DOI 10.1016/j.colsurfa.2010.06.009; Cunningham Mary Ann, 2008, Urban Ecosystems, V11, P17, DOI 10.1007/s11252-007-0031-x; Di Cosimo JI, 1998, J CATAL, V178, P499, DOI 10.1006/jcat.1998.2161; Dong LJ, 2014, SOLID STATE SCI, V31, P8, DOI 10.1016/j.solidstatesciences.2014.02.006; Dussault L, 2005, THERMOCHIM ACTA, V434, P93, DOI 10.1016/j.tca.2005.01.012; Fay L, 2012, WATER AIR SOIL POLL, V223, P2751, DOI 10.1007/s11270-011-1064-6; Feng DC, 2010, COLD REG SCI TECHNOL, V62, P34, DOI 10.1016/j.coldregions.2010.02.002; Galuszka A, 2011, ENVIRON MONIT ASSESS, V176, P451, DOI 10.1007/s10661-010-1596-z; Gao XR, 2013, J SOLID STATE CHEM, V203, P174, DOI 10.1016/j.jssc.2013.04.028; Giuliani F, 2012, CONSTR BUILD MATER, V30, P174, DOI 10.1016/j.conbuildmat.2011.12.036; Hellsten PP, 2005, ENVIRON SCI TECHNOL, V39, P5095, DOI 10.1021/es0482738; Huang ZJ, 2012, APPL CLAY SCI, V65-66, P87, DOI 10.1016/j.clay.2012.05.007; Iyi N, 2004, CHEM MATER, V16, P2926, DOI 10.1021/cm049579g; JONES PH, 1981, ENVIRON CONSERV, V8, P33, DOI 10.1017/S0376892900026655; Liu ZZ, 2014, CONSTR BUILD MATER, V51, P133, DOI 10.1016/j.conbuildmat.2013.09.057; LOCKE CE, 1987, TRANSPORT RES REC, V1113, P30; Mameri N, 1998, WATER RES, V32, P1604, DOI 10.1016/S0043-1354(97)00357-6; MANNING DG, 1989, TRANSPORT RES REC, V1246, P18; MIYATA S, 1983, CLAY CLAY MINER, V31, P305, DOI 10.1346/CCMN.1983.0310409; Ninomiya H, 1993, TRANSPORT RES REC, V1387, P151; PALMER DA, 1987, TRANSPORT RES REC, V1127, P34; Shi XM, 2009, CORROS REV, V27, P23, DOI 10.1515/CORRREV.2009.27.1-2.23; Starck P, 2007, J MATER SCI, V42, P676, DOI 10.1007/s10853-006-0316-0; SZATKOWSKI WS, 1986, RES REP TRANSPORT RO, V84, P1; [谭忆秋 Tan Yiqiu], 2013, [中国公路学报, China Journal of Highway and Transport], V26, P23; WANG ZJ, 2013, INT J PAVEMENT RES T, V6, P372; Wong F, 2004, PROG ORG COAT, V51, P91, DOI 10.1016/j.porgcoat.2004.07.001; Yong Z, 2002, ENERG CONVERS MANAGE, V43, P1865, DOI 10.1016/S0196-8904(01)00125-X; Zhou JB, 2011, J MATER CHEM, V21, P19353, DOI 10.1039/c1jm13645c; Zhou JB, 2011, J HAZARD MATER, V192, P1114, DOI 10.1016/j.jhazmat.2011.06.013	34	7	8	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115721	10.1371/journal.pone.0115721	http://dx.doi.org/10.1371/journal.pone.0115721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625279	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821400009
J	Nowak, JK; Grulkowski, I; Karnowski, K; Wojtkowski, M; Walkowiak, J				Nowak, Jan K.; Grulkowski, Ireneusz; Karnowski, Karol; Wojtkowski, Maciej; Walkowiak, Jaroslaw			Optical Coherence Tomography Identifies Lower Labial Salivary Gland Surface Density in Cystic Fibrosis	PLOS ONE			English	Article							3-DIMENSIONAL ENDOMICROSCOPY; TRANSPORT	The labial minor salivary glands (LSGs) are easily accessible mucus-secreting structures of the alimentary tract that may provide new information on the basis of gastrointestinal complications of cystic fibrosis (CF). It was shown that they are destructed in the course of cystic fibrosis. We employed wide-field, micrometer resolution in vivo optical coherence tomography to assess the surface density of LSGs in 18 patients with CF and 18 healthy subjects. The median LSGs' surface densities in CF patients, and in the control group were 4.32 glands/cm(2) and 6.58 glands/cm(2), respectively (p = 0.006; Mann-Whitney U test). A lower LSG surface density is a previously unrecognized CF-related pathology of the alimentary tract.	[Nowak, Jan K.; Walkowiak, Jaroslaw] Poznan Univ Med Sci, Dept Pediat Gastroenterol & Metab Dis, PL-60572 Poznan, Poland; [Grulkowski, Ireneusz; Karnowski, Karol; Wojtkowski, Maciej] Nicholas Copernicus Univ, Inst Phys, Fac Phys Astron & Informat, PL-87100 Torun, Poland	Poznan University of Medical Sciences; Nicolaus Copernicus University	Nowak, JK (corresponding author), Poznan Univ Med Sci, Dept Pediat Gastroenterol & Metab Dis, Ul Szpitalna 27-33, PL-60572 Poznan, Poland.	jarwalk@ump.edu.pl	Nowak, Jan Krzysztof/J-7775-2019; Karnowski, Karol/D-6222-2014; Wojtkowski, Maciej/D-6822-2014; Grulkowski, Ireneusz/N-9655-2013	Nowak, Jan Krzysztof/0000-0003-0953-2188; Karnowski, Karol/0000-0002-5426-5878; Grulkowski, Ireneusz/0000-0001-7688-1826; Wojtkowski, Maciej/0000-0003-0599-0878; Walkowiak, Jaroslaw/0000-0001-5813-5707	Polish National Science Centre grants [2013/09/N/NZ5/02820, 2011/02/A/ST2/00302]; Polish Ministry of Science and Higher Education	Polish National Science Centre grants; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Supported by the Polish National Science Centre grants (JKN-no. 2013/09/N/NZ5/02820; MW-no.2011/02/A/ST2/00302)-http://ncn.gov.pl/, and the scholarship of the Polish Ministry of Science and Higher Education for 2013-2016 (IG)-http://mnisw.gov.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DC, 2007, NAT PHOTONICS, V1, P709, DOI 10.1038/nphoton.2007.228; Adler DC, 2009, OPT EXPRESS, V17, P784, DOI 10.1364/OE.17.000784; [Anonymous], 2007, Z13612007 ANSI; Aps JKM, 2002, CLIN CHEM LAB MED, V40, P345, DOI 10.1515/CCLM.2002.055; AUBERT B, 1990, BIOCHEM BIOPH RES CO, V170, P1144, DOI 10.1016/0006-291X(90)90512-L; Birket SE, 2014, AM J RESP CRIT CARE, V190, P421, DOI 10.1164/rccm.201404-0670OC; Bouma BE, 2000, GASTROINTEST ENDOSC, V51, P467, DOI 10.1016/S0016-5107(00)70449-4; Bradley PJ, 2011, SALIVARY GLAND DISOR; Eliasson L, 2010, EUR J ORAL SCI, V118, P435, DOI 10.1111/j.1600-0722.2010.00766.x; Familiari L, 2006, AM J GASTROENTEROL, V101, P2833, DOI 10.1111/j.1572-0241.2006.00826.x; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Gelfond D, 2013, CLIN GASTROENTEROL H, V11, P333, DOI 10.1016/j.cgh.2012.11.006; Grulkowski I, 2014, BIOMED OPT EXPRESS, V5, P259, DOI 10.1364/BOE.5.000259; Hand AR, 1999, ARCH ORAL BIOL, V44, pS3, DOI 10.1016/S0003-9969(99)00042-4; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Liu LB, 2014, AM J RESP CELL MOL, V51, P485, DOI 10.1165/rcmb.2013-0499MA; MESKIN LH, 1964, JAMA-J AM MED ASSOC, V188, P82; Nowak JK, 2014, ZENODO, DOI [10.5281/zenodo.13257, DOI 10.5281/ZENODO.13257]; Park S, 2013, GASTROENTEROLOGY, V145, P232, DOI 10.1053/j.gastro.2013.03.047; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Walkowiak J, 2004, J PEDIATR-US, V145, P285, DOI 10.1016/j.jpeds.2004.06.033; Walkowiak J, 2004, ACTA PAEDIATR, V93, P1042, DOI 10.1111/j.1651-2227.2004.tb02715.x; WARWICK WJ, 1964, PEDIATRICS, V34, P621; WIESMANN UN, 1972, LANCET, V2, P510; Wojtkowski M, 2010, APPL OPTICS, V49, pD30, DOI 10.1364/AO.49.000D30; Zhou C, 2012, GASTROINTEST ENDOSC, V76, P32, DOI 10.1016/j.gie.2012.02.003; [No title captured]	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2015	10	1							e0117517	10.1371/journal.pone.0117517	http://dx.doi.org/10.1371/journal.pone.0117517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AZ8MR	25622042	Green Published, Green Submitted, gold			2022-12-26	WOS:000348470400024
J	Hoch, L; Faure, H; Roudaut, H; Schoenfelder, A; Mann, A; Girard, N; Bihannic, L; Ayrault, O; Petricci, E; Taddei, M; Rognan, D; Ruat, M				Hoch, Lucile; Faure, Helene; Roudaut, Hermine; Schoenfelder, Angele; Mann, Andre; Girard, Nicolas; Bihannic, Laure; Ayrault, Olivier; Petricci, Elena; Taddei, Maurizio; Rognan, Didier; Ruat, Martial			MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor	FASEB JOURNAL			English	Article						antagonist; medulloblastoma; molecular modeling; stem cell	BASAL-CELL CARCINOMA; PATHWAY INHIBITOR; MEDULLOBLASTOMA DEVELOPMENT; ACQUIRED-RESISTANCE; CANCER; ITRACONAZOLE; ANTAGONISTS; ACTIVATION; MODULATOR; BRAIN	The Smoothened (Smo) receptor, a member of class F G protein-coupled receptors, is the main transducer of the Hedgehog (Hh) signaling pathway implicated in a wide range of developmental and adult processes. Smo is the target of anticancer drugs that bind to a long and narrow cavity in the 7-transmembrane (7TM) domain. X-ray structures of human Smo (hSmo) bound to several ligands have revealed 2 types of 7TM-directed antagonists: those binding mostly to extracellular loops (site 1, e.g., LY2940680) and those penetrating deeply in the 7TM cavity (site 2, e.g., SANT-1). Here we report the development of the acylguanidine MRT-92, which displays subnanomolar antagonist activity against Smo in various Hh cell-based assays. MRT-92 inhibits rodent cerebellar granule cell proliferation induced by Hh pathway activation through pharmacologic (half maximal inhibitory concentration [IC50] = 0.4 nM) or genetic manipulation. Using [H-3]MRT-92 (K-d = 0.3 nM for hSmo), we created a comprehensive framework for the interaction of small molecule modulators with hSmo and for understanding chemoresistance linked to hSmo mutations. Guided by molecular docking and site-directed mutagenesis data, our work convincingly confirms that MRT-92 simultaneously recognized and occupied both sites 1 and 2. Our data demonstrate the existence of a third type of Smo antagonists, those entirely filling the Smo binding cavity from the upper extracellular part to the lower cytoplasmic-proximal subpocket. Our studies should help design novel potent Smo antagonists and more effective therapeutic strategies for treating Hh-linked cancers and associated chemoresistance.	[Hoch, Lucile; Faure, Helene; Roudaut, Hermine; Ruat, Martial] CNRS, Neurosci Paris Saclay Inst, Mol Circuits Dept, Signal Transduct & Dev Neuropharmacol Team,UMR 91, F-91198 Gif Sur Yvette, France; [Schoenfelder, Angele; Mann, Andre; Girard, Nicolas; Rognan, Didier] Univ Strasbourg, CNRS, Lab Innovat Therapeut, Unite Mixte Rech 7200, Illkirch Graffenstaden, France; [Bihannic, Laure; Ayrault, Olivier] Univ Paris 11, INSERM, CNRS, Inst Curie,Ctr Univ,Unite Mixte Rech 3306,U1005, F-91405 Orsay, France; [Petricci, Elena; Taddei, Maurizio] Univ Siena, Dipartimento Biotecnol Chim & Farm, I-53100 Siena, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; University of Siena	Ruat, M (corresponding author), CNRS, Neurosci Paris Saclay Inst, Mol Circuits Dept, Signal Transduct & Dev Neuropharmacol Team,UMR 91, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	ruat@inaf.cnrs-gif.fr	Ruat, Martial/E-5544-2016; Girard, Nicolas/ABE-3618-2021; Petricci, Elena/AAB-9275-2022; Girard, Nicolas/B-3910-2017; FAURE, Helene/E-4641-2010; Rognan, Didier/B-9939-2014	Girard, Nicolas/0000-0001-9909-2299; Girard, Nicolas/0000-0003-4610-9872; Hoch, Lucile/0000-0002-7264-9031; PETRICCI, ELENA/0000-0002-9685-6342; FAURE, Helene/0000-0002-0005-9331	La Ligue contre le Cancer (Comite des Yvelines); Fondation Association pour la Recherche sur le Cancer (ARC); l'Institut National du Cancer (INCa) [R10067LS]; Marie Curie Integration Grant [FP7-PEOPLE-2011-CIG 294010]; Centre National de la Recherche Scientifique/Institut National de la Sante et de la Recherche Medicale (CNRS/INSERM); La Ligue contre le Cancer and la Fondation Recherche Medicale [FDT20140930825]; Ministere de l'Enseignement Superieur et de la Recherche; Institut Curie	La Ligue contre le Cancer (Comite des Yvelines); Fondation Association pour la Recherche sur le Cancer (ARC); l'Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Marie Curie Integration Grant; Centre National de la Recherche Scientifique/Institut National de la Sante et de la Recherche Medicale (CNRS/INSERM); La Ligue contre le Cancer and la Fondation Recherche Medicale; Ministere de l'Enseignement Superieur et de la Recherche; Institut Curie	This work has benefited from the facilities of the TEFOR Molecular Biology Unit, IMAGIF, Gif Research Center. This work was supported by grants from La Ligue contre le Cancer (Comite des Yvelines) and Fondation Association pour la Recherche sur le Cancer (ARC) to M.R. from l'Institut National du Cancer (INCa R10067LS), Marie Curie Integration Grant FP7-PEOPLE-2011-CIG 294010, Centre National de la Recherche Scientifique/Institut National de la Sante et de la Recherche Medicale (CNRS/INSERM) and Institut Curie (to O.A.). L.H. is the recipient of a doctoral fellowship from La Ligue contre le Cancer and la Fondation Recherche Medicale (FDT20140930825) and L.B. from the Ministere de l'Enseignement Superieur et de la Recherche.	Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Brinkhuizen T, 2014, J AM ACAD DERMATOL, V71, P1005, DOI 10.1016/j.jaad.2014.08.001; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Charytoniuk D, 2002, J PHYSIOLOGY-PARIS, V96, P9, DOI 10.1016/S0928-4257(01)00075-4; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Coulombe J, 2004, MOL CELL NEUROSCI, V25, P323, DOI 10.1016/j.mcn.2003.10.024; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gorojankina T, 2013, MOL PHARMACOL, V83, P1020, DOI 10.1124/mol.112.084590; Hadden MK, 2014, CHEMMEDCHEM, V9, P27, DOI 10.1002/cmdc.201300358; Hadden MK, 2013, EXPERT OPIN THER PAT, V23, P345, DOI 10.1517/13543776.2013.757304; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Kim DJ, 2014, J CLIN ONCOL, V32, P745, DOI 10.1200/JCO.2013.49.9525; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Manetti F, 2010, MOL PHARMACOL, V78, P658, DOI 10.1124/mol.110.065102; Masdeu C, 2007, NEUROREPORT, V18, P395, DOI 10.1097/WNR.0b013e32801421ce; Masdeu C, 2006, BIOCHEM BIOPH RES CO, V349, P471, DOI 10.1016/j.bbrc.2006.07.216; McMillan R, 2012, CLIN CANCER RES, V18, P4883, DOI 10.1158/1078-0432.CCR-11-2509; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Petrel C, 2003, J BIOL CHEM, V278, P49487, DOI 10.1074/jbc.M308010200; Rana R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3965; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Roudaut H, 2011, MOL PHARMACOL, V79, P453, DOI 10.1124/mol.110.069708; Ruat M, 2014, TRENDS PHARMACOL SCI, V35, P237, DOI 10.1016/j.tips.2014.03.002; Ruat M, 2012, DIFFERENTIATION, V83, pS97, DOI 10.1016/j.diff.2011.11.011; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Solinas A, 2012, J MED CHEM, V55, P1559, DOI 10.1021/jm2013369; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tao HY, 2011, CHEM BIOL, V18, P432, DOI 10.1016/j.chembiol.2011.01.018; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	50	43	45	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1817	1829		10.1096/fj.14-267849	http://dx.doi.org/10.1096/fj.14-267849			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25636740	Green Published			2022-12-26	WOS:000354114600018
J	Crichton, PG; Lee, Y; Ruprecht, JJ; Cerson, E; Thangaratnarajah, C; King, MS; Kunji, ERS				Crichton, Paul G.; Lee, Yang; Ruprecht, Jonathan J.; Cerson, Elizabeth; Thangaratnarajah, Chancievan; King, Martin S.; Kunji, Edmund R. S.			Trends in Thermostability Provide Information on the Nature of Substrate, Inhibitor, and Lipid Interactions with Mitochondrial Carriers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; UNCOUPLING PROTEIN-1 UCP1; ADP/ATP CARRIER; MEMBRANE-PROTEINS; NUCLEOTIDE-BINDING; CYANIDIOSCHYZON-MEROLAE; TRANSPORT ACTIVITY; FAT MITOCHONDRIA; MECHANISM; YEAST	Mitochondrial carriers, including uncoupling proteins, are unstable in detergents, which hampers structural and mechanistic studies. To investigate carrier stability, we have purified ligand-free carriers and assessed their stability with a fluorescence- based thermostability assay that monitors protein unfolding with a thiol-reactive dye. We find that mitochondrial carriers from both mesophilic and thermophilic organisms exhibit poor stability in mild detergents, indicating that instability is inherent to the protein family. Trends in the thermostability of yeast ADP/ATP carrier AAC2 and ovine uncoupling protein UCP1 allow optimal conditions for stability in detergents to be established but also provide mechanistic insights into the interactions of lipids, substrates, and inhibitors with these proteins. Both proteins exhibit similar stability profiles across various detergents, where stability increases with the size of the associated detergent micelle. Detailed analysis shows that lipids stabilize carriers indirectly by increasing the associated detergent micelle size, but cardiolipin stabilizes by direct interactions as well. Cardiolipin reverses destabilizing effects of ADP and bongkrekic acid on AAC2 and enhances large stabilizing effects of carboxyatractyloside, revealing that this lipid interacts in the m-state and possibly other states of the transport cycle, despite being in a dynamic interface. Fatty acid activators destabilize UCP1 in a similar way, which can also be prevented by cardiolipin, indicating that they interact like transport substrates. Our controls show that carriers can be soluble but unfolded in some commonly used detergents, such as the zwitterionic Fos-choline-12, which emphasizes the need for simple validation assays like the one used here.	[Crichton, Paul G.; Lee, Yang; Ruprecht, Jonathan J.; Cerson, Elizabeth; Thangaratnarajah, Chancievan; King, Martin S.; Kunji, Edmund R. S.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Kunji, ERS (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	ek@mrc-mbu.cam.ac.uk	Kunji, Edmund/AAH-2362-2020; King, Martin S/B-6361-2012	Kunji, Edmund/0000-0002-0610-4500; Ruprecht, Jonathan/0000-0002-1838-7245; Thangaratnarajah, Chancievan/0000-0002-0279-6642; King, Martin/0000-0001-6030-5154; Crichton, Paul/0000-0003-3786-8359; Lee, Yang/0000-0002-8040-3648	European Drug Initiative on Channels and Transporters [HEALTH-F4-2007-201924]; Medical Research Council; MRC [MC_U105663139] Funding Source: UKRI; Medical Research Council [MC_U105663139] Funding Source: researchfish	European Drug Initiative on Channels and Transporters; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Drug Initiative on Channels and Transporters via contract HEALTH-F4-2007-201924 (EDICT) and the Medical Research Council.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; AQUILA H, 1987, FEBS LETT, V212, P1, DOI 10.1016/0014-5793(87)81546-6; Bamber L, 2006, P NATL ACAD SCI USA, V103, P16224, DOI 10.1073/pnas.0607640103; Barbier G, 2005, PLANT PHYSIOL, V137, P460, DOI 10.1104/pp.104.051169; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Blesneac I, 2012, BBA-BIOMEMBRANES, V1818, P798, DOI 10.1016/j.bbamem.2011.12.016; Cannon B, 1979, Methods Enzymol, V55, P65; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Crichton PG, 2013, J BIOL CHEM, V288, P22163, DOI 10.1074/jbc.M113.484329; Dehez F, 2008, J AM CHEM SOC, V130, P12725, DOI 10.1021/ja8033087; Divakaruni AS, 2012, J BIOL CHEM, V287, P36845, DOI 10.1074/jbc.M112.381780; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Douette P, 2004, BIOCHEM J, V380, P139, DOI 10.1042/BJ20031957; Echtay KS, 1997, BIOCHEMISTRY-US, V36, P8253, DOI 10.1021/bi970513r; Echtay KS, 1999, FEBS LETT, V450, P8, DOI 10.1016/S0014-5793(99)00460-3; ECKERSKORN C, 1987, FEBS LETT, V226, P166, DOI 10.1016/0014-5793(87)80572-0; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Garlid KD, 1998, FEBS LETT, V438, P10, DOI 10.1016/S0014-5793(98)01246-0; Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8; Hoang T, 2013, J BIOL CHEM, V288, P36244, DOI 10.1074/jbc.M113.509935; Hoang T, 2012, BIOCHEMISTRY-US, V51, P4004, DOI 10.1021/bi3003378; Ivanova MV, 2010, BIOCHEMISTRY-US, V49, P512, DOI 10.1021/bi901742g; Jelokhani-Niaraki M, 2008, BIOCHEM J, V411, P593, DOI 10.1042/bj20071326; KLINGENBERG M, 1988, BIOCHEMISTRY-US, V27, P781, DOI 10.1021/bi00402a044; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; KLINGENBERG M, 1989, EUR J BIOCHEM, V180, P123, DOI 10.1111/j.1432-1033.1989.tb14622.x; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; KRAMER R, 1989, BIOCHIM BIOPHYS ACTA, V974, P1, DOI 10.1016/S0005-2728(89)80160-4; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Kunji ERS, 2008, METHODS, V46, P62, DOI 10.1016/j.ymeth.2008.10.020; Kunji ERS, 2003, J BIOL CHEM, V278, P36985, DOI 10.1074/jbc.C300304200; LIN CS, 1982, BIOCHEMISTRY-US, V21, P2950, DOI 10.1021/bi00541a023; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Monne M, 2012, J BIOL CHEM, V287, P7925, DOI 10.1074/jbc.M111.324855; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; RICCIO P, 1975, FEBS LETT, V56, P133, DOI 10.1016/0014-5793(75)80127-X; Riccio P, 1975, FEBS Lett, V56, P192; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Ruprecht JJ, 2014, P NATL ACAD SCI USA, V111, pE426, DOI 10.1073/pnas.1320692111; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Shabalina IG, 2004, J BIOL CHEM, V279, P38236, DOI 10.1074/jbc.M402375200; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; Thangaratnarajah C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6491; VIGNAIS PV, 1973, BIOCHEMISTRY-US, V12, P1508, DOI 10.1021/bi00732a007; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105; Zoonens M, 2013, J AM CHEM SOC, V135, P15174, DOI 10.1021/ja407424v	58	51	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8206	8217		10.1074/jbc.M114.616607	http://dx.doi.org/10.1074/jbc.M114.616607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25653283	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000351662600018
J	Duan, XL; Liu, NN; Yang, YT; Li, HH; Li, M; Dou, SX; Xi, XG				Duan, Xiao-Lei; Liu, Na-Nv; Yang, Yan-Tao; Li, Hai-Hong; Li, Ming; Dou, Shuo-Xing; Xi, Xu-Guang			G-quadruplexes Significantly Stimulate Pif1 Helicase-catalyzed Duplex DNA Unwinding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Helicase; DNA Replication; G-quadruplex; Genomic Instability; Kinetics; Replication Origin	ESCHERICHIA-COLI RECQ; SINGLE-STRANDED-DNA; HUMAN TUMOR-CELLS; GENOME-WIDE; SACCHAROMYCES-CEREVISIAE; SMALL-MOLECULE; REGULATORY ELEMENTS; REPLICATION ORIGINS; BINDING PROTEIN; GENE-EXPRESSION	Background: G-quadruplexes (G4s) play a variety of roles in DNA transactions. Results: Pif1-catalyzed duplex DNA unwinding was greatly stimulated by G4s in several aspects, including the unwinding rate and amplitude and the chemical-mechanical coupling efficiency. Conclusion: G4s significantly activate helicase Pif1-catalyzed duplex DNA unwinding through a mechanism of G4-induced dimerization. Significance: The G4-activating effect may be implicated in the rescue of stalled replication forks, activating of replication origins, and lagging strand maturation. The evolutionarily conserved G-quadruplexes (G4s) are faithfully inherited and serve a variety of cellular functions such as telomere maintenance, gene regulation, DNA replication initiation, and epigenetic regulation. Different from the Watson-Crick base-pairing found in duplex DNA, G4s are formed via Hoogsteen base pairing and are very stable and compact DNA structures. Failure of untangling them in the cell impedes DNA-based transactions and leads to genome instability. Cells have evolved highly specific helicases to resolve G4 structures. We used a recombinant nuclear form of Saccharomyces cerevisiae Pif1 to characterize Pif1-mediated DNA unwinding with a substrate mimicking an ongoing lagging strand synthesis stalled by G4s, which resembles a replication origin and a G4-structured flap in Okazaki fragment maturation. We find that the presence of G4 may greatly stimulate the Pif1 helicase to unwind duplex DNA. Further studies reveal that this stimulation results from G4-enhanced Pif1 dimerization, which is required for duplex DNA unwinding. This finding provides new insights into the properties and functions of G4s. We discuss the observed activation phenomenon in relation to the possible regulatory role of G4s in the rapid rescue of the stalled lagging strand synthesis by helping the replicator recognize and activate the replication origin as well as by quickly removing the G4-structured flap during Okazaki fragment maturation.	[Duan, Xiao-Lei; Liu, Na-Nv; Yang, Yan-Tao; Li, Hai-Hong; Xi, Xu-Guang] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Li, Ming; Dou, Shuo-Xing] Chinese Acad Sci, CAS Key Lab Soft Matter Phys, Int Associated Lab CNRS Inst Phys, Beijing 100190, Peoples R China; [Xi, Xu-Guang] Ecole Normale Super, Lab Biol & Pharmacol Appl, CNRS, F-94235 Cachan, France	Northwest A&F University - China; Chinese Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Dou, SX (corresponding author), Chinese Acad Sci, CAS Key Lab Soft Matter Phys, Beijing 100190, Peoples R China.	sxdou@iphy.ac.cn; xxi01@ens-cachan.fr	Xi, Xu Guang/AAK-4511-2020	Dou, Shuo-Xing/0000-0002-7201-2081	National Natural Science Foundation of China [31370798, 11304252, 31301632]; Ministry of Education of China [985, 211]; CNRS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the National Natural Science Foundation of China Grants 31370798, 11304252, and 31301632 and Projects 985 and 211 from the Ministry of Education of China. The research was partially financed by a grant from CNRS and conducted within the context of the "LIA helicase-mediated G-quadruplex DNA unwinding and genome stability."	Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Basu A, 2012, NAT STRUCT MOL BIOL, V19, P538, DOI 10.1038/nsmb.2278; Besnard E, 2012, NAT STRUCT MOL BIOL, V19, P837, DOI 10.1038/nsmb.2339; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bjornson KP, 1996, BIOCHEMISTRY-US, V35, P2268, DOI 10.1021/bi9522763; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budhathoki JB, 2014, NUCLEIC ACIDS RES, V42, P11528, DOI 10.1093/nar/gku856; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Cayrou C, 2012, CELL CYCLE, V11, P658, DOI 10.4161/cc.11.4.19097; Cayrou C, 2011, GENOME RES, V21, P1438, DOI 10.1101/gr.121830.111; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Du Z, 2009, NUCLEIC ACIDS RES, V37, P6784, DOI 10.1093/nar/gkp710; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Fischer CJ, 2007, BIOCHEMISTRY-US, V46, P12416, DOI 10.1021/bi700930n; George T, 2009, NUCLEIC ACIDS RES, V37, P6491, DOI 10.1093/nar/gkp671; Nguyen GH, 2014, P NATL ACAD SCI USA, V111, P9905, DOI 10.1073/pnas.1404807111; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Gomez D, 2006, J BIOL CHEM, V281, P38721, DOI 10.1074/jbc.M605828200; Hou XM, 2015, BIOCHEM J, V466, P189, DOI 10.1042/BJ20140997; Izbicka E, 1999, CANCER RES, V59, P639; Konig SLB, 2013, NUCLEIC ACIDS RES, V41, P7453, DOI 10.1093/nar/gkt476; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8; Lattmann S, 2011, NUCLEIC ACIDS RES, V39, P9390, DOI 10.1093/nar/gkr630; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Neidle S, 2008, BIOCHIMIE, V90, P1184, DOI 10.1016/j.biochi.2008.03.003; Oei SL, 2004, GENOMICS, V83, P873, DOI 10.1016/j.ygeno.2003.11.001; Okoh MP, 2006, BIOCHEMISTRY-US, V45, P14764, DOI 10.1021/bi060960j; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Piazza A, 2010, NUCLEIC ACIDS RES, V38, P4337, DOI 10.1093/nar/gkq136; Pike JE, 2010, J BIOL CHEM, V285, P41712, DOI 10.1074/jbc.M110.146894; Rajendran A, 2014, ANGEW CHEM INT EDIT, V53, P4107, DOI 10.1002/anie.201308903; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rodriguez R, 2012, NAT CHEM BIOL, V8, P301, DOI [10.1038/nchembio.780, 10.1038/NCHEMBIO.780]; Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w; Salvati E, 2010, ONCOGENE, V29, P6280, DOI 10.1038/onc.2010.344; Sanders CM, 2010, BIOCHEM J, V430, P119, DOI 10.1042/BJ20100612; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Tarsounas M, 2013, J MOL BIOL, V425, P4782, DOI 10.1016/j.jmb.2013.09.026; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; Valton AL, 2014, EMBO J, V33, P732, DOI 10.1002/embj.201387506; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Verma A, 2009, NUCLEIC ACIDS RES, V37, P4194, DOI 10.1093/nar/gkn1076; Whitehouse I, 2013, CURR OPIN GENET DEV, V23, P140, DOI 10.1016/j.gde.2012.12.007; Xu YN, 2012, NUCLEIC ACIDS RES, V40, P9802, DOI 10.1093/nar/gks728; Youds JL, 2008, MOL CELL BIOL, V28, P1470, DOI 10.1128/MCB.01641-07; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200; Zhou RB, 2014, ELIFE, V3, DOI 10.7554/eLife.02190; Zhou YJ, 2007, J PHYS CHEM B, V111, P13600, DOI 10.1021/jp073708+	60	39	44	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7722	7735		10.1074/jbc.M114.628008	http://dx.doi.org/10.1074/jbc.M114.628008			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25627683	Green Published, hybrid			2022-12-26	WOS:000351613600033
J	Ma, Y; Keil, V; Sun, JJ				Ma, Yue; Keil, Verena; Sun, Jianjun			Characterization of Mycobacterium tuberculosis EsxA Membrane Insertion ROLES OF N- AND C-TERMINAL FLEXIBLE ARMS AND CENTRAL HELIX-TURN-HELIX MOTIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTHRAX PROTECTIVE ANTIGEN; T-CELL ANTIGEN; COMPLEX-FORMATION; ESAT-6-CFP-10 COMPLEX; CALMETTE-GUERIN; PORE FORMATION; BOVIS BCG; ESAT-6; VIRULENCE; SECRETION	EsxA (LSAT-6), an important virulence factor of Mycobacterium tuberculosis, plays an essential role in phagosome rupture and bacterial cytosolic translocation within host macrophages. Our previous study showed that EsxA exhibits a unique membrane-interacting activity that is not found in its ortholog from nonpathogenic Mycobacterium smegmatis. However, the molecular mechanism of EsxA membrane insertion remains unknown. In this study, we generated truncated EsxA proteins with deletions of the N- and/or C-terminal flexible arm. Using a fluorescence-based liposome leakage assay, we found that both the N- and C-terminal arms were required for membrane disruption. Moreover, we found that, upon acidification, EsxA converted into a more organized structure with increased a-helical content, which was evidenced by CD analysis and intrinsic tryptophan fluorescence. Finally, using an environmentally sensitive fluorescent dye, we obtained direct evidence that the central helix-turn-helix motif of EsxA inserted into the membranes and formed a membrane-spanning pore. A model of EsxA membrane insertion is proposed and discussed.	[Sun, Jianjun] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Sun, Jianjun] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Sun, JJ (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 West Univ Ave, El Paso, TX 79968 USA.	jsun@utep.edu			National Institutes of Health from the National Center for Research Resources [5G12RR008124]; NIMHD [G12MD007592]; University of Texas at El Paso new faculty startup funds; German Academic Exchange Service (DAAD) Research Internships in Science and Engineering; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); University of Texas at El Paso new faculty startup funds; German Academic Exchange Service (DAAD) Research Internships in Science and Engineering(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grant 5G12RR008124 from the National Center for Research Resources and Grant G12MD007592 from NIMHD. This work was also supported by University of Texas at El Paso new faculty startup funds (to J. S.) and German Academic Exchange Service (DAAD) Research Internships in Science and Engineering (to V. K.).	Aguilo JI, 2013, CELL MICROBIOL, V15, P1994, DOI 10.1111/cmi.12169; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; De Leon J, 2012, J BIOL CHEM, V287, P44184, DOI 10.1074/jbc.M112.420869; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Jacquez P, 2014, PROTEIN EXPRES PURIF, V95, P149, DOI 10.1016/j.pep.2013.12.010; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Lakowicz R, 1983, PRINCIPLES FLUORESCE; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Lightbody KL, 2008, J BIOL CHEM, V283, P17681, DOI 10.1074/jbc.M800123200; MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Medie FM, 2014, INFECT IMMUN, V82, P4572, DOI 10.1128/IAI.02153-14; Meher AK, 2006, FEBS J, V273, P1445, DOI 10.1111/j.1742-4658.2006.05166.x; Okkels LM, 2004, PROTEOMICS, V4, P2954, DOI 10.1002/pmic.200400906; Orme I, 2004, CURR OPIN MICROBIOL, V7, P58, DOI 10.1016/j.mib.2003.11.002; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Poulsen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089313; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Sun J, 2008, P NATL ACAD SCI USA, V105, P4346, DOI 10.1073/pnas.0800701105; Sun JJ, 2007, J BIOL CHEM, V282, P1059, DOI 10.1074/jbc.M609869200; Sun JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010553; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Wards BJ, 2000, TUBERCLE LUNG DIS, V80, P185, DOI 10.1054/tuld.2000.0244	38	42	43	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7314	7322		10.1074/jbc.M114.622076	http://dx.doi.org/10.1074/jbc.M114.622076			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25645924	hybrid, Green Published			2022-12-26	WOS:000350991500059
J	Mukhopadhyay, S; Saqcena, M; Chatterjee, A; Garcia, A; Frias, MA; Foster, DA				Mukhopadhyay, Suman; Saqcena, Mahesh; Chatterjee, Amrita; Garcia, Avalon; Frias, Maria A.; Foster, David A.			Reciprocal Regulation of AMP-activated Protein Kinase and Phospholipase D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; PHOSPHATIDIC-ACID; MAMMALIAN TARGET; COMPLEX 1; MTOR; LKB1; PHOSPHORYLATION; NUTRIENT; PATHWAY; SIGNALS	AMP-activated protein kinase (AMPK), a critical sensor of energy sufficiency, acts as central metabolic switch in cell metabolism. Once activated by low energy status, AMPK phosphorylates key regulatory substrates and turns off anabolic biosynthetic pathways. In contrast, the mammalian/mechanistic target of rapamycin (mTOR) is active when there are sufficient nutrients for anabolic reactions. A critical factor regulating mTOR is phosphatidic acid (PA), a central metabolite of membrane lipid biosynthesis and the product of the phospholipase D (PLD)-catalyzed hydrolysis of phosphatidylcholine. PLD is a downstream target of the GTPase Rheb, which is turned off in response to AMPK via the tuberous sclerosis complex. Although many studies have linked AMPK with mTOR, very little is known about the connection between AMPK and PLD. In this report, we provide evidence for reciprocal regulation of PLD by AMPK and regulation of AMPK by PLD and PA. Suppression of AMPK activity led to an increase in PLD activity, and conversely, activation of AMPK suppressed PLD activity. Suppression of PLD activity resulted in elevated AMPK activity. Exogenously supplied PA abolished the inhibitory effects of elevated AMPK activity on mTOR signaling. In contrast, exogenously supplied PA could not overcome the effect AMPK activation if either mTOR or Raptor was suppressed, indicating that the inhibitory effects of PLD and PA on AMPK activity are mediated by mTOR. These data suggest a reciprocal feedback mechanism involving AMPK and the PLD/mTOR signaling node in cancer cells with therapeutic implications.	[Mukhopadhyay, Suman; Saqcena, Mahesh; Chatterjee, Amrita; Garcia, Avalon; Frias, Maria A.; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10065 USA.	foster@genectr.hunter.cuny.edu	Mukhopadhyay, Suman/N-3556-2017; Saqcena, Mahesh/U-5973-2017	Mukhopadhyay, Suman/0000-0002-4658-1942; Saqcena, Mahesh/0000-0002-2210-3444; Frias, Maria A/0000-0001-7753-6290	National Institutes of Health from NCI [R01-CA046677, R01-CA179542]; National Institutes of Health Research Centers in Minority Institutions Award from the National Center for Research Resources [RR-03039]; NATIONAL CANCER INSTITUTE [R01CA179542, R01CA046677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S03RR003039] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Research Centers in Minority Institutions Award from the National Center for Research Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA046677 and R01-CA179542 from NCI and by National Institutes of Health Research Centers in Minority Institutions Award RR-03039 from the National Center for Research Resources (to the Department of Biological Sciences, Hunter College of the City University of New York).	Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Blagosklonny MV, 2011, AGING-US, V3, P1130, DOI 10.18632/aging.100422; Blaskovich MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078632; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster DA, 2003, MOL CANCER RES, V1, P789; Foster DA, 2014, J BIOL CHEM, V289, P22583, DOI 10.1074/jbc.R114.566091; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Habib SL, 2010, EUR J CANCER, V46, P2806, DOI 10.1016/j.ejca.2010.06.117; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jang YH, 2014, CELL DEATH DIFFER, V21, P533, DOI 10.1038/cdd.2013.174; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kim JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009600; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Rehman G, 2014, ARCH PHARM, V347, P457, DOI 10.1002/ardp.201300402; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shackelford David B, 2013, J Carcinog, V12, P16, DOI 10.4103/1477-3163.116323; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Shirwany NA, 2014, FRONT BIOSCI-LANDMRK, V19, P447, DOI 10.2741/4218; SONG JG, 1993, BIOCHEM J, V294, P711, DOI 10.1042/bj2940711; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Toschi A, 2008, ONCOGENE, V27, P2746, DOI 10.1038/sj.onc.1210927; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Yellen P, 2013, CANCER LETT, V333, P239, DOI 10.1016/j.canlet.2013.01.041; Yellen P, 2011, CELL CYCLE, V10, P3948, DOI 10.4161/cc.10.22.18124; Yoon MS, 2011, J CELL BIOL, V195, P435, DOI 10.1083/jcb.201107033; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	55	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6986	6993		10.1074/jbc.M114.622571	http://dx.doi.org/10.1074/jbc.M114.622571			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25632961	Green Published, hybrid			2022-12-26	WOS:000350991500032
J	Adrion, ER; Aucott, J; Lemke, KW; Weiner, JP				Adrion, Emily R.; Aucott, John; Lemke, Klaus W.; Weiner, Jonathan P.			Health Care Costs, Utilization and Patterns of Care following Lyme Disease	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; UNITED-STATES; PREVENTION; IMPACT	Background Lyme disease is the most frequently reported vector borne infection in the United States. The Centers for Disease Control have estimated that approximately 10% to 20% of individuals may experience Post-Treatment Lyme Disease Syndrome - a set of symptoms including fatigue, musculoskeletal pain, and neurocognitive complaints that persist after initial antibiotic treatment of Lyme disease. Little is known about the impact of Lyme disease or post-treatment Lyme disease symptoms (PTLDS) on health care costs and utilization in the United States. Objectives 1) to examine the impact of Lyme disease on health care costs and utilization, 2) to understand the relationship between Lyme disease and the probability of developing PTLDS, 3) to understand how PTLDS may impact health care costs and utilization. Methods This study utilizes retrospective data on medical claims and member enrollment for persons aged 0-64 years who were enrolled in commercial health insurance plans in the United States between 2006-2010. 52,795 individuals treated for Lyme disease were compared to 263,975 matched controls with no evidence of Lyme disease exposure. Results Lyme disease is associated with $2,968 higher total health care costs (95% CI: 2,8073,128, p<.001) and 87% more outpatient visits (95% CI: 86%-89%, p<.001) over a 12-month period, and is associated with 4.77 times greater odds of having any PTLDS-related diagnosis, as compared to controls (95% CI: 4.67-4.87, p<.001). Among those with Lyme disease, having one or more PTLDS-related diagnosis is associated with $3,798 higher total health care costs (95% CI: 3,542-4,055, p<.001) and 66% more outpatient visits ( 95% CI: 64%-69%, p<.001) over a 12-month period, relative to those with no PTLDS-related diagnoses. Conclusions Lyme disease is associated with increased costs above what would be expected for an easy to treat infection. The presence of PTLDS-related diagnoses after treatment is associated with significant health care costs and utilization.	[Adrion, Emily R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MA USA; [Aucott, John] Johns Hopkins Univ, Div Rheumatol, Johns Hopkins Greenspring Stn, Sch Med, Baltimore, MD 21218 USA; [Adrion, Emily R.] Johns Hopkins Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Weiner, Jonathan P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Aucott, J (corresponding author), Johns Hopkins Univ, Div Rheumatol, Johns Hopkins Greenspring Stn, Sch Med, 10755 Falls Rd,Suite 200, Baltimore, MD 21218 USA.	Jaucott2@jhmi.edu	DeHaas, Keith/I-4957-2017	Lemke, Klaus/0000-0001-6936-5946	Lyme Disease Research Foundation	Lyme Disease Research Foundation	The acquisition and analysis of the data was funded by a grant from the Lyme Disease Research Foundation. The Lyme Disease Research Foundation was not involved in the design and conduct of the study, the statistical analysis or in any publication decisions.	AgueroRosenfeld ME, 1996, J CLIN MICROBIOL, V34, P1; Aucott JN, 2013, QUAL LIFE RES, V22, P75, DOI 10.1007/s11136-012-0126-6; Aucott JN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-173; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Centers for Disease Control and Prevention, 2013, POST TREATM LYM DIS; Centers for Disease Control and Prevention, 2012, REP CAS LYM DIS YEAR; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P669; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Henningsson AJ, 2010, CLIN MICROBIOL INFEC, V16, P1245, DOI 10.1111/j.1469-0691.2009.03059.x; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Johns Hopkins School of Public Health, J HOPK ACG R SYST VE; Johnson L, 2011, HEALTH POLICY, V102, P64, DOI 10.1016/j.healthpol.2011.05.007; Joss AWL, 2003, PUBLIC HEALTH, V117, P264, DOI 10.1016/S0033-3506(03)00067-2; Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202; Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E; LEY C, 1994, JAMA-J AM MED ASSOC, V271, P460, DOI 10.1001/jama.271.6.460; Maes E, 1998, CLIN THER, V20, P993, DOI 10.1016/S0149-2918(98)80081-7; MAGID D, 1992, NEW ENGL J MED, V327, P534, DOI 10.1056/NEJM199208203270806; Muller I, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/595427; Shadick NA, 1999, ANN INTERN MED, V131, P919, DOI 10.7326/0003-4819-131-12-199912210-00003; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Vanderhoof IT, 1993, CONTINGENCIES    JAN, P42; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Zhang XZ, 2006, EMERG INFECT DIS, V12, P653, DOI 10.3201/eid1204.050602	26	121	124	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116767	10.1371/journal.pone.0116767	http://dx.doi.org/10.1371/journal.pone.0116767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA9NG	25650808	Green Submitted, gold, Green Published			2022-12-26	WOS:000349250700006
J	Andersen, JP; Bogsted, M; Dybkaer, K; Mellqvist, UH; Morgan, GJ; Goldschmidt, H; Dimopoulos, MA; Einsele, H; San Miguel, J; Palumbo, A; Sonneveld, P; Johnsen, HE				Andersen, Jens Peter; Bogsted, Martin; Dybkaer, Karen; Mellqvist, Ulf-Henrik; Morgan, Gareth J.; Goldschmidt, Hartmut; Dimopoulos, Meletios A.; Einsele, Hermann; San Miguel, Jesus; Palumbo, Antonio; Sonneveld, Pieter; Johnsen, Hans Erik			Global Myeloma Research Clusters, Output, and Citations: A Bibliometric Mapping and Clustering Analysis	PLOS ONE			English	Article							MULTIPARAMETRIC FLOW-CYTOMETRY; MULTIPLE-MYELOMA; NAME DISAMBIGUATION; CONSENSUS STATEMENT; EUROPEAN EXPERTS; NETWORK; THERAPY	Background International collaborative research is a mechanism for improving the development of disease-specific therapies and for improving health at the population level. However, limited data are available to assess the trends in research output related to orphan diseases. Methods and Findings We used bibliometric mapping and clustering methods to illustrate the level of fragmentation in myeloma research and the development of collaborative efforts. Publication data from Thomson Reuters Web of Science were retrieved for 2005-2009 and followed until 2013. We created a database of multiple myeloma publications, and we analysed impact and co-authorship density to identify scientific collaborations, developments, and international key players over time. The global annual publication volume for studies on multiple myeloma increased from 1,144 in 2005 to 1,628 in 2009, which represents a 43% increase. This increase is high compared to the 24% and 14% increases observed for lymphoma and leukaemia. The major proportion (> 90% of publications) was from the US and EU over the study period. The output and impact in terms of citations, identified several successful groups with a large number of intra-cluster collaborations in the US and EU. The US-based myeloma clusters clearly stand out as the most productive and highly cited, and the European Myeloma Network members exhibited a doubling of collaborative publications from 2005 to 2009, still increasing up to 2013. Conclusion and Perspective Multiple myeloma research output has increased substantially in the past decade. The fragmented European myeloma research activities based on national or regional groups are progressing, but they require a broad range of targeted research investments to improve multiple myeloma health care.	[Andersen, Jens Peter] Aalborg Univ Hosp, Med Lib, Aalborg, Denmark; [Bogsted, Martin; Dybkaer, Karen; Johnsen, Hans Erik] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Mellqvist, Ulf-Henrik] Sahlgrenska Hosp, Dept Hematol, Gothenburg, Sweden; [Morgan, Gareth J.] Inst Canc Res Haematol & Oncol, London, England; [Goldschmidt, Hartmut] Natl Ctr Tumorerkrankungen, Heidelberg, Germany; [Dimopoulos, Meletios A.] Univ Athens, Alexandra Gen Hosp, Dept Clin Therapeut, Athens, Greece; [Einsele, Hermann] Univ Wurzburg, Dept Internal Med 2, D-97070 Wurzburg, Germany; [San Miguel, Jesus] Univ Navarra, E-31080 Pamplona, Spain; [Palumbo, Antonio] Univ Turin, Dept Hematol, Turin, Italy; [Sonneveld, Pieter] Erasmus Univ Hosp, Dept Hematol, Rotterdam, Netherlands; [Mellqvist, Ulf-Henrik; Morgan, Gareth J.; Goldschmidt, Hartmut; Dimopoulos, Meletios A.; Einsele, Hermann; San Miguel, Jesus; Palumbo, Antonio; Sonneveld, Pieter; Johnsen, Hans Erik] European Myeloma Network Board, Aalborg, Denmark; [Bogsted, Martin; Dybkaer, Karen; Johnsen, Hans Erik] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark; [Bogsted, Martin; Dybkaer, Karen; Johnsen, Hans Erik] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Sahlgrenska University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Alexandra Hospital; National & Kapodistrian University of Athens; University of Wurzburg; University of Navarra; University of Turin; Erasmus University Rotterdam; Erasmus MC; Aalborg University; Aalborg University Hospital; Aalborg University	Johnsen, HE (corresponding author), Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark.	haej@rn.dk	Andersen, Jens Peter/H-4247-2019; Dimopoulos, Meletios Athanasios/AAD-4130-2019; San-Miguel, Jesús F./V-8977-2018; Goldschmidt, Hartmut/AAL-8069-2021	Andersen, Jens Peter/0000-0003-2444-6210; San-Miguel, Jesús F./0000-0002-9183-4857; Dybkaer, Karen/0000-0003-2488-435X; Dimopoulos, Meletios/0000-0001-8990-3254; Bogsted, Martin/0000-0001-9192-1814; Johnsen, Hans Erik/0000-0001-8253-2913; morgan, gareth/0000-0002-4271-6360	EU 6th FP [LSHC-CT-2006-037602]; Danish Cancer Society; Danish Research Agency [2101-07-0007]; KE Jensen Foundation; Obelske Family Foundation	EU 6th FP(European Commission); Danish Cancer Society(Danish Cancer Society); Danish Research Agency; KE Jensen Foundation; Obelske Family Foundation	This study was supported by research funds from the EU 6th FP to MSCNET (LSHC-CT-2006-037602, coordinator HEJ) (http://ec.europa.eu/research/fp6/index_en.cfm); from the Danish Cancer Society (http://www.cancer.dk/research/research+center+danish+cancer+society/); from the Danish Research Agency to CHEPRE (#2101-07-0007) (http://ufm.dk/en); from the KE Jensen Foundation 2006-2013) to HEJ and KD (http://www.kejfond.dk/); and from the Obelske Family Foundation to HEJ and MB (2006-2013) (http://www.obel.com/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DW, 2012, J INFORMETR, V6, P36, DOI 10.1016/j.joi.2011.08.002; Batagelj V, 2011, PAJEK PROGRAM ANAL V; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Dana Farber Cancer Institute Mayo Clinic, 2011, MULT MYEL SPORE GRAN; Dimopoulos MA, 2011, LEUKEMIA, V25, P749, DOI 10.1038/leu.2011.3; Engelhardt M, 2010, LEUKEMIA LYMPHOMA, V51, P2006, DOI 10.3109/10428194.2010.516378; Engelhardt M, 2010, LEUKEMIA LYMPHOMA, V51, P1424, DOI 10.3109/10428194.2010.487959; Fayers PM, 2011, BLOOD, V118, P1239, DOI 10.1182/blood-2011-03-341669; GARFIELD E, 1979, SCIENTOMETRICS, V1, P359, DOI 10.1007/BF02019306; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; Han H, 2005, ACM-IEEE J CONF DIG, P334, DOI 10.1145/1065385.1065462; Han H, 2004, ACM-IEEE J CONF DIG, P296, DOI 10.1145/996350.996419; Johnsen HE, 2010, CYTOM PART B-CLIN CY, V78B, P338, DOI 10.1002/cyto.b.20523; Leydesdorff L, 2010, J INFORMETR, V4, P644, DOI 10.1016/j.joi.2010.05.003; Liu WL, 2014, J ASSOC INF SCI TECH, V65, P765, DOI 10.1002/asi.23063; Morgan G, 2012, MYELOMA GENETICS INT; Morris A, 2008, ANNU REV INFORM SCI, V42, P213, DOI [10.1002/aris.2008.1440420113, DOI 10.1002/ARIS.2008.1440420113]; Otte E, 2002, J INF SCI, V28, P441, DOI 10.1177/016555150202800601; Palumbo A, 2011, BLOOD, V118, P4519, DOI 10.1182/blood-2011-06-358812; PETERS HPF, 1991, SCIENTOMETRICS, V20, P235, DOI 10.1007/BF02018157; Rawstron AC, 2008, HAEMATOLOGICA, V93, P431, DOI 10.3324/haematol.11080; Ross FM, 2012, HAEMATOL-HEMATOL J, V97, P1272, DOI 10.3324/haematol.2011.056176; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Sonneveld P, 2005, ACTA HAEMATOL-BASEL, V114, P14, DOI 10.1159/000087039; Sonneveld P, 2009, LEUKEMIA LYMPHOMA, V50, P1581, DOI [10.3109/10428190903191874, 10.1080/10428190903191874]; Terpos E, 2009, ANN ONCOL, V20, P1303, DOI 10.1093/annonc/mdn796; The U.S. National Cancer Institute, 2011, MYEL RES GRANT; Waltman L, 2013, J AM SOC INF SCI TEC, V64, P372, DOI 10.1002/asi.22775; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2419, DOI 10.1002/asi.22708; Waltman L, 2011, J INFORMETR, V5, P37, DOI 10.1016/j.joi.2010.08.001	30	5	5	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116966	10.1371/journal.pone.0116966	http://dx.doi.org/10.1371/journal.pone.0116966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629620	Green Published, gold			2022-12-26	WOS:000348732100053
J	Chaudhry, V; Bhatia, A; Bharti, SK; Mishra, SK; Chauhan, PS; Mishra, A; Sidhu, OP; Nautiyal, CS				Chaudhry, Vasvi; Bhatia, Anil; Bharti, Santosh Kumar; Mishra, Shashank Kumar; Chauhan, Puneet Singh; Mishra, Aradhana; Sidhu, Om Prakash; Nautiyal, Chandra Shekhar			Metabolite Profiling Reveals Abiotic Stress Tolerance in Tn5 Mutant of Pseudomonas putida	PLOS ONE			English	Article							CYTOCHROME MUTANTS; GLYCINE-BETAINE; PLANT-GROWTH; PHOSPHATIDYLCHOLINE; EXPRESSION; ACID; TEMPERATURE; POLYAMINES; GENES; NMR	Pseudomonas is an efficient plant growth-promoting rhizobacteria (PGPR); however, intolerance to drought and high temperature limit its application in agriculture as a bioinoculant. Transposon 5 (Tn5) mutagenesis was used to generate a stress tolerant mutant from a PGPR Pseudomonas putida NBRI1108 isolated from chickpea rhizosphere. A mutant NBRI1108T, selected after screening of nearly 10,000 transconjugants, exhibited significant tolerance towards high temperature and drought. Southern hybridization analysis of EcoRI and XhoI restricted genomic DNA of NBRI1108T confirmed that it had a single Tn5 insertion. The metabolic changes in the polar and non-polar extracts of NBRI1108 and NBRI1108T were examined using H-1, P-31 nuclear magnetic resonance (NMR) spectroscopy and gas chromatography-mass spectrometry (GC-MS). Thirty six chemically diverse metabolites consisting of amino acids, fatty acids and phospholipids were identified and quantified. Insertion of Tn5 influenced amino acid and phospholipid metabolism and resulted in significantly higher concentration of aspartic acid, glutamic acid, glycinebetaine, glycerophosphatidylcholine (GPC) and putrescine in NBRI1108T as compared to that in NBRI1108. The concentration of glutamic acid, glycinebetaine and GPC increased by 34%, 95% and 100%, respectively in the NBRI1108T as compared to that in NBRI1108. High concentration of glycerophosphatidylethanolamine (GPE) and undetected GPC in NBRI1108 indicates that biosynthesis of GPE may have taken place via the methylation pathway of phospholipid biosynthesis. However, high GPC and low GPE concentration in NBRI1108T suggest that methylation pathway and phosphatidylcholine synthase (PCS) pathway of phospholipid biosynthesis are being followed in the NBRI1108T. Application of multivariate principal component analysis (PCA) on the quantified metabolites revealed clear variations in NBRI1108 and NBRI1108T in polar and non-polar metabolites. Identification of abiotic stress tolerant metabolites from the NBRI1108T suggest that Tn5 mutagenesis enhanced tolerance towards high temperature and drought. Tolerance to drought was further confirmed in greenhouse experiments with maize as host plant, where NBRI1108T showed relatively high biomass under drought conditions.	[Chaudhry, Vasvi; Bhatia, Anil; Bharti, Santosh Kumar; Mishra, Shashank Kumar; Chauhan, Puneet Singh; Mishra, Aradhana; Sidhu, Om Prakash; Nautiyal, Chandra Shekhar] Natl Bot Res Inst, CSIR, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Nautiyal, CS (corresponding author), Natl Bot Res Inst, CSIR, Rana Pratap Marg, Lucknow 226001, Uttar Pradesh, India.	nautiyalnbri@lycos.com	Chaudhry, Vasvi/AAH-9871-2020; Chauhan, Puneet Singh/AAB-7606-2019; Chaudhry, Vasvi/AAB-9095-2020; Bhatia, Anil/G-4566-2015	Chaudhry, Vasvi/0000-0001-9078-9292; Chauhan, Puneet Singh/0000-0001-5955-8656; Bhatia, Anil/0000-0001-8286-5574; Nautiyal, Chandra/0000-0003-3899-5034	New Initiative (as a Cross Flow Technology project) "Root Biology and its Correlation to Sustainable Plant Development and Soil Fertility" from Council of Scientific and Industrial Research (CSIR), New Delhi, India	New Initiative (as a Cross Flow Technology project) "Root Biology and its Correlation to Sustainable Plant Development and Soil Fertility" from Council of Scientific and Industrial Research (CSIR), New Delhi, India	The study was supported by New Initiative (as a Cross Flow Technology project) "Root Biology and its Correlation to Sustainable Plant Development and Soil Fertility" from Council of Scientific and Industrial Research (CSIR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELSALAM MS, 1987, MOL GEN GENET, V210, P165, DOI 10.1007/BF00337774; Bhatia A, 2013, PHYTOCHEMISTRY, V93, P105, DOI 10.1016/j.phytochem.2013.03.013; Boeris PS, 2012, MICROBIOL-SGM, V158, P1249, DOI 10.1099/mic.0.054072-0; BOTSFORD JL, 1990, APPL ENVIRON MICROB, V56, P488, DOI 10.1128/AEM.56.2.488-494.1990; Canamas TP, 2007, LETT APPL MICROBIOL, V45, P6, DOI 10.1111/j.1472-765X.2007.02156.x; Canovas D, 2000, MICROBIOL-SGM, V146, P455, DOI 10.1099/00221287-146-2-455; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Chaudhry V, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00560-13; Chauhan PS, 2010, LETT APPL MICROBIOL, V50, P205, DOI 10.1111/j.1472-765X.2009.02779.x; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukumori F, 1998, EXTREMOPHILES, V2, P395, DOI 10.1007/s007920050084; Kiewietdejonge A, 2006, FEMS YEAST RES, V6, P205, DOI 10.1111/j.1567-1364.2006.00030.x; KLOEPPER JW, 1980, NATURE, V286, P885, DOI 10.1038/286885a0; KRIAT M, 1993, J LIPID RES, V34, P1009; Kruger NJ, 2008, NAT PROTOC, V3, P1001, DOI 10.1038/nprot.2008.64; Markley JL, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P157; Martinez-Morales F, 2003, MICROBIOL-SGM, V149, P3461, DOI 10.1099/mic.0.26522-0; Medeot DB, 2007, CURR MICROBIOL, V54, P31, DOI 10.1007/s00284-006-0233-0; MENESES P, 1988, J LIPID RES, V29, P679; Mishra S, 2012, J APPL MICROBIOL, V112, P793, DOI 10.1111/j.1365-2672.2012.05256.x; Nakada Y, 2003, MICROBIOL-SGM, V149, P707, DOI 10.1099/mic.0.26009-0; NAUTIYAL CS, 1989, PLANT PHYSIOL, V90, P553, DOI 10.1104/pp.90.2.553; OBRIAN MR, 1987, J BACTERIOL, V169, P1089, DOI 10.1128/jb.169.3.1089-1094.1987; Oshima T, 2007, AMINO ACIDS, V33, P367, DOI 10.1007/s00726-007-0526-z; Page AF, 2012, AMINO ACIDS, V42, P295, DOI 10.1007/s00726-010-0807-9; Pinkart HC, 1997, J BACTERIOL, V179, P4219, DOI 10.1128/jb.179.13.4219-4226.1997; Rehman A, 2002, CURR MICROBIOL, V45, P368, DOI 10.1007/s00284-002-3770-1; Shen B, 1999, PLANT PHYSIOL, V121, P45, DOI 10.1104/pp.121.1.45; Srivastava S, 2008, CURR MICROBIOL, V56, P453, DOI 10.1007/s00284-008-9105-0; Srivastava S, 2012, PLANT SIGNAL BEHAV, V7, P235, DOI 10.4161/psb.18957; Styczynski MP, 2007, ANAL CHEM, V79, P966, DOI 10.1021/ac0614846; TALIBART R, 1994, J BACTERIOL, V176, P5210, DOI 10.1128/JB.176.17.5210-5217.1994; Viant MR, 2008, MOL BIOSYST, V4, P980, DOI 10.1039/b805354e; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Wright LC, 1997, EUR J BIOCHEM, V243, P328, DOI 10.1111/j.1432-1033.1997.0328a.x; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	39	11	12	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0113487	10.1371/journal.pone.0113487	http://dx.doi.org/10.1371/journal.pone.0113487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629312	Green Submitted, Green Published, gold			2022-12-26	WOS:000348732100003
J	Tai, MLS; Norhatta, N; Goh, KJ; Moy, FM; Sujarita, R; Asraff, AA; Lee, QZ; Ng, JH; Tan, ECL; Mahadeva, S				Tai, Mei-Ling Sharon; Norhatta, Norbelinda; Goh, Khean Jin; Moy, Foong Ming; Sujarita, Ramanujam; Asraff, Azman Ahmad; Lee, Qin Zhi; Ng, Jiun Hoong; Tan, Eugene Choon Li; Mahadeva, Sanjiv			The Impact of Dyspepsia on Symptom Severity and Quality of Life in Adults with Headache	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; FUNCTIONAL GASTROINTESTINAL DISORDERS; NONULCER DYSPEPSIA; DEPRESSION SCALE; LEEDS DYSPEPSIA; ANXIETY; QUESTIONNAIRE; COMORBIDITY; PREVALENCE; VALIDATION	Background Dyspepsia and headache frequently co-exist, but the clinical implication of this association is uncertain. We planned to examine the prevalence and impact of dyspepsia in adults with headache. Methods A cross-sectional study was conducted in a secondary care setting. Clinical, psychological and health-related quality of life (HRQOL) data were compared between subjects with headache and controls (non-headache subjects). The impact of dyspepsia was analysed further in subjects with headache alone. Results 280 subjects (93 cases with headache and 187 matched controls) were recruited. The following baseline characteristics of subjects were as follows: mean age 45.0 +/- 17.3 years, 57.0% females and ethnic distribution-Malaysian = 45 (48.4%), Chinese n = 24 (25.8%) and Indians n = 24 (25.8%). Headache sub-types among cases with headache were as follows: tension-type headache (TTH) n = 53 (57.0%) and migraine n = 40 (43.0%). Dyspepsia was more prevalent in cases with headache compared to controls (25.8% vs 12.8%, p = 0.011), and headache was independently associated with dyspepsia (OR 2.75, 95% CI 1.39-5.43). Among cases with headache, there was a trend towards a higher prevalence of dyspepsia in those with migraine (27.5%) compared to TTH (24.5%). Subjects with headache and dyspepsia, compared to those with headache alone, had a greater severity of headache symptoms (63.67 +/- 22.85 mm vs 51.20 +/- 24.0 mm VAS, p = 0.029). Overall HRQOL scores were lower in headache subjects with dyspepsia (EQ-5D summary score 0.82 +/- 0.18 vs 0.90 +/- 0.16, p = 0.037 and EQ-5D VAS 62.08 +/- 17.50 mmvs 72.62 +/- 18.85mm, p = 0.018), compared to those without dyspepsia. Conclusion Dyspepsia is associated with more severe headache symptoms and results in a lower HRQOL in patients with headache.	[Tai, Mei-Ling Sharon; Norhatta, Norbelinda; Goh, Khean Jin; Asraff, Azman Ahmad; Lee, Qin Zhi; Ng, Jiun Hoong; Tan, Eugene Choon Li] Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia; [Moy, Foong Ming] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Sujarita, Ramanujam] Univ Malaya, Fac Med, Dept Primary Care, Kuala Lumpur, Malaysia; [Mahadeva, Sanjiv] Univ Malaya, Fac Med, Dept Med, Div Gastroenterol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Tai, MLS (corresponding author), Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia.	sharont1990@gmail.com	Moy, Foong Ming/B-7899-2010; Sharon, Tai Mei Ling/C-4458-2011; Goh, Khean Jin/D-1990-2010; Mahadeva, Sanjiv/E-1711-2011	Moy, Foong Ming/0000-0002-0306-4419; Sharon, Tai Mei Ling/0000-0001-9900-0446; Goh, Khean Jin/0000-0001-5416-9627; Mahadeva, Sanjiv/0000-0001-5824-0590	High Impact Research, University of Malaya [UM.C/625/1/HIR/MED/08 H-50001-00-E000035]	High Impact Research, University of Malaya	This work was supported by a grant from High Impact Research, University of Malaya UM.C/625/1/HIR/MED/08 H-50001-00-E000035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt AH, 2008, CEPHALALGIA, V28, P144, DOI 10.1111/j.1468-2982.2007.01486.x; Arakawa Tetsuo, 1997, Journal of Smooth Muscle Research, V33, P81; BECH P, 1981, ACTA PSYCHIAT SCAND, V63, P290, DOI 10.1111/j.1600-0447.1981.tb00676.x; Beghi E, 2007, NEUROL SCI, V28, pS217, DOI 10.1007/s10072-007-0780-6; Beghi E, 2010, J HEADACHE PAIN, V11, P141, DOI 10.1007/s10194-010-0187-2; Brooks R, 2005, QUAL LIFE RES, V14, P571; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Edvinsson L, 2001, CNS DRUGS, V15, P745, DOI 10.2165/00023210-200115100-00001; Fatt QK, 2007, INT J IMPOT RES, V19, P321, DOI 10.1038/sj.ijir.3901528; Guitera V, 2002, NEUROLOGY, V58, P1062, DOI 10.1212/WNL.58.7.1062; Hartono JL, 2012, J DIGEST DIS, V13, P252, DOI 10.1111/j.1751-2980.2012.00581.x; Herdman M, 2003, MEASUREMENT VALUATIO; Holtmann G, 1996, AM J GASTROENTEROL, V91, P485; KANEKO H, 1993, AM J GASTROENTEROL, V88, P898; Kurth T, 2006, CEPHALALGIA, V26, P506, DOI 10.1111/j.1468-2982.2005.01076.x; Lebedeva ER, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-101; Lucas C, 2012, HEADACHE, V52, P1005, DOI 10.1111/j.1526-4610.2012.02157.x; Mahadeva S, 2010, ALIMENT PHARM THER, V31, P1141, DOI 10.1111/j.1365-2036.2010.04270.x; Mahadeva S, 2006, WORLD J GASTROENTERO, V12, P2661, DOI 10.3748/wjg.v12.i17.2661; Mahadeva S, 2011, J GASTROEN HEPATOL, V26, P1669, DOI 10.1111/j.1440-1746.2011.06806.x; Mahadeva S, 2011, J GASTROEN HEPATOL, V26, P49, DOI 10.1111/j.1440-1746.2011.06656.x; Mahadeva S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-20; Manabe N, 2010, SCAND J GASTROENTERO, V45, P567, DOI 10.3109/00365521003592663; Meucci G, 2005, ENDOSCOPY, V37, P622, DOI 10.1055/s-2005-870251; Moayyedi P, 1998, ALIMENT PHARM THER, V12, P1257; Plourde V, 1997, AM J PHYSIOL-GASTR L, V273, pG191, DOI 10.1152/ajpgi.1997.273.1.G191; SICUTERI F, 1991, CLIN J PAIN, V7, pS38; Tai MLS, 2012, J HEADACHE PAIN, V13, P291, DOI 10.1007/s10194-012-0434-9; Tajti J, 2001, CEPHALALGIA, V21, P96, DOI 10.1046/j.1468-2982.2001.00140.x; TALLEY NJ, 1991, ALIMENT PHARM THERAP, V5, P145; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; van Kerkhoven LAS, 2009, J CLIN GASTROENTEROL, V43, P118, DOI 10.1097/MCG.0b013e31815591f7; Yu SY, 2011, J HEADACHE PAIN, V12, P141, DOI 10.1007/s10194-011-0336-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115838	10.1371/journal.pone.0115838	http://dx.doi.org/10.1371/journal.pone.0115838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629323	Green Submitted, Green Published, gold			2022-12-26	WOS:000348732100026
J	Foley, PL; Hsieh, PK; Luciano, DJ; Belasco, JG				Foley, Patricia L.; Hsieh, Ping-kun; Luciano, Daniel J.; Belasco, Joel G.			Specificity and Evolutionary Conservation of the Escherichia coil RNA Pyrophosphohydrolase RppH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; BACILLUS-SUBTILIS; DEGRADATION; COLI; ENZYME; DECAY; INITIATION; STABILITY; HYDROLASE; REMOVAL	Bacterial RNA degradation often begins with conversion of the 5'-terminal triphosphate to a monophosphate by the RNA pyrophosphohydrolase RppH, an event that triggers rapid ribonucleolytic attack. Besides its role as the master regulator of 5'-end-dependent mRNA decay, RppH is important for the ability of pathogenic bacteria to invade host cells, yet little is known about how it chooses its targets. Here, we show that Escherichia call RppH (EcRppH) requires at least two unpaired nucleotides at the RNA 5' end and prefers three or more such nucleotides, It can tolerate any nucleotide at the first three positions but has a modest preference for A at the 5' terminus and either a G or A at the second position. Mutational analysis has identified EcRppH residues crucial for substrate recognition or catalysis. The promiscuity of EcRppH differentiates it from its Bacillus subtilis counterpart, which has a strict RNA sequence requirement. EcRppH orthologs likely to share its relaxed sequence specificity are widespread in all classes of Proteobacteria, except Deltaproteobacteria, and in flowering plants. By contrast, the phylogenetic range of recognizable B. subtilis RppH orthologs appears to be restricted to the order Bacillales. These findings help to explain the selective influence of RppH on bacterial mRNA decay and show that RppH-dependent degradation has diversified significantly during the course of evolution.	NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10016 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Belasco, JG (corresponding author), NYU, Sch Med, Skirball Inst, 540 First Ave, New York, NY 10016 USA.	joel.belasco@med.nyu.edu			National Institutes of Health Research [R01GM035769]; National Institutes of Health Fellowship [T32AI007180]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035769] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant R01GM035769 (to J. G. B).r Supported by National Institutes of Health Fellowship T32AI007180.	Arnold TE, 1998, RNA, V4, P319; Badger JL, 2000, MOL MICROBIOL, V36, P174, DOI 10.1046/j.1365-2958.2000.01840.x; Baker KE, 2003, MOL MICROBIOL, V47, P75, DOI 10.1046/j.1365-2958.2003.03292.x; Bi YC, 2009, BIOMOL NMR ASSIGN, V3, P149, DOI 10.1007/s12104-009-9162-8; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Celesnik H, 2008, METHOD ENZYMOL, V447, P83, DOI 10.1016/S0076-6879(08)02205-2; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Dorleans A, 2011, STRUCTURE, V19, P1252, DOI 10.1016/j.str.2011.06.018; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Gabelli SB, 2004, STRUCTURE, V12, P927, DOI 10.1016/j.str.2004.03.028; Heck C, 1996, MOL MICROBIOL, V20, P1165, DOI 10.1111/j.1365-2958.1996.tb02637.x; Hsieh PK, 2013, P NATL ACAD SCI USA, V110, P8864, DOI 10.1073/pnas.1222670110; Laalami S, 2014, CELL MOL LIFE SCI, V71, P1799, DOI 10.1007/s00018-013-1472-4; Liu H, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00013; Luciano DJ, 2012, J BACTERIOL, V194, P6233, DOI 10.1128/JB.01223-12; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Maksel D, 2001, BIOCHEM J, V357, P399, DOI 10.1042/0264-6021:3570399; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995; Piton J, 2013, P NATL ACAD SCI USA, V110, P8858, DOI 10.1073/pnas.1221510110; Ramirez-Pena E, 2010, MOL MICROBIOL, V78, P1332, DOI 10.1111/j.1365-2958.2010.07427.x; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; Unniraman S, 2002, NUCLEIC ACIDS RES, V30, P5376, DOI 10.1093/nar/gkf697; Vasilyev N, 2015, J BIOL CHEM, V290, P9487, DOI 10.1074/jbc.M114.634824	24	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9478	9486		10.1074/jbc.M114.634659	http://dx.doi.org/10.1074/jbc.M114.634659			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25657006	Green Published, hybrid			2022-12-26	WOS:000352729400015
J	Hudson, DM; Joeng, KS; Werther, R; Rajagopal, A; Weis, M; Lee, BH; Eyre, DR				Hudson, David M.; Joeng, Kyu Sang; Werther, Rachel; Rajagopal, Abbhirami; Weis, MaryAnn; Lee, Brendan H.; Eyre, David R.			Post-translationally Abnormal Collagens of Prolyl 3-Hydroxylase-2 Null Mice Offer a Pathobiological Mechanism for the High Myopia Linked to Human LEPREL1 Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE; CYCLOPHILIN-B; I COLLAGEN; 3-HYDROXYPROLINE; DEFICIENCY; EXPRESSION; PROTEIN; SCLERA; CRTAP; FORM	Myopia, the leading cause of visual impairment worldwide, results from an increase in the axial length of the eyeball. Mutations in LEPREL1, the gene encoding prolyl 3-hydroxylase-2 (P3H2), have recently been identified in individuals with recessively inherited nonsyndromic severe myopia. P3H2 is a member of a family of genes that includes three isoenzymes of prolyl 3-hydroxylase (P3H), P3H1, P3H2, and P3H3. Fundamentally, it is understood that P3H1 is responsible for converting proline to 3-hydroxyproline. This limited additional knowledge also suggests that each isoenzyme has evolved different collagen sequence-preferred substrate specificities. In this study, differences in prolyl 3-hydroxylation were screened in eye tissues from P3h2-null (P3h2(n/n)) and wild-type mice to seek tissue-specific effects due the lack of P3H2 activity on post-translational collagen chemistry that could explain myopia. The mice were viable and had no gross musculoskeletal phenotypes. Tissues from sclera and cornea(type I collagen) and lens capsule (type IV collagen) were dissected from mouse eyes, and multiple sites of prolyl 3-hydroxylation were identified by mass spectrometry. The level of prolyl 3-hydroxylation at multiple substrate sites from type I collagen chains was high in sclera, similar to tendon. Almost every known site of prolyl 3-hydroxylation in types I and IV collagen from P3h2(n/n) mouse eye tissues was significantly under-hydroxylated compared with their wild-type littermates. We conclude that altered collagen prolyl 3-hydroxylationis caused by loss of P3H2. We hypothesize that this leads to structural abnormalities in multiple eye tissues, but particularly sclera, causing progressive myopia.	[Hudson, David M.; Werther, Rachel; Weis, MaryAnn; Eyre, David R.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Joeng, Kyu Sang; Rajagopal, Abbhirami; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; Baylor College of Medicine	Eyre, DR (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	deyre@u.washington.edu			National Institutes of Health from NIAMS [AR37694, AR37318, AR063616]; National Institutes of Health from NICHD [HD22657, HD070394]; National Institutes of Health from the Eunice Kennedy Shriver NICHD [P30 HD024064, AI036211, P30 CA125123, RR024574]; Ernest M. Burgess Endowed Chair research program of the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, P01HD070394, U54HD083092] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, F32AR063616, R01AR037318, R37AR037318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445] Funding Source: NIH RePORTER	National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health from NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health from the Eunice Kennedy Shriver NICHD; Ernest M. Burgess Endowed Chair research program of the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37694 and AR37318 from NIAMS (to D. R. E.), HD22657 and HD070394 from NICHD (to B. H. L. and D. R. E.), AR063616 from NIAMS (to K. S. J.), P30 HD024064 from the Eunice Kennedy Shriver NICHD (to the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center), and AI036211, P30 CA125123, and RR024574 (to the Baylor College of Medicine Advanced Technology Cores). This work was also supported by the Ernest M. Burgess Endowed Chair research program of the University of Washington.	Aldahmesh MA, 2013, AM J HUM GENET, V93, P313, DOI 10.1016/j.ajhg.2013.06.002; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Barnes AM, 2010, NEW ENGL J MED, V362, P521, DOI 10.1056/NEJMoa0907705; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; DEAN DC, 1983, J BIOL CHEM, V258, P590; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2011, J BIOL CHEM, V286, P7732, DOI 10.1074/jbc.C110.195768; Fernandes RJ, 2011, J BIOL CHEM, V286, P30662, DOI 10.1074/jbc.M111.267906; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; Guo H, 2014, CLIN GENET, V86, P575, DOI 10.1111/cge.12309; Guo H, 2014, J MED GENET, V51, P518, DOI 10.1136/jmedgenet-2014-102351; Halfter W, 2006, INVEST OPHTH VIS SCI, V47, P3586, DOI 10.1167/iovs.05-1480; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; HENKEL W, 1976, EUR J BIOCHEM, V69, P223, DOI 10.1111/j.1432-1033.1976.tb10877.x; Hornbeak DM, 2009, CURR OPIN OPHTHALMOL, V20, P356, DOI 10.1097/ICU.0b013e32832f8040; Hudson DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093467; Hudson DM, 2013, CONNECT TISSUE RES, V54, P245, DOI 10.3109/03008207.2013.800867; Hudson DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019336; Ishikawa Y, 2012, J BIOL CHEM, V287, P22253, DOI 10.1074/jbc.M111.333336; Jarnum S, 2004, BIOCHEM BIOPH RES CO, V317, P342, DOI 10.1016/j.bbrc.2004.03.060; Kaufman RM, 2001, BLOOD, V98, P65, DOI 10.1182/blood.V98.1.65; Liu HH, 2010, INVEST OPHTH VIS SCI, V51, P2865, DOI 10.1167/iovs.09-4322; Marini JC, 2010, CELL TISSUE RES, V339, P59, DOI 10.1007/s00441-009-0872-0; McBrien NA, 2000, INVEST OPHTH VIS SCI, V41, P3713; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Mordechai S, 2011, AM J HUM GENET, V89, P438, DOI 10.1016/j.ajhg.2011.08.003; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; OGLE JD, 1962, J BIOL CHEM, V237, P3667; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PHILLIPS JR, 1995, OPHTHAL PHYSL OPT, V15, P357, DOI 10.1016/0275-5408(95)00062-I; Pokidysheva E, 2014, P NATL ACAD SCI USA, V111, P161, DOI 10.1073/pnas.1307597111; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Ren SY, 2002, DEV DYNAM, V225, P305, DOI 10.1002/dvdy.10171; RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Tran-Viet KN, 2013, AM J HUM GENET, V92, P820, DOI 10.1016/j.ajhg.2013.04.005; van Dijk FS, 2009, AM J HUM GENET, V85, P521, DOI 10.1016/j.ajhg.2009.09.001; Vranka J, 2009, CELL STRUCT FUNCT, V34, P97, DOI 10.1247/csf.09002; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907	45	27	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8613	8622		10.1074/jbc.M114.634915	http://dx.doi.org/10.1074/jbc.M114.634915			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645914	Green Published, hybrid			2022-12-26	WOS:000351662600051
J	Hung, ME; Leonard, JN				Hung, Michelle E.; Leonard, Joshua N.			Stabilization of Exosome-targeting Peptides via Engineered Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-DELIVERY SYSTEMS; EXTRACELLULAR VESICLES; CELLS; ELECTROPORATION; LIPOSOME; SIRNA	Exosomes are secreted extracellular vesicles that mediate intercellular transfer of cellular contents and are attractive vehicles for therapeutic delivery of bimolecular cargo such as nucleic acids, proteins, and even drugs. Efficient exosome-mediated delivery in vivo requires targeting vesicles for uptake by specific recipient cells. Although exosomes have been successfully targeted to several cellular receptors by displaying peptides on the surface of the exosomes, identifying effective exosome-targeting peptides for other receptors has proven challenging. Furthermore, the biophysical rules governing targeting peptide success remain poorly understood. To evaluate one factor potentially limiting exosome delivery, we investigated whether peptides displayed on the exosome surface are degraded during exosome biogenesis, for example by endosomal proteases. Indeed, peptides fused to theNterminus of exosome-associated transmembrane protein Lamp2b were cleaved in samples derived from both cells and exosomes. To suppress peptide loss, we engineered targeting peptide-Lamp2b fusion proteins to include a glycosylation motif at various positions. Introduction of this glycosylation motif both protected the peptide from degradation and led to an increase in overall Lamp2b fusion protein expression in both cells and exosomes. Moreover, glycosylationstabilized peptides enhanced targeted delivery of exosomes to neuroblastoma cells, demonstrating that such glycosylation does not ablate peptide-target interactions. Thus, we have identified a strategy for achieving robust display of targeting peptides on the surface of exosomes, which should facilitate the evaluation and development of new exosome-based therapeutics.	[Hung, Michelle E.] Northwestern Univ, Interdisciplinary Biol Sci Program, Evanston, IL 60208 USA; [Leonard, Joshua N.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Leonard, Joshua N.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Leonard, Joshua N.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Leonard, JN (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,Rm E136, Evanston, IL 60208 USA.	j-leonard@northwestern.edu	Leonard, Joshua/B-7649-2009; Hung, Michelle/J-3336-2014	Leonard, Joshua/0000-0003-4359-6126; Hung, Michelle/0000-0002-1909-8162	Northwestern University Office for Research; National Center for Research Resources [1S10RR025092]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE [P50CA090386, P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008449] Funding Source: NIH RePORTER	Northwestern University Office for Research; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Charlene Wilke for assistance with transmission electron microscopy, as well as Myrick Dennis and Dr. Arabela Grigorescu for assistance with NanoSight analysis. We thank the laboratory of Richard Morimoto for Neuro2A cells. NanoSight analysis was performed at the Northwestern University Keck Biophysics Facility. TEM was performed at the Northwestern University Biological Imaging Facility on a JEOL 3200 FETEM supported by the Northwestern University Office for Research and National Center for Research Resources Grant 1S10RR025092. Traditional sequencing services were performed at the Northwestern University Genomics Core Facility. BCA assays were performed at the Northwestern University High Throughput Analysis Lab, which is supported by the Chicago Biomedical Consortium and The Searle Funds at The Chicago Community Trust.	Akao Y, 2011, MOL THER, V19, P395, DOI 10.1038/mt.2010.254; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Bano-Polo M, 2011, PROTEIN SCI, V20, P179, DOI 10.1002/pro.551; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Hood JL, 2014, ANAL BIOCHEM, V448, P41, DOI 10.1016/j.ab.2013.12.001; Kooijmans SAA, 2013, J CONTROL RELEASE, V172, P229, DOI 10.1016/j.jconrel.2013.08.014; Kraft JC, 2014, J PHARM SCI-US, V103, P29, DOI 10.1002/jps.23773; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; LEE N, 1990, J BIOL CHEM, V265, P20476; Li X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044045; Liang YX, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.606269; Marcus ME, 2013, PHARMACEUTICALS-BASE, V6, P659, DOI 10.3390/ph6050659; Mizrak A, 2013, MOL THER, V21, P101, DOI 10.1038/mt.2012.161; Montecalvo A, 2008, J IMMUNOL, V180, P3081, DOI 10.4049/jimmunol.180.5.3081; Neefjes J, 2013, NAT CHEM BIOL, V9, P769, DOI [10.1038/NCHEMBIO.1391, 10.1038/nchembio.1391]; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; van der Meel R, 2014, J CONTROL RELEASE, V195, P72, DOI 10.1016/j.jconrel.2014.07.049; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; Veron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163	24	179	189	8	97	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8166	8172		10.1074/jbc.M114.621383	http://dx.doi.org/10.1074/jbc.M114.621383			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25657008	Green Published, hybrid			2022-12-26	WOS:000351662600014
J	Liu, XS; Weidle, K; Schrock, K; Tonjes, A; Schleinitz, D; Breitfeld, J; Stumvoll, M; Bottcher, Y; Schoneberg, T; Kovacs, P				Liu, Xuanshi; Weidle, Kerstin; Schroeck, Kristin; Toenjes, Anke; Schleinitz, Dorit; Breitfeld, Jana; Stumvoll, Michael; Boettcher, Yvonne; Schoeneberg, Torsten; Kovacs, Peter			Signatures of Natural Selection at the FTO (Fat Mass and Obesity Associated) Locus in Human Populations	PLOS ONE			English	Article							AMINO-ACID SITES; POSITIVE SELECTION; BODY-MASS; PHYLOGENETIC ANALYSIS; STATISTICAL-METHODS; CODON-SUBSTITUTION; GENE-EXPRESSION; VARIANTS; MODELS; GENOME	Background and aims Polymorphisms in the first intron of FTO have been robustly replicated for associations with obesity. In the Sorbs, a Slavic population resident in Germany, the strongest effect on body mass index (BMI) was found for a variant in the third intron of FTO (rs17818902). Since this may indicate population specific effects of FTO variants, we initiated studies testing FTO for signatures of selection in vertebrate species and human populations. Methods First, we analyzed the coding region of 35 vertebrate FTO orthologs with Phylogenetic Analysis by Maximum Likelihood (PAML, omega = dN/dS) to screen for signatures of selection among species. Second, we investigated human population (Europeans/CEU, Yoruba/YRI, Chinese/CHB, Japanese/JPT, Sorbs) SNP data for footprints of selection using DnaSP version 4.5 and the Haplotter/PhaseII. Finally, using ConSite we compared transcription factor (TF) binding sites at sequences harbouring FTO SNPs in intron three. Results PAML analyses revealed strong conservation in coding region of FTO (omega<1). Sliding-window results from population genetic analyses provided highly significant (p<0.001) signatures for balancing selection specifically in the third intron (e.g. Tajima's D in Sorbs = 2.77). We observed several alterations in TF binding sites, e.g. TCF3 binding site introduced by the rs17818902 minor allele. Conclusion Population genetic analysis revealed signatures of balancing selection at the FTO locus with a prominent signal in intron three, a genomic region with strong association with BMI in the Sorbs. Our data support the hypothesis that genes associated with obesity may have been under evolutionary selective pressure.	[Liu, Xuanshi; Breitfeld, Jana; Stumvoll, Michael; Boettcher, Yvonne; Kovacs, Peter] Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany; [Liu, Xuanshi] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Weidle, Kerstin; Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Schroeck, Kristin; Schoeneberg, Torsten] Univ Leipzig, Inst Biochem, Dept Med, D-04109 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Kovacs, P (corresponding author), Univ Leipzig, IFB Adipos Dis, D-04109 Leipzig, Germany.	peter.kovacs@medizin.uni-leipzig.de	Stumvoll, Michael/ABE-1121-2021	Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423	Boehringer Ingelheim Foundation; IFB AdiposityDiseases [ADI-K50D, ADI-K7-45, ADI-K60E]; Collaborative Research Center (CRC) [1052, B03]; German Research Foundation [BO 3147/4-1]; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1001]	Boehringer Ingelheim Foundation(Boehringer Ingelheim); IFB AdiposityDiseases; Collaborative Research Center (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This project was supported by grants from the Boehringer Ingelheim Foundation to P.K., from the IFB AdiposityDiseases (ADI-K50D and ADI-K7-45 to Y.B. and ADI-K60E to P. K.), and from the Collaborative Research Center granted by the DFG (CRC 1052; B03). The work was further funded by the German Research Foundation (BO 3147/4-1 to Y.B.). IFB AdiposityDiseases is supported by the Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01EO1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Ayub Q, 2014, AM J HUM GENET, V94, P176, DOI 10.1016/j.ajhg.2013.12.010; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friese RS, 2013, HUM MOL GENET, V22, P3624, DOI 10.1093/hmg/ddt213; FU YX, 1993, GENETICS, V133, P693; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gorkin DU, 2014, NATURE, V507, P309, DOI 10.1038/nature13212; Hennig BJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-21; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Kulzer JR, 2014, AM J HUM GENET, V94, P186, DOI 10.1016/j.ajhg.2013.12.011; LEWONTIN RC, 1973, ANNU REV GENET, V7, P1, DOI 10.1146/annurev.ge.07.120173.000245; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Ma YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094911; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Melas PA, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.31; Metzger KJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-139; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; NEEL JV, 1962, AM J HUM GENET, V14, P353; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nielsen R, 1998, GENETICS, V148, P929; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Pybus M, 2014, NUCLEIC ACIDS RES, V42, pD903, DOI 10.1093/nar/gkt1188; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Southam L, 2009, DIABETOLOGIA, V52, P1846, DOI 10.1007/s00125-009-1419-3; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonjes A, 2010, EUR J HUM GENET, V18, P104, DOI 10.1038/ejhg.2009.107; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yajnik CS, 2009, DIABETOLOGIA, V52, P247, DOI 10.1007/s00125-008-1186-6; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283	57	9	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117093	10.1371/journal.pone.0117093	http://dx.doi.org/10.1371/journal.pone.0117093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647475	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600054
J	Yang, YQ; Dong, C; Yang, SH; Li, X; Sun, XD; Yang, YP				Yang, Yunqiang; Dong, Chao; Yang, Shihai; Li, Xiong; Sun, Xudong; Yang, Yongping			Physiological and Proteomic Adaptation of the Alpine Grass Stipa purpurea to a Drought Gradient	PLOS ONE			English	Article							OSMOTIC ADJUSTMENT; TIBETAN PLATEAU; HEAT-STRESS; ARABIDOPSIS; RESPONSES; PLANT; ABA; GROWTH; ROOT; CELL	Stipa purpurea, an endemic forage species on the Tibetan Plateau, is highly resistant to cold and drought, but the mechanisms underlying its responses to drought stress remain elusive. An understanding of such mechanisms may be useful for developing cultivars that are adaptable to water deficit. In this study, we analyzed the physiological and proteomic responses of S. purpurea under increasing drought stress. Seedlings of S. purpurea were subjected to a drought gradient in a controlled experiment, and proteins showing changes in abundance under these conditions were identified by two-dimensional electrophoresis followed by mass spectrometry analysis. A western blotting analysis was conducted to confirm the increased abundance of a heat-shock protein, NCED2, and a dehydrin in S. purpurea seedlings under drought conditions. We detected carbonylated proteins to identify oxidation-sensitive proteins in S. purpurea seedlings, and found that ribulose-1, 5-bisphosphate carboxylase oxygenase (RuBisCO) was one of the oxidation-sensitive proteins under drought. Together, these results indicated drought stress might inhibit photosynthesis in S. purpurea by oxidizing RuBisCO, but the plants were able to maintain photosynthetic efficiency by a compensatory upregulation of unoxidized RuBisCO and other photosynthesis-related proteins. Further analyses confirmed that increased abundance of antioxidant enzymes could balance the redox status of the plants to mitigate drought induced oxidative damage.	[Yang, Yunqiang; Dong, Chao; Li, Xiong; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China; [Yang, Yunqiang; Dong, Chao; Li, Xiong; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Yang, Yunqiang; Dong, Chao; Li, Xiong; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Inst Tibetan Plateau Res Kunming, Kunming, Peoples R China; [Yang, Shihai] Chinese Acad Sci, Key Lab Tibetan Environm Changes & Land Surface P, Inst Tibetan Plateau Res, Beijing, Peoples R China; [Dong, Chao; Yang, Shihai; Li, Xiong] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, XD (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China.	sunxudong@mail.kib.ac.cn; yangyp@mail.kib.ac.cn	Sun, Xudong/HHN-3905-2022; Yang, Shihai/J-1593-2012	Yang, Shihai/0000-0002-6497-968X	National Natural Science Foundation of China (NSFC) [41271058]; Major State Basic Research Development Program of China [2010CB951704]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was financially supported by the National Natural Science Foundation of China (NSFC) (No. 41271058) and the Major State Basic Research Development Program of China ( No. 2010CB951704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Bernstein N, 2010, FREE RADICAL BIO MED, V49, P1161, DOI 10.1016/j.freeradbiomed.2010.06.032; Bonhomme L, 2009, PROTEOMICS, V9, P4121, DOI 10.1002/pmic.200900047; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Broin M, 2002, PLANT CELL, V14, P1417, DOI 10.1105/tpc.001644; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa MA, 2010, TREES-STRUCT FUNCT, V24, P275, DOI 10.1007/s00468-009-0397-x; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Ding SH, 2009, PLANT MOL BIOL, V69, P577, DOI 10.1007/s11103-008-9440-3; Duan BL, 2005, PHYSIOL PLANTARUM, V124, P476, DOI 10.1111/j.1399-3054.2005.00535.x; Gou XH, 2007, INT J CLIMATOL, V27, P1497, DOI 10.1002/joc.1480; GRENECHE M, 1991, SEED SCI TECHNOL, V19, P147; Grigorova B, 2011, BIOL PLANTARUM, V55, P105, DOI 10.1007/s10535-011-0014-x; He CM, 2011, EUPHYTICA, V177, P151, DOI 10.1007/s10681-010-0263-3; Jiang SL, 2012, J EXP BOT, V63, P2693, DOI 10.1093/jxb/err452; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Kang Y, 2012, PLANT SIGNAL BEHAV, V7, P539, DOI 10.4161/psb.19780; Kim K, 2005, PLANT CELL PHYSIOL, V46, P522, DOI 10.1093/pcp/pci052; KOCHERT G, 1978, P95; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Lippert DN, 2009, PROTEOMICS, V9, P350, DOI 10.1002/pmic.200800252; Liu FL, 2003, FUNCT PLANT BIOL, V30, P65, DOI 10.1071/FP02170; Lounifi I, 2013, PROTEOMICS, V13, P568, DOI 10.1002/pmic.201200304; Lu SY, 2009, PLANT CELL REP, V28, P517, DOI 10.1007/s00299-008-0649-z; LUDLOW MM, 1990, AUST J AGR RES, V41, P67, DOI 10.1071/AR9900067; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; MITTLER R, 1994, PLANT J, V5, P397, DOI 10.1111/j.1365-313X.1994.00397.x; Ni J, 2000, MT RES DEV, V20, P80, DOI 10.1659/0276-4741(2000)020[0080:ASOBOT]2.0.CO;2; Ozkur O, 2009, ENVIRON EXP BOT, V66, P487, DOI 10.1016/j.envexpbot.2009.04.003; Pandey A, 2008, MOL CELL PROTEOMICS, V7, P88, DOI 10.1074/mcp.M700314-MCP200; Plomion C, 2006, PROTEOMICS, V6, P6509, DOI 10.1002/pmic.200600362; Raven EL, 2002, ENZYME CATALYZED ELE, P317, DOI DOI 10.1007/0-306-46828-X_; Riccardi F, 1998, PLANT PHYSIOL, V117, P1253, DOI 10.1104/pp.117.4.1253; Sanchez FJ, 1998, FIELD CROP RES, V59, P225, DOI 10.1016/S0378-4290(98)00125-7; Sandalio LM, 2001, J EXP BOT, V52, P2115, DOI 10.1093/jexbot/52.364.2115; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sung DY, 2003, PLANT PHYSIOL, V132, P979, DOI 10.1104/pp.102.019398; Taiz L., 1998, PLANT PHYSIOL, P725; Wang XQ, 2009, PLANT PHYSIOL, V149, P1739, DOI 10.1104/pp.108.131714; Wilkinson S, 2010, PLANT CELL ENVIRON, V33, P510, DOI 10.1111/j.1365-3040.2009.02052.x; Windhof A, 2011, THESIS LMU; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Xu CP, 2008, J EXP BOT, V59, P4183, DOI 10.1093/jxb/ern258; Xu LX, 2013, ENVIRON EXP BOT, V89, P28, DOI 10.1016/j.envexpbot.2012.12.001; Yamasaki Simone, 1999, Revista Brasileira de Fisiologia Vegetal, V11, P69; Yue PP, 2011, RUSS J ECOL+, V42, P50, DOI 10.1134/S1067413611010140; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhang MH, 2010, PROTEOMICS, V10, P3117, DOI 10.1002/pmic.200900637; Zhu JM, 2007, PLANT PHYSIOL, V145, P1533, DOI 10.1104/pp.107.107250; Zhuang Q, 2010, GLOBAL ECOL BIOGEOGR, V19, P649, DOI 10.1111/j.1466-8238.2010.00559.x	55	25	29	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117475	10.1371/journal.pone.0117475	http://dx.doi.org/10.1371/journal.pone.0117475			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646623	Green Submitted, gold, Green Published			2022-12-26	WOS:000348822600071
J	Berland, A; Gaillard, P; Guidetti, M; Barone, P				Berland, Aurore; Gaillard, Pascal; Guidetti, Michele; Barone, Pascal			Perception of Everyday Sounds: A Developmental Study of a Free Sorting Task	PLOS ONE			English	Article							CATEGORIZATION; INFANTS; SPEECH; IDENTIFICATION; VOICE; ACQUISITION; INHIBITION; SIMILARITY; CHILDREN; OBJECT	Objectives The analysis of categorization of everyday sounds is a crucial aspect of the perception of our surrounding world. However, it constitutes a poorly explored domain in developmental studies. The aim of our study was to understand the nature and the logic of the construction of auditory cognitive categories for natural sounds during development. We have developed an original approach based on a free sorting task (FST). Indeed, categorization is fundamental for structuring the world and cognitive skills related to, without having any need of the use of language. Our project explored the ability of children to structure their acoustic world, and to investigate how such structuration matures during normal development. We hypothesized that age affects the listening strategy and the category decision, as well as the number and the content of individual categories. Design Eighty-two French children (6-9 years), 20 teenagers (12-13 years), and 24 young adults participated in the study. Perception and categorization of everyday sounds was assessed based on a FST composed of 18 different sounds belonging to three a priori categories: non-linguistic human vocalizations, environmental sounds, and musical instruments. Results Children listened to the sounds more times than older participants, built significantly more classes than adults, and used a different strategy of classification. We can thus conclude that there is an age effect on how the participants accomplished the task. Analysis of the auditory categorization performed by 6-year-old children showed that this age constitutes a pivotal stage, in agreement with the progressive change from a non-logical reasoning based mainly on perceptive representations to the logical reasoning used by older children. In conclusion, our results suggest that the processing of auditory object categorization develops through different stages, while the intrinsic basis of the classification of sounds is already present in childhood.	[Berland, Aurore; Gaillard, Pascal; Guidetti, Michele] Univ Toulouse Jean Jaures, Lab Cognit Commun & Dev, EA4156, Unite Rech Interdisciplinaire Octogone, Toulouse, France; [Berland, Aurore; Barone, Pascal] Univ Toulouse UPS, Ctr Rech Cerveau & Cognit, CNRS UMR 5549, Toulouse, France	Universite de Toulouse; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE)	Barone, P (corresponding author), Univ Toulouse UPS, Ctr Rech Cerveau & Cognit, CNRS UMR 5549, Toulouse, France.	barone@cerco.ups-tlse.fr	Barone, Pascal/A-4008-2009; BARONE, Pascal/AHE-2323-2022; Gaillard, Pascal/H-7048-2018	BARONE, Pascal/0000-0003-0125-7468; Gaillard, Pascal/0000-0003-0389-1593; Guidetti, Michele/0000-0002-1678-946X	Center of Research and Higher Education of Toulouse; CNRS; Octogone-ECCD	Center of Research and Higher Education of Toulouse; CNRS(Centre National de la Recherche Scientifique (CNRS)); Octogone-ECCD	Support provided by the Center of Research and Higher Education of Toulouse (http://www.univ-toulouse.fr) and the recurrent funding of the CNRS, and of Octogone-ECCD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 1990, Lecture Notes in Biomathematics, V84, P43; Aldrich KM, 2009, Q J EXP PSYCHOL, V62, P63, DOI 10.1080/17470210701814451; BALLAS JA, 1993, J EXP PSYCHOL HUMAN, V19, P250, DOI 10.1037/0096-1523.19.2.250; Ballas JA, 1991, HUM PERFORM, V4, P199, DOI DOI 10.1207/S15327043HUP0403_3; Barthelemy J-P, 1991, SEMANTIQUE COGNITION, P205, DOI [10.1167/15.1.18, DOI 10.1167/15.1.18]; Barthelemy JP, 1991, TREES PROXIMITY REPR; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Belin P, 2010, NEURON, V65, P733, DOI 10.1016/j.neuron.2010.03.018; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; BERTONCINI J, 1988, J EXP PSYCHOL GEN, V117, P21, DOI 10.1037/0096-3445.117.1.21; Bertoncini J, 2011, J ACOUST SOC AM, V129, P2761, DOI 10.1121/1.3571424; Blaye A, 2006, EUR J DEV PSYCHOL, V3, P163, DOI 10.1080/17405620500412267; Bonthoux F, 2004, NAISSANCE DEV CONCEP; Brenac T, 2002, CONTRIBUTION METHODE; BURNHAM DK, 1991, J CHILD LANG, V18, P231, DOI 10.1017/S0305000900011041; Cabrera L, 2013, J SPEECH LANG HEAR R, V56, P1733, DOI 10.1044/1092-4388(2013/12-0169); CECI SJ, 1991, DEV PSYCHOL, V27, P703, DOI 10.1037/0012-1649.27.5.703; Chanquoy L, 2007, CHARGE COGNITIVE THE, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Coulet JC, 1998, ANN PSYCHOL, V98, P9; DAEHLER MW, 1979, CHILD DEV, V50, P170, DOI 10.1111/j.1467-8624.1979.tb02991.x; David S, 2002, CAHIERS LCPE CNRS AR, V6, P29; Demany Laurent, 2008, V29, P77; Dowling WJ, 1999, PSYCHOL MUSIC, P603, DOI DOI 10.1016/B978-012213564-4/50016-0; Dubois D, 1991, SEMANTIQUE COGNITION; DUBOIS D., 2000, COGNITIVE SCI Q, V1, P35; Dubois D., 1997, CATEGORISATION COGNI; DURLACH NI, 1969, J ACOUST SOC AM, V46, P372, DOI 10.1121/1.1911699; Eisenberg Daniel, 2015, J MENT HEALTH, V20, P222, DOI [10.3109/10673229.2012.712839, DOI 10.3109/09638237.2014.954693, 10.3109/08039481003777484]; FAYE P., 2011, REV MODULAD, V43, P1; FENSON L, 1988, CHILD DEV, V59, P897, DOI 10.1111/j.1467-8624.1988.tb03243.x; Gaillard P, 2009, SENTIR DIRE CONCEPTS, P189; Garner W. R., 1974, PROCESSING INFORM ST; GAVER WW, 1993, ECOL PSYCHOL, V5, P1, DOI 10.1207/s15326969eco0501_1; GAVER WW, 1993, ECOL PSYCHOL, V5, P285, DOI 10.1207/s15326969eco0504_2; Gentner D, 1999, COGNITIVE DEV, V14, P487, DOI 10.1016/S0885-2014(99)00016-7; Gentner D, 2006, CURR DIR PSYCHOL SCI, V15, P297, DOI 10.1111/j.1467-8721.2006.00456.x; Giordano BL, 2011, MULTIVAR BEHAV RES, V46, P779, DOI 10.1080/00273171.2011.606748; Giordano BL, 2010, BRAIN COGNITION, V73, P7, DOI 10.1016/j.bandc.2010.01.005; Gooding L., 2011, UPDATE APPL RES MUSI, V30, P32, DOI [DOI 10.1177/8755123311418481, 10.1177/8755123311418481]; GOPNIK A, 1987, CHILD DEV, V58, P1523, DOI 10.2307/1130692; Goudbeek M, 2005, HDB CATEGORIZATION C, P497; Grossmann T, 2010, NEURON, V65, P852, DOI 10.1016/j.neuron.2010.03.001; Guastavino C, 2007, CAN J EXP PSYCHOL, V61, P54, DOI 10.1037/cjep2007006; Guenoche A, 2000, LECT NOTES COMPUTER, V2066, P45; Guenoche A, 2012, MATH SCI HUMAINES, V197, P65, DOI [10.1016/j.ejmp.2014.12.008, DOI 10.1016/J.EJMP.2014.12.008]; Guenoche A, 2011, ADV DATA ANAL CLASSI, V5, P215, DOI 10.1007/s11634-011-0087-6; Guyot F, 1996, THESIS U MAINE, P41; Guyot F, 1997, CATEGORISATION COGNI, P41, DOI [10.3855/jidc.5778, DOI 10.3855/JIDC.5778]; Gygi B, 2001, THESIS INDIANA U IND; Gygi B, 2007, PERCEPT PSYCHOPHYS, V69, P839, DOI 10.3758/BF03193921; Hailstone JC, 2010, NEUROPSYCHOLOGIA, V48, P1104, DOI 10.1016/j.neuropsychologia.2009.12.011; Houde O, 1996, REV NEUROPSYCHOL, V6, P329; Houde O, 2000, COGNITIVE DEV, V15, P63, DOI 10.1016/S0885-2014(00)00015-0; HOUDE O, 1995, REV NEUROPSYCHOL, V5, P281; Houde O, 1992, CATEGORISATION DEV C; Houde O, 1995, RATINOALITE DEV INHI; Houix O, 2012, J EXP PSYCHOL-APPL, V18, P52, DOI 10.1037/a0026240; Inverso Y, 2009, PERSPECTIVES HEARING, V19, P43; Inverso Y, 2010, EAR HEARING, V31, P505, DOI 10.1097/AUD.0b013e3181d99a52; JUSCZYK PW, 1995, COGNITIVE PSYCHOL, V29, P1, DOI 10.1006/cogp.1995.1010; Kail M, 2000, ACQUISITION LANGAGE, DOI [10.1016/j.arcped.2014.10.027, DOI 10.1016/J.ARCPED.2014.10.027]; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; KUHL PK, 1983, INFANT BEHAV DEV, V6, P263, DOI 10.1016/S0163-6383(83)80036-8; KUHL PK, 1979, J ACOUST SOC AM, V66, P1668, DOI 10.1121/1.383639; Kuhl PK, 2009, PERCEPTION SPEECH SO, P103; Lautrey J, 1998, PIAG APR PIAG PIAG P; LAWSON AE, 1993, J RES SCI TEACH, V30, P1029, DOI 10.1002/tea.3660300904; Lemaitre G, 2010, J EXP PSYCHOL-APPL, V16, P16, DOI 10.1037/a0018762; LUCARIELLO J, 1992, CHILD DEV, V63, P978; Marcell ME, 2000, J CLIN EXP NEUROPSYC, V22, P830, DOI 10.1076/jcen.22.6.830.949; MARKMAN EM, 1981, DEV PSYCHOL, V17, P115, DOI 10.1037/0012-1649.17.1.115; Markman EM, 1991, CATEGORIZATION NAMIN; McAdams S, 1993, THINKING IN SOUND; Moon C, 2013, ACTA PAEDIATR, V102, P156, DOI 10.1111/apa.12098; Mounoud P, 1994, ENFANCE, V47, P5; Namy LL, 2002, J EXP PSYCHOL GEN, V131, P5, DOI 10.1037//0096-3445.131.1.5; NELSON K., 1985, MAKING SENSE ACQUISI; Parizet E, 2012, APPL ACOUST, V73, P61, DOI 10.1016/j.apacoust.2011.07.007; Piaget J, 1959, GENESE STRUCTURES LO; Poitevineau J, 2002, ARBRES CLASSES DISTA; Poitevineau J, 2009, PRENDRE SES DISTANCE, P255; Polka L, 2013, P M ACOUSTICS, V19; Pothos EM, 2011, COGNITION, V121, P83, DOI 10.1016/j.cognition.2011.06.002; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rosch E, 1976, B PSYCHOL, P242; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; ROSCH EH, 1973, COGNITIVE PSYCHOL, V4, P328, DOI 10.1016/0010-0285(73)90017-0; Sattah A, 1977, PSYCHOMETRIKA, V42, P19; SCOTT MS, 1982, INT J BEHAV DEV, V5, P243, DOI 10.1177/016502548200500206; Seifert KL, 2006, HDB RES ED YOUNG CHI; Shafiro V, 2008, EAR HEARING, V29, P401, DOI 10.1097/AUD.0b013e31816a0cf1; SMILEY SS, 1979, J EXP CHILD PSYCHOL, V28, P249, DOI 10.1016/0022-0965(79)90087-0; Swingley D, 2000, COGNITION, V76, P147, DOI 10.1016/S0010-0277(00)00081-0; Trawick-Smith J, 2003, EARLY CHILDHOOD DEV; Trehub SE, 2006, COGNITION, V100, P73, DOI 10.1016/j.cognition.2005.11.006; Valentin D, 2012, J EXP CHILD PSYCHOL, V113, P337, DOI 10.1016/j.jecp.2012.05.007; Vanderveer NJ, 1979, ECOLOGICAL ACOUSTICS; Weinberger NM, 1999, PSYCHOL MUSIC, P47; Werner L, 2007, WHAT DO CHILDREN HEA; WERNEROLSHO L, 1988, J ACOUST SOC AM, V84, P1316, DOI 10.1121/1.396630; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	104	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115557	10.1371/journal.pone.0115557	http://dx.doi.org/10.1371/journal.pone.0115557			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QK	25643286	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821200011
J	George, BJ; Reif, DM; Gallagher, JE; Williams-DeVane, CR; Heidenfelder, BL; Hudgens, EE; Jones, W; Neas, L; Hubal, EAC; Edwards, SW				George, Barbara Jane; Reif, David M.; Gallagher, Jane E.; Williams-DeVane, ClarLynda R.; Heidenfelder, Brooke L.; Hudgens, Edward E.; Jones, Wendell; Neas, Lucas; Hubal, Elaine A. Cohen; Edwards, Stephen W.			Data-Driven Asthma Endotypes Defined from Blood Biomarker and Gene Expression Data	PLOS ONE			English	Article							EXHALED NITRIC-OXIDE; OBESE INDIVIDUALS; PHENOTYPES; ASSOCIATION; IDENTIFICATION; ADIPONECTIN; CHILDREN; DISEASE	The diagnosis and treatment of childhood asthma is complicated by its mechanistically distinct subtypes (endotypes) driven by genetic susceptibility and modulating environmental factors. Clinical biomarkers and blood gene expression were collected from a stratified, cross-sectional study of asthmatic and non-asthmatic children from Detroit, MI. This study describes four distinct asthma endotypes identified via a purely data-driven method. Our method was specifically designed to integrate blood gene expression and clinical biomarkers in a way that provides new mechanistic insights regarding the different asthma endotypes. For example, we describe metabolic syndrome-induced systemic inflammation as an associated factor in three of the four asthma endotypes. Context provided by the clinical biomarker data was essential in interpreting gene expression patterns and identifying putative endotypes, which emphasizes the importance of integrated approaches when studying complex disease etiologies. These synthesized patterns of gene expression and clinical markers from our research may lead to development of novel serum-based biomarker panels.	[George, Barbara Jane] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA; [Reif, David M.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA; [Gallagher, Jane E.; Heidenfelder, Brooke L.; Hudgens, Edward E.; Neas, Lucas] US EPA, Natl Hlth & Environm Effects Res Lab, Environm Publ Hlth Div, Res Triangle Pk, NC 27711 USA; [Williams-DeVane, ClarLynda R.; Edwards, Stephen W.] US EPA, Natl Hlth & Environm Effects Res Lab, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA; [Jones, Wendell] Quintiles Co, Dept Bioinformat, Express Anal, Durham, NC USA; [Hubal, Elaine A. Cohen] US EPA, Off Res & Dev, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; IQVIA; United States Environmental Protection Agency	Edwards, SW (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Integrated Syst Toxicol Div, Res Triangle Pk, NC 27711 USA.	edwards.stephen@epa.gov	Jones, Wendell/AAM-4831-2021	Neas, Lucas/0000-0002-9377-8334; Williams-DeVane, ClarLynda/0000-0002-1013-5545; Edwards, Stephen/0000-0002-7985-111X; Jones, Wendell/0000-0002-9676-5387; Reif, David/0000-0001-7815-6767	National Health and Environmental Effects Research Laboratory; National Center for Computational Toxicology within the U.S. Environmental Protection Agency (EPA) Office of Research and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043446] Funding Source: NIH RePORTER	National Health and Environmental Effects Research Laboratory; National Center for Computational Toxicology within the U.S. Environmental Protection Agency (EPA) Office of Research and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the National Health and Environmental Effects Research Laboratory and the National Center for Computational Toxicology within the U.S. Environmental Protection Agency (EPA) Office of Research and Development. This manuscript has been subjected to review by the US Environmental Protection Agency, National Health and Environmental Effects Research Laboratory and approved for publication. Approval does not signify that the contents reflect the views of the Agency, nor does the mention of trade names or commercial products constitute endorsement or recommendation for use. Except as noted above, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami Lara J, 2011, Natl Health Stat Report, P1; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Assad N, 2013, AM J RESP CRIT CARE, V188, P319, DOI 10.1164/rccm.201303-0457OC; Baines KJ, 2011, J ALLERGY CLIN IMMUN, V127, P153, DOI 10.1016/j.jaci.2010.10.024; Barnes Kathleen C, 2007, Proc Am Thorac Soc, V4, P58, DOI 10.1513/pats.200607-146JG; Bhakta NR, 2011, IMMUNOL REV, V242, P220, DOI 10.1111/j.1600-065X.2011.01032.x; Bjornsdottir US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021902; Borrell LN, 2013, AM J RESP CRIT CARE, V187, P697, DOI 10.1164/rccm.201211-2116OC; Boudier A, 2013, AM J RESP CRIT CARE, V188, P550, DOI 10.1164/rccm.201301-0156OC; Bryborn M, 2010, ALLERGY, V65, P220, DOI 10.1111/j.1398-9995.2009.02141.x; Carolan BJ, 2013, AM J RESP CRIT CARE, V188, P561, DOI 10.1164/rccm.201212-2299OC; Chawes BLK, 2011, AM J RESP CRIT CARE, V184, P656, DOI 10.1164/rccm.201101-0111OC; Choy DF, 2011, J IMMUNOL, V186, P1861, DOI 10.4049/jimmunol.1002568; Desai D, 2013, AM J RESP CRIT CARE, V188, P657, DOI 10.1164/rccm.201208-1470OC; Dixon AE, 2012, AM J RESP CRIT CARE, V186, P395, DOI 10.1164/rccm.201206-1092ED; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; FAJANS SS, 1989, DIABETES METAB REV, V5, P579, DOI 10.1002/dmr.5610050705; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Fogg DK, 2002, BIOCHEMISTRY-US, V41, P4953, DOI 10.1021/bi012045y; Gallagher J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-344; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; GUIGNARD F, 1995, BIOCHEM J, V309, P395, DOI 10.1042/bj3090395; Holguin F, 2013, AM J RESP CRIT CARE, V187, P153, DOI 10.1164/rccm.201207-1270OC; Juel CTB, 2012, J ASTHMA ALLERGY, V5, P21, DOI 10.2147/JAA.S32232; Just J, 2012, J ALLERGY CLIN IMMUN, V130, P103, DOI 10.1016/j.jaci.2012.02.041; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Lugogo NL, 2012, AM J RESP CRIT CARE, V186, P404, DOI 10.1164/rccm.201109-1671OC; Lugogo NL, 2010, J APPL PHYSIOL, V108, P729, DOI 10.1152/japplphysiol.00845.2009; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; McNicholl DM, 2012, AM J RESP CRIT CARE, V186, P1102, DOI 10.1164/rccm.201204-0587OC; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Mullane K, 2011, BIOCHEM PHARMACOL, V82, P586, DOI 10.1016/j.bcp.2011.06.033; Nakanishi K, 2011, AM J RESP CRIT CARE, V183, P1164, DOI 10.1164/rccm.201007-1091OC; Naqvi M, 2007, J ALLERGY CLIN IMMUN, V120, P137, DOI 10.1016/j.jaci.2007.02.045; Paraskakis E, 2006, AM J RESP CRIT CARE, V174, P260, DOI 10.1164/rccm.200506-962OC; Pendharkar S, 2008, CAN RESPIR J, V15, P99, DOI 10.1155/2008/463762; Peters MC, 2013, AM J RESP CRIT CARE, V188, P633, DOI 10.1164/rccm.201307-1360ED; Potapov Viktor A, 2008, Rev Diabet Stud, V5, P28, DOI 10.1900/RDS.2008.5.28; Research Triangle Institute, 2012, SUDAAN LANG MAN, V2; Research Triangle Institute, 2012, SUDAAN LANG MAN, V1; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; *SAS I INC, 2010, SAS 9 2 LANG REF DIC, P13897; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Sood A, 2012, AM J RESP CRIT CARE, V186, P41, DOI 10.1164/rccm.201110-1767OC; Sutherland ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036631; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979; Tahvanainen J, 2009, BLOOD, V113, P1268, DOI 10.1182/blood-2008-07-166553; Verrills NM, 2011, AM J RESP CRIT CARE, V183, P1633, DOI 10.1164/rccm.201010-1623OC; von Mutius E, 2013, AM J RESP CRIT CARE, V188, P150, DOI 10.1164/rccm.201303-0468UP; Welsch R, 1980, REGRESSION DIAGNOSTI; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Williams-DeVane CR, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-119; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Yang LL, 2011, INT ARCH ALLERGY IMM, V156, P373, DOI 10.1159/000324448	59	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117445	10.1371/journal.pone.0117445	http://dx.doi.org/10.1371/journal.pone.0117445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643280	Green Submitted, gold, Green Published			2022-12-26	WOS:000348821200038
J	Almonte, M; Ferreccio, C; Luciani, S; Gonzales, M; Delgado, JM; Santos, C; Alvarez, M; Cuzick, J; Sasieni, P				Almonte, Maribel; Ferreccio, Catterina; Luciani, Silvana; Gonzales, Miguel; Delgado, Jose M.; Santos, Carlos; Alvarez, Manuel; Cuzick, Jack; Sasieni, Peter			Visual Inspection after Acetic Acid (VIA) Is Highly Heterogeneous in Primary Cervical Screening in Amazonian Peru	PLOS ONE			English	Article							CANCER PREVENTION; ACCURACY; CYTOLOGY; TESTS; WOMEN	Background Conventional cytology (Pap) and visual inspection after the application of acetic acid (VIA) are currently used in primary screening in Peru. Studies suggest that the quality of VIA is highly variable. Over 36 000 women were screened with Pap and VIA in the TATI (Tamizaje y Tratamiento Inmediato de Lesiones Cervico-uterinas) project conducted in Amazonian Peru. Within a nested study to compare several screening techniques (C-TATI), a total of 5435 women were additionally screened with liquid-based cytology (LBC) and high-risk human papillomavirus testing (HR-HPV). We investigate the variation of positivity rates of VIA, Pap, LBC and HR-HPV in C-TATI and of VIA in the full TATI intervention. Methods At the screening visit, midwives collected three cervical samples for Pap, LBC and HC2 before performing VIA. The dispersion factor "D" (D = Pearson chi-square value/degrees-of-freedom) was used to measure the variability of tests results. Within C-TATI, the variability of positivity rates of VIA, Pap, LBC and HR-HPV was also graphically assessed with box- and scatter plots by midwife and month of screening. Funnel plots and smoothed scatter plots were used to correlate the variation of VIA by the number of examinations performed by each midwife over the full TATI intervention. Results Consistently over TATI, VIA results were highly variable, independently of the examiner, the time when the test was performed and the number of tests the examiner performed (D>6, p-values<0.001). In C-TATI, VIA results varied the most while those of HR-HPV varied the least (Ds>25, p-values<0.001 for VIA, Ds<1.6, p-values>0.05 for HR-HPV). No evidence for correlation between the number of VIAs done per midwife and the variability of VIA results was observed. Conclusion The lack of over-dispersion for HR-HPV detection suggests that the variable VIA results do not reflect true variation in underlying disease, but a lack of consistency in human judgement.	[Almonte, Maribel] Int Agcy Res Canc, F-69372 Lyon, France; [Almonte, Maribel; Cuzick, Jack; Sasieni, Peter] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Canc Prevent, London, England; [Ferreccio, Catterina] Pontificia Univ Catolica Chile, Fac Med, Adv Ctr Chron Dis, ACCDIS FONDAP, Santiago, Chile; [Luciani, Silvana] Pan Amer Hlth Org, Washington, DC USA; [Gonzales, Miguel; Delgado, Jose M.] Direcc Reg Salud San Martin, San Martin, Peru; [Santos, Carlos; Alvarez, Manuel] Inst Nacl Enfermedades Neoplasicas, Lima, Peru	World Health Organization; International Agency for Research on Cancer (IARC); University of London; Queen Mary University London; Pontificia Universidad Catolica de Chile; Pan American Health Organization; Instituto Nacional de Enfermedades Neoplasicas	Almonte, M (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	AlmonteM@iarc.fr	Bardales, José Manuel Delgado/AAL-1882-2021; Almonte, Maribel/O-3286-2016	Bardales, José Manuel Delgado/0000-0001-6574-2759; ferreccio, catterina/0000-0001-6331-5534; Sasieni, Peter/0000-0003-1509-8744	Bill & Melinda Gates Foundation through the Alliance for Cervical Cancer Prevention; Cancer Research UK; Cancer Research UK [16892, 16893, 16891] Funding Source: researchfish	Bill & Melinda Gates Foundation through the Alliance for Cervical Cancer Prevention(Bill & Melinda Gates Foundation); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The TATI project was conducted with the generous support of the Bill & Melinda Gates Foundation to the Pan American Health Organization through the Alliance for Cervical Cancer Prevention. Cancer Research UK provided financial support for the additional work involved in this study including the cost of HPV and LBC testing.	Ajenifuja KO, 2013, INT J GYNECOL CANCER, V23, P507, DOI 10.1097/IGC.0b013e318280f395; Almonte M, 2007, INT J CANCER, V121, P796, DOI 10.1002/ijc.22757; [Anonymous], 2005, IARC HANDBOOKS OF CA, V10; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Belinson J, 2001, GYNECOL ONCOL, V83, P439, DOI 10.1006/gyno.2001.6370; CECCHINI S, 1993, TUMORI, V79, P22, DOI 10.1177/030089169307900104; Chirenje Z. M., 1999, Central African Journal of Medicine, V45, P30; Chirenje ZM, 1999, CENT AFR J MED, V45, P79; Denny L, 2002, CANCER-AM CANCER SOC, V94, P1699, DOI 10.1002/cncr.10381; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Luciani S, 2006, CERVICAL CANCER PREV; Murillo R, 2010, INT J GYNECOL OBSTET, V109, P230, DOI 10.1016/j.ijgo.2010.01.019; Perez-Cruz E, 2005, SALUD PUBLICA MEXICO, V47, P39, DOI 10.1590/S0036-36342005000100007; Robles SC, 2009, REV PANAM SALUD PUBL, V25, P189, DOI 10.1590/S1020-49892009000300001; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sarian LO, 2005, J MED SCREEN, V12, P142, DOI 10.1258/0969141054855328; Sasieni P, 1999, BRIT MED J, V318, P1244; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Vedantham H, 2010, CANCER EPIDEM BIOMAR, V19, P1373, DOI 10.1158/1055-9965.EPI-09-1282; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization, 2013, WHO GUIDELINES FOR S	24	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115355	10.1371/journal.pone.0115355	http://dx.doi.org/10.1371/journal.pone.0115355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635965	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700009
J	Ma, XY; Zheng, CT; Hu, YJ; Wang, L; Yang, XF; Jiang, ZY				Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong			Dietary L-Arginine Supplementation Affects the Skeletal Longissimus Muscle Proteome in Finishing Pigs	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; MEAT QUALITY TRAITS; MYOSIN HEAVY-CHAIN; PORCINE ADIPOSE-TISSUE; SERUM RESPONSE FACTOR; TROPONIN-I GENE; INTRAMUSCULAR FAT; EXTRACELLULAR-MATRIX; PORK QUALITY; NITRIC-OXIDE	Forty-eight Duroc x Landrace x Large White gilts were used to determine the relationship between proteome changes of longissimus muscle and intramuscular fat (IMF) content in arginine-supplemented pigs. Beginning at 60 kg BW, pigs were fed a corn- and soybean meal-based diet supplemented or not with 1% L-arginine until they reached a BW of 100 kg. Supplementation with 1% L-arginine did not affect the growth performance or carcass traits, while it increased IMF content by 32% (P < 0.01), it also decreased the drip loss at 48 h post-mortem and the b* meat color value at 24 h post-mortem; supplementation with 1% dietary L-arginine did not change the proportion of SFA and MUFA in muscle lipids. The proteome changes in longissimus muscle between the control and supplemented pigs showed that L-arginine significantly influenced the abundance of proteins related to energy metabolism, fiber type and structure. The increase in IMF content was positively correlated with the increased abundance of slow twitch troponin I (TNNI1) protein and negatively correlated with myosin heavy chain IIb (MyHC IIb) protein content. It is suggested that the proteome changes in longissimus muscle contributed to the greater IMF content in L-arginine supplemented pigs.	[Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China; [Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong] State Key Lab Livestock & Poultry Breeding, Guangzhou, Guangdong, Peoples R China; [Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong] Minist Agr, Key Lab Anim Nutr & Feed Sci South China, Guangzhou, Guangdong, Peoples R China; [Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong] Guangdong Publ Lab Anim Breeding & Nutr, Guangzhou, Guangdong, Peoples R China; [Ma, Xianyong; Zheng, Chuntian; Hu, Youjun; Wang, Li; Yang, Xuefen; Jiang, Zongyong] Guangdong Key Lab Anim Breeding & Nutr, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Jiang, ZY (corresponding author), Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Guangdong, Peoples R China.	jiangz28@qq.com	Yang, Xuefen/GQB-3094-2022	Zheng, Chuntian/0000-0002-1967-9477	Guangdong Natural Science foundation [10151064001000031]; earmarked fund for Modern Agro-industry Technology Research System [CARS-36]; National 973' Project of China [2012CB124706-4, 2012CB124706-5]; national 948 plan [2013-S24]	Guangdong Natural Science foundation(National Natural Science Foundation of Guangdong Province); earmarked fund for Modern Agro-industry Technology Research System; National 973' Project of China(National Basic Research Program of China); national 948 plan	This work was supported by grants from Guangdong Natural Science foundation (10151064001000031) (http://gdsf.gdstc.gov.cn/User/User.aspx), the earmarked fund for Modern Agro-industry Technology Research System (CARS-36) (http://119.253.58.231), the National 973' Project of China (2012CB124706-4 and 2012CB124706-5) (http://www.973.gov.cn/AreaMana.aspx) and the national 948 plan (2013-S24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 1995, 99136 AOAC; AZAIN MJ, 1993, J ANIM SCI, V71, P3011, DOI 10.2527/1993.71113011x; BANKS RD, 1979, NATURE, V279, P773, DOI 10.1038/279773a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broos S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049281; Cameron ND, 2000, MEAT SCI, V55, P187, DOI 10.1016/S0309-1740(99)00142-4; Chang KC, 2003, MEAT SCI, V64, P93, DOI 10.1016/S0309-1740(02)00208-5; Choi SH, 2014, AMINO ACIDS, V46, P353, DOI 10.1007/s00726-013-1622-x; Choi YM, 2007, MEAT SCI, V76, P281, DOI 10.1016/j.meatsci.2006.11.009; CORIN SJ, 1994, J BIOL CHEM, V269, P10651; Dai ZL, 2013, BIOFACTORS, V39, P383, DOI 10.1002/biof.1099; ESSENGUSTAVSSON B, 1994, MEAT SCI, V38, P269, DOI 10.1016/0309-1740(94)90116-3; FERNANDEZ JLR, 1989, DIFFERENTIATION, V42, P65, DOI 10.1111/j.1432-0436.1989.tb00608.x; Fernandez X, 1999, MEAT SCI, V53, P59, DOI 10.1016/S0309-1740(99)00037-6; Fu WJJ, 2005, J NUTR, V135, P714, DOI 10.1093/jn/135.4.714; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Go G, 2012, AMINO ACIDS, V43, P1713, DOI 10.1007/s00726-012-1255-5; Grider A, 2007, J NUTR BIOCHEM, V18, P753, DOI 10.1016/j.jnutbio.2006.11.013; Guo W, 2008, ASIAN AUSTRAL J ANIM, V21, P11, DOI 10.5713/ajas.2008.60256; Han ZD, 2012, MED ONCOL, V29, P2877, DOI 10.1007/s12032-011-0149-9; He QH, 2009, AMINO ACIDS, V37, P199, DOI 10.1007/s00726-008-0192-9; Hwang IH, 2005, MEAT SCI, V69, P79, DOI 10.1016/j.meatsci.2004.06.019; Jobgen WJ, 2009, J NUTR, V139, P230, DOI 10.3945/jn.108.096362; Jobgen W, 2009, AMINO ACIDS, V37, P187, DOI 10.1007/s00726-009-0246-7; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699; Keady SM, 2013, J ANIM SCI, V91, P654, DOI 10.2527/jas.2012-5850; Kharbanda KK, 2009, BIOCHEM BIOPH RES CO, V381, P523, DOI 10.1016/j.bbrc.2009.02.082; Kim NK, 2009, BMB REP, V42, P433, DOI 10.5483/BMBRep.2009.42.7.433; Kim SW, 2004, J NUTR, V134, P625, DOI 10.1093/jn/134.3.625; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; Lametsch R, 2006, J ANIM SCI, V84, P918, DOI 10.2527/2006.844918x; Lawrie RA, 1985, MEAT SCI, DOI [10.1016/0309-1740(85)90052-X, DOI 10.1016/0309-1740(85)90052-X]; Li AN, 2013, MAMM GENOME, V24, P72, DOI 10.1007/s00335-012-9440-0; Lonergan SM, 2007, J ANIM SCI, V85, P1074, DOI 10.2527/jas.2006-413; Ma XY, 2010, AMINO ACIDS, V38, P95, DOI 10.1007/s00726-008-0213-8; Mason LM, 2005, MEAT SCI, V70, P307, DOI 10.1016/j.meatsci.2005.01.017; McKnight JR, 2010, AMINO ACIDS, V39, P349, DOI 10.1007/s00726-010-0598-z; Mullen AJ, 2000, GENE, V242, P313, DOI 10.1016/S0378-1119(99)00519-3; Muroya S, 2010, MEAT SCI, V86, P764, DOI 10.1016/j.meatsci.2010.06.019; Nall JL, 2009, J NUTR, V139, P1279, DOI 10.3945/jn.108.102301; Nirmalan NJ, 2009, J PATHOL, V217, P497, DOI 10.1002/path.2504; NPPC, 1991, 3 NAT PORK PROD COUN; Obel Linea F, 2012, Front Neuroenergetics, V4, P3, DOI 10.3389/fnene.2012.00003; Pas MFWT, 2009, MEAT SCI, V83, P744, DOI 10.1016/j.meatsci.2009.08.030; Pierzchala M, 2014, J ANIM BREED GENET, DOI [10.1111/jbg.12122, DOI 10.1111/JBG.12122]; Polly P, 2003, J BIOL CHEM, V278, P36603, DOI 10.1074/jbc.M212814200; Pomies P, 2007, MOL BIOL CELL, V18, P1723, DOI 10.1091/mbc.E06-09-0815; Raj S, 2010, MEAT SCI, V86, P324, DOI 10.1016/j.meatsci.2010.04.037; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Science and Technology Ministry of China, 2006, 398 SCI TECHN MIN CH; Sherwood RI, 2006, TRENDS MOL MED, V12, P189, DOI 10.1016/j.molmed.2006.03.002; Singh J, 2007, MOL CELL BIOCHEM, V294, P163, DOI 10.1007/s11010-006-9256-x; Tan BE, 2012, FRONT BIOSCI-LANDMRK, V17, P2237, DOI 10.2741/4047; Tan B, 2011, J NUTR BIOCHEM, V22, P441, DOI 10.1016/j.jnutbio.2010.03.012; Tan B, 2009, AMINO ACIDS, V37, P169, DOI 10.1007/s00726-008-0148-0; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; van de Wiel DFM, 2007, MEAT SCI, V77, P46, DOI 10.1016/j.meatsci.2007.04.017; Vincent B, 2007, PHYSIOL GENOMICS, V32, P58, DOI 10.1152/physiolgenomics.00173.2007; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang JJ, 2006, J NUTR, V136, P1759, DOI 10.1093/jn/136.7.1759; Wimmers K, 2008, J ANIM SCI, V86, P795, DOI 10.2527/jas.2006-521; Wu GY, 2014, ANNU REV ANIM BIOSCI, V2, P387, DOI 10.1146/annurev-animal-022513-114113; Wu ZL, 2012, CURR OPIN CLIN NUTR, V15, P529, DOI 10.1097/MCO.0b013e3283595cff; Xia HH, 1997, J CELL BIOL, V139, P507, DOI 10.1083/jcb.139.2.507; Xu YJ, 2008, BRIT J NUTR, V99, P455, DOI 10.1017/S0007114507812074; Xu YJ, 2012, J PROTEOMICS, V75, P2093, DOI 10.1016/j.jprot.2012.01.013; YAMASHITA K, 1991, J MUSCLE RES CELL M, V12, P37, DOI 10.1007/BF01781172; Yang H, 2010, J APPL GENET, V51, P51, DOI 10.1007/BF03195710; Yu KF, 2013, INT J BIOL SCI, V9, P108, DOI 10.7150/ijbs.5306	70	205	210	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117294	10.1371/journal.pone.0117294	http://dx.doi.org/10.1371/journal.pone.0117294			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635834	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700078
J	Worku, AG; Tessema, GA; Zeleke, AA				Worku, Abebaw Gebeyehu; Tessema, Gizachew Assefa; Zeleke, Atinkut Alamirrew			Trends of Modern Contraceptive Use among Young Married Women Based on the 2000, 2005, and 2011 Ethiopian Demographic and Health Surveys: A Multivariate Decomposition Analysis	PLOS ONE			English	Article								Introduction Accessing family planning can reduce a significant proportion of maternal, infant, and childhood deaths. In Ethiopia, use of modern contraceptive methods is low but it is increasing. This study aimed to analyze the trends and determinants of changes in modern contraceptive use over time among young married women in Ethiopia. Methods T he study used data from the three Demographic Health Surveys conducted in Ethiopia, in 2000, 2005, and 2011. Young married women age 15-24 years with sample sizes of 2,157 in 2000, 1,904 in 2005, and 2,146 in 2011 were included. Logit-based decomposition analysis technique was used for analysis of factors contributing to the recent changes. STATA 12 was employed for data management and analyses. All calculations presented in this paper were weighted for the sampling probabilities and non-response. Complex sampling procedures were also considered during testing of statistical significance. Results Among young married women, modern contraceptive prevalence increased from 6% in 2000 to 16% in 2005 and to 36% in 2011. The decomposition analysis indicated that 34% of the overall change in modern contraceptive use was due to difference in women's characteristics. Changes in the composition of young women's characteristics according to age, educational status, religion, couple concordance on family size, and fertility preference were the major sources of this increase. Two-thirds of the increase in modern contraceptive use was due to difference in coefficients. Most importantly, the increase was due to change in contraceptive use behavior among the rural population (33%) and among Orthodox Christians (16%) and Protestants (4%). Conclusions Modern contraceptive use among young married women has showed a remarkable increase over the last decade in Ethiopia. Programmatic interventions targeting poor, younger (adolescent), illiterate, and Muslim women would help to maintain the increasing trend in modern contraceptive use.	[Worku, Abebaw Gebeyehu; Tessema, Gizachew Assefa] Univ Gondar, Inst Publ Hlth, Dept Reprod Hlth, Gondar, Ethiopia; [Zeleke, Atinkut Alamirrew] Univ Gondar, Inst Publ Hlth, Dept Hlth Informat, Gondar, Ethiopia	University of Gondar; University of Gondar	Worku, AG (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Reprod Hlth, Gondar, Ethiopia.	abebawgebeyehu@yahoo.com	Zeleke, Atinkut Alamirrew/I-4137-2019; Tessema, Gizachew A/J-9235-2018	Zeleke, Atinkut Alamirrew/0000-0001-7838-9050; Tessema, Gizachew A/0000-0002-4784-8151; Worku, Abebaw Gebeyehu/0000-0002-1146-3399	DHS fellowship program	DHS fellowship program	This study was supported by the 2014 DHS fellowship program. The program covered costs for preparation of the working paper. However, there is no funding support for publication in a journal. The funders had no role in study design, data collection (data extraction in our case) and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Cleland J, 2012, LANCET, V0140-6736, P60609; Cleland J, 2006, REPROD HEALTH MATTER, V14, P17, DOI 10.1016/S0968-8080(06)28250-8; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; CSA Ethiopia and DHS Macro, 2001, ETH DEM HLTH SURV RE; CSA [Ethiopia] and ICF International, 2012, ETH DEM HLTH SURV RE; CSA Ethiopia and ORC Macro, 2005, ETH DEM HLTH SURV PR; FMOH Ethiopia, 2011, NAT GUID FAM PLANN S; FMOH Ethiopia, 2007, HLTH EXT PROGR ETH; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Lakew Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-52; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Mekonnen W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-37; Mohammed A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-13; Muhoza DN, 2013, MEASURING SUCCESS FA; Pillai VK, 2011, OPEN ACCESS J CONTRA, V2011; Population Action International, 2013, FAM PLANN SMART INV; RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061; Singh S, 2012, ADD IT COSTS BENEFIT; Transitional Government of Ethiopia, 1993, POP POL TRANS GOV ET; UNEPA, 2012, DEC CHANG CONTR US E; USAID/Africa Bureau, 2011, 3 SUCC SUBS AFR FAM; World Bank, 2007, WORLD DEV REP 2007 D; World Bank, 2010, WORLD DEV IND	24	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116525	10.1371/journal.pone.0116525	http://dx.doi.org/10.1371/journal.pone.0116525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635389	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700042
J	Yin, Q; Fan, Q; Zhao, Y; Cheng, MY; Liu, H; Li, J; Lu, FF; Jia, JT; Cheng, W; Yan, CD				Yin, Qin; Fan, Qin; Zhao, Yu; Cheng, Ming-Yue; Liu, He; Li, Jing; Lu, Fei-Fei; Jia, Jin-Tai; Cheng, Wei; Yan, Chang-Dong			Spinal NF-kappa B and Chemokine Ligand 5 Expression during Spinal Glial Cell Activation in a Neuropathic Pain Model	PLOS ONE			English	Article							NERVE-INJURY; MECHANICAL ALLODYNIA; INTRATHECAL INFUSION; UP-REGULATION; RAT MODEL; MINOCYCLINE; RECEPTORS; INVOLVEMENT; LIGATION; RANTES	Background The NF-kappa B pathway and chemokine (C-C motif) ligand 5 (CCL5) are involved in pain modulation; however, the precise mechanisms of their interactions in chronic neuropathic pain have yet to be established. Methods The present study examined the roles of spinal NF-kappa B and CCL5 in a neuropathic pain model after chronic constriction injury (CCI) surgery. CCI-induced pain facilitation was evaluated using the Plantar and von Frey tests. The changes in NF-kappa B and CCL5 expression were analyzed by immunohistochemistry and Western blot analyses. Results Spinal NF-kappa B and CCL5 expression increased after CCI surgery. Repeated intrathecal infusions of pyrrolidine dithiocarbamate (PDTC, a NF-kappa B inhibitor) decreased CCL5 expression, inhibited the activation of microglia and astrocytes, and attenuated CCI-induced allodynia and hyperalgesia. Intrathecal injection of a CCL5-neutralizing antibody attenuated CCI-induced pain facilitation and also suppressed spinal glial cell activation after CCI surgery. However, the CCL5-neutralizing antibody did not affect NF-kappa B expression. Furthermore, selective glial inhibitors, minocycline and fluorocitrate, attenuated the hyperalgesia induced by intrathecal CCL5. Conclusions The inhibition of spinal CCL5 expression may provide a new method to prevent and treat nerve injury-induced neuropathic pain.	[Yin, Qin; Zhao, Yu; Cheng, Ming-Yue; Liu, He; Li, Jing; Lu, Fei-Fei; Cheng, Wei; Yan, Chang-Dong] Xuzhou Med Coll, Xuzhou, Peoples R China; [Yin, Qin; Fan, Qin; Zhao, Yu; Cheng, Ming-Yue; Liu, He; Li, Jing; Lu, Fei-Fei; Cheng, Wei; Yan, Chang-Dong] Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China; [Yin, Qin; Fan, Qin; Zhao, Yu; Cheng, Ming-Yue; Liu, He; Li, Jing; Lu, Fei-Fei; Cheng, Wei; Yan, Chang-Dong] Ctr Pain Res & Treatment, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China; [Yin, Qin; Fan, Qin; Zhao, Yu; Cheng, Ming-Yue; Liu, He; Cheng, Wei] Xuzhou Med Coll, Affiliated Hosp, Xuzhou, Peoples R China; [Fan, Qin; Jia, Jin-Tai] Changzhi Med Coll, Affiliated Heping Hosp, Changzhi, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Changzhi Medical College	Jia, JT (corresponding author), Changzhi Med Coll, Affiliated Heping Hosp, Changzhi, Peoples R China.	1538753325@qq.com; cheng.wei.1@hotmail.com; yancd55@163.com	Liu, He/C-9799-2012	Liu, He/0000-0002-4103-312X	National Natural Science Foundation of China [31100801, 81200858, 81300957]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (31100801, 81200858, and 81300957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DK, 2005, BRAIN RES BULL, V66, P50, DOI 10.1016/j.brainresbull.2005.03.015; Bacon KB, 2000, J NEUROIMMUNOL, V104, P92, DOI 10.1016/S0165-5728(99)00266-0; Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x; Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; Benamar K, 2008, EUR J PHARMACOL, V592, P93, DOI 10.1016/j.ejphar.2008.07.009; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Gosselin RD, 2008, CURR MED CHEM, V15, P2866, DOI 10.2174/092986708786242822; Guasti L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-35; Hang LH, 2013, BASIC CLIN PHARMACOL, V113, P325, DOI 10.1111/bcpt.12099; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hui J, 2013, J PAIN, V14, P747, DOI 10.1016/j.jpain.2013.02.003; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Keswani SC, 2003, ANN NEUROL, V54, P287, DOI 10.1002/ana.10645; Kiguchi N, 2010, NEUROSCI LETT, V484, P17, DOI 10.1016/j.neulet.2010.07.085; Knerlich-Lukoschus F, 2011, J NEUROSURG-SPINE, V14, P583, DOI 10.3171/2010.12.SPINE10480; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Laughlin TM, 2000, PAIN, V84, P159, DOI 10.1016/S0304-3959(99)00195-5; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Ledeboer A, 2005, EUR J NEUROSCI, V22, P1977, DOI 10.1111/j.1460-9568.2005.04379.x; Lin CS, 2007, REGION ANESTH PAIN M, V32, P209, DOI 10.1016/j.rapm.2007.01.005; Liou Jiin-Tarng, 2013, Acta Anaesthesiol Taiwan, V51, P127, DOI 10.1016/j.aat.2013.08.006; Liou JT, 2013, J PAIN, V14, P24, DOI 10.1016/j.jpain.2012.09.015; Liou JT, 2012, PAIN, V153, P1283, DOI 10.1016/j.pain.2012.03.008; Lunzer MM, 2007, P NATL ACAD SCI USA, V104, P6061, DOI 10.1073/pnas.0700295104; Mei XP, 2013, NEUROSIGNALS, V21, P184, DOI 10.1159/000338049; Mei XP, 2011, NEUROSCI RES, V70, P305, DOI 10.1016/j.neures.2011.03.012; Milligan ED, 1999, J NEUROSCI METH, V90, P81, DOI 10.1016/S0165-0270(99)00075-8; O'Rielly DD, 2008, NEUROSCIENCE, V155, P902, DOI 10.1016/j.neuroscience.2008.04.077; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Pan YD, 2010, REGION ANESTH PAIN M, V35, P231, DOI 10.1097/AAP.0b013e3181df245b; Pevida M, 2014, NEUROSCIENCE, V259, P113, DOI 10.1016/j.neuroscience.2013.11.055; Pu SF, 2013, J PHYSIOL BIOCHEM, V69, P349, DOI 10.1007/s13105-012-0217-4; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Sommer C, 2003, CURR OPIN NEUROL, V16, P623, DOI 10.1097/00019052-200310000-00009; Sun T, 2006, BRIT J ANAESTH, V97, P553, DOI 10.1093/bja/ael209; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Tokami H, 2013, BRAIN RES, V1517, P122, DOI 10.1016/j.brainres.2013.04.022; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; Wei XH, 2007, EXP NEUROL, V205, P471, DOI 10.1016/j.expneurol.2007.03.012; White FA, 2008, CURR OPIN ANESTHESIO, V21, P580, DOI 10.1097/ACO.0b013e32830eb69d; Wieseler-Frank J, 2004, NEUROCHEM INT, V45, P389, DOI 10.1016/j.neuint.2003.09.009; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu LC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-4; Zhang X, 2012, J NEURAL TRANSM, V119, P329, DOI 10.1007/s00702-011-0713-7; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	48	39	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115120	10.1371/journal.pone.0115120	http://dx.doi.org/10.1371/journal.pone.0115120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635831	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700006
J	Chen, WC; Bei, YJ; Li, HH				Chen, Weicai; Bei, Yongjian; Li, Hanhua			Genetic Variation of the Major Histocompatibility Complex (MHC Class II B Gene) in the Threatened Hume's Pheasant, Syrmaticus humiae	PLOS ONE			English	Article							DIVERSITY; POLYMORPHISM; POPULATION; SEQUENCE; LOCI; EVOLUTION; NUMBERS; QUAIL; BIRD	Major histocompatibility complex (MHC) genes are the most polymorphic genes in vertebrates and encode molecules that play a crucial role in pathogen resistance. As a result of their diversity, they have received much attention in the fields of evolutionary and conservation biology. Here, we described the genetic variation of MHC class II B (MHCIIB) exon 2 in a wild population of Hume's pheasant (Syrmaticus humiae), which has suffered a dramatic decline in population over the last three decades across its ranges in the face of heavy exploitation and habitat loss. Twenty-four distinct alleles were found in 73 S. humiae specimens. We found seven shared alleles among four geographical groups as well as six rare MHCIIB alleles. Most individuals displayed between one to five alleles, suggesting that there are at least three MHCIIB loci of the Hume's pheasant. The d(N)/d(S) ratio at putative antigen-binding sites (ABS) was significantly greater than one, indicating balancing selection is acting on MHCIIB exon 2. Additionally, recombination and gene conversion contributed to generating MHCIIB diversity in the Hume's pheasant. One to three recombination events and seventy-five significant gene conversion events were observed within the Hume's pheasant MHCIIB loci. The phylogenetic tree and network analysis revealed that the Hume's pheasant alleles do not cluster together, but are scattered through the tree or network indicating a trans-species evolutionary mode. These findings revealed the evolution of the Hume's pheasant MHC after suffering extreme habitat fragmentation.	[Chen, Weicai] Nat Hist Museum Guangxi, Nanning 530012, Peoples R China; [Bei, Yongjian] Yulin Normal Univ, Coll Life Sci & Technol, Yulin 537000, Peoples R China; [Li, Hanhua] Guangxi Normal Univ, Coll Life Sci, Guangxi Key Lab Rare & Endangered Anim Ecol, Guilin 541004, Peoples R China	Yulin Normal University; Guangxi Normal University	Bei, YJ (corresponding author), Yulin Normal Univ, Coll Life Sci & Technol, Yulin 537000, Peoples R China.	beiyongjian@163.com		Chen, Weicai/0000-0002-2398-4079	National Natural Science Foundation of China [31260150]; Natural Science Foundation of Guangxi Province, China [2012GXNSFAA053057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi Province, China(National Natural Science Foundation of Guangxi Province)	This study was supported by National Natural Science Foundation of China (Grant No. 31260150), Natural Science Foundation of Guangxi Province, China (Grant No. 2012GXNSFAA053057).	Alcaide M, 2007, J MOL EVOL, V65, P541, DOI 10.1007/s00239-007-9033-9; Alcaide M, 2014, ECOL EVOL, V4, P688, DOI 10.1002/ece3.974; Bei YJ, 2005, THESIS; Bei YJ, 2014, BIOCHEM SYST ECOL, V57, P69, DOI 10.1016/j.bse.2014.07.006; Boyce WM, 1997, GENETICS, V145, P421; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Canales-Delgadillo JC, 2012, J AVIAN BIOL, V43, P168, DOI 10.1111/j.1600-048X.2011.05372.x; Cheng K-m, 1998, CHINA RED DATA BOOK; Choudhury A, 2002, REPORT; Choudhury Anwaruddin, 2009, Tigerpaper (Bangkok), V36, P4; Collar NJ, 2001, THREATENED BIRDS OF; Doherty P C, 1975, Nature, V256, P50; Eimes JA, 2011, J EVOLUTION BIOL, V24, P1847, DOI 10.1111/j.1420-9101.2011.02311.x; Eimes JA, 2010, GENETICA, V138, P265, DOI 10.1007/s10709-009-9417-4; Garrigan D, 2003, EVOLUTION, V57, P1707; Hale ML, 2009, J EVOLUTION BIOL, V22, P1284, DOI 10.1111/j.1420-9101.2009.01746.x; Hedrick PW, 2001, MOL ECOL, V10, P1399, DOI 10.1046/j.1365-294X.2001.01289.x; Hosomichi K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-322; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Kennedy LJ, 2002, IMMUNOGENETICS, V54, P348, DOI 10.1007/s00251-002-0465-5; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; Klein J, 1998, SCAND J IMMUNOL, V47, P199; Klein J, 1986, NATURAL HISTORY OF T; Langefors AH, 2005, ENVIRON BIOL FISH, V74, P297, DOI 10.1007/s10641-005-0501-z; Li HH, 1998, J GUANGXI NORM U NAT, V16, P76; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ohta T, 1998, J MOL EVOL, V46, P633, DOI 10.1007/PL00006343; OHTA T, 1995, J MOL EVOL, V41, P115, DOI 10.1007/BF00170662; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Promerova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069135; Reed KM, 2011, IMMUNOGENETICS, V63, P753, DOI 10.1007/s00251-011-0549-1; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Sawyer S, 1999, GENECONV A COMPUTER; Shafer ABA, 2012, J HERED, V103, P371, DOI 10.1093/jhered/esr138; Shiina T, 2006, ANIM SCI J, V77, P151, DOI 10.1111/j.1740-0929.2006.00333.x; Shiina T, 2004, J IMMUNOL, V172, P6751, DOI 10.4049/jimmunol.172.11.6751; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Strand T, 2007, IMMUNOGENETICS, V59, P725, DOI 10.1007/s00251-007-0234-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wittzell H, 1999, MOL BIOL EVOL, V16, P479, DOI 10.1093/oxfordjournals.molbev.a026130; Worley K, 2008, IMMUNOGENETICS, V60, P233, DOI 10.1007/s00251-008-0288-0; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu Tailin, 2012, Jiyinzuxue Yu Yingyong Shengwuxue, V31, P369; Zhou TF, 2005, COASTAL ENTERPRISES, V68, P49, DOI [10.1016/j.chemosphere.2011.08.010, DOI 10.1016/J.CHEMOSPHERE.2011.08.010]; [No title captured]	50	3	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116499	10.1371/journal.pone.0116499	http://dx.doi.org/10.1371/journal.pone.0116499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629763	gold, Green Submitted, Green Published			2022-12-26	WOS:000348732100038
J	Hu, J; Lin, T; Gao, YH; Xu, JY; Jiang, C; Wang, GH; Bu, GJ; Xu, HX; Chen, HF; Zhang, YW				Hu, Jin; Lin, Ting; Gao, Yuehong; Xu, Junyue; Jiang, Chao; Wang, Guanghui; Bu, Guojun; Xu, Huaxi; Chen, Haifeng; Zhang, Yun-wu			The Resveratrol Trimer Miyabenol C Inhibits beta-Secretase Activity and beta-Amyloid Generation	PLOS ONE			English	Article							PROTEIN-CLEAVING ENZYME; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; OLIGOMERIC STILBENES; CARAGANA-SINICA; GAMMA-SECRETASE; CELL-LINES; IN-VIVO; BACE1; CLEAVAGE	Accumulation and deposition of amyloid-beta peptide (A beta) in the brain is a primary cause of the pathogenesis of Alzheimer's disease (AD). Aa is generated from amyloid-beta precursor protein (APP) through sequential cleavages first by beta-secretase and then by.-secretase. Inhibiting a-secretase activity is believed to be one of the most promising strategies for AD treatment. In the present study, we found that a resveratrol trimer, miyabenol C, isolated from stems and leaves of the small-leaf grape (Vitisthunbergii var. taiwaniana), can markedly reduce Aa and sAPP beta levels in both cell cultures and the brain of AD model mice. Mechanistic studies revealed that miyabenol C affects neither protein levels of APP, the two major alpha-secretases ADAM10 and TACE, and the gamma-secretase component Presenilin 1, nor gamma-secretase-mediated Notch processing and TACE activity. In contrast, although miyabenol C has no effect on altering protein levels of the beta-secretase BACE1, it can inhibit both in vitro and in vivo beta-secretase activity. Together, our results indicate that miyabenol C is a prominent beta-secretase inhibitor and lead compound for AD drug development.	[Hu, Jin; Lin, Ting; Xu, Junyue; Jiang, Chao; Wang, Guanghui; Xu, Huaxi; Chen, Haifeng] Xiamen Univ, Sch Pharmaceut Sci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361102, Peoples R China; [Hu, Jin; Gao, Yuehong; Bu, Guojun; Xu, Huaxi; Zhang, Yun-wu] Xiamen Univ, Coll Med, Inst Neurosci, Xiamen 361102, Peoples R China	Xiamen University; Xiamen University	Chen, HF (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361102, Peoples R China.	haifeng@xmu.edu.cn; yunzhang@xmu.edu.cn	Xu, Huaxi/AAV-7177-2021	Zhang, Yun-wu/0000-0002-7152-7630	National Natural Science Foundation of China [81202419, 81225008, 81161120496, 91332112, 91332114]; Xiamen Science and Technology Key program grant [3502Z20100006]; Fundamental Research Funds for the Central Universities of China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xiamen Science and Technology Key program grant; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Natural Science Foundation of China (Nos. 81202419, 81225008, 81161120496, 91332112, and 91332114), Xiamen Science and Technology Key program grant (No. 3502Z20100006), and Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barjot C, 2007, LIFE SCI, V81, P1565, DOI 10.1016/j.lfs.2007.08.047; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; BIEDLER JL, 1978, CANCER RES, V38, P3751; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Chaher N, 2014, J SCI FOOD AGR, V94, P951, DOI 10.1002/jsfa.6341; Chen G, 2001, PLANTA MED, V67, P665, DOI 10.1055/s-2001-17367; Das P, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-39; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Ebrahimi A, 2012, AGEING RES REV, V11, P329, DOI 10.1016/j.arr.2012.01.006; Gonzalez-Sarrias A, 2011, J AGR FOOD CHEM, V59, P8632, DOI 10.1021/jf201561e; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jin Q, 2012, BIOORG MED CHEM LETT, V22, P973, DOI 10.1016/j.bmcl.2011.12.012; Johnston JA, 2005, BIOCHEM SOC T, V33, P1096, DOI 10.1042/BST0331096; Kim DH, 2010, BIOL PHARM BULL, V33, P2024, DOI 10.1248/bpb.33.2024; KULANTHAIVEL P, 1995, PLANTA MED, V61, P41, DOI 10.1055/s-2006-957996; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lambert C, 2013, J AGR FOOD CHEM, V61, P11392, DOI 10.1021/jf403716y; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li XX, 2013, NEUROSCI LETT, V548, P90, DOI 10.1016/j.neulet.2013.05.018; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Meng YH, 2001, PHYTOCHEMISTRY, V57, P393, DOI 10.1016/S0031-9422(01)00061-9; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; ONO M, 1995, CHEM PHARM BULL, V43, P868; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sorensen EB, 2010, TRAFFIC, V11, P1234, DOI 10.1111/j.1600-0854.2010.01090.x; Tanaka T, 2000, PHYTOCHEMISTRY, V53, P1009, DOI 10.1016/S0031-9422(00)00016-9; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Tian CY, 2003, ACTA BIOCH BIOPH SIN, V35, P77; Tian CY, 2002, ACTA PHARMACOL SIN, V23, P572; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Wang CK, 2010, J MED FOOD, V13, P170, DOI 10.1089/jmf.2009.1162; Wang KT, 2011, J AGR FOOD CHEM, V59, P3649, DOI 10.1021/jf104718g; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xu G., 1994, Yaoxue Xuebao, V29, P818; Yang JB, 2014, J ASIAN NAT PROD RES, V16, P275, DOI 10.1080/10286020.2013.877451; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhang YW, 2009, NEURON, V64, P328, DOI 10.1016/j.neuron.2009.08.036; Zhao YH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-30; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	53	19	19	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115973	10.1371/journal.pone.0115973	http://dx.doi.org/10.1371/journal.pone.0115973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629409	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100027
J	Mohamad, S; Lsa, NM; Muhammad, R; Emran, NA; Kitan, NM; Kang, P; Kang, IN; Taid, NAM; Teo, SH; Akmal, SN				Mohamad, Suriati; lsa, Nurismah Md; Muhammad, Rohaizak; Emran, Nor Aina; Kitan, Nor Mayah; Kang, Peter; Kang, In Nee; Taid, Nur Aishah Mohd; Teo, Soo Hwang; Akmal, Sharifah Noor			Low Prevalence of CHEK2 Gene Mutations in Multiethnic Cohorts of Breast Cancer Patients in Malaysia	PLOS ONE			English	Article							HEREDITARY BREAST; 1100DELC MUTATION; DNA-DAMAGE; HIGH-RISK; SUSCEPTIBILITY; BRCA1; WOMEN; VARIANTS; FAMILIES; POPULATION	CHEK2 is a protein kinase that is involved in cell-cycle checkpoint control after DNA damage. Germline mutations in CHEK2 gene have been associated with increase in breast cancer risk. The aim of this study is to identify the CHEK2 gene germline mutations among high-risk breast cancer patients and its contribution to the multiethnic population in Malaysia. We screened the entire coding region of CHEK2 gene on 59 high-risk breast cancer patients who tested negative for BRCA1/2 germline mutations from UKM Medical Centre (UKMMC), Hospital Kuala Lumpur (HKL) and Hospital Putrajaya (HPJ). Sequence variants identified were screened further in case-control cohorts consisting of 878 unselected invasive breast cancer patients (180 Malays, 526 Chinese and 172 Indian) and 270 healthy individuals (90 Malays, 90 Chinese and 90 Indian). By screening the entire coding region of the CHEK2 gene, two missense mutations, c.480A>G (p.I160M) and c.538C>T (p.R180C) were identified in two unrelated patients (3.4%). Further screening of these missense mutations on the case-control cohorts unveiled the variant p.I160M in 2/172 (1.1%) Indian cases and 1/90 (1.1%) Indian control, variant p. R180C in 2/526 (0.38%) Chinese cases and 0/90 Chinese control, and in 2/180 (1.1%) of Malay cases and 1/90 (1.1%) of Malay control. The results of this study suggest that CHEK2 mutations are rare among high-risk breast cancer patients and may play a minor contributing role in breast carcinogenesis among Malaysian population.	[Mohamad, Suriati; lsa, Nurismah Md; Akmal, Sharifah Noor] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Muhammad, Rohaizak] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Emran, Nor Aina] Hosp Kuala Lumpur, Dept Gen Surg, Kuala Lumpur, Malaysia; [Kang, Peter; Kang, In Nee; Teo, Soo Hwang] Hosp Putrajaya, Dept Endocrine Surg, Putrajaya, Malaysia; [Kang, Peter; Kang, In Nee] Canc Res Initiat Fdn CARIF, Subang Jaya, Selangor, Malaysia; [Taid, Nur Aishah Mohd; Teo, Soo Hwang] Univ Malaya, Fac Med, Univ Malaya Canc Res Inst, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Malaya	Akmal, SN (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia.	sharifah@ppukm.ukm.edu.my	Kang, In Nee/AAK-7206-2020; Taib, Nur Aishah Mohd/B-2370-2010; Teo, Soo-hwang/H-2353-2014; Muhammad, Rohaizak/F-6199-2015	Taib, Nur Aishah Mohd/0000-0001-8419-0478; 	Research University Fund (UKM) [UKM-GUP-TKP-08-18-065]	Research University Fund (UKM)	This study was supported by The Research University Fund (UKM): UKM-GUP-TKP-08-18-065. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DW, 2007, INT J CANCER, V121, P2661, DOI 10.1002/ijc.23026; Bogdanova N, 2005, INT J CANCER, V116, P263, DOI 10.1002/ijc.21022; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Choi DH, 2008, BREAST CANCER RES TR, V112, P569, DOI 10.1007/s10549-007-9878-z; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Cybulski C, 2007, BREAST CANCER RES TR, V102, P119, DOI 10.1007/s10549-006-9320-y; Desrichard A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3062; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Dufault MR, 2004, INT J CANCER, V110, P320, DOI 10.1002/ijc.20073; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Friedrichsen DM, 2004, BREAST CANCER RES, V6, pR629, DOI 10.1186/bcr933; Gonzalez-Hormazabal P, 2008, BREAST CANCER RES TR, V110, P543, DOI 10.1007/s10549-007-9743-0; Kang PCE, 2014, BREAST CANCER RES TR, V144, P635, DOI 10.1007/s10549-014-2894-x; Kilpivaara O, 2004, INT J CANCER, V111, P543, DOI 10.1002/ijc.20299; Kleibl Z, 2005, BREAST CANCER RES TR, V90, P165, DOI 10.1007/s10549-004-4023-8; Kuusisto KM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2832; Laitman Y, 2007, ISRAEL MED ASSOC J, V9, P791; Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810; LEE ASG, 2008, J CLIN ONCOL, V26, P2419, DOI DOI 10.1200/JC0.2008.16.4335; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Liu Y, 2011, HUM MUTAT, V32, P1000, DOI 10.1002/humu.21538; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Nevanlinna H, 2006, ONCOGENE, V25, P5912, DOI 10.1038/sj.onc.1209877; Novak DJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-239; Osorio A, 2004, INT J CANCER, V108, P54, DOI 10.1002/ijc.11414; Rajkumar Thangarajan, 2003, Asian Pac J Cancer Prev, V4, P203; Rashid MU, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-312; Roeb W, 2012, HUMAN MOL GENETICS; Schutte M, 2003, AM J HUM GENET, V72, P1023, DOI 10.1086/373965; Shaag A, 2005, HUM MOL GENET, V14, P555, DOI 10.1093/hmg/ddi052; Sodha N, 2002, HUM MUTAT, V19, P173, DOI 10.1002/humu.10031; Sodha N, 2002, BRIT J CANCER, V87, P1445, DOI 10.1038/sj.bjc.6600637; Sodha N, 2006, CANCER RES, V66, P8966, DOI 10.1158/0008-5472.CAN-06-1990; Song Chuan-gui, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P443; Thirthagiri E, 2009, FAM CANC; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Wang C, 2008, ADV THER, V25, P496, DOI 10.1007/s12325-008-0057-3; Zhang SY, 2008, CANCER RES, V68, P2154, DOI 10.1158/0008-5472.CAN-07-5187	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117104	10.1371/journal.pone.0117104	http://dx.doi.org/10.1371/journal.pone.0117104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629968	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100064
J	Schweinhuber, SK; Messerschmidt, T; Hansch, R; Korte, M; Rothkegel, M				Schweinhuber, Stefanie K.; Messerschmidt, Tania; Haensch, Robert; Korte, Martin; Rothkegel, Martin			Profilin Isoforms Modulate Astrocytic Morphology and the Motility of Astrocytic Processes	PLOS ONE			English	Article							PROTEIN-KINASE-C; IN-VIVO; LENTIVIRAL VECTOR; ACTIN-BINDING; GENE DELIVERY; CELLS; CAMP; PHOSPHORYLATION; STELLATION; EXOCYTOSIS	The morphology of astrocytic processes determines their close structural association with synapses referred to as the 'tripartite synapse'. Concerted morphological plasticity processes at tripartite synapses are supposed to shape neuronal communication. Morphological changes in astrocytes as well as the motility of astrocytic processes require remodeling of the actin cytoskeleton. Among the regulators of fast timescale actin-based motility, the actin binding protein profilin 1 has recently been shown to control the activity-dependent outgrowth of astrocytic processes. Here, we demonstrate that cultured murine astrocytes in addition to the ubiquitous profilin 1 also express the neuronal isoform profilin 2a. To analyze the cellular function of both profilins in astrocytes, we took advantage of a shRNA mediated isoform-specific downregulation. Interestingly, consistent with earlier results in neurons, we found redundant as well as isoform-specific functions of both profilins in modulating cellular physiology. The knockdown of either profilin 1 or profilin 2a led to a significant decrease in cell spreading of astrocytes. In contrast, solely the knockdown of profilin 2a resulted in a significantly reduced morphological complexity of astrocytes in both dissociated and slice culture astrocytes. Moreover, both isoforms proved to be crucial for forskolin-induced astrocytic stellation. Furthermore, forskolin treatment resulted in isoform-specific changes in the phosphorylation level of profilin 1 and profilin 2a, leading to a PKA-dependent phosphorylation of profilin 2a. In addition, transwell assays revealed an involvement of both isoforms in the motility of astrocytic processes, while FRAP analysis displayed an isoform-specific role of profilin 1 in the regulation of actin dynamics in peripheral astrocytic processes. Taken together, we suggest profilin isoforms to be important modulators of astrocytic morphology and motility with overlapping as well as isoform-specific functions.	[Schweinhuber, Stefanie K.; Messerschmidt, Tania; Korte, Martin; Rothkegel, Martin] TU Braunschweig, Inst Zool, Braunschweig, Germany; [Haensch, Robert] TU Braunschweig, Inst Plant Biol, D-38106 Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology	Rothkegel, M (corresponding author), TU Braunschweig, Inst Zool, Braunschweig, Germany.	m.rothkegel@tu-bs.de		Hansch, Robert/0000-0003-1310-8419; , Martin/0000-0001-5041-4429				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; Bernardinelli Y, 2014, CURR BIOL, V24, P1679, DOI 10.1016/j.cub.2014.06.025; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Di Nardo A, 2000, J CELL SCI, V113, P3795; Ding ZH, 2012, ACTA APPL MATH, V118, P1, DOI 10.1007/s10440-012-9692-4; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Fang KM, 2012, J CELL BIOCHEM, V113, P3019, DOI 10.1002/jcb.24180; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Gorlich A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030068; GOLDMAN JE, 1990, BRAIN RES, V528, P189, DOI 10.1016/0006-8993(90)91657-3; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; Grantham J, 2012, PROTOPLASMA, V249, P1001, DOI 10.1007/s00709-012-0403-9; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hu ED, 2001, EXP NEPHROL, V9, P265; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kullmann JA, 2012, NEUROSCIENCE, V223, P355, DOI 10.1016/j.neuroscience.2012.07.055; Kullmann JA, 2012, EMBO REP, V13, P75, DOI 10.1038/embor.2011.211; Lambrechts A, 2000, MOL CELL BIOL, V20, P8209, DOI 10.1128/MCB.20.21.8209-8219.2000; Lorente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085817; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Mayboroda O, 1997, CELL MOTIL CYTOSKEL, V37, P166, DOI 10.1002/(SICI)1097-0169(1997)37:2<166::AID-CM9>3.0.CO;2-6; Michaelsen K, 2010, P NATL ACAD SCI USA, V107, P15780, DOI 10.1073/pnas.1004406107; Miki T, 2009, J BIOL CHEM, V284, P5753, DOI 10.1074/jbc.M806191200; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Molotkov D, 2013, CELL CALCIUM, V53, P338, DOI 10.1016/j.ceca.2013.03.001; Murk K, 2013, J CELL SCI, V126, P3873, DOI 10.1242/jcs.125146; Murk K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034167; Murk K, 2009, J CELL SCI, V122, P957, DOI 10.1242/jcs.041715; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neuhoff H, 2005, EUR J NEUROSCI, V21, P15, DOI 10.1111/j.1460-9568.2004.03814.x; Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425; Obermann H, 2005, MOL HUM REPROD, V11, P53, DOI 10.1093/molehr/gah132; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perez V, 2005, EUR J NEUROSCI, V21, P26, DOI 10.1111/j.1460-9568.2004.03845.x; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Polet D, 2007, FEBS LETT, V581, P211, DOI 10.1016/j.febslet.2006.12.013; Racchetti G, 2012, GLIA, V60, P465, DOI 10.1002/glia.22280; Ramakers GJA, 1998, EXP CELL RES, V245, P252, DOI 10.1006/excr.1998.4224; Rawe VY, 2006, HUM REPROD, V21, P1143, DOI 10.1093/humrep/dei480; Reichenbach A, 2010, BRAIN RES REV, V63, P11, DOI 10.1016/j.brainresrev.2010.02.003; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Thomsen R, 2011, GLIA, V59, P1782, DOI 10.1002/glia.21223; Treisman R, 2013, TRENDS BIOCHEM SCI, V38, P376, DOI 10.1016/j.tibs.2013.06.004; Vemuri B, 2001, CELL SIGNAL, V13, P433, DOI 10.1016/S0898-6568(01)00164-4; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Won CK, 2000, BRAIN RES, V887, P250, DOI 10.1016/S0006-8993(00)02922-X; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	69	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117244	10.1371/journal.pone.0117244	http://dx.doi.org/10.1371/journal.pone.0117244			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629407	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100075
J	Wifling, D; Bernhardt, G; Dove, S; Buschauer, A				Wifling, David; Bernhardt, Guenther; Dove, Stefan; Buschauer, Armin			The Extracellular Loop 2 (ECL2) of the Human Histamine H-4 Receptor Substantially Contributes to Ligand Binding and Constitutive Activity	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HIGH-AFFINITY STATE; DISULFIDE BOND; DRY MOTIF; 2ND; ACTIVATION; AGONIST; POTENT; SITE; H-4-RECEPTOR	In contrast to the corresponding mouse and rat orthologs, the human histamine H-4 receptor (hH(4)R) shows extraordinarily high constitutive activity. In the extracellular loop (ECL), replacement of F169 by V as in the mouse H4R significantly reduced constitutive activity. Stabilization of the inactive state was even more pronounced for a double mutant, in which, in addition to F169V, S179 in the ligand binding site was replaced by M. To study the role of the FF motif in ECL2, we generated the hH(4)R-F168A mutant. The receptor was coexpressed in Sf9 insect cells with the G-protein subunits G alpha(12) and G beta(1)gamma(2), and the membranes were studied in [H-3] histamine binding and functional [S-35] GTP gamma S assays. The potency of various ligands at the hH(4)R-F168A mutant decreased compared to the wild-type hH(4)R, for example by 30-and more than 100-fold in case of the H4R agonist UR-PI376 and histamine, respectively. The high constitutive activity of the hH(4)R was completely lost in the hH(4)R-F168A mutant, as reflected by neutral antagonism of thioperamide, a full inverse agonist at the wild-type hH(4)R. By analogy, JNJ7777120 was a partial inverse agonist at the hH(4)R, but a partial agonist at the hH(4)R-F168A mutant, again demonstrating the decrease in constitutive activity due to F168A mutation. Thus, F168 was proven to play a key role not only in ligand binding and potency, but also in the high constitutive activity of the hH(4)R.	[Wifling, David; Bernhardt, Guenther; Dove, Stefan; Buschauer, Armin] Univ Regensburg, Inst Pharm, D-93053 Regensburg, Germany	University of Regensburg	Buschauer, A (corresponding author), Univ Regensburg, Inst Pharm, D-93053 Regensburg, Germany.	armin.buschauer@chemie.uni-regensburg.de	Wifling, David/AAB-8213-2020	Wifling, David/0000-0002-1370-2138	Deutsche Forschungsgemeinschaft (DFG) within the Graduate Training Programs [GRK760, GRK1910]; DFG	Deutsche Forschungsgemeinschaft (DFG) within the Graduate Training Programs(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) within the Graduate Training Programs GRK760, "Medicinal Chemistry: Molecular Recognition - Ligand-Receptor Interactions" and GRK1910, "Medicinal Chemistry of Selective GPCR Ligands", and within the DFG funding program Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alewijnse AE, 2000, MOL PHARMACOL, V57, P890; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Brunskole I, 2011, N-S ARCH PHARMACOL, V384, P301, DOI 10.1007/s00210-011-0673-3; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cook JVF, 1997, ENDOCRINOLOGY, V138, P2800, DOI 10.1210/en.138.7.2800; DAVIDSON FF, 1994, P NATL ACAD SCI USA, V91, P4029, DOI 10.1073/pnas.91.9.4029; GETHER U, 1995, J BIOL CHEM, V270, P28268; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Igel P, 2009, J MED CHEM, V52, P6297, DOI 10.1021/jm900526h; Igel P, 2009, J MED CHEM, V52, P2623, DOI 10.1021/jm9000693; Jablonowski JA, 2003, J MED CHEM, V46, P3957, DOI 10.1021/jm0341047; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kooistra AJ, 2013, BRIT J PHARMACOL, V170, P101, DOI 10.1111/bph.12248; LANGE JHM, 1995, TETRAHEDRON, V51, P13447, DOI 10.1016/0040-4020(95)00881-8; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Lim HD, 2008, J PHARMACOL EXP THER, V327, P88, DOI 10.1124/jpet.108.140343; Lim HD, 2006, J MED CHEM, V49, P6650, DOI 10.1021/jm060880d; Lim HD, 2010, MOL PHARMACOL, V77, P734, DOI 10.1124/mol.109.063040; Massotte D, 2005, NAT STRUCT MOL BIOL, V12, P287, DOI 10.1038/nsmb0405-287; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Nanevicz T, 1996, J BIOL CHEM, V271, P702, DOI 10.1074/jbc.271.2.702; NODA K, 1994, J BIOL CHEM, V269, P6743; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; SCHMUTZ J, 1967, HELV CHIM ACTA, V50, P245, DOI 10.1002/hlca.19670500131; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Schneider EH, 2009, BIOCHEMISTRY-US, V48, P1424, DOI 10.1021/bi802050d; Schnell D, 2011, N-S ARCH PHARMACOL, V383, P457, DOI 10.1007/s00210-011-0612-3; Schultes S, 2013, MEDCHEMCOMM, V4, P193, DOI 10.1039/c2md20212c; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; Seifert R, 2013, TRENDS PHARMACOL SCI, V34, P33, DOI 10.1016/j.tips.2012.11.001; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Smits RA, 2006, J MED CHEM, V49, P4512, DOI 10.1021/jm051008s; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wifling D, 2015, BRIT J PHARMACOL, V172, P785, DOI 10.1111/bph.12801; Wittmann Hans-Joachim, 2014, In Silico Pharmacology, V2, P1, DOI 10.1186/s40203-014-0001-y	41	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117185	10.1371/journal.pone.0117185	http://dx.doi.org/10.1371/journal.pone.0117185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629160	gold, Green Published, Green Submitted			2022-12-26	WOS:000348732100073
J	Xiao, QY; Ma, ZW; Li, SS; Liu, Y				Xiao, Qingyang; Ma, Zongwei; Li, Shenshen; Liu, Yang			The Impact of Winter Heating on Air Pollution in China	PLOS ONE			English	Article							SOURCE APPORTIONMENT; LIFE EXPECTANCY; PM2.5; AEROSOL	Fossil-fuel combustion related winter heating has become a major air quality and public health concern in northern China recently. We analyzed the impact of winter heating on aerosol loadings over China using the MODIS-Aqua Collection 6 aerosol product from 2004-2012. Absolute humidity (AH) and planetary boundary layer height (PBL)-adjusted aerosol optical depth (AOD*) was constructed to reflect ground-level PM2.5 concentrations. GIS analysis, standard statistical tests, and statistical modeling indicate that winter heating is an important factor causing increased PM2.5 levels in more than three-quarters of central and eastern China. The heating season AOD* was more than five times higher as the nonheating season AOD*, and the increase in AOD* in the heating areas was greater than in the non-heating areas. Finally, central heating tend to contribute less to air pollution relative to other means of household heating.	[Xiao, Qingyang; Ma, Zongwei; Li, Shenshen; Liu, Yang] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Ma, Zongwei] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China; [Li, Shenshen] Chinese Acad Sci, Jointly Sponsored Inst Remote Sensing Applicat, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Li, Shenshen] Beijing Normal Univ, Beijing 100875, Peoples R China	Emory University; Rollins School Public Health; Nanjing University; Chinese Academy of Sciences; Beijing Normal University	Liu, Y (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.	yang.liu@emory.edu	Ma, Zongwei/ABG-4851-2020; Liu, Yang/AAA-7224-2019; Xiao, Qingyang/AAE-4883-2022	Ma, Zongwei/0000-0003-0257-5695; Liu, Yang/0000-0001-5477-2186; 	USEPA [R834799]; Rollins Earn and Learn program; NASA Applied Sciences Program [NNX11AI53G]	USEPA(United States Environmental Protection Agency); Rollins Earn and Learn program; NASA Applied Sciences Program(National Aeronautics & Space Administration (NASA))	This publication was made possible by USEPA grant R834799 (http://www.epa.gov/ord/airscience/air-cleanairresearchcenters.htm). Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the USEPA. Further, USEPA does not endorse the purchase of any commercial products or services mentioned in the publication. The work of Q. Xiao was partly supported by the Rollins Earn and Learn program (http://sph.emory.edu/current_students/REAL/index.html). Additional funding was received from the NASA Applied Sciences Program (grant no. NNX11AI53G, PI: Yang Liu, http://www.nasa.gov/applied-sciences/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CHINA ELECT POWER YB, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; [Anonymous], 2005, CHINA STAT YB 2005; [Anonymous], 2013, CHINA STAT YB 2013, DOI [10.1016/j.amsu.2013.12.001, DOI 10.1016/J.AMSU.2013.12.001]; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; Donald MW, 1970, GEN INVERSES, P591; Hoff RM, 2009, J AIR WASTE MANAGE, V59, P645, DOI 10.3155/1047-3289.59.6.645; Koelemeijer RBA, 2006, ATMOS ENVIRON, V40, P5304, DOI 10.1016/j.atmosenv.2006.04.044; Lee YC, 2003, ATMOS ENVIRON, V37, P2927, DOI 10.1016/S1352-2310(03)00296-6; Levy RC, 2013, ATMOSPHERIC MEASUREM, P159; Liu Y, 2005, ENVIRON SCI TECHNOL, V39, P3269, DOI 10.1021/es049352m; Ma Z, 2014, ENV SCI TECHNOL; Molod A., 2012, NASA TECHNICAL REPOR; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2013, P NATL ACAD SCI USA, V110, P12861, DOI 10.1073/pnas.1310925110; Remer LA, 2008, J GEOPHYS RES ATMOSP; Song Y, 2006, ATMOS ENVIRON, V40, P1526, DOI 10.1016/j.atmosenv.2005.10.039; Song Y, 2006, SCI TOTAL ENVIRON, V372, P278, DOI 10.1016/j.scitotenv.2006.08.041; Tsai TC, 2011, ATMOS ENVIRON, V45, P4777, DOI 10.1016/j.atmosenv.2009.10.006; Wang XM, 2004, J ARID ENVIRON, V58, P559, DOI 10.1016/j.jaridenv.2003.11.009; Wang ZX, 2013, ENVIRON INT, V51, P150, DOI 10.1016/j.envint.2012.10.011; You CF, 2010, ENERGY, V35, P4467, DOI 10.1016/j.energy.2009.04.019; Yu Y, 2011, J ENVIRON MONITOR, V13, P334, DOI 10.1039/c0em00467g; Zhang L, 2010, ENERGIES, P26; Zhang L, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012299; Zhang R, 2013, ATMOS CHEM PHYS, V13, P7053, DOI 10.5194/acp-13-7053-2013; Zhang WJ, 2006, BIOMED ENVIRON SCI, V19, P461; Zhao PS, 2013, ATMOS CHEM PHYS, V13, P4631, DOI 10.5194/acp-13-4631-2013; Zhao Y, 2008, ATMOS ENVIRON, V42, P8442, DOI 10.1016/j.atmosenv.2008.08.021	28	90	91	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117311	10.1371/journal.pone.0117311	http://dx.doi.org/10.1371/journal.pone.0117311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629878	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100079
J	Hiram-Bab, S; Liron, T; Deshet-Unger, N; Mittelman, M; Gassmann, M; Rauner, M; Franke, K; Wielockx, B; Neumann, D; Gabet, Y				Hiram-Bab, Sahar; Liron, Tamar; Deshet-Unger, Naamit; Mittelman, Moshe; Gassmann, Max; Rauner, Martina; Franke, Kristin; Wielockx, Ben; Neumann, Drorit; Gabet, Yankel			Erythropoietin directly stimulates osteoclast precursors and induces bone loss	FASEB JOURNAL			English	Article						Tg6 mice; bone turnover; osteoclastogenesis; macrophages; trabecular bone	RECOMBINANT-HUMAN-ERYTHROPOIETIN; HIGH-ALTITUDE; RECEPTOR; MICE; MASS; DIFFERENTIATION; CELLS; BETA; EPO; MICROENVIRONMENT	Erythropoietin (EPO) primarily regulates red blood cell formation, and EPO serum levels are increased on hypoxic stress (e.g., anemia and altitude). In addition to anemia, recent discoveries suggest new therapeutic indications for EPO, unrelated to erythropoiesis. We investigated the skeletal role of EPO using several models of overexpression (Tg6 mice) and EPO administration (intermittent/continuous, high/low doses) in adult C57B16 female mice. Using microcomputed tomography, histology, and serum markers, we found that EPO induced a 32%-61% trabecular bone loss caused by increased bone resorption (+60%-88% osteoclast number) and reduced bone formation rate (-19 to -74%; P < 0.05 throughout). EPO targeted the monocytic lineage by increasing the number of bone monocytes/macrophages, preosteoclasts, and mature osteoclasts. In contrast to the attenuated bone formation in vivo, EPO treatment in vitro did not inhibit osteoblast differentiation and activity, suggesting an indirect effect of EPO on osteoblasts. However, EPO had a direct effect on preosteoclasts by stimulating osteoclastogenesis in isolated cultures (+60%) via the Jak2 and PI3K pathways. In summary, our findings demonstrate that EPO negatively regulates bone mass and thus bears significant clinical implications for the potential management of patients with endogenously or therapeutically elevated EPO levels.	[Hiram-Bab, Sahar; Deshet-Unger, Naamit; Neumann, Drorit] Tel Aviv Univ, Dept Cell & Dev Biol, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Hiram-Bab, Sahar; Liron, Tamar; Gabet, Yankel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Mittelman, Moshe] Tel Aviv Univ, Sackler Fac Med, Dept Med, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; [Gassmann, Max] Univ Zurich, Inst Vet Physiol, Vetsuisse Fac, Zurich, Switzerland; [Gassmann, Max] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Rauner, Martina] Dresden Univ, Med Ctr, Dept Med 3, Dresden, Germany; [Franke, Kristin; Wielockx, Ben] Tech Univ Dresden, Inst Pathol, Dresden, Germany	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Technische Universitat Dresden; Technische Universitat Dresden	Neumann, D (corresponding author), Tel Aviv Univ, Dept Cell & Dev Biol, Sackler Fac Med, POB 39040, IL-69978 Tel Aviv, Israel.	histo6@post.tau.ac.il; yankel@post.tau.ac.il	Wielockx, Ben/AAC-6854-2020; Gabet, Yankel/I-6244-2019	Wielockx, Ben/0000-0002-4923-2596; Gabet, Yankel/0000-0002-7494-0631; Gassmann, Max/0000-0003-2750-8878; Neumann, Drorit/0000-0002-4805-7511	Israel Science Foundation [1822/12, 1367/12]; Deutsche Forschungsgemeinschaft [RA1923/4-2]; Emmy Noether and Heisenberg programs [WI3291/1-1, WI3291/1-2, WI3291/5-1]; Elsbeth Bonhoff Foundation; Center for Regenerative Therapies Dresden (CRTD); FP7-Health European commission EpoCan Grant [282551]; Open University Research Authority (Raanana, Israel)	Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Emmy Noether and Heisenberg programs; Elsbeth Bonhoff Foundation; Center for Regenerative Therapies Dresden (CRTD); FP7-Health European commission EpoCan Grant; Open University Research Authority (Raanana, Israel)	This article is dedicated to the memory of Professor Itai Bab (1945-2014) from the Hebrew University of Jerusalem. Prof. Bab participated in this study by providing guidance and technical support. The authors thank Dr. Russel S. Taichman (University of Michigan) for helpful discussion and comments on this manuscript. This work was supported by Israel Science Foundation Grants 1822/12 and 1367/12 (to Y.G.), and grants from the Deutsche Forschungsgemeinschaft to M.R. (RA1923/4-2) and B.W. (Emmy Noether and Heisenberg programs, WI3291/1-1, 1-2 and 5-1), the Elsbeth Bonhoff Foundation, and a Center for Regenerative Therapies Dresden (CRTD) seed grant (to M.R. and B.W). This work was also supported by FP7-Health European commission EpoCan Grant 282551 (to D.N. and M.G.), and a grant from the Open University Research Authority (Raanana, Israel) to Prof. Miriam C. Souroujon. We express our deepest gratitude and appreciation to our dear friend and colleague, Prof. M. Souroujon, who died during the course of this study. She will be remembered for her vision, deep insight, and exceptional scientific conduct. The authors declare no conflicts of interest.	Ahmet I, 2013, J PHARMACOL EXP THER, V345, P446, DOI 10.1124/jpet.113.202945; Alnaeeli M, 2014, DIABETES, V63, P2415, DOI 10.2337/db13-0883; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Bab I. A., 2007, MICROTOMOGRAPHIC ATL; Bakhshi H, 2013, TRAUMA MON, V17, P386, DOI 10.5812/traumamon.7099; Bartesaghi S, 2005, NEUROTOXICOLOGY, V26, P923, DOI 10.1016/j.neuro.2005.01.016; Basu M, 2013, HIGH ALT MED BIOL, V14, P150, DOI 10.1089/ham.2012.1042; BERGLUND B, 1992, SPORTS MED, V14, P289, DOI 10.2165/00007256-199214050-00002; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chang J, 2014, ARTHRITIS RHEUMATOL, V66, P1789, DOI 10.1002/art.38403; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Fried W, 2009, EXP HEMATOL, V37, P1007, DOI 10.1016/j.exphem.2009.05.010; Gabet Yankel, 2011, Curr Osteoporos Rep, V9, P177, DOI 10.1007/s11914-011-0072-1; Gabet Y, 2010, BLOOD, V116, P3964, DOI 10.1182/blood-2010-01-263830; Garcia P, 2011, J ORTHOP RES, V29, P165, DOI 10.1002/jor.21219; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Guillard C, 2003, J BIOL CHEM, V278, P11050, DOI 10.1074/jbc.M208834200; Guneli E, 2007, MOL MED, V13, P509, DOI 10.2119/2007-00032.Guneli; Holstein JH, 2011, BONE, V49, P1037, DOI 10.1016/j.bone.2011.08.004; Holstein JH, 2007, LIFE SCI, V80, P893, DOI 10.1016/j.lfs.2006.11.023; Jelkmann W, 2011, BLOOD, V118, P2395, DOI 10.1182/blood-2011-02-303271; Kim J, 2012, J CELL BIOCHEM, V113, P220, DOI 10.1002/jcb.23347; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Lamon S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00176; Leclerc N, 2008, J CELL BIOCHEM, V103, P1938, DOI 10.1002/jcb.21587; LEE MY, 1991, BLOOD, V77, P2135; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Lu J, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-105; Mcgee SJ, 2012, GROWTH FACTORS, V30, P22, DOI 10.3109/08977194.2011.637034; Mihmanli A, 2009, J ORAL MAXIL SURG, V67, P2337, DOI 10.1016/j.joms.2008.06.082; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Myklebust JH, 2000, BLOOD, V95, P510, DOI 10.1182/blood.V95.2.510; Nakazawa Y, 2013, J NEPHROL, V26, P527, DOI 10.5301/jn.5000178; Nangaku M, 2013, KIDNEY INT, V84, P427, DOI 10.1038/ki.2013.140; Neya M, 2013, INT J SPORT PHYSIOL, V8, P366, DOI 10.1123/ijspp.8.4.366; Noh T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005438; Ohashi Y, 2013, CANCER SCI, V104, P481, DOI 10.1111/cas.12105; Peng HS, 2014, SURG TODAY, V44, P1109, DOI 10.1007/s00595-014-0889-1; Ramanath V, 2012, REV RECENT CLIN TRIA, V7, P187, DOI 10.2174/157488712802281222; Robach P, 2004, MED SCI SPORT EXER, V36, P1493, DOI 10.1249/01.MSS.0000139889.56481.E0; Rolfing JHD, 2014, STEM CELL REV REP, V10, P69, DOI 10.1007/s12015-013-9476-x; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; Ruschitzka FT, 2000, P NATL ACAD SCI USA, V97, P11609, DOI 10.1073/pnas.97.21.11609; Sanchis-Gomar F, 2014, INT J CARDIOL, V171, P116, DOI 10.1016/j.ijcard.2013.12.011; Shiozawa Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010853; Singbrant S, 2011, BLOOD, V117, P5631, DOI 10.1182/blood-2010-11-320564; SPIVAK JL, 1991, BLOOD, V77, P1228; Sun HL, 2012, TISSUE ENG PT A, V18, P2095, DOI [10.1089/ten.tea.2011.0742, 10.1089/ten.TEA.2011.0742]; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tamma Roberto, 2012, Inflammation & Allergy Drug Targets, V11, P196; Tanaka H., 1992, J BONE MINER METAB, V10, P31; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Watowich SS, 2011, J INVEST MED, V59, P1067, DOI 10.2310/JIM.0b013e31820fb28c; Wish JB, 2009, ADV CHRONIC KIDNEY D, V16, P101, DOI 10.1053/j.ackd.2008.12.005; Xu H, 2014, INVEST OPHTH VIS SCI, V55, P1519, DOI 10.1167/iovs.13-13155; Yasuda Y, 2001, MARC MALPIG SYMP SER, V8, P215; Zoi K, 2008, BRIT J HAEMATOL, V141, P100, DOI 10.1111/j.1365-2141.2008.06993.x	59	75	78	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1890	1900		10.1096/fj.14-259085	http://dx.doi.org/10.1096/fj.14-259085			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25630969				2022-12-26	WOS:000354114600024
J	Low, LH; Chow, YL; Li, YJ; Goh, CP; Putz, U; Silke, J; Ouchi, T; Howitt, J; Tan, SS				Low, Ley-Hian; Chow, Yuh-Lit; Li, Yijia; Goh, Choo-Peng; Putz, Ulrich; Silke, John; Ouchi, Toru; Howitt, Jason; Tan, Seong-Seng			Nedd4 Family Interacting Protein 1 (Ndfip1) Is Required for Ubiquitination and Nuclear Trafficking of BRCA1-associated ATM Activator 1 (BRAT1) during the DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL SURVIVAL; PTEN; LIGASES; KINASE	During injury, cells are vulnerable to apoptosis from a variety of stress conditions including DNA damage causing double-stranded breaks. Without repair, these breaks lead to aberrations in DNA replication and transcription, leading to apoptosis. A major response to DNA damage is provided by the protein kinase ATM (ataxia telangiectasia mutated) that is capable of commanding a plethora of signaling networks for DNA repair, cell cycle arrest, and even apoptosis. A key element in the DNA damage response is the mobilization of activating proteins into the cell nucleus to repair damaged DNA. BRAT1 is one of these proteins, and it functions as an activator of ATM by maintaining its phosphorylated status while also keeping other phosphatases at bay. However, it is unknown how BRAT1 is trafficked into the cell nucleus to maintain ATM phosphorylation. Here we demonstrate that Ndfip1-mediated ubiquitination of BRAT1 leads to BRAT1 trafficking into the cell nucleus. Without Ndfip1, BRAT1 failed to translocate to the nucleus. Under genotoxic stress, cells showed increased expression of both Ndfip1 and phosphorylated ATM. Following brain injury, neurons show increased expression of Ndlip1 and nuclear translocation of BRATE These results point to Ndfip1 as a sensor protein during cell injury and Ndfip1 up-regulation as a cue for BRAT1 ubiquitination by Nedd4 E3 ligases, followed by nuclear translocation of BRAT1.	[Low, Ley-Hian; Chow, Yuh-Lit; Li, Yijia; Goh, Choo-Peng; Putz, Ulrich; Howitt, Jason; Tan, Seong-Seng] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Silke, John] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3010, Australia; [Ouchi, Toru] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Roswell Park Cancer Institute	Howitt, J (corresponding author), Univ Melbourne, Brain Dev & Regenerat Lab, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.	jhowitt@florey.edu.au; stan@florey.edu.au	Silke, John/B-7622-2008	Silke, John/0000-0002-7611-5774; Howitt, Jason/0000-0001-9922-7931	National Health and Medical Research Council; Victorian Government through the Operational Infrastructure Scheme; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government through the Operational Infrastructure Scheme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council and the Victorian Government through the Operational Infrastructure Scheme.	Aglipay JA, 2006, J BIOL CHEM, V281, P9710, DOI 10.1074/jbc.M510332200; [Anonymous], TRENDS PHARM SCI, V31, P596; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Goh CP, 2014, EXP NEUROL, V252, P37, DOI 10.1016/j.expneurol.2013.11.017; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Howitt J, 2012, J CELL BIOL, V196, P29, DOI 10.1083/jcb.201105009; Howitt J, 2009, P NATL ACAD SCI USA, V106, P15489, DOI 10.1073/pnas.0904880106; Kuo LJ, 2008, IN VIVO, V22, P305; Lackovic J, 2012, EXP NEUROL, V235, P326, DOI 10.1016/j.expneurol.2012.02.014; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li YJ, 2014, TRAFFIC, V15, P749, DOI 10.1111/tra.12175; MIZUMOTO K, 1994, MOL PHARMACOL, V46, P890; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Ouchi Mutsuko, 2010, Genes Cancer, V1, P1211, DOI 10.1177/1947601911404222; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Putz U, 2008, J BIOL CHEM, V283, P32621, DOI 10.1074/jbc.M804120200; Putz U, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003084; Saitsu H, 2014, J HUM GENET, V59, P687, DOI 10.1038/jhg.2014.91; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; So Eui Young, 2014, BMC Cancer, V14, P548, DOI 10.1186/1471-2407-14-548; So EY, 2011, EXP THER MED, V2, P443, DOI 10.3892/etm.2011.232; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002	27	15	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7141	7150		10.1074/jbc.M114.613687	http://dx.doi.org/10.1074/jbc.M114.613687			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631046	Green Published, hybrid			2022-12-26	WOS:000350991500044
J	Chaudhary, N; Sharma, AK; Agarwal, P; Gupta, A; Sharma, VK				Chaudhary, Nikhil; Sharma, Ashok K.; Agarwal, Piyush; Gupta, Ankit; Sharma, Vineet K.			16S Classifier: A Tool for Fast and Accurate Taxonomic Classification of 16S rRNA Hypervariable Regions in Metagenomic Datasets	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; IDENTIFICATION; SEQUENCES; RESOURCE; DATABASE; SEARCH	The diversity of microbial species in a metagenomic study is commonly assessed using 16S rRNA gene sequencing. With the rapid developments in genome sequencing technologies, the focus has shifted towards the sequencing of hypervariable regions of 16S rRNA gene instead of full length gene sequencing. Therefore, 16S Classifier is developed using a machine learning method, Random Forest, for faster and accurate taxonomic classification of short hypervariable regions of 16S rRNA sequence. It displayed precision values of up to 0.91 on training datasets and the precision values of up to 0.98 on the test dataset. On real metagenomic datasets, it showed up to 99.7% accuracy at the phylum level and up to 99.0% accuracy at the genus level. 16S Classifier is available freely at http://metagenomics.iiserb.ac.in/16Sclassifier and http://metabiosys.iiserb.ac.in/16Sclassifier.	[Chaudhary, Nikhil; Sharma, Ashok K.; Agarwal, Piyush; Gupta, Ankit; Sharma, Vineet K.] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Metagen & Syst Biol Grp, MetaInformat Lab, Bhopal, Madhya Pradesh, India; [Agarwal, Piyush] Indian Inst Sci Educ & Res Bhopal, Dept Phys, Bhopal, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal; Indian Institute of Science Education & Research (IISER) - Bhopal	Sharma, VK (corresponding author), Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Metagen & Syst Biol Grp, MetaInformat Lab, Bhopal, Madhya Pradesh, India.	vineetks@iiserb.ac.in	Agarwal, Piyush/B-7443-2017; Sharma, Ashok K/X-1149-2018; Sharma, Ashok Kumar/AAU-7623-2020	Agarwal, Piyush/0000-0001-7485-7531; Sharma, Ashok K/0000-0002-2264-7628; Sharma, Ashok Kumar/0000-0002-2264-7628; K. Sharma, Vineet/0000-0002-2958-6215	intramural funding received from Indian Institute of Science Education and Research Bhopal (IISER Bhopal)	intramural funding received from Indian Institute of Science Education and Research Bhopal (IISER Bhopal)	This work was supported by the intramural funding received from Indian Institute of Science Education and Research Bhopal (IISER Bhopal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Aravindraja C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076724; Biau G, 2012, J MACH LEARN RES, V13, P1063; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Claesson Marcus J, 2010, Nucleic Acids Res, V38, pe200, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; D'Argenio V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/325340; Desai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060204; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fuhrman Jed A, 2012, F1000 Biol Rep, V4, P15, DOI 10.3410/B4-15; Gupta A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093907; Hao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049785; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jonasson J, 2002, APMIS, V110, P263, DOI 10.1034/j.1600-0463.2002.100309.x; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mitra S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S17; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Mullan Lisa J, 2002, Brief Bioinform, V3, P92, DOI 10.1093/bib/3.1.92; Panov P., 2007, COMBINING BAGGING RA; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; QUNFENG D, 2012, METAGENOMICS; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; ZHANG J, 2006, IEEE; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	42	45	47	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116106	10.1371/journal.pone.0116106	http://dx.doi.org/10.1371/journal.pone.0116106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646627	Green Submitted, gold, Green Published			2022-12-26	WOS:000348822600019
J	Garay, T; Kenessey, I; Molnar, E; Juhasz, E; Reti, A; Laszlo, V; Rozsas, A; Dobos, J; Dome, B; Berger, W; Klepetko, W; Tovari, J; Timar, J; Hegedus, B				Garay, Tamas; Kenessey, Istvan; Molnar, Eszter; Juhasz, Eva; Reti, Andrea; Laszlo, Viktoria; Rozsas, Anita; Dobos, Judit; Doeme, Balazs; Berger, Walter; Klepetko, Walter; Tovari, Jozsef; Timar, Jozsef; Hegedus, Balazs			Prenylation Inhibition-Induced Cell Death in Melanoma: Reduced Sensitivity in BRAF Mutant/PTEN Wild-Type Melanoma Cells	PLOS ONE			English	Article							ZOLEDRONIC ACID; IN-VITRO; SIGNALING PATHWAYS; CANCER-CELLS; N-RAS; BISPHOSPHONATE PAMIDRONATE; METASTATIC MELANOMA; GENETIC ALTERATIONS; INDUCED APOPTOSIS; POTENT INHIBITOR	While targeted therapy brought a new era in the treatment of BRAF mutant melanoma, therapeutic options for non-BRAF mutant cases are still limited. In order to explore the antitumor activity of prenylation inhibition we investigated the response to zoledronic acid treatment in thirteen human melanoma cell lines with known BRAF, NRAS and PTEN mutational status. Effect of zoledronic acid on proliferation, clonogenic potential, apoptosis and migration of melanoma cells as well as the activation of downstream elements of the RAS/RAF pathway were investigated in vitro with SRB, TUNEL and PARP cleavage assays and videomicroscopy and immunoblot measurements, respectively. Subcutaneous and spleen-to-liver colonization xenograft mouse models were used to evaluate the influence of zoledronic acid treatment on primary and disseminated tumor growth of melanoma cells in vivo. Zoledronic acidmore efficiently decreased short-term in vitro viability in NRAS mutant cells when compared to BRAF mutant and BRAF/NRAS wild-type cells. In line with this finding, following treatment decreased activation of ribosomal protein S6 was found in NRAS mutant cells. Zoledronic acid demonstrated no significant synergism in cell viability inhibition or apoptosis induction with cisplatin or DTIC treatment in vitro. Importantly, zoledronic acid could inhibit clonogenic growth in the majority of melanoma cell lines except in the three BRAFmutant but PTEN wild-type melanoma lines. A similar pattern was observed in apoptosis induction experiments. In vivo zoledronic acid did not inhibit the subcutaneous growth or spleen-to-liver colonization of melanoma cells. Altogether our data demonstrates that prenylation inhibition may be a novel therapeutic approach in NRASmutant melanoma. Nevertheless, we also demonstrated that therapeutic sensitivity might be influenced by the PTEN status of BRAF mutant melanoma cells. However, further investigations are needed to identify drugs that have appropriate pharmacological properties to efficiently target prenylation in melanoma cells.	[Garay, Tamas; Kenessey, Istvan; Molnar, Eszter; Juhasz, Eva; Reti, Andrea; Timar, Jozsef] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Garay, Tamas; Rozsas, Anita; Doeme, Balazs] Natl Koranyi Inst TB & Pulmonol, Budapest, Hungary; [Garay, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Laszlo, Viktoria; Rozsas, Anita; Doeme, Balazs; Klepetko, Walter; Hegedus, Balazs] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Dobos, Judit; Tovari, Jozsef] Natl Inst Oncol, Dept Expt Pharmacol, Budapest, Hungary; [Doeme, Balazs] Semmelweis Univ, Natl Inst Oncol, Dept Thorac Surg, H-1085 Budapest, Hungary; [Berger, Walter] Med Univ Vienna, Inst Canc Res, Vienna, Austria; [Berger, Walter] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria; [Timar, Jozsef; Hegedus, Balazs] Hungarian Acad Sci, MTA SE Mol Oncol Res Grp, Budapest, Hungary	Semmelweis University; Eotvos Lorand University; Medical University of Vienna; National Institute of Oncology Hungary; National Institute of Oncology Hungary; Semmelweis University; Medical University of Vienna; Medical University of Vienna; Hungarian Academy of Sciences	Hegedus, B (corresponding author), Med Univ Vienna, Dept Thorac Surg, Vienna, Austria.	balazs.hegedus@meduniwien.ac.at	laszlo, viktoria/A-4667-2017; Hegedus, Balazs/B-6076-2008	laszlo, viktoria/0000-0002-6567-3965; Hegedus, Balazs/0000-0002-4341-4153; Dome, Balazs/0000-0001-8799-8624; Berger, Walter/0000-0003-0014-1658	TAMOP [4.2.1/B-09/1/MKR-2010-0001]; National Innovation Office INNO [08-3-2009-0248]; Hungarian Science Foundation (OTKA) MOB [80325, PD109580]; OTKA [CNK77649, K84173]; National Development Agency-NFU KTIA AIK [12-12013-0041]; Herzfelder'schen Familienstiftung, Vienna; Osterreichischer Austauschdienst; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	TAMOP; National Innovation Office INNO; Hungarian Science Foundation (OTKA) MOB; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency-NFU KTIA AIK; Herzfelder'schen Familienstiftung, Vienna; Osterreichischer Austauschdienst; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was financially supported by TAMOP 4.2.1/B-09/1/MKR-2010-0001, the National Innovation Office INNO 08-3-2009-0248, the Hungarian Science Foundation (OTKA) MOB 80325, PD109580, OTKA CNK77649, K84173 and the National Development Agency-NFU KTIA AIK 12-12013-0041 research grants and by the Herzfelder'schen Familienstiftung, Vienna. BH was a Magyary Zoltan postdoctoral fellow. GT acknowledges the Ernst Mach fellowship from the Osterreichischer Austauschdienst. IK is a recipient of Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN D, 1992, J LIPID RES, V33, P1657; Aparicio A, 1998, LEUKEMIA, V12, P220, DOI 10.1038/sj.leu.2400892; Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Berger W, 1997, INT J CANCER, V71, P108, DOI 10.1002/(SICI)1097-0215(19970328)71:1<108::AID-IJC18>3.0.CO;2-E; Blum R, 2005, DRUG RESIST UPDATE, V8, P369, DOI 10.1016/j.drup.2005.11.002; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; Blum R, 2007, CANCER RES, V67, P3320, DOI 10.1158/0008-5472.CAN-06-4287; Budman DR, 2006, ONCOLOGY-BASEL, V70, P147, DOI 10.1159/000093006; Buzzeo R, 2005, CLIN CANCER RES, V11, P6057, DOI 10.1158/1078-0432.CCR-04-2685; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042598; Collisson EA, 2003, CANCER RES, V63, P5669; Corey E, 2003, CLIN CANCER RES, V9, P295; Cremers SCLM, 2005, CLIN PHARMACOKINET, V44, P551, DOI 10.2165/00003088-200544060-00001; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demunter A, 2001, J INVEST DERMATOL, V117, P1483, DOI 10.1046/j.0022-202x.2001.01601.x; Derenne S, 1999, J BONE MINER RES, V14, P2048, DOI 10.1359/jbmr.1999.14.12.2048; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Egozi Y, 1999, INT J CANCER, V80, P911, DOI 10.1002/(SICI)1097-0215(19990315)80:6<911::AID-IJC18>3.0.CO;2-4; Fabbri F, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-43; Forsea AM, 2004, BRIT J CANCER, V91, P803, DOI 10.1038/sj.bjc.6602052; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Garay T, 2013, EXP CELL RES, V319, P3094, DOI 10.1016/j.yexcr.2013.08.018; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Guenther A, 2010, INT J CANCER, V126, P239, DOI 10.1002/ijc.24758; Haapajarvi T, 1999, CELL GROWTH DIFFER, V10, P163; Haluska FG, 2006, CLIN CANCER RES, V12, p2301S, DOI 10.1158/1078-0432.CCR-05-2518; Hegedus B, 2004, J NEURO-ONCOL, V67, P147, DOI 10.1023/B:NEON.0000021826.73020.f3; Hegedus B, 2000, J NEUROSURG, V92, P428, DOI 10.3171/jns.2000.92.3.0428; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; Iguchi T, 2003, CELL SIGNAL, V15, P719, DOI 10.1016/S0898-6568(03)00007-X; Jagdev SP, 2001, BRIT J CANCER, V84, P1126, DOI 10.1054/bjoc.2001.1727; Ji ZY, 2012, TRENDS MOL MED, V18, P27, DOI 10.1016/j.molmed.2011.08.001; Kloog Y, 2004, SEMIN CANCER BIOL, V14, P253, DOI 10.1016/j.semcancer.2004.04.004; Kumar R, 2003, CLIN CANCER RES, V9, P3362; LADANYI A, 1990, INT J CANCER, V46, P456, DOI 10.1002/ijc.2910460322; Ladanyi Andrea, 2001, Pathology and Oncology Research, V7, P260; Lazar V, 2009, MODERN PATHOL, V22, P1367, DOI 10.1038/modpathol.2009.109; Lee MV, 2001, CANCER RES, V61, P2602; Lerner EC, 1997, ONCOGENE, V15, P1283, DOI 10.1038/sj.onc.1201296; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mathieu V, 2009, J CELL MOL MED, V13, P3960, DOI 10.1111/j.1582-4934.2009.00708.x; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; MUELLER BM, 1991, CANCER RES, V51, P2193; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Neville-Webbe HL, 2005, INT J CANCER, V113, P364, DOI 10.1002/ijc.20602; Niessner H, 2011, J INVEST DERMATOL, V131, P468, DOI 10.1038/jid.2010.297; Nikolaou VA, 2012, J INVEST DERMATOL, V132, P854, DOI 10.1038/jid.2011.421; Nissan MH, 2014, CANCER RES, V74, P2340, DOI 10.1158/0008-5472.CAN-13-2625; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Peng HJ, 2007, CANCER RES, V67, P9346, DOI 10.1158/0008-5472.CAN-06-4508; Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Raz T, 2007, BLOOD, V110, P2102, DOI 10.1182/blood-2006-12-064907; Riebeling C, 2002, BRIT J CANCER, V87, P366, DOI 10.1038/sj.bjc.6600476; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sebti SM, 2000, ONCOGENE, V19, P6584, DOI 10.1038/sj.onc.1204146; Senaratne SG, 2000, BRIT J CANCER, V82, P1459, DOI 10.1054/bjoc.1999.1131; Shipman CM, 1997, BRIT J HAEMATOL, V98, P665, DOI 10.1046/j.1365-2141.1997.2713086.x; Smalley KSM, 2003, INT J CANCER, V105, P165, DOI 10.1002/ijc.11064; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sonnemann J, 2001, ANTI-CANCER DRUG, V12, P459, DOI 10.1097/00001813-200106000-00007; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Stachnik A, 2014, P NATL ACAD SCI USA, DOI [10.1073/pnas.1421566112, DOI 10.1073/PNAS.1421566112]; Tassone P, 2003, BRIT J CANCER, V88, P1971, DOI 10.1038/sj.bjc.6600986; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; van Beek E, 1999, BIOCHEM BIOPH RES CO, V264, P108, DOI 10.1006/bbrc.1999.1499; Weiss HM, 2008, DRUG METAB DISPOS, V36, P2043, DOI 10.1124/dmd.108.021071; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Yuen T, 2014, P NATL ACAD SCI USA, DOI [10.1073/pnas.1421566112, DOI 10.1073/PNAS.1421566112]	77	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117021	10.1371/journal.pone.0117021	http://dx.doi.org/10.1371/journal.pone.0117021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646931	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000348822600049
J	Knudsen, ML; Ljungberg, K; Tatoud, R; Weber, J; Esteban, M; Liljestrom, P				Knudsen, Maria L.; Ljungberg, Karl; Tatoud, Roger; Weber, Jonathan; Esteban, Mariano; Liljestrom, Peter			Alphavirus Replicon DNA Expressing HIV Antigens Is an Excellent Prime for Boosting with Recombinant Modified Vaccinia Ankara (MVA) or with HIV gp140 Protein Antigen	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; T-CELL RESPONSES; CLADE-C; DENDRITIC CELLS; IMMUNOGENICITY; IMMUNIZATION; INTERFERON; INDUCTION; ELECTROPORATION; IMMUNODOMINANCE	Vaccination with DNA is an attractive strategy for induction of pathogen-specific T cells and antibodies. Studies in humans have shown that DNA vaccines are safe, but their immunogenicity needs further improvement. As a step towards this goal, we have previously demonstrated that immunogenicity is increased with the use of an alphavirus DNA-launched replicon (DREP) vector compared to conventional DNA vaccines. In this study, we investigated the effect of varying the dose and number of administrations of DREP when given as a prime prior to a heterologous boost with poxvirus vector (MVA) and/or HIV gp140 protein formulated in glucopyranosyl lipid A (GLA-AF) adjuvant. The DREP and MVA vaccine constructs encoded Env and a Gag-Pol-Nef fusion protein from HIV clade C. One to three administrations of 0.2 mu g DREP induced lower HIV-specific T cell and IgG responses than the equivalent number of immunizations with 10 mu g DREP. However, the two doses were equally efficient as a priming component in a heterologous prime-boost regimen. The magnitude of immune responses depended on the number of priming immunizations rather than the dose. A single low dose of DREP prior to a heterologous boost resulted in greatly increased immune responses compared to MVA or protein antigen alone, demonstrating that a mere 0.2 mu g DREP was sufficient for priming immune responses. Following a DREP prime, T cell responses were expanded greatly by an MVA boost, and IgG responses were also expanded when boosted with protein antigen. When MVA and protein were administered simultaneously following multiple DREP primes, responses were slightly compromised compared to administering them sequentially. In conclusion, we have demonstrated efficient priming of HIV-specific T cell and IgG responses with a low dose of DREP, and shown that the priming effect depends on number of primes administered rather than dose.	[Knudsen, Maria L.; Ljungberg, Karl; Liljestrom, Peter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Tatoud, Roger; Weber, Jonathan] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Div Med, London, England; [Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain	Karolinska Institutet; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Knudsen, ML (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	maria.knudsen@ki.se; peter.liljestrom@ki.se	Esteban, Mariano/ABG-5375-2020	Esteban, Mariano/0000-0003-0846-2827; TATOUD, Roger/0000-0002-3999-8264; Ljungberg, Karl/0000-0001-7192-6204; Liljestrom, Peter/0000-0002-2132-0981	Swedish Research Council; UK HIV Vaccine Consortium (HVC) Programme; Wellcome. GENEART AG (Regensburg, Germany) [EP1240333B1]; National Institute for Health Research [NF-SI-0513-10093] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); UK HIV Vaccine Consortium (HVC) Programme; Wellcome. GENEART AG (Regensburg, Germany); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Swedish Research Council (www.vr.se) and by the UK HIV Vaccine Consortium (HVC; www.ukhvc.org) Programme. The CN54 env and ZM96 gag-pol-nef (DNA-C) plasmids were developed as part of the UK HVC. The UK HVC is funded by an award from the Wellcome. GENEART AG (Regensburg, Germany) owns a European Patent EP1240333B1 covering the complete clade C/B' HIV-1 97CN54 coding sequence and codon optimized genes used for the creation of the DREP-C CN54. The 96ZM651-8 clone construct used as a template to build the DREP-C ZM96 candidate vaccine is the property of the University of Alabama at Birmingham Research Foundation (UABRF; www.uab.edu/uabrf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA Y, 1984, CANCER RES, V44, P5127; Akram A, 2012, CLIN IMMUNOL, V143, P99, DOI 10.1016/j.clim.2012.01.015; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Barry G, 2010, J VIROL, V84, P7369, DOI 10.1128/JVI.02310-09; Barry G, 2009, J GEN VIROL, V90, P1382, DOI 10.1099/vir.0.007336-0; Berglund P, 1998, NAT BIOTECHNOL, V16, P562, DOI 10.1038/nbt0698-562; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brave A, 2006, VACCINE, V24, P4524, DOI 10.1016/j.vaccine.2005.08.018; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; De Filette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087837; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Excler JL, 2014, CLIN VACCINE IMMUNOL, V21, P1023, DOI 10.1128/CVI.00230-14; Excler JL, 2014, HUM VACC IMMUNOTHER, V10, P1734, DOI 10.4161/hv.28462; Glasgow GM, 1997, J GEN VIROL, V78, P1559, DOI 10.1099/0022-1317-78-7-1559; Graw F, 2014, J VIROL, V88, P10134, DOI 10.1128/JVI.00647-14; Hallengard D, 2014, J VIROL, V88, P13333, DOI 10.1128/JVI.01926-14; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Hanke T, 1998, VACCINE, V16, P439, DOI 10.1016/S0264-410X(97)00226-0; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hariharan MJ, 1998, J VIROL, V72, P950, DOI 10.1128/JVI.72.2.950-958.1998; Hidmark AS, 2005, J VIROL, V79, P10376, DOI 10.1128/JVI.79.16.10376-10385.2005; Hidmark AS, 2006, J VIROL, V80, P7100, DOI 10.1128/JVI.02579-05; Johansson DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029732; Knudsen ML, 2014, METHODS MOL BIOL, V1121, P147, DOI 10.1007/978-1-4614-9632-8_13; Knudsen ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065964; Knudsen ML, 2012, J VIROL, V86, P4082, DOI 10.1128/JVI.06535-11; Knudsen ML, 2014, J VIROL, V88, P12438, DOI 10.1128/JVI.02223-14; Littel-van den Hurk SV, 2010, EXPERT REV VACCINES, V9, P503, DOI [10.1586/erv.10.42, 10.1586/ERV.10.42]; Liu JY, 2006, J VIROL, V80, P11991, DOI 10.1128/JVI.01348-06; Ljungberg K, 2014, EXPERT REV VACCINES, P1; Ljungberg K, 2007, J VIROL, V81, P13412, DOI 10.1128/JVI.01799-07; Lux A, 2010, ANN RHEUM DIS, V69, P92, DOI 10.1136/ard.2009.117101; McKay PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084707; Muthumani K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084234; Naslund TI, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-36; Nkolola JP, 2014, VACCINE, V32, P2109, DOI 10.1016/j.vaccine.2014.02.001; Nordstrom EKL, 2005, J GEN VIROL, V86, P349, DOI 10.1099/vir.0.80481-0; Paris RM, 2010, EXPERT REV VACCINES, V9, P1055, DOI 10.1586/ERV.10.106; Pattacini L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042163; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Wang SX, 2006, VIROLOGY, V350, P34, DOI 10.1016/j.virol.2006.02.032; Wijesundara DK, 2011, IMMUNOL CELL BIOL, V89, P367, DOI 10.1038/icb.2010.118; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038	51	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117042	10.1371/journal.pone.0117042	http://dx.doi.org/10.1371/journal.pone.0117042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643354	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821200032
J	Chen, SC; Teng, CJ; Hu, YW; Yeh, CM; Hung, MH; Hu, LY; Ku, FC; Tzeng, CH; Chiou, TJ; Chen, TJ; Liu, CJ				Chen, San-Chi; Teng, Chung-Jen; Hu, Yu-Wen; Yeh, Chiu-Mei; Hung, Man-Hsin; Hu, Li-Yu; Ku, Fan-Chen; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Chen, Tzeng-Ji; Liu, Chia-Jen			Secondary Primary Malignancy Risk among Patients with Esophageal Cancer in Taiwan: A Nationwide Population-Based Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; 2ND PRIMARY-CANCER; POOLED ANALYSIS; INTERNATIONAL HEAD; BARRETTS-ESOPHAGUS; CIGARETTE-SMOKING; NECK-CANCER; EPIDEMIOLOGY; ADENOCARCINOMA; TOBACCO	Background To evaluate the risk and sites of metachronous secondary primary malignancies (SPMs) among patients with esophageal cancer. Methods Newly diagnosed esophageal cancer patients between 1997 and 2011 were recruited. To avoid surveillance bias, SPMs that developed within one year were excluded. Standardized incidence ratios (SIRs) of metachronous SPMs in these patients were calculated by comparing to the cancer incidence in the general population. Risk factors for SPM development, included age, sex, comorbidities and cancer-related treatments, were estimated by Cox proportional hazards models. Results During the 15-year study period, 870 SPMs developed among 18,026 esophageal cancer patients, with a follow-up of 27,056 person-years. The SIR for all cancers was 3.53. The SIR of follow-up period >= 10 years was 3.56; 5-10 years, 3.14; and 1-5 years, 3.06. The cancer SIRs of head and neck (15.83), stomach (3.30), lung and mediastinum (2.10), kidney (2.24) and leukemia (2.72), were significantly increased. Multivariate analysis showed that age >= 60 years (hazard ratio [HR] 0.74), being male (HR 1.46) and liver cirrhosis (HR 1.46) were independent factors. According to the treatments, major surgery (HR 1.24) increased the risk, but chemotherapy was nearly significant. Conclusions Patients with esophageal cancer were at increased risk of developing metachronous SPMs. The SIR remained high in follow-up > 10 years, so that close monitoring may be needed for early detection of SPM among these esophageal cancer patients.	[Chen, San-Chi; Hung, Man-Hsin; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Teng, Chung-Jen] Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Teng, Chung-Jen; Hu, Yu-Wen; Hung, Man-Hsin; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Chen, Tzeng-Ji; Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Hu, Li-Yu] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Ku, Fan-Chen] Changhua Show Chwan Mem Hosp, Div Hematol & Oncol, Dept Med, Changhua, Taiwan; [Chiou, Tzeon-Jye] Taipei Vet Gen Hosp, Div Transfus Med, Dept Med, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	Taipei Veterans General Hospital; Far Eastern Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital; Show Chwan Memorial Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Teng, CJ (corresponding author), Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan.	dodol73@gmail.com; chiajenliu@gmail.com	Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X; Chen, San-Chi/0000-0002-9436-5400	Taipei Veterans General Hospital [V103B-022, V103E10-001]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study is supported by a grant from Taipei Veterans General Hospital (V103B-022 and V103E10-001) and is based in part on data from the National Health Insurance Research Database, provided by the Bureau of National Health Insurance, Department of Health, and managed by National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the Bureau of National Health Insurance, Department of Health or National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Chen S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062291, 10.1371/journal.pone.0082812]; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chuang SC, 2008, CANCER EPIDEM BIOMAR, V17, P1543, DOI 10.1158/1055-9965.EPI-07-2876; FOGEL TD, 1985, CANCER, V55, P1882, DOI 10.1002/1097-0142(19850501)55:9<1882::AID-CNCR2820550907>3.0.CO;2-I; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Hunt JD, 2005, INT J CANCER, V114, P101, DOI 10.1002/ijc.20618; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalaitzakis E, 2011, CLIN GASTROENTEROL H, V9, P168, DOI 10.1016/j.cgh.2010.10.014; Kleinberg L, 2003, INT J RADIAT ONCOL, V56, P328, DOI 10.1016/S0360-3016(02)04598-4; Kubo A, 2004, AM J GASTROENTEROL, V99, P582, DOI 10.1111/j.1572-0241.2004.04131.x; Lee CH, 2005, INT J CANCER, V113, P475, DOI 10.1002/ijc.20619; Lo SF, 2013, INT J CANCER, V132, P182, DOI 10.1002/ijc.27597; Lu CL, 2010, CANCER CAUSE CONTROL, V21, P269, DOI 10.1007/s10552-009-9458-0; Matsubara T, 2003, J CLIN ONCOL, V21, P4336, DOI 10.1200/JCO.2003.12.074; Motoyama S, 2003, J AM COLL SURGEONS, V197, P914, DOI 10.1016/j.jamcollsurg.2003.07.014; Natsugoe S, 2005, WORLD J SURG, V29, P46, DOI 10.1007/s00268-004-7525-y; Poon RTP, 1998, ANN THORAC SURG, V65, P1529, DOI 10.1016/S0003-4975(98)00177-5; SHIBUYA H, 1995, CANCER, V76, P101, DOI 10.1002/1097-0142(19950701)76:1<101::AID-CNCR2820760115>3.0.CO;2-D; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; Sugiura T, 2002, J AM COLL SURGEONS, V194, P578, DOI 10.1016/S1072-7515(02)01135-3; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; Wong A, 2005, CLIN GASTROENTEROL H, V3, P1, DOI 10.1016/S1542-3565(04)00602-0; Wyss A, 2013, AM J EPIDEMIOL, V178, P679, DOI 10.1093/aje/kwt029; Zhu G, 2012, DIS ESOPHAGUS, V25, P505, DOI 10.1111/j.1442-2050.2011.01273.x	27	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116384	10.1371/journal.pone.0116384	http://dx.doi.org/10.1371/journal.pone.0116384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635388	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700034
J	Lee, HK; Tang, JWT; Loh, TP; Hurt, AC; Oon, LLE; Koay, ESC				Lee, Hong Kai; Tang, Julian Wei-Tze; Loh, Tze Ping; Hurt, Aeron C.; Oon, Lynette Lin-Ean; Koay, Evelyn Siew-Chuan			Molecular Surveillance of Antiviral Drug Resistance of Influenza A/H3N2 Virus in Singapore, 2009-2013	PLOS ONE			English	Article							NEURAMINIDASE INHIBITOR RESISTANCE; UNITED-STATES; B VIRUSES; A(H3N2) VIRUSES; GENETIC-CHARACTERISTICS; OSELTAMIVIR RESISTANCE; VACCINE EPIDEMIOLOGY; A VIRUSES; SUSCEPTIBILITY; WORLDWIDE	Adamantanes and neuraminidase inhibitors (NAIs) are two classes of antiviral drugs available for the chemoprophylaxis and treatment of influenza infections. To determine the frequency of drug resistance in influenza A/H3N2 viruses in Singapore, large-scale sequencing of neuraminidase (NA) and matrix protein (MP) genes was performed directly without initial culture amplification. 241 laboratory-confirmed influenza A/H3N2 clinical samples, collected between May 2009 and November 2013 were included. In total, 229 NA (95%) and 241 MP (100%) complete sequences were obtained. Drug resistance mutations in the NA and MP genes were interpreted according to published studies. For the NAIs, a visual inspection of the aligned NA sequences revealed no known drug resistant genotypes (DRGs). For the adamantanes, the well-recognised S31N DRG was identified in all 241 MP genes. In addition, there was an increasing number of viruses carrying the combination of D93G+Y155F+D251V (since May 2013) or D93G (since March 2011) mutations in the NA gene. However, in-vitro NAI testing indicated that neither D93G+Y155F+D251V nor D93G alone conferred any changes in NAI susceptibility. Lastly, an I222T mutation in the NA gene that has previously been reported to cause oseltamivir-resistance in influenza A/H1N1/2009, B, and A/H5N1, was detected from a treatment-naive patient. Further in-vitro NAI testing is required to confirm the effect of this mutation in A/H3N2 virus.	[Lee, Hong Kai; Koay, Evelyn Siew-Chuan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 117595, Singapore; [Lee, Hong Kai; Loh, Tze Ping; Koay, Evelyn Siew-Chuan] Natl Univ Hlth Syst, Natl Univ Hosp, Dept Lab Med, Singapore, Singapore; [Tang, Julian Wei-Tze] Leicester Royal Infirm, Clin Microbiol, Leicester, Leics, England; [Hurt, Aeron C.] WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia; [Hurt, Aeron C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Oon, Lynette Lin-Ean] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore	National University of Singapore; National University of Singapore; University of Leicester; World Health Organization; University of Melbourne; Singapore General Hospital	Tang, JWT (corresponding author), Leicester Royal Infirm, Clin Microbiol, Leicester, Leics, England.	julian.tang@uhl-tr.nhs.uk; evelyn_koay@nuhs.edu.sg		Hurt, Aeron/0000-0003-1826-4314; Loh, Tze Ping/0000-0002-4272-0001; Tang, Julian/0000-0002-4963-1028	Singapore National Medical Research Council [NMRC/1247/2010]; Australian Government Department of Health	Singapore National Medical Research Council(National Medical Research Council, Singapore); Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	This study was supported by a grant from Singapore National Medical Research Council, (http://www.nmrc.gov.sg) (ref: NMRC/1247/2010 to JWT and ESK). The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, Wkly Epidemiol Rec, V88, P477; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P101; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P369; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P83; Barr IG, 2014, VACCINE, V32, P4713, DOI 10.1016/j.vaccine.2014.02.014; Blanton Lenee, 2011, Morbidity and Mortality Weekly Report, V60, P1239; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Burnham AJ, 2014, ANTIMICROB AGENTS CH, V58, P2718, DOI 10.1128/AAC.02628-13; Dapat C, 2013, ANTIVIR RES, V99, P261, DOI 10.1016/j.antiviral.2013.06.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Epperson Scott, 2012, Morbidity and Mortality Weekly Report, V61, P785; Govorkova EA, 2013, ANTIVIR RES, V98, P297, DOI 10.1016/j.antiviral.2013.02.013; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Huang L, 2014, ANTIMICROB AGENTS CH, V58, P1639, DOI 10.1128/AAC.01848-13; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Hurt Aeron C, 2012, Methods Mol Biol, V865, P115, DOI 10.1007/978-1-61779-621-0_7; Jhung M., 2010, Morbidity and Mortality Weekly Report, V59, P1270; KLIMOV AI, 1995, J INFECT DIS, V172, P1352, DOI 10.1093/infdis/172.5.1352; Klimov AI, 2012, VACCINE, V30, P6461, DOI 10.1016/j.vaccine.2012.07.089; Leang SK, 2014, INFLUENZA OTHER RESP, V8, P135, DOI 10.1111/irv.12187; Lee HK, 2014, J CLIN MICROBIOL, V52, P1749, DOI 10.1128/JCM.00538-14; Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079252; Lee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064785; Lee HK, 2012, J MED VIROL, V84, P1646, DOI 10.1002/jmv.23375; Lee HK, 2010, J MOL DIAGN, V12, P636, DOI 10.2353/jmoldx.2010.100010; McKimm-Breschkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066105; Mishin VP, 2014, ANTIVIR RES, V101, P93, DOI 10.1016/j.antiviral.2013.11.001; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Nguyen HT, 2012, ANTIVIR THER, V17, P159, DOI 10.3851/IMP2067; Okomo-Adhiambo M, 2013, INFLUENZA OTHER RESP, V7, P44, DOI [10.1111/irv.12113, 10.1111/irv.12051]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pizzorno A, 2014, ANTIMICROB AGENTS CH, V58, P6398, DOI 10.1128/AAC.02956-14; Prudhomme IT, 1997, CLIN DIAGN VIROL, V8, P41, DOI 10.1016/S0928-0197(97)00011-1; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; Tang JW, 2008, J MED VIROL, V80, P895, DOI 10.1002/jmv.21155; Tang JW, 2012, EXPERT REV ANTI-INFE, V10, P751, DOI [10.1586/ERI.12.63, 10.1586/eri.12.63]; Wang DY, 2013, ANTIVIR RES, V97, P240, DOI 10.1016/j.antiviral.2012.12.013; Whitley RJ, 2013, CLIN INFECT DIS, V56, P1197, DOI 10.1093/cid/cis1220	40	10	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117822	10.1371/journal.pone.0117822	http://dx.doi.org/10.1371/journal.pone.0117822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635767	Green Published, gold			2022-12-26	WOS:000350680700100
J	Olofsson, JK; Pereira, V; Borsting, C; Morling, N				Olofsson, Jill Katharina; Pereira, Vania; Borsting, Claus; Morling, Niels			Peopling of the North Circumpolar Region - Insights from Y Chromosome STR and SNP Typing of Greenlanders	PLOS ONE			English	Article							NATIVE-AMERICANS; MICROSATELLITE HAPLOTYPES; POPULATION-STRUCTURE; MIGRATION HISTORY; MITOCHONDRIAL-DNA; GENETIC DIVERSITY; EAST-ASIA; RESOLUTION; EVOLUTIONARY; HIMALAYAS	The human population in Greenland is characterized by migration events of Paleo-and Neo-Eskimos, as well as admixture with Europeans. In this study, the Y-chromosomal variation in male Greenlanders was investigated in detail by typing 73 Y-chromosomal single nucleotide polymorphisms (Y-SNPs) and 17 Y-chromosomal short tandem repeats (Y-STRs). Approximately 40% of the analyzed Greenlandic Y chromosomes were of European origin (I-M170, R1a-M513 and R1b-M343). Y chromosomes of European origin were mainly found in individuals from the west and south coasts of Greenland, which is in agreement with the historic records of the geographic placements of European settlements in Greenland. Two Inuit Y-chromosomal lineages, Q-M3 (xM19, M194, L663, SA01 and L766) and Q-NWT01 (xM265) were found in 23% and 31% of the male Greenlanders, respectively. The time to the most recent common ancestor (TMRCA) of the Q-M3 lineage of the Greenlanders was estimated to be between 4,400 and 10,900 years ago (y. a.) using two different methods. This is in agreement with the theory that the North Circumpolar Region was populated via a second expansion of humans in the North American continent. The TMRCA of the Q-NWT01 (xM265) lineage in Greenland was estimated to be between 7,000 and 14,300 y. a. using two different methods, which is older than the previously reported TMRCA of this lineage in other Inuit populations. Our results indicate that Inuit individuals carrying the Q-NWT01 (xM265) lineage may have their origin in the northeastern parts of North America and could be descendants of the Dorset culture. This in turn points to the possibility that the current Inuit population in Greenland is comprised of individuals of both Thule and Dorset descent.	[Olofsson, Jill Katharina; Pereira, Vania; Borsting, Claus; Morling, Niels] Univ Copenhagen, Dept Forens Med, Fac Hlth & Med Sci, Sect Forens Genet, Copenhagen, Denmark	University of Copenhagen	Olofsson, JK (corresponding author), Univ Copenhagen, Dept Forens Med, Fac Hlth & Med Sci, Sect Forens Genet, Copenhagen, Denmark.	jill.olofsson@sund.ku.dk	Olofsson, Jill/ABE-9797-2020; Pereira, Vania/T-7709-2019; Pereira, Vania/S-8082-2018	Pereira, Vania/0000-0002-8789-5286; Pereira, Vania/0000-0002-8789-5286; Olofsson, Jill/0000-0002-9527-6573; Morling, Niels/0000-0002-9463-5087; Borsting, Claus/0000-0003-0421-7429				Andersen MM, 2014, FORENSIC SCI INT-GEN, V11, P182, DOI 10.1016/j.fsigen.2014.03.016; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Battaglia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071390; Bisso-Machado R, 2011, AM J HUM BIOL, V23, P563, DOI 10.1002/ajhb.21173; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Bosch E, 2003, HUM GENET, V112, P353, DOI 10.1007/s00439-003-0913-9; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Dupuy BM, 2006, FORENSIC SCI INT, V164, P10, DOI 10.1016/j.forsciint.2005.11.009; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gad F., 1984, HDB N AM INDIANS, P556; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gjertson DW, 2007, FORENSIC SCI INT-GEN, V1, P223, DOI 10.1016/j.fsigen.2007.06.006; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Jensen J., 2006, MEDDELELSER GRONLAND, V32, P1; Johansen P, 2013, FORENSIC SCI INT-GEN, V7, P482, DOI 10.1016/j.fsigen.2013.04.009; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karlsson AO, 2006, EUR J HUM GENET, V14, P963, DOI 10.1038/sj.ejhg.5201651; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kleivan Inge, 1984, HDB N AM INDIANS, V5, P549; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; McGhee R, 2000, IDENTITIES CULTURAL, P181; Mulligan CJ, 2004, ANNU REV GENOM HUM G, V5, P295, DOI 10.1146/annurev.genom.5.061903.175920; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Olofsson JK, 2013, FORENS SCI INT-GEN S, V4, pE220, DOI 10.1016/j.fsigss.2013.10.113; Oppenheimer S, 2012, PHILOS T R SOC B, V367, P770, DOI 10.1098/rstb.2011.0306; Park Robert, 2000, IDENTITIES CULTURE C, P192; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Regueiro M, 2013, AM J PHYS ANTHROPOL, V150, P333, DOI 10.1002/ajpa.22207; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Roewer L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003460; Sanchez JJ, 2004, INT CONGR SER, V1261, P347, DOI 10.1016/S0531-5131(03)01635-2; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Schurr TG, 2012, AM J PHYS ANTHROPOL, V148, P422, DOI 10.1002/ajpa.22068; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Sutherland P.D., 2000, IDENTITIES CULTURAL, P159; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	46	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116573	10.1371/journal.pone.0116573	http://dx.doi.org/10.1371/journal.pone.0116573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635810	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700045
J	Li, W; Garringer, HJ; Goodwin, CB; Richine, B; Acton, A; VanDuyn, N; Muhoberac, BB; Irimia-Dominguez, J; Chan, RJ; Peacock, M; Nass, R; Ghetti, B; Vidal, R				Li, Wei; Garringer, Holly J.; Goodwin, Charles B.; Richine, Briana; Acton, Anthony; VanDuyn, Natalia; Muhoberac, Barry B.; Irimia-Dominguez, Jose; Chan, Rebecca J.; Peacock, Munro; Nass, Richard; Ghetti, Bernardino; Vidal, Ruben			Systemic and Cerebral Iron Homeostasis in Ferritin Knock-Out Mice	PLOS ONE			English	Article							LIGHT-CHAIN; H-FERRITIN; MUTANT FORM; NEURODEGENERATION; GENE; HYPERFERRITINEMIA; POLYPEPTIDE; HEREDITARY; DEFICIENCY; METABOLISM	Ferritin, a 24-mer heteropolymer of heavy (H) and light (L) subunits, is the main cellular iron storage protein and plays a pivotal role in iron homeostasis by modulating free iron levels thus reducing radical-mediated damage. The H subunit has ferroxidase activity (converting Fe(II) to Fe(III)), while the L subunit promotes iron nucleation and increases ferritin stability. Previous studies on the H gene (Fth) in mice have shown that complete inactivation of Fth is lethal during embryonic development, without ability to compensate by the L subunit. In humans, homozygous loss of the L gene (FTL) is associated with generalized seizure and atypical restless leg syndrome, while mutations in FTL cause a form of neurodegeneration with brain iron accumulation. Here we generated mice with genetic ablation of the Fth and Ftl genes. As previously reported, homozygous loss of the Fth allele on a wild-type Ftl background was embryonic lethal, whereas knock-out of the Ftl allele (Ftl(-/-)) led to a significant decrease in the percentage of Ftl(-/-)newborn mice. Analysis of Ftl(-/-)mice revealed systemic and brain iron dyshomeostasis, without any noticeable signs of neurodegeneration. Our findings indicate that expression of the H subunit can rescue the loss of the L subunit and that H ferritin homopolymers have the capacity to sequester iron in vivo. We also observed that a single allele expressing the H subunit is not sufficient for survival when both alleles encoding the L subunit are absent, suggesting the need of some degree of complementation between the subunits as well as a dosage effect.	[Li, Wei; Garringer, Holly J.; Irimia-Dominguez, Jose; Ghetti, Bernardino; Vidal, Ruben] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Goodwin, Charles B.; Richine, Briana; Chan, Rebecca J.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Acton, Anthony; Peacock, Munro] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [VanDuyn, Natalia; Nass, Richard] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Muhoberac, Barry B.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Vidal, R (corresponding author), Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	rvidal@iupui.edu		Ryan, Natalia/0000-0003-1889-2169	National Institute on Neurological Disorders and Stroke [NS050227, NS063056]; NATIONAL CANCER INSTITUTE [R01CA134777] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063056, R01NS050227] Funding Source: NIH RePORTER	National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the National Institute on Neurological Disorders and Stroke NS050227 and NS063056 (RV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraibar MA, 2008, J BIOL CHEM, V283, P31679, DOI 10.1074/jbc.M805532200; Baraibar MA, 2012, FREE RADICAL BIO MED, V52, P1692, DOI 10.1016/j.freeradbiomed.2012.02.015; Baraibar MA, 2010, J BIOL CHEM, V285, P1950, DOI 10.1074/jbc.M109.042986; Barbeito AG, 2009, J NEUROCHEM, V109, P1067, DOI 10.1111/j.1471-4159.2009.06028.x; Bennett TM, 2013, MOL VIS, V19, P835; Berg Daniela, 2006, Top Magn Reson Imaging, V17, P5, DOI 10.1097/01.rmr.0000245461.90406.ad; Bowes O, 2014, LANCET, V383, P1520, DOI 10.1016/S0140-6736(14)60484-0; Cozzi A, 2013, J EXP MED, V210, P1779, DOI 10.1084/jem.20130315; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Ferreira C, 2001, BLOOD, V98, P525, DOI 10.1182/blood.V98.3.525; FINCH CA, 1986, WESTERN J MED, V145, P657; Gkouvatsos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085530; Kato J, 2001, AM J HUM GENET, V69, P191, DOI 10.1086/321261; Madsen E, 2007, ANNU REV NEUROSCI, V30, P317, DOI 10.1146/annurev.neuro.30.051606.094232; Muhoberac BB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00032; Patel BN, 2002, J NEUROSCI, V22, P6578; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Spijker S, 2011, NEUROMETHODS, V57, P13, DOI 10.1007/978-1-61779-111-6_2; Thompson K, 2003, J NEUROSCI RES, V71, P46, DOI 10.1002/jnr.10463; VanDuyn N, 2013, J NEUROCHEM, V124, P147, DOI 10.1111/jnc.12072; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P787, DOI 10.1093/jnen/63.8.787; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008	22	42	43	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117435	10.1371/journal.pone.0117435	http://dx.doi.org/10.1371/journal.pone.0117435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629408	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100083
J	Moffitt, SE; Moffitt, RA; Sauthoff, W; Davis, CV; Hewett, K; Hill, TM				Moffitt, Sarah E.; Moffitt, Russell A.; Sauthoff, Wilson; Davis, Catherine V.; Hewett, Kathryn; Hill, Tessa M.			Paleoceanographic Insights on Recent Oxygen Minimum Zone Expansion: Lessons for Modern Oceanography	PLOS ONE			English	Article							SANTA-BARBARA BASIN; GLACIAL-INTERGLACIAL VARIABILITY; PACIFIC INTERMEDIATE WATER; CALIFORNIA CURRENT SYSTEM; TROPICAL NORTH PACIFIC; SUB-ARCTIC PACIFIC; ARABIAN SEA; BENTHIC FORAMINIFERA; LAST DEGLACIATION; LATE PLEISTOCENE	Climate-driven Oxygen Minimum Zone (OMZ) expansions in the geologic record provide an opportunity to characterize the spatial and temporal scales ofOMZ change. Here we investigate OMZ expansion through the global- scale warming event of the most recent deglaciation (18- 11 ka), an event with clear relevance to understanding modern anthropogenic climate change. Deglacial marine sediment records were compiled to quantify the vertical extent, intensity, surface area and volume impingements of hypoxic waters upon continental margins. By integrating sediment records (183-2,309 meters below sea level; mbsl) containing one or more geochemical, sedimentary or microfossil oxygenation proxies integrated with analyses of eustatic sea level rise, we reconstruct the timing, depth and intensity of seafloor hypoxia. The maximum vertical OMZ extent during the deglaciation was variable by region: Subarctic Pacific (similar to 600-2,900 mbsl), California Current (similar to 330-1,500 mbsl), Mexico Margin (similar to 330-830 mbsl), and the Humboldt Current and Equatorial Pacific (similar to 110-3,100 mbsl). The timing ofOMZ expansion is regionally coherent but not globally synchronous. Subarctic Pacific and California Current continental margins exhibit tight correlation to the oscillations of Northern Hemisphere deglacial events (Termination IA, Bolling-Allerod, Younger Dryas and Termination IB). Southern regions (Mexico Margin and the Equatorial Pacific and Humboldt Current) exhibit hypoxia expansion prior to Termination IA (similar to 14.7 ka), and no regional oxygenation oscillations. Our analyses provide new evidence for the geographically and vertically extensive expansion of OMZs, and the extreme compression of upper-ocean oxygenated ecosystems during the geologically recent deglaciation.	[Moffitt, Sarah E.; Davis, Catherine V.; Hill, Tessa M.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA; [Moffitt, Sarah E.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Moffitt, Russell A.] Marine Conservat Inst, Glen Ellen, CA USA; [Sauthoff, Wilson; Davis, Catherine V.; Hill, Tessa M.] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Hewett, Kathryn] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Moffitt, SE (corresponding author), Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA.	semoffitt@ucdavis.edu	Hill, Tessa Michelle/P-3401-2019; Sauthoff, Wilson/AAP-4898-2020	Hill, Tessa Michelle/0000-0003-4159-9104; Sauthoff, Wilson/0000-0001-9683-1578; Davis, Catherine/0000-0003-4279-5369	National Science Foundation (OCE) [0825322, 1255194]; University of California Multicampus Research Programs and Initiatives; University of California Davis REACH IGERT; Mia Tegner Historical Ecology; EPA STAR Fellowship; Switzer Environmental Fellowship; Division Of Ocean Sciences [1255194] Funding Source: National Science Foundation	National Science Foundation (OCE)(National Science Foundation (NSF)); University of California Multicampus Research Programs and Initiatives; University of California Davis REACH IGERT; Mia Tegner Historical Ecology; EPA STAR Fellowship(United States Environmental Protection Agency); Switzer Environmental Fellowship; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support was provided by the National Science Foundation (OCE 0825322 and OCE 1255194 to TMH), the University of California Multicampus Research Programs and Initiatives (to TMH), University of California Davis REACH IGERT (to SEM), Mia Tegner Historical Ecology Grant (to SEM), the EPA STAR Fellowship (to SEM) and Switzer Environmental Fellowship (to SEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes F, 2000, EARTH PLANET SC LETT, V176, P7, DOI 10.1016/S0012-821X(99)00312-X; Addison JA, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002161; Agnihotri R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025864; Agnihotri R, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001744; Alley RB, 1999, ANNU REV EARTH PL SC, V27, P149, DOI 10.1146/annurev.earth.27.1.149; Alley RB, 2000, QUATERNARY SCI REV, V19, P213, DOI 10.1016/S0277-3791(99)00062-1; Altabet M.A., 1996, CARBON CYCLING GLACI, P281; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; ANDERSON RY, 1987, QUATERNARY RES, V28, P307, DOI 10.1016/0033-5894(87)90069-X; ANDREWS W R H, 1980, Progress in Oceanography, V9, P1, DOI 10.1016/0079-6611(80)90015-4; BAILEY GW, 1991, GEOL SOC SPEC PUBL, P171, DOI 10.1144/GSL.SP.1991.058.01.12; Banse K., 1984, MARINE GEOLOGY OCEAN, P271; Barron JA, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000768; Barron JA, 2007, PALAEOGEOGR PALAEOCL, V248, P313, DOI 10.1016/j.palaeo.2006.12.009; Barron JA, 2009, MAR MICROPALEONTOL, V72, P176, DOI 10.1016/j.marmicro.2009.04.006; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Behl R. J., 1995, P OCEAN DRILL PROGRA, V146, P295; Behl RJ, 1996, NATURE, V379, P243, DOI 10.1038/379243a0; Benway HM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001208; BERNHARD JM, 1991, BIOGEOCHEMISTRY, V15, P127; BERNHARD JM, 1986, J FORAMIN RES, V16, P207, DOI 10.2113/gsjfr.16.3.207; BERNHARD JM, 1992, DEEP-SEA RES, V39, P585, DOI 10.1016/0198-0149(92)90090-G; Bernhard JM, 2000, NATURE, V403, P77, DOI 10.1038/47476; Bindoff NL, 2000, J PHYS OCEANOGR, V30, P1207, DOI 10.1175/1520-0485(2000)030<1207:DCAAIO>2.0.CO;2; Blanchet CL, 2007, QUATERNARY SCI REV, V26, P3118, DOI 10.1016/j.quascirev.2007.07.008; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bostock HC, 2010, DEEP-SEA RES PT I, V57, P847, DOI 10.1016/j.dsr.2010.04.005; Bradtmiller LI, 2010, EARTH PLANET SC LETT, V299, P417, DOI 10.1016/j.epsl.2010.09.022; Brandes JA, 2007, CHEM REV, V107, P577, DOI 10.1021/cr050377t; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; Bryan SP, 2010, EARTH PLANET SC LETT, V298, P244, DOI 10.1016/j.epsl.2010.08.025; Bull D, 2000, GEOLOGY, V28, P1007; CALVERT SE, 1970, NATURE, V227, P593, DOI 10.1038/227593a0; Cannariato KG, 1999, GEOLOGY, V27, P63, DOI 10.1130/0091-7613(1999)027<0063:BRTLQR>2.3.CO;2; Cannariato KG, 1999, GEOLOGY, V27, P975, DOI 10.1130/0091-7613(1999)027<0975:CRMSFI>2.3.CO;2; Cartapanis O, 2012, QUATERNARY SCI REV, V53, P24, DOI 10.1016/j.quascirev.2012.08.009; Cartapanis O, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002126; Chelton D.B., 1982, CAL COOP OCEAN FISH, V23, P130; Cheshire H, 2005, J QUATERNARY SCI, V20, P457, DOI 10.1002/jqs.944; CORLISS B, 1993, GEOLOGY, V21, P991, DOI 10.1130/0091-7613(1993)021<0991:RGODSB>2.3.CO;2; CORLISS BH, 1991, MAR MICROPALEONTOL, V17, P195, DOI 10.1016/0377-8398(91)90014-W; Cowie G, 2005, PROG OCEANOGR, V65, P260, DOI 10.1016/j.pocean.2005.03.003; Crusius J, 2004, GEOLOGY, V32, P633, DOI 10.1130/G20508.1; Crusius J, 1996, EARTH PLANET SC LETT, V145, P65, DOI 10.1016/S0012-821X(96)00204-X; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; Curry WB, 1987, PALEOCEANOGRAPHY, V2, P489, DOI 10.1029/PA002i005p00489; Daneri G, 2000, MAR ECOL PROG SER, V197, P41, DOI 10.3354/meps197041; Davies MH, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002051; De Pol-Holz R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024477; De Pol-Holz R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001308; de Vernal A, 1997, PALEOCEANOGRAPHY, V12, P821, DOI 10.1029/97PA02167; Dean WE, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001239; Dean WE, 2007, QUATERNARY SCI REV, V26, P98, DOI 10.1016/j.quascirev.2006.08.006; DEAN WE, 1994, PALEOCEANOGRAPHY, V9, P47, DOI 10.1029/93PA02829; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; Deutsch C, 2014, SCIENCE, V345, P665, DOI 10.1126/science.1252332; DEVRIES TJ, 1981, MAR MICROPALEONTOL, V6, P157, DOI 10.1016/0377-8398(81)90003-7; DIESTERHAASS L, 1986, MAR GEOL, V73, P1, DOI 10.1016/0025-3227(86)90108-8; Dubois N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048325; Dubois N, 2011, QUATERNARY SCI REV, V30, P210, DOI 10.1016/j.quascirev.2010.10.012; Dugdale RC, 2002, DEEP-SEA RES PT II, V49, P2513, DOI 10.1016/S0967-0645(02)00046-2; DUPLESSY JC, 1989, RADIOCARBON, V31, P493; Emerson S, 2001, GLOBAL BIOGEOCHEM CY, V15, P535, DOI 10.1029/2000GB001320; EMERY KO, 1961, DEEP-SEA RES, V8, P165, DOI 10.1016/0146-6313(61)90019-3; Emmer E, 2000, PALEOCEANOGRAPHY, V15, P377, DOI 10.1029/1999PA000417; ESRI, 2009, ARCMAP 9 2 REDL; Farias L, 2007, DEEP-SEA RES PT I, V54, P164, DOI 10.1016/j.dsr.2006.11.003; Fiedler PC, 2006, PROG OCEANOGR, V69, P143, DOI 10.1016/j.pocean.2006.03.008; Fine RA, 2001, J GEOPHYS RES-OCEANS, V106, P22159, DOI 10.1029/1999JC000184; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; Fontanier C, 2005, DEEP-SEA RES PT I, V52, P1189, DOI 10.1016/j.dsr.2005.01.006; Fontanier C, 2002, DEEP-SEA RES PT I, V49, P751, DOI 10.1016/S0967-0637(01)00078-4; FRANCOIS R, 1988, MAR GEOL, V83, P285, DOI 10.1016/0025-3227(88)90063-1; Frieder CA, 2012, BIOGEOSCIENCES, V9, P3917, DOI 10.5194/bg-9-3917-2012; Fuenzalida R, 2009, DEEP-SEA RES PT II, V56, P1027, DOI 10.1016/j.dsr2.2008.11.001; Gage JD, 2000, DEEP-SEA RES PT II, V47, P1; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Galbraith ED, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001518; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Ganeshram RS, 1998, PALEOCEANOGRAPHY, V13, P634, DOI 10.1029/98PA02508; Ganeshram RS, 1999, GEOCHIM COSMOCHIM AC, V63, P1723, DOI 10.1016/S0016-7037(99)00073-3; Ganeshram RS, 2002, NATURE, V415, P156, DOI 10.1038/415156a; Garcia HE, 2010, WORLD OCEAN ATLAS 20, P344; Gardner J.V., 1995, PROC OCEAN DRILL SCI, V146, P103; Gardner JV, 1997, PALEOCEANOGRAPHY, V12, P207, DOI 10.1029/96PA03567; GARDNER JV, 1986, GEOLOGY, V14, P691, DOI 10.1130/0091-7613(1986)14<691:EFASOZ>2.0.CO;2; Gardner JV, 1992, PALEOCEANOGRAPHY CAL; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Hanawa K., 2001, OCEAN CIRCULATION CL, P373, DOI DOI 10.1016/S0074-6142(01)80129-7; Hendy IL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025975; Hendy IL, 2000, PALEOCEANOGRAPHY, V15, P30, DOI 10.1029/1999PA000413; Hendy IL, 2003, QUATERNARY SCI REV, V22, P673, DOI 10.1016/S0277-3791(02)00186-5; Hendy IL, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001123; Hendy IL, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000965; Hendy IL, 1999, GEOLOGY, V27, P291, DOI 10.1130/0091-7613(1999)027<0291:LQNPSW>2.3.CO;2; Hendy IL, 2002, QUATERNARY SCI REV, V21, P1167, DOI 10.1016/S0277-3791(01)00138-X; Hermelin J.O.R., 1992, Geological Society Special Publication, P151; Hickey B. M., 1979, Progress in Oceanography, V8, P191, DOI 10.1016/0079-6611(79)90002-8; Hickey B.M., 1998, SEA, V11, P345; Higginson MJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020511; Hill TM, 2006, QUATERNARY SCI REV, V25, P2835, DOI 10.1016/j.quascirev.2006.03.012; Hill T. M., 2013, PALEOCEANOGRAPHY, V29, P1; Hofmann AF, 2011, DEEP-SEA RES PT I, V58, P1212, DOI 10.1016/j.dsr.2011.09.004; HOOD RR, 1990, J GEOPHYS RES-OCEANS, V95, P18081, DOI 10.1029/JC095iC10p18081; HOPKINS DM, 1959, SCIENCE, V129, P1519, DOI 10.1126/science.129.3362.1519; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Ivanochko TS, 2004, QUATERNARY SCI REV, V23, P467, DOI 10.1016/j.quascirev.2003.06.006; Jaccard SL, 2013, GEOPHYS RES LETT, V40, P199, DOI 10.1029/2012GL054118; Jaccard SL, 2009, EARTH PLANET SC LETT, V277, P156, DOI 10.1016/j.epsl.2008.10.017; Jaccard SL, 2012, NAT GEOSCI, V5, P151, DOI [10.1038/ngeo1352, 10.1038/NGEO1352]; Jorissen FJ, 2007, DEV MARINE GEOL, V1, P263, DOI 10.1016/S1572-5480(07)01012-3; Kaufman DS, 2004, DEV QUA SCI, V2, P9; Keeling RF, 2009, GEOCHIM COSMOCHIM AC, V73, pA632; Keigwin LD, 1990, PALEOCEANOGRAPHY, V5, P1009, DOI 10.1029/PA005i006p01009; Keigwin LD, 2002, J OCEANOGR, V58, P421, DOI 10.1023/A:1015830313175; KEIGWIN LD, 1992, EARTH PLANET SC LETT, V111, P425, DOI 10.1016/0012-821X(92)90194-Z; Keigwin LD, 1998, PALEOCEANOGRAPHY, V13, P323, DOI 10.1029/98PA00874; Kennett J.P., 1995, SCI RESULTS, V146, P3; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; KENNETT JP, 2000, P OC DRILL PROGR SCI, V0167; Kienast SS, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001357; Kienast SS, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000650; Kienast SS, 2001, GEOPHYS RES LETT, V28, P1563, DOI 10.1029/2000GL012543; KLINKHAMMER GP, 1991, GEOCHIM COSMOCHIM AC, V55, P1799, DOI 10.1016/0016-7037(91)90024-Y; Koutavas A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000894; Kusch S, 2010, EARTH PLANET SC LETT, V290, P340, DOI 10.1016/j.epsl.2009.12.030; Lambeck K, 1998, GEOPHYS J INT, V134, P102, DOI 10.1046/j.1365-246x.1998.00541.x; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; LEVIN LA, 1991, J MAR RES, V49, P763, DOI 10.1357/002224091784995756; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; Levin LA, 2009, TRENDS ECOL EVOL, V24, P606, DOI 10.1016/j.tree.2009.04.012; LEVINTON JS, 1970, LETHAIA, V3, P69, DOI 10.1111/j.1502-3931.1970.tb01264.x; Loubere P, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000986; LYNN RJ, 1987, J GEOPHYS RES-OCEANS, V92, P12947, DOI 10.1029/JC092iC12p12947; Mackas D. L, 2006, SEA, P21; Martin PA, 2002, EARTH PLANET SC LETT, V198, P193, DOI 10.1016/S0012-821X(02)00472-7; Martinez P, 2010, BIOGEOSCIENCES, V7, P1, DOI 10.5194/bg-7-1-2010; Martinez P, 1999, MAR GEOL, V158, P57, DOI 10.1016/S0025-3227(98)00161-3; Matear RJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001997; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; McDonald D, 1999, DEEP-SEA RES PT II, V46, P2993, DOI 10.1016/S0967-0645(99)00091-0; McGann M, 2011, QUATERN INT, V235, P26, DOI 10.1016/j.quaint.2010.09.005; McKay JL, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2003PA000979; Milne GA, 2005, QUATERNARY SCI REV, V24, P1183, DOI 10.1016/j.quascirev.2004.10.005; Mix AC, 1999, GEOPH MONOG SERIES, V112, P127; Moffitt SE, 2014, PALEOCEANOGRAPHY, V29, P44, DOI 10.1002/2013PA002483; Mohtadi M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001003; Molina V, 2005, MAR ECOL PROG SER, V288, P35, DOI 10.3354/meps288035; Mollenhauer G, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001488; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Montgomery RB, 1962, J HOPKINS OCEANOGRAP, V1, P68; Murray JW, 2001, MAR MICROPALEONTOL, V41, P1, DOI 10.1016/S0377-8398(00)00057-8; Naidu PD, 1995, MAR MICROPALEONTOL, V26, P49, DOI 10.1016/0377-8398(95)00014-3; Nam S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049549; Nameroff TJ, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000912; Nameroff TJ, 2002, GEOCHIM COSMOCHIM AC, V66, P1139, DOI 10.1016/S0016-7037(01)00843-2; O'Connor BM, 2002, DEEP-SEA RES PT I, V49, P1571, DOI 10.1016/S0967-0637(02)00087-0; Ono T, 2001, GEOPHYS RES LETT, V28, P3285, DOI 10.1029/2001GL012948; Ortiz JD, 2004, GEOLOGY, V32, P521, DOI 10.1130/G20234.1; Oschlies A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003147; Overpeck J, 1996, CLIM DYNAM, V12, P213, DOI 10.1007/BF00211619; PARULEKAR AH, 1982, DEEP-SEA RES, V29, P1531, DOI 10.1016/0198-0149(82)90041-3; PAULMIER A, 2009, PROG OCEANOGR, V80, P113, DOI DOI 10.1016/J.POCEAN.2008.08.001; Pedersen TF, 1988, PALEOCEANOGRAPHY, V3, P157, DOI 10.1029/PA003i002p00157; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Petit JR, 2001, IGBP PAGES WORLD CTR, V76; Pichevin L, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002852; Pichevin LE, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001754; Pride C, 1999, PALEOCEANOGRAPHY, V14, P397, DOI 10.1029/1999PA900004; Rea D.K., 1995, P ODP SCI RESULTS, V145, P577, DOI [10.2973/odp.proc.ir.145.1993, DOI 10.2973/ODP.PROC.IR.145.1993, 10.2973/odp.proc.sr.145.146.1995, DOI 10.2973/ODP.PROC.SR.145.146.1995]; Reichart GJ, 1997, PALAEOGEOGR PALAEOCL, V134, P149, DOI 10.1016/S0031-0182(97)00071-0; Reichart GJ, 1998, PALEOCEANOGRAPHY, V13, P607, DOI 10.1029/98PA02203; Reichart GJ, 2002, MAR GEOL, V185, P403, DOI 10.1016/S0025-3227(02)00184-6; Reid J. L., 1965, INTERMEDIATE WATERS; REID JL, 1962, J GEOPHYS RES, V67, P2491, DOI 10.1029/JZ067i006p02491; Reid JL, 1997, PROG OCEANOGR, V39, P263, DOI 10.1016/S0079-6611(97)00012-8; REIMERS CE, 1983, MAR CHEM, V13, P141, DOI 10.1016/0304-4203(83)90022-1; Robinson RS, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001702; Robinson RS, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002321; ROSENTHAL Y, 1995, EARTH PLANET SC LETT, V132, P99, DOI 10.1016/0012-821X(95)00056-I; SARKAR A, 1990, NATURE, V343, P549, DOI 10.1038/343549a0; SARKAR A, 1993, GEOCHIM COSMOCHIM AC, V57, P1009, DOI 10.1016/0016-7037(93)90036-V; Schmiedl G, 2003, PALAEOGEOGR PALAEOCL, V190, P139, DOI 10.1016/S0031-0182(02)00603-X; Schneider W, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017086; Schulte S, 1999, EARTH PLANET SC LETT, V173, P205, DOI 10.1016/S0012-821X(99)00232-0; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Sellanes J, 2010, MAR ECOL-EVOL PERSP, V31, P111, DOI 10.1111/j.1439-0485.2009.00332.x; Send U, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007517; SenGupta BK, 1996, GEOLOGY, V24, P227, DOI 10.1130/0091-7613(1996)024<0227:SODICS>2.3.CO;2; SHACKLETON NJ, 1983, EARTH PLANET SC LETT, V65, P233, DOI 10.1016/0012-821X(83)90162-0; Shaffer G, 2009, NAT GEOSCI, V2, P105, DOI 10.1038/NGEO420; Shakun JD, 2012, NATURE, V484, P49, DOI 10.1038/nature10915; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; SILVA N, 1979, DEEP-SEA RES, V26, P1387; Silva N, 2009, DEEP-SEA RES PT II, V56, P992, DOI 10.1016/j.dsr2.2008.12.013; Skinner LC, 2005, QUATERNARY SCI REV, V24, P571, DOI 10.1016/j.quascirev.2004.11.008; Somes CJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003767; SOUTAR A, 1977, GEOL SOC AM BULL, V88, P1161, DOI 10.1130/0016-7606(1977)88<1161:SACPIT>2.0.CO;2; Spero HJ, 2002, SCIENCE, V296, P522, DOI 10.1126/science.1069401; Stabeno PJ, 2004, CONT SHELF RES, V24, P859, DOI 10.1016/j.csr.2004.02.007; Stein R, 1995, P ODP SCI RES 2, P125; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; TALLEY LD, 1993, J PHYS OCEANOGR, V23, P517, DOI 10.1175/1520-0485(1993)023<0517:DAFONP>2.0.CO;2; TAPPAN H, 1986, J PALEONTOL, V60, P545, DOI 10.1017/S0022336000022113; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; Toggweiler JR, 1995, DAHL WS ENV, V18, P337; Tribovillard N, 2006, CHEM GEOL, V232, P12, DOI 10.1016/j.chemgeo.2006.02.012; TSUCHIYA M, 1981, J PHYS OCEANOGR, V11, P794, DOI 10.1175/1520-0485(1981)011<0794:TOOTPE>2.0.CO;2; van Geen A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000911; van Geen A, 2001, BAJA CALIFORNIA CORI; vanGeen A, 1996, PALEOCEANOGRAPHY, V11, P519, DOI 10.1029/96PA01860; VANGEEN A, 1995, PALEOCEANOGRAPHY, V10, P159, DOI 10.1029/94PA03352; VONRAD U, 1995, MAR GEOL, V125, P7, DOI 10.1016/0025-3227(95)00051-Y; Wang CZ, 2001, GEOPHYS RES LETT, V28, P1635, DOI 10.1029/2000GL011763; Watson EB, 2011, RESTOR ECOL, V19, P765, DOI 10.1111/j.1526-100X.2010.00722.x; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Wijffels SE, 1996, DEEP-SEA RES PT I, V43, P501, DOI 10.1016/0967-0637(96)00006-4; Willard DA, 2007, FRONT ECOL ENVIRON, V5, P491, DOI 10.1890/070015; Wyllie JG, 1966, CALCOFI ATLAS 14, V14; WYRTKI K, 1962, DEEP-SEA RES, V9, P11, DOI 10.1016/0011-7471(62)90243-7; Wyrtki K., 1966, OCEANOGRAPHY MARINE, V4, P33; YANG YL, 1995, GEOLOGY, V23, P1115, DOI 10.1130/0091-7613(1995)023<1115:GROTPB>2.3.CO;2; Yu EF, 1999, TERR ATMOS OCEAN SCI, V10, P201, DOI 10.3319/TAO.1999.10.1.201(IMAGES); Zahn R, 1991, PALEOCEANOGRAPHY, V6, P543, DOI 10.1029/91PA01327; Zettler ML, 2009, MAR BIOL, V9, P1946; Zhang J, 2010, BIOGEOSCIENCES, V7, P1443, DOI 10.5194/bg-7-1443-2010; Zheng Y, 2000, GEOCHIM COSMOCHIM AC, V64, P4165, DOI 10.1016/S0016-7037(00)00495-6; Zheng Y, 2000, PALEOCEANOGRAPHY, V15, P528, DOI 10.1029/1999PA000473	235	64	65	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115246	10.1371/journal.pone.0115246	http://dx.doi.org/10.1371/journal.pone.0115246			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629508	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100013
J	Tian, D; Solodin, NM; Rajbhandari, P; Bjorklund, K; Alarid, ET; Kreeger, PK				Tian, Dan; Solodin, Natalia M.; Rajbhandari, Prashant; Bjorklund, Kelsi; Alarid, Elaine T.; Kreeger, Pamela K.			A kinetic model identifies phosphorylated estrogen receptor-alpha (ER alpha) as a critical regulator of ER alpha dynamics in breast cancer	FASEB JOURNAL			English	Article						systems biology; mathematical modeling; nuclear receptor; feedback	GENE-EXPRESSION; PROGESTERONE-RECEPTORS; ENDOCRINE RESISTANCE; SIGNALING PATHWAYS; MECHANISMS; ACTIVATION; CELLS; QUANTIFICATION; POSTMENOPAUSAL; TRANSCRIPTION	Receptor levels are a key mechanism by which cells regulate their response to stimuli. The levels of estrogen receptor- (ER) impact breast cancer cell proliferation and are used to predict prognosis and sensitivity to endocrine therapy. Despite the clinical application of this information, it remains unclear how different cellular processes interact as a system to control ER levels. To address this question, experimental results from the ER-positive human breast cancer cell line (MCF-7) treated with 17--estradiol or vehicle control were used to develop a mass-action kinetic model of ER regulation. Model analysis determined that RNA dynamics could be captured through phosphorylated ER (pER)-dependent feedback on transcription. Experimental analysis confirmed that pER-S118 binds to the estrogen receptor-1 (ESR1) promoter, suggesting that pER can feedback on ESR1 transcription. Protein dynamics required a separate mechanism in which the degradation rate for pER was 8.3-fold higher than nonphosphorylated ER. Using a model with both mechanisms, the root mean square error was 0.078. Sensitivity analysis of this combined model determined that while multiple mechanisms regulate ER levels, pER-dependent feedback elicited the strongest effect. Combined, our computational and experimental results identify phosphorylation of ER as a critical decision point that coordinates the cellular circuitry to regulate ER levels.	[Tian, Dan; Kreeger, Pamela K.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Solodin, Natalia M.; Rajbhandari, Prashant; Bjorklund, Kelsi; Alarid, Elaine T.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, Madison, WI USA; [Alarid, Elaine T.; Kreeger, Pamela K.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kreeger, PK (corresponding author), Dept Biomed Engn, ECB 2154, 1550 Engn Dr, Madison, WI 53706 USA.	kreeger@wisc.edu		Kreeger, Pamela/0000-0001-8193-1007; Rajbhandari, Prashant/0000-0002-8146-3861	U.S. National Science Foundation [CBET-0951613]; National Cancer Institute [CA-159578];  [1DP2CA195766-01]; NATIONAL CANCER INSTITUTE [R01CA159578, T32CA009135, DP2CA195766] Funding Source: NIH RePORTER	U.S. National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the U.S. National Science Foundation (Grant CBET-0951613; to P.K.K.) and the (Director's New Innovator Award Program, Grant 1DP2CA195766-01; to P.K.K.) and (National Cancer Institute, Grant CA-159578; to E.T.A.). The authors declare no conflicts of interest.U.S. National Institutes of Health	Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Barone I, 2010, CLIN CANCER RES, V16, P2702, DOI 10.1158/1078-0432.CCR-09-1753; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bordeaux JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036559; Callige M, 2005, MOL CELL BIOL, V25, P4349, DOI 10.1128/MCB.25.11.4349-4358.2005; Chen C, 2013, FEBS LETT, V587, P3327, DOI 10.1016/j.febslet.2013.08.022; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; CIDLOWSKI JA, 1978, BIOL REPROD, V18, P234, DOI 10.1095/biolreprod18.2.234; Clarke R, 2001, PHARMACOL REV, V53, P25; Cohen AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004901; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; de Leeuw R, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/232435; de-Leon SBT, 2009, DEV BIOL, V325, P317, DOI 10.1016/j.ydbio.2008.10.043; DENTON RR, 1992, J BIOL CHEM, V267, P7263; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; FABRIS G, 1987, J STEROID BIOCHEM, V27, P171, DOI 10.1016/0022-4731(87)90307-4; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Giuliano M, 2011, BREAST, V20, pS42, DOI 10.1016/S0960-9776(11)70293-4; GRONEMEYER H, 1991, ANNU REV GENET, V25, P89, DOI 10.1146/annurev.ge.25.120191.000513; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Khan SA, 1999, CANCER EPIDEM BIOMAR, V8, P867; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; Khodor YL, 2011, GENE DEV, V25, P2502, DOI 10.1101/gad.178962.111; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Lebedeva G, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-138; Lumachi F, 2013, CURR MED CHEM, V20, P596, DOI 10.2174/092986713804999303; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MARKOPOULOS C, 1988, BRIT MED J, V296, P1349, DOI 10.1136/bmj.296.6633.1349; Marsaud V, 2003, MOL ENDOCRINOL, V17, P2013, DOI 10.1210/me.2002-0269; Matthias Ruth B. H., 1997, MODELING DYNAMIC BIO; May FEB, 2014, CANCER MANAG RES, V6, P225, DOI 10.2147/CMAR.S35024; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Osborne CK, 1998, BREAST CANCER RES TR, V51, P227, DOI 10.1023/A:1006132427948; Patani N, 2013, INT J CANCER, V133, P1, DOI 10.1002/ijc.27997; Rajbhandari P, 2014, ONCOGENE, V33, P1438, DOI 10.1038/onc.2013.78; READ LD, 1989, MOL ENDOCRINOL, V3, P295, DOI 10.1210/mend-3-2-295; RICKETTS D, 1991, CANCER RES, V51, P1817; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; ROMAIN S, 1994, INT J CANCER, V59, P17, DOI 10.1002/ijc.2910590105; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shanle EK, 2010, ADV DRUG DELIVER REV, V62, P1265, DOI 10.1016/j.addr.2010.08.001; Shoker BS, 1999, AM J PATHOL, V155, P1811, DOI 10.1016/S0002-9440(10)65498-3; THORPE SM, 1993, EUR J CANCER, V29A, P971, DOI 10.1016/S0959-8049(05)80204-7; Tremblay GB, 2002, CRIT REV EUKAR GENE, V12, P1, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i1.10; Tyson JJ, 2011, NAT REV CANCER, V11, P523, DOI 10.1038/nrc3081; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Valley CC, 2008, J MOL ENDOCRINOL, V40, P23, DOI 10.1677/JME-07-0067; Welsh AW, 2011, J CLIN ONCOL, V29, P2978, DOI 10.1200/JCO.2010.32.9706; Williams C, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.370; Zhou W, 2014, NAT REV CANCER, V14, P26, DOI 10.1038/nrc3622; Zwart W, 2011, WIRES SYST BIOL MED, V3, P216, DOI 10.1002/wsbm.109	64	9	9	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2022	2031		10.1096/fj.14-265637	http://dx.doi.org/10.1096/fj.14-265637			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25648997	Green Published			2022-12-26	WOS:000354114600035
J	Sarbeng, EB; Liu, QD; Tian, XL; Yang, J; Li, HT; Wong, JL; Zhou, L; Liu, QL				Sarbeng, Evans Boateng; Liu, Qingdai; Tian, Xueli; Yang, Jiao; Li, Hongtao; Wong, Jennifer Li; Zhou, Lei; Liu, Qinglian			A Functional DnaK Dimer Is Essential for the Efficient Interaction with Hsp40 Heat Shock Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE DNAK; NUCLEOTIDE EXCHANGE FACTOR; ESCHERICHIA-COLI; HSP70 CHAPERONES; SUBSTRATE-BINDING; PEPTIDE-BINDING; MITOCHONDRIAL HSP70; CRYSTAL-STRUCTURE; ALLOSTERIC REGULATION; INTERDOMAIN LINKER	Highly conserved molecular chaperone Hsp70 heat shock proteins play a key role in maintaining protein homeostasis (proteostasis). DnaK, a major Hsp70 in Escherichia coli, has been widely used as a paradigm for studying Hsp70s. In the absence of ATP, purified DnaK forms low-ordered oligomer, whereas ATP binding shifts the equilibrium toward the monomer. Recently, we solved the crystal structure of DnaK in complex with ATP. There are two molecules of DnaK-ATP in the asymmetric unit. Interestingly, the interfaces between the two molecules of DnaK are large with good surface complementarity, suggesting functional importance of this crystallographic dimer. Biochemical analyses of DnaK protein supported the formation of dimer in solution. Furthermore, our cross-linking experiment based on the DnaK-ATP structure confirmed that DnaK forms specific dimer in an ATP-dependent manner. To understand the physiological function of the dimer, we mutated five residues on the dimer interface. Four mutations, R56A, T301A, N537A, and D540A, resulted in loss of chaperone activity and compromised the formation of dimer, indicating the functional importance of the dimer. Surprisingly, neither the intrinsic biochemical activities, the ATP-induced allosteric coupling, nor GrpE co-chaperone interaction is affected appreciably in all of the mutations except for R56A. Unexpectedly, the interaction with co-chaperone Hsp40 is significantly compromised. In summary, this study suggests that DnaK forms a transient dimer upon ATP binding, and this dimer is essential for the efficient interaction of DnaK with Hsp40.	[Sarbeng, Evans Boateng; Liu, Qingdai; Tian, Xueli; Yang, Jiao; Li, Hongtao; Wong, Jennifer Li; Zhou, Lei; Liu, Qinglian] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Liu, QL (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	qliu3@vcu.edu		Yang, Jiao/0000-0002-0518-1475	National Institutes of Health [1R01GM098592, 1RO1GM109193]; Virginia Commonwealth University School of Medicine; New Scholar Award in Aging from the Ellison Medical Foundation [AG-NS-0587-09]; American Heart Association [11GRNT7460003]; National Natural Science Foundation of China [31271676, 30900339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109193, R01GM098592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University School of Medicine; New Scholar Award in Aging from the Ellison Medical Foundation; American Heart Association(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM098592 (to Qinglian Liu). This work was also supported by startup funds from the Virginia Commonwealth University School of Medicine (to Qinglian Liu), New Scholar Award in Aging Grant AG-NS-0587-09 from the Ellison Medical Foundation (to Qinglian Liu), and Grant-in-aid Award 11GRNT7460003 from the American Heart Association (to Qinglian Liu).; Supported in part by Grants 31271676 and 30900339 from National Natural Science Foundation of China.; Supported in part by National Institutes of Health Grant 1RO1GM109193.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BENAROUDJ N, 1995, BIOCHEMISTRY-US, V34, P15282, DOI 10.1021/bi00046a037; BLONDELGUINDI S, 1993, CELL, V75, P717, DOI 10.1016/0092-8674(93)90492-9; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burkholder WF, 1996, P NATL ACAD SCI USA, V93, P10632, DOI 10.1073/pnas.93.20.10632; CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; GEORGOPOULOS C, 1982, J BACTERIOL, V149, P1175, DOI 10.1128/JB.149.3.1175-1177.1982; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hendrickson WA, 2008, STRUCTURE, V16, P1153, DOI 10.1016/j.str.2008.07.002; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jiang RF, 1997, J BIOL CHEM, V272, P6141, DOI 10.1074/jbc.272.10.6141; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Thompson AD, 2012, CELL STRESS CHAPERON, V17, P313, DOI 10.1007/s12192-011-0307-1; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	71	54	55	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8849	8862		10.1074/jbc.M114.596288	http://dx.doi.org/10.1074/jbc.M114.596288			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25635056	Green Published, hybrid			2022-12-26	WOS:000352207100014
J	Staquicini, FI; Qian, MD; Salameh, A; Dobroff, AS; Edwards, JK; Cimino, DF; Moeller, BJ; Kelly, P; Nunez, MI; Tang, XM; Liu, DD; Lee, JJ; Hong, WK; Ferrara, F; Bradbury, ARM; Lobb, RR; Edelman, MJ; Sidman, RL; Wistuba, II; Arap, W; Pasqualini, R				Staquicini, Fernanda I.; Qian, Ming D.; Salameh, Ahmad; Dobroff, Andrey S.; Edwards, Julianna K.; Cimino, Daniel F.; Moeller, Benjamin J.; Kelly, Patrick; Nunez, Maria I.; Tang, Ximing; Liu, Diane D.; Lee, J. Jack; Hong, Waun Ki; Ferrara, Fortunato; Bradbury, Andrew R. M.; Lobb, Roy R.; Edelman, Martin J.; Sidman, Richard L.; Wistuba, Ignacio I.; Arap, Wadih; Pasqualini, Renata			Receptor Tyrosine Kinase EphA5 Is a Functional Molecular Target in Human Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; DNA Damage; DNA Damage Response; DNA Repair; Monoclonal Antibody; Receptor Tyrosine Kinase; Ionizing Radiation	GROWTH-FACTOR RECEPTOR; DNA-DAMAGE RESPONSE; SIGNALING NETWORKS; ATM; EXPRESSION; PHOSPHORYLATION; PATHOGENESIS; CHECKPOINTS; PATHWAY; FAMILY	Background: EphA5 is a functional target in lung cancer, the most common cause of tumor-related death in mankind. Results: EphA5 regulates cell cycle checkpoints and DNA damage repair induced by ionizing radiation. Conclusion: EphA5 is a novel regulator of DNA damage repair with clinical implications. Significance: EphA5 may serve as a novel biomarker of radioresistance and a candidate target for therapeutic intervention in human lung cancer. Lung cancer is often refractory to radiotherapy, but molecular mechanisms of tumor resistance remain poorly defined. Here we show that the receptor tyrosine kinase EphA5 is specifically overexpressed in lung cancer and is involved in regulating cellular responses to genotoxic insult. In the absence of EphA5, lung cancer cells displayed a defective G(1)/S cell cycle checkpoint, were unable to resolve DNA damage, and became radiosensitive. Upon irradiation, EphA5 was transported into the nucleus where it interacted with activated ATM (ataxia-telangiectasia mutated) at sites of DNA repair. Finally, we demonstrate that a new monoclonal antibody against human EphA5 sensitized lung cancer cells and human lung cancer xenografts to radiotherapy and significantly prolonged survival, thus suggesting the likelihood of translational applications.	[Staquicini, Fernanda I.; Dobroff, Andrey S.; Cimino, Daniel F.; Ferrara, Fortunato; Arap, Wadih; Pasqualini, Renata] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Staquicini, Fernanda I.; Dobroff, Andrey S.; Cimino, Daniel F.; Ferrara, Fortunato; Pasqualini, Renata] Univ New Mexico, Sch Med, Dept Internal Med, Div Mol Med, Albuquerque, NM 87131 USA; Univ New Mexico, Sch Med, Dept Internal Med, Div Hematol Med Oncol, Albuquerque, NM 87131 USA; [Qian, Ming D.; Salameh, Ahmad; Edwards, Julianna K.; Moeller, Benjamin J.; Kelly, Patrick] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Moeller, Benjamin J.; Kelly, Patrick] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Nunez, Maria I.; Tang, Ximing; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Liu, Diane D.; Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Biostat, Houston, TX 77030 USA; [Hong, Waun Ki] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Bradbury, Andrew R. M.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Lobb, Roy R.; Edelman, Martin J.] Arrowhead Res Corp, Alvos Therapeut, Pasadena, CA 91101 USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Sidman, Richard L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA	University of New Mexico; University of New Mexico; University of New Mexico; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; United States Department of Energy (DOE); Los Alamos National Laboratory; University System of Maryland; University of Maryland Baltimore; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Arap, W (corresponding author), Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA.	warap@salud.unm.edu; rpasqual@salud.unm.edu	Dobroff, Andrey/A-9814-2016; Lee, Jack/P-7331-2019; Edelman, Martin/HGA-7272-2022; Ferrara, Fortunato/AAD-5947-2019; Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019	Dobroff, Andrey/0000-0003-2162-9951; Lee, Jack/0000-0002-4584-929X; Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Edelman, Martin/0000-0002-3752-0726; Bradbury, Andrew/0000-0002-5567-8172; Bronk, Julianna/0000-0003-3459-1833; Ferrara, Fortunato/0000-0002-4615-035X	National Institutes of Health; National Cancer Institute; Department of Defense; Specialized Program of Research Excellence in Lung Cancer; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA103830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Specialized Program of Research Excellence in Lung Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants (to R. P. and W. A.). This work was also supported by funds from the National Cancer Institute (to R. P., W. A., and I. I. W.), the Department of Defense (to R. P., W. A., I. I. W., and W. K. H.), and the Specialized Program of Research Excellence in Lung Cancer (to I. I. W.). The University of Texas M. D. Anderson Cancer Center and some of its researchers at the time (W. A. and R. P.) had equity positions in Alvos Therapeutics (Arrowhead Research Corporation, Pasadena, CA), which was subjected to certain restrictions under university policy; the University manages and monitors the terms of these arrangements in accordance with its conflict-of-interest policy. F. I. S., W. A., and R. P. are coinventors of issued patents filed by Alvos Therapeutics that cover the mAb 11C12 and are entitled to royalties that could result from commercial success of the drug.	Ambrose M, 2013, BLOOD, V121, P4036, DOI 10.1182/blood-2012-09-456897; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Boohaker Rebecca J, 2014, Biomed J, V37, P3, DOI 10.4103/2319-4170.125655; Chatterjee N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a019836; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrara F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049535; Fu DY, 2010, HUM PATHOL, V41, P48, DOI 10.1016/j.humpath.2009.06.007; Giaginis C, 2010, PATHOL ONCOL RES, V16, P267, DOI 10.1007/s12253-009-9221-6; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hoppin J, 2011, J PHARMACOL EXP THER, V337, P350, DOI 10.1124/jpet.110.172916; Huang PH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.287re6; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kolonin MG, 2006, CANCER RES, V66, P34, DOI 10.1158/0008-5472.CAN-05-2748; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pasqualini R, 2000, CANCER RES, V60, P722; Pejovic T, 2009, TRANSL ONCOL, V2, P341, DOI 10.1593/tlo.09199; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Rengan R, 2011, CLIN CANCER RES, V17, P4192, DOI 10.1158/1078-0432.CCR-10-2760; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; TAYLOR V, 1994, NEUROSCIENCE, V63, P163, DOI 10.1016/0306-4522(94)90014-0; von Stechow L, 2013, ARCH TOXICOL, V87, P1635, DOI 10.1007/s00204-013-1106-5; Xu B, 2002, CANCER RES, V62, P4588; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhou RP, 1997, CELL TISSUE RES, V290, P251, DOI 10.1007/s004410050929	40	34	36	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7345	7359		10.1074/jbc.M114.630525	http://dx.doi.org/10.1074/jbc.M114.630525			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25623065	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000351613600003
J	Schwarzer, C; Fu, Z; Morita, T; Whitt, AG; Neely, AM; Li, C; Machen, TE				Schwarzer, Christian; Fu, Zhu; Morita, Takeshi; Whitt, Aaron G.; Neely, Aaron M.; Li, Chi; Machen, Terry E.			Paraoxonase 2 Serves a Proapopotic Function in Mouse and Human Cells in Response to the Pseudomonas aeruginosa Quorum-sensing Molecule N-(3-Oxododecanoyl)-homoserine Lactone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; N-3-OXODODECANOYL HOMOSERINE LACTONE; GENE-EXPRESSION; INDUCED APOPTOSIS; EPITHELIAL-CELLS; ER STRESS; SIGNAL; INACTIVATION; LEUKEMIA; THAPSIGARGIN	Pseudomonas aeruginosa use quorum-sensing molecules, including N-(3-oxododecanoyl)-homoserine lactone (C12), for intercellular communication. C12 activated apoptosis in mouse embryo fibroblasts (MEF) from both wild type (WT) and Bax/Bak double knock-out mice (WT MET and DKO MET that were responsive to C12, DKOR MEI): nuclei fragmented; mitochondrial membrane potential (Delta psi(mito)) depolarized; Ca2+ was released from the endoplasmic reticulum (ER), increasing cytosolic [Ca2+] (Ca-cyto); and caspase 3/7 was activated. DKOR MEF had been isolated from a nondonal pool of DKO MEE that were non-responsive to C12 (DKONR MEF). RNA seq analysis, quantitative PCR, and Western blots showed that WT and DKOR MEF both expressed genes associated with cancer, including paraoxonase 2 (PON2), whereas DKONR MEF expressed little PON2. Adenovirus-mediated expression of human PON2 in DKONR MEF rendered them responsive to C12: Delta psi(mito) depolarized, Ca-cyto increased, and caspase 3/7 activated. Human embryonic kidney 293T (HEK293T) cells expressed low levels of endogenous PON2, and these cells were also less responsive to C12. Overexpression of PON2, but not PON2-H114Q (no lactonase activity) in HEK293T cells caused them to become sensitive to C12. Because [C12] may reach high levels in biofilms in lungs of cystic fibrosis (CF) patients, PON2 lactonase activity may control Delta psi(mito), Ca2+ release from the ER, and apoptosis in CF airway epithelia. Coupled with previous data, these results also indicate that PON2 uses its lactonase activity to prevent Bax- and Bak-dependent apoptosis in response to common proapoptotic drugs like doxorubicin and staurosporine, but activates Bax- and Bak-independent apoptosis in response to C12.	[Schwarzer, Christian; Fu, Zhu; Morita, Takeshi; Machen, Terry E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Whitt, Aaron G.; Neely, Aaron M.; Li, Chi] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Med, Louisville, KY 40202 USA; [Whitt, Aaron G.; Neely, Aaron M.; Li, Chi] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Pharmacol, Louisville, KY 40202 USA; [Whitt, Aaron G.; Neely, Aaron M.; Li, Chi] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Toxicol, Louisville, KY 40202 USA	University of California System; University of California Berkeley; University of Louisville; University of Louisville; University of Louisville	Machen, TE (corresponding author), Univ Calif Berkeley, 231 LSA, Berkeley, CA 94720 USA.	tmachen@berkeley.edu		Morita, Takeshi/0000-0002-8570-6744	National Institutes of Health [PN2-EY-018241, R01AM10141, K01CA106599, P20RR018733, R01 CA175003]; Cystic Fibrosis Research, Inc.; University of Louisville; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM010141] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA175003, K01CA106599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Research, Inc.; University of Louisville; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants PN2-EY-018241, R01AM10141, K01CA106599, P20RR018733, and R01 CA175003, Cystic Fibrosis Research, Inc. (New Horizons), and a Research Initiation Grant from the University of Louisville.	Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bar-Rogovsky H, 2013, J BIOL CHEM, V288, P23914, DOI 10.1074/jbc.M112.427922; Barathi Subramanian, 2010, J Ocul Biol Dis Infor, V3, P64, DOI 10.1007/s12177-011-9057-7; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Chambers CE, 2005, FEMS MICROBIOL LETT, V244, P297, DOI 10.1016/j.femsle.2005.01.055; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; CHRISTENSEN SB, 1993, FEBS LETT, V335, P345, DOI 10.1016/0014-5793(93)80416-R; Chun CK, 2004, P NATL ACAD SCI USA, V101, P3587, DOI 10.1073/pnas.0308750101; Devarajan A, 2014, ADV EXP MED BIOL, V824, P33, DOI 10.1007/978-3-319-07320-0_5; Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Frank O, 2006, LEUKEMIA, V20, P1400, DOI 10.1038/sj.leu.2404270; Griffin PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042241; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagmann H, 2014, FASEB J, V28, P1769, DOI 10.1096/fj.13-240309; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Jacobi CA, 2009, INT J MED MICROBIOL, V299, P509, DOI 10.1016/j.ijmm.2009.03.005; Kirisits MJ, 2006, CELL MICROBIOL, V8, P1841, DOI 10.1111/j.1462-5822.2006.00817.x; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Li L, 2004, ONCOGENE, V23, P4894, DOI 10.1038/sj.onc.1207612; Li Y, 2002, J CANCER RES CLIN, V128, P369, DOI 10.1007/s00432-002-0347-0; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Pise-Masison CA, 2002, CANCER RES, V62, P3562; Ribarska Teodora, 2010, Cancer Genomics & Proteomics, V7, P51; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Rumbaugh KP, 2000, MICROBES INFECT, V2, P1721, DOI 10.1016/S1286-4579(00)01327-7; Schwarzer C, 2008, J BIOL CHEM, V283, P27144, DOI 10.1074/jbc.M709693200; Schwarzer C, 2014, CELL MICROBIOL, V16, P1094, DOI 10.1111/cmi.12263; Schwarzer C, 2014, AM J PHYSIOL-CELL PH, V306, pC844, DOI 10.1152/ajpcell.00002.2014; Schwarzer C, 2012, CELL MICROBIOL, V14, P698, DOI 10.1111/j.1462-5822.2012.01753.x; Schwarzer C, 2010, J BIOL CHEM, V285, P34850, DOI 10.1074/jbc.M110.167668; Schweikert EM, 2012, CELL DEATH DIFFER, V19, P1549, DOI 10.1038/cdd.2012.35; Schweikert EM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/352857; Shiner EK, 2006, CELL MICROBIOL, V8, P1601, DOI 10.1111/j.1462-5822.2006.00734.x; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Staudinger BJ, 2014, AM J RESP CRIT CARE, V189, P812, DOI 10.1164/rccm.201312-2142OC; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Telford G, 1998, INFECT IMMUN, V66, P36, DOI 10.1128/IAI.66.1.36-42.1998; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valentine CD, 2014, CELL MICROBIOL, V16, P1, DOI 10.1111/cmi.12176; Valentine CD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003576; Wang X, 2011, CELL DEATH DIFFER, V18, P38, DOI 10.1038/cdd.2010.68; Williams SC, 2004, J BACTERIOL, V186, P2281, DOI 10.1128/JB.186.8.2281-2287.2004; Witte I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.91; Witte I, 2012, J LIPIDS, V2012, DOI 10.1155/2012/342806	53	18	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7247	7258		10.1074/jbc.M114.620039	http://dx.doi.org/10.1074/jbc.M114.620039			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627690	Green Published, hybrid			2022-12-26	WOS:000350991500053
J	Federau, C; O'Brien, K; Birbaumer, A; Meuli, R; Hagmann, P; Maeder, P				Federau, Christian; O'Brien, Kieran; Birbaumer, Adrien; Meuli, Reto; Hagmann, Patric; Maeder, Philippe			Functional Mapping of the Human Visual Cortex with Intravoxel Incoherent Motion MRI	PLOS ONE			English	Article							APPARENT-DIFFUSION-COEFFICIENT; CEREBRAL-BLOOD-FLOW; MATTER FMRI ACTIVATION; HUMAN BRAIN; WHITE-MATTER; SPATIAL LOCALIZATION; NEURONAL ACTIVATION; GRADIENT-ECHO; OXYGENATION; CONTRAST	Functional imaging with intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) is demonstrated. Images were acquired at 3 Tesla using a standard Stejskal-Tanner diffusion-weighted echo-planar imaging sequence with multiple b-values. Cerebro-spinal fluid signal, which is highly incoherent, was suppressed with an inversion recovery preparation pulse. IVIM microvascular perfusion parameters were calculated according to a two-compartment (vascular and non-vascular) diffusion model. The results obtained in 8 healthy human volunteers during visual stimulation are presented. The IVIM blood flow related parameter fD* increased 170% during stimulation in the visual cortex, and 70% in the underlying white matter.	[Federau, Christian; Birbaumer, Adrien; Meuli, Reto; Hagmann, Patric; Maeder, Philippe] CHU Vaudois, Dept Diagnost & Intervent Radiol, Lausanne, Switzerland; [Federau, Christian; Birbaumer, Adrien; Meuli, Reto; Hagmann, Patric; Maeder, Philippe] Univ Lausanne, Lausanne, Switzerland; [O'Brien, Kieran] Univ Geneva, Ctr Biomed Imaging CIBM, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Geneva	Federau, C (corresponding author), CHU Vaudois, Dept Diagnost & Intervent Radiol, Lausanne, Switzerland.	christian.federau@gmail.com	O'Brien, Kieran/B-7276-2016	O'Brien, Kieran/0000-0003-1996-3563	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; UNIGE; HUG; CHUV; EPFL; Leenaards Foundation; Jeantet Foundation; Faculte de biologie et de medecine of the University of Lausanne	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; UNIGE; HUG; CHUV; EPFL; Leenaards Foundation; Jeantet Foundation; Faculte de biologie et de medecine of the University of Lausanne	This work was supported by the Centre d'Imagerie BioMedicale (CIBM) of the UNIL, UNIGE, HUG, CHUV, EPFL and the Leenaards and Jeantet Foundations. CF was supported by the Faculte de biologie et de medecine of the University of Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso T, 2012, NEUROIMAGE, V67C, P25; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; CHRISTIANSEN P, 1994, MAGN RESON IMAGING, V12, P1237, DOI 10.1016/0730-725X(94)90088-9; COX SB, 1993, J CEREBR BLOOD F MET, V13, P899, DOI 10.1038/jcbfm.1993.113; D'Arcy RCN, 2006, MAGN RESON MED, V55, P952, DOI 10.1002/mrm.20839; Darquie A, 2001, P NATL ACAD SCI USA, V98, P9391, DOI 10.1073/pnas.151125698; Donahue MJ, 2006, MAGN RESON MED, V56, P1261, DOI 10.1002/mrm.21072; Federau C, 2012, RADIOLOGY, V265, P874, DOI 10.1148/radiol.12120584; Feng CM, 2004, NEUROIMAGE, V22, P443, DOI 10.1016/j.neuroimage.2004.01.017; Gangstead SL, 2002, MAGNET RESON MED, V48, P385, DOI 10.1002/mrm.10189; Ito H, 2005, ANN NUCL MED, V19, P65, DOI 10.1007/BF03027383; Jin T, 2008, NEUROIMAGE, V41, P801, DOI 10.1016/j.neuroimage.2008.03.014; Jin T, 2010, NEUROIMAGE, V51, P1378, DOI 10.1016/j.neuroimage.2010.03.047; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; LASSEN NA, 1985, J CEREBR BLOOD F MET, V5, P347, DOI 10.1038/jcbfm.1985.48; Le Bihan D, 2006, P NATL ACAD SCI USA, V103, P8263, DOI 10.1073/pnas.0600644103; Le Bihan D, 2012, NEUROIMAGE, V62, P1131, DOI 10.1016/j.neuroimage.2011.09.058; LEBIHAN D, 1992, MAGNET RESON MED, V27, P171, DOI 10.1002/mrm.1910270116; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lee SP, 1999, MAGNET RESON MED, V42, P919, DOI 10.1002/(SICI)1522-2594(199911)42:5<919::AID-MRM12>3.0.CO;2-8; Liang CL, 2013, NEUROIMAGE, V64, P104, DOI 10.1016/j.neuroimage.2012.08.077; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Mazerolle EL, 2010, NEUROIMAGE, V50, P616, DOI 10.1016/j.neuroimage.2009.12.102; McWhinney SR, 2012, J NEUROSCI METH, V209, P351, DOI 10.1016/j.jneumeth.2012.06.014; Michelich CR, 2006, NMR BIOMED, V19, P566, DOI 10.1002/nbm.1035; Miller KL, 2007, P NATL ACAD SCI USA, V104, P20967, DOI 10.1073/pnas.0707257105; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pauling L, 1936, P NATL ACAD SCI USA, V22, P210, DOI 10.1073/pnas.22.4.210; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Piechnik SK, 2009, MAGN RESON MED, V61, P579, DOI 10.1002/mrm.21897; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Roy C S, 1890, J Physiol, V11, P85; Scouten A, 2008, MAGN RESON MED, V59, P308, DOI 10.1002/mrm.21427; Seber G. A. F., 2003, NONLINEAR REGRESSION; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Song AW, 2012, NEUROIMAGE, V62, P949, DOI 10.1016/j.neuroimage.2012.01.001; Song AW, 2003, NEUROIMAGE, V20, P955, DOI 10.1016/S1053-8119(03)00292-1; Song AW, 2002, NEUROIMAGE, V17, P742, DOI 10.1006/nimg.2002.1217; Song AW, 1996, MAGNET RESON MED, V35, P155, DOI 10.1002/mrm.1910350204; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; TURNER R, 1990, RADIOLOGY, V177, P407, DOI 10.1148/radiology.177.2.2217777; Turner R, 2002, NEUROIMAGE, V16, P1062, DOI 10.1006/nimg.2002.1082; van Zijl PCM, 1998, NAT MED, V4, P159, DOI 10.1038/nm0298-159; Weber B, 2008, CEREB CORTEX, V18, P2318, DOI 10.1093/cercor/bhm259; Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257	58	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117706	10.1371/journal.pone.0117706	http://dx.doi.org/10.1371/journal.pone.0117706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647423	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600081
J	Lopez, A; Vera, M; Planas, M; Bouza, C				Lopez, Almudena; Vera, Manuel; Planas, Miquel; Bouza, Carmen			Conservation Genetics of Threatened Hippocampus guttulatus in Vulnerable Habitats in NW Spain: Temporal and Spatial Stability of Wild Populations with Flexible Polygamous Mating System in Captivity	PLOS ONE			English	Article							ENDANGERED KNYSNA SEAHORSE; COMPUTER-PROGRAM; LIFE-HISTORY; MICROSATELLITE MARKERS; GEOGRAPHICAL VARIATION; MULTIPLE PATERNITY; SOCIAL PROMISCUITY; SEXUAL SELECTION; SOFTWARE; SIZE	This study was focused on conservation genetics of threatened Hippocampus guttulatus on the Atlantic coast of NW Iberian Peninsula. Information about spatial structure and temporal stability of wild populations was obtained based on microsatellite markers, and used for monitoring a captive breeding program firstly initiated in this zone at the facilities of the Institute of Marine Research (Vigo, Spain). No significant major genetic structure was observed regarding the biogeographical barrier of Cape Finisterre. However, two management units under continuous gene flow are proposed based on the allelic differentiation between South-Atlantic and Cantabrian subpopulations, with small to moderate contemporary effective size based on single-sample methods. Temporal stability was observed in South-Atlantic population samples of H. guttulatus for the six-year period studied, suggesting large enough effective population size to buffer the effects of genetic drift within the time frame of three generations. Genetic analysis of wild breeders and offspring in captivity since 2009 allowed us to monitor the breeding program founded in 2006 in NW Spain for this species. Similar genetic diversity in the renewed and founder broodstock, regarding the wild population of origin, supports suitable renewal and rearing processes to maintain genetic variation in captivity. Genetic parentage proved single-brood monogamy in the wild and in captivity, but flexible short- and long-term mating system under captive conditions, from strict monogamy to polygamy within and/or among breeding seasons. Family analysis showed high reproductive success in captivity under genetic management assisted by molecular relatedness estimates to avoid inbreeding. This study provides genetic information about H. guttulatus in the wild and captivity within an uncovered geographical range for this data deficient species, to be taken into account for management and conservation purposes.	[Lopez, Almudena; Bouza, Carmen] Univ Santiago de Compostela, Fac Vet Sci, Dept Genet, Lugo, Spain; [Vera, Manuel] Univ Girona, Fac Sci, Dept Biol, Lab Ictiol Genet, Girona, Spain; [Planas, Miquel] Inst Invest Marinas CSIC, Dept Ecol & Marine Resources, Vigo, Spain	Universidade de Santiago de Compostela; Universitat de Girona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Bouza, C (corresponding author), Univ Santiago de Compostela, Fac Vet Sci, Dept Genet, Campus Lugo, Lugo, Spain.	mcarmen.bouza@usc.es	Vera, Manuel/B-7429-2012; Bouza, Carmen/K-9322-2014; Planas, Miquel/A-8780-2008; Gómez, ACUIGEN/ABD-5337-2020	Vera, Manuel/0000-0003-1584-6140; Bouza, Carmen/0000-0002-9501-4506; Planas, Miquel/0000-0003-1217-5716; 	Spanish Government [CGL2005-05927-C03-01/-03, CGL2009-08386]; Regional Government of Galicia [09MDS022402PR]	Spanish Government(Spanish GovernmentEuropean Commission); Regional Government of Galicia	This work was supported by the Spanish Government (CGL2005-05927-C03-01/-03; CGL2009-08386) and the Regional Government of Galicia (09MDS022402PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaunza P, 2008, FISH RES, V89, P196, DOI 10.1016/j.fishres.2007.09.022; Allendorf FW, 2007, CONSERV GENET, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Avise JC, 2011, P NATL ACAD SCI USA, V108, P7091, DOI 10.1073/pnas.1103329108; Blanco A, 2014, AQUACULTURE, V433, P214, DOI 10.1016/j.aquaculture.2014.06.019; Caballero A, 2010, CONSERV GENET, V11, P409, DOI 10.1007/s10592-009-0020-0; Caballero A, 2013, GENETICS, V195, P1373, DOI 10.1534/genetics.113.158410; CITES, 2002, 12 M C PART SANT CHI; CITES, 2004, 13 M C PART BANGK TH; Clynick BG, 2008, AQUAT CONSERV, V18, P483, DOI 10.1002/aqc.856; Correia M, 2013, J EXP MAR BIOL ECOL, V448, P258, DOI 10.1016/j.jembe.2013.08.001; Curtis JMR, 2006, J FISH BIOL, V68, P707, DOI 10.1111/j.0022-1112.2006.00952.x; Curtis JMR, 2004, PROJECT SEAHORSE TEC, V8; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Diekmann OE, 2005, MAR ECOL PROG SER, V290, P89, DOI 10.3354/meps290089; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fiumera AC, 2004, CONSERV BIOL, V18, P94, DOI 10.1111/j.1523-1739.2004.00521.x; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fraser DJ, 2008, EVOL APPL, V1, P501, DOI 10.1111/j.1752-4571.2008.00037.x; Galbusera PHA, 2007, MOL ECOL NOTES, V7, P638, DOI 10.1111/j.1471-8286.2007.01688.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guinand B, 2003, P ROY SOC B-BIOL SCI, V270, P425, DOI 10.1098/rspb.2002.2250; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hedrick P.W., 2011, GENETICS POPULATIONS; Hellyer CB, 2011, AQUAT CONSERV, V21, P582, DOI 10.1002/aqc.1217; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IUCN, 2011, CBSG NEWS        JAN; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jones AG, 2003, P NATL ACAD SCI USA, V100, P6598, DOI 10.1073/pnas.1131969100; Jones AG, 2001, J HERED, V92, P150, DOI 10.1093/jhered/92.2.150; Jones AG, 1998, MOL ECOL, V7, P1497, DOI 10.1046/j.1365-294x.1998.00481.x; Jones AG, 2005, MOL ECOL NOTES, V5, P708, DOI 10.1111/j.1471-8286.2005.01029.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kaiser MJ, 2002, FISH FISH, V3, P114, DOI 10.1046/j.1467-2979.2002.00079.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kelly CD, 1999, P ROY SOC B-BIOL SCI, V266, P2403, DOI 10.1098/rspb.1999.0938; Kvarnemo C, 2000, J EVOLUTION BIOL, V13, P882, DOI 10.1046/j.1420-9101.2000.00228.x; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; Lopez A, 2012, AQUACULTURE, V356, P153, DOI 10.1016/j.aquaculture.2012.05.021; Lopez A, 2010, CONSERV GENET, V11, P2431, DOI 10.1007/s10592-010-0116-6; LOPEZJAMAR E, 1992, J MAR RES, V50, P465, DOI 10.1357/002224092784797584; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Lundy CJ, 1999, MOL ECOL, V8, P1889, DOI 10.1046/j.1365-294x.1999.00789.x; Martin-Smith KM, 2004, OCEAN COAST MANAGE, V47, P165, DOI 10.1016/j.ocecoaman.2004.02.002; Martinez P, 2008, ESTIMATING PARENTAGE; Mobley KB, 2007, MOL ECOL, V16, P2596, DOI 10.1111/j.1365-294X.2007.03337.x; Mobley KB, 2009, MOL ECOL, V18, P1476, DOI 10.1111/j.1365-294X.2009.04104.x; Montgomery ME, 1997, ZOO BIOL, V16, P377, DOI 10.1002/(SICI)1098-2361(1997)16:5<377::AID-ZOO1>3.0.CO;2-7; Muthusamy Thangaraj, 2012, Notulae Scientia Biologicae, V4, P7; Naud MJ, 2009, BEHAV ECOL, V20, P160, DOI 10.1093/beheco/arn128; Nei M., 1987, MOL EVOLUTIONARY GEN; Nickel J, 2012, NEW ZEAL J MAR FRESH, V46, P207, DOI 10.1080/00288330.2011.632014; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Olivotto I, 2011, J WORLD AQUACULT SOC, V42, P135, DOI 10.1111/j.1749-7345.2011.00453.x; OSPAR Commission, 2008, CAS REP OSPAR LIST T; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Panithanarak T, 2010, ZOOL STUD, V49, P564; Pascoal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007268; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearse DE, 2009, MOL ECOL, V18, P3124, DOI 10.1111/j.1365-294X.2009.04268.x; Peel D., 2004, NEESTIMATOR SOFTWARE; Perez-Figueroa A, 2009, CONSERV GENET, V10, P1097, DOI 10.1007/s10592-008-9718-7; Pineira J, 2008, MAR ECOL PROG SER, V357, P175, DOI 10.3354/meps07278; Pino-Querido A, 2010, AQUAC RES, V41, P528, DOI 10.1111/j.1365-2109.2009.02344.x; Planas M, 2012, J EXP MAR BIOL ECOL, V438, P154, DOI 10.1016/j.jembe.2012.10.003; Planas M, 2010, ANIM REPROD SCI, V122, P66, DOI 10.1016/j.anireprosci.2010.07.008; Planas M, 2013, AQUACULTURE, V388, P147, DOI 10.1016/j.aquaculture.2013.01.030; Plesnar-Bielak A, 2013, P R SOC B, V279, P4661; Pritchard JK, 2000, GENETICS, V155, P945; Reiss H, 2009, FISH FISH, V10, P361, DOI 10.1111/j.1467-2979.2008.00324.x; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saarman NP, 2010, CONSERV GENET, V11, P1989, DOI 10.1007/s10592-010-0092-x; Sogabe A, 2007, ETHOLOGY, V113, P764, DOI 10.1111/j.1439-0310.2007.01370.x; Taggart JB, 2007, MOL ECOL NOTES, V7, P412, DOI 10.1111/j.1471-8286.2006.01616.x; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Teske PR, 2005, MAR ECOL PROG SER, V286, P249, DOI 10.3354/meps286249; Teske PR, 2003, MOL ECOL, V12, P1703, DOI 10.1046/j.1365-294X.2003.01852.x; Valladares S, 2011, 1 SYNGN BIOL INT S F; van de Vliet MS, 2009, CONSERV GENET RESOUR, V1, P93, DOI 10.1007/s12686-009-9022-y; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vincent ACJ, 2011, J FISH BIOL, V78, P1681, DOI 10.1111/j.1095-8649.2011.03003.x; Wang JL, 2002, GENETICS, V160, P1203; Waples RS, 2007, CONSERV BIOL, V21, P964, DOI 10.1111/j.1523-1739.2007.00730.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Wedekind C, 2002, CONSERV BIOL, V16, P1204, DOI 10.1046/j.1523-1739.2002.01217.x; Wilson AB, 2007, MOL ECOL, V16, P2345, DOI 10.1111/j.1365-294X.2007.03243.x; Woodall L., 2009, THESIS U LONDON UK; Woodall LC, 2011, J FISH BIOL, V78, P1738, DOI 10.1111/j.1095-8649.2011.02974.x; Woodall LC, 2011, CONSERV GENET, V12, P1645, DOI 10.1007/s10592-011-0253-6; Zarraonaindia I, 2009, ICES J MAR SCI, V66, P2176, DOI 10.1093/icesjms/fsp187	105	14	14	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117538	10.1371/journal.pone.0117538	http://dx.doi.org/10.1371/journal.pone.0117538			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646777	Green Published, gold			2022-12-26	WOS:000348822600073
J	Shi, M; Sun, WL; Hua, YY; Han, B; Shi, L				Shi, Ming; Sun, Wan-Li; Hua, Yan-Yan; Han, Bo; Shi, Long			Effects of Entecavir on Hepatitis B Virus Covalently Closed Circular DNA in Hepatitis B e Antigen-Positive Patients with Hepatitis B	PLOS ONE			English	Article							REAL-TIME PCR; LAMIVUDINE THERAPY; NUCLEIC-ACIDS; HBV CCCDNA; PEGINTERFERON ALPHA-2B; COMBINATION THERAPY; ANTIVIRAL THERAPY; SERUM; SUPPRESSION; INFECTION	The aim of this study was to assess the effect of 48-week entecavir therapy on serum and intrahepatic hepatitis B virus, covalently closed circular DNA (HBV cccDNA) levels in hepatitis B e antigen (HBeAg)-positive patients. A total of 120 patients with HBeAg-positive chronic hepatitis were treated with entecavir for 48 weeks. Serum HBV markers, total HBV DNA, and HBV cccDNA levels were measured at baseline and week 48. Biopsies from 20 patients were available for both intrahepatic total HBV DNA and cccDNA testing at these timepoints. HBV cccDNA levels were decreased from a median level of 5.1x10(6) copies/mL at baseline to a median level of 2.4x10(3) copies/mL at week 48. Reduction magnitudes of HBV cccDNA in patients with normalized alanine aminotransferase levels and those undergoing HBeAg seroconversion were significantly greater than those in alanine aminotransferase-abnormal and HBeAg positive patients. Intrahepatic HBV cccDNA was decreased significantly after 48 weeks of treatment, but could not be eradicated. In conclusion, treatment of HBeAg-positive hepatitis B patients with entecavir for 48 weeks decreased serum and intrahepatic HBV cccDNA significantly, and the magnitude of HBV cccDNA reduction was related to total HBV DNA decrease, alanine aminotransferase normalization, and HBeAg seroconversion.	[Shi, Ming; Sun, Wan-Li; Hua, Yan-Yan; Han, Bo; Shi, Long] 6 Hosp Dalian, Dept Lab Med, Dalian, Peoples R China		Shi, M (corresponding author), 6 Hosp Dalian, Dept Lab Med, Dalian, Peoples R China.	zhsh6655@sohu.com						Bourne EJ, 2007, J VIRAL HEPATITIS, V14, P55, DOI 10.1111/j.1365-2893.2006.00775.x; Breitkreutz R, 2001, ANN NY ACAD SCI, V945, P195; Caruntu Florin Alexandru, 2005, Rom J Gastroenterol, V14, P373; Chen Y, 2004, WORLD J GASTROENTERO, V10, P82; Hagiwara S, 2013, J MED VIROL, V85, P987, DOI 10.1002/jmv.23564; He ML, 2002, BIOCHEM BIOPH RES CO, V295, P1102, DOI 10.1016/S0006-291X(02)00813-6; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Loustaud-Ratti V, 2013, CLIN RES HEPATOL GAS, V37, P373, DOI 10.1016/j.clinre.2012.11.002; Mazet-Wagner AA, 2006, J VIROL METHODS, V138, P70, DOI 10.1016/j.jviromet.2006.07.019; Moraleda G, 1997, J VIROL, V71, P9392, DOI 10.1128/JVI.71.12.9392-9399.1997; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shi M, 2006, J ANTIMICROB CHEMOTH, V58, P1031, DOI 10.1093/jac/dkl385; Su Q, 2001, CLIN CANCER RES, V7, P2005; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wong DKH, 2006, ANTIVIR THER, V11, P909; Wong DKH, 2004, HEPATOLOGY, V40, P727, DOI 10.1002/hep.20353; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282; YOKOSUKA O, 1985, HEPATOLOGY, V5, P728, DOI 10.1002/hep.1840050505; Yuen MF, 2005, AM J GASTROENTEROL, V100, P1099, DOI 10.1111/j.1572-0241.2005.41530.x; Zhang W, 2003, J MED VIROL, V71, P24, DOI 10.1002/jmv.10464; Zhou TL, 2000, J VIROL, V74, P11754, DOI 10.1128/JVI.74.24.11754-11763.2000	23	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117741	10.1371/journal.pone.0117741	http://dx.doi.org/10.1371/journal.pone.0117741			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647607	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600083
J	Clouse, MD; Shikiya, RA; Bartz, JC; Kincaid, AE				Clouse, Melissa D.; Shikiya, Ronald A.; Bartz, Jason C.; Kincaid, Anthony E.			Nasal Associated Lymphoid Tissue of the Syrian Golden Hamster Expresses High Levels of PrPC	PLOS ONE			English	Article							TRANSMISSIBLE MINK ENCEPHALOPATHY; PRION PROTEIN PRPC; SCRAPIE AGENT; MICE; PATHOGENESIS; INFECTION; DISEASE; NEUROINVASION; VIRUS; ROUTE	The key event in the pathogenesis of the transmissible spongiform encephalopathies is a template-dependent misfolding event where an infectious isoform of the prion protein (PrPSc) comes into contact with native prion protein (PrPC) and changes its conformation to PrPSc. In many extraneurally inoculated models of prion disease this PrPC misfolding event occurs in lymphoid tissues prior to neuroinvasion. The primary objective of this study was to compare levels of total PrPC in hamster lymphoid tissues involved in the early pathogenesis of prion disease. Lymphoid tissues were collected from golden Syrian hamsters and Western blot analysis was performed to quantify PrPC levels. PrPC immunohistochemistry (IHC) of paraffin embedded tissue sections was performed to identify PrPC distribution in tissues of the lymphoreticular system. Nasal associated lymphoid tissue contained the highest amount of total PrPC followed by Peyer's patches, mesenteric and submandibular lymph nodes, and spleen. The relative levels of PrPC expression in IHC processed tissue correlated strongly with the Western blot data, with high levels of PrPC corresponding with a higher percentage of PrPC positive B cell follicles. High levels of PrPC in lymphoid tissues closely associated with the nasal cavity could contribute to the relative increased efficiency of the nasal route of entry of prions, compared to other routes of infection.	[Clouse, Melissa D.; Kincaid, Anthony E.] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA; [Shikiya, Ronald A.; Bartz, Jason C.; Kincaid, Anthony E.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA; [Kincaid, Anthony E.] Creighton Univ, Dept Pharm Sci, Omaha, NE 68178 USA	Creighton University; Creighton University; Creighton University	Kincaid, AE (corresponding author), Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA.	akincaid@creighton.edu		Bartz, Jason/0000-0003-4081-7886; Kincaid, Anthony/0000-0002-5700-5887	National Institute for Neurological Disorders and Stroke [RO1 NS061994, RO1 NS061994-03S1]; National Center for Research Resources [CO6 RR17417-01, G20 RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061994] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute for Neurological Disorders and Stroke (RO1 NS061994 and RO1 NS061994-03S1 to AEK) and the National Center for Research Resources (CO6 RR17417-01 and G20 RR024001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz JC, 2005, J VIROL, V79, P11858, DOI 10.1128/JVI.79.18.11858-11863.2005; Bartz JC, 2003, J VIROL, V77, P583, DOI 10.1128/JVI.77.1.583-591.2003; Bartz JC, 2002, J VIROL, V76, P5759, DOI 10.1128/JVI.76.11.5759-5768.2002; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Brown KL, 2009, J IMMUNOL, V183, P5199, DOI 10.4049/jimmunol.0802695; BRUCE ME, 1985, J GEN VIROL, V66, P2517, DOI 10.1099/0022-1317-66-12-2517; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CHEN LL, 1978, J CELL BIOL, V77, P148, DOI 10.1083/jcb.77.1.148; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Dron M, 2010, J BIOL CHEM, V285, P10252, DOI 10.1074/jbc.M109.083857; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; HADLOW WJ, 1987, J VIROL, V61, P3235, DOI 10.1128/JVI.61.10.3235-3240.1987; Hamir AN, 2008, VET PATHOL, V45, P7, DOI 10.1354/vp.45-1-7; Haybaeck J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001257; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Kincaid AE, 2012, J VIROL, V86, P12731, DOI 10.1128/JVI.01930-12; LEAVITT R, 1977, J BIOL CHEM, V252, P9018; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Maignien T, 1999, J GEN VIROL, V80, P3035, DOI 10.1099/0022-1317-80-11-3035; Mays CE, 2009, BIOCHEM BIOPH RES CO, V388, P306, DOI 10.1016/j.bbrc.2009.07.163; McDonald AJ, 2014, J BIOL CHEM, V289, P803, DOI 10.1074/jbc.M113.502351; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; Pan T, 2002, J NEUROCHEM, V81, P1092, DOI 10.1046/j.1471-4159.2002.00909.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; SAKAGUCHI S, 1995, J VIROL, V69, P7586, DOI 10.1128/JVI.69.12.7586-7592.1995; Sbriccoli M, 2009, ACTA NEUROPATHOL, V117, P175, DOI 10.1007/s00401-008-0474-z; Shikiya RA, 2010, J VIROL, V84, P5706, DOI 10.1128/JVI.00243-10; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4	38	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117935	10.1371/journal.pone.0117935	http://dx.doi.org/10.1371/journal.pone.0117935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642714	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821200041
J	Koprivnikar, J; Penalva, L				Koprivnikar, Janet; Penalva, Laura			Lesser of Two Evils? Foraging Choices in Response to Threats of Predation and Parasitism	PLOS ONE			English	Article							ANTIPARASITE BEHAVIOR; AMPHIBIAN METAMORPHOSIS; PREY INTERACTIONS; LIMB DEVELOPMENT; LARVAL ANURANS; LIFE-HISTORY; RISK; INFECTION; TADPOLES; AVOIDANCE	Predators have documented post-encounter (density-mediated) effects on prey but their pre-encounter impacts, including behavioural alterations, can be substantial as well. While it is increasingly evident that this "ecology of fear" is important to understand for natural enemy-victim relationships, fear responses of hosts to the threat of infection by a parasite are relatively unknown. We examined larval amphibian (Lithobates pipiens) foraging choices by experimentally manipulating the presence of cues relating to predator (larval odonate) or parasite (the trematode Ribeiroia ondatrae) threats. Tadpoles avoided foraging where predator or parasite cues were present; however, they did not treat these as equal hazards. When both threats were simultaneously present, tadpoles strongly preferred to forage under the threat of parasitism compared to predation, likely driven by their relative lethality in our study. Our results indicate that altered spatial use is an important anti-parasite behaviour, and demonstrate that parasite avoidance can affect foraging in a manner similar to predators, warranting greater study of the pre-encounter effects of this enemy type.	[Koprivnikar, Janet] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Penalva, Laura] Brandon Univ, Dept Biol, Brandon, MB R7A 6A9, Canada	Toronto Metropolitan University; Brandon University	Koprivnikar, J (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada.	jkoprivn@ryerson.ca			Natural Sciences and Engineering Research Council of Canada [386691-2010]; Canada-Brazil Ciencia Sem Fronteiras Scholarship Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada-Brazil Ciencia Sem Fronteiras Scholarship Program	This study was supported by a Discovery Grant (386691-2010) to JK from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), and the Canada-Brazil Ciencia Sem Fronteiras Scholarship Program to LP (http://www.cbie.ca/what-we-do/student-portal/brazil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2010, ISR J ECOL EVOL, V56, P313, DOI 10.1560/IJEE.56.3-4.313; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Baker RL, 1997, OECOLOGIA, V109, P622, DOI 10.1007/s004420050125; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; BROWN JS, 1988, OECOLOGIA, V76, P408, DOI 10.1007/BF00377036; Bustnes JO, 2004, CAN J ZOOL, V82, P1566, DOI 10.1139/Z04-139; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; Daly EW, 2011, OECOLOGIA, V165, P1043, DOI 10.1007/s00442-010-1778-y; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; DOBSON AP, 1986, TRENDS ECOL EVOL, V1, P11, DOI 10.1016/0169-5347(86)90060-1; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Ferrari MCO, 2009, ANIM BEHAV, V78, P11, DOI 10.1016/j.anbehav.2009.03.016; Fritzsche A, 2012, ECOHEALTH, V9, P70, DOI 10.1007/s10393-012-0744-z; Garnick SW, 2010, BEHAV ECOL, V21, P129, DOI 10.1093/beheco/arp162; Goodman BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020193; Gosner K. L., 1960, Herpetologica, V16, P183; Hammond JI, 2007, ECOLOGY, V88, P1525, DOI 10.1890/06-1236; HART BL, 1994, PARASITOLOGY, V109, pS139, DOI 10.1017/S0031182000085140; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Hossie TJ, 2011, ETHOLOGY, V117, P777, DOI 10.1111/j.1439-0310.2011.01927.x; James CT, 2008, J FISH BIOL, V73, P2238, DOI 10.1111/j.1095-8649.2008.02052.x; Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104; Johnson Pieter T. J., 2009, P249, DOI 10.1007/978-0-387-09577-6_11; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2004, ADV PARASIT, V57, P191, DOI 10.1016/S0065-308X(04)57003-3; Kiesecker JM, 2000, ECOLOGY, V81, P2939, DOI 10.1890/0012-9658(2000)081[2939:COOSBG]2.0.CO;2; Kiesecker JM, 1999, P NATL ACAD SCI USA, V96, P9165, DOI 10.1073/pnas.96.16.9165; Koprivnikar J, 2006, CAN J ZOOL, V84, P1623, DOI 10.1139/Z06-158; Koprivnikar J, 2014, OECOLOGIA, V174, P1179, DOI 10.1007/s00442-013-2857-7; Koprivnikar J, 2012, ECOHEALTH, V9, P342, DOI 10.1007/s10393-012-0785-3; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Low PA, 2014, ANIM BEHAV, V90, P337, DOI 10.1016/j.anbehav.2014.02.020; LOZANO GA, 1991, OIKOS, V60, P391, DOI 10.2307/3545084; McCarthy TM, 2000, FRESHWATER BIOL, V44, P387, DOI 10.1046/j.1365-2427.2000.00576.x; MICHALAKIS Y, 1994, PARASITE, V1, P291, DOI 10.1051/parasite/1994014291; Moore J., 2002, PARASITES BEHAV ANIM; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Petranka J, 1998, BEHAV ECOL SOCIOBIOL, V42, P263, DOI 10.1007/s002650050438; Poulin R, 1999, INT J PARASITOL, V29, P903, DOI 10.1016/S0020-7519(99)00045-4; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Poulin R, 2011, BIOL LETTERS, V7, P241, DOI 10.1098/rsbl.2010.0640; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Preston DL, 2014, FUNCT ECOL, V28, P1472, DOI 10.1111/1365-2435.12293; Raffel TR, 2008, TRENDS ECOL EVOL, V23, P610, DOI 10.1016/j.tree.2008.06.015; Raveh A, 2011, ECOL LETT, V14, P47, DOI 10.1111/j.1461-0248.2010.01549.x; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Rohr JR, 2009, OECOLOGIA, V159, P447, DOI 10.1007/s00442-008-1208-6; Schotthoefer AM, 2003, CAN J ZOOL, V81, P1144, DOI [10.1139/z03-099, 10.1139/Z03-099]; Szuroczki D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049592; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075841; Taylor CN, 2004, CAN J ZOOL, V82, P701, DOI [10.1139/z04-037, 10.1139/Z04-037]; Thiemann GW, 2000, BIOL J LINN SOC, V71, P513, DOI [10.1111/j.1095-8312.2000.tb01272.x, 10.1006/bijl.2000.0459]; Tompkins DM, 1999, PARASITOL TODAY, V15, P311, DOI 10.1016/S0169-4758(99)01484-2; WERNER EE, 1986, AM NAT, V128, P319, DOI 10.1086/284565; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; Yi M, 2011, EVOLUTION, V65, P1482, DOI [10.1111/j.1558-5646.2011.01240.x, DOI 10.1111/J.1558-5646.2011.01240.X]	60	28	28	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116569	10.1371/journal.pone.0116569	http://dx.doi.org/10.1371/journal.pone.0116569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635765	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700044
J	Afonso, AS; Hazin, FHV				Afonso, Andre S.; Hazin, Fabio H. V.			Vertical Movement Patterns and Ontogenetic Niche Expansion in the Tiger Shark, Galeocerdo cuvier	PLOS ONE			English	Article							FRENCH FRIGATE SHOALS; HABITAT USE; SEXUAL SEGREGATION; DIVING BEHAVIOR; LONGLINE CATCH; PELAGIC SHARKS; ABUNDANCE; BIOLOGY; RATES; CONSERVATION	Sharks are top predators in many marine ecosystems and can impact community dynamics, yet many shark populations are undergoing severe declines primarily due to overfishing. Obtaining species-specific knowledge on shark spatial ecology is important to implement adequate management strategies for the effective conservation of these taxa. This is particularly relevant concerning highly-mobile species that use wide home ranges comprising coastal and oceanic habitats, such as tiger sharks, Galeocerdo cuvier. We deployed satellite tags in 20 juvenile tiger sharks off northeastern Brazil to assess the effect of intrinsic and extrinsic factors on depth and temperature usage. Sharks were tracked for a total of 1184 d and used waters up to 1112 m in depth. The minimum temperature recorded equaled 4 degrees C. All sharks had a clear preference for surface (< 5 m) waters but variability in depth usage was observed as some sharks used mostly shallow (< 60 m) waters whereas others made frequent incursions into greater depths. A diel behavioral shift was detected, with sharks spending considerably more time in surface (< 10 m) waters during the night. Moreover, a clear ontogenetic expansion in the vertical range of tiger shark habitat was observed, with generalized linear models estimating a similar to 4-fold increase in maximum diving depth from 150- to 300-cm size-classes. The time spent in the upper 5 m of the water column did not vary ontogenetically but shark size was the most important factor explaining the utilization of deeper water layers. Young-of-the-year tiger sharks seem to associate with shallow, neritic habitats but they progressively move into deeper oceanic habitats as they grow larger. Such an early plasticity in habitat use could endow tiger sharks with access to previously unavailable prey, thus contributing to a wider ecological niche.	[Afonso, Andre S.; Hazin, Fabio H. V.] Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil; [Afonso, Andre S.] Univ Algarve, Fac Ciencias & Tecnol, Faro, Portugal	Universidade Federal Rural de Pernambuco (UFRPE); Universidade do Algarve	Afonso, AS (corresponding author), Univ Fed Rural Pernambuco, Dept Pesca & Aquicultura, Recife, PE, Brazil.	afonso.andre@gmail.com		Hazin, Fabio/0000-0003-3755-5379; Afonso, Andre/0000-0001-9129-278X	State Government of Pernambuco; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BJT/A049/2013]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/37065/2007]	State Government of Pernambuco; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This study received financial support from the State Government of Pernambuco (www.pe.gov.br). Research grants provided to the first author by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br; contract no. BJT/A049/2013) and by the Fundacao para a Ciencia e Tecnologia, Portugal (www.fct.pt; contract no. SFRH/BD/37065/2007) are deeply acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2011, MAR BIOL, V158, P1175, DOI 10.1007/s00227-011-1639-1; Afonso AS, 2012, J FISH BIOL, V81, P2080, DOI 10.1111/j.1095-8649.2012.03455.x; Afonso A.S., 2013, BIOECOLOGY MOVEMENT; Afonso AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102369; Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Afonso AS, 2011, FISH RES, V108, P336, DOI 10.1016/j.fishres.2011.01.007; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baum JK, 2010, FISH RES, V102, P229, DOI 10.1016/j.fishres.2009.11.006; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; BRANSTETTER S, 1987, FISH B-NOAA, V85, P269; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Campana SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016854; Campbell RA, 2004, FISH RES, V70, P209, DOI 10.1016/j.fishres.2004.08.026; Carlson JK, 2012, J FISH BIOL, V80, P1749, DOI 10.1111/j.1095-8649.2011.03193.x; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno L.J.V., 1984, FAO Fisheries Synopsis, P251; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Driggers WB, 2008, AQUAT BIOL, V2, P161, DOI 10.3354/ab00045; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FAINSTEIN R, 1979, AAPG BULL, V63, P218; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Gallagher AJ, 2012, J FISH BIOL, V80, P1727, DOI 10.1111/j.1095-8649.2012.03235.x; Garcia VB, 2008, P ROY SOC B-BIOL SCI, V275, P83, DOI 10.1098/rspb.2007.1295; Grubbs RD, 2010, CRC MAR BIOL SER, P319; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hazin FHV, 2014, ANIM CONSERV, V17, P287, DOI 10.1111/acv.12096; Hazin FHV, 2008, B MAR SCI, V82, P199; Hazin FHV, 2013, AN ACAD BRAS CIENC, V85, P1053, DOI 10.1590/S0001-37652013005000055; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2013, MAR ECOL PROG SER, V481, P225, DOI 10.3354/meps10235; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holmes BJ, 2014, MAR BIOL, V161, P2645, DOI 10.1007/s00227-014-2536-1; Jennings DE, 2008, ENVIRON BIOL FISH, V83, P369, DOI 10.1007/s10641-008-9357-3; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; Lowe Christopher G., 2006, Atoll Research Bulletin, P281; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Papastamatiou YP, 2013, ECOLOGY, V94, P2595, DOI 10.1890/12-2014.1; Polacheck T, 2006, MAR POLICY, V30, P470, DOI 10.1016/j.marpol.2005.06.016; Polovina JJ, 1993, MAR FISH REV, V55, P1; RANDALL JE, 1992, AUST J MAR FRESH RES, V43, P21; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Saunders RA, 2011, ICES J MAR SCI, V68, P166, DOI 10.1093/icesjms/fsq145; Seitz JC, 2006, MAR POLLUT BULL, V52, P1533, DOI 10.1016/j.marpolbul.2006.07.016; Sepulveda CA, 2004, MAR BIOL, V145, P191, DOI 10.1007/s00227-004-1356-0; Shepherd TD, 2005, ECOL LETT, V8, P1095, DOI 10.1111/j.1461-0248.2005.00807.x; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; Sims DW, 2010, CRC MAR BIOL SER, P351; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; TRICAS TC, 1981, COPEIA, P904, DOI 10.2307/1444199; Vaudo JJ, 2014, ECOL EVOL, V4, P1768, DOI 10.1002/ece3.1053; Walters C, 2003, CAN J FISH AQUAT SCI, V60, P1433, DOI 10.1139/F03-152; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; Whitney NM, 2007, MAR BIOL, V151, P63, DOI 10.1007/s00227-006-0476-0; Wirsing AJ, 2006, MAR BIOL, V149, P961, DOI 10.1007/s00227-006-0278-4; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	75	39	39	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116720	10.1371/journal.pone.0116720	http://dx.doi.org/10.1371/journal.pone.0116720			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629732	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100046
J	Mattoni, CI; Garcia-Hernandez, S; Botero-Trujillo, R; Ochoa, JA; Ojanguren-Affilastro, AA; Pinto-Da-Rocha, R; Prendini, L				Mattoni, Camilo I.; Garcia-Hernandez, Solimary; Botero-Trujillo, Ricardo; Ochoa, Jose A.; Ojanguren-Affilastro, Andres A.; Pinto-da-Rocha, Ricardo; Prendini, Lorenzo			Scorpion Sheds 'Tail' to Escape: Consequences and Implications of Autotomy in Scorpions (Buthidae: Ananteris)	PLOS ONE			English	Article							LIGHT; MICROANANTERIS; LOURENCO; URODACUS; THORELL; BRAZIL	Autotomy, the voluntary shedding or detachment of a body part at a determined cleavage plane, is a common anti-predation defense mechanism in several animal taxa, including arthropods. Among arachnids, autotomy has been observed in harvestmen, mites, and spiders, always involving the loss of legs. Autotomy of the opisthosoma (abdomen) was recently reported in a single species of the Neotropical buthid scorpion genus Ananteris Thorell, 1891, but few details were revealed. Based on observations in the field and laboratory, examination of material in museum collections, and scanning electron microscopy, we document autotomy of the metasoma (the hind part of the opisthosoma, or 'tail') in fourteen species of Ananteris. Autotomy is more common in males than females, and has not been observed in juveniles. When the scorpion is held by the metasoma, it is voluntarily severed at the joints between metasomal segments I and II, II and III, or III and IV, allowing the scorpion to escape. After detachment, the severed metasoma moves (twitches) automatically, much like the severed tail of a lizard or the severed leg of a spider, and reacts to contact, even attempting to sting. The severed surface heals rapidly, scar tissue forming in five days. The lost metasomal segments and telson cannot be regenerated. Autotomy of the metasoma and telson results in permanent loss of the posterior part of the scorpion's digestive system (the anus is situated posteriorly on metasomal segment V) and the ability to inject venom by stinging. After autotomy, scorpions do not defecate and can only capture small prey items. However, males can survive and mate successfully for up to eight months in the laboratory. In spite of diminished predation ability after autotomy, survival allows males to reproduce. Autotomy in Ananteris therefore appears to be an effective, adaptive, anti-predation escape mechanism.	[Mattoni, Camilo I.] Univ Nacl Cordoba, RA-5000 Cordoba, Argentina; [Garcia-Hernandez, Solimary] Univ Ind Santander, Bucaramanga, Colombia; [Botero-Trujillo, Ricardo; Ojanguren-Affilastro, Andres A.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Ojanguren-Affilastro, Andres A.] Frankfurt Zool Soc, Cuzco, Peru; [Botero-Trujillo, Ricardo] Pontificia Univ Javeriana, Bogota, Colombia; [Ochoa, Jose A.; Pinto-da-Rocha, Ricardo] Univ Sao Paulo, Sao Paulo, Brazil; [Prendini, Lorenzo] Amer Museum Nat Hist, New York, NY USA	National University of Cordoba; Universidad Industrial de Santander; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Pontificia Universidad Javeriana; Universidade de Sao Paulo; American Museum of Natural History (AMNH)	Mattoni, CI (corresponding author), Univ Nacl Cordoba, RA-5000 Cordoba, Argentina.	cmattoni@efn.uncor.edu	GARCIA-HERNANDEZ, SOLIMARY/ABA-5826-2020; Pinto-da-Rocha, Ricardo/J-6774-2012; Prendini, Lorenzo/AAY-6611-2021	GARCIA-HERNANDEZ, SOLIMARY/0000-0002-4458-8948; Pinto-da-Rocha, Ricardo/0000-0002-3959-2205; Prendini, Lorenzo/0000-0001-8727-7106; Mattoni, Camilo/0000-0001-8570-8814; Jose Antonio, Ochoa/0000-0001-6580-7268	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/06604-7, 2012/02969-6]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-1764, PICT 2006-750, 2010-0906]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	Financial support was provided by: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, http://www.fapesp.br), grant numbers 2008/06604-7 and 2012/02969-6 to RPR; and Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar), grant numbers PICT 2010-1764 to AAOA, PICT 2006-750 and 2010-0906 to CIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; ARNOLD EN, 1984, J NAT HIST, V18, P127, DOI 10.1080/00222938400770131; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Blass GRC, 2008, ANIM BEHAV, V76, P365, DOI 10.1016/j.anbehav.2007.12.022; Botero-Trujillo R, 2011, ZOOTAXA, P1; Botero-Trujillo R, 2011, ZOOTAXA, P37; Bradstock C. A., 1950, Zoology Publications from Victoria University College, V7, P1; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Chen XL, 2013, MAR FRESHW BEHAV PHY, V46, P321, DOI 10.1080/10236244.2013.833365; Fleming PA, 2007, BIOL REV, V82, P481, DOI 10.1111/j.1469-185X.2007.00020.x; Fredericq L, 1883, ARCH ZOOL EXP GEN 2, V1, P413; Garcia Hernandez S, 2011, 3 C LAT AR MEM RES, P135; Gnaspini Pedro, 2007, P374; Hadley N.F., 1990, P321; Higham TE, 2010, BIOL LETTERS, V6, P70, DOI 10.1098/rsbl.2009.0577; Hjelle J.T., 1990, P9; LAWRENCE JM, 1986, J EXP MAR BIOL ECOL, V102, P47, DOI 10.1016/0022-0981(86)90125-5; Lewis J. G. E., 1981, BIOL CENTIPEDES; Lira AFA, 2014, J INSECT BEHAV, V27, P279, DOI 10.1007/s10905-013-9431-3; Lourenco W. R., 2012, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V16, P41; Lourenco WR, 2013, AN ACAD BRAS CIENC, V85, P709, DOI 10.1590/S0001-37652013000200016; Lourenco Wilson R., 2012, Boletin de la SEA, V50, P73; Lourenco WR, 2012, CR BIOL, V335, P555, DOI 10.1016/j.crvi.2012.06.005; Lourenco Wilson R., 2011, Boletin de la SEA, V48, P105; Mattoni CI, 2001, 3 C LAT AR MEM RES, P83; Nelson Ximena J., 2011, P99; Ojanguren-Affilastro A.A., 2001, PHYSIS C, V58, P15; Polis G.A., 1990, P161; Polis GA, 1990, BIOL SCORPIONS; RAO G, 1973, J EXP BIOL, V58, P189; STAHNKE HL, 1972, BIOSCIENCE, V22, P604, DOI 10.2307/1296207; Weygoldt P., 2000, WHIP SPIDERS CHELICE; Wilkie IC, 2001, MICROSC RES TECHNIQ, V55, P369, DOI 10.1002/jemt.1185; Wood FD, 1926, J MORPHOL PHYSIOL, V42, P143, DOI 10.1002/jmor.1050420106; ZWICKY KT, 1968, LIFE SCI PT 1 PHYSI, V7, P257, DOI 10.1016/0024-3205(68)90020-9; ZWICKY KT, 1970, EXPERIENTIA, V26, P317, DOI 10.1007/BF01900120	36	17	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116639	10.1371/journal.pone.0116639	http://dx.doi.org/10.1371/journal.pone.0116639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629529	Green Submitted, Green Published, gold			2022-12-26	WOS:000348732100044
J	Fujita, T; Yamashita, D; Uehara, N; Inokuchi, G; Hasegawa, S; Otsuki, N; Nibu, K				Fujita, Takeshi; Yamashita, Daisuke; Uehara, Natsumi; Inokuchi, Go; Hasegawa, Shingo; Otsuki, Naoki; Nibu, Ken-ichi			A High-Fat Diet Delays Age-Related Hearing Loss Progression in C57BL/6J Mice	PLOS ONE			English	Article							INNER-EAR; OBESITY; PREVENTION; DAMAGE; ANTIOXIDANTS; RESTRICTION; CADHERIN-23; STRAINS; DISEASE; FORMS	Objective Age-related hearing loss (AHL), or presbycusis, is the most common sensory disorder among the elderly. We used C57BL/6J mice as an AHL model to determine a possible association between AHL and a high-fat diet (HFD). Methods Forty C57BL/6J mice were randomly assigned to a control or HFD group. Each group was divided into the following subgroups: 1-, 3-, 5- and 12-month groups (HFD, n = 5/subgroup; control, n = 5/subgroup). Nine CBA/N-slc mice were also used as a 12-month control (n = 5) or 12-month HFD (n = 4) group. The mice were fed a HFD or normal (control) diet throughout this study. Hearing function was evaluated at 1, 3, 5 and 12 months using auditory evoked brainstem responses (ABRs). Spiral ganglion cells (SGCs) were also counted. Results The elevation of ABR thresholds (at 4 and 32 kHz) at 3 and 5 months was significantly suppressed in the HFD group compared with the control groups for C57BL/6Jmice. After 12 months, the elevation of ABR thresholds was significantly suppressed in the HFD group at all frequencies for C57BL/6J mice. In contrast, CBA/N-slc mice displayed opposite outcomes, as ABR thresholds at all frequencies at 12 months were significantly elevated in the HFD group compared with the control group. For the C57BL/6J mice at 12 months, SGC numbers significantly decreased in all parts of the cochleae in the control group compared with the HFD groups. In contrast, for the CBA/N-slc mice, SGC numbers significantly decreased, particularly in the upper parts of the cochleae in the HFD group compared with the control groups. Conclusions The elevation in ABR thresholds and SGC loss associated with aging in the HFD-fed C57BL/6J mice were significantly suppressed compared with those in the normal diet-fed mice. These results suggest that HFD delays AHL progression in the C57B/6J mice.	[Fujita, Takeshi; Yamashita, Daisuke; Uehara, Natsumi; Inokuchi, Go; Hasegawa, Shingo; Otsuki, Naoki; Nibu, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo 657, Japan	Kobe University	Yamashita, D (corresponding author), Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo 657, Japan.	daiy1013@aol.com	Otsuki, Naoki/AAH-2468-2020; Fujita, Takeshi/ABD-6485-2021	Otsuki, Naoki/0000-0002-9682-2548	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported by a Grant-in-Aid for Young Scientists (B) (to T.F) and a Grant-in-Aid for Scientific Research (C) (to D.Y) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Brownlow BS, 1996, PHYSIOL BEHAV, V60, P37, DOI 10.1016/0031-9384(95)02210-4; Di Palma F, 2001, GENE, V281, P31, DOI 10.1016/S0378-1119(01)00761-2; Du ZD, 2012, HEARING RES, V287, P15, DOI 10.1016/j.heares.2012.04.012; Evans MB, 2006, OTOL NEUROTOL, V27, P609, DOI 10.1097/01.mao.0000226286.19295.34; Frisina RD, 2011, NEUROBIOL AGING, V32, P1716, DOI 10.1016/j.neurobiolaging.2009.09.009; Fujita T, 2012, DIABETES, V61, P2980, DOI 10.2337/db11-1845; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Gopinath B, 2011, J NUTR, V141, P1355, DOI 10.3945/jn.111.138610; Guilford B., 2011, EXP DIABETES RES, V2011, P1; Guimaraes P, 2004, HEARING RES, V192, P83, DOI 10.1016/j.heares.2004.01.013; Heman-Ackah SE, 2010, OTOLARYNG HEAD NECK, V143, P429, DOI 10.1016/j.otohns.2010.04.266; Hwang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060730; Jiang Q, 2014, FREE RADICAL BIO MED, V72, P76, DOI 10.1016/j.freeradbiomed.2014.03.035; Jones NS, 1999, CLIN OTOLARYNGOL, V24, P531, DOI 10.1046/j.1365-2273.1999.00310.x; Kashio A, 2009, BIOCHEM BIOPH RES CO, V390, P394, DOI 10.1016/j.bbrc.2009.09.003; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; Le Prell CG, 2011, TRANSL RES, V158, P38, DOI 10.1016/j.trsl.2011.02.006; Le T, 2007, HEARING RES, V226, P194, DOI 10.1016/j.heares.2006.04.003; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Seidman MD, 2000, LARYNGOSCOPE, V110, P727, DOI 10.1097/00005537-200005000-00003; Seidman MD, 2002, OTOLARYNG HEAD NECK, V127, P138, DOI 10.1067/mhn.2002.127627; Sha SH, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.023; Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Suzuki K, 2000, LARYNGOSCOPE, V110, P1736, DOI 10.1097/00005537-200010000-00033; Vasilyeva ON, 2009, HEARING RES, V249, P44, DOI 10.1016/j.heares.2009.01.007; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	34	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117547	10.1371/journal.pone.0117547	http://dx.doi.org/10.1371/journal.pone.0117547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625852	gold, Green Submitted, Green Published			2022-12-26	WOS:000348821400035
J	Yates, SC; Zafar, A; Rabai, EM; Foxall, JB; Nagy, S; Morrison, KE; Clarke, C; Esiri, MM; Christie, S; Smith, AD; Nagy, Z				Yates, Sharon C.; Zafar, Amen; Rabai, Erzsebet M.; Foxall, James B.; Nagy, Sheila; Morrison, Karen E.; Clarke, Carl; Esiri, Margaret M.; Christie, Sharon; Smith, A. David; Nagy, Zsuzsanna			The Effects of Two Polymorphisms on p21(cip1) Function and Their Association with Alzheimer's Disease in a Population of European Descent	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; KINASE INHIBITOR GENE; CELL-CYCLE; IDENTIFIES VARIANTS; VASCULAR DEMENTIA; COMMON VARIANTS; HUMAN CANCER; EXPRESSION; ONSET	With the exception of ApoE4, genome-wide association studies have failed to identify strong genetic risk factors for late-onset Alzheimer's disease, despite strong evidence of heritability, suggesting that many low penetrance genes may be involved. Additionally, the nature of the identified genetic risk factors and their relation to disease pathology is also largely obscure. Previous studies have found that a cancer-associated variant of the cell cycle inhibitor gene p21(cip1) is associated with increased risk of Alzheimer's disease. The aim of this study was to confirm this association and to elucidate the effects of the variant on protein function and Alzheimer-type pathology. We examined the association of the p21(cip1) variant with Alzheimer's disease and Parkinson's disease with dementia. The genotyping studies were performed on 719 participants of the Oxford Project to Investigate Memory and Ageing, 225 participants of a Parkinson's disease DNA bank, and 477 participants of the Human Random Control collection available from the European Collection of Cell Cultures. The post mortem studies were carried out on 190 participants. In the in-vitro study, human embryonic kidney cells were transfected with either the common or rare p21(cip1) variant; and cytometry was used to assess cell cycle kinetics, p21(cip1) protein expression and sub-cellular localisation. The variant was associated with an increased risk of Alzheimer's disease, and Parkinson's disease with dementia, relative to age matched controls. Furthermore, the variant was associated with an earlier age of onset of Alzheimer's disease, and a more severe phenotype, with a primary influence on the accumulation of tangle pathology. In the in-vitro study, we found that the SNPs reduced the cell cycle inhibitory and anti-apoptotic activity of p21(cip1). The results suggest that the cancer-associated variant of p21(cip1) may contribute to the loss of cell cycle control in neurons that may lead to Alzheimer-type neurodegeneration.	[Yates, Sharon C.; Zafar, Amen; Rabai, Erzsebet M.; Foxall, James B.; Nagy, Sheila; Morrison, Karen E.; Clarke, Carl; Nagy, Zsuzsanna] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Esiri, Margaret M.] Univ Oxford, John Radcliffe Hosp, Dept Neuropathol, Oxford OX3 9DU, England; [Christie, Sharon] Univ Oxford, John Radcliffe Hosp, OPTIMA, Oxford OX3 9DU, England; [Smith, A. David] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Birmingham; University of Oxford; University of Oxford; University of Oxford	Nagy, Z (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England.	z.nagy@bham.ac.uk	Smith, Anthony D./A-4233-2010; Nagy, Zsuzsanna/L-8446-2013	Smith, Anthony D./0000-0002-1095-6722; Nagy, Zsuzsanna/0000-0002-6700-4829; Morrison, Karen Elaine/0000-0003-0216-5717; Clarke, Carl/0000-0003-2478-3436; Yates, Sharon Christine/0000-0002-3001-8725	Sir Jules Thorn Charitable Trust; CytOx Ltd; University of Birmingham; Medical Research Council UK; Midlands Neuroscience Teaching and Research Fund; Movement Disorders Research Charity; National Institute for Health Research via Oxford Biomedical Research Centre; MRC [MR/L022656/1] Funding Source: UKRI; Medical Research Council [MR/L022656/1] Funding Source: researchfish	Sir Jules Thorn Charitable Trust; CytOx Ltd; University of Birmingham; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Midlands Neuroscience Teaching and Research Fund; Movement Disorders Research Charity; National Institute for Health Research via Oxford Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by grants from The Sir Jules Thorn Charitable Trust (http://www.julesthorntrust.org.uk/) (ZN), CytOx Ltd (http://www.cytoxgroup.com/) (ZN), and the University of Birmingham (ZN). Funding for the PDGEN DNA bank was from the Medical Research Council UK (http://www.mrc.ac.uk/) (KEM and CC), Midlands Neuroscience Teaching and Research Fund (https://sites.google.com/site/mntrfund/projects) (KEM and CC), and Movement Disorders Research Charity (KEM and CC). The completion of the project was enabled by the generous support of a private donor. Margaret M Esiri was in receipt of financial support from The National Institute for Health Research via the Oxford Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-44; Arendt T, 1996, NEUROREPORT, V7, P3047; Arendt T, 1998, J NEURAL TRANSM, V105, P949, DOI 10.1007/s007020050104; Arendt T, 2003, PROG NEUROBIOL, V71, P83, DOI 10.1016/j.pneurobio.2003.09.007; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Bahl R, 2000, ONCOGENE, V19, P323, DOI 10.1038/sj.onc.1203325; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bialopiotrowicz E, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.017; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; CHEDID M, 1994, ONCOGENE, V9, P3021; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chen WC, 2002, UROL ONCOL, V7, P63, DOI 10.1016/S1078-1439(01)00152-1; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; Crean S, 2011, DEMENT GERIATR COGN, V31, P20, DOI 10.1159/000321984; Currais A, 2009, AGING-US, V1, P363, DOI 10.18632/aging.100045; Darzynkierricz Z, 2001, CYTOMETRY METHODS CE; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Devlin AM, 2003, AM J PHYSIOL-RENAL, V284, pF753, DOI 10.1152/ajprenal.00252.2002; Elias-Sonnenschein LS, 2012, BIOMARK MED, V6, P477, DOI [10.2217/BMM.12.56, 10.2217/bmm.12.56]; Engidawork E, 2001, NEUROSCI LETT, V303, P79, DOI 10.1016/S0304-3940(01)01618-4; Esiri MM, 1997, J NEUROL NEUROSUR PS, V63, P749, DOI 10.1136/jnnp.63.6.749; Esiri MM, 2000, ANN NY ACAD SCI, V903, P239, DOI 10.1111/j.1749-6632.2000.tb06373.x; Esteras N, 2013, NEUROBIOL AGING, V34, P1090, DOI 10.1016/j.neurobiolaging.2012.10.014; Evdokiou A, 2000, J MOL ENDOCRINOL, V25, P195, DOI 10.1677/jme.0.0250195; Evdokiou A, 1999, MOL ENDOCRINOL, V13, P1738, DOI 10.1210/me.13.10.1738; Facher EA, 1997, CANCER, V79, P2424, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2424::AID-CNCR19>3.0.CO;2-T; Fiorelli T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057979; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Gravina S, 2009, AGING-US, V1, P470, DOI 10.18632/aging.100041; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Hiltunen M, 2001, NEUROLOGY, V57, P1663, DOI 10.1212/WNL.57.9.1663; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holmans P, 2005, AM J MED GENET B, V135B, P24, DOI 10.1002/ajmg.b.30114; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; HUPPERT FA, 1995, BRIT J CLIN PSYCHOL, V34, P529, DOI 10.1111/j.2044-8260.1995.tb01487.x; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jaluria P, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-71; Jellinger KA, 2008, ACTA NEUROPATHOL, V115, P427, DOI 10.1007/s00401-008-0347-5; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Katsel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068361; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2006, ARCH NEUROL-CHICAGO, V63, P1591, DOI 10.1001/archneur.63.11.1591; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Liu F, 2011, MUTAGENESIS, V26, P513, DOI 10.1093/mutage/ger010; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mirra S., 1991, NEUROLOGY, V4, P479; MOUSSES S, 1995, HUM MOL GENET, V4, P1089, DOI 10.1093/hmg/4.6.1089; Nagy Z, 1997, J NEUROPATH EXP NEUR, V56, P165, DOI 10.1097/00005072-199702000-00007; Nagy Z, 2005, J CELL MOL MED, V9, P531, DOI 10.1111/j.1582-4934.2005.tb00485.x; NAGY Z, 1995, NEUROSCIENCE, V69, P757, DOI 10.1016/0306-4522(95)00331-C; Nagy Z, 2007, BBA-MOL BASIS DIS, V1772, P402, DOI 10.1016/j.bbadis.2006.11.001; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Oh H, 2002, P NATL ACAD SCI USA, V99, P5430, DOI 10.1073/pnas.082123999; Ormerod MG, 2000, FLOW CYTOMETRY PRACT, P83; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Ressiniotis Thomas, 2005, BMC Ophthalmol, V5, P5, DOI 10.1186/1471-2415-5-5; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; Sjalander A, 1996, HUM HERED, V46, P221, DOI 10.1159/000154357; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Vechterova L, 2003, NEUROREPORT, V14, P87, DOI 10.1097/00001756-200301200-00017; Wider C, 2012, J NEUROL NEUROSUR PS, V83, P424, DOI 10.1136/jnnp-2011-301413; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Yoon MK, 2009, PROTEIN SCI, V18, P337, DOI 10.1002/pro.34	77	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0114050	10.1371/journal.pone.0114050	http://dx.doi.org/10.1371/journal.pone.0114050			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625488	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000348821400003
J	Mauro, L; Pellegrino, M; Giordano, F; Ricchio, E; Rizza, P; De Amicis, F; Catalano, S; Bonofiglio, D; Panno, ML; Ando, S				Mauro, Loredana; Pellegrino, Michele; Giordano, Francesca; Ricchio, Emilia; Rizza, Pietro; De Amicis, Francesca; Catalano, Stefania; Bonofiglio, Daniela; Panno, Maria Luisa; Ando, Sebastiano			Estrogen receptor-alpha drives adiponectin effects on cyclin D1 expression in breast cancer cells	FASEB JOURNAL			English	Article						AMPK; MAPK; xenografts; Sp1; corepressors	IN-VIVO; GENE-TRANSCRIPTION; SIGNALING PATHWAY; TUMOR-GROWTH; LEPTIN; SP1; ACTIVATION; PROMOTER; PROTEIN; RISK	Obesity is a risk factor for breast cancer, largely due to altered expression of various adipocytokines. As it concerns adiponectin, there are not univocal results regarding its role in breast cancer occurrence and progression. Here, we demonstrate that in animals injected with human estrogen receptor (ER)-alpha-negative MDA-MB-231 cells pretreated with adiponectin (1 and 5 mu g/ml), a significant reduction (60 and 40%, respectively) in tumor volume is observed, whereas an increased tumor growth (54 and 109%, respectively) is evidenced in the animals receiving human ER-positive MCF-7 cells. Moreover, cyclin D1 (CD1) mRNA and protein levels are decreased in MDA-MB-231 cells, whereas they are up-regulated in ER-alpha-positive cells by adiponectin. These findings fit with the opposite effects of adiponectin on CD1 promoter: 0.44- and 0.34-fold decrease in MDA-MB-231 cells and 0.63- and 0.95-fold increase in MCF-7 cells, treated with 1 and 5 mu g/ml, respectively. Functional studies indicate that these effects are mediated by the specific protein 1 motif located in the CD1 promoter. In the absence of ER-alpha, the adiponectin-mediated down-regulation of CD1 involves the recruitment of corepressors. In the presence of ER-alpha, the adiponectin-induced expression of CD1 requires the involvement of an activator complex. In conclusion, we propose that a possible mechanism through which adiponectin differently affects breast cancer growth is the opposite modulation of CD1 levels accordingly to ER-alpha expression.	[Mauro, Loredana; Pellegrino, Michele; Giordano, Francesca; Ricchio, Emilia; Rizza, Pietro; De Amicis, Francesca; Catalano, Stefania; Bonofiglio, Daniela; Panno, Maria Luisa; Ando, Sebastiano] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy; [De Amicis, Francesca; Catalano, Stefania; Bonofiglio, Daniela; Ando, Sebastiano] Univ Calabria, Ctr Sanitario, Arcavacata Di Rende, Italy	University of Calabria; University of Calabria	Mauro, L (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, Via P Buccicubo4C, I-87036 Arcavacata Di Rende, Italy.	doclollo@yahoo.com; sebastiano.ando@unical.it	Bonofiglio, Daniela/AAV-8371-2020	Pellegrino, Michele/0000-0002-4046-4243; De Amicis, Francesca/0000-0001-7079-1037; CATALANO, Stefania/0000-0002-6352-9628; BONOFIGLIO, Daniela/0000-0002-4142-0496; GIORDANO, Francesca/0000-0002-7621-1969; RIZZA, Pietro/0000-0002-1267-3910	Associazione Italiana Ricerca sul Cancro [AIRC] [6180, 11595]; Progetti di Ricerca di Interesse Nazionale-Ministero Istruzione Universita e Ricerca [20085Y7XT5]; European Commission/Fondo Sociale Europeo/Regione Calabria	Associazione Italiana Ricerca sul Cancro [AIRC](Fondazione AIRC per la ricerca sul cancro); Progetti di Ricerca di Interesse Nazionale-Ministero Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); European Commission/Fondo Sociale Europeo/Regione Calabria	The authors thank Dr. Pasquale Cicirelli for his technical assistance. This work was supported by the Associazione Italiana Ricerca sul Cancro [AIRC; My First AIRC Grant (MFAG) 6180 and Investigator Grant 11595], Progetti di Ricerca di Interesse Nazionale-Ministero Istruzione Universita e Ricerca (Grant 20085Y7XT5), and European Commission/Fondo Sociale Europeo/Regione Calabria (to E.R.).	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Benasciutti E, 2004, BLOOD, V104, P256, DOI 10.1182/blood-2003-08-2661; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Catalano S, 2003, J BIOL CHEM, V278, P28668, DOI 10.1074/jbc.M301695200; Catalano S, 2009, J CELL PHYSIOL, V218, P490, DOI 10.1002/jcp.21622; Catalano S, 2011, AM J PATHOL, V179, P1030, DOI 10.1016/j.ajpath.2011.04.026; Chen XP, 2011, MED ONCOL, V28, P1288, DOI 10.1007/s12032-010-9617-x; Dal Maso L, 2004, J CLIN ENDOCR METAB, V89, P1160, DOI 10.1210/jc.2003-031716; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; De Amicis F, 2009, MOL ENDOCRINOL, V23, P454, DOI 10.1210/me.2008-0267; De Siervi A, 2004, CANCER RES, V64, P743, DOI 10.1158/0008-5472.CAN-03-2505; Deepa SS, 2011, MOL ENDOCRINOL, V25, P1773, DOI 10.1210/me.2011-0082; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Dos Santos E, 2008, ONCOL REP, V20, P971, DOI 10.3892/or_00000098; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; GILLETT C, 1994, CANCER RES, V54, P1812; Goktas S, 2005, UROLOGY, V65, P1168, DOI 10.1016/j.urology.2004.12.053; Grossmann ME, 2008, BRIT J CANCER, V98, P370, DOI 10.1038/sj.bjc.6604166; Hwang SL, 2014, J ALLERGY CLIN IMMUN, V134, P714, DOI 10.1016/j.jaci.2014.05.001; Hwang SL, 2013, BRIT J PHARMACOL, V169, P69, DOI 10.1111/bph.12124; Ishikawa M, 2005, CLIN CANCER RES, V11, P466; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; Mauro L, 2007, CANCER RES, V67, P3412, DOI 10.1158/0008-5472.CAN-06-2890; Mauro L, 2014, CELL CYCLE, V13, P553, DOI 10.4161/cc.27455; Mauro L, 2010, BREAST CANCER RES TR, V121, P79, DOI 10.1007/s10549-009-0456-4; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Obeid Stephanie, 2012, Cancer Biology Medicine, V9, P213, DOI 10.7497/j.issn.2095-3941.2012.04.001; Patani N, 2013, INT J CANCER, V133, P1, DOI 10.1002/ijc.27997; PlanasSilva MD, 1997, MOL CELL BIOL, V17, P4059, DOI 10.1128/MCB.17.7.4059; Prall OWJ, 1998, J STEROID BIOCHEM, V65, P169, DOI 10.1016/S0960-0760(98)00021-1; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Walsh CA, 2012, INT J BIOL SCI, V8, P470, DOI 10.7150/ijbs.4125; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	45	47	50	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2150	2160		10.1096/fj.14-262808	http://dx.doi.org/10.1096/fj.14-262808			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25657113				2022-12-26	WOS:000354114600045
J	Gerganova, V; Maurer, S; Stoliar, L; Japaridze, A; Dietler, G; Nasser, W; Kutateladze, T; Travers, A; Muskhelishvili, G				Gerganova, Veneta; Maurer, Sebastian; Stoliar, Liubov; Japaridze, Aleksandre; Dietler, Giovanni; Nasser, William; Kutateladze, Tamara; Travers, Andrew; Muskhelishvili, Georgi			Upstream Binding of Idling RNA Polymerase Modulates Transcription Initiation from a Nearby Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-RECEPTOR PROTEIN; COLI-FIS PROMOTER; ESCHERICHIA-COLI; STRINGENT CONTROL; ALPHA-SUBUNIT; BIDIRECTIONAL PROMOTERS; DIVERGENT TRANSCRIPTION; BACTERIAL PROMOTERS; MULTIPLE PROMOTERS; DNA-BINDING	The bacterial gene regulatory regions often demonstrate distinctly organized arrays of RNA polymerase binding sites of illdefined function. Previously we observed a module of closely spaced polymerase binding sites upstream of the canonical promoter of the Escherichia coli fis operon. FIS is an abundant nucleoid- associated protein involved in adjusting the chromosomal DNA topology to changing cellular physiology. Here we show that simultaneous binding of the polymerase at the canonical fis promoter and an upstream transcriptionally inactive site stabilizes a RNAP oligomeric complex in vitro. Wefurther show that modulation of the upstream binding of RNA polymerase affects the fis promoter activity both in vivo and in vitro. The effect of the upstream RNA polymerase binding on the fis promoter activity depends on the spatial arrangement of polymerase binding sites and DNA supercoiling. Our data suggest that a specific DNA geometry of the nucleoprotein complex stabilized on concomitant binding of RNA polymerase molecules at the fis promoter and the upstream region acts as a topological device regulating the fis transcription. We propose that transcriptionally inactive RNA polymerase molecules can act as accessory factors regulating the transcription initiation from a nearby promoter.	Jacobs Univ Bremen, D-28759 Bremen, Germany; [Japaridze, Aleksandre; Dietler, Giovanni] Ecole Polytech Fed Lausanne, Lab Phys Living Matter, CH-1015 Lausanne, Switzerland; [Nasser, William] Univ Lyon, UCB, INSA, UMR5240,CNRS, F-69003 Villeurbanne, France; [Nasser, William] INSA Lyon, F-69621 Villeurbanne, France; [Kutateladze, Tamara] Ivane Beritashvili Ctr Expt Biomed, Tbilisi, Georgia; [Travers, Andrew] MRC, Mol Biol Lab, Cambridge CB2 QH, England; [Gerganova, Veneta; Maurer, Sebastian; Stoliar, Liubov; Muskhelishvili, Georgi] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany	Jacobs University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Jacobs University	Muskhelishvili, G (corresponding author), Jacobs Univ Bremen, Campus Ring 1, D-28759 Bremen, Germany.	g.muskhelishvili@jacobs-university.de	Japaridze, Aleksandre/AAK-5062-2020; NASSER, William/C-9611-2019; Maurer, Sebastian P/D-4727-2009	Japaridze, Aleksandre/0000-0002-9581-9128; NASSER, William/0000-0001-9848-3597; Maurer, Sebastian P/0000-0003-4532-1994; Gerganova, Veneta/0000-0002-1491-1249	Deutsche Forschungsgemeinschaft; Medical Research Council [MC_U105178783] Funding Source: researchfish; MRC [MC_U105178783] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (to G. M.).	Auner H, 2003, J MOL BIOL, V331, P331, DOI 10.1016/S0022-2836(03)00727-7; Bae JY, 2008, APPL BIOCHEM BIOTECH, V145, P69, DOI 10.1007/s12010-007-8076-0; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Blot N, 2006, EMBO REP, V7, P710, DOI 10.1038/sj.embor.7400729; Bordes P, 2003, MOL MICROBIOL, V48, P561, DOI 10.1046/j.1365-2958.2003.03461.x; Cameron ADS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084382; CHAMBERL.M, 1970, NATURE, V228, P227, DOI 10.1038/228227a0; Crozat E, 2010, MOL BIOL EVOL, V27, P2113, DOI 10.1093/molbev/msq099; El-Robh MS, 2002, BIOCHEM J, V368, P835, DOI 10.1042/BJ20021003; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Geertz M, 2011, MBIO, V2, DOI 10.1128/mBio.00034-11; Gonzalez-Gil G, 1998, EMBO J, V17, P2877, DOI 10.1093/emboj/17.10.2877; GonzalezGil G, 1996, MOL MICROBIOL, V22, P21, DOI 10.1111/j.1365-2958.1996.tb02652.x; GOODRICH JA, 1991, TRENDS BIOCHEM SCI, V16, P394, DOI 10.1016/0968-0004(91)90162-O; Govantes F, 2000, MOL MICROBIOL, V38, P1061, DOI 10.1046/j.1365-2958.2000.02215.x; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Guerin M, 1996, EMBO J, V15, P5397, DOI 10.1002/j.1460-2075.1996.tb00923.x; HANAMURA A, 1991, NUCLEIC ACIDS RES, V19, P4413, DOI 10.1093/nar/19.16.4413; Hu HY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-457; Huerta AM, 2006, PLOS GENET, V2, P1740, DOI 10.1371/journal.pgen.0020185; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Jauregui R, 2003, NUCLEIC ACIDS RES, V31, P6770, DOI 10.1093/nar/gkg882; Kansara SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018990; Kelly A, 2004, MICROBIOL-SGM, V150, P2037, DOI 10.1099/mic.0.27209-0; Kolmsee T, 2011, MICROBIOL-SGM, V157, P2871, DOI 10.1099/mic.0.052357-0; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; LEGRICE SFJ, 1982, J MOL BIOL, V162, P551, DOI 10.1016/0022-2836(82)90388-6; Lepoivre C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-914; LESLEY SA, 1990, J BACTERIOL, V172, P6871, DOI 10.1128/jb.172.12.6871-6874.1990; Li MJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-19; LIEBIG B, 1995, MOL GEN GENET, V249, P328, DOI 10.1007/BF00290534; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Mallik P, 2004, J BACTERIOL, V186, P122, DOI 10.1128/JB.186.1.122-135.2004; Marinello J, 2013, NUCLEIC ACIDS RES, V41, P10110, DOI 10.1093/nar/gkt778; Maurer S, 2006, EMBO J, V25, P3784, DOI 10.1038/sj.emboj.7601261; Mechold U, 2013, NUCLEIC ACIDS RES, V41, P6175, DOI 10.1093/nar/gkt302; MENENDEZ M, 1987, EMBO J, V6, P4227, DOI 10.1002/j.1460-2075.1987.tb02771.x; Meng WM, 2001, NUCLEIC ACIDS RES, V29, P4166, DOI 10.1093/nar/29.20.4166; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Murakami KS, 2013, J BIOL CHEM, V288, P9126, DOI 10.1074/jbc.M112.430900; Murley LL, 1998, CELL, V95, P553, DOI 10.1016/S0092-8674(00)81622-0; MUSKHELISHVILI G, 1995, EMBO J, V14, P1446, DOI 10.1002/j.1460-2075.1995.tb07131.x; Muskhelishvili G, 2010, BACTERIAL CHROMATIN, P323, DOI 10.1007/978-90-481-3473-1_14; Muskhelishvili G, 2010, MOL BIOSYST, V6, P662, DOI 10.1039/b909192k; Nafissi M, 2012, J BACTERIOL, V194, P2458, DOI 10.1128/JB.00053-12; Nakagawa H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001484; Nasser W, 2002, EMBO J, V21, P715, DOI 10.1093/emboj/21.4.715; Nasser W, 2001, J BIOL CHEM, V276, P17878, DOI 10.1074/jbc.M100632200; Naughton C, 2013, TRANSCR-AUSTIN, V4, P162, DOI 10.4161/trns.25554; Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2; NILSSON L, 1992, J BACTERIOL, V174, P921, DOI 10.1128/jb.174.3.921-929.1992; NILSSON L, 1992, FEMS MICROBIOL LETT, V99, P85; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; Opel ML, 2001, MOL MICROBIOL, V39, P191, DOI 10.1046/j.1365-2958.2001.02249.x; Ozoline ON, 1999, NUCLEIC ACIDS RES, V27, P4768, DOI 10.1093/nar/27.24.4768; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Pratt TS, 1997, J BACTERIOL, V179, P6367, DOI 10.1128/jb.179.20.6367-6377.1997; Qi HY, 1997, J MOL BIOL, V267, P481, DOI 10.1006/jmbi.1997.0901; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Rice PA, 2010, BIOCHEM SOC T, V38, P384, DOI 10.1042/BST0380384; RICHARDS.JP, 1966, P NATL ACAD SCI USA, V55, P1616, DOI 10.1073/pnas.55.6.1616; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; SAVOCHKINA L P, 1979, Molekulyarnaya Biologiya (Moscow), V13, P509; Schneider R, 1999, MOL MICROBIOL, V34, P953, DOI 10.1046/j.1365-2958.1999.01656.x; Schneider R, 2000, MOL MICROBIOL, V38, P167, DOI 10.1046/j.1365-2958.2000.02129.x; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; SHANER SL, 1982, BIOCHEMISTRY-US, V21, P5539, DOI 10.1021/bi00265a025; Shavkunov KS, 2009, NUCLEIC ACIDS RES, V37, P4919, DOI 10.1093/nar/gkp490; Strainic MG, 2000, J BACTERIOL, V182, P216, DOI 10.1128/JB.182.1.216-220.2000; Tichopad A, 2002, BIOTECHNOL LETT, V24, P2053, DOI 10.1023/A:1021319421153; Travers AA, 2012, PHILOS T R SOC A, V370, P2960, DOI 10.1098/rsta.2011.0231; TSEDINH YC, 1988, J MOL BIOL, V202, P735, DOI 10.1016/0022-2836(88)90554-2; Uesaka M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-35; Valle F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.158105; Wade JT, 2014, NAT REV MICROBIOL, V12, P647, DOI 10.1038/nrmicro3316; Walker KA, 2004, J BIOL CHEM, V279, P50818, DOI 10.1074/jbc.M406285200; Yamada M, 2003, J MOL MICROB BIOTECH, V6, P206, DOI 10.1159/000077251; Zhang XY, 1996, J MOL BIOL, V259, P27, DOI 10.1006/jmbi.1996.0299	84	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8095	8109		10.1074/jbc.M114.628131	http://dx.doi.org/10.1074/jbc.M114.628131			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25648898	Green Published, hybrid			2022-12-26	WOS:000351662600008
J	Guo, EZ; Xu, ZH				Guo, Emily Z.; Xu, Zhaohui			Distinct Mechanisms of Recognizing Endosomal Sorting Complex Required for Transport III (ESCRT-III) Protein IST1 by Different Microtubule Interacting and Trafficking (MIT) Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; MEMBRANE-TRAFFICKING; TROYER-SYNDROME; VPS4; RECOGNITION; SPARTIN; VTA1; CYTOKINESIS; SCISSION; SPASTIN	The endosomal sorting complex required for transport (ESCRT) machinery is responsible for membrane remodeling in a number of biological processes including multivesicular body biogenesis, cytokinesis, and enveloped virus budding. In mammalian cells, efficient abscission during cytokinesis requires proper function of the ESCRT-III protein IST1, which binds to the microtubule interacting and trafficking (MIT) domains of VPS4, LIP5, and Spartin via its C-terminal MIT-interacting motif (MIM). Here, we studied the molecular interactions between IST1 and the three MIT domain-containing proteins to understand the structural basis that governs pairwiseMIT-MIM interaction. Crystal structures of the three molecular complexes revealed that IST1 binds to the MIT domains of VPS4, LIP5, and Spartin using two different mechanisms (MIM1 mode versus MIM3 mode). Structural comparison revealed that structural features in both MIT andMIMcontribute to determine the specific binding mechanism. Within the IST1 MIM sequence, two phenylalanine residues were shown to be important in discriminating MIM1 versus MIM3 binding. These observations enabled us to deduce a preliminary binding code, which we applied to provide CHMP2A, a protein that normally only binds the MIT domain in the MIM1 mode, the additional ability to bind the MIT domain of Spartin in the MIM3 mode.	[Guo, Emily Z.; Xu, Zhaohui] Univ Michigan, Inst Life Sci, Sch Med, Ann Arbor, MI 48109 USA; [Xu, Zhaohui] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, ZH (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	zhaohui@umich.edu			United States DOE [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769] Funding Source: NIH RePORTER	United States DOE(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source Sector 21 (21-ID-F) for access and help with data collection. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817). We thank C. Vild and Y. Li for helpful discussion and K. Chinnaswamy and B. Wanfor access and help for ITC experiments.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Norgan AP, 2013, J BIOL CHEM, V288, P26147, DOI 10.1074/jbc.M113.494112; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937; Renvoise B, 2012, HUM MOL GENET, V21, P3604, DOI 10.1093/hmg/dds191; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Solomons J, 2011, STRUCTURE, V19, P1149, DOI 10.1016/j.str.2011.05.011; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Vild CJ, 2014, J BIOL CHEM, V289, P10378, DOI 10.1074/jbc.M113.532960; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	54	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8396	8408		10.1074/jbc.M114.607903	http://dx.doi.org/10.1074/jbc.M114.607903			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25657007	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000351662600033
J	Sato, T; Kinoshita, M; Yamamoto, TS; Ito, M; Nishida, T; Takeuchi, M; Saitoh, DZ; Seki, SH; Mukai, YS				Sato, Tomohito; Kinoshita, Manabu; Yamamoto, Tetsuo; Ito, Masataka; Nishida, Takafumi; Takeuchi, Masaru; Saitoh, Daizoh; Seki, Shuhji; Mukai, Yasuo			Treatment of Irradiated Mice with High-Dose Ascorbic Acid Reduced Lethality	PLOS ONE			English	Article							ACUTE OXALATE NEPHROPATHY; IONIZING-RADIATION; VITAMIN-C; CELLS; DEFICIENCY; HEMOLYSIS; RADICALS; INJURY; DAMAGE; TUMOR	Ascorbic acid is an effective antioxidant and free radical scavenger. Therefore, it is expected that ascorbic acid should act as a radioprotectant. We investigated the effects of post-radiation treatment with ascorbic acid on mouse survival. Mice received whole body irradiation (WBI) followed by intraperitoneal administration of ascorbic acid. Administration of 3 g/kg of ascorbic acid immediately after exposure significantly increased mouse survival after WBI at 7 to 8 Gy. However, administration of less than 3 g/kg of ascorbic acid was ineffective, and 4 or more g/kg was harmful to the mice. Post-exposure treatment with 3 g/kg of ascorbic acid reduced radiation-induced apoptosis in bone marrow cells and restored hematopoietic function. Treatment with ascorbic acid (3 g/kg) up to 24 h (1, 6, 12, or 24 h) after WBI at 7.5 Gy effectively improved mouse survival; however, treatments beyond 36 h were ineffective. Two treatments with ascorbic acid (1.5 g/kg x 2, immediately and 24 h after radiation, 3 g/kg in total) also improved mouse survival after WBI at 7.5 Gy, accompanied with suppression of radiation-induced free radical metabolites. In conclusion, administration of high-dose ascorbic acid might reduce radiation lethality in mice even after exposure.	[Sato, Tomohito; Yamamoto, Tetsuo; Nishida, Takafumi; Mukai, Yasuo] Mil Med Res Unit, Tokyo, Setagaya, Japan; [Kinoshita, Manabu; Seki, Shuhji] Natl Def Med Coll, Dept Immunol Microbiol, Tokorozawa, Saitama 359, Japan; [Ito, Masataka] Natl Def Med Coll, Dept Dev Anat & Regenerat Biol, Tokorozawa, Saitama 359, Japan; [Takeuchi, Masaru] Natl Def Med Coll, Dept Ophthalmol, Tokorozawa, Saitama, Japan; [Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan; National Defense Medical College - Japan	Kinoshita, M (corresponding author), Natl Def Med Coll, Dept Immunol Microbiol, Tokorozawa, Saitama 359, Japan.	manabu@ndmc.ac.jp			National Defense Medical College; Ministry of Defense	National Defense Medical College; Ministry of Defense	This work was supported by a grant-in-aid for Special Research Program (Host stress responses to internal and external factors) from the National Defense Medical College to M.K. and S.S. and a grant-in-aid for Promoted Research Program of Defense Medicine (Host defense against radiation) from the Ministry of Defense to M.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; Archambeau JO, 2013, REDOX BIOL, V1, P599, DOI 10.1016/j.redox.2013.10.002; Brown SL, 2010, RADIAT RES, V173, P462, DOI 10.1667/RR1716.1; Buonocore G, 2000, PEDIATR RES, V47, P221, DOI 10.1203/00006450-200002000-00012; CAMPBELL GD, 1975, ANN INTERN MED, V82, P810, DOI 10.7326/0003-4819-82-6-810_1; Cesarone MR, 1999, INT ANGIOL, V18, P127; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Cole A, 1965, CELLULAR RAD BIOL, P267; DiCarlo AL, 2011, DISASTER MED PUBLIC, V5, pS32, DOI 10.1001/dmp.2011.17; Dohi K, 2005, IN VIVO, V19, P855; FLOMENBERG N, 1992, BONE MARROW TRANSPL, V10, P115; Gridley DS, 2007, ANTICANCER RES, V27, P3101; Guelman LR, 2005, INT J DEV NEUROSCI, V23, P1, DOI 10.1016/j.ijdevneu.2004.10.001; Hensley ML, 1999, J CLIN ONCOL, V17, P3333, DOI 10.1200/JCO.1999.17.10.3333; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; Hogan DE, 2002, AM J MED SCI, V323, P341, DOI 10.1097/00000441-200206000-00006; Ito Y, 2013, INT J MOL SCI, V14, P19618, DOI 10.3390/ijms141019618; Jia D, 2010, RADIAT RES, V173, P579, DOI 10.1667/RR2030.1; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koenig KL, 2005, ANN EMERG MED, V45, P643, DOI 10.1016/j.annemergmed.2005.01.020; Koyama S, 1998, MUTAT RES-FUND MOL M, V421, P45, DOI 10.1016/S0027-5107(98)00153-5; LAWTON JM, 1985, ARCH INTERN MED, V145, P950, DOI 10.1001/archinte.145.5.950; MCALLISTER CJ, 1984, JAMA-J AM MED ASSOC, V252, P1684, DOI 10.1001/jama.1984.03350130016019; OKUNIEFF P, 1991, AM J CLIN NUTR, V54, pS1281; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; REES DC, 1993, BRIT MED J, V306, P841, DOI 10.1136/bmj.306.6881.841; ROOTS R, 1975, RADIAT RES, V64, P306, DOI 10.2307/3574267; Van der Meeren A, 2005, RADIAT RES, V163, P144, DOI 10.1667/RR3293; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weiss JF, 2003, TOXICOLOGY, V189, P1, DOI 10.1016/S0300-483X(03)00149-5; WONG K, 1994, AUST NZ J MED, V24, P410, DOI 10.1111/j.1445-5994.1994.tb01477.x; Yamamoto T, 2010, J RADIAT RES, V51, P145, DOI 10.1269/jrr.09078	32	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0117020	10.1371/journal.pone.0117020	http://dx.doi.org/10.1371/journal.pone.0117020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651298	gold, Green Published, Green Submitted			2022-12-26	WOS:000349250700009
J	Maiwulanjiang, M; Bi, CWC; Lee, PSC; Xin, G; Miernisha, A; Lau, KM; Xiong, A; Li, N; Dong, TTX; Aisa, HA; Tsim, KWK				Maiwulanjiang, Maitinuer; Bi, Cathy W. C.; Lee, Pinky S. C.; Xin, Guizhong; Miernisha, Abudureyimu; Lau, Kei M.; Xiong, Aizhen; Li, Ning; Dong, Tina T. X.; Aisa, Haji A.; Tsim, Karl W. K.			The Volatile Oil of Nardostachyos Radix et Rhizoma Induces Endothelial Nitric Oxide Synthase Activity in HUVEC Cells	PLOS ONE			English	Article							PHOSPHORYLATION; AKT; IDENTIFICATION; ACTIVATION; JATAMANSI; OXYGEN; ENOS	Nardostahyos Radix et Rhizoma (NRR; the root and rhizome of Nardostachys jatamansi DC.) is a widely used medicinal herb. Historically, NRR is being used for the treatment of cardiovascular and neurological diseases. To search for active ingredients of NRR, we investigated the vascular benefit of NRR volatile oil in (i) the vasodilation in rat aorta ring, and (ii) the release of nitric oxide (NO) and the phosphorylation of endothelial NO synthase (eNOS) in cultured human umbilical vein endothelial cells (HUVECs). By measuring the fluorescence signal in cultures, application of NRR volatile oil resulted in a rapid activation of NO release as well as the phosphorylation of eNOS: both inductions were markedly reduced by L-NAME. In parallel, the phosphorylation level of Akt kinase was markedly increased by the oil treatment, which was partially attenuated by PI3K/Akt inhibitor LY294002. This inhibitor also blocked the NRR-induced NO production and eNOS phosphorylation. In HUVECs, application of NRR volatile oil elevated the intracellular Ca2+ level, and BAPTA-AM, a Ca2+ chelator, reduced the Ca2+ surge: the blockage were also applied to NRR-induced eNOS phosphorylation and NO production. These findings suggested the volatile oil of NRR was the major ingredient in triggering the vascular dilatation, and which was mediated via the NO production.	[Maiwulanjiang, Maitinuer; Bi, Cathy W. C.; Lee, Pinky S. C.; Xin, Guizhong; Miernisha, Abudureyimu; Lau, Kei M.; Xiong, Aizhen; Li, Ning; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China; [Maiwulanjiang, Maitinuer; Bi, Cathy W. C.; Lee, Pinky S. C.; Xin, Guizhong; Miernisha, Abudureyimu; Lau, Kei M.; Xiong, Aizhen; Li, Ning; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Peoples R China; [Aisa, Haji A.] Chinese Acad Sci, Xinjiang Tech Inst Phys & Chem, Xinjiang Key Lab Plant Resources & Nat Prod Chem, Urumqi, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; Xinjiang Technical Institute of Physics & Chemistry, CAS	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China.	BOTSIM@UST.HK	Li, Ning/D-6576-2015		Hong Kong Research Grants Council Theme-based Research Scheme [T13-607/12R]; GRF [661110, 662911, 660411, 663012, 662713]; Hong Kong Jockey Club Charities Trust [TUYF12SC03]; Foundation of The Awareness of Nature [TAON12SC01]	Hong Kong Research Grants Council Theme-based Research Scheme(Hong Kong Research Grants Council); GRF; Hong Kong Jockey Club Charities Trust; Foundation of The Awareness of Nature	This research was supported by Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), GRF (661110, 662911, 660411, 663012, 662713), TUYF12SC03, The Hong Kong Jockey Club Charities Trust and Foundation of The Awareness of Nature (TAON12SC01) to Karl Tsim. M. Maiwulanjiang received a Kanya Lee Scholarship from Lee's Pharmaceutical C. Ltd. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airi S, 2000, CURR SCI INDIA, V79, P1467; Bi CWC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051670; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Choi Roy Chi-Yan, 2010, Chin Med, V5, P38, DOI 10.1186/1749-8546-5-38; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Guo AJY, 2011, J BIOL CHEM, V286, P27882, DOI 10.1074/jbc.M111.236281; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Kutala VK, 2007, ANTIOXID REDOX SIGN, V9, P1193, DOI 10.1089/ars.2007.1636; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Liang MJ, 2005, LIFE SCI, V78, P128, DOI 10.1016/j.lfs.2005.04.038; Lu J.N., 2003, J MED PHARM CHINESE, V9, P13; LUSCHER TF, 1991, EUR HEART J, V12, P2; Maiwulanjiang M, 2014, J ETHNOPHAR IN PRESS; Maiwulanjiang M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/687958; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Nautiyal B. P., 2003, Plant Genetic Resources Newsletter, P34; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Subashini R, 2006, J PHARM PHARMACOL, V58, P257, DOI 10.1211/jpp.58.2.0014; Tuerhong E, 2009, TRADITIONAL UYGHUR M, DOI [10. 1016/j.ijid.2014.12.037, DOI 10.1016/J.IJID.2014.12.037]; Vanhoutte PM, 1997, EUR HEART J, V18, pE19, DOI 10.1016/S0195-668X(97)90005-1; Yasen T, 1999, DRUG STANDARD TRADIT; Yusup A, 2011, ECAM, V2011; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634; Zhang Xu, 2007, Zhong Yao Cai, V30, P38	32	15	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116761	10.1371/journal.pone.0116761	http://dx.doi.org/10.1371/journal.pone.0116761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643147	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821200023
J	Zhu, H; Zhao, ZJ; Xia, S; Hu, ZY; Liu, GX				Zhu, Huan; Zhao, Zhijuan; Xia, Shuang; Hu, Zhengyu; Liu, Guoxiang			Morphological Examination and Phylogenetic Analyses of Phycopeltis spp. (Trentepohliales, Ulvophyceae) from Tropical China	PLOS ONE			English	Article							PRINTZINA TRENTEPOHLIALES; SEQUENCE ALIGNMENT; CHLOROPHYTA; DIVERSITY; INTERFACE; EVOLUTION; TAXONOMY; ECOLOGY; ALGAE	During an investigation of Trentepohliales (Ulvophyceae) from tropical areas in China, four species of the genus Phycopeltis were identified: Phycopeltis aurea, P. epiphyton, P. flabellata and P. prostrata. The morphological characteristics of both young and adult thalli were observed and compared. Three species (P. flabellata, P. aurea and P. epiphyton) shared a symmetrical development with dichotomously branching vegetative cells during early stages; conversely, P. prostrata had dishevelled filaments with no dichotomously branching filaments and no symmetrical development. The adult thalli of the former three species shared common morphological characteristics, such as equally dichotomous filaments, absence of erect hair and gametangia formed in prostate vegetative filaments. Phylogenetic analyses based on SSU and ITS rDNA sequences showed that the three morphologically similar species were in a clade that was sister to a clade containing T. umbrina and T. abietina, thus confirming morphological monophyly. Conversely, Phycopeltis prostrata, a species with erect filaments, sessile gametangia on the basal erect hair, larger length/width ratio of vegetative cells and very loosely coalescent prostrate filaments, branched separately from the core Phycopeltis group and the T. umbrina and T. abietina clade. Based on morphological and molecular evidence, the genus Phycopeltis was paraphyletic. Furthermore, the traditional taxonomic criteria for Phycopeltis must be reassessed based on phylogeny using more species. A new circumscription of the Phycopeltis and the erection of new genera are recommended.	[Zhu, Huan; Zhao, Zhijuan; Xia, Shuang; Hu, Zhengyu; Liu, Guoxiang] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China; [Zhu, Huan; Zhao, Zhijuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xia, Shuang] South Cent Univ Nationalities, Coll Life Sci, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; South Central Minzu University	Liu, GX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China.	liugx@ihb.ac.cn	Liu, Guoxiang/L-7413-2019	Liu, Guoxiang/0000-0001-8565-2363				Allali HA, 2013, NOVA HEDWIGIA, V96, P309, DOI 10.1127/0029-5035/2013/0096; Boedeker C, 2013, PHYCOL RES, V61, P133, DOI 10.1111/pre.12011; CHAPMAN RL, 1984, SYSTEMATICS OF THE G; CHAPMAN RL, 1983, ALGAL SYMBIOSIS A CO; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; FRITZ L, 1985, J PHYCOL, V21, P662, DOI 10.1111/j.0022-3646.1985.00662.x; GOOD BH, 1978, J PHYCOL, V14, P374, DOI 10.1111/j.1529-8817.1978.tb00317.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hametner C, 2014, SYMBIOSIS, V63, P31, DOI 10.1007/s13199-014-0285-z; Hametner C, 2014, PHYCOL RES, V62, P170, DOI 10.1111/pre.12055; Hayakawa YI, 2012, PHYCOL RES, V60, P86, DOI 10.1111/j.1440-1835.2012.00641.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Liu GX, 2008, NOVA HEDWIGIA, V87, P487, DOI 10.1127/0029-5035/2008/0087-0487; Lopez-Bautista JM, 2003, INT J SYST EVOL MICR, V53, P1715, DOI 10.1099/ijs.0.02561-0; Lopez-Bautista JM, 2006, INT J SYST EVOL MICR, V56, P1709, DOI 10.1099/ijs.0.63990-0; LuEpez-Bautista J.M., 2002, CONSTANCEA, V83; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Nelsen MP, 2011, J PHYCOL, V47, P282, DOI 10.1111/j.1529-8817.2011.00962.x; Neustupa J, 2005, CRYPTOGAMIE ALGOL, V26, P229; Neustupa J, 2003, NOVA HEDWIGIA, V76, P487, DOI 10.1127/0029-5035/2003/0076-0487; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRINTZ HENRIK, 1939, NYTT MAG NATURVIDENSK, V80, P137; Raven J.A., 1987, Prog Phycol Res, V5, P1; Rindi F, 2005, PHYCOLOGIA, V44, P270, DOI 10.2216/0031-8884(2005)44[270:TADOTA]2.0.CO;2; Rindi F, 2004, CRYPTOGAMIE ALGOL, V25, P3; Rindi F, 2003, CRYPTOGAMIE ALGOL, V24, P133; Rindi F, 2002, J PHYCOL, V38, P39, DOI 10.1046/j.1529-8817.2002.01193.x; Rindi F, 2002, PHYCOLOGIA, V41, P421, DOI 10.2216/i0031-8884-41-4-421.1; Rindi F, 2008, NOVA HEDWIGIA, V87, P421, DOI 10.1127/0029-5035/2008/0087-0421; Rindi F, 2008, CRYPTOGAMIE ALGOL, V29, P13; Rindi F, 2006, NOVA HEDWIGIA, V83, P431, DOI 10.1127/0029-5035/2006/0083-0431; Rindi F, 2009, MOL PHYLOGENET EVOL, V52, P329, DOI 10.1016/j.ympev.2009.01.009; Sarma P., 1986, NOVA HEDWIGIA, V58, P1; SCHMIDLE W, 1897, BER DEUT BOT GES, V15, P456; SCHMIDLE W, 1897, HEDWIGIA, V36, P277; SLUIMAN H J, 1989, Cryptogamic Botany, V1, P83; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suutari M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-86; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON RH, 1992, J PHYCOL, V28, P232, DOI 10.1111/j.0022-3646.1992.00232.x; THOMPSON RH, 1997, MORPHOLOGY TAXONOMY; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WILDEMAN DE, 1896, NOTRISIA, V11, P84	45	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0114936	10.1371/journal.pone.0114936	http://dx.doi.org/10.1371/journal.pone.0114936			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643363	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821200005
J	Cenedese, V; Mezzavilla, M; Morgan, A; Marino, R; Ettorre, CP; Margaglione, M; Gasparini, P; Menini, A				Cenedese, Valentina; Mezzavilla, Massimo; Morgan, Anna; Marino, Renato; Ettorre, Cosimo Pietro; Margaglione, Maurizio; Gasparini, Paolo; Menini, Anna			Assessment of the Olfactory Function in Italian Patients with Type 3 von Willebrand Disease Caused by a Homozygous 253 Kb Deletion Involving VWF and TMEM16B/ANO2	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; SMELL IDENTIFICATION TEST; VONWILLEBRAND-FACTOR; TMEM16A; PROTEIN; CURRENTS; GERMAN; SITES; GENE	Type 3 Von Willebrand disease is an autosomal recessive disease caused by the virtual absence of the von Willebrand factor (VWF). A rare 253 kb gene deletion on chromosome 12, identified only in Italian and German families, involves both the VWF gene and the N-terminus of the neighbouring TMEM16B/ANO2 gene, a member of the family named transmembrane 16 (TMEM16) or anoctamin (ANO). TMEM16B is a calcium-activated chloride channel expressed in the olfactory epithelium. As a patient homozygous for the 253 kb deletion has been reported to have an olfactory impairment possibly related to the partial deletion of TMEM16B, we assessed the olfactory function in other patients using the University of Pennsylvania Smell Identification Test (UPSIT). The average UPSIT score of 4 homozygous patients was significantly lower than that of 5 healthy subjects with similar sex, age and education. However, 4 other members of the same family, 3 heterozygous for the deletion and 1 wild type, had a slightly reduced olfactory function indicating that socio-cultural or other factors were likely to be responsible for the observed difference. These results show that the ability to identify odorants of the homozygous patients for the deletion was not significantly different from that of the other members of the family, showing that the 253 kb deletion does not affect the olfactory performance. As other genes may compensate for the lack of TMEM16B, we identified some predicted functional partners from in silico studies of the protein-protein network of TMEM16B. Calculation of diversity for the corresponding genes for individuals of the 1000 Genomes Project showed that TMEM16B has the highest level of diversity among all genes of the network, indicating that TMEM16B may not be under purifying selection and suggesting that other genes in the network could compensate for its function for olfactory ability.	[Cenedese, Valentina; Menini, Anna] SISSA, Int Sch Adv Studies, Neurobiol Grp, I-34014 Trieste, Italy; [Mezzavilla, Massimo; Morgan, Anna; Gasparini, Paolo] Univ Trieste, Ist Ricovero & Cura Carattere Sci Burlo Garofo, Inst Maternal & Child Hlth, Trieste, Italy; [Mezzavilla, Massimo; Morgan, Anna; Gasparini, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Marino, Renato; Ettorre, Cosimo Pietro] Azienda Osped Univ Osped Policlin Consorziale Gio, Ctr Emofilia & Trombosi, Bari, Italy; [Margaglione, Maurizio] Univ Foggia, Dipartimento Med Clin & Sperimentale, Genet Med, Foggia, Italy	International School for Advanced Studies (SISSA); University of Trieste; University of Trieste; University of Foggia	Menini, A (corresponding author), SISSA, Int Sch Adv Studies, Neurobiol Grp, I-34014 Trieste, Italy.	menini@sissa.it	Gasparini, Paolo/B-6173-2014; Morgan, Anna/K-2238-2018; Mezzavilla, Massimo/AAL-8225-2020; Mezzavilla, Massimo/J-2948-2018	Morgan, Anna/0000-0001-6290-445X; Mezzavilla, Massimo/0000-0002-9000-4595; Mezzavilla, Massimo/0000-0002-9000-4595; Menini, Anna/0000-0001-9304-0412; MARGAGLIONE, MAURIZIO/0000-0001-5627-9221; Gasparini, Paolo/0000-0002-0859-0856	PRIN grant from the Italian Ministry of Education, University and Research (MIUR) [2010599KBR]	PRIN grant from the Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work is supported by PRIN 2010599KBR grant from the Italian Ministry of Education, University and Research (MIUR)to A. Menini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; BLOOM AL, 1991, MAYO CLIN PROC, V66, P743, DOI 10.1016/S0025-6196(12)62088-6; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castaman G, 2013, CURR OPIN HEMATOL, V20, P424, DOI 10.1097/MOH.0b013e328363c11f; Cenedese V, 2012, J GEN PHYSIOL, V139, P285, DOI 10.1085/jgp.201110764; Cumming AM, 2010, J COAG DIS, V2, P29; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Eikenboom JCJ, 1998, THROMB HAEMOSTASIS, V79, P709; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gonzalez-Silva C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069295; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Klimmeck D, 2009, J COMP NEUROL, V515, P585, DOI 10.1002/cne.22075; MANNUCCI PM, 1984, BRIT J HAEMATOL, V57, P163, DOI 10.1111/j.1365-2141.1984.tb02876.x; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Nei M., 1987, MOLECULAR EVOLUTIONA; NGO KY, 1988, P NATL ACAD SCI USA, V85, P2753, DOI 10.1073/pnas.85.8.2753; Nickell MD, 2012, J COMP NEUROL, V520, P2608, DOI 10.1002/cne.23052; Parola S, 1999, ITAL J NEUROL SCI, V20, P287, DOI 10.1007/s100720050043; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Picillo M, 2014, NEUROL SCI, V35, P379, DOI 10.1007/s10072-013-1522-6; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pifferi S, 2012, EXP PHYSIOL, V97, P193, DOI 10.1113/expphysiol.2011.058230; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Piirsoo M, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-10; Rasche S, 2010, CHEM SENSES, V35, P239, DOI 10.1093/chemse/bjq007; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sagheddu C, 2010, J PHYSIOL-LONDON, V588, P4189, DOI 10.1113/jphysiol.2010.194407; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; Schneppenheim R, 2007, J THROMB HAEMOST, V5, P722, DOI 10.1111/j.1538-7836.2007.02460.x; SCHNEPPENHEIM R, 1994, HUM GENET, V94, P640; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; SHELTONINLOES BB, 1987, J CLIN INVEST, V79, P1459, DOI 10.1172/JCI112974; Sondo E, 2014, BBA-BIOMEMBRANES, V1838, P89, DOI 10.1016/j.bbamem.2013.08.010; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu TT, 2005, J COMP NEUROL, V483, P251, DOI 10.1002/cne.20429	41	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116483	10.1371/journal.pone.0116483	http://dx.doi.org/10.1371/journal.pone.0116483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635880	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700040
J	Petrantonakis, PC; Poirazi, P				Petrantonakis, Panagiotis C.; Poirazi, Panayiota			Dentate Gyrus Circuitry Features Improve Performance of Sparse Approximation Algorithms	PLOS ONE			English	Article							PATTERN SEPARATION; COMPUTATIONAL THEORY; PLACE CELLS; HIPPOCAMPUS; CA3; INTERNEURONS; OSCILLATIONS; INHIBITION; PLASTICITY; FREQUENCY	Memory-related activity in the Dentate Gyrus (DG) is characterized by sparsity. Memory representations are seen as activated neuronal populations of granule cells, the main encoding cells in DG, which are estimated to engage 2-4% of the total population. This sparsity is assumed to enhance the ability of DG to perform pattern separation, one of the most valuable contributions of DG during memory formation. In this work, we investigate how features of the DG such as its excitatory and inhibitory connectivity diagram can be used to develop theoretical algorithms performing Sparse Approximation, a widely used strategy in the Signal Processing field. Sparse approximation stands for the algorithmic identification of few components from a dictionary that approximate a certain signal. The ability of DG to achieve pattern separation by sparsifing its representations is exploited here to improve the performance of the state of the art sparse approximation algorithm "Iterative Soft Thresholding" (IST) by adding new algorithmic features inspired by the DG circuitry. Lateral inhibition of granule cells, either direct or indirect, via mossy cells, is shown to enhance the performance of the IST. Apart from revealing the potential of DG-inspired theoretical algorithms, this work presents new insights regarding the function of particular cell types in the pattern separation task of the DG.	[Petrantonakis, Panagiotis C.; Poirazi, Panayiota] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH)	Poirazi, P (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.	poirazi@imbb.forth.gr	Petrantonakis, Panagiotis/L-2286-2018	Poirazi, Panayiota/0000-0001-6152-595X	European Research Council Starting Grant dEMORY [ERC-2012-StG-311435]	European Research Council Starting Grant dEMORY	Support was provided by the European Research Council Starting Grant dEMORY (ERC-2012-StG-311435) [URL: http://erc.europa.eu/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsady L, 2007, PROG BRAIN RES, V163, P577, DOI 10.1016/S0079-6123(07)63031-3; Akam T, 2012, NAT NEUROSCI, V15, P763, DOI 10.1038/nn.3081; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Daubechies I, 2004, COMMUN PUR APPL MATH, V57, P1413, DOI 10.1002/cpa.20042; de Almeida L, 2009, J NEUROSCI, V29, P7497, DOI 10.1523/JNEUROSCI.6044-08.2009; Donoho DL, 2009, P NATL ACAD SCI USA, V106, P18914, DOI 10.1073/pnas.0909892106; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Figueiredo MAT, 2007, IEEE T IMAGE PROCESS, V16, P2980, DOI 10.1109/TIP.2007.909318; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Jinde S, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00014; Jinde S, 2012, NEURON, V76, P1189, DOI 10.1016/j.neuron.2012.10.036; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lisman JE, 2005, NEURAL NETWORKS, V18, P1191, DOI 10.1016/j.neunet.2005.08.008; Maleki A, 2010, IEEE J-STSP, V4, P330, DOI 10.1109/JSTSP.2009.2039176; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Myers CE, 2011, HIPPOCAMPUS, V21, P1190, DOI 10.1002/hipo.20828; Myers CE, 2009, HIPPOCAMPUS, V19, P321, DOI 10.1002/hipo.20516; Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Petrantonakis P, 2014, COMPRESSED SENSING P; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Rolls ET, 2010, BEHAV BRAIN RES, V215, P180, DOI 10.1016/j.bbr.2010.03.027; Ross ST, 2001, P NATL ACAD SCI USA, V98, P8874, DOI 10.1073/pnas.141042398; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Sardy S, 2000, J COMPUT GRAPH STAT, V9, P361, DOI 10.2307/1390659; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209	36	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117023	10.1371/journal.pone.0117023	http://dx.doi.org/10.1371/journal.pone.0117023			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635776	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700068
J	Rajaram, N; Reesor, AF; Mulvey, CS; Frees, AE; Ramanujam, N				Rajaram, Narasimhan; Reesor, Andrew F.; Mulvey, Christine S.; Frees, Amy E.; Ramanujam, Nirmala			Non-Invasive, Simultaneous Quantification of Vascular Oxygenation and Glucose Uptake in Tissue	PLOS ONE			English	Article							TUMOR OXYGENATION; AEROBIC GLYCOLYSIS; PYRUVATE-KINASE; METABOLIC MICROMILIEU; OPTICAL SPECTROSCOPY; BLOOD-FLOW; CANCER; HYPOXIA; METASTASES; M2	We report the development of non-invasive, fiber-based diffuse optical spectroscopy for simultaneously quantifying vascular oxygenation (SO2) and glucose uptake in solid tumors in vivo. Glucose uptake was measured using a fluorescent glucose analog, 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-deoxyglucose (2-NBDG). Quantification of label-free SO2 and 2-NBDG-fluorescence-based glucose uptake 60 minutes after administration of the tracer (2-NBDG(60)) was performed using computational models of light-tissue interaction. This study was carried out on normal tissue and 4T1 and 4T07 murine mammary tumor xenografts in vivo. Injection of 2-NBDG did not cause a significant change in optical measurements of SO2, demonstrating its suitability as a functional reporter of tumor glucose uptake. Correction of measured 2-NBDG-fluorescence for the effects of absorption and scattering significantly improved contrast between tumor and normal tissue. The 4T1 and 4T07 tumors showed significantly decreased SO2, and 4T1 tumors demonstrated increased 2-NBDG(60) compared with normal tissue (60 minutes after the administration of 2-NBDG when perfusion-mediated effects have cleared). 2-NBDG-fluorescence was found to be highly sensitive to food deprivation-induced reduction in blood glucose levels, demonstrating that this endpoint is indeed sensitive to glycolytic demand. 2-NBDG(60) was also found to be linearly related to dose, underscoring the importance of calibrating for dose when comparing across animals or experiments. 4T1 tumors demonstrated an inverse relationship between 2-NBDG(60) and SO2 that was consistent with the Pasteur effect, particularly when exposed to hypoxic gas breathing. Our results illustrate the potential of optical spectroscopy to provide valuable information about the metabolic status of tumors, with important implications for cancer prognosis.	[Rajaram, Narasimhan; Reesor, Andrew F.; Mulvey, Christine S.; Frees, Amy E.; Ramanujam, Nirmala] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Rajaram, N (corresponding author), Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA.	nrajaram@uark.edu	Rajaram, Narasimhan/A-2249-2010; Ramanujam, Nimmi/AAA-7575-2021	Rajaram, Narasimhan/0000-0003-1224-8567; Ramanujam, Nimmi/0000-0001-7319-8415; Martinez, Amy/0000-0002-8088-7398	Department of Defense Era of Hope Scholar Award [W81XWH-091-0410]	Department of Defense Era of Hope Scholar Award(United States Department of Defense)	Funding was provided by a Department of Defense Era of Hope Scholar Award (W81XWH-091-0410; PI: Nirmala Ramanujam). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Bender JE, 2009, IEEE T BIO-MED ENG, V56, P960, DOI 10.1109/TBME.2008.2005994; Brizel DM, 1996, CANCER RES, V56, P941; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Brown JQ, 2009, CANCER RES, V69, P2919, DOI 10.1158/0008-5472.CAN-08-3370; Busk M, 2008, INT J CANCER, V122, P2726, DOI 10.1002/ijc.23449; Bydlon TM, 2010, OPT EXPRESS, V18, P8058, DOI 10.1364/OE.18.008058; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DeBerardinis RJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-5; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Frees AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115529; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heppner GH, 2000, BREAST CANCER RES, V2, P331; KALLINOWSKI F, 1988, CANCER RES, V48, P7264; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; Kasischke KA, 2011, J CEREBR BLOOD F MET, V31, P68, DOI 10.1038/jcbfm.2010.158; KHANDELWAL SR, 1993, AM J PHYSIOL, V265, pH1450, DOI 10.1152/ajpheart.1993.265.4.H1450; Khodarev NN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005821; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lim LA, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3525288; Liu CB, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077012; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091; Marcinek DJ, 2003, AM J PHYSIOL-HEART C, V285, pH1900, DOI 10.1152/ajpheart.00192.2003; Matsumoto S, 2008, J CLIN INVEST, V118, P1965, DOI 10.1172/JCI34928; Matsumoto S, 2013, MAGN RESON MED, V69, P1443, DOI 10.1002/mrm.24355; Miller S, 2010, BOOK MIDWIVES CARE P, V2nd, P1; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Palmer GM, 2006, APPL OPTICS, V45, P1062, DOI 10.1364/AO.45.001062; Palmer GM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523363; Palmer GM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907161; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pitroda SP, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-68; Rajaram N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076524; Rajaram N, 2010, LASER SURG MED, V42, P716, DOI 10.1002/lsm.21009; Rajendran JG, 2005, RADIOL CLIN N AM, V43, P169, DOI 10.1016/j.rcl.2004.08.004; Robey IF, 2008, NEOPLASIA, V10, P745, DOI 10.1593/neo.07724; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Snyder SA, 2001, INT J RADIAT ONCOL, V51, P494, DOI 10.1016/S0360-3016(01)01654-6; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; Vishwanath K, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251013; Vishwanath K, 2009, NEOPLASIA, V11, P889, DOI 10.1593/neo.09580; Young CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023205; Yu B, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3524303; Zasadny KR, 2003, EUR J NUCL MED MOL I, V30, P274, DOI 10.1007/s00259-002-1022-z; Zhang GQ, 2009, NAT MATER, V8, P747, DOI [10.1038/NMAT2509, 10.1038/nmat2509]	50	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117132	10.1371/journal.pone.0117132	http://dx.doi.org/10.1371/journal.pone.0117132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635865	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700071
J	Yan, RT; He, L; Zhan, WJ; Wang, SZ				Yan, Run-Tao; He, Li; Zhan, Wenjie; Wang, Shu-Zhen			Induction of Ectopic Retina-Like Tissue by Transgenic Expression of neurogenin	PLOS ONE			English	Article							CILIARY EPITHELIAL-CELLS; PHOTORECEPTOR-LIKE CELLS; ADULT MAMMALIAN EYE; PIGMENT-EPITHELIUM; IN-VIVO; NEURAL RETINA; STEM-CELLS; MACULAR DEGENERATION; RPE CELLS; MOUSE	Degeneration of retinal neurons is an underlying cause of several major types of blinding diseases, and effective therapies remain to be developed. The suppositive strategy of re-populating a degenerative retina with new cells generated onsite faces serious challenges, because the mammalian retina seems to lack the ability to regenerate itself or replace its lost neurons. We investigated the possibility of using a transcriptional factor with proneural activities to reprogram ocular tissue with regenerative capability to give rise to retinal cells. Transgenic mice were generated with DNA constructs that targeted the expression in the retinal pigment epithelium of proneural gene neurogenin1 from the promoter of Bestrophin1, or neurogenin3 from RPE65 promoter. Here we report the presence of ectopic retina-like tissue in some of the transgenic mice, young and aged. The ectopic retina-like tissue contained cells positive for photoreceptor proteins Crx, recoverin, red opsin, and rhodopsin, and cells positive for proteins that label other types of retinal neurons, including AP2 alpha and Pax6 for amacrine cells, Otx2 for bipolar cells, and Brn3A for ganglion cells. The retina-like tissue often co-existed with darkly pigmented tissue positive for RPE proteins: cytokeratin 18, Otx2, and RPE65. The ectopic retina-like tissue was detected in the subretinal space, including two retinae co-existing in the same eye, and/or in the optic nerve or in the vicinity of the optic nerve head. On rare occasions, it was detected in the choroid and in the vicinity of the ciliary body. The presence of ectopic retina-like tissue in the transgenic mouse supports the possibility of inducing retinal regeneration in the mammalian eyes through gene-directed reprograming.	[Yan, Run-Tao; He, Li; Zhan, Wenjie; Wang, Shu-Zhen] Univ Alabama Birmingham, Dept Ophthalmol, Med Sch Birmingham, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Wang, SZ (corresponding author), Univ Alabama Birmingham, Dept Ophthalmol, Med Sch Birmingham, Birmingham, AL 35294 USA.	szwang@uab.edu	He, Li/I-6060-2015		NIH/NEI grant [EY011640]; International Retinal Research Foundation grant [FY2011-12-276]; Research to Prevent Blindness; NIH/NEI core grant [P30 EY003039]; NATIONAL EYE INSTITUTE [R01EY011640, P30EY003039] Funding Source: NIH RePORTER	NIH/NEI grant; International Retinal Research Foundation grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH/NEI core grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by NIH/NEI grant EY011640, the International Retinal Research Foundation grant FY2011-12-276, Research to Prevent Blindness (non-restricted award to the University of Alabama Department of Ophthalmology), and NIH/NEI core grant P30 EY003039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; Al-Hussaini H, 2008, MOL VIS, V14, P1784; ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Bakall B, 2003, INVEST OPHTH VIS SCI, V44, P3622, DOI 10.1167/iovs.03-0030; Bassett EA, 2010, HUM MOL GENET, V19, P1791, DOI 10.1093/hmg/ddq060; Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450; Bernier G, 2000, MECH DEVELOP, V93, P59, DOI 10.1016/S0925-4773(00)00271-9; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Bumsted KM, 2000, INVEST OPHTH VIS SCI, V41, P903; Chow RL, 1999, DEVELOPMENT, V126, P4213; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; COULOMBRE JL, 1965, DEV BIOL, V12, P79, DOI 10.1016/0012-1606(65)90022-9; Crisanti S, 1995, INVEST OPHTH VIS SCI, V36, P391; DELPRIORE LV, 1995, ARCH OPHTHALMOL-CHIC, V113, P939, DOI 10.1001/archopht.1995.01100070113034; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Gualdoni S, 2010, STEM CELLS, V28, P1048, DOI 10.1002/stem.423; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Kiilgaard JF, 2007, INVEST OPHTH VIS SCI, V48, P355, DOI 10.1167/iovs.05-1565; Kubota R, 2002, DEV BRAIN RES, V134, P31, DOI 10.1016/S0165-3806(01)00287-5; la Cour M, 2008, ACTA OPHTHALMOL, V86, P593, DOI 10.1111/j.1755-3768.2008.01373.x; Lagutin O, 2001, DEV DYNAM, V221, P342, DOI 10.1002/dvdy.1148; Lauqa H, 1975, AM J OPHTHALMOL, V80, P913; Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649; LOPEZ PF, 1995, ARCH OPHTHALMOL-CHIC, V113, P1437, DOI 10.1001/archopht.1995.01100110097032; Ma WX, 2009, MOL CELL NEUROSCI, V40, P187, DOI 10.1016/j.mcn.2008.10.006; MACHEMER R, 1975, AM J OPHTHALMOL, V80, P1; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Ohta K, 2008, DEV GROWTH DIFFER, V50, P253, DOI [10.1111/j.1440-169x.2008.01006.x, 10.1111/j.1440-169X.2008.01006.x]; Ozaki S, 1997, CURR EYE RES, V16, P349, DOI 10.1076/ceyr.16.4.349.10696; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; Rabenlehner D, 2008, GRAEF ARCH CLIN EXP, V246, P345, DOI 10.1007/s00417-007-0658-6; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Sakami S, 2008, MECH DEVELOP, V125, P106, DOI 10.1016/j.mod.2007.10.001; Salero E, 2012, CELL STEM CELL, V10, P88, DOI 10.1016/j.stem.2011.11.018; Sugino IK, 2003, MOL NEUROBIOL, V28, P177, DOI 10.1385/MN:28:2:177; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Vergara MN, 2009, MOL VIS, V15, P1000; Yan RT, 2013, INVEST OPHTH VIS SCI, V54, P4766, DOI 10.1167/iovs.13-11936; Yan RT, 2013, MOL VIS, V19, P1178; Yan RT, 2010, J COMP NEUROL, V518, P526, DOI 10.1002/cne.22236; Yan RT, 2009, INVEST OPHTH VIS SCI, V50, P5567, DOI 10.1167/iovs.09-3647; ZHANG NL, 1993, INVEST OPHTH VIS SCI, V34, P2412; ZHAO SL, 1995, BRAIN RES, V677, P300, DOI 10.1016/0006-8993(95)00163-K; Zhu ML, 2010, ADV EXP MED BIOL, V664, P211, DOI 10.1007/978-1-4419-1399-9_24	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116171	10.1371/journal.pone.0116171	http://dx.doi.org/10.1371/journal.pone.0116171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635399	gold, Green Submitted, Green Published			2022-12-26	WOS:000350680700026
J	Fjellstrom, O; Akkaya, S; Beisel, HG; Eriksson, PO; Erixon, K; Gustafsson, D; Jurva, U; Kang, D; Karis, D; Knecht, W; Nerme, V; Nilsson, I; Olsson, T; Redzic, A; Roth, R; Sandmark, J; Tigerstrom, A; Oster, L				Fjellstrom, Ola; Akkaya, Sibel; Beisel, Hans-Georg; Eriksson, Per-Olof; Erixon, Karl; Gustafsson, David; Jurva, Ulrik; Kang, Daiwu; Karis, David; Knecht, Wolfgang; Nerme, Viveca; Nilsson, Ingemar; Olsson, Thomas; Redzic, Alma; Roth, Robert; Sandmark, Jenny; Tigerstrom, Anna; Oster, Linda			Creating Novel Activated Factor XI Inhibitors through Fragment Based Lead Generation and Structure Aided Drug Design	PLOS ONE			English	Article							COAGULATION-FACTOR XI; PROTEIN-LIGAND COMPLEXES; RAY CRYSTALLOGRAPHY; CRYSTAL-STRUCTURES; BIOLOGICAL EVALUATION; THROMBUS PROPAGATION; PROVIDES PROTECTION; ACCURATE DOCKING; CHEMICAL BIOLOGY; ISCHEMIC-STROKE	Activated factor XI (FXIa) inhibitors are anticipated to combine anticoagulant and profibrinolytic effects with a low bleeding risk. This motivated a structure aided fragment based lead generation campaign to create novel FXIa inhibitor leads. A virtual screen, based on docking experiments, was performed to generate a FXIa targeted fragment library for an NMR screen that resulted in the identification of fragments binding in the FXIa S1 binding pocket. The neutral 6-chloro-3,4-dihydro-1H-quinolin-2-one and the weakly basic quinolin-2-amine structures are novel FXIa P1 fragments. The expansion of these fragments towards the FXIa prime side binding sites was aided by solving the X-ray structures of reported FXIa inhibitors that we found to bind in the S1-S1'-S2' FXIa binding pockets. Combining the X-ray structure information from the identified S1 binding 6-chloro-3,4-dihydro-1H-quinolin-2-one fragment and the S1-S1'-S2' binding reference compounds enabled structure guided linking and expansion work to achieve one of the most potent and selective FXIa inhibitors reported to date, compound 13, with a FXIa IC50 of 1.0 nM. The hydrophilicity and large polar surface area of the potent S1-S1'-S2' binding FXIa inhibitors compromised permeability. Initial work to expand the 6-chloro-3,4-dihydro-1H-quinolin-2-one fragment towards the prime side to yield molecules with less hydrophilicity shows promise to afford potent, selective and orally bioavailable compounds.	[Fjellstrom, Ola; Akkaya, Sibel; Beisel, Hans-Georg; Erixon, Karl; Karis, David; Nilsson, Ingemar; Olsson, Thomas; Redzic, Alma] AstraZeneca R&D, Med Chem, Cardiovasc & Metab Dis Innovat Medicines, Molndal, Sweden; [Eriksson, Per-Olof; Roth, Robert; Sandmark, Jenny; Tigerstrom, Anna; Oster, Linda] AstraZeneca R&D, Discovery Sci, Molndal, Sweden; [Gustafsson, David; Kang, Daiwu; Knecht, Wolfgang; Nerme, Viveca] AstraZeneca R&D, Biosci, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden; [Jurva, Ulrik] AstraZeneca R&D, Drug Metab & Pharmacokinet, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Fjellstrom, O (corresponding author), AstraZeneca R&D, Med Chem, Cardiovasc & Metab Dis Innovat Medicines, Molndal, Sweden.	ola.fjellstrom@astrazeneca.com						[Anonymous], 2013, ACD PKADB VERS 6 0, DOI [10.1016/j.amsu.2013.12.001, DOI 10.1016/J.AMSU.2013.12.001]; Antonysamy SS, 2008, BIOORG MED CHEM LETT, V18, P2990, DOI 10.1016/j.bmcl.2008.03.056; ASAKAI R, 1991, NEW ENGL J MED, V325, P153, DOI 10.1056/NEJM199107183250303; Baker M, 2013, NAT REV DRUG DISCOV, V12, P5, DOI 10.1038/nrd3926; Basse N, 2010, CHEM BIOL, V17, P46, DOI 10.1016/j.chembiol.2009.12.011; Blundell TL, 2002, NAT REV DRUG DISCOV, V1, P45, DOI 10.1038/nrd706; Brough PA, 2009, J MED CHEM, V52, P4794, DOI 10.1021/jm900357y; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cushman M, 2009, BLOOD, V114, P2878, DOI 10.1182/blood-2009-05-219915; Dalvit C, 2002, J MED CHEM, V45, P2610, DOI 10.1021/jm011122k; Danielson UH, 2009, CURR TOP MED CHEM, V9, P1725, DOI 10.2174/156802609790102392; Deng HF, 2006, BIOORG MED CHEM LETT, V16, P3049, DOI 10.1016/j.bmcl.2006.02.052; Doggen CJM, 2006, BLOOD, V108, P4045, DOI 10.1182/blood-2005-12-023697; Drinkwater N, 2010, BIOCHEM J, V431, P51, DOI 10.1042/BJ20100651; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fradera X, 2012, ACTA CRYSTALLOGR F, V68, P404, DOI 10.1107/S1744309112009037; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gailani D, 1997, BLOOD COAGUL FIBRIN, V8, P134, DOI 10.1097/00001721-199703000-00008; Geschwindner S, 2007, J MED CHEM, V50, P5903, DOI 10.1021/jm070825k; Gruber A, 2003, BLOOD, V102, P953, DOI 10.1182/blood-2003-01-0324; Hajduk PJ, 1997, J AM CHEM SOC, V119, P12257, DOI 10.1021/ja9715962; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Halgren T, 2007, CHEM BIOL DRUG DES, V69, P146, DOI 10.1111/j.1747-0285.2007.00483.x; Hanessian S, 2010, BIOORG MED CHEM LETT, V20, P6925, DOI 10.1016/j.bmcl.2010.09.141; He R, 2012, THROMB RES, V129, P541, DOI 10.1016/j.thromres.2011.11.051; Howard N, 2006, J MED CHEM, V49, P1346, DOI 10.1021/jm050850v; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Innasimuthu AL, 2013, CARDIOLOGY, V126, P41, DOI 10.1159/000353484; Jacobson L, 2007, ASSAY DRUG DEV TECHN, V5, P403, DOI 10.1089/adt.2007.059; Jin L, 2005, ACTA CRYSTALLOGR D, V61, P1418, DOI [10.1107/S0907444905024340, 10.1107/S090744905024340]; Jin L, 2005, J BIOL CHEM, V280, P4704, DOI 10.1074/jbc.M411309200; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Lazarova TI, 2006, BIOORG MED CHEM LETT, V16, P5022, DOI 10.1016/j.bmcl.2006.07.043; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leung PY, 2012, TRANSL STROKE RES, V3, P381, DOI 10.1007/s12975-012-0186-5; Lin J, 2006, J MED CHEM, V49, P7781, DOI 10.1021/jm060978s; Lowenberg EC, 2010, J THROMB HAEMOST, V8, P2349, DOI 10.1111/j.1538-7836.2010.04031.x; Lu YX, 2012, EXPERT OPIN DRUG DIS, V7, P375, DOI 10.1517/17460441.2012.678829; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Minnema MC, 1998, J CLIN INVEST, V101, P10, DOI 10.1172/JCI781; Murray CW, 2007, J MED CHEM, V50, P1116, DOI 10.1021/jm0611962; Murray CW, 2002, J COMPUT AID MOL DES, V16, P741, DOI 10.1023/A:1022446720849; Murray JS, 2010, AUST J CHEM, V63, P1598, DOI 10.1071/CH10259; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navratilova I, 2010, ACS MED CHEM LETT, V1, P44, DOI 10.1021/ml900002k; Nazare M, 2012, ANGEW CHEM INT EDIT, V51, P905, DOI 10.1002/anie.201107091; Neumann T, 2007, CURR TOP MED CHEM, V7, P1630, DOI 10.2174/156802607782341073; Pinto DJ, 2008, PCT Int Appl, Patent No. [2007-US87396, 2006-870110P, 200787396]; Pinto DJP, 2008, PCT Int Appl, Patent No. [2008-US66506, 2007-943791P, 200866506]; Pinto DJP, 2007, PCT Int Appl, Patent No. [2006-US62005, 2005-750130P, 200662005]; Politzer P, 2013, CHEMPHYSCHEM, V14, P278, DOI 10.1002/cphc.201200799; Quan MML, 2014, J MED CHEM, V57, P955, DOI 10.1021/jm401670x; Rosen ED, 2002, THROMB HAEMOSTASIS, V87, P774; Salomon O, 2006, HAEMOPHILIA, V12, P490, DOI 10.1111/j.1365-2516.2006.01304.x; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schumacher WA, 2007, EUR J PHARMACOL, V570, P167, DOI 10.1016/j.ejphar.2007.05.043; Schumacher WA, 2010, ARTERIOSCL THROM VAS, V30, P388, DOI 10.1161/ATVBAHA.109.197178; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; Seligsohn U, 2009, J THROMB HAEMOST, V7, P84, DOI 10.1111/j.1538-7836.2009.03395.x; Seligsohn U, 2007, THROMB HAEMOSTASIS, V98, P84, DOI 10.1160/Th07-04-0246; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang XK, 2006, J THROMB HAEMOST, V4, P1982, DOI 10.1111/j.1538-7836.2006.02093.x; Wang X, 2005, J THROMB HAEMOST, V3, P695, DOI 10.1111/j.1538-7836.2005.01236.x; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wyatt PG, 2008, J MED CHEM, V51, P4986, DOI 10.1021/jm800382h; Xiang YB, 2011, BIOORG MED CHEM LETT, V21, P3050, DOI 10.1016/j.bmcl.2011.03.030; Yamashita A, 2006, J THROMB HAEMOST, V4, P1496, DOI 10.1111/j.1538-7836.2006.01973.x; Yang DT, 2006, AM J CLIN PATHOL, V126, P411, DOI 10.1309/QC259F09UNMKVP0R; Young MB, 2004, J MED CHEM, V47, P2995, DOI 10.1021/jm030303e; Younis HS, 2012, BLOOD, V119, P2401, DOI 10.1182/blood-2011-10-387134; Zhang H, 2010, BLOOD, V116, P4684, DOI 10.1182/blood-2010-04-277798	82	25	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0113705	10.1371/journal.pone.0113705	http://dx.doi.org/10.1371/journal.pone.0113705			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629509	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100005
J	Lakota, K; Carns, M; Podlusky, S; Mrak-Poljsak, K; Hinchcliff, M; Lee, J; Tomsic, M; Sodin-Semrl, S; Varga, J				Lakota, Katja; Carns, Mary; Podlusky, Sofia; Mrak-Poljsak, Katjusa; Hinchcliff, Monique; Lee, Jungwha; Tomsic, Matija; Sodin-Semrl, Snezna; Varga, John			Serum Amyloid A Is a Marker for Pulmonary Involvement in Systemic Sclerosis	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; C-REACTIVE PROTEIN; CORONARY-ARTERY; INTERLEUKIN-6; INFLAMMATION; VALIDITY; SKIN; OVEREXPRESSION; ACTIVATION; RESPONSES	Inflammation in systemic sclerosis (SSc) is a prominent, but incompletely characterized feature in early stages of the disease. The goal of these studies was to determine the circulating levels, clinical correlates and biological effects of the acute phase protein serum amyloid A (SAA), a marker of inflammation, in patients with SSc. Circulating levels of SAA were determined by multiplex assays in serum from 129 SSc patients and 98 healthy controls. Correlations between SAA levels and clinical and laboratory features of disease were analyzed. The effects of SAA on human pulmonary fibroblasts were studied ex vivo. Elevated levels of SAA were found in 25% of SSc patients, with the highest levels in those with early-stage disease and diffuse cutaneous involvement. Significant negative correlations of SAA were found with forced vital capacity and diffusion capacity for carbon monoxide. Patients with elevated SAA had greater dyspnea and more frequent interstitial lung disease, and had worse scores on patient-reported outcome measures. Incubation with recombinant SAA induced dose-dependent stimulation of IL-6 and IL-8 in normal lung fibroblasts in culture. Serum levels of the inflammatory marker SAA are elevated in patients with early diffuse cutaneous SSc, and correlate with pulmonary involvement. In lung fibroblasts, SAA acts as a direct stimulus for increased cytokine production. These findings suggest that systemic inflammation in SSc may be linked to lung involvement and SAA could serve as a potential biomarker for this complication.	[Lakota, Katja; Mrak-Poljsak, Katjusa; Tomsic, Matija; Sodin-Semrl, Snezna] Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia; [Lakota, Katja; Carns, Mary; Podlusky, Sofia; Hinchcliff, Monique; Varga, John] Northwestern Univ, Div Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Lee, Jungwha] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Sodin-Semrl, Snezna] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia	University Medical Centre Ljubljana; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Primorska	Lakota, K (corresponding author), Univ Med Ctr Ljubljana, Dept Rheumatol, Ljubljana, Slovenia.	katja.lakota@guest.arnes.si	Sodin-Semrl, Snezna/AAJ-8954-2020; Varga, John/AAK-6472-2021; Lakota, Katja/AAH-8033-2020	Lakota, Katja/0000-0002-8062-7908; Hinchcliff, Monique/0000-0002-8652-9890; Lee, Jungwha/0000-0002-0806-0847	Fullbright Foreign Student Program, grants from the National Institutes of Health [AR-42309]; National Research Program (Ministry of Higher Education, Science and Technology of Slovenia) [P3-0314]; Association for the Development of Rheumatology, Slovenia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042309, K23AR059763, R56AR042309] Funding Source: NIH RePORTER	Fullbright Foreign Student Program, grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Program (Ministry of Higher Education, Science and Technology of Slovenia); Association for the Development of Rheumatology, Slovenia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Fullbright Foreign Student Program, grants from the National Institutes of Health (AR-42309), the National Research Program (Ministry of Higher Education, Science and Technology of Slovenia, #P3-0314), and the Association for the Development of Rheumatology, Slovenia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Bargagli E, 2011, RESP MED, V105, P775, DOI 10.1016/j.rmed.2010.12.010; Beretta L, 2007, RHEUMATOLOGY, V46, P296, DOI 10.1093/rheumatology/kel221; Bhattacharyya S, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S18; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; BRANDWEIN SR, 1984, ANN RHEUM DIS, V43, P586, DOI 10.1136/ard.43.4.586; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; Czirjak L, 2008, ANN RHEUM DIS, V67, P59, DOI 10.1136/ard.2006.066340; De Lauretis A, 2013, J RHEUMATOL, V40, P435, DOI 10.3899/jrheum.120725; Dullaart RPF, 2013, OBESITY, V21, P361, DOI 10.1002/oby.20058; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Fasshauer M, 2004, J ENDOCRINOL, V183, P561, DOI 10.1677/joe.1.05699; Faty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034031; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gourh P, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2821; Hinchcliff M, 2011, J RHEUMATOL, V38, P2172, DOI 10.3899/jrheum.101243; Hinchcliff M, 2011, ARTHRIT CARE RES, V63, P1620, DOI 10.1002/acr.20591; Hudson M, 2007, SEMIN ARTHRITIS RHEU, V37, P93, DOI 10.1016/j.semarthrit.2007.01.005; Joven BE, 2010, SEMIN ARTHRITIS RHEU, V39, P285, DOI 10.1016/j.semarthrit.2009.06.002; Kadono T, 1998, J RHEUMATOL, V25, P296, DOI 10.1016/S0923-1811(98)84143-1; Khan K, 2012, ANN RHEUM DIS, V71, P1235, DOI 10.1136/annrheumdis-2011-200955; Kim TH, 2010, AM J RESP CRIT CARE, V182, P633, DOI 10.1164/rccm.200905-0659OC; King VL, 2011, CURR OPIN LIPIDOL, V22, P302, DOI 10.1097/MOL.0b013e3283488c39; Kitaba S, 2012, AM J PATHOL, V180, P165, DOI 10.1016/j.ajpath.2011.09.013; KRALING BM, 1995, PATHOBIOLOGY, V63, P48, DOI 10.1159/000163933; Lakota K, 2007, EUR J INFLAMM, V5, P73, DOI 10.1177/1721727X0700500203; Lakota K, 2013, MICROVASC RES, V90, P55, DOI 10.1016/j.mvr.2013.07.011; Lakota K, 2010, RECENT PATENTS ENDOC, V4, P89, DOI 10.2174/187221410791196632; Liu XC, 2013, ARTHRIT CARE RES, V65, P1375, DOI 10.1002/acr.21968; Liu XC, 2013, ARTHRITIS RHEUM-US, V65, P226, DOI 10.1002/art.37742; Lopez-Campos JL, 2013, INT J MED SCI, V10, P938, DOI 10.7150/ijms.6152; Migita K, 1998, LAB INVEST, V78, P535; Milette K, 2013, RHEUMATOLOGY, V52, P1715, DOI 10.1093/rheumatology/ket223; Minier T, 2010, RHEUMATOLOGY, V49, P1133, DOI 10.1093/rheumatology/keq022; Muangchan C, 2012, ARTHRIT CARE RES, V64, P1405, DOI 10.1002/acr.21716; O'Reilly S, 2014, IMMUNOLOGY, pn/a; O'Reilly S, 2012, CYTOKINE GROWTH F R, V23, P99, DOI 10.1016/j.cytogfr.2012.04.003; Obici L, 2009, ARTHRIT CARE RES, V61, P1435, DOI 10.1002/art.24735; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; REITAMO S, 1993, ARCH DERMATOL, V129, P189, DOI 10.1001/archderm.129.2.189; Schmidt K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2766; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Shima Y, 2010, RHEUMATOLOGY, V49, P2408, DOI 10.1093/rheumatology/keq275; Sodin-Semrl S, 2004, INT J IMMUNOPATH PH, V17, P145, DOI 10.1177/039463200401700206; Song CJ, 2009, ATHEROSCLEROSIS, V207, P374, DOI 10.1016/j.atherosclerosis.2009.05.007; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Strange C, 2008, AM J RESP CRIT CARE, V177, P91, DOI 10.1164/rccm.200705-655OC; Thorn CF, 2004, SCAND J IMMUNOL, V59, P152, DOI 10.1111/j.0300-9475.2004.01369.x; Tolle M, 2012, CARDIOVASC RES, V94, P154, DOI 10.1093/cvr/cvs089; Weihrauch D, 2007, AM J PHYSIOL-HEART C, V293, pH1432, DOI 10.1152/ajpheart.00038.2007; Wilson PG, 2008, AM J PATHOL, V173, P1902, DOI 10.2353/ajpath.2008.080201; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yeager ME, 2012, PROTEOM CLIN APPL, V6, P257, DOI 10.1002/prca.201100078; Yilmaz N, 2012, RHEUMATOL INT, V32, P1921, DOI 10.1007/s00296-011-1872-4	55	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0110820	10.1371/journal.pone.0110820	http://dx.doi.org/10.1371/journal.pone.0110820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629975	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100001
J	Lam, PY; Mangos, S; Green, JM; Reiser, J; Huttenlocher, A				Lam, Pui-ying; Mangos, Steve; Green, Julie M.; Reiser, Jochen; Huttenlocher, Anna			In Vivo Imaging and Characterization of Actin Microridges	PLOS ONE			English	Article							NEUTROPHIL MOTILITY; FOCAL ADHESIONS; SURFACE; MORPHOGENESIS; WOUNDS; MODEL; CARP	Actin microridges form labyrinth like patterns on superficial epithelial cells across animal species. This highly organized assembly has been implicated in mucus retention and in the mechanical structure of mucosal surfaces, however the mechanisms that regulate actin microridges remain largely unknown. Here we characterize the composition and dynamics of actin microridges on the surface of zebrafish larvae using live imaging. Microridges contain phospho-tyrosine, cortactin and VASP, but not focal adhesion kinase. Time-lapse imaging reveals dynamic changes in the length and branching of microridges in intact animals. Transient perturbation of the microridge pattern occurs before cell division with rapid re-assembly during and after cytokinesis. Microridge assembly is maintained with constitutive activation of Rho or inhibition of myosin II activity. However, expression of dominant negative RhoA or Rac alters microridge organization, with an increase in distance between microridges. Latrunculin A treatment and photoconversion experiments suggest that the F-actin filaments are actively treadmilling in microridges. Accordingly, inhibition of Arp2/3 or PI3K signaling impairs microridge structure and length. Taken together, actin microridges in zebrafish represent a tractable in vivo model to probe pattern formation and dissect Arp2/3-mediated actin dynamics in vivo.	[Lam, Pui-ying; Green, Julie M.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Lam, Pui-ying] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Mangos, Steve; Reiser, Jochen] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rush University; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	huttenlocher@wisc.edu		Lam, Pui-Ying/0000-0002-6319-5752; Mangos, Steve/0000-0003-1402-1008	NIH/NCI [R01 CA085862]; NIH [R01 GM102924-01]; NATIONAL CANCER INSTITUTE [R01CA085862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102924] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH/NCI R01 CA085862 and NIH R01 GM102924-01 to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Blanco MT, 2012, J CELL SCI, V125, P5984, DOI 10.1242/jcs.109066; Bereither-Hahn J, 1979, J ULTRASTRUCT RES, V69, P15; Brock J, 1996, J CELL BIOL, V135, P1097, DOI 10.1083/jcb.135.4.1097; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Burridge K, 1997, TRENDS CELL BIOL, V7, P342, DOI 10.1016/S0962-8924(97)01127-6; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chen CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020654; Clark AG, 2009, CURR BIOL, V19, P1389, DOI 10.1016/j.cub.2009.06.044; Collin HB, 2000, PHILOS T ROY SOC B, V355, P1171, DOI 10.1098/rstb.2000.0661; Correr S, 2006, HISTOL HISTOPATHOL, V21, P219, DOI 10.14670/HH-21.219; Deng Q, 2011, DEV CELL, V21, P735, DOI 10.1016/j.devcel.2011.07.013; Doyle AD, 2005, J CELL SCI, V118, P369, DOI 10.1242/jcs.01590; Figard Lauren, 2014, Bioarchitecture, V4, P39, DOI 10.4161/bioa.29069; Figard L, 2013, DEV CELL, V27, P648, DOI 10.1016/j.devcel.2013.11.006; Gamal AM, 2012, J BASIC APPL ZOOLOGY, V65, P8; GARDNER IC, 1976, MICRON, V7, P199, DOI 10.1016/0047-7206(76)90003-0; Gilmore AP, 1996, STRUCTURE, V4, P647, DOI 10.1016/S0969-2126(96)00069-X; Hafez EAAE, 2013, J HISTOLOGY, V2013, P10; Holt MR, 1998, INT J BIOCHEM CELL B, V30, P307, DOI 10.1016/S1357-2725(97)00101-5; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Li JJ, 2013, J CELL SCI, V126, P5005, DOI 10.1242/jcs.133421; Li QL, 2011, DIS MODEL MECH, V4, P777, DOI 10.1242/dmm.007146; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Miyazawa S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1071; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Rice WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057051; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sharma A, 2005, FEBS LETT, V579, P2001, DOI 10.1016/j.febslet.2005.02.049; Simmich J, 2012, CLIN EXP OPTOM, V95, P140, DOI 10.1111/j.1444-0938.2011.00701.x; SPERRY DG, 1976, ANAT RECORD, V185, P253, DOI 10.1002/ar.1091850212; Thie M, 1998, HUMAN REPROD, V13, P9; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; UEHARA K, 1991, ANAT REC, V230, P164, DOI 10.1002/ar.1092300203; Uppal RK, 2013, VET OPHTHALMOL; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Villava CE, 2007, BIOTECHNIQUES, V43, P313, DOI 10.2144/000112555; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wong CKC, 2000, AQUAT TOXICOL, V48, P517, DOI 10.1016/S0166-445X(99)00060-0; Yashpal M, 2006, BELG J ZOOL, V136, P155; Yashpal M, 2009, J MORPHOL, V270, P714, DOI 10.1002/jmor.10713; Yoo SK, 2012, J CELL BIOL, V199, P225, DOI 10.1083/jcb.201203154; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015; Zhao XPC, 2006, INVEST OPHTH VIS SCI, V47, P4341, DOI 10.1167/iovs.05-1611	47	29	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115639	10.1371/journal.pone.0115639	http://dx.doi.org/10.1371/journal.pone.0115639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629723	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100023
J	Broniowska, KA; Oleson, BJ; McGraw, J; Naatz, A; Mathews, CE; Corbett, JA				Broniowska, Katarzyna A.; Oleson, Bryndon J.; McGraw, Jennifer; Naatz, Aaron; Mathews, Clayton E.; Corbett, John A.			How the Location of Superoxide Generation Influences the beta-Cell Response to Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell (B-cell); Cytokine; Diabetes; Nitric Oxide; Oxidative Stress; Peroxynitrite; Type 1 Diabetes	CYTOKINE-INDUCED DESTRUCTION; INSULIN-SECRETION; REACTIVE OXYGEN; PANCREATIC-ISLETS; ALR/LT MICE; PEROXYNITRITE; DEATH; ACTIVATION; SYNTHASE; INTERLEUKIN-1-BETA	Background: Although nitric oxide inhibits -cell function, the impact of superoxide on nitric oxide signaling remains unknown. Results: Superoxide produced within -cells inhibits nitric oxide-dependent responses, whereas extracellular generation does not. Conclusion: The reaction of nitric oxide with superoxide regulates the -cell response to nitric oxide. Significance: The location of radical generation dictates the functional response of -cells to reactive species. Cytokines impair the function and decrease the viability of insulin-producing -cells by a pathway that requires the expression of inducible nitric oxide synthase (iNOS) and generation of high levels of nitric oxide. In addition to nitric oxide, excessive formation of reactive oxygen species, such as superoxide and hydrogen peroxide, has been shown to cause -cell damage. Although the reaction of nitric oxide with superoxide results in the formation of peroxynitrite, we have shown that -cells do not have the capacity to produce this powerful oxidant in response to cytokines. When -cells are forced to generate peroxynitrite using nitric oxide donors and superoxide-generating redox cycling agents, superoxide scavenges nitric oxide and prevents the inhibitory and destructive actions of nitric oxide on mitochondrial oxidative metabolism and -cell viability. In this study, we show that the -cell response to nitric oxide is regulated by the location of superoxide generation. Nitric oxide freely diffuses through cell membranes, and it reacts with superoxide produced within cells and in the extracellular space, generating peroxynitrite. However, only when it is produced within cells does superoxide attenuate nitric oxide-induced mitochondrial dysfunction, gene expression, and toxicity. These findings suggest that the location of radical generation and the site of radical reactions are key determinants in the functional response of -cells to reactive oxygen species and reactive nitrogen species. Although nitric oxide is freely diffusible, its biological function can be controlled by the local generation of superoxide, such that when this reaction occurs within -cells, superoxide protects -cells by scavenging nitric oxide.	[Broniowska, Katarzyna A.; Oleson, Bryndon J.; McGraw, Jennifer; Naatz, Aaron; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Mathews, Clayton E.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	Medical College of Wisconsin; State University System of Florida; University of Florida	Broniowska, KA (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	kbroniow@mcw.edu; jcorbett@mcw.edu		Broniowska, Katarzyna/0000-0002-8000-9093	National Institutes of Health [DK-052194, AI-44458, DK-074656]; American Diabetes Association; American Heart Association [13POST16940076, 14PRE20380585]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI042288, R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK074656, R01DK052194, UC4DK104194, R01DK074656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-052194 and AI-44458 (to J. A. C) and DK-074656 (to C. E. M.) This work was also supported by a grant from the American Diabetes Association (to C. E. M.); American Heart Association Postdoctoral Fellowship 13POST16940076 (to K. A. B); American Heart Association Predoctoral Fellowship 14PRE20380585 (to B. J. O.); and a gift from the Forest County Potawatomi Foundation.	Andreone T, 2012, AM J PHYSIOL-ENDOC M, V303, pE172, DOI 10.1152/ajpendo.00055.2012; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broniowska KA, 2013, J BIOL CHEM, V288, P36567, DOI 10.1074/jbc.M113.522243; Broniowska KA, 2013, BIOCHEMISTRY-US, V52, P4364, DOI 10.1021/bi400342t; BRUNMARK A, 1989, FREE RADICAL BIO MED, V7, P435, DOI 10.1016/0891-5849(89)90126-3; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Chambers KT, 2007, AM J PHYSIOL-ENDOC M, V292, pE1052, DOI 10.1152/ajpendo.00274.2006; Chiara F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.184; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Delaney CA, 1996, FEBS LETT, V394, P300, DOI 10.1016/0014-5793(96)00977-5; EIZIRIK DL, 1993, FEBS LETT, V317, P62, DOI 10.1016/0014-5793(93)81492-I; Godoy JR, 2011, BBA-GEN SUBJECTS, V1810, P2, DOI 10.1016/j.bbagen.2010.05.006; Gusdon AM, 2007, J BIOL CHEM, V282, P5171, DOI 10.1074/jbc.M609367200; Huang S, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-38; Hughes KJ, 2011, J BIOL CHEM, V286, P8338, DOI 10.1074/jbc.M110.204768; Hughes KJ, 2009, J BIOL CHEM, V284, P27402, DOI 10.1074/jbc.M109.046912; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Khan P, 2014, APPL BIOCHEM BIOTECH, V173, P333, DOI 10.1007/s12010-014-0850-1; Klotz LO, 2000, BIOCHEM J, V352, P219, DOI 10.1042/0264-6021:3520219; Lakey JRT, 2001, LAB INVEST, V81, P1683, DOI 10.1038/labinvest.3780381; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Mathews CE, 2005, J IMMUNOL, V175, P1248, DOI 10.4049/jimmunol.175.2.1248; Mathews CE, 2002, FREE RADICAL BIO MED, V32, P744, DOI 10.1016/S0891-5849(02)00747-5; Mathews CE, 1999, FREE RADICAL BIO MED, V27, P449, DOI 10.1016/S0891-5849(99)00084-2; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Meares GP, 2011, EXP CELL RES, V317, P1621, DOI 10.1016/j.yexcr.2011.02.012; Newsholme P, 2012, ADV EXP MED BIOL, V942, P235, DOI 10.1007/978-94-007-2869-1_10; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SCHWIZER RW, 1984, TRANSPLANTATION, V37, P539, DOI 10.1097/00007890-198406000-00002; Son YO, 2013, TOXICOL APPL PHARM, V271, P239, DOI 10.1016/j.taap.2013.04.036; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; STOCCHI V, 1987, ANAL BIOCHEM, V167, P181, DOI 10.1016/0003-2697(87)90150-3; SuarezPinzon WL, 1997, DIABETES, V46, P907, DOI 10.2337/diabetes.46.5.907; SUMOSKI W, 1989, DIABETOLOGIA, V32, P792; Syed I, 2011, DIABETES, V60, P2843, DOI 10.2337/db11-0809; Thayer TC, 2011, DIABETES, V60, P2144, DOI 10.2337/db10-1222; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	57	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7952	7960		10.1074/jbc.M114.627869	http://dx.doi.org/10.1074/jbc.M114.627869			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648890	hybrid, Green Published			2022-12-26	WOS:000351613600052
J	Okuda, M; Niwa, T; Taguchi, H				Okuda, Momoko; Niwa, Tatsuya; Taguchi, Hideki			Single-molecule Analyses of the Dynamics of Heat Shock Protein 104 (Hsp104) and Protein Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases Associated with Diverse Cellular Activities (AAA); Chaperone; Fluorescence Correlation Spectroscopy (FCS); Protein Aggregation; Single-molecule Biophysics; Hsp104; Total Internal Reflection Fluorescence (TIRF) Microscopy	AAA PLUS DISAGGREGASE; CHAPERONE SYSTEM; ESCHERICHIA-COLI; LIGHT-SCATTERING; CENTRAL PORE; M-DOMAINS; CLPB; MECHANISM; HSP70; BINDING	Background: The process of disaggregation by heat shock protein 104 (Hsp104) and heat shock protein 70/40 (Hsp70/40) has not been elucidated. Results: We developed several methods to investigate the dynamics of Hsp104 at single-molecule levels. Conclusion: Statistical analyses revealed that Hsp70/40 affected the dynamics of Hsp104. Significance: Single-molecule approaches are a unique way to unravel the functional mechanisms of disaggregases. Hsp104 solubilizes protein aggregates in cooperation with Hsp70/40. Although the framework of the disaggregase function has been elucidated, the actual process of aggregate solubilization by Hsp104-Hsp70/40 remains poorly understood. Here we developed several methods to investigate the functions of Hsp104 and Hsp70/40 from Saccharomyces cerevisiae, at single-molecule levels. The single-molecule methods, which provide the size distribution of the aggregates, revealed that Hsp70/40 prevented the formation of large aggregates from small aggregates and that the solubilization of the small aggregates required both Hsp104 and Hsp70/40. We directly visualized the individual association-dissociation dynamics of Hsp104 on immobilized aggregates and found that the lifetimes of the Hsp104-aggregate complex are divided into two groups: short (approximate to 4 s) and long (approximate to 30 s). Hsp70/40 stimulated the association of Hsp104 with aggregates and increased the duration of this association. The single-molecule data provide novel insights into the functional mechanism of the Hsp104 disaggregation machine.	[Okuda, Momoko; Niwa, Tatsuya; Taguchi, Hideki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Taguchi, H (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, B-56,4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	taguchi@bio.titech.ac.jp	Taguchi, Hideki/B-6946-2009; taguchi, hideki/AAM-2663-2021	Taguchi, Hideki/0000-0002-6612-9339; taguchi, hideki/0000-0002-6612-9339; Niwa, Tatsuya/0000-0002-1330-8974	Japan Society for the Promotion of Science (JSPS) [19058002, 24113705, 26116002]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research 19058002, 24113705 and 26116002 (to H. T.) from Japan Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Doyle SM, 2013, NAT REV MOL CELL BIO, V14, P617, DOI 10.1038/nrm3660; Endo T, 1996, J BIOL CHEM, V271, P4161; Georgalis Y, 1998, P NATL ACAD SCI USA, V95, P6118, DOI 10.1073/pnas.95.11.6118; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Inou Y, 2004, J BIOL CHEM, V279, P52319, DOI 10.1074/jbc.M408159200; Kawai-Noma S, 2006, GENES CELLS, V11, P1085, DOI 10.1111/j.1365-2443.2006.01004.x; Kawai-Noma S, 2010, J CELL BIOL, V190, P223, DOI 10.1083/jcb.201002149; Kubo Y, 1999, J MOL BIOL, V286, P447, DOI 10.1006/jmbi.1998.2465; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Panyukov Y, 2007, BIOPHYS CHEM, V127, P9, DOI 10.1016/j.bpc.2006.11.006; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Saito K, 2003, FEBS LETT, V541, P126, DOI 10.1016/S0014-5793(03)00324-7; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Yokota H, 2009, CHEM LETT, V38, P308, DOI 10.1246/cl.2009.308; Zhou ZP, 2011, J BIOCHEM, V149, P609, DOI 10.1093/jb/mvr010; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083	42	10	10	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7833	7840		10.1074/jbc.M114.620427	http://dx.doi.org/10.1074/jbc.M114.620427			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25635051	hybrid, Green Published			2022-12-26	WOS:000351613600041
J	Fukuchi, M; Nakashima, F; Tabuchi, A; Shimotori, M; Tatsumi, S; Okuno, H; Bito, H; Tsuda, M				Fukuchi, Mamoru; Nakashima, Fukumi; Tabuchi, Akiko; Shimotori, Masataka; Tatsumi, Saori; Okuno, Hiroyuki; Bito, Haruhiko; Tsuda, Masaaki			Class I Histone Deacetylase-mediated Repression of the Proximal Promoter of the Activity-regulated Cytoskeleton-associated Protein Gene Regulates Its Response to Brain-derived Neurotrophic Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; RAT CORTICAL-NEURONS; ARC MESSENGER-RNA; DENTATE GYRUS; TRANSCRIPTION FACTORS; SYNAPTIC PLASTICITY; GROWTH-FACTOR; ARC/ARG3.1; EXPRESSION	We examined the transcriptional regulation of the activity-regulated cytoskeleton-associated protein gene (Arc), focusing on BDNF-induced Arc expression in cultured rat cortical cells. Although the synaptic activity-responsive element (SARE), located -7 kbp upstream of the Arc transcription start site, responded to NMDA, BDNF, or FGF2, the proximal region of the promoter (Arc/-1679) was activated by BDNF or FGF2, but not by NMDA, suggesting the presence of at least two distinct Arc promoter regions, distal and proximal, that respond to extracellular stimuli. Specificity protein 4 (SP4) and early growth response 1 (EGR1) controlled Arc/-1679 transcriptional activity via the region encompassing -169 to -37 of the Arc promoter. We found that trichostatin A(TSA), a histone deacetylase (HDAC) inhibitor, significantly enhanced the inductive effects of BDNF or FGF2, but not those of NMDA on Arc expression. Inhibitors of class I/IIb HDACs, SAHA, and class I HDACs, MS-275, but not of class II HDACs, MC1568, enhanced BDNF-induced Arc expression. The enhancing effect of TSA was mediated by the region from -1027 to -1000 bp, to which serum response factor (SRF) and HDAC1 bound. The binding of HDAC1 to this region was reduced by TSA. Thus, Arc expression was suppressed by class I HDAC-mediated mechanisms via chromatin modification of the proximal promoter whereas the inhibition of HDAC allowed Arc expression to be markedly enhanced in response to BDNF or FGF2. These results contribute to our understanding of the physiological role of Arc expression in neuronal functions such as memory consolidation.	[Fukuchi, Mamoru; Nakashima, Fukumi; Tabuchi, Akiko; Shimotori, Masataka; Tatsumi, Saori; Tsuda, Masaaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Biol Chem, Toyama 9300194, Japan; [Okuno, Hiroyuki; Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan	University of Toyama; University of Tokyo	Tsuda, M (corresponding author), Toyama Univ, Fac Pharmaceut Sci, Dept Biol Chem, 2630 Sugitani, Toyama 9300194, Japan.	tsuda@pha.u-toyama.ac.jp	Bito, Haruhiko/A-8635-2008	Fukuchi, Mamoru/0000-0002-6807-8707; Bito, Haruhiko/0000-0001-6315-9594; OKUNO, HIROYUKI/0000-0001-6237-6503	Ministry of Education, Science, Sports and Culture, Japan [20390023]; Mitsubishi Foundation	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation	This study was supported in part by a Grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan (Project Number: 20390023, to M. T.) and the Mitsubishi Foundation (to M. T.).	Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; Fukuchi M, 2004, J BIOL CHEM, V279, P47856, DOI 10.1074/jbc.M409090200; Fukuchi M, 2010, BRAIN RES, V1366, P18, DOI 10.1016/j.brainres.2010.10.034; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; Hara D, 2009, BIOCHEM BIOPH RES CO, V384, P506, DOI 10.1016/j.bbrc.2009.05.007; Hu E., 2003, IDENTIFICATION NOVEL; Ishimaru N, 2007, J NEUROCHEM, V100, P520, DOI 10.1111/j.1471-4159.2006.04216.x; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Koppel I, 2013, NEUROPHARMACOLOGY, V75, P106, DOI 10.1016/j.neuropharm.2013.07.015; Levkovitz Y, 2001, J NEUROSCI, V21, P45, DOI 10.1523/JNEUROSCI.21-01-00045.2001; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Peng FW, 2010, J BIOL CHEM, V285, P21615, DOI 10.1074/jbc.M110.107003; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pintchovski SA, 2009, J NEUROSCI, V29, P1525, DOI 10.1523/JNEUROSCI.5575-08.2009; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Ramos B, 2007, P NATL ACAD SCI USA, V104, P9882, DOI 10.1073/pnas.0701946104; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Timmusk T, 1999, J BIOL CHEM, V274, P1078; Veyrac A, 2014, PROG MOL BIOL TRANSL, V122, P89, DOI 10.1016/B978-0-12-420170-5.00004-0; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yasuda M, 2007, J NEUROCHEM, V103, P626, DOI 10.1111/j.1471-4159.2007.04851.x; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621	43	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6825	6836		10.1074/jbc.M114.617258	http://dx.doi.org/10.1074/jbc.M114.617258			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25623071	hybrid, Green Published			2022-12-26	WOS:000350991500018
J	Liu, N; Li, P; Zang, SL; Liu, Q; Ma, DX; Sun, XL; Ji, CY				Liu, Na; Li, Peng; Zang, Shaolei; Liu, Qiang; Ma, Daoxin; Sun, Xiulian; Ji, Chunyan			Novel Agent Nitidine Chloride Induces Erythroid Differentiation and Apoptosis in CML Cells through c-Myc-miRNAs Axis	PLOS ONE			English	Article							BCR-ABL; SIGNALING PATHWAY; IMATINIB; INHIBITION; MIR-17-92; MICRORNA; CLUSTER; PROLIFERATION; RESISTANCE; P21	The proto-oncogene c-Myc plays critical roles in human malignancies including chronic myeloid leukemia (CML), suggesting that the discovery of specific agents targeting c-Myc would be extremely valuable for CML treatment. Nitidine Chloride (NC), a natural bioactive alkaloid, is suggested to possess anti-tumor effects. However, the function of NC in leukemia and the underlying molecular mechanisms have not been established. In this study, we found that NC induced erythroid differentiation, accompanied by increased expression of erythroid differentiation markers, e. g. alpha-, epsilon-, gamma-globin, CD235a, CD71 and alpha-hemoglobin stabilizing protein (AHSP) in CML cells. We also observed that NC induced apoptosis and upregulated cleaved caspase-3 and Parp-1 in K562 cells. These effects were associated with concomitant attenuation of c-Myc. Our study showed that NC treatment in CML cells enhanced phosphorylation of Thr58 residue and subsequently accelerated degradation of c-Myc. A specific group of miRNAs, which had been reported to be activated by c-Myc, mediated biological functions of c-Myc. We found that most of these miRNAs, especially miR17 and miR-20a showed strong decrement after NC treatment or c-Myc interference. Furthermore, overexpression of c-Myc or miR-17/20a alleviated NC induced differentiation and apoptosis in K562 cells. More importantly, NC enhanced the effects of imatinib in K562 and primary CML cells. We further found that even imatinib resistant CML cell line (K562/G01) and CML primary cells exhibited high sensitivity to NC, which showed potential possibility to overcome imatinib resistance. Taken together, our results clearly suggested that NC promoted erythroid differentiation and apoptosis through c-Myc-miRNAs regulatory axis, providing potential possibility to overcome imatinib resistance.	[Liu, Na; Li, Peng; Zang, Shaolei; Ma, Daoxin; Ji, Chunyan] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Liu, Qiang; Sun, Xiulian] Shandong Univ, Qilu Hosp, Key Lab Otolaryngol, Jinan 250100, Peoples R China	Shandong University; Shandong University	Ji, CY (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China.	jichunyan@sdu.edu.cn			National Natural Science Foundation of China [81370662, 81000223]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China: 81370662(CJ), 81000223(SZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albajar M, 2011, MOL CANCER RES, V9, P564, DOI 10.1158/1541-7786.MCR-10-0356; An X, 2010, LEUKEMIA RES, V34, P1255, DOI 10.1016/j.leukres.2010.04.016; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benassi B, 2006, MOL CELL, V21, P509, DOI 10.1016/j.molcel.2006.01.009; Bouquet J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-67; Breccia M, 2012, LEUKEMIA RES, V36, P1498, DOI 10.1016/j.leukres.2012.09.006; Chen J, 2012, MOL CANCER THER, V11, P277, DOI 10.1158/1535-7163.MCT-11-0648; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Dai BB, 2011, CANCER RES, V71, P3658, DOI 10.1158/0008-5472.CAN-10-3647; Del Poeta M, 1999, ANTIMICROB AGENTS CH, V43, P2862, DOI 10.1128/AAC.43.12.2862; Dews M, 2010, CANCER RES, V70, P8233, DOI 10.1158/0008-5472.CAN-10-2412; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Fang ZQ, 2014, FOOD CHEM TOXICOL, V66, P210, DOI 10.1016/j.fct.2014.01.049; Fang ZQ, 2013, FOOD CHEM TOXICOL, V60, P246, DOI 10.1016/j.fct.2013.07.062; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Frenquelli M, 2010, BLOOD, V115, P3949, DOI 10.1182/blood-2009-11-254656; Gocek E, 2011, CANCER RES, V71, P6230, DOI 10.1158/0008-5472.CAN-11-1717; Gomez-Casares MT, 2013, ONCOGENE, V32, P2239, DOI 10.1038/onc.2012.246; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; JACKSTADT R, 2014, BIOCH BIOPHYS ACTA, P28669; Kang M, 2014, J BUON, V19, P130; Kawano T, 2004, ANTICANCER RES, V24, P2705; Kim BY, 2010, FEBS LETT, V584, P4524, DOI 10.1016/j.febslet.2010.10.031; Kirito K, 1998, BLOOD, V92, P462, DOI 10.1182/blood.V92.2.462.414k15_462_471; Lamontanara AJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1449, DOI 10.1016/j.bbapap.2012.12.009; Liao J, 2013, INT J MOL MED, V32, P79, DOI 10.3892/ijmm.2013.1358; Liu L, 2012, BIOCHEM BIOPH RES CO, V425, P368, DOI 10.1016/j.bbrc.2012.07.098; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Liu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097974; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Mi SL, 2010, P NATL ACAD SCI USA, V107, P3710, DOI 10.1073/pnas.0914900107; Mitchell KO, 1999, CELL GROWTH DIFFER, V10, P223; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Nagel S, 2009, LEUKEMIA LYMPHOMA, V50, P101, DOI 10.1080/10428190802626632; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pan XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105381; Pan XH, 2011, CANCER LETT, V313, P181, DOI 10.1016/j.canlet.2011.09.001; Porro A, 2011, MOL CANCER RES, V9, P1054, DOI 10.1158/1541-7786.MCR-10-0510; PULVERER BJ, 1994, ONCOGENE, V9, P59; Qi Jing, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P337; Qian J, 2013, LEUKEMIA RES, V37, P765, DOI 10.1016/j.leukres.2013.03.014; Redner RL, 2010, ONCOLOGIST, V15, P182, DOI 10.1634/theoncologist.2009-0297; Rinaldi A, 2007, LEUKEMIA LYMPHOMA, V48, P410, DOI 10.1080/10428190601059738; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; SUN M, 2014, TUMOUR BIOL, P28669; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wall M, 2008, BLOOD, V112, P2305, DOI 10.1182/blood-2007-09-111856; Wang ZZ, 2010, INT J ONCOL, V37, P1315, DOI 10.3892/ijo_00000783; Wang ZQ, 2012, J ETHNOPHARMACOL, V144, P145, DOI 10.1016/j.jep.2012.08.041; Wong P, 2010, CANCER RES, V70, P3833, DOI 10.1158/0008-5472.CAN-09-3268; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65; Zhang QL, 2011, J CELL BIOCHEM, V112, P2910, DOI 10.1002/jcb.23207	65	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116880	10.1371/journal.pone.0116880	http://dx.doi.org/10.1371/journal.pone.0116880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647305	Green Submitted, Green Published, gold			2022-12-26	WOS:000348822600041
J	Yang, XW; Zhu, JJ; Tung, CY; Gardiner, G; Wang, Q; Chang, HC; Zhou, BH				Yang, Xiaowei; Zhu, Jingjing; Tung, Chun-Yu; Gardiner, Gail; Wang, Qun; Chang, Hua-Chen; Zhou, Baohua			Lunasin Alleviates Allergic Airway Inflammation while Increases Antigen-Specific Tregs	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; SOYBEAN PEPTIDE LUNASIN; REGULATORY T-CELLS; FACTOR-KAPPA-B; ASTHMA; IMMUNOTHERAPY; RESPONSES; INDUCTION; BINDS	Lunasin is a naturally occurring peptide isolated from soybeans and has been explored in cancer treatment. Lunasin inhibits NF-kappa B activation and thus pro-inflammatory cytokine and mediator production in macrophages. In this study we demonstrate that lunasin can effectively suppress allergic airway inflammation in two murine models of asthma. In an OVA+Alum sensitization model, intranasal lunasin treatment at the time of OVA challenges significantly reduced total cells counts in bronchoalveolar lavage (BAL) fluid and eosinophilia, peribronchiolar inflammatory infiltration, goblet cell metaplasia and airway IL-4 production. In an OVA+LPS intranasal sensitization model, lunasin treatment either at the time of sensitization or challenge has similar effects in suppress allergic airway inflammation including significantly reduced total cell and eosinophil counts in BAL fluid, inflammatory gene Fizz1 expression in the lung, and IL-4 production by OVA re-stimulated cells from mediastinal lymph nodes. We further show that intranasal instillation of OVA+lunasin significantly increases OVA-specific regulatory T cell (Treg) accumulation in the lung comparing to OVA only treatment. Taken together, our results suggest lunasin as an anti-inflammatory agent can be potentially used in asthma therapy or as an adjuvant to enhance the induction of antigen-specific Tregs and thus boost the efficacy of allergy immunotherapy.	[Yang, Xiaowei; Zhu, Jingjing; Wang, Qun; Zhou, Baohua] Indiana Univ Sch Med, Dept Pediat, HB Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Gardiner, Gail; Zhou, Baohua] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Yang, Xiaowei] Southwest Univ Rongchang, Dept Vet Med, Rongchang, Peoples R China; [Tung, Chun-Yu; Chang, Hua-Chen] Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Chang, HC (corresponding author), Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA.	huchang@iupui.edu; zhoub@iu.edu			United States Public Health Service [RO1 AI085046]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085046] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Service Grant RO1 AI085046 to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; Cam A, 2012, MOL NUTR FOOD RES, V56, P1569, DOI 10.1002/mnfr.201200301; Chang HC, 2014, CANCER IMMUNOL IMMUN, V63, P283, DOI 10.1007/s00262-013-1513-8; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI [10.1089/ars.2008.2425, 10.1089/ARS.2008.2425]; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; de Mejia EG, 2009, PEPTIDES, V30, P2388, DOI 10.1016/j.peptides.2009.08.005; Dia VP, 2011, CANCER LETT, V313, P167, DOI 10.1016/j.canlet.2011.09.002; Dia VP, 2009, J AGR FOOD CHEM, V57, P1260, DOI 10.1021/jf803303k; Dong L, 2008, J ASTHMA, V45, P648, DOI 10.1080/02770900802126941; Donovan CE, 1999, J IMMUNOL, V163, P6827; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fujita Hiroyuki, 2012, Clin Transl Allergy, V2, P2, DOI 10.1186/2045-7022-2-2; Galvez AF, 2001, CANCER RES, V61, P7473; Galvez AF, 1999, NAT BIOTECHNOL, V17, P495, DOI 10.1038/8676; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Han SW, 2006, ONCOGENE, V25, P4341, DOI 10.1038/sj.onc.1209460; Hankin CS, 2014, CURR OPIN ALLERGY CL, V14, P363, DOI 10.1097/ACI.0000000000000084; Hernandez-Ledesma B, 2009, BIOCHEM BIOPH RES CO, V390, P803, DOI 10.1016/j.bbrc.2009.10.053; Hernandez-Ledesma B, 2009, PEPTIDES, V30, P426, DOI 10.1016/j.peptides.2008.11.002; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hsieh CC, 2010, J FOOD SCI, V75, pH311, DOI 10.1111/j.1750-3841.2010.01861.x; Janssen-Heininger Yvonne M W, 2009, Proc Am Thorac Soc, V6, P249, DOI 10.1513/pats.200806-054RM; Garcia-Nebot MJ, 2014, FOOD CHEM TOXICOL, V65, P155, DOI 10.1016/j.fct.2013.12.021; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Khare A, 2013, J IMMUNOL, V191, P25, DOI 10.4049/jimmunol.1300193; Lei LY, 2011, J IMMUNOL, V186, P2254, DOI 10.4049/jimmunol.1002503; Li XM, 2011, MT SINAI J MED, V78, P697, DOI 10.1002/msj.20294; Loubaki L, 2010, MOL IMMUNOL, V47, P2112, DOI 10.1016/j.molimm.2010.03.011; Nelson HS, 2014, CHEM IMMUNOL ALLERGY, V100, P333, DOI 10.1159/000360047; ODANI S, 1987, J BIOL CHEM, V262, P10502; Piggott DA, 2005, J CLIN INVEST, V115, P459, DOI 10.1172/JCI200522462; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Tai XG, 2012, BLOOD, V119, P5155, DOI 10.1182/blood-2011-11-388918; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739; Zhang YL, 2012, EUR J IMMUNOL, V42, P1735, DOI 10.1002/eji.201142123; Zhou BH, 2008, J IMMUNOL, V181, P6557, DOI 10.4049/jimmunol.181.9.6557; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	42	24	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115330	10.1371/journal.pone.0115330	http://dx.doi.org/10.1371/journal.pone.0115330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646897	gold, Green Published			2022-12-26	WOS:000348822600011
J	Papoff, G; Trivieri, N; Marsilio, S; Crielesi, R; Lalli, C; Castellani, L; Balog, EM; Ruberti, G				Papoff, Giuliana; Trivieri, Nadia; Marsilio, Sonia; Crielesi, Roberta; Lalli, Cristiana; Castellani, Loriana; Balog, Edward M.; Ruberti, Giovina			N-Terminal and C-Terminal Domains of Calmodulin Mediate FADD and TRADD Interaction	PLOS ONE			English	Article							DEATH DOMAIN; OXIDIZED CALMODULIN; GLUTAMINE SUBSTITUTIONS; DEPENDENT ACTIVATION; METHIONINE RESIDUES; TARGET RECOGNITION; PYRIN DOMAIN; OXIDATION; PROTEIN; BINDING	FADD (Fas-associated death domain) and TRADD (Tumor Necrosis Factor Receptor 1-associated death domain) proteins are important regulators of cell fate in mammalian cells. They are both involved in death receptors mediated signaling pathways and have been linked to the Toll-like receptor family and innate immunity. Here we identify and characterize by database search analysis, mutagenesis and calmodulin (CaM) pull-down assays a calcium-dependent CaM binding site in the alpha-helices 1-2 of TRADD death domain. We also show that oxidation of CaM methionines drastically reduces CaM affinity for FADD and TRADD suggesting that oxidation might regulate CaM-FADD and CaM-TRADD interactions. Finally, using Met-to-Leu CaM mutants and binding assays we show that both the Nand C-terminal domains of CaM are important for binding.	[Papoff, Giuliana; Trivieri, Nadia; Marsilio, Sonia; Crielesi, Roberta; Lalli, Cristiana; Castellani, Loriana; Ruberti, Giovina] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Castellani, Loriana] Univ Cassino, Dept Human Sci Soc & Hlth, I-03043 Cassino, Italy; [Balog, Edward M.] Georgia Inst Technol, Sch Appl Physiol, Atlanta, GA 30332 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Cassino; University System of Georgia; Georgia Institute of Technology	Ruberti, G (corresponding author), CNR, Inst Cell Biol & Neurobiol, Campus Adriano Buzzati Traverso, Rome, Italy.	gruberti@ibc.cnr.it	PAPOFF, GIULIANA/AAX-9520-2020; trivieri, nadia/GVS-1410-2022	PAPOFF, GIULIANA/0000-0003-2251-8794; RUBERTI, Giovina/0000-0003-2367-9709; Castellani, Loriana/0000-0002-8519-3504	National Research Council Project RTL "FADD and TRADD non apoptotic functions"; National Research Council Project "FaReBio di Qualita" - Italian Ministry of Economy and Finance	National Research Council Project RTL "FADD and TRADD non apoptotic functions"; National Research Council Project "FaReBio di Qualita" - Italian Ministry of Economy and Finance	This work was supported by grants (to G.R.) from the National Research Council: i) Project RTL "FADD and TRADD non apoptotic functions"; ii) Project "FaReBio di Qualita" financed by the Italian Ministry of Economy and Finance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Balog EM, 2009, BIOCHEMISTRY-US, V48, P3005, DOI 10.1021/bi802117k; Balog EM, 2006, AM J PHYSIOL-HEART C, V290, pH794, DOI 10.1152/ajpheart.00706.2005; Balog EM, 2003, J BIOL CHEM, V278, P15615, DOI 10.1074/jbc.M209180200; Bartlett RK, 2003, BIOCHEMISTRY-US, V42, P3231, DOI 10.1021/bi026956z; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Boschek CB, 2008, BIOCHEMISTRY-US, V47, P131, DOI 10.1021/bi701352w; BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1; Chen BW, 2005, BIOCHEMISTRY-US, V44, P4737, DOI 10.1021/bi0474113; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chin D, 1996, J BIOL CHEM, V271, P30465, DOI 10.1074/jbc.271.48.30465; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; DAVIS TN, 1986, CELL, V47, P423, DOI 10.1016/0092-8674(86)90599-4; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Dickens LS, 2012, EXP CELL RES, V318, P1269, DOI 10.1016/j.yexcr.2012.04.005; Driscoll PC, 2014, METHOD ENZYMOL, V545, P201, DOI 10.1016/B978-0-12-801430-1.00009-3; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Fairbrother WJ, 2001, PROTEIN SCI, V10, P1911, DOI 10.1110/ps.13801; Fernandez TF, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.471821; Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Gao J, 1998, BIOCHEMISTRY-US, V37, P9536, DOI 10.1021/bi9803877; Gao J, 2001, BIOPHYS J, V80, P1791, DOI 10.1016/S0006-3495(01)76149-8; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Jang TH, 2014, BIOCHEMISTRY-US, V53, P5424, DOI 10.1021/bi500585u; Jones EM, 2008, BIOPHYS J, V95, P5268, DOI 10.1529/biophysj.108.139634; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lu JV, 2014, SEMIN CELL DEV BIOL, V35, P33, DOI 10.1016/j.semcdb.2014.07.003; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; Michaelis ML, 1996, LIFE SCI, V59, P405, DOI 10.1016/0024-3205(96)00319-0; Montgomery HJ, 2003, BIOCHEMISTRY-US, V42, P7759, DOI 10.1021/bi027097h; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Papoff G, 2010, BBA-MOL CELL RES, V1803, P898, DOI 10.1016/j.bbamcr.2010.04.006; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; Pawar PS, 2008, BIOCHEM J, V412, P459, DOI 10.1042/BJ20071507; Robison AJ, 2007, BIOCHEM BIOPH RES CO, V356, P97, DOI 10.1016/j.bbrc.2007.02.087; Sacksteder CA, 2006, BIOPHYS J, V91, P1480, DOI 10.1529/biophysj.106.086033; Sandu C, 2005, J BIOL CHEM, V280, P31974, DOI 10.1074/jbc.M506938200; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; STRASBURG GM, 1988, J BIOL CHEM, V263, P542; Suever JD, 2008, BIOPHYS J, V95, P5913, DOI 10.1529/biophysj.108.130542; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Tsao DHH, 2007, J BIOMOL NMR, V39, P337, DOI 10.1007/s10858-007-9198-y; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vougier S, 2004, J BIOL CHEM, V279, P30210, DOI 10.1074/jbc.M400604200; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yao YH, 1996, BIOCHEMISTRY-US, V35, P2767, DOI 10.1021/bi951712i; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	69	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116251	10.1371/journal.pone.0116251	http://dx.doi.org/10.1371/journal.pone.0116251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643035	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821200015
J	Kang, N; Kim, H; Jae, Y; Lee, N; Ku, CR; Margolis, F; Lee, EJ; Bahk, YY; Kim, MS; Koo, J				Kang, NaNa; Kim, Hyerin; Jae, YoonGyu; Lee, NaHye; Ku, Cheol Ryong; Margolis, Frank; Lee, Eun Jig; Bahk, Young Yil; Kim, Min-Soo; Koo, JaeHyung			Olfactory Marker Protein Expression Is an Indicator of Olfactory Receptor-Associated Events in Non-Olfactory Tissues	PLOS ONE			English	Article							ODORANT RECEPTOR; GENE-EXPRESSION; FUNCTIONAL EXPRESSION; INTERSTITIAL-CELLS; SENSORY NEURONS; URINARY-BLADDER; MOLECULAR-BASIS; MOUSE; OMP; IDENTIFICATION	Olfactory receptor (OR)-associated events are mediated by well-conserved components in the olfactory epithelium, including olfactory G-protein (G(olf)), adenylate cyclase III (ACIII), and olfactory marker protein (OMP). The expression of ORs has recently been observed in non-olfactory tissues where they are involved in monitoring extracellular chemical cues. The large number of OR genes and their sequence similarities illustrate the need to find an effective and simple way to detect non-olfactory OR-associated events. In addition, expression profiles and physiological functions of ORs in non-olfactory tissues are largely unknown. To overcome limitations associated with using OR as a target protein, this study used OMP with G(olf) and ACIII as targets to screen for potential OR-mediated sensing systems in non-olfactory tissues. Here, we show using western blotting, real-time PCR, and single as well as double immunoassays that ORs and OR-associated proteins are co-expressed in diverse tissues. The results of immunohistochemical analyses showed OMP (+) cells in mouse heart and in the following cells using the corresponding marker proteins c-kit, keratin 14, calcitonin, and GFAP in mouse tissues: interstitial cells of Cajal of the bladder, medullary thymic epithelial cells of the thymus, parafollicular cells of the thyroid, and Leydig cells of the testis. The expression of ORs in OMP (+) tissues was analyzed using a refined microarray analysis and validated with RT-PCR and real-time PCR. Three ORs (olfr544, olfr558, and olfr1386) were expressed in the OMP (+) cells of the bladder and thyroid as shown using a co-immunostaining method. Together, these results suggest that OMP is involved in the OR-mediated signal transduction cascade with olfactory canonical signaling components between the nervous and endocrine systems. The results further demonstrate that OMP immunohistochemical analysis is a useful tool for identifying expression of ORs, suggesting OMP expression is an indicator of potential OR-mediated chemoreception in non-olfactory systems.	[Kang, NaNa; Jae, YoonGyu; Lee, NaHye; Koo, JaeHyung] DGIST, Dept Brain Sci, Taegu, South Korea; [Kim, Hyerin; Kim, Min-Soo] DGIST, Dept Informat & Commun Engn, Taegu, South Korea; [Ku, Cheol Ryong; Lee, Eun Jig] Yonsei Univ, Coll Med, Seoul, South Korea; [Margolis, Frank] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Bahk, Young Yil] Konkuk Univ, Dept Biotechnol, Chungju, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Yonsei University; Yonsei University Health System; University System of Maryland; University of Maryland Baltimore; Konkuk University	Kim, MS (corresponding author), DGIST, Dept Informat & Commun Engn, Taegu, South Korea.	mskim@dgist.ac.kr; jkoo001@dgist.ac.kr	Koo, JaeHyung/R-3036-2019	Koo, JaeHyung/0000-0002-5538-8001; Lee, Eun Jig/0000-0002-9876-8370; Ku, Cheol Ryong/0000-0001-8693-9630	National Research Foundation of Korea [2013R1A1A2009145]; Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs [HI13C0423]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Health Technology R&D Project, Ministry for Health, Welfare Family Affairs	This work was supported by the National Research Foundation of Korea [No. 2013R1A1A2009145 (JHK)]; Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs (HI13C0423).	BAKER H, 1989, J COMP NEUROL, V285, P246, DOI 10.1002/cne.902850207; Baldisseri DM, 2002, J MOL BIOL, V319, P823, DOI 10.1016/S0022-2836(02)00282-6; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; Chen HY, 2005, J NEUROCYTOL, V34, P37, DOI 10.1007/s11068-005-5046-8; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Davidoff MS, 2002, ACTA HISTOCHEM, V104, P39, DOI 10.1078/0065-1281-00630; Doucet S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007579; Ekberg JAK, 2011, J NEUROSCI METH, V196, P88, DOI 10.1016/j.jneumeth.2011.01.008; Farbman A, 2000, NEUROBIOLOGY TASTE S, P131; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fleischer J, 2006, HISTOCHEM CELL BIOL, V125, P337, DOI 10.1007/s00418-005-0077-x; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Fuss SH, 2005, EUR J NEUROSCI, V22, P2649, DOI 10.1111/j.1460-9568.2005.04468.x; Gray SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053423; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Horth L, 2007, GENOMICS, V90, P159, DOI 10.1016/j.ygeno.2007.03.021; Ivic L, 2000, NAT NEUROSCI, V3, P1113, DOI 10.1038/80632; Jacob S, 2002, HORM BEHAV, V42, P274, DOI 10.1006/hbeh.2002.1826; Kang N, 2012, BMB REP, V45, P612, DOI 10.5483/BMBRep.2012.45.11.232; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Koo JH, 2005, J COMP NEUROL, V487, P1, DOI 10.1002/cne.20486; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kubota Y, 2011, ADV UROL, V2011, DOI 10.1155/2011/816342; Kwon HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004260; Ma MH, 2012, ADV EXP MED BIOL, V739, P93, DOI 10.1007/978-1-4614-1704-0_6; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MARGOLIS FL, 1972, P NATL ACAD SCI USA, V69, P1221, DOI 10.1073/pnas.69.5.1221; McCloskey KD, 2010, NEUROUROL URODYNAM, V29, P82, DOI 10.1002/nau.20739; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Morillo-Bernal J, 2009, J ANAT, V215, P150, DOI 10.1111/j.1469-7580.2009.01095.x; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Murphy C, 2009, ANN NY ACAD SCI, V1170, P680, DOI 10.1111/j.1749-6632.2009.04491.x; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Nguyen MQ, 2010, J NEUROSCI, V30, P9271, DOI 10.1523/JNEUROSCI.1502-10.2010; Pifferi S., 2010, NEUROBIOLOGY OLFACTI; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Reisert J, 2007, J PHYSIOL-LONDON, V585, P731, DOI 10.1113/jphysiol.2007.142471; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Restrepo D, 1996, J NEUROBIOL, V30, P37; Shepard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068758; Smith PC, 2002, J MOL BIOL, V319, P807, DOI 10.1016/S0022-2836(02)00242-5; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Ukhanov K, 2011, J NEUROSCI, V31, P273, DOI 10.1523/JNEUROSCI.3698-10.2011; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Welge-Lussen A, 2009, B-ENT, P129; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Youngentob SL, 2001, BEHAV NEUROSCI, V115, P626, DOI 10.1037//0735-7044.115.3.626; Youngentob SL, 2003, J NEUROPHYSIOL, V90, P3864, DOI 10.1152/jn.00806.2002; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	67	49	49	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116097	10.1371/journal.pone.0116097	http://dx.doi.org/10.1371/journal.pone.0116097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635859	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700023
J	Sathyamoorthy, T; Sandhu, G; Tezera, LB; Thomas, R; Singhania, A; Woelk, CH; Dimitrov, BD; Agranoff, D; Evans, CAW; Friedland, JS; Elkington, PT				Sathyamoorthy, Tarangini; Sandhu, Gurjinder; Tezera, Liku B.; Thomas, Richard; Singhania, Akul; Woelk, Christopher H.; Dimitrov, Borislav D.; Agranoff, Dan; Evans, Carlton A. W.; Friedland, Jon S.; Elkington, Paul T.			Gender-Dependent Differences in Plasma Matrix Metalloproteinase-8 Elevated in Pulmonary Tuberculosis	PLOS ONE			English	Article							TISSUE INHIBITORS; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE-9; DISEASE; PROTEIN; SEVERITY; LEVEL; MMP-8; SERUM	Tuberculosis (TB) remains a global health pandemic and greater understanding of underlying pathogenesis is required to develop novel therapeutic and diagnostic approaches. Matrix metalloproteinases (MMPs) are emerging as key effectors of tissue destruction in TB but have not been comprehensively studied in plasma, nor have gender differences been investigated. We measured the plasma concentrations of MMPs in a carefully characterised, prospectively recruited clinical cohort of 380 individuals. The collagenases, MMP-1 and MMP-8, were elevated in plasma of patients with pulmonary TB relative to healthy controls, and MMP-7 (matrilysin) and MMP-9 (gelatinase B) were also increased. MMP-8 was TB- specific (p<0.001), not being elevated in symptomatic controls (symptoms suspicious of TB but active disease excluded). Plasma MMP-8 concentrations inversely correlated with body mass index. Plasma MMP-8 concentration was 1.51-fold higher in males than females with TB (p<0.05) and this difference was not due to greater disease severity in men. Gender-specific analysis of MMPs demonstrated consistent increase in MMP-1 and -8 in TB, but MMP-8 was a better discriminator for TB in men. Plasma collagenases are elevated in pulmonary TB and differ between men and women. Gender must be considered in investigation of TB immunopathology and development of novel diagnostic markers.	[Sathyamoorthy, Tarangini; Sandhu, Gurjinder; Agranoff, Dan; Evans, Carlton A. W.; Friedland, Jon S.; Elkington, Paul T.] Univ London Imperial Coll Sci Technol & Med, Infect Dis & Immun, London, England; [Tezera, Liku B.; Singhania, Akul; Woelk, Christopher H.; Dimitrov, Borislav D.; Elkington, Paul T.] Univ Southampton, Fac Med, NIHR Southampton Resp Biomed Res Unit, Clin & Expt Sci Acad Unit, Southampton SO9 5NH, Hants, England; [Thomas, Richard] Royal London Hosp, London, England; [Dimitrov, Borislav D.] Univ Southampton, Fac Med, Primary Care & Populat Sci, Southampton SO9 5NH, Hants, England; [Agranoff, Dan] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Evans, Carlton A. W.] Univ Peruana Cayetano Heredia, Microbiol, Lima, Peru; [Elkington, Paul T.] Univ Southampton, Inst Life Sci, Southampton, Hants, England	Imperial College London; University of Southampton; Barts Health NHS Trust; Royal London Hospital; University of Southampton; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; Universidad Peruana Cayetano Heredia; University of Southampton	Elkington, PT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Infect Dis & Immun, London, England.	p.elkington@soton.ac.uk	Singhania, Akul/I-4633-2019; Evans, Carlton/AAI-1653-2020; Dimitrov, Borislav D/A-1246-2010; Tezera, Liku/GYJ-3244-2022	Singhania, Akul/0000-0002-6941-3618; Evans, Carlton/0000-0002-6873-5447; Dimitrov, Borislav D/0000-0002-5896-2072; Woelk, Christopher/0000-0002-1977-0502; Friedland, Jonathan S/0000-0001-7789-9649; Elkington, Paul/0000-0003-0390-0613	MRC; Wellcome Clinical Research training fellowship; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme at Imperial College; Imperial College Healthcare Charity; MRC [MR/K007467/1, G0900429] Funding Source: UKRI; Medical Research Council [MR/K007467/1, G0900429] Funding Source: researchfish; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1118545] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Clinical Research training fellowship; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme at Imperial College; Imperial College Healthcare Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative	TS was funded by an MRC and GS by a Wellcome Clinical Research training fellowship. PE and JSF are grateful for support from the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) funding scheme at Imperial College. The authors are grateful for support from the Imperial College Healthcare Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktogu S, 1996, EUR RESPIR J, V9, P2031, DOI 10.1183/09031936.96.09102031; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Chen MS, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-32; Chiang TY, 2012, CLIN CHEM LAB MED, V50, P449, DOI [10.1515/cclm.2011.805, 10.1515/CCLM.2011.805]; Choi CM, 2007, INT J TUBERC LUNG D, V11, P233; DAVIDSON JM, 1990, EUR RESPIR J, V3, P1048; De Groote MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061002; Diwan VK, 1999, LANCET, V353, P1000, DOI 10.1016/S0140-6736(99)01318-5; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Elkington PT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001847; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390; Hartog CM, 2003, AM J RESP CRIT CARE, V167, P593, DOI 10.1164/rccm.200203-258OC; HIBBS MS, 1989, J CLIN INVEST, V84, P1395, DOI 10.1172/JCI114312; Hrabec E, 2002, INT J TUBERC LUNG D, V6, P713; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; Mannello F, 2008, ARTERIOSCL THROM VAS, V28, P611, DOI 10.1161/ATVBAHA.107.159608; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Mattey DL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4042; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Nhamoyebonde S, 2014, J INFECT DIS, V209, pS100, DOI 10.1093/infdis/jiu147; Parks WC, 2001, RESP RES, V2, P10, DOI 10.1186/rr33; Puljiz I, 2012, MED SCI MONITOR, V18, pCR500, DOI 10.12659/MSM.883270; Rodrigo T, 1997, INT J TUBERC LUNG D, V1, P352; Sandhu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038080; Seddon J, 2013, J INFECT DIS, V208, P1571, DOI 10.1093/infdis/jit343; SEPPER R, 1995, CHEST, V107, P1641, DOI 10.1378/chest.107.6.1641; Smith JM, 2007, AM J REPROD IMMUNOL, V58, P111, DOI 10.1111/j.1600-0897.2007.00494.x; Sundararajan S, 2012, HUM IMMUNOL, V73, P985, DOI 10.1016/j.humimm.2012.07.042; Tadokera R, 2014, EUR J IMMUNOL, V44, P127, DOI 10.1002/eji.201343593; Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663; Ugarte-Gil CA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061333, 10.1371/journal.pone.0069514]; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Walker NF, 2012, AM J RESP CRIT CARE, V185, P989, DOI 10.1164/rccm.201110-1769OC; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Weiss MG, 2006, GENDER AND TUBERCULO; WHO, 2014, GLOBAL TUBERCULOSIS; Yang SF, 2005, CLIN CHIM ACTA, V352, P209, DOI 10.1016/j.cccn.2004.09.025; Yoder MA, 2004, CURR SCI INDIA, V86, P74	41	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117605	10.1371/journal.pone.0117605	http://dx.doi.org/10.1371/journal.pone.0117605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635689	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000350680700091
J	Kucharzewska, P; Christianson, HC; Belting, M				Kucharzewska, Paulina; Christianson, Helena C.; Belting, Mattias			Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR 1-ALPHA; ALDOSE REDUCTASE; CANCER-CELLS; TUMOR-GROWTH; CELLULAR-METABOLISM; MEDIATED INDUCTION; MALIGNANT GLIOMA; INHIBITION; EXPRESSION	Oncogenetic events and unique phenomena of the tumor microenvironment together induce adaptive metabolic responses that may offer new diagnostic tools and therapeutic targets of cancer. Hypoxia, or low oxygen tension, represents a well- established and universal feature of the tumor microenvironment and has been linked to increased tumor aggressiveness as well as resistance to conventional oncological treatments. Previous studies have provided important insights into hypoxia induced changes of the transcriptome and proteome; however, how this translates into changes at the metabolite level remains to be defined. Here, we have investigated dynamic, time- dependent effects of hypoxia on the cancer cell metabolome across all families of macromolecules, i.e., carbohydrate, protein, lipid and nucleic acid, in human glioblastoma cells. Using GC/MS and LC/MS/ MS, 345 and 126 metabolites were identified and quantified in cells and corresponding media, respectively, at short (6 h), intermediate (24 h), and prolonged (48 h) incubation at normoxic or hypoxic (1% O-2) conditions. In conjunction, we performed gene array studies with hypoxic and normoxic cells following short and prolonged incubation. We found that levels of several key metabolites varied with the duration of hypoxic stress. In some cases, metabolic changes corresponded with hypoxic regulation of key pathways at the transcriptional level. Our results provide new insights into the metabolic response of glioblastoma cells to hypoxia, which should stimulate further work aimed at targeting cancer cell adaptive mechanisms to microenvironmental stress.	[Kucharzewska, Paulina; Christianson, Helena C.; Belting, Mattias] Lund Univ, Dept Clin Sci, Sect Oncol & Pathol, Lund, Sweden; [Belting, Mattias] Skane Univ Hosp, Skane Oncol Clin, Lund, Sweden	Lund University; Lund University; Skane University Hospital	Belting, M (corresponding author), Lund Univ, Dept Clin Sci, Sect Oncol & Pathol, Lund, Sweden.	mattias.belting@med.lu.se	Kucharzewska, Paulina/AAI-6248-2020	Belting, Mattias/0000-0003-1585-5434	Swedish Cancer Fund; Swedish Research Council; Gunnar Nilsson; Anna Lisa and Sven Eric Lundgren; Kamprad Foundations; Skayne University Hospital donation funds	Swedish Cancer Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson; Anna Lisa and Sven Eric Lundgren; Kamprad Foundations; Skayne University Hospital donation funds	This work was supported by grants (to MB) from the Swedish Cancer Fund (www.cancerfonden. se); the Swedish Research Council (www.vr.se); the Gunnar Nilsson (www.cancerstiftelsen.com), Anna Lisa and Sven Eric Lundgren (www.med.lu.se), and Kamprad Foundations (www.med.lu.se); the Skayne University Hospital donation funds (www.med.lu.se); and the Governmental funding of clinical research within the national health services (www.med.lu.se).	Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chinnaiyan P, 2012, CANCER RES, V72, P5878, DOI 10.1158/0008-5472.CAN-12-1572-T; Crucet M, 2013, ATHEROSCLEROSIS, V229, P110, DOI 10.1016/j.atherosclerosis.2013.04.034; Delikatny EJ, 2011, NMR BIOMED, V24, P592, DOI 10.1002/nbm.1661; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Eberstal S, 2014, INT J CANCER, V134, P2748, DOI 10.1002/ijc.28607; Elsherbiny ME, 2013, PROG LIPID RES, V52, P562, DOI 10.1016/j.plipres.2013.08.004; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Ferretti A, 2002, BRIT J CANCER, V86, P1180, DOI 10.1038/sj/bjc/6600189; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GARTY H, 1991, AM J PHYSIOL, V260, pF650, DOI 10.1152/ajprenal.1991.260.5.F650; Glunde K, 2008, CANCER RES, V68, P172, DOI 10.1158/0008-5472.CAN-07-2678; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Gorin A, 2012, CURR OPIN PHARMACOL, V12, P710, DOI 10.1016/j.coph.2012.06.011; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hla T, 2012, CELL METAB, V16, P420, DOI 10.1016/j.cmet.2012.06.017; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Kuruvilla R, 1998, J NEUROCHEM, V71, P775; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liu HB, 2010, CANCER RES, V70, P6368, DOI 10.1158/0008-5472.CAN-09-4615; Lorenzi M, 2007, EXP DIABETES RES, DOI 10.1155/2007/61038; Lynch TP, 2011, CELL CYCLE, V10, P1712, DOI 10.4161/cc.10.11.15561; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Myung J, 2010, NEUROPATHOLOGY, V30, P224, DOI 10.1111/j.1440-1789.2009.01072.x; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pelletier J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00018; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Sato S, 2003, CHEM-BIOL INTERACT, V143, P363, DOI 10.1016/S0009-2797(02)00209-0; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Simic P, 2013, CELL REP, V3, P1175, DOI 10.1016/j.celrep.2013.03.019; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki K, 2013, NEURO-ONCOLOGY, V15, P1186, DOI 10.1093/neuonc/not062; Svensson KJ, 2008, CANCER RES, V68, P9291, DOI 10.1158/0008-5472.CAN-08-2340; Tammali R, 2011, CURR CANCER DRUG TAR, V11, P560, DOI 10.2174/156800911795655958; Tammali R, 2011, J BIOL CHEM, V286, P24089, DOI 10.1074/jbc.M111.219733; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Uzozie A, 2014, MOL CELL PROTEOMICS, V13, P1198, DOI 10.1074/mcp.M113.035105; Wang T, 2014, P NATL ACAD SCI US; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wu LY, 2010, CELL STRESS CHAPERON, V15, P387, DOI 10.1007/s12192-009-0153-6; Yandim MK, 2013, CANCER CHEMOTH PHARM, V71, P13, DOI 10.1007/s00280-012-1984-x; Yin J, 2010, FEBS LETT, V584, P1872, DOI 10.1016/j.febslet.2009.11.019; Yuan HF, 2013, ONCOTARGETS THER, V6, P1399, DOI 10.2147/OTT.S37750; Zhang CZ, 2013, NEURO-ONCOLOGY, V15, P1114, DOI 10.1093/neuonc/not087; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zodro E, 2014, TUMOR BIOL, V35, P2607, DOI 10.1007/s13277-013-1344-4	65	64	65	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116740	10.1371/journal.pone.0116740	http://dx.doi.org/10.1371/journal.pone.0116740			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633823	Green Published, Green Submitted, gold			2022-12-26	WOS:000348609800009
J	Sundaramoorthy, P; Sim, JJ; Jang, YS; Mishra, SK; Jeong, KY; Mander, P; Chul, OB; Shim, WS; Oh, SH; Nam, KY				Sundaramoorthy, Pasupathi; Sim, Jae Jun; Jang, Yeong-Su; Mishra, Siddhartha Kumar; Jeong, Keun-Yeong; Mander, Poonam; Chul, Oh Byung; Shim, Won-Sik; Oh, Seung Hyun; Nam, Ky-Youb			Modulation of Intracellular Calcium Levels by Calcium Lactate Affects Colon Cancer Cell Motility through Calcium-Dependent Calpain	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; TUMOR-GROWTH; METABOLISM; P53; MICROENVIRONMENT; PROLIFERATION; DIETARY	Cancer cell motility is a key phenomenon regulating invasion and metastasis. Focal adhesion kinase (FAK) plays a major role in cellular adhesion and metastasis of various cancers. The relationship between dietary supplementation of calcium and colon cancer has been extensively investigated. However, the effect of calcium (Ca2+) supplementation on calpain-FAK-motility is not clearly understood. We sought to identify the mechanism of FAK cleavage through Ca2+ bound lactate (CaLa), its downstream signaling and role in the motility of human colon cancer cells. We found that treating HCT116 and HT-29 cells with CaLa immediately increased the intracellular Ca2+ (iCa(2+)) levels for a prolonged period of time. Ca2+ influx induced cleavage of FAK into an N-terminal FAK (FERM domain) in a dose-dependent manner. Phosphorylated FAK (p-FAK) was also cleaved in to its p-N-terminal FAK. CaLa increased colon cancer cells motility. Calpeptin, a calpain inhibitor, reversed the effects of CaLa on FAK and pFAK cleavage in both cancer cell lines. The cleaved FAK translocates into the nucleus and modulates p53 stability through MDM2-associated ubiquitination. CaLa-induced Ca2+ influx increased the motility of colon cancer cells was mediated by calpain activity through FAK and pFAK protein destabilization. In conclusion, these results suggest that careful consideration may be given in deciding dietary Ca2+ supplementation to patient undergoing treatment for metastatic cancer.	[Sundaramoorthy, Pasupathi; Sim, Jae Jun; Jang, Yeong-Su; Mishra, Siddhartha Kumar; Jeong, Keun-Yeong; Mander, Poonam; Chul, Oh Byung; Shim, Won-Sik; Oh, Seung Hyun; Nam, Ky-Youb] Gachon Univ, Gachon Inst Pharmaceut Sci, Inchon 406840, South Korea; [Chul, Oh Byung] Gachon Univ, Dept Mol Med, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea; [Mishra, Siddhartha Kumar] Dr Harisingh Gour Cent Univ, Sch Biol Sci, Dept Zool, Sagar 470003, India	Gachon University; Gachon University; Dr. Hari Singh Gour University	Nam, KY (corresponding author), Gachon Univ, Gachon Inst Pharmaceut Sci, Inchon 406840, South Korea.	hwanmook@gachon.ac.kr	Oh, Seung/AAN-6744-2021; Jeong, Keun-Yeong/B-8845-2015; Sundaramoorthy, Pasupathi/AAC-9823-2021; Mishra, Siddhartha Kumar/A-4344-2016; Sundaramoorthy, Pasupathi/I-4307-2019; Shim, Won-Sik/HGU-0398-2022	Jeong, Keun-Yeong/0000-0002-4933-3493; Sundaramoorthy, Pasupathi/0000-0003-1045-093X; Mishra, Siddhartha Kumar/0000-0003-1627-1377; Sundaramoorthy, Pasupathi/0000-0003-1045-093X; 	Gachon Institute of Pharmaceutical Sciences Research Fund, Gachon University, Republic of Korea	Gachon Institute of Pharmaceutical Sciences Research Fund, Gachon University, Republic of Korea	This work was supported by Gachon Institute of Pharmaceutical Sciences Research Fund 2013, Gachon University, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Choi SYC, 2013, J PATHOL, V230, P350, DOI 10.1002/path.4218; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Golubovskaya VM, 2009, INT J CANCER, V125, P1735, DOI 10.1002/ijc.24486; Hao HF, 2012, BIOCHEM BIOPH RES CO, V423, P744, DOI 10.1016/j.bbrc.2012.06.030; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kato Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-89; Kennedy KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075154; Kim Y, 2009, CURR MOL MED, V9, P425, DOI 10.2174/156652409788167113; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mierke CT, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/6/065005; Miller EA, 2007, CANCER-AM CANCER SOC, V109, P510, DOI 10.1002/cncr.22453; Mishra SK, 2013, EUR J INFLAMM, V11, P615, DOI 10.1177/1721727X1301100306; Mishra SK, 2013, MOL CELLS, V36, P219, DOI 10.1007/s10059-013-0050-9; Mishra SK, 2012, J ETHNOPHARMACOL, V143, P524, DOI 10.1016/j.jep.2012.07.008; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Parkash J, 2010, LIFE SCI, V87, P587, DOI 10.1016/j.lfs.2010.09.013; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rinella ES, 2012, CANCER BIOL THER, V13, P130, DOI 10.4161/cbt.13.3.18690; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	31	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116984	10.1371/journal.pone.0116984	http://dx.doi.org/10.1371/journal.pone.0116984			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629974	gold, Green Published, Green Submitted			2022-12-26	WOS:000348732100056
J	Wang, QX; Li, SH; Zhang, X; Xie, L; Cai, PQ; An, X; Pan, ZZ; Ding, PR				Wang, Qiao-Xuan; Li, Shao-Hua; Zhang, Xu; Xie, Lan; Cai, Pei-Qiang; An, Xin; Pan, Zhi-Zhong; Ding, Pei-Rong			Identification of Locally Advanced Rectal Cancer with Low Risk of Local Recurrence	PLOS ONE			English	Article							TOTAL MESORECTAL EXCISION; CIRCUMFERENTIAL RESECTION MARGIN; SPHINCTER PRESERVATION RATE; PREOPERATIVE RADIOTHERAPY; POSTOPERATIVE CHEMORADIOTHERAPY; NEOADJUVANT CHEMORADIOTHERAPY; PROGNOSTIC-SIGNIFICANCE; FOLLOW-UP; SURGERY; MULTICENTER	Background The routine application of neoadjuvant chemoradiotherapy for T3N0 rectal cancer remains controversial. The aim of this study was to use clinical, Magnetic resonance imaging, and pathological parameters to identify a subgroup of patients with low risk of local recurrence who might be precluded from neoadjuvant chemoradiotherapy. Methods We retrospectively reviewed a prospectively maintained database of consecutive rectal cancer patients who underwent curative resection. 166 pathologic confirmed T3N0 rectal cancer patients with tumor located 5-12cm above the anal verge and preoperative circumferential resection margin> 1mm were included in analysis. The primary outcomes measured were 3-and 5-year local recurrence rates. Results Local recurrence was demonstrated during follow-up in 5 patients; the actuarial overall 3-and 5-year local recurrence rates were 2.5% and 3.4%, respectively. Inadequate sampling of lymph nodes (<= 12) was associated with higher local recurrence (P = 0.03) in this group of patients. Conclusion For upper and middle T3N0 rectal cancer with preoperative circumferential resection margin> 1mm, local recurrence rate after total mesorectal excision is low and surgery alone may be enough for this group of patients.	[Wang, Qiao-Xuan; Li, Shao-Hua; Zhang, Xu; Xie, Lan; Cai, Pei-Qiang; An, Xin; Pan, Zhi-Zhong; Ding, Pei-Rong] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Wang, Qiao-Xuan; Li, Shao-Hua; Zhang, Xu; Xie, Lan; Cai, Pei-Qiang; An, Xin; Pan, Zhi-Zhong; Ding, Pei-Rong] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Qiao-Xuan] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Shao-Hua] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xu] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Lan] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Pei-Qiang] Sun Yat Sen Univ, Ctr Canc, Dept Med Imaging & Intervent Radiol, Guangzhou 510275, Guangdong, Peoples R China; [An, Xin] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Zhi-Zhong; Ding, Pei-Rong] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Pan, ZZ (corresponding author), Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	panzhzh@sysucc.org.cn; dingpr@mail.sysu.edu.cn						Al-Sukhni E, 2012, ANN SURG ONCOL, V19, P2212, DOI 10.1245/s10434-011-2210-5; Baik SH, 2008, J GASTROINTEST SURG, V12, P176, DOI 10.1007/s11605-007-0254-4; Beets-Tan RGH, 2001, LANCET, V357, P497, DOI 10.1016/S0140-6736(00)04040-X; Birgisson H, 2008, BRIT J SURG, V95, P206, DOI 10.1002/bjs.5918; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Dahlberg M, 1998, DIS COLON RECTUM, V41, P543, DOI 10.1007/BF02235256; De Caluwe L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006041.pub3; Engstrom PF, 2009, J NATL COMPR CANC NE, V7, P838, DOI 10.6004/jnccn.2009.0057; ENKER WE, 1995, J AM COLL SURGEONS, V181, P335; Ferenschild FTJ, 2009, DIGEST SURG, V26, P291, DOI 10.1159/000227771; Frasson M, 2011, CANCER-AM CANCER SOC, V117, P3118, DOI 10.1002/cncr.25866; Glimelius B, 2013, ANN ONCOL, V24, P81, DOI 10.1093/annonc/mdt240; HEALD RJ, 1986, LANCET, V1, P1479; Kim DW, 2006, EJSO-EUR J SURG ONC, V32, P162, DOI 10.1016/j.ejso.2005.10.002; Kim SH, 2009, J MAGN RESON IMAGING, V29, P1093, DOI 10.1002/jmri.21742; MCDERMOTT FT, 1985, BRIT J SURG, V72, P34, DOI 10.1002/bjs.1800720115; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Nissan A, 2006, J CLIN ONCOL, V24, P4078, DOI 10.1200/JCO.2006.06.2968; Picon AI, 2003, INT J COLORECTAL DIS, V18, P487, DOI 10.1007/s00384-003-0504-1; Sarli L, 2005, EUR J CANCER, V41, P272, DOI 10.1016/j.ejca.2004.10.010; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Wibe A, 2002, BRIT J SURG, V89, P327, DOI 10.1046/j.0007-1323.2001.02024.x	24	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117141	10.1371/journal.pone.0117141	http://dx.doi.org/10.1371/journal.pone.0117141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629521	Green Submitted, Green Published, gold			2022-12-26	WOS:000348732100068
J	Webster, B; Hayes, W; Pike, TW				Webster, Ben; Hayes, William; Pike, Thomas W.			Avian Egg Odour Encodes Information on Embryo Sex, Fertility and Development	PLOS ONE			English	Article							OLFACTORY NAVIGATION; CHEMICAL CUES; BIRDS; YOLK; CAROTENOIDS; TEMPERATURE; ATTRACTION; INVESTMENT; EVOLUTION; RESPONSES	Avian chemical communication is a rapidly emerging field, but has been hampered by a critical lack of information on volatile chemicals that communicate ecologically relevant information (semiochemicals). A possible, but as yet unexplored, function of olfaction and chemical communication in birds is in parent-embryo and embryo-embryo communication. Communication between parents and developing embryos may act to mediate parental behaviour, while communication between embryos can control the synchronicity of hatching. Embryonic vocalisations and vibrations have been implicated as a means of communication during the later stages of development but in the early stages, before embryos are capable of independent movement and vocalisation, this is not possible. Here we show that volatiles emitted from developing eggs of Japanese quail (Coturnix japonica) convey information on egg fertility, along with the sex and developmental status of the embryo. Specifically, egg volatiles changed over the course of incubation, differed between fertile and infertile eggs, and were predictive of embryo sex as early as day 1 of incubation. Egg odours therefore have the potential to facilitate parent-embryo and embryo-embryo interactions by allowing the assessment of key measures of embryonic development long before this is possible through other modalities. It also opens up the intriguing possibility that parents may be able to glean further relevant information from egg volatiles, such as the health, viability and heritage of embryos. By determining information conveyed by egg-derived volatiles, we hope to stimulate further investigation into the ecological role of egg odours.	[Webster, Ben; Hayes, William; Pike, Thomas W.] Lincoln Univ, Sch Life Sci, Lincoln, England	University of Lincoln	Pike, TW (corresponding author), Lincoln Univ, Sch Life Sci, Lincoln, England.	tpike@lincoln.ac.uk			Natural Environment Research Council [NE/J01382X/1]; Royal Society; NERC [NE/J01382X/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by grants awarded to TWP from the Natural Environment Research Council (NE/J01382X/1) and Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ar A, 2004, AVIAN POULT BIOL REV, V15, P105, DOI 10.3184/147020604783638218; Badyaev AV, 2006, J EVOLUTION BIOL, V19, P1044, DOI 10.1111/j.1420-9101.2006.01106.x; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Balthazart J, 2009, BEHAV BRAIN RES, V200, P248, DOI 10.1016/j.bbr.2008.08.036; Berlin KE, 1998, ETHOLOGY, V104, P531, DOI 10.1111/j.1439-0310.1998.tb00088.x; Boal JG, 2010, J CHEM ECOL, V36, P834, DOI 10.1007/s10886-010-9816-0; Brua RB, 1996, AUK, V113, P525, DOI 10.2307/4088972; Brua RB, 2002, OX ORN SER, V13, P88; Campagna S, 2012, CHEM SENSES, V37, P3, DOI 10.1093/chemse/bjr067; Cook MI, 2004, BEHAV ECOL, V15, P205, DOI 10.1093/beheco/arg096; Cunningham GB, 2012, ANTARCT SCI, V24, P337, DOI 10.1017/S0954102012000168; EVANS RM, 1990, ANIM BEHAV, V40, P969, DOI 10.1016/S0003-3472(05)80999-6; EVANS RM, 1990, ANIM BEHAV, V40, P963, DOI 10.1016/S0003-3472(05)80998-4; FRANKEL EN, 1989, LIPIDS, V24, P976, DOI 10.1007/BF02544544; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gilbert L, 2005, NATURWISSENSCHAFTEN, V92, P178, DOI 10.1007/s00114-004-0603-z; Golubeya TB, 1985, ACT 18 INT ORN C NAU, P259; GRUBB TC, 1974, ANIM BEHAV, V22, P192, DOI 10.1016/S0003-3472(74)80069-2; Himanen SJ, 2010, PLANT SIGNAL BEHAV, V5, P1234, DOI 10.4161/psb.5.10.12919; Jahantigh Mohammad, 2012, Comparative Clinical Pathology, V21, P1049, DOI 10.1007/s00580-011-1226-3; Kochhar HPS, 2001, THERIOGENOLOGY, V55, P3, DOI 10.1016/S0093-691X(00)00441-6; MAGA JA, 1982, J AGR FOOD CHEM, V30, P9, DOI 10.1021/jf00109a002; MAGRATH RD, 1992, AUK, V109, P474; Mardon J, 2010, CHEM SENSES, V35, P309, DOI 10.1093/chemse/bjq021; Martins TLF, 2004, BEHAV ECOL, V15, P174, DOI 10.1093/beheco/arg094; McNabb FMA, 1998, AVIAN GROWTH DEV, P288; Meiners T, 2000, ENTOMOL EXP APPL, V95, P151, DOI 10.1023/A:1004098802806; Mirza RS, 2002, J FISH BIOL, V61, P532, DOI 10.1006/jfbi.2002.2052; Moreno J, 2003, ECOL LETT, V6, P803, DOI 10.1046/j.1461-0248.2003.00505.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Petrie M, 2001, NATURE, V412, P498, DOI 10.1038/35087652; Pike TW, 2011, AVIAN BIOL RES, V4, P231, DOI 10.3184/175815511X13228268534598; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; Rajchard J, 2008, VET MED-CZECH, V53, P412, DOI 10.17221/1926-VETMED; Reed WL, 2011, INTEGR COMP BIOL, V51, P73, DOI 10.1093/icb/icr032; Rubel EW M, HDB SENSORY PHYSL DE, P13; Saino N, 2003, J EVOLUTION BIOL, V16, P516, DOI 10.1046/j.1420-9101.2003.00534.x; SCHWAGMEYER PL, 1991, ANIM BEHAV, V41, P887, DOI 10.1016/S0003-3472(05)80355-0; Spurr E. B., 1999, Science for Conservation, P1; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; Surai P. F., 2002, NATURAL ANTIOXIDANTS; Trimeche A, 1997, CRYOBIOLOGY, V34, P385, DOI 10.1006/cryo.1997.2009; VINCE MA, 1970, ANIM BEHAV, V18, P210, DOI 10.1016/S0003-3472(70)80030-6; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; Weissmann A, 2013, THERIOGENOLOGY, V80, P199, DOI 10.1016/j.theriogenology.2013.04.014; Whittaker DJ, 2011, J CHEM ECOL, V37, P1349, DOI 10.1007/s10886-011-0050-1; Whittaker DJ, 2010, BEHAV ECOL, V21, P608, DOI 10.1093/beheco/arq033; Yavno S, 2011, J FISH BIOL, V78, P1944, DOI 10.1111/j.1095-8649.2011.02964.x	51	33	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116345	10.1371/journal.pone.0116345	http://dx.doi.org/10.1371/journal.pone.0116345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629413	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000348732100035
J	Fei, YR; Shimizu, E; McBurney, MW; Partridge, NC				Fei, Yurong; Shimizu, Emi; McBurney, Michael W.; Partridge, Nicola C.			Sirtuin 1 Is a Negative Regulator of Parathyroid Hormone Stimulation of Matrix Metalloproteinase 13 Expression in Osteoblastic Cells ROLE OF SIRTUIN 1 IN THE ACTION OF PTH ON OSTEOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; RAT COLLAGENASE-3 PROMOTER; ACTIVATOR PROTEIN-1; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; C-JUN; RESVERATROL; DIFFERENTIATION; RECEPTOR; GROWTH	Parathyroid hormone (PTH) is the only current anabolic treatment for osteoporosis in the United States. PTH stimulates expression of matrix metalloproteinase 13 (MMP13) in bone. Sirtuin 1 (SIRT1), an NAD-dependent deacetylase, participates in a variety of human diseases. Here we identify a role for SIRT1 in the action of PTH in osteoblasts. We observed increased Mmp13 mRNA expression and protein levels in bone from Sirt1 knock-out mice compared with wild type mice. PTH-induced Mmp13 expression was significantly blocked by the SIRT1 activator, resveratrol, in osteoblastic UMR 106-01 cells. In contrast, the SIRT1 inhibitor, EX527, significantly enhanced PTH-induced Mmp13 expression. Two h of PTH treatment augmented SIRT1 association with c-Jun, a component of the transcription factor complex, activator protein 1 (AP-1), and promoted SIRT1 association with the AP-1 site of the Mmp13 promoter. This binding was further increased by resveratrol, implicating SIRT1 as a feedback inhibitor regulating Mmp13 transcription. The AP-1 site of the Mmp13 promoter is required for PTH stimulation of Mmp13 transcriptional activity. When the AP-1 site was mutated, EX527 was unable to increase PTH-stimulated Mmp13 promoter activity, indicating a role for the AP-1 site in SIRT1 inhibition. We further showed that SIRT1 deacetylates c-Jun and that the cAMP pathway participates in this deacetylation process. These data indicate that SIRT1 is a negative regulator of MMP13 expression, SIRT1 activation inhibits PTH stimulation of Mmp13 expression, and this regulation is mediated by SIRT1 association with c-Jun at the AP-1 site of the Mmp13 promoter.	[Fei, Yurong; Shimizu, Emi; Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [McBurney, Michael W.] Ottawa Hlth Res Ctr Inst, Ottawa, ON K1H 8L6, Canada	New York University; University of Ottawa; Ottawa Hospital Research Institute	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 E 24th St,902A, New York, NY 10010 USA.	ncp234@nyu.edu		Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [5R01DK047420-20]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01DK047420-20 (to N. C. P.).	Andereya S, 2006, RHEUMATOL INT, V26, P432, DOI 10.1007/s00296-005-0006-2; Backesjo CM, 2006, J BONE MINER RES, V21, P993, DOI 10.1359/JBMR.060415; Barmina OY, 1999, J BIOL CHEM, V274, P30087, DOI 10.1074/jbc.274.42.30087; BERNDT TJ, 1981, ENDOCRINOLOGY, V108, P2005, DOI 10.1210/endo-108-5-2005; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; Edwards JR, 2013, J BONE MINER RES, V28, P960, DOI 10.1002/jbmr.1824; Elmali N, 2005, INFLAMM RES, V54, P158, DOI 10.1007/s00011-004-1341-6; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gagarina V, 2010, ARTHRITIS RHEUM-US, V62, P1383, DOI 10.1002/art.27369; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Khan A, 2000, CAN MED ASSOC J, V163, P184; Knight CM, 2011, DIABETES, V60, P2691, DOI 10.2337/db10-0987; Lee HS, 2013, ARTHRITIS RHEUM-US, V65, P1776, DOI 10.1002/art.37963; Lee M, 2010, J BIOL CHEM, V285, P38014, DOI 10.1074/jbc.M110.142141; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357; Matsushita T, 2013, J ORTHOP RES, V31, P531, DOI 10.1002/jor.22268; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mizutani K, 2000, J NUTR SCI VITAMINOL, V46, P78, DOI 10.3177/jnsv.46.78; Niederer F, 2011, ANN RHEUM DIS, V70, P1866, DOI 10.1136/ard.2010.148957; OMURA TH, 1994, J BIOL CHEM, V269, P24994; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piao J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03022; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; SCOTT DK, 1992, MOL ENDOCRINOL, V6, P2153, DOI 10.1210/me.6.12.2153; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; Shakibaei M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035712; Shimizu E, 2010, J BIOL CHEM, V285, P9616, DOI 10.1074/jbc.M109.094862; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tseng PC, 2011, J BONE MINER RES, V26, P2552, DOI 10.1002/jbmr.460; Uchida M, 2001, J BONE MINER METAB, V19, P207, DOI 10.1007/s007740170022; Walling HW, 1998, J CELL PHYSIOL, V177, P563, DOI 10.1002/(SICI)1097-4652(199812)177:4<563::AID-JCP7>3.0.CO;2-B; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Winchester SK, 2000, J BIOL CHEM, V275, P23310, DOI 10.1074/jbc.M003004200; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yang JH, 2010, ENDOCRINE, V37, P365, DOI 10.1007/s12020-010-9314-8; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zainabadi K., 2009, THESIS MIT; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	59	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8373	8382		10.1074/jbc.M114.602763	http://dx.doi.org/10.1074/jbc.M114.602763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25631045	Green Published, hybrid			2022-12-26	WOS:000351662600031
J	Schmidt, T; Suk, JE; Ye, F; Situ, AJ; Mazumder, P; Ginsberg, MH; Ulmer, TS				Schmidt, Thomas; Suk, Jae-Eun; Ye, Feng; Situ, Alan J.; Mazumder, Parichita; Ginsberg, Mark H.; Ulmer, Tobias S.			Annular Anionic Lipids Stabilize the Integrin alpha IIb beta 3 Transmembrane Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; PHOSPHOLIPID-BILAYER NANODISCS; MOLECULAR-DYNAMICS SIMULATIONS; MEMBRANE-PROTEIN; PLASMA-MEMBRANE; LIGAND-BINDING; WATER; MODULATION; ACTIVATION; RECEPTOR	Cationic membrane-proximal amino acids determine the topology of membrane proteins by interacting with anionic lipids that are restricted to the intracellular membrane leaflet. This mechanism implies that anionic lipids interfere with electrostatic interactions of membrane proteins. The integrin alpha IIb beta 3 transmembrane (TM) complex is stabilized by a membraneproximal alpha IIb(Arg(995))-alpha 3(Asp(723)) interaction; here, we examine the influence of anionic lipids on this complex. Anionic lipids compete for alpha IIb(Arg(995)) contacts with beta 3(Asp(723)) but paradoxically do not diminish the contribution of alpha IIb(Arg(995))-beta 3(Asp(723)) to TM complex stability. Overall, anionic lipids in annular positions stabilize the similar to IIb similar to 3 TM complex by up to 0.50 +/- 0.02 kcal/mol relative to zwitterionic lipids in a headgroup structure-dependent manner. Comparatively, integrin receptor activation requires TM complex destabilization of 1.5 +/- 0.2 kcal/mol, revealing a sizeable influence of lipid composition onTMcomplex stability. Weimplicate changes in lipid headgroup accessibility to small molecules (physical membrane characteristics) and specific but dynamic protein-lipid contacts in thisTMhelix-helix stabilization. Thus, anionic lipids in ubiquitous annular positions can benefit the stability of membrane proteins while leaving membrane-proximal electrostatic interactions intact.	[Schmidt, Thomas; Suk, Jae-Eun; Situ, Alan J.; Mazumder, Parichita; Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Schmidt, Thomas; Suk, Jae-Eun; Situ, Alan J.; Mazumder, Parichita; Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Ye, Feng; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Southern California; University of Southern California; University of California System; University of California San Diego	Ulmer, TS (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90033 USA.	tulmer@usc.edu		Mazumder, Parichita/0000-0001-7578-7854	National Institutes of Health [HL31950, HL078784, HL117807]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950, P01HL078784, R01HL117807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL31950, HL078784, and HL117807 (to M. H. G.).	Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x; Bogdanov M, 2009, J BIOL CHEM, V284, P9637, DOI 10.1074/jbc.R800081200; Brini M, 2010, J BIOL CHEM, V285, P30779, DOI 10.1074/jbc.M110.140475; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; CONFORTI G, 1990, J BIOL CHEM, V265, P4011; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Fleming KG, 2002, J MOL BIOL, V323, P563, DOI 10.1016/S0022-2836(02)00920-8; GarciaGuerra R, 1996, PLATELETS, V7, P195, DOI 10.3109/09537109609023579; Gumbart J, 2005, CURR OPIN STRUC BIOL, V15, P423, DOI 10.1016/j.sbi.2005.07.007; HENRY GD, 1995, J BIOMOL NMR, V6, P59, DOI 10.1007/BF00417492; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalli AC, 2011, STRUCTURE, V19, P1477, DOI 10.1016/j.str.2011.07.014; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Koldso H, 2012, J PHYS CHEM LETT, V3, P3498, DOI 10.1021/jz301570w; KOUNS WC, 1992, J BIOL CHEM, V267, P18844; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Petrache HI, 2004, BIOPHYS J, V86, P1574, DOI 10.1016/S0006-3495(04)74225-3; Powl AM, 2005, BIOCHEMISTRY-US, V44, P5873, DOI 10.1021/bi047439e; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Situ AJ, 2014, J MOL BIOL, V426, P3670, DOI 10.1016/j.jmb.2014.08.020; SMYTH SS, 1992, J BIOL CHEM, V267, P15568; Suk JE, 2012, J AM CHEM SOC, V134, P9030, DOI 10.1021/ja304247f; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tellinghuisen J, 2008, ANAL BIOCHEM, V373, P395, DOI 10.1016/j.ab.2007.08.039; Triba MN, 2005, BIOPHYS J, V88, P1887, DOI 10.1529/biophysj.104.055061; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Ulmer TS, 2010, CELL ADHES MIGR, V4, P243, DOI 10.4161/cam.4.2.10592; Ulmer TS, 2004, J MAGN RESON, V166, P190, DOI 10.1016/j.jmr.2003.10.012; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhang YL, 1998, ANAL BIOCHEM, V261, P139, DOI 10.1006/abio.1998.2738; Zhao W, 2007, BIOPHYS J, V92, P1114, DOI 10.1529/biophysj.106.086272; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022; ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	58	21	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8283	8293		10.1074/jbc.M114.623504	http://dx.doi.org/10.1074/jbc.M114.623504			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25632962	hybrid, Green Published			2022-12-26	WOS:000351662600024
J	Howlader, MSA; Nair, A; Gopalan, SV; Merila, J				Howlader, Mohammad Sajid Ali; Nair, Abhilash; Gopalan, Sujith V.; Merilae, Juha			A New Species of Euphlyctis (Anura: Dicroglossidae) from Barisal, Bangladesh	PLOS ONE			English	Article							GENETIC-DIVERGENCE; AMPHIBIA; INDIA; RANIDAE	A new species of the genus Euphlyctis is described from the Barisal district of Bangladesh and compared with its morphologically similar and geographically proximate congeners. The new species is highly divergent in comparison to other congeneric species on basis of sequence divergence in mitochondrial DNA gene sequences (ranging from 5.5% to 17.8% divergence). Euphlyctis kalasgramensis sp. nov. can be readily diagnosed by having the following combination of characters: snout-vent length (SVL) 30.44 - 37.88 mm, absence of mid-dorsal line, nostril-snout length 3% of SVL, nostril much closer to snout tip than eye, nostril-snout length 48% of distance from front of eyes to nostril, relative length of fingers (shortest to longest: 1 = 2 < 4 < 3), tibia length 59% of SVL, foot length 55% of SVL.	[Howlader, Mohammad Sajid Ali; Nair, Abhilash; Merilae, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland; [Gopalan, Sujith V.] Rajiv Gandhi Ctr Biotechnol, Mol Ecol Lab, Thiruvananthapuram, Kerala, India	University of Helsinki; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Howlader, MSA (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	sajidpabc@gmail.com	Gopalan, Sujith V/J-6807-2014; Nair, Abhilash/AAE-4011-2019; Merila, Juha/A-4061-2008	Gopalan, Sujith V/0000-0002-4744-9935; Nair, Abhilash/0000-0003-3487-1114; Merila, Juha/0000-0001-9614-0072; Howlader, Mohammad Sajid Ali/0000-0002-4941-6125	Center for International Mobility (CIMO; Finland); Finnish Cultural Foundation	Center for International Mobility (CIMO; Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was funded by the Center for International Mobility (CIMO; Finland) and the Finnish Cultural Foundation (https://www.skr.fi/en/finnishcultural-foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alam MS, 2008, MOL PHYLOGENET EVOL, V48, P515, DOI 10.1016/j.ympev.2008.04.020; Asmat G.M.S., 2003, U J ZOOL RAJSHAHI U, V22, P141; Bauer Aaron M., 1998, Hamadryad, V23, P133; Boulenger G. A., 1890; Boulenger G.A., 1882, CATALOGUE BATRACHIA, VSecond; Cantor T., 1847, J ASIATIC SOC BENGAL, V16, P1026; Chanda S.K., 1990, Hamadryad, V15, P16; Chanda SK, 2002, HDB INDIAN AMPHIBIAN; De Silva P.H.D.H., 1958, SPOLIA ZEYLANICA COL, V28; Djong TH, 2007, ZOOL SCI, V24, P1197, DOI 10.2108/zsj.24.1197; Drummond AJ, 2010, GENEIOUS V5 0 4; DUBOIS A, 1981, MONIT ZOOL ITAL, V15, P225, DOI 10.1080/03749444.1981.10736637; Dumeril A. M. C., 1841, ERPETOLOGIE GEN HIST; Dutta SK, 1996, AMPHIBIAN FAUNA SRI; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Glaw F, 2007, FIELD GUIDE AMPHIBIA, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Gray J.E., 1830, ILLUSTRATIONS INDIAN; Gunther, 1860, P ZOOL SOC LOND, V1860, P148; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hasan Mahmudul, 2012, Zootaxa, V3312, P45; Hasan M, 2012, ZOOL SCI, V29, P162, DOI 10.2108/zsj.29.162; Howlader MSA, 2011, ZOOTAXA, P41, DOI 10.11646/zootaxa.2761.1.3; Howlader Mohammad Sajid Ali, 2010, Russian Journal of Herpetology, V17, P255; Islam MM, 2008, ZOOL SCI, V25, P1084, DOI 10.2108/zsj.25.1084; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Joshy S. Hareesh, 2009, Alytes (Paris), V26, P97; Khan MS, 2009, IUCN 2012 IUCN RED L; Khan Muhammad Sharif, 1997, Pakistan Journal of Zoology, V29, P107; Kurabayashi A, 2005, ZOOL SCI, V22, P525, DOI 10.2108/zsj.22.525; Kuramoto Mitsuru, 2007, Current Herpetology, V26, P81, DOI 10.3105/1881-1019(2007)26[81:TGFARI]2.0.CO;2; Kuramoto Mitsuru, 2006, Current Herpetology, V25, P15, DOI 10.3105/1345-5834(2006)25[15:MAACOM]2.0.CO;2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schneider J.G., 1799, FASCICULUS PRIMUS CO; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Veith Michael, 2001, Alytes (Paris), V19, P5	39	17	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116666	10.1371/journal.pone.0116666	http://dx.doi.org/10.1371/journal.pone.0116666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651541	Green Published, gold, Green Submitted			2022-12-26	WOS:000349250700004
J	Al-Hajoj, S; Shoukri, M; Memish, Z; AlHakeem, R; AlRabiah, F; Varghese, B				Al-Hajoj, Sahal; Shoukri, Mohammed; Memish, Ziad; AlHakeem, Raafat; AlRabiah, Fahad; Varghese, Bright			Exploring the Sociodemographic and Clinical Features of Extrapulmonary Tuberculosis in Saudi Arabia	PLOS ONE			English	Article							PRIMARY IMMUNODEFICIENCY DISEASES; RISK-FACTORS; EPIDEMIOLOGY; CHILDREN; CONSANGUINITY; INFECTIONS; DISORDERS; PULMONARY	Background Saudi Arabia annually reports a relatively higher proportion (28-32%) of extrapulmonary tuberculosis (EPTB) cases in comparison to other global regions. However, there were few studies conducted so far to determine the sociodemographic factors and clinical manifestations associated with EPTB at a nationwide level. Methodology A retrospective analysis on culture positive EPTB isolates collected from all the provinces of the country were conducted for a period of 12 months to determine the spectrum of diversity in EPTB infection sites and the confounding factors. A detailed clinical and demographical data analysis was carried out along with first line drug susceptibility testing. Principal Findings Intra-thoracic and extra-thoracic lymph nodes (44.6%) were the most common sites of infection followed by gastrointestinal (17.3%) and central nervous systems (11.8%). Male patients were mostly infected (58.8%), in contrary to the global trend. Any drug resistance was observed in 23.1% isolates with a 2.1% of multi-drug resistance. HIV reactivity was found only in 2.2% cases. A higher proportion of Saudi nationals (58.8%) were infected compared to the immigrants, descending mostly from South Asia (34.4%) and South East Asia (31.2%). The Saudi population predominated with all forms of EPTB while immigrants showed no significant variations. Conclusions Saudi Arabia faces a serious threat from EPTB, particularly to the central nervous system and gastrointestinal systems. More effective diagnostic strategies and control measures must be implemented to reduce the high rate of EPTB in the country. In addition, these findings warrant further detailed research to explore all related comorbid conditions of EPTB development, particularly the host-related factors.	[Al-Hajoj, Sahal; Varghese, Bright] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Shoukri, Mohammed] King Faisal Specialist Hosp & Res Ctr, Natl Biotechnol Ctr, Riyadh 11211, Saudi Arabia; [Memish, Ziad; AlHakeem, Raafat] Minist Hlth, Prevent Med Directorate, Riyadh, Saudi Arabia; [AlRabiah, Fahad] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Ministry of Health - Saudi Arabia; King Faisal Specialist Hospital & Research Center	Al-Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.	hajoj@kfshrc.edu.sa	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia [AT-116/28]	King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia	The study was financially supported by King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia (www.kacst.edu.sa; Grant code AT-116/28). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghri NM, 2012, J IMMUNOL, V188, P1325, DOI 10.4049/jimmunol.1101954; Al-Hajoj S, 2013, ANTIMICROB AGENTS CH, V57, P2161, DOI 10.1128/AAC.02403-12; Al-Herbish AS, 2008, SAUDI MED J, V29, P1285; Al-Muhsen S, 2012, ANN NY ACAD SCI, V1250, P56, DOI 10.1111/j.1749-6632.2011.06379.x; Al-Muhsen Saleh Z, 2010, Saudi J Gastroenterol, V16, P66, DOI 10.4103/1319-3767.61230; Al-Otaibi F, 2010, INDIAN J PATHOL MICR, V53, P227, DOI 10.4103/0377-4929.64327; Alrabiaah AA, 2012, ANN SAUDI MED, V32, P4, DOI 10.5144/0256-4947.2012.4; Asghar RJ, 2008, ARCH INTERN MED, V168, P936, DOI 10.1001/archinte.168.9.936; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; Bukhary ZA, 2004, SAUDI MED J, V25, P881; Cailhol J, 2005, J CLIN EPIDEMIOL, V58, P1066, DOI 10.1016/j.jclinepi.2005.02.023; CDC, 2013, REP TUB US 2012; Chandir S, 2010, J PAK MED ASSOC, V60, P105; Chen CY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-324; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; El Mouzan MI, 2008, ANN SAUDI MED, V28, P169, DOI 10.5144/0256-4947.2008.169; ELHAZMI MAF, 1995, J MED GENET, V32, P623, DOI 10.1136/jmg.32.8.623; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Garcia-Rodriguez JF, 2011, ENFERM INFEC MICR CL, V29, P502, DOI 10.1016/j.eimc.2011.03.005; Galkina E, 2007, ADV EXP MED BIOL, V601, P75; Gomes T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-9; Kipp AM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-107; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Lee PPW, 2013, ASIAN PAC J ALLERGY, V31, P217; Lee WI, 2011, J FORMOS MED ASSOC, V110, P750, DOI 10.1016/j.jfma.2011.11.004; Mazroa Mohammed A A I, 2012, PLoS One, V7, pe45919, DOI 10.1371/journal.pone.0045919; Memish ZA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095654; Ministry of Health Saudi Arabia, 2007, STAT BOOK YEAR 1427, V1427; Ministry of Health Saudi Arabia, 2012, STAT BOOK YEAR 1432, V1432; Rowinska-Zakrzewska Ewa, 2013, Pneumonol Alergol Pol, V81, P121; Solovic I, 2013, EUROSURVEILLANCE, V18, P12; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Suliaman F, 2006, ALLERGY IMMUNOL, V19, P14; Suliaman Fawzi, 2009, Pediatric Asthma Allergy & Immunology, V22, P21, DOI 10.1089/pai.2008.0513; Varghese B, 2013, TUBERCULOSIS, V93, P246, DOI 10.1016/j.tube.2012.12.001; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644	37	22	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0101667	10.1371/journal.pone.0101667	http://dx.doi.org/10.1371/journal.pone.0101667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647300	Green Submitted, Green Published, gold			2022-12-26	WOS:000348822600001
J	An, Y; Toyoda, A; Zhao, C; Fujiyama, A; Agata, K				An, Yang; Toyoda, Atsushi; Zhao, Chen; Fujiyama, Asao; Agata, Kiyokazu			A Colony Multiplex Quantitative PCR-Based 3S3DBC Method and Variations of It for Screening DNA Libraries	PLOS ONE			English	Article							ARTIFICIAL CHROMOSOME CLONES; POLYMERASE-CHAIN-REACTION; RAPID IDENTIFICATION; GENOMIC LIBRARY; BAC LIBRARY; HYBRIDIZATION; CONSTRUCTION; SEQUENCES; STRATEGY; PLAQUES	A DNA library is a collection of DNA fragments cloned into vectors and stored individually in host cells, and is a valuable resource for molecular cloning, gene physical mapping, and genome sequencing projects. To take the best advantage of a DNA library, a good screening method is needed. After describing pooling strategies and issues that should be considered in DNA library screening, here we report an efficient colony multiplex quantitative PCR-based 3-step, 3-dimension, and binary-code (3S3DBC) method we used to screen genes from a planarian genomic DNA fosmid library. This method requires only 3 rounds of PCR reactions and only around 6 hours to distinguish one or more desired clones from a large DNA library. According to the particular situations in different research labs, this method can be further modified and simplified to suit their requirements.	[An, Yang; Agata, Kiyokazu] Kyoto Univ, Dept Biophys, Kyoto, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 411, Japan; [Zhao, Chen] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China	Kyoto University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Fudan University	An, Y (corresponding author), Kyoto Univ, Dept Biophys, Kyoto, Japan.	yangan@mdb.biophys.kyoto-u.ac.jp; agata@mdb.biophys.kyoto-u.ac.jp		Agata, Kiyokazu/0000-0002-5195-2576	Scientific Research on Innovative Areas [22124001]; Creative Scientific Research [17GS0318]; Global COE Program A06 of Kyoto University; National Institute of Genetics Collaborative Research Program; Japan Society for the Promotion of Science (JSPS) Research Fellowship [13J01078]	Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Creative Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program A06 of Kyoto University; National Institute of Genetics Collaborative Research Program; Japan Society for the Promotion of Science (JSPS) Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas to K.A. (22124001), a Grant-in-Aid for Creative Scientific Research to K.A. (17GS0318), Global COE Program A06 of Kyoto University, National Institute of Genetics Collaborative Research Program, and a Japan Society for the Promotion of Science (JSPS) Research Fellowship to Y.A. (13J01078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa S, 1998, GENOMICS, V49, P209, DOI 10.1006/geno.1998.5242; BARILLOT E, 1991, NUCLEIC ACIDS RES, V19, P6241, DOI 10.1093/nar/19.22.6241; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BLOEM LJ, 1990, NUCLEIC ACIDS RES, V18, P2830, DOI 10.1093/nar/18.9.2830; Bouzidi MF, 2006, THEOR APPL GENET, V113, P81, DOI 10.1007/s00122-006-0274-6; Campbell TN, 2002, J MOL MICROB BIOTECH, V4, P551; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; Crooijmans RPMA, 2000, MAMM GENOME, V11, P360, DOI 10.1007/s003350010068; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Farrar K, 2007, NAT PROTOC, V2, P1661, DOI 10.1038/nprot.2007.204; Febrer M, 2009, GENOME, V52, P993, DOI 10.1139/G09-073; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; GUSSOW D, 1989, NUCLEIC ACIDS RES, V17, P4000; Han CS, 2000, GENOME RES, V10, P714, DOI 10.1101/gr.10.5.714; HANAHAN D, 1983, METHOD ENZYMOL, V100, P333; Henegariu O, 1997, BIOTECHNIQUES, V23, P504, DOI 10.2144/97233rr01; ISRAEL DI, 1993, NUCLEIC ACIDS RES, V21, P2627, DOI 10.1093/nar/21.11.2627; Jin FL, 2006, NAT METHODS, V3, P183, DOI 10.1038/nmeth859; Kim CG, 2003, GENOMICS, V82, P571, DOI 10.1016/S0888-7543(03)00174-5; Klein PE, 2000, GENOME RES, V10, P789, DOI 10.1101/gr.10.6.789; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; LIBERT F, 1993, GENOMICS, V18, P270, DOI 10.1006/geno.1993.1465; LIU J, 1995, GENOMICS, V26, P178, DOI 10.1016/0888-7543(95)80199-V; Liu W, 2003, ANIM BIOTECHNOL, V14, P145, DOI 10.1081/ABIO-120026484; Pollier J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024978; SANZEY B, 1976, P NATL ACAD SCI USA, V73, P3394, DOI 10.1073/pnas.73.10.3394; Seidman J, 1994, CURRENT PROTOCOLS MO; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; TRAVER CN, 1989, P NATL ACAD SCI USA, V86, P5898, DOI 10.1073/pnas.86.15.5898; Vu GTH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-301; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	34	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116997	10.1371/journal.pone.0116997	http://dx.doi.org/10.1371/journal.pone.0116997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646755	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600046
J	Arnold, DT; Bhatnagar, R; Fairbanks, LD; Zahan-Evans, N; Clive, AO; Morley, AJ; Medford, ARL; Maskell, NA				Arnold, David T.; Bhatnagar, Rahul; Fairbanks, Lynette D.; Zahan-Evans, Natalie; Clive, Amelia O.; Morley, Anna J.; Medford, Andrew R. L.; Maskell, Nicholas A.			Pleural Fluid Adenosine Deaminase (Pfada) in the Diagnosis of Tuberculous Effusions in a Low Incidence Population	PLOS ONE			English	Article							STORAGE TIME	Introduction Previous studies have assessed the diagnostic ability of pleural fluid adenosine deaminase (pfADA) in detecting tuberculous pleural effusions, with good specificity and sensitivity reported. However, in North Western Europe pfADA is not routinely used in the investigation of a patient with an undiagnosed pleural effusion, mainly due to a lack of evidence as to its utility in populations with low mycobacterium tuberculosis (mTB) incidence. Methods Patients presenting with an undiagnosed pleural effusion to a tertiary pleural centre in South-West England over a 3 year period, were prospectively recruited to a pleural biomarker study. Pleural fluid from consecutive patients with robust 12-month follow up data and confirmed diagnosis were sent for pfADA analysis. Results Of 338 patients enrolled, 7 had confirmed tuberculous pleural effusion (2%). All mTB effusions were lymphocyte predominant with a median pfADA of 72.0 IU/L (range-26.7 to 91.5) compared to a population median of 12.0 IU/L (range-0.3 to 568.4). The optimal pfADA cut off was 35 IU/L, which had a negative predictive value (NPV) of 99.7%(95% CI; 98.2-99.9%) for the exclusion of mTB, and sensitivity of 85.7% (95% CI; 42.2-97.6%) with an area under the curve of 0.88 (95% CI; 0.732-1.000). Discussion This is the first study examining the diagnostic utility of pfADA in a low mTB incidence area. The chance of an effusion with a pfADA under 35 IU/L being of tuberculous aetiology was negligible. A pfADA of over 35 IU/L in lymphocyte-predominant pleural fluid gives a strong suspicion of mTB.	[Arnold, David T.; Bhatnagar, Rahul; Clive, Amelia O.; Maskell, Nicholas A.] Univ Bristol, Acad Resp Unit, Sch Clin Sci, Bristol, Avon, England; [Bhatnagar, Rahul; Zahan-Evans, Natalie; Clive, Amelia O.; Morley, Anna J.; Medford, Andrew R. L.; Maskell, Nicholas A.] Southmead Hosp, North Bristol Lung Ctr, Bristol, Avon, England; [Fairbanks, Lynette D.] St Thomas Hosp, Purine Res Lab, London, England	University of Bristol; Southmead Hospital; Guy's & St Thomas' NHS Foundation Trust	Arnold, DT (corresponding author), Univ Bristol, Acad Resp Unit, Sch Clin Sci, Bristol, Avon, England.	arnold.dta@gmail.com		Arnold, David/0000-0003-3158-7740; Bhatnagar, Rahul/0000-0003-3906-1997; Medford, Andrew/0000-0001-5445-5949; maskell, nick/0000-0002-1276-6500	National Institute for Health Research [CL-2014-25-502] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Antonangelo L, 2006, RESPIROLOGY, V11, P488, DOI 10.1111/j.1440-1843.2006.00866.x; Antonangelo L, 2012, J BRAS PNEUMOL, V38, P181, DOI 10.1590/S1806-37132012000200006; Bhatnagar R, 2013, THORAX, V68, pA170, DOI 10.1136/thoraxjnl-2013-204457.361; Bielsa S, 2014, CLIN LAB, V60, P501, DOI 10.7754/Clin.Lab.2013.130311; Chakrabarti B, 2006, CHEST, V129, P1549, DOI 10.1378/chest.129.6.1549; Chung JH, 2004, YONSEI MED J, V45, P661, DOI 10.3349/ymj.2004.45.4.661; Diacon AH, 2003, EUR RESPIR J, V22, P589, DOI 10.1183/09031936.03.00017103a; Garcia-Zamalloa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038729; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Kapisyzi P, 2011, CHEST, V140, p703A, DOI [10.1378/chest.1108296, DOI 10.1378/CHEST.1108296]; Lee SJ, 2014, AM J MED SCI, DOI [10.1097/MAJ.0b013e31828ffcd6, DOI 10.1097/MAJ.0B013E31828FFCD6]; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Maskell NA, 2003, THORAX, V58, pII8, DOI 10.1136/thorax.58.suppl_2.ii8; McGrath EE, 2010, EUR J CLIN MICROBIOL, V29, P1187, DOI 10.1007/s10096-010-0986-z; Porcel JM, 2010, EUR J INTERN MED, V21, P419, DOI 10.1016/j.ejim.2010.03.011; Public Health England, TUBERCULOSIS UK 2013; SEIBERT AF, 1991, CHEST, V99, P883, DOI 10.1378/chest.99.4.883; Tay TR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-546; Valdes L, 1996, EUR RESPIR J, V9, P747, DOI 10.1183/09031936.96.09040747; Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017; Villegas MV, 2000, CHEST, V118, P1355, DOI 10.1378/chest.118.5.1355; Yao CW, 2014, QJM; Zemlin AE, 2009, INT J TUBERC LUNG D, V13, P214	24	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0113047	10.1371/journal.pone.0113047	http://dx.doi.org/10.1371/journal.pone.0113047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647479	Green Submitted, Green Published, gold			2022-12-26	WOS:000348822600003
J	Harrington, KA; Hrabik, TR; Mensinger, AF				Harrington, Kelly A.; Hrabik, Thomas R.; Mensinger, Allen F.			Visual Sensitivity of Deepwater Fishes in Lake Superior	PLOS ONE			English	Article							INHABITING CHESAPEAKE BAY; DIEL VERTICAL MIGRATION; SEA FISHES; PHOTOSENSITIVE PIGMENTS; PHOTIC ENVIRONMENT; COTTOID FISH; LIGHT; ABUNDANCE; VISION; IRRADIANCE	The predator-prey interactions in the offshore food web of Lake Superior have been well documented, but the sensory systems mediating these interactions remain unknown. The deepwater sculpin, (Myoxocephalus thompsoni), siscowet (Salvelinus namaycush siscowet), and kiyi (Coregonus kiyi) inhabit low light level environments. To investigate the potential role of vision in predator-prey interactions, electroretinography was used to determine visual sensitivity for each species. Spectral sensitivity curves revealed peak sensitivity at 525 nm for each species which closely corresponds to the prevalent downwelling light spectrum at depth. To determine if sufficient light was available to mediate predator-prey interactions, visual sensitivity was correlated with the intensity of downwelling light in Lake Superior to construct visual depth profiles for each species. Sufficient daytime irradiance exists for visual interactions to approximately 325 m for siscowet and kiyi and 355 m for the deepwater sculpin during summer months. Under full moon conditions, sufficient irradiance exists to elicit ERG response to light available at approximately 30 m for the siscowet and kiyi and 45 m for the deepwater sculpin. Visual interactions are therefore possible at the depths and times when these organisms overlap in the water column indicating that vision may play a far greater role at depth in deep freshwater lakes than had been previously documented.	[Harrington, Kelly A.; Hrabik, Thomas R.; Mensinger, Allen F.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth	Harrington, KA (corresponding author), Univ Minnesota, Dept Biol, 1035 Kirby Dr, Duluth, MN 55812 USA.	harr1582@umn.edu	Hrabik, Thomas/GYA-2566-2022		Minnesota Sea Grant (Sea Grant Research Project) [R/F 35]; United States Geological Survey; Lake Superior Biological Station; University of Minnesota Duluth Biology Department	Minnesota Sea Grant (Sea Grant Research Project); United States Geological Survey(United States Geological Survey); Lake Superior Biological Station; University of Minnesota Duluth Biology Department	Funding for this project was provided by Minnesota Sea Grant (http://www.seagrant.umn.edu/) to TH (Sea Grant Research Project R/F 35), the United States Geological Survey (usgs.gov), Lake Superior Biological Station (http://www.glsc.usgs.gov/content/lake-superior-biological-station) and the University of Minnesota Duluth Biology Department (d.umn.edu/biology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrenstorff TD, 2012, ENVIRON BIOL FISH, V94, P465, DOI 10.1007/s10641-011-9961-5; Ahrenstorff TD, 2011, T AM FISH SOC, V140, P1504, DOI 10.1080/00028487.2011.637004; Auer MT, 2013, J GREAT LAKES RES, V39, P33, DOI 10.1016/j.jglr.2012.12.020; Auer NA, 2004, J GREAT LAKES RES, V30, P340, DOI 10.1016/S0380-1330(04)70396-2; BEETON AM, 1982, HYDROBIOLOGIA, V93, P53, DOI 10.1007/BF00008098; BOWMAKER JK, 1994, VISION RES, V34, P591, DOI 10.1016/0042-6989(94)90015-9; BOWMAKER JK, 1988, J COMP PHYSIOL A, V163, P685, DOI 10.1007/BF00603853; Bridges CDB, 1972, HDB SENSORY PHYSIOLO, P417, DOI DOI 10.1007/978-3-642-65066-6_11; Clarke GL, 1936, ECOLOGY, V17, P452, DOI 10.2307/1931845; Cramer CE, 2013, J RES NATL INST STAN, V118, P396, DOI 10.6028/jres.118.020; CRESCITELLI F, 1985, J COMP PHYSIOL A, V157, P323, DOI 10.1007/BF00618122; Dartnall H. J. A., 1965, Vision Research, V5, P81, DOI 10.1016/0042-6989(65)90057-X; Dartnall H.J.A., 1975, P543; DENTON EJ, 1957, J MAR BIOL ASSOC UK, V36, P651, DOI 10.1017/S0025315400025911; Douglas RH, 1997, J FISH BIOL, V50, P68; Effler SW, 2010, J GREAT LAKES RES, V36, P656, DOI 10.1016/j.jglr.2010.08.001; FAHNENSTIEL GL, 1984, J GREAT LAKES RES, V10, P399, DOI 10.1016/S0380-1330(84)71856-9; Frank TM, 2012, J EXP BIOL, V215, P3344, DOI 10.1242/jeb.072033; Gamble AE, 2011, J GREAT LAKES RES, V37, P550, DOI 10.1016/j.jglr.2011.06.008; GEFFEN AJ, 1992, J FISH BIOL, V41, P101, DOI 10.1111/j.1095-8649.1992.tb03872.x; Gensler WG, 1984, P NATO ADV STUD I DO; Gorman OT, 2012, STATUS TRENDS FISH C; Guthrie DM, 1993, BEHAV TELEOST FISHES, P89; Habermann R, 2012, MINNESOTA SEA GRAN S; Horodysky AZ, 2008, J EXP BIOL, V211, P3601, DOI 10.1242/jeb.023358; Horodysky AZ, 2010, J EXP BIOL, V213, P1751, DOI 10.1242/jeb.038117; Hrabik TR, 2006, CAN J FISH AQUAT SCI, V63, P2286, DOI 10.1139/F06-124; Hunt DM, 1996, VISION RES, V36, P1217, DOI 10.1016/0042-6989(95)00228-6; Isaac EJ, 2012, J GREAT LAKES RES, V38, P326, DOI 10.1016/j.jglr.2012.02.017; Jerlov N.G., 1968, OPTICAL OCEANOGRAPHY; JEROME JH, 1983, J GREAT LAKES RES, V9, P60, DOI 10.1016/S0380-1330(83)71872-1; Johnsen S. N., 2012, OPTICS LIFE BIOL GUI; Jokela-Maatta M, 2007, VISUAL NEUROSCI, V24, P389, DOI 10.1017/S0952523807070459; Lepparanta M, 2003, NORD HYDROL, V34, P245; LOEW ER, 1976, PROC R SOC SER B-BIO, V193, P31, DOI 10.1098/rspb.1976.0029; LYTHGOE JN, 1989, J EXP BIOL, V146, P1; MANSFIELD PJ, 1983, T AM FISH SOC, V112, P162, DOI 10.1577/1548-8659(1983)112<162:DAAOLB>2.0.CO;2; Marshall NJ, 2003, COPEIA, P467, DOI 10.1643/01-056; McFarl WN., 1959, PUBL I MAR SCI, V6, P22; MCFARLAND WN, 1975, VISION RES, V15, P1063, DOI 10.1016/0042-6989(75)90002-4; MUNZ FW, 1973, VISION RES, V13, P1829, DOI 10.1016/0042-6989(73)90060-6; MUNZ FW, 1958, J PHYSIOL-LONDON, V140, P220, DOI 10.1113/jphysiol.1958.sp005929; Nicol J. A. C., 1978, BIOLUMINESCENE ACTIO, P367; Palmer LM, 2005, J EXP BIOL, V208, P3441, DOI 10.1242/jeb.01766; PARTRIDGE JC, 1988, J COMP PHYSIOL A, V162, P543, DOI 10.1007/BF00612519; Pitcher T. J, 1993, BEHAV TELEOST FISHES; RONG W, 1990, P NATL ACAD SCI USA, V87, P2117, DOI 10.1073/pnas.87.6.2117; SELGEBY JH, 1988, J GREAT LAKES RES, V14, P44, DOI 10.1016/S0380-1330(88)71531-2; Sitar SP, 2008, J GREAT LAKES RES, V34, P276, DOI 10.3394/0380-1330(2008)34[276:SOSLTA]2.0.CO;2; Stockwell JD, 2010, CAN J FISH AQUAT SCI, V67, P473, DOI 10.1139/F09-198; Utne-Palm AC, 2006, J EXP BIOL, V209, P2034, DOI 10.1242/jeb.02171; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; WELLS L, 1968, US FISH WLD S FISH B, V67, P1	54	27	27	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116173	10.1371/journal.pone.0116173	http://dx.doi.org/10.1371/journal.pone.0116173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646781	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600022
J	Nemirovsky, SI; Cordoba, M; Zaiat, JJ; Completa, SP; Vega, PA; Gonzalez-Moron, D; Medina, NM; Fabbro, M; Romero, S; Brun, B; Revale, S; Ogara, MF; Pecci, A; Marti, M; Vazquez, M; Turjanski, A; Kauffman, MA				Nemirovsky, Sergio I.; Cordoba, Marta; Zaiat, Jonathan J.; Completa, Sabrina P.; Vega, Patricia A.; Gonzalez-Moron, Dolores; Medina, Nancy M.; Fabbro, Monica; Romero, Soledad; Brun, Bianca; Revale, Santiago; Florencia Ogara, Maria; Pecci, Adali; Marti, Marcelo; Vazquez, Martin; Turjanski, Adrian; Kauffman, Marcelo A.			Whole Genome Sequencing Reveals a De Novo SHANK3 Mutation in Familial Autism Spectrum Disorder	PLOS ONE			English	Article							FRAMEWORK; DATABASE; DISCOVERY; RESOURCE; DBNSFP; SNPS	Introduction Clinical genomics promise to be especially suitable for the study of etiologically heterogeneous conditions such as Autism Spectrum Disorder (ASD). Here we present three siblings with ASD where we evaluated the usefulness of Whole Genome Sequencing (WGS) for the diagnostic approach to ASD. Methods We identified a family segregating ASD in three siblings with an unidentified cause. We performed WGS in the three probands and used a state-of-the-art comprehensive bioinformatic analysis pipeline and prioritized the identified variants located in genes likely to be related to ASD. We validated the finding by Sanger sequencing in the probands and their parents. Results Three male siblings presented a syndrome characterized by severe intellectual disability, absence of language, autism spectrum symptoms and epilepsy with negative family history for mental retardation, language disorders, ASD or other psychiatric disorders. We found germline mosaicism for a heterozygous deletion of a cytosine in the exon 21 of the SHANK3 gene, resulting in a missense sequence of 5 codons followed by a premature stop codon (NM_033517: c. 3259_3259delC, p. Ser1088Profs*6). Conclusions We reported an infrequent form of familial ASD where WGS proved useful in the clinic. We identified a mutation in SHANK3 that underscores its relevance in Autism Spectrum Disorder.	[Nemirovsky, Sergio I.; Zaiat, Jonathan J.; Completa, Sabrina P.; Marti, Marcelo; Turjanski, Adrian] UBA, Fac Ciencias Exactas & Nat, Inst Calculo, Buenos Aires, DF, Argentina; [Fabbro, Monica; Romero, Soledad; Brun, Bianca; Revale, Santiago; Vazquez, Martin] Consejo Nacl Invest Cient & Tecn, Predio CCT, Inst Agrobiotecnol Rosario INDEAR, Rosario, Argentina; [Marti, Marcelo; Turjanski, Adrian] Consejo Nacl Invest Cient & Tecn, INQUIMAE, UBA, Fac Ciencias Exactas & Nat,Dept Quim Biol, RA-1033 Buenos Aires, DF, Argentina; [Cordoba, Marta; Vega, Patricia A.; Gonzalez-Moron, Dolores; Medina, Nancy M.; Kauffman, Marcelo A.] Consejo Nacl Invest Cient & Tecn, Hosp JM Ramos Mejia, IBCN Eduardo, Robert UBA,Consultorio & Lab Neurogenet, RA-1033 Buenos Aires, DF, Argentina; Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, IFIBYNE,Dept Quim Biol, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital Ramos Mejia; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Kauffman, MA (corresponding author), Consejo Nacl Invest Cient & Tecn, Hosp JM Ramos Mejia, IBCN Eduardo, Robert UBA,Consultorio & Lab Neurogenet, RA-1033 Buenos Aires, DF, Argentina.	marcelokauffman@gmail.com		Kauffman, Marcelo/0000-0003-1680-5092; Nemirovsky, Sergio I./0000-0003-4501-7052; Fabbro, Monica/0000-0003-0192-4777; Revale, Santiago/0000-0001-5219-9582; Marti, Marcelo/0000-0002-7911-9340; Cordoba, Marta/0000-0002-2814-1636; Turjanski, Adrian/0000-0003-2190-137X	Ministry of Science and Technology of the government of Argentina	Ministry of Science and Technology of the government of Argentina	This work was supported by an unrestricted grant from the Ministry of Science and Technology of the government of Argentina. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Betancur C, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-17; Boccuto L, 2013, EUR J HUM GENET, V21, P310, DOI 10.1038/ejhg.2012.175; Boycott KM, 2013, NAT REV GENET, V14, P681, DOI 10.1038/nrg3555; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Wang XM, 2014, DEV NEUROBIOL, V74, P123, DOI 10.1002/dneu.22084; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229	27	40	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							116358	10.1371/journal.pone.0116358	http://dx.doi.org/10.1371/journal.pone.0116358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646853	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600025
J	Sun, Q; Zhang, JQ; Zhou, N; Liu, XR; Shen, Y				Sun, Qiang; Zhang, Jianqian; Zhou, Nan; Liu, Xiaorong; Shen, Ying			DNA Methylation in Cosmc Promoter Region and Aberrantly Glycosylated IgA1 Associated with Pediatric IgA Nephropathy	PLOS ONE			English	Article							OXFORD CLASSIFICATION; O-GLYCOSYLATION; MONONUCLEAR-CELLS; CHAPERONE COSMC; EXPRESSION; TN; GENES	IgA nephropathy (IgAN) is one of the most common glomerular diseases leading to endstage renal failure. Elevation of aberrantly glycosylated IgA1 is a key feature of it. The expression of the specific molecular chaperone of core1 beta 1, 3galactosyl transferase (Cosmc) is known to be reduced in IgAN. We aimed to investigate whether the methylation of CpG islands of Cosmc gene promoter region could act as a possible mechanism responsible for down-regulation of Cosmc and related higher secretion of aberrantly glycosylated IgA1in lymphocytes from children with IgA nephropathy. Three groups were included: IgAN children (n = 26), other renal diseases (n = 11) and healthy children (n = 13). B-lymphocytes were isolated and cultured, treated or not with IL-4 or 5-Aza-2'-deoxycytidine (AZA). The levels of DNA methylation of Cosmc promotor region were not significantly different between the lymphocytes of the three children populations (P = 0.113), but there were significant differences between IgAN lymphocytes and lymphocytes of the other two children populations after IL-4 (P<0.0001) or AZA (P<0.0001). Cosmc mRNA expression was low in IgAN lymphocytes compared to the other two groups (P<0.0001). The level of aberrantly glycosylated IgA1 was markedly higher in IgAN group compared to the other groups (P<0.0001). After treatment with IL-4, the levels of Cosmc DNA methylation and aberrantly glycosylated IgA1 in IgAN lymphocytes were remarkably higher than the other two groups (P<0.0001) with more markedly decreased Cosmc mRNA content (P<0.0001). After treatment with AZA, the levels in IgAN lymphocytes were decreased, but was still remarkably higher than the other two groups (P<0.0001), while Cosmc mRNA content in IgAN lymphocytes were more markedly increased than the other two groups (P<0.0001). The alteration of DNA methylation by IL-4 or AZA specifically correlates in IgAN lymphocytes with alterations in Cosmc mRNA expression and with the level of aberrantly glycosylated IgA1 (r = -0.948, r = 0.707). Our results suggested that hypermethylation of Cosmc promoter region could be a key mechanism for the reduction of Cosmc mRNA expression in IgAN lymphocytes with associated increase in aberrantly glycosylated IgA1.	[Sun, Qiang; Zhou, Nan; Liu, Xiaorong; Shen, Ying] Capital Med Univ, Beijing Childrens Hosp, Dept Nephrol, Beijing, Peoples R China; [Zhang, Jianqian] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Shen, Y (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Dept Nephrol, Beijing, Peoples R China.	ying_116sh@sohu.com	shen, ying/HHS-5635-2022		National Natural Science Foundation of China [81070565]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No.81070565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal RP, 2012, J BIOL CHEM, V287, P15317, DOI 10.1074/jbc.M111.312587; Bellur SS, 2011, NEPHROL DIAL TRANSPL, V26, P2533, DOI 10.1093/ndt/gfq812; Berger EG, 1999, BBA-MOL BASIS DIS, V1455, P255, DOI 10.1016/S0925-4439(99)00069-1; Buck KS, 2008, KIDNEY INT, V73, P1128, DOI 10.1038/sj.ki.5002748; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Coppo R, 2009, KIDNEY INT, V75, P536, DOI 10.1038/ki.2008.579; DAMICO G, 2010, AM J KIDNEY DIS, V362, P227; Hartono C, 2014, DISCOV MED, V17, P131; He LY, 2013, AM J NEPHROL, V38, P321, DOI 10.1159/000355393; ICHIEI N, 2008, CLIN EXP NEPHROL, V12, P332, DOI DOI 10.1007/S10157-008-0054-5; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Malycha F, 2009, NEPHROL DIAL TRANSPL, V24, P321, DOI 10.1093/ndt/gfn538; Mestecky J, 2008, KIDNEY BLOOD PRESS R, V31, P29, DOI 10.1159/000112922; Mi RJ, 2012, J BIOL CHEM, V287, P41523, DOI 10.1074/jbc.M112.371989; Moriyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091756; MOTOTSUGU T, 2011, CLIN DEV IMMUNOL, V2011, DOI DOI 10.1155/2011/470803; NAN Z, 2013, CHIN J PEDIAT, V51, P549; Qin W, 2008, NEPHROL DIAL TRANSPL, V23, P1608, DOI 10.1093/ndt/gfm781; Qin Wei, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P762; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Serino G, 2012, J AM SOC NEPHROL, V23, P814, DOI 10.1681/ASN.2011060567; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2014, J BIOL CHEM, V289, P5330, DOI 10.1074/jbc.M113.512277; Westman G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096779; Xie LS, 2013, INT UROL NEPHROL, V45, P571, DOI 10.1007/s11255-012-0313-y; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; YANG G, 2014, BIOL TRACE ELEM RES; Zhang YW, 2014, EPIGENETICS-US, V9, P896, DOI 10.4161/epi.28601	29	19	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0112305	10.1371/journal.pone.0112305	http://dx.doi.org/10.1371/journal.pone.0112305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647400	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600002
J	Berg, S; Kaschka, I; Utz, KS; Huhn, K; Lammer, A; Lammer, R; Waschbisch, A; Kloska, S; Lee, DH; Doerfler, A; Linker, RA				Berg, Sebastian; Kaschka, Iris; Utz, Kathrin S.; Huhn, Konstantin; Laemmer, Alexandra; Laemmer, Robert; Waschbisch, Anne; Kloska, Stephan; Lee, De-Hyung; Doerfler, Arnd; Linker, Ralf A.			Baseline Magnetic Resonance Imaging of the Optic Nerve Provides Limited Predictive Information on Short-Term Recovery after Acute Optic Neuritis	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; VISUAL DYSFUNCTION; AXONAL LOSS; MRI; ENHANCEMENT; ASSOCIATION; MANAGEMENT; DIAGNOSIS; RISK	Background In acute optic neuritis, magnetic resonance imaging (MRI) may help to confirm the diagnosis as well as to exclude alternative diagnoses. Yet, little is known on the value of optic nerve imaging for predicting clinical symptoms or therapeutic outcome. Purpose To evaluate the benefit of optic nerve MRI for predicting response to appropriate therapy and recovery of visual acuity. Methods Clinical data as well as visual evoked potentials (VEP) and MRI results of 104 patients, who were treated at the Department of Neurology with clinically definite optic neuritis between December 2010 and September 2012 were retrospectively reviewed including a follow up within 14 days. Results Both length of the Gd enhancing lesion (r = -0.38; p = 0.001) and the T2 lesion (r = -0.25; p = 0.03) of the optic nerve in acute optic neuritis showed a medium correlation with visual acuity after treatment. Although visual acuity pre-treatment was little but nonsignificantly lower if Gd enhancement of the optic nerve was detected via orbital MRI, improvement of visual acuity after adequate therapy was significantly better (0.40 vs. 0.24; p = 0.04). Intraorbitally located Gd enhancing lesions were associated with worse visual improvement compared to canalicular, intracranial and chiasmal lesions (0.35 vs. 0.54; p = 0.02). Conclusion Orbital MRI is a broadly available, valuable tool for predicting the improvement of visual function. While the accurate individual prediction of long-term outcomes after appropriate therapy still remains difficult, lesion length of Gd enhancement and T2 lesion contribute to its prediction and a better short-term visual outcome may be associated with detection and localization of Gd enhancement along the optic nerve.	[Berg, Sebastian; Utz, Kathrin S.; Huhn, Konstantin; Laemmer, Alexandra; Waschbisch, Anne; Lee, De-Hyung; Linker, Ralf A.] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany; [Kaschka, Iris; Kloska, Stephan; Doerfler, Arnd] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Neuroradiol, Erlangen, Germany; [Laemmer, Robert] Univ Erlangen Nurnberg, Dept Ophthalmol, Univ Hosp Erlangen, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Linker, RA (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany.	ralf.linker@uk-erlangen.de	Mühlen, Iris/AAN-4729-2020; Laemmer, Robert/C-1810-2017; Linker, Ralf/AAD-8884-2020	Laemmer, Robert/0000-0002-6294-0730; Muhlen, Iris/0000-0001-8679-2587	Novartis; Biogen Idec; Merck Serono; Genzyme; Bayer Schering	Novartis(Novartis); Biogen Idec(Biogen); Merck Serono(Merck & Company); Genzyme(Sanofi-AventisGenzyme Corporation); Bayer Schering(Bayer AG)	Dr. Sebastian Berg reports personal fees from Biogen Idec, personal fees from Novartis, outside the submitted work. Dr. Iris Kaschka has nothing to disclose. Dr. Kathrin Utz reports grants from Novartis, grants from Biogen Idec, outside the submitted work. Dr. Konstantin Huhn reports personal fees from Biogen Idec, personal fees from Novartis, personal fees from Merck Serono, outside the submitted work. Dr. Alexandra Lammer has nothing to disclose. Dr. Robert Lammer has nothing to disclose. Dr. Anne Waschbisch reports grants, personal fees and non-financial support from Biogen Idec GmbH, grants, personal fees and non-financial support from Merck Serono GmbH, personal fees and non-financial support from Teva/Sanofi Aventis, grants and personal fees from Bayer Schering, outside the submitted work. Dr. Stephan Kloska has nothing to disclose. Dr. De-Hyung Lee has nothing to disclose. Dr. Arnd Dorfler has nothing to disclose. Dr. Ralf Linker received honoraria and travel support from Bayer, BiogenIdec, Genzyme, Merck Serono, Novartis, TEVA Pharma and Research Support from BiogenIdec, Merck Serono and Genzyme, outside the submitted work. The authors confirm that co-author Ralf Linker is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria.	Arnold AC, 2005, AM J OPHTHALMOL, V139, P1101, DOI 10.1016/j.ajo.2005.01.031; Balcer LJ, 2006, NEW ENGL J MED, V354, P1273, DOI 10.1056/NEJMcp053247; Costello F, 2008, MULT SCLER J, V14, P893, DOI 10.1177/1352458508091367; de Seze J, 2012, REV NEUROL-FRANCE, V168, P697, DOI 10.1016/j.neurol.2012.07.013; Deschamps R, 2002, REV NEUROL-FRANCE, V158, P446; Dooley Mary Caitlin, 2010, J Ophthalmic Vis Res, V5, P182; Dunker S, 1996, OPHTHALMOLOGY, V103, P1768, DOI 10.1016/S0161-6420(96)30429-6; Foroozan Rod, 2002, Curr Opin Ophthalmol, V13, P375, DOI 10.1097/00055735-200212000-00006; Frederiksen JL, 1999, SURV OPHTHALMOL, V44, pS54, DOI 10.1016/S0039-6257(99)00095-8; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Gal RL, 2008, OPHTHALMOLOGY, V115, P1079, DOI 10.1016/j.ophtha.2007.08.004; Gass A, 1996, NEURORADIOLOGY, V38, P317; GUY J, 1992, OPHTHALMOLOGY, V99, P713; Hickman SJ, 2005, NEURORADIOLOGY, V47, P51, DOI 10.1007/s00234-004-1308-x; Hickman SJ, 2004, J NEUROL, V251, P996, DOI 10.1007/s00415-004-0477-1; Hickman SJ, 2004, BRAIN, V127, P2498, DOI 10.1093/brain/awh284; Hickman SJ, 2004, BRAIN, V127, P692, DOI 10.1093/brain/awh076; Hoorbakht H, 2012, OPEN OPHTHALMOL J, V6, P65, DOI 10.2174/1874364101206010065; Jeon J, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-36; Kale N, 2012, CURR OPIN OPHTHALMOL, V23, P472, DOI 10.1097/ICU.0b013e328358b202; KATZ D, 1993, ANN NEUROL, V34, P661, DOI 10.1002/ana.410340507; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Klistorner A, 2008, DOC OPHTHALMOL, V116, P19, DOI 10.1007/s10633-007-9072-y; Klistorner A, 2007, INVEST OPHTH VIS SCI, V48, P4549, DOI 10.1167/iovs.07-0381; Kolbe S, 2009, NEUROIMAGE, V45, P679, DOI 10.1016/j.neuroimage.2008.12.047; Kupersmith MJ, 2002, BRAIN, V125, P812, DOI 10.1093/brain/awf087; Lim SA, 2009, ANN ACAD MED SINGAP, V38, P821; MILLER DH, 1988, NEUROLOGY, V38, P175, DOI 10.1212/WNL.38.2.175; Naismith RT, 2009, NEUROLOGY, V72, P589, DOI 10.1212/01.wnl.0000335766.22758.cd; Naismith RT, 2012, ARCH NEUROL-CHICAGO, V69, P65, DOI 10.1001/archneurol.2011.243; Nilsson P, 2005, J NEUROL, V252, P396, DOI 10.1007/s00415-005-0655-9; Pirko I, 2004, ARCH NEUROL-CHICAGO, V61, P1401, DOI 10.1001/archneur.61.9.1401; Roesner S, 2012, ACTA NEUROL SCAND, V126, P103, DOI 10.1111/j.1600-0404.2011.01612.x; Ruprecht K, 2004, NEUROLOGY, V63, P1081, DOI 10.1212/01.WNL.0000138437.99046.6B; Schinzel J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-94; Smith SA, 2011, AM J NEURORADIOL, V32, P1662, DOI 10.3174/ajnr.A2574; Swanton JK, 2010, MULT SCLER, V16, P156, DOI 10.1177/1352458509353650; Swanton JK, 2007, LANCET NEUROL, V6, P677, DOI 10.1016/S1474-4422(07)70176-X; TIEN RD, 1991, J COMPUT ASSIST TOMO, V15, P223, DOI 10.1097/00004728-199103000-00006; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Tourbah A, 2012, REV NEUROL-FRANCE, V168, P702, DOI 10.1016/j.neurol.2012.07.012; Trip SA, 2006, NEUROIMAGE, V30, P498, DOI 10.1016/j.neuroimage.2005.09.024; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; van der Walt A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083825; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052291; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437	46	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0113961	10.1371/journal.pone.0113961	http://dx.doi.org/10.1371/journal.pone.0113961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635863	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700001
J	Derache, A; Shin, HS; Balamane, M; White, E; Israelski, D; Klausner, JD; Freeman, AH; Katzenstein, D				Derache, Anne; Shin, Hyoung-Shik; Balamane, Maya; White, Elizabeth; Israelski, Dennis; Klausner, Jeffrey D.; Freeman, Alexandra H.; Katzenstein, David			HIV Drug Resistance Mutations in Proviral DNA from a Community Treatment Program	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; BLOOD MONONUCLEAR-CELLS; CD4(+) T-CELLS; LONG-TERM HAART; REVERSE-TRANSCRIPTASE; INFECTED PATIENTS; IMMUNOLOGICAL CONSEQUENCES; HIV-1-INFECTED PATIENTS; GENOTYPIC RESISTANCE; VIROLOGICAL FAILURE	Background Drug resistance mutations archived in resting memory CD4+ cells may persist despite suppression of HIV RNA to <50 copies/ml. We sequenced pol gene from proviral DNA among viremic and suppressed patients to identify drug resistance mutations. Methods The Peninsula AIDS Research Cohort study enrolled and followed over 2 years 120 HIV infected patients from San Mateo and San Francisco Counties. HIV-1 pol genotyping by bulk sequencing was performed on 38 DNA and RNA from viremic patients and DNA only among 82 suppressed patients at baseline. Antiretroviral susceptibility was predicted by HIVDB.stanford.edu. Results Among 120 subjects, 81% were on antiretroviral therapy and had been treated for a median time of 7 years. Thirty-two viremic patients showed concordant RNA and DNA genotypes (84%); the discordant profiles were mainly observed in patients with low-level viremia. Among suppressed patients, 21 had drug resistance mutations in proviral DNA (26%) with potential resistance to one, two or three ARV classes in 16, 4 and 1 samples respectively. Conclusions The high level of genotype concordance between DNA and RNA in viremic patients suggested that DNA genotyping might be used to assess drug resistance in resource-limited settings, and further investigation of extracted DNA from dried blood spots is needed. Drug resistance mutations in proviral DNA in 26% of subjects with less than 50 copies/ml pose a risk for the transmission of drug resistant virus with virologic failure, treatment interruption or decreased adherence.	[Derache, Anne; Balamane, Maya; White, Elizabeth; Israelski, Dennis; Katzenstein, David] Stanford Univ, Dept Infect Dis, Sch Med, Stanford, CA 94305 USA; [Shin, Hyoung-Shik] Natl Med Ctr, Ctr Infect Dis, Seoul, South Korea; [Klausner, Jeffrey D.] Univ Calif Los Angeles, Los Angeles, CA USA; [Freeman, Alexandra H.] Kaiser Permanente San Francisco, San Francisco, CA USA	Stanford University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; National Medical Center - Korea; University of California System; University of California Los Angeles; Kaiser Permanente	Derache, A (corresponding author), Stanford Univ, Dept Infect Dis, Sch Med, Stanford, CA 94305 USA.	aderache@stanford.edu	Shin, Hyoung-Shik/H-6772-2018	Shin, Hyoung-Shik/0000-0001-6504-3413; katzenstein, david/0000-0002-8593-4560	California HIV Research Program [CH05-SMCH-612]	California HIV Research Program	This work was funded by California HIV Research Program CH05-SMCH-612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa NDoHS, 2010, CLINICAL GUIDELINES; Banks Lauren, 2012, J AIDS Clin Res, V3, P141; Bi XQ, 2003, JAIDS-J ACQ IMM DEF, V34, P1, DOI 10.1097/00126334-200309010-00001; Bon I, 2007, NEW MICROBIOL, V30, P313; Bon I, 2007, J CLIN VIROL, V38, P313, DOI 10.1016/j.jcv.2006.12.018; Bowser BP, 2014, JOURNAL OF EQUITY IN, V3, P45; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Chew CB, 2005, J CLIN VIROL, V33, P206, DOI 10.1016/j.jcv.2004.11.006; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Delaugerre C, 2012, HIV MED, V13, P517, DOI 10.1111/j.1468-1293.2012.01002.x; Delaugerre C, 2010, AIDS, V24, P2391, DOI 10.1097/QAD.0b013e32833d214c; Delaugerre C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-85; Devereux HL, 2000, AIDS RES HUM RETROV, V16, P1025, DOI 10.1089/08892220050075273; Diallo K, 2012, INT J MOL EPIDEMIOL, V3, P56; Falasca F, 2013, CLIN MICROBIOL INFEC, V19, pE318, DOI 10.1111/1469-0691.12175; Felsenstein J, 2008, PHYLIP PHYLOGENY INF; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fourati S, 2012, J ANTIMICROB CHEMOTH, V67, P2323, DOI 10.1093/jac/dks219; Fourati S, 2012, AIDS, V26, P1619, DOI 10.1097/QAD.0b013e3283560703; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Geretti AM, 2014, J ANTIMICROB CHEMOTH, V69, P1090, DOI 10.1093/jac/dkt474; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; Gunthard HF, 1998, J VIROL, V72, P2422; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]; Imaz A, 2013, ANTIVIR THER, V18, P125, DOI 10.3851/IMP2249; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Kabamba-Mukadi B, 2010, HIV MED, V11, P483, DOI 10.1111/j.1468-1293.2009.00814.x; Kantor R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093537; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Kleyn TJ, 2014, ANN PHARMACOTHER; Lai CC, 2012, J ANTIMICROB CHEMOTH, V67, P1254, DOI 10.1093/jac/dkr601; Lambotte O, 2004, AIDS, V18, P1147, DOI 10.1097/00002030-200405210-00008; Macias J, 2005, J INFECTION, V51, P195, DOI 10.1016/j.jinf.2004.11.010; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; Martinez V, 2005, AIDS, V19, P1065, DOI 10.1097/01.aids.0000174453.55627.de; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; Mohamed S, 2014, J MED VIROL, V86, P394, DOI 10.1002/jmv.23853; Monno L, 2003, J MED VIROL, V70, P1, DOI 10.1002/jmv.10354; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Murillo W, 2010, HIV MED, V11, P95, DOI 10.1111/j.1468-1293.2009.00747.x; Neogi U, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18472; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; Nottet HSLM, 2009, JAIDS-J ACQ IMM DEF, V50, P345, DOI 10.1097/QAI.0b013e318197eb04; Organization WH, 2014, TO THE 2013 CONSOLID; Pace C, 2006, J VIROL, V80, P9259, DOI 10.1128/JVI.00888-06; Palmisano L, 2009, HIV MED, V10, P477, DOI 10.1111/j.1468-1293.2009.00715.x; Pillay S, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-3; Prakash R, 2009, DNA STRUCTURE IS MOR; Quan YD, 2014, J ANTIMICROB CHEMOTH, V69, P21, DOI 10.1093/jac/dkt326; Rowley CF, 2010, AIDS RES HUM RETROV, V26, P293, DOI 10.1089/aid.2009.0082; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Soto-Ramirez LE, 2008, AIDS RES HUM RETROV, V24, P797, DOI 10.1089/aid.2007.0246; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Trotter AB, 2013, AIDS REV, V15, P162; Turriziani O, 2010, CLIN MICROBIOL INFEC, V16, P1518, DOI 10.1111/j.1469-0691.2010.03329.x; Verhofstede C, 2004, JAIDS-J ACQ IMM DEF, V35, P473, DOI 10.1097/00126334-200404150-00005; Verhofstede C, 1999, AIDS, V13, P2541, DOI 10.1097/00002030-199912240-00007; Vlad IM, 2008, ADVANCES IN NEURAL I; WATTERS JK, 1994, J ACQ IMMUN DEF SYND, V7, P1276; Wirden M, 2011, J ANTIMICROB CHEMOTH, V66, P709, DOI 10.1093/jac/dkq544; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6	68	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117430	10.1371/journal.pone.0117430	http://dx.doi.org/10.1371/journal.pone.0117430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635815	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700085
J	Koepke, J; Dresel, M; Schmid, S; Greulich, T; Beutel, B; Schmeck, B; Vogelmeier, CF; Janciauskiene, S; Koczulla, AR				Koepke, Janine; Dresel, Marc; Schmid, Severin; Greulich, Timm; Beutel, Bjoern; Schmeck, Bernd; Vogelmeier, Claus Franz; Janciauskiene, Sabina; Koczulla, Andreas Rembert			Therapy with Plasma Purified Alpha1-Antitrypsin (Prolastin((R))) Induces Time-Dependent Changes in Plasma Levels of MMP-9 and MPO	PLOS ONE			English	Article							FC-ALPHA-RI; AUGMENTATION THERAPY; GELATINASE-B; MATRIX METALLOPROTEINASES; ANTITRYPSIN DEFICIENCY; Z ALPHA(1)-ANTITRYPSIN; HUMAN NEUTROPHILS; SERUM BIOMARKERS; ALPHA-1-ANTITRYPSIN; MATRIX-METALLOPROTEINASE-9	The common Z mutation (Glu342Lys) of alpha 1-antitrypsin (A1AT) results in the polymerization and intracellular retention of A1AT protein. The concomitant deficiency of functional A1AT predisposes PiZZ subjects to early onset emphysema. Clinical studies have implied that, among the biomarkers associated with emphysema, matrix metalloproteinase 9 (MMP-9) is of particular importance. Increased plasma MMP-9 levels are proposed to predict the decline of lung function as well as greater COPD exacerbations in A1AT deficiency-associated emphysema. The aim of the present study was to investigate the effect of A1AT therapy (Prolastin) on plasma MMP-9 and myeloperoxidase (MPO) levels. In total 34 PiZZ emphysema patients were recruited: 12 patients without and 22 with weekly intravenous (60 mg/kg body weight) A1AT therapy. The quantitative analysis of A1AT, MMP-9 and MPO was performed in serum and in supernatants of blood neutrophils isolated from patients before and after therapy. Patients with Prolastin therapy showed significantly lower serum MMP-9 and MPO levels than those without therapy. However, parallel analysis revealed that a rapid infusion of Prolastin is accompanied by a transient elevation of plasma MMP-9 and MPO levels. Experiments with freshly isolated blood neutrophils confirmed that therapy with Prolastin causes transient MMP-9 and MPO release. Prolastin induced the rapid release of MMP-9 and MPO when added directly to neutrophil cultures and this reaction was associated with the presence of IgA in A1AT preparation. Our data support the conclusion that changes in plasma levels of MMP-9 and MPO mirror the effect of Prolastin on blood neutrophils.	[Koepke, Janine; Dresel, Marc; Schmid, Severin; Greulich, Timm; Beutel, Bjoern; Vogelmeier, Claus Franz; Koczulla, Andreas Rembert] Univ Marburg, Dept Med Pulm & Crit Care Med, Univ Med Ctr Giessen & Marburg, Marburg, Germany; [Schmeck, Bernd] Univ Marburg, Inst Lung Res, Univ Giessen, Lung Ctr, Marburg, Germany; [Schmeck, Bernd] Univ Marburg, Inst Lung Res, Univ Marburg, Lung Ctr, Marburg, Germany; [Janciauskiene, Sabina] Hannover Med Sch, Dept Resp Med, Hannover, Germany	University Hospital of Giessen & Marburg; Justus Liebig University Giessen; Philipps University Marburg; Philipps University Marburg; Hannover Medical School	Koepke, J (corresponding author), Univ Marburg, Dept Med Pulm & Crit Care Med, Univ Med Ctr Giessen & Marburg, Baldingerstr 1, Marburg, Germany.	koepke@staff.uni-marburg.de		Schmid, Severin/0000-0001-8077-082X; Schmeck, Bernd/0000-0002-2767-3606	German Center for Lung Reseach (DZL, COPD II)	German Center for Lung Reseach (DZL, COPD II)	This study was supported by the German Center for Lung Reseach (DZL, COPD II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Omari M, 2011, MOL MED, DOI [10.2119/molmed.2011.00303, DOI 10.2119/MOLMED.2011.00303]; Alam S, 2011, AM J RESP CELL MOL, V45, P261, DOI 10.1165/rcmb.2010-0328OC; Aldonyte Ruta, 2004, COPD, V1, P155, DOI 10.1081/COPD-120030828; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Bergin DA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007116; Blanco I, 2006, EUR RESPIR J, V27, P77, DOI 10.1183/09031936.06.00062305; Boschetto P, 2006, THORAX, V61, P1037, DOI 10.1136/thx.2006.058321; Boskovic G, 1997, BIOCHEM J, V322, P751, DOI 10.1042/bj3220751; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Brajer B, 2008, J PHYSIOL PHARMACOL, V59, P145; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Cowden DI, 2005, CURR MED RES OPIN, V21, P877, DOI 10.1185/030079905X46395; Dickens JA, 2011, DRUG DES DEV THER, V5, P391, DOI 10.2147/DDDT.S14018; Ferry G, 1997, FEBS LETT, V402, P111, DOI 10.1016/S0014-5793(96)01508-6; Higashimoto Y, 2009, RESP MED, V103, P1231, DOI 10.1016/j.rmed.2009.01.021; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jonigk D, 2013, P NATL ACAD SCI USA, V110, P15007, DOI 10.1073/pnas.1309648110; Kalsheker NA, 2009, J CLIN PATHOL, V62, P865, DOI 10.1136/jcp.2008.063495; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kolarich D, 2006, TRANSFUSION, V46, P1959, DOI 10.1111/j.1537-2995.2006.01004.x; Kowluru RA, 2012, EXPERT OPIN INV DRUG, V21, P797, DOI 10.1517/13543784.2012.681043; Lieberman J, 2000, CHEST, V118, P1480, DOI 10.1378/chest.118.5.1480; Mahadeva R, 2005, AM J PATHOL, V166, P377, DOI 10.1016/S0002-9440(10)62261-4; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; Mohanka M, 2012, EXPERT OPIN BIOL TH, V12, P685, DOI 10.1517/14712598.2012.676638; Nita I, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-12; Omachi TA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-35; Opdenakker G, 1998, IMMUNOL TODAY, V19, P182, DOI 10.1016/S0167-5699(97)01243-7; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Otten MA, 2004, IMMUNOL LETT, V92, P23, DOI 10.1016/j.imlet.2003.11.018; Ozeri E, 2012, J IMMUNOL, V189, P146, DOI 10.4049/jimmunol.1101340; Parmar JS, 2002, AM J RESP CELL MOL, V26, P723, DOI 10.1165/ajrcmb.26.6.4739; Parr DG, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-75; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; Pruijt JFM, 1999, P NATL ACAD SCI USA, V96, P10863, DOI 10.1073/pnas.96.19.10863; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Schmid ST, 2012, INT J CHRONIC OBSTR, V7, P687, DOI 10.2147/COPD.S34560; Seersholm N, 1998, THORAX, V53, P265, DOI 10.1136/thx.53.4.265; Seersholm N, 1997, EUR RESPIR J, V10, P2260, DOI 10.1183/09031936.97.10102260; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shand JA, 2010, BIOMARK MED, V4, P385, DOI 10.2217/BMM.10.16; Stockley RA, 2002, AM J RESP CRIT CARE, V165, P1494, DOI 10.1164/rccm.2109013; Stockley RA, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-149; Stockley RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-136; Stone H, 2012, EUR RESPIR J, V40, P561, DOI 10.1183/09031936.00162811; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vernooy JHJ, 2004, CHEST, V126, P1802, DOI 10.1378/chest.126.6.1802; VOULGARI F, 1982, BRIT HEART J, V48, P352; Vreim CE, 1998, AM J RESP CRIT CARE, V158, P49; Wang KF, 2013, CORONARY ARTERY DIS, V24, P23, DOI 10.1097/MCA.0b013e32835aab4a; Wehrli M, 2014, J IMMUNOL, V193, P5649, DOI 10.4049/jimmunol.1400028; Wencker M, 2001, CHEST, V119, P737, DOI 10.1378/chest.119.3.737	54	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117497	10.1371/journal.pone.0117497	http://dx.doi.org/10.1371/journal.pone.0117497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635861	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700087
J	Mishra, S; Upadhyay, S; Sen, MR; Maurya, AP; Choudhury, D; Bhattacharjee, A				Mishra, Shweta; Upadhyay, Supriya; Sen, Malay Ranjan; Maurya, Anand Prakash; Choudhury, Debarati; Bhattacharjee, Amitabha			Genetic Acquisition of NDM Gene Offers Sustainability among Clinical Isolates of Pseudomonas aeruginosa in Clinical Settings	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; CARBAPENEM RESISTANCE; PCR; ENTEROBACTERIACEAE; IDENTIFICATION; BLA(NDM-1)	New Delhi metallo beta-lactamases are one of the most significant emerging resistance determinants towards carbapenem drugs. Their persistence and adaptability often depends on their genetic environment and linkage. This study reports a unique and novel arrangement of bla(NDM-1) gene within clinical isolates of Pseudomonas aeruginosa from a tertiary referral hospital in north India. Three NDM positive clonally unrelated clinical isolates of P. aeruginosa were recovered from hospital patients. Association of integron with bla(NDM-1) and presence of gene cassettes were assessed by PCR. Genetic linkage of NDM gene with ISAba125 was determined and in negative cases linkage in upstream region was mapped by inverse PCR. In which only one isolate's NDM gene was linked with ISAba125 for mobility, while other two reveals new genetic arrangement and found to be inserted within DNA directed RNA polymerase gene of the host genome detected by inverse PCR followed by sequencing analysis. In continuation significance of this novel linkage was further analyzed wherein promoter site detected by Softberry BPROM software and activity were assessed by cloning succeeding semi-quantitative RT-PCR indicating the higher expression level of NDM gene. This study concluded out that the unique genetic makeup of NDM gene with DNA-dependent-RNA-polymerase favours adaptability to the host in hospital environment against huge antibiotic pressure.	[Mishra, Shweta; Sen, Malay Ranjan] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi 221005, Uttar Pradesh, India; [Upadhyay, Supriya] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Shillong, Meghalaya, India; [Maurya, Anand Prakash; Bhattacharjee, Amitabha] Assam Univ, Dept Microbiol, Silchar 788011, India; [Choudhury, Debarati] Assam Univ, Dept Life Sci & Bioinformat, Silchar 788011, India	Banaras Hindu University (BHU); North Eastern Hill University; Assam University; Assam University	Sen, MR (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi 221005, Uttar Pradesh, India.	mr_senbhu@yahoo.com		Maurya, Anand Prakash/0000-0001-5231-8174	Department of Biotechnology, Govt. of India, New Delhi, India [P-07-467, BT/PR11812/BRB/10/692]	Department of Biotechnology, Govt. of India, New Delhi, India(Department of Biotechnology (DBT) India)	This work was financially supported by Department of Biotechnology, Govt. of India, New Delhi, India under the research project (P-07-467), Grant BT/PR11812/BRB/10/692. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bercot B, 2011, J ANTIMICROB CHEMOTH, V66, P2295, DOI 10.1093/jac/dkr296; Bhattacharjee A, 2008, J ANTIMICROB CHEMOTH, V61, P309, DOI 10.1093/jac/dkm494; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; CLSI, 2005, PAM100S15 CLSI; Collee JG, 1996, MACKIE MCCARTNEY PRA; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dortet L, 2012, ANTIMICROB AGENTS CH, V56, P1693, DOI 10.1128/AAC.05583-11; Janvier F, 2013, ANTIMICROB AGENTS CH, V57, P3408, DOI 10.1128/AAC.02334-12; Jeong SH, 2006, J MICROBIOL, V44, P423; Karthikeyan K, 2010, J ANTIMICROB CHEMOTH, V65, P2253, DOI 10.1093/jac/dkq273; Koeleman JGM, 2001, J CLIN MICROBIOL, V39, P8, DOI 10.1128/JCM.39.1.8-13.2001; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Mesaros N, 2007, J ANTIMICROB CHEMOTH, V59, P378, DOI 10.1093/jac/dkl504; Mishra S, 2013, INT J ANTIMICROB AG, V41, P452, DOI 10.1016/j.ijantimicag.2013.01.007; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Patridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6605; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Quale J, 2003, CLIN INFECT DIS, V37, P214, DOI 10.1086/375821; Sambrook J, 1989, MOL CLONING LAB MANU, P32, DOI Cold Spring Harbour, N.Y; Seema K, 2011, J ANTIMICROB CHEMOTH, V66, P1646, DOI 10.1093/jac/dkr180; Senda K, 1996, J CLIN MICROBIOL, V34, P2909, DOI 10.1128/JCM.34.12.2909-2913.1996; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; Toleman MA, 2012, ANTIMICROB AGENTS CH, V56, P2773, DOI 10.1128/AAC.06297-11; Tsakris A, 2000, J CLIN MICROBIOL, V38, P1290, DOI 10.1128/JCM.38.3.1290-1292.2000; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Yong DE, 2002, J CLIN MICROBIOL, V40, P3798, DOI 10.1128/JCM.40.10.3798-3801.2002; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116611	10.1371/journal.pone.0116611	http://dx.doi.org/10.1371/journal.pone.0116611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635921	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700048
J	Shen, HS; Liang, D; Luo, MY; Duan, CJ; Cai, WL; Zhu, SS; Qiu, JP; Li, WR				Shen, Hesong; Liang, Dan; Luo, Mingyue; Duan, Chaijie; Cai, Wenli; Zhu, Shanshan; Qiu, Jianping; Li, Wenru			Pilot Study on Image Quality and Radiation Dose of CT Colonography with Adaptive Iterative Dose Reduction Three-Dimensional	PLOS ONE			English	Article							TUBE-CURRENT MODULATION; COLORECTAL LESIONS; MDCT COLONOGRAPHY; RECONSTRUCTION; FEASIBILITY; CANCER; RISK; REIMBURSEMENT; COLONOSCOPY; PERFORMANCE	Objective To investigate image quality and radiation dose of CT colonography (CTC) with adaptive iterative dose reduction three-dimensional (AIDR3D). Methods Ten segments of porcine colon phantom were collected, and 30 pedunculate polyps with diameters ranging from 1 to 15 mm were simulated on each segment. Image data were acquired with tube voltage of 120 kVp, and current doses of 10 mAs, 20 mAs, 30 mAs, 40 mAs, 50 mAs, respectively. CTC images were reconstructed using filtered back projection (FBP) and AIDR3D. Two radiologists blindly evaluated image quality. Quantitative evaluation of image quality included image noise, signal-to-noise ratio (SNR), and contrast-tonoise ratio (CNR). Qualitative image quality was evaluated with a five-score scale. Radiation dose was calculated based on dose-length product. Ten volunteers were examined supine 50 mAs with FBP and prone 20 mAs with AIDR3D, and image qualities were assessed. Paired t test was performed for statistical analysis. Results For 20 mAs with AIDR3D and 50 mAs with FBP, image noise, SNRs and CNRs were (16.4 +/- 1.6) HU vs. (16.8 +/- 2.6) HU, 1.9 +/- 0.2 vs. 1.9 +/- 0.4, and 62.3 +/- 6.8 vs. 62.0 +/- 6.2, respectively; qualitative image quality scores were 4.1 and 4.3, respectively; their differences were all not statistically significant. Compared with 50 mAs with FBP, radiation dose (1.62 mSv) of 20 mAs with AIDR3D was decreased by 60.0%. There was no statistically significant difference in image noise, SNRs, CNRs and qualitative image quality scores between prone 20 mAs with AIDR3D and supine 50 mAs with FBP in 10 volunteers, the former reduced radiation dose by 61.1%. Conclusion Image quality of CTC using 20 mAs with AIDR3D could be comparable to standard 50 mAs with FBP, radiation dose of the former reduced by about 60.0% and was only 1.62 mSv.	[Shen, Hesong; Liang, Dan; Luo, Mingyue; Zhu, Shanshan; Qiu, Jianping; Li, Wenru] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China; [Duan, Chaijie] Tsinghua Univ, Grad Sch Shenzhen, Biomed Engn Res Ctr, Shenzhen 518057, Guangdong, Peoples R China; [Cai, Wenli] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Cai, Wenli] Harvard Univ, Sch Med, Boston, MA USA	Sun Yat Sen University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Luo, MY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Radiol, Guangzhou 510275, Guangdong, Peoples R China.	myluo720@163.com	Li, Wenjun/F-5634-2015	Li, Wenjun/0000-0001-5335-7386	National Natural Science Foundation of China [81230035]; Guangdong Provincial Science and Technology Program [2011B031800182, 2013B051000016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Program	This study was supported by The National Natural Science Foundation of China (81230035), http://www.nsfc.gov.cn/; and Guangdong Provincial Science and Technology Program (2011B031800182, 2013B051000016), http://pro.gdstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JM, 2013, AM J ROENTGENOL, V201, pW81, DOI 10.2214/AJR.12.9226; An S, 2008, AM J ROENTGENOL, V191, pW100, DOI 10.2214/AJR.07.3367; Branschofsky M, 2006, EUR J MED RES, V11, P13; Brenner DJ, 2005, GASTROENTEROLOGY, V129, P328, DOI 10.1053/j.gastro.2005.05.021; Chang KJ, 2013, ABDOM IMAGING, V38, P224, DOI 10.1007/s00261-012-9968-1; Chang KJ, 2013, RADIOLOGY, V266, P791, DOI 10.1148/radiol.12120134; Chen JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092414; Chen ZY, 2013, WORLD J GASTROENTERO, V19, P561, DOI 10.3748/wjg.v19.i4.561; Cohnen M, 2004, AM J ROENTGENOL, V183, P1355, DOI 10.2214/ajr.183.5.1831355; Cohnen M, 2002, ROFO-FORTSCHR RONTG, V174, P835, DOI 10.1055/s-2002-32691; Dachman AH, 2013, J AM COLL RADIOL, V10, P937, DOI 10.1016/j.jacr.2013.09.014; de Gonzalez AB, 2011, AM J ROENTGENOL, V196, P816, DOI 10.2214/AJR.10.4907; Duan XH, 2011, AM J ROENTGENOL, V197, P689, DOI 10.2214/AJR.10.6061; Elojeimy S, 2010, RADIAT PROT DOSIM, V141, P43, DOI 10.1093/rpd/ncq138; Fei WU, 2012, CHIN CANC, V21, P81; Fisichella VA, 2010, EUR RADIOL, V20, P630, DOI 10.1007/s00330-009-1601-5; Flicek KT, 2010, AM J ROENTGENOL, V195, P126, DOI 10.2214/AJR.09.3855; Graser A, 2006, AM J ROENTGENOL, V187, P695, DOI 10.2214/AJR.05.0662; Iannaccone R, 2003, RADIOLOGY, V229, P775, DOI 10.1148/radiol.2293021399; Iannaccone R, 2005, RADIOLOGY, V237, P927, DOI 10.1148/radiol.2373041747; Iannaccone R, 2003, EUR RADIOL, V13, P1297, DOI 10.1007/s00330-002-1704-8; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Kambadakone AR, 2011, AM J ROENTGENOL, V196, pW743, DOI 10.2214/AJR.10.5303; Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lieberman D, 2014, JAMA INTERN MED, V174, P10, DOI 10.1001/jamainternmed.2013.11499; Liedenbaum MH, 2008, EUR RADIOL, V18, P2222, DOI 10.1007/s00330-008-0994-x; Robbins JB, 2013, SEMIN ROENTGENOL, V48, P264, DOI 10.1053/j.ro.2013.03.010; Silva AC, 2010, AM J ROENTGENOL, V194, P191, DOI 10.2214/AJR.09.2953; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Steward MJ, 2014, COLORECTAL DIS, V16, P347, DOI 10.1111/codi.12451; van Gelder RE, 2004, RADIOLOGY, V232, P611, DOI 10.1148/radiol.2322031069; van Gelder RE, 2002, RADIOLOGY, V224, P25, DOI 10.1148/radiol.2241011126; Yee J, 2013, AM J ROENTGENOL, V201, P73, DOI 10.2214/AJR.13.10656; Yoo RE, 2013, INT J CARDIOVAS IMAG, V29, P669, DOI 10.1007/s10554-012-0113-6; Yoon MA, 2012, J COMPUT ASSIST TOMO, V36, P596, DOI 10.1097/RCT.0b013e31826092be	37	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117116	10.1371/journal.pone.0117116	http://dx.doi.org/10.1371/journal.pone.0117116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635839	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700070
J	Smole, U; Radauer, C; Lengger, N; Svoboda, M; Rigby, N; Bublin, M; Gaier, S; Hoffmann-Sommergruber, K; Jensen-Jarolim, E; Mechtcheriakova, D; Breiteneder, H				Smole, Ursula; Radauer, Christian; Lengger, Nina; Svoboda, Martin; Rigby, Neil; Bublin, Merima; Gaier, Sonja; Hoffmann-Sommergruber, Karin; Jensen-Jarolim, Erika; Mechtcheriakova, Diana; Breiteneder, Heimo			The Major Birch Pollen Allergen Bet v 1 Induces Different Responses in Dendritic Cells of Birch Pollen Allergic and Healthy Individuals	PLOS ONE			English	Article							NF-KAPPA-B; FC-EPSILON-RI; IMMUNE-RESPONSES; FOOD ALLERGENS; RECEPTOR; IGE; PROTEIN; AFFINITY; ACTIVATION; EPITHELIUM	Dendritic cells play a fundamental role in shaping the immune response to allergens. The events that lead to allergic sensitization or tolerance induction during the interaction of the major birch pollen allergen Bet v 1 and dendritic cells are not very well studied. Here, we analyzed the uptake of Bet v 1 and the cross-reactive celery allergen Api g 1 by immature monocyte-derived dendritic cells (iMoDCs) of allergic and normal donors. In addition, we characterized the allergen-triggered intracellular signaling and transcriptional events. Uptake kinetics, competitive binding, and internalization pathways of labeled allergens by iMoDCs were visualized by live-cell imaging. Surface-bound IgE was detected by immunofluorescence microscopy and flow cytometry. Allergen- and IgE-induced gene expression of early growth response genes and Th1 and Th2 related cytokines and chemokines were analyzed by real-time PCR. Phosporylation of signaling kinases was analyzed by Western blot. Internalization of Bet v 1 by iMoDCs of both donor groups, likely by receptor-mediated caveolar endocytosis, followed similar kinetics. Bet v 1 outcompeted Api g 1 in cell surface binding and uptake. MoDCs of allergic and healthy donors displayed surface-bound IgE and showed a pronounced upregulation of Th2 cytokine-and NF kappa B-dependent genes upon non-specific Fc epsilon receptor cross-linking. In contrast to these IgE-mediated responses, Bet v 1-stimulation increased transcript levels of the Th2 cytokines IL-4 and IL-13 but not of NF kappa B-related genes in MoDCs of BP allergic donors. Cells of healthy donors were either unresponsive or showed elevated mRNA levels of Th1-promoting chemokines. Moreover, Bet v 1 was able to induce Erk1/2 and p38 MAPK activation in BP allergics but only a slight p38 activation in normal donors. In conclusion, our data indicate that Bet v 1 favors the activation of a Th2 program only in DCs of BP allergic individuals.	[Smole, Ursula; Radauer, Christian; Lengger, Nina; Svoboda, Martin; Bublin, Merima; Gaier, Sonja; Hoffmann-Sommergruber, Karin; Jensen-Jarolim, Erika; Mechtcheriakova, Diana; Breiteneder, Heimo] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Smole, Ursula] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Rigby, Neil] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Jensen-Jarolim, Erika] Vet Univ Vienna, Med Univ Vienna, Messerli Res Inst, Vienna, Austria; [Jensen-Jarolim, Erika] Univ Vienna, A-1010 Vienna, Austria	Medical University of Vienna; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Mechtcheriakova, D (corresponding author), Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	diana.mechtcheriakova@meduniwien.ac.at; heimo.breiteneder@meduniwien.ac.at	Radauer, Christian/AAN-6260-2021; Jensen-Jarolim, Erika/C-5120-2018	Radauer, Christian/0000-0001-9920-4449; Jensen-Jarolim, Erika/0000-0003-4019-5765; Breiteneder, Heimo/0000-0003-2022-8689; Smole, Ursula/0000-0001-5124-2024; Bublin, Merima/0000-0002-7191-9431; Mechtcheriakova, Diana/0000-0002-8737-3592; Hoffmann-Sommergruber, Karin/0000-0002-8830-058X	Austrian Science Fund (FWF) [SFB-F4608, P 22441-B13]; Erwin Schroedinger Fellowship [J3332-B21]; Austrian Science Fund (FWF) [J 3332] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Erwin Schroedinger Fellowship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the following three Austrian Science Fund (FWF; http://www.fwf.ac.at/) grants: SFB-F4608 to HB, P 22441-B13 to DM, and the Erwin Schroedinger Fellowship J3332-B21 to US. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Bellinghausen I, 2008, CLIN EXP ALLERGY, V38, P539, DOI 10.1111/j.1365-2222.2007.02910.x; Bellinghausen I, 2003, IMMUNOLOGY, V108, P167, DOI 10.1046/j.1365-2567.2003.01576.x; Bieber T, 2007, IMMUNOBIOLOGY, V212, P499, DOI 10.1016/j.imbio.2007.03.001; Bohle B, 2007, ALLERGY, V62, P3, DOI 10.1111/j.1398-9995.2006.01258.x; Bohle B, 2003, EUR J IMMUNOL, V33, P3303, DOI 10.1002/eji.200324321; Bratke K, 2011, ALLERGY, V66, P386, DOI 10.1111/j.1398-9995.2010.02497.x; Calderon Moises A, 2012, Clin Transl Allergy, V2, P20, DOI 10.1186/2045-7022-2-20; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Emara M, 2012, J BIOL CHEM, V287, P5756, DOI 10.1074/jbc.M111.312520; Gilles S, 2009, J IMMUNOL, V182, P6653, DOI 10.4049/jimmunol.0802613; Goel C, 2012, CLIN EXP ALLERGY, V42, P412, DOI 10.1111/j.1365-2222.2011.03937.x; Herre J, 2013, J IMMUNOL, V191, P1529, DOI 10.4049/jimmunol.1300284; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jacquet A, 2011, CLIN EXP ALLERGY, V41, P305, DOI 10.1111/j.1365-2222.2010.03661.x; Joenvaara S, 2009, J ALLERGY CLIN IMMUN, V124, P135, DOI 10.1016/j.jaci.2008.11.048; Kazemi-Shirazi L, 2000, J ALLERGY CLIN IMMUN, V105, P116, DOI 10.1016/S0091-6749(00)90186-6; Kean DE, 2006, J IMMUNOL, V177, P1561, DOI 10.4049/jimmunol.177.3.1561; Kitzmuller C, 2012, ALLERGY, V67, P1375, DOI 10.1111/all.12016; Kraft S, 2002, J INVEST DERMATOL, V118, P830, DOI 10.1046/j.1523-1747.2002.01757.x; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Lebre MC, 2005, IMMUNOL CELL BIOL, V83, P525, DOI 10.1111/j.1440-1711.2005.01365.x; Li B, 2006, BLOOD, V107, P2814, DOI 10.1182/blood-2005-09-3610; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lohoff M, 2010, J BIOL CHEM, V285, P1643, DOI 10.1074/jbc.M109.011585; Lundberg K, 2008, CLIN IMMUNOL, V128, P358, DOI 10.1016/j.clim.2008.04.011; Maroof A, 2006, IMMUNOLOGY, V117, P271, DOI 10.1111/j.1365-2567.2005.02305.x; MAURER D, 1995, J IMMUNOL, V154, P6285; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Neves BM, 2009, MOL IMMUNOL, V46, P2481, DOI 10.1016/j.molimm.2009.05.021; Noirey N, 2000, J ALLERGY CLIN IMMUN, V105, P1194, DOI 10.1067/mai.2000.106545; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286; Renkonen J, 2009, ALLERGY, V64, P868, DOI 10.1111/j.1398-9995.2008.01919.x; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; Salazar F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00356; Saxon A, 2005, NAT IMMUNOL, V6, P223, DOI 10.1038/ni0305-223; Seutter von Loetzen C, 2014, BIOCHEM J, V457, P379, DOI 10.1042/BJ20130413; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Smole U, 2010, ALLERGY, V65, P1388, DOI 10.1111/j.1398-9995.2010.02407.x; Smole U, 2008, INT ARCH ALLERGY IMM, V147, P289, DOI 10.1159/000144036; Smole U, 2010, IMMUNOBIOLOGY, V215, P903, DOI 10.1016/j.imbio.2009.11.003; Thomas WR, 2013, CLIN EXP ALLERGY, V43, P152, DOI 10.1111/j.1365-2222.2012.04059.x; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; van Riet E, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-9; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; Wallner M, 2011, J ALLERGY CLIN IMMUN, V127, P1571, DOI 10.1016/j.jaci.2011.01.064; Wills-Karp M, 2010, CURR OPIN IMMUNOL, V22, P777, DOI 10.1016/j.coi.2010.10.011; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080	58	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117904	10.1371/journal.pone.0117904	http://dx.doi.org/10.1371/journal.pone.0117904			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635684	Green Submitted, gold, Green Published			2022-12-26	WOS:000350680700107
J	Zhang, XL; Wang, Q; Xu, J; Gilliam, FS; Tremblay, N; Li, CH				Zhang, Xuelin; Wang, Qun; Xu, Jun; Gilliam, Frank S.; Tremblay, Nicolas; Li, Chaohai			In Situ Nitrogen Mineralization, Nitrification, and Ammonia Volatilization in Maize Field Fertilized with Urea in Huanghuaihai Region of Northern China	PLOS ONE			English	Article							USE EFFICIENCY; CEREAL PRODUCTION; PADDY FIELDS; SOIL; MANAGEMENT; YIELD; CROP; EMISSIONS; SYSTEM; FLUXES	Nitrogen (N) fertilization potentially affects soil N mineralization and leaching, and can enhance NH3 volatilization, thus impacting crop production. A fertilizer experiment with five levels of N addition (0, 79, 147, 215 and 375 kg N ha(-1)) was performed in 2009 and 2010 in a maize field in Huanghuaihai region, China, where > 300 kg N ha(-1) has been routinely applied to soil during maize growth period of 120 days. Responses of net N mineralization, inorganic N flux (0-10cm), NH3 volatilization, and maize yield to N fertilization were measured. During the growth period, net N mineralization and nitrification varied seasonally, with higher rates occurring in August and coinciding with the R1 stage of maize growth. Soil NO3--N contributed to more than 60% of inorganic N flux during maize growth. Cumulative NH3 volatilization increased with N additions, with total NH3 volatilization during maize growth accounting for about 4% of added N. Relative to the control, mean maize yield in the fertilizer treatments increased by 17% and 20% in 2009 and 2010, respectively. However, grain yield, aboveground biomass, and plant N accumulation did not increase with added N at levels > 215 kg N ha(-1). These results suggest that the current N rate of 300 kg N ha(-1) is not only excessive, but also reduces fertilizer efficacy and may contribute to environmental problems such as global warming and eutrophication of ground water and streams.	[Zhang, Xuelin; Wang, Qun; Xu, Jun; Li, Chaohai] Henan Agr Univ, Agron Coll, Collaborat Innovat Ctr Henan Grain Crops, Incubat Base Natl Key Lab Physiol Ecol & Genet Im, Zhengzhou 450002, Peoples R China; [Gilliam, Frank S.] Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA; [Tremblay, Nicolas] Agr & Agri Food Canada, Hort Res & Dev Ctr, St Jean, PQ J3B 3E6, Canada	Henan Agricultural University; Marshall University; Agriculture & Agri Food Canada	Zhang, XL (corresponding author), Henan Agr Univ, Agron Coll, Collaborat Innovat Ctr Henan Grain Crops, Incubat Base Natl Key Lab Physiol Ecol & Genet Im, 95 Wenhua Rd, Zhengzhou 450002, Peoples R China.	xuelinzhang1998@163.com	Tremblay, Nicolas/AAG-7408-2020; Gilliam, Frank S./M-9767-2019	Tremblay, Nicolas/0000-0003-1409-4442; Gilliam, Frank S./0000-0002-5525-0766	Henan Science and Technology Department of China under the Key Research Project [30200051]	Henan Science and Technology Department of China under the Key Research Project	This study was financially supported by grants from the Henan Science and Technology Department of China under the Key Research Project (30200051).	Basso B, 2005, AGR ECOSYST ENVIRON, V108, P329, DOI 10.1016/j.agee.2005.01.011; Cao YS, 2013, FIELD CROP RES, V147, P23, DOI 10.1016/j.fcr.2013.03.015; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Cui ZL, 2010, FIELD CROP RES, V116, P140, DOI 10.1016/j.fcr.2009.12.004; Dawson JC, 2008, FIELD CROP RES, V107, P89, DOI 10.1016/j.fcr.2008.01.001; Delgado JA, 2008, ECOL ENG, V32, P108, DOI 10.1016/j.ecoleng.2007.10.006; Delin S, 2002, ACTA AGR SCAND B-S P, V52, P78, DOI 10.1080/090647102321089819; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Heumann S, 2013, NUTR CYCL AGROECOSYS, V95, P395, DOI 10.1007/s10705-013-9572-y; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kadono A, 2008, SOIL BIOL BIOCHEM, V40, P947, DOI 10.1016/j.soilbio.2007.11.015; Korsaeth A, 2002, SOIL BIOL BIOCHEM, V34, P789, DOI 10.1016/S0038-0717(02)00008-1; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; Loecke TD, 2012, NUTR CYCL AGROECOSYS, V93, P65, DOI 10.1007/s10705-012-9500-6; Ma BL, 2010, AGRON J, V102, P134, DOI 10.2134/agronj2009.0021; Ma WQ, 2008, AGR SYST, V99, P53, DOI 10.1016/j.agsy.2008.10.001; Malhi SS, 2001, SOIL TILL RES, V60, P101, DOI 10.1016/S0167-1987(01)00176-3; Martines AM, 2010, BIORESOURCE TECHNOL, V101, P4690, DOI 10.1016/j.biortech.2010.01.104; NOMMIK H, 1973, PLANT SOIL, V39, P309, DOI 10.1007/BF00014798; RAISON RJ, 1987, SOIL BIOL BIOCHEM, V19, P521, DOI 10.1016/0038-0717(87)90094-0; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Rodhe L, 2006, SOIL USE MANAGE, V22, P229, DOI 10.1111/j.1475-2743.2006.00043.x; Roelle PA, 2002, ATMOS ENVIRON, V36, P1087, DOI 10.1016/S1352-2310(01)00355-7; Saarijarvi K, 2006, ATMOS ENVIRON, V40, P5137, DOI 10.1016/j.atmosenv.2006.03.052; Schjorring JK, 1998, NEW PHYTOL, V139, P59, DOI 10.1046/j.1469-8137.1998.00173.x; Schroder JJ, 2000, FIELD CROP RES, V66, P151, DOI 10.1016/S0378-4290(00)00072-1; Sehy U, 2003, AGR ECOSYST ENVIRON, V99, P97, DOI 10.1016/S0167-8809(03)00139-7; Shisanya CA, 2009, SOIL TILL RES, V103, P239, DOI 10.1016/j.still.2008.05.016; Smil V, 2002, AMBIO, V31, P126, DOI 10.1639/0044-7447(2002)031[0126:NAFPPF]2.0.CO;2; Sommer SG, 2004, ADV AGRON, V82, P557, DOI 10.1016/S0065-2113(03)82008-4; Sommer SG, 2003, EUR J AGRON, V19, P465, DOI 10.1016/S1161-0301(03)00037-6; Stokstad E, 2014, SCIENCE, V343, P238, DOI 10.1126/science.343.6168.238; Subbarao GV, 2009, P NATL ACAD SCI USA, V106, P17302, DOI 10.1073/pnas.0903694106; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Wu TY, 2008, NUTR CYCL AGROECOSYS, V81, P279, DOI 10.1007/s10705-007-9163-x; Xing GX, 2000, NUTR CYCL AGROECOSYS, V57, P67, DOI 10.1023/A:1009717603427; Zhang JS, 2011, AGR ECOSYST ENVIRON, V140, P164, DOI 10.1016/j.agee.2010.11.023; Zhang X, 2012, GRASS FORAGE SCI, V67, P219, DOI 10.1111/j.1365-2494.2011.00836.x; Zhou S, 2009, WATER AIR SOIL POLL, V201, P135, DOI 10.1007/s11270-008-9933-3; Zhu JH, 2005, AGR ECOSYST ENVIRON, V111, P70, DOI 10.1016/j.agee.2005.04.025; Zhu X, 2013, P NATL ACAD SCI USA, V110, P6328, DOI 10.1073/pnas.1219993110	44	20	24	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115649	10.1371/journal.pone.0115649	http://dx.doi.org/10.1371/journal.pone.0115649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635864	gold, Green Submitted, Green Published			2022-12-26	WOS:000350680700016
J	Lankester, F; Lugelo, A; Kazwala, R; Keyyu, J; Cleaveland, S; Yoder, J				Lankester, Felix; Lugelo, Ahmed; Kazwala, Rudovick; Keyyu, Julius; Cleaveland, Sarah; Yoder, Jonathan			The Economic Impact of Malignant Catarrhal Fever on Pastoralist Livelihoods	PLOS ONE			English	Article							CATTLE; WILDEBEEST; PREFERENCE; WILDLIFE; REGION; AGENT	This study is the first to partially quantify the potential economic benefits that a vaccine, effective at protecting cattle against malignant catarrhal fever (MCF), could accrue to pastoralists living in East Africa. The benefits would result from the removal of household resource and management costs that are traditionally incurred avoiding the disease. MCF, a fatal disease of cattle caused by a virus transmitted from wildebeest calves, has plagued Maasai communities in East Africa for generations. The threat of the disease forces the Maasai to move cattle to less productive grazing areas to avoid wildebeest during calving season when forage quality is critical. To assess the management and resource costs associated with moving, we used household survey data. To estimate the costs associated with changes in livestock body condition that result from being herded away from wildebeest calving grounds, we exploited an ongoing MCF vaccine field trial and we used a hedonic price regression, a statistical model that allows estimation of the marginal contribution of a good's attributes to its market price. We found that 90 percent of households move, on average, 82 percent of all cattle away from home to avoid MCF. In doing so, a herd's productive contributions to the household was reduced, with 64 percent of milk being unavailable for sale or consumption by the family members remaining at the boma (the children, women, and the elderly). In contrast cattle that remained on the wildebeest calving grounds during the calving season (and survived MCF) remained fully productive to the family and gained body condition compared to cattle that moved away. This gain was, however, short-lived. We estimated the market value of these condition gains and losses using hedonic regression. The value of a vaccine for MCF is the removal of the costs incurred in avoiding the disease.	[Lankester, Felix] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Lankester, Felix; Cleaveland, Sarah] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Lugelo, Ahmed; Kazwala, Rudovick] Sokoine Univ Agr, Fac Vet Med, Morogoro, Tanzania; [Keyyu, Julius] Tanzanian Wildlife Res Inst, Arusha, Tanzania; [Yoder, Jonathan] Washington State Univ, Sch Econ, Pullman, WA 99164 USA	Washington State University; University of Glasgow; Sokoine University of Agriculture; Washington State University	Lankester, F (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	lankesterf@vetmed.wsu.edu	Yoder, Jonathan K/F-4840-2011	Cleaveland, Sarah/0000-0002-0456-0959; Lankester, Felix/0000-0002-0802-0693	Biotechnology and Biological Science Research Council [BB/H009035/1]; BBSRC [BB/H009116/1, BB/H009035/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H009116/1, BB/H009035/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Science Research Council (grant number BB/H009035/1 to SC RK JK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BAS FACTS FIG HUM SE; Ayele G, 2006, J FOOD PROD MARK, V12, P59, DOI 10.1300/J038v12n04_05; Bedelian C, 2007, PREV VET MED, V78, P296, DOI 10.1016/j.prevetmed.2006.10.012; Ben-shahar AR, 2014, OECOLOGIA, V90, P422; Boone R, 2002, INTEGRATED ASSESSMEN; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRIDGEN A, 1991, RES VET SCI, V50, P38, DOI 10.1016/0034-5288(91)90051-O; Cleaveland S, 2001, TECHNICAL REPORT; Coatney K. T., 1996, Review of Agricultural Economics, V18, P193, DOI 10.2307/1349432; Cook R. D., 1982, RESIDUALS INFLUENCE, V5; Davidson R, 1993, ESTIMATION INFERENCE; ESTES R D, 1976, East African Wildlife Journal, V14, P135; EVANS DG, 1978, ANIM PROD, V26, P119, DOI 10.1017/S0003356100039520; Food and Agricultural Organization / World Health Organization (FAO/ WHO), 1973, WHO TECHN REP SER, V522; Fratkin EM, 1999, CURR ANTHROPOL, V40, P729, DOI 10.1086/300093; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Getachew Terefe, 2012, Ethiopian Veterinary Journal, V16, P15; Greene H., 2003, ECONOMETRIC ANAL; Haig DM, 2008, VACCINE, V26, P4461, DOI 10.1016/j.vaccine.2008.06.056; Holdo RM, 2009, AM NAT, V173, P431, DOI 10.1086/597229; Homewood K. M., 1992, Ecology of Food and Nutrition, V29, P61, DOI 10.1080/03670244.1992.9991291; Homewood K, 2009, STUD HUM ECOL ADAPT, V5, P369, DOI 10.1007/978-0-387-87492-0_10; Jahnke H. E., 1982, Livestock production systems and livestock development in tropical Africa.; Jan vanGarderen K., 2003, ECONOMET J, DOI [10.1111/1368-423x.00078, 10.1111/1368-423x.00078., DOI 10.1111/1368-423X.00078]; Jehle G. A., 2011, ADV MICROECONOMIC TH; Kennedy PE, 1981, AM EC REV, V71; Li H, 2008, J GEN VIROL, V89, P1699, DOI 10.1099/vir.0.2008/000554-0; Lybbert TJ, 2004, ECON J, V114, P750, DOI 10.1111/j.1468-0297.2004.00242.x; Mdoe N, 1997, AGR ECON, V17, P75, DOI 10.1016/S0169-5150(97)00006-6; Morrison TA, 2012, J ANIM ECOL, V81, P543, DOI 10.1111/j.1365-2656.2011.01941.x; Nicholson M, 1984, PASTORALISM MILK PRO; Plowright W, 1986, Rev Sci Tech, V5, P897, DOI 10.20506/rst.5.4.271; PLOWRIGHT W, 1960, NATURE, V188, P1167, DOI 10.1038/1881167a0; ROSEN S, 1974, J POLIT ECON, V82, P34, DOI 10.1086/260169; Russell GC, 2009, VET J, V179, P324, DOI 10.1016/j.tvjl.2007.11.007; Sachedina HT, 2010, ANTIPODE, V42, P603, DOI 10.1111/j.1467-8330.2010.00765.x; Scarpa R, 2003, ECOL ECON, V45, P409, DOI 10.1016/S0921-8009(03)00094-6; Trench P. C., 2010, STAYING MAASAI LIVEL; Voeten M, 1999, THESIS WAGENINGEN U; Voeten MM, 1999, OECOLOGIA, V120, P287, DOI 10.1007/s004420050860; WANDERSTOCK JJ, 1946, J ANIM SCI, V5, P264, DOI 10.2527/jas1946.53264x; WESTERN D, 1986, HUM ECOL, V14, P77, DOI 10.1007/BF00889211	42	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116059	10.1371/journal.pone.0116059	http://dx.doi.org/10.1371/journal.pone.0116059			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA2IM	25629896	Green Accepted, Green Published, gold			2022-12-26	WOS:000348732100031
J	Weber, CF; King, GM; Aho, K				Weber, Carolyn F.; King, Gary M.; Aho, Ken			Relative Abundance of and Composition within Fungal Orders Differ between Cheatgrass (Bromus tectorum) and Sagebrush (Artemisia tridentate)-Associated Soils	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ANNUAL GRASS; CARBON; MOISTURE; GLOMALIN; DIVERSITY; STEPPE; CYCLE; AGGREGATION; COMMUNITIES	Nonnative Bromus tectorum (cheatgrass) is decimating sagebrush steppe, one of the largest ecosystems in the Western United States, and is causing regional-scale shifts in the predominant plant-fungal interactions. Sagebrush, a native perennial, hosts arbuscular mycorrhizal fungi (AMF), whereas cheatgrass, a winter annual, is a relatively poor host of AMF. This shift is likely intertwined with decreased carbon (C)-sequestration in cheatgrass-invaded soils and alterations in overall soil fungal community composition and structure, but the latter remain unresolved. We examined soil fungal communities using high throughput amplicon sequencing (ribosomal large subunit gene) in the 0-4 cm and 4-8 cm depth intervals of six cores from cheatgrass- and six cores from sagebrush-dominated soils. Sagebrush core surfaces (0-4 cm) contained higher nitrogen and total C than cheatgrass core surfaces; these differences mirrored the presence of glomalin related soil proteins (GRSP), which has been associated with AMF activity and increased C-sequestration. Fungal richness was not significantly affected by vegetation type, depth or an interaction of the two factors. However, the relative abundance of seven taxonomic orders was significantly affected by vegetation type or the interaction between vegetation type and depth. Teloschistales, Spizellomycetales, Pezizales and Cantharellales were more abundant in sagebrush libraries and contain mycorrhizal, lichenized and basal lineages of fungi. Only two orders (Coniochaetales and Sordariales), which contain numerous economically important pathogens and opportunistic saprotrophs, were more abundant in cheatgrass libraries. Pleosporales, Agaricales, Helotiales and Hypocreales were most abundant across all libraries, but the number of genera detected within these orders was as much as 29 times lower in cheatgrass relative to sagebrush libraries. These compositional differences between fungal communities associated with cheatgrass-and sagebrush-dominated soils warrant future research to examine soil fungal community composition across more sites and time points as well as in association with native grass species that also occupy cheatgrass-invaded ecosystems.	[Weber, Carolyn F.; Aho, Ken] Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA; [King, Gary M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Idaho; Idaho State University; Louisiana State University System; Louisiana State University	Weber, CF (corresponding author), Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA.	webecaro@isu.edu			National Science Foundation EPSCoR [EPS-0814387]; Idaho State University Office of Research; College of Science and Engineering; Direct For Biological Sciences [1241069] Funding Source: National Science Foundation	National Science Foundation EPSCoR(National Science Foundation (NSF)); Idaho State University Office of Research; College of Science and Engineering; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by new faculty start up funding provided by a National Science Foundation EPSCoR grant (EPS-0814387) and new faculty startup funds from the Idaho State University Office of Research and the College of Science and Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho K.A., 2014, FDN APPL STAT BIOL U; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; [Anonymous], 2006, BLACKWELL PUB PROF; [Anonymous], 2005, GEN TECHNICAL REPORT; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Baughman OW, 2013, INVAS PLANT SCI MANA, V6, P105, DOI 10.1614/IPSM-D-12-00043.1; Bedini S, 2009, SOIL BIOL BIOCHEM, V41, P1491, DOI 10.1016/j.soilbio.2009.04.005; Belnap J, 2001, ECOL APPL, V11, P1261; Belnap J, 1994, ECOLOGY MANAGEMENT A; Blight GE, 2012, MECH RESIDUAL SOILS, p[50, 41], DOI [10.3390/jpm2020050, DOI 10.3390/JPM2020050]; BOYLE SA, 2005, COLORADO SAGEBRUSH C; Bradley BA, 2005, REMOTE SENS ENVIRON, V94, P204, DOI 10.1016/j.rse.2004.08.016; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brunner E, 2002, NONPARAMETRIC ANAL L; Busby RR, 2012, J ECOSYS ECOG, pS8; Busby RR, 2013, MYCORRHIZA, V23, P129, DOI 10.1007/s00572-012-0455-x; Carter KA, 2014, MYCORRHIZA, V24, P301, DOI 10.1007/s00572-013-0537-4; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Chambers JC, 2007, ECOL MONOGR, V77, P117, DOI 10.1890/05-1991; Cregger MA, 2012, APPL ENVIRON MICROB, V78, P8587, DOI 10.1128/AEM.02050-12; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; DUKE SE, 1994, CAN J BOT, V72, P998, DOI 10.1139/b94-125; EVANS RD, 1993, OECOLOGIA, V94, P314, DOI 10.1007/BF00317104; Evans RD, 2001, ECOL APPL, V11, P1259; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Goldberry S, 2006, NCUR 20 U N CAR ASH; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; HARRIS GA, 1970, ECOLOGY, V51, P530, DOI 10.2307/1935392; Hawkes CV, 2006, PLANT SOIL, V281, P369, DOI 10.1007/s11104-005-4826-3; Hoover AN, 2012, RANGELAND ECOL MANAG, V65, P160, DOI 10.2111/REM-D-11-00026.1; HULBERT LC, 1955, ECOL MONOGR, V25, P181, DOI 10.2307/1943550; Inouye RS, 2006, J ARID ENVIRON, V65, P604, DOI 10.1016/j.jaridenv.2005.10.005; Inouye RS, 2002, WEST N AM NATURALIST, V62, P360; King GM, 2011, TRENDS MICROBIOL, V19, P75, DOI 10.1016/j.tim.2010.11.006; Klironomos JN, 1998, NEW PHYTOL, V138, P599, DOI 10.1046/j.1469-8137.1998.00141.x; Knapp PA, 1996, GLOBAL ENVIRON CHANG, V6, P37, DOI 10.1016/0959-3780(95)00112-3; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kuske CR, 2002, APPL ENVIRON MICROB, V68, P1854, DOI 10.1128/AEM.68.4.1854-1863.2002; Letcher PM, 2002, MYCOLOGIA, V94, P761, DOI 10.2307/3761691; Lindahl BD, 2010, ISME J, V4, P872, DOI 10.1038/ismej.2010.19; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; McDonald MC, 2013, NEW PHYTOL, V199, P241, DOI 10.1111/nph.12257; Menkis A, 2012, FOREST PATHOL, V42, P79, DOI 10.1111/j.1439-0329.2011.00712.x; Meyer SE, 2008, USDA FOREST SERVICE; Nash III TH, 2008, PHYSL SYMBIOSIS, P134, DOI [10.1161/CIRCOUTCOMES.108.825232, DOI 10.1161/CIRCOUTCOMES.108.825232]; Norton JB, 2004, USDA FOREST SERVICE; Norton U, 2008, SOIL BIOL BIOCHEM, V40, P1421, DOI 10.1016/j.soilbio.2007.12.021; Norton U, 2012, SOIL SCI SOC AM J, V76, P1038, DOI 10.2136/sssaj2011.0270; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pellant M, 1996, CHEATGRASSS INVADER; Porras-Alfaro A, 2008, APPL ENVIRON MICROB, V74, P2805, DOI 10.1128/AEM.02769-07; Porras-Alfaro A, 2011, MYCOLOGIA, V103, P10, DOI 10.3852/09-297; Promputtha I, 2007, MICROB ECOL, V53, P579, DOI 10.1007/s00248-006-9117-x; R Core Team, 2021, R LANGUAGE ENV STAT; Rau BM, 2011, RANGELAND ECOL MANAG, V64, P139, DOI 10.2111/REM-D-10-00063.1; Rillig MC, 2010, SOIL BIOL BIOCHEM, V42, P1189, DOI 10.1016/j.soilbio.2010.03.027; Rillig MC, 2002, SOIL BIOL BIOCHEM, V34, P1371, DOI 10.1016/S0038-0717(02)00060-3; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2003, PLANT SOIL, V253, P293, DOI 10.1023/A:1024807820579; Sankey JB, 2012, INT J WILDLAND FIRE, V21, P545, DOI 10.1071/WF11092; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt SK, 2012, FUNGAL ECOL, V5, P443, DOI 10.1016/j.funeco.2011.10.005; Sigma-Aldrich Co. LLC, 2013, BRADF REAG TECHN B; Sperry LJ, 2006, ECOLOGY, V87, P603, DOI 10.1890/05-0836; van der Putten WH, 2007, ISME J, V1, P28, DOI 10.1038/ismej.2007.9; Weber CF, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00078; West NE, 1999, PUBLICATION BOISE ST; WHISENANT SG, 1990, USDA INTERM, V276, P4; Wilcox RR, 2005, INTRO ROBUST ESTIMAT, P369; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wisdom MJ, 2005, HABITAT THREATS SAGE, p[5, 5]	72	18	18	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117026	10.1371/journal.pone.0117026	http://dx.doi.org/10.1371/journal.pone.0117026			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629158	Green Published, gold			2022-12-26	WOS:000348732100057
J	Deplanche, M; El-Aouar, RA; Alekseeva, L; Ladier, E; Jardin, J; Henry, G; Azevedo, V; Miyoshi, A; Beraud, L; Laurent, F; Lina, G; Vandenesch, F; Steghens, JP; Le Loir, Y; Otto, M; Gotz, F; Berkova, N				Deplanche, Martine; El-Aouar Filho, Rachid Aref; Alekseeva, Ludmila; Ladier, Emilie; Jardin, Julien; Henry, Gwenaele; Azevedo, Vasco; Miyoshi, Anderson; Beraud, Laetitia; Laurent, Frederic; Lina, Gerard; Vandenesch, Francois; Steghens, Jean-Paul; Le Loir, Yves; Otto, Michael; Goetz, Friedrich; Berkova, Nadia			Phenol-soluble modulin alpha induces G2/M phase transition delay in eukaryotic HeLa cells	FASEB JOURNAL			English	Article						Staphylococcus aureus; cell cycle alteration; defensins; toxin; innate immune response	BETA-DEFENSIN 2; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; INFECTION; CYCLE; EXPRESSION; PROTEINS; INHIBIT; SKIN	Staphylococcus aureus is a gram-positive bacterium responsible for a wide range of infections. Host cell cycle alteration is a sophisticated mechanism used by pathogens to hijack the defense functions of host cells. We previously demonstrated that S. aureus MW2 (USA400) bacteria induced a G2/M phase transition delay in HeLa cells. We demonstrate here that this activity is triggered by culture supernatant compounds. Using size exclusion chromatography of the MW2 supernatant, followed by mass spectroscopy analysis of corresponding peaks, we identified phenol-soluble modulin (PSM) peptides as the likely candidates for this effect. Indeed, synthetic PSM1 and PSM3 caused a G2/M phase transition delay. The implication of PSM in cell cycle alteration was confirmed by comparison of S. aureus Los Angeles County clone (LAC) wild-type with the isogenic mutant LACpsm, which lacks the psm operon encoding PSM1-4. PSM-induced G2/M transition delay correlated with a decrease in the defensin genes expression suggesting a diminution of antibacterial functions of epithelial cells. By testing the supernatant of S. aureus human clinical isolates, we found that the degree of G2/M phase transition delay correlated with PSM1 production. We show that PSMs secreted by S. aureus alter the host cell cycle, revealing a newly identified mechanism for fostering an infection.	[Deplanche, Martine; El-Aouar Filho, Rachid Aref; Alekseeva, Ludmila; Ladier, Emilie; Jardin, Julien; Henry, Gwenaele; Le Loir, Yves; Berkova, Nadia] INRA, STLO, UMR1253, Agrocampus Ouest, 65 Rue St Brieuc, F-35042 Rennes, France; [Deplanche, Martine; El-Aouar Filho, Rachid Aref; Alekseeva, Ludmila; Ladier, Emilie; Jardin, Julien; Henry, Gwenaele; Le Loir, Yves; Berkova, Nadia] Agrocampus Ouest, UMR1253, STLO, Rennes, France; [El-Aouar Filho, Rachid Aref; Azevedo, Vasco; Miyoshi, Anderson] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Alekseeva, Ludmila] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Beraud, Laetitia; Laurent, Frederic; Lina, Gerard; Vandenesch, Francois] Univ Lyon 1, CNRS, INSERM U111, Ctr Int Rech Infectiol,Unite Mixtes Rech5308, F-69365 Lyon, France; [Laurent, Frederic; Lina, Gerard; Vandenesch, Francois; Steghens, Jean-Paul] Hosp Civil Lyon, Lyon, France; [Otto, Michael] NIH, Lab Human Bacterial Pathogenesis, Bethesda, MD 20892 USA; [Goetz, Friedrich] Univ Tubingen, Microbial Genet, Tubingen, Germany	INRAE; Institut Agro; Agrocampus Ouest; Institut Agro; Agrocampus Ouest; Universidade Federal de Minas Gerais; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; National Institutes of Health (NIH) - USA; Eberhard Karls University of Tubingen	Berkova, N (corresponding author), INRA, STLO, UMR1253, Agrocampus Ouest, 65 Rue St Brieuc, F-35042 Rennes, France.	nadia.berkova@rennes.inra.fr	Azevedo, Vasco A.C/F-4315-2011; JARDIN, Julien/A-3241-2012; Azevedo, Vasco/B-1556-2019; Vandenesch, Francois/C-7209-2014; LAURENT, Frederic/AGM-0706-2022; LE LOIR, Yves/AAD-1879-2021	Azevedo, Vasco A.C/0000-0002-4775-2280; JARDIN, Julien/0000-0003-0520-9391; Azevedo, Vasco/0000-0002-4775-2280; Vandenesch, Francois/0000-0001-9412-7106; Le Loir, Yves/0000-0002-0355-1065; Otto, Michael/0000-0002-2222-4115; Lina, Gerard/0000-0002-9236-7998; Berkova, Nadia/0000-0001-6246-5549; laurent, frederic/0000-0003-0609-9091	French National Institute for Agricultural Research (INRA) [P10552]; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases' Intramural Research Program; German Research Foundation [SFB766]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Brazil); France-Russia Bilateral Collaboration; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	French National Institute for Agricultural Research (INRA); U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases' Intramural Research Program; German Research Foundation(German Research Foundation (DFG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); France-Russia Bilateral Collaboration; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Gail Wagman and Mary Bret for revising the English. This work was supported by French National Institute for Agricultural Research (INRA), Ruminflame P10552 (to N.B., M.D., J.J., G.H., and Y.L.L.), the U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases' Intramural Research Program (to M.O.), and the German Research Foundation, SFB766 (to F.G.). R.A.E.-A.F. is a recipient of a Ph.D. fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Brazil), and L.A. is a recipient of a postdoctoral fellowship (France-Russia Bilateral Collaboration). The authors declare no conflicts of interest.	Alekseeva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063279; Alkuwaity K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042660; Berkova N, 2006, INT IMMUNOL, V18, P139, DOI 10.1093/intimm/dxh356; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964; CASEWELL MW, 1986, J ANTIMICROB CHEMOTH, V18, P1; Cheung GYC, 2012, MICROBES INFECT, V14, P380, DOI 10.1016/j.micinf.2011.11.013; CHRISTIE CDC, 1988, PEDIATR INFECT DIS J, V7, P791, DOI 10.1097/00006454-198811000-00010; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Grosz M, 2014, CELL MICROBIOL, V16, P451, DOI 10.1111/cmi.12233; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Le Marechal C, 2009, J MICROBIOL METH, V79, P131, DOI 10.1016/j.mimet.2009.08.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller LS, 2011, NAT REV IMMUNOL, V11, P505, DOI 10.1038/nri3010; Nikitas G, 2011, J EXP MED, V208, P2263, DOI 10.1084/jem.20110560; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Otri AM, 2012, INVEST OPHTH VIS SCI, V53, P757, DOI 10.1167/iovs.11-8467; Otto M, 2012, J INFECT DIS, V205, P1483, DOI 10.1093/infdis/jis248; OWEN TA, 1989, J CELL PHYSIOL, V139, P424, DOI 10.1002/jcp.1041390227; Park K, 2014, J DERMATOL SCI, V75, P94, DOI 10.1016/j.jdermsci.2014.04.011; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; SUGAI M, 1992, J BIOL CHEM, V267, P2600; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Varon C, 2014, J INFECT DIS, V209, P588, DOI 10.1093/infdis/jit539; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wu WN, 2011, J VIROL, V85, P10300, DOI 10.1128/JVI.05164-11; Zanger P, 2010, INFECT IMMUN, V78, P3112, DOI 10.1128/IAI.00078-10	34	20	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1950	1959		10.1096/fj.14-260513	http://dx.doi.org/10.1096/fj.14-260513			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25648996	Green Published			2022-12-26	WOS:000354114600029
J	Chen, GY; Arginteanu, DFJ; Hancock, WO				Chen, Geng-Yuan; Arginteanu, David F. J.; Hancock, William O.			Processivity of the Kinesin-2 KIF3A Results from Rear Head Gating and Not Front Head Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Kinesin; Microtubule; Intracellular Trafficking; Enzyme Kinetics; Single-molecule Biophysics; Molecular Motor; Cilia	STIMULATED ATP HYDROLYSIS; MOTOR PROTEIN; INTRACELLULAR-TRANSPORT; SUPERFAMILY PROTEIN; MICROTUBULE; MECHANISM; DOMAIN; FORCE; KINETICS; COORDINATION	The kinesin-2 family motor KIF3A/B works together with dynein to bidirectionally transport intraflagellar particles, melanosomes, and neuronal vesicles. Compared with kinesin-1, kinesin-2 is less processive, and its processivity is more sensitive to load, suggesting that processivity may be controlled by different gating mechanisms. We used stopped-flow and steady-state kinetics experiments, along with single-molecule and multimotor assays to characterize the entire kinetic cycle of a KIF3A homodimer that exhibits motility similar to that of full-length KIF3A/B. Upon first encounter with a microtubule, the motor rapidly exchanges both mADP and mATP. When adenosine 5-[(,)-imido]triphosphate was used to entrap the motor in a two-head-bound state, exchange kinetics were unchanged, indicating that rearward strain in the two-head-bound state does not alter nucleotide binding to the front head. A similar lack of front head gating was found when intramolecular strain was enhanced by shortening the neck linker domain from 17 to 14 residues. In single-molecule assays in ADP, the motor dissociates at 2.1 s(-1), 20-fold slower than the stepping rate, demonstrating the presence of rear head gating. In microtubule pelleting assays, the K<sub arrange="stack">D<sup arrange="stack">Mt is similar in ADP and ATP. The data and accompanying simulations suggest that, rather than KIF3A processivity resulting from strain-dependent regulation of nucleotide binding (front head gating), the motor spends a significant fraction of its hydrolysis cycle in a low affinity state but dissociates only slowly from this state. This work provides a mechanism to explain differences in the load-dependent properties of kinesin-1 and kinesin-2.	[Chen, Geng-Yuan; Arginteanu, David F. J.; Hancock, William O.] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hancock, WO (corresponding author), Penn State Univ, Dept Biomed Engn, 205 Hallowell Bldg, University Pk, PA 16802 USA.	wohbio@engr.psu.edu	Hancock, William/E-7653-2016	Hancock, William/0000-0001-5547-8755	National Institutes of Health [R01 GM076476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076476 (to W. O. H.).	Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Andreasson J. O., 2015, CURR BIOL IN PRESS; Arpag G, 2014, BIOPHYS J, V107, P1896, DOI 10.1016/j.bpj.2014.09.009; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Brunnbauer M, 2012, MOL CELL, V46, P147, DOI 10.1016/j.molcel.2012.04.005; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Cheng JQ, 1998, BIOCHEMISTRY-US, V37, P5288, DOI 10.1021/bi972742j; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cole DG, 1999, CELL MOL LIFE SCI, V56, P217, DOI 10.1007/s000180050423; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; DIVITA G, 1993, J BIOL CHEM, V268, P13178; GILBERT SP, 1994, BIOCHEMISTRY-US, V33, P1951, DOI 10.1021/bi00173a044; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; HACKNEY DD, 1994, J BIOL CHEM, V269, P16508; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Hancock WO, 2014, NAT REV MOL CELL BIO, V15, P615, DOI 10.1038/nrm3853; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Hendricks AG, 2012, CURR BIOL, V22, pR1053, DOI 10.1016/j.cub.2012.11.009; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; HOWARD J, 1995, BIOPHYS J, V68, pS245; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; Ma YZ, 1997, J BIOL CHEM, V272, P717, DOI 10.1074/jbc.272.2.717; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; Milic B, 2014, P NATL ACAD SCI USA, V111, P14136, DOI 10.1073/pnas.1410943111; Moffitt JR, 2010, METHOD ENZYMOL, V475, P221, DOI 10.1016/S0076-6879(10)75010-2; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Muthukrishnan G, 2009, CURR BIOL, V19, P442, DOI 10.1016/j.cub.2009.01.058; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Romberg L, 1998, J CELL BIOL, V140, P1407, DOI 10.1083/jcb.140.6.1407; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; SCHNAPP BJ, 1990, P NATL ACAD SCI USA, V87, P10053, DOI 10.1073/pnas.87.24.10053; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Soppina V, 2014, P NATL ACAD SCI USA, V111, P5562, DOI 10.1073/pnas.1400759111; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; Toprak E, 2009, P NATL ACAD SCI USA, V106, P12717, DOI 10.1073/pnas.0808396106; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; Uppalapati M., 2009, METHODS BIOENGINEERI, P311; Uyeda K, 1997, J BIOL CHEM, V272, P7867, DOI 10.1074/jbc.272.12.7867; Vertommen D, 1996, J BIOL CHEM, V271, P17875, DOI 10.1074/jbc.271.30.17875; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	67	26	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10274	10294		10.1074/jbc.M114.628032	http://dx.doi.org/10.1074/jbc.M114.628032			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25657001	Green Published, hybrid			2022-12-26	WOS:000353241100032
J	Kudalkar, SN; Nikas, SP; Kingsley, PJ; Xu, S; Galligan, JJ; Rouzer, CA; Banerjee, S; Ji, LP; Eno, MR; Makriyannis, A; Marnett, LJ				Kudalkar, Shalley N.; Nikas, Spyros P.; Kingsley, Philip J.; Xu, Shu; Galligan, James J.; Rouzer, Carol A.; Banerjee, Surajit; Ji, Lipin; Eno, Marsha R.; Makriyannis, Alexandros; Marnett, Lawrence J.			13-Methylarachidonic Acid Is a Positive Allosteric Modulator of Endocannabinoid Oxygenation by Cyclooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Cyclooxygenase (COX); Endocannabinoid; Enzyme Kinetics; Site-directed Mutagenesis	COX-2 OXIDATIVE METABOLITE; PROSTAGLANDIN-H SYNTHASE; SYNAPTIC-TRANSMISSION; ARACHIDONIC-ACID; STRUCTURAL BASIS; GLYCEROL ESTER; CROSS-TALK; INHIBITION; 2-ARACHIDONOYLGLYCEROL; STOICHIOMETRY	Background: The structurally identical monomers of cyclooxygenase-2 act as distinct catalytic and allosteric subunits. Results: 13-Methylarachidonic acid strongly potentiates cyclooxygenase-2-mediated endocannabinoid oxygenation without affecting arachidonic acid oxygenation. Conclusion: 13-Methylarachidonic acid is a substrate-selective allosteric potentiator of cyclooxygenase-2-mediated endocannabinoid oxygenation. Significance: 13-Methylarachidonic acid is a valuable tool for probing cyclooxygenase-dependent endocannabinoid oxygenation. Cyclooxygenase-2 (COX-2) oxygenates arachidonic acid (AA) and the endocannabinoids 2-arachidonoylglycerol (2-AG) and arachidonylethanolamide to prostaglandins, prostaglandin glyceryl esters, and prostaglandin ethanolamides, respectively. A structural homodimer, COX-2 acts as a conformational heterodimer with a catalytic and an allosteric monomer. Prior studies have demonstrated substrate-selective negative allosteric regulation of 2-AG oxygenation. Here we describe AM-8138 (13(S)-methylarachidonic acid), a substrate-selective allosteric potentiator that augments 2-AG oxygenation by up to 3.5-fold with no effect on AA oxygenation. In the crystal structure of an AM-8138.COX-2 complex, AM-8138 adopts a conformation similar to the unproductive conformation of AA in the substrate binding site. Kinetic analysis suggests that binding of AM-8138 to the allosteric monomer of COX-2 increases 2-AG oxygenation by increasing k(cat) and preventing inhibitory binding of 2-AG. AM-8138 restored the activity of COX-2 mutants that exhibited very poor 2-AG oxygenating activity and increased the activity of COX-1 toward 2-AG. Competition of AM-8138 for the allosteric site prevented the inhibition of COX-2-dependent 2-AG oxygenation by substrate-selective inhibitors and blocked the inhibition of AA or 2-AG oxygenation by nonselective time-dependent inhibitors. AM-8138 selectively enhanced 2-AG oxygenation in intact RAW264.7 macrophage-like cells. Thus, AM-8138 is an important new tool compound for the exploration of allosteric modulation of COX enzymes and their role in endocannabinoid metabolism.	[Kudalkar, Shalley N.; Kingsley, Philip J.; Xu, Shu; Galligan, James J.; Rouzer, Carol A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA; [Kudalkar, Shalley N.; Kingsley, Philip J.; Xu, Shu; Galligan, James J.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37232 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; [Rouzer, Carol A.; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ctr Mol Toxicol, Nashville, TN 37232 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; [Nikas, Spyros P.; Ji, Lipin; Eno, Marsha R.; Makriyannis, Alexandros] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Banerjee, Surajit] Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Northeastern University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu	Xu, Shu/O-6667-2019; Ji, Lipin/AAG-3845-2022; Makriyannis, Alexandros/GRF-1518-2022; Ji, Lipin/AFK-5292-2022	Xu, Shu/0000-0002-6876-7991; Ji, Lipin/0000-0001-9956-3855; Makriyannis, Alexandros/0000-0003-3272-3687; Ji, Lipin/0000-0001-9956-3855; Rouzer, Carol/0000-0001-6827-1534; Kudalkar, Shalley/0000-0001-9377-335X; Banerjee, Surajit/0000-0002-9414-7163	National Institutes of Health from the NIGMS [P41 GM103403]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009158, R37DA003801, R01DA007215, R01DA003801] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank James A. Wepy for valuable input in developing the AM-8138 potentiation scheme. We also thank William N. Beavers for helpful discussions and suggestions. This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by National Institutes of Health Grant P41 GM103403 from the NIGMS. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Beavers WN, 2014, J AM CHEM SOC, V136, P11529, DOI 10.1021/ja506038v; Blankman JL, 2013, PHARMACOL REV, V65, P849, DOI 10.1124/pr.112.006387; COPELAND RA, 1994, P NATL ACAD SCI USA, V91, P11202, DOI 10.1073/pnas.91.23.11202; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; Hermanson DJ, 2013, NAT NEUROSCI, V16, P1291, DOI 10.1038/nn.3480; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kim J, 2004, NAT NEUROSCI, V7, P697, DOI 10.1038/nn1262; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2001, J BIOL CHEM, V276, P30072, DOI 10.1074/jbc.M104467200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; PERCIVAL MD, 1994, ARCH BIOCHEM BIOPHYS, V315, P111, DOI 10.1006/abbi.1994.1478; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Sang N, 2006, J PHYSIOL-LONDON, V572, P735, DOI 10.1113/jphysiol.2006.105569; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Vane J. R., 1998, AM J MED, V104, p2S, DOI [DOI 10.1016/S0002-9343(97)00203-9, 10.1016/S0002-9343(97)00203-9]; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Vecchio AJ, 2011, FASEB J, V25; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu S, 2014, J BIOL CHEM, V289, P6799, DOI 10.1074/jbc.M113.517987; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	47	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7897	7909		10.1074/jbc.M114.634014	http://dx.doi.org/10.1074/jbc.M114.634014			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648895	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000351613600047
J	Liu, YJ; Sun, B; Xiao, ZC; Wang, RW; Guo, WT; Zhang, JZ; Mi, T; Wang, YD; Jones, PP; Van Petegem, F; Chen, SRW				Liu, Yingjie; Sun, Bo; Xiao, Zhichao; Wang, Ruiwu; Guo, Wenting; Zhang, Joe Z.; Mi, Tao; Wang, Yundi; Jones, Peter P.; Van Petegem, Filip; Chen, S. R. Wayne			Roles of the NH2-terminal Domains of Cardiac Ryanodine Receptor in Ca2+ Release Activation and Termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Imaging; Calcium Intracellular Release; Cardiac Muscle; Ryanodine Receptor; Sarcoplasmic Reticulum (SR)	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; POLYMORPHIC VENTRICULAR-TACHYCARDIA; DISEASE MUTATIONS; SUDDEN-DEATH; MOLECULAR-IDENTIFICATION; CRYSTAL-STRUCTURES; BINDING SITE; BETA-STRAND; LIGAND; THRESHOLD	Background: The NH2-terminal region of cardiac ryanodine receptor (RyR2) contains three domains (A, B, and C) that harbor many disease-causing mutations. Results: Domains A, B, and C distinctively regulate the activation and termination of Ca2+ release. Conclusion: Individual NH2-terminal domains play distinct roles in RyR2 channel function. Significance: These data shed new insights into the actions of RyR2 NH2-terminal disease mutations. The NH2-terminal region (residues 1-543) of the cardiac ryanodine receptor (RyR2) harbors a large number of mutations associated with cardiac arrhythmias and cardiomyopathies. Functional studies have revealed that the NH2-terminal region is involved in the activation and termination of Ca2+ release. The three-dimensional structure of the NH2-terminal region has recently been solved. It is composed of three domains (A, B, and C). However, the roles of these individual domains in Ca2+ release activation and termination are largely unknown. To understand the functional significance of each of these NH2-terminal domains, we systematically deleted these domains and assessed their impact on caffeine- or Ca2+-induced Ca2+ release and store overload-induced Ca2+ release (SOICR) in HEK293 cells. We found that all deletion mutants were capable of forming caffeine- and ryanodine-sensitive functional channels, indicating that the NH2-terminal region is not essential for channel gating. Ca2+ release measurements revealed that deleting domain A markedly reduced the threshold for SOICR termination but had no effect on caffeine or Ca2+ activation or the threshold for SOICR activation, whereas deleting domain B substantially enhanced caffeine and Ca2+ activation and lowered the threshold for SOICR activation and termination. Conversely, deleting domain C suppressed caffeine activation, abolished Ca2+ activation and SOICR, and diminished protein expression. These results suggest that domain A is involved in channel termination, domain B is involved in channel suppression, and domain C is critical for channel activation and expression. Our data shed new insights into the structure-function relationship of the NH2-terminal domains of RyR2 and the action of NH2-terminal disease mutations.	[Liu, Yingjie; Sun, Bo; Xiao, Zhichao; Wang, Ruiwu; Guo, Wenting; Mi, Tao; Wang, Yundi; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Liu, Yingjie; Sun, Bo; Xiao, Zhichao; Wang, Ruiwu; Guo, Wenting; Mi, Tao; Wang, Yundi; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Zhang, Joe Z.; Jones, Peter P.] Univ Otago, Dept Physiol, Dunedin 9054, New Zealand; [Zhang, Joe Z.; Jones, Peter P.] Univ Otago, HeartOtago, Dunedin 9054, New Zealand; [Van Petegem, Filip] Univ British Columbia, Inst Life Sci, Cardiovasc Res Grp, Vancouver, BC V6T 1Z3, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Otago; University of Otago; University of British Columbia	Chen, SRW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, HRIC G48,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	zhang, joe/AAO-5273-2020; Van Petegem, Filip/M-6061-2016	Van Petegem, Filip/0000-0003-2728-8537; Jones, Pete/0000-0001-7977-1737	Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta; Northwest Territories; Nunavut; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS); AIHS; Alberta Innovates [201400104, 201500221, 201300501] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Northwest Territories; Nunavut; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS); AIHS; Alberta Innovates	This work was supported in part by research grants from the Canadian Institutes of Health Research; the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; the Canada Foundation for Innovation; and the Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research (to S. R. W. C.).; Recipient of an Alberta Innovates-Health Solutions (AIHS) graduate studentship award.; Recipient of an AIHS fellowship award.	Amador FJ, 2013, J MOL BIOL, V425, P4034, DOI 10.1016/j.jmb.2013.08.015; Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; CHEEK TR, 1993, J BIOL CHEM, V268, P27076; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; Du GG, 2001, P NATL ACAD SCI USA, V98, P13625, DOI 10.1073/pnas.241516898; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Jiang DW, 2010, CHANNELS, V4, P302, DOI 10.4161/chan.4.4.12666; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kimlicka L, 2013, STRUCTURE, V21, P1440, DOI 10.1016/j.str.2013.06.012; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Liu YJ, 2013, BIOCHEM J, V454, P123, DOI 10.1042/BJ20130594; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; MacLennan DH, 2011, BBA-MOL CELL RES, V1813, P948, DOI 10.1016/j.bbamcr.2010.11.009; Masumiya H, 2001, J BIOL CHEM, V276, P39727, DOI 10.1074/jbc.M106557200; Mohamed U, 2007, J CARDIOVASC ELECTR, V18, P791, DOI 10.1111/j.1540-8167.2007.00766.x; Muschol M, 1999, BIOPHYS J, V77, P577, DOI 10.1016/S0006-3495(99)76914-6; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Tian XX, 2013, J BIOL CHEM, V288, P4066, DOI 10.1074/jbc.M112.427864; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhong XW, 2013, STRUCTURE, V21, P2051, DOI 10.1016/j.str.2013.09.004	41	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7736	7746		10.1074/jbc.M114.618827	http://dx.doi.org/10.1074/jbc.M114.618827			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25627681	hybrid, Green Published			2022-12-26	WOS:000351613600034
J	Su, C; Zhang, CY; Tecle, A; Fu, X; He, JY; Song, J; Zhang, W; Sun, XM; Ren, YY; Silvennoinen, O; Yao, Z; Yang, X; Wei, MX; Yang, J				Su, Chao; Zhang, Chunyan; Tecle, Adiam; Fu, Xue; He, Jinyan; Song, Juan; Zhang, Wei; Sun, Xiaoming; Ren, Yuanyuan; Silvennoinen, Olli; Yao, Zhi; Yang, Xi; Wei, Minxin; Yang, Jie			Tudor Staphylococcal Nuclease (Tudor-SN), a Novel Regulator Facilitating G(1)/S Phase Transition, Acting as a Co-activator of E2F-1 in Cell Cycle Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN P100; HISTONE DEACETYLASE; DOWN-REGULATION; KINASE; IDENTIFICATION; PROLIFERATION; INTERACTS; TARGET; STAT6; CDK4	Tudor staphylococcal nuclease (Tudor-SN) is a multifunctional protein implicated in a variety of cellular processes. In the present study, we identified Tudor-SN as a novel regulator in cell cycle. Tudor-SN was abundant in proliferating cells whereas barely expressed in terminally differentiated cells. Functional analysis indicated that ectopic overexpression of Tudor-SN promoted the G(1)/S transition, whereas knockdown of Tudor-SN caused G(1) arrest. Moreover, the live-cell time-lapse experiment demonstrated that the cell cycle of MEF-/- (knock-out of Tudor-SN in mouse embryonic fibroblasts) was prolonged compared with wild-type MEF+/+ We noticed that Tudor-SN was constantly expressed in every cell cycle phase, but was highly phosphorylated in the G(1)/S border. Further study revealed that Tudor-SN was a potential substrate of Cdk2/4/6, supportively, we found the physical interaction of endogenous Tudor-SN with Cdk4/6 in G(1) and the G(1)/S border, and with Cdk2 in the G(1)/S border and S phase. In addition, roscovitine (Cdk1/2/5 inhibitor) or CINK4 (Cdk4/6 inhibitor) could inhibit the phosphorylation of Tudor-SN, whereas ectopic overexpression of Cdk2/4/6 increased the Tudor-SN phosphorylation. The underlying molecular mechanisms indicated that Tudor-SN could physically interact with E2F-1 in vivo, and could enhance the physical association of E2F-1 with GCN5 (a cofactor of E2F-1, which possesses histone acetyltransferase activity), and promote the binding ability of E2F-1 to the promoter region of its target genes CYCLIN A and E2F-1, and as a result, facilitate the gene transcriptional activation. Taken together, Tudor-SN is identified as a novel co-activator of E2F-1, which could facilitate E2F-1-mediated gene transcriptional activation of target genes, which play essential roles in G(1)/S transition.	[Su, Chao; Zhang, Chunyan; Fu, Xue; Song, Juan; Zhang, Wei; Sun, Xiaoming; Ren, Yuanyuan; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin 300070, Peoples R China; [Su, Chao; Zhang, Chunyan; Tecle, Adiam; Fu, Xue; Song, Juan; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Tianjin 300070, Peoples R China; [Su, Chao; Zhang, Chunyan; Tecle, Adiam; Fu, Xue; Song, Juan; Yang, Jie] Tianjin Med Univ, Lab Mol Immunol, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China; [Su, Chao; Zhang, Chunyan; Tecle, Adiam; Fu, Xue; He, Jinyan; Song, Juan; Zhang, Wei; Sun, Xiaoming; Ren, Yuanyuan; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Tianjin Key Lab Cellular & Mol Immunol, Tianjin 300070, Peoples R China; [Su, Chao; Zhang, Chunyan; Tecle, Adiam; Fu, Xue; He, Jinyan; Song, Juan; Zhang, Wei; Sun, Xiaoming; Ren, Yuanyuan; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Key Lab, Key Lab Educ Minist China, Tianjin 300070, Peoples R China; [Yang, Xi] Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 0T5, Canada; [Silvennoinen, Olli; Yang, Jie] Univ Tampere, Tampere Univ Hosp, Inst Med Technol, FI-33014 Tampere, Finland; [Wei, Minxin] Tianjin Med Univ, Gen Hosp, Dept Cardiovasc Surg, Tianjin 300070, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; University of Manitoba; Tampere University; Tampere University Hospital; Tianjin Medical University	Wei, MX (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Cardiovasc Surg, Tianjin 300070, Peoples R China.	minxinw@126.com; yangj@tijmu.edu.cn	Song, Juan/O-5818-2017	Song, Juan/0000-0001-7350-9578; Yang, Xi/0000-0002-8831-7488	National Science Foundation for Distinguished Young Scholars of China [31125012]; National Science Foundation of China [31370749, 31170830, 31100967, 90919032]; Program for Innovative Research team of Ministry of Education [IRT13085]; Natural Science Foundation of Tianjin [13JCYBJC21400]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research team of Ministry of Education; Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by National Science Foundation for Distinguished Young Scholars of China Grant 31125012, National Science Foundation of China Grants 31370749, 31170830, 31100967, and 90919032, Program for Innovative Research team of Ministry of Education Grant IRT13085, and Natural Science Foundation of Tianjin Grant 13JCYBJC21400.	Alberts B, 2008, MOL BIOL CELL; Barriere C, 2007, MOL ONCOL, V1, P72, DOI 10.1016/j.molonc.2007.03.001; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Brooks G, 1997, J MOL CELL CARDIOL, V29, P2261, DOI 10.1006/jmcc.1997.0471; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Choi Jina, 2014, J Cancer Prev, V19, P187, DOI 10.15430/JCP.2014.19.3.187; Dynlacht BD, 1997, MOL CELL BIOL, V17, P3867, DOI 10.1128/MCB.17.7.3867; Gao XJ, 2010, FEBS LETT, V584, P3525, DOI 10.1016/j.febslet.2010.07.022; Hogel H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027112; KITAGAWA M, 1995, ONCOGENE, V10, P229; Klausen P, 2004, J LEUKOCYTE BIOL, V75, P569, DOI 10.1189/jlb.1003474; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Navarro Garcia- Jove, 2013, PLOS ONE, V8; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Paukku K, 2003, MOL ENDOCRINOL, V17, P1805, DOI 10.1210/me.2002-0256; Prives C, 1993, CURR OPIN CELL BIOL, V5, P214, DOI 10.1016/0955-0674(93)90105-Y; Rivard N, 1999, AM J PHYSIOL-CELL PH, V277, pC652, DOI 10.1152/ajpcell.1999.277.4.C652; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; TONG X, 1995, MOL CELL BIOL, V15, P4735; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Yin J, 2013, ANAT REC, V296, P1568, DOI 10.1002/ar.22737; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yu WS, 2011, NUCLEIC ACIDS RES, V39, P2234, DOI 10.1093/nar/gkq1117	34	37	41	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7208	7220		10.1074/jbc.M114.625046	http://dx.doi.org/10.1074/jbc.M114.625046			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627688	Green Published, hybrid			2022-12-26	WOS:000350991500050
J	Vild, CJ; Li, Y; Guo, EZ; Liu, Y; Xu, ZH				Vild, Cody J.; Li, Yan; Guo, Emily Z.; Liu, Yuan; Xu, Zhaohui			A Novel Mechanism of Regulating the ATPase VPS4 by Its Cofactor LIP5 and the Endosomal Sorting Complex Required for Transport (ESCRT)-III Protein CHMP5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCRT-III; STRUCTURAL BASIS; MEMBRANE SCISSION; PLASMA-MEMBRANE; VTA1; RECOGNITION; BINDING; ACTIVATION; DYNAMICS; MODEL	Disassembly of the endosomal sorting complex required for transport (ESCRT) machinery from biological membranes is a critical final step in cellular processes that require the ESCRT function. This reaction is catalyzed by VPS4, an AAA-ATPase whose activity is tightly regulated by a host of proteins, including LIP5 and the ESCRT-III proteins. Here, we present structural and functional analyses of molecular interactions between human VPS4, LIP5, and the ESCRT-III proteins. The N-terminal domain of LIP5 (LIP5NTD) is required for LIP5-mediated stimulation of VPS4, and the ESCRT-III protein CHMP5 strongly inhibits the stimulation. Both of these observations are distinct from what was previously described for homologous yeast proteins. The, crystal structure of LIP5NTD in complex with the MIT (microtubule-interacting and transport)-interacting motifs of CHMP5 and a second ESCRT-III protein, CHMP1B, was determined at 1 A resolution. It reveals an ESCRT-III binding induced moderate conformational change in LIP5NTD, which results from insertion of a conserved CHMP5 tyrosine residue (Tyr(182)) at the core of LIP5NTD structure. Mutation of Tyr(182) partially relieves the inhibition displayed by CHMP5. Together, these results suggest a novel mechanism of VPS4 regulation in metazoans, where CHMP5 functions as a negative allosteric switch to control LIPS-mediated stimulation of VPS4.	[Vild, Cody J.; Li, Yan; Guo, Emily Z.; Liu, Yuan; Xu, Zhaohui] Univ Michigan, Inst Life Sci, Sch Med, Ann Arbor, MI 48109 USA; [Vild, Cody J.; Xu, Zhaohui] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, ZH (corresponding author), Univ Michigan, Life Sci Inst 3163B, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	zhaohui@umich.edu		LIU, YUAN/0000-0001-9452-0442	National Institutes of Health [GM095769]; United States Department of Energy [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]; Michigan Economic Development Corporation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor; Michigan Economic Development Corporation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095769 (to Z. X.). Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adell MAY, 2014, J CELL BIOL, V205, P33, DOI 10.1083/jcb.201310114; Adell MAY, 2011, FEBS LETT, V585, P3191, DOI 10.1016/j.febslet.2011.09.001; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bricogne G., 2011, BUSTER VERSION 2 10; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Davies BA, 2014, J BIOL CHEM, V289, P28707, DOI 10.1074/jbc.M114.580696; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lata S, 2009, BIOCHEM SOC T, V37, P156, DOI 10.1042/BST0370156; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monroe N, 2014, J MOL BIOL, V426, P510, DOI 10.1016/j.jmb.2013.09.043; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Norgan AP, 2013, J BIOL CHEM, V288, P26147, DOI 10.1074/jbc.M113.494112; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Schuh AL, 2014, CRIT REV BIOCHEM MOL, V49, P242, DOI 10.3109/10409238.2014.881777; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Vild CJ, 2014, J BIOL CHEM, V289, P10378, DOI 10.1074/jbc.M113.532960; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724	53	24	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7291	7303		10.1074/jbc.M114.616730	http://dx.doi.org/10.1074/jbc.M114.616730			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25637630	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000350991500057
J	Fesquet, D; De Bettignies, G; Bellis, M; Espeut, J; Devault, A				Fesquet, Didier; De Bettignies, Geoffroy; Bellis, Michel; Espeut, Julien; Devault, Alain			Binding of Kif23-iso1/CHO1 to 14-3-3 Is Regulated by Sequential Phosphorylations at Two LATS Kinase Consensus Sites	PLOS ONE			English	Article							SIGNALING PATHWAY; CLEAVAGE FURROW; MIDBODY RING; F-ACTIN; CYTOKINESIS; PROTEIN; DEGRADATION; AUTOPHAGY; YAP; DIFFERENTIATION	Kif23 kinesin is an essential actor of cytokinesis in animals. It exists as two major isoforms, known as MKLP1 and CHO1, the longest of which, CHO1, contains two HXRXXS/T NDR/LATS kinase consensus sites. We demonstrate that these two sites are readily phosphorylated by NDR and LATS kinases in vitro, and this requires the presence of an upstream -5 histidine residue. We further show that these sites are phosphorylated in vivo and provide evidence revealing that LATS1,2 participate in the phosphorylation of the most C-terminal S814 site, present on both isoforms. This S814 phosphosite was previously reported to constitute a 14-3-3 binding site, which plays a role in Kif23 clustering during cytokinesis. Surprisingly, we found that phosphorylation of the upstream S716 NDR/LATS consensus site, present only in the longest Kif23 isoform, is required for efficient phosphorylation at S814, thus revealing sequential phosphorylation at these two sites, and differential regulation of Kif23-14-3-3 interaction for the two Kif23 isoforms. Finally, we provide evidence that Kif23 is largely unphosphorylated on S814 in post-abscission midbodies, making this Kif23 post-translational modification a potential marker to probe these structures.	[Fesquet, Didier] CNRS, CRBM UMR 5237, Montpellier, France; Univ Montpellier, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier	Fesquet, D (corresponding author), CNRS, CRBM UMR 5237, Montpellier, France.	dfesquet@crbm.cnrs.fr; alain.devault@crbm.cnrs.fr	Fesquet, didier/M-9750-2019	Fesquet, didier/0000-0001-5657-9689	Fondation ARC [5479]	Fondation ARC	Funding by Fondation ARC 5479 (http://www.fondation-arc.org) (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2006, FEBS LETT, V580, P782, DOI 10.1016/j.febslet.2005.12.096; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Bohnert KA, 2013, GENE DEV, V27, P2164, DOI 10.1101/gad.224154.113; Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chen CT, 2013, TRENDS CELL BIOL, V23, P118, DOI 10.1016/j.tcb.2012.10.012; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cornils H, 2011, MOL CELL BIOL, V31, P1382, DOI 10.1128/MCB.01216-10; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Crowell EF, 2013, BIOESSAYS, V35, P472, DOI 10.1002/bies.201200132; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Douglas ME, 2010, CURR BIOL, V20, P927, DOI 10.1016/j.cub.2010.03.055; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ettinger AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1511; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Gupta S, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-19; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Hergovich A, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-32; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hotz M, TRENDS CELL BIOL; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hutterer A, 2009, CURR BIOL, V19, P2043, DOI 10.1016/j.cub.2009.10.050; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Isakson P, 2013, AUTOPHAGY, V9, P1955, DOI 10.4161/auto.26085; Johnson AE, 2012, CYTOSKELETON, V69, P686, DOI 10.1002/cm.21044; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Kuriyama R, 2002, J CELL BIOL, V156, P783, DOI 10.1083/jcb.200109090; Lee KY, 2012, J CELL SCI, V125, P3495, DOI 10.1242/jcs.094672; Lin S, 2012, J NEUROSCI, V32, P14033, DOI 10.1523/JNEUROSCI.3070-12.2012; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Matuliene J, 2004, MOL BIOL CELL, V15, P3083, DOI 10.1091/mbc.E03-12-0888; Mazanka E, 2008, PLOS BIOL, V6, P1778, DOI 10.1371/journal.pbio.0060203; Meitinger F, 2011, GENE DEV, V25, P875, DOI 10.1101/gad.622411; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; Oh Y, 2012, MOL BIOL CELL, V23, P2445, DOI 10.1091/mbc.E12-01-0033; Okada N, 2011, J CELL SCI, V124, P57, DOI 10.1242/jcs.072918; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pinheiro D, 2014, DEV CELL, V28, P219, DOI 10.1016/j.devcel.2014.01.026; Rena G, 2001, BIOCHEM J, V354, P605, DOI 10.1042/0264-6021:3540605; Salzmann V, 2014, MOL BIOL CELL, V25, P267, DOI 10.1091/mbc.E13-09-0541; Schink KO, 2011, CURR BIOL, V21, pR958, DOI 10.1016/j.cub.2011.10.035; Scott MT, 2002, EMBO J, V21, P6771, DOI 10.1093/emboj/cdf684; Sharp DJ, 1997, J CELL BIOL, V138, P833, DOI 10.1083/jcb.138.4.833; Singh D, 2014, DEV CELL, V28, P253, DOI 10.1016/j.devcel.2014.01.002; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Suzuki H, 2013, J CELL SCI, V126, P4358, DOI 10.1242/jcs.125815; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Uchida S, 2004, J CELL SCI, V117, P3011, DOI 10.1242/jcs.01086; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	56	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117857	10.1371/journal.pone.0117857	http://dx.doi.org/10.1371/journal.pone.0117857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658096	Green Published, Green Submitted, gold			2022-12-26	WOS:000349444900232
J	Ndumbi, P; Gilbert, L; Tsoukas, CM				Ndumbi, Patricia; Gilbert, Louise; Tsoukas, Christos M.			Comprehensive Evaluation of the Immune Risk Phenotype in Successfully Treated HIV-Infected Individuals	PLOS ONE			English	Article							T-LYMPHOCYTE SUBPOPULATIONS; NECROSIS-FACTOR-ALPHA; SWEDISH NONA IMMUNE; ANTIRETROVIRAL THERAPY; CYTOMEGALOVIRUS-INFECTION; TELOMERE LENGTH; LATE-LIFE; RECEPTOR G1; AGE; CELLS	Background Despite successful treatment and CD4+ T-cell recovery, HIV-infected individuals often experience a profound immune dysregulation characterized by a persistently low CD4:CD8 T-cell ratio. This residual immune dysregulation is reminiscent of the Immune Risk Phenotype (IRP) previously associated with morbidity and mortality in the uninfected elderly (> 85 years). The IRP consists of laboratory markers that include: a low CD4:CD8 T-cell ratio, an expansion of CD8+CD28- T-cells and cytomegalovirus (CMV) seropositivity. Despite the significant overlap in immunological phenotypes between normal aging and HIV infection, the IRP has never been evaluated in HIV-infected individuals. In this pilot study we characterized immune changes associated with the IRP in a sample of successfully treated HIV-infected subjects. Methods 18 virologically suppressed HIV-infected subjects were categorized into 2 groups based on their IRP status; HIV+IRP+, (n = 8) and HIV+IRP-, (n = 10) and compared to 15 age-matched HIV uninfected IRP negative controls. All individuals were assessed for functional and phenotypic immune characteristics including: pro-inflammatory cytokine production, antigen-specific proliferation capacity, replicative senescence, T-cell differentiation and lymphocyte telomere length. Results Compared to HIV-infected subjects without an IRP, HIV+IRP+ subjects exhibited a higher frequency of TNF-alpha-producing CD8+ T-cells (p = 0.05) and a reduced proportion of CD8+ naive T-cells (p = 0.007). The IRP status was also associated with a marked upregulation of the replicative senescence markers CD57 and KLGR1, on the surface of CD8+ T-cells (p = 0.004). Finally, HIV+IRP+ individuals had a significantly shorter mean lymphocyte telomere length than their non-IRP counterparts (p = 0.03). Conclusions Our findings suggest that, despite similar levels of treatment-mediated viral suppression, the phenotypic and functional immune characteristics of HIV+IRP+individuals are distinct from those observed in non-IRP individuals. The IRP appears to identify a subset of treated HIV-infected individuals with a higher degree of immune senescence.	[Ndumbi, Patricia; Gilbert, Louise; Tsoukas, Christos M.] McGill Univ, Ctr Hlth, Immune Deficiency Treatment Ctr, Montreal, PQ, Canada	McGill University	Ndumbi, P (corresponding author), McGill Univ, Ctr Hlth, Immune Deficiency Treatment Ctr, Montreal, PQ, Canada.	patricia.ndumbi@mail.mcgill.ca; chris.tsoukas@muhc.mcgill.ca			Canadian Institutes of Health Research (CIHR) [HOP-75353]; Anna Maria Solinas Laroche Foundation; McGill University Health Center (MUHC) graduate fellowship award; Grete Roggenburg Research Award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Anna Maria Solinas Laroche Foundation; McGill University Health Center (MUHC) graduate fellowship award; Grete Roggenburg Research Award	This work was supported by research funding from the Canadian Institutes of Health Research (CIHR) grant HOP-75353 and by the Anna Maria Solinas Laroche Foundation. Patricia Ndumbi was also supported by the McGill University Health Center (MUHC) graduate fellowship award and the Grete Roggenburg Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanzar G, 2005, J VIROL, V79, P3675, DOI 10.1128/JVI.79.6.3675-3683.2005; Blazevic V, 2000, AIDS RES HUM RETROV, V16, P1887, DOI 10.1089/08892220050195847; Boren E, 2004, AUTOIMMUN REV, V3, P401, DOI 10.1016/j.autrev.2004.03.004; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chong LK, 2008, EUR J IMMUNOL, V38, P995, DOI 10.1002/eji.200737687; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Derhovanessian E, 2009, CURR OPIN IMMUNOL, V21, P440, DOI 10.1016/j.coi.2009.05.012; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Leung V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077665; McComsey GA, 2014, JAIDS-J ACQ IMM DEF, V65, P167, DOI 10.1097/01.qai.0000437171.00504.41; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Ndumbi P, 2014, HIV MED, V15, P153, DOI 10.1111/hiv.12096; Ndumbi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094018; O'Callaghan NJ, 2008, BIOTECHNIQUES, V44, P807, DOI 10.2144/000112761; Olivieri F, 2009, ATHEROSCLEROSIS, V206, P588, DOI 10.1016/j.atherosclerosis.2009.03.034; Olsson J, 2000, MECH AGEING DEV, V121, P187; Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294; Pawelec G, 2001, MECH AGEING DEV, V122, P132, DOI 10.1016/S0047-6374(00)00240-2; Plonquet A, 2011, IMMUN AGEING, V8, DOI 10.1186/1742-4933-8-8; RIANCHO JA, 1994, GERONTOLOGY, V40, P8; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Stowe RP, 2012, J MED VIROL, V84, P1797, DOI 10.1002/jmv.23397; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; van de Berg PJEJ, 2010, J IMMUNOL, V184, P3417, DOI 10.4049/jimmunol.0903442; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wikby A, 2008, BIOGERONTOLOGY, V9, P299, DOI 10.1007/s10522-008-9138-6; Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Zanni F, 2003, EXP GERONTOL, V38, P981, DOI 10.1016/S0531-5565(03)00160-8	45	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117039	10.1371/journal.pone.0117039	http://dx.doi.org/10.1371/journal.pone.0117039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647167	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600051
J	Paredes, D; Cayuela, L; Gurr, GM; Campos, M				Paredes, Daniel; Cayuela, Luis; Gurr, Geoff M.; Campos, Mercedes			Is Ground Cover Vegetation an Effective Biological Control Enhancement Strategy against Olive Pests?	PLOS ONE			English	Article							NATURAL ENEMIES; HABITAT MANAGEMENT; AGRICULTURAL LANDSCAPES; BENEFICIAL ARTHROPODS; INTRAGUILD PREDATION; TETRANYCHUS-URTICAE; PEACH ORCHARDS; CONTROL AGENTS; INSECT PESTS; DIVERSITY	Ground cover vegetation is often added or allowed to generate to promote conservation biological control, especially in perennial crops. Nevertheless, there is inconsistent evidence of its effectiveness, with studies reporting positive, nil or negative effects on pest control. This might arise from differences between studies at the local scale (e.g. orchard management and land use history), the landscape context (e.g. presence of patches of natural or semi-natural vegetation near the focal orchard), or regional factors, particularly climate in the year of the study. Here we present the findings from a long-term regional monitoring program conducted on four pest species (Bactrocera oleae, Prays oleae, Euphyllura olivina, Saissetia oleae) in 2,528 olive groves in Andalusia (Spain) from 2006 to 2012. Generalized linear mixed effect models were used to analyze the effect of ground cover on different response variables related to pest abundance, while accounting for variability at the local, landscape and regional scales. There were small and inconsistent effects of ground cover on the abundance of pests whilst local, landscape and regional variability explained a large proportion of the variability in pest response variables. This highlights the importance of local and landscape-related variables in biological control and the potential effects that might emerge from their interaction with practices, such as groundcover vegetation, implemented to promote natural enemy activity. The study points to perennial vegetation close to the focal crop as a promising alternative strategy for conservation biological control that should receive more attention.	[Paredes, Daniel; Campos, Mercedes] CSIC, Estac Expt Zaidin, Dept Protecc Ambiental, Granada, Andalucia, Spain; [Cayuela, Luis] Univ Rey Juan Carlos I, Dept Biol & Geol, Madrid, Spain; [Gurr, Geoff M.] New South Wales Dept Primary Ind, Graham Ctr Agr Innovat, Orange, NSW, Australia; [Gurr, Geoff M.] Charles Sturt Univ, Orange, NSW, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Universidad Rey Juan Carlos; NSW Department of Primary Industries; Charles Sturt University	Paredes, D (corresponding author), CSIC, Estac Expt Zaidin, Dept Protecc Ambiental, Granada, Andalucia, Spain.	daniel.paredes@eez.csic.es	Cayuela, Luis/K-7255-2015; GURR, GEOFFREY M/F-3519-2011; Paredes, Daniel/A-2183-2009; Campos, Mercedes/L-6323-2014	Cayuela, Luis/0000-0003-3562-2662; Paredes, Daniel/0000-0002-2681-2256; Campos, Mercedes/0000-0003-4313-7069; Gurr, Geoff/0000-0001-5008-7966	Junta de Andalucia [PO7-AGR-2747]; project REMEDINAL-2 (Comunidad de Madrid) [S2009/AMB-1783]; Ministry of Education of Spain (FPU grant) [AP-2007-03970]	Junta de Andalucia(Junta de Andalucia); project REMEDINAL-2 (Comunidad de Madrid)(Comunidad de Madrid); Ministry of Education of Spain (FPU grant)	The authors thank Mr. Ricardo Alarcon Roldan, Head of the Crop Protection Service of the Junta de Andalusia (Spain), for providing the data to develop this work. This study was grant-aided by Junta de Andalucia (PO7-AGR-2747), project REMEDINAL-2 (Comunidad de Madrid, S2009/AMB-1783), and the Ministry of Education of Spain (D. P. FPU grant AP-2007-03970). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Fenollosa E, 2011, CROP PROT, V30, P1328, DOI 10.1016/j.cropro.2011.05.011; Arambourg Y, 1986, TRAITE ENTOMOLOGIE O; ARGOV Y, 1993, ENTOMOPHAGA, V38, P89, DOI 10.1007/BF02373143; Baggen LR, 1998, BIOL CONTROL, V11, P9, DOI 10.1006/bcon.1997.0566; Bates D, 2013, IME4 LINEAR MIXED S4; Begum M, 2006, J APPL ECOL, V43, P547, DOI 10.1111/j.1365-2664.2006.01168.x; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Boccaccio L, 2009, BIOCONTROL, V54, P607, DOI 10.1007/s10526-009-9214-0; Boller E. F., 2004, ECOLOGICAL INFRASTRU; Bowie MH, 1999, INT J PEST MANAGE, V45, P69, DOI 10.1080/096708799228076; Castrignano A, 2012, PRECIS AGRIC, V13, P421, DOI 10.1007/s11119-012-9259-4; Colloff MJ, 2013, BIOL CONTROL, V67, P170, DOI 10.1016/j.biocontrol.2013.07.017; CROFT BA, 1975, ANNU REV ENTOMOL, V20, P285, DOI 10.1146/annurev.en.20.010175.001441; Cullen R, 2008, BIOL CONTROL, V45, P272, DOI 10.1016/j.biocontrol.2008.01.016; De Andres F., 2001, ENFERMEDADES PLAGAS; Ditner N, 2013, BIODIVERS CONSERV, V22, P1049, DOI 10.1007/s10531-013-0469-5; Dong Jie, 2005, Great Lakes Entomologist, V38, P186; Duarte J., 2009, SOSTENIBILIDAD PRODU; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Gurr GM, 2010, BIOL CONTROL, V52, P198, DOI 10.1016/j.biocontrol.2009.02.013; Hardman JM, 2011, EXP APPL ACAROL, V53, P215, DOI 10.1007/s10493-010-9397-1; Hartwig NL, 2002, WEED SCI, V50, P688, DOI 10.1614/0043-1745(2002)050[0688:AIACCA]2.0.CO;2; Hodge MA, 1999, J ARACHNOL, V27, P351; Jarraya A., 2004, PRINCIPAUX NUISIBLES; Junta de Andalucia, 2012, PROT CAMP PAR SEG CU; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Logan JD, 2006, ECOL MODEL, V196, P471, DOI 10.1016/j.ecolmodel.2006.02.034; Malumphy C., 2011, British Journal of Entomology and Natural History, V24, P17; Martin EA, 2013, P NATL ACAD SCI USA, V110, P5534, DOI 10.1073/pnas.1215725110; Martinat P.J., 1987, P241; MCCLURE MS, 1982, J ECON ENTOMOL, V75, P64, DOI 10.1093/jee/75.1.64; MEAGHER RL, 1990, EXP APPL ACAROL, V9, P149, DOI 10.1007/BF01193424; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P283; Ortega M, 2013, SPATIO TEMPORAL ANAL, DOI [10.1111/afe.12030, DOI 10.1111/AFE.12030]; Paredes D., 2013, Ecosistemas, V22, P56; Paredes D, 2013, PEERJ, V1, DOI 10.7717/peerj.116; Paredes D, 2013, AGR ECOSYST ENVIRON, V173, P72, DOI 10.1016/j.agee.2013.04.016; Perovic DJ, 2010, BIOL CONTROL, V52, P263, DOI 10.1016/j.biocontrol.2009.09.014; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramos P, 1998, CROP PROT, V17, P645, DOI 10.1016/S0261-2194(98)00065-9; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; Rusch A, 2013, J APPL ECOL, V50, P345, DOI 10.1111/1365-2664.12055; Silva EB, 2010, B ENTOMOL RES, V100, P489, DOI 10.1017/S0007485309990526; Simon S, 2010, AGRON SUSTAIN DEV, V30, P139, DOI 10.1051/agro/2009013; Skaug H., 2013, GEN LINEAR MIXED MOD; Smith MW, 1996, BIOL CONTROL, V6, P164, DOI 10.1006/bcon.1996.0021; Song BZ, 2010, BIOCONTROL, V55, P741, DOI 10.1007/s10526-010-9301-2; Song BZ, 2011, PEST MANAG SCI, V67, P1107, DOI 10.1002/ps.2156; Stephens MJ, 1998, BIOCONTROL SCI TECHN, V8, P547, DOI 10.1080/09583159830063; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Tscheulin T, 2011, B ENTOMOL RES, V101, P557, DOI 10.1017/S0007485311000149; Tsitsilas A, 2011, AUST J ENTOMOL, V50, P37, DOI 10.1111/j.1440-6055.2010.00779.x; Valentine BJ, 1996, AUST J EXP AGR, V36, P501, DOI 10.1071/EA9960501; Wan Nian-feng, 2011, Shengtaixue Zazhi, V30, P30; Woltz JM, 2012, AGR ECOSYST ENVIRON, V152, P40, DOI 10.1016/j.agee.2012.02.008	57	45	46	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117265	10.1371/journal.pone.0117265	http://dx.doi.org/10.1371/journal.pone.0117265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646778	Green Submitted, gold, Green Published			2022-12-26	WOS:000348822600061
J	Samardakiewicz, S; Krzeszowiec-Jelen, W; Bednarski, W; Jankowski, A; Suski, S; Gabrys, H; Wozny, A				Samardakiewicz, Slawomir; Krzeszowiec-Jelen, Weronika; Bednarski, Waldemar; Jankowski, Artur; Suski, Szymon; Gabrys, Halina; Wozny, Adam			Pb-Induced Avoidance-Like Chloroplast Movements in Fronds of Lemna trisulca L.	PLOS ONE			English	Article							PHOTOTROPIN FAMILY PROTEINS; VAR. MACOUNII XANTHOPHYTA; BLUE-LIGHT; ARABIDOPSIS-THALIANA; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; ACTIN-FILAMENTS; PHOTOSYNTHETIC APPARATUS; MECHANICAL STIMULATION; MESOPHYLL CHLOROPLASTS	Lead ions are particularly dangerous to the photosynthetic apparatus, but little is known about the effects of trace metals, including Pb, on regulation of chloroplast redistribution. In this study a new effect of lead on chloroplast distribution patterns and movements was demonstrated in mesophyll cells of a small-sized aquatic angiosperm Lemna trisulca L. (star duckweed). An analysis of confocal microscopy images of L. trisulca fronds treated with lead (15 mu MPb2+, 24 h) in darkness or in weak white light revealed an enhanced accumulation of chloroplasts in the profile position along the anticlinal cell walls, in comparison to untreated plants. The rearrangement of chloroplasts in their response to lead ions in darkness was similar to the avoidance response of chloroplasts in plants treated with strong white light. Transmission electron microscopy X-ray microanalysis showed that intracellular chloroplast arrangement was independent of the location of Pb deposits, suggesting that lead causes redistribution of chloroplasts, which looks like a light-induced avoidance response, but is not a real avoidance response to the metal. Furthermore, a similar redistribution of chloroplasts in L. trisulca cells in darkness was observed also under the influence of exogenously applied hydrogen peroxide (H2O2). In addition, we detected an enhanced accumulation of endogenous H2O2 after treatment of plants with lead. Interestingly, H2O2-specific scavenger catalase partly abolished the Pb-induced chloroplast response. These results suggest that H2O2 can be involved in the avoidance-like movement of chloroplasts induced by lead. Analysis of photometric measurements revealed also strong inhibition (but not complete) of blue-light-induced chloroplast movements by lead. This inhibition may result from disturbances in the actin cytoskeleton, as we observed fragmentation and disappearance of actin filaments around chloroplasts. Results of this study show that the mechanisms of the toxic effect of lead on chloroplasts can include disturbances in their movement and distribution pattern.	[Samardakiewicz, Slawomir] Adam Mickiewicz Univ, Fac Biol, Lab Elect & Confocal Microscopy, Poznan, Poland; [Krzeszowiec-Jelen, Weronika; Gabrys, Halina] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Plant Biotechnol, Krakow, Poland; [Bednarski, Waldemar] Polish Acad Sci, Inst Mol Phys, Poznan, Poland; [Jankowski, Artur; Wozny, Adam] Adam Mickiewicz Univ, Fac Biol, Inst Expt Biol, Lab Gen Bot, Poznan, Poland; [Suski, Szymon] Polish Acad Sci, Nencki Inst Expt Biol, Lab Elect Microscopy, Warsaw, Poland	Adam Mickiewicz University; Jagiellonian University; Polish Academy of Sciences; Institute of Molecular Physics of the Polish Academy of Sciences; Adam Mickiewicz University; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Samardakiewicz, S (corresponding author), Adam Mickiewicz Univ, Fac Biol, Lab Elect & Confocal Microscopy, Poznan, Poland.	sas@amu.edu.pl	Krzeszowiec-Jeleń, Weronika/C-9431-2017; Krzeszowiec-Jeleń, Weronika/AAB-7814-2022; Samardakiewicz, Sławomir/A-6741-2008; Bednarski, Waldemar/U-8837-2018	Krzeszowiec-Jeleń, Weronika/0000-0003-4564-2499; Bednarski, Waldemar/0000-0003-1956-7501; Suski, Szymon/0000-0002-3805-3760; Samardakiewicz, Slawomir/0000-0003-4924-253X	Polish National Science Centre Project (NCN) [8066/B/P01/2011/40]	Polish National Science Centre Project (NCN)	Slawomir Samardakiewicz was supported by the Polish National Science Centre Project (NCN) grant no. 8066/B/P01/2011/40. The X-ray microanalysis were performed in the Laboratory of Electron Microscopy, Nencki Institute of Experimental Biology (Warsaw, Poland) by using electron microscope JEM 1400 (JEOL Co., Japan, 2008), equipped with energy-dispersive full range X-ray microanalysis system (EDS INCA Energy TEM, Oxford Instruments, Great Britain) and high resolution digital camera CCD MORADA, SiS-Olympus,	Aggarwal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055393; Alessa L, 2001, ENVIRON EXP BOT, V45, P205, DOI 10.1016/S0098-8472(00)00087-3; Alessa L, 2001, ENVIRON EXP BOT, V45, P223, DOI 10.1016/S0098-8472(00)00088-5; Anielska-Mazur A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-64; Augustynowicz J, 1999, PLANT CELL ENVIRON, V22, P1239, DOI 10.1046/j.1365-3040.1999.00487.x; Banas AK, 2012, J EXP BOT, V63, P1559, DOI 10.1093/jxb/err429; Banas AK, 2010, ACTA PHYSIOL PLANT, V32, P773, DOI 10.1007/s11738-010-0462-5; Banas AK, 2007, PLANT SIGNAL BEHAV, V2, P221, DOI 10.4161/psb.2.4.4392; BASILE A, 1995, ANN BOT-LONDON, V76, P597, DOI 10.1006/anbo.1995.1137; BECANA M, 1986, PLANT PHYSIOL, V82, P1169, DOI 10.1104/pp.82.4.1169; Berg R, 2006, PHOTOSYNTH RES, V87, P303, DOI 10.1007/s11120-005-9012-1; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Davis PA, 2012, PHOTOSYNTH RES, V112, P153, DOI 10.1007/s11120-012-9755-4; DeBlasio SL, 2003, PLANT PHYSIOL, V133, P1471, DOI 10.1104/pp.103.029116; Delmail D, 2014, PHYSL MECH ADAPTATIO, P31, DOI DOI 10.1007/9781461486008_2; Devi R, 2013, PHYSIOL MOL BIOL PLA, V19, P81, DOI 10.1007/s12298-012-0143-5; Dong XJ, 1996, PROTOPLASMA, V195, P18, DOI 10.1007/BF01279183; Dong XJ, 1998, PLANT CELL PHYSIOL, V39, P1299, DOI 10.1093/oxfordjournals.pcp.a029334; Eckstein A, 2012, J PLANT GROWTH REGUL, V31, P90, DOI 10.1007/s00344-011-9222-z; Fahr M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00175; Frolec J, 2010, PLANT CELL REP, V29, P705, DOI 10.1007/s00299-010-0856-2; GABRYS H, 1980, Acta Physiologiae Plantarum, V2, P291; Gabrys H, 1997, J PHOTOCH PHOTOBIO B, V38, P35, DOI 10.1016/S1011-1344(96)07396-4; GABRYS H, 2014, BIOL DIVERSITY CELL, P9, DOI DOI 10.1016/J.JEP.2014.12.058; GABRYS H, 1980, ACTA PHYSIOL PLANT, V4, P281; Gabrys H, 2012, PROG BOT, V73, P189, DOI 10.1007/978-3-642-22746-2_7; GARLAND CJ, 1981, NEW PHYTOL, V87, P581, DOI 10.1111/j.1469-8137.1981.tb03229.x; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goh CH, 2009, PLANT MOL BIOL, V69, P605, DOI 10.1007/s11103-008-9442-1; Grabalska M, 2004, PHOTOCHEM PHOTOBIOL, V79, P343, DOI 10.1562/LE-03-16.1; Guralnick LJ, 2002, FUNCT PLANT BIOL, V29, P763, DOI 10.1071/PP01176; Han IS, 2013, PLANT CELL PHYSIOL, V54, P48, DOI 10.1093/pcp/pcs098; Harada A, 2003, P NATL ACAD SCI USA, V100, P8583, DOI 10.1073/pnas.1336802100; Harada A, 2007, PHOTOCHEM PHOTOBIOL, V83, P102, DOI 10.1562/2006-03-08-IR-837; HAUPT W, 1990, PLANT CELL ENVIRON, V13, P595, DOI 10.1111/j.1365-3040.1990.tb01078.x; Heald R, 2014, CURR OPIN CELL BIOL, V26, P79, DOI 10.1016/j.ceb.2013.10.006; Huang HG, 2012, ENVIRON SCI POLLUT R, V19, P1640, DOI 10.1007/s11356-011-0675-1; Huang JW, 1996, NEW PHYTOL, V134, P75, DOI 10.1111/j.1469-8137.1996.tb01147.x; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; JELESNIANSKA J, 1981, Acta Physiologiae Plantarum, V3, P3; Kabata-Pendias Alina, 2010, P1; KADOTA A, 1992, PROTOPLASMA, V167, P97, DOI 10.1007/BF01353585; Kadota A, 2009, P NATL ACAD SCI USA, V106, P13106, DOI 10.1073/pnas.0906250106; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kagawa T, 2004, PLANT CELL PHYSIOL, V45, P416, DOI 10.1093/pcp/pch045; Kandasamy MK, 1999, CELL MOTIL CYTOSKEL, V44, P110, DOI 10.1002/(SICI)1097-0169(199910)44:2<110::AID-CM3>3.0.CO;2-O; Kasahara M, 2002, NATURE, V420, P829, DOI 10.1038/nature01213; Kaur G, 2013, PROTOPLASMA, V250, P53, DOI 10.1007/s00709-011-0372-4; Kim YY, 2002, PHYSIOL PLANTARUM, V116, P368, DOI 10.1034/j.1399-3054.2002.1160312.x; Kobayashi H, 2009, PLANT CELL PHYSIOL, V50, P129, DOI 10.1093/pcp/pcn177; Kodama Y, 2008, J PLANT RES, V121, P441, DOI 10.1007/s10265-008-0165-9; Kodama Y, 2010, P NATL ACAD SCI USA, V107, P19591, DOI 10.1073/pnas.1007836107; Koniger M, 2014, ADV PHOTOSYNTH RESP, V37, P131, DOI 10.1007/978-94-007-6988-5_8; Kondo A, 2004, PLANTA, V219, P500, DOI 10.1007/s00425-004-1252-3; Kong SG, 2014, BBA-BIOENERGETICS, V1837, P522, DOI 10.1016/j.bbabio.2013.12.004; Kong SG, 2013, PLANT CELL, V25, P572, DOI 10.1105/tpc.113.109694; Kong SG, 2011, MOL PLANT, V4, P771, DOI 10.1093/mp/ssr061; KRUPA Z, 1995, ACTA PHYSIOL PLANT, V17, P177; Krzeslowska M, 2002, BIOL PLANTARUM, V45, P99, DOI 10.1023/A:1015104726046; Krzeslowska M, 2010, ENVIRON POLLUT, V158, P325, DOI 10.1016/j.envpol.2009.06.035; Krzeszowiec W, 2007, BIOL CELL, V99, P251, DOI 10.1042/BC20060077; Krzeszowiec W, 2011, SIGNAL COMMUN PLANTS, P91, DOI 10.1007/978-3-642-19091-9_4; Kumar A, 2012, CHEMOSPHERE, V89, P1056, DOI 10.1016/j.chemosphere.2012.05.070; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Landolt E, 1986, BIOSYSTEMATIC INVEST, V2, P566; LECHOWSKI Z, 1973, Acta Societatis Botanicorum Poloniae, V42, P461; Liu DH, 2009, ECOTOXICOLOGY, V18, P134, DOI 10.1007/s10646-008-0266-1; Luesse DR, 2010, J EXP BOT, V61, P4387, DOI 10.1093/jxb/erq242; Maai E, 2011, J EXP BOT, V62, P3213, DOI 10.1093/jxb/err008; Maberly SC, 1998, FUNCT ECOL, V12, P99, DOI 10.1046/j.1365-2435.1998.00172.x; MAKSYMIEC W, 2008, ABIOTIC STRESS PLANT, P139; Maksymiec W, 2007, ACTA PHYSIOL PLANT, V29, P177, DOI 10.1007/s11738-007-0036-3; Malec P, 1996, PLANT SCI, V120, P127, DOI 10.1016/S0168-9452(96)04506-2; Malecka A, 2009, ACTA PHYSIOL PLANT, V31, P1053, DOI 10.1007/s11738-009-0326-z; Morita MT, 2012, CURR OPIN PLANT BIOL, V15, P722, DOI 10.1016/j.pbi.2012.08.003; MYSLIWAKURDZIEL B, 2004, HEAVY METAL STRESS P, P462; Naus J, 2010, PHOTOSYNTH RES, V105, P265, DOI 10.1007/s11120-010-9587-z; Oelze ML, 2012, J EXP BOT, V63, P1297, DOI 10.1093/jxb/err356; Ogasawara Y, 2013, PLANT CELL ENVIRON, V36, P1520, DOI 10.1111/pce.12085; Oikawa K, 2008, PLANT PHYSIOL, V148, P829, DOI 10.1104/pp.108.123075; Olyslaegers G, 1998, J MICROSC-OXFORD, V192, P73, DOI 10.1046/j.1365-2818.1998.00398.x; Oliver JP, 2009, PLANTA, V230, P569, DOI 10.1007/s00425-009-0969-4; Park YI, 1996, PLANT PHYSIOL, V111, P867, DOI 10.1104/pp.111.3.867; Parys E, 1998, ACTA PHYSIOL PLANT, V20, P313, DOI 10.1007/s11738-998-0064-7; Petrov VD, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls014; Pokorna J, 2004, PLANT CELL ENVIRON, V27, P641, DOI 10.1111/j.1365-3040.2004.01186.x; Pourrut B., 2013, HEAVY METAL STRESS P, P121, DOI DOI 10.1007/978-3-642-38469-1_7; Pourrut B, 2008, J PLANT PHYSIOL, V165, P571, DOI 10.1016/j.jplph.2007.07.016; Pressel S, 2008, ANN BOT-LONDON, V102, P227, DOI 10.1093/aob/mcn080; Pribyl P, 2005, PROTOPLASMA, V226, P231, DOI 10.1007/s00709-005-0123-5; Przymusinki R, 2007, ACTA PHYSIOL PLANT, V29, P411, DOI 10.1007/s11738-007-0049-y; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Rodrigues V, 2007, CURR SCI INDIA, V92, P1610; Rosler J, 2010, PLANT CELL PHYSIOL, V51, P1248, DOI 10.1093/pcp/pcq091; Romanowska E, 2006, PLANT PHYSIOL BIOCH, V44, P387, DOI 10.1016/j.plaphy.2006.06.003; Romanowska E, 2002, PHYSIOLOGY AND BIOCHEMISTRY OF METAL TOXICITY AND TOLERANCE IN PLANTS, P257; Romanowska E, 2012, J PLANT PHYSIOL, V169, P345, DOI 10.1016/j.jplph.2011.10.006; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Samardakiewicz S, 2000, PLANT SOIL, V226, P107, DOI 10.1023/A:1026440730839; Sato Y, 1999, PLANT PHYSIOL, V121, P37, DOI 10.1104/pp.121.1.37; Sato Y, 2003, PLANTA, V216, P772, DOI 10.1007/s00425-002-0927-x; Sato Y, 2003, J PLANT RES, V116, P1, DOI 10.1007/s10265-002-0073-3; Sato Y, 2001, PLANT PHYSIOL, V127, P497, DOI 10.1104/pp.010405; Sato Y, 2001, J CELL SCI, V114, P269; Sato Yoshikatsu, 2006, V23, P527; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Sharon Y., 2011, J MAR BIOL, V2011, DOI [10.1155/2011/483428, DOI 10.1155/2011/483428]; Sharon Y, 2008, AQUAT BOT, V88, P273, DOI 10.1016/j.aquabot.2007.11.006; Shiihira-Ishikawa I, 2007, PHOTOCHEM PHOTOBIOL, V83, P1101, DOI 10.1111/j.1751-1097.2007.00167.x; Singh HP, 2011, BIOL TRACE ELEM RES, V144, P1295, DOI 10.1007/s12011-011-9129-3; Singh R, 2010, BIORESOURCE TECHNOL, V101, P3025, DOI 10.1016/j.biortech.2009.12.031; Snowman BN, 2002, PLANT CELL, V14, P2613, DOI 10.1105/tpc.002998; Stobrawa K, 2007, SCI TOTAL ENVIRON, V373, P157, DOI 10.1016/j.scitotenv.2006.11.019; STRASBURGER E, 1954, KLEINE BOT PRAKTIKUM, P28669; Suetsugu N, 2005, PLANT PHYSIOL, V139, P151, DOI 10.1104/pp.105.067371; Suetsugu N, 2007, BIOL CHEM, V388, P927, DOI 10.1515/BC.2007.118; Suetsugu N, 2007, PHOTOCHEM PHOTOBIOL, V83, P87, DOI 10.1562/2006-02-27-IR-817; Suetsugu N, 2012, ADVANCES IN PHOTOSYNTHESIS - FUNDAMENTAL ASPECTS, P215; Sytar O, 2013, ACTA PHYSIOL PLANT, V35, P985, DOI 10.1007/s11738-012-1169-6; Sztatelman O, 2010, J PLANT PHYSIOL, V167, P709, DOI 10.1016/j.jplph.2009.12.015; Takagi S, 2003, J EXP BIOL, V206, P1963, DOI 10.1242/jeb.00215; Tanaka A, 2007, TREE PHYSIOL, V27, P641, DOI 10.1093/treephys/27.5.641; TERASHIMA I, 1995, PLANT CELL ENVIRON, V18, P1111, DOI 10.1111/j.1365-3040.1995.tb00623.x; Terashima I, 2014, PLANT CELL PHYSIOL, V55, P237, DOI 10.1093/pcp/pcu022; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Tholen D, 2008, PLANT CELL ENVIRON, V31, P1688, DOI 10.1111/j.1365-3040.2008.01875.x; Tlalka M, 1999, PLANT J, V20, P461, DOI 10.1046/j.1365-313x.1999.00621.x; TLALKA M, 1993, PLANTA, V189, P491, DOI 10.1007/BF00198211; Trojan A, 1996, PLANT PHYSIOL, V111, P419, DOI 10.1104/pp.111.2.419; Tsuboi H, 2007, PLANT CELL PHYSIOL, V48, P892, DOI 10.1093/pcp/pcm057; Tsuboi H, 2012, J PLANT RES, V125, P417, DOI 10.1007/s10265-011-0444-8; Tsuboi H, 2012, J PLANT RES, V125, P301, DOI 10.1007/s10265-011-0433-y; Mai VC, 2013, PHYTOCHEMISTRY, V93, P49, DOI 10.1016/j.phytochem.2013.02.011; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Vorob'yev V. N., 1995, Biophysics (English Translation of Biofizika), V40, P537; Wada M, 2004, CURR OPIN PLANT BIOL, V7, P626, DOI 10.1016/j.pbi.2004.09.005; Wada M, 2013, PLANT SCI, V210, P177, DOI 10.1016/j.plantsci.2013.05.016; WALCZAK T, 1980, PHOTOSYNTHETICA, V14, P65; Wang PF, 2012, ECOTOX ENVIRON SAFE, V78, P28, DOI 10.1016/j.ecoenv.2011.11.008; WANG WC, 1990, ENVIRON RES, V52, P7, DOI 10.1016/S0013-9351(05)80147-1; Wang YQ, 2013, J INTEGR PLANT BIOL, V55, P202, DOI 10.1111/jipb.12032; Wen F, 2008, J EXP BOT, V59, P2891, DOI 10.1093/jxb/ern147; Wierzbicka MH, 2007, PROTOPLASMA, V231, P99, DOI 10.1007/s00709-006-0227-6; Wituszynska W, 2013, ABIOTIC STRESS - PLANT RESPONSES AND APPLICATIONS IN AGRICULTURE, P207, DOI 10.5772/53127; Wong CSC, 2006, ENVIRON POLLUT, V142, P1, DOI 10.1016/j.envpol.2005.09.004; Yamada M, 2009, PLANT CELL PHYSIOL, V50, P1736, DOI 10.1093/pcp/pcp116; ZURZYCHI J, 1972, ACTA PROTOZOOL  S MO, V11, P189; ZURZYCKA A, 1950, ACTA SOC BOT POL, V20, P665; ZURZYCKA A, 1951, ACTA SOC BOT POL, V21, P113; Zurzycki J., 1980, The blue light syndrome [Senger, H. (Editor)]., P50; ZURZYCKI J, 1983, PLANTA, V157, P502, DOI 10.1007/BF00396880; ZURZYCKI J., 1955, ACTA SOC BOT POLON, V24, P27; ZURZYCKI JAN, 1962, ACTA SOC BOT POLON, V31, P489; ZURZYCKL J., 1960, ACTA SOC BOT POLON, V29, P385	156	18	18	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116757	10.1371/journal.pone.0116757	http://dx.doi.org/10.1371/journal.pone.0116757			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646776	gold, Green Submitted, Green Published			2022-12-26	WOS:000348822600034
J	Wang, O; Liu, J; Cheng, Q; Guo, XX; Wang, Y; Zhao, L; Zhou, F; Ji, BP				Wang, Ou; Liu, Jia; Cheng, Qian; Guo, Xiaoxuan; Wang, Yong; Zhao, Liang; Zhou, Feng; Ji, Baoping			Effects of Ferulic Acid and gamma-Oryzanol on High-Fat and High-Fructose Diet-Induced Metabolic Syndrome in Rats	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; RICE BRAN OIL; INSULIN-RESISTANCE; PLANT STEROLS; HEPATIC STEATOSIS; CARDIOVASCULAR RISK; HIGH-CARBOHYDRATE; LIPID-METABOLISM; LIVER-DISEASE; HEPG2 CELLS	Background The high morbidity of metabolic dysfunction diseases has heightened interest in seeking natural and safe compounds to maintain optimal health. gamma-Oryzanol (OZ), the ferulic acid (FA) ester with phytosterols, mainly present in rice bran has been shown to improve markers of metabolic syndrome. This study investigates the effects of FA and OZ on alleviating high-fat and high-fructose diet (HFFD)-induced metabolic syndrome parameters. Methods Male SD rats were fed with a regular rodent diet, HFFD, or HFFD supplemented with 0.05% FA or 0.16% OZ (equimolar concentrations) for 13 weeks. Food intake, organ indices, serum lipid profiles, glucose metabolism, insulin resistance (IR) index and cytokine levels were analyzed. The mechanisms were further investigated in oleic acid-stimulated HepG2 cells by analyzing triglyceride (TG) content and lipogenesis-related gene expressions. Results In the in vivo study, FA and OZ exhibited similar effects in alleviating HFFD-induced obesity, hyperlipidemia, hyperglycemia, and IR. However, only OZ treatment significantly decreased liver index and hepatic TG content, lowered serum levels of C-reactive protein and IL-6, and increased serum concentration of adiponectin. In the in vitro assay, only OZ administration significantly inhibited intracellular TG accumulation and down-regulated expression of stearoyl coenzyme-A desaturase-1, which might facilitate OZ to enhance its hepatoprotective effect. Conclusion OZ is more effective than FA in inhibiting hepatic fat accumulation and inflammation. Thus, FA and OZ could be used as dietary supplements to alleviate the deleterious effects of HFFD.	[Wang, Ou; Cheng, Qian; Guo, Xiaoxuan; Wang, Yong; Zhao, Liang; Zhou, Feng; Ji, Baoping] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Liu, Jia] China Natl Res Inst Food & Fermentat Ind, Beijing, Peoples R China	China Agricultural University	Ji, BP (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.	jibp330@hotmail.com		Zhao, Liang/0000-0003-2542-9279				Alwahsh SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104220; Ardiansyah, 2006, J AGR FOOD CHEM, V54, P1914, DOI 10.1021/jf052561l; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Baumgartner S, 2011, CURR PHARM DESIGN, V17, P922, DOI 10.2174/138161211795428795; Berger A, 2005, EUR J NUTR, V44, P163, DOI 10.1007/s00394-004-0508-9; Chen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045693; Chotimarkorn C, 2008, PHYTOMEDICINE, V15, P951, DOI 10.1016/j.phymed.2008.02.014; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; DILLS WL, 1993, AM J CLIN NUTR, V58, P779, DOI 10.1093/ajcn/58.5.779S; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; FUJIWARA S, 1980, YAKUGAKU ZASSHI, V100, P1011, DOI 10.1248/yakushi1947.100.10_1011; GARCIA MJL, 2009, FOOD CHEM, V115, P389; Ghatak SB, 2011, CURR NUTR FOOD SCI, V7, P10, DOI 10.2174/157340111794941120; GRUNFELD C, 1990, ENDOCRINOLOGY, V127, P46, DOI 10.1210/endo-127-1-46; Hiratsuka T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013280; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang CCJ, 2003, THESIS LOUISIANA STA; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kim HK, 2003, CLIN CHIM ACTA, V327, P129, DOI 10.1016/S0009-8981(02)00344-3; Kozuka C, 2012, DIABETES, V61, P3084, DOI 10.2337/db11-1767; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061499; Liu J, 2014, FOOD FUNCT, V5, P1038, DOI 10.1039/c3fo60524h; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Micallef MA, 2009, ATHEROSCLEROSIS, V204, P476, DOI 10.1016/j.atherosclerosis.2008.09.020; Nashed B, 2005, J NUTR, V135, P2438, DOI 10.1093/jn/135.10.2438; *NAT RES COUNC, 1985, NIH PUBL, V85, P23; Othman RA, 2011, NUTR REV, V69, P371, DOI 10.1111/j.1753-4887.2011.00399.x; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pan ZX, 2011, MOL BIOL REP, V38, P3417, DOI 10.1007/s11033-010-0451-1; Panchal SK, 2010, J BIOMED BIOTECHNOL, V2011, P1; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Postic C, 2008, DIABETES METAB, V34, P643, DOI 10.1016/S1262-3636(08)74599-3; Poudyal H, 2010, J NUTR, V140, P946, DOI 10.3945/jn.109.117812; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Silbernagel G, 2013, CURR OPIN LIPIDOL, V24, P12, DOI 10.1097/MOL.0b013e32835b6271; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Sloboda DM, 2014, J OBESITY, V2014; Son MJ, 2011, J FOOD SCI, V76, pH7, DOI 10.1111/j.1750-3841.2010.01907.x; Son MJ, 2010, J CLIN BIOCHEM NUTR, V46, P150, DOI 10.3164/jcbn.09-98; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Vidyashankar S, 2013, TOXICOL IN VITRO, V27, P945, DOI 10.1016/j.tiv.2013.01.014; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Wilson TA, 2007, J NUTR BIOCHEM, V18, P105, DOI 10.1016/j.jnutbio.2006.03.006; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang HJ, 2009, HORM METAB RES, V41, P40, DOI 10.1055/s-0028-1087187; Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039	54	87	91	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0118135	10.1371/journal.pone.0118135	http://dx.doi.org/10.1371/journal.pone.0118135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646799	Green Submitted, gold, Green Published			2022-12-26	WOS:000348822600100
J	Kandasamy, R; Gurung, M; Thapa, A; Ndimah, S; Adhikari, N; Murdoch, DR; Kelly, DF; Waldron, DE; Gould, KA; Thorson, S; Shrestha, S; Hinds, J; Pollard, AJ				Kandasamy, Rama; Gurung, Meeru; Thapa, Anushil; Ndimah, Susan; Adhikari, Neelam; Murdoch, David R.; Kelly, Dominic F.; Waldron, Denise E.; Gould, Katherine A.; Thorson, Stephen; Shrestha, Shrijana; Hinds, Jason; Pollard, Andrew J.			Multi-Serotype Pneumococcal Nasopharyngeal Carriage Prevalence in Vaccine Naive Nepalese Children, Assessed Using Molecular Serotyping	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; RESISTANT PNEUMOCOCCI; YOUNG-CHILDREN; ACQUISITION; POPULATION; RATES; DNA	Invasive pneumococcal disease is one of the major causes of death in young children in resource poor countries. Nasopharyngeal carriage studies provide insight into the local prevalence of circulating pneumococcal serotypes. There are very few data on the concurrent carriage of multiple pneumococcal serotypes. This study aimed to identify the prevalence and serotype distribution of pneumococci carried in the nasopharynx of young healthy Nepalese children prior to the introduction of a pneumococcal conjugate vaccine using a microarray-based molecular serotyping method capable of detecting multi-serotype carriage. We conducted a cross-sectional study of healthy children aged 6 weeks to 24 months from the Kathmandu Valley, Nepal between May and October 2012. Nasopharyngeal swabs were frozen and subsequently plated on selective culture media. DNA extracts of plate sweeps of pneumococcal colonies from these cultures were analysed using a molecular serotyping microarray capable of detecting relative abundance of multiple pneumococcal serotypes. 600 children were enrolled into the study: 199 aged 6 weeks to <6 months, 202 aged 6 months to < 12 months, and 199 aged 12 month to 24 months. Typeable pneumococci were identified in 297/600 (49.5%) of samples with more than one serotype being found in 67/297 (20.2%) of these samples. The serotypes covered by the thirteen-valent pneumococcal conjugate vaccine were identified in 44.4% of samples containing typeable pneumococci. Application of a molecular serotyping approach to identification of multiple pneumococcal carriage demonstrates a substantial prevalence of co-colonisation. Continued surveillance utilising this approach following the introduction of routine use of pneumococcal conjugate vaccinates in infants will provide a more accurate understanding of vaccine efficacy against carriage and a better understanding of the dynamics of subsequent serotype and genotype replacement.	[Kandasamy, Rama; Ndimah, Susan; Kelly, Dominic F.; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Kandasamy, Rama; Ndimah, Susan; Kelly, Dominic F.; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Gurung, Meeru; Thapa, Anushil; Adhikari, Neelam; Thorson, Stephen; Shrestha, Shrijana] Patan Acad Hlth Sci, Paediat Res Unit, Kathmandu, Nepal; [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Waldron, Denise E.; Hinds, Jason] Univ London, Div Clin Sci, London, England	University of Oxford; University of Oxford; University of Otago; University of London	Kandasamy, R (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.	rama.kandasamy@paediatrics.ox.ac.uk	Murdoch, David/A-2012-2009	Kandasamy, Rama/0000-0002-3111-5586; Hinds, Jason/0000-0002-2739-1908; Gould, Katherine/0000-0002-2528-9512; Shrestha, Shrijana/0000-0001-9484-0227; Kelly, Dominic/0000-0002-6063-8896	Oxford Vaccine Group, University of Oxford, United Kingdom	Oxford Vaccine Group, University of Oxford, United Kingdom	This study was funded by the Oxford Vaccine Group, University of Oxford, United Kingdom. The University of Oxford, the study sponsor, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2007, J CLIN MICROBIOL, V45, P3408, DOI 10.1128/JCM.01393-07; Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Bakkali M, 2013, ARCH MICROBIOL, V195, P279, DOI 10.1007/s00203-013-0870-1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Coles CL, 2008, J NUTR, V138, P2462, DOI 10.3945/jn.108.095422; Coles CL, 2009, TROP MED INT HEALTH, V14, P1025, DOI 10.1111/j.1365-3156.2009.02331.x; Coles CL, 2002, EPIDEMIOL INFECT, V129, P491, DOI 10.1017/S0950268802007586; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Donkor ES, 2011, MBIO, V2, DOI 10.1128/mBio.00040-11; Elberse KEM, 2012, VACCINE, V30, P7644, DOI 10.1016/j.vaccine.2012.04.021; *ENGL PH, 2013, CUM WEEKL NUMB REP I, P13897; Feil EJ, 2000, GENETICS, V154, P1439; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; *GAVI, GAVI ALLIANCE COUNTR, P13897; Gaynor BD, 2005, BRIT J OPHTHALMOL, V89, P1097, DOI 10.1136/bjo.2005.068981; GRATTEN M, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P501; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hanieh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098739; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Joshi HH, 2008, J CLIN MICROBIOL, V46, P3175, DOI 10.1128/JCM.00906-08; Kelly DF, 2011, INT J INFECT DIS, V15, pE17, DOI 10.1016/j.ijid.2010.05.021; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Lee NY, 2001, CLIN INFECT DIS, V32, P1463, DOI 10.1086/320165; Newton R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-88; Nurhonen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056079; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Rivera-Olivero IA, 2009, J MED MICROBIOL, V58, P584, DOI 10.1099/jmm.0.006726-0; Salter SJ, 2012, MICROBIOL-SGM, V158, P1560, DOI 10.1099/mic.0.056580-0; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Turner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038271; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Weinberger DM, 2011, EPIDEMIOLOGY, V22, P199, DOI 10.1097/EDE.0b013e3182087634	38	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0114286	10.1371/journal.pone.0114286	http://dx.doi.org/10.1371/journal.pone.0114286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643355	gold, Green Published, Green Accepted			2022-12-26	WOS:000348821200004
J	All, AH; Gharibani, P; Gupta, S; Bazley, FA; Pashai, N; Chou, BK; Shah, S; Resar, LM; Cheng, LZ; Gearhart, JD; Kerr, CL				All, Angelo H.; Gharibani, Payam; Gupta, Siddharth; Bazley, Faith A.; Pashai, Nikta; Chou, Bin-Kuan; Shah, Sandeep; Resar, Linda M.; Cheng, Linzhao; Gearhart, John D.; Kerr, Candace L.			Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS; NEURAL DIFFERENTIATION; CONTUSION MODEL; GLIAL SCAR; TRANSPLANTATION; RECOVERY; RATS; TISSUE; HYPOTHERMIA	Induced pluripotent stem (iPS) cells are at the forefront of research in regenerative medicine and are envisaged as a source for personalized tissue repair and cell replacement therapy. Here, we demonstrate for the first time that oligodendrocyte progenitors (OPs) can be derived from iPS cells generated using either an episomal, non-integrating plasmid approach or standard integrating retroviruses that survive and differentiate into mature oligodendrocytes after early transplantation into the injured spinal cord. The efficiency of OP differentiation in all 3 lines tested ranged from 40% to 60% of total cells, comparable to those derived from human embryonic stem cells. iPS cell lines derived using episomal vectors or retroviruses generated a similar number of early neural progenitors and glial progenitors while the episomal plasmid-derived iPS line generated more OPs expressing late markers O1 and RIP. Moreover, we discovered that iPS-derived OPs (iPS-OPs) engrafted 24 hours following a moderate contusive spinal cord injury (SCI) in rats survived for approximately two months and that more than 70% of the transplanted cells differentiated into mature oligodendrocytes that expressed myelin associated proteins. Transplanted OPs resulted in a significant increase in the number of myelinated axons in animals that received a transplantation 24 h after injury. In addition, nearly a 5-fold reduction in cavity size and reduced glial scarring was seen in iPS-treated groups compared to the control group, which was injected with heat-killed iPS-OPs. Although further investigation is needed to understand the mechanisms involved, these results provide evidence that patient-specific, iPS-derived OPs can survive for three months and improve behavioral assessment (BBB) after acute transplantation into SCI. This is significant as determining the time in which stem cells are injected after SCI may influence their survival and differentiation capacity.	[All, Angelo H.; Gharibani, Payam; Gupta, Siddharth; Bazley, Faith A.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Chou, Bin-Kuan; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD USA; [Chou, Bin-Kuan; Resar, Linda M.; Cheng, Linzhao; Kerr, Candace L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Shah, Sandeep; Resar, Linda M.; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [All, Angelo H.; Pashai, Nikta] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kerr, Candace L.] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21205 USA; [Gearhart, John D.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Gearhart, John D.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Resar, Linda M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Resar, Linda M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [All, Angelo H.; Bazley, Faith A.] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore 117548, Singapore; [All, Angelo H.] Natl Univ Singapore, Dept Orthoped Surg, Div Neurol, Singapore 117548, Singapore; [All, Angelo H.] Natl Univ Singapore, Dept Biomed Engn, Div Neurol, Singapore 117548, Singapore; [All, Angelo H.] Natl Univ Singapore, Dept Med, Div Neurol, Singapore 117548, Singapore; [Kerr, Candace L.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Johns Hopkins University	Kerr, CL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	ckerr@som.umaryland.edu		Gharibani, Payam/0000-0002-4546-0890	Maryland Stem Cell Research Fund (MSCRF) [2007-MSCRFII-0159-00, 2009-MSCRFII-0091-00, 2013-MSCRFII-0109-00]; National Institute of Child Health and Human Development [R21HD057487-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057487] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund (MSCRF); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided by the Maryland Stem Cell Research Fund (MSCRF): Grant#2007-MSCRFII-0159-00 (awarded to CLK), Grant#2009-MSCRFII-0091-00 (awarded to AHA), and Grant#2013-MSCRFII-0109-00 (awarded to AHA). URL: http://mscrf.org/. Grant# R21HD057487-01A1 from National Institute of Child Health and Human Development (awarded to CLK). URL: https://www.nichd.nih.gov/Pages/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; All AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047645; Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bazley FA, 2014, IEEE T NEUR SYS REH, V22, P953, DOI 10.1109/TNSRE.2014.2319313; Bazley FA, 2014, THER HYPOTHERMIA TEM, V4, P115, DOI 10.1089/ther.2014.0002; Bazley FA, 2012, J NEUROSURG-SPINE, V16, P414, DOI 10.3171/2012.1.SPINE11684; Bilic J, 2012, STEM CELLS, V30, P33, DOI 10.1002/stem.700; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Chaerkady R, 2011, PROTEOMICS, V11, P4007, DOI 10.1002/pmic.201100107; Chaerkady R, 2009, J PROTEOME RES, V8, P1315, DOI 10.1021/pr8006667; Chang YW, 2009, J NEUROTRAUM, V26, P979, DOI 10.1089/neu.2008-0762; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Czepiel M, 2011, GLIA, V59, P882, DOI 10.1002/glia.21159; Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Durongphongtorn S, 2006, AM J VET RES, V67, P32, DOI 10.2460/ajvr.67.1.32; English K, 2011, J CELL BIOCHEM, V112, P1963, DOI 10.1002/jcb.23119; Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gunaseeli I, 2010, CURR MED CHEM, V17, P759, DOI 10.2174/092986710790514480; HAMEED A, 1994, HUM PATHOL, V25, P872, DOI 10.1016/0046-8177(94)90005-1; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009; Jang J, 2011, ANN NEUROL, V70, P402, DOI 10.1002/ana.22486; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keirstead HS, 1999, J NEUROSCI, V19, P7529, DOI 10.1523/JNEUROSCI.19-17-07529.1999; Kerr CL, 2010, INT J NEUROSCI, V120, P305, DOI 10.3109/00207450903585290; Kerr DA, 2003, J NEUROSCI, V23, P5131; Krsulovic J, 1999, BIOL RES, V32, P253; Kumagai G, 2013, EXP NEUROL, V248, P369, DOI 10.1016/j.expneurol.2013.06.028; Lau Frank, 2009, F1000 Biol Rep, V1, P84, DOI 10.3410/B1-84; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Li J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/786475; Lu P, 2014, CURR OPIN NEUROBIOL, V27, P103, DOI 10.1016/j.conb.2014.03.010; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Lu HZ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-127; Maybhate A, 2012, CRIT CARE MED, V40, P573, DOI 10.1097/CCM.0b013e318232d97e; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Mohammad-Gharibani P, 2013, CYTOTHERAPY, V15, P1073, DOI 10.1016/j.jcyt.2013.05.002; Montague P, 2006, DEV NEUROSCI-BASEL, V28, P479, DOI 10.1159/000095110; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Onifer SM, 2007, ILAR J, V48, P385, DOI 10.1093/ilar.48.4.385; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Park DY, 2013, GLOB SPINE J, V3, P1, DOI 10.1055/s-0033-1337118; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Pawelczyk E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006712; Penha EM, 2014, STEM CELLS INT, V2014, P437; Pouya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027925; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Reeves A, 2012, ADV EXP MED BIOL, V760, P16; Ronaghi M, 2010, STEM CELLS, V28, P93, DOI 10.1002/stem.253; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tokumoto Y, 2010, J BIOSCI BIOENG, V109, P622, DOI 10.1016/j.jbiosc.2009.11.013; Torres-Espin A, 2014, EUR J NEUROSCI, V39, P1704, DOI 10.1111/ejn.12542; TRAPP BD, 1989, J CELL BIOL, V109, P2417, DOI 10.1083/jcb.109.5.2417; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Urdzikova LM, 2014, INT J MOL SCI, V15, P11275, DOI 10.3390/ijms150711275; Wang LJ, 2014, ACTA NEUROCHIR, V156, P1409, DOI 10.1007/s00701-014-2089-6; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Watanabe M, 2006, J NEUROSCI RES, V84, P525, DOI 10.1002/jnr.20950; WU E, 1992, LAB INVEST, V67, P88; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yoshihara H, 2006, BRAIN RES, V1119, P65, DOI 10.1016/j.brainres.2006.08.080; Young W, 2002, PROG BRAIN RES, V137, P231; Yuan YM, 2013, NEUROSCI BULL, V29, P421, DOI 10.1007/s12264-013-1358-3; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	78	54	57	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116933	10.1371/journal.pone.0116933	http://dx.doi.org/10.1371/journal.pone.0116933			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635918	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700064
J	Montagna, M; Chouaia, B; Mazza, G; Prosdocimi, EM; Crotti, E; Mereghetti, V; Vacchini, V; Giorgi, A; De Biase, A; Longo, S; Cervo, R; Lozzia, GC; Alma, A; Bandi, C; Daffonchio, D				Montagna, Matteo; Chouaia, Bessem; Mazza, Giuseppe; Prosdocimi, Erica Maria; Crotti, Elena; Mereghetti, Valeria; Vacchini, Violetta; Giorgi, Annamaria; De Biase, Alessio; Longo, Santi; Cervo, Rita; Lozzia, Giuseppe Carlo; Alma, Alberto; Bandi, Claudio; Daffonchio, Daniele			Effects of the Diet on the Microbiota of the Red Palm Weevil (Coleoptera: Dryophthoridae)	PLOS ONE			English	Article							RHYNCHOPHORUS-FERRUGINEUS COLEOPTERA; NONPARAMETRIC-ESTIMATION; GENOMIC PERSPECTIVE; BACTERIAL COMMUNITY; R PACKAGE; SYMBIONTS; CURCULIONIDAE; DIVERSITY; EVOLUTION; GUT	Rhynchophorus ferrugineus, also known as the red palm weevil, is regarded as the major pest of palm trees. Although studies of the microbiota associated with this species have been performed in recent years, little attention has been dedicated to the influence of the diet in shaping the host bacterial community. Here, we investigated the influence of food sources (i.e. palm tissues vs apple based substrate) on the microbial diversity associated with RPW, which was compared with the microbiota associated with wild individuals of the sister species Rhynchophorus vulneratus. The bacterial characterization was performed using a culture independent approach, i.e. the 16S rRNA pyrotag, and a culture dependent approach for a subset of the samples, in order to obtain bacterial isolates from RPW tissues. The bacterial community appeared significantly influenced by diet. Proteobacteria resulted to be the most abundant clade and was present in all the specimens of the three examined weevil groups. Within Proteobacteria, Enterobacteriaceae were identified in all the organs analysed, including hemolymph and reproductive organs. The apple-fed RPWs and the wild R. vulneratus showed a second dominant taxon within Firmicutes that was scarcely present in the microbiota associated with palm-fed RPWs. A comparative analysis on the bacteria associated with the palm tissues highlighted that 12 bacterial genera out of the 13 identified in the plant tissues were also present in weevils, thus indicating that palm tissues may present a source for bacterial acquisition.	[Montagna, Matteo; Giorgi, Annamaria; Lozzia, Giuseppe Carlo] Univ Milan, Dipartimento Sci Agr & Ambientali, Milan, Italy; [Chouaia, Bessem; Prosdocimi, Erica Maria; Crotti, Elena; Vacchini, Violetta; Daffonchio, Daniele] Univ Milan, Dipartimento Sci Alimenti, Nutr, Ambiente, Milan, Italy; [Mazza, Giuseppe] Res Ctr Agrobiol & Pedol, Consiglio Ric Sperimentaz Agr, Cascine Del Riccio, Italy; [Mereghetti, Valeria; Bandi, Claudio] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy; [De Biase, Alessio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Longo, Santi] Univ Catania, Dipartimento Gest Sistemi Agroalimentari & Ambien, Catania, Italy; [Cervo, Rita] Univ Florence, Dipartimento Biol, Florence, Italy; [Alma, Alberto] Univ Turin, Dipartimento Sci Agr Forestali & Alimentari, Grugliasco, Italy; [Daffonchio, Daniele] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia	University of Milan; University of Milan; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Milan; Sapienza University Rome; University of Catania; University of Florence; University of Turin; King Abdullah University of Science & Technology	Montagna, M (corresponding author), Univ Milan, Dipartimento Sci Agr & Ambientali, Milan, Italy.	matteo.montagna@unimi.it	Bandi, Claudio/J-7835-2018; Mazza, Giuseppe/Y-9504-2019; Daffonchio, Daniele/AAF-4922-2019; Montagna, Matteo/AAF-8281-2021; CERVO, Rita/B-5441-2018	Bandi, Claudio/0000-0002-0181-4618; Mazza, Giuseppe/0000-0002-6644-1429; Daffonchio, Daniele/0000-0003-0947-925X; Montagna, Matteo/0000-0003-4465-7146; CERVO, Rita/0000-0002-0405-6402; chouaia, bessem/0000-0003-0726-7237; Crotti, Elena/0000-0002-3466-8274; giorgi, annamaria/0000-0001-5386-7378	European Union [GA-245746]; Italian Ministry of Education, University and Research (MIUR) [009L27YC8_003]; Linea B Piano di sviluppo Unimi [15-6-3]; "Accordo di Programma, affermazione in Edolo del Centro di Eccellenza Universita della Montagna" MIUR-Universita degli Studi di Milano [1293-05/08/2011]	European Union(European Commission); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Linea B Piano di sviluppo Unimi; "Accordo di Programma, affermazione in Edolo del Centro di Eccellenza Universita della Montagna" MIUR-Universita degli Studi di Milano	This work was supported by the project BIODESERT GA-245746 "Biotechnology from Desert Microbial Extremophiles for Supporting Agriculture Research Potential in Tunisia and Southern Europe" (European Union), the Prin 2009 (grant 009L27YC8_003) from the Italian Ministry of Education, University and Research (MIUR), Linea B Piano di sviluppo Unimi 2014 (grant 15-6-3) and "Accordo di Programma, affermazione in Edolo del Centro di Eccellenza Universita della Montagna" MIUR-Universita degli Studi di Milano, prot. n. 1293-05/08/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; Al-Ayedh H, 2008, FLA ENTOMOL, V91, P353, DOI 10.1653/0015-4040(2008)91[353:EODPCF]2.0.CO;2; Anonymous, 2008, Bulletin OEPP, V38, P55; Barranco P., 1996, PHYTOMA ESPANA, V76, P36; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baumann L, 1999, J MOL EVOL, V48, P77, DOI 10.1007/PL00006447; Behar A, 2005, MOL ECOL, V14, P2637, DOI 10.1111/j.1365-294X.2005.02615.x; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Butera G, 2012, LETT APPL MICROBIOL, V54, P530, DOI 10.1111/j.1472-765X.2012.03238.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chouaia B, 2010, APPL ENVIRON MICROB, V76, P7444, DOI 10.1128/AEM.01747-10; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Costopoulos K, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-5; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Dembilio O, 2009, J APPL ENTOMOL, V133, P565, DOI 10.1111/j.1439-0418.2009.01385.x; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Epis S, 2013, TICKS TICK-BORNE DIS, V4, P39, DOI 10.1016/j.ttbdis.2012.06.005; Esteban-Duran J., 1998, Boletin de Sanidad Vegetal Plagas, V24, P737; Estes AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079061; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foster SD, 2010, BIOMETRICS, V66, P186, DOI 10.1111/j.1541-0420.2009.01263.x; Giblin-Davis RM, 2013, CABI INVASIVE SER, P1, DOI 10.1079/9781845938291.0001; GiblinDavis RM, 1996, FLA ENTOMOL, V79, P153, DOI 10.2307/3495812; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Hui W, 2008, J STAT SOFTW, V28, P1; Hurwitz I, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-82; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Jia SG, 2013, ENVIRON MICROBIOL, V15, P3020, DOI 10.1111/1462-2920.12262; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khiyami M, 2008, AFR J BIOTECHNOL, V7, P1432; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Kounatidis I, 2009, APPL ENVIRON MICROB, V75, P3281, DOI 10.1128/AEM.02933-08; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kuriwada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013101; Lancaster Jeremiah D, 2012, BMC Res Notes, V5, P688, DOI 10.1186/1756-0500-5-688; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Li YZ, 2009, FLA ENTOMOL, V92, P386, DOI 10.1653/024.092.0229; Llacer E, 2012, PEST MANAG SCI, V68, P878, DOI 10.1002/ps.3245; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Lopez-Sanchez MJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000721; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mazza G, 2014, B INSECTOL, V67, P281; Mazza G, 2014, BIOL CONTROL, V77, P83, DOI 10.1016/j.biocontrol.2014.06.010; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Montagna M, 2015, INSECT SCI, V22, P340, DOI 10.1111/1744-7917.12143; Montagna M, 2013, APPL ENVIRON MICROB, V79, P3241, DOI 10.1128/AEM.03971-12; Montagna M, 2012, ECOL ENG, V47, P242, DOI 10.1016/j.ecoleng.2012.06.025; Montagna M, 2012, FRONT MICROBIOL SER, P29; Moran NA, 2003, P NATL ACAD SCI USA, V100, P14543, DOI 10.1073/pnas.2135345100; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Murphy ST, 1999, BIOCONTROL NEWS INF, V20, P35; Nardon P, 2002, SYMBIOSIS, V33, P227; Peccoud J, 2014, INSECT SCI, V21, P291, DOI 10.1111/1744-7917.12083; Petti S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078999, 10.1371/journal.pone.0073827]; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rector BG, 2010, INVAS PLANT SCI MANA, V3, P429, DOI 10.1614/IPSM-D-10-00019.1; Ricci I, 2012, PATHOG GLOB HEALTH, V106, P380, DOI 10.1179/2047773212Y.0000000051; Rugman-Jones PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078379; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Sacchetti P, 2005, NOTIZIARIO CTR SPERI, V144, P6; Sacchetti P, 2006, INFORM FITOPATOLOGIC, V20, P35; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Tagliavia M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-136; Takiya DM, 2006, MOL ECOL, V15, P4175, DOI 10.1111/j.1365-294X.2006.03071.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thomas MC, 2010, GIANT PALM WEEVILS O; Valzano M., 2012, Journal of Entomological and Acarological Research, V44, P85, DOI 10.4081/jear.2012.e16; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Yuliansyah AT, 2012, RESOUR MANAG SUSTAIN, P3; Zhang RZ, 2003, CHINA FOREST INSECT, V22, P3, DOI DOI 10.1673/031.013.9101; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	87	53	55	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117439	10.1371/journal.pone.0117439	http://dx.doi.org/10.1371/journal.pone.0117439			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635833	Green Published, gold			2022-12-26	WOS:000350680700086
J	Monleon, VJ; Lintz, HE				Monleon, Vicente J.; Lintz, Heather E.			Evidence of Tree Species' Range Shifts in a Complex Landscape	PLOS ONE			English	Article							DRIVE DOWNHILL SHIFTS; CLIMATE; MIGRATION; MORTALITY; BUTTERFLIES; EXPANSION; RESPONSES; RICHNESS; UPSLOPE; FORESTS	Climate change is expected to change the distribution of species. For long-lived, sessile species such as trees, tracking the warming climate depends on seedling colonization of newly favorable areas. We compare the distribution of seedlings and mature trees for all but the rarest tree species in California, Oregon and Washington, United States of America, a large, environmentally diverse region. Across 46 species, the mean annual temperature of the range of seedlings was 0.120 degrees C colder than that of the range of trees (95% confidence interval from 0.096 to 0.144 degrees C). The extremes of the seedling distributions also shifted towards colder temperature than those of mature trees, but the change was less pronounced. Although the mean elevation and mean latitude of the range of seedlings was higher than and north of those of the range of mature trees, elevational and latitudinal shifts run in opposite directions for the majority of the species, reflecting the lack of a direct biological relationship between species' distributions and those variables. The broad scale, environmental diversity and variety of disturbance regimes and land uses of the study area, the large number and exhaustive sampling of tree species, and the direct causal relationship between the temperature response and a warming climate, provide strong evidence to attribute the observed shifts to climate change.	[Monleon, Vicente J.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Lintz, Heather E.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Oregon Climate Change Res Inst, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Forest Service; Oregon State University	Monleon, VJ (corresponding author), US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA.	vjmonleon@fs.fed.us			Oregon Department of Forestry	Oregon Department of Forestry	HEL received partial funding from the Oregon Department of Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; BECHTOLD WA, 2005, ENHANCED FOREST INVE, P27; Bell DM, 2014, GLOBAL ECOL BIOGEOGR, V23, P168, DOI 10.1111/geb.12109; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Blackburn TM, 2004, ECOGRAPHY, V27, P715, DOI 10.1111/j.0906-7590.2004.03999.x; Breshears DD, 2008, P NATL ACAD SCI USA, V105, P11591, DOI 10.1073/pnas.0806579105; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CORDY CB, 1993, STAT PROBABIL LETT, V18, P353, DOI 10.1016/0167-7152(93)90028-H; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DAVIS MB, 1989, CLIMATIC CHANGE, V15, P75, DOI 10.1007/BF00138846; *FAO, 2000, 33 FAO FOR RES ASS; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Fellows AW, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002044; Geils BW, 2010, FOREST PATHOL, V40, P147, DOI 10.1111/j.1439-0329.2010.00654.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Hitchcock C.L., 1973, FLORA PACIFIC NW; Holzinger B, 2008, PLANT ECOL, V195, P179, DOI 10.1007/s11258-007-9314-9; Horn H.S., 1975, ECOLOGY EVOLUTION CO, P196; Jenkins MA, 2002, J TORREY BOT SOC, V129, P194, DOI 10.2307/3088770; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2009, ECOGRAPHY, V32, P765, DOI 10.1111/j.1600-0587.2009.05791.x; Little E.L., 1971, MISC PUBL, V1146; Little E. L. J., 1976, USDA MISCELLANEOUS P, V3; MCROBERTS RE, 2005, SRS80 USDA FOR SERV, P1; Murphy HT, 2010, ECOL LETT, V13, P1233, DOI 10.1111/j.1461-0248.2010.01526.x; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P374; Parmesan C, 2011, NAT CLIM CHANGE, V1, P2, DOI 10.1038/nclimate1056; Sarndal C.-E., 1992, MODEL ASSISTED SURVE; Schwilk DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031173; Smith W. B., 2009, WO78 USDA FOR SERV; Stephenson NL, 2011, SCIENCE, V334, DOI 10.1126/science.1205740; *USDA FOR SERV, 2008, FIELD INSTR ANN INV; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wolf A, 2011, SCIENCE, V334, DOI 10.1126/science.1204607; Woodall CW, 2009, FOREST ECOL MANAG, V257, P1434, DOI 10.1016/j.foreco.2008.12.013; Zhu K, 2014, GLOBAL CHANGE BIOL, V20, P251, DOI 10.1111/gcb.12382; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	44	46	51	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0118069	10.1371/journal.pone.0118069	http://dx.doi.org/10.1371/journal.pone.0118069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25634090	gold, Green Published, Green Submitted			2022-12-26	WOS:000348609800015
J	Boutin, S; Graeber, SY; Weitnauer, M; Panitz, J; Stahl, M; Clausznitzer, D; Kaderali, L; Einarsson, G; Tunney, MM; Elborn, JS; Mall, MA; Dalpke, AH				Boutin, Sebastien; Graeber, Simon Y.; Weitnauer, Michael; Panitz, Jessica; Stahl, Mirjam; Clausznitzer, Diana; Kaderali, Lars; Einarsson, Gisli; Tunney, Michael M.; Elborn, J. Stuart; Mall, Marcus A.; Dalpke, Alexander H.			Comparison of Microbiomes from Different Niches of Upper and Lower Airways in Children and Adolescents with Cystic Fibrosis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; INFECTION; IDENTIFICATION; EPIDEMIOLOGY; BACTERIA; DISEASE	Changes in the airway microbiome may be important in the pathophysiology of chronic lung disease in patients with cystic fibrosis. However, little is known about the microbiome in early cystic fibrosis lung disease and the relationship between the microbiomes from different niches in the upper and lower airways. Therefore, in this cross-sectional study, we examined the relationship between the microbiome in the upper (nose and throat) and lower (sputum) airways from children with cystic fibrosis using next generation sequencing. Our results demonstrate a significant difference in both a and beta-diversity between the nose and the two other sampling sites. The nasal microbiome was characterized by a polymicrobial community while the throat and sputum communities were less diverse and dominated by a few operational taxonomic units. Moreover, sputum and throat microbiomes were closely related especially in patients with clinically stable lung disease. There was a high inter-individual variability in sputum samples primarily due to a decrease in evenness linked to increased abundance of potential respiratory pathogens such as Pseudomonas aeruginosa. Patients with chronic Pseudomonas aeruginosa infection exhibited a less diverse sputum microbiome. A high concordance was found between pediatric and adult sputum microbiomes except that Burkholderia was only observed in the adult cohort. These results indicate that an adult-like lower airways microbiome is established early in life and that throat swabs may be a good surrogate in clinically stable children with cystic fibrosis without chronic Pseudomonas aeruginosa infection in whom sputum sampling is often not feasible.	[Boutin, Sebastien; Weitnauer, Michael; Panitz, Jessica; Dalpke, Alexander H.] Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany; [Graeber, Simon Y.; Stahl, Mirjam; Mall, Marcus A.] Univ Heidelberg Hosp, Dept Translat Pulmonol, Heidelberg, Germany; [Graeber, Simon Y.; Stahl, Mirjam; Mall, Marcus A.] Univ Heidelberg Hosp, Div Pediat Pulmonol & Allergol, Heidelberg, Germany; [Graeber, Simon Y.; Stahl, Mirjam; Mall, Marcus A.] Univ Heidelberg Hosp, Cyst Fibrosis Ctr, Dept Pediat, Heidelberg, Germany; [Boutin, Sebastien; Graeber, Simon Y.; Panitz, Jessica; Stahl, Mirjam; Mall, Marcus A.; Dalpke, Alexander H.] Translat Lung Res Ctr Heidelberg TLRC, Heidelberg, Germany; [Clausznitzer, Diana; Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometry, D-01062 Dresden, Germany; [Einarsson, Gisli; Tunney, Michael M.; Elborn, J. Stuart] Queens Univ Belfast, CF & Airways Microbiol Grp, Belfast, Antrim, North Ireland; [Tunney, Michael M.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Elborn, J. Stuart] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Queens University Belfast; Queens University Belfast; Queens University Belfast	Dalpke, AH (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany.	alexander.dalpke@med.uni-heidelberg.de	Boutin, Sébastien/AAX-5334-2021; Mall, Marcus A./AAA-1498-2022; Graeber, Simon/AGX-6006-2022; Stahl, Mirjam/S-9442-2019	Boutin, Sébastien/0000-0002-0499-2460; Mall, Marcus A./0000-0002-4057-2199; Kaderali, Lars/0000-0002-2359-2294; Graeber, Simon Y./0000-0002-1666-8924; Einarsson, Gisli/0000-0003-1353-950X; TUNNEY, MICHAEL/0000-0002-7433-7074	European Commission (Seventh Framework Programme Project) [603038]; Gilead; Public Health Agency [CDV/3650/07, COM/4978/14, STL/3713/07] Funding Source: researchfish	European Commission (Seventh Framework Programme Project); Gilead(Gilead Sciences); Public Health Agency	This study was supported in part by a grant to MAM, JSE, MT and GE from the European Commission (Seventh Framework Programme Project No. 603038, CFMatters). This study was further supported by a grant from Gilead to AD and MAM. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Gilead had no impact on design, realization and interpretation of this study or on manuscript preparation.	Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005; Bonestroo HJC, 2010, J CYST FIBROS, V9, P130, DOI 10.1016/j.jcf.2010.01.001; BRANDT I, 1988, KLIN PADIATR, V200, P451, DOI 10.1055/s-2008-1033752; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Coenye T, 2002, EMERG INFECT DIS, V8, P692, DOI 10.3201/eid0807.010472; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; De Boeck K, 2011, J CYST FIBROS, V10, pS53, DOI 10.1016/S1569-1993(11)60009-X; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; GILLIGAN PH, 1991, CLIN MICROBIOL REV, V4, P35, DOI 10.1128/CMR.4.1.35-51.1991; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; GOVAN JRW, 1992, BRIT MED BULL, V48, P912, DOI 10.1093/oxfordjournals.bmb.a072585; Hansen CR, 2010, J CYST FIBROS, V9, P51, DOI 10.1016/j.jcf.2009.10.005; Hansen CR, 2008, J CYST FIBROS, V7, P523, DOI 10.1016/j.jcf.2008.06.009; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; Hirtz S, 2004, GASTROENTEROLOGY, V127, P1085, DOI 10.1053/j.gastro.2004.07.006; HOIBY N, 1977, Acta Pathologica et Microbiologica Scandinavica Supplementum, V262, P8; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Jorgensen IM, 2003, PEDIATR PULM, V36, P439, DOI 10.1002/ppul.10383; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Marchandin H, 2012, CYSTIC FIBROSIS RENE, P225, DOI 10.1007/s12070-011-0437-x; Maughan H, 2012, PULMONARY MED, V2012; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Nonnenmacher C, 2004, J MICROBIOL METH, V59, P117, DOI 10.1016/j.mimet.2004.06.006; Pressler T, 2011, J CYST FIBROS, V10, pS75, DOI 10.1016/S1569-1993(11)60011-8; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Sauer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002843; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Zhao JC, 2014, EUR RESPIR MONOGR, P32, DOI 10.1183/1025448x.10008713	49	97	98	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116029	10.1371/journal.pone.0116029	http://dx.doi.org/10.1371/journal.pone.0116029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629612	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100029
J	Chen, YY; Chang, JR; Kuo, SC; Tseng, FC; Huang, WC; Huang, TS; Chen, YS; Chiueh, TS; Sun, JR; Su, IJ; Dou, HY				Chen, Yih-Yuan; Chang, Jia-Ru; Kuo, Shu-Chen; Tseng, Fan-Chen; Huang, Wel-Chen; Huang, Tsl-Shu; Chen, Yao-Shen; Chiueh, Tzong-Shi; Sun, Jun-Ren; Su, Ih-Jen; Dou, Horng-Yunn			Molecular Epidemiology of Tuberculosis in Kaohsiung City Located at Southern Taiwan, 2000-2008	PLOS ONE			English	Article							LEVEL STREPTOMYCIN RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; GENETIC DIVERSITY; MUTATIONS; FITNESS; ASSOCIATION; DATABASE; LINEAGE; STRAINS	Background We present the first comprehensive analysis of Mycobacterium tuberculosis (MTB) isolates circulating in southern Taiwan. In this 9-year population-based study, the TB situation in the Kaohsiung region was characterized by genotypic analysis of 421 MTB isolates. Methods All 421 isolates of MTB were analyzed by spoligotyping and MIRU-VNTR typing. Drug-resistance patterns were also analyzed. Results The percentage of EAI (East African-Indian) strains increased across sampling years (2000-2008) in southern Taiwan, whereas the proportion of Beijing lineages remained unchanged. Clustering was more frequent with EAI genotype infections (odds ratio = 3.6, p<0.0001) when compared to Beijing genotypes. Notably, MTB resistance to streptomycin (STR) had significantly increased over time, but resistance to other antibiotics, including multidrug resistance, had not. Three major genes (gidB, rpsL and rrs) implicated in STR resistance were sequenced and specific mutations identified. Conclusions This study revealed that EAI strains were highly transmissible and that STR resistance has increased between 2000 and 2008 in Kaohsiung, Taiwan.	[Chen, Yih-Yuan; Chang, Jia-Ru; Kuo, Shu-Chen; Tseng, Fan-Chen; Huang, Wel-Chen; Su, Ih-Jen; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan; [Tseng, Fan-Chen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Huang, Tsl-Shu; Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Microbiol, Kaohsiung, Taiwan; [Chiueh, Tzong-Shi; Sun, Jun-Ren] Triserv Gen Hosp, Dept Pathol, Div Clin Pathol, Taipei, Taiwan; [Chiueh, Tzong-Shi; Sun, Jun-Ren] Natl Def Med Ctr, Taipei, Taiwan; [Chen, Yih-Yuan] Ditmanson Med Fdn Chiayi Christian Hosp, Dept Internal Med, Chiaya City, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; Kaohsiung Veterans General Hospital; Tri-Service General Hospital; National Defense Medical Center; Chia-Yi Christian Hospital	Dou, HY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan.	hydou@nhri.org.tw	Tseng, Fan-Chen/D-2097-2010; Kuo, Shu-Chen/G-9108-2011; Su, Ih-Jen/B-2655-2010; Dou, Horng-Yunn/B-2652-2010	Sun, jun-ren/0000-0002-8769-9170	National Health Research Institutes; National Science Council, Taiwan (HYD) [NSC 102-2320-B-400-006]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); National Science Council, Taiwan (HYD)	This project was supported by grants from National Health Research Institutes and National Science Council (NSC 102-2320-B-400-006), Taiwan (HYD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1993, INFECT IMMUN, V61, P4173, DOI 10.1128/IAI.61.10.4173-4181.1993; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; CDC, 2012, TUB CONTR REP 2012; Chang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043018; Chen YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039792; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Feuerriegel S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-90; Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Huang SF, 2012, INFECT GENET EVOL, V12, P28, DOI 10.1016/j.meegid.2011.10.001; KOLK AHJ, 1992, J CLIN MICROBIOL, V30, P2567, DOI 10.1128/JCM.30.10.2567-2575.1992; Krishnan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023870; Lee JH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1724; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Nhu NTQ, 2012, INT J TUBERC LUNG D, V16, P527, DOI 10.5588/ijtld.11.0202; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Pepperell CS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003543; Qin LH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-247; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tudo G, 2010, J ANTIMICROB CHEMOTH, V65, P2341, DOI 10.1093/jac/dkq322; von Groll A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010191; Von Groll A, 2010, FEMS IMMUNOL MED MIC, V58, P119, DOI 10.1111/j.1574-695X.2009.00611.x; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10	28	11	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117061	10.1371/journal.pone.0117061	http://dx.doi.org/10.1371/journal.pone.0117061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629610	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100061
J	Hozhabri, NST; Benson, MD; Vu, MD; Patel, RH; Martinez, RM; Nakhaie, FN; Kim, HKW; Varanasi, VG				Hozhabri, Neda S. T.; Benson, M. Douglas; Vu, Michael D.; Patel, Rinkesh H.; Martinez, Rebecca M.; Nakhaie, Fatemeh N.; Kim, Harry K. W.; Varanasi, Venu G.			Decreasing NF-kappa B Expression Enhances Odontoblastic Differentiation and Collagen Expression in Dental Pulp Stem Cells Exposed to Inflammatory Cytokines	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PROTEASOME INHIBITION; GENE-EXPRESSION; IN-VIVO; TNF; ACTIVATION; INDUCTION; SYNOVIOCYTES; CHONDROCYTES; DEGRADATION	Inflammatory response in the dental pulp can alter the collagen matrix formation by dental pulp stem cells and lead to a delay or poor healing of the pulp. This inflammatory response is mediated by cytokines, including interleukin-1 beta and tumor necrosis factor-alpha. In this study, it is hypothesized that suppressing the actions of these inflammatory cytokines by knocking down the activity of transcription factor Nuclear Factor-kappa B will lead to dental pulp stem cell differentiation into odontoblasts and the production of collagen. Here, the role of Nuclear Factor-kappa B signaling and its reduction was examined during odontogenic behavior in the presence of these cytokines. The results showed a significant increase in Nuclear Factor-kappa B gene expression and p65 protein expression by interleukin-1 beta and tumor necrosis factor-alpha. Nuclear Factor-kappa B activation in the presence of these cytokines decreased significantly in a dose-dependent manner by a Nuclear Factor-kappa B inhibitor (MG132) and p65 siRNA. Down-regulation of Nuclear Factor-kappa B activity also enhanced the gene expression of the odontoblastic markers (dentin sialophosphoprotein, Nestin, and alkaline phosphatase) and displayed an odontoblastic cell morphology indicating the promotion of odontogenic differentiation of dental pulp stem cells. Finally, dental pulp stem cells exposed to reduced Nuclear Factor-kappa B activity resulted in a significant increase in collagen (I)-alpha 1 expression in the presence of these cytokines. In conclusion, a decrease in Nuclear Factor-kappa B in dental pulp stem cells in the presence of inflammatory cytokines enhanced odontoblastic differentiation and collagen matrix formation.	[Hozhabri, Neda S. T.; Benson, M. Douglas; Vu, Michael D.; Patel, Rinkesh H.; Martinez, Rebecca M.; Nakhaie, Fatemeh N.; Varanasi, Venu G.] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Hozhabri, Neda S. T.; Benson, M. Douglas; Vu, Michael D.; Patel, Rinkesh H.; Martinez, Rebecca M.; Nakhaie, Fatemeh N.; Varanasi, Venu G.] Texas A&M Univ, Baylor Coll Dent, Ctr Craniofacial Res & Diag, Dallas, TX 75246 USA; [Kim, Harry K. W.] Texas Scottish Rite Hosp Children, Ctr Excellence Hip Disorders, Dallas, TX 75219 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas Scottish Rite Hospital for Children	Varanasi, VG (corresponding author), Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA.	varanasi@bcd.tamhsc.edu	Kim, Harry/AAF-7176-2020; Kim, Harry/AAE-1892-2020; Benson, M. Douglas/L-9125-2019	Kim, Harry/0000-0002-0330-4777; 	TAMHSC [304-244441]; NIH/NIDCR [P30DE20742]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P30DE020742] Funding Source: NIH RePORTER	TAMHSC; NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was supported by TAMHSC 304-244441 and NIH/NIDCR P30DE20742.	Ahmed AS, 2010, ARTHRITIS RHEUM-US, V62, P2160, DOI 10.1002/art.27492; Aupperle KR, 1999, J IMMUNOL, V163, P427; Avino A, 2000, J ENDOVASC THER, V7, P469, DOI 10.1583/1545-1550(2000)007<0469:DPCONS>2.0.CO;2; Awasthi N, 2008, INVEST OPHTH VIS SCI, V49, P1998, DOI 10.1167/iovs.07-0624; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Barron MJ, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/915620; Bletsa A, 2004, NEUROIMMUNOMODULAT, V11, P376, DOI 10.1159/000080148; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Braun T, 2006, BLOOD, V107, P1156; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chang J, 2005, J DENT RES, V84, P994, DOI 10.1177/154405910508401105; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; Clutterbuck AL, 2009, ANN NY ACAD SCI, V1171, P428, DOI 10.1111/j.1749-6632.2009.04687.x; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Etienne S, 2008, BIO-MED MATER ENG, V18, P253, DOI 10.3233/BME-2008-0534; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goldberg M, 2008, PHARMACOL RES, V58, P137, DOI 10.1016/j.phrs.2008.05.013; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Ke J, 2007, J DENT RES, V86, P363, DOI 10.1177/154405910708600412; Lee UJ, 2008, MOL BIOL REP, V35, P291, DOI 10.1007/s11033-007-9084-4; Lianxu C, 2006, OSTEOARTHR CARTILAGE, V14, P367, DOI 10.1016/j.joca.2005.10.009; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Paula-Silva FWG, 2009, J DENT RES, V88, P339, DOI 10.1177/0022034509334070; Pezelj-Ribaric S, 2002, ARCH MED RES, V33, P482, DOI 10.1016/S0188-4409(02)00396-X; Rutherford RB, 2000, EUR J ORAL SCI, V108, P202, DOI 10.1034/j.1600-0722.2000.108003202.x; Safranek R, 2006, INT J EXP PATHOL, V87, P369, DOI 10.1111/j.1365-2613.2006.00490.x; Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x; Smith Anthony J, 2003, J Dent Educ, V67, P678; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tian F, 2006, ACTA BIOCH BIOPH SIN, V38, P318, DOI 10.1111/j.1745-7270.2006.00166.x; Tipton DA, 2006, TOXICOL IN VITRO, V20, P248, DOI 10.1016/j.tiv.2005.07.004; Tousi NS, 2013, MAT SCI ENG C-MATER, V33, P2757, DOI 10.1016/j.msec.2013.02.044; Varanasi VG, 2009, ACTA BIOMATER, V5, P3536, DOI 10.1016/j.actbio.2009.05.035; Varanasi VG, 2012, J ORAL IMPLANTOL, V38, P325, DOI 10.1563/AAID-JOI-D-11-00108; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wisithphrom K, 2006, J ENDODONT, V32, P853, DOI 10.1016/j.joen.2006.03.017; Yamakoshi Y, 2005, J BIOL CHEM, V280, P17472, DOI 10.1074/jbc.M413220200; Yamaza T, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt5; [杨雪超 YANG Xuechao], 2011, [中华口腔医学杂志, Chinese Journal of Stomatology], V46, P406; Zehnder M, 2003, CYTOKINE, V22, P84, DOI 10.1016/S1043-4666(03)00116-9	40	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0113334	10.1371/journal.pone.0113334	http://dx.doi.org/10.1371/journal.pone.0113334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629155	Green Submitted, Green Published, gold			2022-12-26	WOS:000348732100002
J	Rawi, R; El Anbari, M; Bensmail, H				Rawi, Reda; El Anbari, Mohamed; Bensmail, Halima			Model Selection Emphasises the Importance of Non-Chromosomal Information in Genetic Studies	PLOS ONE			English	Article							MISSING HERITABILITY; INHERITANCE	Ever since the case of the missing heritability was highlighted some years ago, scientists have been investigating various possible explanations for the issue. However, none of these explanations include non-chromosomal genetic information. Here we describe explicitly how chromosomal and non-chromosomal modifiers collectively influence the heritability of a trait, in this case, the growth rate of yeast. Our results show that the non-chromosomal contribution can be large, adding another dimension to the estimation of heritability. We also discovered, combining the strength of LASSO with model selection, that the interaction of chromosomal and non-chromosomal information is essential in describing phenotypes.	[Rawi, Reda; El Anbari, Mohamed; Bensmail, Halima] Qatar Comp Res Inst, Computat Sci & Engn Ctr, Doha, Qatar; [El Anbari, Mohamed] Sidra Med & Res Ctr, Div Biomed Informat, Doha, Qatar	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; Sidra Medical & Research Center	Bensmail, H (corresponding author), Qatar Comp Res Inst, Computat Sci & Engn Ctr, Doha, Qatar.	hbensmail@qf.org.qa	Bensmail, Halima/AAT-7858-2020					[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; Bien J, 2013, ANN STAT, V41, P1111, DOI 10.1214/13-AOS1096; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Bogdan M, 2004, GENETICS, V167, P989, DOI 10.1534/genetics.103.021683; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Edwards MD, 2014, P NATL ACAD SCI USA, V111, P7719, DOI 10.1073/pnas.1407126111; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; FINK GR, 1972, P NATL ACAD SCI USA, V69, P2846, DOI 10.1073/pnas.69.10.2846; Kim HS, 2009, GENETICS, V183, P1141, DOI 10.1534/genetics.109.108068; Magliani W, 1997, CLIN MICROBIOL REV, V10, P369, DOI 10.1128/CMR.10.3.369; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nadeau JH, 2009, HUM MOL GENET, V18, pR202, DOI 10.1093/hmg/ddp366; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117014	10.1371/journal.pone.0117014	http://dx.doi.org/10.1371/journal.pone.0117014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25626013	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821400027
J	Rohatgi, RA; Janusis, J; Leonard, D; Bellve, KD; Fogarty, KE; Baehrecke, EH; Corvera, S; Shaw, LM				Rohatgi, R. A.; Janusis, J.; Leonard, D.; Bellve, K. D.; Fogarty, K. E.; Baehrecke, E. H.; Corvera, S.; Shaw, L. M.			Beclin 1 regulates growth factor receptor signaling in breast cancer	ONCOGENE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; EARLY ENDOSOMES; AUTOPHAGY; GENE; TUMORIGENESIS; TRAFFICKING; TRANSFERRIN; METASTASIS; MATURATION; MEMBRANE	Beclin 1 is a haploinsufficient tumor suppressor that is decreased in many human tumors. The function of beclin 1 in cancer has been attributed primarily to its role in the degradative process of macroautophagy. However, beclin 1 is a core component of the vacuolar protein sorting 34 (Vps34)/class III phosphatidylinositoI-3 kinase (PI3KC3) and Vps15/p150 complex that regulates multiple membrane-trafficking events. In the current study, we describe an alternative mechanism of action for beclin 1 in breast cancer involving its control of growth factor receptor signaling. We identify a specific stage of early endosome maturation that is regulated by beclin 1, the transition of APPL1-containing phosphatidyIinositol 3-phosphate-negative (PI3P(-)) endosomes to PI3P(+) endosomes. Beclin 1 regulates PI3P production in response to growth factor stimulation to control the residency time of growth factor receptors in the PI3P(-)/APPL(+)-signaling-competent compartment. As a result, suppression of BECN1 sustains growth factor-stimulated AKT and ERK activation resulting in increased breast carcinoma cell invasion. In human breast tumors, beclin 1 expression is inversely correlated with AKT and ERK phosphorylation. Our data identify a novel role for beclin 1 in regulating growth factor signaling and reveal a mechanism by which loss of beclin 1 expression would enhance breast cancer progression.	[Rohatgi, R. A.; Janusis, J.; Baehrecke, E. H.; Shaw, L. M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Leonard, D.; Corvera, S.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Bellve, K. D.; Fogarty, K. E.] Univ Massachusetts, Sch Med, Biomed Imaging Grp, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Shaw, LM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 364 Plantat St, Worcester, MA 01605 USA.	leslie.shaw@umassmed.edu			National Institute of Health (NIH) [CA142782, CA177167, DK60564, CA159314]; NATIONAL CANCER INSTITUTE [R01CA177167, R01CA159314, R01CA142782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK060564] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health (NIH) grants CA142782 and CA177167 (LMS), DK60564 (SC) and CA159314 (EHB). We thank Lawrence M Lifshitz and Clive Standley of the UMass Biomedical Imaging Group for their contributions to the programs used to analyze the TESM data. We thank Sha Zhu for assistance with cloning, Usha Acharya for assistance with the PI3P lipid measurements and Chung-Cheng Hsieh for statistical advice.	Arboleda MJ, 2003, CANCER RES, V63, P196; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cicchini M, 2014, AUTOPHAGY, V10, P2036, DOI 10.4161/auto.34398; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Dong M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0355-0; Dutta Dipannita, 2012, Cell Logist, V2, P203; Er EE, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004015; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kametaka S, 1996, GENE, V178, P139, DOI 10.1016/0378-1119(96)00354-X; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Knaevelsrud H, 2010, AUTOPHAGY, V6, P863, DOI 10.4161/auto.6.7.13033; Laddha SV, 2014, MOL CANCER RES, V12, P485, DOI 10.1158/1541-7786.MCR-13-0614; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Li ZD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-98; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lorincz P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/851349; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109; Pankratz SL, 2009, J BIOL CHEM, V284, P2031, DOI 10.1074/jbc.M804776200; Park HS, 2014, MODERN PATHOL, V27, P1212, DOI 10.1038/modpathol.2013.251; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Resnik JL, 1998, CANCER RES, V58, P1159; Ryu JY, 2014, CELL REP, V7, P1227, DOI 10.1016/j.celrep.2014.04.006; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Shravage BV, 2013, DEVELOPMENT, V140, P1321, DOI 10.1242/dev.089490; STEPHENS L, 1994, CURR BIOL, V4, P203, DOI 10.1016/S0960-9822(00)00049-X; Wang JR, 2013, J INEQUAL APPL, P1, DOI 10.1186/1029-242X-2013-308; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	47	50	55	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2015	34	42					5352	5362		10.1038/onc.2014.454	http://dx.doi.org/10.1038/onc.2014.454			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EI	25639875	Green Accepted			2022-12-26	WOS:000363479200005
J	Alvard, M; Carlson, D; McGaffey, E				Alvard, Michael; Carlson, David; McGaffey, Ethan			Using a Partial Sum Method and GPS Tracking Data to Identify Area Restricted Search by Artisanal Fishers at Moored Fish Aggregating Devices in the Commonwealth of Dominica	PLOS ONE			English	Article							SMALL-SCALE FISHERY; SYSTEM VMS DATA; SPATIAL-DISTRIBUTION; LONGLINE FISHERY; FLOATING OBJECTS; SOLOMON-ISLANDS; PATCH; KNOWLEDGE; TIME; TRAJECTORIES	Foragers must often travel from a central place to exploit aggregations of prey. These patches can be identified behaviorally when a forager shifts from travel to area restricted search, identified by a decrease in speed and an increase in sinuosity of movement. Faster, more directed movement is associated with travel. Differentiating foraging behavior at patches from travel to patches is important for a variety of research questions and has now been made easier by the advent of small, GPS devices that can track forager movement with high resolution. In the summer and fall of 2012, movement data were collected from GPS devices placed on foraging trips originating in the artisanal fishing village of Desa Ikan (pseudonym), on the east coast of the Caribbean island nation of the Commonwealth Dominica. Moored FADs are human-made structures anchored to the ocean floor with fish attraction material on or near the surface designed to effectively create a resource patch. The ultimate goal of the research is to understand how property rights are emerging after the introduction of fish aggregating device (FAD) technology at the site in 1999. This paper reports on research to identify area-restricted search foraging behavior at FAD patches. For 22 foraging trips simultaneous behavioral observations were made to ground-truth the GPS movement data. Using a cumulative sum method, area restricted search was identified as negative deviations from the mean travel speed and the method was able to correctly identify FAD patches in every case.	[Alvard, Michael; Carlson, David] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [McGaffey, Ethan] Univ N Texas, Dept Anthropol, Denton, TX 76203 USA	Texas A&M University System; Texas A&M University College Station; University of North Texas System; University of North Texas Denton	Alvard, M (corresponding author), Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA.	alvard@tamu.edu			Wenner-Gren Foundation for Anthropological Research; National Science Foundation [BCS-126020]; Enhance Scholarly and Creative Activities, Texas A&M, Office of the Vice President for Research; Division Of Behavioral and Cognitive Sci [1260201] Funding Source: National Science Foundation	Wenner-Gren Foundation for Anthropological Research; National Science Foundation(National Science Foundation (NSF)); Enhance Scholarly and Creative Activities, Texas A&M, Office of the Vice President for Research; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Funding to MA was provided from the Program to Enhance Scholarly and Creative Activities, Texas A&M, Office of the Vice President for Research (http://vpr.tamu.edu/researchdevelopment/funding/internal/ScholarlyCreative2013), the Wenner-Gren Foundation for Anthropological Research (http://www.wennergren.org), and the National Science Foundation under Grant No. BCS-126020 (http://www.nsf.gov). The funders had no role in study	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Alvard M, 2014, FIELD METHO IN PRESS; ALVARD MS, 1993, HUM ECOL, V21, P355, DOI 10.1007/BF00891140; [Anonymous], 2014, R LANG ENV STAT COMP; Aswani S, 1998, OCEAN COAST MANAGE, V40, P207, DOI 10.1016/S0964-5691(98)00047-7; Bartumeus F, 2009, J PHYS A, V42, P1; Ben-Yami M, 1989, MAKE SET FADS FISH A; Bene C, 2001, HUM ECOL, V29, P157, DOI 10.1023/A:1011059830170; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Beverly S, 2012, RAP PUBLICATION, V2012/20; Bird DW, 2009, AM ANTIQUITY, V74, P3, DOI 10.2307/25470536; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyer D, 2010, PHILOS T R SOC A, V368, P5645, DOI 10.1098/rsta.2010.0275; Breed GA, 2012, ECOL MODEL, V235, P49, DOI 10.1016/j.ecolmodel.2012.03.021; Buchin M, 2011, J SPAT INT SCI, P33, DOI 10.5311/JOSIS.2011.3.66; Bush S, 2014, ENV SCI POL IN PRESS; Castro JJ, 2001, REV FISH BIOL FISHER, V11, P255, DOI 10.1023/A:1020302414472; Chang SK, 2014, CAN J FISH AQUAT SCI, V71, P1363, DOI 10.1139/cjfas-2013-0552; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Dagorn L, 2013, FISH FISH, V14, P391, DOI 10.1111/j.1467-2979.2012.00478.x; Daw TM, 2008, FISH RES, V90, P17, DOI 10.1016/j.fishres.2007.09.027; Defoe J, 2007, 2 M WECAFC AD HOC WO; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Dickson J, 2000, PECHE THONIERE DISPO, DOI [10.1016/j.virol.2014.12.023, DOI 10.1016/J.VIROL.2014.12.023]; Dray S, 2010, ECOL RES, V25, P673, DOI 10.1007/s11284-010-0701-7; Eifler DA, 2012, J ETHOL, V30, P197, DOI 10.1007/s10164-011-0293-x; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fonteneau A, 2013, AQUAT LIVING RESOUR, V26, P37, DOI 10.1051/alr/2013046; Freeman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009236; Fronhofer EA, 2013, OIKOS, V122, P857, DOI 10.1111/j.1600-0706.2012.21021.x; Furusawa T, 2012, FIELD METHOD, V24, P216, DOI 10.1177/1525822X11434002; Gabriel O, 2005, FISH CATCHING METHODS OF THE WORLD, 4TH EDITION, P1, DOI 10.1002/9780470995648; Gomes C, 1998, FISH RES, V34, P47, DOI 10.1016/S0165-7836(97)00079-9; GOODING RM, 1967, PAC SCI, V21, P486; Grant S, 2007, FISH RES, V84, P162, DOI 10.1016/j.fishres.2006.10.012; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hawkins M, 1998, CUMULATIVE SUM CHART; HILL K, 1987, ETHOL SOCIOBIOL, V8, P1, DOI 10.1016/0162-3095(87)90055-0; Hills TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060488; HJORLAND B, 1995, J AM SOC INFORM SCI, V46, P400, DOI 10.1002/(SICI)1097-4571(199507)46:6<400::AID-ASI2>3.0.CO;2-Y; Hutchinson JMC, 2008, ANIM BEHAV, V75, P1331, DOI 10.1016/j.anbehav.2007.09.006; Jensen JR, 2007, REMOTE SENSING ENV E; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Knell A, 2011, THESIS U ESSEX; Knell AS, 2012, THEOR ECOL-NETH, V5, P325, DOI 10.1007/s12080-011-0130-4; Kotzerka J, 2010, J ORNITHOL, V151, P459, DOI 10.1007/s10336-009-0479-y; Laland KN, 2001, J EVOLUTION BIOL, V14, P22, DOI 10.1046/j.1420-9101.2001.00262.x; Lambert GI, 2012, ICES J MAR SCI, V69, P682, DOI 10.1093/icesjms/fss018; Laube P, 2011, T GIS, V15, P401, DOI 10.1111/j.1467-9671.2011.01256.x; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; [李楠 Li Nan], 2012, [高技术通讯, Chinese High Technology Letters], V22, P490; Maina J., 2011, SPATIAL BEHAV ARTISA; Marshall HH, 2013, J ANIM ECOL, V82, P894, DOI 10.1111/1365-2656.12089; Morgan A. C, 2011, FISH AGGREGATING DEV; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Odling-Smee FJ, 2003, NICHE CONSTRUCTION N; Orians G, 1977, ANAL ECOLOGICAL SYST, P155; Ostrom E., 1990, GOVERNING COMMONS EV; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Papastamatiou YP, 2012, MAR ECOL PROG SER, V456, P233, DOI 10.3354/meps09721; Papworth SK, 2012, METHODS ECOL EVOL, V3, P584, DOI 10.1111/j.2041-210X.2012.00189.x; Pauly D., 2006, MAR STUD MAST, V4, P7, DOI DOI 10.1126/SCIENCE.279.5352.860.PMID:9452385; Postlethwaite CM, 2013, J THEOR BIOL, V317, P175, DOI 10.1016/j.jtbi.2012.10.007; Radeloff VC, 2000, ECOGRAPHY, V23, P81, DOI 10.1034/j.1600-0587.2000.230109.x; Raichlen DA, 2014, P NATL ACAD SCI USA, V111, P728, DOI 10.1073/pnas.1318616111; Rey-Valette H, 2000, AQUAT LIVING RESOUR, V13, P241, DOI 10.1016/S0990-7440(00)01060-3; RHINE R J, 1978, Primates, V19, P353, DOI 10.1007/BF02382803; Sebastian R, 2007, NATL REPORTS TECHNIC; Shainee M, 2011, FISH RES, V109, P42, DOI 10.1016/j.fishres.2011.01.015; Smith E. A., 1991, INUJJUAMIUT FORAGING; SMITH EA, 1983, CURR ANTHROPOL, V24, P625, DOI 10.1086/203066; Solana-Sansores R, 2001, CIENC MAR, V27, P423; Sommerfeld J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063742; Sosis R, 2001, HUM NATURE-INT BIOS, V12, P221, DOI 10.1007/s12110-001-1008-8; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Stewart KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014451; Taquet M, 2013, AQUAT LIVING RESOUR, V26, P25, DOI 10.1051/alr/2013043; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P1, DOI 10.1007/s00265-005-0131-7; Wajnberg E, 2013, BEHAV ECOL SOCIOBIOL, V67, P2053, DOI 10.1007/s00265-013-1615-5; Walker E, 2010, ECOL MODEL, V221, P2008, DOI 10.1016/j.ecolmodel.2010.05.007; Webster DG, 2009, GLOB ENVIRON ACCORD, P1; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Zavalaga CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019966	87	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115552	10.1371/journal.pone.0115552	http://dx.doi.org/10.1371/journal.pone.0115552			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647288	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600014
J	Cai, SL; Jiang, GB; Ye, NH; Chu, ZZ; Xu, XZ; Zhang, JH; Zhu, GH				Cai, Shanlan; Jiang, Guobin; Ye, Nenghui; Chu, Zhizhan; Xu, Xuezhong; Zhang, Jianhua; Zhu, Guohui			A Key ABA Catabolic Gene, OsABA8ox3, Is Involved in Drought Stress Resistance in Rice	PLOS ONE			English	Article							ABSCISIC-ACID BIOSYNTHESIS; SEED DORMANCY; SIGNAL-TRANSDUCTION; ARABIDOPSIS; 8'-HYDROXYLASE; TOLERANCE; METABOLISM; EXPRESSION; ACCUMULATION; GERMINATION	Expressions of ABA biosynthesis genes and catabolism genes are generally co-regulated in plant development and responses to environmental stress. Up-regulation of OsNCED3 gene, a key gene in ABA biosynthesis, has been suggested as a way to enhance plant drought resistance but little is known for the role of ABA catabolic genes during drought stress. In this study, we found that OsABA8ox3 was the most highly expressed gene of the OsABA8ox family in rice leaves. Expression of OsABA8ox3 was promptly induced by rehydration after PEG-mimic dehydration, a tendency opposite to the changes of ABA level. We therefore constructed rice OsABA8ox3 silencing (RNA interference, RNAi) and overexpression plants. There were no obvious phenotype differences between the transgenic seedlings and wild type under normal condition. However, OsABA8ox3 RNAi lines showed significant improvement in drought stress tolerance while the overexpression seedlings were hypersensitive to drought stress when compared with wild type in terms of plant survival rates after 10 days of unwatering. Enzyme activity analysis indicated that OsABA8ox3 RNAi plants had higher superoxide dismutase (SOD) and catalase (CAT) activities and lessmalondialdehyde (MDA) content than those of wild type when the plants were exposed to dehydration treatment, indicating a better anti-oxidative stress capability and less membrane damage. DNA microarray and real-time PCR analysis under dehydration treatment revealed that expressions of a group of stress/drought-related genes, i.e. LEA genes, were enhanced with higher transcript levels in OsABA8ox3 RNAi transgenic seedlings. We therefore conclude that that OsABA8ox3 gene plays an important role in controlling ABA level and drought stress resistance in rice.	[Cai, Shanlan; Jiang, Guobin; Chu, Zhizhan; Xu, Xuezhong; Zhu, Guohui] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Ye, Nenghui] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Zhang, Jianhua] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China; [Zhu, Guohui] South China Agr Univ, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; South China Agricultural University	Zhu, GH (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	ghzhu@scau.edu.cn	Ye, Nenghui/AAU-4370-2021; Ye, Nenghui/AGK-4828-2022	Zhang, Jianhua/0000-0002-3819-2437; Ye, Nenghui/0000-0002-3126-3562	National Natural Science Foundation of China [31171466, 30900873]; National Basic Research Program (973 Program) [2012CB114306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (31171466,30900873) and the National Basic Research Program (973 Program 2012CB114306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Cho D, 2009, J PLANT BIOL, V52, P102, DOI 10.1007/s12374-009-9019-9; DAVIES WJ, 1991, ANNU REV PLANT PHYS, V42, P55, DOI 10.1146/annurev.pp.42.060191.000415; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hu HH, 2014, ANNU REV PLANT BIOL, V65, P715, DOI 10.1146/annurev-arplant-050213-040000; Hu XL, 2006, PLANT CELL PHYSIOL, V47, P1484, DOI 10.1093/pcp/pcl014; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hwang SG, 2010, PLANT SCI, V178, P12, DOI 10.1016/j.plantsci.2009.09.014; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Ji XM, 2011, PLANT PHYSIOL, V156, P647, DOI 10.1104/pp.111.176164; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Krochko JE, 1998, PLANT PHYSIOL, V118, P849, DOI 10.1104/pp.118.3.849; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Liu YG, 2009, NEW PHYTOL, V183, P1030, DOI 10.1111/j.1469-8137.2009.02899.x; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nitsch LMC, 2009, PLANTA, V229, P1335, DOI 10.1007/s00425-009-0913-7; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Ren HB, 2007, J EXP BOT, V58, P211, DOI [10.1093/jxb/erl1117, 10.1093/jxb/erl117]; Saika H, 2007, PLANT CELL PHYSIOL, V48, P287, DOI 10.1093/pcp/pcm003; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Yang SH, 2006, BIOCHEM BIOPH RES CO, V350, P685, DOI 10.1016/j.bbrc.2006.09.098; ZEEVAART JAD, 1988, ANNU REV PLANT PHYS, V39, P439, DOI 10.1146/annurev.pp.39.060188.002255; Zhu GH, 2009, PLANT CELL PHYSIOL, V50, P644, DOI 10.1093/pcp/pcp022; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	45	39	42	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116646	10.1371/journal.pone.0116646	http://dx.doi.org/10.1371/journal.pone.0116646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647508	gold, Green Published, Green Submitted			2022-12-26	WOS:000348822600031
J	Niroula, A; Urolagin, S; Vihinen, M				Niroula, Abhishek; Urolagin, Siddhaling; Vihinen, Mauno			PON-P2: Prediction Method for Fast and Reliable Identification of Harmful Variants	PLOS ONE			English	Article							MISSENSE MUTATIONS; DISEASE; DATABASE; PATHOGENICITY; POLYMORPHISMS; CONFORMATION; EXPRESSION; INFERENCE; SELECTON; CANCER	More reliable and faster prediction methods are needed to interpret enormous amounts of data generated by sequencing and genome projects. We have developed a new computational tool, PON-P2, for classification of amino acid substitutions in human proteins. The method is a machine learning-based classifier and groups the variants into pathogenic, neutral and unknown classes, on the basis of random forest probability score. PON-P2 is trained using pathogenic and neutral variants obtained from VariBench, a database for benchmark variation datasets. PON-P2 utilizes information about evolutionary conservation of sequences, physical and biochemical properties of amino acids, GO annotations and if available, functional annotations of variation sites. Extensive feature selection was performed to identify 8 informative features among altogether 622 features. PON-P2 consistently showed superior performance in comparison to existing state-of-the-art tools. In 10-fold cross-validation test, its accuracy and MCC are 0.90 and 0.80, respectively, and in the independent test, they are 0.86 and 0.71, respectively. The coverage of PON-P2 is 61.7% in the 10-fold cross-validation and 62.1% in the test dataset. PON-P2 is a powerful tool for screening harmful variants and for ranking and prioritizing experimental characterization. It is very fast making it capable of analyzing large variant datasets. PON-P2 is freely available at http://structure.bmc.lu.se/PON-P2/.	[Niroula, Abhishek; Urolagin, Siddhaling; Vihinen, Mauno] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Vihinen, M (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	mauno.vihinen@med.lu.se	Vihinen, Mauno/A-8452-2012; Niroula, Abhishek/AAB-3998-2022; Niroula, Abhishek/G-4865-2017	Vihinen, Mauno/0000-0002-9614-7976; Niroula, Abhishek/0000-0002-5904-0635; Niroula, Abhishek/0000-0002-5904-0635	Faculty of Medicine, Lund University; Vetenskapsradet	Faculty of Medicine, Lund University; Vetenskapsradet(Swedish Research Council)	MV received funding from Faculty of Medicine, Lund University (http://www.med.lu.se/english). MV received funding from Vetenskapsradet (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anca MH, 2004, AM J MED GENET A, V124A, P89, DOI 10.1002/ajmg.a.20328; Arbiza L, 2006, J MOL BIOL, V358, P1390, DOI 10.1016/j.jmb.2006.02.067; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baux D, 2014, HUM MUTAT, V35, P1179, DOI 10.1002/humu.22608; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2008, HUM MUTAT, V29, P198, DOI 10.1002/humu.20628; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; CHOW CK, 1970, IEEE T INFORM THEORY, V16, P41, DOI 10.1109/TIT.1970.1054406; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Fawcett T., 2004, MACH LEARN, V31, P1, DOI DOI 10.1016/J.PATREC.2005.10.010; Fernald GH, 2011, BIOINFORMATICS, V27, P1741, DOI 10.1093/bioinformatics/btr295; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hanczar B, 2008, BIOINFORMATICS, V24, P1889, DOI 10.1093/bioinformatics/btn349; Hershfield MS, 2003, CURR OPIN IMMUNOL, V15, P571, DOI 10.1016/S0952-7915(03)00104-3; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Kawabata T, 1999, NUCLEIC ACIDS RES, V27, P355, DOI 10.1093/nar/27.1.355; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; KOSHI JM, 1995, PROTEIN ENG, V8, P641; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Nair PS, 2013, HUM MUTAT, V34, P42, DOI 10.1002/humu.22204; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; RACKOVSKY S, 1982, MACROMOLECULES, V15, P1340, DOI 10.1021/ma00233a025; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; TANAKA S, 1977, MACROMOLECULES, V10, P9, DOI 10.1021/ma60055a002; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Vihinen M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S2; Vihinen M, 2014, GENOME RES, V24, P356, DOI 10.1101/gr.157495.113; Vihinen M, 2013, HUM MUTAT, V34, P275, DOI 10.1002/humu.22253; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wei Qiong, 2013, PLoS One, V8, pe67863, DOI 10.1371/journal.pone.0067863	47	135	137	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117380	10.1371/journal.pone.0117380	http://dx.doi.org/10.1371/journal.pone.0117380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647319	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600067
J	Muriel-Millan, LF; Moreno, S; Romero, Y; Bedoya-Perez, LP; Castaneda, M; Segura, D; Espin, G				Felipe Muriel-Millan, Luis; Moreno, Soledad; Romero, Yanet; Patricia Bedoya-Perez, Leidy; Castaneda, Miguel; Segura, Daniel; Espin, Guadalupe			The Unphosphorylated EIIA(Ntr) Protein Represses the Synthesis of Alkylresorcinols in Azotobacter vinelandii	PLOS ONE			English	Article							CYST DESICCATION RESISTANCE; ESCHERICHIA-COLI; BETA-HYDROXYBUTYRATE; BIOSYNTHETIC GENES; EXPRESSION; RPOS; ENCYSTMENT; BACTERIA; IIA(NTR); CASSETTES	Upon encystment induction, Azotobacter vinelandii produces the phenolic lipids alkylresorcinols (ARs) that are structural components of the cysts. The enzymes responsible for the ARs synthesis are encoded in the arsABCD operon, whose expression is activated by ArpR. The transcription of arpR is initiated from an RpoS dependent promoter. The nitrogen-related phosphotransferase system (PTSNtr) is a global regulatory system present in Gram negative bacteria. It comprises the EINtr, NPr and EIIA(Ntr) proteins encoded by ptsP, ptsO and ptsN genes respectively. These proteins participate in a phosphoryl-group transfer from phosphoenolpyruvate to protein EIIA(Ntr) via the phosphotransferases EINtr and NPr. In A. vinelandii, the non-phosphorylated form of EIIA(Ntr) was previously shown to repress the synthesis of poly-beta-hydroxybutyrate. In this work, we show that PTSNtr also regulates the synthesis of ARs. In a strain that carries unphosphorylated EIIA(Ntr), the expression of arpR was reduced, while synthesis of ARs and transcription of arsA were almost abrogated. The expression of arpR from an RpoS-independent promoter in this strain restored the ARs synthesis. Taken together these results indicate that unphosphorylated EIIA(Ntr) negatively affects activation of arpR transcription by RpoS.	[Felipe Muriel-Millan, Luis; Moreno, Soledad; Romero, Yanet; Patricia Bedoya-Perez, Leidy; Segura, Daniel; Espin, Guadalupe] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca, Morelos, Mexico; [Castaneda, Miguel] Benemerita Univ Autonoma Puebla, Inst Ciencias, Ctr Invest Ciencias Microbiol, Puebla, Mexico	Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla	Espin, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca, Morelos, Mexico.	espin@ibt.unam.mx		ROMERO, YANET/0000-0002-8383-4128; Muriel, Luis/0000-0002-0507-2519	grant DGAPA-PAPIIT [209814]; CONACyT	grant DGAPA-PAPIIT; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grant DGAPA-PAPIIT 209814. LFMM received financial support by CONACyT during his PhD studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXEYEV MF, 1995, GENE, V160, P63, DOI 10.1016/0378-1119(95)00108-I; BALI A, 1992, APPL ENVIRON MICROB, V58, P1711, DOI 10.1128/AEM.58.5.1711-1718.1992; BARRY T, 1992, NUCLEIC ACIDS RES, V20, P4940, DOI 10.1093/nar/20.18.4940; Chang-Ro Lee S-HC, 2007, P NATL ACAD SCI USA, V104, P4124; Choi J, 2010, P NATL ACAD SCI USA, V107, P20506, DOI 10.1073/pnas.1000759107; Cocotl-Yanez M, 2014, MICROBIOL-SGM, V160, P479, DOI 10.1099/mic.0.073353-0; Cocotl-Yanez M, 2011, MICROBIOL-SGM, V157, P1685, DOI 10.1099/mic.0.046268-0; Funa N, 2006, P NATL ACAD SCI USA, V103, P6356, DOI 10.1073/pnas.0511227103; Hernandez- Eligio A, 2012, MICROBIOLOGY, V158, P11; Hernandez-Eligio A, 2011, MICROBIOL-SGM, V157, P3014, DOI 10.1099/mic.0.051649-0; Higa F, 2001, INFECT IMMUN, V69, P4782, DOI 10.1128/IAI.69.8.4782-4789.2001; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lee CR, 2010, MOL MICROBIOL, V78, P1468, DOI 10.1111/j.1365-2958.2010.07419.x; Lee CR, 2005, MOL MICROBIOL, V58, P334, DOI 10.1111/j.1365-2958.2005.04834.x; LIN LP, 1968, J BACTERIOL, V95, P2336, DOI 10.1128/JB.95.6.2336-2343.1968; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luttmann D, 2012, MOL MICROBIOL, V86, P96, DOI 10.1111/j.1365-2958.2012.08176.x; Luttmann D, 2009, MOL MICROBIOL, V72, P978, DOI 10.1111/j.1365-2958.2009.06704.x; MartinezSalazar JM, 1996, J BACTERIOL, V178, P1800, DOI 10.1128/jb.178.7.1800-1808.1996; Michiels J, 1998, J BACTERIOL, V180, P1729, DOI 10.1128/JB.180.7.1729-1740.1998; Noguez R, 2008, J MOL MICROB BIOTECH, V15, P244, DOI 10.1159/000108658; Peralta-Gil M, 2002, J BACTERIOL, V184, P5672, DOI 10.1128/JB.184.20.5672-5677.2002; Pfluger-Grau K, 2010, TRENDS MICROBIOL, V18, P205, DOI 10.1016/j.tim.2010.02.003; REUSCH RN, 1983, J BACTERIOL, V156, P778, DOI 10.1128/JB.156.2.778-788.1983; Romero Y, 2013, J BACTERIOL, V195, P1834, DOI 10.1128/JB.01946-12; Sadoff HL, 1975, MICROBIOL MOL BIOL R, V39, P516; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Segura D, 2003, ARCH MICROBIOL, V179, P437, DOI 10.1007/s00203-003-0553-4; Segura D, 2009, J BACTERIOL, V191, P3142, DOI 10.1128/JB.01575-08; Untiet V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064682; WILSON KJ, 1995, MICROBIOL-SGM, V141, P1691, DOI 10.1099/13500872-141-7-1691	32	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117184	10.1371/journal.pone.0117184	http://dx.doi.org/10.1371/journal.pone.0117184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642700	gold, Green Submitted, Green Published			2022-12-26	WOS:000348821200034
J	Zhuang, LP; Xu, LT; Wang, P; Meng, ZQ				Zhuang, Liping; Xu, Litao; Wang, Peng; Meng, Zhiqiang			Serum miR-128-2 Serves as a Prognostic Marker for Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							MICRORNA EXPRESSION; CANCER; GENE; METASTASIS; BIOMARKERS; APOPTOSIS; DIAGNOSIS; SURVIVAL	Circulating miRNAs are promising biomarkers for predicting the aggressiveness of hepatocellular carcinoma (HCC). We aimed to identify differentially expressed miRNAs in the serum of HCC patients with different Barcelona Clinic Liver Cancer (BCLC) stage, and to investigate the potential of serum miRNAs as biomarkers for patient outcomes. In the discovery stage, TaqMan Low-Density Array was used to test the difference in levels of serum miRNAs between 20 patients with portal vein tumor thrombosis (PVTT) and 20 patients without PVTT. The detected serum miRNAs then were validated in 182 patients. Fifteen serum miRNAs showed more than two-fold higher expression in patients with PVTT, and miR-128-2 was found to be significantly up-regulated and was selected for further validation. In the validation stage, patients were divided into two groups with low or high serum miR-128-2 using the median expression level of all 182 cases as the cut-off point. Kaplan-Meier analysis revealed that patients with low level of serum miR-128-2 had favorable trends of survival (log rank = 13.031, p < 0.001). The median survivals for patients with a low and high level of serum miR-128-2 were 625 (95% CI, 527-722) days and 426 (95% CI, 362-491) days, respectively. MiR-128-2 was also an independent factor of overall survival (p = 0.001, HR 2.793, 95% CI 1.550, 5.033). Serum levels of the ubiquitously expressed miR-128-2 showed no significant correlation with parameters of liver damage or liver function. In addition, expressions of miR-128-2 in HCC tissues were up-regulated in comparison with adjacent non-tumor tissues. In conclusion, serum level of miR-128-2 serves as a noninvasive biomarker for the overall survival of patients with hepatocellular carcinoma.	[Zhuang, Liping; Xu, Litao; Wang, Peng; Meng, Zhiqiang] Fudan Univ, Shanghai Canc Ctr, Dept Integrat Med, Dept Oncol,Shanghai Med Coll, Shanghai 200032, Peoples R China	Fudan University	Meng, ZQ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Integrat Med, Dept Oncol,Shanghai Med Coll, Shanghai 200032, Peoples R China.	mengzhq@yeah.net	Meng, Zhiqiang/ABE-7747-2021	Zhuang, Liping/0000-0003-1998-8250				Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chau GY, 2005, WORLD J SURG, V29, P1374, DOI 10.1007/s00268-005-7766-4; Cheng SQ, 2007, HEPATO-GASTROENTEROL, V54, P499; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Lim HY, 2013, ANN SURG ONCOL, V20, P3747, DOI 10.1245/s10434-013-3070-y; Lin DX, 2011, J CANCER RES CLIN, V137, P139, DOI 10.1007/s00432-010-0868-x; Liu SP, 2012, J HEPATOL, V56, P389, DOI 10.1016/j.jhep.2011.08.008; LOK ASF, 1989, HEPATOLOGY, V9, P110, DOI 10.1002/hep.1840090119; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Peck-Radosavljevic M, 2012, J HEPATOL, V56, P488, DOI 10.1016/j.jhep.2011.06.023; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Shi J, 2010, ANN SURG ONCOL, V17, P2073, DOI 10.1245/s10434-010-0940-4; Tang ZY, 2001, WORLD J GASTROENTERO, V7, P445; Venkataraman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010748; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; YUKI K, 1990, CANCER-AM CANCER SOC, V66, P2174, DOI 10.1002/1097-0142(19901115)66:10<2174::AID-CNCR2820661022>3.0.CO;2-A; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	37	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117274	10.1371/journal.pone.0117274	http://dx.doi.org/10.1371/journal.pone.0117274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642945	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821200035
J	Markiewicz-Zukowska, R; Gutowska, A; Borawska, MH				Markiewicz-Zukowska, Renata; Gutowska, Anna; Borawska, Maria H.			Serum Zinc Concentrations Correlate with Mental and Physical Status of Nursing Home Residents	PLOS ONE			English	Article							GERIATRIC DEPRESSION SCALE; PLASMA-CONCENTRATIONS; TRACE-ELEMENTS; MICRONUTRIENT; HEALTH; COPPER; PREVALENCE; WOMEN; PERFORMANCE; DISABILITY	Introduction Zinc (Zn) is one of the most important trace elements in the body. Zn deficiency seems to play a role in the development of age-related diseases and impairment of quality of life. Zn status has been especially studied in free-living or hospitalised people, but data from older residents of nursing homes are scarce. This study aimed to determine the Zn status among the older individuals in correlation to their mental and physical performance. Methods A total of 100 participants aged between 60-102 years were recruited between October 2010 and May 2012 at the nursing home in Bialystok (Poland). Zn status was evaluated by determining the concentration in serum by flame atomic absorption spectrometry. Anthropometric variables and fitness score (FS) were measured. Abbreviated Mental Test Score (AMTS), Geriatric Depression Scale (GDS), Self-Rated Health (SRH), independence in Activities of Daily Living (ADL) were recorded. Results and Discussion The mean serum Zn concentration was 0.83 +/- 0.20 mg/L, 28% of residents had Zn deficiency. Cognitive functions were impaired (AMTS <= 8) in 45% of the studied persons and 48% showed depressive symptoms (GDS >= 1). The ability to independently perform activities of daily living (ADL = 6) was found in 61% of participants, but most of them (90%) had weak body type (FS<70), correlating with GDS, SRH and body mass index (BMI). Serum Zn concentration correlated with mental efficiency and was statistically significantly higher in older people with normal cognitive function and without depression than in patients with memory impairment and showing depressive symptoms. Conclusions Nursing home residents seem at risk of marginal Zn status, which correlates with their mental status as measured by the AMTS and GDS. Their low FS is associated with mental health deterioration and obesity.	[Markiewicz-Zukowska, Renata; Borawska, Maria H.] Med Univ Bialystok, Dept Bromatol, Bialystok, Poland; [Gutowska, Anna] Nursing Home Bialystok, Bialystok, Poland	Medical University of Bialystok	Borawska, MH (corresponding author), Med Univ Bialystok, Dept Bromatol, Bialystok, Poland.	bromatos@umb.edu.pl		Borawska, Maria/0000-0003-0999-9650; Markiewicz Zukowska, Renata/0000-0003-0716-9573	Polish Ministry of Science and Higher Education [133 16523F]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was funded by a grant from Polish Ministry of Science and Higher Education (No 133 16523F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani R, 2010, BIOL TRACE ELEM RES, V137, P150, DOI 10.1007/s12011-009-8572-x; Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, pS37, DOI 10.1038/sj.ejcn.1602296; [Anonymous], 2013, OB OV; Bailey AL, 1997, BRIT J NUTR, V77, P225, DOI 10.1079/BJN19970026; Bartali B, 2006, ARCH INTERN MED, V166, P2335, DOI 10.1001/archinte.166.21.2335; BLAZER DG, 1979, J AM GERIATR SOC, V27, P330, DOI 10.1111/j.1532-5415.1979.tb06051.x; Bureau I, 2002, J TRACE ELEM MED BIO, V16, P9, DOI 10.1016/S0946-672X(02)80003-7; Cheng ST, 2005, INT J GERIATR PSYCH, V20, P1131, DOI 10.1002/gps.1405; DATH P, 1994, FAM PRACT, V11, P260, DOI 10.1093/fampra/11.3.260; Del Corso L, 2000, PANMINERVA MED, V42, P273; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Gensler G, 2002, J NUTR, V132, P697; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gray Shelly L, 2003, Am J Geriatr Pharmacother, V1, P3, DOI 10.1016/S1543-5946(03)80011-9; Gronli O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082793; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Hoshi T., 2013, Health, V5, P1303; Hotz C, 2003, AM J CLIN NUTR, V78, P756, DOI 10.1093/ajcn/78.4.756; Hyun TH, 2004, AM J CLIN NUTR, V80, P715; Jackson TA, 2013, AGE AGEING, V42, P689, DOI 10.1093/ageing/aft145; Jongenelis K, 2004, J AFFECT DISORDERS, V83, P135, DOI 10.1016/j.jad.2004.06.001; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KING JC, 1994, J NUTR, V124, P508, DOI 10.1093/jn/124.4.508; Laudisio A, 2008, CLIN NUTR, V27, P747, DOI 10.1016/j.clnu.2008.07.001; MAES M, 1994, J AFFECT DISORDERS, V31, P135, DOI 10.1016/0165-0327(94)90117-1; Maes M, 1997, BIOL PSYCHIAT, V42, P349, DOI 10.1016/S0006-3223(96)00365-4; MCGIVNEY SA, 1994, J AM GERIATR SOC, V42, P490, DOI 10.1111/j.1532-5415.1994.tb04969.x; MCLOUGHLIN IJ, 1990, ACTA PSYCHIAT SCAND, V82, P451, DOI 10.1111/j.1600-0447.1990.tb03077.x; Meunier N, 2005, EUR J CLIN NUTR, V59, pS1, DOI 10.1038/sj.ejcn.1602286; Meydani M, 2001, ANN NY ACAD SCI, V928, P226; Neumeister B, 2013, KLIN LABORDIAGNOSTIK; Nowak G, 1999, HUM PSYCHOPHARM CLIN, V14, P83, DOI 10.1002/(SICI)1099-1077(199903)14:2<83::AID-HUP74>3.3.CO;2-Y; Paik HY, 1999, BIOL TRACE ELEM RES, V69, P45, DOI 10.1007/BF02783914; Paoletti P, 2009, NEUROSCIENCE, V158, P126, DOI 10.1016/j.neuroscience.2008.01.061; Pepersack T, 2001, ARCH GERONTOL GERIAT, V33, P243, DOI 10.1016/S0167-4943(01)00186-8; Perruccio AV, 2010, SOC SCI MED, V71, P1636, DOI 10.1016/j.socscimed.2010.07.042; PRASAD AS, 1965, J LAB CLIN MED, V66, P508; Ravaglia G, 2000, J CLIN ENDOCR METAB, V85, P2260, DOI 10.1210/jc.85.6.2260; Rockwood K, 1996, J AM GERIATR SOC, V44, P578, DOI 10.1111/j.1532-5415.1996.tb01446.x; Romero CD, 2002, J TRACE ELEM MED BIO, V16, P75, DOI 10.1016/S0946-672X(02)80032-3; ROVNER BW, 1991, JAMA-J AM MED ASSOC, V265, P993, DOI 10.1001/jama.265.8.993; Rukgauer M, 1997, J TRACE ELEM MED BIO, V11, P92; Schmuck A, 1996, J AM COLL NUTR, V15, P462; Semba RD, 2006, J GERONTOL A-BIOL, V61, P594, DOI 10.1093/gerona/61.6.594; Siwek M, 2009, J AFFECT DISORDERS, V118, P187, DOI 10.1016/j.jad.2009.02.014; Smalbrugge M, 2006, INT J GERIATR PSYCH, V21, P325, DOI 10.1002/gps.1466; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Socha K, 2009, FRESEN ENVIRON BULL, V18, P1932; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Swain DG, 1999, CLIN REHABIL, V13, P503, DOI 10.1191/026921599670895633; Takeda A, 2005, NEUROCHEM INT, V46, P221, DOI 10.1016/j.neuint.2004.10.003; Teresi J, 2001, SOC PSYCH PSYCH EPID, V36, P613, DOI 10.1007/s127-001-8202-7; Webber AP, 2005, J AM GERIATR SOC, V53, P1017, DOI 10.1111/j.1532-5415.2005.53322.x	55	31	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117257	10.1371/journal.pone.0117257	http://dx.doi.org/10.1371/journal.pone.0117257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635818	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700077
J	Shen, ZW; Stanger, BZ				Shen, Zhewei; Stanger, Ben Z.			YAP Regulates S-Phase Entry in Endothelial Cells	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; ORGAN SIZE CONTROL; LARGE GENE LISTS; TUMOR-SUPPRESSOR; DNA-REPLICATION; HIPPO PATHWAY; OVARIAN-CANCER; PROLIFERATION; EXPRESSION; ONCOGENE	The Hippo pathway regulates cell proliferation and apoptosis through the Yes-associated protein (YAP) transcriptional activator. YAP has a well-described role in promoting cell proliferation and survival, but the precise mechanisms and transcriptional targets that underlie these properties are still unclear and likely context-dependent. We found, using siRNA-mediated knockdown, that YAP is required for proliferation in endothelial cells but not HeLa cells. Specifically, YAP is required for S-phase entry and its absence causes cells to accumulate in G1. Microarray analysis suggests that YAP mediates this effect by regulating the transcription of genes involved in the assembly and/or firing of replication origins and homologous recombination of DNA. These findings thus provide insight into the molecular mechanisms by which YAP regulates cell cycle progression.	[Shen, Zhewei; Stanger, Ben Z.] Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shen, Zhewei; Stanger, Ben Z.] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shen, Zhewei; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Stanger, BZ (corresponding author), Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA.	bstanger@exchange.upenn.edu		Stanger, Ben/0000-0003-0410-4037; Shen, Zhewei/0000-0002-5811-3521	National Institutes of Health Pew Charitable Trusts [R01-DK083355]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083355] Funding Source: NIH RePORTER	National Institutes of Health Pew Charitable Trusts; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R01-DK083355 (BZS) Pew Charitable Trusts http://www.pewtrusts.org/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chalasani P, 2013, ONCOLOGIST, V18, P909, DOI 10.1634/theoncologist.2013-0039; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Cottini F, 2014, NAT MED, V20, P599, DOI 10.1038/nm.3562; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; Francken AB, 2013, BREAST, V22, P561, DOI 10.1016/j.breast.2013.07.045; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kim JM, 2003, MUTAT RES-FUND MOL M, V532, P29, DOI 10.1016/j.mrfmmm.2003.08.008; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liu T, 2014, CELL MOL LIFE SCI, V71, P3779, DOI 10.1007/s00018-014-1649-5; LOGAN TJ, 1995, CANCER RES, V55, P2883; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; MacLachlan TK, 2000, FUNCTIONAL INTERACTI; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mizuno T, 2012, ONCOGENE, V31, P5117, DOI 10.1038/onc.2012.5; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Shimizu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034102; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Stoeber K, 2001, J CELL SCI, V114, P2027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsuyama T, 2005, NUCLEIC ACIDS RES, V33, P765, DOI 10.1093/nar/gki226; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091770; Xiao WF, 2013, BIOCHEM BIOPH RES CO, V439, P167, DOI 10.1016/j.bbrc.2013.08.071; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	57	40	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117522	10.1371/journal.pone.0117522	http://dx.doi.org/10.1371/journal.pone.0117522			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635998	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700089
J	Lan, B; Hayama, E; Kawaguchi, N; Furutani, Y; Nakanishi, T				Lan, Beidi; Hayama, Emiko; Kawaguchi, Nanako; Furutani, Yoshiyuki; Nakanishi, Toshio			Therapeutic Efficacy of Valproic Acid in a Combined Monocrotaline and Chronic Hypoxia Rat Model of Severe Pulmonary Hypertension	PLOS ONE			English	Article							HISTONE DEACETYLASE; HDAC INHIBITORS; ACETYLATION; EXPRESSION; TARGET; CANCER; GENE	Background Pulmonary hypertension (PH) is a serious disease with poor prognosis. Reports show that cells in remodeled pulmonary arteries of PH patients have similar characteristics to cancer cells, such as exuberant inflammation, increased proliferation, and decreased apoptosis. An ideal strategy for developing PH therapies is to directly target pulmonary vascular remodeling. High levels of histone deacetylase (HDAC) expression and activity are found in certain cancers, and research has shown the potential of HDAC inhibitors in repressing tumor growth via anti-inflammatory and anti-proliferative effects. To date, little is known about the effectiveness of HDAC inhibitors against pulmonary vascular remodeling in severe PH. Objective To investigate whether class I HDAC inhibitors suppress or reverse the development of severe PH in rats. Methods Male Sprague-Dawley rats were injected with a single, subcutaneous dose of monocrotaline (60mg/kg), and were exposed to chronic hypoxia to induce severe PH. Valproic acid, a class I HDAC inhibitor, was administered to rats daily via gastric gavage (300mg/kg) in a PH prevention study (during the first 3 weeks) or a PH reversal study (from 3 to 5 weeks). At the end of experiment, hemodynamic indices were measured, ventricular hypertrophy indices were calculated and vascular remodeling phenotypes were analyzed. Results: After 3 weeks exposure to a combined stimulation of monocrotaline and chronic hypoxia, rats exhibited a reduced body weight, elevated right ventricular systolic pressure, an increased Fulton index, right ventricle weight ratio, medial wall thickness and muscularized peripheral pulmonary arteries. These parameters for PH evaluation were exacerbated from 3 to 5 weeks. Daily administration of valproic acid therapy prevented and partially reversed the development of severe PH in rats, and decreased inflammation and proliferation in remodeled pulmonary arteries. Conclusion These data show that class I HDAC inhibitors may be effective for treating severe PH.	[Lan, Beidi; Hayama, Emiko; Kawaguchi, Nanako; Furutani, Yoshiyuki; Nakanishi, Toshio] Tokyo Womens Med Univ, Dept Pediat Cardiol, Tokyo, Japan	Tokyo Women's Medical University	Nakanishi, T (corresponding author), Tokyo Womens Med Univ, Dept Pediat Cardiol, Tokyo, Japan.	pnakanis@hij.twmu.ac.jp						Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brodie SA, 2014, EXPERT REV ANTICANC, V14, P1, DOI [10.1586/14737140.2014.863713, DOI 10.1586/14737140.2014.863713]; Bush EW, 2010, CIRC RES, V106, P272, DOI 10.1161/CIRCRESAHA.109.209338; Calao M, 2008, TRENDS BIOCHEM SCI, V33, P339, DOI 10.1016/j.tibs.2008.04.015; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Cho YK, 2010, CIRC J, V74, P760, DOI 10.1253/circj.CJ-09-0580; Dahal BK, 2010, EUR RESPIR J, V36, P808, DOI 10.1183/09031936.00140309; Diebold I, 2010, MOL BIOL CELL, V21, P2087, DOI 10.1091/mbc.E09-12-1003; Duenas-Gonzalez A, 2008, CANCER TREAT REV, V34, P206, DOI 10.1016/j.ctrv.2007.11.003; Glenn DJ, 2009, HYPERTENSION, V53, P549, DOI 10.1161/HYPERTENSIONAHA.108.125088; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Iyer A, 2010, BRIT J PHARMACOL, V159, P1408, DOI 10.1111/j.1476-5381.2010.00637.x; Jurkin J, 2011, CELL CYCLE, V10, P406, DOI 10.4161/cc.10.3.14712; Klampfer L, 2004, J BIOL CHEM, V279, P30358, DOI 10.1074/jbc.M401359200; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Morimatsu Y, 2012, J VASC RES, V49, P33, DOI 10.1159/000329594; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Okada K, 1997, AM J PATHOL, V151, P1019; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rondelet B, 2003, CIRCULATION, V107, P1329, DOI 10.1161/01.CIR.0000053443.27512.33; Sharma NL, 2013, BJU INT, V111, P537, DOI 10.1111/j.1464-410X.2012.11647.x; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176	27	33	36	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117211	10.1371/journal.pone.0117211	http://dx.doi.org/10.1371/journal.pone.0117211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629315	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100074
J	Maddaloni, M; Kochetkova, I; Jun, S; Callis, G; Thornburg, T; Pascual, DW				Maddaloni, Massimo; Kochetkova, Irina; Jun, SangMu; Callis, Gayle; Thornburg, Theresa; Pascual, David W.			Milk-Based Nutraceutical for Treating Autoimmune Arthritis via the Stimulation of IL-10-and TGF-beta-producing CD39(+) Regulatory T Cells	PLOS ONE			English	Article							FACTOR ANTIGEN-I; RHEUMATOID-ARTHRITIS; AUTOANTIGEN PROTECTS; ESCHERICHIA-COLI; VACCINATION; EXPRESSION; FIMBRIAE; THERAPY; ABSENCE; CFA/I	Autoimmune diseases arise from the loss of tolerance to self, and because the etiologies of such diseases are largely unknown, symptomatic treatments rely on anti-inflammatory and analgesic agents. Tolerogenic treatments that can reverse disease are preferred, but again, often thwarted by not knowing the responsible auto-antigens (auto-Ags). Hence, a viable alternative to stimulating regulatory T cells (Tregs) is to induce bystander tolerance. Colonization factor antigen I (CFA/I) has been shown to evoke bystander immunity and to hasten Ag-specific Treg development independent of auto-Ag. To translate in treating human autoimmune diseases, the food-based Lactococcus was engineered to express CFA/I fimbriae, and Lactococcus-CFA/I fermented milk fed to arthritic mice proved highly efficacious. Protection occurred via CD39(+) Tregs producing TGF-beta and IL-10 to potently suppress TNF-alpha production and neutrophil influx into the joints. Thus, these data demonstrate the feasibility of oral nutraceuticals for treating arthritis, and potency of protection against arthritis was improved relative to that obtained with Salmonella-CFA/I.	[Maddaloni, Massimo; Jun, SangMu; Pascual, David W.] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA; [Kochetkova, Irina; Callis, Gayle; Thornburg, Theresa] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	State University System of Florida; University of Florida; Montana State University System; Montana State University Bozeman	Pascual, DW (corresponding author), Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.	pascuald@ufl.edu	Pascual, David/AAC-2248-2022		U.S. Public Health [P01 AT-004986]; University of Florida; Emerging Pathogens Institute; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004986] Funding Source: NIH RePORTER	U.S. Public Health(United States Department of Health & Human ServicesUnited States Public Health Service); University of Florida(University of Florida); Emerging Pathogens Institute; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by U.S. Public Health Grant P01 AT-004986, and in part by funds from the University of Florida and by the Emerging Pathogens Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantha RP, 2004, INFECT IMMUN, V72, P7190, DOI 10.1128/IAI.72.12.7190-7201.2004; Behnsen J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010074; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brand DD, 2004, METH MOLEC MED, V102, P295; Carmona L, 2010, BEST PRACT RES CL RH, V24, P733, DOI 10.1016/j.berh.2010.10.001; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1261; Cross M, 2014, ANN RHEUM DIS, V73, P1316, DOI 10.1136/annrheumdis-2013-204627; Daniel C, 2013, APPL ENVIRON MICROB, V79, P1086, DOI 10.1128/AEM.03221-12; Daniel C, 2011, TRENDS BIOTECHNOL, V29, P499, DOI 10.1016/j.tibtech.2011.05.002; De Keyser F, 2011, CURR RHEUMATOL REV, V7, P77, DOI 10.2174/157339711794474620; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hu YP, 2013, CLIN RHEUMATOL, V32, P161, DOI 10.1007/s10067-012-2041-1; Kannan Krishnaswamy, 2005, Pathophysiology, V12, P167, DOI 10.1016/j.pathophys.2005.07.011; Kochetkova I, 2008, J IMMUNOL, V181, P2741, DOI 10.4049/jimmunol.181.4.2741; Kochetkova I, 2014, J IMMUNOL, V192, P804, DOI 10.4049/jimmunol.1302018; Kochetkova I, 2011, J IMMUNOL, V187, P4654, DOI 10.4049/jimmunol.1100530; Kochetkova I, 2010, J IMMUNOL, V184, P7144, DOI 10.4049/jimmunol.0902739; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; Ochoa-Reparaz J, 2007, J IMMUNOL, V178, P1791, DOI 10.4049/jimmunol.178.3.1791; Oddone GM, 2009, PLASMID, V61, P151, DOI 10.1016/j.plasmid.2008.12.001; Pascual D. W., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P203, DOI 10.2174/187153007781662549; Rosenblum H, 2011, AUTOIMMUN REV, V10, P563, DOI 10.1016/j.autrev.2011.04.010; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; SMITH HR, 1982, J BACTERIOL, V149, P264, DOI 10.1128/JB.149.1.264-275.1982; Steidler L, 2009, ANN NY ACAD SCI, V1182, P135, DOI 10.1111/j.1749-6632.2009.05067.x; Wells J, 2011, ANNU REV FOOD SCI T, V2, P423, DOI 10.1146/annurev-food-022510-133640; WU SG, 1995, INFECT IMMUN, V63, P4933, DOI 10.1128/IAI.63.12.4933-4938.1995	31	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117825	10.1371/journal.pone.0117825	http://dx.doi.org/10.1371/journal.pone.0117825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629976	gold, Green Published, Green Submitted			2022-12-26	WOS:000348732100096
J	Vasilyev, N; Serganov, A				Vasilyev, Nikita; Serganov, Alexander			Structures of RNA Complexes with the Escherichia coli RNA Pyrophosphohydrolase RppH Unveil the Basis for Specific 5 '-End-dependent mRNA Decay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUDIX HYDROLASE; COLORIMETRIC DETERMINATION; PROTEIN; RECOGNITION; DEGRADATION; PYROPHOSPHATE; MECHANISM; INSIGHTS; K1	5'-End-dependent RNA degradation impacts virulence, stress responses, and DNA repair in bacteria by controlling the decay of hundreds of mRNAs. The RNA pyrophosphohydrolase RppH, a member of the Nudix hydrolase superfamily, triggers this degradation pathway by removing pyrophosphate from the triphosphorylated RNA 5' terminus Here, we report the x-ray structures of Escherichia call RppH (EcRppH) in apo- and RNA-bound forms. These structures show distinct conformations of EcRppH.RNA complexes on the catalytic pathway and suggest a common catalytic mechanism for Nudix hydrolases. EcRppH interacts with RNA by a bipartite mechanism involving specific recognition of the 5'-terminal triphosphate and the second nucleotide, thus enabling discrimination against mononudeotides as substrates. The structures also reveal the molecular basis for the preference of the enzyme for RNA substrates bearing guanine in the second position by identifying a protein cleft in which guanine interacts with EcRppH side chains via cation-pi contacts and hydrogen bonds. These interactions explain the modest specificity of EcRppH at the 5' terminus and distinguish the enzyme from the highly selective RppH present in Bacillus subtilis. The divergent means by which RNA is recognized by these two functionally and structurally analogous enzymes have important implications for mRNA decay and the regulation of protein biosynthesis in bacteria.	[Vasilyev, Nikita; Serganov, Alexander] NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 First Ave, New York, NY 10016 USA	New York University	Serganov, A (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, 550 First Ave, New York, NY 10016 USA.	alexander.serganov@nyumc.org		Serganov, Alexander/0000-0001-8328-9310	New York University	New York University	This work was supported by New York University start-up funds (to A. S.).	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Badger JL, 2000, MOL MICROBIOL, V36, P174, DOI 10.1046/j.1365-2958.2000.01840.x; Bailey S, 2002, STRUCTURE, V10, P589, DOI 10.1016/S0969-2126(02)00746-3; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Bessman MJ, 2001, J BIOL CHEM, V276, P37834; Bi YC, 2009, BIOMOL NMR ASSIGN, V3, P149, DOI 10.1007/s12104-009-9162-8; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Fletcher JI, 2002, STRUCTURE, V10, P205, DOI 10.1016/S0969-2126(02)00696-2; Foley PL, 2015, J BIOL CHEM, V290, P9478, DOI 10.1074/jbc.M114.634659; Gabelli SB, 2002, BIOCHEMISTRY-US, V41, P9279, DOI 10.1021/bi0259296; HEINONEN JK, 1981, ANAL BIOCHEM, V117, P293, DOI 10.1016/0003-2697(81)90725-9; Hsieh PK, 2013, P NATL ACAD SCI USA, V110, P8864, DOI 10.1073/pnas.1222670110; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang LW, 2003, STRUCTURE, V11, P1015, DOI 10.1016/S0969-2126(03)00154-0; Leung DW, 2012, CURR OPIN STRUC BIOL, V22, P297, DOI 10.1016/j.sbi.2012.03.011; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luciano DJ, 2012, J BACTERIOL, V194, P6233, DOI 10.1128/JB.01223-12; Lundin A, 2003, J BIOL CHEM, V278, P12574, DOI 10.1074/jbc.M212542200; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; McLennan AG, 2013, CELL MOL LIFE SCI, V70, P373, DOI 10.1007/s00018-012-1210-3; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Miyazaki K, 2002, BIOTECHNIQUES, V33, P1033, DOI 10.2144/02335st03; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Piton J, 2013, P NATL ACAD SCI USA, V110, P8858, DOI 10.1073/pnas.1221510110; PUTNINS RF, 1975, ANAL BIOCHEM, V68, P185, DOI 10.1016/0003-2697(75)90693-4; Richards J, 2011, MOL CELL, V43, P940, DOI 10.1016/j.molcel.2011.07.023; Scarsdale JN, 2006, STRUCTURE, V14, P331, DOI 10.1016/j.str.2005.11.010; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wintjens R, 2000, J MOL BIOL, V302, P395, DOI 10.1006/jmbi.2000.4040	44	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9487	9499		10.1074/jbc.M114.634824	http://dx.doi.org/10.1074/jbc.M114.634824			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25657011	hybrid, Green Published			2022-12-26	WOS:000352729400016
J	Devaraneni, PK; Martin, GM; Olson, EM; Zhou, Q; Shyng, SL				Devaraneni, Prasanna K.; Martin, Gregory M.; Olson, Erik M.; Zhou, Qing; Shyng, Show-Ling			Structurally Distinct Ligands Rescue Biogenesis Defects of the K-ATP Channel Complex via a Converging Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-binding Cassette Transporter Subfamily C Member 8 (ABCC8); Chaperone; Potassium Channel; Protein Assembly; Protein Cross-linking; Carbamazepine; Glibenclamide; Pharmacological Chaperone; Sulfonylurea Receptor 1; Unnatural Amino Acid	SENSITIVE POTASSIUM CHANNELS; SULFONYLUREA RECEPTOR SUR1; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; CORRECT TRAFFICKING DEFECTS; PHARMACOLOGICAL CHAPERONES; CONGENITAL HYPERINSULINISM; INSULIN-SECRETION; HIGH-AFFINITY; N-TERMINUS; CROSS-LINKERS	Background: Carbamazepine and glibenclamide correct K-ATP channel trafficking defects. Results: Carbamazepine and glibenclamide share a binding pocket in the channel and enhance cross-linking of Kir6.2 to SUR1. Conclusion: The two structurally distinct drugs correct K-ATP channel biogenesis defects caused by mutations in SUR1 and Kir6.2 by promoting interactions between the two channel subunits. Significance: The heteromeric subunit interface is an important target for pharmacological chaperones. Small molecules that correct protein misfolding and misprocessing defects offer a potential therapy for numerous human diseases. However, mechanisms underlying pharmacological correction of such defects, especially in heteromeric complexes with structurally diverse constituent proteins, are not well understood. Here we investigate how two chemically distinct compounds, glibenclamide and carbamazepine, correct biogenesis defects in ATP-sensitive potassium (K-ATP) channels composed of sulfonylurea receptor 1 (SUR1) and Kir6.2. We present evidence that despite structural differences, carbamazepine and glibenclamide compete for binding to K-ATP channels, and both drugs share a binding pocket in SUR1 to exert their effects. Moreover, both compounds engage Kir6.2, in particular the distal N terminus of Kir6.2, which is involved in normal channel biogenesis, for their chaperoning effects on SUR1 mutants. Conversely, both drugs can correct channel biogenesis defects caused by Kir6.2 mutations in a SUR1-dependent manner. Using an unnatural, photocross-linkable amino acid, azidophenylalanine, genetically encoded in Kir6.2, we demonstrate in living cells that both drugs promote interactions between the distal N terminus of Kir6.2 and SUR1. These findings reveal a converging pharmacological chaperoning mechanism wherein glibenclamide and carbamazepine stabilize the heteromeric subunit interface critical for channel biogenesis to overcome defective biogenesis caused by mutations in individual subunits.	[Devaraneni, Prasanna K.; Martin, Gregory M.; Olson, Erik M.; Zhou, Qing; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Devaraneni, PK (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	devarane@ohsu.edu; shyngs@ohsu.edu			National Institutes of Health [DK57699, DK066485, T32 DK007680]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007680, R01DK066485, R01DK057699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57699 (to S.-L. S.), DK066485 (S.-L. S.), and T32 DK007680 (to G. M. M.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Bessadok A, 2011, J BIOL CHEM, V286, P3552, DOI 10.1074/jbc.M110.155200; Bruederle CE, 2011, TRAFFIC, V12, P1242, DOI 10.1111/j.1600-0854.2011.01227.x; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Carlile GW, 2007, CHEMBIOCHEM, V8, P1012, DOI 10.1002/cbic.200700027; Cartier EA, 2003, J BIOL CHEM, V278, P7081, DOI 10.1074/jbc.M211395200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chen PC, 2013, J BIOL CHEM, V288, P34098, DOI 10.1074/jbc.M113.516880; Chen PC, 2013, J BIOL CHEM, V288, P20942, DOI 10.1074/jbc.M113.470948; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Conti LR, 2001, J BIOL CHEM, V276, P41270, DOI 10.1074/jbc.M106555200; Crane A, 2004, J BIOL CHEM, V279, P9080, DOI 10.1074/jbc.M311079200; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gopalakrishnan M, 2000, BRIT J PHARMACOL, V129, P1323, DOI 10.1038/sj.bjp.0703181; Grell W, 1998, J MED CHEM, V41, P5219, DOI 10.1021/jm9810349; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Grunbeck A, 2013, METHOD ENZYMOL, V520, P307, DOI 10.1016/B978-0-12-391861-1.00014-9; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; Hambrock A, 2002, BRIT J PHARMACOL, V136, P995, DOI 10.1038/sj.bjp.0704801; Hambrock A, 2001, MOL PHARMACOL, V60, P190, DOI 10.1124/mol.60.1.190; Hanrahan JW, 2013, TRENDS PHARMACOL SCI, V34, P119, DOI 10.1016/j.tips.2012.11.006; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hu SL, 2000, J PHARMACOL EXP THER, V293, P444; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; Kobayashi H, 2009, TRAFFIC, V10, P1019, DOI 10.1111/j.1600-0854.2009.00932.x; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; Kuhner P, 2012, N-S ARCH PHARMACOL, V385, P299, DOI 10.1007/s00210-011-0709-8; Lavoie H, 2013, NAT CHEM BIOL, V9, P428, DOI [10.1038/NCHEMBIO.1257, 10.1038/nchembio.1257]; Li LX, 2013, CURR ALZHEIMER RES, V10, P433, DOI 10.2174/1567205011310040008; Lin CW, 2006, DIABETES, V55, P1738, DOI 10.2337/db05-1571; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063758; Martin GM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00386; Mecozzi VJ, 2014, NAT CHEM BIOL, V10, P443, DOI [10.1038/NCHEMBIO.1508, 10.1038/nchembio.1508]; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nichols CG, 2013, CIRC RES, V112, P1059, DOI 10.1161/CIRCRESAHA.112.300514; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Pratt EB, 2012, J GEN PHYSIOL, V140, P175, DOI 10.1085/jgp.201210803; Proks P, 2007, HUM MOL GENET, V16, P2011, DOI 10.1093/hmg/ddm149; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Ringe Dagmar, 2009, J Biol, V8, P80, DOI 10.1186/jbiol186; Sampson HM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-11; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Snider KE, 2013, J CLIN ENDOCR METAB, V98, pE355, DOI 10.1210/jc.2012-2169; Srinivasan R, 2014, PHARMACOL RES, V83, P20, DOI 10.1016/j.phrs.2014.02.005; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Vila-Carriles WH, 2007, FASEB J, V21, P18, DOI 10.1096/fj.06-6730hyp; Winkler M, 2012, N-S ARCH PHARMACOL, V385, P287, DOI 10.1007/s00210-011-0708-9; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Yu W, 2011, J BIOL CHEM, V286, P24714, DOI 10.1074/jbc.M111.239699; Yuriev E, 2004, EUR J MED CHEM, V39, P835, DOI 10.1016/j.ejmech.2004.06.004; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou Q, 2014, CHANNELS, V8, P376, DOI 10.4161/chan.29117; Zhou Q, 2013, CHANNELS, V7, P313, DOI 10.4161/chan.25003; Zhou Q, 2010, J CLIN ENDOCR METAB, V95, pE473, DOI 10.1210/jc.2010-1231; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	70	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7980	7991		10.1074/jbc.M114.634576	http://dx.doi.org/10.1074/jbc.M114.634576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25637631	Green Published, hybrid			2022-12-26	WOS:000351613600055
J	Wang, WS; Han, WJ; Cai, XY; Zheng, XY; Sugahara, K; Li, FC				Wang, Wenshuang; Han, Wenjun; Cai, Xingya; Zheng, Xiaoyu; Sugahara, Kazuyuki; Li, Fuchuan			Cloning and Characterization of a Novel Chondroitin Sulfate/Dermatan Sulfate 4-O-Endosulfatase from a Marine Bacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin Sulfate; Dermatan Sulfate; Glycosaminoglycan; Oligosaccharide; Polysaccharide; Endosulfatase; Marine Bacterium; Sulfated Polysaccharide	SIMPLEX-VIRUS INFECTIVITY; DERMATAN SULFATE; NEURITE OUTGROWTH; GLUCURONIC-ACID; GROWTH-FACTORS; HYBRID CHAINS; GLYCOSAMINOGLYCANS; BINDING; BIOSYNTHESIS; EXPRESSION	Background: To date, few glycosaminoglycan (GAG) endosulfatases have been identified. Results: A novel chondroitin sulfate/dermatan sulfate (CS/DS) endosulfatase was identified for the first time from a marine bacterium. Conclusion: The endosulfatase has low homology to the conventional GAG sulfatases and can specifically remove 4-O-sulfate from CS/DS chains. Significance: The endosulfatase will be a useful tool for CS/DS-related research and applications. Sulfatases are potentially useful tools for structure-function studies of glycosaminoglycans (GAGs). To date, various GAG exosulfatases have been identified in eukaryotes and prokaryotes. However, endosulfatases that act on GAGs have rarely been reported. Recently, a novel HA and CS lyase (HCLase) was identified for the first time from a marine bacterium (Han, W., Wang, W., Zhao, M., Sugahara, K., and Li, F. (2014) J. Biol. Chem. 289, 27886-27898). In this study, a putative sulfatase gene, closely linked to the hclase gene in the genome, was recombinantly expressed and characterized in detail. The recombinant protein showed a specific N-acetylgalactosamine-4-O-sulfatase activity that removes 4-O-sulfate from both disaccharides and polysaccharides of chondroitin sulfate (CS)/dermatan sulfate (DS), suggesting that this sulfatase represents a novel endosulfatase. The novel endosulfatase exhibited maximal reaction rate in a phosphate buffer (pH 8.0) at 30 degrees C and effectively removed 17-65% of 4-O-sulfates from various CS and DS and thus significantly inhibited the interactions of CS and DS with a positively supercharged fluorescent protein. Moreover, this endosulfatase significantly promoted the digestion of CS by HCLase, suggesting that it enhances the digestion of CS/DS by the bacterium. Therefore, this endosulfatase is a potential tool for use in CS/DS-related studies and applications.	[Wang, Wenshuang; Han, Wenjun; Cai, Xingya; Zheng, Xiaoyu; Li, Fuchuan] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Wang, Wenshuang; Han, Wenjun; Cai, Xingya; Zheng, Xiaoyu; Li, Fuchuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Proteoglycan Signaling & Therapeut Res Grp, Fac Adv Life Sci, Sapporo, Hokkaido 0070021, Japan	Shandong University; Shandong University; Hokkaido University	Li, FC (corresponding author), Shandong Univ, Natl Glycoengn Res Ctr, 27 South Shanda Rd, Jinan 250100, Peoples R China.	fuchuanli@sdu.edu.cn			Major State Basic Research Development Program of China [2012CB822102]; National High Technology Research and Development Program of China [2012AA021504]; Shandong Province Science and Technology Development Plan [2013GSF12106]; National Natural Science Foundation of China [31300664]; Japan Society for the Promotion of Science [25670018]	Major State Basic Research Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shandong Province Science and Technology Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Major State Basic Research Development Program of China Grant 2012CB822102, National High Technology Research and Development Program of China Grant 2012AA021504, Shandong Province Science and Technology Development Plan Grant 2013GSF12106, and National Natural Science Foundation of China Grant 31300664. This study was also supported in part by Grant-in-aid for Challenging Exploratory Research 25670018 from the Japan Society for the Promotion of Science.	Bergefall K, 2005, J BIOL CHEM, V280, P32193, DOI 10.1074/jbc.M503645200; BIELICKI J, 1995, BIOCHEM J, V311, P333, DOI 10.1042/bj3110333; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BRAMHALL S, 1969, ANAL BIOCHEM, V31, P146, DOI 10.1016/0003-2697(69)90251-6; CHENG F, 1994, GLYCOBIOLOGY, V4, P685, DOI 10.1093/glycob/4.5.685; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Han WJ, 2014, J BIOL CHEM, V289, P27886, DOI 10.1074/jbc.M114.590752; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; LAFONT F, 1992, DEVELOPMENT, V114, P17; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Li FC, 2008, GLYCOCONJUGATE J, V25, P603, DOI 10.1007/s10719-008-9124-x; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Maeda N, 2006, J BIOL CHEM, V281, P4894, DOI 10.1074/jbc.M507750200; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Mizumoto S, 2012, J BIOL CHEM, V287, P18985, DOI 10.1074/jbc.M111.313437; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Narita K, 2007, J BIOL CHEM, V282, P14413, DOI 10.1074/jbc.M611395200; SAITO H, 1968, J BIOL CHEM, V243, P1536; Sambrook J, 2001, MOL CLONING LAB MANU; Seffouh A, 2013, FASEB J, V27, P2431, DOI 10.1096/fj.12-226373; SHAKLEE PN, 1985, J BIOL CHEM, V260, P9146; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 1996, EUR J BIOCHEM, V239, P865, DOI 10.1111/j.1432-1033.1996.0865u.x; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; Ulmer JE, 2014, J BIOL CHEM, V289, P24289, DOI 10.1074/jbc.M114.573303; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Williams RK, 1997, J VIROL, V71, P1375, DOI 10.1128/JVI.71.2.1375-1380.1997; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523	43	17	17	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7823	7832		10.1074/jbc.M114.629154	http://dx.doi.org/10.1074/jbc.M114.629154			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648894	Green Published, hybrid			2022-12-26	WOS:000351613600040
J	Nowak, G; Bakajsova, D				Nowak, Grazyna; Bakajsova, Diana			Protein Kinase C-alpha Interaction with F0F1-ATPase Promotes F0F1-ATPase Activity and Reduces Energy Deficits in Injured Renal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ATP SYNTHASE; OXIDATIVE-PHOSPHORYLATION; FOCUSED PROTEOMICS; NA+ TRANSPORT; DELTA-SUBUNIT; BETA-SUBUNIT; F1F0 ATPASE; ACTIVATION; ACID; METABOLISM	We showed previously that active PKC-alpha maintains F0F1-ATPase activity, whereas inactive PKC-alpha mutant (dnPKC-alpha) blocks recovery of F0F1-ATPase activity after injury in renal proximal tubules (RPTC). This study tested whether mitochondrial PKC-alpha interacts with and phosphorylates F0F1-ATPase. Wild-type PKC-alpha (wtPKC-alpha) and dnPKC-alpha were overexpressed in RPTC to increase their mitochondrial levels, and RPTC were exposed to oxidant or hypoxia. Mitochondrial levels of the gamma-subunit, but not the alpha- and beta-subunits, were decreased by injury, an event associated with 54% inhibition of F0F1-ATPase activity. Overexpressing wtPKC-alpha blocked decreases in gamma-subunit levels, maintained F0F1-ATPase activity, and improved ATP levels after injury. Deletion of PKC-alpha decreased levels of alpha-, beta-, and gamma-subunits, decreased F0F1-ATPase activity, and hindered the recovery of ATP content after RPTC injury. Mitochondrial PKC-alpha co-immunoprecipitated with alpha-, beta-, and gamma-subunits of F0F1-ATPase. The association of PKC-alpha with these subunits decreased in injured RPTC overexpressing dnPKC-alpha. Immunocapture of F0F1-ATPase and immunoblotting with phospho(Ser) PKC substrate antibody identified phosphorylation of serine in the PKC consensus site on the alpha- or beta- and gamma-subunits. Overexpressing wtPKC-alpha increased phosphorylation and protein levels, whereas deletion of PKC-alpha decreased protein levels of alpha-, beta-, and gamma-subunits of F0F1-ATPase in RpTc. Phosphoproteomics revealed phosphorylation of Ser(146) on the gamma subunit in response to wtPKC-alpha overexpression. We concluded that active PKC-alpha 1) prevents injury-induced decreases in levels of gamma subunit of F0F1-ATPase, 2) interacts with alpha-, beta-, and gamma-subunits leading to increases in their phosphorylation, and 3) promotes the recovery of F0F1-ATPase activity and ATP content after injury in RPTC.	[Nowak, Grazyna; Bakajsova, Diana] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Coll Pharm, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Nowak, G (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, 4301 West Markham St, Little Rock, AR 72205 USA.	gnowak@uams.edu			National Institutes of Health [R01 DK059558, UL1 RR029884]; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK059558 (to G. N.) and UL1 RR029884, from the National Center for Research Resources, which provided partial funding for the Proteomic Core Facility at the University of Arkansas for Medical Sciences Translational Research Institute.	Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Andrew CD, 2002, BIOCHEMISTRY-US, V41, P1897, DOI 10.1021/bi0113216; Arrell DK, 2006, CIRC RES, V99, P706, DOI 10.1161/01.RES.0000243995.74395.f8; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Boja ES, 2009, J PROTEOME RES, V8, P4665, DOI 10.1021/pr900387b; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Covian R, 2012, AM J PHYSIOL-HEART C, V303, pH940, DOI 10.1152/ajpheart.00077.2012; Di Pancrazio F, 2006, PROTEOMICS, V6, P921, DOI 10.1002/pmic.200500077; Fujisawa Y, 2009, BIOCHEM J, V423, P219, DOI 10.1042/BJ20090594; Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Kane L, 2006, PROTEOMICS, V6, P5683, DOI 10.1002/pmic.200600267; Kane LA, 2010, CIRC RES, V106, P504, DOI 10.1161/CIRCRESAHA.109.214155; Ko YH, 2002, MITOCHONDRION, V1, P339, DOI 10.1016/S1567-7249(01)00036-8; Kowalczyk JE, 2012, MITOCHONDRION, V12, P138, DOI 10.1016/j.mito.2011.06.002; Law RHP, 1995, METHOD ENZYMOL, V260, P133, DOI 10.1016/0076-6879(95)60135-X; Liu XL, 2004, AM J PHYSIOL-RENAL, V287, pF64, DOI 10.1152/ajprenal.00216.2003; Murray J, 2004, BBA-BIOENERGETICS, V1659, P206, DOI 10.1016/j.bbabio.2004.07.005; Murray J, 2004, ELECTROPHORESIS, V25, P2520, DOI 10.1002/elps.200406006; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; Nowak G, 2004, TOXICOL LETT, V147, P161, DOI 10.1016/j.toxlet.2003.11.002; Nowak G, 2003, AM J PHYSIOL-RENAL, V285, pF440, DOI 10.1152/ajprenal.00233.2002; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; NOWAK G, 1995, AM J PHYSIOL-CELL PH, V268, pC1053, DOI 10.1152/ajpcell.1995.268.4.C1053; Nowak G, 1996, AM J PHYSIOL-CELL PH, V271, pC2072, DOI 10.1152/ajpcell.1996.271.6.C2072; Nowak G, 2006, AM J PHYSIOL-RENAL, V291, pF840, DOI 10.1152/ajprenal.00219.2005; Nowak G, 2013, AM J PHYSIOL-RENAL, V305, pF764, DOI 10.1152/ajprenal.00061.2013; Nowak G, 2012, AM J PHYSIOL-RENAL, V303, pF515, DOI 10.1152/ajprenal.00072.2012; Phillips D, 2011, BIOCHEMISTRY-US, V50, P2515, DOI 10.1021/bi101434x; Porter MJ, 2003, AM J PHYSIOL-CELL PH, V285, pC39, DOI 10.1152/ajpcell.00461.2002; Saraswathy S, 2011, MOL VIS, V17, P1814; Shaik ZP, 2007, AM J PHYSIOL-RENAL, V292, pF292, DOI 10.1152/ajprenal.00082.2006; Signorile A, 2014, BBA-MOL CELL RES, V1843, P675, DOI 10.1016/j.bbamcr.2013.12.017; Sugawara K, 2013, FEBS LETT, V587, P3843, DOI 10.1016/j.febslet.2013.10.012; Wang SB, 2011, CIRC RES, V109, P750, DOI 10.1161/CIRCRESAHA.111.246124; Yang LF, 2010, BIOCHEM BIOPH RES CO, V400, P16, DOI 10.1016/j.bbrc.2010.07.126; Yarian CS, 2005, BIOCHEM BIOPH RES CO, V330, P151, DOI 10.1016/j.bbrc.2005.02.135; ZHANG FX, 1995, J NEUROCHEM, V65, P2812	41	11	11	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7054	7066		10.1074/jbc.M114.588244	http://dx.doi.org/10.1074/jbc.M114.588244			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627689	Green Published, hybrid			2022-12-26	WOS:000350991500038
J	Pinhasi, R; Eshed, V; von Cramon-Taubadel, N				Pinhasi, Ron; Eshed, Vered; von Cramon-Taubadel, Noreen			Incongruity between Affinity Patterns Based on Mandibular and Lower Dental Dimensions following the Transition to Agriculture in the Near East, Anatolia and Europe	PLOS ONE			English	Article							HUNTER-GATHERER SUBSISTENCE; OCCLUSAL VARIATION; TOOTH WEAR; MALOCCLUSION; CULTURE; LEVANT; SIZE	While it has been suggested that malocclusion is linked with urbanisation, it remains unclear as to whether its high prevalence began 8,000 years earlier concomitant with the transition to agriculture. Here we investigate the extent to which patterns of affinity (i.e., among-population distances), based on mandibular form and dental dimensions, respectively, match across Epipalaeolithic, Mesolithic, and Neolithic samples from the Near East/Anatolia and Europe. Analyses were conducted using morphological distance matrices reflecting dental and mandibular form for the same 292 individuals across 21 archaeological populations. Thereafter, statistical analyses were undertaken on four sample aggregates defined on the basis of their subsistence strategy, geography, and chronology to test for potential differences in dental and mandibular form across and within groups. Results show a clear separation based on mandibular morphology between European hunter-gatherers, European farmers, and Near Eastern transitional farmers and semi-sedentary hunter-gatherers. In contrast, the dental dimensions show no such pattern and no clear association between the position of samples and their temporal or geographic attributes. Although later farming groups have, on average, smaller teeth and mandibles, shape analyses show that the mandibles of farmers are not simply size-reduced versions of earlier hunter-gatherer mandibles. Instead, it appears that mandibular form underwent a complex series of shape changes commensurate with the transition to agriculture that are not reflected in affinity patterns based on dental dimensions. In the case of hunter-gatherers there is a correlation between inter-individual mandibular and dental distances, suggesting an equilibrium between these two closely associated morphological units. However, in the case of semi-sedentary hunter-gatherers and farming groups, no such correlation was found, suggesting that the incongruity between dental and mandibular form began with the shift towards sedentism and agricultural subsistence practices in the core region of the Near East and Anatolia.	[Pinhasi, Ron] Univ Coll Dublin, Earth Inst, Dublin 2, Ireland; [Pinhasi, Ron] Univ Coll Dublin, Sch Archaeol, Dublin 2, Ireland; [Eshed, Vered] Israel Antiqu Author, Jerusalem, Israel; [von Cramon-Taubadel, Noreen] SUNY Buffalo, Dept Anthropol, Buffalo, NY 14260 USA	University College Dublin; University College Dublin; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Pinhasi, R (corresponding author), Univ Coll Dublin, Earth Inst, Dublin 2, Ireland.	ron.pinhasi@ucd.ie	Pinhasi, Ron/AAT-1531-2020	Pinhasi, Ron/0000-0003-1629-8131	European Research Council Starting Grant [ERC-2010-StG 263441]	European Research Council Starting Grant(European Research Council (ERC))	This research was supported by the European Research Council Starting Grant (ERC-2010-StG 263441). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel J. L., 1944, HUMAN BIOL, V16, P283; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; BarYosef O, 1995, SCH AM RES, V354, P39; BEECHER RM, 1981, ANGLE ORTHOD, V51, P61; Bilimoria KF, 1963, J ALL INDIA DENT ASS, V36, P293; BISHARA SE, 1994, ANGLE ORTHOD, V64, P89; Blockley SPE, 2011, QUATERNARY SCI REV, V30, P98, DOI 10.1016/j.quascirev.2010.09.021; Brauer G., 1988, HDB VERGLEICHENDEN B, V1, P160; Christensen AF, 1998, J HUM EVOL, V34, P333, DOI 10.1006/jhev.1997.0194; Clinch L, 1951, T EUR ORTHOD SOC, P80; Corruccini R.S, 1999, ANTHR INFORMS ORTHOD; CORRUCCINI RS, 1989, ARCH ORAL BIOL, V34, P839, DOI 10.1016/0003-9969(89)90037-X; CORRUCCINI RS, 1990, AM J PHYS ANTHROPOL, V82, P257, DOI 10.1002/ajpa.1330820304; CORRUCCINI RS, 1982, SCIENCE, V218, P74, DOI 10.1126/science.7123221; CORRUCCINI RS, 1981, AM J ORTHOD DENTOFAC, V79, P250, DOI 10.1016/0002-9416(81)90073-7; CORRUCCINI RS, 1984, AM J ORTHOD DENTOFAC, V86, P419, DOI 10.1016/S0002-9416(84)90035-6; Davies DM, 1972, INFLUENCE TEETH DIET; DAVIES G. N., 1956, JOUR DENTAL RES, V35, P115, DOI 10.1177/00220345560350010401; Eshed V, 2006, AM J PHYS ANTHROPOL, V130, P145, DOI 10.1002/ajpa.20362; FALSETTI AB, 1993, INT J PRIMATOL, V14, P551, DOI 10.1007/BF02215447; Frayer DW, 1984, ORIGINS MODERN HUMAN, P211; Goring-Morris AN, 2011, CURR ANTHROPOL, V52, pS195, DOI 10.1086/658860; Goring-Morris N., 2010, EARLY VILLAGE SOC GL, P62; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harpending H.C., 1982, BIOCH ASPECTS EVOLUT, P213; Holmes MA, 2011, AM J PHYS ANTHROPOL, V145, P615, DOI 10.1002/ajpa.21554; HUNT EE, 1961, AM J ORTHOD DENTOFAC, V47, P406, DOI 10.1016/0002-9416(61)90220-2; INOUE N, 1984, J ANTHROPOL SOC NIP, V92, P13; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kaifu Y, 2003, YEARB PHYS ANTHROPOL, V46, P47, DOI 10.1002/ajpa.10329; Kuijt I, 1994, J MEDITERR ARCHAEOL, V7, P41; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; LARSEN CS, 1997, BIOARCHAEOLOGY; LAVELLE CLB, 1973, ANGLE ORTHOD, V43, P412; Lieberman DE, 2004, J HUM EVOL, V46, P655, DOI 10.1016/j.jhevol.2004.03.005; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; LOMBARDI AV, 1982, AM J ORTHOD DENTOFAC, V81, P38, DOI 10.1016/0002-9416(82)90286-X; MANTEL N, 1967, CANCER RES, V27, P209; MARTIN R, 1957, LEHRBUCH ANTHR SYSTE, V1; MOHLIN B, 1978, Ossa, V5, P57; MOLNAR S, 1972, CURR ANTHROPOL, V13, P511, DOI 10.1086/201284; MOORREES COENRAAD F. A., 1957, JOUR DENTAL RES, V36, P39, DOI 10.1177/00220345570360011501; Mossey P A, 1999, Br J Orthod, V26, P103; Newman MT, 1942, BUR AM ETHNOL BULL, P393; NISWANDER JD, 1967, AM J HUM GENET, V19, P543; Pinhasi R, 2008, AM J PHYS ANTHROPOL, V135, P136, DOI 10.1002/ajpa.20715; Pinhasi R, 2011, HUMAN BIOARCHAEOLOGY OF THE TRANSITION TO AGRICULTURE, P451; PRICE W. A., 1936, Journal of the American Dental Association, V23, P417; PRICE W. A., 1935, Dental Cosmos, V77, P1033; Proffit W R, 1998, Int J Adult Orthodon Orthognath Surg, V13, P97; RELETHFORD JH, 1990, HUM BIOL, V62, P5; Rose JC, 1998, DENTAL ANTHROPOLOGY, P349; Rose Jerome C, 2009, Compend Contin Educ Dent, V30, P292; Sarig R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080771; SHARMA K, 1986, EUR J ORTHODONT, V8, P91, DOI 10.1093/ejo/8.2.91; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Stahl AB., 1989, FORAGING FARMING EVO, P171; Varrela J, 2006, SEMIN ORTHOD, V12, P102; von Cramon-Taubadel N, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1337; von Cramon-Taubadel N, 2011, P NATL ACAD SCI USA, V108, P19546, DOI 10.1073/pnas.1113050108; Williams C, 1943, J PERIODONTOL, V14, P34; WOLPOFF MH, 1971, METRIC TRENDS HOMINI; WOOD BF, 1971, AMER J ORTHODONTICS, V60, P344, DOI 10.1016/0002-9416(71)90147-3; WRIGHT KI, 1994, AM ANTIQUITY, V59, P238, DOI 10.2307/281929	64	61	62	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0117301	10.1371/journal.pone.0117301	http://dx.doi.org/10.1371/journal.pone.0117301			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651540	gold, Green Published			2022-12-26	WOS:000349250700012
J	Pereira, IVA; Buchmann, B; Sandmann, L; Sprinzl, K; Schlaphoff, V; Dohner, K; Vondran, F; Sarrazin, C; Manns, MP; de Oliveira, CPMS; Sodeik, B; Ciesek, S; von Hahn, T				Alves Pereira, Isabel Veloso; Buchmann, Bettina; Sandmann, Lisa; Sprinzl, Kathrin; Schlaphoff, Verena; Doehner, Katinka; Vondran, Florian; Sarrazin, Christoph; Manns, Michael P.; Marques Souza de Oliveira, Claudia Pinto; Sodeik, Beate; Ciesek, Sandra; von Hahn, Thomas			Primary Biliary Acids Inhibit Hepatitis D Virus (HDV) Entry into Human Hepatoma Cells Expressing the Sodium-Taurocholate Cotransporting Polypeptide (NTCP)	PLOS ONE			English	Article							SERUM BILE-ACIDS; CHENODEOXYCHOLIC ACID; DELTA VIRUS; INTRAHEPATIC CHOLESTASIS; URSODEOXYCHOLIC ACID; CYCLOSPORINE-A; HEPATOCYTES; INFECTION; THERAPY; CHOLESTEROL	Background The sodium-taurocholate cotransporting polypeptide (NTCP) is both a key bile acid (BA) transporter mediating uptake of BA into hepatocytes and an essential receptor for hepatitis B virus (HBV) and hepatitis D virus (HDV). In this study we aimed to characterize to what extent and through what mechanism BA affect HDV cell entry. Methods HuH-7 cells stably expressing NTCP (HuH-7/NTCP) and primary human hepatocytes (PHH) were infected with in vitro generated HDV particles. Infectivity in the absence or presence of compounds was assessed using immunofluorescence staining for HDV antigen, standard 50% tissue culture infectious dose (TCID50) assays and quantitative PCR. Results Addition of primary conjugated and unconjugated BA resulted in a dose dependent reduction in the number of infected cells while secondary, tertiary and synthetic BA had a lesser effect. This effect was observed both in HuH-7/NTCP and in PHH. Other replication cycle steps such as replication and particle assembly and release were unaffected. Moreover, inhibitory BA competed with a fragment from the large HBV envelope protein for binding to NTCP-expressing cells. Conversely, the sodium/BA-cotransporter function of NTCP seemed not to be required for HDV infection since infection was similar in the presence or absence of a sodium gradient across the plasma membrane. When chenodeoxycolic acid (15 mg per kg body weight) was administered to three chronically HDV infected individuals over a period of up to 16 days there was no change in serum HDV RNA. Conclusions Primary BA inhibit NTCP-mediated HDV entry into hepatocytes suggesting that modulation of the BA pool may affect HDV infection of hepatocytes.	[Alves Pereira, Isabel Veloso; Buchmann, Bettina; von Hahn, Thomas] Hannover Med Sch, Inst Mol Biol, Hannover, Germany; [Alves Pereira, Isabel Veloso; Marques Souza de Oliveira, Claudia Pinto] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Clin Div,Hepatol Branch,LIM 07, Sao Paulo, Brazil; [Alves Pereira, Isabel Veloso; Sandmann, Lisa; Schlaphoff, Verena; Manns, Michael P.; Ciesek, Sandra; von Hahn, Thomas] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany; [Sprinzl, Kathrin; Sarrazin, Christoph] Univ Frankfurt Klinikum, Med Klin 1, Frankfurt, Germany; [Doehner, Katinka; Sodeik, Beate] Hannover Med Sch, Inst Virol, Hannover, Germany; [Vondran, Florian] Hannover Med Sch, Klin Allgemein Viszeral & Transplantationschirurg, Hannover, Germany	Hannover Medical School; Universidade de Sao Paulo; Hannover Medical School; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hannover Medical School; Hannover Medical School	Ciesek, S (corresponding author), Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, Hannover, Germany.	Ciesek.sandra@mh-hannover.de; vonhahn.thomas@mh-hannover.de	Ciesek, Sandra/AAO-4719-2020; Oliveira, Claudia PMS/D-1216-2014; Sandmann, Lisa/ABD-1803-2020; Veloso Alves Pereira, Isabel/N-4616-2014	Ciesek, Sandra/0000-0002-1802-7565; Veloso Alves Pereira, Isabel/0000-0002-3439-1658; Sodeik, Beate/0000-0003-4650-3036	Deutsche Forschungsgemeinschaft through collaborative research center [900]; 'Emmy Noether' grant [HA4394/2-1]; Brazilian research-funding agency CNPq; 'Ciencias sem Fronteiras' program	Deutsche Forschungsgemeinschaft through collaborative research center; 'Emmy Noether' grant(German Research Foundation (DFG)); Brazilian research-funding agency CNPq; 'Ciencias sem Fronteiras' program	This work was supported by Deutsche Forschungsgemeinschaft through collaborative research center 900 (Chronic infections) to BS, SC and TVH and an 'Emmy Noether' grant (HA4394/2-1) to TVH. IVAP was the recipient of a doctoral grant from Brazilian research-funding agency CNPq and the 'Ciencias sem Fronteiras' program to IVAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros-Rudolph CM, 2007, ARCH DERMATOL, V143, P757, DOI 10.1001/archderm.143.6.757; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; Chen W, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003181.pub2; DANZINGER RG, 1972, NEW ENGL J MED, V286, P1, DOI 10.1056/NEJM197201062860101; Gehring G, 2014, J ANTIMICROB CHEMOTH, V69, P2123, DOI 10.1093/jac/dku091; Heidrich B, 2014, HEPATOLOGY, V60, P87, DOI 10.1002/hep.27102; Heidrich B, 2013, CURR INFECT DIS REP, V15, P31, DOI 10.1007/s11908-012-0307-z; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Jansen P.L.M., 2012, ZAKIM BOYERS HEPATOL, P47; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Konig A, 2014, J HEPATOL, V61, P867, DOI 10.1016/j.jhep.2014.05.018; KullakUblick GA, 1997, GASTROENTEROLOGY, V113, P1295, DOI 10.1053/gast.1997.v113.pm9322525; KUO MYP, 1989, J VIROL, V63, P1945, DOI 10.1128/JVI.63.5.1945-1950.1989; Mederacke I, 2010, J CLIN MICROBIOL, V48, P2022, DOI 10.1128/JCM.00084-10; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; NEALE G, 1971, GUT, V12, P145, DOI 10.1136/gut.12.2.145; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Schukfeh N, 2012, J PEDIATR SURG, V47, P501, DOI 10.1016/j.jpedsurg.2011.08.010; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Sulkowski MS, 2014, J INFECT DIS, V209, P658, DOI 10.1093/infdis/jit503; Sureau C, 2010, METHODS MOL BIOL, V640, P463, DOI 10.1007/978-1-60761-688-7_25; THISTLE JL, 1973, NEW ENGL J MED, V289, P655, DOI 10.1056/NEJM197309272891303; TINT GS, 1986, GASTROENTEROLOGY, V91, P1007, DOI 10.1016/0016-5085(86)90708-0; Triolo M, 2014, LIVER INT, V34, P139, DOI 10.1111/liv.12394; von Hahn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024142; Watashi K, 2014, HEPATOLOGY, V59, P1726, DOI 10.1002/hep.26982; Wedemeyer H, 2011, NEW ENGL J MED, V364, P322, DOI 10.1056/NEJMoa0912696; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	32	20	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117152	10.1371/journal.pone.0117152	http://dx.doi.org/10.1371/journal.pone.0117152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646622	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600058
J	Coley, JS; Calderon, TM; Gaskill, PJ; Eugenin, EA; Berman, JW				Coley, Jacqueline S.; Calderon, Tina M.; Gaskill, Peter J.; Eugenin, Eliseo A.; Berman, Joan W.			Dopamine Increases CD14(+)CD16(+) Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; IMMUNODEFICIENCY-VIRUS-INFECTION; CENTRAL-NERVOUS-SYSTEM; CHRONIC HEPATITIS-C; FREELY MOVING RATS; NUCLEUS-ACCUMBENS; NEUROCOGNITIVE DISORDERS; PERIVASCULAR MACROPHAGES; EXTRACELLULAR DOPAMINE; ANTIRETROVIRAL THERAPY	Drug abuse is a major comorbidity of HIV infection and cognitive disorders are often more severe in the drug abusing HIV infected population. CD14(+)CD16(+) monocytes, a mature subpopulation of peripheral blood monocytes, are key mediators of HIV neuropathogenesis. Infected CD14(+)CD16(+) monocyte transmigration across the blood brain barrier mediates HIV entry into the brain and establishes a viral reservoir within the CNS. Despite successful antiretroviral therapy, continued influx of CD14(+)CD16(+) monocytes, both infected and uninfected, contributes to chronic neuroinflammation and the development of HIV associated neurocognitive disorders (HAND). Drug abuse increases extracellular dopamine in the CNS. Once in the brain, CD14(+)CD16(+) monocytes can be exposed to extracellular dopamine due to drug abuse. The direct effects of dopamine on CD14(+)CD16(+) monocytes and their contribution to HIV neuropathogenesis are not known. In this study, we showed that CD14(+)CD16(+) monocytes express mRNA for all five dopamine receptors by qRT-PCR and D1R, D5R and D4R surface protein by flow cytometry. Dopamine and the D1-like dopamine receptor agonist, SKF38393, increased CD14(+)CD16(+) monocyte migration that was characterized as chemokinesis. To determine whether dopamine affected cell motility and adhesion, live cell imaging was used to monitor the accumulation of CD14(+)CD16(+) monocytes on the surface of a tissue culture dish. Dopamine increased the number and the rate at which CD14(+)CD16(+) monocytes in suspension settled to the dish surface. In a spreading assay, dopamine increased the area of CD14(+)CD16(+) monocytes during the early stages of cell adhesion. In addition, adhesion assays showed that the overall total number of adherent CD14(+)CD16(+) monocytes increased in the presence of dopamine. These data suggest that elevated extracellular dopamine in the CNS of HIV infected drug abusers contributes to HIV neuropathogenesis by increasing the accumulation of CD14(+)CD16(+) monocytes in dopamine rich brain regions.	[Coley, Jacqueline S.; Calderon, Tina M.; Gaskill, Peter J.; Berman, Joan W.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Berman, Joan W.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Eugenin, Eliseo A.] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07102 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Berman, JW (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	joan.berman@einstein.yu.edu	Gaskill, Peter Jesse/O-5096-2019	Gaskill, Peter Jesse/0000-0003-0095-5424	National Institutes of Drug Abuse [DA025567, DA029476]; National Institutes of Mental Health [MH090958, MH075679]; National Institutes of Health Centers for AIDS Research at the Albert Einstein College of Medicine [CFAR/AI-051519]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075679, R01MH096625, R01MH090958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029476, R01DA025567] Funding Source: NIH RePORTER	National Institutes of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Centers for AIDS Research at the Albert Einstein College of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Drug Abuse (http://www.drugabuse.gov/) (DA025567 to JWB and DA029476 to PJG), the National Institutes of Mental Health (http://www.nimh.nih.gov/) (MH090958 and MH075679 to JWB) and the National Institutes of Health Centers for AIDS Research (http://www.niaid.nih.gov/labsandresources/resources/cfar/Pages/default.aspx) grant (CFAR/AI-051519) at the Albert Einstein College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ancuta P, 2006, VIROLOGY, V344, P267, DOI 10.1016/j.virol.2005.10.027; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bell JE, 2002, JAIDS-J ACQ IMM DEF, V31, pS35, DOI 10.1097/00126334-200210012-00003; Beyrer C, 2010, JAIDS-J ACQ IMM DEF, V55, pS10, DOI 10.1097/QAI.0b013e3181f9c0c9; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Buckner CM, 2011, CELL IMMUNOL, V267, P109, DOI 10.1016/j.cellimm.2010.12.004; CARBONI E, 1989, NEUROSCIENCE, V28, P653, DOI 10.1016/0306-4522(89)90012-2; Chen J, 2009, EUR J NEUROSCI, V29, P287, DOI 10.1111/j.1460-9568.2008.06590.x; Cherner M, 2005, NEUROLOGY, V64, P1343, DOI 10.1212/01.WNL.0000158328.26897.0D; Cinque P, 1998, AIDS, V12, P1327, DOI 10.1097/00002030-199811000-00014; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Czub S, 2004, ACTA NEUROPATHOL, V107, P216, DOI 10.1007/s00401-003-0801-3; Czub S, 2001, ACTA NEUROPATHOL, V101, P85; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Duport S, 1998, P NATL ACAD SCI USA, V95, P1840, DOI 10.1073/pnas.95.4.1840; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Farber K, 2005, MOL CELL NEUROSCI, V29, P128, DOI 10.1016/j.mcn.2005.01.003; Fiorentini C, 2011, J NEUROCHEM, V117, P253, DOI 10.1111/j.1471-4159.2011.07196.x; Fischer-Smith T, 2004, AM J PATHOL, V164, P2089, DOI 10.1016/S0002-9440(10)63767-4; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Fischer-Smith T, 2008, J NEUROVIROL, V14, P318, DOI 10.1080/13550280802132857; Fischer-Smith T, 2008, AIDS RES HUM RETROV, V24, P417, DOI 10.1089/aid.2007.0193; Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688; GARRIS PA, 1994, J NEUROSCI, V14, P6084; Gaskill PJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-203; Gaskill PJ, 2009, AM J PATHOL, V175, P1148, DOI 10.2353/ajpath.2009.081067; GRAY F, 1992, J NEUROPATH EXP NEUR, V51, P177, DOI 10.1097/00005072-199203000-00007; Grover VPB, 2012, J VIRAL HEPATITIS, V19, pE89, DOI 10.1111/j.1365-2893.2011.01510.x; Hanami K, 2013, BONE, V56, P1, DOI 10.1016/j.bone.2013.04.019; Harezlak J, 2011, AIDS, V25, P625, DOI 10.1097/QAD.0b013e3283427da7; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hilsabeck RC, 2003, J INT NEUROPSYCH SOC, V9, P847, DOI 10.1017/S1355617703960048; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Kamat A, 2012, JAIDS-J ACQ IMM DEF, V60, P234, DOI 10.1097/QAI.0b013e318256f3bc; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; Kraft-Terry SD, 2010, NEUROBIOL DIS, V37, P542, DOI 10.1016/j.nbd.2009.12.015; Kustrimovic N, 2014, J NEUROIMMUNE PHARM, V9, P302, DOI 10.1007/s11481-014-9541-5; Langford D, 2003, JAIDS-J ACQ IMM DEF, V34, P467, DOI 10.1097/00126334-200312150-00004; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Meade CS, 2011, J BEHAV MED, V34, P128, DOI 10.1007/s10865-010-9293-5; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V98, P369, DOI 10.1111/j.1365-2249.1994.tb05499.x; Ortega E, 2000, MOL CELL BIOCHEM, V203, P113, DOI 10.1023/A:1007094614047; PARSONS LH, 1992, J NEUROCHEM, V58, P212, DOI 10.1111/j.1471-4159.1992.tb09298.x; PELUSO R, 1985, VIROLOGY, V147, P231, DOI 10.1016/0042-6822(85)90246-6; Peng H, 2006, GLIA, V54, P619, DOI 10.1002/glia.20409; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Pulliam L, 1997, LANCET, V349, P692, DOI 10.1016/S0140-6736(96)10178-1; Rodriguez-Munoz Y, 2011, ALIMENT PHARM THER, V34, P960, DOI 10.1111/j.1365-2036.2011.04807.x; Shiramizu B, 2007, J NEUROPSYCH CLIN N, V19, P157, DOI 10.1176/appi.neuropsych.19.2.157; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Straub RH, 2000, J LEUKOCYTE BIOL, V67, P553, DOI 10.1002/jlb.67.4.553; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Valcour VG, 2010, J LEUKOCYTE BIOL, V87, P621, DOI 10.1189/jlb.0809571; Watanabe Y, 2006, J IMMUNOL, V176, P848, DOI 10.4049/jimmunol.176.2.848; Weber E, 2013, J NEUROVIROL, V19, P65, DOI 10.1007/s13365-012-0141-y; Weiss JM, 1998, J IMMUNOL, V161, P6896; Weissenborn K, 2004, J HEPATOL, V41, P845, DOI 10.1016/j.jhep.2004.07.022; Wilkinson J, 2010, GUT, V59, P1394, DOI 10.1136/gut.2009.199356; Williams DW, 2014, CURR HIV RES, V12, P85, DOI 10.2174/1570162X12666140526114526; Williams DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069270; Williams KC, 2001, J EXP MED, V193, P905, DOI 10.1084/jem.193.8.905; Wu DT, 2000, J NEUROVIROL, V6, pS82; Xi ZX, 2009, NEUROSCIENCE, V161, P392, DOI 10.1016/j.neuroscience.2009.03.060; Zachek MK, 2010, BIOSENS BIOELECTRON, V25, P1179, DOI 10.1016/j.bios.2009.10.008; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902	79	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117450	10.1371/journal.pone.0117450	http://dx.doi.org/10.1371/journal.pone.0117450			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647501	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600069
J	Hoencamp, R; Idenburg, FJ; van Dongen, TTCF; de Kruijff, LGM; Huizinga, EP; Plat, MCJ; Hoencamp, E; Leenen, LPH; Hamming, JF; Vermetten, E				Hoencamp, Rigo; Idenburg, Floris J.; van Dongen, Thijs T. C. F.; de Kruijff, Loes G. M.; Huizinga, Eelco P.; Plat, Marie-Christine J.; Hoencamp, Erik; Leenen, Luke P. H.; Hamming, Jaap F.; Vermetten, Eric			Long-Term Impact of Battle Injuries; Five-Year Follow-Up of Injured Dutch Servicemen in Afghanistan 2006-2010	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC STRESS; CASUALTIES; HEALTH; IRAQ; WAR; VALIDATION; COHORT; SCALE; CARE	Objectives Units deployed to armed conflicts are at high risk for exposure to combat events. Many battle casualties (BCs) have been reported in the recent deployment to Afghanistan. The long-term impact of these combat injuries, at their five-year end point, is currently unknown. To date, no systematic inventory has been performed of an identified group of BCs in comparison to non-injured service members from the same operational theatre. Design Observational cross-sectional cohort study. Setting Open online survey among Dutch BCs that deployed to Afghanistan (2006-2010). Participants The Dutch BCs (n = 62) were compared to two control groups of non-injured combat groups (battle exposed [n = 53], and non-battle exposed [n = 73]). Main Outcome Measures Participants rated their impact of trauma exposure (Impact of Events [IES]), post deployment reintegration (Post Deployment Reintegration Scale [PDRS]), general symptoms of distress (Symptom Checklist 90 [SCL-90]), as well as their current perceived quality of life (EuroQol-6D [EQ-6D]). Also cost effectiveness (Short From health survey [SF-36]) and care consumption were assessed (Trimbos/iMTA questionnaire). Results Over 90% of BCs were still in active duty. The mean scores of all questionnaires (IES, EQ-6D, SF-36, and SCL-90) of the BC group were significantly higher than in the control groups (p<0.05). The PDRS showed a significantly lower (p<0.05) outcome in the negative subscales. The mean consumption of care was triple that of both control groups. A lower score on quality of life was related to higher levels of distress and impact of trauma exposure. Conclusions This study showed a clear long-term impact on a wide range of scales that contributes to a reduced quality of life in a group of BCs. Low perceived cost effectiveness matched with high consumption of care in the BC group in comparison to the control groups. These results warrant continuous monitoring of BCs.	[Hoencamp, Rigo; Hamming, Jaap F.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Idenburg, Floris J.] Med Ctr Haaglanden, Dept Surg, The Hague, Netherlands; [van Dongen, Thijs T. C. F.; Huizinga, Eelco P.; Leenen, Luke P. H.] Univ Med Ctr, Dept Surg, Utrecht, Netherlands; [de Kruijff, Loes G. M.] Rehabil Ctr Hoogstraat, Dept Physiatrist, Utrecht, Netherlands; [Plat, Marie-Christine J.] Minist Def, Expert Ctr Force Hlth Protect, Utrecht, Netherlands; [Hoencamp, Erik] Leiden Univ, Med Ctr, Leiden, Netherlands; [Vermetten, Eric] Leiden Univ, Med Ctr, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hoencamp, R (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	r.hoencamp@LUMC.nl	Vermetten, Eric/B-1335-2008; Hoencamp, Rigo/AAL-4984-2021	Vermetten, Eric/0000-0003-0579-4404; Kubickova, Karolina/0000-0002-9556-3185				Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Arrindell W.A., 1981, NEDERLANDS TIJDSCHRI, V36, P77; Arrindell WA, 1986, SCL 90 MANUAL MULTID; Baker MS, 2014, MIL MED, V179, P348, DOI 10.7205/MILMED-D-13-00471; Beder J, 2011, SOC WORK HEALTH CARE, V50, P515, DOI 10.1080/00981389.2011.554279; Blais AR, 2009, MIL PSYCHOL, V21, P365, DOI 10.1080/08995600902914727; Bouwmans C, 2013, HANDLEIDING TRIMBOS, DOI [10.1016/j.amsu.2013.12.001, DOI 10.1016/J.AMSU.2013.12.001]; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Fikretoglu D, 2010, DEV NORMS POSTDEPLOY; Greenberg N, 2008, J R Army Med Corps, V154, P124; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Hoencamp R, INJURY IN PRESS; Hoencamp R, 2014, WORLD J SUR IN PRESS; Hoencamp R, 2014, WORLD J SURG, V38, P1713, DOI 10.1007/s00268-014-2462-x; Hoencamp R, 2014, INJURY, V45, P1028, DOI 10.1016/j.injury.2014.02.012; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Kuhn E, 2014, MIL MED, V179, P12, DOI 10.7205/MILMED-D-13-00271; Nasky KM, 2009, MIL MED, V174, P689, DOI 10.7205/MILMED-D-04-3608; Oostenbrink J, 2004, HANDLEIDING KOSTENON; Scott DJ, 2014, J VASC SURG, V59, P173, DOI 10.1016/j.jvs.2013.07.103; Smith TC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-69; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Taal EM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23667; Turner MA, 2005, BRIT J PSYCHIAT, V186, P476, DOI 10.1192/bjp.186.6.476; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Woodruff SI, 2014, MIL MED, V179, P265, DOI 10.7205/MILMED-D-13-00444	28	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115119	10.1371/journal.pone.0115119	http://dx.doi.org/10.1371/journal.pone.0115119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QK	25643003	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821200008
J	Sawhney, S; Hood, K; Shaw, A; Braithwaite, AW; Stubbs, R; Hung, NA; Royds, JA; Slatter, TL				Sawhney, Sonal; Hood, Kylie; Shaw, Alisha; Braithwaite, Antony W.; Stubbs, Richard; Hung, Noelyn A.; Royds, Janice A.; Slatter, Tania L.			Alpha-Enolase Is Upregulated on the Cell Surface and Responds to Plasminogen Activation in Mice Expressing a Delta 133p53a Mimic	PLOS ONE			English	Article							NUCLEAR RIBONUCLEOPROTEIN K; P53 TRANSCRIPTIONAL ACTIVATION; WILD-TYPE P53; DNA-DAMAGE; TUMOR REVERSION; HNRNP-K; PROTEIN; ISOFORM; CANCER; INFLAMMATION	The p53 protein is a master regulator of the stress response. It acts as a tumor suppressor by inducing transcriptional activation of p53 target genes, with roles in apoptosis, cell cycle arrest and metabolism. The discovery of at least 12 isoforms of p53, some of which have tumor-promoting properties, has opened new avenues of research. Our previous work studied tumor phenotypes in four mouse models with different p53 backgrounds: wild-type p53, p53 null, mutant p53 lacking the proline domain (m Delta pro), and a mimic for the human Delta 133p53a p53 isoform (Delta 122p53). To identify the major proteins affected by p53 function early in the response to DNA damage, the current study investigated the entire proteome of bone marrow, thymus, and lung in the four p53 models. Protein extracts from untreated controls and those treated with amsacrine were analyzed using two-dimensional fluorescence difference gel electrophoresis. In the bone marrow, reactive proteins were universally decreased by wild-type p53, including alpha-enolase. Further analysis of alpha-enolase in the p53 models revealed that it was instead increased in Delta 122p53 hematopoietic and tumor cell cytosol and on the cell surface. Alpha-enolase on the surface of Delta 122p53 cells acted as a plasminogen receptor, with tumor necrosis factor alpha induced upon plasminogen stimulation. Taken together, these data identified new proteins associated with p53 function. One of these proteins, alpha-enolase, is regulated differently by wild-type p53 and Delta 122p53 cells, with reduced abundance as part of a wild-type p53 response and increased abundance with Delta 122p53 function. Increased cell surface alpha-enolase on Delta 122p53 cells provides a possible explanation for the model's pro-inflammatory features and suggests that p53 isoforms may direct an inflammatory response by increasing the amount of a-enolase on the cell surface.	[Sawhney, Sonal; Hood, Kylie; Stubbs, Richard] Univ Otago, Wakefield Biomed Res Unit, Wellington, New Zealand; [Shaw, Alisha; Braithwaite, Antony W.; Hung, Noelyn A.; Royds, Janice A.; Slatter, Tania L.] Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand; [Braithwaite, Antony W.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia	University of Otago; University of Otago; Children's Medical Research Institute - Australia; University of Sydney	Slatter, TL (corresponding author), Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand.	tania.slatter@otago.ac.nz			Health Research Council New Zealand [10/442]; Genesis Oncology Trust; Dunedin School of Medicine	Health Research Council New Zealand(Health Research Council of New Zealand); Genesis Oncology Trust; Dunedin School of Medicine	This work was supported by Health Research Council New Zealand 10/442, Genesis Oncology Trust, and Dunedin School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoubala M, 2011, CELL DEATH DIFFER, V18, P248, DOI 10.1038/cdd.2010.91; Bae S, 2012, J IMMUNOL, V189, P365, DOI 10.4049/jimmunol.1102073; Bernard H, 2013, ONCOGENE, V32, P2150, DOI 10.1038/onc.2012.242; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Campbell HG, 2013, ONCOGENE, V32, P827, DOI 10.1038/onc.2012.102; Campbell HG, 2012, CELL CYCLE, V11, P446, DOI 10.4161/cc.11.3.19054; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Chang GC, 2006, CLIN CANCER RES, V12, P5746, DOI 10.1158/1078-0432.CCR-06-0324; Chang JW, 2009, INT IMMUNOL, V21, P1351, DOI 10.1093/intimm/dxp106; Chen WM, 2013, CELL CYCLE, V12, P2321, DOI 10.4161/cc.25404; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Flaman JM, 1996, ONCOGENE, V12, P813; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gao R, 2013, J BIOL CHEM, V288, P15046, DOI 10.1074/jbc.M113.466136; Han YH, 2010, TOXICOL IN VITRO, V24, P1237, DOI 10.1016/j.tiv.2010.02.005; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hsiao KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069354; Katayama M, 2006, SURG TODAY, V36, P1085, DOI 10.1007/s00595-006-3301-y; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; Kluza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021924; Komarova EA, 2000, ONCOGENE, V19, P3791, DOI 10.1038/sj.onc.1203717; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Love Ian M, 2013, Methods Mol Biol, V962, P63, DOI 10.1007/978-1-62703-236-0_5; Lung J, 2010, FEBS J, V277, P4308, DOI 10.1111/j.1742-4658.2010.07819.x; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Mizukami Y, 2004, J BIOL CHEM, V279, P50120, DOI 10.1074/jbc.M402299200; Mondal AM, 2013, J CLIN INVEST, V123, P5247, DOI 10.1172/JCI70355; Moumen A, 2013, CELL CYCLE, V12, P698, DOI 10.4161/cc.23592; Nutthasirikul N, 2013, INT J ONCOL, V42, P1181, DOI 10.3892/ijo.2013.1818; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pant V, 2012, BLOOD, V120, P5118, DOI 10.1182/blood-2012-05-356014; Pelisch F, 2012, J BIOL CHEM, V287, P30789, DOI 10.1074/jbc.M112.390120; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; Quadrato G, 2012, INT REV NEUROBIOL, V105, P71, DOI 10.1016/B978-0-12-398309-1.00005-6; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Rohaly G, 2010, J VIROL, V84, P10727, DOI 10.1128/JVI.00122-10; Sawhney S, 2009, PROTEOMICS, V9, P4087, DOI 10.1002/pmic.200800949; Sedoris KC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-157; Shi HJ, 2009, ELECTROPHORESIS, V30, P2442, DOI 10.1002/elps.200800767; Slatter TL, 2010, CELL DEATH DIFFER, V17, P540, DOI 10.1038/cdd.2009.136; Slatter TL, 2011, BLOOD, V117, P5166, DOI 10.1182/blood-2010-11-321851; Stavridi ES, 2001, CANCER RES, V61, P7030; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; Terrier O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003246; Terrier O, 2012, J VIROL, V86, P8452, DOI 10.1128/JVI.07143-11; Trinidad AG, 2013, MOL CELL, V50, P805, DOI 10.1016/j.molcel.2013.05.002; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Wei JX, 2012, P NATL ACAD SCI USA, V109, pE2543, DOI 10.1073/pnas.1205664109; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Yin X, 2003, J CELL PHYSIOL, V196, P474, DOI 10.1002/jcp.10329; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zhang Y, 2004, J BIOL CHEM, V279, P42545, DOI 10.1074/jbc.M314213200; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744	66	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116270	10.1371/journal.pone.0116270	http://dx.doi.org/10.1371/journal.pone.0116270			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643152	gold, Green Published, Green Submitted			2022-12-26	WOS:000348821200016
J	Magnus, MC; Stigum, H; Haberg, SE; Nafstad, P; London, SJ; Nystad, W				Magnus, Maria C.; Stigum, Hein; Haberg, Siri E.; Nafstad, Per; London, Stephanie J.; Nystad, Wenche			Peak Weight and Height Velocity to Age 36 Months and Asthma Development: The Norwegian Mother and Child Cohort Study	PLOS ONE			English	Article							EUROPEAN BIRTH COHORTS; LUNG DEVELOPMENT; INFANT GROWTH; FETAL-GROWTH; GENERATION R; RISK; SYMPTOMS; NEWBORNS; GAIN; 1ST	Background The immediate postnatal period is the period of the fastest growth in the entire life span and a critical period for lung development. Therefore, it is interesting to examine the association between growth during this period and childhood respiratory disorders. Methods We examined the association of peak weight and height velocity to age 36 months with maternal report of current asthma at 36 months (n = 50,311), recurrent lower respiratory tract infections (LRTIs) by 36 months (n = 47,905) and current asthma at 7 years (n = 24,827) in the Norwegian Mother and Child Cohort Study. Peak weight and height velocity was calculated using the Reed1 model through multilevel mixed-effects linear regression. Multivariable log-binomial regression was used to calculate adjusted relative risks (adj.RR) and 95% confidence intervals (CI). We also conducted a sibling pair analysis using conditional logistic regression. Results Peak weight velocity was positively associated with current asthma at 36 months [adj. RR 1.22 (95% CI: 1.18, 1.26) per standard deviation (SD) increase], recurrent LRTIs by 36 months [adj. RR 1.14 (1.10, 1.19) per SD increase] and current asthma at 7 years [adj. RR 1.13 (95% CI: 1.07, 1.19) per SD increase]. Peak height velocity was not associated with any of the respiratory disorders. The positive association of peak weight velocity and asthma at 36 months remained in the sibling pair analysis. Conclusions Higher peak weight velocity, achieved during the immediate postnatal period, increased the risk of respiratory disorders. This might be explained by an influence on neonatal lung development, shared genetic/epigenetic mechanisms and/or environmental factors.	[Magnus, Maria C.; Stigum, Hein; Nafstad, Per; Nystad, Wenche] Norwegian Inst Publ Hlth, Div Epidemiol, Dept Chron Dis, Oslo, Norway; [Stigum, Hein; Nafstad, Per] Univ Oslo, Fac Med, Dept Community Med, Oslo, Norway; [Haberg, Siri E.] Norwegian Inst Publ Hlth, Inst Management & Staff, Oslo, Norway; [London, Stephanie J.] NIEHS, Epidemiol Branch, Div Intramural Res, NIH,US Dept HHS, Res Triangle Pk, NC 27709 USA	Norwegian Institute of Public Health (NIPH); University of Oslo; Norwegian Institute of Public Health (NIPH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Magnus, MC (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Dept Chron Dis, Oslo, Norway.	Maria.Christine.Magnus@fhi.no	London, Stephanie/C-3734-2019	London, Stephanie/0000-0003-4911-5290	National Institutes of Health (NIH) (NIH/National Institute of Environmental Health Sciences (NIEHS)) [N01-ES-75558]; National Institutes of Health (NIH) (NIH/National Institute of Neurological Disorders and Stroke) [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; Norwegian Research Council/FUGE [151918/S10]; Division of Intramural Research, NIEHS, NIH; Norwegian Extra-Foundation for Health and Rehabilitation [2011.2.0218]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	National Institutes of Health (NIH) (NIH/National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health (NIH) (NIH/National Institute of Neurological Disorders and Stroke); Norwegian Research Council/FUGE(Research Council of Norway); Division of Intramural Research, NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Norwegian Extra-Foundation for Health and Rehabilitation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort Study is supported by National Institutes of Health (NIH) (NIH/National Institute of Environmental Health Sciences (NIEHS) contract number N01-ES-75558, NIH/National Institute of Neurological Disorders and Stroke grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1) and the Norwegian Research Council/FUGE (grant number 151918/S10). Supported in part by the Division of Intramural Research, NIEHS, NIH. Ms. Magnus is also supported by the Norwegian Extra-Foundation for Health and Rehabilitation (grant number 2011.2.0218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2013, PEDIAT ALLERG IMM-UK, V24, P122, DOI 10.1111/pai.12049; BERKEY CS, 1987, HUM BIOL, V59, P973; Bisgaard H, 2012, AM J RESP CRIT CARE, V185, P1183, DOI 10.1164/rccm.201110-1922OC; Bisgaard H, 2009, J ALLERGY CLIN IMMUN, V123, P651, DOI 10.1016/j.jaci.2008.11.036; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Brew BK, 2011, PAEDIATR PERINAT EP, V25, P507, DOI 10.1111/j.1365-3016.2011.01233.x; Chirwa ED, 2014, ANN HUM BIOL, V41, P166, DOI 10.3109/03014460.2013.839742; Dijk FN, 2013, CURR OPIN ALLERGY CL, V13, P193, DOI 10.1097/ACI.0b013e32835eb707; Engel SM, 2014, AM J EPIDEMIOL, V179, P834, DOI 10.1093/aje/kwt433; Flexeder C, 2012, ALLERGY, V67, P257, DOI 10.1111/j.1398-9995.2011.02748.x; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Furu K, 2011, J CLIN EPIDEMIOL, V64, P878, DOI 10.1016/j.jclinepi.2010.10.014; Galambos C, 2008, PATHOLOGY, V40, P124, DOI 10.1080/00313020701818981; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Govarts E, 2012, ENVIRON HEALTH PERSP, V120, P162, DOI 10.1289/ehp.1103767; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Haberg SE, 2011, J ALLERGY CLIN IMMUN, V127, P262, DOI 10.1016/j.jaci.2010.10.004; Hansen S, 2014, ENVIRON HEALTH PERSP, V122, P93, DOI 10.1289/ehp.1206397; Haschke F, 2013, WORLD REV NUTR DIET, V106, P33, DOI 10.1159/000342559; Henderson J, 2009, ARCH DIS CHILD, V94, P333, DOI 10.1136/adc.2008.143636; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Mai XM, 2005, PEDIAT ALLERG IMM-UK, V16, P380, DOI 10.1111/j.1399-3038.2005.00290.x; Mannino DM, 2006, INT J OBESITY, V30, P6, DOI 10.1038/sj.ijo.0803145; Maritz GS, 2001, PEDIATR PULM, V32, P201, DOI 10.1002/ppul.1109; Metsala J, 2008, AM J EPIDEMIOL, V168, P170, DOI 10.1093/aje/kwn105; Mook-Kanamori DO, 2011, EUR J ENDOCRINOL, V165, P623, DOI 10.1530/EJE-11-0067; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nwaru BI, 2011, CLIN RESPIR J, V5, P211, DOI 10.1111/j.1752-699X.2010.00222.x; Paul IM, 2010, PEDIAT ALLERG IMM-UK, V21, P82, DOI 10.1111/j.1399-3038.2009.00926.x; Pike KC, 2010, THORAX, V65, P1099, DOI 10.1136/thx.2010.134742; Rona RJ, 2005, THORAX, V60, P549, DOI 10.1136/thx.2004.032359; Rzehak P, 2013, J ALLERGY CLIN IMMUN, V131, P1528, DOI 10.1016/j.jaci.2013.01.001; Scholtens S, 2009, J ALLERGY CLIN IMMUN, V123, P1312, DOI 10.1016/j.jaci.2009.02.029; Sevelsted A, 2012, ALLERGY, V67, P670, DOI 10.1111/j.1398-9995.2012.02805.x; Sharma S, 2010, AM J RESP CRIT CARE, V181, P328, DOI 10.1164/rccm.200907-1009OC; SIMONDON KB, 1992, AM J HUM BIOL, V4, P327, DOI 10.1002/ajhb.1310040308; Sonnenschein-van der Voort AMM, 2012, AM J RESP CRIT CARE, V185, P731, DOI 10.1164/rccm.201107-1266OC; Suren P, 2013, EPIDEMIOLOGY, V24, P660, DOI 10.1097/EDE.0b013e31829e1d45; Taveras EM, 2008, J ALLERGY CLIN IMMUN, V121, P1161, DOI 10.1016/j.jaci.2008.03.021; Tedner SG, 2012, CLIN EXP ALLERGY, V42, P1430, DOI 10.1111/j.1365-2222.2012.03997.x; The Norwegian Directorate of Health, 2010, NASJ FAGL RETN VEIIN; Turner S, 2011, AM J RESP CRIT CARE, V184, P407, DOI 10.1164/rccm.201012-2075OC; van der Gugten AC, 2012, EUR RESPIR J, V39, P403, DOI 10.1183/09031936.00188310; van der Valk RJP, 2012, ALLERGY, V67, P767, DOI 10.1111/j.1398-9995.2012.02819.x; Voort AMMSVD, 2014, J ALLERGY CLIN IMMUN, V133, P1317, DOI 10.1016/j.jaci.2013.12.1082; Weber D, 2013, EUR J CLIN NUTR, V67, P1029, DOI 10.1038/ejcn.2013.158	48	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116362	10.1371/journal.pone.0116362	http://dx.doi.org/10.1371/journal.pone.0116362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635872	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700031
J	Schmidt, VJ; Hilgert, JG; Covi, JM; Leibig, N; Wietbrock, JO; Arkudas, A; Polykandriotis, E; de Wit, C; Horch, RE; Kneser, U				Schmidt, Volker J.; Hilgert, Johannes G.; Covi, Jennifer M.; Leibig, Nico; Wietbrock, Johanna O.; Arkudas, Andreas; Polykandriotis, Elias; de Wit, Cor; Horch, Raymund E.; Kneser, Ulrich			Flow Increase Is Decisive to Initiate Angiogenesis in Veins Exposed to Altered Hemodynamics	PLOS ONE			English	Article							CONSTRUCTED ARTERIOVENOUS-FISTULA; CAPILLARY BED FORMATION; GAP-JUNCTIONS; BLOOD-FLOW; IN-VIVO; ENDOTHELIAL-CELLS; VASCULAR-TONE; SHUNT LOOP; TISSUE; CONNEXIN43	Exposing a vein to altered hemodynamics by creating an arteriovenous (AV) shunt evokes considerable vessel formation that may be of therapeutic potential. However, it is unclear whether the introduction of oscillatory flow and/or flow increase is decisive. To distinguish between these mechanical stimuli we grafted a femoral vein into the arterial flow pathway of the contralateral limb in rats creating an arterioarterial (AA) loop (n = 7). Alternatively, we connected the femoral artery and vein using the vein graft, whereby we created an AV-loop (n = 27). Vessel loops were embedded in a fibrin filled chamber and blood flow was measured by means of flow probes immediately after surgery (day 0) and 15 days after loop creation. On day 15, animals were sacrificed and angiogenesis was evaluated using mu CT and histological analysis. Mean flow increased from 0.5 to 2.4 mL/min and was elevated throughout the cardiac cycle at day 0 in AV-loops whereas, as expected, it remained unchanged in AA-loops. Flow in AV-loops decreased with time, and was at day 15 not different from untreated femoral vessels or AA-loop grafts. Pulsatile flow oscillations were similar in AV-and AA-loops at day 0. The flow amplitude amounted to similar to 1.3 mL/min which was comparable to values in untreated arteries. Flow amplitude remained constant in AA-loops, whereas it decreased in AV-loops (day 15: 0.4 mL/min). A large number of newly formed vessels were present in AV-loops at day 15 arising from the grafted vein. In marked contrast, angiogenesis originating from the grafted vein was absent in AA-loops. We conclude that exposure to substantially increased flow is required to initiate angiogenesis in grafted veins, whereas selective enhancement of pulsatile flow is unable to do so. This suggests that indeed flow and most likely wall shear stress is decisive to initiate formation of vessels in this hemodynamically driven angiogenesis model.	[Schmidt, Volker J.; Hilgert, Johannes G.; Covi, Jennifer M.; Arkudas, Andreas; Polykandriotis, Elias; Horch, Raymund E.; Kneser, Ulrich] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, D-91054 Erlangen, Germany; [Schmidt, Volker J.; Leibig, Nico; Wietbrock, Johanna O.; Kneser, Ulrich] Heidelberg Univ, Dept Hand Plast & Reconstruct Surg, BG Unfallklin Ludwigshafen, Heidelberg, Germany; [de Wit, Cor] Med Univ Lubeck, Dept Physiol, D-23538 Lubeck, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; University of Lubeck	Schmidt, VJ (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, D-91054 Erlangen, Germany.	schmidtvolker@gmx.net	Arkudas, Andreas/AAQ-6745-2021; Horch, Raymund E./H-8128-2019; de Wit, Cor/A-5560-2009	Horch, Raymund E./0000-0002-6561-2353; de Wit, Cor/0000-0003-4621-0399; Arkudas, Andreas/0000-0002-2473-5816; Polykandriotis, Elias/0000-0002-8152-6420	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg [TP J-15]; Xue Hong und Hans Georg Geis Foundation	Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg; Xue Hong und Hans Georg Geis Foundation	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University Erlangen-Nuremberg (to VJS, TP J-15, www.izkf.med.unierlangen.de) and by the Xue Hong und Hans Georg Geis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkudas A, 2007, MOL MED, V13, P480, DOI 10.2119/2007-00057.Arkudas; Arkudas A, 2013, TISSUE ENG PART C-ME, V19, P479, DOI [10.1089/ten.tec.2012.0572, 10.1089/ten.TEC.2012.0572]; Arkudas A, 2012, PLAST RECONSTR SURG, V129, p55E, DOI 10.1097/PRS.0b013e3182361f97; Arkudas A, 2010, TISSUE ENG PART C-ME, V16, P1503, DOI 10.1089/ten.tec.2010.0016; Asano Y, 2005, MED BIOL ENG COMPUT, V43, P126, DOI 10.1007/BF02345133; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Conway Daniel, 2012, F1000 Biol Rep, V4, P1, DOI 10.3410/B4-1; Cowan DB, 1998, CIRC RES, V82, P786, DOI 10.1161/01.RES.82.7.786; de Wit C, 2006, BIOL CHEM, V387, P3, DOI 10.1515/BC.2006.002; de Wit C, 2007, CURR PHARM BIOTECHNO, V8, P11; Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3; EROL OO, 1979, SURG FORUM, V30, P530; EROL OO, 1980, PLAST RECONSTR SURG, V66, P109, DOI 10.1097/00006534-198007000-00021; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Gabriels JE, 1998, CIRC RES, V83, P636, DOI 10.1161/01.RES.83.6.636; Glen K, 2012, J CELL PHYSIOL, V227, P2710, DOI 10.1002/jcp.23015; Hofer SOP, 2005, BRIT J PLAST SURG, V58, P1104, DOI 10.1016/j.bjps.2005.04.033; Horch RE, 2014, J CELL MOL MED, V18, P1478, DOI 10.1111/jcmm.12296; Horch RE, 2013, J CELL MOL MED, V17, P1197, DOI 10.1111/jcmm.12130; HUANG M, 1992, AM J PHYSIOL, V262, pH846; Klumpp D, 2012, J BIOMED MATER RES A, V100A, P2302, DOI 10.1002/jbm.a.34172; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Liu D, 2011, INT J DEV BIOL, V55, P419, DOI 10.1387/ijdb.103220dl; Lokmic Z, 2007, FASEB J, V21, P511, DOI 10.1096/fj.06-6614com; Manasseri B, 2007, MICROSURG, V27, P623, DOI 10.1002/micr.20415; Mian RW, 2000, TISSUE ENG, V6, P595, DOI 10.1089/10763270050199541; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Obi S, 2012, AM J PHYSIOL-CELL PH, V303, pC595, DOI 10.1152/ajpcell.00133.2012; Polykandriotis E, 2008, MICROVASC RES, V75, P25, DOI 10.1016/j.mvr.2007.04.003; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Schmidt VJ, 2008, PHARMACOL REP, V60, P68; Schmidt VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078782; Schmidt VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042287; Tanaka Y, 2003, PLAST RECONSTR SURG, V112, P1636, DOI 10.1097/01.PRS.0000086140.49022.AB; Tanaka Y, 2000, BRIT J PLAST SURG, V53, P51, DOI 10.1054/bjps.1999.3186; Wang HH, 2008, CARDIOVASC RES, V79, P509, DOI 10.1093/cvr/cvn112; Watson O, 2013, CARDIOVASC RES, V100, P252, DOI 10.1093/cvr/cvt170; Westerband A, 2001, J VASC SURG, V33, P561, DOI 10.1067/mva.2001.112230; Wragg JW, 2014, MICROCIRCULATION, DOI [10.1111/micc.12186PMID: 25556713, DOI 10.1111/MICC.12186]; Zdolsek JM, 2011, J VASC SURG, V53, P435, DOI 10.1016/j.jvs.2010.08.019	43	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117407	10.1371/journal.pone.0117407	http://dx.doi.org/10.1371/journal.pone.0117407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635764	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700084
J	Xu, DB; Chen, M; Ma, YN; Xu, ZS; Li, LC; Chen, YF; Ma, YZ				Xu, Dong-bei; Chen, Ming; Ma, Ya-nan; Xu, Zhao-shi; Li, Lian-cheng; Chen, Yao-feng; Ma, You-zhi			A G-Protein beta Subunit, AGB1, Negatively Regulates the ABA Response and Drought Tolerance by Down-Regulating AtMPK6-Related Pathway in Arabidopsis	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; ABIOTIC STRESS TOLERANCE; ABSCISIC-ACID REGULATION; ALPHA-SUBUNIT; GAMMA-SUBUNIT; BZIP PROTEIN; GENE; EXPRESSION; INTERACTS; KINASE	Heterotrimeric G-proteins are versatile regulators involved in diverse cellular processes in eukaryotes. In plants, the function of G-proteins is primarily associated with ABA signaling. However, the downstream effectors and the molecular mechanisms in the ABA pathway remain largely unknown. In this study, an AGB1 mutant (agb1-2) was found to show enhanced drought tolerance, indicating that AGB1 might negatively regulate drought tolerance in Arabidopsis. Data showed that AGB1 interacted with protein kinase AtMPK6 that was previously shown to phosphorylate AtVIP1, a transcription factor responding to ABA signaling. Our study found that transcript levels of three ABA responsive genes, AtMPK6, AtVIP1 and AtMYB44 (downstream gene of AtVIP1), were significantly up-regulated in agb1-2 lines after ABA or drought treatments. Other ABA-responsive and drought-inducible genes, such as RD29A (downstream gene of AtMYB44), were also up-regulated in agb1-2 lines. Furthermore, overexpression of AtVIP1 resulted in hypersensitivity to ABA at seed germination and seedling stages, and significantly enhanced drought tolerance in transgenic plants. These results suggest that AGB1 was involved in the ABA signaling pathway and drought tolerance in Arabidopsis through down-regulating the AtMPK6, AtVIP1 and AtMYB44 cascade.	[Xu, Dong-bei; Ma, Ya-nan; Chen, Yao-feng] Northwest A&F Univ, Coll Agr, Yangling 712100, Shaanxi, Peoples R China; [Xu, Dong-bei; Chen, Ming; Ma, Ya-nan; Xu, Zhao-shi; Li, Lian-cheng; Ma, You-zhi] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Triticeae Crops, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci,Minist Agr, Beijing 100081, Peoples R China	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Chen, YF (corresponding author), Northwest A&F Univ, Coll Agr, Yangling 712100, Shaanxi, Peoples R China.	chenf3828@126.com; mayouzhi@caas.cn	Ma, Yanan/ABG-4104-2021		National Key Project for Research on Transgenic Biology [2013ZX08002-002]; Natural Science Foundation of China [31271715]	National Key Project for Research on Transgenic Biology; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Project for Research on Transgenic Biology (2013ZX08002-002) and Natural Science Foundation of China (31271715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2013, J PROTEOME RES, V12, P1487, DOI 10.1021/pr301159u; Anderson DJ, 2007, PLANT CELL REP, V26, P1469, DOI 10.1007/s00299-007-0356-1; Bhardwaj D, 2011, PLANT SIGNAL BEHAV, V6, P287, DOI 10.4161/psb.6.2.14971; Booker KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012833; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chen JG, 2004, PLANT PHYSIOL, V135, P907, DOI 10.1104/pp.104.038992; Chen Jin-Gui, 2008, Front Biosci, V13, P3321; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kansup J, 2013, J EXP BOT, V64, P5611, DOI 10.1093/jxb/ert327; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Kobayashi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049207; LANG V, 1992, PLANT MOL BIOL, V20, P951, DOI 10.1007/BF00027165; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Mishra NS, 2006, ARCH BIOCHEM BIOPHYS, V452, P55, DOI 10.1016/j.abb.2006.05.001; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Mudgil Y, 2009, PLANT CELL, V21, P3591, DOI 10.1105/tpc.109.065557; Nilson SE, 2010, NEW PHYTOL, V185, P734, DOI 10.1111/j.1469-8137.2009.03120.x; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitzschke A, 2010, CELL CYCLE, V9, P18, DOI 10.4161/cc.9.1.10329; Pitzschke A, 2009, P NATL ACAD SCI USA, V106, P18414, DOI 10.1073/pnas.0905599106; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Shi HT, 2013, J EXP BOT, V64, P1367, DOI 10.1093/jxb/ers400; Shi HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053422; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Tsugama D, 2013, PLANT PHYSIOL BIOCH, V71, P240, DOI 10.1016/j.plaphy.2013.07.024; Tsugama D, 2013, J EXP BOT, V64, P3213, DOI 10.1093/jxb/ert159; Tsugama D, 2012, BBA-MOL CELL RES, V1823, P2254, DOI 10.1016/j.bbamcr.2012.10.001; Tsugama D, 2012, BIOCHEM BIOPH RES CO, V426, P626, DOI 10.1016/j.bbrc.2012.08.141; Tsugama D, 2012, PLANT PHYSIOL, V159, P144, DOI 10.1104/pp.112.197020; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang HX, 2006, MOL BIOL CELL, V17, P4257, DOI 10.1091/mbc.E06-01-0046; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Xing Y, 2009, PLANT MOL BIOL, V70, P725, DOI 10.1007/s11103-009-9503-0; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Nguyen XC, 2012, BIOCHEM BIOPH RES CO, V423, P703, DOI 10.1016/j.bbrc.2012.06.019; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang JF, 2008, PLANT CELL ENVIRON, V31, P562, DOI 10.1111/j.1365-3040.2008.01786.x; Zhao J, 2004, J BIOL CHEM, V279, P1794, DOI 10.1074/jbc.M309529200	61	44	49	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116385	10.1371/journal.pone.0116385	http://dx.doi.org/10.1371/journal.pone.0116385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635681	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700035
J	Cranford, TW; Krysl, P				Cranford, Ted W.; Krysl, Petr			Fin Whale Sound Reception Mechanisms: Skull Vibration Enables Low-Frequency Hearing	PLOS ONE			English	Article							ATLANTIC RIGHT WHALES; BALAENOPTERA-ACUTOROSTRATA; MINKE WHALE; NORTH; TRANSMISSION; CETACEANS; PLAYBACK; PHYSALUS; MIDDLE; NOISE	Hearing mechanisms in baleen whales (Mysticeti) are essentially unknown but their vocalization frequencies overlap with anthropogenic sound sources. Synthetic audiograms were generated for a fin whale by applying finite element modeling tools to X-ray computed tomography (CT) scans. We CT scanned the head of a small fin whale (Balaenoptera physalus) in a scanner designed for solid-fuel rocket motors. Our computer (finite element) modeling toolkit allowed us to visualize what occurs when sounds interact with the anatomic geometry of the whale's head. Simulations reveal two mechanisms that excite both bony ear complexes, (1) the skull-vibration enabled bone conduction mechanism and (2) a pressure mechanism transmitted through soft tissues. Bone conduction is the predominant mechanism. The mass density of the bony ear complexes and their firmly embedded attachments to the skull are universal across the Mysticeti, suggesting that sound reception mechanisms are similar in all baleen whales. Interactions between incident sound waves and the skull cause deformations that induce motion in each bony ear complex, resulting in best hearing sensitivity for low-frequency sounds. This predominant low-frequency sensitivity has significant implications for assessing mysticete exposure levels to anthropogenic sounds. The din of man-made ocean noise has increased steadily over the past half century. Our results provide valuable data for U.S. regulatory agencies and concerned largescale industrial users of the ocean environment. This study transforms our understanding of baleen whale hearing and provides a means to predict auditory sensitivity across a broad spectrum of sound frequencies.	[Cranford, Ted W.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Cranford, Ted W.] Quantitat Morphol Consulting Inc, San Diego, CA USA; [Krysl, Petr] Univ Calif San Diego, Dept Struct Engn, La Jolla, CA 92093 USA	California State University System; San Diego State University; University of California System; University of California San Diego	Cranford, TW (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	Ted.W.Cranford@gmail.com		Krysl, Petr/0000-0003-1761-5047	Michael Wiese and James Eckman, at the Office of Naval Research [N00014-12-1-0516]; Frank Stone, Ernie Young, and Robert Gisiner at the Chief of Naval Operations Environmental Readiness Division as well as Curtis Collins and John Joseph at the Naval Postgraduate School [N00244-08-1-0025]	Michael Wiese and James Eckman, at the Office of Naval Research; Frank Stone, Ernie Young, and Robert Gisiner at the Chief of Naval Operations Environmental Readiness Division as well as Curtis Collins and John Joseph at the Naval Postgraduate School	TWC received funding from Michael Wiese and James Eckman, at the Office of Naval Research (N00014-12-1-0516); Frank Stone, Ernie Young, and Robert Gisiner at the Chief of Naval Operations Environmental Readiness Division as well as Curtis Collins and John Joseph at the Naval Postgraduate School (N00244-08-1-0025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castellote M, 2012, BIOL CONSERV, V147, P115, DOI 10.1016/j.biocon.2011.12.021; Clark C.W., 2004, ECHOLOCATION BATS DO, P564; Clark CW, 2006, IEEE J OCEANIC ENG, V31, P120, DOI 10.1109/JOE.2006.872213; CLARK CW, 1990, NATO ADV SCI I A-LIF, V196, P571; CLARK CW, 1980, SCIENCE, V207, P663, DOI 10.1126/science.207.4431.663; Cranford TW, 2008, ANAT REC, V291, P353, DOI 10.1002/ar.20652; Cranford TW, 2014, BIOACOUSTICS, V23, P161, DOI 10.1080/09524622.2013.843061; Cranford TW, 2012, ADV EXP MED BIOL, V730, P69, DOI 10.1007/978-1-4419-7311-5_15; Cranford TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011927; Cranford TW, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/016001; Croll DA, 2001, ANIM CONSERV, V4, P13, DOI 10.1017/S1367943001001020; DAHLHEIM ME, 1990, NATO ADV SCI I A-LIF, V196, P335; DeVRIES H., 1950, ACTA OTO LARYNGOL, V38, P262, DOI 10.3109/00016485009118384; DWIGHT T, 1872, DESCRIPTION BALAENOP; Ekdale EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021311; FLEISCHER G, 1976, J PALEONTOL, V50, P133; Fleischer G., 1980, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V28, P891; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; FRASER F. C., 1960, BULL BRIT MUS [NAT HIST] ZOOL, V7, P1; Ginsberg J.H., 2001, MECH STRUCTURAL VIBR; HICKLING R, 1966, J ACOUST SOC AM, V39, P276, DOI 10.1121/1.1909887; Hildebrand J, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P101; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Homma K, 2011, AIP CONF PROC, V1403, DOI 10.1063/1.3658146; JOHNSON CS, 1968, J ACOUST SOC AM, V44, P965, DOI 10.1121/1.1911236; KELLOGG R, 1936, REV ARCHAROCETI; Ketten D.R., 1994, IEEE P UNDERWATER AC, V1, P264; Ketten Darlene R., 1997, Bioacoustics, V8, P103; Ketten DR, 2000, SPR HDB AUD, V12, P43; KETTEN DR, 1992, MARINE MAMMAL SENSORY SYSTEMS, P53; Krysl P, 2006, J ACOUST SOC AM, V120, P2328, DOI 10.1121/1.2257988; KRYSL P, 2014, EFFECTS NOISE AQUATI; Krysl P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042591; Lancaster W.C., 1990, Journal of Vertebrate Paleontology, V10, P117; Lancaster WC, 2015, MAR MAMMAL SCI, V31, P369, DOI 10.1111/mms.12145; Li Z, 2014, AM MINERAL, V99, P645, DOI 10.2138/am.2014.4571; Lillie D.G., 1910, P ZOOL SOC LOND, VLXXIV, P769, DOI DOI 10.1111/J.1096-3642.1910.TB01916.X; Matthews J. N., 1999, Bioacoustics, V10, P47; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; MEAD JG, 2009, SMITHSONIAN CONTRIB, V627, P216; *NAT RES COUNC, 2003, OC NOIS MAR MAMM, P208; Norris K. S., 1964, P317; Norris K. S., 1969, P391; Norris K.S., 1968, EVOLUTION ENV, P297; Nummela S, 2007, ANAT REC, V290, P716, DOI 10.1002/ar.20528; OBERRECHT SP, 2014, EFFECTS NOISE AQUATI; Parks SE, 2003, MAR MAMMAL SCI, V19, P563, DOI 10.1111/j.1748-7692.2003.tb01321.x; Parks SE, 2009, J ACOUST SOC AM, V125, P1230, DOI 10.1121/1.3050282; Purves P.E., 1966, WHALES DOLPHINS PORP, P320; Rayleigh J.W.S.B, 1896, THEORY SOUND, V2; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Ruggero MA, 2002, P NATL ACAD SCI USA, V99, P13206, DOI 10.1073/pnas.202492699; Sargent J.R., 1975, BIOCH BIOPHYSICAL PE, V2, P215; Schilt CR, 2012, ADV EXP MED BIOL, V730, P105, DOI 10.1007/978-1-4419-7311-5_23; Sirovic A, 2013, MAR BIOL, V160, P47, DOI 10.1007/s00227-012-2061-z; Southall BL, 2012, MAR TECHNOL SOC J, V46, P48, DOI 10.4031/MTSJ.46.4.1; Southall Brandon L., 2007, Aquatic Mammals, V33, pI; Stokstad Erik, 2014, Science, V343, P128, DOI 10.1126/science.343.6167.128; Szymanski MD, 1999, J ACOUST SOC AM, V106, P1134, DOI 10.1121/1.427121; Thompson T.J., 1979, Behavior of Marine Animals, V3, P403; True F. W., 1904, WHALEBONE WHALES W N; Tubelli AA, 2012, J ACOUST SOC AM, V132, P3263, DOI 10.1121/1.4756950; Tyack PL, 2000, SPR HDB AUD, V12, P156; WATKINS WA, 1985, MAR MAMMAL SCI, V1, P219, DOI 10.1111/j.1748-7692.1985.tb00011.x; Yamato M, 2012, ANAT REC, V295, P991, DOI 10.1002/ar.22459	65	37	37	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116222	10.1371/journal.pone.0116222	http://dx.doi.org/10.1371/journal.pone.0116222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633412	Green Published, Green Submitted, gold			2022-12-26	WOS:000348609800006
J	Kim, Y; Powathil, G; Kang, H; Trucu, D; Kim, H; Lawler, S; Chaplain, M				Kim, Yangjin; Powathil, Gibin; Kang, Hyunji; Trucu, Dumitru; Kim, Hyeongi; Lawler, Sean; Chaplain, Mark			Strategies of Eradicating Glioma Cells: A Multi-Scale Mathematical Model with miR-451-AMPK-mTOR Control	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HYBRID MODEL; BREAST-CANCER; TUMOR; INVASION; BRAIN; PROLIFERATION; GLIOBLASTOMA; MIGRATION; MICROENVIRONMENT	The cellular dispersion and therapeutic control of glioblastoma, the most aggressive type of primary brain cancer, depends critically on the migration patterns after surgery and intracellular responses of the individual cancer cells in response to external biochemical and bio-mechanical cues in the microenvironment. Recent studies have shown that a particular microRNA, miR-451, regulates downstream molecules including AMPK and mTOR to determine the balance between rapid proliferation and invasion in response to metabolic stress in the harsh tumor microenvironment. Surgical removal of main tumor is inevitably followed by recurrence of the tumor due to inaccessibility of dispersed tumor cells in normal brain tissue. In order to address this multi-scale nature of glioblastoma proliferation and invasion and its response to conventional treatment, we propose a hybrid model of glioblastoma that analyses spatio-temporal dynamics at the cellular level, linking individual tumor cells with the macroscopic behaviour of cell organization and the microenvironment, and with the intracellular dynamics of miR-451-AMPK-mTOR signaling within a tumour cell. The model identifies a key mechanism underlying the molecular switches between proliferative phase and migratory phase in response to metabolic stress and biophysical interaction between cells in response to fluctuating glucose levels in the presence of blood vessels (BVs). The model predicts that cell migration, therefore efficacy of the treatment, not only depends on oxygen and glucose availability but also on the relative balance between random motility and strength of chemoattractants. Effective control of growing cells near BV sites in addition to relocalization of invisible migratory cells back to the resection site was suggested as a way of eradicating these migratory cells.	[Kim, Yangjin; Kang, Hyunji] Konkuk Univ, Dept Math, Seoul 143701, South Korea; [Kim, Yangjin] Ohio State Univ, Dept Math, Columbus, OH 43210 USA; [Powathil, Gibin; Trucu, Dumitru; Chaplain, Mark] Univ Dundee, Div Math, Dundee, Scotland; [Kim, Hyeongi] Konkuk Univ, Dept Phys, Seoul 143701, South Korea; [Lawler, Sean] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Powathil, Gibin] Swansea Univ, Dept Math, Swansea, W Glam, Wales	Konkuk University; University System of Ohio; Ohio State University; University of Dundee; Konkuk University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Swansea University	Kim, Y (corresponding author), Konkuk Univ, Dept Math, Seoul 143701, South Korea.	ahyouhappy@konkuk.ac.kr	Kim, Yangjin/C-9681-2014; POWATHIL, GIBIN/D-4711-2014; Chaplain, Mark AJ/A-5355-2010	Kim, Yangjin/0000-0002-8905-8481; POWATHIL, GIBIN/0000-0002-8372-7349; Chaplain, Mark AJ/0000-0001-5727-2160	Konkuk University, South Korea	Konkuk University, South Korea	This work was supported by 2014 Faculty research grant at Konkuk University, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Chintala SK, 1999, INT J DEV NEUROSCI, V17, P495, DOI 10.1016/S0736-5748(99)00010-6; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dallon JC, 2004, J THEOR BIOL, V231, P203, DOI 10.1016/j.jtbi.2004.06.015; Davis F G, 2001, Expert Rev Anticancer Ther, V1, P395, DOI 10.1586/14737140.1.3.395; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Enderling H, 2012, MATH MED BIOL, V29, P21, DOI 10.1093/imammb/dqq015; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gordon K, 2006, THESIS, P154; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hong BJ, 2013, AM J CLIN ONCOL-CANC, V36, P261, DOI 10.1097/COC.0b013e3182467bb1; Jacobs VL, 2011, ASN NEURO, V3, DOI 10.1042/AN20110014; JAIN RK, 1987, CANCER RES, V47, P3039; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kim HD, 2008, MOL BIOL CELL, V19, P4249, DOI 10.1091/mbc.E08-05-0501; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim Y, 2007, MATH MOD METH APPL S, V17, P1773, DOI 10.1142/S0218202507002479; Kim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102499; Kim Y, 2013, B MATH BIOL, V75, P1304, DOI 10.1007/s11538-012-9787-0; Kim Y, 2013, DISCRETE CONT DYN-B, V18, P969, DOI 10.3934/dcdsb.2013.18.969; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kim Y, 2011, PROG BIOPHYS MOL BIO, V106, P353, DOI 10.1016/j.pbiomolbio.2011.06.006; Kim Y, 2010, B MATH BIOL, V72, P1029, DOI 10.1007/s11538-009-9481-z; Kim Y, 2009, J THEOR BIOL, V260, P359, DOI 10.1016/j.jtbi.2009.06.025; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; KUDLOW JE, 1986, J BIOL CHEM, V261, P4134; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; LI CKN, 1982, CANCER-AM CANCER SOC, V50, P2066, DOI 10.1002/1097-0142(19821115)50:10<2066::AID-CNCR2820501017>3.0.CO;2-X; MCCABE M, 1975, BIOCHIM BIOPHYS ACTA, V399, P131, DOI 10.1016/0304-4165(75)90219-6; Mercapide J, 2003, INT J CANCER, V106, P676, DOI 10.1002/ijc.11286; MUELLERKLIESER WF, 1984, ADV EXP MED BIOL, V180, P311; Owen MR, 2004, J THEOR BIOL, V226, P377, DOI 10.1016/j.jtbi.2003.09.004; Palsson E, 2000, P NATL ACAD SCI USA, V97, P10448, DOI 10.1073/pnas.97.19.10448; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Pogoda K, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/075002; Powathil G, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/410602; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; Rong ZM, 2006, ANALYST, V131, P816, DOI 10.1039/b600334f; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Silbergeld DL, 1997, J NEUROSURG, V86, P525, DOI 10.3171/jns.1997.86.3.0525; Stylli SS, 2005, J CLIN NEUROSCI, V12, P389, DOI 10.1016/j.jocn.2005.01.006; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	59	57	60	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0114370	10.1371/journal.pone.0114370	http://dx.doi.org/10.1371/journal.pone.0114370			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629604	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100006
J	Shaw, AK; Pickup, MW; Chytil, A; Aakre, M; Owens, P; Moses, HL; Novitskiy, SV				Shaw, Aubie K.; Pickup, Michael W.; Chytil, Anna; Aakre, Mary; Owens, Philip; Moses, Harold L.; Novitskiy, Sergey V.			TGF beta Signaling in Myeloid Cells Regulates Mammary Carcinoma Cell Invasion through Fibroblast Interactions	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BREAST-CANCER CELLS; SUPPRESSOR-CELLS; TUMOR-METASTASIS; II RECEPTOR; T-CELLS; EXPRESSION; THERAPY; CXCR3; MODEL	Metastasis is the most devastating aspect of cancer, however we know very little about the mechanisms of local invasion, the earliest step of metastasis. During tumor growth CD11b(+)Gr1(+) cells, known also as MDSCs, have been shown to promote tumor progression by a wide spectrum of effects that suppress the anti-tumor immune response. In addition to immunosuppression, CD11b(+)Gr1(+) cells promote metastasis by mechanisms that are currently unknown. CD11b(+)Gr1(+) cells localize near fibroblasts, which remodel the ECM and leave tracks for collective cell migration of carcinoma cells. In this study we discovered that CD11b(+)Gr1(+) cells promote invasion of mammary carcinoma cells by increasing fibroblast migration. This effect was directed by secreted factors derived from CD11b(+)Gr1(+) cells. We have identified several CD11b(+)Gr1(+) cell secreted proteins that activate fibroblast migration, including CXCL11, CXCL15, FGF2, IGF-I, IL1Ra, Resistin, and Shh. The combination of CXCL11 and FGF2 had the strongest effect on fibroblast migration that is associated with Akt1 and ERK1/2 phosphorylation. Analysis of subsets of CD11b(+)Gr1(+) cells identified that CD11b(+)Ly6C(high)Ly6G(low) cells increase fibroblast migration more than other myeloid cell populations. Additionally, tumor-derived CD11b(+)Gr1(+) cells promote fibroblast migration more than splenic CD11b(+)Gr1(+) cells of tumor-bearing mice. While TGF beta signaling in fibroblasts does not regulate their migration toward CD11b(+)Gr1(+) cells, however deletion of TGF beta receptor II on CD11b(+)Gr1(+) cells downregulates CXCL11, Shh, IGF1 and FGF2 resulting in reduced fibroblast migration. These studies show that TGF beta signaling in CD11b(+)Gr1(+) cells promotes fibroblast directed carcinoma invasion and suggests that perivascular CD11b(+)Ly6C(high)Ly6G(low) cells may be the stimulus for localized invasion leading to metastasis.	[Shaw, Aubie K.; Pickup, Michael W.; Chytil, Anna; Aakre, Mary; Owens, Philip; Moses, Harold L.; Novitskiy, Sergey V.] Vanderbilt Univ, Dept Canc Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA	Vanderbilt University	Novitskiy, SV (corresponding author), Vanderbilt Univ, Dept Canc Biol, Vanderbilt Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	sergey.v.novitskiy@vanderbilt.edu		Shaw, Aubie/0000-0002-5298-801X	Vanderbilt-Ingram Cancer Center [P30 CA068485]; T.J. Martell Foundation/Frances Preston Williams Laboratory; Department of Defense Breast Cancer Research Program [W81XWH-09-4-0468, W81XWH-09-1-0421]; National Institutes of Health [CA085492, CA102162]; Robert J. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE [R01CA085492, P30CA068485, R01CA102162] Funding Source: NIH RePORTER	Vanderbilt-Ingram Cancer Center; T.J. Martell Foundation/Frances Preston Williams Laboratory; Department of Defense Breast Cancer Research Program(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert J. and Helen C. Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Vanderbilt-Ingram Cancer Center Core Facilities P30 CA068485; T.J. Martell Foundation/Frances Preston Williams Laboratory; Department of Defense Breast Cancer Research Program Postdoctoral Fellowship W81XWH-09-4-0468 (to AS); Department of Defense Breast Cancer Research Program Postdoctoral Fellowship W81XWH-09-1-0421 (to P.O.); National Institutes of Health grants CA085492, CA102162 and the Robert J. and Helen C. Kleberg Foundation to HLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PROPOSAL TO WITHDRAW; Barcellos-Hoff MH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2224; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Fang WB, 2011, CLIN EXP METASTAS, V28, P351, DOI 10.1007/s10585-011-9373-0; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Hartog H, 2012, ANTICANCER RES, V32, P1309; Iiizumi M, 2008, BBA-REV CANCER, V1786, P87, DOI 10.1016/j.bbcan.2008.07.002; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kerbel RS, 2011, BREAST, V20, pS56, DOI 10.1016/S0960-9776(11)70295-8; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Korah R, 2004, BREAST CANCER RES TR, V88, P17, DOI 10.1007/s10459-004-6006-2; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; Li RS, 2009, J MED CHEM, V52, P4981, DOI 10.1021/jm9002395; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Matise LA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3217; Mognetti B, 2013, J CELL MOL MED, V17, P287, DOI 10.1111/jcmm.12010; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Novitskiy SV, 2012, J LEUKOCYTE BIOL, V92, P641, DOI 10.1189/jlb.1211639; Pang YL, 2013, CANCER DISCOV, V3, P936, DOI 10.1158/2159-8290.CD-12-0527; Perks Claire M, 2003, Breast Dis, V18, P45; Richardsen E, 2009, ANTICANCER RES, V29, P3861; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Ryzhov S, 2011, J IMMUNOL, V187, P6120, DOI 10.4049/jimmunol.1101225; Ryzhov SV, 2014, J IMMUNOL, V193, P3155, DOI 10.4049/jimmunol.1400578; Vlaicu P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-197; Walser TC, 2006, CANCER RES, V66, P7701, DOI 10.1158/0008-5472.CAN-06-0709; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yan HH, 2010, CANCER RES, V70, P6139, DOI 10.1158/0008-5472.CAN-10-0706; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yiangou C, 1997, BRIT J CANCER, V75, P28, DOI 10.1038/bjc.1997.5; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117908	10.1371/journal.pone.0117908	http://dx.doi.org/10.1371/journal.pone.0117908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629162	Green Submitted, gold, Green Published			2022-12-26	WOS:000348732100097
J	Takahashi, A; Inoue, H; Mishima, K; Ide, F; Nakayama, R; Hasaka, A; Ryo, K; Ito, Y; Sakurai, T; Hasegawa, Y; Saito, I				Takahashi, Ayako; Inoue, Hiroko; Mishima, Kenji; Ide, Fumio; Nakayama, Ryoko; Hasaka, Ayaka; Ryo, Koufuchi; Ito, Yumi; Sakurai, Takashi; Hasegawa, Yoshinori; Saito, Ichiro			Evaluation of the Effects of Quercetin on Damaged Salivary Secretion	PLOS ONE			English	Article							OXIDATIVE STRESS; POSSIBLE INVOLVEMENT; INDUCED XEROSTOMIA; SJOGRENS-SYNDROME; WATER CHANNELS; PAROTID-GLAND; MICE; RADIATION; CELLS; IRRADIATION	With the aim of discovering an effective method to treat dry mouth, we analyzed the effects of quercetin on salivary secretion and its mechanism of action. We created a mouse model with impaired salivary secretion by exposure to radiation and found that impaired secretion is suppressed by quercetin intake. Moreover, secretion levels were enhanced in quercetinfed normal mice. To elucidate the mechanisms of these effects on salivary secretion, we conducted an analysis using mouse submandibular gland tissues, a human salivary gland epithelial cell line (HSY), and mouse aortic endothelial cells (MAECs). The results showed that quercetin augments aquaporin 5 (AQP5) expression and calcium uptake, and suppresses oxidative stress and inflammatory responses induced by radiation exposure, suggesting that quercetin intake may be an effective method to treat impaired salivary secretion.	[Takahashi, Ayako; Inoue, Hiroko; Ide, Fumio; Nakayama, Ryoko; Hasaka, Ayaka; Ryo, Koufuchi; Ito, Yumi; Saito, Ichiro] Tsurumi Univ, Sch Dent Med, Dept Pathol, Yokohama, Kanagawa, Japan; [Inoue, Hiroko] Nihon Pharmaceut Univ, Dept Pharmaceut Sci, Saitama, Japan; [Mishima, Kenji] Showa Univ, Sch Dent, Dept Oral Diagnost Sci, Div Pathol, Tokyo 142, Japan; [Sakurai, Takashi] Kanagawa Dent Univ, Grad Sch Dent, Dept Radiopraxis Sci, Yokosuka, Kanagawa, Japan; [Hasegawa, Yoshinori] Kazusa DNA Res Inst, Dept Human Genome Res, Chiba, Japan	Tsurumi University; Showa University; Kanagawa Dental College; Kazusa DNA Research Institute	Saito, I (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Pathol, Yokohama, Kanagawa, Japan.	saito-i@tsurumi-u.ac.jp		Hasegawa, Yoshinori/0000-0003-2904-6611; Ushikoshi, Ryoko/0000-0002-6688-0413	Ministry of Agriculture, Forestry and Fisheries of Japan; Grants-in-Aid for Scientific Research [24592783] Funding Source: KAKEN	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for a research project towards the creation of new agricultural products from the Ministry of Agriculture, Forestry and Fisheries of Japan.	Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Botsoglou Nickos A., 1994, J AGR FOOD CHEM, V42, P1931; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Coppes RP, 2001, BRIT J CANCER, V85, P1055, DOI 10.1054/bjoc.2001.2038; Cotrim AP, 2007, MOL THER, V15, P2101, DOI 10.1038/sj.mt.6300296; De Zwart LL, 1999, FREE RADICAL BIO MED, V26, P202, DOI 10.1016/S0891-5849(98)00196-8; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; DUARTE J, 1993, GEN PHARMACOL-VASC S, V24, P857, DOI 10.1016/0306-3623(93)90159-U; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Evans RL, 2000, J BIOL CHEM, V275, P26720; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Ishikawa Y, 2006, J PHARMACOL SCI, V100, P495, DOI 10.1254/jphs.CRJ06007X; Jung JH, 2012, NUTR RES PRACT, V6, P301, DOI 10.4162/nrp.2012.6.4.301; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Kobori M, 2009, MOL NUTR FOOD RES, V53, P859, DOI 10.1002/mnfr.200800310; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Lamas DJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069106; McClung JM, 2007, J PHYSIOL-LONDON, V585, P203, DOI 10.1113/jphysiol.2007.141119; Mishima K, 2012, STEM CELLS, V30, P1925, DOI 10.1002/stem.1173; Mohammadi Narmin, 2007, J Dent Res Dent Clin Dent Prospects, V1, P65, DOI 10.5681/joddd.2007.011; Morita T, 2011, ARCH ORAL BIOL, V56, P1356, DOI 10.1016/j.archoralbio.2011.06.001; MOUTSOPOULOS HM, 1994, CLIN IMMUNOL IMMUNOP, V72, P162, DOI 10.1006/clin.1994.1123; Murdiastuti K, 2002, PFLUG ARCH EUR J PHY, V445, P405, DOI 10.1007/s00424-002-0940-8; Nakamura T, 2004, J PHYSIOL-LONDON, V558, P561, DOI 10.1113/jphysiol.2004.064626; Nishida S, 2009, KOREAN J PHYSIOL PHA, V13, P361, DOI 10.4196/kjpp.2009.13.5.361; Nishiyama T, 2007, J VASC RES, V44, P138, DOI 10.1159/000098520; Ryo K, 2006, PATHOBIOLOGY, V73, P252, DOI 10.1159/000098211; Singh BB, 2001, FASEB J, V15, P1652, DOI 10.1096/fj.00-0749fje; Surni M, 2013, LIFE SCI, V93, P814, DOI 10.1016/j.lfs.2013.09.005; Tai Y, 2009, RADIAT RES, V172, P331, DOI 10.1667/RR1557.1; Turner MD, 2007, J AM DENT ASSOC, V138, p15S, DOI 10.14219/jada.archive.2007.0358; VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Vitolo JM, 2004, CLIN CANCER RES, V10, P1807, DOI 10.1158/1078-0432.CCR-03-0194; Xu LP, 2013, LARYNGOSCOPE, V123, pE23, DOI 10.1002/lary.24276; Yamamoto T, 2004, ANTICANCER RES, V24, P3065; YANAGAWA T, 1986, VIRCHOWS ARCH B, V51, P187, DOI 10.1007/BF02899028; Yemisci M, 2008, CEREBROVASC DIS, V26, P190, DOI 10.1159/000145327	41	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116008	10.1371/journal.pone.0116008	http://dx.doi.org/10.1371/journal.pone.0116008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629520	Green Submitted, gold, Green Published			2022-12-26	WOS:000348732100028
J	Haney, SL; Hlady, RA; Opavska, J; Klinkebiel, D; Pirruccello, SJ; Dutta, S; Datta, K; Simpson, MA; Wu, L; Opavsky, R				Haney, S. L.; Hlady, R. A.; Opavska, J.; Klinkebiel, D.; Pirruccello, S. J.; Dutta, S.; Datta, K.; Simpson, M. A.; Wu, L.; Opavsky, R.			Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; DE-NOVO; DNA METHYLATION; GENE; MUTATIONS; TUMORIGENESIS; EXPRESSION; MICE; TRANSCRIPTION; PATHOGENESIS	DNA methyltransferase 3A (DNMT3A) catalyzes cytosine methylation of mammalian genomic DNA. In addition to myeloid malignancies, mutations in DNMT3A have been recently reported in T-cell lymphoma and leukemia, implying a possible involvement in the pathogenesis of human diseases. However, the role of Dnmt3a in T-cell transformation in vivo is poorly understood. Here we analyzed the functional consequences of Dnmt3a inactivation in a mouse model of MYC-induced T-cell lymphomagenesis (MTCL). Loss of Dnmt3a delayed tumorigenesis by suppressing cellular proliferation during disease progression. Gene expression profiling and pathway analysis identified upregulation of 17 putative tumor suppressor genes, including DNA methyltransferase Dnmt3b, in Dnmt3a-deficient lymphomas as molecular events potentially responsible for the delayed lymphomagenesis in Dnmt3a(Delta/Delta) mice. Interestingly, promoter and gene body methylation of these genes was not substantially changed between control and Dnmt3a-deficient lymphomas, suggesting that Dnmt3a may inhibit their expression in a methylation-independent manner. Re-expression of both wild type and catalytically inactive Dnmt3a in Dnmt3a(Delta/Delta) lymphoma cells in vitro inhibited Dnmt3b expression, indicating that Dnmt3b upregulation may be directly repressed by Dnmt3a. Importantly, genetic inactivation of Dnmt3b accelerated lymphomagenesis in Dnmt3a(Delta/Delta) mice, demonstrating that upregulation of Dnmt3b is a relevant molecular change in Dnmt3a-deficient lymphomas that inhibits disease progression. Collectively, our data demonstrate an unexpected oncogenic role for Dnmt3a in MTCL through methylation-independent repression of Dnmt3b and possibly other tumor suppressor genes.	[Haney, S. L.; Opavsky, R.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Hlady, R. A.; Opavska, J.; Opavsky, R.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Klinkebiel, D.; Dutta, S.; Datta, K.] Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pirruccello, S. J.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Simpson, M. A.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Wu, L.] Rutgers New Jersey Med Sch, Ctr Canc, Dept Microbiol & Mol Genet, Newark, NJ USA; [Opavsky, R.] Univ Nebraska Med Ctr, Ctr Lymphoma & Leukemia Res, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Lincoln; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Nebraska System; University of Nebraska Medical Center	Opavsky, R (corresponding author), Univ Nebraska Med Ctr, DRCII, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr,Room 4031, Omaha, NE 68198 USA.	ropavsky@unmc.edu			NCI NIH HHS [T32 CA009476] Funding Source: Medline; NIGMS NIH HHS [P30 GM110768, P20 GM103471] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103471, P30GM110768] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baudino TA, 2003, MOL CELL, V11, P905, DOI 10.1016/S1097-2765(03)00102-3; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Couronne L, 2012, NEW ENGL J MED, V366, P95, DOI 10.1056/NEJMc1111708; Datta J, 2005, CANCER RES, V65, P10891, DOI 10.1158/0008-5472.CAN-05-1455; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fernandez AF, 2012, TRENDS GENET, V28, P474, DOI 10.1016/j.tig.2012.05.006; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hlady RA, 2012, J CLIN INVEST, V122, P163, DOI 10.1172/JCI57292; Iskander K, 2008, CANCER RES, V68, P7915, DOI 10.1158/0008-5472.CAN-08-0766; Kim SJ, 2013, BLOOD, V122, P4086, DOI 10.1182/blood-2013-02-483487; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Li HX, 2014, BLOOD, V123, P1487, DOI 10.1182/blood-2013-05-500264; Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88; Liu JG, 2004, J IMMUNOL, V173, P1184, DOI 10.4049/jimmunol.173.2.1184; Neumann M, 2013, BLOOD, V121, P4749, DOI 10.1182/blood-2012-11-465138; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Opavsky R, 2007, PLOS GENET, V3, P1757, DOI 10.1371/journal.pgen.0030167; Opavsky R, 2007, P NATL ACAD SCI USA, V104, P15400, DOI 10.1073/pnas.0706307104; Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103; Palamarchuk A, 2012, P NATL ACAD SCI USA, V109, P2555, DOI 10.1073/pnas.1200003109; Peters SL, 2014, LEUKEMIA, V28, P1138, DOI 10.1038/leu.2013.364; Peters SL, 2013, MOL CELL BIOL, V33, P4321, DOI 10.1128/MCB.00776-13; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Ramkumar C, 2012, CANCER RES, V72, P2714, DOI 10.1158/0008-5472.CAN-11-3773; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Schaetzlein S, 2013, P NATL ACAD SCI USA, V110, pE2470, DOI 10.1073/pnas.1308512110; Schuster C, 2011, BLOOD, V118, P4635, DOI 10.1182/blood-2010-10-313098; Shang QJ, 2012, MOL MED REP, V5, P1401, DOI 10.3892/mmr.2012.844; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Thorns C, 2007, GENE CHROMOSOME CANC, V46, P37, DOI 10.1002/gcc.20386; Vasanthakumar A, 2013, BLOOD, V121, P2059, DOI 10.1182/blood-2012-04-421065; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang Y, 2010, ONCOGENE, V29, P3044, DOI 10.1038/onc.2010.78; Wang YA, 2005, CANCER BIOL THER, V4, P1138, DOI 10.4161/cbt.4.10.2073; Weis B, 2015, ONCOGENE, V34, P1822, DOI 10.1038/onc.2014.114; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485	50	18	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2015	34	43					5436	5446		10.1038/onc.2014.472	http://dx.doi.org/10.1038/onc.2014.472			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EM	25639876	Green Accepted			2022-12-26	WOS:000363479700004
J	Gospodarska, E; Nowialis, P; Kozak, LP				Gospodarska, Emilia; Nowialis, Pawel; Kozak, Leslie P.			Mitochondrial Turnover A PHENOTYPE DISTINGUISHING BROWN ADIPOCYTES FROM INTERSCAPULAR BROWN ADIPOSE TISSUE AND WHITE ADIPOSE TISSUE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN THERMOGENIN; WHITE FAT; C57BL/6J MICE; IN-VIVO; UCP1; EXPRESSION; INDUCTION; COLD; DEGRADATION; OBESITY	To determine the differences between brown adipocytes from interscapular brown tissue (iBAT) and those induced in white adipose tissue (WAT) with respect to their thermogenic capacity, we examined two essential characteristics: the dynamics of mitochondrial turnover during reversible transitions from 29 degrees C to 4 degrees C and the quantitative relationship between UCP1 and selected subunits of mitochondrial respiratory complex in the fully recruited state. Tofollowthekineticsofinductionandinvolutionofmitochondria, we determined the expression pattern of UCP1 and other mitochondrial proteins as well as analyzed mtDNA content after cold stimulation and reacclimation to thermoneutrality. We showed that UCP1 turnover is very different in iBAT and inguinal WAT (ingWAT); the former showed minimal changes in protein content, whereas the latter showed major changes. Similarly, in iBAT both mtDNA content and the expression of mitochondrial proteins were stable and expressed at similar levels during reversible transitions from 29 degrees C to 4 degrees C, whereas ingWAT revealed dynamic changes. Further analysis showed that in iBAT, the expression patterns for UCP1 and other mitochondrial proteins resembled each other, whereas in ingWAT, UCP1 varied similar to 100-fold during the transition from cold to warmth, and no other mitochondrial proteins matched UCP1. In turn, quantitative analysis of thermogenic capacity determined by estimating the proportion of UCP1 to respiratory complex components showed no significant differences between brown and brite adipocytes, suggesting similar thermogenic potentiality. Ourresults indicate that dynamics ofbrownadipocytes turnover during reversible transition from warm to cold may determine the thermogenic capacity of an individual in a changing temperature environment.	[Gospodarska, Emilia; Nowialis, Pawel; Kozak, Leslie P.] Polish Acad Sci, Inst Anim Reprod & Food Res, PL-10748 Olsztyn, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Kozak, LP (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Ul Tuwima 10, PL-10748 Olsztyn, Poland.	l.kozak@pan.olsztyn.pl		GOSPODARSKA, Emilia/0000-0003-1276-3761	Foundation for Polish Science [WELCOME/20104/3]; European Union Structural Funds in Poland; REFRESH project [FP7-REGPOT-2010-1-264103]	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union Structural Funds in Poland(European Commission); REFRESH project	This work was supported by the Foundation for Polish Science, WELCOME/20104/3, and by European Union Structural Funds in Poland within the Innovative Economy Programme and REFRESH project FP7-REGPOT-2010-1-264103 (to L. P. K.).	Andersson U, 1997, BIOCHEM J, V323, P379, DOI 10.1042/bj3230379; BUKOWIECKI L, 1982, AM J PHYSIOL, V242, pE353, DOI 10.1152/ajpendo.1982.242.6.E353; Cancello R, 1998, ENDOCRINOLOGY, V139, P4747, DOI 10.1210/en.139.11.4747; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Clarke KJ, 2012, BBA-BIOENERGETICS, V1817, P1759, DOI 10.1016/j.bbabio.2012.03.035; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; Cousin B, 1996, J CELL PHYSIOL, V167, P285, DOI 10.1002/(SICI)1097-4652(199605)167:2<285::AID-JCP12>3.0.CO;2-7; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Giordano A, 2014, EUR J ENDOCRINOL, V170, pR159, DOI 10.1530/EJE-13-0945; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HOUSTEK J, 1995, J BIOL CHEM, V270, P7689, DOI 10.1074/jbc.270.13.7689; JACOBSSON A, 1994, AM J PHYSIOL-REG I, V267, pR999, DOI 10.1152/ajpregu.1994.267.4.R999; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; KLAUS S, 1991, INT J BIOCHEM, V23, P791, DOI 10.1016/0020-711X(91)90062-R; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Kozak LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030392; Kozak LP, 2010, PROG MOL BIOL TRANSL, V94, P75, DOI 10.1016/S1877-1173(10)94004-0; Kramarova TV, 2008, FASEB J, V22, P55, DOI 10.1096/fj.07-8581com; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Moazed B, 2002, CAN J PHYSIOL PHARM, V80, P515, DOI 10.1139/Y02-067; Moazed B, 2002, CAN J PHYSIOL PHARM, V80, P541, DOI 10.1139/Y02-078; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Neutzner Albert, 2007, Novartis Found Symp, V287, P4; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; PUIGSERVER P, 1992, BIOCHEM J, V284, P393, DOI 10.1042/bj2840393; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Rossmeisl M, 2002, EUR J BIOCHEM, V269, P19, DOI 10.1046/j.0014-2956.2002.02627.x; ROTHWELL NJ, 1979, J COMP PHYSIOL PSYCH, V93, P1024, DOI 10.1037/h0077631; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Stefl B, 1998, AM J PHYSIOL-ENDOC M, V274, pE527, DOI 10.1152/ajpendo.1998.274.3.E527; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005	45	37	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8243	8255		10.1074/jbc.M115.637785	http://dx.doi.org/10.1074/jbc.M115.637785			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645913	hybrid, Green Published			2022-12-26	WOS:000351662600021
J	Zhang, FQ; Hao, F; An, D; Zeng, LL; Wang, Y; Xu, XM; Cui, MZ				Zhang, Fuqiang; Hao, Feng; An, Dong; Zeng, Linlin; Wang, Yi; Xu, Xuemin; Cui, Mei-Zhen			The Matricellular Protein Cyr61 Is a Key Mediator of Platelet-derived Growth Factor-induced Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FOCAL ADHESION KINASE; IMMEDIATE-EARLY GENE; PAXILLIN TYROSINE PHOSPHORYLATION; HEPARAN-SULFATE PROTEOGLYCANS; VEIN ENDOTHELIAL-CELLS; HUMAN SKIN FIBROBLASTS; PDGFR-BETA; INTEGRINS ALPHA(V)BETA(3); NEOINTIMAL HYPERPLASIA	Platelet-derived growth factor (PDGF), a potent chemoattractant, induces cell migration via the MAPK and PI3K/Akt pathways. However, the downstream mediators are still elusive. In particular, the role of extracellular mediators is largely unknown. In this study, we identified the matricellular protein Cyr61, which is de novo synthesized in response to PDGF stimulation, as the key downstream mediator of the ERK and JNK pathways, independent of the p38 MAPK and AKT pathways, and, thereby, it mediates PDGF-induced smooth muscle cell migration but not proliferation. Our results revealed that, when Cyr61 was newly synthesized by PDGF, it was promptly translocated to the extracellular matrix and physically interacted with the plasma membrane integrins alpha 6 beta 1 and alpha v beta 3. We further demonstrate that Cyr61 and integrins are integral components of the PDGF signaling pathway via an " outside-in" signaling route to activate intracellular focal adhesion kinase (FAK), leading to cell migration. Therefore, this study provides the first evidence that the PDGF-induced endogenous extracellular matrix component Cyr61 is a key mediator in modulating cell migration by connecting intracellular PDGF-ERK and JNK signals with integrin/FAK signaling. Therefore, extracellular Cyr61 convergencewithgrowthfactorsignalingandintegrin/FAKsignaling is a new concept of growth factor-induced cell migration. The discovered signaling pathway may represent an important therapeutic target in growth factor-mediated cell migration/invasionrelated vascular diseases and tumorigenesis.	[Zhang, Fuqiang; Hao, Feng; An, Dong; Zeng, Linlin; Xu, Xuemin; Cui, Mei-Zhen] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Zhang, Fuqiang; Wang, Yi] Jilin Univ, Coll Pharm, Dept Regenerat Med, Changchun 130021, Peoples R China; [An, Dong] Jilin Univ, Coll Life Sci, Changchun 130021, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Jilin University; Jilin University	Cui, MZ (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, 2407 River Dr, Knoxville, TN 37996 USA.	cuim@utk.edu	An, Dong/ABB-6635-2021	An, Dong/0000-0002-7770-2284; Cui, Mei-Zhen/0000-0003-4745-6999; xu, xuemin/0000-0002-7426-272X	National Institutes of Health [HL107466, AG026640]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026640, R21AG039596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL107466 (to M.Z.C.) and AG026640 (to X.X.).	ABEDI H, 1995, J BIOL CHEM, V270, P11367, DOI 10.1074/jbc.270.19.11367; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bilato C, 1997, J CLIN INVEST, V100, P693, DOI 10.1172/JCI119582; Bleau AM, 2005, FRONT BIOSCI-LANDMRK, V10, P998, DOI 10.2741/1594; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BROCK TA, 1985, HYPERTENSION, V7, pI105, DOI 10.1161/01.HYP.7.3_Pt_2.I105; Buetow BS, 2003, AM J PATHOL, V163, P979, DOI 10.1016/S0002-9440(10)63457-8; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cao YH, 2013, TRENDS MOL MED, V19, P460, DOI 10.1016/j.molmed.2013.05.002; Chai YC, 1996, J BIOL CHEM, V271, P17791, DOI 10.1074/jbc.271.30.17791; Changsirikulchai S, 2002, KIDNEY INT, V62, P2043, DOI 10.1046/j.1523-1755.2002.00662.x; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; CHEN HC, 1994, J BIOL CHEM, V269, P31229; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; CHOI ET, 1994, J VASC SURG, V19, P125, DOI 10.1016/S0741-5214(94)70127-X; Choudhury GG, 1997, AM J PHYSIOL-RENAL, V273, pF931, DOI 10.1152/ajprenal.1997.273.6.F931; Evanko SP, 1998, AM J PATHOL, V152, P533; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010; Grzeszkiewicz TM, 2002, ENDOCRINOLOGY, V143, P1441, DOI 10.1210/en.143.4.1441; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hilfiker A, 2002, CIRCULATION, V106, P254, DOI 10.1161/01.CIR.0000021426.87274.62; JACKSON CL, 1993, ARTERIOSCLER THROMB, V13, P1218, DOI 10.1161/01.ATV.13.8.1218; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Kappert K, 2001, BASIC RES CARDIOL, V96, P42, DOI 10.1007/s003950170076; KIRCHBERG K, 1995, EXP CELL RES, V220, P29, DOI 10.1006/excr.1995.1288; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; KOTITE NJ, 1984, BIOCHEMISTRY-US, V23, P3099, DOI 10.1021/bi00308a038; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Leppanen O, 2000, ARTERIOSCL THROM VAS, V20, pE89, DOI 10.1161/01.ATV.20.11.e89; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Marek I, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-102; Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6; Noiseux N, 2000, CIRCULATION, V102, P1330, DOI 10.1161/01.CIR.102.11.1330; O'Kelly J, 2008, INT J ONCOL, V33, P59; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; RANKIN S, 1994, J BIOL CHEM, V269, P704; Sano H, 2001, CIRCULATION, V103, P2955, DOI 10.1161/01.CIR.103.24.2955; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Seki J, 1996, CIRC RES, V78, P596, DOI 10.1161/01.RES.78.4.596; Sirois MG, 1997, CIRCULATION, V95, P669, DOI 10.1161/01.CIR.95.3.669; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Varadarajulu J, 2005, BIOCHEM BIOPH RES CO, V331, P404, DOI 10.1016/j.bbrc.2005.03.175; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266; Witzenbichler B, 1999, J CLIN INVEST, V104, P1469, DOI 10.1172/JCI7251; Wu DD, 2014, J BIOL CHEM, V289, P5774, DOI 10.1074/jbc.M113.533042; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	56	18	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8232	8242		10.1074/jbc.M114.623074	http://dx.doi.org/10.1074/jbc.M114.623074			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25623072	Green Published, hybrid			2022-12-26	WOS:000351662600020
J	Chen, JX; Enns, CA				Chen, Juxing; Enns, Caroline A.			CD81 Promotes Both the Degradation of Transferrin Receptor 2 (TfR2) and the Tfr2-mediated Maintenance of Hepcidin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Iron; Iron Metabolism; Protein Degradation; Tetraspanin	EPIDERMAL-GROWTH-FACTOR; ANTIMICROBIAL PEPTIDE HEPCIDIN; E3 UBIQUITIN LIGASE; SIGNAL-TRANSDUCTION; IRON OVERLOAD; JUVENILE HEMOCHROMATOSIS; MEDIATED ENDOCYTOSIS; HUMAN FIBROBLASTS; KNOCKOUT MOUSE; EGF RECEPTOR	Background: Loss of function mutations in TfR2 cause iron overload in the body. Results: CD81, a scaffold protein, controls the level of TfR2 and links TfR2 to E3 ligase, GRAIL. Conclusion: CD81 down-regulates TfR2 and increases hepcidin levels in Hep3B cells. Significance: The association of TfR2 with CD81 controls both TfR2 trafficking and hepcidin mRNA. Mutations in transferrin receptor 2 (TfR2) cause a rare form of the hereditary hemochromatosis, resulting in iron overload predominantly in the liver. TfR2 is primarily expressed in hepatocytes and is hypothesized to sense iron levels in the blood to positively regulate the expression of hepcidin through activation of the BMP signaling pathway. Hepcidin is a peptide hormone that negatively regulates iron egress from cells and thus limits intestinal iron uptake. In this study, a yeast two-hybrid approach using the cytoplasmic domain of TfR2 identified CD81 as an interacting protein. CD81 is an abundant tetraspanin in the liver. Co-precipitations of CD81 with different TfR2 constructs demonstrated that both the cytoplasmic and ecto-transmembrane domains of TfR2 interact with CD81. Knockdown of CD81 using siRNA significantly increased TfR2 levels by increasing the half-life of TfR2, indicating that CD81 promotes degradation of TfR2. Previous studies showed that CD81 is targeted for degradation by GRAIL, an ubiquitin E3 ligase. Knockdown of GRAIL in Hep3B-TfR2 cells increased TfR2 levels, consistent with inhibition of CD81 ubiquitination. These results suggest that down-regulation of CD81 by GRAIL targets TfR2 for degradation. Surprisingly, knockdown of CD81 decreased hepcidin expression, implying that the TfR2/CD81 complex is involved in the maintenance of hepcidin mRNA. Moreover, knockdown of CD81 did not affect the stimulation of hepcidin expression by BMP6 but increased both the expression of ID1 and SMAD7, direct targets of BMP signaling pathway, and the phosphorylation of ERK1/2, indicating that the CD81 regulates hepcidin expression differently from the BMP and ERK1/2 signaling pathways.	[Chen, Juxing; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA	Oregon Health & Science University	Enns, CA (corresponding author), Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ennsca@ohsu.edu			National Institutes of Health [R01-DK072166, R37-DK054488]; American Heart Association [11POST5250029]; Collins Medical Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166, R37DK054488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Collins Medical Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK072166 and R37-DK054488 (to C. A. E.). This work was also supported by American Heart Association Grant 11POST5250029 and a Collins Medical Trust grant (to J. C.).	Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Carloni V, 2004, ONCOGENE, V23, P1566, DOI 10.1038/sj.onc.1207287; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; CARPENTER G, 1975, J BIOL CHEM, V250, P4297; Chen JX, 2007, J BIOL CHEM, V282, P6201, DOI 10.1074/jbc.M610127200; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Corradini E, 2011, GASTROENTEROLOGY, V141, P1907, DOI 10.1053/j.gastro.2011.06.077; Cottrell GS, 2003, BIOCHEM SOC T, V31, P1191; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; DUNN WA, 1986, J CELL BIOL, V102, P24, DOI 10.1083/jcb.102.1.24; Falzacappa MVV, 2008, J MOL MED, V86, P531, DOI 10.1007/s00109-008-0313-7; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; Guihard S, 2010, BLOOD, V115, P3686, DOI 10.1182/blood-2009-09-242487; JOHNSON AE, 1993, BRAIN RES, V622, P9, DOI 10.1016/0006-8993(93)90795-O; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI WH, 1986, ENDOCRINOLOGY, V118, P413, DOI 10.1210/endo-118-1-413; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Lineberry N, 2008, J BIOL CHEM, V283, P28497, DOI 10.1074/jbc.M805092200; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; MILLER K, 1986, J CELL BIOL, V102, P500, DOI 10.1083/jcb.102.2.500; Nakamichi S, 2009, J MOL ENDOCRINOL, V42, P161, DOI 10.1677/JME-08-0145; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Poll M, 2010, HAEMATOL-HEMATOL J, V95, P1832, DOI 10.3324/haematol.2010.027003; Ramey G, 2009, HAEMATOL-HEMATOL J, V94, P765, DOI 10.3324/haematol.2008.003541; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Rocha-Perugini V, 2013, MOL CELL BIOL, V33, P3644, DOI 10.1128/MCB.00302-13; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Seaman MNJ, 1996, CURR OPIN CELL BIOL, V8, P549, DOI 10.1016/S0955-0674(96)80034-2; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Truksa J, 2009, BLOOD, V113, P688, DOI 10.1182/blood-2008-05-160184; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Vogt TM, 2003, BLOOD, V101, P2008, DOI 10.1182/blood-2002-09-2742; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; Wallace DF, 2002, BLOOD, V100, P692, DOI 10.1182/blood.V100.2.692; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Zona L, 2014, VIRUSES-BASEL, V6, P875, DOI 10.3390/v6020875	54	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7841	7850		10.1074/jbc.M114.632778	http://dx.doi.org/10.1074/jbc.M114.632778			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25635054	Green Published, hybrid			2022-12-26	WOS:000351613600042
J	Chotewutmontri, P; Bruce, BD				Chotewutmontri, Prakitchai; Bruce, Barry D.			Non-native, N-terminal Hsp70 Molecular Motor Recognition Elements in Transit Peptides Support Plastid Protein Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-Kilodalton Heat Shock Protein (Hsp70); Arabidopsis thaliana; Cell Biology; Chloroplast; Molecular Motor; Protein Translocation; Transit Peptide	IN-VIVO IMPORT; SMALL-SUBUNIT; SEQUENCE MOTIFS; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS CHLOROPLASTS; SUBSTRATE-SPECIFICITY; ENVELOPE MEMBRANES; TARGETING SEQUENCE; PRECURSOR PROTEINS; ESCHERICHIA-COLI	Background: Transit peptides direct the import of the majority of chloroplast-destined proteins into chloroplasts. Results: Multiple unrelated Hsp70 recognition elements are able to substitute for the translocation determinant domain of transit peptides. Conclusion: The majority of transit peptides utilize Hsp70-interacting property to initiate import. Significance: This finding expands the mechanistic view of the chloroplast protein import process. Previously, we identified the N-terminal domain of transit peptides (TPs) as a major determinant for the translocation step in plastid protein import. Analysis of Arabidopsis TP dataset revealed that this domain has two overlapping characteristics, highly uncharged and Hsp70-interacting. To investigate these two properties, we replaced the N-terminal domains of the TP of the small subunit of ribulose-1,5-bisphosphate carboxylase/oxygenase and its reverse peptide with a series of unrelated peptides whose affinities to the chloroplast stromal Hsp70 have been determined. Bioinformatic analysis indicated that eight out of nine peptides in this series are not similar to the TP N terminus. Using in vivo and in vitro protein import assays, the majority of the precursors containing Hsp70-binding elements were targeted to plastids, whereas none of the chimeric precursors lacking an N-terminal Hsp70-binding element were targeted to the plastids. Moreover, a pulse-chase assay showed that two chimeric precursors with the most uncharged peptides failed to translocate into the stroma. The ability of multiple unrelated Hsp70-binding elements to support protein import verified that the majority of TPs utilize an N-terminal Hsp70-binding domain during translocation and expand the mechanistic view of the import process. This work also indicates that synthetic biology may be utilized to create de novo TPs that exceed the targeting activity of naturally occurring sequences.	[Chotewutmontri, Prakitchai; Bruce, Barry D.] Univ Tennessee, Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Bruce, Barry D.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Bruce, BD (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	bbruce@utk.edu	Chotewutmontri, Prakitchai/AAB-7079-2019	Chotewutmontri, Prakitchai/0000-0002-8672-2973	National Science Foundation Program in Cell Biology [MCB-0628670, MCB-0344601]; TN-SCORE, a multidisciplinary research program - NSF-EPSCOR [EPS-1004083]; Gibson Family Foundation	National Science Foundation Program in Cell Biology; TN-SCORE, a multidisciplinary research program - NSF-EPSCOR; Gibson Family Foundation	This work was supported in part by National Science Foundation Program in Cell Biology Grants MCB-0628670 and MCB-0344601 (to B. D. B.), TN-SCORE, a multidisciplinary research program sponsored by NSF-EPSCOR Grant EPS-1004083 (to B. D. B.), and support from the Gibson Family Foundation (to B. D. B.).	Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMERICA T, 1994, PLANT MOL BIOL, V24, P283, DOI 10.1007/BF00020168; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bionda T, 2010, J MOL BIOL, V402, P510, DOI 10.1016/j.jmb.2010.07.052; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; Bruce BD, 1998, PLANT MOL BIOL, V38, P223, DOI 10.1023/A:1006094308805; Bruch EM, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-57; Chotewutmontri P, 2012, PLANT CELL, V24, P3040, DOI 10.1105/tpc.112.098327; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Chu CC, 2012, PLANT PHYSIOL, V158, P1656, DOI 10.1104/pp.112.193300; Constan D, 2004, PLANT PHYSIOL, V136, P3605, DOI 10.1104/pp.104.052928; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dabney-Smith C, 1999, J BIOL CHEM, V274, P32351, DOI 10.1074/jbc.274.45.32351; de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r; DOBBERSTEIN B, 1977, P NATL ACAD SCI USA, V74, P1082, DOI 10.1073/pnas.74.3.1082; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Flores-Perez U, 2013, BBA-MOL CELL RES, V1833, P332, DOI 10.1016/j.bbamcr.2012.03.019; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Henikoff S, 1996, CURR OPIN STRUC BIOL, V6, P353, DOI 10.1016/S0959-440X(96)80055-8; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Inoue H, 2013, P NATL ACAD SCI USA, V110, P3173, DOI 10.1073/pnas.1219229110; Ivey RA, 2000, PLANT PHYSIOL, V122, P1289, DOI 10.1104/pp.122.4.1289; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Keegstra K, 1999, PLANT CELL, V11, P557, DOI 10.1105/tpc.11.4.557; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Klee EW, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-256; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; KLEIN RR, 1992, PLANT PHYSIOL, V98, P546, DOI 10.1104/pp.98.2.546; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; Kovacheva S, 2007, PLANT J, V50, P364, DOI 10.1111/j.1365-313X.2007.03060.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Lee DW, 2008, PLANT CELL, V20, P1603, DOI 10.1105/tpc.108.060541; Lee DW, 2009, PLANT PHYSIOL, V151, P129, DOI 10.1104/pp.109.140673; Lee DW, 2006, PLANT PHYSIOL, V140, P466, DOI 10.1104/pp.105.074575; Lee KH, 2002, MOL CELLS, V14, P388; Li HM, 2013, TRENDS PLANT SCI, V18, P360, DOI 10.1016/j.tplants.2013.04.003; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; MARSHALL JS, 1992, PLANT PHYSIOL, V100, P1048, DOI 10.1104/pp.100.2.1048; MARSHALL JS, 1990, P NATL ACAD SCI USA, V87, P374, DOI 10.1073/pnas.87.1.374; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Mizuno S, 2012, FEBS J, V279, P1474, DOI 10.1111/j.1742-4658.2012.08540.x; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olinares PDB, 2011, BBA-BIOENERGETICS, V1807, P999, DOI 10.1016/j.bbabio.2010.12.003; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; PILON M, 1995, J BIOL CHEM, V270, P3882, DOI 10.1074/jbc.270.8.3882; Pinnaduwage P, 1996, J BIOL CHEM, V271, P32907, DOI 10.1074/jbc.271.51.32907; Reddick LE, 2008, METHOD CELL BIOL, V90, P365, DOI 10.1016/S0091-679X(08)00816-9; Rensink WA, 1998, PLANT PHYSIOL, V118, P691, DOI 10.1104/pp.118.2.691; Rial DV, 2000, EUR J BIOCHEM, V267, P6239, DOI 10.1046/j.1432-1327.2000.01707.x; Rial DV, 2003, J BIOL CHEM, V278, P46473, DOI 10.1074/jbc.M306684200; Richly E, 2004, GENE, V329, P11, DOI 10.1016/j.gene.2004.01.008; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Ruprecht M, 2010, MOL PLANT, V3, P499, DOI 10.1093/mp/ssp116; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHMITT M, 1995, EMBO J, V14, P3434, DOI 10.1002/j.1460-2075.1995.tb07349.x; SCHNELL DJ, 1994, SCIENCE, V266, P1007, DOI 10.1126/science.7973649; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; SHANKLIN J, 1995, PLANT CELL, V7, P1713, DOI 10.1105/tpc.7.10.1713; Shi LX, 2013, BBA-MOL CELL RES, V1833, P314, DOI 10.1016/j.bbamcr.2012.10.002; Shi LX, 2011, PLANT SIGNAL BEHAV, V6, P1397, DOI 10.4161/psb.6.9.16916; Shi LX, 2010, PLANT CELL, V22, P205, DOI 10.1105/tpc.109.071464; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Soll J, 2004, NAT REV MOL CELL BIO, V5, P198, DOI 10.1038/nrm1333; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Teng YS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001416; THEG SM, 1989, J BIOL CHEM, V264, P6730; vandenWijngaard PWJ, 1997, J BIOL CHEM, V272, P29430, DOI 10.1074/jbc.272.47.29430; VONHEIJNE G, 1991, FEBS LETT, V278, P1, DOI 10.1016/0014-5793(91)80069-F; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; VONHEIJNE G, 1991, PLANT MOL BIOL REP, V9, P104; Wilkins MR, 1999, METH MOL B, V112, P531; Xia D, 2004, J STRUCT BIOL, V146, P166, DOI 10.1016/j.jsb.2003.11.025; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	92	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7602	7621		10.1074/jbc.M114.633586	http://dx.doi.org/10.1074/jbc.M114.633586			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25645915	hybrid, Green Published			2022-12-26	WOS:000351613600024
J	Liang, X; Samways, DSK; Wolf, K; Bowles, EA; Richards, JP; Bruno, J; Dutertre, S; DiPaolo, RJ; Egan, TM				Liang, Xin; Samways, Damien S. K.; Wolf, Kyle; Bowles, Elizabeth A.; Richards, Jennifer P.; Bruno, Jonathan; Dutertre, Sebastien; DiPaolo, Richard J.; Egan, Terrance M.			Quantifying Ca2+ Current and Permeability in ATP-gated P2X7 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Transport; Ion Channel; Lymphocyte; Macrophage; Purinergic Receptor; Fractional Calcium Current; Ligand-gated Ion Channel; Pore Dilation; Relative Calcium Permeability	CENTRAL-NERVOUS-SYSTEM; P2X(7) RECEPTOR; EXTRACELLULAR ATP; NEUROTRANSMITTER RELEASE; ALLOSTERIC MODULATION; CALCIUM PERMEABILITY; CATION PERMEABILITY; IL-1-BETA SECRETION; NUCLEOTIDE RECEPTOR; DIVALENT-CATIONS	Background: Ca2+ triggers many of the actions of extracellular ATP. Results: We measured the Ca2+ component of the ATP-gated non-selective cation current of P2X7 receptors. Conclusion: Ca2+ flux varied with the species of origin, the splice variant, and the agonist concentration. Significance: Our results suggest that domains that lie outside of the pore regulate the Ca2+ flux of P2X7 receptors. ATP-gated P2X7 receptors are prominently expressed in inflammatory cells and play a key role in the immune response. A major consequence of receptor activation is the regulated influx of Ca2+ through the self-contained cation non-selective channel. Although the physiological importance of the resulting rise in intracellular Ca2+ is universally acknowledged, the biophysics of the Ca2+ flux responsible for the effects are poorly understood, largely because traditional methods of measuring Ca2+ permeability are difficult to apply to P2X7 receptors. Here we use an alternative approach, called dye-overload patch-clamp photometry, to quantify the agonist-gated Ca2+ flux of recombinant P2X7 receptors of dog, guinea pig, human, monkey, mouse, rat, and zebrafish. We find that the magnitude of the Ca2+ component of the ATP-gated current depends on the species of origin, the splice variant, and the concentration of the purinergic agonist. We also measured a significant contribution of Ca2+ to the agonist-gated current of the native P2X7Rs of mouse and human immune cells. Our results provide cross-species quantitative measures of the Ca2+ current of the P2X7 receptor for the first time, and suggest that the cytoplasmic N terminus plays a meaningful role in regulating the flow of Ca2+ through the channel.	[Liang, Xin; Bowles, Elizabeth A.; Richards, Jennifer P.; Egan, Terrance M.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Liang, Xin; Bowles, Elizabeth A.; Richards, Jennifer P.; Egan, Terrance M.] St Louis Univ, Sch Med, Ctr Neurosci, St Louis, MO 63104 USA; [Wolf, Kyle; DiPaolo, Richard J.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Bruno, Jonathan] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA; [Samways, Damien S. K.] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA; [Dutertre, Sebastien] Univ Montpellier 2, CNRS, UMR 5247, Inst Biomol Max Mousseron, Montpellier, France	Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; Clarkson University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Egan, TM (corresponding author), 1402 South Grand Blvd, St Louis, MO 63104 USA.	egantm@slu.edu	Bruno, Jonathan/HII-3034-2022	Egan, Terrance/0000-0002-7249-3161; Wolf, Kyle/0000-0003-4874-2911; Dutertre, Sebastien/0000-0002-2945-1484	National Institutes of Health [HL56236]; American Cancer Society [12-171-01-LIB]; St. Louis University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); St. Louis University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL56236 (to T. M. E.) American Cancer Society Research Scholar Grant 12-171-01-LIB (to R. J. D.), and Blue Ribbon Funding from the St. Louis University School of Medicine (to T. M. E.).	Adinolfi E, 2010, FASEB J, V24, P3393, DOI 10.1096/fj.09-153601; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Alloisio S, 2008, FEBS LETT, V582, P3948, DOI 10.1016/j.febslet.2008.10.041; Baconguis I, 2013, CURR OPIN STRUC BIOL, V23, P277, DOI 10.1016/j.sbi.2013.04.005; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; BRETSCHNEIDER F, 1995, PFLUG ARCH EUR J PHY, V429, P691, DOI 10.1007/BF00373990; Browne LE, 2013, J NEUROSCI, V33, P3557, DOI 10.1523/JNEUROSCI.2235-12.2013; Browne LE, 2011, NAT NEUROSCI, V14, P17, DOI 10.1038/nn.2705; Burnashev N, 1996, CURR OPIN NEUROBIOL, V6, P311, DOI 10.1016/S0959-4388(96)80113-9; Burnashev N, 1998, CELL CALCIUM, V24, P325, DOI 10.1016/S0143-4160(98)90056-2; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; Chen LF, 2006, CRIT REV IMMUNOL, V26, P499, DOI 10.1615/CritRevImmunol.v26.i6.30; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Cuadra AE, 2014, J CELL PHYSIOL, V229, P333, DOI 10.1002/jcp.24453; Davies John Q, 2005, Methods Mol Biol, V290, P91; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Di Virgilio F, 2009, CURR OPIN PHARMACOL, V9, P507, DOI 10.1016/j.coph.2009.06.021; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; DIVIRGILIO F, 1990, IMMUNOL TODAY, V11, P274, DOI 10.1016/0167-5699(90)90111-L; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Faroni A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.268; Fischer W, 2003, J NEUROCHEM, V85, P779, DOI 10.1046/j.1471-4159.2003.01716.x; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Frings S, 2000, METHOD ENZYMOL, V315, P797; Gallin E. K., 1989, NEUTROPHIL CELLULAR, P243; Glaser T, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-12; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; Grol MW, 2009, PURINERG SIGNAL, V5, P205, DOI 10.1007/s11302-009-9139-1; Gudipaty L, 2003, AM J PHYSIOL-CELL PH, V285, pC286, DOI 10.1152/ajpcell.00070.2003; Guerra AN, 2007, PURINERG SIGNAL, V3, P39, DOI 10.1007/s11302-006-9035-x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hanley PJ, 2012, J BIOL CHEM, V287, P10650, DOI 10.1074/jbc.M111.332676; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; He ML, 2003, AM J PHYSIOL-CELL PH, V285, pC467, DOI 10.1152/ajpcell.00042.2003; Hille B., 1992, IONIC CHANNELS EXCIT, P21; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jatzke C, 2002, J PHYSIOL-LONDON, V538, P25, DOI 10.1113/jphysiol.2001.012897; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2012, CELL HEALTH CYTOSKEL, V4, P83, DOI 10.2147/CHC.S27196; Jiang LH, 2009, EUR BIOPHYS J BIOPHY, V38, P339, DOI 10.1007/s00249-008-0315-y; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Koles L, 2011, ADV PHARMACOL, V61, P441, DOI 10.1016/B978-0-12-385526-8.00014-X; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Marcoli M, 2008, J NEUROCHEM, V105, P2330, DOI 10.1111/j.1471-4159.2008.05322.x; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Nicke A, 2004, EUR J BIOCHEM, V271, P2293, DOI 10.1111/j.1432-1033.2004.04171.x; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; Norenberg W, 2012, BRIT J PHARMACOL, V167, P48, DOI 10.1111/j.1476-5381.2012.01987.x; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Ozaki H, 2004, NEUROGASTROENT MOTIL, V16, P39, DOI 10.1046/j.1365-2982.2003.00461.x; Pankratov Y, 2014, EUR J PHARMACOL, V739, P60, DOI 10.1016/j.ejphar.2013.11.017; Partridge LD, 1998, METHOD ENZYMOL, V293, P371; Paukert M, 2002, FEBS LETT, V513, P253, DOI 10.1016/S0014-5793(02)02324-4; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; ROGERS M, 1995, BIOPHYS J, V68, P501, DOI 10.1016/S0006-3495(95)80211-0; Rubini P, 2014, N-S ARCH PHARMACOL, V387, P943, DOI 10.1007/s00210-014-1005-1; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Samways DSK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00006; Samways DSK, 2012, J BIOL CHEM, V287, P7594, DOI 10.1074/jbc.M111.322461; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Scatizzi JC, 2009, EUR J IMMUNOL, V39, P820, DOI 10.1002/eji.200838683; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Schwarz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041269; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sim JA, 2007, BRIT J PHARMACOL, V152, P1283, DOI 10.1038/sj.bjp.0707504; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Sperlagh B, 2007, PURINERG SIGNAL, V3, P269, DOI 10.1007/s11302-007-9080-0; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stojilkovic SS, 2014, ANTIOXID REDOX SIGN, V21, P953, DOI 10.1089/ars.2013.5549; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taylor SRJ, 2009, J LEUKOCYTE BIOL, V85, P978, DOI 10.1189/jlb.0408251; Torres GE, 1999, J BIOL CHEM, V274, P22359, DOI 10.1074/jbc.274.32.22359; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Weisman GA, 2012, MOL NEUROBIOL, V46, P96, DOI 10.1007/s12035-012-8263-z; Wollmuth LP, 1998, J GEN PHYSIOL, V112, P623, DOI 10.1085/jgp.112.5.623; Xu XJ, 2012, J CELL SCI, V125, P3776, DOI 10.1242/jcs.099374; Yan ZH, 2011, J GEN PHYSIOL, V138, P437, DOI 10.1085/jgp.201110647; Yan ZH, 2010, J NEUROSCI, V30, P14213, DOI 10.1523/JNEUROSCI.2390-10.2010; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059; Zeilhofer HU, 1996, J NEUROPHYSIOL, V76, P2834, DOI 10.1152/jn.1996.76.5.2834; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	100	27	27	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7930	7942		10.1074/jbc.M114.627810	http://dx.doi.org/10.1074/jbc.M114.627810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25645917	Green Published, hybrid			2022-12-26	WOS:000351613600050
J	Abraham, S; Paknikar, R; Bhumbra, S; Luan, D; Garg, R; Dressler, GR; Patel, SR				Abraham, Saji; Paknikar, Raghavendra; Bhumbra, Samina; Luan, Danny; Garg, Rohan; Dressler, Gregory R.; Patel, Sanjeevkumar R.			The Groucho-associated Phosphatase PPM1B Displaces Pax Transactivation Domain Interacting Protein (PTIP) to Switch the Transcription Factor Pax2 from a Transcriptional Activator to a Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRCT-DOMAIN; METHYLTRANSFERASE COMPLEX; H3K4 METHYLATION; GENES; CHROMATIN; 2C; PHOSPHORYLATION; COREPRESSOR; RECOGNITION; EXPRESSION	Pax genes encode developmental regulatory proteins that specify cell lineages and tissues in metazoans. Upon binding to DNA through the conserved paired domain, Pax proteins can recruit both activating and repressing complexes that imprint distinct patterns of histone methylation associated with either gene activation or silencing. How the switch from Pax-mediated activation to repression is regulated remains poorly understood. In this report, we identify the phosphatase PPM1B as an essential component of the Groucho4 repressor complex that is recruited by Pax2 to chromatin. PPM1B can dephosphorylate the Pax2 activation domain and displace the adaptor protein PTIP, thus inhibiting H3K4 methylation and gene activation. Loss of PPM1B prevents Groucho-mediated gene repression. Thus, PPM1B helps switch Pax2 from a transcriptional activator to a repressor protein. This can have profound implications for developmental regulation by Pax proteins and suggests a model for imprinting specific epigenetic marks depending on the availability of co-factors.	[Abraham, Saji; Paknikar, Raghavendra; Bhumbra, Samina; Luan, Danny; Garg, Rohan; Patel, Sanjeevkumar R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Dressler, Gregory R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Patel, SR (corresponding author), Univ Michigan, Dept Internal Med, 1560 W Med Ctr Dr,1560 MSRBII, Ann Arbor, MI 48109 USA.	sanjeevk@umich.edu	Bhumbra, Samina/AAX-8266-2020	Bhumbra, Samina/0000-0002-4036-0479; Abraham, Saji/0000-0001-7035-0610	National Institutes of Health [DK082409, DK073722, DK054740]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062914, R01DK054740, R01DK082409, R01DK073722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK082409 (to S. R. P.) and DK073722 and DK054740 (to G. R. D.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blake JA, 2008, DEV DYNAM, V237, P2791, DOI 10.1002/dvdy.21711; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Cai Y, 2003, EMBO J, V22, P5522, DOI 10.1093/emboj/cdg536; Cai Y, 2002, J BIOL CHEM, V277, P1217, DOI 10.1074/jbc.M109663200; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Kim D, 2009, STEM CELLS, V27, P1516, DOI 10.1002/stem.79; Klumpp S, 1998, FEBS LETT, V437, P229, DOI 10.1016/S0014-5793(98)01237-X; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Lefevre GM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001142; Linderson Y, 2004, EMBO REP, V5, P291, DOI 10.1038/sj.embor.7400089; Liu Y, 2014, BIOCHEM BIOPH RES CO, V444, P634, DOI 10.1016/j.bbrc.2014.01.143; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Papamichos-Chronakis M, 2000, J BIOL CHEM, V275, P8397, DOI 10.1074/jbc.275.12.8397; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Patel SR, 2012, MOL CELL, V45, P185, DOI 10.1016/j.molcel.2011.11.007; Patel SR, 2004, DEV BIOL, V267, P505, DOI 10.1016/j.ydbio.2003.11.002; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Schwab KR, 2011, MOL CELL BIOL, V31, P1503, DOI 10.1128/MCB.00990-10; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shimizu K, 2001, MOL CELL BIOL, V21, P3901, DOI 10.1128/MCB.21.12.3901-3912.2001; Soofi A, 2012, DEV BIOL, V365, P241, DOI 10.1016/j.ydbio.2012.02.032; Stein AB, 2011, J CLIN INVEST, V121, P2641, DOI 10.1172/JCI44641; Tasdelen I, 2013, BIOCHEM J, V451, P45, DOI 10.1042/BJ20121113; Torres M, 1995, DEVELOPMENT, V121, P4057; Torres MA, 1996, DEVELOPMENT, V122, P3381; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; Yien YY, 2012, J BIOL CHEM, V287, P15193, DOI 10.1074/jbc.M112.350496	44	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7185	7194		10.1074/jbc.M114.607424	http://dx.doi.org/10.1074/jbc.M114.607424			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631048	Green Published, hybrid			2022-12-26	WOS:000350991500048
J	Lee, SA; Kim, SM; Suh, BK; Sun, HY; Park, YU; Hong, JH; Park, C; Nguyen, MD; Nagata, K; Yoo, JY; Park, SK				Lee, Seol-Ae; Kim, Seong-Mo; Suh, Bo Kyoung; Sun, Hwa-Young; Park, Young-Un; Hong, Ji-Ho; Park, Cana; Minh Dang Nguyen; Nagata, Koh-ichi; Yoo, Joo-Yeon; Park, Sang Ki			Disrupted-in-schizophrenia 1 (DISC1) Regulates Dysbindin Function by Enhancing Its Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL-FORMATION; UBIQUITIN-LIGASE; ORGANELLES COMPLEX-1; SUSCEPTIBILITY GENE; NEURITE OUTGROWTH; PROTEIN; DTNBP1; BLOC-1; ASSOCIATION; BIOGENESIS	Dysbindin and DISC1 are schizophrenia susceptibility factors playing roles in neuronal development. Here we show that the physical interaction between dysbindin and DISCI is critical for the stability of dysbindin and for the process of neurite outgrowth. We found that DISCI forms a complex with dysbindin and increases its stability in association with a reduction in ubiquitylation. Furthermore, knockdown of DISCI or expression of a deletion mutant, DISCI lacking amino acid residues 403-504 of DISC1 (DISC1(Delta 403-504)), effectively decreased levels of endogenous dysbindin. Finally, the neurite outgrowth defect induced by knockdown of DISCI was partially reversed by coexpression of dysbindin. Taken together, these results indicate that dysbindin and DISC1 form a physiologically functional complex that is essential for normal neurite outgrowth.	[Lee, Seol-Ae; Kim, Seong-Mo; Suh, Bo Kyoung; Sun, Hwa-Young; Park, Young-Un; Hong, Ji-Ho; Park, Cana; Yoo, Joo-Yeon; Park, Sang Ki] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Minh Dang Nguyen] Univ Calgary, Hotchkiss Brain Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Nagata, Koh-ichi] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Kasugai, Aichi 4800392, Japan	Pohang University of Science & Technology (POSTECH); University of Calgary; University of Calgary; University of Calgary	Park, SK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea.	skpark@postech.ac.kr			ministry of science, ICT, and future planning ((MSIP) [NRF-2012R1A2A2A01012923, NRF-2012R1A4A1028200, NRF-2013R1A1A2074251]; national research foundation (NRF) of Korea [NRF-2012K2A1A2033117]; POSTECH basic science research institute (BSRI) Fund	ministry of science, ICT, and future planning ((MSIP); national research foundation (NRF) of Korea(National Research Foundation of Korea); POSTECH basic science research institute (BSRI) Fund	This work was supported by Grants (NRF-2012R1A2A2A01012923, NRF-2012R1A4A1028200, and NRF-2013R1A1A2074251 from the ministry of science, ICT, and future planning ((MSIP) and by the Framework of International Cooperation Program managed by national research foundation (NRF) of Korea (Grant NRF-2012K2A1A2033117). This work was also supported by the POSTECH basic science research institute (BSRI) Fund.	ARNOLD SE, 1991, P NATL ACAD SCI USA, V88, P10850, DOI 10.1073/pnas.88.23.10850; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Buxhoeveden D, 2000, BIOL PSYCHIAT, V47, P681, DOI 10.1016/S0006-3223(99)00275-9; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Carr GV, 2013, BEHAV BRAIN RES, V241, P173, DOI 10.1016/j.bbr.2012.12.021; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Fukuda T, 2010, J BIOL CHEM, V285, P40554, DOI 10.1074/jbc.M110.179481; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Guo AY, 2009, MOL PSYCHIATR, V14, P18, DOI 10.1038/mp.2008.88; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hattori T, 2007, MOL PSYCHIATR, V12, P398, DOI 10.1038/sj.mp.4001945; Hattori T, 2010, MOL PSYCHIATR, V15, P798, DOI 10.1038/mp.2010.60; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; Ito H, 2010, MOL PSYCHIATR, V15, P976, DOI [10.1038/mp.2010.69, 10.1038/mp.2010.93]; Jaaro-Peled H, 2009, PROG BRAIN RES, V179, P75, DOI 10.1016/S0079-6123(09)17909-8; Kalus P, 2000, NEUROREPORT, V11, P3621, DOI 10.1097/00001756-200011090-00044; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Ma TM, 2013, MOL PSYCHIATR, V18, P557, DOI 10.1038/mp.2012.97; Ma X, 2011, MOL PSYCHIATR, V16, P1105, DOI 10.1038/mp.2011.43; Mead CLR, 2010, J NEUROCHEM, V113, P1491, DOI 10.1111/j.1471-4159.2010.06690.x; Meyer KD, 2009, HUM MOL GENET, V18, P3286, DOI 10.1093/hmg/ddp266; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Morris DW, 2008, BIOL PSYCHIAT, V63, P24, DOI 10.1016/j.biopsych.2006.12.025; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; O'Donovan MC, 2003, HUM MOL GENET, V12, pR125, DOI 10.1093/hmg/ddg302; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Papaleo F, 2012, MOL PSYCHIATR, V17, P85, DOI 10.1038/mp.2010.106; Park YU, 2010, P NATL ACAD SCI USA, V107, P17785, DOI 10.1073/pnas.1004361107; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Selemon LD, 2004, AM J PSYCHIAT, V161, P1564, DOI 10.1176/appi.ajp.161.9.1564; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041	49	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7087	7096		10.1074/jbc.M114.614750	http://dx.doi.org/10.1074/jbc.M114.614750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25635053	Green Published, hybrid			2022-12-26	WOS:000350991500040
J	Wang, NL; Wu, XB; Kehrwald, N; Li, Z; Li, QL; Jiang, X; Pu, JC				Wang, Ninglian; Wu, Xiaobo; Kehrwald, Natalie; Li, Zhen; Li, Quanlian; Jiang, Xi; Pu, Jianchen			Fukushima Nuclear Accident Recorded in Tibetan Plateau Snow Pits	PLOS ONE			English	Article							ICE CORE; FALLOUT; CHERNOBYL; ACCUMULATION; RADIATION; GLACIER	The beta radioactivity of snow-pit samples collected in the spring of 2011 on four Tibetan Plateau glaciers demonstrate a remarkable peak in each snow pit profile, with peaks about ten to tens of times higher than background levels. The timing of these peaks suggests that the high radioactivity resulted from the Fukushima nuclear accident that occurred on March 11, 2011 in eastern Japan. Fallout monitoring studies demonstrate that this radioactive material was transported by the westerlies across the middle latitudes of the Northern Hemisphere. The depth of the peak beta radioactivity in each snow pit compared with observational precipitation records, suggests that the radioactive fallout reached the Tibetan Plateau and was deposited on glacier surfaces in late March 2011, or approximately 20 days after the nuclear accident. The radioactive fallout existed in the atmosphere over the Tibetan Plateau for about one month.	[Wang, Ninglian; Wu, Xiaobo; Li, Zhen; Li, Quanlian; Pu, Jianchen] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou, Peoples R China; [Wang, Ninglian] CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Kehrwald, Natalie] Univ Venice, Dept Environm Sci Informat & Stat, I-30123 Venice, Italy; [Jiang, Xi] Nanjing Univ Informat Sci & Technol, Coll Atmospher Sci, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Universita Ca Foscari Venezia; Nanjing University of Information Science & Technology	Wang, NL (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryospher Sci, Lanzhou, Peoples R China.	nlwang@lzb.ac.cn	Kehrwald, Natalie M/A-3848-2013	Kehrwald, Natalie M/0000-0002-9160-2239	Chinese Academy of Sciences [XDB03030204]; National Natural Science Foundation of China [41190084, 41150110475]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Academy of Sciences (Grant No. XDB03030204) and the National Natural Science Foundation of China (Grant Nos. 41190084, 41150110475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beresford NA, 2012, J ENVIRON RADIOACTIV, V114, P48, DOI 10.1016/j.jenvrad.2011.12.008; Beresford Nicholas A., 2011, Integrated Environmental Assessment and Management, V7, P371, DOI 10.1002/ieam.238; Biegalski SR, 2012, J ENVIRON RADIOACTIV, V114, P15, DOI 10.1016/j.jenvrad.2011.11.007; Bolsunovsky A, 2011, J ENVIRON RADIOACTIV, V102, P1062, DOI 10.1016/j.jenvrad.2011.06.007; Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Cosma C, 2012, J ENVIRON RADIOACTIV, V114, P94, DOI 10.1016/j.jenvrad.2011.11.020; Cuffey K. M., 2010, THE PHYSICS OF GLACI; DIBB JE, 1990, NATURE, V345, P25, DOI 10.1038/345025a0; Heikkila U, 2009, ATMOS CHEM PHYS, V9, P4145, DOI 10.5194/acp-9-4145-2009; Hou SG, 2007, CHINESE SCI BULL, V52, P428, DOI 10.1007/s11434-007-0041-3; Hsu SC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL049986; Karlof L, 2000, J GEOPHYS RES-ATMOS, V105, P12471, DOI 10.1029/1999JD901119; Kritidis P, 2012, J ENVIRON RADIOACTIV, V114, P100, DOI 10.1016/j.jenvrad.2011.12.006; Mousseau TA, 2014, OECOLOGIA, V175, P429, DOI 10.1007/s00442-014-2908-8; Pittauerova D, 2011, J ENVIRON RADIOACTIV, V102, P877, DOI 10.1016/j.jenvrad.2011.06.003; POURCHET M, 1988, J GLACIOL, V34, P183, DOI 10.3189/S0022143000032214; Priyadarshi A, 2011, P NATL ACAD SCI USA, V108, P14422, DOI 10.1073/pnas.1109449108; Qiao FL, 2011, CHINESE SCI BULL, V56, P1890, DOI 10.1007/s11434-011-4513-0; Tian LD, 2008, SCI CHINA SER D, V51, P1121, DOI 10.1007/s11430-008-0089-1; Tian LD, 2007, CHINESE SCI BULL, V52, P1436, DOI 10.1007/s11434-007-0188-y; Tositti L, 2012, J ENVIRON RADIOACTIV, V114, P105, DOI 10.1016/j.jenvrad.2012.01.016; Wang H, 2012, CHINESE SCI BULL, V57, P3518, DOI 10.1007/s11434-012-5171-6; Wang N, 2003, GEOPHYS RES LETT, V30, DOI [10.1029/2003GL018188, DOI 10.1029/2003GL018188]; Wang NL, 2002, ANN GLACIOL-SER, V35, P273, DOI 10.3189/172756402781816825; Yao TD, 1996, J GEOPHYS RES-ATMOS, V101, P29531, DOI 10.1029/96JD02683; Yasumura S, 2011, SCIENCE, V333, P684, DOI 10.1126/science.333.6043.684; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Zhang DQ, 2005, SCI CHINA SER D, V48, P266, DOI 10.1360/02yd0219	28	5	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116580	10.1371/journal.pone.0116580	http://dx.doi.org/10.1371/journal.pone.0116580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658094	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900052
J	Arias-Martorell, J; Potau, JM; Bello-Hellegouarch, G; Perez-Perez, A				Arias-Martorell, Julia; Maria Potau, Josep; Bello-Hellegouarch, Gaelle; Perez-Perez, Alejandro			Like Father, Like Son: Assessment of the Morphological Affinities of AL 288-1 (A. afarensis), Sts 7 (A. africanus) and Omo 119-73-2718 (Australopithecus sp.) through a Three-Dimensional Shape Analysis of the Shoulder Joint	PLOS ONE			English	Article							KNUCKLE-WALKING; POSTCRANIAL ROBUSTICITY; FUNCTIONAL-MORPHOLOGY; SKELETAL ALLOMETRY; MIDDLE MIOCENE; LOCOMOTION; MUSCLES; PROPORTIONS; EVOLUTION; HADAR	The postcranial evidence for the Australopithecus genus indicates that australopiths were able bipeds; however, the morphology of the forelimbs and particularly that of the shoulder girdle suggests that they were partially adapted to an arboreal lifestyle. The nature of such arboreal adaptations is still unclear, as are the kind of arboreal behaviors in which australopiths might have engaged. In this study we analyzed the shape of the shoulder joint (proximal humerus and glenoid cavity of the scapula) of three australopith specimens: A. L. 288-1 (A. afarensis), Sts 7 (A. africanus) and Omo 119-73-2718 (Australopithecus sp.) with three-dimensional geometric morphometrics. The morphology of the specimens was compared with that of a wide array of living anthropoid taxa and some additional fossil hominins (the Homo erectus specimen KNM-WT 15000 and the H. neanderthalensis specimen Tabun 1). Our results indicate that A. L. 288-1 shows mosaic traits resembling H. sapiens and Pongo, whereas the Sts 7 shoulder is most similar to the arboreal apes and does not present affinities with H. sapiens. Omo 119-73-2718 exhibits morphological affinities with the more arboreal and partially suspensory New World monkey Lagothrix. The shoulder of the australopith specimens thus shows a combination of primitive and derived traits (humeral globularity, enhancement of internal and external rotation of the joint), related to use of the arm in overhead positions. The genus Homo specimens show overall affinities with H. sapiens at the shoulder, indicating full correspondence of these hominin shoulders with the modern human morphotype.	[Arias-Martorell, Julia; Bello-Hellegouarch, Gaelle; Perez-Perez, Alejandro] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Maria Potau, Josep] Univ Barcelona, Dept Obstet Ginecol Pediat Radiol & Anat, Barcelona, Spain	University of Barcelona; University of Barcelona	Perez-Perez, A (corresponding author), Univ Barcelona, Dept Biol Anim, Barcelona, Spain.	martinez.perez-perez@ub.edu	Ginés, Josep Maria Potau/L-1037-2016; Arias-Martorell, Julia/B-6764-2019; Pérez-Pérez, Alejandro/K-6715-2014; Bello-Hellegouarch, Gaëlle/F-8666-2015	Ginés, Josep Maria Potau/0000-0003-3387-8760; Arias-Martorell, Julia/0000-0001-8110-2946; Pérez-Pérez, Alejandro/0000-0002-1442-1397; 	Spanish Ministerio de Economia y Competitividad [CGL2011-22999, CGL2010-15340]; Generalitat de Catalunya (DURSI) [SGR 884]; Ajudes Predoctorals of the Universitat de Barcelona [APIF-UB 2009/10]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya (DURSI)(Generalitat de Catalunya); Ajudes Predoctorals of the Universitat de Barcelona	This research was funded by the Spanish Ministerio de Economia y Competitividad (CGL2011-22999, CGL2010-15340, both to APP; http://www.mineco.gob.es/portal/site/mineco/), the Generalitat de Catalunya (DURSI 2009 SGR 884 to APP; www.gencat.es/dursi), and the Ajudes Predoctorals of the Universitat de Barcelona (APIF-UB 2009/10 to JAM; http://www.ub.edu/beques/3rcicle/ub/apif/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Aiello L, 1990, AN INTRODUCTION TO E; Alba DM, 2003, J HUM EVOL, V44, P225, DOI 10.1016/S0047-2484(02)00207-5; Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Almecija S, 2014, J HUM EVOL IN PRESS; [Anonymous], 1966, BOWD COLL M STUD GRO; Arias-Martorell J, 2014, AM J PRIMATOL, DOI [10.1002/ajp.22364, DOI 10.1002/AJP.22364]; Arias-Martorell J, 2014, AM J PHYS ANTHROPOL, V154, P459, DOI 10.1002/ajpa.22520; Arias-Martorell J, 2012, J ANAT, V221, P394, DOI 10.1111/j.1469-7580.2012.01560.x; ASHTON E. H., 1963, TRANS ZOOL SOC LONDON, V29, P553; Bello-Hellegouarch G, 2013, INT J PRIMATOL, V34, P315, DOI 10.1007/s10764-013-9660-5; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F. L, 1991, MORPHOMETRIC TOOLS F; Broom R, 1950, STERKFONTEIN APE MEN; BROWN F, 1985, NATURE, V316, P788, DOI 10.1038/316788a0; Cant JGH, 2003, J HUM EVOL, V44, P685, DOI 10.1016/S0047-2484(03)00060-5; Chan LK, 2008, AM J PHYS ANTHROPOL, V136, P265, DOI 10.1002/ajpa.20800; Chan LK, 2007, FOLIA PRIMATOL, V78, P1, DOI 10.1159/000095682; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; Dainton M, 1999, J HUM EVOL, V36, P171, DOI 10.1006/jhev.1998.0265; Dean M. C., 2009, 1 HUMANS ORIGIN EARL, P101; Di Vincenzo F, 2012, J HUM EVOL, V62, P274, DOI 10.1016/j.jhevol.2011.11.010; Doran Diane M., 1994, P93; DORAN DM, 1993, AM J PHYS ANTHROPOL, V91, P83, DOI 10.1002/ajpa.1330910106; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Duren DL, 2001, THESIS; Duren DL, 1995, AM J PHYS ANTHR S20, VS20, P86; Green DJ, 2008, J HUM EVOL, V54, P705, DOI 10.1016/j.jhevol.2007.10.007; Green DJ, 2007, J HUM EVOL, V52, P187, DOI 10.1016/j.jhevol.2006.09.001; Green DJ, 2012, SCIENCE, V338, P514, DOI 10.1126/science.1227123; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARRISON T, 1989, J HUM EVOL, V18, P3, DOI 10.1016/0047-2484(89)90022-5; Hollihn U., 1984, P85; Howell F.C., 1978, P154; Howell F. C., 1976, EARLIEST MAN ENV LAK, P522; HUNT KD, 1991, INT J PRIMATOL, V12, P95, DOI 10.1007/BF02547576; Inman VT, 1944, J BONE JOINT SURG, V26, P1; Jellema Lyman M., 1993, P294; Johanson D., 1976, AM J PHYS ANTHROPOL, V44, P188; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; JUNGERS WL, 1983, J HUM EVOL, V12, P673, DOI 10.1016/S0047-2484(83)80007-4; JUNGERS WL, 1982, NATURE, V297, P676, DOI 10.1038/297676a0; Kagaya M, 2007, ANTHROPOL SCI, V115, P17, DOI 10.1537/ase.041209; Kapandji IA, 2007, THE PHYSIOLOGY OF TH, VI; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Kivell TL, 2009, P NATL ACAD SCI USA, V106, P14241, DOI 10.1073/pnas.0901280106; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Lague MR, 2014, J HUM EVOL, DOI [10.1016/j.jhevol.2014.10.017, DOI 10.1016/J.JHEVOL.2014.10.017]; LARSON SG, 1986, AM J ANAT, V176, P171, DOI 10.1002/aja.1001760207; LARSON SG, 1995, AM J PHYS ANTHROPOL, V98, P13, DOI 10.1002/ajpa.1330980103; Larson SG, 1996, J HUM EVOL, V31, P239, DOI 10.1006/jhev.1996.0059; LARSON SG, 1987, J ZOOL, V212, P629, DOI 10.1111/j.1469-7998.1987.tb05961.x; Larson Susan G., 1993, P45; Larson SG, 2007, EVOL ANTHROPOL, V16, P172, DOI 10.1002/evan.20149; Larson SG, 2007, AM J PHYS ANTHROPOL, V133, P819, DOI 10.1002/ajpa.20505; Larson Susan G., 2013, P247; Larson Susan G., 2007, P437, DOI 10.1007/978-0-387-33507-0_13; LATIMER B, 1987, AM J PHYS ANTHROPOL, V74, P155, DOI 10.1002/ajpa.1330740204; Latimer B., 1991, P169; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; MacLatchy L, 2000, J HUM EVOL, V39, P159, DOI 10.1006/jhev.2000.0407; McCown TD, 1939, THE STONE AGE OF MOU, V2; McHenry H.M, 1979, YEARB PHYS ANTHROPOL, V22, P105; McHenry HM, 2008, J HUM EVOL, V55, P639, DOI 10.1016/j.jhevol.2008.03.012; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Nakatsukasa Masato, 1994, African Study Monographs Supplementary Issue, V21, P1; O'Higgins P, 2000, J ANAT, V197, P103, DOI 10.1046/j.1469-7580.2000.19710103.x; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; OXNARD CE, 1968, J MORPHOL, V126, P249, DOI 10.1002/jmor.1051260302; PICKFORD M, 1983, AM J PHYS ANTHROPOL, V60, P337, DOI 10.1002/ajpa.1330600306; Potau JM, 2009, INT J PRIMATOL, V30, P697, DOI 10.1007/s10764-009-9368-8; R Core Team, 2018, R LANG ENV STAT COMP; Richmond BG, 2000, NATURE, V404, P382, DOI 10.1038/35006045; Richmond BG, 2001, AM J PHYS ANTHROPOL, V116, P70, DOI DOI 10.1002/AJPA.10019; Roberts D., 1974, P171; Robinson JT, 1972, EARLY HOMININD POSTU; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rose M.D., 1991, P37; Rose M.D., 1983, P405; ROSE MD, 1989, J HUM EVOL, V18, P131, DOI 10.1016/0047-2484(89)90067-5; ROSE MD, 1986, J HUM EVOL, V15, P333, DOI 10.1016/S0047-2484(86)80016-1; Rose Michael D., 1993, P252; RUFF CB, 1993, AM J PHYS ANTHROPOL, V91, P21, DOI 10.1002/ajpa.1330910103; Scheuer L, 2004, THE JUVENILE SKELETO; Senut B, 2006, CR PALEVOL, V5, P89, DOI 10.1016/j.crpv.2005.11.003; SENUT B, 1980, COLLEGIUM ANTROPOL, V4, P87; Shapiro Liza, 1993, P121; STERN JT, 1981, AM J PHYS ANTHROPOL, V55, P153, DOI 10.1002/ajpa.1330550203; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Stern JT, 1975, YEARB PHYS ANTHROPOL, V19, P69; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; Sylvester AD, 2006, J THEOR BIOL, V242, P581, DOI 10.1016/j.jtbi.2006.04.016; Tardieu C, 1996, FOLIA PRIMATOL, V66, P68, DOI 10.1159/000157186; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Trinkaus E, 1983, THE SHANIDAR NEANDER; TUTTLE RH, 1978, AM J PHYS ANTHROPOL, V49, P57, DOI 10.1002/ajpa.1330490110; TUTTLE RH, 1978, AM J PHYS ANTHROPOL, V49, P47, DOI 10.1002/ajpa.1330490109; Voisin JL, 2006, ANAT REC, V288A, P44; VRBA ES, 1979, AM J PHYS ANTHROPOL, V51, P117, DOI 10.1002/ajpa.1330510114; Walker A, 1993, THE NARIOKOTOME HOMO; WARD C V, 1991, American Journal of Physical Anthropology, P180; Ward Carol V., 2013, P235; Ward CV, 2012, J HUM EVOL, V63, P1, DOI 10.1016/j.jhevol.2011.11.012; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Wiley D. F., 2006, LANDMARK EDITOR; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; [No title captured]	113	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0117408	10.1371/journal.pone.0117408	http://dx.doi.org/10.1371/journal.pone.0117408			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25651542	Green Published, gold, Green Submitted			2022-12-26	WOS:000349250700013
J	Chen, XH; Eksioglu, EA; Carter, JD; Fortenbery, N; Donatelli, SS; Zhou, JM; Liu, JH; Yang, LL; Gilvary, D; Djeu, J; Wei, S				Chen, Xianghong; Eksioglu, Erika A.; Carter, John D.; Fortenbery, Nicole; Donatelli, Sarah S.; Zhou, Junmin; Liu, Jinhong; Yang, Lili; Gilvary, Danielle; Djeu, Julie; Wei, Sheng			Inactivation of DAP12 in PMN Inhibits TREM1-Mediated Activation in Rheumatoid Arthritis	PLOS ONE			English	Article							MYELOID CELLS-1; OSTEOCLAST DIFFERENTIATION; DAP12-ASSOCIATED RECEPTOR; TREM-1 EXPRESSION; INNATE IMMUNITY; CUTTING EDGE; INFLAMMATION; NEUTROPHILS; INTERVENTION; MACROPHAGES	Rheumatoid arthritis (RA) is an autoimmune disease characterized by dysregulated and chronic systemic inflammatory responses that affect the synovium, bone, and cartilage causing damage to extra-articular tissue. Innate immunity is the first line of defense against invading pathogens and assists in the initiation of adaptive immune responses. Polymorphonuclear cells (PMNs), which include neutrophils, are the largest population of white blood cells in peripheral blood and functionally produce their inflammatory effect through phagocytosis, cytokine production and natural killer-like cytotoxic activity. TREM1 (triggering receptor expressed by myeloid cells) is an inflammatory receptor in PMNs that signals through the use of the intracellular activating adaptor DAP12 to induce downstream signaling. After TREM crosslinking, DAP12's tyrosines in its ITAM motif get phosphorylated inducing the recruitment of Syk tyrosine kinases and eventual activation of PI3 kinases and ERK signaling pathways. While both TREM1 and DAP12 have been shown to be important activators of RA pathogenesis, their activity in PMNs or the importance of DAP12 as a possible therapeutic target have not been shown. Here we corroborate, using primary RA specimens, that isolated PMNs have an increased proportion of both TREM1 and DAP12 compared to normal healthy control isolated PMNs both at the protein and gene expression levels. This increased expression is highly functional with increased activation of ERK and MAPKs, secretion of IL-8 and RANTES and cytotoxicity of target cells. Importantly, based on our hypothesis of an imbalance of activating and inhibitory signaling in the pathogenesis of RA we demonstrate that inhibition of the DAP12 signaling pathway inactivates these important inflammatory cells.	[Chen, Xianghong; Eksioglu, Erika A.; Fortenbery, Nicole; Donatelli, Sarah S.; Zhou, Junmin; Liu, Jinhong; Gilvary, Danielle; Djeu, Julie; Wei, Sheng] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA; [Carter, John D.] Univ S Florida, Coll Med, Dept Internal Med, Div Rheumatol, Tampa, FL 33612 USA; [Yang, Lili; Wei, Sheng] Tianjin Med Univ, Canc Hosp, Dept Immunol, Tianjin, Peoples R China; [Yang, Lili; Wei, Sheng] Res Inst, Tianjin, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Tianjin Medical University	Wei, S (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Immunol, Tampa, FL 33682 USA.	sheng.wei@moffitt.org	Eksioglu, Erika/E-6315-2015	Eksioglu, Erika/0000-0003-4458-7192	NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA076292] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bajpai M, 2008, EXPERT OPIN INV DRUG, V17, P641, DOI [10.1517/13543784.17.5.641, 10.1517/13543784.17.5.641 ]; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Burmester GR, 2014, NAT REV RHEUMATOL, V10, P77, DOI 10.1038/nrrheum.2013.168; Chen DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086105; Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580; Chen XH, 2009, BLOOD, V113, P3226, DOI 10.1182/blood-2008-07-168245; Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682; Collins CE, 2009, ANN RHEUM DIS, V68, P1768, DOI 10.1136/ard.2008.089557; Cope AP, 2003, RHEUMATOLOGY, V42, P716, DOI 10.1093/rheumatology/keg262; Crotti TN, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4088; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Derive Marc, 2010, Self Nonself, V1, P225, DOI 10.4161/self.1.3.12891; Feist E, 2013, RHEUMATOLOGY, V52, P1352, DOI 10.1093/rheumatology/kes417; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gibot S, 2006, J INFECT DIS, V194, P975, DOI 10.1086/506950; Gierut A, 2010, RHEUM DIS CLIN N AM, V36, P271, DOI 10.1016/j.rdc.2010.03.004; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Joyce-Shaikh B, 2010, J EXP MED, V207, P579, DOI 10.1084/jem.20090516; Kasama T, 2000, CLIN EXP IMMUNOL, V121, P533, DOI 10.1046/j.1365-2249.2000.01272.x; Kasama Tsuyoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P273, DOI 10.2174/1568010054022114; Kim TH, 2012, MED HYPOTHESES, V78, P270, DOI 10.1016/j.mehy.2011.10.042; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kuai J, 2009, RHEUMATOLOGY, V48, P1352, DOI 10.1093/rheumatology/kep235; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lindstrom TM, 2010, RHEUM DIS CLIN N AM, V36, P367, DOI 10.1016/j.rdc.2010.02.005; Molad Y, 2013, INNATE IMMUN-LONDON, V19, P623, DOI 10.1177/1753425913476970; Murakami Y, 2009, ARTHRITIS RHEUM-US, V60, P1615, DOI 10.1002/art.24554; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; O'Shea JJ, 2013, NEW ENGL J MED, V368, P161, DOI 10.1056/NEJMra1202117; Ornatowska M, 2007, AM J PHYSIOL-LUNG C, V293, pL1377, DOI 10.1152/ajplung.00140.2007; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Rankin James A, 2004, AACN Clin Issues, V15, P3, DOI 10.1097/00044067-200401000-00002; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Salliot C, 2011, ANN RHEUM DIS, V70, P266, DOI 10.1136/ard.2010.132134; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Simard JF, 2011, RHEUMATOLOGY, V50, P204, DOI 10.1093/rheumatology/keq326; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Tsao NW, 2012, BEST PRACT RES CL RH, V26, P659, DOI 10.1016/j.berh.2012.07.012; ULICH TR, 1986, AM J PATHOL, V124, P53; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wang DY, 2004, WORLD J GASTROENTERO, V10, P2744, DOI 10.3748/wjg.v10.i18.2744; Wiersinga WJ, 2007, J INFECT DIS, V196, P1707, DOI 10.1086/522141	53	63	75	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115116	10.1371/journal.pone.0115116	http://dx.doi.org/10.1371/journal.pone.0115116			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642940	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821200007
J	Cummings, MT; Joh, RI; Motamedi, M				Cummings, Michael T.; Joh, Richard I.; Motamedi, Mo			PRIMED: PRIMEr Database for Deleting and Tagging All Fission and Budding Yeast Genes Developed Using the Open-Source Genome Retrieval Script (GRS)	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; VERSATILE; RESOURCE; SEQUENCE; MODULES	The fission (Schizosaccharomyces pombe) and budding (Saccharomyces cerevisiae) yeasts have served as excellent models for many seminal discoveries in eukaryotic biology. In these organisms, genes are deleted or tagged easily by transforming cells with PCR-generated DNA inserts, flanked by short (50-100bp) regions of gene homology. These PCR reactions use especially designed long primers, which, in addition to the priming sites, carry homology for gene targeting. Primer design follows a fixed method but is tedious and time-consuming especially when done for a large number of genes. To automate this process, we developed the Python-based Genome Retrieval Script (GRS), an easily customizable open-source script for genome analysis. Using GRS, we created PRIMED, the complete PRIMEr D atabase for deleting and C-terminal tagging genes in the main S. pombe and five of the most commonly used S. cerevisiae strains. Because of the importance of noncoding RNAs (ncRNAs) in many biological processes, we also included the deletion primer set for these features in each genome. PRIMED are accurate and comprehensive and are provided as downloadable Excel files, removing the need for future primer design, especially for large-scale functional analyses. Furthermore, the open-source GRS can be used broadly to retrieve genome information from custom or other annotated genomes, thus providing a suitable platform for building other genomic tools by the yeast or other research communities.	[Motamedi, Mo] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Med, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University	Motamedi, M (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA.	mmotamedi@hms.harvard.edu	Joh, Richard/AAJ-6753-2021	Joh, Richard/0000-0003-0583-8032	NCI Proton Beam [C06 CA059267]; V Scholar Award; NATIONAL CANCER INSTITUTE [C06CA059267] Funding Source: NIH RePORTER	NCI Proton Beam; V Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MTC is the 2014 Alvan T. and Viola D. Fuller American Cancer Society Junior Research Fellow. This work was supported by an NCI Proton Beam Grant (C06 CA059267) and a V Scholar Award (http://www.jimmyv.org/) to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Durbin R, 2008, SACCHAROMYCES GENOME; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Kaur R, 1997, NUCLEIC ACIDS RES, V25, P1080, DOI 10.1093/nar/25.5.1080; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Penkett CJ, 2006, YEAST, V23, P921, DOI 10.1002/yea.1422; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281, DOI DOI 10.1016/0076-6879(91)94022-5; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014	13	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116657	10.1371/journal.pone.0116657	http://dx.doi.org/10.1371/journal.pone.0116657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643023	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821200022
J	De-Oliveira, ACAX; Poca, KS; Totino, PRR; Paumgartten, FJR				De-Oliveira, Ana C. A. X.; Poca, Katia S.; Totino, Paulo R. R.; Paumgartten, Francisco J. R.			Modulation of Cytochrome P450 2A5 Activity by Lipopolysaccharide: Low-Dose Effects and Non-Monotonic Dose-Response Relationship	PLOS ONE			English	Article							OXIDATIVE STRESS; COUMARIN 7-HYDROXYLASE; METABOLIZING-ENZYMES; TRANSCRIPTION FACTOR; S-NITROSYLATION; SEPTIC SHOCK; MOUSE MODEL; CYP2A5; EXPRESSION; LIVER	Mouse cytochrome P450 (CYP) 2A5 is induced by inflammatory conditions and infectious diseases that down-regulate the expression and activity of most other CYP isoforms. Enhanced oxidative stress and nuclear factor (erythroid 2-related factor) 2 (Nrf2) transcription factor activation have been hypothesised to mediate up-regulation of CYP2A5 expression in the murine liver. The unique and complex regulation of CYP2A5, however, is far from being thoroughly elucidated. Sepsis and high doses of bacterial lipopolysaccharide (LPS) elicit oxidative stress in the liver, but depression, not induction, of CYP2A5 has been observed in studies of mice treated with LPS. The foregoing facts prompted us to evaluate the response of CYP2A5 liver activity in female DBA-2 mice over a broad range of LPS doses (0, 0.025, 0.05, 0.1, 0.2, 0.5, 1, 2, 5, 10, and 20 mg/kg). Cytokine levels (interleukin [IL]-2, IL-4, IL-6, IL-10, IL-17A, interferon gamma, tumour necrosis factor alpha) and nitric oxide (NO) were measured in the blood serum. Activities of CYP1A (EROD) and CYP2B (BROD) in the liver were also determined for comparative purposes. LPS depressed CYP2A5 at low doses (0.025-2.0 mg/kg) but not at doses (>2 mg/kg) that increased pro-inflammatory cytokines and NO serum levels, and depressed CYP1A and CYP2B activities. Blockade of proinflammatory cytokines and the overproduction of NO induced by co-treatment with pentoxifylline and LPS and iNOS inhibition with aminoguanidine both extended down-regulation of CYP2A5 to the high dose range while not affecting LPS-induced depression of CYP1A and CYP2B. Overall, the results suggested that NO plays a role in the reversal of the low-dose LPS-induced depression of CYP2A5 observed when mice were challenged with higher doses of LPS.	[De-Oliveira, Ana C. A. X.; Poca, Katia S.; Paumgartten, Francisco J. R.] Fundacao Oswaldo Cruz, Lab Environm Toxicol, Dept Biol Sci, Natl Sch Publ Hlth,Oswaldo Cruz Inst, BR-21040361 Rio De Janeiro, RJ, Brazil; [Totino, Paulo R. R.] Fundacao Oswaldo Cruz, Malaria Res Lab, Inst Oswaldo Cruz, BR-21040361 Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	De-Oliveira, ACAX (corresponding author), Fundacao Oswaldo Cruz, Lab Environm Toxicol, Dept Biol Sci, Natl Sch Publ Hlth,Oswaldo Cruz Inst, BR-21040361 Rio De Janeiro, RJ, Brazil.	ana.oliveira@ensp.fiocruz.br	Totino, Paulo/GLV-4516-2022; Paumgartten, Francisco JR/R-3618-2016	Paumgartten, Francisco JR/0000-0002-6207-0149; Totino, Paulo/0000-0002-4790-3317	Fundacao Carlos Chagas Filho de Amparo a Pesquisa (FAPERJ) [E-26/111.706/2012]; Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)/FIOCRUZ [407754/2012-1]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)/FIOCRUZ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This study was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa (FAPERJ), (www.faperj.br) Grant number E-26/111.706/2012; Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)/FIOCRUZ, (www.papes.fiocruz.br/edital_papesVI) Grant number 407754/2012-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Bakar A, 2012, TOXICOL APPL PHARM, V261, P50, DOI 10.1016/j.taap.2012.03.010; Abu-Bakar A, 2011, TOXICOL APPL PHARM, V257, P14, DOI 10.1016/j.taap.2011.08.011; Aitken AE, 2006, ANNU REV PHARMACOL, V46, P123, DOI 10.1146/annurev.pharmtox.46.120604.141059; Arpiainen S, 2008, TOXICOL APPL PHARM, V232, P135, DOI 10.1016/j.taap.2008.06.001; Begara-Morales JC, 2014, J EXP BOT, V65, P527, DOI 10.1093/jxb/ert396; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley DB, 2007, DRUG METAB DISPOS, V35, P121, DOI 10.1124/dmd.106.012070; Chemin I, 1996, HEPATOLOGY, V24, P649, DOI 10.1002/hep.510240330; Chomarat P, 1997, CARCINOGENESIS, V18, P2179, DOI 10.1093/carcin/18.11.2179; Conte FP, 2007, BRAZ J MED BIOL RES, V40, P657, DOI 10.1590/S0100-879X2007000500008; De-Oliveira ACAX, 2006, EXP PARASITOL, V113, P256, DOI 10.1016/j.exppara.2006.01.013; De-Oliveira ACAX, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-81; DeOliveira ACAX, 1997, TOXICOL LETT, V92, P39, DOI 10.1016/S0378-4274(97)00034-9; Gilmore WJ, 2004, J PHARMACOL EXP THER, V308, P600, DOI 10.1124/jpet.103.060111; Gilmore WJ, 2003, TOXICOLOGY, V184, P211, DOI 10.1016/S0300-483X(02)00581-4; HAHNEMANN B, 1992, BIOCHEM J, V286, P289, DOI 10.1042/bj2860289; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hou CC, 2011, EUR J PHARMACOL, V667, P6, DOI 10.1016/j.ejphar.2011.05.075; JUVONEN RO, 1988, EUR J BIOCHEM, V171, P205, DOI 10.1111/j.1432-1033.1988.tb13777.x; KENNEDY SW, 1994, ANAL BIOCHEM, V222, P217, DOI 10.1006/abio.1994.1476; Kim SD, 2013, TOXICOL APPL PHARM, V270, P129, DOI 10.1016/j.taap.2013.04.013; KIRBY GM, 1994, MOL CARCINOGEN, V11, P81, DOI 10.1002/mc.2940110205; KIRBY GM, 1994, MOL CARCINOGEN, V11, P74, DOI 10.1002/mc.2940110204; Kirby GM, 2011, CURR DRUG METAB, V12, P186; KOBLIAKOV V, 1993, MOL CARCINOGEN, V7, P276, DOI 10.1002/mc.2940070411; Lamsa V, 2012, TOXICOL SCI, V130, P132, DOI 10.1093/toxsci/kfs237; Montero R, 1999, MUTAGENESIS, V14, P217, DOI 10.1093/mutage/14.2.217; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Mori M, 2007, J NUTR, V137, p1616S, DOI 10.1093/jn/137.6.1616S; Nichols KD, 2008, BIOCHEM PHARMACOL, V75, P1230, DOI 10.1016/j.bcp.2007.10.032; Nichols KD, 2008, BIOCHEM PHARMACOL, V75, P538, DOI 10.1016/j.bcp.2007.09.009; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Renton KW, 2004, CURR DRUG METAB, V5, P235, DOI 10.2174/1389200043335559; Sakaguchi S, 2006, FEMS IMMUNOL MED MIC, V47, P167, DOI 10.1111/j.1574-695X.2006.00072.x; Salvemini D, 2002, FREE RADICAL BIO MED, V33, P1173, DOI 10.1016/S0891-5849(02)00961-9; SCHMIDT HHHW, 1989, BIOCHEM BIOPH RES CO, V165, P284, DOI 10.1016/0006-291X(89)91067-X; Su T, 2004, TOXICOL APPL PHARM, V199, P285, DOI 10.1016/j.taap.2003.11.029; Um HC, 2011, NITRIC OXIDE-BIOL CH, V25, P161, DOI 10.1016/j.niox.2011.06.001; VANIERSEL M, 1994, FOOD CHEM TOXICOL, V32, P387, DOI 10.1016/0278-6915(94)90078-7	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117842	10.1371/journal.pone.0117842	http://dx.doi.org/10.1371/journal.pone.0117842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635819	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700101
J	Tsou, SH; Chen, TM; Hsiao, HT; Chen, YH				Tsou, Shang-Hsun; Chen, Tzer-Ming; Hsiao, Hui-Ting; Chen, Yen-Hui			A Critical Dose of Doxorubicin Is Required to Alter the Gene Expression Profiles in MCF-7 Cells Acquiring Multidrug Resistance	PLOS ONE			English	Article							BREAST-CANCER CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR PROTEIN; DRUG-RESISTANCE; STEM-CELLS; DOWN-REGULATION; OVARIAN-CANCER; MUTANT P53; MDR1; TRANSPORTERS	Cellular mechanisms of multidrug resistance (MDR) are related to ABC transporters, apoptosis, antioxidation, drug metabolism, DNA repair and cell proliferation. It remains unclear whether the process of resistance development is programmable. We aimed to study gene expression profiling circumstances in MCF-7 during MDR development. Eleven MCF-7 sublines with incremental doxorubicin resistance were established as a valued tool to study resistance progression. MDR marker P-gp was overexpressed only in cells termed MCF-7/ADR-1024 under the selection dose approaching 1024 nM. MCF-7/ADR-1024 and authentic MCF-7/ADR shared common features in cell morphology and DNA ploidy status. MCF-7/ADR-1024 and authentic MCF-7/ADR down regulated repair genes BRCA1/2 and wild type p53, apoptosis-related gene Bcl-2 and epithelial-mesenchymal transition (EMT) epithelial marker gene E-cadherin. While detoxifying enzymes glutathione-S transferase-p and protein kinase C-a were up-regulated. The genes involving in EMT mesenchymal formation were also overexpressed, including N-cadherin, vimentin and the E-cadherin transcription reppressors Slug, Twist and ZEB1/2. PI3K/AKT inhibitor wortmannin suppressed expression of Slug, Twist and mdr1. Mutant p53 with a deletion at codons 127-133 markedly appeared in MCF-7/ADR-1024 and authentic MCF-7/ADR as well. In addition, MCF-7/ADR-1024 cells exerted CSC-like cell surface marker CD44 high/CD24 low and form mammospheres. Overall, results suggest that resistance marker P-gp arises owing to turn on/off or mutation of the genes involved in DNA repair, apoptosis, detoxifying enzymes, EMT and ABC transporters at a turning point (1.024 mu M doxorubicin challenge). Behind this point, no obvious alterations were found in most tested genes. Selection for CSC-like cells under this dose may importantly attribute to propagation of the population presenting invasive properties and drug resistance. We thereby suggest two models in the induction of drug resistance. Model 1: Selection for CSC-like cells. Model 2: Mutations for gain-of resistance. Either model 1 or model 2 requires doxorubicin dose approaching 1 mu M to alter gene regulation.	[Tsou, Shang-Hsun; Hsiao, Hui-Ting; Chen, Yen-Hui] Natl Taiwan Univ, Coll Med, Sch Pharm, Grad Inst Pharmaceut Sci, Taipei 10764, Taiwan; [Chen, Tzer-Ming] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Chen, Yen-Hui] Natl Taiwan Univ, Coll Med, Sch Pharm, Grad Inst Clin Pharm, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chen, YH (corresponding author), Natl Taiwan Univ, Coll Med, Sch Pharm, Grad Inst Pharmaceut Sci, Taipei 10764, Taiwan.	tcyhchen@ntu.edu.tw			Taiwan Cancer Foundation [TCF100-TM01-B2]	Taiwan Cancer Foundation	This work was supported by the Taiwan Cancer Foundation (www.cancercare.org.tw) #TCF100-TM01-B2. YC received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bahr O, 2001, J CLIN INVEST, V107, P643, DOI 10.1172/JCI12415; BALCERKUBICZEK EK, 1995, RADIAT RES, V142, P256, DOI 10.2307/3579133; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; CAAMANO J, 1992, PROG CLIN BIOL RES, V376, P331; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Colas E, 2012, CLIN TRANSL ONCOL, V14, P715, DOI 10.1007/s12094-012-0866-3; Dhillon KK, 2011, CANCER SCI, V102, P663, DOI 10.1111/j.1349-7006.2010.01840.x; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Furusawa S, 2001, BIOL PHARM BULL, V24, P474, DOI 10.1248/bpb.24.474; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gudjonsson T, 2005, APMIS, V113, P922, DOI 10.1111/j.1600-0463.2005.apm_371.x; Hardt O, 2012, CANCER LETT, V325, P165, DOI 10.1016/j.canlet.2012.06.010; Iseri OD, 2011, BIOMED PHARMACOTHER, V65, P40, DOI 10.1016/j.biopha.2010.10.004; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kuo MT, 2009, ANTIOXID REDOX SIGN, V11, P99, DOI 10.1089/ars.2008.2095; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Li XX, 2012, BIOCHEM BIOPH RES CO, V419, P728, DOI 10.1016/j.bbrc.2012.02.090; Lim B, 2013, ADV EXP MED BIOL, V779, P35, DOI 10.1007/978-1-4614-6176-0_2; Lin X, 2012, NEOPLASMA, V59, P248, DOI 10.4149/neo_2012_032; Liu YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-145; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; MAXWELL SA, 1994, CRIT REV ONCOGENESIS, V5, P23, DOI 10.1615/CritRevOncog.v5.i1.20; Mehta K, 2002, J NATL CANCER I, V94, P1652; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Munoz M, 2007, IUBMB LIFE, V59, P752, DOI 10.1080/15216540701736285; Nugoli M, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-13; O'Connor R, 2007, ANTICANCER RES, V27, P1267; O'Flaherty JD, 2012, J THORAC ONCOL, V7, P1880, DOI 10.1097/JTO.0b013e31826bfbc6; Ogretmen B, 1997, ONCOGENE, V14, P499, DOI 10.1038/sj.onc.1200855; Ogretmen B, 1996, INT J CANCER, V67, P608, DOI 10.1002/(SICI)1097-0215(19960904)67:5<608::AID-IJC3>3.0.CO;2-Y; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; Rusetskaya N. V., 2009, Experimental Oncology, V31, P140; RYAN JJ, 1994, P NATL ACAD SCI USA, V91, P5878, DOI 10.1073/pnas.91.13.5878; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Saleh EM, 2009, CELL BIOCHEM BIOPHYS, V55, P95, DOI 10.1007/s12013-009-9058-3; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Saxena M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.61; Schuliga M, 2002, TOXICOL SCI, V70, P183, DOI 10.1093/toxsci/70.2.183; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Shim GS, 2009, FREE RADICAL BIO MED, V47, P1619, DOI 10.1016/j.freeradbiomed.2009.09.006; Shinoda C, 2005, INT J CANCER, V117, P21, DOI 10.1002/ijc.21094; Stavrovskaya AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P592, DOI 10.1134/S0006297908050118; Subramaniam D, 2010, MINI-REV MED CHEM, V10, P359, DOI 10.2174/138955710791330954; Walsh AC, 2001, TOXICOL SCI, V61, P218, DOI 10.1093/toxsci/61.2.218; Walter RB, 2003, BLOOD, V102, P1466, DOI 10.1182/blood-2003-02-0396; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Weberpals J, 2009, INT J CANCER, V124, P806, DOI 10.1002/ijc.23987; WOSIKOWSKI K, 1995, CELL GROWTH DIFFER, V6, P1395; Yu ST, 2007, BIOCHEM BIOPH RES CO, V358, P79, DOI 10.1016/j.bbrc.2007.04.107; Yu ST, 2009, ANTI-CANCER DRUG, V20, P382, DOI 10.1097/CAD.0b013e32832a2cd4; Zhao LJ, 2012, ASIAN PAC J CANCER P, V13, P3631, DOI 10.7314/APJCP.2012.13.8.3631	55	56	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116747	10.1371/journal.pone.0116747	http://dx.doi.org/10.1371/journal.pone.0116747			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635866	gold, Green Submitted, Green Published			2022-12-26	WOS:000350680700056
J	Zhao, BH; Zhao, Q; Li, JH; Xing, T; Wang, F; Wang, NS				Zhao, Binghui; Zhao, Qing; Li, Junhui; Xing, Tao; Wang, Feng; Wang, Niansong			Renalase Protects against Contrast-Induced Nephropathy in Sprague-Dawley Rats	PLOS ONE			English	Article							INSULIN-RESISTANCE; KIDNEY; HYPERTENSION; OXIDASE; TISSUE	Background Contrast-induced nephropathy (CIN) is the third leading cause of hospital-acquired acute renal failure. Oxidative stress, apoptosis and inflammation play crucial roles in CIN. Renalase is a newly discovered monoamine oxidase from the kidney. We hypothesize that renalase could protect against CIN through anti-oxidation, anti-inflammation and anti-apoptosis pathways. Methods We tested our hypothesis in vivo with a rat model of Ioversol-induced CIN and in vitro. Sprague-Dawley rats were divided into 4 groups (n = 6 per group): control group, Ioversol group (rats subjected to Ioversol-induced CIN), Ioversol plus vehicle group (CIN rats pretreated with vehicle) and Ioversol plus renalase group (CIN rats pretreated with 2 mg/kg recombinant renalase). HK2 cells were treated with Ioversol or H2O2. Results The results showed that pretreatment with renalase attenuated the deterioration of renal function, tubular necrosis, oxidative stress, apoptosis and inflammation (P< 0.05). Furthermore, renalase protected HK2 cells against the cytotoxicity of Ioversol and suppressed Caspase-3 activity, oxidative stress and apoptosis induced by H2O2. Conclusion Recombinant renalase protected CIN in rats through anti-oxidation, anti-apoptosis and antiinflammation mechanisms.	[Zhao, Binghui] Tongji Univ, Affiliated Shanghai Peoples Hosp 10, Dept Radiol, Shanghai 200092, Peoples R China; [Li, Junhui; Wang, Feng; Wang, Niansong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200030, Peoples R China; [Zhao, Qing] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Cardiol, Shanghai 200030, Peoples R China; [Xing, Tao] St Vincents Hosp, Melbourne, Vic, Australia	Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; St Vincent's Hospital Melbourne	Zhao, BH (corresponding author), Tongji Univ, Affiliated Shanghai Peoples Hosp 10, Dept Radiol, Shanghai 200092, Peoples R China.	drzhaobinghui@163.com; zyzwq1030@gmail.com			National Natural Science Foundation of China [81100528]; New-100 Talent Plan of Shanghai Jiao Tong University School of Medicine; Shanghai talents development fund; Shanghai Science and Technology Commission [124119a4900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New-100 Talent Plan of Shanghai Jiao Tong University School of Medicine; Shanghai talents development fund; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was sponsored by the National Natural Science Foundation of China (81100528) (http://www.nsfc.gov.cn/), the New-100 Talent Plan of Shanghai Jiao Tong University School of Medicine, Shanghai talents development fund and Shanghai Science and Technology Commission (124119a4900)(http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2009, CIRC J, V73, P1518, DOI 10.1253/circj.CJ-08-0784; Ari E, 2012, BRIT J RADIOL, V85, P1038, DOI 10.1259/bjr/16327485; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Buyuklu M, 2014, EUR REV MED PHARMACO, V18, P461; Caiazza A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/578974; Desir GV, 2014, NEPHROL DIAL TRANSPL, V29, P22, DOI 10.1093/ndt/gft083; Finn WF, 2006, NEPHROL DIAL TRANSPL, V21, pi2, DOI DOI 10.1093/NDT/GFL213; Guo XJ, 2014, CURR OPIN NEPHROL HY, V23, P513, DOI 10.1097/MNH.0000000000000044; James MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kodama A, 2013, KIDNEY INT, V83, P446, DOI 10.1038/ki.2012.429; Kwasa EA, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130738; Lee HT, 2013, J AM SOC NEPHROL, V24, P445, DOI 10.1681/ASN.2012090943; Mahmoodi Khalil, 2014, Heart Views, V15, P33, DOI 10.4103/1995-705X.137489; Melnikov VY, 2002, J CLIN INVEST, V110, P1083, DOI 10.1172/JCI200215623; Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329; Romano G, 2008, EUR HEART J, V29, P2569, DOI 10.1093/eurheartj/ehn197; Sendeski MM, 2011, CLIN EXP PHARMACOL P, V38, P292, DOI 10.1111/j.1440-1681.2011.05503.x; Solomon R, 2010, CIRCULATION, V122, P2451, DOI 10.1161/CIRCULATIONAHA.110.953851; Thomsen HS, 2008, ACTA RADIOL, V49, P646, DOI 10.1080/02841850801995413; Wang F, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/203458; Wang F, 2014, RENAL FAILURE, V36, P552, DOI 10.3109/0886022X.2013.876352; Wang F, 2013, RENAL FAILURE, V35, P1255, DOI 10.3109/0886022X.2013.823874; Wang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046442; Wang Feng, 2009, Journal of Shanghai Jiaotong University (English Edition), V14, P376, DOI 10.1007/s12204-009-0376-9; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066	27	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116583	10.1371/journal.pone.0116583	http://dx.doi.org/10.1371/journal.pone.0116583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635854	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700046
J	Ahmad, P; Sarwat, M; Bhat, NA; Wani, MR; Kazi, AG; Tran, LSP				Ahmad, Parvaiz; Sarwat, Maryam; Bhat, Nazir Ahmad; Wani, Mohd Rafiq; Kazi, Alvina Gul; Lam-Son Phan Tran			Alleviation of Cadmium Toxicity in Brassica juncea L. (Czern. & Coss.) by Calcium Application Involves Various Physiological and Biochemical Strategies	PLOS ONE			English	Article							LIPID-PEROXIDATION; OXIDATIVE DAMAGE; STRESS; ANTIOXIDANTS; EXPRESSION; TOLERANCE; ASCORBATE; RESPONSES; PROLINE; CELLS	Calcium (Ca) plays important role in plant development and response to various environmental stresses. However, its involvement in mitigation of heavy metal stress in plants remains elusive. In this study, we examined the effect of Ca (50 mM) in controlling cadmium (Cd) uptake in mustard (Brassica juncea L.) plants exposed to toxic levels of Cd (200 mg L-1 and 300 mg L-1). The Cd treatment showed substantial decrease in plant height, root length, dry weight, pigments and protein content. Application of Ca improved the growth and biomass yield of the Cd-stressed mustard seedlings. More importantly, the oil content of mustard seeds of Cd-stressed plants was also enhanced with Ca treatment. Proline was significantly increased in mustard plants under Cd stress, and exogenously sprayed Ca was found to have a positive impact on proline content in Cd-stressed plants. Different concentrations of Cd increased lipid peroxidation but the application of Ca minimized it to appreciable level in Cd-treated plants. Excessive Cd treatment enhanced the activities of antioxidant enzymes superoxide dismutase, ascorbate peroxidase and glutathione reductase, which were further enhanced by the addition of Ca. Additionally, Cd stress caused reduced uptake of essential elements and increased Cd accumulation in roots and shoots. However, application of Ca enhanced the concentration of essential elements and decreased Cd accumulation in Cd-stressed plants. Our results indicated that application of Ca enables mustard plant to withstand the deleterious effect of Cd, resulting in improved growth and seed quality of mustard plants.	[Ahmad, Parvaiz] SP Coll, Dept Bot, Srinagar 190001, Jammu & Kashmir, India; [Sarwat, Maryam] Amity Univ, Amity Inst Pharm, NOIDA, Noida 201303, India; [Sarwat, Maryam] Prince Salman Bin Abdul Aziz Univ, Coll Appl Med Sci, Riyadh 11942, Saudi Arabia; [Bhat, Nazir Ahmad; Wani, Mohd Rafiq] Govt Degree Coll Boys, Dept Bot, Anantnag 192102, Jammu & Kashmir, India; [Kazi, Alvina Gul] Natl Univ Sci & Technol, Atta Ur Rehman Sch Appl Biosci, Islamabad 44000, Pakistan; [Lam-Son Phan Tran] RIKEN, Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa 2300045, Japan	Amity University Noida; Prince Sattam Bin Abdulaziz University; National University of Sciences & Technology - Pakistan; RIKEN	Ahmad, P (corresponding author), SP Coll, Dept Bot, Srinagar 190001, Jammu & Kashmir, India.	parvaizbot@yahoo.com; son.tran@riken.jp	ahmad, parvaiz/D-2887-2009; Sarwat, Maryam/E-6836-2010; Ahmad, Parvaiz/Y-3531-2019; Gul, Alvina/Z-4497-2019; Tran, Lam-Son P/A-1346-2009	ahmad, parvaiz/0000-0003-2734-4180; Sarwat, Maryam/0000-0003-3972-3321; Ahmad, Parvaiz/0000-0003-2734-4180; Gul, Alvina/0000-0002-7323-1905; Tran, Lam-Son P/0000-0001-9883-9768; Wani, Mohd Rafiq/0000-0003-0548-9581				Ahmad P, 2008, INT J PLANT PROD, V2, P353; Ahmad P, 2011, S AFR J BOT, V77, P36, DOI 10.1016/j.sajb.2010.05.003; Ahmad P, 2010, RUSS J PLANT PHYSL+, V57, P509, DOI 10.1134/S1021443710040084; Ahmad P., 2012, ENV ADAPTATIONS STRE, P297, DOI DOI 10.1007/978-1-4614-0815-4_14; Ahmad P, 2012, FRESEN ENVIRON BULL, V21, P2953; Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; AIDID SB, 1993, BIOMETALS, V6, P245, DOI 10.1007/BF00187763; Anjum NA, 2008, PLANT GROWTH REGUL, V54, P271, DOI 10.1007/s10725-007-9251-6; Arnon DI, 1940, SOIL SCI, V50, P463; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Behera RK, 2002, J PLANT PHYSIOL, V159, P967, DOI 10.1078/0176-1617-00823; Beyer WN, 2000, J ENVIRON QUAL, V29, P1380, DOI 10.2134/jeq2000.00472425002900050002x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Choudhary SP, 2012, J EXP BOT, V63, P5659, DOI 10.1093/jxb/ers219; Choudhary SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033210; DalCorso G, 2010, PLANT SIGNAL BEHAV, V5, P663, DOI 10.4161/psb.5.6.11425; Gopavajhula VR, 2013, GENET MOL BIOL, V36, P225, DOI [10.1590/S1415-47572013005000023, 10.1590/s1415-47572013005000023]; Hajiboland R, 2010, SOIL SCI PLANT NUTR, V56, P427, DOI 10.1111/j.1747-0765.2010.00478.x; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hirschi KD, 2004, PLANT PHYSIOL, V136, P2438, DOI 10.1104/pp.104.046490; Indra V, 2006, J ENVIRON BIOL, V27, P723; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jihen E, 2010, TOXICOL LETT, V196, P104, DOI 10.1016/j.toxlet.2010.04.006; Jogaiah S, 2013, CRIT REV BIOTECHNOL, V33, P23, DOI 10.3109/07388551.2012.659174; John R., 2009, International Journal of Plant Production, V3, P65; Kader MA, 2010, PLANT SIGNAL BEHAV, V5, P233, DOI 10.4161/psb.5.3.10740; Kangasjarvi S, 2008, BIOCHEM J, V412, P275, DOI 10.1042/BJ20080030; Khan GA, 2014, J EXP BOT, V65, P871, DOI 10.1093/jxb/ert444; Kupper H, 1996, J EXP BOT, V47, P259, DOI 10.1093/jxb/47.2.259; Lag M, 2010, TOXICOL LETT, V193, P252, DOI 10.1016/j.toxlet.2010.01.015; Liu D, 2003, BIOL PLANTARUM, V47, P79, DOI 10.1023/A:1027384932338; Luck H., 1965, METHOD ENZYMATIC ANA, P885, DOI DOI 10.1016/B978-0-12-395630-9.50158-4; Mishra S, 2006, PLANT PHYSIOL BIOCH, V44, P25, DOI 10.1016/j.plaphy.2006.01.007; Monteiro MS, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P387, DOI 10.1007/978-1-4614-0634-1_21; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; PADMAJA K, 1990, PHOTOSYNTHETICA, V24, P399; Palma JM, 2002, PLANT PHYSIOL BIOCH, V40, P521, DOI 10.1016/S0981-9428(02)01404-3; Park HY, 2008, P NATL ACAD SCI USA, V105, P542, DOI 10.1073/pnas.0710810105; POSCHENRIEDER C, 1989, PLANT PHYSIOL, V90, P1365, DOI 10.1104/pp.90.4.1365; Sarwat M, 2013, CRIT REV BIOTECHNOL, V33, P97, DOI 10.3109/07388551.2012.672398; Schutzendubel A, 2001, PLANT PHYSIOL, V127, P887, DOI 10.1104/pp.010318; SHARMA P, 2006, CADMIUM TOXICITY TOL, P63; Sharma P., 2012, J BOT, V2012, P26, DOI [10.1155/2012/217037, DOI 10.1155/2012/217037]; Siddiqui MH, 2012, INT J MOL SCI, V13, P6604, DOI 10.3390/ijms13066604; Siddiqui MH, 2011, PROTOPLASMA, V248, P503, DOI 10.1007/s00709-010-0197-6; Singh AP, 2001, SUSTAINABLE USE CHEM, V2, P23; Song WY, 2008, INT J BIOL SCI, V4, P116; Srivalli B., 2003, J PLANT BIOL, V30, P121; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; Suzuki N, 2005, PLANT BIOTECHNOL, V22, P19, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.22.19; Tian SK, 2011, CHEMOSPHERE, V84, P63, DOI 10.1016/j.chemosphere.2011.02.054; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P525, DOI 10.4161/psb.3.8.6186; van Rossum MWPC, 1997, PLANT SCI, V130, P207, DOI 10.1016/S0168-9452(97)00215-X; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; Vig K, 2003, ADV ENVIRON RES, V8, P121, DOI 10.1016/S1093-0191(02)00135-1; Watanabe T, 1998, SCI TOTAL ENVIRON, V217, P1, DOI 10.1016/S0048-9697(98)00151-X; Yamauchi Y, 2008, PLANT PHYSIOL BIOCH, V46, P786, DOI 10.1016/j.plaphy.2008.04.018; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Zhifang G, 2003, PLANT CELL ENVIRON, V26, P275, DOI 10.1046/j.1365-3040.2003.00958.x; Zorrig W., 2012, African Journal of Biotechnology, V11, P8441	63	206	213	10	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0114571	10.1371/journal.pone.0114571	http://dx.doi.org/10.1371/journal.pone.0114571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629695	gold, Green Published, Green Submitted			2022-12-26	WOS:000348732100007
J	Belbachir, F; Pettorelli, N; Wacher, T; Belbachir-Bazi, A; Durant, SM				Belbachir, Farid; Pettorelli, Nathalie; Wacher, Tim; Belbachir-Bazi, Amel; Durant, Sarah M.			Monitoring Rarity: The Critically Endangered Saharan Cheetah as a Flagship Species for a Threatened Ecosystem	PLOS ONE			English	Article							CAPTURE PROBABILITIES VARY; ACINONYX-JUBATUS; POPULATION-SIZE; RECAPTURE DATA; CAMERA-TRAPS; HOME-RANGE; CONSERVATION; AFRICA; BIODIVERSITY; DENSITY	Deserts are particularly vulnerable to human impacts and have already suffered a substantial loss of biodiversity. In harsh and variable desert environments, large herbivores typically occur at low densities, and their large carnivore predators occur at even lower densities. The continued survival of large carnivores is key to healthy functioning desert ecosystems, and the ability to gather reliable information on these rare low density species, including presence, abundance and density, is critical to their monitoring and management. Here we test camera trap methodologies as a monitoring tool for an extremely rare wide-ranging large felid, the critically endangered Saharan cheetah (Acinonyx jubatus hecki). Two camera trapping surveys were carried out over 2-3 months across a 2,551km(2) grid in the Ti-nhaggen region in the Ahaggar Cultural Park, south central Algeria. A total of 32 records of Saharan cheetah were obtained. We show the behaviour and ecology of the Saharan cheetah is severely constrained by the harsh desert environment, leading them to be more nocturnal, be more wide-ranging, and occur at lower densities relative to cheetah in savannah environments. Density estimates ranged from 0.21-0.55/1,000km(2), some of the lowest large carnivore densities ever recorded in Africa, and average home range size over 2-3 months was estimated at 1,583km(2). We use our results to predict that, in order to detect presence of cheetah with p>0.95 a survey effort of at least 1,000 camera trap days is required. Our study identifies the Ahaggar Cultural Park as a key area for the conservation of the Saharan cheetah. The Saharan cheetah meets the requirements for a charismatic flagship species that can be used to "market" the Saharan landscape at a sufficiently large scale to help reverse the historical neglect of threatened Saharan ecosystems.	[Belbachir, Farid; Pettorelli, Nathalie; Durant, Sarah M.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Belbachir, Farid] UCL, Dept Anthropol, London, England; [Belbachir, Farid; Belbachir-Bazi, Amel] Univ Bejaia, Lab Ecol & Environm, Bejaia, Algeria; [Wacher, Tim] Zool Soc London, Conservat Programmes, London, England; [Durant, Sarah M.] Wildlife Conservat Soc, Bronx, NY USA	Zoological Society of London; University of London; University College London; Universite de Bejaia; Zoological Society of London; Wildlife Conservation Society	Durant, SM (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	s.durant@ucl.ac.uk	Pettorelli, Nathalie/AAW-8438-2021; Durant, Sarah M/AAB-9659-2019	Durant, Sarah M/0000-0003-0724-0878	Office National du Parc Culturel de l'Ahaggar/Ministry of Culture (Algeria); Institute of Zoology and Zoological Society of London; University College London and Wildlife Conservation Society; Howard G. Buffett Foundation; PANTHERA and Dunstable Runners; Dorothy Hodgkins Postgraduate Award	Office National du Parc Culturel de l'Ahaggar/Ministry of Culture (Algeria); Institute of Zoology and Zoological Society of London; University College London and Wildlife Conservation Society; Howard G. Buffett Foundation; PANTHERA and Dunstable Runners; Dorothy Hodgkins Postgraduate Award	The following institutions and persons are warmly thanked for their support: the Office National du Parc Culturel de l'Ahaggar/Ministry of Culture (Algeria), Institute of Zoology and Zoological Society of London, University College London and Wildlife Conservation Society. The study was funded by the Howard G. Buffett Foundation, PANTHERA and Dunstable Runners and FB was supported by a Dorothy Hodgkins Postgraduate Award. This study would not have been possible without the support of the staff and Former Director, F. Ighilahriz, of the Office du Parc National de l'Ahaggar (now the Office National du Parc Culturel de l'Ahaggar). The authors would also like to thank T. Abaigar from the Estacion Experimental de Zonas Aridas (Spain) for her inputs and support.	[Anonymous], 1991, USERS GUIDE INTERACT; [Anonymous], 2012, REG CONS STRAT CHEET; BATES P. J. J., 1991, MAMMALS ARABIA; Belbachir, 2008, ACINONYX JUBATUS SSP, DOI DOI 10.2305/IUCN.UK.2008.RLTS.T221A13035738.EN; Belbachir Farid, 2009, Cat News, V50, P17; Bernezat JL, 2004, SAHARIEN, V170, P33; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Bowland T, 1995, CUSTOS, P8; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Broomhall LS, 2003, J ZOOL, V261, P119, DOI 10.1017/S0952836903004059; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Busby G.B.J., 2006, REPORT SAHELO SAHA 5; Busby GBJ, 2009, ORYX, V43, P412, DOI 10.1017/S0030605309001197; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Caro T., 1994, CHEETAHS SERENGETI P; CARO TM, 1991, J HERED, V82, P8, DOI 10.1093/jhered/82.1.8; CHAO A, 1992, BIOMETRICS, V48, P201, DOI 10.2307/2532750; Charruau P, 2011, MOL ECOL, V20, P706, DOI 10.1111/j.1365-294X.2010.04986.x; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Darkoh MBK, 2003, J ARID ENVIRON, V54, P261, DOI 10.1006/jare.2002.1089; Davies J, 2012, CONSERVING DRYLAND B; Dillon A, 2008, J ZOOL, V275, P391, DOI 10.1111/j.1469-7998.2008.00452.x; Dragesco-Joffe A., 1993, VIE SAUVAGE SAHARA; Durant SM, 2014, DIVERS DISTRIB, V20, P114, DOI 10.1111/ddi.12157; Durant SM, 2012, SCIENCE, V336, P1379, DOI 10.1126/science.336.6087.1379; Durant Sarah M., 2013, P313; Durant SM, 2011, J APPL ECOL, V48, P1490, DOI 10.1111/j.1365-2664.2011.02042.x; Durant Sarah M., 2010, P373; Durant SM, 2004, BEHAV ECOL, V15, P11, DOI 10.1093/beheco/arg098; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Government of Algeria, 2003, CONS SUST US G UNPUB; Hamdine W, 2003, MAMMALIA, V67, P439, DOI 10.1515/mamm.2003.67.3.439; Hirche A, 2011, ENVIRON MONIT ASSESS, V179, P403, DOI 10.1007/s10661-010-1744-5; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Jackson Rodney M., 2010, P417; Jones Julia P.G., 2013, P335; Journal Officiel de la Republique Alg?rienne D?mocratique et Populaire (JORADP), 2012, J OFFICIEL REPUBLIQU; Kohl I, 2010, J ANTHROPOL RES, V66, P449, DOI 10.3998/jar.0521004.0066.401; Kruger O, 2005, BIODIVERS CONSERV, V14, P579, DOI 10.1007/s10531-004-3917-4; Lhote H., 1946, MAMMALIA, V10, P26, DOI 10.1515/mamm.1946.10.1.26; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Marker L, 2002, THESIS U OXFORD; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; Marnewick KA, 2006, S AFR J WILDL RES, V36, P139; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; McCabe J. Terrence, 2004, CATTLE BRING US OUR; McNeilage Alastair, 1996, P334; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Nichols James D., 2002, P121; O'Farrell PJ, 2011, J ARID ENVIRON, V75, P612, DOI 10.1016/j.jaridenv.2011.01.005; Oliver LJ, 2011, ECOL MODEL, V222, P776, DOI 10.1016/j.ecolmodel.2010.11.021; Olson KA, 2010, J ARID ENVIRON, V74, P1435, DOI 10.1016/j.jaridenv.2010.05.022; Otis DL, 1978, STAT INFERENCE CAPTU, P7; Scantlebury DM, 2014, SCIENCE, V346, P79, DOI 10.1126/science.1256424; Sharma RK, 2010, ANIM CONSERV, V13, P94, DOI 10.1111/j.1469-1795.2009.00305.x; Sharp NCC, 1997, J ZOOL, V241, P493, DOI 10.1111/j.1469-7998.1997.tb04840.x; Smith RJ, 2012, CONSERV LETT, V5, P205, DOI 10.1111/j.1755-263X.2012.00229.x; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Stanley TR, 2005, WILDLIFE SOC B, V33, P782, DOI 10.2193/0091-7648(2005)33[782:SRAPFT]2.0.CO;2; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Sunquist ME, 2002, WILD CATS WORLD; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Turner MD, 2008, HUM ECOL, V36, P59, DOI 10.1007/s10745-007-9149-y; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Verissimo D, 2011, CONSERV LETT, V4, P1, DOI 10.1111/j.1755-263X.2010.00151.x; Verlinden A, 1998, AFR J ECOL, V36, P117; WACHER T, 2005, SAHELO SAHARAN INTER; Walpole MJ, 2002, BIODIVERS CONSERV, V11, P543, DOI 10.1023/A:1014864708777; White G.C., 1982, LA8787NERP; Xiang ZF, 2011, CHINESE SCI BULL, V56, P2553, DOI 10.1007/s11434-011-4613-x	71	40	40	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115136	10.1371/journal.pone.0115136	http://dx.doi.org/10.1371/journal.pone.0115136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629400	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100012
J	Ebert, M; Kolbl-Ebert, M; Lane, JA				Ebert, Martin; Koelbl-Ebert, Martina; Lane, Jennifer A.			Fauna and Predator-Prey Relationships of Ettling, an Actinopterygian Fish-Dominated Konservat-Lagerstatte from the Late Jurassic of Southern Germany	PLOS ONE			English	Article							CROSSOGNATHIFORM FISHES; TELEOSTEI; LIMESTONES; AREA	The newly recognized Konservat-Lagerstatte of Ettling (Bavaria), field site of the Jura-Museum Eichstatt (JME), is unique among Late Jurassic plattenkalk basins (Solnhofen region) in its abundant, extremely well preserved fossil vertebrates, almost exclusively fishes. We report actinopterygians (ginglymodins, pycnodontiforms, halecomorphs, aspidorynchiforms, "pholidophoriforms,"teleosts); turtles; and non-vertebrates (echinoderms, arthropods, brachiopods, mollusks, jellyfish, sponges, biomats, plants) in a current faunal list. Ettling has yielded several new fish species (Bavarichthys incognitus; Orthogonikleithrus hoelli; Aspidorhynchus sanzenbacheri; Macrosemimimus fegerti). Upper and lower Ettling strata differ in faunal content, with the lower dominated by the small teleost Orthogonikleithrus hoelli (absent from the upper layers, where other prey fishes, Leptolepides sp. and Tharsis sp., occur instead). Pharyngeal and stomach contents of Ettling fishes provide direct evidence that Orthogonikleithrus hoelli was a primary food source during early Ettling times. Scarcity of ammonites and absence of vampyromorph coleoids at Ettling differ markedly from the situation at other nearby localities in the region (e.g., Eichstett,Painten, Schamhaupten, the Mornsheim beds), where they are more common. Although the exact biochronological age of Ettling remains uncertain (lack of suitable index fossils), many Ettling fishes occur in other plattenkalk basins of Germany (e.g., Kelheim) and France (Cerin) dated as Late Kimmeridgian to Early Tithonian (eigeltingense horizon), suggesting a comparable geologic age. The Ettling deposits represent an independent basin within the larger Upper Jurassic "Solnhofen Archipelago", a shallow subtropical sea containing scattered islands, sponge-microbial and coral reefs, sandbars, and deeper basins on a vast carbonate platform along the northern margin of the Tethys Ocean.	[Ebert, Martin; Koelbl-Ebert, Martina] Jura Museum Eichstatt, Eichstatt, Germany; [Lane, Jennifer A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Lane, JA (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	jlane@amnh.org		Ebert, Martin/0000-0002-0732-7706	Volkswagen Foundation [I/84 636]	Volkswagen Foundation(Volkswagen)	Funding for this project was provided by Volkswagen Foundation grant I/84 636 "The Dynamic of the Solnhofen Archipelago (to MKE), in the years 2010-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1833, RECHERCHES POISSONS; Arratia G, 2001, J VERTEBR PALEONTOL, V21, P767, DOI 10.1671/0272-4634(2001)021[0767:TSGOTC]2.0.CO;2; Arratia G, 2009, ACTA ZOOL S1, V90, P259; Arratia G., 2008, MESOZOIC FISHES 4 HO, P40; Arratia G, 2007, J VERTEBR PALEONTOL, V27, P838, DOI 10.1671/0272-4634(2007)27[838:ANHFFT]2.0.CO;2; Arratia Gloria, 1999, P265; Arratia G, 2013, J VERTEBR PALEONTOL, V33, P1, DOI 10.1080/02724634.2013.835642; Arratia Gloria, 1997, Palaeo Ichthyologica, V7, P5; Arratia G, 2010, FOSS REC, V13, P317, DOI 10.1002/mmng.201000005; Arratia Gloria, 2000, Palaeontologische Zeitschrift, V74, P113; Arratia G, 2008, GEOL SOC SPEC PUBL, V295, P71, DOI 10.1144/SP295.6; Barthel K. W., 1978, SOLNHOFEN BLICK ERDG; Barthel K.W., 1990, SOLNHOFEN STUDY MESO; Berg L. S., 1940, T I ZOOLOGY ACAD SCI, V5, P85; BERNIER P, 1991, SEDIMENTOLOGY, V38, P127, DOI 10.1111/j.1365-3091.1991.tb01858.x; BOUCOT AJ, 1990, EVOLUTIONARY PALEOBI, P1; Brito PM, 2009, CR PALEVOL, V8, P395, DOI 10.1016/j.crpv.2008.12.003; Brito PM, 2002, C R PALEVOL, V1, P697, DOI 10.1016/S1631-0683(02)00080-5; Clarkson ENK, 1986, INVERTEBRATE PALEONT; de Pinna Mario C.C., 1996, P147; DIETL G., 2001, REICH MEERENGEL NUSP; Ebert Martin, 2011, Archaeopteryx, V29, P41; Ebert Martin, 2010, Archaeopteryx, V28, P1; Ebert Martin, 2009, Archaeopteryx, V27, P45; Ebert Martin, 2008, Archaeopteryx, V26, P61; Ebert Martin, 2008, Archaeopteryx, V26, P11; Egger LM, 2011, ARCHAEOPTERYX, V29, P24; Enay Raymond, 1994, Geobios Memoire Special (Villeurbanne), V16, P25; Fesefeldt K., 1962, ERLANGER GEOL ABH, V46, P1; Frey E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031945; Fuersich FT, 2007, PALAEOGEOGR PALAEOCL, V243, P92, DOI 10.1016/j.palaeo.2006.07.007; Giebel CG, 1848, FAUNA VORWELT STETER; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; GRANDE L, 1984, GEOLOGICAL SURVEY WY, V63; Grande L, 2010, SPECIAL PUBLICATION, V6; Hanlon RT, 1996, CEPHALOPOD BEHAV; Helfman GS, 2009, DIVERSITY FISHES BIO; Joyce Walter G., 2003, Paleobios, V23, P1; Keupp H., 1993, GEOBIOS-LYON, V16, P71; Keupp H, 2007, NEUES JAHRB GEOL P-A, V245, P3, DOI 10.1127/0077-7749/2007/0245-0003; Konwert Martin, 2011, Archaeopteryx, V29, P31; Kroger B, 2011, BIOESSAYS, V33, P602, DOI 10.1002/bies.201100001; Lane J, 2015, J VERT PALE IN PRESS; Lane JA, 2012, J VERTEBR PALEONTOL, V32, P799, DOI 10.1080/02724634.2012.680325; MAISEY JG, 1994, ENVIRON BIOL FISH, V40, P1, DOI 10.1007/BF00002179; MARTILL DM, 1990, PALAEONTOLOGY, V33, P739; Meyer R, 1983, ERDGESCHICHTE SICHTB; Moers T, 1993, N JB GEOL PALAONTOL, V188, P345; Munnecke A, 2008, SEDIMENTOLOGY, V55, P1931, DOI 10.1111/j.1365-3091.2008.00975.x; Munster G von, 1836, N JB MINER GEOGR GEO, V1836, P580; Nursall J. Ralph, 1999, P189; Nursall J. Ralph, 1996, P125; Nybelin O., 1964, Goteborgs Vetenskaps Samhalles Handlingar (6), V9B, P1; Nybelin O., 1974, ACTA REGIAE SOC SCI, V9, P1; PATTERSON C, 1977, Bulletin of the American Museum of Natural History, V158, P83; Patterson C., 1977, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V14, P579; Patzelt W, 1963, ERLANGEN GEOL ABH, V50, P1; Poyato-Ariza Francisco Jose, 2005, Bulletin of the Kitakyushu Museum of Natural History and Human History Series A Natural History, V3, P169; Poyato-Ariza Francisco Jose, 2002, Geodiversitas, V24, P139; Prothero DR, 1997, SEDIMENTARY GEOLOGY; REIMCHEN TE, 1991, CAN J ZOOL, V69, P2912, DOI 10.1139/z91-410; Reisdorf Achim G., 2012, Palaeobiodiversity Palaeoenvironments, V92, P119, DOI 10.1007/s12549-011-0068-y; Roper M, 2005, ZITTELIANA, V26, P57; Rpper M, 2000, PLATTENKALKE SCHERNF; Saint-Seine P.de., 1949, Nouvelles Archives du Museum d'Histoire Naturelle de Lyon Fasc, V2, P1; Schnitzer WA, 1965, ERLANGER GEOL ABH, V57, P1; Schroder KM, 2012, J VERTEBR PALEONTOL, V32, P512, DOI 10.1080/02724634.2012.649626; Schweigert G, 1998, JBER MITT OBERRHEIN, V80, P271; Schweigert G, 2007, NEUES JAHRB GEOL P-A, V245, P117, DOI 10.1127/0077-7749/2007/0245-0117; Taverne L., 2011, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V81, P129; Thiolliere, 1850, ANN SCI PHYS NATUR 2, V2, P111; Tischlinger H, 1992, PFORRING 1850 JAHRE, P9; Tischlinger Helmut, 1998, Archaeopteryx, V16, P1; Viohl G., 1990, P287; Viohl G., 1987, Archaeopteryx, V5, P33; Viohl G, 1979, F10 ABTEILUNG SOLNHO; Viohl G, 2006, ARCHAEOPTERYX, V24, P27; Viohl Gunter, 1998, Archaeopteryx, V16, P37; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Wenz S, 1993, GEOBIOS MS, V16, P61; [No title captured]	81	34	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116140	10.1371/journal.pone.0116140	http://dx.doi.org/10.1371/journal.pone.0116140			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629970	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100032
J	Grindler, NM; Allsworth, JE; Macones, GA; Kannan, K; Roehl, KA; Cooper, AR				Grindler, Natalia M.; Allsworth, Jenifer E.; Macones, George A.; Kannan, Kurunthachalam; Roehl, Kimberly A.; Cooper, Amber R.			Persistent Organic Pollutants and Early Menopause in US Women	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; POLYCHLORINATED-BIPHENYLS PCBS; OVARIAN ANTRAL FOLLICLES; PREIMPLANTATION EMBRYOS; REPRODUCTIVE TOXICITY; NATURAL MENOPAUSE; EXPOSURE; HEALTH; NHANES; MOUSE	Objective Endocrine-disrupting chemicals (EDCs) adversely affect human health. Our objective was to determine the association of EDC exposure with earlier age of menopause. Methods Cross-sectional survey using National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2008 (n = 31,575 females). Eligible participants included: menopausal women > 30 years of age; not currently pregnant, breastfeeding, using hormonal contraception; no history of bilateral oophorectomy or hysterectomy. Exposures, defined by serum lipid and urine creatinine-adjusted measures of EDCs, data were analyzed: > 90th percentile of the EDC distribution among all women, log-transformed EDC level, and decile of EDC level. Multi linear regression models considered complex survey design characteristics and adjusted for age, race/ethnicity, smoking, body mass index. EDCs were stratified into long (> 1 year), short, and unknown half-lives; principle analyses were performed on those with long half-lives as well as phthalates, known reproductive toxicants. Secondary analysis determined whether the odds of being menopausal increased with EDC exposure among women aged 45-55 years. Findings This analysis examined 111 EDCs and focused on known reproductive toxicants or chemicals with half-lives >1 year. Women with high levels of beta-hexachlorocyclohexane, mirex, p,p'-DDE, 1,2,3,4,6,7,8-heptachlorodibenzofuran, mono-(2-ethyl-5-hydroxyhexyl) and mono-(2-ethyl-5-oxohexyl) phthalate, polychlorinated biphenyl congeners -70, -99, -105, -118, -138, -153, -156, -170, and -183 had mean ages of menopause 1.9 to 3.8 years earlier than women with lower levels of these chemicals. EDC-exposed women were up to 6 times more likely to be menopausal than non-exposed women. Conclusions This study of a representative sample of US women documents an association between EDCs and earlier age at menopause. We identified 15 EDCs that warrant closer evaluation because of their persistence and potential detrimental effects on ovarian function. Earlier menopause can alter the quantity and quality of a woman's life and has profound implications for fertility, human reproduction, and our global society.	[Grindler, Natalia M.] Univ Colorado Denver, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Aurora, CO USA; [Grindler, Natalia M.; Cooper, Amber R.] Washington Univ, Barnes Jewish Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, St Louis, MO 63130 USA; [Allsworth, Jenifer E.] Univ Missouri, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO 64108 USA; [Macones, George A.; Roehl, Kimberly A.] Washington Univ, Barnes Jewish Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, St Louis, MO USA; [Kannan, Kurunthachalam] SUNY Albany, Wadsworth Ctr, New York State Dept Hlth, Albany, NY 12222 USA; [Kannan, Kurunthachalam] SUNY Albany, Dept Environm Hlth Sci, Albany, NY 12222 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Barnes-Jewish Hospital; Washington University (WUSTL); University of Missouri System; University of Missouri Kansas City; Barnes-Jewish Hospital; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Cooper, AR (corresponding author), Washington Univ, Barnes Jewish Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, St Louis, MO 63130 USA.	coopera@wudosis.wustl.edu	Allsworth, Jenifer/J-2475-2019	Kannan, Kurunthachalam/0000-0002-1926-7456	National Institute of Health [K12HD063086-01, UL1RR024992]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD063086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was support by National Institute of Health grants K12HD063086-01 (ARC) and UL1RR024992 (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Soc Reprod Med, 2013, FERTIL STERIL, V100, P931, DOI 10.1016/j.fertnstert.2013.08.043; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; BEAN JA, 1979, AM J EPIDEMIOL, V109, P181, DOI 10.1093/oxfordjournals.aje.a112673; Bergman A, 2012, STATE OF THE SCIENCE; Bergman EA, 2012, J ACAD NUTR DIET, V112, P1709, DOI 10.1016/j.jand.2012.09.014; Buttke DE, 2012, ENVIRON HEALTH PERSP, V120, P1613, DOI 10.1289/ehp.1104748; Cooper GS, 1999, EPIDEMIOLOGY, V10, P771, DOI 10.1097/00001648-199911000-00021; Craig ZR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105122; Curtin Lester R, 2012, Vital Health Stat 2, P1; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Denham M, 2005, PEDIATRICS, V115, pE127, DOI 10.1542/peds.2004-1161; Fleming LE, 2008, MENOPAUSE, V15, P1103, DOI 10.1097/gme.0b013e3181706292; Hannon PR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.119032; Harada Kouji H., 2009, Environmental Health and Preventive Medicine, V14, P7, DOI 10.1007/s12199-008-0058-5; Kato I, 1998, J CLIN EPIDEMIOL, V51, P1271, DOI 10.1016/S0895-4356(98)00119-X; KHOLKUTE SD, 1994, REPROD TOXICOL, V8, P69, DOI 10.1016/0890-6238(94)90069-8; Knox SS, 2011, J CLIN ENDOCR METAB, V96, P1747, DOI 10.1210/jc.2010-2401; Krogenaes AK, 1998, REPROD TOXICOL, V12, P575, DOI 10.1016/S0890-6238(98)00040-9; Kuchenhoff A, 1999, MOL REPROD DEV, V54, P126, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;126::AID-MRD4&gt;3.0.CO;2-B; Layton AC, 2002, TOXICOL APPL PHARM, V180, P157, DOI 10.1006/taap.2002.9395; Lindenau A, 1996, REPROD TOXICOL, V10, P227, DOI 10.1016/0890-6238(96)00026-3; Louis GMB, 2013, ENVIRON HEALTH PERSP, V121, P231, DOI 10.1289/ehp.1205301; MELTON LJ, 1986, AM J EPIDEMIOL, V124, P254, DOI 10.1093/oxfordjournals.aje.a114383; Ogliari KS, 2013, FERTIL STERIL, V99, P1681, DOI 10.1016/j.fertnstert.2013.01.103; Pocar P, 2012, TOXICOL SCI, V126, P213, DOI 10.1093/toxsci/kfr327; Quinn CL, 2011, ENVIRON HEALTH PERSP, V119, P641, DOI 10.1289/ehp.1002415; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Shekhar PVM, 1997, JNCI-J NATL CANCER I, V89, P1774, DOI 10.1093/jnci/89.23.1774; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Sinkkonen S, 2000, CHEMOSPHERE, V40, P943, DOI 10.1016/S0045-6535(99)00337-9; Sweeney AM, 2001, ENVIRON RES, V86, P128, DOI 10.1006/enrs.2001.4261; Taylor KW, 2014, ENVIRON HEALTH PERSP, V122, P145, DOI 10.1289/ehp.1306707; Tuttle AM, 2009, HUM REPROD, V24, P1452, DOI 10.1093/humrep/dep023; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; Vo TT, 2008, CANCER EPIDEM BIOMAR, V17, P2729, DOI 10.1158/1055-9965.EPI-08-0379; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Walker NJ, 2005, ENVIRON HEALTH PERSP, V113, P43, DOI 10.1289/ehp.7351; Wang W, 2012, TOXICOL APPL PHARM, V258, P288, DOI 10.1016/j.taap.2011.11.008; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	40	79	81	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116057	10.1371/journal.pone.0116057	http://dx.doi.org/10.1371/journal.pone.0116057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629726	gold, Green Published, Green Submitted			2022-12-26	WOS:000348732100030
J	Lundin, S; Jemt, A; Terje-Hegge, F; Foam, N; Pettersson, E; Kaller, M; Wirta, V; Lexow, P; Lundeberg, J				Lundin, Sverker; Jemt, Anders; Terje-Hegge, Finn; Foam, Napoleon; Pettersson, Erik; Kaller, Max; Wirta, Valtteri; Lexow, Preben; Lundeberg, Joakim			Endonuclease Specificity and Sequence Dependence of Type IIS Restriction Enzymes	PLOS ONE			English	Article							GENE-EXPRESSION; DNA RESTRICTION; CLEAVAGE; GENOME; RECOGNITION; SYSTEMS	Restriction enzymes that recognize specific sequences but cleave unknown sequence outside the recognition site are extensively utilized tools in molecular biology. Despite this, systematic functional categorization of cleavage performance has largely been lacking. We established a simple and automatable model system to assay cleavage distance variation (termed slippage) and the sequence dependence thereof. We coupled this to massively parallel sequencing in order to provide sensitive and accurate measurement. With this system 14 enzymes were assayed (AcuI, BbvI, BpmI, BpuEI, BseRI, BsgI, Eco57I, Eco57MI, EcoP15I, FauI, FokI, GsuI, MmeI and SmuI). We report significant variation of slippage ranging from 1-54%, variations in sequence context dependence, as well as variation between isoschizomers. We believe this largely overlooked property of enzymes with shifted cleavage would benefit from further large scale classification and engineering efforts seeking to improve performance. The gained insights of in-vitro performance may also aid the in-vivo understanding of these enzymes.	[Lundin, Sverker; Jemt, Anders; Lundeberg, Joakim] KTH, Sci Life Lab, S-17165 Solna, Sweden; [Terje-Hegge, Finn; Foam, Napoleon; Pettersson, Erik; Kaller, Max; Wirta, Valtteri; Lexow, Preben] LingVitae AS, N-3132 Husoysund, Norway	Royal Institute of Technology	Lundeberg, J (corresponding author), KTH, Sci Life Lab, S-17165 Solna, Sweden.	joakim.lundeberg@scilifelab.se		Jemt, Anders/0000-0002-2219-0197	European Community's Seventh Framework Programme FP7 [222913]; Norwegian SkatteFUNN system; Swedish Foundation for Strategic Research; Swedish Scientific Council; LingVitae AS	European Community's Seventh Framework Programme FP7; Norwegian SkatteFUNN system; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Scientific Council; LingVitae AS	The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 (under grant agreement 222913) http://ec.europa.eu/research/fp7/index_en.cfm, the Norwegian SkatteFUNN system, Swedish Foundation for Strategic Research, and the Swedish Scientific Council. At the time when the experiments were performed, Finn Terje-Hegge, Napoleon Foam, Erik Pettersson, Max Kaller, Valtteri Wirta and Preben Lexow were employed by LingVitae AS. LingVitae AS provided support in the form of salaries for authors Finn Terje-Hegge, Napoleon Foam, Erik Pettersson, Max Kaller, Valtteri Wirta and Preben Lexow, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; BRINKLEY P, 1991, GENE, V100, P267, DOI 10.1016/0378-1119(91)90379-P; Chan SH, 2011, NUCLEIC ACIDS RES, V39, P1, DOI 10.1093/nar/gkq742; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Drmanac R, 2009, SCIENCE; GEORGE J, 1980, J BIOL CHEM, V255, P6521; Kamps-Hughes N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt257; KESSLER C, 1986, GENE, V47, P1, DOI 10.1016/0378-1119(86)90245-3; KLEID D, 1976, P NATL ACAD SCI USA, V73, P293, DOI 10.1073/pnas.73.2.293; MALYGUINE E, 1980, GENE, V8, P163, DOI 10.1016/0378-1119(80)90035-9; Matsumura H, 2005, CELL MICROBIOL, V7, P11, DOI 10.1111/j.1462-5822.2004.00478.x; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; VENETIANER P, 1988, NUCLEIC ACIDS RES, V16, P3053, DOI 10.1093/nar/16.7.3053; VISSEL B, 1988, NUCLEIC ACIDS RES, V16, P4731, DOI 10.1093/nar/16.10.4731; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; Xu SY, 2012, J BACTERIOL, V194, P49, DOI 10.1128/JB.06248-11	26	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117059	10.1371/journal.pone.0117059	http://dx.doi.org/10.1371/journal.pone.0117059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629514	gold, Green Submitted, Green Published			2022-12-26	WOS:000348732100060
J	Papuc, E; Kurys-Denis, E; Krupski, W; Rejdak, K				Papuc, Ewa; Kurys-Denis, Ewa; Krupski, Witold; Rejdak, Konrad			Humoral Response against Small Heat Shock Proteins in Parkinson's Disease	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; IGG ANTIBODY REPERTOIRE; FIBRIL FORMATION; SYNUCLEIN; AUTOANTIBODIES; AUTOIMMUNITY; ANTIGENS	Introduction In the light of evidence for the increased heat shock proteins (HSP) expression in neurodegenerative disorders, the presence of the adaptive humoral response of the immune system can be expected. The aim of the study was to check whether Parkinson's disease (PD) has the ability to elicit immune response against small heat shock proteins. Methods IgG and IgM autoantibodies against alpha beta-crystallin were assessed in 26 PD patients 26 healthy subjects. For the assessment of anti-HSP IgG autoantibodies serum samples from 31 parkinsonian patients and 31 healthy control subjects were collected. Serum samples from PD patients and healthy control subjects were collected twice, at baseline and after mean of 13 months follow up. Results Both IgM and IgG autoantibodies against alpha beta-crystallin in PD patients were significantly higher compared to healthy controls (p<0.05). We also found statistically significant increase in antibodies titers against alpha beta-crystallin over the time of 13 months, both for IgG (p = 0.021) and for IgM (p<0.0001). Additionally, PD patients presented higher levels of anti-HSP IgG autoantibodies than healthy controls (p = 0.02). Conclusions Increase of IgG and IgM autoantibodies against alpha B-crystallin in PD patients over time may suggest their involvement in the disease pathogenesis and progression. Further studies are required to confirm the role of this antibody as a biomarker of the disease progression.	[Papuc, Ewa; Rejdak, Konrad] Med Univ, Chair & Dept Neurol, Lublin, Poland; [Kurys-Denis, Ewa; Krupski, Witold] Med Univ, Dept Radiol 2, Lublin, Poland	Medical University of Lublin; Medical University of Lublin	Papuc, E (corresponding author), Med Univ, Chair & Dept Neurol, Lublin, Poland.	ewapap@yahoo.pl	Kurys-Denis, Ewa/AAT-8967-2020	Kurys-Denis, Ewa/0000-0002-2664-7588; Rejdak, Konrad/0000-0002-7019-6681				Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; COHEN IR, 1991, IMMUNOL TODAY, V12, P105, DOI 10.1016/0167-5699(91)90093-9; Coutinho A, 1995, CURR OPIN IMMUNOL, V7, P812, DOI 10.1016/0952-7915(95)80053-0; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Dehle FC, 2010, CELL STRESS CHAPERON, V15, P1013, DOI 10.1007/s12192-010-0212-z; Dufek M, 2009, PARKINSONISM RELAT D, V15, P318, DOI 10.1016/j.parkreldis.2008.05.014; Ellis RJ, 2007, ADV EXP MED BIOL, V594, P1; Ghayour-Mobarhan M, 2007, INT J EXP PATHOL, V88, P249, DOI 10.1111/j.1365-2613.2007.00542.x; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; LACROIXDESMAZES S, 1995, EUR J IMMUNOL, V25, P2598, DOI 10.1002/eji.1830250929; Mayr M, 1999, ISR MED ASSOC J, V1, P272; Moudgil KD, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/621417; Mouthon L, 1996, SCAND J IMMUNOL, V44, P243, DOI 10.1046/j.1365-3083.1996.d01-306.x; MOUTHON L, 1995, J IMMUNOL, V154, P5769; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Prohaszka Z, 2001, EUR J CLIN INVEST, V31, P285, DOI 10.1046/j.1365-2362.2001.00819.x; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rothbard JB, 2011, J IMMUNOL, V186, P4263, DOI 10.4049/jimmunol.1003934; Shoenfeld Y, 2000, J AUTOIMMUN, V15, P199, DOI 10.1006/jaut.2000.0393; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Temajo NO, 2014, AUTOIMMUN REV, V13, P1013, DOI 10.1016/j.autrev.2014.08.030; Varbiro S, 2010, ACTA PHYSIOL HUNG, V97, P1, DOI 10.1556/APhysiol.97.2010.1.1; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Wick G, 2004, Autoimmun Rev, V3 Suppl 1, pS30; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Yokota S, 2010, MICROBIOL IMMUNOL, V54, P299, DOI 10.1111/j.1348-0421.2010.00214.x	29	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115480	10.1371/journal.pone.0115480	http://dx.doi.org/10.1371/journal.pone.0115480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629316	Green Published, gold			2022-12-26	WOS:000348732100019
J	Yang, XL; Chen, YQ; Pacenka, S; Gao, WS; Zhang, M; Sui, P; Steenhuis, TS				Yang, Xiaolin; Chen, Yuanquan; Pacenka, Steven; Gao, Wangsheng; Zhang, Min; Sui, Peng; Steenhuis, Tammo S.			Recharge and Groundwater Use in the North China Plain for Six Irrigated Crops for an Eleven Year Period	PLOS ONE			English	Article							WATER-USE EFFICIENCY; WINTER-WHEAT; DEFICIT IRRIGATION; PIEDMONT REGION; YIELD; BALANCE; MAIZE; SYSTEM; TABLE; CONSUMPTION	Water tables are dropping by approximately one meter annually throughout the North China Plain mainly due to water withdrawals for irrigating winter wheat year after year. In order to examine whether the drawdown can be reduced we calculate the net water use for an 11 year field experiment from 2003 to 2013 where six irrigated crops (winter wheat, summer maize, cotton, peanuts, sweet potato, ryegrass) were grown in different crop rotations in the North China Plain. As part of this experiment moisture contents were measured each at 20 cm intervals in the top 1.8 m. Recharge and net water use were calculated based on these moisture measurement. Results showed that winter wheat and ryegrass had the least recharge with an average of 27 mm/year and 39 mm/year, respectively; cotton had the most recharge with an average of 211 mm/year) followed by peanuts with 118 mm/year, sweet potato with 76 mm/year, and summer maize with 44 mm/year. Recharge depended on the amount of irrigation water pumped from the aquifer and was therefore a poor indicator of future groundwater decline. Instead net water use (recharge minus irrigation) was found to be a good indicator for the decline of the water table. The smallest amount of net (ground water) used was cotton with an average of 14 mm/year, followed by peanut with 32 mm/year, summer maize with 71 mm/year, sweet potato with 74 mm/year. Winter wheat and ryegrass had the greatest net water use with the average of 198 mm/year and 111 mm/year, respectively. Our calculations showed that any single crop would use less water than the prevalent winter wheat summer maize rotation. This growing one crop instead of two will reduce the decline of groundwater and in some rain rich years increase the ground water level, but will result in less income for the farmers.	[Yang, Xiaolin; Chen, Yuanquan; Gao, Wangsheng; Zhang, Min; Sui, Peng] China Agr Univ, Coll Agron & Biotechnol, Beijing 100193, Peoples R China; [Yang, Xiaolin; Pacenka, Steven; Steenhuis, Tammo S.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14853 USA	China Agricultural University; Cornell University	Sui, P (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Beijing 100193, Peoples R China.	tss1@cornell.edu; suipeng@cau.edu.cn	Chen, Yuanquan/AAU-9492-2020	Yang, XiaoLin/0000-0001-9146-8722	National Key Technology R&D Program of the People's Republic of China [2011BAD16B15, 2012BAD14B03]; China Scholarship Council for Xiaolin Yang [201306350107]; Chinese Universities Scientific Fund [2013YJ001]; College of Agriculture and Life Sciences at Cornell University	National Key Technology R&D Program of the People's Republic of China(National Key Technology R&D Program); China Scholarship Council for Xiaolin Yang(China Scholarship Council); Chinese Universities Scientific Fund; College of Agriculture and Life Sciences at Cornell University	The authors are grateful for grants from the National Key Technology R&D Program of the People's Republic of China (2011BAD16B15 and 2012BAD14B03), the China Scholarship Council for Xiaolin Yang (Grant No. 201306350107) and the Chinese Universities Scientific Fund (2013YJ001) and the support of College of Agriculture and Life Sciences at Cornell University by providing the use of their facilities free of charge.	Allen RG, 2006, AGR WATER MANAGE, V81, P1, DOI 10.1016/j.agwat.2005.03.007; BRADBURY KR, 2000, REFINEMENT 2 METHODS, P42331; Chen C, 2010, AGR WATER MANAGE, V97, P1175, DOI 10.1016/j.agwat.2008.11.012; Chen JY, 2003, ENVIRON GEOL, V44, P564, DOI 10.1007/s00254-003-0792-3; Cui NB, 2008, AGR WATER MANAGE, V95, P489, DOI 10.1016/j.agwat.2007.11.007; Currell MJ, 2012, HYDROL PROCESS, V26, P4050, DOI 10.1002/hyp.9208; Fan ZL, 2013, EUR J AGRON, V45, P52, DOI 10.1016/j.eja.2012.10.010; Fang QX, 2010, AGR WATER MANAGE, V97, P1102, DOI 10.1016/j.agwat.2010.01.008; Fang QX, 2006, PLANT SOIL, V284, P335, DOI 10.1007/s11104-006-0055-7; Hou XQ, 2012, FIELD CROP RES, V129, P7, DOI 10.1016/j.fcr.2011.12.021; Hu TT, 2009, AGR WATER MANAGE, V96, P208, DOI 10.1016/j.agwat.2008.07.011; Hu YK, 2010, J HYDROL, V393, P219, DOI 10.1016/j.jhydrol.2010.08.017; Huo ZL, 2012, IRRIG DRAIN, V61, P348, DOI 10.1002/ird.685; [贾金生 Jia Jinsheng], 2002, [地理学报, Acta Geographica Sinica], V57, P201; Kendy E, 2004, HYDROL PROCESS, V18, P2289, DOI 10.1002/hyp.5529; Kendy E, 2003, HYDROL PROCESS, V17, P2011, DOI 10.1002/hyp.1240; Kong FL, 2012, PROCEDIA ENGINEER, V28, P376, DOI 10.1016/j.proeng.2012.01.736; LIN XY, 1991, WATER SCI TECHNOL, V24, P71, DOI 10.2166/wst.1991.0338; Liu CM, 2002, AGR FOREST METEOROL, V111, P109, DOI 10.1016/S0168-1923(02)00015-1; Liu HJ, 2011, AGR WATER MANAGE, V98, P483, DOI 10.1016/j.agwat.2010.09.006; Liu MX, 2013, PEDOSPHERE, V23, P620, DOI 10.1016/S1002-0160(13)60055-7; Liu XW, 2013, AGR WATER MANAGE, V129, P173, DOI 10.1016/j.agwat.2013.08.002; *LUANCH COUNT WAT, 1993, INVESTIGATION REPORT, P42331; [马丽 MA Li], 2008, [干旱地区农业研究, Agricultural Research in the Arid Areas], V26, P177; Ma Y, 2013, AGR WATER MANAGE, V127, P13, DOI 10.1016/j.agwat.2013.05.011; Mo XG, 2009, AGR ECOSYST ENVIRON, V134, P67, DOI 10.1016/j.agee.2009.05.017; Moiwo JP, 2010, HYDROL PROCESS, V24, P3026, DOI 10.1002/hyp.7716; National Bureau of Statistics of China, 2008, CHIN STAT YB 2008; Passioura J, 2006, AGR WATER MANAGE, V80, P176, DOI 10.1016/j.agwat.2005.07.012; Qin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078828; Sas I.I., 2011, SAS STAT US GUID VER; Shu YQ, 2012, J HYDROL, V464, P79, DOI 10.1016/j.jhydrol.2012.06.048; Sun HY, 2006, AGR WATER MANAGE, V85, P211, DOI 10.1016/j.agwat.2006.04.008; Sun HY, 2010, AGR WATER MANAGE, V97, P1139, DOI 10.1016/j.agwat.2009.06.004; Sun QP, 2011, AGR WATER MANAGE, V98, P808, DOI 10.1016/j.agwat.2010.12.007; Yang JF, 2007, HYDROL PROCESS, V21, P717, DOI 10.1002/hyp.6246; YANG XL, 2014, DATA RECHARGE GROUND, P42331; Yang YM, 2010, AGR WATER MANAGE, V97, P1711, DOI 10.1016/j.agwat.2010.06.002; Yang YH, 2006, AGR WATER MANAGE, V82, P25, DOI 10.1016/j.agwat.2005.07.020; Yang YH, 2002, WATER SA, V28, P171; Ye YL, 2008, CHINESE AGR SCI B, V24, P445; [张敏 Zhang Min], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P251; Zhang MY, 2013, J CLEAN PROD, V54, P101, DOI 10.1016/j.jclepro.2013.04.033; Zhang XY, 2008, IRRIGATION SCI, V27, P1, DOI 10.1007/s00271-008-0131-2; Zhang XY, 2013, IRRIGATION SCI, V31, P1103, DOI 10.1007/s00271-012-0391-8; Zhang YQ, 2004, AGR WATER MANAGE, V64, P107, DOI 10.1016/S0378-3774(03)00201-4; ZHANG Z, 2003, REV CHINA AGR TECHNO, V5, P42; Zhao LY, 2013, ACTA METEOROL SIN, V27, P585, DOI 10.1007/s13351-013-0405-3; Zhao RF, 2006, AGRON J, V98, P938, DOI 10.2134/agronj2005.0157; Zwart SJ, 2004, AGR WATER MANAGE, V69, P115, DOI 10.1016/j.agwat.2004.04.007	50	47	50	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115269	10.1371/journal.pone.0115269	http://dx.doi.org/10.1371/journal.pone.0115269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625765	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821400006
J	Makino, S; Mishima, Y; Inoue, K; Inada, T				Makino, Shiho; Mishima, Yuichiro; Inoue, Kunio; Inada, Toshifumi			Roles of mRNA Fate Modulators Dhh1 and Pat1 in TNRC6-dependent Gene Silencing Recapitulated in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL REPRESSION; CCR4-NOT COMPLEX; MEDIATED DEADENYLATION; DECAPPING COMPLEXES; ZEBRAFISH MIR-430; GW182 PROTEINS; MIRNA TARGETS; IN-VITRO; DROSOPHILA; MICRORNAS	The CCR4-NOT complex, the major deadenylase in eukaryotes, plays crucial roles in gene expression at the levels of transcription, mRNA decay, and protein degradation. GW182/TNRC6 proteins, which are core components of the microRNAinduced silencing complex in animals, stimulate deadenylation and repress translation via recruitment of the CCR4-NOT complex. Here we report a heterologous experimental system that recapitulates the recruitment of CCR4-NOT complex by TNRC6 in S. cerevisiae. Using this system, we characterize conserved functions of theCCR4-NOTcomplex. The complex stimulates degradation of mRNA from the 5' end by Xrn1, in a manner independent of both translation and deadenylation. This degradation pathway is probably conserved in miRNA-mediated gene silencing in zebrafish. Furthermore, the mRNA fate modulators Dhh1 and Pat1 redundantly stimulatemRNAdecay, but both factors are required for poly(A) tail-independent translation repression by tethered TNRC6A. Our tethering-based reconstitution system reveals that the conserved architecture of Not1/CNOT1 provides a binding surface for TNRC6, thereby connecting microRNA-induced silencing complex to the decapping machinery as well as the translation apparatus.	[Makino, Shiho; Inada, Toshifumi] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Mishima, Yuichiro] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Mishima, Yuichiro] Univ Tokyo, Dept Med Genome Sci, Bunkyo Ku, Tokyo 1130032, Japan; [Inoue, Kunio] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan	Tohoku University; University of Tokyo; University of Tokyo; Kobe University	Mishima, Y (corresponding author), Univ Tokyo, Dept Med Genome Sci, Bunkyo Ku, Tokyo 1130032, Japan.	mishima@iam.u-tokyo.ac.jp; tinada@m.tohoku.ac.jp	Mishima, Yuichiro/I-3881-2019; Inada, Toshifumi/AAE-1517-2019	Mishima, Yuichiro/0000-0002-1075-9454; Makino, Shiho/0000-0001-6147-737X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20112006, 26116003, 24115711]; Mitsubishi Foundation; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [13J02601] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-aid for Scientific Research on Innovative Areas "RNA regulation" (20112006) and "Nascent chain biology" (26116003) (to T. I.) and "non-coding RNA" (24115711) (to Y. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Research Grants in the Natural Sciences, Mitsubishi Foundation (to T. I.).; Recipient of a Japan Society for the Promotion of Science Research Fellowship.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Anderson JSJ, 1996, CURR BIOL, V6, P780; Barisic-Jager E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071860; Basquin J, 2012, MOL CELL, V48, P207, DOI 10.1016/j.molcel.2012.08.014; Bawankar P, 2013, RNA BIOL, V10, P228, DOI 10.4161/rna.23018; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Braun JE, 2012, NAT STRUCT MOL BIOL, V19, P1324, DOI 10.1038/nsmb.2413; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chekulaeva M, 2009, RNA, V15, P794, DOI 10.1261/rna.1364909; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fukao A, 2014, MOL CELL, V56, P79, DOI 10.1016/j.molcel.2014.09.005; Fukaya T, 2014, MOL CELL, V56, P67, DOI 10.1016/j.molcel.2014.09.004; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Fukaya T, 2011, EMBO J, V30, P4998, DOI 10.1038/emboj.2011.426; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Haas G, 2010, J CELL BIOL, V189, P289, DOI 10.1083/jcb.200910141; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Jager E, 2010, RNA BIOL, V7, P381; Kuroha K, 2009, EMBO REP, V10, P1265, DOI 10.1038/embor.2009.200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Maillet L, 2002, J BIOL CHEM, V277, P2835, DOI 10.1074/jbc.M107979200; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Miller JE, 2012, CRIT REV BIOCHEM MOL, V47, P315, DOI 10.3109/10409238.2012.667214; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Mishima Y, 2012, P NATL ACAD SCI USA, V109, P1104, DOI 10.1073/pnas.1113350109; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Nishihara T, 2013, NUCLEIC ACIDS RES, V41, P8692, DOI 10.1093/nar/gkt619; Ozgur S, 2010, MOL CELL BIOL, V30, P4308, DOI 10.1128/MCB.00429-10; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Petit AP, 2012, NUCLEIC ACIDS RES, V40, P11058, DOI 10.1093/nar/gks883; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Suk K, 2011, NUCLEIC ACIDS RES, V39, pE43, DOI 10.1093/nar/gkq1321; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Tritschler F, 2008, MOL CELL BIOL, V28, P6695, DOI 10.1128/MCB.00759-08; Tritschler F, 2009, P NATL ACAD SCI USA, V106, P21591, DOI 10.1073/pnas.0909871106; Tsuboi T, 2010, J BIOL CHEM, V285, P33589, DOI 10.1074/jbc.M110.117150; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Wahle E, 2013, BBA-GENE REGUL MECH, V1829, P561, DOI 10.1016/j.bbagrm.2013.01.003; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009	67	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8331	8347		10.1074/jbc.M114.615088	http://dx.doi.org/10.1074/jbc.M114.615088			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25657010	Green Published, hybrid			2022-12-26	WOS:000351662600028
J	Manchekar, M; Liu, YW; Sun, ZH; Richardson, PE; Dashti, N				Manchekar, Medha; Liu, Yanwen; Sun, Zhihuan; Richardson, Paul E.; Dashti, Nassrin			Phospholipid Transfer Protein Plays a Major Role in the Initiation of Apolipoprotein B-containing Lipoprotein Assembly in Mouse Primary Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY-LIPOPROTEIN; MCA-RH7777 CELLS; ABETALIPOPROTEINEMIA GENE; PLASMA LIPOPROTEINS; A-I; SECRETION; PARTICLE; MICE; DEFICIENCY	In this study, we tested the hypothesis that phospholipid transfer protein (PLTP) is a plausible mediator of phospholipid (PL) transfer to the N-terminal 1000 residues of apoB (apoB: 1000) leading to the initiation of apoB-containing lipoprotein assembly. To this end, primary hepatocytes from wild type (WT) and PLTP knock-out (KO) mice were transduced with adenovirus- apoB:1000 with or without co-transduction with adenovirus- PLTP, and the assembly and secretion of apoB:1000-containing lipoproteins were assessed. PLTP deficiency resulted in a 65 and 72% reduction in the protein and lipid content, respectively, of secreted apoB:1000-containing lipoproteins. Particles secreted by WT hepatocytes contained 69% PL, 9% diacylglycerol (DAG), and 23% triacylglycerol (TAG) with a stoichiometry of 46 PL, 6 DAG, and 15 TAG molecules per apoB:1000. PLTP absence drastically altered the lipid composition of apoB:1000 lipoproteins; these particles contained 46% PL, 13% DAG, and 41% TAG with a stoichiometry of 27 PL, 10 DAG, and 23 TAG molecules per apoB:1000. Reintroduction of Pltp gene into PLTP-KO hepatocytes stimulated the lipidation and secretion of apoB:1000-containing lipoproteins by similar to 3-fold; the lipid composition and stoichiometry of these particles were identical to those secreted byWThepatocytes. In contrast to the WT, apoB: 1000 in PLTP-KO hepatocytes was susceptible to intracellular degradation predominantly in the post-endoplasmic reticulum, presecretory compartment. Reintroduction of Pltp gene into PLTP-KO hepatocytes restored the stability of apoB:1000. These results provide compelling evidence that in hepatocytes initial recruitment of PL by apoB:1000 leading to the formation of the PL-rich apoB-containing initiation complex is mediated to a large extent by PLTP.	[Manchekar, Medha; Liu, Yanwen; Sun, Zhihuan; Dashti, Nassrin] Univ Alabama Birmingham, Div Gerontol Geriatr & Palliat Care, Dept Med, Basic Sci Sect, Birmingham, AL 35294 USA; [Richardson, Paul E.] Coastal Carolina Univ, Dept Chem & Phys, Conway, SC 29528 USA	University of Alabama System; University of Alabama Birmingham; Coastal Carolina University	Dashti, N (corresponding author), Univ Alabama Birmingham, Div Gerontol Geriatr & Palliat Care, Dept Med, 1808 7th Ave S,BDB-D680, Birmingham, AL 35292 USA.	ndashti@uabmc.edu			National Institutes of Health [RO1 HL-112647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL-112647.	ALAUPOVI.P, 1972, BIOCHIM BIOPHYS ACTA, V260, P689, DOI 10.1016/0005-2760(72)90018-5; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; DASHTI N, 1980, BIOCHIM BIOPHYS ACTA, V618, P347, DOI 10.1016/0005-2760(80)90041-7; Dashti N, 2002, BIOCHEMISTRY-US, V41, P6978, DOI 10.1021/bi011757l; Dashti N, 2007, J BIOL CHEM, V282, P28597, DOI 10.1074/jbc.M700229200; DAVIS RA, 1982, J BIOL CHEM, V257, P908; EDELSTEIN C, 1979, J LIPID RES, V20, P143; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Hamilton RL, 1998, J LIPID RES, V39, P1543; Honkakoski P, 1998, BIOCHEM J, V330, P889, DOI 10.1042/bj3300889; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; Jiang XC, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-75; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu YW, 2010, J LIPID RES, V51, P2253, DOI 10.1194/jlr.M005371; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo Y, 2010, J PHARMACOL EXP THER, V332, P1100, DOI 10.1124/jpet.109.161232; Manchekar M, 2004, J BIOL CHEM, V279, P39757, DOI 10.1074/jbc.M406302200; Manchekar M, 2008, J BIOL CHEM, V283, P29251, DOI 10.1074/jbc.M804912200; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Okazaki H, 2010, J BIOL CHEM, V285, P6801, DOI 10.1074/jbc.M109.079459; Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8; Oram JF, 2008, J BIOL CHEM, V283, P11541, DOI 10.1074/jbc.M800117200; Ponsin G, 2003, BIOCHEMISTRY-US, V42, P4444, DOI 10.1021/bi027006g; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; Rava P, 2006, J BIOL CHEM, V281, P11019, DOI 10.1074/jbc.M512823200; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; SHOULDERS CC, 1994, NAT STRUCT BIOL, V1, P285, DOI 10.1038/nsb0594-285; Siggins S, 2007, ATHEROSCLEROSIS, V190, P114, DOI 10.1016/j.atherosclerosis.2006.02.037; Tran K, 2000, J BIOL CHEM, V275, P25023, DOI 10.1074/jbc.M908971199; van Haperen R, 2002, J BIOL CHEM, V277, P48938, DOI 10.1074/jbc.M209128200; van Tol A, 2002, CURR OPIN LIPIDOL, V13, P135, DOI 10.1097/00041433-200204000-00004; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; WETTERAU JR, 1992, SCIENCE, V258, P999; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; YAO ZM, 1992, J BIOL CHEM, V267, P1175; Yazdanyar A, 2013, ARTERIOSCL THROM VAS, V33, P2058, DOI 10.1161/ATVBAHA.113.301628; Yazdanyar A, 2012, HEPATOLOGY, V56, P576, DOI 10.1002/hep.25648	45	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8196	8205		10.1074/jbc.M114.602748	http://dx.doi.org/10.1074/jbc.M114.602748			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25638820	hybrid, Green Published			2022-12-26	WOS:000351662600017
J	Nardi, F; Hoffmann, TM; Stretton, C; Cwiklinski, E; Taylor, PM; Hundal, HS				Nardi, Francesca; Hoffmann, Thorsten M.; Stretton, Clare; Cwiklinski, Emma; Taylor, Peter M.; Hundal, Harinder S.			Proteasomal Modulation of Cellular SNAT2 (SLC38A2) Abundance and Function by Unsaturated Fatty Acid Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; SYSTEM-A; UBIQUITIN-PROTEASOME; INNATE IMMUNITY; TRANSPORTER; ACTIVATION; PATHWAYS; INSULIN; DEGRADATION; GENE	Expression and activity of the System A/SNAT2 (SLC38A2) amino acid transporter is up-regulated by amino acid starvation and hypertonicity by a mechanism dependent on both ATF4mediated transcription of the SLC38A2 gene and enhanced stabilization of SNAT2 itself, which forms part of an integrated cellular stress response to nutrient deprivation and osmotic stress. Here we demonstrate that this adaptive increase in System A function is restrained in cells subjected to prior incubation with linoleic acid (LOA, an unsaturated C18: 2 fatty acid) for 24 h. While fatty acid treatment had no detectable effect upon stress-induced SNAT2 or ATF4 gene transcription, the associated increase in SNAT2 protein/membrane transport activity were strongly suppressed in L6 myotubes or HeLa cells preincubated with LOA. Cellular ubiquitination of many proteins was increased by LOA and although the fatty acid-induced loss of SNAT2 could be attenuated by proteasomal inhibition, the functional increase in System A transport activity associated with amino acid starvation/hypertonicity that depends upon processing/maturation and delivery ofSNAT2to the cell surface could not be rescued. LOA up-regulated cellular expression of Nedd4.2, an E3-ligase implicated in SNAT2 ubiquitination, but shRNA-directed Nedd4.2 gene silencing could not curb fatty acid-induced loss of SNAT2 adaptation. However, expression of SNAT2 in which seven putative lysyl-ubiquitination sites in the cytoplasmic N-terminal domain were mutated to alanine protected SNAT2 against LOA-induced proteasomal degradation. Collectively, our findings indicate that increased availability of unsaturated fatty acids can compromise the stress-induced induction/adaptation in SNAT2 expression and function by promoting its degradation via the ubiquitin-proteasome system.	[Nardi, Francesca; Hoffmann, Thorsten M.; Stretton, Clare; Cwiklinski, Emma; Taylor, Peter M.; Hundal, Harinder S.] Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland	University of Dundee	Hundal, HS (corresponding author), Univ Dundee, Coll Life Sci, Sir James Black Ctr, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland.	h.s.hundal@dundee.ac.uk	Hundal, Hari/A-8990-2008	Hundal, Hari/0000-0002-7621-4932	Diabetes UK; Wellcome Trust; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I007261/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I007261/1] Funding Source: researchfish	Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Diabetes UK, The Wellcome Trust, and the Biotechnology and Biological Sciences Research Council.	Ando H, 2004, J BIOL CHEM, V279, P15427, DOI 10.1074/jbc.M313701200; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; DAHLMANN B, 1985, BIOCHEM J, V228, P171, DOI 10.1042/bj2280171; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; GAZZOLA GC, 1981, J BIOL CHEM, V256, P3191; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Hyde R, 2003, BIOCHEM J, V373, P1, DOI 10.1042/BJ20030405; Hyde R, 2002, J BIOL CHEM, V277, P13628, DOI 10.1074/jbc.M108609200; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Hyde Russell, 2005, FASEB J, V19, P461; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jones HN, 2010, DIABETES, V59, P1161, DOI 10.2337/db09-0824; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Lopez-Fontanals M, 2003, J GEN PHYSIOL, V122, P5, DOI 10.1085/jgp.200308800; Luzio JP, 2009, BIOCHEM SOC T, V37, P1019, DOI 10.1042/BST0371019; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Ringseis R, 2013, BBA-GEN SUBJECTS, V1830, P2105, DOI 10.1016/j.bbagen.2012.09.024; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wijngaarden MA, 2014, AM J PHYSIOL-ENDOC M, V307, pE885, DOI 10.1152/ajpendo.00215.2014; Zhao NN, 2014, P NATL ACAD SCI USA, V111, P9175, DOI 10.1073/pnas.1405355111; Zhou Q, 2007, ENDOCRINOLOGY, V148, P5696, DOI 10.1210/en.2007-0183	36	27	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8173	8184		10.1074/jbc.M114.625137	http://dx.doi.org/10.1074/jbc.M114.625137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25653282	Green Published, hybrid			2022-12-26	WOS:000351662600015
J	Sawada, J; Li, FF; Komatsu, M				Sawada, Junko; Li, Fangfei; Komatsu, Masanobu			R-Ras Protein Inhibits Autophosphorylation of Vascular Endothelial Growth Factor Receptor 2 in Endothelial Cells and Suppresses Receptor Activation in Tumor Vasculature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INTEGRIN ACTIVATION; BLOOD-VESSELS; ANTIANGIOGENIC THERAPY; EPITHELIAL-CELLS; ANGIOGENESIS; NORMALIZATION; ENDOCYTOSIS; METASTASIS; KINASE	Abnormal angiogenesis is associated with a broad range of medical conditions, including cancer. The formation of neovasculature with functionally defective blood vessels significantly impacts tumor progression, metastasis, and the efficacy of anticancer therapies. Vascular endothelial growth factor (VEGF) potently induces vascular permeability and vessel growth in the tumor microenvironment, and its inhibition normalizes tumor vasculature. In contrast, the signaling of the small GTPase R-Ras inhibits excessive angiogenic growth and promotes the maturation of regenerating blood vessels. R-Ras signaling counteracts VEGF-induced vessel sprouting, permeability, and invasive activities of endothelial cells. In this study, we investigated the effect of R-Ras on VEGF receptor 2 (VEGFR2) activation by VEGF, the key mechanism for angiogenic stimulation. We show that tyrosine phosphorylation of VEGFR2 is significantly elevated in the tumor vasculature and dermal microvessels of VEGF-injected skin in R-Ras knockout mice. In cultured endothelial cells, R-Ras suppressed the internalization of VEGFR2, which is required for full activation of the receptor by VEGF. Consequently, R-Ras strongly suppressed autophosphorylation of the receptor at all five major tyrosine phosphorylation sites. Conversely, silencing of R-Ras resulted in increased VEGFR2 phosphorylation. This effect of R-Ras onVEGFR2was, at least in part, dependent on vascular endothelial cadherin. These findings identify a novel function of R-Ras to control the response of endothelial cells to VEGF and suggest an underlying mechanism by which R-Ras regulates angiogenesis.	Sanford Burnham Med Res Inst Lake Nona, Cardiovasc Pathobiol Program, Orlando, FL 32827 USA; Sanford Burnham Med Res Inst Lake Nona, Tumor Microenvironm & Metastasis Program, Orlando, FL 32827 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Komatsu, M (corresponding author), Sanford Burnham Med Res Inst Lake Nona, 6400 Sanger Rd, Orlando, FL 32827 USA.	mkomatsu@sanfordburnham.org	Komatsu, Masanobu/AAV-3013-2020	Komatsu, Masanobu/0000-0001-7548-137X	NCI/National Institutes of Health [CA125255]; Florida Department of Health Bankhead-Coley Cancer Research Program [4BB17]; Florida Breast Cancer Foundation [3021180]; NATIONAL CANCER INSTITUTE [R01CA125255] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health Bankhead-Coley Cancer Research Program; Florida Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI/National Institutes of Health Grant CA125255. This work was also supported by Florida Department of Health Bankhead-Coley Cancer Research Program 4BB17 and by Florida Breast Cancer Foundation Grant 3021180.	Barbieri MA, 1998, J BIOL CHEM, V273, P19367, DOI 10.1074/jbc.273.31.19367; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Conklin MW, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-14; De Bock K, 2011, CURR OPIN GENET DEV, V21, P73, DOI 10.1016/j.gde.2010.10.008; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fehrenbacher N, 2009, CURR BIOL, V19, pR454, DOI 10.1016/j.cub.2009.04.045; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jeong HW, 2005, CANCER RES, V65, P507; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; LOWE DG, 1987, CELL, V48, P137, DOI 10.1016/0092-8674(87)90364-3; LOWE DG, 1987, MOL CELL BIOL, V7, P2845, DOI 10.1128/MCB.7.8.2845; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Marte BM, 1997, CURR BIOL, V7, P63, DOI 10.1016/S0960-9822(06)00028-5; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Misaki R, 2010, J CELL BIOL, V191, P23, DOI 10.1083/jcb.200911143; Mora N, 2007, CANCER IMMUNOL IMMUN, V56, P535, DOI 10.1007/s00262-006-0205-z; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pitulescu ME, 2014, CELL ADHES MIGR, V8, P366, DOI 10.4161/19336918.2014.970010; Rincon-Arano H, 2003, CANCER, V97, P575, DOI 10.1002/cncr.11093; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Sawada J, 2012, CELL CYCLE, V11, P4285, DOI 10.4161/cc.22465; Sawada J, 2012, CANCER CELL, V22, P235, DOI 10.1016/j.ccr.2012.06.013; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; SELF AJ, 1993, ONCOGENE, V8, P655; Sethi T, 1999, MOL BIOL CELL, V10, P1799, DOI 10.1091/mbc.10.6.1799; Song J, 2014, ONCOL REP, V31, P2776, DOI 10.3892/or.2014.3121; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Wang BC, 2000, J BIOL CHEM, V275, P5222, DOI 10.1074/jbc.275.7.5222; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Yu Y, 2002, ONCOGENE, V21, P7557, DOI 10.1038/sj.onc.1205961; Yu Y, 2006, MOL CELL BIOL, V26, P6372, DOI 10.1128/MCB.00509-05; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813; Zou JX, 2002, J BIOL CHEM, V277, P1824, DOI 10.1074/jbc.M103133200	49	23	23	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8133	8145		10.1074/jbc.M114.591511	http://dx.doi.org/10.1074/jbc.M114.591511			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645912	Green Published, hybrid			2022-12-26	WOS:000351662600011
J	Allan, CM; Awad, AM; Johnson, JS; Shirasaki, DI; Wang, C; Blaby-Haas, CE; Merchant, SS; Loo, JA; Clarke, CF				Allan, Christopher M.; Awad, Agape M.; Johnson, Jarrett S.; Shirasaki, Dyna I.; Wang, Charles; Blaby-Haas, Crysten E.; Merchant, Sabeeha S.; Loo, Joseph A.; Clarke, Catherine F.			Identification of Coq11, a New Coenzyme Q Biosynthetic Protein in the CoQ-Synthome in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mass Spectrometry (MS); Mitochondrial Metabolism; Protein Complex; Proteomics; Saccharomyces cerevisiae; Ubiquinone; Yeast; Q Biosynthetic Intermediates; Coenzyme Q; Immunoprecipitation	PARA-AMINOBENZOIC ACID; MITOCHONDRIAL FERREDOXIN; C-METHYLTRANSFERASE; YEAST MITOCHONDRIA; ACETOHYDROXYACID SYNTHASE; REGULATORY SUBUNIT; BINDING-PROTEIN; ESSENTIAL GENE; POLYPEPTIDE; KINASE	Background: Yeast synthesizes coenzyme Q via a macromolecular protein complex. Results: The Q biosynthetic complex includes Coq8 and the uncharacterized protein YLR290C; the ylr290c mutant exhibits impaired Q synthesis. Conclusion: YLR290C (Coq11) is a novel protein required for efficient yeast Q biosynthesis. Significance: Discovery and characterization of yeast Coq biosynthetic proteins leads to an improved understanding of coenzyme Q biosynthesis and regulation. Coenzyme Q (Q or ubiquinone) is a redox active lipid composed of a fully substituted benzoquinone ring and a polyisoprenoid tail and is required for mitochondrial electron transport. In the yeast Saccharomyces cerevisiae, Q is synthesized by the products of 11 known genes, COQ1-COQ9, YAH1, and ARH1. The function of some of the Coq proteins remains unknown, and several steps in the Q biosynthetic pathway are not fully characterized. Several of the Coq proteins are associated in a macromolecular complex on the matrix face of the inner mitochondrial membrane, and this complex is required for efficient Q synthesis. Here, we further characterize this complex via immunoblotting and proteomic analysis of tandem affinity-purified tagged Coq proteins. We show that Coq8, a putative kinase required for the stability of the Q biosynthetic complex, is associated with a Coq6-containing complex. Additionally Q(6) and late stage Q biosynthetic intermediates were also found to co-purify with the complex. A mitochondrial protein of unknown function, encoded by the YLR290C open reading frame, is also identified as a constituent of the complex and is shown to be required for efficient de novo Q biosynthesis. Given its effect on Q synthesis and its association with the biosynthetic complex, we propose that the open reading frame YLR290C be designated COQ11.	[Allan, Christopher M.; Awad, Agape M.; Johnson, Jarrett S.; Shirasaki, Dyna I.; Wang, Charles; Blaby-Haas, Crysten E.; Merchant, Sabeeha S.; Loo, Joseph A.; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Allan, Christopher M.; Awad, Agape M.; Johnson, Jarrett S.; Shirasaki, Dyna I.; Wang, Charles; Blaby-Haas, Crysten E.; Merchant, Sabeeha S.; Loo, Joseph A.; Clarke, Catherine F.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Loo, Joseph A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Merchant, Sabeeha S.; Loo, Joseph A.] Univ Calif Los Angeles, US DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 156905, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu		Blaby, Crysten/0000-0002-1583-1291	National Institutes of Health [S10RR024605, R01GM103479]; National Science Foundation [MCB-1330803]; Kirschstein National Research Service Award NIH [GM100753]; Office of Science (Biological and Environmental Research), U.S. Department of Energy [DE-FC02-02ER63421]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055052, R01GM103479, F32GM100753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Kirschstein National Research Service Award NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science (Biological and Environmental Research), U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants S10RR024605 and R01GM103479 (to J. A. L.). This work was also supported by National Science Foundation Grant MCB-1330803 (to C. F. C.), Kirschstein National Research Service Award NIH GM100753 (to C. E. B.-H.), and Grant DE-FC02-02ER63421 from the Office of Science (Biological and Environmental Research), U.S. Department of Energy.	Allan CM, 2013, BBA-MOL CELL BIOL L, V1831, P776, DOI 10.1016/j.bbalip.2012.12.007; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Baba SW, 2004, J BIOL CHEM, V279, P10052, DOI 10.1074/jbc.M313712200; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Barros MH, 2002, J BIOL CHEM, V277, P9997, DOI 10.1074/jbc.M112025200; Barros MH, 1999, GENE, V233, P197, DOI 10.1016/S0378-1119(99)00137-7; Belogrudov GI, 2001, ARCH BIOCHEM BIOPHYS, V392, P48, DOI 10.1006/abbi.2001.2448; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Blaby-Haas CE, 2012, BBA-MOL CELL RES, V1823, P1531, DOI 10.1016/j.bbamcr.2012.04.010; Brachmann CB, 1998, YEAST, V14, P115; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; Burke D., 2000, METHODS YEAST GENETI, P177; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Crane F. L., 1965, BIOCH QUINONES, P183; Cui TZ, 2009, FEBS J, V276, P748, DOI 10.1111/j.1742-4658.2008.06821.x; Cullin C, 1996, YEAST, V12, P1511, DOI 10.1002/(SICI)1097-0061(199612)12:15<1511::AID-YEA41>3.0.CO;2-B; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gin P, 2005, J BIOL CHEM, V280, P2676, DOI 10.1074/jbc.M411527200; Gin P, 2003, J BIOL CHEM, V278, P25308, DOI 10.1074/jbc.M303234200; Glerum DM, 1997, J BIOL CHEM, V272, P19088, DOI 10.1074/jbc.272.30.19088; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Grandier-Vazeille X, 2001, BIOCHEMISTRY-US, V40, P9758, DOI 10.1021/bi010277r; Gulmezian M., 2006, THESIS UCLA LOS ANGE; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; He CWH, 2014, BBA-MOL CELL BIOL L, V1841, P630, DOI 10.1016/j.bbalip.2013.12.017; Hershey HP, 1999, PLANT MOL BIOL, V40, P795, DOI 10.1023/A:1006273224977; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Hsieh EJ, 2004, BIOCHEM BIOPH RES CO, V317, P648, DOI 10.1016/j.bbrc.2004.03.096; Huang MS, 2013, J PROTEOME RES, V12, P491, DOI 10.1021/pr300952g; Johnson A, 2005, J BIOL CHEM, V280, P31397, DOI 10.1074/jbc.M503277200; Kopec J, 2011, ACTA CRYSTALLOGR F, V67, P1184, DOI 10.1107/S174430911102923X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Laredj LN, 2014, BIOCHIMIE, V100, P78, DOI 10.1016/j.biochi.2013.12.006; Lee YT, 2001, BIOCHEMISTRY-US, V40, P6836, DOI 10.1021/bi002775q; Lenaz G., 1985, COENZYME Q, P165; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Lohman DC, 2014, P NATL ACAD SCI USA, V111, pE4697, DOI 10.1073/pnas.1413128111; Lundquist PK, 2012, TRENDS PLANT SCI, V17, P546, DOI 10.1016/j.tplants.2012.05.010; Lundquist PK, 2012, PLANT PHYSIOL, V158, P1172, DOI 10.1104/pp.111.193144; Manzella L, 1998, YEAST, V14, P839, DOI 10.1002/(SICI)1097-0061(19980630)14:9<839::AID-YEA283>3.0.CO;2-A; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mukai N, 2010, J BIOSCI BIOENG, V109, P564, DOI 10.1016/j.jbiosc.2009.11.011; Murai M, 2014, BIOCHEMISTRY-US, V53, P3995, DOI 10.1021/bi500347s; Nguyen TPT, 2014, BBA-MOL CELL BIOL L, V1841, P1628, DOI 10.1016/j.bbalip.2014.08.007; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Pang SS, 2001, BIOCHEM J, V357, P749, DOI 10.1042/0264-6021:3570749; Perocchi F, 2006, PLOS GENET, V2, P1612, DOI 10.1371/journal.pgen.0020170; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Piller LE, 2012, J EXP BOT, V63, P1609, DOI 10.1093/jxb/ers016; Poon WW, 1999, J BIOL CHEM, V274, P21665, DOI 10.1074/jbc.274.31.21665; Rangarajan ES, 2004, PROTEIN SCI, V13, P3006, DOI 10.1110/ps.04953004; Rea SL, 2010, DEV DISABIL RES REV, V16, P200, DOI 10.1002/ddrr.114; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Stefely JA, 2015, MOL CELL, V57, P83, DOI 10.1016/j.molcel.2014.11.002; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Tay Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055041; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1994, J BIOL CHEM, V269, P26144; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Wheeler B, 2015, PROTEIN EXPRES PURIF, V108, P13, DOI 10.1016/j.pep.2014.12.008; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	90	52	54	1	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7517	7534		10.1074/jbc.M114.633131	http://dx.doi.org/10.1074/jbc.M114.633131			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25631044	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000351613600019
J	Tiano, JP; Springer, DA; Rane, SG				Tiano, Joseph P.; Springer, Danielle A.; Rane, Sushil G.			SMAD3 Negatively Regulates Serum Irisin and Skeletal Muscle FNDC5 and Peroxisome Proliferator-activated Receptor gamma Coactivator 1-alpha (PGC-1 alpha) during Exercise	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exercise; Obesity; Skeletal Muscle; SMAD Transcription Factor; Transforming Growth Factor Beta (TGF-B); Irisin	BROWN ADIPOSE-TISSUE; TGF-BETA; TRANSCRIPTION FACTORS; TARGETED DISRUPTION; INSULIN-RESISTANCE; AEROBIC EXERCISE; OBESITY; FAT; GROWTH; EXPRESSION	Background: Mothers against decapentaplegic homolog 3 (SMAD3) and FNDC5/irisin are molecules that modulate energy metabolism and body weight regulation. Results: SMAD3 negatively regulates irisin during exercise and suppresses FNDC5 and PGC-1 in cultured skeletal muscle cells. Conclusion: SMAD3 suppresses irisin/FNDC5 in skeletal muscle. Significance: This study sheds light on the poorly understood regulation of irisin/FNDC5 in skeletal muscle. Beige adipose cells are a distinct and inducible type of thermogenic fat cell that express the mitochondrial uncoupling protein-1 and thus represent a powerful target for treating obesity. Mice lacking the TGF- effector protein SMAD3 are protected against diet-induced obesity because of browning of their white adipose tissue (WAT), leading to increased whole body energy expenditure. However, the role SMAD3 plays in WAT browning is not clearly understood. Irisin is an exercise-induced skeletal muscle hormone that induces WAT browning similar to that observed in SMAD3-deficient mice. Together, these observations suggested that SMAD3 may negatively regulate irisin production and/or secretion from skeletal muscle. To address this question, we used wild-type and SMAD3 knock-out (Smad3(-/-)) mice subjected to an exercise regime and C2C12 myotubes treated with TGF-, a TGF- receptor 1 pharmacological inhibitor, adenovirus expressing constitutively active SMAD3, or siRNA against SMAD3. We find that in Smad3(-/-) mice, exercise increases serum irisin and skeletal muscle FNDC5 (irisin precursor) and its upstream activator peroxisome proliferator-activated receptor coactivator 1- (PGC-1) to a greater extent than in wild-type mice. In C2C12 myotubes, TGF- suppresses FNDC5 and PGC-1 mRNA and protein levels via SMAD3 and promotes SMAD3 binding to the FNDC5 and PGC-1 promoters. These data establish that SMAD3 suppresses FNDC5 and PGC-1 in skeletal muscle cells. These findings shed light on the poorly understood regulation of irisin/FNDC5 by demonstrating a novel association between irisin and SMAD3 signaling in skeletal muscle.	[Tiano, Joseph P.; Rane, Sushil G.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Springer, Danielle A.] NHLBI, Murine Phenotyping Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rane, SG (corresponding author), NIDDK, Cell Growth & Metab Sect, Diabet Endocrinol & Obes Branch, NIH,Clin Res Ctr, West Labs 5-5940,10 Ctr Dr, Bethesda, MD 20892 USA.	ranes@niddk.nih.gov			National Institutes of Health intramural program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZIGHL006190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055106, ZIADK055107] Funding Source: NIH RePORTER	National Institutes of Health intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health intramural program.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Bonala S, 2014, J BIOL CHEM, V289, P7654, DOI 10.1074/jbc.M113.529925; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Crawford AG, 2010, POPUL HEALTH MANAG, V13, P151, DOI 10.1089/pop.2009.0039; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dalbo VJ, 2011, J GERONTOL A-BIOL, V66, P855, DOI 10.1093/gerona/glr091; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Ferrer-Martinez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Goodman CA, 2013, MOL ENDOCRINOL, V27, P1946, DOI 10.1210/me.2013-1194; Hofmann T, 2014, PEPTIDES, V54, P89, DOI 10.1016/j.peptides.2014.01.016; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim WK, 2012, INT J BIOCHEM CELL B, V44, P327, DOI 10.1016/j.biocel.2011.11.004; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kraemer RR, 2014, HORM METAB RES, V46, P150, DOI 10.1055/s-0033-1355381; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lecker SH, 2012, CIRC-HEART FAIL, V5, P812, DOI 10.1161/CIRCHEARTFAILURE.112.969543; Lee P., 2013, INT J OBES LOND, V38, P170; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843; Millet C, 2009, J BIOL CHEM, V284, P19808, DOI 10.1074/jbc.M109.016667; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073680; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sacks HS, 2013, J CLIN ENDOCR METAB, V98, pE1448, DOI 10.1210/jc.2013-1265; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sohn EJ, 2012, CELL MOL BIOL, V58, P1763, DOI 10.1170/207; Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Trachtman H, 2011, KIDNEY INT, V79, P1236, DOI 10.1038/ki.2011.33; Tsuchiya Y, 2014, TOHOKU J EXP MED, V233, P135, DOI 10.1620/tjem.233.135; Tsurutani Y, 2011, BIOCHEM BIOPH RES CO, V407, P68, DOI 10.1016/j.bbrc.2011.02.106; Watts R, 2013, OBESITY, V21, P525, DOI 10.1002/oby.20070; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yoshida H, 2013, BBA-GEN SUBJECTS, V1830, P5027, DOI 10.1016/j.bbagen.2013.06.036; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	66	52	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7671	7684		10.1074/jbc.M114.617399	http://dx.doi.org/10.1074/jbc.M114.617399			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25648888	hybrid, Green Published			2022-12-26	WOS:000351613600029
J	Nagata, Y; Yoshihisa, Y; Matsunaga, K; Rehman, MU; Kitaichi, N; Shimizu, T				Nagata, Yuka; Yoshihisa, Yoko; Matsunaga, Kenji; Rehman, Mati Ur; Kitaichi, Nobuyuki; Shimizu, Tadamichi			Role of Macrophage Migration Inhibitory Factor (MIF) in Pollen-Induced Allergic Conjunctivitis and Pollen Dermatitis in Mice	PLOS ONE			English	Article							JAPANESE CEDAR POLLEN; II INVARIANT CHAIN; ATOPIC-DERMATITIS; EPITHELIAL-CELLS; CYTOKINE; CD74; EXPRESSION; ASTHMA; ENDOTOXEMIA; ACTIVATION	Pollen is a clinically important airborne allergen and one of the major causes of allergic conjunctivitis. A subpopulation of patients with atopic dermatitis (AD) are also known to have exacerbated skin eruptions on the face, especially around the eyelids, after contact with pollen. This pollen-induced skin reaction is now known as pollen dermatitis. Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine that plays an essential role in allergic inflammation. Recent findings suggest that MIF is involved in several allergic disorders, including AD. In this study, MIF knockout (KO), MIF transgenic (Tg) and WT littermate mice were immunized with ragweed (RW) pollen or Japanese cedar (JC) pollen and challenged via eye drops. We observed that the numbers of conjunctiva-and eyelid-infiltrating eosinophils were significantly increased in RW and JC pollen-sensitized MIF Tg compared with WT mice or MIF KO mice. The mRNA expression levels of eotaxin, interleukin (IL)-5 and IL-13 were increased in pollen-sensitized eyelid skin sites of MIF Tg mice. An in vitro analysis revealed that high eotaxin expression was induced in dermal fibroblasts by MIF combined with stimulation of IL-4 or IL-13. This eotaxin expression was inhibited by the treatment with CD74 siRNA in fibroblasts. These findings indicate that MIF can induce eosinophil accumulation in the conjunctiva and eyelid dermis exposed to pollen. Therefore, targeted inhibition of MIF might result as a new option to control pollen-induced allergic conjunctivitis and pollen dermatitis.	[Nagata, Yuka; Yoshihisa, Yoko; Matsunaga, Kenji; Rehman, Mati Ur; Shimizu, Tadamichi] Toyama Univ, Dept Dermatol, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Kitaichi, Nobuyuki] Hlth Sci Univ Hokkaido, Dept Ophthalmol, Sapporo, Hokkaido, Japan	University of Toyama; Health Sciences University of Hokkaido	Shimizu, T (corresponding author), Toyama Univ, Dept Dermatol, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	shimizut@med.u-toyama.ac.jp	Rehman, Mati Ur/AAE-6885-2019	Shimizu, Tadamichi/0000-0002-3231-0279				ADINOFF AD, 1988, J ALLERGY CLIN IMMUN, V81, P736, DOI 10.1016/0091-6749(88)91047-0; Akagi Y, 1997, KIDNEY INT, V51, P1265, DOI 10.1038/ki.1997.172; Barrera CA, 2005, J HISTOCHEM CYTOCHEM, V53, P1481, DOI 10.1369/jhc.4A6552.2005; Benedek G, 2013, EUR J IMMUNOL, V43, P1309, DOI 10.1002/eji.201243162; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bucala R, 1996, FASEB J, V7, P19; Calheiros AS, 2011, AM J RESP CELL MOL B, V44, P509, DOI [10.1165/rcmb.2010-0004OC, DOI 10.1165/RCMB.2010-00040C]; Das R, 2011, J CLIN IMMUNOL, V31, P666, DOI 10.1007/s10875-011-9541-7; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Grize L, 2006, ALLERGY, V61, P556, DOI 10.1111/j.1398-9995.2006.01030.x; Honma N, 2000, IMMUNOLOGY, V100, P84, DOI 10.1046/j.1365-2567.2000.00011.x; Kitaichi N, 2006, GRAEF ARCH CLIN EXP, V244, P825, DOI 10.1007/s00417-005-0168-3; Kondo H, 1998, EUR J IMMUNOL, V28, P769, DOI 10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H; Kusunoki Takashi, 2002, Arerugi, V51, P15; Leung DYM, 2004, ANN ALLERG ASTHMA IM, V93, pS1, DOI 10.1016/S1081-1206(10)61385-3; Lue HQ, 2011, CELL SIGNAL, V23, P135, DOI 10.1016/j.cellsig.2010.08.013; Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248; Murakami Yukako, 2011, Allergology International, V60, P397, DOI 10.2332/allergolint.10-CR-0268; Oiwa M, 2008, CLIN EXP ALLERGY, V38, P1357, DOI 10.1111/j.1365-2222.2008.03007.x; Ong GL, 1999, IMMUNOLOGY, V98, P296; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Sasaki S, 2004, KIDNEY INT, V65, P469, DOI 10.1111/j.1523-1755.2004.00394.x; Schopf L, 2005, INVEST OPHTH VIS SCI, V46, P2772, DOI 10.1167/iovs.04-0899; Schwartz V, 2012, EUR J CELL BIOL, V91, P435, DOI 10.1016/j.ejcb.2011.08.006; Shimizu T, 2005, J DERMATOL SCI, V37, P65, DOI 10.1016/j.jdermsci.2004.08.007; Shimizu T, 1999, J ALLERGY CLIN IMMUN, V104, P659, DOI 10.1016/S0091-6749(99)70339-8; Shimizu T, 2004, CLIN EXP ALLERGY, V34, P103, DOI 10.1111/j.1365-2222.2004.01836.x; Shimizu T, 1997, BIOCHEM BIOPH RES CO, V240, P173, DOI 10.1006/bbrc.1997.7633; Tanihara S, 1999, J Epidemiol, V9, P20; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; WEISER WY, 1989, P NATL ACAD SCI USA, V86, P7522, DOI 10.1073/pnas.86.19.7522; WRAIGHT CJ, 1990, J BIOL CHEM, V265, P5787; Xie LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016428; Yokozeki H, 2006, ACTA DERM-VENEREOL, V86, P148, DOI 10.2340/00015555-0020; Yokozeki H, 2007, CONTACT DERMATITIS, V56, P224, DOI 10.1111/j.1600-0536.2004.00491.x; Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418	38	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115593	10.1371/journal.pone.0115593	http://dx.doi.org/10.1371/journal.pone.0115593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647395	gold, Green Published, Green Submitted			2022-12-26	WOS:000348822600015
J	Shi, JL; Fu, L; Li, YH; Yu, L; Wang, WD				Shi Jinlong; Fu Lin; Li Yonghui; Yu Li; Wang Weidong			Identification of let-7a-2-3p or/and miR-188-5p as Prognostic Biomarkers in Cytogenetically Normal Acute Myeloid Leukemia	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; TUMOR-SUPPRESSOR; CEBPA MUTATIONS; OLDER PATIENTS; CELL-CYCLE; CANCER; GENE; PROLIFERATION; TRANSCRIPTION; PATHWAY	Cytogenetically normal acute myeloid leukemia (CN-AML) is the largest and most heterogeneous AML subgroup. It lacks sensitive and specific biomarkers. Emerging evidences have suggested that microRNAs are involved in the pathogenesis of various leukemias. This paper evaluated the association between microRNA expression and prognostic outcome for CN-AML, based on the RNA/microRNA sequencing data of CN-AML patients. High let-7a-2-3p expression and low miR-188-5p expression were identified to be significantly associated with longer overall survival (OS) and event free survival (EFS) for CN-AML, independently or in a combined way. Their prognostic values were further confirmed in European Leukemia Net (ELN) genetic categories. Also, in multivariable analysis with other known risk factors, high let-7a-2-3p and low miR-188-5p expression remained to be associated with longer OS and EFS. In addition, the prognostic value of these two microRNAs was confirmed in patients who received hematopoietic stem cell transplantation (HSCT). To gain more biological insights of the underlying mechanisms, we derived the genome-wide differential gene/microRNA signatures associated with the expression of let-7a-2-3p and miR-188-5p. Several common microRNA signatures indicating favorable outcome in previous studies were up-regulated in both high let-7a-2-3p expressers and low miR-188-5p expressers, including miR-135a, miR-335 and miR-125b and all members of miR-181 family. Additionally, common up-regulated genes included FOSB, IGJ, SNORD50A and ZNF502, and FOSB was a known favorable signature in AML. These common signatures further confirmed the underlying common mechanisms for these two microRNAs value as favorable prognostic biomarkers. We concluded that high let-7a-2-3p and low miR-188-5p expression could be potentially used as favorably prognostic biomarkers independently or in a combined way in CN-AML patients, whether they received HSCT or not.	[Shi Jinlong] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Med Engn Div, Sanya, Hainan, Peoples R China; [Shi Jinlong; Wang Weidong] Chinese Peoples Liberat Army Gen Hosp, Med Engn Support Ctr, Beijing 100853, Peoples R China; [Fu Lin] Peking Univ, Hosp 3, Dept Hematol, Beijing, Peoples R China; [Fu Lin] Peking Univ, Hosp 3, Lymphoma Res Ctr, Beijing, Peoples R China; [Li Yonghui; Yu Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Peking University; Peking University; Chinese People's Liberation Army General Hospital	Yu, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China.	chunhuiliyu@yahoo.com; wangwd301@126.com		Yu, Li/0000-0001-6872-2665	National Natural Science Foundation of China [61372047]; National High-tech R&D Program of China [2013BAI03B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China)	The work was supported by grants from the National Natural Science Foundation of China (61372047) and the National High-tech R&D Program of China (2013BAI03B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemdehy MF, 2012, CURR OPIN HEMATOL, V19, P261, DOI 10.1097/MOH.0b013e328353d4e9; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becker H, 2010, BLOOD, V116, P788, DOI 10.1182/blood-2010-01-262543; Burnett  AK, 2002, BRIT J HAEMATOL, V118, P357, DOI 10.1046/j.1365-2141.2002.03698.x; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Emmrich S, 2014, LEUKEMIA, V28, P1022, DOI 10.1038/leu.2013.357; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Frohling S, 2004, J CLIN ONCOL, V22, P624, DOI 10.1200/JCO.2004.06.060; GAO L, 2014, TUMOUR BIOL, P28669; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Khanim FL, 2009, BRIT J HAEMATOL, V144, P332, DOI 10.1111/j.1365-2141.2008.07449.x; Kiyoi H, 1999, BLOOD, V93, P3074; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lee HJ, 2013, CLIN CANCER RES, V19, P327, DOI 10.1158/1078-0432.CCR-12-2087; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marcucci G, 2008, NEW ENGL J MED, V358, P1919, DOI 10.1056/NEJMoa074256; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Metzeler KH, 2012, BLOOD, V120, P2118, DOI 10.1182/blood-2012-02-411827; Mian YA, 2010, CURR DRUG TARGETS, V11, P801; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; Qiu TZ, 2014, FEBS LETT, V588, P1168, DOI 10.1016/j.febslet.2014.02.054; Schotte D, 2012, LEUKEMIA, V26, P1, DOI 10.1038/leu.2011.151; Schwind S, 2010, BLOOD, V116, P5660, DOI 10.1182/blood-2010-06-290536; Schwind S, 2010, J CLIN ONCOL, V28, P5257, DOI 10.1200/JCO.2010.29.2953; Sirotkin AV, 2010, J CELL PHYSIOL, V223, P49, DOI 10.1002/jcp.21999; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tang WW, 2014, CELL SIGNAL, V26, P1420, DOI 10.1016/j.cellsig.2014.03.002; Ufkin ML, 2014, LEUKEMIA RES, V38, P402, DOI 10.1016/j.leukres.2013.12.021; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van der Weyden L, 2013, ONCOGENE, V32, P397, DOI 10.1038/onc.2012.56; Vasilatou D, 2010, EUR J HAEMATOL, V84, P1, DOI 10.1111/j.1600-0609.2009.01348.x; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zheng YS, 2012, ONCOGENE, V31, P80, DOI 10.1038/onc.2011.208	42	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0118099	10.1371/journal.pone.0118099	http://dx.doi.org/10.1371/journal.pone.0118099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646775	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600099
J	Aguado, E; Pascaretti-Grizon, F; Goyenvalle, E; Audran, M; Chappard, D				Aguado, Eric; Pascaretti-Grizon, Florence; Goyenvalle, Eric; Audran, Maurice; Chappard, Daniel			Bone Mass and Bone Quality Are Altered by Hypoactivity in the Chicken	PLOS ONE			English	Article							BOTULINUM TOXIN INJECTION; X-RAY RADIOGRAPHS; CANCELLOUS BONE; TRABECULAR BONE; JAPANESE-QUAIL; SIMULATED WEIGHTLESSNESS; SKELETAL DEFORMITIES; DISUSE OSTEOPOROSIS; MUSCLE PARALYSIS; TEXTURE ANALYSIS	Disuse induces a rapid bone loss in adults; sedentarity is now recognized as a risk factor for osteoporosis. Hypoactivity or confinement also decrease bone mass in adults but their effects are largely unknown and only few animal models have been described. We have used 10 chickens of the rapidly growing strain 857K bred in a large enclosure (FREE group); 10 others were confined in small cages with little space to move around (HYPO group). They were sacrificed at 53 days and femurs and tibias were evaluated by texture analysis, dual energy X-ray densitometry, microcomputed tomography (microCT) and histomorphometry. Hypoactivity had no effect on the length and diameter of the bones. Bone mineral density (BMD), microCT (trabecular bone volume and trabecular microarchitecture) and texture analysis were always found significantly reduced in the animals of the HYPO group. BMD was reduced at both femur and tibia diaphysises; BMD of the metaphysis was significantly reduced in the femur but not in the tibia. An increase in osteoid volume and surfaces was noted in the HYPO group. However, there was no alteration of the mineral phase as the osteoid thickness did not differ from control animals. Bone loss was much more pronounced at the lower femur metaphysis than at the upper metaphysis of the tibia. At the tibia, only microarchitectural changes of trabecular bone could be evidenced. The confined chicken represents a new method for the study of hypodynamia since these animals do not have surgical lesions.	[Aguado, Eric; Goyenvalle, Eric] ONIRIS, Ecole Natl Vet, Unite Biol & Biomat Tissu Osseux Chirurg Expt, F-44307 Nantes 3, France; [Aguado, Eric; Pascaretti-Grizon, Florence; Goyenvalle, Eric; Audran, Maurice; Chappard, Daniel] LUNAM Univ, CHU Angers, LHEA Lab Histol Embryol, GEROM Grp Etud Remodelage Osseux & BioMat,IBS, F-49933 Angers, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Chappard, D (corresponding author), LUNAM Univ, CHU Angers, LHEA Lab Histol Embryol, GEROM Grp Etud Remodelage Osseux & BioMat,IBS, F-49933 Angers, France.	daniel.chappard@univ-angers.fr		Aguado, Eric/0000-0003-1094-1042	Contrat Region Pays de la Loire: Bioregos2 program	Contrat Region Pays de la Loire: Bioregos2 program(Region Pays de la Loire)	This work was made possible by grants from Contrat Region Pays de la Loire: Bioregos2 program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikle Daniel D, 2003, Gravit Space Biol Bull, V16, P45; Bizeray D, 2004, PROD ANIM, V17, P45; Bouvard B, 2012, BONE, V50, P858, DOI 10.1016/j.bone.2011.12.023; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; Caldwell CB, 1998, J BONE MINER RES, V13, P978, DOI 10.1359/jbmr.1998.13.6.978; Chappard D, 2005, J BONE MINER METAB, V23, P24, DOI 10.1007/s00774-004-0536-9; Chappard D, 2005, J BONE MINER RES, V20, P1177, DOI 10.1359/JBMR.050205; Chappard D, 2011, OSTEOPOROSIS INT, V22, P2225, DOI 10.1007/s00198-011-1573-6; Chappard D, 2003, BIOMATERIALS, V24, P1399, DOI 10.1016/S0142-9612(02)00524-0; Chappard D, 2001, BONE, V28, P72, DOI 10.1016/S8756-3282(00)00438-5; Chappard D, 1986, AMPUTATION INDUCED O, P115; Chappard D, 2010, BONE CANCER: PROGRESSION AND THERAPEUTIC APPROACHES, P203; COMPSTON JE, 1987, BONE, V8, P289, DOI 10.1016/8756-3282(87)90004-4; Cook ME, 2000, POULTRY SCI, V79, P982, DOI 10.1093/ps/79.7.982; Croucher PI, 1996, J BONE MINER RES, V11, P955; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Frost H M, 1983, Henry Ford Hosp Med J, V31, P3; Grimston SK, 2011, J BONE MINER RES, V26, P2151, DOI 10.1002/jbmr.425; Hiney KM, 2004, J ANIM SCI, V82, P2313; Jee W.S.S., 1999, Morphologie, V83, P25; Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773; Jurani M, 1996, ACTA VET BRNO, V65, P57, DOI 10.2754/avb199665010057; KROLNER B, 1983, CLIN SCI, V64, P537, DOI 10.1042/cs0640537; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Le Drevo M, 2008, J BONE MINER RES, V23, pS130; LEBLANC B, 1986, POULTRY SCI, V65, P1787, DOI 10.3382/ps.0651787; Leterrier C, 1998, PROD ANIM, V11, P125; LI XJ, 1990, ANAT RECORD, V227, P12, DOI 10.1002/ar.1092270103; Manske SL, 2010, BONE, V46, P24, DOI 10.1016/j.bone.2009.10.016; Miller ME, 1999, CALCIFIED TISSUE INT, V64, P137, DOI 10.1007/s002239900592; Milstead JR, 2004, TECH PAPERS ISA, V449, P105; MINAIRE P, 1974, CALC TISS RES, V17, P57, DOI 10.1007/BF02547214; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; Oganov VS, 1988, ONTOGENESIS MAMMALS, P56; Passi N, 2005, J BIOMECH ENG-T ASME, V127, P198, DOI 10.1115/1.1835366; Pinheiro MM, 2009, OSTEOPOROSIS INT, V20, P399, DOI 10.1007/s00198-008-0680-5; Rittweger J, 2005, BONE, V36, P1019, DOI 10.1016/j.bone.2004.11.014; Sharrard W J, 1967, J Bone Joint Surg Br, V49, P731; Shen V, 1997, BONE, V21, P345, DOI 10.1016/S8756-3282(97)00153-1; Shen V, 1997, BONE, V21, P71, DOI 10.1016/S8756-3282(97)00070-7; Shipov A, 2010, VET J, V183, P153, DOI 10.1016/j.tvjl.2008.11.015; Simsa S, 2007, POULTRY SCI, V86, P565, DOI 10.1093/ps/86.3.565; SKERRY TM, 1990, CALCIFIED TISSUE INT, V46, P318, DOI 10.1007/BF02563823; Skrobanek P, 2004, ACTA VET BRNO, V73, P157, DOI 10.2754/avb200473020157; Tarlton JF, 2013, BONE, V52, P578, DOI 10.1016/j.bone.2012.11.003; Thomsen JS, 2012, CALCIFIED TISSUE INT, V90, P294, DOI 10.1007/s00223-012-9576-7; TURNER RT, 1986, J BONE MINER RES, V1, P399; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Weiler U, 2006, J VET MED A, V53, P450, DOI 10.1111/j.1439-0442.2006.00885.x; Whitehead CC, 2004, POULTRY SCI, V83, P193, DOI 10.1093/ps/83.2.193; WRONSKI TJ, 1987, AVIAT SPACE ENVIR MD, V58, P63; Zerath E, 1999, J Gravit Physiol, V6, pP77; Zibrin M, 2003, ACTA VET BRNO, V72, P143, DOI 10.2754/avb200372020143	54	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116763	10.1371/journal.pone.0116763	http://dx.doi.org/10.1371/journal.pone.0116763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635404	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700058
J	Konstantynowicz-Nowicka, K; Harasim, E; Baranowski, M; Chabowski, A				Konstantynowicz-Nowicka, Karolina; Harasim, Ewa; Baranowski, Marcin; Chabowski, Adrian			New Evidence for the Role of Ceramide in the Development of Hepatic Insulin Resistance	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; MUSCLE-CELLS; LIVER-CELLS; IN-VIVO; HEPATOCYTES; PALMITATE; DIACYLGLYCEROL; TRAFFICKING; MECHANISMS; STEATOSIS	Aim There are few and contradictory data on the role of excessive accumulation of intracellular sphingolipids, particularly ceramides, in the development of hepatic insulin resistance. In our study we assessed accumulated sphingolipid fractions and clarify the mechanisms of hepatic insulin resistance development as well as involvement of fatty acid and ceramide transporters in this process. Methods In culture of primary rat hepatocytes, exposed to high concentration of palmitic acid (0.75mM) during short and prolonged incubation, high performance liquid chromatography was used to assess intra- and extracellular sphingolipid fractions content. Degree of palmitate-induced insulin resistance was estimated by measuring changes in phosphorylation of insulin pathway proteins by western blotting as well as changes in expression of different type of transporters. Results In our study short and prolonged exposure of primary hepatocytes to palmitic acid resulted in increased intracellular accumulation of ceramide which inhibited insulin signaling pathway. We observed a significant increase in the expression of fatty-acid transport protein (FATP2) and ceramide transfer protein (CERT) what is consistent with enhanced intracellular ceramide content. The content of extracellular ceramide was increased nearly threefold after short and twofold after long incubation period. Expression of microsomal triglyceride transfer protein (MTP) and ATP-binding cassette transporter (ABCA1) was increased significantly mainly after short palmitate incubation. Conclusion Our data showed that increase in intarcellular ceramide content contributes to the development of hepatic insulin resistance. We suggest pivotal role of transporters in facilitating fatty acid influx (FATP2), accumulation of ceramides (CERT) and export to themedia (MTP and ABCA1).	[Konstantynowicz-Nowicka, Karolina; Harasim, Ewa; Baranowski, Marcin; Chabowski, Adrian] Med Univ Bialystok, Dept Physiol, Bialystok, Poland	Medical University of Bialystok	Konstantynowicz-Nowicka, K (corresponding author), Med Univ Bialystok, Dept Physiol, Bialystok, Poland.	karolina.konstantynowicz@umb.edu.pl	Baranowski, Marcin/F-6718-2011; Chabowski, Adrian/T-2225-2018; Harasim-Symbor, Ewa/T-6483-2018; Konstantynowicz-Nowicka, Karolina/T-9339-2018	Baranowski, Marcin/0000-0002-3714-5815; Chabowski, Adrian/0000-0002-7407-8156; Harasim-Symbor, Ewa/0000-0003-3507-4686; Konstantynowicz-Nowicka, Karolina/0000-0001-9274-5488	Medical University of Bialystok [134-18711L, 134-18715L, 25/KNOW/2013]	Medical University of Bialystok	These studies were funded by the Medical University of Bialystok (Grant 134-18711L, 134-18715L, 25/KNOW/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard CS, 2012, ENDOCRINOLOGY, V153, P2164, DOI 10.1210/en.2011-1881; Aguilera-Romero A, 2014, BBA-MOL CELL BIOL L, V1841, P647, DOI 10.1016/j.bbalip.2013.10.014; Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Bechmann LP, 2010, LIVER INT, V30, P850, DOI 10.1111/j.1478-3231.2010.02248.x; Bonen A, 1999, CAN J APPL PHYSIOL, V24, P515, DOI 10.1139/h99-033; Bouzakri K, 2005, CURR DIABETES REV, V1, P167, DOI 10.2174/1573399054022785; Cai N, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-28; Chabowski A, 2013, ACTA PHYSIOL, V207, P346, DOI 10.1111/apha.12022; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Falcon A, 2010, AM J PHYSIOL-ENDOC M, V299, pE384, DOI 10.1152/ajpendo.00226.2010; Galbo T, 2013, P NATL ACAD SCI USA, V110, P12780, DOI 10.1073/pnas.1311176110; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Hamilton JA, 1998, J LIPID RES, V39, P467; Hamilton JA, 2002, MOL CELL BIOCHEM, V239, P17, DOI 10.1023/A:1020542220599; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Knapp M, 2013, PROSTAG OTH LIPID M, V106, P53, DOI 10.1016/j.prostaglandins.2013.10.001; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Longato L, 2012, HEPATOL RES, V42, P412, DOI 10.1111/j.1872-034X.2011.00934.x; Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Moya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030014; Oram JF, 2001, J LIPID RES, V42, P1173; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Watt MJ, 2012, DIABETOLOGIA, V55, P2741, DOI 10.1007/s00125-012-2649-3; Wierzbicki M, 2009, ADV MED SCI-POLAND, V54, P59, DOI 10.2478/v10039-009-0010-y; Yew NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011239	34	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116858	10.1371/journal.pone.0116858	http://dx.doi.org/10.1371/journal.pone.0116858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635851	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700062
J	Lee, SH; Moon, JY; Jung, SJ; Kang, JG; Choi, SP; Jang, JH				Lee, Sang Hoon; Moon, Jee Youn; Jung, Sung Jun; Kang, Jin Gu; Choi, Seung Pyo; Jang, Jun Ho			Eugenol Inhibits the GABA(A) Current in Trigeminal Ganglion Neurons	PLOS ONE			English	Article							SPINAL-CORD; RECEPTOR; SUBUNIT; SUPERFAMILY	Eugenol has sedative, antioxidant, anti-inflammatory, and analgesic effects, but also serves as an irritant through the regulation of a different set of ion channels. Activation of gamma aminobutyric acid (GABA) receptors on sensory neurons leads to the stabilization of neuronal excitability but contributes to formalin-induced inflammatory pain. In this study, we examined the effect of eugenol on the GABA-induced current in rat trigeminal ganglia (TG) neurons and in human embryonic kidney (HEK) 293 cells expressing the GABA(A) receptor alpha 1 beta 2 gamma 2 subtype using the whole-cell patch clamp technique. RT-PCR and Western blot analysis were used to confirm the expression of GABA(A) receptor gamma 2 subunit mRNA and protein in the TG and hippocampus. Eugenol decreased the amplitude ratio of the GABA-induced current to 27.5 +/- 3.2% (p < 0.05) in TG neurons, which recovered after a 3-min washout. In HEK 293 cells expressing the alpha 1 beta 2.2 subtype, eugenol inhibited GABA-induced currents in a dose-dependent manner. Application of eugenol also decreased the GABA response in the presence of a G-protein blocker. Eugenol pretreatment with different concentrations of GABA resulted in similar inhibition of the GABA-induced current in a noncompetitive manner. In conclusion, eugenol inhibits the GABA-induced current in TG neurons and HEK 293 cells expressing the GABA(A) receptor in a reversible, dose-dependent, and non-competitive manner, but not via the G-protein pathway. We suggest that the GABA(A) receptor could be a molecular target for eugenol in the modulation of nociceptive information.	[Lee, Sang Hoon; Jang, Jun Ho] Hanyang Univ, Grad Sch Biomed Sci, Engn, Dept Biomed Sci, Seoul 133791, South Korea; [Moon, Jee Youn; Choi, Seung Pyo] Seoul Natl Univ Hosp, Coll Med, Dept Anesthesiol & Pain Med, Seoul 110744, South Korea; [Jung, Sung Jun] Hanyang Univ, Sch Med, Dept Physiol, Seoul 133791, South Korea; [Kang, Jin Gu] Hallim Univ, Dongtan Sacred Heart Hosp, Dept Anaesthesiol & Pain Med, Kyonggi Do, South Korea	Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Hanyang University	Moon, JY (corresponding author), Seoul Natl Univ Hosp, Coll Med, Dept Anesthesiol & Pain Med, Seoul 110744, South Korea.	jymoon0901@gmail.com; eurijj@hanyang.ac.kr			Basic Science Research Program and Nano and Material Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2012R1A1A2009458, NRF-2012M3A7B4035199]	Basic Science Research Program and Nano and Material Technology Development Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program and Nano and Material Technology Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2012R1A1A2009458 and NRF-2012M3A7B4035199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasipour F, 2009, INT ENDOD J, V42, P794, DOI 10.1111/j.1365-2591.2009.01585.x; Alvarez FJ, 1996, J COMP NEUROL, V365, P392, DOI 10.1002/(SICI)1096-9861(19960212)365:3<392::AID-CNE5>3.0.CO;2-#; Aoshima H, 1999, BIOSCI BIOTECH BIOCH, V63, P743, DOI 10.1271/bbb.63.743; AULT B, 1994, NEUROPHARMACOLOGY, V33, P109, DOI 10.1016/0028-3908(94)90104-X; Bravo-Hernandez M, 2014, EUR J PHARMACOL, V734, P91, DOI 10.1016/j.ejphar.2014.03.051; Carlton SM, 1999, NEUROSCIENCE, V93, P713, DOI 10.1016/S0306-4522(99)00101-3; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x; Chung G, 2008, J DENT RES, V87, P137, DOI 10.1177/154405910808700201; CURTIS DR, 1977, BRAIN RES, V130, P360, DOI 10.1016/0006-8993(77)90283-9; Hayasaki H, 2006, EUR J NEUROSCI, V23, P745, DOI 10.1111/j.1460-9568.2006.04602.x; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Klein AH, 2014, NEUROSCIENCE, V271, P45, DOI 10.1016/j.neuroscience.2014.04.019; Krishek BJ, 1996, NEUROPHARMACOLOGY, V35, P1289, DOI 10.1016/S0028-3908(96)00089-5; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; Lee MH, 2005, J DENT RES, V84, P848, DOI 10.1177/154405910508400913; Li HY, 2007, J DENT RES, V86, P898, DOI 10.1177/154405910708600918; MA W, 1993, J COMP NEUROL, V338, P337, DOI 10.1002/cne.903380303; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; MACHU TK, 1993, J NEUROCHEM, V61, P375, DOI 10.1111/j.1471-4159.1993.tb03582.x; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Park CK, 2006, J DENT RES, V85, P900, DOI 10.1177/154405910608501005; Park SH, 2011, ARCH PHARM RES, V34, P501, DOI 10.1007/s12272-011-0320-z; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SINGER E, 1980, BRAIN RES, V202, P484, DOI 10.1016/0006-8993(80)90160-2; WHITING P, 1990, P NATL ACAD SCI USA, V87, P9966, DOI 10.1073/pnas.87.24.9966; Whiting PJ, 1995, INT REV NEUROBIOL, V38, P95, DOI 10.1016/S0074-7742(08)60525-5; Yang BH, 2003, J DENT RES, V82, P781, DOI 10.1177/154405910308201004; Yano S, 2006, EUR J PHARMACOL, V553, P99, DOI 10.1016/j.ejphar.2006.09.020; Yeon KY, 2011, PAIN, V152, P2108, DOI 10.1016/j.pain.2011.05.018; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	32	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117316	10.1371/journal.pone.0117316	http://dx.doi.org/10.1371/journal.pone.0117316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635877	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700080
J	Osborne, A; Aldarwesh, A; Rhodes, JD; Broadway, DC; Everitt, C; Sanderson, J				Osborne, Andrew; Aldarwesh, Amal; Rhodes, Jeremy D.; Broadway, David C.; Everitt, Claire; Sanderson, Julie			Hydrostatic Pressure Does Not Cause Detectable Changes in Survival of Human Retinal Ganglion Cells	PLOS ONE			English	Article							OPTIC-NERVE HEAD; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; DEATH; BIOMECHANICS; APOPTOSIS; NEURODEGENERATION; ACTIVATION; ISCHEMIA; KINASES	Purpose Elevated intraocular pressure (IOP) is a major risk factor for glaucoma. One consequence of raised IOP is that ocular tissues are subjected to increased hydrostatic pressure (HP). The effect of raised HP on stress pathway signaling and retinal ganglion cell (RGC) survival in the human retina was investigated. Methods A chamber was designed to expose cells to increased HP (constant and fluctuating). Accurate pressure control (10-100mmHg) was achieved using mass flow controllers. Human organotypic retinal cultures (HORCs) from donor eyes (<24h post mortem) were cultured in serum-free DMEM/HamF12. Increased HP was compared to simulated ischemia (oxygen glucose deprivation, OGD). Cell death and apoptosis were measured by LDH and TUNEL assays, RGC marker expression by qRT-PCR (THY-1) and RGC number by immunohistochemistry (NeuN). Activated p38 and JNK were detected by Western blot. Results Exposure of HORCs to constant (60mmHg) or fluctuating (10-100mmHg; 1 cycle/min) pressure for 24 or 48h caused no loss of structural integrity, LDH release, decrease in RGC marker expression (THY-1) or loss of RGCs compared with controls. In addition, there was no increase in TUNEL-positive NeuN-labelled cells at either time-point indicating no increase in apoptosis of RGCs. OGD increased apoptosis, reduced RGC marker expression and RGC number and caused elevated LDH release at 24h. p38 and JNK phosphorylation remained unchanged in HORCs exposed to fluctuating pressure (10-100mmHg; 1 cycle/min) for 15, 30, 60 and 90min durations, whereas OGD (3h) increased activation of p38 and JNK, remaining elevated for 90min post-OGD. Conclusions Directly applied HP had no detectable impact on RGC survival and stress-signalling in HORCs. Simulated ischemia, however, activated stress pathways and caused RGC death. These results show that direct HP does not cause degeneration of RGCs in the ex vivo human retina.	[Osborne, Andrew; Aldarwesh, Amal; Broadway, David C.; Sanderson, Julie] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Rhodes, Jeremy D.; Broadway, David C.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Broadway, David C.] Norfolk & Norwich Univ Hosp, Dept Ophthalmol, Norwich, Norfolk, England; [Everitt, Claire] Pfizer Ltd, Design Ctr Excellence, Cambridge, England	University of East Anglia; University of East Anglia; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Pfizer	Sanderson, J (corresponding author), Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England.	j.sanderson@uea.ac.uk	Aldarwesh, Amal/HDM-1182-2022; Aldarwesh, Amal/ABC-8238-2020	Aldarwesh, Amal/0000-0002-0922-8541; Aldarwesh, Amal/0000-0002-0922-8541	Humane Research Trust; Norwich Glaucoma Research Fund; Edith Murphy Foundation	Humane Research Trust; Norwich Glaucoma Research Fund; Edith Murphy Foundation	This work was supported by The Humane Research Trust, The Edith Murphy Foundation, and The Norwich Glaucoma Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Downs JC, 2011, EXP EYE RES, V93, P133, DOI 10.1016/j.exer.2010.08.004; Dreixler JC, 2009, EXP EYE RES, V89, P782, DOI 10.1016/j.exer.2009.07.006; Ethier CR, 2006, INVEST OPHTH VIS SCI, V47, P1991, DOI 10.1167/iovs.05-0327; Inatani M, 2008, J GLAUCOMA, V17, P275, DOI 10.1097/IJG.0b013e31815c3ab7; Kikuchi M, 2000, J NEUROSCI, V20, P5037; Lei Y, 2011, INVEST OPHTH VIS SCI, V52, P6329, DOI 10.1167/iovs.11-7836; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Leske MC, 1997, ARCH OPHTHALMOL-CHIC, V115, P1051, DOI 10.1001/archopht.1997.01100160221012; MAO LK, 1991, AM J OPHTHALMOL, V111, P51, DOI 10.1016/S0002-9394(14)76896-5; Mester L, 2009, NEUROTOX RES, V16, P68, DOI 10.1007/s12640-009-9049-6; Morris G, 1974, BIOL PHYS CHEM; Niyadurupola N, 2013, INVEST OPHTH VIS SCI, V54, P2163, DOI 10.1167/iovs.12-10968; Niyadurupola N, 2011, BRIT J OPHTHALMOL, V95, P720, DOI 10.1136/bjo.2010.181404; Osborne NN, 1999, BRIT J OPHTHALMOL, V83, P980, DOI 10.1136/bjo.83.8.980; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resta V, 2007, EUR J NEUROSCI, V25, P2741, DOI 10.1111/j.1460-9568.2007.05528.x; Ribas VT, 2011, NEUROSCIENCE, V180, P64, DOI 10.1016/j.neuroscience.2011.01.059; Roth S, 2003, INVEST OPHTH VIS SCI, V44, P5383, DOI 10.1167/iovs.03-0451; Sappington RM, 2006, INVEST OPHTH VIS SCI, V47, P2932, DOI 10.1167/iovs.05-1407; Sappington RM, 2009, INVEST OPHTH VIS SCI, V50, P717, DOI 10.1167/iovs.08-2321; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Tezel G, 2000, J NEUROSCI, V20, P8693; The AGIS Investigators, 2000, AM J OPHTHALMOL, V130, P429, DOI DOI 10.1016/S0002-9394(00)00538-9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059	29	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115591	10.1371/journal.pone.0115591	http://dx.doi.org/10.1371/journal.pone.0115591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635827	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700014
J	Gautam, A; Arpa, PD; Donohue, DE; Muhie, S; Chakraborty, N; Luke, BT; Grapov, D; Carroll, EE; Meyerhoff, JL; Hammamleh, R; Jett, M				Gautam, Aartl; Arpa, Peter D'; Donohue, Duncan E.; Muhie, Seid; Chakraborty, Nabarun; Luke, Brian T.; Grapov, Dmitry; Carroll, Erica E.; Meyerhoff, James L.; Hammamleh, Rasha; Jett, Marti			Acute and Chronic Plasma Metabolomic and Liver Transcriptomic Stress Effects in a Mouse Model with Features of Post-Traumatic Stress Disorder	PLOS ONE			English	Article							GUT MICROBIOTA; PSYCHOSOCIAL STRESS; ACID-METABOLISM; INJURY; PHASE; PTSD; MATRIX-METALLOPROTEINASE-9; MYELOPEROXIDASE; COMORBIDITY; COMPLEMENT	Acute responses to intense stressors can give rise to post-traumatic stress disorder (PTSD). PTSD diagnostic criteria include trauma exposure history and self-reported symptoms. Individuals who meet PTSD diagnostic criteria often meet criteria for additional psychiatric diagnoses. Biomarkers promise to contribute to reliable phenotypes of PTSD and comorbidities by linking biological system alterations to behavioral symptoms. Here we have analyzed unbiased plasma metabolomics and other stress effects in a mouse model with behavioral features of PTSD. In this model, C57BL/6 mice are repeatedly exposed to a trained aggressor mouse (albino SJL) using a modified, resident-intruder, social defeat paradigm. Our recent studies using this model found that aggressor-exposed mice exhibited acute stress effects including changed behaviors, body weight gain, increased body temperature, as well as inflammatory and fibrotic histopathologies and transcriptomic changes of heart tissue. Some of these acute stress effects persisted, reminiscent of PTSD. Here we report elevated proteins in plasma that function in inflammation and responses to oxidative stress and damaged tissue at 24 hrs post-stressor. Additionally at this acute time point, transcriptomic analysis indicated liver inflammation. The unbiased metabolomics analysis showed altered metabolites in plasma at 24 hrs that only partially normalized toward control levels after stress-withdrawal for 1.5 or 4 wks. In particular, gut-derived metabolites were altered at 24 hrs post-stressor and remained altered up to 4 wks after stress-withdrawal. Also at the 4 wk time point, hyperlipidemia and suppressed metabolites of amino acids and carbohydrates in plasma coincided with transcriptomic indicators of altered liver metabolism (activated xenobiotic and lipid metabolism). Collectively, these system-wide sequelae to repeated intense stress suggest that the simultaneous perturbed functioning of multiple organ systems (e.g., brain, heart, intestine and liver) can interact to produce injuries that lead to chronic metabolic changes and disorders that have been associated with PTSD.	[Gautam, Aartl; Arpa, Peter D'; Donohue, Duncan E.; Chakraborty, Nabarun; Meyerhoff, James L.; Hammamleh, Rasha; Jett, Marti] US Army Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA; [Gautam, Aartl; Arpa, Peter D'; Donohue, Duncan E.; Chakraborty, Nabarun; Meyerhoff, James L.] Geneva Fdn, Tacoma, WA 98402 USA; [Muhie, Seid; Luke, Brian T.] Adv Biomed Comp Ctr, Frederick Natl Lab Canc Res, Frederick, MD USA; [Grapov, Dmitry] Univ Calif Davis, NIH, West Coast Metabol Ctr, Davis, CA USA; [Carroll, Erica E.] Army Inst Publ Hlth, Aberdeen Proving Ground, MD 21010 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; University of California System; University of California Davis	Jett, M (corresponding author), US Army Ctr Environm Hlth Res, Ft Detrick, Ft Detrick, MD 21702 USA.	marti.jett-tilton.civ@mail.mil		Grapov, Dmitry/0000-0002-7204-3128; Hammamieh, Rasha/0000-0001-8643-6232; D'Arpa, Peter/0000-0002-0562-0263; Donohue, Duncan/0000-0002-3137-8773	Office of the Assistant Secretary of Defense for Health Affairs; Military Operational Medicine Research Program (MOMRP); NIH [1 U24 DK097154];  [09284002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097154] Funding Source: NIH RePORTER	Office of the Assistant Secretary of Defense for Health Affairs; Military Operational Medicine Research Program (MOMRP)(United States Department of DefenseUnited States ArmyUnited States Army Medical Research & Development Command (USAMRDC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project is supported by the Office of the Assistant Secretary of Defense for Health Affairs and the Military Operational Medicine Research Program (MOMRP), and the support of grant #USAMRMC NO: 09284002 is highly acknowledged. DG was supported by NIH 1 U24 DK097154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055766; ARAGOZZINI F, 1979, APPL ENVIRON MICROB, V38, P544, DOI 10.1128/AEM.38.3.544-546.1979; Association AP, 2013, DIAGN STAT MAN MENT, DOI [10.1016/j.amsu.2013.12.001, DOI 10.1016/J.AMSU.2013.12.001]; Atkinson C, 2005, EXP BIOL MED, V230, P155, DOI 10.1177/153537020523000302; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2006, J NEUROIMMUNOL, V171, P29, DOI 10.1016/j.jneuroim.2005.09.008; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Bartoli F, 2013, METAB SYNDR RELAT D, V11, P301, DOI 10.1089/met.2013.0010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Bessede A, 2014, NATURE; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Calabrese JR, 2011, J CLIN PSYCHIAT, V72, P1072, DOI 10.4088/JCP.11m06956; Camprecios G, 2009, GROWTH FACTORS, V27, P300, DOI 10.1080/08977190903137736; Cho JH, 2014, P NATL ACAD SCI USA, V111, P3188, DOI 10.1073/pnas.1400113111; Choudhary SP, 2011, CURR MED CHEM, V18, P4557; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; Coughlin SS, 2011, OPEN CARDIOVASC MED, V5, P164, DOI 10.2174/1874192401105010164; CRISPENS CG, 1973, LAB ANIM SCI, V23, P408; Czech B, 2013, INT J CLIN EXP PATHO, V6, P1585; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Freidman MJ, 2007, PTSD HIST OVERVIEW, DOI [10.1093/jxb/erm028, DOI 10.1093/JXB/ERM028]; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Galley JD, 2014, GUT MICROBES, V5, DOI [10.4161/19490976.2014.973349, DOI 10.4161/19490976.2014.973349]; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Garvin P, 2009, PSYCHOSOM MED, V71, P292, DOI 10.1097/PSY.0b013e3181960e7f; GOODWIN BL, 1994, BIOCHEM PHARMACOL, V47, P2294, DOI 10.1016/0006-2952(94)90268-2; Green BT, 2012, FOOD CHEM TOXICOL, V50, P2049, DOI 10.1016/j.fct.2012.03.049; Gupta MA, 2013, INT REV PSYCHIATR, V25, P86, DOI 10.3109/09540261.2012.736367; Hall JE, 2011, GUYTON HALL TXB MED, DOI [10.3390/jpm1010005, DOI 10.3390/JPM1010005]; Hammamieh R, 2012, BEHAV BRAIN RES, V235, P55, DOI 10.1016/j.bbr.2012.07.022; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; Health NIoM, 2008, NAT I MENT HLTH STRA; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Heslop CL, 2010, J AM COLL CARDIOL, V55, P1102, DOI 10.1016/j.jacc.2009.11.050; HOLLANDER M, 1973, NONPARAMETRIC STAT M, P15; Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146; Jensen KJ, 2013, COMPR PHYSIOL, V3, P655, DOI 10.1002/cphy.c120018; JOYCE PR, 1992, BIOL PSYCHIAT, V32, P1035, DOI 10.1016/0006-3223(92)90065-8; KEANE TM, 1987, J CLIN PSYCHOL, V43, P32, DOI 10.1002/1097-4679(198701)43:1<32::AID-JCLP2270430106>3.0.CO;2-X; Keeney A, 2006, J NEUROENDOCRINOL, V18, P330, DOI 10.1111/j.1365-2826.2006.01422.x; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kramer A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-253; Lee CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076817; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord RS, 2008, ALTERN MED REV, V13, P292; Lu K, 2012, J PROTEOME RES, V11, P4916, DOI 10.1021/pr300429x; Lyte M, 2011, CELL TISSUE RES, V343, P23, DOI 10.1007/s00441-010-1050-0; Ma BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047416; MacFarlane G.T., 1991, LARGE INTESTINE PHYS, P51; Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89; McFarlane AC, 2010, WORLD PSYCHIATRY, V9, P3; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; R Core Team, 2018, R LANG ENV STAT COMP; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Sanchez O, 2002, CELL STRESS CHAPERON, V7, P36, DOI 10.1379/1466-1268(2002)007<0036:ASITII>2.0.CO;2; Sanchez O, 2007, AM J PHYSIOL-REG I, V293, pR1908, DOI 10.1152/ajpregu.00113.2007; Sanghez V, 2013, PSYCHONEUROENDOCRINO, V38, P2933, DOI 10.1016/j.psyneuen.2013.07.022; Saura-Calixto F, 2010, MOL NUTR FOOD RES, V54, P939, DOI 10.1002/mnfr.200900276; Savignac HM, 2011, BEHAV BRAIN RES, V216, P576, DOI 10.1016/j.bbr.2010.08.049; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith EA, 1997, ANAEROBE, V3, P327, DOI 10.1006/anae.1997.0121; SONG C, 1994, J AFFECT DISORDERS, V30, P283, DOI 10.1016/0165-0327(94)90135-X; Stengel A, 2009, ANNU REV PHYSIOL, V71, P219, DOI 10.1146/annurev.physiol.010908.163221; Sundstrom J, 2006, CURR OPIN LIPIDOL, V17, P45, DOI 10.1097/01.mol.0000203891.34890.b5; Uschold-Schmidt N, 2013, J ENDOCRINOL, V218, P193, DOI 10.1530/JOE-13-0027; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wilson EB, J AM STAT ASS, V22, P209; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhao Y, 2013, J PROTEOME RES, V12, P2987, DOI 10.1021/pr400263n	88	33	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117092	10.1371/journal.pone.0117092	http://dx.doi.org/10.1371/journal.pone.0117092			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629821	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100063
J	Kriebel, S; Schmidt, D; Holdenrieder, S; Goltz, D; Kristiansen, G; Moritz, R; Fisang, C; Muller, SC; Ellinger, J				Kriebel, Stephanie; Schmidt, Doris; Holdenrieder, Stefan; Goltz, Diane; Kristiansen, Glen; Moritz, Rudolf; Fisang, Christian; Mueller, Stefan C.; Ellinger, Joerg			Analysis of Tissue and Serum MicroRNA Expression in Patients with Upper Urinary Tract Urothelial Cancer	PLOS ONE			English	Article							BLADDER-CANCER; CIRCULATING MICRORNAS; PROSTATE-CANCER; MIRNA; BIOMARKERS; DIAGNOSIS; GROWTH; GENES	Introduction MicroRNAs play an important role in many human malignancies; so far, their expression remains to be studied in upper urinary tract urothelial cancer (UUTUC). Materials and Methods The expression of eleven microRNAs (miR-10a, miR-21, miR-96, miR-135, miR-141, miR-182, miR-200b, miR-205, miR-429, miR-520b, miR-1244) formerly shown to be upregulated in urothelial bladder cancer were studied in corresponding normal and cancerous tissue samples of patients undergoing nephroureterectomy for UUTUC. Upregulated microRNAs were then measured in serum samples of patients with UUTUC and patients with nonmalignant urological diseases to evaluate their potential as non-invasive biomarkers for UUTUC. Results MicroRNA expression allowed differentiation of normal and cancerous tissue: miR-21, miR-96, miR-135, miR-141, miR-182, miR-205, miR-429 and miR-520b were significantly over-expressed. Furthermore, miR-205 was upregulated in poorly differentiated UUTUC. The analysis of circulating RNA in serum demonstrated an increase of miR-141 in patients with UUTUC; receiver operator characteristic analysis demonstrated an area under the curve of 0.726 for miR-141 as a diagnostic biomarker. Furthermore, we observed lower levels of miR-10a and miR-135 in UUTUC patients. Conclusions MicroRNA expression is altered in UUTUC. The analysis of circulating miR-141 may be useful to identify patients with UUTUC.	[Kriebel, Stephanie; Schmidt, Doris; Fisang, Christian; Mueller, Stefan C.; Ellinger, Joerg] Univ Klinikum Bonn, Klin & Poliklin Urol & Kinderurol, Bonn, Germany; [Holdenrieder, Stefan] Univ Klinikum Bonn, Inst Klin Chem & Klin Pharmakol, Bonn, Germany; [Goltz, Diane; Kristiansen, Glen] Univ Klinikum Bonn, Inst Pathol, Bonn, Germany; [Moritz, Rudolf] Univ Klinikum Munster, Urol Klin, Munster, Germany	University of Bonn; University of Bonn; University of Bonn; University of Munster	Ellinger, J (corresponding author), Univ Klinikum Bonn, Klin & Poliklin Urol & Kinderurol, Bonn, Germany.	joerg.ellinger@ukb.uni-bonn.de	Ellinger, Jörg/D-8389-2011	Ellinger, Jörg/0000-0002-7526-0857	Deutsche Krebshilfe	Deutsche Krebshilfe(Deutsche Krebshilfe)	The collection of serum and tissue samples at the Universitatsklinikum Bonn was performed within the framework of the Biobank initiative at the Centrum fur integrierte Onkologie (CIO) Koln Bonn (http://www.cio-koelnbonn.de/mediziner/biobank/), which is financially supported by the Deutsche Krebshilfe. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Dieckmann KP, 2012, BRIT J CANCER, V107, P1754, DOI 10.1038/bjc.2012.469; Dietrich D, 2014, CRIT REV CLIN LAB SC, V30, P1, DOI DOI 10.3109/10408363.2014.950407; Dip N, 2012, J UROLOGY, V188, P1951, DOI 10.1016/j.juro.2012.07.004; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Izquierdo L, 2013, BJU INT, DOI [10.1111/bju.12334, DOI 10.1111/BJU.12334]; Johannes JR, 2010, J UROLOGY, V184, P879, DOI 10.1016/j.juro.2010.05.023; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Messer J, 2011, BJU INT, V108, P701, DOI 10.1111/j.1464-410X.2010.09899.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pignot G, 2013, INT J CANCER, V132, P2479, DOI 10.1002/ijc.27949; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Ratert N, 2013, J MOL DIAGN, V15, P695, DOI 10.1016/j.jmoldx.2013.05.008; Sanders I, 2012, INT J UROL, V19, P1017, DOI 10.1111/j.1442-2042.2012.03082.x; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Scheffer AR, 2012, WORLD J UROL, DOI [10.1007/s00345-012-1015-x, DOI 10.1007/S00345-012-1015-X]; Selth LA, 2013, BRIT J CANCER, V109, P641, DOI 10.1038/bjc.2013.369; Song T, 2010, ASIAN PAC J CANCER P, V11, P905; van Jaarsveld MTM, 2013, ONCOGENE, V32, P4284, DOI 10.1038/onc.2012.433; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Verhoest G, 2011, WORLD J UROL, V29, P495, DOI 10.1007/s00345-011-0710-3; Walsh IK, 2001, UROLOGY, V58, P532, DOI 10.1016/S0090-4295(01)01307-3; Wang G, 2012, CLIN GENITOURIN CANC, V10, P106, DOI 10.1016/j.clgc.2012.01.001; Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-6; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Westermann AM, 2014, ANTICANCER RES, V34, P665; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Zaravinos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091646; Zaravinos A, 2012, J UROLOGY, V188, P615, DOI 10.1016/j.juro.2012.03.122; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335	40	33	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117284	10.1371/journal.pone.0117284	http://dx.doi.org/10.1371/journal.pone.0117284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629698	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100078
J	Loch, C; Kieser, JA; Fordyce, RE				Loch, Carolina; Kieser, Jules A.; Fordyce, R. Ewan			Enamel Ultrastructure in Fossil Cetaceans (Cetacea: Archaeoceti and Odontoceti)	PLOS ONE			English	Article							DIETARY ADAPTATIONS; DENTAL ENAMEL; WHALES; MICROSTRUCTURE; DELPHINOIDEA; EVOLUTION; MAMMALS; ORIGIN	The transition from terrestrial ancestry to a fully pelagic life profoundly altered the body systems of cetaceans, with extreme morphological changes in the skull and feeding apparatus. The Oligocene Epoch was a crucial time in the evolution of cetaceans when the ancestors of modern whales and dolphins (Neoceti) underwent major diversification, but details of dental structure and evolution are poorly known for the archaeocete-neocete transition. We report the morphology of teeth and ultrastructure of enamel in archaeocetes, and fossil platanistoids and delphinoids, ranging from late Oligocene (Waitaki Valley, New Zealand) to Pliocene (Caldera, Chile). Teeth were embedded in epoxy resin, sectioned in cross and longitudinal planes, polished, etched, and coated with gold palladium for scanning electron microscopy (SEM) observation. SEM images showed that in archaeocetes, squalodontids and Prosqualodon (taxa with heterodont and nonpolydont/limited polydont teeth), the inner enamel was organized in Hunter-Schreger bands (HSB) with an outer layer of radial enamel. This is a common pattern in most large-bodied mammals and it is regarded as a biomechanical adaptation related to food processing and crack resistance. Fossil Otekaikea sp. and delphinoids, which were polydont and homodont, showed a simpler structure, with inner radial and outer prismless enamel. Radial enamel is regarded as more wear-resistant and has been retained in several mammalian taxa in which opposing tooth surfaces slide over each other. These observations suggest that the transition from a heterodont and nonpolydont/limited polydont dentition in archaeocetes and early odontocetes, to homodont and polydont teeth in crownward odontocetes, was also linked to a marked simplification in the enamel Schmelzmuster. These patterns probably reflect functional shifts in food processing from shear-and-mastication in archaeocetes and early odontocetes, to pierce-and-grasp occlusion in crownward odontocetes, with the implication of less demanding feeding biomechanics as seen in most extant odontocetes.	[Loch, Carolina; Fordyce, R. Ewan] Univ Otago, Dept Geol, Dunedin, New Zealand; [Loch, Carolina; Kieser, Jules A.] Univ Otago, Fac Dent, Sir John Walsh Res Inst, Dunedin, New Zealand	University of Otago; University of Otago	Loch, C (corresponding author), Univ Otago, Dept Geol, Dunedin, New Zealand.	carolina.loch@otago.ac.nz		Loch, Carolina/0000-0001-8949-4008; Fordyce, Ewan/0000-0002-2656-730X	University of Otago; Sir John Walsh Research Institute	University of Otago; Sir John Walsh Research Institute	CL received an University of Otago PhD scholarship and Sir John Walsh Research Institute Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergqvist L.P., 2003, BRAZ J ORAL SCI, V2, P249, DOI 10.20396/bjos.v2i6.8641693; BOYDE A, 1967, P ROY SOC MED, V60, P923, DOI 10.1177/003591576706000965; Boyde A, 1980, REP INT WHALING COMM, V3, P65; CARLSON S J, 1985, Contributions from the Museum of Paleontology University of Michigan, V27, P1; Carpenter K., 1986, Mississippi Geology, V7, P1; Ciampaglio CN, 2005, SEDIMENTARY REC, V3, P4, DOI [DOI 10.1371/JOURNAL.P0NE.0063586, 10.2110/sedred.2005.4.4]; Fahlke JM, 2013, PALAEOGEOGR PALAEOCL, V386, P690, DOI 10.1016/j.palaeo.2013.06.032; Fordyce RE, 2004, J VERTEBR PALEONTOL, V24, p59A; Fordyce RE, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P201; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; Gingerich PD, 1998, ADV VERT PALEOBIOL, P423; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; Hillson S, 2005, TEETH, V2nd, P373; ISHIYAMA M, 1987, SCANNING MICROSCOPY, V1, P1071; Karlsen K., 1962, HVALRADETS SKRIFTER, V45, P5; Kellogg R, 1928, Q REV BIOL, V3, P29, DOI 10.1086/394293; Lawn BR, 2009, ACTA BIOMATER, V5, P2213, DOI 10.1016/j.actbio.2009.02.001; Loch C, 2013, ZOOMORPHOLOGY, V132, P215, DOI 10.1007/s00435-012-0180-1; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Maas MC, 1999, EVOL ANTHROPOL, V8, P133; Maas MC, 1995, J PALEONTOL, P1154; Murakami M, 2012, J VERTEBR PALEONTOL, V32, P1157, DOI 10.1080/02724634.2012.677299; Nanci A, 2007, 10 CATES ORAL HISTOL, P418; RENSBERGER JM, 1992, SCANNING MICROSCOPY, V6, P495; ROTHAUSEN K, 1968, Palaeontologische Zeitschrift, V42, P83; Sahni A, 1997, TOOTH ENAMEL MICROSTRUCTURE, P177; Sahni A, 1981, J PALAEONTOL SOC IND, V25, P33; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Tomilin AG, 1957, CAN J FISH AQUAT SCI, V95, P1; Uhen MD, 2000, J MAMMAL, V81, P123, DOI 10.1644/1545-1542(2000)081<0123:RODFPA>2.0.CO;2; Ungar PS, 2010, MAMMAL TEETH ORIGIN, P304; von Koenigswald W., 2000, P107, DOI 10.1017/CBO9780511542626.008; von Koenigswald W., 1991, P113; Von Koenigswald W, 1997, TOOTH ENAMEL MICROST, P267; Von Koenigswald W, 2010, J VERTEBR PALEONTOL, V30, P1797, DOI 10.1080/02724634.2010.521931; VONKOENIGSWALD W, 1992, SCANNING MICROSCOPY, V6, P195; vonKoenigswald W, 1997, TOOTH ENAMEL MICROSTRUCTURE, P203; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Wood C. B., 1999, Journal of Mammalian Evolution, V6, P177, DOI 10.1023/A:1020624222324	40	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116557	10.1371/journal.pone.0116557	http://dx.doi.org/10.1371/journal.pone.0116557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629995	Green Submitted, gold, Green Published			2022-12-26	WOS:000348732100040
J	Ricketts, CD; Bates, WR; Reid, SD				Ricketts, Chelsea D.; Bates, William R.; Reid, Scott D.			The Effects of Acute Waterborne Exposure to Sublethal Concentrations of Molybdenum on the Stress Response in Rainbow Trout, Oncorhynchus mykiss	PLOS ONE			English	Article							HEPATIC METALLOTHIONEIN; HEAT-SHOCK; SALMO-GAIRDNERI; ACUTE TOXICITY; SWIMMING PERFORMANCE; PLASMA-CORTISOL; EXPRESSION; FISH; INDUCTION; PROTEINS	To determine if molybdenum (Mo) is a chemical stressor fingerling and juvenile rainbow trout (Oncorhynchus mykiss) were exposed to waterborne sodium molybdate (0 2 20 or 1,000 mg l(-1) of Mo) and components of the physiological (plasma cortisol blood glucose and hematocrit) and cellular (heat shock protein [hsp] 72 hsp73 and hsp90 in the liver gills heart and erythrocytes and metallothionein [MT] in the liver and gills) stress responses were measured prior to initiation of exposure and at 8 24 and 96 h. During the acute exposure plasma cortisol blood glucose and hematocrit levels remained unchanged in all treatments. Heat shock protein 72 was not induced as a result of exposure and there were no detectable changes in total hsp70 (72 and 73) hsp90 and MT levels in any of the tissues relative to controls. Both fingerling and juvenile fish responded with similar lack of apparent sensitivity to Mo exposure. These experiments demonstrate that exposure to waterborne Mo of up to 1,000 mg l(-1) did not activate a physiological or cellular stress response in fish. Information from this study suggests that Mo water quality guidelines for the protection of aquatic life are highly protective of freshwater fish namely rainbow trout.	[Ricketts, Chelsea D.; Bates, William R.; Reid, Scott D.] Univ British Columbia, Dept Biol, Irving K Barber Sch Arts & Sci, Kelowna, BC V1V 1V7, Canada	University of British Columbia	Reid, SD (corresponding author), Univ British Columbia, Dept Biol, Irving K Barber Sch Arts & Sci, Okanagan Campus,3333 Univ Way, Kelowna, BC V1V 1V7, Canada.	scott.reid@ubc.ca			NSERC Discovery Grant awarded; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund; University of British Columbia; Pacific Leaders Graduate Fellowship	NSERC Discovery Grant awarded; Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; University of British Columbia; Pacific Leaders Graduate Fellowship	This work was funded primarily through an NSERC Discovery Grant awarded to Dr. S.D.Reid and a Graduate Scholarship awarded to Ms. C.D. Ricketts (www.nserc-crsng.gc.ca). Supplemental funding was provided from the Canadian Foundation for Innovation (http://www.innovation.ca), the British Columbia Knowledge Development Fund (http://www. aved.gov.bc.ca/researchandinnovation/Funding/ BCKDF/) and the University of British Columbia (Dr. S.D. Reid) and a Pacific Leaders Graduate Fellowship (http://www2.gov.bc.ca/myhr/article.page?ContentID=542bf8d0-f652-c01e-eaa7-2e8ded21542f; Ms. C.D. Ricketts). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PA, 2001, J AQUAT ANIM HEALTH, V13, P173, DOI 10.1577/1548-8667(2001)013&lt;0173:PACSRO&gt;2.0.CO;2; ALBORES A, 1992, CHEM-BIOL INTERACT, V85, P127, DOI 10.1016/0009-2797(92)90057-R; Anke MB, 1985, TRACE ELEMENTS MAN A, P154; Basu N, 2003, COMP BIOCHEM PHYS A, V134, P655, DOI 10.1016/S1095-6433(02)00372-0; Benfey TJ, 2000, AQUACULTURE, V184, P167, DOI 10.1016/S0044-8486(99)00314-2; Bentley RE, 1973, ACUTE TOXICITY SODIU; Bleau H, 1996, AQUAT TOXICOL, V34, P221, DOI 10.1016/0166-445X(95)00040-B; Boone AN, 2002, COMP BIOCHEM PHYS C, V132, P223, DOI 10.1016/S1532-0456(02)00066-2; BROWN SB, 1986, GEN COMP ENDOCR, V62, P493, DOI 10.1016/0016-6480(86)90060-2; Canadian Council of Ministers of the Environment, 1999, CAN WAT QUAL GUID PR; CARBALLO M, 1995, APPL ENVIRON MICROB, V61, P2108, DOI 10.1128/AEM.61.6.2108-2112.1995; Chappell WR, 1979, EPA600179006 HLTH EF; Cho WJ, 1997, BIOCHEM BIOPH RES CO, V233, P316, DOI 10.1006/bbrc.1997.6387; Chowdhury MJ, 2004, COMP BIOCHEM PHYS C, V139, P163, DOI 10.1016/j.cca.2004.10.006; Currie S, 2000, J FISH BIOL, V56, P398, DOI 10.1111/j.1095-8649.2000.tb02114.x; Currie S, 2008, PHYSIOL BIOCHEM ZOOL, V81, P414, DOI 10.1086/589095; DE SK, 1990, J BIOL CHEM, V265, P15267; Dethloff GM, 1999, ARCH ENVIRON CON TOX, V36, P415, DOI 10.1007/PL00006614; Duffy LK, 1999, COMP BIOCHEM PHYS C, V124, P181, DOI 10.1016/S0742-8413(99)00055-9; DURNAM DM, 1981, J BIOL CHEM, V256, P5712; Eisler R, 1989, 85119 US FISH WILDL; FLEET JC, 1990, AM J PHYSIOL, V258, pG926, DOI 10.1152/ajpgi.1990.258.6.G926; Goyer R.A., 1986, CASARETT DOULLS TOXI, P582; Gregory TR, 1999, PHYSIOL BIOCHEM ZOOL, V72, P286, DOI 10.1086/316673; Grosell M, 2012, FISH PHYSIOL, V31A, P53, DOI 10.1016/S1546-5098(11)31002-3; HAMILTON SJ, 1990, ARCH ENVIRON CON TOX, V19, P366, DOI 10.1007/BF01054980; Hamilton SJ, 1997, ECOTOX ENVIRON SAFE, V38, P296, DOI 10.1006/eesa.1997.1600; Harper ER, 2007, ENVIRON POLLUT, V147, P677, DOI 10.1016/j.envpol.2006.09.013; Hassanein HMA, 1999, ARCH ENVIRON CON TOX, V37, P78, DOI 10.1007/s002449900492; Heath A.G., 1995, WATER POLLUTION FISH; HEIKKILA JJ, 1982, J BIOL CHEM, V257, P2000; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; HODSON PV, 1978, WATER RES, V12, P869, DOI 10.1016/0043-1354(78)90039-8; HODSON PV, 1980, CAN J FISH AQUAT SCI, V37, P233, DOI 10.1139/f80-030; Hogstrand C., 2011, FISH PHYSIOL, V31, P135; Hollis L, 1999, AQUAT TOXICOL, V46, P101, DOI 10.1016/S0166-445X(98)00118-0; Hori TSF, 2008, COMP BIOCHEM PHYS C, V147, P416, DOI 10.1016/j.cbpc.2008.01.003; Jakobsen SS, 2007, BASIC CLIN PHARMACOL, V101, P441, DOI 10.1111/j.1742-7843.2007.00137.x; Janz DM, 1997, TOXICOL APPL PHARM, V147, P391, DOI 10.1006/taap.1997.8283; Jones CE, 1999, P 1999 WORKSH MOL IS, P1; KAGI JHR, 1993, ADV LIF SCI, P29; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; Kobayashi K, 2005, BIOL PHARM BULL, V28, P1859, DOI 10.1248/bpb.28.1859; Kobayashi K, 2006, TOXICOLOGY, V228, P162, DOI 10.1016/j.tox.2006.08.022; KOIZUMI T, 1984, CHEM-BIOL INTERACT, V51, P219, DOI 10.1016/0009-2797(84)90031-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martinez C. B. R., 2004, Braz. J. Biol., V64, P797, DOI 10.1590/S1519-69842004000500009; Matsuura H, 2003, ANAL SCI, V19, P117, DOI 10.2116/analsci.19.117; MCBRIDE JR, 1979, B ENVIRON CONTAM TOX, V23, P806, DOI 10.1007/BF01770046; MCCARTHY DH, 1973, J FISH BIOL, V5, P1, DOI 10.1111/j.1095-8649.1973.tb04425.x; MCCONNELL RP, 1977, MOLYBDENUM ENV GEOCH, P725; McGeer JC, 2012, FISH PHYSIOL, V31B, P125, DOI 10.1016/S1546-5098(11)31025-4; McNeely RN, 1979, MOLYBDENUM WATER QUA; Miller LL, 2007, AQUAT TOXICOL, V83, P263, DOI 10.1016/j.aquatox.2007.05.001; MILLIGAN CL, 1987, J EXP BIOL, V133, P263; Ministry of Environment and Energy, 1994, WAT MAN POL GUID PRO; MISRA S, 1989, BIOCHIM BIOPHYS ACTA, V1007, P325, DOI 10.1016/0167-4781(89)90155-3; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Mugnier C, 1998, AQUACULT INT, V6, P33, DOI 10.1023/A:1009217719227; NADDY RB, 1995, ENVIRON TOXICOL CHEM, V14, P329, DOI 10.1002/etc.5620140219; NELL JA, 1980, BRIT POULTRY SCI, V21, P193, DOI 10.1080/00071668008416657; NIEBOER E, 1980, ENVIRON POLLUT B, V1, P3, DOI 10.1016/0143-148X(80)90017-8; NRIAGU JO, 1988, NATURE, V333, P134, DOI 10.1038/333134a0; Pane EF, 2003, AQUAT TOXICOL, V63, P65, DOI 10.1016/S0166-445X(02)00131-5; Phillips G. R., 1978, EPA600378103 ENV RES; Pyle GG, 2001, ECOTOX ENVIRON SAFE, V48, P202, DOI 10.1006/eesa.2000.2016; Reid SD, 2012, FISH PHYSIOL, V31A, P375, DOI 10.1016/S1546-5098(11)31008-4; Reid SD, 2002, COMP BIOCHEM PHYS C, V133, P355, DOI 10.1016/S1532-0456(02)00121-7; Rendell JL, 2006, COMP BIOCHEM PHYS D, V1, P238, DOI 10.1016/j.cbd.2005.12.004; Ricard AC, 1998, ARCH ENVIRON CON TOX, V34, P377, DOI 10.1007/s002449900333; Ron B, 1995, AQUACULTURE, V135, P216, DOI 10.1016/0044-8486(96)81306-8; Ruane NM, 2000, FISH SHELLFISH IMMUN, V10, P451, DOI 10.1006/fsim.1999.0260; Ruane NM, 2002, AQUAC RES, V33, P777, DOI 10.1046/j.1365-2109.2002.00717.x; SANDERS BM, 1993, CRIT REV TOXICOL, V23, P49, DOI 10.3109/10408449309104074; Sanders BM, 1995, COMP BIOCHEM PHYS C, V112, P335, DOI 10.1016/0742-8413(95)02029-2; SMITH C, 1987, J ENVIRON QUAL, V16, P377, DOI 10.2134/jeq1987.00472425001600040015x; Sohlberg S, 1996, J VET PHARMACOL THER, V19, P460, DOI 10.1111/j.1365-2885.1996.tb00083.x; SOIVIO A, 1975, J EXP BIOL, V63, P207; Suzuki Y, 1976, IND HLTH, V14, P25; Swain LG, 1986, WATER QUALITY CRITER; Syvokiene Janina, 2006, Acta Zoologica Lituanica, V16, P235, DOI 10.1080/13921657.2006.10512737; Trucco RG, 1990, P 17 ANN AQ TOX WORK, V1774, P102; Ulmer D. D., 1969, TRACE SUBSTANCES ENV, VII, P7; United States Geological Survey, 2004, MIN COMM SUMM MOL; United States Geological Survey, 2009, MIN COMM SUMM MOL; Vijayan MM, 1998, AQUAT TOXICOL, V40, P101, DOI 10.1016/S0166-445X(97)00057-X; WAALKES MP, 1984, TOXICOL LETT, V20, P33, DOI 10.1016/0378-4274(84)90179-6; Washburn BS, 2002, ENVIRON TOXICOL CHEM, V21, P557, DOI [10.1897/1551-5028(2002)021&lt;0557:EOHOHS&gt;2.0.CO;2, 10.1002/etc.5620210313]; Watanabe T, 1997, AQUACULTURE, V151, P185, DOI 10.1016/S0044-8486(96)01503-7; WELLS RMG, 1991, J FISH BIOL, V38, P53, DOI 10.1111/j.1095-8649.1991.tb03090.x; WHITING ER, 1994, J FRESHWATER ECOL, V9, P299, DOI 10.1080/02705060.1994.9664900; Williams JH, 1996, ENVIRON TOXICOL CHEM, V15, P1324, DOI [10.1002/etc.5620150810, 10.1897/1551-5028(1996)015&lt;1324:AOHIJA&gt;2.3.CO;2]; WOLF KENNETH W., 1963, PROGR FISH CULT, V25, P135, DOI 10.1577/1548-8659(1963)25[135:PSFFT]2.0.CO;2; Wood AW, 1996, CAN J FISH AQUAT SCI, V53, P2424, DOI 10.1139/cjfas-53-11-2424; Wood Chris M., 2001, P1; Wu SM, 2006, ZOOL STUD, V45, P363; Yamaguchi S, 2007, AQUAT TOXICOL, V83, P43, DOI 10.1016/j.aquatox.2007.03.010; Zarate J, 2003, AQUACULTURE, V223, P175, DOI 10.1016/S0044-8486(03)00160-1	99	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115334	10.1371/journal.pone.0115334	http://dx.doi.org/10.1371/journal.pone.0115334			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629693	Green Submitted, gold, Green Published			2022-12-26	WOS:000348732100015
J	Somoza, JR; Koditek, D; Villasenor, AG; Novikov, N; Wong, MH; Liclican, A; Xing, WM; Lagpacan, L; Wang, R; Schultz, BE; Papalia, GA; Samuel, D; Lad, L; McGrath, ME				Somoza, John R.; Koditek, David; Villasenor, Armando G.; Novikov, Nikolai; Wong, Melanie H.; Liclican, Albert; Xing, Weimei; Lagpacan, Leanna; Wang, Ruth; Schultz, Brian E.; Papalia, Giuseppe A.; Samuel, Dharmaraj; Lad, Latesh; McGrath, Mary E.			Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PI3K-DELTA INHIBITOR; P110-DELTA; CAL-101; PI3K; WORTMANNIN; MECHANISMS; NETWORKS; BIACORE; ANTIGEN; MAP	Idelalisib (also known as GS-1101, CAL-101, IC489666, and Zydelig) is a PI3K delta inhibitor that has recently been approved for the treatment of several hematological malignancies. Given its use in human diseases, we needed a clear picture of how idelalisib binds to and inhibits PI3K delta. Our data show that idelalisib is a potent and selective inhibitor of the kinase activity of PI3K delta. A kinetic characterization clearly demonstrated ATP-competitive inhibition, and several additional biochemical and biophysical assays showed that the compound binds reversibly and noncovalently to the kinase. A crystal structure of idelalisib bound to the p110 delta subunit of PI3K delta furthers our understanding of the binding interactions that confer the potency and selectivity of idelalisib.	[Somoza, John R.; Villasenor, Armando G.; McGrath, Mary E.] Gilead Sci Inc, Dept Struct Chem, Foster City, CA 94404 USA; [Koditek, David; Novikov, Nikolai; Wong, Melanie H.; Liclican, Albert; Xing, Weimei; Lagpacan, Leanna; Wang, Ruth; Schultz, Brian E.; Papalia, Giuseppe A.; Samuel, Dharmaraj; Lad, Latesh] Gilead Sci Inc, Dept Biol, Foster City, CA 94404 USA	Gilead Sciences; Gilead Sciences	Somoza, JR (corresponding author), Gilead Sci Inc, 333 Lakeside Dr, Foster City, CA 94404 USA.	john.somoza@gilead.com			National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy [DE-AC02-05CH11231]	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported in part by funds from National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute (to the Berkeley Center for Structural Biology) and by Contract DE-AC02-05CH11231 from the Director of the Office of Science, Office of Basic Energy Sciences, U.S. Department of Energy (to the Advanced Light Source).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Bartok B, 2012, AM J PATHOL, V180, P1906, DOI 10.1016/j.ajpath.2012.01.030; Bernal A, 2001, BLOOD, V98, P3050, DOI 10.1182/blood.V98.10.3050; Berndt A, 2010, NAT CHEM BIOL, V6, P117, DOI [10.1038/nchembio.293, 10.1038/NCHEMBIO.293]; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Copeland RA., 2000, ENZYME PRACTICAL INT, P266, DOI 10.1002/0471220639.ch8; Cushing TD, 2015, J MED CHEM, V58, P480, DOI 10.1021/jm501624r; EMA, 2014, ZYD SUMM OP IN AUTH; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; FDA, 2014, FDA APPR ZYD 3 TYP B; Firestein GS, 2004, J CLIN INVEST, V114, P471, DOI 10.1172/JCI200422651; Flinn IW, 2014, BLOOD, V123, P3406, DOI 10.1182/blood-2013-11-538546; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Gopal AK, 2014, NEW ENGL J MED, V370, P1008, DOI 10.1056/NEJMoa1314583; Hoellenriegel J, 2011, BLOOD, V118, P3603, DOI 10.1182/blood-2011-05-352492; Kahl BS, 2014, BLOOD, V123, P3398, DOI 10.1182/blood-2013-11-537555; Karlsson R, 1999, J MOL RECOGNIT, V12, P285, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<285::AID-JMR469>3.0.CO;2-Y; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Meadows SA, 2012, BLOOD, V119, P1897, DOI 10.1182/blood-2011-10-386763; Myszka DG, 1998, BIOPHYS J, V75, P583, DOI 10.1016/S0006-3495(98)77549-6; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Park SJ, 2010, EUR RESPIR J, V36, P1448, DOI 10.1183/09031936.00106609; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Randis TM, 2008, EUR J IMMUNOL, V38, P1215, DOI 10.1002/eji.200838266; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wymann MP, 1996, MOL CELL BIOL, V16, P1722	37	102	107	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8439	8446		10.1074/jbc.M114.634683	http://dx.doi.org/10.1074/jbc.M114.634683			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25631052	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000351662600036
J	Chang, JT; Yang, CS; Chen, YS; Chen, BC; Chiang, AJ; Chang, YH; Tsai, WL; Lin, YS; Chao, D; Chang, TH				Chang, Jenn-Tzong; Yang, Chih-Shiang; Chen, Yao-Shen; Chen, Bao-Chen; Chiang, An-Jen; Chang, Yu-Hsiang; Tsai, Wei-Lun; Lin, You-Sheng; Chao, David; Chang, Tsung-Hsien			Genome and Infection Characteristics of Human Parechovirus Type 1: The Interplay between Viral Infection and Type I Interferon Antiviral System	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; REAL-TIME PCR; PICORNAVIRUS GROUP; IRF-3 ACTIVATION; CLINICAL-SAMPLES; CELL-CULTURE; VIRUS; RECOMBINATION; IDENTIFICATION; ENTEROVIRUS	Human parechoviruses (HPeVs), members of the family Picornaviridae, are associated with severe human clinical conditions such as gastrointestinal disease, encephalitis, meningitis, respiratory disease and neonatal sepsis. A new contemporary strain of HPeV1, KVP6 (accession no. KC769584), was isolated from a clinical specimen. Full-genome alignment revealed that HPeV1 KVP6 shares high genome homology with the German strain of HPeV1, 7555312 (accession no. FM178558) and could be classified in the clade 1B group. An intertypic recombination was shown within the P2-P3 genome regions of HPeV1. Celltype tropism test showed that T84 cells (colon carcinoma cells), A549 cells (lung carcinoma cells) and DBTRG-5MG cells (glioblastoma cells) were susceptible to HPeV1 infection, which might be relevant clinically. A facilitated cytopathic effect and increased viral titers were reached after serial viral passages in Vero cells, with viral genome mutation found in later passages. HPeV1 is sensitive to elevated temperature because 39 degrees C incubation impaired virion production. HPeV1 induced innate immunity with phosphorylation of interferon (IFN) regulatory transcription factor 3 and production of type I IFN in A549 but not T84 cells. Furthermore, type I IFN inhibited HPeV1 production in A549 cells but not T84 cells; T84 cells may be less responsive to type I IFN stimulation. Moreover, HPeV1-infected cells showed downregulated type I IFN activation, which indicated a type I IFN evasion mechanism. The characterization of the complete genome and infection features of HPeV1 provide comprehensive information about this newly isolated HPeV1 for further diagnosis, prevention or treatment strategies.	[Chang, Jenn-Tzong; Chiang, An-Jen; Chao, David] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Chang, Jenn-Tzong; Yang, Chih-Shiang; Lin, You-Sheng; Chang, Tsung-Hsien] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Chang, Jenn-Tzong; Chang, Yu-Hsiang] Kaohsiung Vet Gen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Infect Dis, Kaohsiung, Taiwan; [Chen, Bao-Chen] Kaohsiung Vet Gen Hosp, Dept Microbiol, Kaohsiung, Taiwan; [Chiang, An-Jen] Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Tsai, Wei-Lun] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Chang, Tsung-Hsien] Tajen Univ, Dept Pharm, Pingtung, Taiwan; [Chang, Tsung-Hsien] Tajen Univ, Grad Inst Pharmaceut Technol, Pingtung, Taiwan	National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital	Chang, TH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.	david@mail.nsysu.edu.tw	Chang, Tsung-Hsien/AAG-9384-2019	Chang, Tsung-Hsien/0000-0003-4806-7864	National Science Council, Taiwan [NSC 101-2320-B-075B-001-MY3]; Kaohsiung Veterans General Hospital [VGHKS101-017]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital	This work was supported by grants from the National Science Council, Taiwan (NSC 101-2320-B-075B-001-MY3) (http://www.most.gov.tw/mp. aspx?mp=7) and Kaohsiung Veterans General Hospital (VGHKS101-017) (http://www.vghks.gov.tw/English/). The funders had no role in the study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Abed Y, 2007, J CLIN MICROBIOL, V45, P2037, DOI 10.1128/JCM.02432-06; Abed Y, 2006, EMERG INFECT DIS, V12, P969, DOI 10.3201/eid1206.051675; Al-Sunaidi M, 2007, J VIROL, V81, P1013, DOI 10.1128/JVI.00584-06; Barral PM, 2007, J VIROL, V81, P3677, DOI 10.1128/JVI.01360-06; Benschop KSM, 2008, J GEN VIROL, V89, P1030, DOI 10.1099/vir.0.83498-0; Benschop KSM, 2010, J GEN VIROL, V91, P145, DOI 10.1099/vir.0.014670-0; Benschop K, 2008, J CLIN VIROL, V41, P69, DOI 10.1016/j.jcv.2007.10.004; Benschop KSM, 2006, CLIN INFECT DIS, V42, P204, DOI 10.1086/498905; BERKOVIC.S, 1968, B NEW YORK ACAD MED, V44, P377; Birenbaum E, 1997, AM J PERINAT, V14, P469, DOI 10.1055/s-2007-994182; Boonyakiat Y, 2001, J VIROL, V75, P10000, DOI 10.1128/JVI.75.20.10000-10004.2001; Bowie AG, 2008, BIOCHEM SOC T, V36, P449, DOI 10.1042/BST0360449; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493; COLLER BAG, 1990, J VIROL, V64, P2692, DOI 10.1128/JVI.64.6.2692-2701.1990; Dalton RM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-58; Drahos J, 2009, J VIROL, V83, P11581, DOI 10.1128/JVI.01490-09; Drexler JF, 2009, EMERG INFECT DIS, V15, P310, DOI 10.3201/eid1502.081028; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Feng Q, 2014, J VIROL, V88, P3369, DOI 10.1128/JVI.02712-13; Fensterl V, 2005, J VIROL, V79, P10968, DOI 10.1128/JVI.79.17.10968-10977.2005; FIGUEROA JP, 1989, J MED VIROL, V29, P315, DOI 10.1002/jmv.1890290418; Ghanem-Zoubi N, 2013, J CLIN VIROL, V58, P205, DOI 10.1016/j.jcv.2013.06.001; Ghazi F, 1998, J GEN VIROL, V79, P2641, DOI 10.1099/0022-1317-79-11-2641; Grist N R, 1978, Prog Med Virol, V24, P114; Harvala H, 2009, J INFECT DIS, V199, P1753, DOI 10.1086/599094; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hu NZ, 2002, WORLD J GASTROENTERO, V8, P872, DOI 10.3748/wjg.v8.i5.872; HYYPIA T, 1992, P NATL ACAD SCI USA, V89, P8847, DOI 10.1073/pnas.89.18.8847; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Khetsuriani N, 2006, PEDIATR INFECT DIS J, V25, P889, DOI 10.1097/01.inf.0000237798.07462.32; Li LL, 2009, EMERG INFECT DIS, V15, P288, DOI 10.3201/eid1502.080341; Lorenzo FR, 2008, VIRUS RES, V137, P86, DOI 10.1016/j.virusres.2008.06.005; Lu J, 2012, J VIROL, V86, P3767, DOI 10.1128/JVI.06687-11; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Nateri AS, 2000, J VIROL, V74, P6269, DOI 10.1128/JVI.74.14.6269-6277.2000; Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277; Samuilova O, 2004, J BIOL CHEM, V279, P37822, DOI 10.1074/jbc.M314203200; SCHULTHEISS T, 1995, J VIROL, V69, P1727, DOI 10.1128/JVI.69.3.1727-1733.1995; Seitsonen J, 2010, J VIROL, V84, P8509, DOI 10.1128/JVI.02176-09; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; STANTON GJ, 1977, INFECT IMMUN, V18, P370, DOI 10.1128/IAI.18.2.370-376.1977; Stanway G, 1999, J VIROL, V73, P5249, DOI 10.1128/JVI.73.7.5249-5254.1999; STANWAY G, 1994, J VIROL, V68, P8232, DOI 10.1128/JVI.68.12.8232-8238.1994; Tapia G, 2008, J MED VIROL, V80, P1835, DOI 10.1002/jmv.21283; Tauriainen S, 2008, J INFECT DIS, V198, P35, DOI 10.1086/588677; Verboon-Maciolek MA, 2008, ANN NEUROL, V64, P266, DOI 10.1002/ana.21445; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10; Watanabe K, 2007, EMERG INFECT DIS, V13, P889, DOI 10.3201/eid1306.060896; Westerhuis BM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-146; Westerhuis BM, 2012, J GEN VIROL, V93, P2363, DOI 10.1099/vir.0.043323-0; WIGAND REINHARD, 1961, ARCH GES VIRUSFORSCH, V11, P224, DOI 10.1007/BF01241688; Williams CH, 2009, J GEN VIROL, V90, P1702, DOI 10.1099/vir.0.008813-0; Zoll J, 2009, J VIROL, V83, P3379, DOI 10.1128/JVI.02529-08	61	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116158	10.1371/journal.pone.0116158	http://dx.doi.org/10.1371/journal.pone.0116158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646764	gold, Green Published, Green Submitted			2022-12-26	WOS:000348822600021
J	Yu, H; Wang, Q; Sun, Y; Shen, M; Li, H; Duan, YR				Yu, Hui; Wang, Qi; Sun, Ying; Shen, Ming; Li, He; Duan, Yourong			A New PAMPA Model Proposed on the Basis of a Synthetic Phospholipid Membrane	PLOS ONE			English	Article							IN-VITRO MODEL; MIMETIC ARTIFICIAL MEMBRANE; UNSTIRRED WATER LAYER; BLOOD-BRAIN-BARRIER; DRUG ABSORPTION; CACO-2 PERMEABILITY; INTESTINAL-ABSORPTION; PERMEATION ASSAY; BBB PERMEABILITY; FAST PREDICTION	The purpose of this work was to investigate the synthetic phospholipid dependence of permeability measured by parallel artificial membrane permeability assay (PAMPA) method. Three phospholipids with hydrophobic groups of different lengths and phosphorylcholine as the hydrophilic group were concisely synthesized. Ten model drug molecules were selected because of their distinct human fraction absorbed (% FA) values and various pK(a) characteristics. In vitro drug permeation experiments were designed to determine the effect of the incubation time (4-20 h), pH gradient (4.6-9.32) and carbon chain length (8, 10, 12) on the drug permeability through the synthetic phospholipid membrane in the PAMPA system. The results showed that intensive and significant synthetic phospholipids dependence of permeability influenced by the length of lipid's hydrophobic carbon chain. The effective permeability constant (P-e) of each drug increased rapidly with time, then decreased slightly after reaching the maximum; the pH gradient changed the drug permeability according to the pH-partition hypothesis for drugs with diverse pK(a) values; and longer hydrophobic chains in the synthetic phospholipid membrane improved the drug permeability, as observed for all test drugs at almost all incubation time points. This newly proposed PAMPA model considered the synthetic phospholipid membrane and showed good P-e-% FA correlation for the passive transport of drugs, making it a helpful supplementary method for PAMPA systems.	[Yu, Hui; Wang, Qi; Sun, Ying; Shen, Ming; Duan, Yourong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai 200032, Peoples R China; [Yu, Hui] Wuyi Univ, Coll Text & Clothing, Engn Technol Res Ctr Funct Text Higher Educ Guang, Jiangmen 529020, Guangdong, Peoples R China; [Li, He] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Tradit Chinese Med Dept, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Wuyi University; Shanghai Jiao Tong University	Li, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Tradit Chinese Med Dept, Shanghai 200127, Peoples R China.	lihe1972@hotmail.com; yrduan@shsci.org	Wang, Qi/T-9749-2018	Wang, Qi/0000-0003-3694-5826	Natural Science Foundation of China [81272568, 81301973, 81472841]; Science Foundation for Young Teachers of Wuyi University [2013zk12]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation for Young Teachers of Wuyi University	This research was supported by the Natural Science Foundation of China (No. 81272568, No. 81301973 and No. 81472841) and the Science Foundation for Young Teachers of Wuyi University (No. 2013zk12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avdeef A, 2006, EUR J PHARM SCI, V28, P43, DOI 10.1016/j.ejps.2005.12.008; Avdeef A, 2005, EUR J PHARM SCI, V24, P333, DOI 10.1016/j.ejps.2004.11.011; Avdeef A, 2004, EUR J PHARM SCI, V22, P365, DOI 10.1016/j.ejps.2004.04.009; Avdeef A, 2001, EUR J PHARM SCI, V14, P271, DOI 10.1016/S0928-0987(01)00191-9; Avdeef Alex, 2005, Expert Opin Drug Metab Toxicol, V1, P325, DOI 10.1517/17425255.1.2.325; Balimane PV, 2005, J PHARMACEUT BIOMED, V39, P8, DOI 10.1016/j.jpba.2005.03.043; Bendels S, 2006, PHARM RES-DORDR, V23, P2525, DOI 10.1007/s11095-006-9137-8; Bermejo M, 2004, EUR J PHARM SCI, V21, P429, DOI 10.1016/j.ejps.2003.10.009; Corti G, 2006, EUR J PHARM SCI, V27, P354, DOI 10.1016/j.ejps.2005.11.005; Dagenais C, 2009, EUR J PHARM SCI, V38, P121, DOI 10.1016/j.ejps.2009.06.009; Di L, 2003, EUR J MED CHEM, V38, P223, DOI 10.1016/S0223-5234(03)00012-6; Fujikawa M, 2005, BIOORGAN MED CHEM, V13, P4721, DOI 10.1016/j.bmc.2005.04.076; GUTKNECHT J, 1973, SCIENCE, V182, P1258, DOI 10.1126/science.182.4118.1258; Hanlan L, 2003, PHARM RES, V20, P1820, DOI DOI 10.1023/B:PHAM.0000003380.44755.5a; Heseya K, 1998, ANAL CHEM, V70, P943, DOI [10.1021/ac9707038, DOI 10.1021/AC9707038]; HIDALGO IJ, 1990, BIOCHIM BIOPHYS ACTA, V1028, P25, DOI 10.1016/0005-2736(90)90261-L; Hidalgo Ismael J., 2001, Current Topics in Medicinal Chemistry, V1, P385, DOI 10.2174/1568026013395010; Hou TJ, 2007, J CHEM INF MODEL, V47, P208, DOI 10.1021/ci600343x; Kansy M, 1998, J MED CHEM, V41, P1007, DOI 10.1021/jm970530e; Karadzovska D, 2013, EUR J PHARM SCI, V50, P569, DOI 10.1016/j.ejps.2013.02.020; Kerns EH, 2004, J PHARM SCI-US, V93, P1440, DOI 10.1002/jps.20075; KIM DC, 1993, PHARMACEUT RES, V10, P1710; Konradsdottir F, 2009, J PHARM PHARMACOL, V61, P121, DOI 10.1211/jpp/61.01.0017; LUCAS ML, 1994, J THEOR BIOL, V167, P147, DOI 10.1006/jtbi.1994.1059; Mandagere AK, 2002, J MED CHEM, V45, P304, DOI 10.1021/jm010152k; Mensch J, 2010, INT J PHARMACEUT, V395, P182, DOI 10.1016/j.ijpharm.2010.05.037; Mensch J, 2010, EUR J PHARM BIOPHARM, V74, P495, DOI 10.1016/j.ejpb.2010.01.003; Nagahara N, 2004, J PHARM SCI-US, V93, P2972, DOI 10.1002/jps.20206; Neuhoff S, 2003, PHARMACEUT RES, V20, P1141, DOI 10.1023/A:1025032511040; Ottaviani G, 2006, J MED CHEM, V49, P3948, DOI 10.1021/jm060230+; PINTO M, 1983, BIOL CELL, V47, P323; Ruell JA, 2003, EUR J PHARM SCI, V20, P393, DOI 10.1016/j.ejps.2003.08.006; Sinko B, 2012, EUR J PHARM SCI, V45, P698, DOI 10.1016/j.ejps.2012.01.011; Sugano K, 2004, INT J PHARM, V275, P271, DOI 10.1016/j.ijpharm.2004.02.010; Sugano K, 2003, INT J PHARM, V257, P245, DOI 10.1016/S0378-5173(03)00161-3; Sugano K, 2001, INT J PHARM, V228, P181, DOI 10.1016/S0378-5173(01)00845-6; SUGAWARA M, 1990, J PHARM PHARMACOL, V42, P314, DOI 10.1111/j.2042-7158.1990.tb05418.x; WALTER A, 1984, J MEMBRANE BIOL, V77, P255, DOI 10.1007/BF01870573; Wessel MD, 1998, J CHEM INF COMP SCI, V38, P726, DOI 10.1021/ci980029a; Yu H, 2008, J APPL POLYM SCI, V110, P2058, DOI 10.1002/app.28694	40	34	35	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116502	10.1371/journal.pone.0116502	http://dx.doi.org/10.1371/journal.pone.0116502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647086	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600027
J	Zhao, HW; Wang, J; Lu, ZL; Wu, QJ; Lv, HJ; Liu, H; Gong, XY				Zhao, Hongwei; Wang, Jin; Lu, Zhonglie; Wu, Qingjie; Lv, Haijuan; Liu, Hu; Gong, Xiangyang			Superficial Siderosis of the Central Nervous System Induced by a Single-Episode of Traumatic Subarachnoid Hemorrhage: A Study Using MRI-Enhanced Gradient Echo T2 Star-Weighted Angiography	PLOS ONE			English	Article							DEPOSITION; DIAGNOSIS; BRAIN	The purpose of this study was to examine whether a single episode of traumatic subarachnoid hemorrhage (tSAH) could cause superficial siderosis of the central nervous system (SS-CNS). This study was approved by the local ethics committee. Thirty-two patients with a history of a single episode of tSAH were enrolled in the study. An episode of tSAH was confirmed in patients based on a CT scan or a lumbar puncture, and a follow-up examination was conducted at least six weeks after the brain trauma. A follow-up MRI examination was performed, using enhanced gradient echo T2 star-weighted angiography (ESWAN) to detect hemosiderin deposition on the cortical surface. The extent to which hemosiderin deposition was associated with several clinical factors was investigated. Various degrees of hemosiderin deposition were detected in 31 of 32 (96.9%) single-episode tSAH patients. Analysis of contingency tables revealed an association between the regions of subarachnoid bleeding based on CT images and the regions of hemosiderin deposition based on ESWAN images (X-2 = 17.73, P<0.05). SS-CNS was determined to be a common consequence after a single episode of tSAH. The extent of hemosiderin deposition is closely correlated with the initial bleeding sites and bleeding volume.	[Zhao, Hongwei; Lu, Zhonglie; Wu, Qingjie; Lv, Haijuan; Liu, Hu] Jiaxing Univ, Affiliated Hosp 2, Dept Radiol, Jiaxing, Peoples R China; [Zhao, Hongwei] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Radiol, Sch Med, Hangzhou 310027, Zhejiang, Peoples R China; [Wang, Jin] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Neurol, Sch Med, Hangzhou 310027, Zhejiang, Peoples R China; [Gong, Xiangyang] Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China	Jiaxing University; Zhejiang University; Zhejiang University; Zhejiang Provincial People's Hospital	Gong, XY (corresponding author), Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China.	cjr.gxy@hotmail.com			Foundation of Science Technology Department of Zhejiang Provincial [2012C33019]; Grant of Health Bureau of Zhejiang Province [2011KYA082]; Science Foundation of Jiaxing Science and Technology Bureau of China [2012AY1071-11]	Foundation of Science Technology Department of Zhejiang Provincial; Grant of Health Bureau of Zhejiang Province; Science Foundation of Jiaxing Science and Technology Bureau of China	This study was supported by the Foundation of Science Technology Department of Zhejiang Provincial (2012C33019), the Grant of Health Bureau of Zhejiang Province (2011KYA082) and the Science Foundation of Jiaxing Science and Technology Bureau of China under Grant (2012AY1071-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstwurm K, 2002, J NEUROL, V249, P1223, DOI 10.1007/s00415-002-0815-0; FEARNLEY JM, 1995, BRAIN, V118, P1051, DOI 10.1093/brain/118.4.1051; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Haacke EM, 2007, AM J NEURORADIOL, V28, P316; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hayashida Y, 2014, ACTA RADIOL, V55, P201, DOI 10.1177/0284185113495836; Imaizumi T, 2003, STROKE, V34, P1693, DOI 10.1161/01.STR.0000075771.88719.CE; IWANOWSKI L, 1960, J NEUROPATH EXP NEUR, V19, P433, DOI 10.1097/00005072-196007000-00010; JANSS AJ, 1993, J NEUROSURG, V79, P756, DOI 10.3171/jns.1993.79.5.0756; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Jurkiewicz E, 2010, POL J RADIOL, V75, P47; Kakeda S, 2010, ACAD RADIOL, V17, P871, DOI 10.1016/j.acra.2010.02.014; Khalatbari Kimia, 2009, Radiology, V250, P292, DOI 10.1148/radiol.2501051201; KOEPPEN AH, 1991, J NEUROPATH EXP NEUR, V50, P579, DOI 10.1097/00005072-199109000-00005; Koeppen AH, 2008, ACTA NEUROPATHOL, V116, P371, DOI 10.1007/s00401-008-0421-z; Kumar N, 2006, NEUROLOGY, V66, P1144, DOI 10.1212/01.wnl.0000208510.76323.5b; Kumar N, 2010, AM J NEURORADIOL, V31, P5, DOI 10.3174/ajnr.A1628; Kumar N, 2007, ARCH NEUROL-CHICAGO, V64, P491, DOI 10.1001/archneur.64.4.491; Kumar N, 2009, NEUROLOGY, V72, P671, DOI 10.1212/01.wnl.0000342457.22536.af; Leussink VI, 2003, ACTA NEUROL SCAND, V107, P54, DOI 10.1034/j.1600-0404.2003.02001.x; Levy M, 2007, NAT CLIN PRACT NEURO, V3, P54, DOI 10.1038/ncpneuro0356; Levy M, 2012, STROKE, V43, P120, DOI 10.1161/STROKEAHA.111.628032; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Rumzan R, 2013, EUR J RADIOL, V82, pE95, DOI 10.1016/j.ejrad.2012.09.006; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Thomas B, 2008, NEURORADIOLOGY, V50, P105, DOI 10.1007/s00234-007-0316-z; Wang J, 2011, CLIN IMAG, V35, P217, DOI 10.1016/j.clinimag.2010.06.003; Wang J, 2009, NEUROLOGY, V72, P1187, DOI 10.1212/01.wnl.0000345359.14275.f2; Yamawaki Takemori, 2013, Brain Nerve, V65, P843	29	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116632	10.1371/journal.pone.0116632	http://dx.doi.org/10.1371/journal.pone.0116632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647424	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600030
J	Burk, LM; Wang, KH; Wait, JM; Kang, E; Willis, M; Lu, JP; Zhou, O; Lee, YZ				Burk, Laurel M.; Wang, Ko-Han; Wait, John Matthew; Kang, Eunice; Willis, Monte; Lu, Jianping; Zhou, Otto; Lee, Yueh Z.			Delayed Contrast Enhancement Imaging of a Murine Model for Ischemia Reperfusion with Carbon Nanotube Micro-CT	PLOS ONE			English	Article							X-RAY SOURCE; TOMOGRAPHY	We aim to demonstrate the application of free-breathing prospectively gated carbon nanotube (CNT) micro-CT by evaluating a myocardial infarction model with a delayed contrast enhancement technique. Evaluation of murine cardiac models using micro-CT imaging has historically been limited by extreme imaging requirements. Newly-developed CNT-based x-ray sources offer precise temporal resolution, allowing elimination of physiological motion through prospective gating. Using free-breathing, cardiac-gated CNT micro-CT, a myocardial infarction model can be studied non-invasively and with high resolution. Myocardial infarction was induced in eight male C57BL/6 mice aged 8-12 weeks. The ischemia reperfusion model was achieved by surgically occluding the LAD artery for 30 minutes followed by 24 hours of reperfusion. Tail vein catheters were placed for contrast administration. Iohexol 300mgI/mL was administered followed by images obtained in diastole. Iodinated lipid blood pool contrast agent was then administered, followed with images at systole and diastole. Respiratory and cardiac signals were monitored externally and used to gate the scans of free-breathing subjects. Seven control animals were scanned using the same imaging protocol. After imaging, the heart was harvested, cut into 1mm slices and stained with TTC. Post-processing analysis was performed using ITK-Snap and MATLAB. All animals demonstrated obvious delayed contrast enhancement in the left ventricular wall following the Iohexol injection. The blood pool contrast agent revealed significant changes in cardiac function quantified by 3-D volume ejection fractions. All subjects demonstrated areas of myocardial infarct in the LAD distribution on both TTC staining and micro-CT imaging. The CNT micro-CT system aids straightforward, free-breathing, prospectively-gated 3D murine cardiac imaging. Delayed contrast enhancement allows identification of infarcted myocardium after a myocardial ischemic event. We demonstrate the ability to consistently identify areas of myocardial infarct in mice and provide functional cardiac information using a delayed contrast enhancement technique.	[Burk, Laurel M.; Wait, John Matthew; Lu, Jianping; Zhou, Otto; Lee, Yueh Z.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Wang, Ko-Han; Lee, Yueh Z.] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA; [Kang, Eunice; Willis, Monte] Univ N Carolina, McAllister Heart Inst, Div Cardiol, Chapel Hill, NC 27599 USA; [Lu, Jianping; Zhou, Otto] Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Burk, LM (corresponding author), Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA.	laurelburk@gmail.com	Lee, Yueh/AAF-1430-2021; Lu, Jianping/E-2457-2018; Willis, Monte S/J-9994-2015	Lee, Yueh/0000-0003-1846-7680; Lu, Jianping/0000-0001-9963-9741; Willis, Monte S/0000-0002-0769-5816; Zhou, Otto/0000-0003-1476-5517	National Institute of Biomedical Imaging and Bioengineering (Bethesda, MD) [4R33EB004204-01]; National Cancer Institute (Bethesda, MD) [U54CA119343]; UNC Clinician-Scientist Training Program in Cardiovascular Medicine [HL083828]; AHA Scientist Development Grant; NHLBI [R01HL104129];  [UCM_443318]; NATIONAL CANCER INSTITUTE [U54CA119343, P50CA058223] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL083828, R01HL104129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB004204] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Cancer Institute (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UNC Clinician-Scientist Training Program in Cardiovascular Medicine; AHA Scientist Development Grant(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by grant 4R33EB004204-01 from the National Institute of Biomedical Imaging and Bioengineering (Bethesda, MD), http://www.nibib.nih.gov/; grant U54CA119343 from the National Cancer Institute (Bethesda, MD), http://www.cancer.gov/; UNC Clinician-Scientist Training Program in Cardiovascular Medicine (HL083828 to E. K.), http://medicine.med.unc.edu/cardiology/fellows/cardiovascular-disease-fellowship; AHA Scientist Development Grant (to J.M.W.), http://my.americanheart.org/professional/Research/FundingOpportunities/ SupportingInformation/Winter-2013-Scientist-Development- Grant_UCM_443318_Article.jsp; and NHLBI, http://www.nhlbi.nih.gov/ (R01HL104129 to J.M.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartling SH, 2007, INVEST RADIOL, V42, P704, DOI 10.1097/RLI.0b013e318070dcad; Bordelon DE, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3043417; Calderon-Colon X, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/32/325707; Cao GH, 2010, MED PHYS, V37, P5306, DOI 10.1118/1.3491806; Curley GF, 2009, ANESTHESIOLOGY, V111, P701, DOI 10.1097/01.anes.0000358753.29528.fb; Li HH, 2011, AM J PATHOL, V178, P1043, DOI 10.1016/j.ajpath.2010.11.049; Mahnken AH, 2009, JACC-CARDIOVASC IMAG, V2, P1167, DOI 10.1016/j.jcmg.2009.05.014; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Nahrendorf M, 2007, AM J PHYSIOL-HEART C, V292, pH3172, DOI 10.1152/ajpheart.01307.2006; Ordovas KG, 2011, RADIOLOGY, V261, P358, DOI 10.1148/radiol.11091882; Qian X, 2012, MED PHYS, V39, P2090, DOI 10.1118/1.3694667; RICH S, 1986, AM HEART J, V112, P392, DOI 10.1016/0002-8703(86)90280-2; Sosnovik DE, 2009, CIRC-CARDIOVASC IMAG, V2, P460, DOI 10.1161/CIRCIMAGING.109.859678; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang J, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2041589	15	2	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115607	10.1371/journal.pone.0115607	http://dx.doi.org/10.1371/journal.pone.0115607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635838	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700015
J	Kaya, M; Lelesius, E; Nagrockaite, R; Sargin, I; Arslan, G; Mol, A; Baran, T; Can, E; Bitim, B				Kaya, Murat; Lelesius, Evaldas; Nagrockaite, Radvile; Sargin, Idris; Arslan, Gulsin; Mol, Abbas; Baran, Talat; Can, Esra; Bitim, Betul			Differentiations of Chitin Content and Surface Morphologies of Chitins Extracted from Male and Female Grasshopper Species	PLOS ONE			English	Article							PHYSICOCHEMICAL CHARACTERIZATION; BETA-CHITIN; CHITOSAN	In this study, we used Fourier transform infrared spectroscopy (FT-IR), elemental analysis (EA), thermogravimetric analysis (TGA), X-ray diffractometry (XRD), and scanning electron microscopy (SEM) to investigate chitin structure isolated from both sexes of four grasshopper species. FT-IR, EA, XRD, and TGA showed that the chitin was in the alpha form. With respect to gender, two main differences were observed. First, we observed that the quantity of chitin was greater in males than in females and the dry weight of chitin between species ranged from 4.71% to 11.84%. Second, using SEM, we observed that the male chitin surface structure contained 25 - 90nm wide nanofibers and 90 - 250 nm nanopores, while no pores or nanofibers were observed in the chitin surface structure of the majority of females (nanofibers were observed only in M. desertus females). In contrast, the elemental analysis, thermal properties, and crystalline index values for chitin were similar in males and females. Also, we carried out enzymatic digestion of the isolated chitins using commercial chitinase from Streptomyces griseus. We observed that there were no big differences in digestion rate of the chitins from both sexes and commercial chitin. The digestion rates were for grasshoppers' chitins; 88.45-95.48% and for commercial chitin; 94.95%.	[Kaya, Murat; Can, Esra; Bitim, Betul] Aksaray Univ, Fac Sci & Letters, Dept Biotechnol & Mol Biol, TR-68100 Aksaray, Turkey; [Kaya, Murat; Lelesius, Evaldas; Nagrockaite, Radvile; Baran, Talat; Can, Esra; Bitim, Betul] Aksaray Univ, Sci & Technol Applicat, TR-68100 Aksaray, Turkey; [Kaya, Murat; Lelesius, Evaldas; Nagrockaite, Radvile; Baran, Talat; Can, Esra; Bitim, Betul] Aksaray Univ, Res Ctr, TR-68100 Aksaray, Turkey; [Lelesius, Evaldas; Nagrockaite, Radvile] Vytautas Magnus Univ, Dept Biol, LT-44404 Kaunas, Lithuania; [Sargin, Idris] Selcuk Univ, Fac Sci, Dept Chem, TR-42075 Konya, Turkey; [Arslan, Gulsin] Selcuk Univ, Fac Sci, Dept Biochem, TR-42075 Konya, Turkey; [Mol, Abbas] Aksaray Univ, Guzelyurt Vocat Sch, Guzelyurt, Aksaray, Turkey; [Baran, Talat] Aksaray Univ, Fac Sci & Letters, Dept Chem, TR-68100 Aksaray, Turkey	Aksaray University; Aksaray University; Aksaray University; Vytautas Magnus University; Selcuk University; Selcuk University; Aksaray University; Ministry of National Education - Turkey; Aksaray University	Kaya, M (corresponding author), Aksaray Univ, Fac Sci & Letters, Dept Biotechnol & Mol Biol, TR-68100 Aksaray, Turkey.	muratkaya3806@yahoo.com	Arslan, Gülşin/AAG-5549-2019; Sargin, Idris/O-6937-2018; Sargın, İdris/AAB-8748-2020; Kaya, Murat/AAA-7668-2020; BARAN, TALAT/GPF-8414-2022; DOGRU, ALI HIKMET/N-5918-2017	Arslan, Gülşin/0000-0002-4836-8651; Sargin, Idris/0000-0003-3785-9575; Sargın, İdris/0000-0003-3785-9575; DOGRU, ALI HIKMET/0000-0003-0992-7024; Kaya, Murat/0000-0001-6954-2703; BARAN, TALAT/0000-0003-0206-3841				Abdou ES, 2008, BIORESOURCE TECHNOL, V99, P1359, DOI 10.1016/j.biortech.2007.01.051; Al Sagheer FA, 2009, CARBOHYD POLYM, V77, P410, DOI 10.1016/j.carbpol.2009.01.032; CABIB E, 1988, MICROBIOL SCI, V5, P370; Domard A., 2001, POLYM BIOMATER, V9, P187, DOI DOI 10.1201/9780203904671.CH9; Ehrlich H, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0339; Felse PA, 1999, BIOPROCESS ENG, V20, P505, DOI 10.1007/s004490050622; FOCHER B, 1992, CARBOHYD POLYM, V18, P43, DOI 10.1016/0144-8617(92)90186-T; Hajji S, 2014, INT J BIOL MACROMOL, V65, P298, DOI 10.1016/j.ijbiomac.2014.01.045; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Ifuku S, 2011, MATERIALS, V4, P1417, DOI 10.3390/ma4081417; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20176; Jiang CJ, 2006, CHEM ENG TECHNOL, V29, P511, DOI 10.1002/ceat.200500293; Juarez-de La Rosa BA, 2012, J MATER SCI, V47, P990, DOI 10.1007/s10853-011-5878-9; Kaya M, 2014, ZOOMORPHOLOGY, V133, P285, DOI 10.1007/s00435-014-0227-6; Kaya M, 2014, INT J BIOL MACROMOL, V65, P553, DOI 10.1016/j.ijbiomac.2014.02.010; Kaya M, 2013, INT J BIOL MACROMOL, V61, P459, DOI 10.1016/j.ijbiomac.2013.08.016; Kaya M, 2013, EXCLI J, V12, P503; Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7; Lavall RL, 2007, BIORESOURCE TECHNOL, V98, P2465, DOI 10.1016/j.biortech.2006.09.002; Liu SF, 2012, MOLECULES, V17, P4604, DOI 10.3390/molecules17044604; Majtan J, 2007, INT J BIOL MACROMOL, V40, P237, DOI 10.1016/j.ijbiomac.2006.07.010; Park BK, 2010, INT J MOL SCI, V11, P5153, DOI 10.3390/ijms11125152; Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032; Proespraiwong P, 2010, COMP BIOCHEM PHYS B, V156, P86, DOI 10.1016/j.cbpb.2010.02.007; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; RUDALL KM, 1973, BIOL REV, V48, P597, DOI 10.1111/j.1469-185X.1973.tb01570.x; Sajomsang W, 2010, MAT SCI ENG C-MATER, V30, P357, DOI 10.1016/j.msec.2009.11.014; Shahidi F, 2005, ADV FOOD NUTR RES, V49, P93, DOI 10.1016/S1043-4526(05)49003-8; Suginta W, 2007, ENZYME MICROB TECH, V41, P212, DOI 10.1016/j.enzmictec.2007.01.006; Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473; Vetter J, 2007, FOOD CHEM, V102, P6, DOI 10.1016/j.foodchem.2006.01.037; Waghmare S, 2013, BIODIVERS ENDANGER S, V1, P110; Wang YC, 2013, CARBOHYD POLYM, V92, P90, DOI 10.1016/j.carbpol.2012.09.084; Xu J, 1996, MACROMOLECULES, V29, P3436, DOI 10.1021/ma951638b; Yen MT, 2009, CARBOHYD POLYM, V75, P15, DOI 10.1016/j.carbpol.2008.06.006; Youn DK, 2009, CARBOHYD POLYM, V78, P41, DOI 10.1016/j.carbpol.2009.03.038; Zhang JZ, 2013, FOOD CHEM, V138, P1225, DOI 10.1016/j.foodchem.2012.11.067; Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3	39	63	64	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115531	10.1371/journal.pone.0115531	http://dx.doi.org/10.1371/journal.pone.0115531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635814	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700013
J	Lebwohl, B; Emilsson, L; Frobert, O; Einstein, AJ; Green, PHR; Ludvigsson, JF				Lebwohl, Benjamin; Emilsson, Louise; Frobert, Ole; Einstein, Andrew J.; Green, Peter H. R.; Ludvigsson, Jonas F.			Mucosal Healing and the Risk of Ischemic Heart Disease or Atrial Fibrillation in Patients with Celiac Disease; A Population-Based Study	PLOS ONE			English	Article							GLUTEN-FREE DIET; FOLLOW-UP; MORTALITY; PREVALENCE; RECOVERY; ADULTS; HISTOPATHOLOGY; INFLAMMATION; VALIDATION; PREDICTION	Background Patients with celiac disease (CD), characterized histologically by villous atrophy (VA) of the small intestine, have an increased risk of ischemic heart disease (IHD) and atrial fibrillation (AF), risks that persist for years after commencing the gluten-free diet. It is unknown whether persistent VA on follow-up biopsy, rather than mucosal healing, affects the risk of IHD or AF. Methods We identified patients with histologic evidence of CD diagnosed at all 28 pathology departments in Sweden. Among patients who underwent a follow-up small intestinal biopsy, we compared patients with persistent VA to those who showed histologic improvement, with regard to the development of IHD (angina pectoris or myocardial infarction) or AF. Results Among patients with CD and a follow-up biopsy (n = 7,440), the median age at follow-up biopsy was 25 years, with 1,063 (14%) patients who were >= 60 years at the time of follow-up biopsy. Some 196 patients developed IHD and 205 patients developed AF. After adjusting for age, gender, duration of CD, calendar period, and educational attainment, there was no significant effect of persistent VA on IHD (adjusted HR 0.97; 95%CI 0.73-1.30). Adjusting for diabetes had a negligible effect (adjusted HR 0.98; 95%CI 0.73-1.31). There was no significant association between persistent VA and the risk of AF (adjusted HR 0.98; 95%CI 0.74-1.30). Conclusions In this population-based study of patients with CD, persistent VA on follow-up biopsy was not associated with an increased risk of IHD or AF. Failed mucosal healing does not influence the risk of these cardiac events.	[Lebwohl, Benjamin; Green, Peter H. R.] Columbia Univ Coll Phys & Surg, Dept Med, Celiac Dis Ctr, New York, NY 10032 USA; [Lebwohl, Benjamin; Ludvigsson, Jonas F.] Karolinska Univ Hosp, Dept Med Epidemiol & Biostatst, Stockholm, Sweden; [Lebwohl, Benjamin; Ludvigsson, Jonas F.] Karolinska Inst, Stockholm, Sweden; [Emilsson, Louise] Vardcentralen Varmlands Nysater, Primary Care Res Unit, Varmlands Nysater, Varmland County, Sweden; [Emilsson, Louise] Univ Orebro, Dept Med, SE-70182 Orebro, Sweden; [Frobert, Ole] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden; [Einstein, Andrew J.] Columbia Univ Coll Phys & Surg, Dept Med, Div Cardiol, New York, NY 10032 USA; [Einstein, Andrew J.] Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA; [Einstein, Andrew J.] New York Presbyterian Hosp, New York, NY USA; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Pediat, Orebro, Sweden	Columbia University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University; Orebro University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Orebro University	Ludvigsson, JF (corresponding author), Karolinska Univ Hosp, Dept Med Epidemiol & Biostatst, Stockholm, Sweden.	jonasludvigsson@yahoo.com	Emilsson, Louise/K-4589-2013; Ludvigsson, Jonas F/A-8560-2012	Emilsson, Louise/0000-0001-9137-2800; Ludvigsson, Jonas F/0000-0003-1024-5602; Frobert, Ole/0000-0002-5846-345X	National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000040]; Orebro University Hospital; Swedish Society of Medicine; Swedish Research Council-Medicine [522-2A09-195]; Swedish Celiac Society; Karolinska Institutet; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Orebro University Hospital; Swedish Society of Medicine; Swedish Research Council-Medicine(Swedish Research Council); Swedish Celiac Society; Karolinska Institutet(Karolinska Institutet); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants to BL from the National Center for Advancing Translational Sciences, National Institutes of Health (UL1 TR000040); and to JFL from Orebro University Hospital, Karolinska Institutet, the Swedish Society of Medicine, the Swedish Research Council-Medicine (522-2A09-195) and the Swedish Celiac Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Daya H, 2013, CLIN GASTROENTEROL H, V11, P1472, DOI 10.1016/j.cgh.2013.05.030; Andersson T, 2013, EUR HEART J, V34, P1061, DOI 10.1093/eurheartj/ehs469; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bardella MT, 2007, HISTOPATHOLOGY, V50, P465, DOI 10.1111/j.1365-2559.2007.02621.x; Brar P, 2006, AM J MED, V119, P786, DOI 10.1016/j.amjmed.2005.12.025; Ciacci C, 2002, DIGESTION, V66, P178, DOI 10.1159/000066757; Collin P, 2004, GASTROINTEST ENDOSC, V59, P158, DOI 10.1016/S0016-5107(03)01311-7; De Marchi S, 2013, ALIMENT PHARM THER, V38, P162, DOI 10.1111/apt.12360; Emilsson L, 2013, ALIMENT PHARM THER, V37, P905, DOI 10.1111/apt.12271; Emilsson L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001594; Emilsson L, 2011, EUR HEART J, V32, P2430, DOI 10.1093/eurheartj/ehr167; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Kabbani TA, 2013, GASTROENTEROLOGY, V144, P912, DOI 10.1053/j.gastro.2013.01.033; KANNEL WB, 1998, AM J CARDIOL, V0082; Lanzini A, 2009, ALIMENT PHARM THER, V29, P1299, DOI 10.1111/j.1365-2036.2009.03992.x; Lebwohl B, 2014, Aliment Pharmacol Ther, V39, P488, DOI 10.1111/apt.12621; Lebwohl B, 2013, ALIMENT PHARM THER, V37, P332, DOI 10.1111/apt.12164; Lebwohl B, PERSISTENT MUCOSAL D; Lebwohl B, 2013, ANN INTERN MED, V159, P169, DOI 10.7326/0003-4819-159-3-201308060-00006; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; Ludvigsson JF, 2005, CLIN GASTROENTEROL H, V3, P869, DOI 10.1016/S1542-3565(05)00414-3; Ludvigsson JF, 2012, J STROKE CEREBROVASC, V21, P860, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.008; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2011, CIRCULATION, V123, P483, DOI 10.1161/CIRCULATIONAHA.110.965624; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-19; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Nilsson A C, 1994, Lakartidningen, V91, P603; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Sharkey LM, 2013, ALIMENT PHARM THER, V38, P1278, DOI 10.1111/apt.12510; Smith JG, 2010, EUR J EPIDEMIOL, V25, P95, DOI 10.1007/s10654-009-9404-1; Snook JA, 1996, GUT, V39, P60, DOI 10.1136/gut.39.1.60; Turesson C, 2007, ANN RHEUM DIS, V66, P70, DOI 10.1136/ard.2006.052506; Wahab PJ, 2002, AM J CLIN PATHOL, V118, P459; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; WHO, 2014, THE TOP 10 CAUSES OF; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117529	10.1371/journal.pone.0117529	http://dx.doi.org/10.1371/journal.pone.0117529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635403	Green Submitted, gold, Green Published			2022-12-26	WOS:000350680700090
J	Soininen, EM; Gauthier, G; Bilodeau, F; Berteaux, D; Gielly, L; Taberlet, P; Gussarova, G; Bellemain, E; Hassel, K; Stenoien, HK; Epp, L; Schroder-Nielsen, A; Brochmann, C; Yoccoz, NG				Soininen, Eeva M.; Gauthier, Gilles; Bilodeau, Frederic; Berteaux, Dominique; Gielly, Ludovic; Taberlet, Pierre; Gussarova, Galina; Bellemain, Eva; Hassel, Kristian; Stenoien, Hans K.; Epp, Laura; Schroder-Nielsen, Audun; Brochmann, Christian; Yoccoz, Nigel G.			Highly Overlapping Winter Diet in Two Sympatric Lemming Species Revealed by DNA Metabarcoding	PLOS ONE			English	Article							DESERT RODENT COMMUNITY; HABITAT USE; DICROSTONYX-GROENLANDICUS; BYLOT ISLAND; NUTRITIONAL ECOLOGY; NORWEGIAN LEMMINGS; MICROTINE RODENTS; ARCTIC VEGETATION; LEMMUS-SIBIRICUS; SHRUB EXPANSION	Sympatric species are expected to minimize competition by partitioning resources, especially when these are limited. Herbivores inhabiting the High Arctic in winter are a prime example of a situation where food availability is anticipated to be low, and thus reduced diet overlap is expected. We present here the first assessment of diet overlap of high arctic lemmings during winter based on DNA metabarcoding of feces. In contrast to previous analyses based on microhistology, we found that the diets of both collared (Dicrostonyx groenlandicus) and brown lemmings (Lemmus trimucronatus) on Bylot Island were dominated by Salix while mosses, which were significantly consumed only by the brown lemming, were a relatively minor food item. The most abundant plant taxon, Cassiope tetragona, which alone composes more than 50% of the available plant biomass, was not detected in feces and can thus be considered to be non-food. Most plant taxa that were identified as food items were consumed in proportion to their availability and none were clearly selected for. The resulting high diet overlap, together with a lack of habitat segregation, indicates a high potential for resource competition between the two lemming species. However, Salix is abundant in the winter habitats of lemmings on Bylot Island and the non-Salix portion of the diets differed between the two species. Also, lemming grazing impact on vegetation during winter in the study area is negligible. Hence, it seems likely that the high potential for resource competition predicted between these two species did not translate into actual competition. This illustrates that even in environments with low primary productivity food resources do not necessarily generate strong competition among herbivores.	[Soininen, Eeva M.; Yoccoz, Nigel G.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway; [Gauthier, Gilles; Bilodeau, Frederic] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Gauthier, Gilles; Bilodeau, Frederic] Univ Laval, Ctr Etudes Nord, Quebec City, PQ, Canada; [Berteaux, Dominique] Univ Quebec Rimouski, Chaire Rech Canada Biodiversite Nord, Quebec City, PQ, Canada; [Berteaux, Dominique] Univ Quebec Rimouski, Ctr Etudes Nord, Quebec City, PQ, Canada; [Gielly, Ludovic; Taberlet, Pierre] Univ Grenoble Alpes, CNRS, Lab Ecol Alpine LECA, Grenoble, France; [Gussarova, Galina; Bellemain, Eva; Epp, Laura; Schroder-Nielsen, Audun; Brochmann, Christian] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Gussarova, Galina] St Petersburg State Univ, Dept Bot, St Petersburg 199034, Russia; [Bellemain, Eva] SPYGEN, Savoie Technolac, Le Bourget Du Lac, France; [Hassel, Kristian; Stenoien, Hans K.] Norwegian Univ Sci & Technol, NTNU Univ Museum, N-7034 Trondheim, Norway	UiT The Arctic University of Tromso; Laval University; Laval University; University of Quebec; Universite du Quebec a Rimouski; University of Quebec; Universite du Quebec a Rimouski; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of Oslo; Saint Petersburg State University; Norwegian University of Science & Technology (NTNU)	Soininen, EM (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway.	eeva.soininen@uit.no	Gielly, Ludovic/ADQ-6036-2022; Brochmann, Christian/A-4105-2009; Epp, Laura Saskia/J-5301-2016; Gussarova, Galina/ABC-8696-2021; Gussarova, Galina/E-4758-2015; Yoccoz, Nigel/C-8561-2014; Soininen, Eeva/AAJ-5909-2021; Epp, Laura/AFS-1695-2022; Hassel, Kristian/AAD-7241-2022; Berteaux, Dominique/J-3276-2016; Yannick, OUTREMAN/B-9309-2012	Epp, Laura Saskia/0000-0002-2230-9477; Gussarova, Galina/0000-0001-5388-7491; Gussarova, Galina/0000-0001-5388-7491; Yoccoz, Nigel/0000-0003-2192-1039; Soininen, Eeva/0000-0003-4280-8350; Hassel, Kristian/0000-0002-1906-8166; Berteaux, Dominique/0000-0003-2728-5985; Gauthier, Gilles/0000-0002-2624-3508; Yannick, OUTREMAN/0000-0002-7337-3049	Oskar Huttunen foundation (PhD scholarship); Research Council of Norway (Leiv Eiriksson scholarship); Research Council of Norway (BarFrost project FRIBIO) [191627/V40]; University of Tromso; Natural Sciences and Engineering Research government's International Polar Year program [MD-021]; Northern Student Training Program; Canadian Network of Centres of Excellence ArcticNet; Polar Continental Shelf Program; SPYGEN	Oskar Huttunen foundation (PhD scholarship); Research Council of Norway (Leiv Eiriksson scholarship)(Research Council of Norway); Research Council of Norway (BarFrost project FRIBIO)(Research Council of Norway); University of Tromso; Natural Sciences and Engineering Research government's International Polar Year program; Northern Student Training Program; Canadian Network of Centres of Excellence ArcticNet; Polar Continental Shelf Program; SPYGEN	This work was financed by Oskar Huttunen foundation (PhD scholarship to EMS), the Research Council of Norway (Leiv Eiriksson scholarship to EMS and the BarFrost project FRIBIO 191627/V40 to CB), the University of Tromso (travel grant for EMS), the Natural Sciences and Engineering Research government's International Polar Year program (project MD-021) and the Northern Student Training Program, both administered by Indian and Northern Affairs Canada, the Canadian Network of Centres of Excellence ArcticNet and the Polar Continental Shelf Program. SPYGEN provided support in the form of a salary for author EB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Baamrane MAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035643; BATZLI GO, 1995, OIKOS, V72, P88, DOI 10.2307/3546042; BATZLI GO, 1980, ARCTIC ALPINE RES, V12, P483, DOI 10.2307/1550496; BATZLI GO, 1983, J MAMMAL, V64, P648, DOI 10.2307/1380521; BATZLI GO, 1983, HOLARCTIC ECOL, V6, P255; BERGMAN CM, 1993, CAN J ZOOL, V71, P1703, DOI 10.1139/z93-241; Bilodeau F, 2014, POLAR BIOL, V37, P845, DOI 10.1007/s00300-014-1486-x; Bilodeau F, 2013, J MAMMAL, V94, P813, DOI 10.1644/12-MAMM-A-260.1; Bilodeau F, 2013, OIKOS, V122, P1167, DOI 10.1111/j.1600-0706.2012.00220.x; Bilodeau F, 2013, OECOLOGIA, V172, P1007, DOI 10.1007/s00442-012-2549-8; Bilodeau F, 2013, ARCTIC, V66, P32; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; BRASSARD G R, 1971, Bryologist, V74, P282, DOI 10.2307/3241638; BRASSARD GR, 1976, BRYOLOGIST, V79, P480, DOI 10.2307/3241941; BRASSARD GR, 1979, LINDBERGIA, V5, P99; BROWN JS, 1989, ECOL MONOGR, V59, P1, DOI 10.2307/2937289; Darmon G, 2012, ECOGRAPHY, V35, P44, DOI 10.1111/j.1600-0587.2011.06664.x; Duchesne D, 2011, OECOLOGIA, V167, P967, DOI 10.1007/s00442-011-2045-6; Elven R., 2011, ANNOTATED CHECKLIST; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; GALINDO C, 1985, OECOLOGIA, V66, P430, DOI 10.1007/BF00378311; Gauthier G, 1996, GEOSCI CAN, V23, P253; Gauthier G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0482; Gauthier G, 2011, ECOSCIENCE, V18, P223, DOI 10.2980/18-3-3453; Gornall JL, 2007, OECOLOGIA, V153, P931, DOI 10.1007/s00442-007-0785-0; Gruyer N, 2008, CAN J ZOOL, V86, P910, DOI 10.1139/Z08-059; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HESKE EJ, 1994, ECOLOGY, V75, P438, DOI 10.2307/1939547; HUGHES RJ, 1994, J WILDLIFE MANAGE, V58, P536, DOI 10.2307/3809326; Ihl C, 2001, J WILDLIFE MANAGE, V65, P964, DOI 10.2307/3803045; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Ims RA, 2011, P NATL ACAD SCI USA, V108, P1970, DOI 10.1073/pnas.1012714108; KLEIN DR, 1994, OECOLOGIA, V97, P439, DOI 10.1007/BF00325880; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; KREBS C J, 1972, P694; Krebs CJ, 2011, P ROY SOC B-BIOL SCI, V278, P481, DOI 10.1098/rspb.2010.1992; Krebs CJ, 2003, CAN J ZOOL, V81, P827, DOI [10.1139/z03-061, 10.1139/Z03-061]; Legagneux P, 2012, ECOLOGY, V93, P1707, DOI 10.1890/11-1973.1; MACLEAN S F JR, 1974, Arctic and Alpine Research, V6, P1, DOI 10.2307/1550365; Manly B., 2002, RESOURCE SELECTION A, V2, DOI 10.1007/978-94-011-1558-2; MOEN J, 1993, ARCTIC ALPINE RES, V25, P130, DOI 10.2307/1551549; Moncrieff GR, 2014, OIKOS, V123, P315, DOI 10.1111/j.1600-0706.2013.00904.x; Morris DW, 2000, EVOL ECOL RES, V2, P41; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Olofsson J, 2012, NAT CLIM CHANGE, V2, P880, DOI 10.1038/NCLIMATE1537; Parker DM, 2006, J WILDLIFE MANAGE, V70, P1477, DOI 10.2193/0022-541X(2006)70[1477:ACOTDA]2.0.CO;2; Plante S, 2014, POLAR BIOL, V37, P611, DOI 10.1007/s00300-014-1461-6; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; PRINS HHT, 1982, OIKOS, V38, P374, DOI 10.2307/3544680; R Core Team, 2021, R LANGUAGE ENV STAT; Ravolainen VT, 2014, J APPL ECOL, V51, P234, DOI 10.1111/1365-2664.12180; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Reid DG, 2012, OECOLOGIA, V168, P935, DOI 10.1007/s00442-011-2167-x; RODGERS AR, 1986, CAN J ZOOL, V64, P2717, DOI 10.1139/z86-396; RODGERS AR, 1986, CAN J ZOOL, V64, P1684, DOI 10.1139/z86-253; RODGERS AR, 1985, CAN J ZOOL, V63, P1161, DOI 10.1139/z85-174; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Saetnan ER, 2009, J MAMMAL, V90, P183, DOI 10.1644/07-MAMM-A-259.1; SALTER KC, 1993, COMMUN STAT SIMULAT, V22, P137, DOI 10.1080/03610919308813085; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Soininen EM, 2014, ISOT ENVIRON HEALT S, V50, P361, DOI 10.1080/10256016.2014.915824; Soininen EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068128; Soininen EM, 2013, POLAR BIOL, V36, P1069, DOI 10.1007/s00300-013-1328-2; Soininen EM, 2010, POLAR RES, V29, P404, DOI 10.1111/j.1751-8369.2010.00172.x; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Soininen EM, 2012, THESIS U TROMSO TROM; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Stech M, 2011, MOL ECOL RESOUR, V11, P404, DOI 10.1111/j.1755-0998.2010.02938.x; Stenseth NC, 1993, BIOL LEMMIMGS; Sundell J, 2012, J ANIM ECOL, V81, P747, DOI 10.1111/j.1365-2656.2012.01956.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tape KD, 2012, ECOSYSTEMS, V15, P711, DOI 10.1007/s10021-012-9540-4; Tarroux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042427; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; VAVRA M, 1980, J RANGE MANAGE, V33, P371, DOI 10.2307/3897886; Virtanen R, 2000, OIKOS, V90, P295, DOI 10.1034/j.1600-0706.2000.900209.x; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Yoccoz Nigel G., 1999, Ecological Bulletins, V47, P137; Zaccarelli N, 2013, METHODS ECOL EVOL, V4, P1018, DOI 10.1111/2041-210X.12079	84	149	152	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115335	10.1371/journal.pone.0115335	http://dx.doi.org/10.1371/journal.pone.0115335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635852	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700007
J	Assenzio, B; Martin, EL; Stankevicius, E; Civiletti, F; Fontanella, M; Boccaletti, R; Berardino, M; Mazzeo, A; Ducati, A; Simonsen, U; Mascia, L				Assenzio, Barbara; Martin, Erica L.; Stankevicius, Edgaras; Civiletti, Federica; Fontanella, Marco; Boccaletti, Riccardo; Berardino, Maurizio; Mazzeo, AnnaTeresa; Ducati, Alessandro; Simonsen, Ulf; Mascia, Luciana			Cerebrospinal Fluid from Patients with Subarachnoid Haemorrhage and Vasospasm Enhances Endothelin Contraction in Rat Cerebral Arteries	PLOS ONE			English	Article							RECEPTOR ANTAGONIST; ETA-RECEPTOR; DOUBLE-BLIND; B-RECEPTOR; CEREBROVASCULAR CHARACTERIZATION; SMOOTH-MUSCLE; UP-REGULATION; CLAZOSENTAN; EXPRESSION; MECHANISMS	Introduction Previous studies have suggested that cerebrospinal fluid from patients with subarachnoid hemorrhage (SAH) leads to pronounced vasoconstriction in isolated arteries. We hypothesized that only cerebrospinal fluid from SAH patients with vasospasm would produce an enhanced contractile response to endothelin-1 in rat cerebral arteries, involving both endothelin ETA and ETB receptors. Methods Intact rat basilar arteries were incubated for 24 hours with cerebrospinal fluid from 1) SAH patients with vasospasm, 2) SAH patients without vasospasm, and 3) control patients. Arterial segments with and without endothelium were mounted in myographs and concentration-response curves for endothelin-1 were constructed in the absence and presence of selective and combined ETA and ETB receptor antagonists. Endothelin concentrations in culture medium and receptor expression were measured. Results Compared to the other groups, the following was observed in arteries exposed to cerebrospinal fluid from patients with vasospasm: 1) larger contractions at lower endothelin concentrations (p < 0.05); 2) the increased endothelin contraction was absent in arteries without endothelium; 3) higher levels of endothelin secretion in the culture medium (p < 0.05); 4) there was expression of ETA receptors and new expression of ETB receptors was apparent; 5) reduction in the enhanced response to endothelin after ETB blockade in the low range and after ETA blockade in the high range of endothelin concentrations; 6) after combined ETA and ETB blockade a complete inhibition of endothelin contraction was observed. Conclusions Our experimental findings showed that in intact rat basilar arteries exposed to cerebrospinal fluid from patients with vasospasm endothelin contraction was enhanced in an endothelium-dependent manner and was blocked by combined ETA and ETB receptor antagonism. Therefore we suggest that combined blockade of both receptors may play a role in counteracting vasospasm in patients with SAH.	[Assenzio, Barbara; Martin, Erica L.; Civiletti, Federica; Berardino, Maurizio; Mazzeo, AnnaTeresa; Mascia, Luciana] Univ Turin, Azienda Osped Citta Salute & Sci Torino, Dept Anesthesia & Intens Care, Turin, Italy; [Stankevicius, Edgaras] Lithuanian Univ Hlth Sci, Med Acad, Inst Physiol & Pharmacol, Kaunas, Lithuania; [Fontanella, Marco; Boccaletti, Riccardo; Ducati, Alessandro] Univ Turin, Azienda Osped Citta Salute & Sci Torino, Dept Neurosci, Div Neurosurg, Turin, Italy; [Simonsen, Ulf] Univ Aarhus, Dept Biomed Pulm & Cardiovasc Pharmacol, Aarhus, Denmark	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Lithuanian University of Health Sciences; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Aarhus University	Mascia, L (corresponding author), Univ Turin, Azienda Osped Citta Salute & Sci Torino, Dept Anesthesia & Intens Care, Turin, Italy.	luciana.mascia@unito.it	FONTANELLA, Marco Maria/AAD-1160-2022; mascia, Luciana/L-3039-2018	FONTANELLA, Marco Maria/0000-0002-4023-1909; Conte, Erica/0000-0002-2699-9591; Mazzeo, Anna Teresa/0000-0002-8454-7243; Fontanella, Marco/0000-0002-2084-0504; BOCCALETTI, Riccardo/0000-0002-9327-6393	Comitato Interministeriale per al Programmazione Economica [CIPE LM2004]; Ministero della Salute, Programma Ricerca Finalizzata [LM2007]	Comitato Interministeriale per al Programmazione Economica; Ministero della Salute, Programma Ricerca Finalizzata	This study was supported by grant CIPE LM2004 from the Comitato Interministeriale per al Programmazione Economica and grant LM2007 from the Ministero della Salute, Programma Ricerca Finalizzata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Beg SS, 2007, J CEREBR BLOOD F MET, V27, P21, DOI 10.1038/sj.jcbfm.9600313; CLOZEL M, 1992, BIOCHEM BIOPH RES CO, V186, P867, DOI 10.1016/0006-291X(92)90826-7; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; De Mey JGR, 2011, TRENDS PHARMACOL SCI, V32, P345, DOI 10.1016/j.tips.2011.02.018; DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Fontanella M, 2008, NEUROL RES, V30, P256, DOI 10.1179/016164107X229939; Hansen-Schwartz J, 2004, ACTA NEUROL SCAND, V109, P33, DOI 10.1034/j.1600-0404.2003.00170.x; Hansen-Schwartz J, 2003, NEUROSURGERY, V52, P1188, DOI 10.1227/01.NEU.0000058467.82442.64; Henriksson M, 2003, STROKE, V34, P1479, DOI 10.1161/01.STR.0000072984.79136.79; Henriksson M, 2007, EXP BRAIN RES, V178, P470, DOI 10.1007/s00221-006-0753-7; Hino A, 1996, J CEREBR BLOOD F MET, V16, P688, DOI 10.1097/00004647-199607000-00020; ITOH S, 1994, J NEUROSURG, V81, P759, DOI 10.3171/jns.1994.81.5.0759; Kikkawa Y, 2012, J CEREBR BLOOD F MET, V32, P341, DOI 10.1038/jcbfm.2011.132; Konczalla J, 2006, EXP BIOL MED, V231, P1064; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Macdonald RL, 2012, RANDOMIZED TRIAL CLA; Maddahi A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-274; MASAOKA H, 1989, LANCET, V2, P1402; Mascia L, 2003, INTENS CARE MED, V29, P1088, DOI 10.1007/s00134-003-1780-5; Mascia L, 2001, STROKE, V32, P1185, DOI 10.1161/01.STR.32.5.1185; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nishizawa S, 2005, TRENDS CARDIOVAS MED, V15, P24, DOI 10.1016/j.tcm.2004.12.002; Ogihara K, 2000, NEUROL RES, V22, P209, DOI 10.1080/01616412.2000.11741063; OKWUASABA FK, 1981, NEUROSURGERY, V9, P402, DOI 10.1227/00006123-198110000-00010; Pluta RM, 1997, J NEUROSURG, V87, P287, DOI 10.3171/jns.1997.87.2.0287; Rapoport RM, 2011, J PHARM PHARMACOL, V63, P1373, DOI 10.1111/j.2042-7158.2011.01334.x; Sauvageau S, 2007, J VASC RES, V44, P375, DOI 10.1159/000102534; Shaw MDM, 2000, J NEUROSURG, V93, P992, DOI 10.3171/jns.2000.93.6.0992; Vajkoczy P, 2005, J NEUROSURG, V103, P9, DOI 10.3171/jns.2005.103.1.0009; Vanhoutte PM, 2008, J PHYSIOL-LONDON, V586, P5295, DOI 10.1113/jphysiol.2008.161430; Vatter H, 2005, J NEUROSURG, V102, P1101, DOI 10.3171/jns.2005.102.6.1101; Vatter H, 2005, J NEUROSURG, V102, P1108, DOI 10.3171/jns.2005.102.6.1108; Vatter H, 2007, J NEUROSURG, V107, P121, DOI 10.3171/JNS-07/07/0121; Vergouwen MDI, 2012, STROKE, V43, P2671, DOI 10.1161/STROKEAHA.112.666693; Walchenbach R, 2002, J NEUROL NEUROSUR PS, V72, P503; Xie A, 2007, J CEREBR BLOOD F MET, V27, P1692, DOI 10.1038/sj.jcbfm.9600471; Zuccarello M, 1998, STROKE, V29, P1924, DOI 10.1161/01.STR.29.9.1924	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116456	10.1371/journal.pone.0116456	http://dx.doi.org/10.1371/journal.pone.0116456			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629621	Green Submitted, gold, Green Published			2022-12-26	WOS:000348732100037
J	Qin, LJ; Lei, MZ; Zhao, DD; Wang, AH; Jin, YP; Qi, XF				Qin, Lijuan; Lei, Mingzhu; Zhao, Dandan; Wang, Aihua; Jin, Yaping; Qi, Xuefeng			Goat Uterine DBA(+) Leukocytes Differentiation and Cytokines Expression Respond Differently to Cloned versus Fertilized Embryos	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; STROMAL CELLS; PROGESTERONE; ENDOMETRIUM; PREGNANCY; MODULATE; SUBSETS; GROWTH	High rate of fetal mortality in ruminant somatic cell nuclear transfer (SCNT) pregnancies is due, at least in part, to immune-mediated abortion of fetuses. In the present study, goat uterine leukocytes were isolated by Dolichos biflorus agglutinin (DBA) coated magnetic beads, and with majority being were CD56(+)CD16(-) in phenotype with low levels of perforin and Granzyme B expression. The responses of the isolated cells to SCNT and in vitro fertilization (IVF) embryos conditioned mediums containing hormone steroids were compared by measuring their phenotype and cytokines expression. The results showed there was a 2-fold increase in the numbers of isolated uterine leukocytes after incubation with different conditioned mediums for 120 h. However, significantly lower percentage and absolute numbers of uterine CD56(+)CD16(-) leukocytes incubated with SCNT conditioned mediums were detected as compared with those incubated with IVF conditioned mediums (P < 0.05). The group treated with progesterone (P-4) or the combination of P-4 and 17 beta-estradiol (E-2) were associated with significantly higher percentage and absolute numbers of CD56(+)CD16(-) cells as compared with those treated with E-2 alone (P < 0.05). Furthermore, in the presence of steroids, the isolated leukocytes incubated with SCNT conditioned mediums associated with greater levels of IFN-gamma secretion and expression, as well as lesser levels of VEGF, as compared with those treated with IVF conditioned mediums (P < 0.05). In conclusion, this study demonstrates that SCNT embryos have a profound effect on the phenotype expression of goat uterine DBA(+) leukocytes, as well as the secretion and expression of IFN-gamma and VEGF by these cells in vitro.	[Qin, Lijuan; Lei, Mingzhu; Zhao, Dandan; Wang, Aihua; Jin, Yaping; Qi, Xuefeng] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Peoples R China	Northwest A&F University - China	Qi, XF (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Peoples R China.	yxyan2002@163.com			National Natural Science Foundation of China [30901089]; Fundamental Research Funds for the Central Universities of China [ZD2013008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was financially supported by National Natural Science Foundation of China (Grant No. 30901089) and the Fundamental Research Funds for the Central Universities of China (Grant No. ZD2013008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2013, ANIM SCI J, V84, P191, DOI 10.1111/asj.12035; Amold DR, 2008, PLACENTA, V29, pS108, DOI 10.1016/j.placenta.2007.11.010; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Bizinotto MC, 2008, J REPROD IMMUNOL, V79, P18, DOI 10.1016/j.jri.2008.07.002; Bridges GA, 2013, J ANIM SCI IN PRESS; Campos DB, 2010, GENET MOL RES, V9, P309, DOI 10.4238/vol9-1gmr729; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Chen ZL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102293; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Croy BA, 2006, IMMUNOL REV, V214, P161; Croy BA, 2010, METHODS MOL BIOL, V612, P465, DOI 10.1007/978-1-60761-362-6_31; Davies CJ, 2007, J ANIM SCI, V85, pE32, DOI 10.2527/jas.2006-492; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Fukui A, 2011, J REPROD IMMUNOL, V90, P105, DOI 10.1016/j.jri.2011.04.006; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; Hansen PJ, 2007, J ANIM SCI, V85, pE30, DOI 10.2527/jas.2006-487; Hill JR, 2002, BIOL REPROD, V67, P55, DOI 10.1095/biolreprod67.1.55; Jonsson AH, 2010, J IMMUNOL, V184, P3424, DOI 10.4049/jimmunol.0904057; Kieckbusch J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4359; Kim M, 2013, EMBO MOL MED, V5, P1415, DOI 10.1002/emmm.201302618; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kohan-Ghadr HR, 2012, REPROD FERT DEVELOP, V24, P588, DOI 10.1071/RD11162; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065379; Mamo S, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099945; Ni F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2484; Noronha LE, 2012, PLACENTA, V33, P379, DOI 10.1016/j.placenta.2012.01.018; Perez-Martinez M, 2002, RES VET SCI, V72, P115, DOI 10.1053/rvsc.2001.0532; Qi XF, 2012, DOMEST ANIM ENDOCRIN, V42, P210, DOI 10.1016/j.domaniend.2011.12.004; Qi XF, 2012, REPROD BIOL, V12, P309, DOI 10.1016/j.repbio.2012.09.003; Rutella S, 2006, BLOOD, V108, P218, DOI 10.1182/blood-2005-08-3141; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Segerson EC, 2000, THERIOGENOLOGY, V54, P1207, DOI 10.1016/S0093-691X(00)00427-1; St-Louis I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-103; Zhang HD, 2013, THERIOGENOLOGY, V80, P228, DOI 10.1016/j.theriogenology.2013.03.027	35	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116649	10.1371/journal.pone.0116649	http://dx.doi.org/10.1371/journal.pone.0116649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629615	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100045
J	Thomas, O; Lybeck, E; Strandberg, K; Tynngard, N; Schott, U				Thomas, Owain; Lybeck, Emanuel; Strandberg, Karin; Tynngard, Nahreen; Schott, Ulf			Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays	PLOS ONE			English	Article							PARTIAL THROMBOPLASTIN TIME; IN-VITRO; SENSITIVITY; FONDAPARINUX; ENOXAPARIN; REAGENTS; DOSAGE; LMWH	Background Low molecular weight heparins (LMWH's) are used to prevent and treat thrombosis. Tests for monitoring LMWH's include anti-factor Xa (anti-FXa), activated partial thromboplastin time (aPTT) and thrombin generation. Anti-FXa is the current gold standard despite LMWH's varying affinities for FXa and thrombin. Aim To examine the effects of two different LMWH's on the results of 4 different aPTT-tests, anti-FXa activity and thrombin generation and to assess the tests' concordance. Method Enoxaparin and tinzaparin were added ex-vivo in concentrations of 0.0, 0.5, 1.0 and 1.5 anti-FXa international units (IU)/mL, to blood from 10 volunteers. aPTT was measured using two whole blood methods (Free oscillation rheometry (FOR) and Hemochron Jr (HCJ)) and an optical plasma method using two different reagents (ActinFSL and PTT-Automat). Anti-FXa activity was quantified using a chromogenic assay. Thrombin generation (Endogenous Thrombin Potential, ETP) was measured on a Ceveron Alpha instrument using the TGA RB and more tissue-factor rich TGA RC reagents. Results Methods' mean aPTT at 1.0 IU/mL LMWH varied between 54s (SD 11) and 69s (SD 14) for enoxaparin and between 101s (SD 21) and 140s (SD 28) for tinzaparin. ActinFSL gave significantly shorter aPTT results. aPTT and anti-FXa generally correlated well. ETP as measured with the TGA RC reagent but not the TGA RB reagent showed an inverse exponential relationship to the concentration of LMWH. The HCJ-aPTT results had the weakest correlation to anti-FXa and thrombin generation (R(s)0.62-0.87), whereas the other aPTT methods had similar correlation coefficients (R(s)0.80-0.92). Conclusions aPTT displays a linear dose-respone to LMWH. There is variation between aPTT assays. Tinzaparin increases aPTT and decreases thrombin generation more than enoxaparin at any given level of anti-FXa activity, casting doubt on anti-FXa's present gold standard status. Thrombin generation with tissue factor-rich activator is a promising method for monitoring LMWH's.	[Thomas, Owain; Lybeck, Emanuel; Strandberg, Karin; Schott, Ulf] Lund Univ, Fac Med, Lund, Sweden; [Thomas, Owain] SUS Lund Univ Hosp, Dept Paediat Anaesthesia & Intens Care, Lund, Sweden; [Strandberg, Karin] Skane Univ Hosp, Div Lab Med, Coagulat Lab, Dept Clin Chem, Malmo, Sweden; [Tynngard, Nahreen] Linkoping Univ, Dept Clin Immunol & Transfus Med, Dept Clin & Expt Med, Linkoping, Sweden; [Tynngard, Nahreen] Linkoping Univ, Dept Clin Chem, Dept Clin Expt Med, Linkoping, Sweden; [Schott, Ulf] SUS Lund Univ Hosp, Dept Anaesthesia & Intens Care, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Linkoping University; Linkoping University	Thomas, O (corresponding author), Lund Univ, Fac Med, Lund, Sweden.	odt@cantab.net	Thomas, Owain/I-6495-2018; Thomas, Owain D/E-2555-2014; Strandberg, Karin/AAW-2777-2021; Schott, Ulf/AAY-6982-2020	Thomas, Owain/0000-0003-2515-6581; Thomas, Owain D/0000-0003-2515-6581; Strandberg, Karin/0000-0001-5554-6631; Tynngard, Nahreen/0000-0001-8591-6074	Medical Faculty, University of Lund; Regional medical research grant, Region Skane ALF	Medical Faculty, University of Lund; Regional medical research grant, Region Skane ALF	1. Medical Faculty, University of Lund. Funding for EL's research term. www.med.lu.se. 2. Regional medical research grant, Region Skane ALF. http://www.skane.se/sv/Webbplatser/FoU-samlingsnod/Forsknings-_och_utvecklingsenheten/Arbetsomraden/ALF_Avtal_om_Lakarutbildning_och_Forskning/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dieri R, 2006, J THROMB HAEMOST, V4, P83, DOI 10.1111/j.1538-7836.2005.01672.x; Al Dieri R, 2004, J THROMB HAEMOST, V2, P1395, DOI 10.1111/j.1538-7836.2004.00798.x; Alban S, 2002, SEMIN THROMB HEMOST, V28, P369, DOI 10.1055/s-2002-34306; Andrassy K, 1996, THROMB RES, V81, pS29, DOI 10.1016/0049-3848(95)00227-8; BENCHEKROUN S, 1986, EUR J CLIN INVEST, V16, P536, DOI 10.1111/j.1365-2362.1986.tb02174.x; Gerotziafas GT, 2007, J THROMB HAEMOST, V5, P955, DOI 10.1111/j.1538-7836.2007.02477.x; Gionis MN, 2013, THROMB RES, V132, P685, DOI 10.1016/j.thromres.2013.09.037; Gouin-Thibault I, 2005, DRUG SAFETY, V28, P333, DOI 10.2165/00002018-200528040-00005; Greaves M, 2002, THROMB HAEMOSTASIS, V87, P163; Hainer JW, 2002, THROMB HAEMOSTASIS, V87, P817; Harris LF, 2010, TALANTA, V81, P1725, DOI 10.1016/j.talanta.2010.03.030; Ip BKH, 2001, PATHOLOGY, V33, P347; Kamal AH, 2007, MAYO CLIN PROC, V82, P864, DOI 10.4065/82.7.864; Kitchen S, 1996, J CLIN PATHOL, V49, P10, DOI 10.1136/jcp.49.1.10; Linkins LA, 2002, THROMB RES, V107, P241, DOI 10.1016/S0049-3848(02)00340-7; Meysman Marc, 2005, Curr Treat Options Cardiovasc Med, V7, P483, DOI 10.1007/s11936-005-0034-y; Sanfelippo MJ, 2009, AM J CLIN PATHOL, V132, P608, DOI 10.1309/AJCPA8KNNLLCV4JI; Shi XB, 2013, CHINESE MED J-PEKING, V126, P3553, DOI 10.3760/cma.j.issn.0366-6999.20131580; Sibbing D, 2014, HAMOSTASEOLOGIE, V34, P78, DOI 10.5482/HAMO-13-11-0055; Takemoto CM, 2013, AM J CLIN PATHOL, V139, P450, DOI 10.1309/AJCPS6OW6DYNOGNH; VERMYLEN CG, 1987, KIDNEY INT, V31, P1396, DOI 10.1038/ki.1987.155; White RH, 2003, BRIT J HAEMATOL, V121, P12, DOI 10.1046/j.1365-2141.2003.04196.x	22	44	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116835	10.1371/journal.pone.0116835	http://dx.doi.org/10.1371/journal.pone.0116835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625201	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821400018
J	Cui, YH; Suh, Y; Lee, HJ; Yoo, KC; Uddin, N; Jeong, YJ; Lee, JS; Hwang, SG; Nam, SY; Kim, MJ; Lee, SJ				Cui, Y-H; Suh, Y.; Lee, H-J; Yoo, K-C; Uddin, N.; Jeong, Y-J; Lee, J-S; Hwang, S-G; Nam, S-Y; Kim, M-J; Lee, S-J			Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; FACTOR G-CSF; SIGNALING PATHWAY; GM-CSF; FEEDBACK LOOP; BETA-CATENIN; METASTASIS; ACTIVATION; CARCINOMA	Despite ionizing radiation (IR) is being widely used as a standard treatment for lung cancer, many evidences suggest that IR paradoxically promotes cancer malignancy. However, its molecular mechanisms underlying radiation-induced cancer progression remain obscure. Here, we report that exposure to fractionated radiation (2 Gy per day for 3 days) induces the secretion of granulocyte-colony-stimulating factor (G-CSF) that has been commonly used in cancer therapies to ameliorate neutropenia. Intriguingly, radiation-induced G-CSF promoted the migratory and invasive properties by triggering the epithelial-mesenchymal cell transition (EMT) in non-small-cell lung cancer cells (NSCLCs). By irradiation, G-CSF was upregulated transcriptionally by beta-catenin/TCF4 complex that binds to the promoter region of G-CSF as a transcription factor. Importantly, irradiation increased the stability of beta-catenin through the activation of PI3K/AKT (phosphatidylinositol 3-kinase/AKT), thereby upregulating the expression of G-CSF. Radiation-induced G-CSF is recognized by G-CSFR and transduced its intracellular signaling JAK/STAT3 (Janus kinase/ signal transducers and activators of transcription), thereby triggering EMT program in NSCLCs. Taken together, our findings suggest that the application of G-CSF in cancer therapies to ameliorate neutropenia should be reconsidered owing to its effect on cancer progression, and G-CSF could be a novel therapeutic target to mitigate the harmful effect of radiotherapy for the treatment of NSCLC.	[Cui, Y-H; Suh, Y.; Yoo, K-C; Uddin, N.; Lee, S-J] Hanyang Univ, Lab Mol Biochem, Dept Life Sci, Res Inst Nat Sci, Seoul 133791, South Korea; [Lee, H-J; Jeong, Y-J] Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul 139706, South Korea; [Lee, J-S] Sungkyunkwan Univ, Dept Biol Sci, Coll Sci, Suwon, South Korea; [Hwang, S-G] Korea Inst Radiol & Med Sci, Div Radiat Canc Biol, Seoul 139706, South Korea; [Nam, S-Y] Korea Hydro & Nucl Power Co Ltd, Radiat Hlth Inst, Seoul, South Korea; [Kim, M-J] Korea Inst Radiol & Med Sci, Lab Radiat Exposure & Therapeut, Natl Radiat Emergency Med Ctr, Seoul 139706, South Korea	Hanyang University; Korea Institute of Radiological & Medical Sciences; Sungkyunkwan University (SKKU); Korea Institute of Radiological & Medical Sciences; Korea Hydro & Nuclear Power; Korea Institute of Radiological & Medical Sciences	Kim, MJ (corresponding author), Korea Inst Radiol & Med Sci, Lab Radiat Exposure & Therapeut, Natl Radiat Emergency Med Ctr, Seoul 139706, South Korea.	kimmj74@kirams.re.kr; sj0420@hanyang.ac.kr	Lee, Jae-Seong/H-6013-2015; Cui, Yanhong/ABB-1148-2021	Lee, Jae-Seong/0000-0003-0944-5172; Cui, Yanhong/0000-0002-4169-6521; Ud Din, Nizam/0000-0002-9845-3109	National Research Foundation (NRF); Ministry of Science, ICT and Future Planning, Korean Government, through its National Nuclear Technology Program [2012M2A2A7035878]; Ministry of Trade, Industry and Energy [20131610101840]	National Research Foundation (NRF); Ministry of Science, ICT and Future Planning, Korean Government, through its National Nuclear Technology Program; Ministry of Trade, Industry and Energy	This work was supported by the National Research Foundation (NRF) and Ministry of Science, ICT and Future Planning, Korean Government, through its National Nuclear Technology Program (2012M2A2A7035878), and the Ministry of Trade, Industry and Energy (Grant No: 20131610101840).	Acosta JC, 2012, TRENDS CELL BIOL, V22, P211, DOI 10.1016/j.tcb.2011.11.006; Bernier J, 2004, NAT REV CANCER, V4, P737, DOI 10.1038/nrc1451; BURGESS AW, 1980, BLOOD, V56, P947; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DALE DC, 1995, J INFECT DIS, V172, P1061, DOI 10.1093/infdis/172.4.1061; DEMETRI GD, 1991, BLOOD, V78, P2791; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Dirks PB, 2008, J CLIN ONCOL, V26, P2916, DOI 10.1200/JCO.2008.17.6792; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Jiang RC, 2011, MOL DIAGN THER, V15, P347, DOI 10.2165/11599190-000000000-00000; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Kawamoto A, 2012, ONCOL REP, V27, P51, DOI 10.3892/or.2011.1485; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310; Liu W, 2014, LAB INVEST, V94, P362, DOI 10.1038/labinvest.2013.153; Looyenga BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030820; Marino VJ, 2008, J CELL BIOCHEM, V103, P1512, DOI 10.1002/jcb.21542; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; Mroczko B, 2004, CLIN CHEM LAB MED, V42, P1347, DOI 10.1515/CCLM.2004.253; Mroczko B, 2000, POL ARCH MED WEWN, V103, P163; Multhoff G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00058; Novak U, 1996, GROWTH FACTORS, V13, P251, DOI 10.3109/08977199609003226; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Ross GM, 1999, ENDOCR-RELAT CANCER, V6, P41, DOI 10.1677/erc.0.0060041; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Squatrito M, 2010, CANCER CELL, V18, P619, DOI 10.1016/j.ccr.2010.10.034; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Teramachi M, 1992, Nihon Kyobu Shikkan Gakkai Zasshi, V30, P1327; Uemura Y, 2004, INT J CANCER, V109, P826, DOI 10.1002/ijc.20023; Uemura Y, 2007, ONCOL REP, V17, P955; Uemura Y, 2006, INT J MOL MED, V18, P365; Wang WC, 2011, J CELL BIOCHEM, V112, P1544, DOI 10.1002/jcb.23067; Wang ZW, 2010, CURR DRUG TARGETS, V11, P745, DOI 10.2174/138945010791170860; Watanabe M, 1998, JPN J CLIN ONCOL, V28, P559, DOI 10.1093/jjco/28.9.559; Wendt Michael K, 2014, JAKSTAT, V3, pe28975, DOI 10.4161/jkst.28975; Yan S, 2013, INT J ONCOL, V42, P1801, DOI 10.3892/ijo.2013.1852; YOUNG MRI, 1994, INT J CANCER, V56, P446, DOI 10.1002/ijc.2910560327; Zhang JN, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-7	42	44	48	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 16	2015	34	42					5372	5382		10.1038/onc.2014.466	http://dx.doi.org/10.1038/onc.2014.466			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EI	25639867				2022-12-26	WOS:000363479200007
J	Belogurov, A; Kuzina, E; Kudriaeva, A; Kononikhin, A; Kovalchuk, S; Surina, Y; Smirnov, I; Lomakin, Y; Bacheva, A; Stepanov, A; Karpova, Y; Lyupina, Y; Kharybin, O; Melamed, D; Ponomarenko, N; Sharova, N; Nikolaev, E; Gabibov, A				Belogurov, Alexey, Jr.; Kuzina, Ekaterina; Kudriaeva, Anna; Kononikhin, Alexey; Kovalchuk, Sergey; Surina, Yelena; Smirnov, Ivan; Lomakin, Yakov; Bacheva, Anna; Stepanov, Alexey; Karpova, Yaroslava; Lyupina, Yulia; Kharybin, Oleg; Melamed, Dobroslav; Ponomarenko, Natalia; Sharova, Natalia; Nikolaev, Eugene; Gabibov, Alexander			Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity	FASEB JOURNAL			English	Article						immunoproteasome; antigen presentation; oligodendrocytes; experimental autoimmune encephalomyelitis; multiple sclerosis	CD8(+) T-CELLS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; PEPTIDE; IMMUNOPROTEASOMES; OLIGODENDROCYTES; PROTEASOMES; INHIBITORS; COMPLEX; ANTIGEN	Recent findings indicate that the ubiquitin-proteasome system is involved in the pathogenesis of cancer as well as autoimmune and several neurodegenerative diseases, and is thus a target for novel therapeutics. One disease that is related to aberrant protein degradation is multiple sclerosis, an autoimmune disorder involving the processing and presentation of myelin autoantigens that leads to the destruction of axons. Here, we show that brain-derived proteasomes from SJL mice with experimental autoimmune encephalomyelitis (EAE) in an ubiquitin-independent manner generate significantly increased amounts of myelin basic protein peptides that induces cytotoxic lymphocytes to target mature oligodendrocytes ex vivo. Ten times enhanced release of immunogenic peptides by cerebral proteasomes from EAE-SJL mice is caused by a dramatic shift in the balance between constitutive and beta 1i(high) immunoproteasomes in the CNS of SJL mice with EAE. We found that during EAE, beta 1i is increased in resident CNS cells, whereas beta 5i is imported by infiltrating lymphocytes through the blood-brain barrier. Peptidyl epoxyketone specifically inhibits brain-derived beta 1i(high) immunoproteasomes in vitro (k(obs)/[I] = 240 M(-1)s(-1)), and at a dose of 0.5 mg/kg, it ameliorates ongoing EAE in vivo. Therefore, our findings provide novel insights into myelin metabolism in pathophysiologic conditions and reveal that the beta 1i subunit of the immunoproteasome is a potential target to treat autoimmune neurologic diseases.	[Belogurov, Alexey, Jr.; Kuzina, Ekaterina; Kudriaeva, Anna; Kovalchuk, Sergey; Surina, Yelena; Smirnov, Ivan; Lomakin, Yakov; Stepanov, Alexey; Ponomarenko, Natalia; Gabibov, Alexander] Russian Acad Sci, Inst Bioorgan Chem, Moscow 117871, Russia; [Belogurov, Alexey, Jr.; Smirnov, Ivan] Kazan Fed Univ, Kazan, Republic Of Tat, Russia; [Belogurov, Alexey, Jr.; Gabibov, Alexander] Russian Acedemy Sci, Inst Gene Biol, Moscow, Russia; [Kuzina, Ekaterina; Smirnov, Ivan; Bacheva, Anna; Gabibov, Alexander] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Kononikhin, Alexey; Nikolaev, Eugene] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Kononikhin, Alexey; Nikolaev, Eugene] Russian Acad Sci, Inst Energy Problems Chem Phys, Moscow 117871, Russia; [Kovalchuk, Sergey] Res Inst Physicochem Med, Moscow, Russia; [Karpova, Yaroslava; Lyupina, Yulia; Kharybin, Oleg; Sharova, Natalia] Russian Acad Sci, Inst Dev Biol, Moscow 117871, Russia; [Nikolaev, Eugene] Russian Acad Med Sci, Inst Biomed Chem, Moscow, Russia; [Melamed, Dobroslav] Assaf Harofeh Med Ctr, IL-70300 Zerifin, Israel	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Kazan Federal University; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University; Moscow Institute of Physics & Technology; Russian Academy of Sciences; N.N. Semenov Federal Research Centre for Chemical Physics, Russian Academy of Sciences; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Shamir Medical Center (Assaf Harofeh); Tel Aviv University	Gabibov, A (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, V-437, Moscow 117871, Russia.	gabibov@mx.ibch.ru	Kovalchuk, Sergey I/J-3247-2014; Sharova, Natalia P/B-8361-2014; Lomakin, Yakov/ABF-7470-2020; Smirnov, Ivan/N-5635-2017; Kudriaeva, Anna/P-5893-2017; Nikolaev, Eugene N/N-4498-2013; Lomakin, Yakov/F-9700-2017; Bacheva, Anna/J-7128-2012; Kononikhin, Alexey/L-3171-2013; Stepanov, Alexey/AAN-8721-2020; Belogurov, Alexey/L-5859-2017; Lyupina, Yulia V/B-8365-2014; Stepanov, Aleksey L/L-5856-2017; Kharybin, Oleg/E-1730-2016	Kovalchuk, Sergey I/0000-0001-5273-3431; Lomakin, Yakov/0000-0002-3514-5395; Smirnov, Ivan/0000-0002-0384-6568; Kudriaeva, Anna/0000-0003-1163-9929; Nikolaev, Eugene N/0000-0001-6209-2068; Lomakin, Yakov/0000-0002-3514-5395; Bacheva, Anna/0000-0002-2169-211X; Stepanov, Alexey/0000-0003-1616-4408; Belogurov, Alexey/0000-0002-2033-9621; Lyupina, Yulia V/0000-0002-9903-3544; Stepanov, Aleksey L/0000-0002-2481-2631; Kuzina, Ekaterina/0000-0002-5468-0262; Kharybin, Oleg/0000-0002-5656-0862	Russian Scientific Foundation project "Molecular mechanism and physiologic significance of the ubiquitin-independent proteasomal degradation of the proteins" [14-14-00585]; Russian Foundation for Basic Research Grant [13-04-40277-H];  [CII 2445.2013.4]	Russian Scientific Foundation project "Molecular mechanism and physiologic significance of the ubiquitin-independent proteasomal degradation of the proteins"(Russian Science Foundation (RSF)); Russian Foundation for Basic Research Grant(Russian Foundation for Basic Research (RFBR)); 	The reported study was performed under the frame of Russian Scientific Foundation project Grant 14-14-00585 "Molecular mechanism and physiologic significance of the ubiquitin-independent proteasomal degradation of the proteins," partially supported by Russian Foundation for Basic Research Grant 13-04-40277-H and Fellowship CII 2445.2013.4 (to A.B.). The work was performed according to the Russian Government Program of Competitive Growth of Kazan Federal University.	ARRIGO AP, 1988, NATURE, V331, P192, DOI 10.1038/331192a0; Basler M, 2012, J IMMUNOL, V189, P1868, DOI 10.4049/jimmunol.1103592; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Belogurov AA, 2013, FASEB J, V27, P222, DOI 10.1096/fj.12-213975; Belogurov A, 2014, J BIOL CHEM, V289, P17758, DOI 10.1074/jbc.M113.544247; Belogurov A, 2009, BIOESSAYS, V31, P1161, DOI 10.1002/bies.200900020; Berthelot L, 2008, EUR J IMMUNOL, V38, P1889, DOI 10.1002/eji.200838023; Cardozo C, 1998, J BIOL CHEM, V273, P16764, DOI 10.1074/jbc.273.27.16764; Caudill CM, 2006, J IMMUNOL, V176, P4075, DOI 10.4049/jimmunol.176.7.4075; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Fissolo N, 2009, MOL CELL PROTEOMICS, V8, P2090, DOI 10.1074/mcp.M900001-MCP200; Frausto RF, 2007, J NEUROIMMUNOL, V192, P124, DOI 10.1016/j.jneuroim.2007.09.024; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Gardner RC, 2000, BIOCHEM J, V346, P447, DOI 10.1042/0264-6021:3460447; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Groll M, 2006, P NATL ACAD SCI USA, V103, P4576, DOI 10.1073/pnas.0600647103; Guillaume B, 2010, P NATL ACAD SCI USA, V107, P18599, DOI 10.1073/pnas.1009778107; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Hensley SE, 2010, J IMMUNOL, V184, P4115, DOI 10.4049/jimmunol.0903003; Ho YK, 2007, CHEM BIOL, V14, P419, DOI 10.1016/j.chembiol.2007.03.008; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Jurewicz A, 1998, J IMMUNOL, V160, P3056; Kuzina ES, 2013, DOKL BIOCHEM BIOPHYS, V453, P300, DOI 10.1134/S1607672913060070; LAATSCH RH, 1962, J EXP MED, V115, P777, DOI 10.1084/jem.115.4.777; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; MARTIN R, 1991, J EXP MED, V173, P19, DOI 10.1084/jem.173.1.19; Mishto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009287; Moebius J, 2010, EUR J IMMUNOL, V40, P3439, DOI 10.1002/eji.201040620; Na SY, 2008, BRAIN, V131, P2353, DOI 10.1093/brain/awn148; Na SY, 2012, IMMUNITY, V37, P134, DOI 10.1016/j.immuni.2012.04.009; Nathan JA, 2013, CELL, V152, P1184, DOI 10.1016/j.cell.2013.01.037; OKSENBERG JR, 1993, NATURE, V362, P68, DOI 10.1038/362068a0; PANITCH HS, 1987, LANCET, V1, P893; PETTE M, 1990, P NATL ACAD SCI USA, V87, P7968, DOI 10.1073/pnas.87.20.7968; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Raule M, 2014, BBA-MOL CELL RES, V1843, P1942, DOI 10.1016/j.bbamcr.2014.05.005; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Schmidtke G, 1998, J EXP MED, V187, P1641, DOI 10.1084/jem.187.10.1641; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Sobottka B, 2009, AM J PATHOL, V175, P1160, DOI 10.2353/ajpath.2009.090340; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; WEBB C, 1974, LANCET, V2, P66; Zheng JZ, 2012, J NEUROCHEM, V121, P486, DOI 10.1111/j.1471-4159.2012.07699.x	49	32	36	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1901	1913		10.1096/fj.14-259333	http://dx.doi.org/10.1096/fj.14-259333			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25634956	Green Published, hybrid			2022-12-26	WOS:000354114600025
J	Wu, HW; Gong, WB; Yao, XZ; Wang, JF; Perrett, S; Feng, YG				Wu, Huiwen; Gong, Weibin; Yao, Xingzhe; Wang, Jinfeng; Perrett, Sarah; Feng, Yingang			Evolutionarily Conserved Binding of Translationally Controlled Tumor Protein to Eukaryotic Elongation Factor 1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTAMINE-RELEASING FACTOR; NUCLEOTIDE EXCHANGE; STRUCTURAL BASIS; IDENTIFICATION; TCTP; EXPRESSION; SITE; ASSIGNMENT; STABILITY; REVEALS	Translationally controlled tumor protein (TCTP) is an abundant protein that is highly conserved in eukaryotes. However, its primary function is still not clear. Human TCTP interacts with the metazoan-specific eukaryotic elongation factor 1B delta (eEF1B delta) and inhibits its guanine nucleotide exchange factor (GEF) activity, but the structural mechanism remains unknown. The interaction between TCTP and eEF1B delta was investigated by NMR titration, structure determination, paramagnetic relaxation enhancement, site-directed mutagenesis, isothermal titration calorimetry, and HADDOCK docking. We first demonstrated that the catalytic GEF domain of eEF1B delta is not responsible for binding to TCTP but rather a previously unnoticed central acidic region (CAR) domain in eEF1B delta. The mutagenesis data and the structural model of the TCTP-eEF1B delta CAR domain complex revealed the key binding residues. These residues are highly conserved in eukaryotic TCTPs and in eEF1B GEFs, including the eukaryotically conserved eEF1B delta, implying the interaction may be conserved in all eukaryotes. Interactions were confirmed between TCTP and the eEF1B delta CAR domain for human, fission yeast, and unicellular photosynthetic microalgal proteins, suggesting that involvement in protein translation through the conserved interaction with eEF1B represents a primary function of TCTP.	[Wu, Huiwen; Gong, Weibin; Wang, Jinfeng; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Yao, Xingzhe; Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao Engn Lab Single Cell Oil, Qingdao 266101, Shandong, Peoples R China; [Yao, Xingzhe; Feng, Yingang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Qingdao 266101, Shandong, Peoples R China; [Wu, Huiwen; Yao, Xingzhe] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	sarah.perrett@cantab.net; fengyg@qibebt.ac.cn	Perrett, Sarah/AAS-9483-2020; Feng, Yingang/B-6304-2008	Perrett, Sarah/0000-0003-0137-0997; Feng, Yingang/0000-0002-0879-1316	National Basic Research Program, Ministry of Science and Technology of China (973 Program) [2012CB911000, 2013CB910700]; National High-tech R&D Program, Ministry of Science and Technology of China (863 Program) [2012AA02A707]; National Natural Science Foundation of China [30800179, 31170701, 31200578, 31470747, 31110103914]; Beijing Natural Science Foundation [5092018]	National Basic Research Program, Ministry of Science and Technology of China (973 Program); National High-tech R&D Program, Ministry of Science and Technology of China (863 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Basic Research Program, Ministry of Science and Technology of China (973 Program) Grants 2012CB911000 and 2013CB910700 (to S. P.), National High-tech R&D Program, Ministry of Science and Technology of China (863 Program) Grant 2012AA02A707 (to Y. F.), National Natural Science Foundation of China Grants 30800179 and 31170701 (to Y. F.), 31200578 and 31470747 (to W. G.), and 31110103914 (to S. P.), and Beijing Natural Science Foundation Grant 5092018 (to Y. F.).	Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Atkinson GC, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-35; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Baxter NJ, 2000, J BIOMOL NMR, V16, P83, DOI 10.1023/A:1008355030833; Bommer UA, 2004, INT J BIOCHEM CELL B, V36, P379, DOI 10.1016/S1357-2725(03)00213-9; Bommer UA, 2012, OPEN ALLERGY J, V5, P19, DOI DOI 10.2174/1874838401205010019; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chen YJ, 2011, J BIOL CHEM, V286, P32575, DOI 10.1074/jbc.M110.217836; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong XC, 2009, J BIOL CHEM, V284, P23754, DOI 10.1074/jbc.M109.012823; Eichhorn T, 2013, BIOCHEM PHARMACOL, V85, P38, DOI 10.1016/j.bcp.2012.10.006; Feng YG, 2007, ARCH BIOCHEM BIOPHYS, V467, P48, DOI 10.1016/j.abb.2007.08.021; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Funston G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042642; Gachet Y, 1999, J CELL SCI, V112, P1257; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hong ST, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3986; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kashiwakura JI, 2012, J CLIN INVEST, V122, P218, DOI 10.1172/JCI59072; Kawakami T., 2012, OPEN ALLERGY J, V5, P41; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Langdon JM, 2004, BBA-MOL BASIS DIS, V1688, P232, DOI 10.1016/j.bbadis.2003.12.007; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Norbeck J, 1997, YEAST, V13, P1519, DOI 10.1002/(SICI)1097-0061(199712)13:16<1519::AID-YEA211>3.0.CO;2-U; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Perez JMJ, 1999, STRUCTURE, V7, P217, DOI 10.1016/S0969-2126(99)80027-6; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Rid R, 2010, J STEROID BIOCHEM, V118, P29, DOI 10.1016/j.jsbmb.2009.09.015; Sasikumar AN, 2012, WIRES RNA, V3, P543, DOI 10.1002/wrna.1118; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Thiele H, 2000, EUR J BIOCHEM, V267, P5473, DOI 10.1046/j.1432-1327.2000.01609.x; Thompson HGR, 2002, GENOME RES, V12, P1517, DOI 10.1101/gr.418402; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang F, 2013, MOL CANCER RES, V11, P1508, DOI 10.1158/1541-7786.MCR-13-0389	50	20	21	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8694	8710		10.1074/jbc.M114.628594	http://dx.doi.org/10.1074/jbc.M114.628594			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25635048	hybrid, Green Published			2022-12-26	WOS:000352207100002
J	Corradini, E; Burgers, PP; Plank, M; Heck, AJR; Scholten, A				Corradini, Eleonora; Burgers, Pepijn P.; Plank, Michael; Heck, Albert J. R.; Scholten, Arjen			Huntingtin-associated Protein 1 (HAP1) Is a cGMP-dependent Kinase Anchoring Protein (GKAP) Specific for the cGMP-dependent Protein Kinase I beta Isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Mass Spectrometry (MS); Protein Kinase G (PKG); Proteomics; Signal Transduction; Chemical Proteomics; HAP1	REVEALS MOLECULAR DETAILS; CHEMICAL PROTEOMICS; CRYSTAL-STRUCTURE; LEUCINE-ZIPPER; MASS-SPECTROMETRY; TFII-I; AKAP; CAMP; BINDING; ALPHA	Background: Protein kinase compartmentalization through anchoring proteins provides spatiotemporal specificity. Results: Competitive elution combined with cyclic nucleotide affinity enrichment identifies HAP1 as a putative novel PKG anchoring protein (GKAP). Conclusion: Secondary structure predictions, in vitro binding studies, and site-directed mutagenesis define the binding domain and classify HAP1 as a GKAP specifically anchoring PKG I. Significance: The repertoire of PKG anchoring proteins is expanded, enforcing that also PKG signaling is tightly spatiotemporally regulated. Protein-protein interactions are important in providing compartmentalization and specificity in cellular signal transduction. Many studies have hallmarked the well designed compartmentalization of the cAMP-dependent protein kinase (PKA) through its anchoring proteins. Much less data are available on the compartmentalization of its closest homolog, cGMP-dependent protein kinase (PKG), via its own PKG anchoring proteins (GKAPs). For the enrichment, screening, and discovery of (novel) PKA anchoring proteins, a plethora of methodologies is available, including our previously described chemical proteomics approach based on immobilized cAMP or cGMP. Although this method was demonstrated to be effective, each immobilized cyclic nucleotide did not discriminate in the enrichment for either PKA or PKG and their secondary interactors. Hence, with PKG signaling components being less abundant in most tissues, it turned out to be challenging to enrich and identify GKAPs. Here we extend this cAMP-based chemical proteomics approach using competitive concentrations of free cyclic nucleotides to isolate each kinase and its secondary interactors. Using this approach, we identified Huntingtin-associated protein 1 (HAP1) as a putative novel GKAP. Through sequence alignment with known GKAPs and secondary structure prediction analysis, we defined a small sequence domain mediating the interaction with PKG I but not PKG I. In vitro binding studies and site-directed mutagenesis further confirmed the specificity and affinity of HAP1 binding to the PKG I N terminus. These data fully support that HAP1 is a GKAP, anchoring specifically to the cGMP-dependent protein kinase isoform I, and provide further evidence that also PKG spatiotemporal signaling is largely controlled by anchoring proteins.	[Corradini, Eleonora; Burgers, Pepijn P.; Plank, Michael; Heck, Albert J. R.; Scholten, Arjen] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [Corradini, Eleonora; Burgers, Pepijn P.; Plank, Michael; Heck, Albert J. R.; Scholten, Arjen] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Corradini, Eleonora; Burgers, Pepijn P.; Plank, Michael; Heck, Albert J. R.; Scholten, Arjen] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	Heck, AJR (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.j.r.heck@uu.nl	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404	European Union [262067]; Netherlands Organization for Scientific Research (NWO) [184.032.201]	European Union(European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Part of this work was performed within the framework of PRIME-XS Project Grant 262067 funded by the European Union 7th Framework Program and the Netherlands Organization for Scientific Research (NWO)-supported large scale proteomics facility Proteins@Work (Project 184.032.201) embedded in the Netherlands Proteomics Centre.	Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; Aye TT, 2012, J MOL CELL CARDIOL, V52, P511, DOI 10.1016/j.yjmcc.2011.06.003; Bantscheff M, 2009, DRUG DISCOV TODAY, V14, P1021, DOI 10.1016/j.drudis.2009.07.001; Burgers PP, 2015, BIOCHEMISTRY-US, V54, P11, DOI 10.1021/bi500721a; Burgers PP, 2012, J BIOL CHEM, V287, P43789, DOI 10.1074/jbc.M112.395970; CARR DW, 1991, J BIOL CHEM, V266, P14188; Casteel DE, 2010, J BIOL CHEM, V285, P32684, DOI 10.1074/jbc.C110.161430; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DEJONGE HR, 1981, ADV CYCLIC NUCL PROT, V14, P315; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Feil R, 2002, CIRC RES, V90, P1080, DOI 10.1161/01.RES.0000019586.95768.40; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; FRENCH PJ, 1995, J BIOL CHEM, V270, P26626, DOI 10.1074/jbc.270.44.26626; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Hundsrucker C, 2010, J BIOL CHEM, V285, P5507, DOI 10.1074/jbc.M109.047944; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; LOHMANN SM, 1981, P NATL ACAD SCI-BIOL, V78, P653, DOI 10.1073/pnas.78.1.653; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Prigge JR, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-76; Reger AS, 2014, J BIOL CHEM, V289, P25393, DOI 10.1074/jbc.M114.575894; Richie-Jannetta R, 2003, J BIOL CHEM, V278, P50070, DOI 10.1074/jbc.M306796200; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Scholten A, 2007, J PROTEOME RES, V6, P1705, DOI 10.1021/pr060601a; Scholten A, 2006, J PROTEOME RES, V5, P1435, DOI 10.1021/pr0600529; Sharma AK, 2008, J BIOL CHEM, V283, P32860, DOI 10.1074/jbc.M804916200; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Stangherlin A, 2011, J CARDIOVASC PHARM, V58, P345, DOI 10.1097/FJC.0b013e3182214f2b; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Vo NK, 1998, BIOCHEM BIOPH RES CO, V246, P831, DOI 10.1006/bbrc.1998.8722; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; WERNET W, 1989, FEBS LETT, V251, P191, DOI 10.1016/0014-5793(89)81453-X; WOLFE L, 1989, J BIOL CHEM, V264, P4157; Wong JWH, 2009, PROTEOMICS, V9, P40, DOI 10.1002/pmic.200800185; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Yuasa K, 2008, BIOCHEM BIOPH RES CO, V374, P522, DOI 10.1016/j.bbrc.2008.07.071	49	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7887	7896		10.1074/jbc.M114.622613	http://dx.doi.org/10.1074/jbc.M114.622613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25653285	hybrid, Green Published			2022-12-26	WOS:000351613600046
J	Hu, YF; Wu, YJ; Li, QW; Zhang, WB; Jin, CW				Hu, Yunfei; Wu, Yujie; Li, Qianwen; Zhang, Wenbo; Jin, Changwen			Solution Structure of Yeast Rpn9 INSIGHTS INTO PROTEASOME LID ASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-15 RESONANCE ASSIGNMENTS; TORSION ANGLE DYNAMICS; 26S PROTEASOME; CRYSTAL-STRUCTURE; 20S PROTEASOME; REGULATORY SUBUNIT; ATP BINDING; DEGRADATION; PROTEINS; DEUBIQUITINATION	The regulatory particle (RP) of the 26 S proteasome functions in preparing polyubiquitinated substrates for degradation. The lid complex of the RP contains an Rpn8-Rpn11 heterodimer surrounded by a horseshoe-shaped scaffold formed by six proteasome-COP9/CSN-initiation factor (PCI)-containing subunits. The PCI domains are essential for lid assembly, whereas the detailed molecular mechanisms remain elusive. Recent cryo-EM studies at near-atomic resolution provided invaluable information on the RP architecture in different functional states. Nevertheless, atomic resolution structural information on the RP is still limited, and deeper understanding of RP assembly mechanism requires further studies on the structures and interactions of individual subunits or subcomplexes. Herein we report the high-resolution NMR structures of the PCI-containing subunit Rpn9 from Saccharomyces cerevisiae. The 45-kDa protein contains an all-helical N-terminal domain and a (-terminal PCI domain linked via a semiflexible hinge. The N-terminal domain mediates interaction with the ubiquitin receptor Rpn10, whereas the PCI domain mediates interaction with the neighboring PCI subunit Rpn5. The Rpn9-Rpn5 interface highlights two structural motifs on the winged helix module forming a hydrophobic center surrounded by ionic pairs, which is a common pattern for all PCI-PCI interactions in the lid. The results suggest that divergence in surface composition among different PCI pairs may contribute to the modulation of lid assembly.	[Hu, Yunfei; Wu, Yujie; Li, Qianwen; Zhang, Wenbo; Jin, Changwen] Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Hu, Yunfei; Jin, Changwen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Wu, Yujie; Li, Qianwen; Zhang, Wenbo; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Jin, Changwen] Peking Univ, Being Natl Lab Mol Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Jin, CW (corresponding author), Peking Univ, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	changwen@pku.edu.cn		Wu, Yujie/0000-0002-9530-7413	Ministry of Science and Technology of China [2006AA02A323]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Ministry of Science and Technology of China Grant 2006AA02A323 (to C. J.).	Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Boehringer J, 2012, BIOCHEM J, V448, P55, DOI 10.1042/BJ20120542; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; FISCHER M, 1994, FEBS LETT, V355, P69, DOI 10.1016/0014-5793(94)01177-X; Fischer MWF, 1999, BIOCHEMISTRY-US, V38, P9013, DOI 10.1021/bi9905213; Forster F, 2013, STRUCTURE, V21, P1551, DOI 10.1016/j.str.2013.08.010; Foerster F, 2010, MOL CELL PROTEOMICS, V9, P1666, DOI 10.1074/mcp.R000002-MCP201; Fukunaga K, 2010, BIOCHEM BIOPH RES CO, V396, P1048, DOI 10.1016/j.bbrc.2010.05.061; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Javadi Y, 2013, CURR OPIN STRUC BIOL, V23, P622, DOI 10.1016/j.sbi.2013.06.011; Jin HL, 2006, PLANT PHYSIOL, V142, P651, DOI 10.1104/pp.106.083519; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Lorieau J, 2008, J AM CHEM SOC, V130, P7536, DOI 10.1021/ja801729f; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; PETERS JM, 1993, J MOL BIOL, V234, P932, DOI 10.1006/jmbi.1993.1646; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Serino G, 2013, PLANT SCI, V203, P89, DOI 10.1016/j.plantsci.2012.12.018; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Takeuchi J, 1999, MOL CELL BIOL, V19, P6575; Tomko RJ, 2011, MOL CELL, V44, P907, DOI 10.1016/j.molcel.2011.11.020; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Unverdorben P, 2014, P NATL ACAD SCI USA, V111, P5544, DOI 10.1073/pnas.1403409111; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Wu YJ, 2014, BIOMOL NMR ASSIGN, V8, P391, DOI 10.1007/s12104-013-9525-z; Wu YJ, 2014, BIOMOL NMR ASSIGN, V8, P307, DOI 10.1007/s12104-013-9506-2; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	55	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6878	6889		10.1074/jbc.M114.626762	http://dx.doi.org/10.1074/jbc.M114.626762			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631053	hybrid, Green Published			2022-12-26	WOS:000350991500023
J	Kim, V; Oros, M; Durra, H; Kelsen, S; Aksoy, M; Cornwell, WD; Rogers, TJ; Criner, GJ				Kim, Victor; Oros, Michelle; Durra, Heba; Kelsen, Steven; Aksoy, Mark; Cornwell, William D.; Rogers, Thomas J.; Criner, Gerard J.			Chronic Bronchitis and Current Smoking Are Associated with More Goblet Cells in Moderate to Severe COPD and Smokers without Airflow Obstruction	PLOS ONE			English	Article							LUNG-VOLUME REDUCTION; PULMONARY-DISEASE; PERIPHERAL AIRWAYS; SPUTUM PRODUCTION; INFLAMMATION; PATHOLOGY; SYMPTOMS; GLANDS	Background Goblet cell hyperplasia is a classic but variable pathologic finding in COPD. Current literature shows that smoking is a risk factor for chronic bronchitis but the relationship of these clinical features to the presence and magnitude of large airway goblet cell hyperplasia has not been well described. We hypothesized that current smokers and chronic bronchitics would have more goblet cells than nonsmokers or those without chronic bronchitis (CB), independent of airflow obstruction. Methods We recruited 15 subjects with moderate to severe COPD, 12 healthy smokers, and 11 healthy nonsmokers. Six endobronchial mucosal biopsies per subject were obtained by bronchoscopy and stained with periodic acid Schiff-Alcian Blue. Goblet cell density (GCD) was quantified as goblet cell number per millimeter of basement membrane. Mucin volume density (MVD) was quantified as volume of mucin per unit area of basement membrane. Results Healthy smokers had a greater GCD and MVD than nonsmokers and COPD subjects. COPD subjects had a greater GCD than nonsmokers. When current smokers (healthy smokers and COPD current smokers, n = 19) were compared with all nonsmokers (nonsmoking controls and COPD ex-smokers, n = 19), current smokers had a greater GCD and MVD. When those with CB (n = 12) were compared to those without CB (n = 26), the CB group had greater GCD. This finding was also seen in those with CB in the COPD group alone. In multivariate analysis, current smoking and CB were significant predictors of GCD using demographics, lung function, and smoking pack years as covariates. All other covariates were not significant predictors of GCD or MVD. Conclusions Current smoking is associated with a more goblet cell hyperplasia and number, and CB is associated with more goblet cells, independent of the presence of airflow obstruction. This provides clinical and pathologic correlation for smokers with and without COPD.	[Kim, Victor; Kelsen, Steven; Aksoy, Mark; Criner, Gerard J.] Temple Univ, Div Pulm & Crit Care Med, Sch Med, Philadelphia, PA 19122 USA; [Oros, Michelle; Durra, Heba] Temple Univ, Dept Pathol, Sch Med, Philadelphia, PA 19122 USA; [Cornwell, William D.; Rogers, Thomas J.] Temple Univ, Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kim, V (corresponding author), Temple Univ, Div Pulm & Crit Care Med, Sch Med, Philadelphia, PA 19122 USA.	Victor.kim@tuhs.temple.edu			National Heart, Lung, and Blood Institute (National Institute of Health) [K23HL094696]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094696] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (National Institute of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work came from the National Heart, Lung, and Blood Institute (National Institute of Health) K23HL094696. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, NHLMI WHO WORKSH REP; [Anonymous], 1979, STEREOLOGICAL METHOD; Burgel PR, 2009, CHEST, V135, P975, DOI 10.1378/chest.08-2062; Caramori G, 2009, HISTOPATHOLOGY, V55, P321, DOI 10.1111/j.1365-2559.2009.03377.x; Forey BA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-36; HARKEMA JR, 1987, J HISTOCHEM CYTOCHEM, V35, P279, DOI 10.1177/35.3.2434556; Hattotuwa K, 2002, CHEST, V122, P1909, DOI 10.1378/chest.122.6.1909; Hogg JC, 2007, AM J RESP CRIT CARE, V176, P454, DOI 10.1164/rccm.200612-1772OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Innes AL, 2006, CHEST, V130, P1102, DOI 10.1378/chest.130.4.1102; Kim V, 2005, AM J RESP CRIT CARE, V171, P40, DOI 10.1164/rccm.200405-659OC; Kim V, 2011, CHEST, V140, P626, DOI 10.1378/chest.10-2948; Kim V, 2011, COPD, V8, P114, DOI 10.3109/15412555.2011.558546; Kim V, 2008, COPD, V5, P329, DOI 10.1080/15412550802522445; Martinez CH, 2013, RESP MED, V15; MULLEN JBM, 1985, BMJ-BRIT MED J, V291, P1235, DOI 10.1136/bmj.291.6504.1235; NAGAI A, 1985, AM REV RESPIR DIS, V132, P946; Pelkonen M, 2006, CHEST, V130, P1129, DOI 10.1378/chest.130.4.1129; REID LM, 1954, LANCET, V1, P275; Saetta M, 1997, AM J RESP CRIT CARE, V156, P1633, DOI 10.1164/ajrccm.156.5.9701081; Saetta M, 2000, AM J RESP CRIT CARE, V161, P1016, DOI 10.1164/ajrccm.161.3.9907080; Sciurba F, 2006, P AM THORAC SOC, V3, pA712; THURLBECK WM, 1975, AM REV RESPIR DIS, V112, P65; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; 2006, IMAGE J	25	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116108	10.1371/journal.pone.0116108	http://dx.doi.org/10.1371/journal.pone.0116108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646735	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600020
J	Kumar, D; Kirti, PB				Kumar, Dilip; Kirti, Pulugurtha Bharadwaja			Transcriptomic and Proteomic Analyses of Resistant Host Responses in Arachis diogoi Challenged with Late Leaf Spot Pathogen, Phaeoisariopsis personata	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; CDNA-AFLP ANALYSIS; THAUMATIN-LIKE PROTEIN; DISEASE RESISTANCE; CELL-DEATH; ANALYSIS REVEALS; ASCORBIC-ACID; CERCOSPORIDIUM-PERSONATUM; ARABIDOPSIS-THALIANA; PROCESSING ENZYME	Late leaf spot is a serious disease of peanut caused by the imperfect fungus, Phaeoisariopsis personata. Wild diploid species, Arachis diogoi. is reported to be highly resistant to this disease and asymptomatic. The objective of this study is to investigate the molecular responses of the wild peanut challenged with the late leaf spot pathogen using cDNA-AFLP and 2D proteomic study. A total of 233 reliable, differentially expressed genes were identified in Arachis diogoi. About one third of the TDFs exhibit no significant similarity with the known sequences in the data bases. Expressed sequence tag data showed that the characterized genes are involved in conferring resistance in the wild peanut to the pathogen challenge. Several genes for proteins involved in cell wall strengthening, hypersensitive cell death and resistance related proteins have been identified. Genes identified for other proteins appear to function in metabolism, signal transduction and defence. Nineteen TDFs based on the homology analysis of genes associated with defence, signal transduction and metabolism were further validated by quantitative real time PCR (qRT-PCR) analyses in resistant wild species in comparison with a susceptible peanut genotype in time course experiments. The proteins corresponding to six TDFs were differentially expressed at protein level also. Differentially expressed TDFs and proteins in wild peanut indicate its defence mechanism upon pathogen challenge and provide initial breakthrough of genes possibly involved in recognition events and early signalling responses to combat the pathogen through subsequent development of resistivity. This is the first attempt to elucidate the molecular basis of the response of the resistant genotype to the late leaf spot pathogen, and its defence mechanism.	[Kumar, Dilip; Kirti, Pulugurtha Bharadwaja] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Kumar, D (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	dilip.hcu@gmail.com	Kirti, P.B./R-1504-2019; KUMAR, DINESH/GRJ-5448-2022; Kumar, Dilip/GQB-0364-2022	KUMAR, DINESH/0000-0002-9641-6662; Kumar, Dilip/0000-0003-3721-4718; Kumar, Dilip/0000-0003-4566-1446	Department of Biotechnology, Government of India [BT/PR/6835/PB/16/627/2005]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by funding from the Department of Biotechnology, Government of India (BT/PR/6835/PB/16/627/2005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou Y. A.-M., 1974, Peanut Science, V1, P6, DOI 10.3146/i0095-3679-1-1-3; AGRIOS GN, 1997, PLANT PATHOLOGY; Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Castillejo MA, 2012, J EXP BOT, V63, P107, DOI 10.1093/jxb/err246; Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; BABIYCHUK E, 1995, J BIOL CHEM, V270, P26224, DOI 10.1074/jbc.270.44.26224; Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Bahramnejad B, 2009, PLANT CELL REP, V28, P703, DOI 10.1007/s00299-009-0672-8; Baisakh N, 2006, PLANT SCI, V170, P1141, DOI 10.1016/j.plantsci.2006.02.001; Bangrak P, 2011, PLANT PHYSIOL BIOCH, V49, P244, DOI 10.1016/j.plaphy.2010.12.007; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Boter M, 2007, PLANT CELL, V19, P3791, DOI 10.1105/tpc.107.050427; Brand Yael, 2010, Peanut Science, V37, P12, DOI 10.3146/PS09-014.1; Bulgarelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012599; Chan YW, 1999, J EXP BOT, V50, P1627, DOI 10.1093/jexbot/50.339.1627; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cheng SF, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-286; Chivasa S, 2006, J EXP BOT, V57, P1553, DOI 10.1093/jxb/erj149; Conklin PL, 2001, PLANT CELL ENVIRON, V24, P383, DOI 10.1046/j.1365-3040.2001.00686.x; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; Dastoor Z, 2000, J CELL SCI, V113, P2845; Datta K, 1999, THEOR APPL GENET, V98, P1138, DOI 10.1007/s001220051178; Ding YF, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue5-fulltext-1; Ditt RF, 2001, P NATL ACAD SCI USA, V98, P10954, DOI 10.1073/pnas.191383498; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Feller U., 2004, PLANT CELL DEATH PRO, P107; Feng SP, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/373768; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fukumura R, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng094; Gao HY, 2005, MOL PLANT MICROBE IN, V18, P1035, DOI 10.1094/MPMI-18-1035; GRICHAR WJ, 1998, GROUNDNUT SCI, V25, P35; Guo BZ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-12; Guo BZ, 2011, TOXINS, V3, P737, DOI 10.3390/toxins3070737; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hu X, 1997, PLANT MOL BIOL, V34, P949, DOI 10.1023/A:1005893119263; Ibeas JI, 2000, PLANT J, V23, P375, DOI 10.1046/j.1365-313x.2000.00792.x; Ishitani R, 1998, MOL PHARMACOL, V53, P701, DOI 10.1124/mol.53.4.701; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones JT, 1998, FUND APPL NEMATOL, V21, P81; Katam R, 2010, J PROTEOME RES, V9, P2236, DOI 10.1021/pr901009n; Kaur P, 2011, J EXP BOT, V62, P1285, DOI 10.1093/jxb/erq365; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Kottapalli KR, 2008, PLANT SCI, V175, P321, DOI 10.1016/j.plantsci.2008.05.005; Kottapalli KR, 2009, PLANT CELL ENVIRON, V32, P380, DOI 10.1111/j.1365-3040.2009.01933.x; Kuhn E, 2001, ANN BOT-LONDON, V87, P139, DOI 10.1006/anbo.2000.1314; Kumar KRR, 2011, PLANT MOL BIOL, V75, P497, DOI 10.1007/s11103-011-9747-3; Kundu S, 2011, J PROTEOMICS, V74, P337, DOI 10.1016/j.jprot.2010.11.012; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Lherminier J, 2009, MOL PLANT MICROBE IN, V22, P868, DOI 10.1094/MPMI-22-7-0868; Liao JL, 2012, PLANT SCI, V196, P32, DOI 10.1016/j.plantsci.2012.07.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo M, 2005, PHYTOPATHOLOGY, V95, P381, DOI 10.1094/PHYTO-95-0381; Mahmood T, 2006, PROTEOMICS, V6, P6053, DOI 10.1002/pmic.200600470; Martinez DE, 2007, J EXP BOT, V58, P1099, DOI 10.1093/jxb/erl270; Mehta A, 2008, FEBS J, V275, P3731, DOI 10.1111/j.1742-4658.2008.06528.x; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; Muskett PR, 2002, PLANT CELL, V14, P979, DOI 10.1105/tpc.001040; Nobile PM, 2008, PLANT SCI, V174, P78, DOI 10.1016/j.plantsci.2007.09.009; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Noel LD, 2007, PLANT CELL, V19, P4061, DOI 10.1105/tpc.107.051896; Okamoto T, 1999, PLANT MOL BIOL, V39, P63, DOI 10.1023/A:1006170518002; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Osbourn AE, 1999, FUNGAL GENET BIOL, V26, P163, DOI 10.1006/fgbi.1999.1133; Padovan L, 2010, PROTEIN PEPTIDE LETT, V17, P297, DOI 10.2174/092986610790780350; Pande S, 2001, PLANT DIS, V85, P851, DOI 10.1094/PDIS.2001.85.8.851; Payton P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-265; Peng Wen-Fang, 2011, Yichuan, V33, P389, DOI 10.3724/SP.J.1005.2011.00389; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Rao NK, 2003, GENET RESOUR CROP EV, V50, P707, DOI 10.1023/A:1025055018954; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sestili S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-122; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shokes F.M., 1997, COMPENDIUM PEANUT DI, V2nd ed., P17; Archana Singh, 1997, International Chickpea and Pigeonpea Newsletter, P39; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; Song YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-286; Stevens R, 2008, PLANT CELL ENVIRON, V31, P1086, DOI 10.1111/j.1365-3040.2008.01824.x; SUTHERLAND MW, 1991, PHYSIOL MOL PLANT P, V39, P79, DOI 10.1016/0885-5765(91)90020-I; Swidzinski JA, 2002, PLANT J, V30, P431, DOI 10.1046/j.1365-313X.2002.01301.x; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Valdes-Rodriguez S, 2010, PLANT PHYSIOL BIOCH, V48, P469, DOI 10.1016/j.plaphy.2010.03.012; Van der Weerden NL, 2013, FUNGAL BIOL REV, V26, P121, DOI 10.1016/j.fbr.2012.08.004; Vinagre F, 2006, J EXP BOT, V57, P559, DOI 10.1093/jxb/erj041; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang L, 2004, PLANT MOL BIOL, V56, P929, DOI 10.1007/s11103-004-6236-y; Wang T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-267; Wang XJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-9; Wang XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-289; Wang XC, 2007, BIOTECHNOL LETT, V29, P1599, DOI 10.1007/s10529-007-9425-3; Wang ZZ, 2012, J PROTEOME RES, V11, P2739, DOI 10.1021/pr201105d; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368; Wu LJ, 2013, J PROTEOMICS, V89, P124, DOI 10.1016/j.jprot.2013.06.005; WYNNE JC, 1991, ANNU REV PHYTOPATHOL, V29, P279, DOI 10.1146/annurev.py.29.090191.001431; Xing T, 1997, PLANT CELL, V9, P249, DOI 10.1105/tpc.9.2.249; Yoon HS, 2004, BBA-BIOENERGETICS, V1658, P181, DOI 10.1016/j.bbabio.2004.05.013; Young ND, 1996, GENOME MAPPING PLANT, P211; Yu CL, 2008, PHYTOCHEMISTRY, V69, P1989, DOI 10.1016/j.phytochem.2008.04.006; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhu BL, 1996, PLANTA, V198, P70	108	23	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117559	10.1371/journal.pone.0117559	http://dx.doi.org/10.1371/journal.pone.0117559			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646800	gold, Green Published, Green Submitted			2022-12-26	WOS:000348822600074
J	Lee, KC; Han, K; Kim, JY; Nam, GE; Han, BD; Shin, KE; Lee, A; Ko, BJ				Lee, Kyu-Chong; Han, Kyungdo; Kim, Jin Yong; Nam, Ga Eun; Han, Byoung-Duck; Shin, Koh-Eun; Lee, Anna; Ko, Byung Joon			Socioeconomic Status and Other Related Factors of Seasonal Influenza Vaccination in the South Korean Adult Population Based on a Nationwide Cross-Sectional Study	PLOS ONE			English	Article							OLDER-ADULTS; COVERAGE; DETERMINANTS; HEALTH; MORTALITY; DISEASE; PEOPLE; IMPACT; RATES	Purpose We investigated the association between seasonal influenza vaccination in South Korea and socioeconomic status (SES) as well as other potential related factors. Methods The study was based on data obtained in the Korea National Health and Nutrition Examination Survey from 2010 to 2011. Education level and household income were used as indicators for SES. Univariate and multiple logistic regression analyses were used to evaluate SES and other demographic variables as related factors for influenza vaccination, the primary outcome. Results Higher household income was positively associated with higher vaccine uptake in the younger (19-49 years) group [adjusted odds ratio (aOR) 1.55, 95% confidence interval (CI) 1.08-2.23], whereas the low-income and low-education group had increased vaccination coverage than the middle-income and middle-education group in the older (>= 50 years) group (aOR 1.36, 95% CI 1.09-1.69). Current smokers tend to be unvaccinated in all age groups. Among individuals aged >= 50, older age, mild to moderate alcohol consumption, regular exercise, and having co-morbidities were positively associated with vaccination, while those who self-reported their health status as good were less likely to be vaccinated. Conclusions The relationship between SES and seasonal influenza vaccination coverage differed between the age groups throughout the adult South Korean population. Public health policies need to address these inequalities.	[Lee, Kyu-Chong] Korea Univ, Coll Med, Dept Radiol, Seoul 136705, South Korea; [Han, Kyungdo] Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Kim, Jin Yong] Korea Univ, Coll Med, Dept Neurosci, Seoul 136705, South Korea; [Nam, Ga Eun; Shin, Koh-Eun; Ko, Byung Joon] Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea; [Han, Byoung-Duck] SahmYook Med Ctr, Dept Family Med, Seoul, South Korea; [Lee, Anna] Univ Pacific, Coll Hlth Professionals, Sch Phys Assistant Studies, Hillsboro, OR USA; [Ko, Byung Joon] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA USA; [Ko, Byung Joon] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Total Healthcare Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of the Pacific; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Sungkyunkwan University (SKKU); Samsung Medical Center	Ko, BJ (corresponding author), Korea Univ, Coll Med, Dept Family Med, Seoul 136705, South Korea.	basslove1@hanmail.net	Nam, Ga Eun/AAU-6055-2020; Nam, Ga Eun/AAA-1577-2021	Nam, Ga Eun/0000-0002-6739-9904; Kim, Jin Yong/0000-0001-8080-3206; Lee, Kyu-chong/0000-0002-4518-8567; han, byoungduck/0000-0003-2830-1174				Andrew MK, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-36; Bohmer MM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-938; Bryant WK, 2006, PREV MED, V43, P60, DOI 10.1016/j.ypmed.2006.03.018; Christenson B, 2002, EPIDEMIOL INFECT, V129, P515, DOI 10.1017/S095026880200780X; Damiani G, 2007, PREV MED, V45, P373, DOI 10.1016/j.ypmed.2007.07.007; Dip RM, 2010, CAD SAUDE PUBLICA, V26, P1035, DOI 10.1590/S0102-311X2010000500025; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Heo JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064230; HUTCHISON BG, 1989, CAN J PUBLIC HEALTH, V80, P271; Jones TF, 2004, CLIN INFECT DIS, V39, P1824, DOI 10.1086/427153; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; *KOR CTR DIS CONTR, 2012 2013 INFLUENZA, P28669; Landi F, 2005, VACCINE, V23, P3896, DOI 10.1016/j.vaccine.2005.03.008; Lang PO, 2012, CLIN INTERV AGING, V7, P55, DOI 10.2147/CIA.S25215; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; Lee YK, 2012, AM J INFECT CONTROL, V40, P481, DOI 10.1016/j.ajic.2011.05.015; Link MW, 2006, AM J EPIDEMIOL, V163, P571, DOI 10.1093/aje/kwj086; de Andres A, 2007, EUR J PUBLIC HEALTH, V17, P272, DOI 10.1093/eurpub/ckl242; Lu PJ, 2005, ARCH INTERN MED, V165, P1849, DOI 10.1001/archinte.165.16.1849; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Mangtani P, 2005, PREV MED, V41, P545, DOI 10.1016/j.ypmed.2005.02.001; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Petersen RL, 1999, MED CARE, V37, P502, DOI 10.1097/00005650-199905000-00009; Phonrat B, 2013, VACCINE, V31, P1503, DOI 10.1016/j.vaccine.2012.12.082; Ryu SY, 2011, INT J ENV RES PUB HE, V8, P4197, DOI 10.3390/ijerph8114197; Sander B, 2010, VACCINE, V28, P6210, DOI 10.1016/j.vaccine.2010.07.010; Savy V, 2013, INFLUENZA OTHER RESP, V7, P1017, DOI 10.1111/irv.12036; Schwartz KL, 2006, J GEN INTERN MED, V21, P346, DOI 10.1111/j.1525-1497.2006.00401.x; SPRENGER MJW, 1993, INT J EPIDEMIOL, V22, P334, DOI 10.1093/ije/22.2.334; Talbot HK, 2011, J INFECT DIS, V203, P500, DOI 10.1093/infdis/jiq076; Vaux S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-159; Wong CM, 2013, INFLUENZA OTHER RESP, V7, P531, DOI 10.1111/j.1750-2659.2012.00411.x; Wu SS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-636	35	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117305	10.1371/journal.pone.0117305	http://dx.doi.org/10.1371/journal.pone.0117305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646847	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600063
J	Galvani, RG; Lemos, R; Areal, RB; Salvador, PA; Zamboni, DS; Wanderley, JLM; Bonomo, A				Galvani, Romulo G.; Lemos, Ramon; Areal, Romulo B.; Salvador, Pollyanna A.; Zamboni, Dario S.; Wanderley, Joao Luiz M.; Bonomo, Adriana			Disease Severity and Mortality Can Be Independently Regulated in a Mouse Model of Experimental Graft versus Host Disease	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; INNATE IMMUNE-SYSTEM; ALPHA TNF-ALPHA; DENDRITIC CELLS; T-CELLS; INFECTIOUS COMPLICATIONS; SECONDARY DISEASE; INTERFERON-GAMMA; MURINE MODEL	Graft versus host disease (GVHD) is the major limitation of allogeneic hematopoietic stem cell transplantation (HSCT) presenting high mortality and morbidity rates. However, the exact cause of death is not completely understood and does not correlate with specific clinical and histological parameters of disease. Here we show, by using a semi-allogeneic mouse model of GVHD, that mortality and morbidity can be experimentally separated. We injected bone marrow-derived dendritic cells (BMDC) from NOD2/CARD15-deficient donors into semi-allogeneic irradiated chimaeras and observed that recipients were protected from death. However, no protection was observed regarding clinical or pathological scores up to 20 days after transplantation. Protection from death was associated with decreased bacterial translocation, faster hematologic recovery and epithelial integrity maintenance despite mononuclear infiltration at day 20 post-GVHD induction with no skew towards different T helper phenotypes. The protected mice recovered from aGVHD and progressively reached scores compatible with healthy animals. Altogether, our data indicate that severity and mortality can be separate events providing a model to study transplant-related mortality.	[Galvani, Romulo G.; Lemos, Ramon; Areal, Romulo B.; Salvador, Pollyanna A.; Wanderley, Joao Luiz M.; Bonomo, Adriana] Inst Nacl Canc, Div Expt Med, Rio De Janeiro, Brazil; [Galvani, Romulo G.; Lemos, Ramon; Bonomo, Adriana] Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Zamboni, Dario S.] Univ Sao Paulo, Dept Biol Celular Mol & Bioagentes Patogen, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Wanderley, Joao Luiz M.] Univ Fed Rio de Janeiro, NUPEM, Rio De Janeiro, Brazil; [Bonomo, Adriana] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Timo, BR-21045900 Rio De Janeiro, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Wanderley, JLM (corresponding author), Inst Nacl Canc, Div Expt Med, Rio De Janeiro, Brazil.	lmwjoao@macae.ufrj.br	Wanderley, Joao Luiz/J-6711-2014; Zamboni, Dario S/D-3024-2012	Zamboni, Dario S/0000-0002-7856-7512; Braga Areal, Romulo/0000-0001-9531-0092	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alousi AM, 2009, BLOOD, V114, P511, DOI 10.1182/blood-2009-03-212290; BEELEN DW, 1992, BLOOD, V80, P2668; Beelen DW, 1999, BLOOD, V93, P3267, DOI 10.1182/blood.V93.10.3267.410k22_3267_3275; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Bjorklund A, 2007, BONE MARROW TRANSPL, V40, P1055, DOI 10.1038/sj.bmt.1705856; Body-Malapel M, 2008, LAB INVEST, V88, P318, DOI 10.1038/labinvest.3700716; Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667; BROK HPM, 1993, J IMMUNOL, V151, P6451; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Choi SW, 2012, BIOL BLOOD MARROW TR, V18, P1525, DOI 10.1016/j.bbmt.2012.03.013; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Couriel D, 2004, BLOOD, V104, P649, DOI 10.1182/blood-2003-12-4241; Dilek N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00208; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Durakovic N, 2006, J IMMUNOL, V177, P4414, DOI 10.4049/jimmunol.177.7.4414; Elmaagacli AH, 2006, TRANSPLANTATION, V81, P247, DOI 10.1097/01.tp.0000188671.94646.16; Eriguchi Y, 2012, BLOOD, V120, P223, DOI 10.1182/blood-2011-12-401166; FERRARA J, 1986, J INVEST DERMATOL, V86, P371, DOI 10.1111/1523-1747.ep12285612; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gerbitz A, 2004, BLOOD, V103, P4365, DOI 10.1182/blood-2003-11-3769; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Goiriz R, 2009, J EUR ACAD DERMATOL, V23, P1398, DOI 10.1111/j.1468-3083.2009.03326.x; Granell M, 2006, HAEMATOLOGICA, V91, P1372; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Hill GR, 1998, J CLIN INVEST, V102, P115, DOI 10.1172/JCI3132; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Holler E, 2008, INT J IMMUNOGENET, V35, P381, DOI 10.1111/j.1744-313X.2008.00795.x; Holler E, 2006, BLOOD, V107, P4189, DOI 10.1182/blood-2005-09-3741; HOLLER E, 1995, BLOOD, V86, P890, DOI 10.1182/blood.V86.3.890.890; Horwitz BH, 2007, INFLAMM BOWEL DIS, V13, P490, DOI 10.1002/ibd.20098; JONES JM, 1971, RADIAT RES, V45, P577, DOI 10.2307/3573066; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KORNGOLD R, 1978, J EXP MED, V148, P1687; Koyama M, 2009, BLOOD, V113, P2088, DOI 10.1182/blood-2008-07-168609; Langier S, 2012, BRAZ J MED BIOL RES, V45, P942, DOI 10.1590/S0100-879X2012007500089; Lorenz E, 2001, BIOL BLOOD MARROW TR, V7, P384, DOI 10.1053/bbmt.2001.v7.pm11529488; Mahnke K, 2005, CURR TOP MICROBIOL, V293, P133, DOI 10.1007/3-540-27702-1_7; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Matte CC, 2004, NAT MED, V10, P987, DOI 10.1038/nm1089; Mayor NP, 2007, J CLIN ONCOL, V25, P4262, DOI 10.1200/JCO.2007.12.1897; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Penack O, 2009, J EXP MED, V206, P2101, DOI 10.1084/jem.20090623; Pidala J, 2011, HAEMATOL-HEMATOL J, V96, P1678, DOI 10.3324/haematol.2011.049841; PIGUET PF, 1987, J EXP MED, V166, P1280, DOI 10.1084/jem.166.5.1280; Rigato O, 1996, INFECTION, V24, P314, DOI 10.1007/BF01743367; Rosenzweig HL, 2009, J LEUKOCYTE BIOL, V85, P711, DOI 10.1189/jlb.0808478; Sairafi D, 2008, BONE MARROW TRANSPL, V41, P961, DOI 10.1038/bmt.2008.9; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Shimabukuro-Vornhagen A, 2009, BLOOD, V114, P4919, DOI 10.1182/blood-2008-10-161638; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; SKINHOJ P, 1987, SCAND J INFECT DIS, V19, P91, DOI 10.3109/00365548709032383; STORB R, 1983, NEW ENGL J MED, V308, P302, DOI 10.1056/NEJM198302103080602; SYMINGTON FW, 1990, TRANSPLANTATION, V50, P518, DOI 10.1097/00007890-199009000-00033; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Travassos LH, 2005, J BIOL CHEM, V280, P36714, DOI 10.1074/jbc.M501649200; van den Brink MRM, 2002, NAT REV IMMUNOL, V2, P273, DOI 10.1038/nri775; van den Brink MRM, 2000, J IMMUNOL, V164, P469, DOI 10.4049/jimmunol.164.1.469; van der Velden WJFM, 2009, BONE MARROW TRANSPL, V44, P243, DOI 10.1038/bmt.2009.21; VANBEKKU.DW, 1974, J NATL CANCER I, V52, P401, DOI 10.1093/jnci/52.2.401; Vasconcelos ZFM, 2006, BLOOD, V107, P2192, DOI 10.1182/blood-2005-08-3239; VOSSEN JM, 1990, EUR J CLIN MICROBIOL, V9, P14, DOI 10.1007/BF01969527; Wanderley JLM, 2013, PARASITE IMMUNOL, V35, P109, DOI 10.1111/pim.12019; Welniak LA, 2000, BIOL BLOOD MARROW TR, V6, P604, DOI 10.1016/S1083-8791(00)70025-5; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Wilson J, 2009, J EXP MED, V206, P387, DOI 10.1084/jem.20070723; WOJNO KJ, 1994, TRANSPLANTATION, V57, P88, DOI 10.1097/00007890-199401000-00016	71	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0118079	10.1371/journal.pone.0118079	http://dx.doi.org/10.1371/journal.pone.0118079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643148	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821200044
J	Holloway, KR; Sinha, VC; Toneff, MJ; Bu, W; Hilsenbeck, SG; Li, Y				Holloway, Kimberly R.; Sinha, Vidya C.; Toneff, Michael J.; Bu, Wen; Hilsenbeck, Susan G.; Li, Yi			Krt6a-Positive Mammary Epithelial Progenitors Are Not at Increased Vulnerability to Tumorigenesis Initiated by ErbB2	PLOS ONE			English	Article							BREAST-CANCER; STEM-CELLS; DIFFERENTIATION; RECEPTOR; EXPRESSION; RENEWAL; LRP5	While most breast cancers are thought to arise from the luminal layer of the breast tissue, it remains unclear which specific cells in the luminal layer are the cells of origin of breast cancer. We have previously reported that WAP-positive luminal epithelial cells are at increased susceptibility to tumor initiation by ErbB2 compared to the bulk population, while the mammary cells with canonical Wnt signaling activity fail to evolve into tumors upon ErbB2 activation. Here, we used retrovirus to introduce ErbB2 into the Krt6a-positive mammary progenitor subset of the luminal epithelium and, for comparison, into the mammary luminal epithelium indiscriminately. Tumors developed from both groups of cells with a similar latency. These data indicate that the Krt6a-positive subset of mammary epithelial cells can be induced to form cancer by ErbB2 but it is not more susceptible to tumorigenesis initiated by ErbB2 than the bulk population of the luminal epithelium.	[Holloway, Kimberly R.; Sinha, Vidya C.; Bu, Wen; Hilsenbeck, Susan G.; Li, Yi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Sinha, Vidya C.; Toneff, Michael J.; Bu, Wen; Li, Yi] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Li, Yi] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Li, Y (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA.	liyi@bcm.edu	Li, Yi/A-7635-2009	Li, Yi/0000-0002-9976-518X	National Institutes of Health [CA124820, RR024574]; National Cancer Institute [T32AG000183]; Duncan Cancer Center [P30CA125123]; National Institute of Allergy and Infectious Diseases;  [U54CA149196];  [CA125123]; NATIONAL CANCER INSTITUTE [R01CA124820, U54CA149196, P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Duncan Cancer Center; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (http://www.nih.gov/): #CA124820 (YL); #RR024574 (Cytometry and Cell Sorting Core at Baylor College of Medicine); #T32AG000183 (KRH); National Cancer Institute (http://www.cancer.gov/): #U54CA149196 to YL (PI Stephen Wong); #CA125123 (Cytometry and Cell Sorting Core at Baylor College of Medicine); #P30CA125123 (Duncan Cancer Center); National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/):	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Bu W, 2011, ONCOGENE, V30, P4399, DOI 10.1038/onc.2011.147; Bu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078720; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; Haricharan S, 2014, MOL CELL ENDOCRINOL, V382, P560, DOI 10.1016/j.mce.2013.03.014; Haricharan S, 2013, ONCOGENE, DOI [10.1038/onc.2013.543, DOI 10.1038/ONC.2013.543]; Haricharan S, 2013, ELIFE, V2, DOI 10.7554/eLife.00996; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Reddy JP, 2010, P NATL ACAD SCI USA, V107, P3728, DOI 10.1073/pnas.0910665107; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; Toneff MJ, 2010, NEOPLASIA, V12, P718, DOI 10.1593/neo.10516; Wagner KU, 2002, DEVELOPMENT, V129, P1377	21	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117239	10.1371/journal.pone.0117239	http://dx.doi.org/10.1371/journal.pone.0117239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635772	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700076
J	Qin, HD; Chen, M; Yi, XD; Bie, S; Zhang, C; Zhang, YC; Lan, JY; Meng, YY; Yuan, YL; Jiao, CH				Qin, Hongde; Chen, Min; Yi, Xianda; Bie, Shu; Zhang, Cheng; Zhang, Youchang; Lan, Jiayang; Meng, Yanyan; Yuan, Youlu; Jiao, Chunhai			Identification of Associated SSR Markers for Yield Component and Fiber Quality Traits Based on Frame Map and Upland Cotton Collections	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; GENETIC-LINKAGE MAP; POPULATION-STRUCTURE; GOSSYPIUM-BARBADENSE; P-VALUES; DISEQUILIBRIUM; DIVERSITY; L.; INFERENCE; LOCI	Detecting QTLs (quantitative trait loci) that enhance cotton yield and fiber quality traits and accelerate breeding has been the focus of many cotton breeders. In the present study, 359 SSR (simple sequence repeat) markers were used for the association mapping of 241 Upland cotton collections. A total of 333 markers, representing 733 polymorphic loci, were detected. The average linkage disequilibrium (LD) decay distances were 8.58 cM (r(2) > 0.1) and 5.76 cM (r(2) > 0.2). 241 collections were arranged into two subgroups using STRUCTURE software. Mixed linear modeling (MLM) methods (with population structure (Q) and relative kinship matrix (K)) were applied to analyze four phenotypic datasets obtained from four environments (two different locations and two years). Forty-six markers associated with the number of bolls per plant (NB), boll weight (BW), lint percentage (LP), fiber length (FL), fiber strength (FS) and fiber micornaire value (FM) were repeatedly detected in at least two environments. Of 46 associated markers, 32 were identified as new association markers, and 14 had been previously reported in the literature. Nine association markers were near QTLs (at a distance of less than 1-2 LD decay on the reference map) that had been previously described. These results provide new useful markers for marker-assisted selection in breeding programs and new insights for understanding the genetic basis of Upland cotton yields and fiber quality traits at the whole-genome level.	[Qin, Hongde; Yi, Xianda; Bie, Shu; Zhang, Cheng; Zhang, Youchang; Lan, Jiayang; Meng, Yanyan] Hubei Acad Agr Sci, Inst Cash Crops, Wuhan, Peoples R China; [Qin, Hongde; Chen, Min; Yi, Xianda; Bie, Shu; Zhang, Cheng; Zhang, Youchang; Lan, Jiayang; Meng, Yanyan] Minist Agr, Key Lab Cotton Biol & Breeding Middle Reaches Cha, Wuhan, Peoples R China; [Yuan, Youlu] Chinese Acad Agr Sci, Inst Cotton Res, Anyan, Peoples R China; [Jiao, Chunhai] Hubei Acad Agr Sci, Wuhan, Peoples R China	Hubei Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Hubei Academy of Agricultural Sciences	Yi, XD (corresponding author), Hubei Acad Agr Sci, Inst Cash Crops, Wuhan, Peoples R China.	13971325545@163.com; jiaoch@hotmail.com	Meng, Yan/HGC-0394-2022; meng, yan/GSE-2653-2022		National Natural Science Foundation of China [30971823]; National Hi-Tech Research and Development Program of China [2012AA101108-03-07]; International S&T Cooperation Program of China [2011DFB31620]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); International S&T Cooperation Program of China	This research was supported by the National Natural Science Foundation of China (Grant No. 30971823), the National Hi-Tech Research and Development Program of China (Grant No. 2012AA101108-03-07), and by International S&T Cooperation Program of China (Grant No. 2011DFB31620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2008, GENOMICS, V92, P478, DOI 10.1016/j.ygeno.2008.07.013; Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cai CP, 2014, J INTEGR PLANT BIOL, V56, P51, DOI 10.1111/jipb.12124; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fang DD, 2013, EUPHYTICA, V191, P391, DOI 10.1007/s10681-013-0886-2; Fountain J., 2011, Peanut Science, V38, P122, DOI 10.3146/PS10-16.1; GIMELFARB A, 1995, THEOR APPL GENET, V91, P522, DOI 10.1007/BF00222983; Goodman SN, 2001, EPIDEMIOLOGY, V12, P295, DOI 10.1097/00001648-200105000-00006; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; He Dao-hua, 2010, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V30, P1557; Katki HA, 2008, AM J EPIDEMIOL, V168, P384, DOI 10.1093/aje/kwn148; Li ChengQi, 2008, Cotton Science, V20, P163; Liang QZ, 2013, CHINESE SCI BULL, V58, P3233, DOI 10.1007/s11434-013-5807-1; Liang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-539; Liu RZ, 2012, MOL BREEDING, V29, P297, DOI 10.1007/s11032-011-9547-0; Liu S, 2000, CROP SCI, V40, P1459, DOI 10.2135/cropsci2000.4051459x; McRae AF, 2002, GENETICS, V160, P1113; Mei HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082193; Mezmouk S, 2011, THEOR APPL GENET, V122, P1149, DOI 10.1007/s00122-010-1519-y; Mohlke KL, 2001, GENOME RES, V11, P1221, DOI 10.1101/gr.173201; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; [秦永生 QIN Yong-Sheng], 2009, [作物学报, Acta Agronomica Sinica], V35, P1812; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Shappley Z. W., 1998, Journal of Cotton Science, V2, P153; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Stich B, 2006, MOL BREEDING, V17, P217, DOI 10.1007/s11032-005-5296-2; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun FD, 2012, MOL BREEDING, V30, P569, DOI 10.1007/s11032-011-9645-z; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Wang BH, 2006, EUPHYTICA, V152, P367, DOI 10.1007/s10681-006-9224-2; Wang FR, 2013, MOL BREEDING, V32, P547, DOI 10.1007/s11032-013-9888-y; Wang FR, 2011, EUPHYTICA, V181, P41, DOI 10.1007/s10681-011-0378-1; Wang Lin, 2012, Cotton Science, V24, P97; Wang P, 2012, THEOR APPL GENET, V124, P1415, DOI 10.1007/s00122-012-1797-7; Whitt Sr, 2003, METH MOL B, V236, P123; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeng LH, 2009, THEOR APPL GENET, V119, P93, DOI 10.1007/s00122-009-1020-7; Zhang JianHong, 2008, Cotton Science, V20, P179; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang ZS, 2011, THEOR APPL GENET, V123, P1075, DOI 10.1007/s00122-011-1649-x; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x; Zhao YL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086308, 10.1371/journal.pone.0099704]	55	42	48	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0118073	10.1371/journal.pone.0118073	http://dx.doi.org/10.1371/journal.pone.0118073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635680	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700115
J	Khurana, S; Coyle, EM; Manischewitz, J; King, LR; Ishioka, G; Alexander, J; Smith, J; Gurwith, M; Golding, H				Khurana, Surender; Coyle, Elizabeth M.; Manischewitz, Jody; King, Lisa R.; Ishioka, Glenn; Alexander, Jeff; Smith, Jon; Gurwith, Marc; Golding, Hana			Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization	PLOS ONE			English	Article							MEMORY B-CELLS; SECRETING CELLS; WILD-TYPE; INFLUENZA; VIRUS; IMMUNOGENICITY; SAFETY; PERSISTENCE; CHIMPANZEES; CHALLENGE	A Phase I trial conducted in 2009-2010 demonstrated that oral vaccination with a replication competent Ad4-H5 (A/Vietnam) vector with dosages ranging from 10(7)-10(11) viral particles was well tolerated. HA-specific T-cell responses were efficiently induced, but very limited hemagglutination-inhibiting (HI) humoral responses were measured. However, a single boost of Ad4-H5-Vtn vaccinated individuals with a unadjuvanted licensed H5N1 (A/Vietnam) subunit vaccine resulted in superior HI titers compared with unprimed subjects. In the current study, the impact of Ad4-H5 priming on the quality of the polyclonal humoral immune response was evaluated using a real-time kinetics assay by surface plasmon resonance (SPR). Total binding of serum polyclonal antibodies from the Ad4-H5-Vtn primed groups against both homologous H5N1-A/Vietnam/1194/2004 (clade 1) and heterologous A/Indonesia- 5/2005 (clade 2.1) HA1 head domain was significantly higher compared with sera from individuals that received subunit H5N1 vaccination alone. SPR measurements also demonstrated that the antigen-antibody complex dissociation rates (a surrogate for antibody affinity) of serum antibodies against the HA1 of H5N1-A/Vietnam were significantly higher in the Ad4-H5 primed groups compared with those from the unprimed group. Furthermore, strong correlations were observed between the antibody affinities for HA1 (but not HA2) and the virus neutralization titers against the homologous strain and a panel of heterologous clade 2 H5N1 strains. These findings support the concept of oral prime-boost vaccine approaches against pandemic influenza to elicit long-term memory B cells with high affinity capable of rapid response to variant pandemic viruses likely to emerge and adapt to human transmissions.	[Khurana, Surender; Coyle, Elizabeth M.; Manischewitz, Jody; King, Lisa R.; Golding, Hana] FDA, CBER, Div Viral Prod, Silver Spring, MD 20903 USA; [Ishioka, Glenn; Alexander, Jeff; Smith, Jon] PaxVax, San Diego, CA 92121 USA; [Gurwith, Marc] PaxVax, Redwood City, CA 94063 USA	US Food & Drug Administration (FDA)	Khurana, S (corresponding author), FDA, CBER, Div Viral Prod, Silver Spring, MD 20903 USA.	surender.khurana@fda.hhs.gov; hana.golding@fda.hhs.gov			Wellcome Trust [Ad4-H5]; PaxVax	Wellcome Trust(Wellcome TrustEuropean Commission); PaxVax	Wellcome Trust funded the development of the Ad4-H5 vector through Phase I clinical trial for PaxVax. Co-authors Glenn Ishioka, Jeff Alexander, Jon Smith and Marc Gurwith are employed by PaxVax. PaxVax provided support in the form of salaries for authors GI, JA, JS and MG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alam S, 2014, J VIROL, V88, P314, DOI 10.1128/JVI.02077-13; Alexander J, 2010, VACCINE, V28, P664, DOI 10.1016/j.vaccine.2009.10.103; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Garcon N, 2012, EXPERT REV VACCINES, V11, P349, DOI [10.1586/erv.11.192, 10.1586/ERV.11.192]; Gurwith M, 2013, LANCET INFECT DIS, V13, P238, DOI 10.1016/S1473-3099(12)70345-6; HYLAND L, 1994, J VIROL, V68, P6083, DOI 10.1128/JVI.68.9.6083-6086.1994; JONES PD, 1987, CELL IMMUNOL, V109, P53, DOI 10.1016/0008-8749(87)90291-7; JONES PD, 1987, VACCINE, V5, P244, DOI 10.1016/0264-410X(87)90109-5; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Khurana S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002920; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; LUBECK MD, 1989, P NATL ACAD SCI USA, V86, P6763, DOI 10.1073/pnas.86.17.6763; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; Moris P, 2011, J CLIN IMMUNOL, V31, P443, DOI 10.1007/s10875-010-9490-6; NATUK RJ, 1994, DEV BIOL STAND, V82, P71; NATUK RJ, 1995, DEV BIOL STAND, V84, P153; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Spensieri F, 2013, P NATL ACAD SCI USA, V110, P14330, DOI 10.1073/pnas.1311998110; Talaat KR, 2014, J INFECT DIS; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Verma S, 2012, J VIROL, V86, P12283, DOI 10.1128/JVI.01596-12; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Zolla-Pazner S, 1998, J VIROL, V72, P1052, DOI 10.1128/JVI.72.2.1052-1059.1998	32	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115476	10.1371/journal.pone.0115476	http://dx.doi.org/10.1371/journal.pone.0115476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629161	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100018
J	Wan, ZH; Wu, YC; Yi, J; You, SL; Liu, HL; Sun, ZQ; Zhu, B; Zang, H; Li, C; Liu, FF; Li, DZ; Mao, YL; Xin, SJ				Wan, Zhihong; Wu, Yichen; Yi, Jing; You, Shaoli; Liu, Hongling; Sun, Zhiqiang; Zhu, Bing; Zang, Hong; Li, Chen; Liu, Fangfang; Li, Dongze; Mao, Yuanli; Xin, Shaojie			Combining Serum Cystatin C with Total Bilirubin Improves Short-Term Mortality Prediction in Patients with HBV-Related Acute-On-Chronic Liver Failure	PLOS ONE			English	Article							RENAL-FUNCTION; DISEASE; MARKER; MODEL; CREATININE; PROGNOSIS; CIRRHOSIS; RISK	Background & Aims HBV-related acute-on-chronic liver failure (HBV-ACLF) is a severe liver disease which results in a high mortality in China. To early predict the prognosis of the patients may prevent the complications and improve the survival. This study was aimed to develop a new prognostic index to estimate the survival related to HBV-ACLF. Methods Consecutive patients with HBV-ACLF were included in a prospective observational study. Serum Cystatin C concentrations were measured by using the particle-enhanced immuno-nephelometry assay. All of the patients were followed for at least 3 months. Cox regression analysis was carried out to identify which factors were predictive of mortality. The area under the receiver operating characteristic curve (AUC) was used to evaluate the efficacy of the variates for early predicting mortality. Results Seventy-two patients with HBV-ACLF were recruited between January 2012 and January 2013. Thirty patients died (41.7%) during 3-months followed up. Cox multivariate regression analysis identified serum cystatin C (CysC) and total bilirubin (TBil) were independent factors significantly (P < 0.01) associated with survival. Our results further showed that new prognostic index (PI) combining serum CysC with TBil was a good indicator for predicting the mortality of patients with HBV-ACLF. Specifically, the PI had a higher accuracy than the CTP, MELD, or MELD-Na scoring for early prediction short-term survival of HBV-ACLF patients with normal levels of serum creatinine (Cr). The survival rate in low risk group (PI < 3.91) was 94.3%, which was markedly higher than those in the high-risk group (PI >= 3.91) (17.4%, P < 0.001). Conclusion We developed a new prognostic index combining serum CysC with TBil which early predicted the short-term mortality of HBV-ACLF patients.	[Wan, Zhihong; Wu, Yichen; You, Shaoli; Liu, Hongling; Zhu, Bing; Zang, Hong; Li, Chen; Liu, Fangfang; Li, Dongze; Xin, Shaojie] Beijing 302 Hosp, Liver Failure Treatment & Res Ctr, Beijing, Peoples R China; [Yi, Jing] Chongqing Med Univ, Sch Publ Hlth & Management, Dept Hlth Stat & Informat Management, Chongqing, Peoples R China; [Sun, Zhiqiang; Mao, Yuanli] Beijing 302 Hosp, Clin Lab Ctr, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Chongqing Medical University; Fifth Medical Center of Chinese PLA General Hospital	Wan, ZH (corresponding author), Beijing 302 Hosp, Liver Failure Treatment & Res Ctr, Beijing, Peoples R China.	wanzhihong302@163.com; xinshaojie302@163.com			Beijing Municipal Science & Technology Commission [Z131107002213018]; National Natural Science Foundation of China [81371800]; 12th Five-Year National Science and Technology Major Project for Infectious Diseases [2012ZX10002004-005]	Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-Year National Science and Technology Major Project for Infectious Diseases(Chinese Academy of Sciences)	This work was supported by Beijing Municipal Science & Technology Commission (No Z131107002213018, to ZW), http://www.bjkw.gov.cn/n8785584/index.html, National Natural Science Foundation of China (No. 81371800, to ZW), http://www.nsfc.gov.cn/ and partially supported by grants from the 12th Five-Year National Science and Technology Major Project for Infectious Diseases (No 2012ZX10002004-005, to SX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomo R, 2004, INTENS CARE MED, V30, P33, DOI 10.1007/s00134-003-2078-3; Cardenas A, 2011, CURR OPIN CRIT CARE, V17, P184, DOI 10.1097/MCC.0b013e328344b3da; Chinese Association of Infectious Diseases and Parasitology Hepatology, 2000, CHINESE J HEPATOLOGY, V6, P324; Cholongitas E, 2007, ALIMENT PHARM THER, V26, P969, DOI 10.1111/j.1365-2036.2007.03443.x; De Souza V, 2014, HEPATOLOGY, V59, P1522, DOI 10.1002/hep.26886; Francoz C, 2012, CRIT CARE, V16, DOI 10.1186/cc11207; Francoz C, 2010, J HEPATOL, V52, P605, DOI 10.1016/j.jhep.2009.11.025; Garg H, 2012, DIGEST LIVER DIS, V44, P166, DOI 10.1016/j.dld.2011.08.029; Gerbes AL, 2002, GUT, V50, P106, DOI 10.1136/gut.50.1.106; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Karvellas CJ, 2010, CRIT CARE MED, V38, P121, DOI 10.1097/CCM.0b013e3181b42a1c; Katoonizadeh A, 2010, GUT, V59, P1561, DOI 10.1136/gut.2009.189639; Ke WM, 2003, J GASTROENTEROL, V38, P861, DOI 10.1007/s00535-003-1162-3; *LIV FAIL ART LIV, 2006, ZHONGHUA GAN ZANG BI, V14, P643; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; NEWMAN DJ, 1995, KIDNEY INT, V47, P312, DOI 10.1038/ki.1995.40; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Seo YS, 2009, LIVER INT, V29, P1521, DOI 10.1111/j.1478-3231.2009.02105.x; Seto WK, 2012, J GASTROEN HEPATOL, V27, P662, DOI 10.1111/j.1440-1746.2011.06971.x; Sharawey MA, 2011, HEPATOL INT, V5, P927, DOI 10.1007/s12072-011-9266-y; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Sun QF, 2009, J VIRAL HEPATITIS, V16, P464, DOI 10.1111/j.1365-2893.2008.01046.x; Wan ZH, 2013, WORLD J GASTROENTERO, V19, P9432, DOI 10.3748/wjg.v19.i48.9432; Wasmuth HE, 2005, J HEPATOL, V42, P195, DOI 10.1016/j.jhep.2004.10.019; Xia Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064379; You SL, 2013, HEPATOL INT, V7, P714, DOI 10.1007/s12072-013-9424-5; Yu JW, 2006, J GASTROEN HEPATOL, V21, P1519, DOI 10.1111/j.1440-1746.2006.04510.x; Zheng MH, 2011, CLIN GASTROENTEROL H, V9, P351, DOI 10.1016/j.cgh.2010.12.027	30	14	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116968	10.1371/journal.pone.0116968	http://dx.doi.org/10.1371/journal.pone.0116968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629773	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100054
J	Choi, SM; Lee, J; Park, YS; Lee, CH; Lee, SM; Yim, JJ; Kim, YW; Han, SK; Yoo, CG				Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Chang-Hoon; Lee, Sang-Min; Yim, Jae-Joon; Kim, Young Whan; Han, Sung Koo; Yoo, Chul-Gyu			Prevalence and Global Initiative for Chronic Obstructive Lung Disease Group Distribution of Chronic Obstructive Pulmonary Disease Detected by Preoperative Pulmonary Function Test	PLOS ONE			English	Article							AIR-FLOW OBSTRUCTION; NONCARDIOTHORACIC SURGERY; COPD; RISK; POPULATION; UNDERDIAGNOSIS; COMPLICATIONS; NONSMOKERS; MORTALITY; BURDEN	Background Despite being a major public health problem, chronic obstructive pulmonary disease (COPD) remains underdiagnosed, and only 2.4% COPD patients are aware of their disease in Korea. The objective of this study was to estimate the prevalence of COPD detected by spirometry performed as a preoperative screening test and to determine the Global Initiative for Chronic Obstructive Lung Disease (GOLD) group distribution and self-awareness of COPD. Methods We reviewed the medical records of adults (age, >= 40 years) who had undergone spirometry during preoperative screening between April and August 2013 at a tertiary hospital in Korea. COPD was defined as a postbronchodilator forced expiratory volume in 1 s/forced vital capacity ratio of <0.7. We analyzed self-administered COPD questionnaires for the assessment of the frequency of acute exacerbation over the previous year and dyspnea severity using the modified Medical Research Council dyspnea scale and COPD assessment test. Results Among 3029 patients aged >40 years who had undergone spirometry as a preoperative screening test, 474 (15.6%; 404 men; median age, 70 years; range, 44-93 years) were diagnosed with COPD. Only 26 (5.5%) patients reported previous diagnosis of COPD (2.1%), emphysema (0.8%), or chronic bronchitis (2.5%). The GOLD group distribution was as follows: 63.3% in group A, 31.2% in group B, 1.7% in group C, and 3.8% in group D. Conclusions The prevalence of COPD diagnosed by preoperative spirometry was 15.6%, and only 5.5% patients were aware of their disease. Approximately one-third of the COPD patients belonged to GOLD groups B, C, and D, which require regular treatment.	[Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Chang-Hoon; Lee, Sang-Min; Yim, Jae-Joon; Kim, Young Whan; Han, Sung Koo; Yoo, Chul-Gyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Div Pulm & Crit Care Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University Hospital	Yoo, CG (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Div Pulm & Crit Care Med, Seoul 151, South Korea.	cgyoo@snu.ac.kr	Lee, Chang-Hoon/AAC-7650-2021	Yim, Jae-Joon/0000-0002-9605-0074				Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Brekke PH, 2008, RESP MED, V102, P1243, DOI 10.1016/j.rmed.2008.04.010; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; Calikoglu M, 2004, RESPIRATION, V71, P45, DOI 10.1159/000075648; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; GrayDonald K, 1996, AM J RESP CRIT CARE, V153, P961, DOI 10.1164/ajrccm.153.3.8630580; Gupta H, 2013, CHEST, V143, P1599, DOI 10.1378/chest.12-1499; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Han MLK, 2013, LANCET RESP MED, V1, P43, DOI 10.1016/S2213-2600(12)70044-9; Jones PW, 2009, COPD, V6, P59, DOI 10.1080/15412550802587943; Kim DS, 2005, AM J RESP CRIT CARE, V172, P842, DOI 10.1164/rccm.200502-259OC; Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435; Licker Marc, 2007, Int J Chron Obstruct Pulmon Dis, V2, P493; Licker MJ, 2006, ANN THORAC SURG, V81, P1830, DOI 10.1016/j.athoracsur.2005.11.048; Linstrom M, 2002, INT J TUBERC LUNG D, V6, P76; Lokke A, 2012, COPD, V9, P458, DOI 10.3109/15412555.2012.685118; Marsh SE, 2008, THORAX, V63, P761, DOI 10.1136/thx.2007.089193; McAlister FA, 2003, AM J RESP CRIT CARE, V167, P741, DOI 10.1164/rccm.200209-985BC; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; Pena VS, 2000, CHEST, V118, P981, DOI 10.1378/chest.118.4.981; Qaseem A, 2006, ANN INTERN MED, V144, P575, DOI 10.7326/0003-4819-144-8-200604180-00008; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Sandelowsky H, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-122; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Takabatake N, 2001, AM J RESP CRIT CARE, V163, P1314, DOI 10.1164/ajrccm.163.6.2004175; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vestbo J, 2012, CLIN RESPIR J, V6, P208, DOI 10.1111/crj.12002; Wada H, 2010, RESPIROLOGY, V15, P1252, DOI 10.1111/j.1440-1843.2010.01854.x; Yoo KH, 2011, RESPIROLOGY, V16, P659, DOI 10.1111/j.1440-1843.2011.01951.x	33	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115787	10.1371/journal.pone.0115787	http://dx.doi.org/10.1371/journal.pone.0115787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625286	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821400010
J	Jung, M; Lee, J; Seo, HY; Lim, JS; Kim, EK				Jung, Minjeong; Lee, Jaemeun; Seo, Hye-Young; Lim, Ji Sun; Kim, Eun-Kyoung			Cathepsin Inhibition-Induced Lysosomal Dysfunction Enhances Pancreatic Beta-Cell Apoptosis in High Glucose	PLOS ONE			English	Article							CHRONIC OXIDATIVE STRESS; ORGANELLAR DYSFUNCTION; MONITORING AUTOPHAGY; CYSTEINE PROTEASES; IMPAIRED AUTOPHAGY; DIABETES-MELLITUS; STORAGE DISEASES; SELF-DIGESTION; LC3; PATHWAYS	Autophagy is a lysosomal degradative pathway that plays an important role in maintaining cellular homeostasis. We previously showed that the inhibition of autophagy causes pancreatic beta-cell apoptosis, suggesting that autophagy is a protective mechanism for the survival of pancreatic beta-cells. The current study demonstrates that treatment with inhibitors and knockdown of the lysosomal cysteine proteases such as cathepsins B and L impair autophagy, enhancing the caspase-dependent apoptosis of INS-1 cells and islets upon exposure to high concentration of glucose. Interestingly, treatment with cathepsin B and L inhibitors prevented the proteolytic processing of cathepsins B, D and L, as evidenced by gradual accumulation of the respective pro-forms. Of note, inhibition of aspartic cathepsins had no effect on autophagy and cell viability, suggesting the selective role of cathepsins B and L in the regulation of beta-cell autophagy and apoptosis. Lysosomal localization of accumulated pro-cathepsins in the presence of cathepsin B and L inhibitors was verified via immunocytochemistry and lysosomal fractionation. Lysotracker staining indicated that cathepsin B and L inhibitors led to the formation of severely enlarged lysosomes in a time-dependent manner. The abnormal accumulation of pro-cathepsins following treatment with inhibitors of cathepsins B and L suppressed normal lysosomal degradation and the processing of lysosomal enzymes, leading to lysosomal dysfunction. Collectively, our findings suggest that cathepsin defects following the inhibition of cathepsin B and L result in lysosomal dysfunction and consequent cell death in pancreatic beta-cells.	[Jung, Minjeong; Lee, Jaemeun; Seo, Hye-Young; Lim, Ji Sun; Kim, Eun-Kyoung] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain Sci, Taegu, South Korea; [Kim, Eun-Kyoung] Daegu Gyeongbuk Inst Sci & Technol, Neurometabol Res Ctr, Taegu, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Kim, EK (corresponding author), Daegu Gyeongbuk Inst Sci & Technol, Dept Brain Sci, Taegu, South Korea.	ekkim@dgist.ac.kr		Lee, Jaemeun/0000-0003-1766-3241	National Research Foundation [2013M3C7A1056099]; Daegu Gyeongbuk Institute of Science and Technology (DGIST) MIREBraiN program; DGIST R&D Program of the Ministry of Science, Information and Communication Technology, and Future Planning [14-BD-0402]	National Research Foundation; Daegu Gyeongbuk Institute of Science and Technology (DGIST) MIREBraiN program; DGIST R&D Program of the Ministry of Science, Information and Communication Technology, and Future Planning	This work was supported by the National Research Foundation (2013M3C7A1056099), the Daegu Gyeongbuk Institute of Science and Technology (DGIST) MIREBraiN program, and the DGIST R&D Program of the Ministry of Science, Information and Communication Technology, and Future Planning (14-BD-0402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bennett BL, 2003, CURR OPIN PHARMACOL, V3, P420, DOI 10.1016/S1471-4892(03)00068-7; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; CHAN SJ, 1986, P NATL ACAD SCI USA, V83, P7721, DOI 10.1073/pnas.83.20.7721; Codogno P, 2006, NAT CELL BIOL, V8, P1045, DOI 10.1038/ncb1006-1045; Elrick MJ, 2013, AUTOPHAGY, V9, P234, DOI 10.4161/auto.22501; ERICKSON AH, 1989, J CELL BIOCHEM, V40, P31, DOI 10.1002/jcb.240400104; Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044; Gukovskaya AS, 2012, AM J PHYSIOL-GASTR L, V303, pG993, DOI 10.1152/ajpgi.00122.2012; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Gukovsky I, 2011, ANTIOXID REDOX SIGN, V15, P2699, DOI 10.1089/ars.2011.4068; Gukovsky I, 2010, AUTOPHAGY, V6, P428, DOI 10.4161/auto.6.3.11530; Han D, 2010, BIOCHEM J, V425, P541, DOI 10.1042/BJ20090429; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; ISHIDOH K, 1987, FEBS LETT, V226, P33, DOI 10.1016/0014-5793(87)80545-8; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Jung HS, 2009, AUTOPHAGY, V5, P241, DOI 10.4161/auto.5.2.7518; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaiser N, 2003, J PEDIATR ENDOCR MET, V16, P5, DOI 10.1515/JPEM.2003.16.1.5; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; KATUNUMA N, 1983, CURR TOP CELL REGUL, V22, P71; Katunuma Nobuhiko, 2010, J Signal Transduct, V2010, P375345, DOI 10.1155/2010/375345; KIDO H, 1986, J IMMUNOL, V136, P1061; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maedler K, 2004, HORM RES, V62, P67, DOI 10.1159/000080503; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Muller S, 2012, BBA-PROTEINS PROTEOM, V1824, P34, DOI 10.1016/j.bbapap.2011.07.003; Otomo T, 2011, J BIOL CHEM, V286, P35283, DOI 10.1074/jbc.M111.267930; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Pitocco Dario, 2010, Rev Diabet Stud, V7, P15, DOI 10.1900/RDS.2010.7.15; PUNNONEN EL, 1992, J HISTOCHEM CYTOCHEM, V40, P1579, DOI 10.1177/40.10.1326577; Quan W, 2013, ARCH PHARM RES, V36, P223, DOI 10.1007/s12272-013-0024-7; Quan W, 2012, EXP MOL MED, V44, P81, DOI 10.3858/emm.2012.44.2.030; Que J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.56; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-5; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saftig P., 2006, PHYSL LYSOSOME; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Turk B, 2000, BBA-PROTEIN STRUCT M, V1477, P98, DOI 10.1016/S0167-4838(99)00263-0; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Uchiyama Y, 2001, ARCH HISTOL CYTOL, V64, P233, DOI 10.1679/aohc.64.233; Victor VM, 2011, CURR PHARM DESIGN, V17, P3947, DOI 10.2174/138161211798764915; Winchester B, 2000, BIOCHEM SOC T, V28, P150, DOI 10.1042/bst0280150; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099	72	61	61	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116972	10.1371/journal.pone.0116972	http://dx.doi.org/10.1371/journal.pone.0116972			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625842	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821400025
J	McMullan, BJ; Desmarini, D; Djordjevic, JT; Chen, SCA; Roper, M; Sorrell, TC				McMullan, Brendan J.; Desmarini, Desmarini; Djordjevic, Julianne T.; Chen, Sharon C-A.; Roper, Michael; Sorrell, Tania C.			Rapid Microscopy and Use of Vital Dyes: Potential to Determine Viability of Cryptococcus neoformans in the Clinical Laboratory	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; COMBINED COHORT; FLOW-CYTOMETRY; MENINGITIS; INFECTION; CELLS	Background Cryptococcus neoformans is the commonest cause of fungal meningitis, with a substantial mortality despite appropriate therapy. Quantitative culture of cryptococci in cerebrospinal fluid (CSF) during antifungal therapy is of prognostic value and has therapeutic implications, but is slow and not practicable in many resource-poor countries. Methods We piloted two rapid techniques for quantifying viable cryptococci using mixtures of live and heat-killed cryptococci cultured in vitro: (i) quantitative microscopy with exclusion staining using trypan blue dye, and (ii) flow cytometry, using the fluorescent dye 2'-7'-Bis-(2-carboxyethyl)-5-(6)-carboxyfluorescein, acetoxymethyl ester (BCECF-AM). Results were compared with standard quantitative cryptococcal cultures. Quantitative microscopy was also performed on cerebrospinal fluid (CSF) samples. Results Both microscopy and flow cytometry distinguished between viable and non-viable cryptococci. Cell counting (on log scale) by microscopy and by quantitative culture were significantly linearly associated (p<0.0001) and Bland-Altman analysis showed a high level of agreement. Proportions of viable cells (on logit scale), as detected by flow cytometry were significantly linearly associated with proportions detected by microscopy (p<0.0001) and Bland-Altman analysis showed a high level of agreement. Conclusions Direct microscopic examination of trypan blue-stained cryptococci and flow-cytometric assessment of BCECF-AM-stained cryptococci were in good agreement with quantitative cultures. These are promising strategies for rapid determination of the viability of cryptococci, and should be investigated in clinical practice.	[McMullan, Brendan J.; Desmarini, Desmarini; Djordjevic, Julianne T.; Chen, Sharon C-A.; Sorrell, Tania C.] Univ Sydney Westmead Hosp, Westmead Millennium Inst, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [McMullan, Brendan J.; Chen, Sharon C-A.] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia; [Desmarini, Desmarini; Djordjevic, Julianne T.; Sorrell, Tania C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW, Australia; [Chen, Sharon C-A.] Westmead Hosp, ICPMR Pathol West, Westmead, NSW, Australia; [Roper, Michael] Univ Sydney, Sydney Med Sch, Westmead Clin Sch, Discipline Infect Dis & Immunol, Westmead, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; University of Sydney; University of Sydney	McMullan, BJ (corresponding author), Sydney Childrens Hosp, Dept Immunol & Infect Dis, Randwick, NSW, Australia.	brendanoch@yahoo.co.uk	Sorrell, Tania/AAZ-5286-2020; McMullan, Brendan/AAR-6174-2020	McMullan, Brendan/0000-0001-5144-3416; Sorrell, Tania/0000-0001-9460-0960; Djordjevic, Julianne/0000-0003-4207-4115	National Health and Medical Research Council of Australia [1050106]; Marie Bashir Institute for Infectious Diseases and Microbiology, University of Sydney; Public Health Capacity Building Infrastructure Grant from New South Wales Health; Centre for Infectious Diseases and Microbiology-Public Health, ICPMR, Westmead (CI-A)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Marie Bashir Institute for Infectious Diseases and Microbiology, University of Sydney; Public Health Capacity Building Infrastructure Grant from New South Wales Health; Centre for Infectious Diseases and Microbiology-Public Health, ICPMR, Westmead (CI-A)	This work was supported by grant #1050106 from the National Health and Medical Research Council of Australia and the Marie Bashir Institute for Infectious Diseases and Microbiology, University of Sydney. TS is a Sydney Medical School Foundation Fellow. MR was funded by a Public Health Capacity Building Infrastructure Grant from New South Wales Health, the Centre for Infectious Diseases and Microbiology-Public Health, ICPMR, Westmead (CI-A, V. Sintchenko). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Barrientos A, 2000, CLIN MICROBIOL REV, V13, P167, DOI 10.1128/CMR.13.2.167-195.2000; [Anonymous], 2006, BCECF PACK INS, P1; [Anonymous], 2010, TRUC TUB PACK INS, P1; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Bicanic T, 2009, AIDS, V23, P701, DOI 10.1097/QAD.0b013e32832605fe; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boyd AR, 2003, FEMS YEAST RES, V3, P11, DOI 10.1016/S1567-1356(02)00125-3; Brouwer AE, 2005, J INFECT DIS, V192, P681, DOI 10.1086/432073; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Carstensen B, 2011, COMP CLIN MEASUREMEN, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Carstensen B., 2013, METHCOMP FUNCTIONS A; Celis JE, 2005, CELL BIOL, P21, DOI [10.1016/j.nepr.2004.02.003, DOI 10.1016/J.NEPR.2004.02.003]; CHAKA W, 1995, CLIN DIAGN LAB IMMUN, V2, P753, DOI 10.1128/CDLI.2.6.753-759.1995; Chen SCA, 2012, CLIN INFECT DIS, V55, P789, DOI 10.1093/cid/cis529; CIMPRICH P, 1995, FEMS MICROBIOL LETT, V130, P245; CORREA B, 1986, MYCOPATHOLOGIA, V96, P91, DOI 10.1007/BF00436666; HAWORTH RS, 1991, BIOCHIM BIOPHYS ACTA, V1098, P79; HIDORE MR, 1991, INFECT IMMUN, V59, P1747, DOI 10.1128/IAI.59.5.1747-1754.1991; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; PERFECT JR, 1983, MEDICINE, V62, P98, DOI 10.1097/00005792-198303000-00003; Robinson PA, 1999, CLIN INFECT DIS, V28, P82, DOI 10.1086/515074; Sigma Aldrich, PROT VIABL CELL COUN; Singh N, 2005, TRANSPLANTATION, V80, P1033, DOI 10.1097/01.tp.0000173774.74388.49; SLAYMAN CL, 1994, J EXP BIOL, V196, P419; Stie J, 2012, MICROBIOL-SGM, V158, P240, DOI 10.1099/mic.0.051524-0; Team RC, 2014, R LANG ENV STAT COMP; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1	28	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117186	10.1371/journal.pone.0117186	http://dx.doi.org/10.1371/journal.pone.0117186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625210	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821400028
J	Wasnik, V; Wingreen, NS; Mukhopadhyay, R				Wasnik, Vaibhav; Wingreen, Ned S.; Mukhopadhyay, Ranjan			Modeling Curvature-Dependent Subcellular Localization of the Small Sporulation Protein SpoVM in Bacillus subtilis	PLOS ONE			English	Article							MEMBRANE CURVATURE; BAR DOMAINS; MECHANISM; CLUSTERS	Recent in vivo experiments suggest that in the bacterium, Bacillus subtilis, the cue for the localization of the small sporulation protein, SpoVM, an essential factor in spore coat formation, is curvature of the bacterial plasma membrane. In vitro measurements of SpoVM adsorption to vesicles of varying sizes also find high sensitivity of adsorption to vesicle radius. This curvature-dependent adsorption is puzzling given the orders of magnitude difference in length scale between an individual protein and the radius of curvature of the cell or vesicle, suggesting protein clustering on the membrane. Here we develop a minimal model to study the relationship between curvature-dependent membrane adsorption and clustering of SpoVM. Based on our analysis, we hypothesize that the radius dependence of SpoVM adsorption observed in vitro is governed primarily by membrane tension, while for in-vivo localization of SpoVM, we propose a highly sensitive mechanism for curvature sensing based on the formation of macroscopic protein clusters on the membrane.	[Wasnik, Vaibhav; Mukhopadhyay, Ranjan] Clark Univ, Dept Phys, Worcester, MA 01610 USA; [Wingreen, Ned S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Clark University; Princeton University	Mukhopadhyay, R (corresponding author), Clark Univ, Dept Phys, Worcester, MA 01610 USA.	ranjan@clarku.edu			NIH [R01 GM082938]; NSF [PHY08-48550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH Grant R01 GM082938, NSF Grant PHY08-48550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bhatia VK, 2010, SEMIN CELL DEV BIOL, V21, P381, DOI 10.1016/j.semcdb.2009.12.004; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09; Destainville N, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051403; Destainville N, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011905; Evans AR, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.041907; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Gitai Z, 2009, CURR OPIN MICROBIOL, V12, P341, DOI 10.1016/j.mib.2009.03.001; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; Groenewold J, 2001, J PHYS CHEM B, V105, P11702, DOI 10.1021/jp011646w; Gurry T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006148; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Huang KC, 2010, MOL MICROBIOL, V76, P822, DOI 10.1111/j.1365-2958.2010.07168.x; JOACHIM OR, 1995, PHYS REV E, V51, P4526; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Meilhac N, 2011, J PHYS CHEM B, V115, P7190, DOI 10.1021/jp1099865; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PHILLIPS R, 2008, PHYSICAL BIOLOGY OF; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Sciortino F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.055701; Segre PN, 2001, PHYS REV LETT, V86, P6042, DOI 10.1103/PhysRevLett.86.6042; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Singh P, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051906; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Stradner A, 2004, NATURE, V432, P492, DOI 10.1038/nature03109; Ursell T, 2007, PLOS COMPUT BIOL, V3, P803, DOI 10.1371/journal.pcbi.0030081; van Ooiij C, 2004, J BACTERIOL, V186, P4441, DOI 10.1128/JB.186.14.4441-4448.2004; van Ooij C, 2003, J BACTERIOL, V185, P1391, DOI 10.1128/JB.185.4.1391-1398.2003; Weikl TR, 1998, PHYS REV E, V57, P6988, DOI 10.1103/PhysRevE.57.6988; Zhu C, 2012, BIOPHYS J, V102, P1837, DOI 10.1016/j.bpj.2012.03.039	33	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0111971	10.1371/journal.pone.0111971	http://dx.doi.org/10.1371/journal.pone.0111971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625300	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821400001
J	Castro-Garcia, P; Diaz-Moreno, M; Gil-Gas, C; Fernandez-Gomez, FJ; Honrubia-Gomez, P; Alvarez-Simon, CB; Sanchez-Sanchez, F; Cano, JCC; Almeida, F; Blanco, V; Jordan, J; Mira, H; Ramirez-Castillejo, C				Castro-Garcia, Paola; Diaz-Moreno, Maria; Gil-Gas, Carmen; Fernandez-Gomez, Francisco J.; Honrubia-Gomez, Paloma; Belen Alvarez-Simon, Carmen; Sanchez-Sanchez, Francisco; Castillo Cano, Juan Carlos; Almeida, Francisco; Blanco, Vicente; Jordan, Joaquin; Mira, Helena; Ramirez-Castillejo, Carmen			Defects in subventricular zone pigmented epithelium-derived factor niche signaling in the senescence-accelerated mouse prone-8	FASEB JOURNAL			English	Article						self-renewal; neural stem cell; PEDF; accelerated senescence; long-term LRC	NEURAL STEM-CELLS; ADULT MAMMALIAN FOREBRAIN; MURINE MODEL; PAX6; BRAIN; MAINTENANCE; EXPRESSION; NEURONS; CANCER; PEDF	We studied potential changes in the sub-ventricular zone (SVZ) stem cell niche of the senescence-accelerated mouse prone-8 (SAM-P8) aging model. Bromodeoxyuridine (BrdU) assays with longtime survival revealed a lower number of label-retaining stem cells in the SAM-P8 SVZ compared with the SAM-Resistant 1 (SAM-R1) control strain. We also found that in SAM-P8 niche signaling is attenuated and the stem cell pool is less responsive to the self-renewal niche factor pigmented epithelium-derived factor (PEDF). Protein analysis demonstrated stable amounts of the PEDF ligand in the SAM-P8 SVZ niche; however, SAM-P8 stem cells present a significant expression decrease of patatin-like phospholipase domain containing 2, a receptor for PEDF (PNPLA2-PEDF) receptor, but not of laminin receptor (LR), a receptor for PEDF (LR-PEDF) receptor. We observed changes in self-renewal related genes (hairy and enhancer of split 1 (Hes1), hairy and enhancer of split 1 (Hes5), Sox2] and report that although these genes are down-regulated in SAM-P8, differentiation genes (Pax6) are up-regulated and neurogenesis is increased. Finally, sheltering mammalian telomere complexes might be also involved given a down-regulation of telomeric repeat binding factor 1 (Terf1) expression was observed in SAM-P8 at young age periods. Differences between these 2 models, SAM-P8 and SAM-R1 controls, have been previously detected at more advanced ages. We now describe alterations in the PEDF signaling pathway and stem cell self-renewal at a very young age, which could be involved in the premature senescence observed in the SAM-P8 model.	[Castro-Garcia, Paola; Gil-Gas, Carmen; Honrubia-Gomez, Paloma; Belen Alvarez-Simon, Carmen; Ramirez-Castillejo, Carmen] Univ Castilla La Mancha, Ctr Reg Invest Biomed, Lab Celulas Madre, Albacete, Spain; [Diaz-Moreno, Maria; Mira, Helena] Inst Salud Carlos III, Unidad Func Invest Enfermedades Cron, Madrid, Spain; [Fernandez-Gomez, Francisco J.; Jordan, Joaquin] Univ Castilla La Mancha, Dept Ciencias Med, Grp Neurofarmacol, Albacete, Spain; [Sanchez-Sanchez, Francisco] Univ Castilla La Mancha, Fac Med Albacete, Area Genet, Albacete, Spain; [Sanchez-Sanchez, Francisco; Jordan, Joaquin] Univ Castilla La Mancha, Inst Invest Discapacidades Neurol, Albacete, Spain; [Castillo Cano, Juan Carlos; Almeida, Francisco; Blanco, Vicente] Univ La Laguna, Dept Estadis IO & Computac, E-38207 San Cristobal la Laguna, Canarias, Spain	Universidad de Castilla-La Mancha; Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC); Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de la Laguna	Ramirez-Castillejo, C (corresponding author), 12 October Hosp UFIEC, ISCIII, Carretera Majadahonda Pozuelo Km 2, Madrid 28220, Spain.	cramirezcastillejo@externos.isciii.es	, francisco/ABF-7718-2021; Fernández-Gómez, Francisco José/GOP-0463-2022; Castro-Garcia, Paola/GMX-3341-2022; Blanco, Vicente/K-9678-2014; Ramirez-Castillejo, Carmen/S-7276-2019; Almeida, Francisco/L-1746-2014	Blanco, Vicente/0000-0003-1166-6310; Ramirez-Castillejo, Carmen/0000-0002-1877-3381; Almeida, Francisco/0000-0002-1279-9636; Fernandez-Gomez, Francisco Jose/0000-0002-7891-8634; Mira, Helena/0000-0001-8574-9544	Asociacion Espanola Contra el Cancer; program of the Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria) [PI081746]; Ministerio de Sanidad y Consumo [04005-00]; Consejeria de Sanidad from Junta de Comunidades de Castilla-La Mancha [PI2007/55]; Comision Interministerial de Ciencia y Tecnologia [SAF2008-05143-C03-1]; Spanish Ministerio de Economia y Competitividad, Fondo de Investigacion Sanitaria [PI12/101]; Comunidad de Madrid [S2010/BMD-2336]; Consejo Nacional de Ciencia y Tecnologia; Spanish Ministerio de Educacion;  [205933]	Asociacion Espanola Contra el Cancer; program of the Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Consejeria de Sanidad from Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Spanish Ministerio de Economia y Competitividad, Fondo de Investigacion Sanitaria; Comunidad de Madrid(Comunidad de Madrid); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Spanish Ministerio de Educacion(Spanish Government); 	The authors thank Rafael Hortiguela for technical support. This work was supported by grants from the Asociacion Espanola Contra el Cancer, the program of the Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria PI081746), and Ministerio de Sanidad y Consumo (04005-00), the Consejeria de Sanidad from Junta de Comunidades de Castilla-La Mancha (PI2007/55); Grant SAF2008-05143-C03-1 from Comision Interministerial de Ciencia y Tecnologia to J.J. and Grant PI12/101 from the Spanish Ministerio de Economia y Competitividad, Fondo de Investigacion Sanitaria and S2010/BMD-2336 from Comunidad de Madrid to H.M. C.R.C. was investigator of the "Ramon y Cajal Programme" from the Spanish "Ministerio de Educacion y Ciencia". P.C.G. has a Consejo Nacional de Ciencia y Tecnologia fellowship for foreign study (Mexico City, Mexico); ID Scholarship 205933. M.D.M. is a recipient of a predoctoral fellowship (FPU) from the Spanish Ministerio de Educacion. The authors declare that no competing financial interests exist and also declare no sources of funding and no contracts relating to this research.	Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Barnstable CJ, 2004, PROG RETIN EYE RES, V23, P561, DOI 10.1016/j.preteyeres.2004.05.002; Batista LFZ, 2014, PROG MOL BIOL TRANSL, V125, P67, DOI 10.1016/B978-0-12-397898-1.00003-7; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Blasco M. A., 2014, INT S ADV ONC THER R; Cao W, 1999, J NEUROSCI RES, V57, P789, DOI 10.1002/(SICI)1097-4547(19990915)57:6<789::AID-JNR4>3.3.CO;2-D; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Castillo CA, 2009, EXP GERONTOL, V44, P453, DOI 10.1016/j.exger.2009.04.006; Castillo J. C., 2014, 1 WORKSH APPL PAR CO; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Diaz-Moreno M, 2013, NEUROBIOL AGING, V34, P2623, DOI 10.1016/j.neurobiolaging.2013.05.011; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Flood JF, 1998, NEUROSCI BIOBEHAV R, V22, P1; Galli R, 2003, CIRC RES, V92, P598, DOI 10.1161/01.RES.0000065580.02404.F4; Gang BZ, 2011, BRAIN RES, V1389, P183, DOI 10.1016/j.brainres.2011.03.039; Gomez-Lopez S, 2011, GLIA, V59, P1588, DOI 10.1002/glia.21201; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; HANSON I, 1995, TRENDS GENET, V11, P268, DOI 10.1016/S0168-9525(00)89073-3; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Fernandez-Gomez FJ, 2008, CHEM-BIOL INTERACT, V175, P332, DOI 10.1016/j.cbi.2008.05.010; Fernandez-Gomez FJ, 2010, J NEUROSCI RES, V88, P155, DOI 10.1002/jnr.22177; Kallos MS, 1999, BIOTECHNOL BIOENG, V65, P589, DOI 10.1002/(SICI)1097-0290(19991205)65:5<589::AID-BIT12>3.0.CO;2-S; Kioussi C, 1999, P NATL ACAD SCI USA, V96, P14378, DOI 10.1073/pnas.96.25.14378; Klapper W, 2001, J NEUROSCI RES, V64, P252, DOI 10.1002/jnr.1073.abs; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Kojima T, 2006, MOL CELL BIOCHEM, V293, P63, DOI 10.1007/s11010-006-2680-0; Kuimov AN, 2004, BIOCHEMISTRY-MOSCOW+, V69, P117, DOI 10.1023/B:BIRY.0000018941.81962.1c; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Manuel M, 2005, BRAIN RES BULL, V66, P387, DOI 10.1016/j.brainresbull.2005.02.006; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Martinez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Osumi N, 2001, TOHOKU J EXP MED, V193, P163, DOI 10.1620/tjem.193.163; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Porlan E, 2013, NAT NEUROSCI, V16, P1567, DOI 10.1038/nn.3545; Pumiglia K, 2006, NAT NEUROSCI, V9, P299, DOI 10.1038/nn0306-299; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Santos A, 2007, LECT NOTES COMPUT SC, V4758, P225; Sevigny JJ, 2008, NEUROLOGY, V71, P1702, DOI 10.1212/01.wnl.0000335163.88054.e7; Smith CP, 2007, EXP EYE RES, V85, P817, DOI 10.1016/j.exer.2007.08.017; Steinle JJ, 2008, J GERONTOL A-BIOL, V63, P135, DOI 10.1093/gerona/63.2.135; Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X; Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8; Tomobe K, 2005, PHYSIOL BEHAV, V84, P505, DOI 10.1016/j.physbeh.2004.12.012; Van Kirk CA, 2011, MOL VIS, V17, P1261; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7	59	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1480	1492		10.1096/fj.13-244442	http://dx.doi.org/10.1096/fj.13-244442			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25636741				2022-12-26	WOS:000354115000033
J	Karlberg, T; Klepsch, M; Thorsell, AG; Andersson, CD; Linusson, A; Schuler, H				Karlberg, Tobias; Klepsch, Mirjam; Thorsell, Ann-Gerd; Andersson, C. David; Linusson, Anna; Schuler, Herwig			Structural Basis for Lack of ADP-ribosyltransferase Activity in Poly(ADP-ribose) Polymerase-13/Zinc Finger Antiviral Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; Molecular Dynamics; Post-translational Modification (PTM); Virus; X-ray Crystallography	CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; RNA HELICASE; FAMILY; PARP; ZAP; INHIBITION; SELECTION; COMPLEX; BINDING	Background: PARP13 contains a divergent PARP homology ADP-ribosyltransferase domain of unknown function. Results: The consensus NAD(+) pocket of PARP13 is occluded by interacting protein side chains. Conclusion: PARP13 lacks the structural requirements for NAD(+) binding. Significance: Evolutionary conservation of enzymatic inactivity suggests a need for a rigid domain structure. The mammalian poly(ADP-ribose) polymerase (PARP) family includes ADP-ribosyltransferases with diphtheria toxin homology (ARTD). Most members have mono-ADP-ribosyltransferase activity. PARP13/ARTD13, also called zinc finger antiviral protein, has roles in viral immunity and microRNA-mediated stress responses. PARP13 features a divergent PARP homology domain missing a PARP consensus sequence motif; the domain has enigmatic functions and apparently lacks catalytic activity. We used x-ray crystallography, molecular dynamics simulations, and biochemical analyses to investigate the structural requirements for ADP-ribosyltransferase activity in human PARP13 and two of its functional partners in stress granules: PARP12/ARTD12, and PARP15/BAL3/ARTD7. The crystal structure of the PARP homology domain of PARP13 shows obstruction of the canonical active site, precluding NAD(+) binding. Molecular dynamics simulations indicate that this closed cleft conformation is maintained in solution. Introducing consensus side chains in PARP13 did not result in 3-aminobenzamide binding, but in further closure of the site. Three-dimensional alignment of the PARP homology domains of PARP13, PARP12, and PARP15 illustrates placement of PARP13 residues that deviate from the PARP family consensus. Introducing either one of two of these side chains into the corresponding positions in PARP15 abolished PARP15 ADP-ribosyltransferase activity. Taken together, our results show that PARP13 lacks the structural requirements for ADP-ribosyltransferase activity.	[Karlberg, Tobias; Thorsell, Ann-Gerd; Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden; [Karlberg, Tobias; Klepsch, Mirjam; Thorsell, Ann-Gerd; Schuler, Herwig] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Andersson, C. David; Linusson, Anna] Umea Univ, Dept Chem, S-90187 Umea, Sweden	Karolinska Institutet; Karolinska Institutet; Umea University	Schuler, H (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501	Structural Genomics Consortium from Canadian Institutes for Health Research [1097737]; Canada Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Swedish Society for Medical Research; Swedish Research Council; Umea University; Swedish Cancer Society; IngaBritt & Arne Lundbergs research foundation	Structural Genomics Consortium from Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Society for Medical Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University; Swedish Cancer Society(Swedish Cancer Society); IngaBritt & Arne Lundbergs research foundation	This work was supported by the Structural Genomics Consortium, a registered charity (Number 1097737) that received funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.; Supported by a stipend from the Swedish Society for Medical Research.; Supported by the Swedish Research Council and Umea University.; Supported by the Swedish Foundation for Strategic Research, the Swedish Research Council, the Swedish Cancer Society, and IngaBritt & Arne Lundbergs research foundation. To whom correspondence should be addressed: Dept.of Medical Biochemistry and Biophysics, Karolinska lnstitutet, 17177 Stockholm, Sweden. Tel.: 46-8-52486840; Fax: 46-8-52486868; E-mail: herwig.schuler@ki.se.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Aguiar RCT, 2000, BLOOD, V96, P4328, DOI 10.1182/blood.V96.13.4328.h8004328_4328_4334; Andersson CD, 2012, J MED CHEM, V55, P7706, DOI 10.1021/jm300746d; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Blanc E., 2011, BUSTER VERSION 2 11; BLANKE SR, 1994, BIOCHEMISTRY-US, V33, P5155, DOI 10.1021/bi00183a019; Cagliani R, 2012, MOL BIOL EVOL, V29, P1599, DOI 10.1093/molbev/mss002; Case A.D., 2012, AMBER 12; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Chen SD, 2012, NAT STRUCT MOL BIOL, V19, P430, DOI 10.1038/nsmb.2243; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Jeong MS, 2010, BIOCHEM BIOPH RES CO, V396, P696, DOI 10.1016/j.bbrc.2010.04.164; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlberg T, 2012, J BIOL CHEM, V287, P24077, DOI 10.1074/jbc.M112.379289; Karlberg T, 2010, J MED CHEM, V53, P5352, DOI 10.1021/jm100249w; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; Leung AKL, 2012, RNA BIOL, V9, P542, DOI 10.4161/rna.19899; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; Molecular Operating Environment (MOE), 2019, MOL OP ENV MOE; Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Ruf A, 1998, J MOL BIOL, V278, P57, DOI 10.1006/jmbi.1998.1673; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Todorova T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6362; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Zhu YP, 2008, RNA BIOL, V5, P65, DOI 10.4161/rna.5.2.6044	53	45	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7336	7344		10.1074/jbc.M114.630160	http://dx.doi.org/10.1074/jbc.M114.630160			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25635049	hybrid, Green Published			2022-12-26	WOS:000351613600002
J	Astegiano, J; Massol, F; Vidal, MM; Cheptou, PO; Guimaraes, PR				Astegiano, Julia; Massol, Francois; Vidal, Mariana Morais; Cheptou, Pierre-Olivier; Guimaraes, Paulo R., Jr.			The Robustness of Plant-Pollinator Assemblages: Linking Plant Interaction Patterns and Sensitivity to Pollinator Loss	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; REPRODUCTIVE SUSCEPTIBILITY; COEVOLUTIONARY NETWORKS; HABITAT FRAGMENTATION; POLLEN LIMITATION; SEED-DISPERSAL; MATING SYSTEM; BAKERS LAW; SPECIALIZATION; NESTEDNESS	Most flowering plants depend on pollinators to reproduce. Thus, evaluating the robustness of plant-pollinator assemblages to species loss is a major concern. How species interaction patterns are related to species sensitivity to partner loss may influence the robustness of plant-pollinator assemblages. In plants, both reproductive dependence on pollinators (breeding system) and dispersal ability may modulate plant sensitivity to pollinator loss. For instance, species with strong dependence (e.g. dioecious species) and low dispersal (e.g. seeds dispersed by gravity) may be the most sensitive to pollinator loss. We compared the interaction patterns of plants differing in dependence on pollinators and dispersal ability in a meta-dataset comprising 192 plant species from 13 plant-pollinator networks. In addition, network robustness was compared under different scenarios representing sequences of plant extinctions associated with plant sensitivity to pollinator loss. Species with different dependence on pollinators and dispersal ability showed similar levels of generalization. Although plants with low dispersal ability interacted with more generalized pollinators, low-dispersal plants with strong dependence on pollinators (i.e. the most sensitive to pollinator loss) interacted with more particular sets of pollinators (i.e. shared a low proportion of pollinators with other plants). Only two assemblages showed lower robustness under the scenario considering plant generalization, dependence on pollinators and dispersal ability than under the scenario where extinction sequences only depended on plant generalization (i.e. where higher generalization level was associated with lower probability of extinction). Overall, our results support the idea that species generalization and network topology may be good predictors of assemblage robustness to species loss, independently of plant dispersal ability and breeding system. In contrast, since ecological specialization among partners may increase the probability of disruption of interactions, the fact that the plants most sensitive to pollinator loss interacted with more particular pollinator assemblages suggest that the persistence of these plants and their pollinators might be highly compromised.	[Astegiano, Julia; Massol, Francois; Cheptou, Pierre-Olivier] Univ Montpellier 3, Univ Montpellier, CNRS, CEFE UMR 5175, F-34032 Montpellier, France; [Astegiano, Julia; Vidal, Mariana Morais; Guimaraes, Paulo R., Jr.] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Massol, Francois] Univ Lille 1, CNRS UMR 8198, Lab GEPV, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; Universite Paul-Valery; Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Lille - ISITE; Universite de Lille	Astegiano, J (corresponding author), Univ Montpellier 3, Univ Montpellier, CNRS, CEFE UMR 5175, EPHE Campus CNRS, F-34032 Montpellier, France.	juastegiano@gmail.com	Guimaraes, Paulo R./E-1915-2016; Guimarães-Junior, Paulo R/M-1298-2016; Vidal, Mariana Morais/B-1216-2013; Massol, Francois/D-9872-2013	Guimaraes, Paulo R./0000-0001-9161-8305; Vidal, Mariana Morais/0000-0003-0863-7818; Massol, Francois/0000-0002-4098-955X; Astegiano, Julia/0000-0003-0583-7291	Sao Paulo Research Foundation-FAPESP [2011/09951-2, 2012/04941-1, 2010/11633-6, 2009/54422-8]; CNPq	Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	JA was supported by grant 2011/09951-2 and grant 2012/04941-1 (Sao Paulo Research Foundation-FAPESP, http://www.fapesp.br); MMV was supported by grant 2010/11633-6 (Sao Paulo Research Foundation-FAPESP, http://www.fapesp.br); FM and POC are researchers from the CNRS; and PRG Jr. was supported by grant 2009/54422-8 (Sao Paulo Research Foundation-FAPESP, http://www.fapesp.br) and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JD, 2012, OIKOS, V121, P1821, DOI 10.1111/j.1600-0706.2011.20193.x; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aizen M.A., 2006, ECOLOGY EVOLUTION FL, P159; Aizen MA, 2002, J VEG SCI, V13, P885, DOI 10.1111/j.1654-1103.2002.tb02118.x; Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; [Anonymous], MATLAB STAT TOOLB RE; [Anonymous], 2013, R PROJECT STAT COMPU; Ashworth L, 2004, J ECOL, V92, P717, DOI 10.1111/j.0022-0477.2004.00910.x; Ashworth L, 2009, BIOL CONSERV, V142, P1050, DOI 10.1016/j.biocon.2009.01.016; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; BAKER HG, 1967, EVOLUTION, V21, P853, DOI 10.1111/j.1558-5646.1967.tb03440.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; BAWA KS, 1994, AM J BOT, V81, P456, DOI 10.2307/2445495; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Cheptou PO, 2012, ANN BOT-LONDON, V109, P633, DOI 10.1093/aob/mcr127; Cheptou PO, 2009, AM NAT, V174, P46, DOI 10.1086/599303; Cresswell JE, 2000, ECOL ENTOMOL, V25, P19, DOI 10.1046/j.1365-2311.2000.00230.x; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Evans DM, 2013, ECOL LETT, V16, P844, DOI 10.1111/ele.12117; Fenster CB, 2007, INT J PLANT SCI, V168, P215, DOI 10.1086/509647; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gomez JM, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P145; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Heilbuth JC, 2001, EVOLUTION, V55, P880, DOI 10.1554/0014-3820(2001)055[0880:TCODFS]2.0.CO;2; HERRERA CM, 1988, BIOL J LINN SOC, V35, P95, DOI 10.1111/j.1095-8312.1988.tb00461.x; HUGHES L, 1994, J ECOL, V82, P933, DOI 10.2307/2261456; James A, 2012, NATURE, V487, P227, DOI 10.1038/nature11214; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Lever JJ, 2014, ECOL LETT, V17, P350, DOI 10.1111/ele.12236; Marten-Rodriguez S, 2010, ECOLOGY, V91, P155, DOI 10.1890/08-2115.1; Massol F, 2011, EVOLUTION, V65, P591, DOI 10.1111/j.1558-5646.2010.01134.x; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Ollerton J, 2007, TAXON, V56, P717, DOI 10.2307/25065856; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Perez F, 2009, AM J BOT, V96, P1168, DOI 10.3732/ajb.0800306; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; ROUBIK DW, 1987, OECOLOGIA, V73, P321, DOI 10.1007/BF00385247; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Sahli HF, 2006, OECOLOGIA, V148, P365, DOI 10.1007/s00442-006-0396-1; Schuett EM, 2010, EVOL BIOL, V37, P19, DOI 10.1007/s11692-010-9082-7; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vidal MM, 2013, BIOL CONSERV, V163, P42, DOI 10.1016/j.biocon.2013.03.025; Vieira MC, 2014, ECOL LETT IN PRESS; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6	64	26	26	6	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117243	10.1371/journal.pone.0117243	http://dx.doi.org/10.1371/journal.pone.0117243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646762	gold, Green Published, Green Submitted			2022-12-26	WOS:000348822600060
J	Gabor, KA; Kim, D; Kim, CH; Hess, ST				Gabor, Kristin A.; Kim, Dahan; Kim, Carol H.; Hess, Samuel T.			Nanoscale Imaging of Caveolin-1 Membrane Domains In Vivo	PLOS ONE			English	Article							FLUORESCENT PROTEINS; SINGLE-MOLECULE; ZEBRAFISH; MICROSCOPY; MODEL; DISEASE; CELLS; ORGANIZATION; INFECTION; EMISSION	Light microscopy enables noninvasive imaging of fluorescent species in biological specimens, but resolution is generally limited by diffraction to similar to 200-250 nm. Many biological processes occur on smaller length scales, highlighting the importance of techniques that can image below the diffraction limit and provide valuable single-molecule information. In recent years, imaging techniques have been developed which can achieve resolution below the diffraction limit. Utilizing one such technique, fluorescence photoactivation localization microscopy (FPALM), we demonstrated its ability to construct super-resolution images from single molecules in a living zebrafish embryo, expanding the realm of previous super-resolution imaging to a living vertebrate organism. We imaged caveolin-1 in vivo, in living zebrafish embryos. Our results demonstrate the successful image acquisition of super-resolution images in a living vertebrate organism, opening several opportunities to answer more dynamic biological questions in vivo at the previously inaccessible nanoscale.	[Gabor, Kristin A.; Kim, Dahan; Hess, Samuel T.] Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA; [Gabor, Kristin A.; Kim, Carol H.] Univ Maine, Grad Sch Biomed Sci, Orono, ME 04469 USA; [Gabor, Kristin A.; Kim, Carol H.; Hess, Samuel T.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Kim, CH (corresponding author), Univ Maine, Grad Sch Biomed Sci, Orono, ME 04469 USA.	carolkim@maine.edu; sam.hess@umit.maine.edu		Kim, Carol/0000-0002-0465-4496	National Institutes of Health [R15-GM094713, K25-AI65459, RO1 GM087308, R15A1065509]; National Science Foundation (NSF) [IGERT-0221625, MRI CHE-0722759]; Maine Technology Institute MTAF [1106, 2061]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [451, 452, P20RR024475-01A2]; Maine Agricultural and Forest Experiment Station Publication [3400]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI065459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103534, R01GM087308, R15GM094713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Maine Technology Institute MTAF; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Maine Agricultural and Forest Experiment Station Publication; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (R15-GM094713, K25-AI65459, RO1 GM087308 and R15A1065509), National Science Foundation (NSF IGERT-0221625 and NSF MRI CHE-0722759) and Maine Technology Institute MTAF (1106 and 2061). Research reported in this publication was also supported by an Institutional Development Award (IDeA) 451 from the National Institute of General Medical Sciences of the National Institutes of Health under grant 452 number 20RR024475-01A2, and Maine Agricultural and Forest Experiment Station Publication #3400. The funders had no role in study design, data collection	Bassett DI, 2003, DEVELOPMENT, V130, P5851, DOI 10.1242/dev.00799; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2008, NAT METHODS, V5, P947, DOI 10.1038/nmeth.1258; Biteen JS, 2011, METHODS MOL BIOL, V783, P139, DOI 10.1007/978-1-61779-282-3_8; Biteen JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000448; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Chudakov DM, 2007, BIOTECHNIQUES, V42, P553, DOI 10.2144/000112470; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Gabor KG, 2011, MICROSCOPY TODAY, V19, P12; Gabor KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068759; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Goody MF, 2010, DEV BIOL, V344, P809, DOI 10.1016/j.ydbio.2010.05.513; Gould TJ, 2008, METHOD CELL BIOL, V89, P329, DOI 10.1016/S0091-679X(08)00612-2; Gould TJ, 2009, NAT PROTOC, V4, P291, DOI 10.1038/nprot.2008.246; Gould TJ, 2008, NAT METHODS, V5, P1027, DOI 10.1038/nmeth.1271; Gudheti MV, 2013, BIOPHYS J, V104, P2182, DOI 10.1016/j.bpj.2013.03.054; Gunewardene MS, 2011, BIOPHYS J, V101, P1522, DOI 10.1016/j.bpj.2011.07.049; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hess ST, 2009, METHODS MOL BIOL, V544, P483, DOI 10.1007/978-1-59745-483-4_32; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Lee SH, 2012, OPT EXPRESS, V20, P12177, DOI 10.1364/OE.20.012177; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; Mione M, 2009, ZEBRAFISH, V6, P445, DOI 10.1089/zeb.2009.0638; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Phelan PE, 2005, J VIROL, V79, P1842, DOI 10.1128/JVI.79.3.1842-1852.2005; Phennicie RT, 2010, INFECT IMMUN, V78, P4542, DOI 10.1128/IAI.00302-10; Prouty MG, 2003, FEMS MICROBIOL LETT, V225, P177, DOI 10.1016/S0378-1097(03)00446-4; Rankin BR, 2011, BIOPHYS J, V100, pL63, DOI 10.1016/j.bpj.2011.05.020; Reck-Peterson S. L., 2010, COLD SPRING HARB PRO, DOI 10/1101/pdb.top73; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schaaf MJM, 2009, BIOPHYS J, V97, P1206, DOI 10.1016/j.bpj.2009.05.044; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002	46	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117225	10.1371/journal.pone.0117225	http://dx.doi.org/10.1371/journal.pone.0117225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646724	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600059
J	Gao, Y; Zong, CJ; Liu, F; Fang, L; Cai, RL; Shi, Y; Chen, X; Qi, Y				Gao, Yuan; Zong, Chuanjie; Liu, Fen; Fang, Lei; Cai, Runlan; Shi, Yue; Chen, Xi; Qi, Yun			Evaluation of the Intestinal Transport of a Phenylethanoid Glycoside-Rich Extract from Cistanche deserticola across the Caco-2 Cell Monolayer Model	PLOS ONE			English	Article							PERMEABILITY; ABSORPTION; PREDICTION; SYSTEM	Phenylethanoid glycosides (PhGs), a class of polyphenolic compounds, are considered one of major bioactive constituents of Cistanche deserticola Y.C. Ma (CD), whose extract is orally used in traditional Chinese medicine. Although previous pharmacological studies have reported that PhGs exert many activities, their intestinal transport profiles have not been clarified. In this study, we investigated the intestinal permeability of a PhG-rich extract (PRE) from CD as an integrated system in the Caco-2 cell monolayer model using a bioassay system. The results showed that PRE is primarily transported via poorly absorbed passive diffusion down a concentration gradient without efflux, which provides the pharma-cokinetic basis for the clinical application of PhGs in CD. We also determined the intestinal permeability of three major PhGs [acteoside (AC), isoacteoside (IS) and echinacoside (EC)] by HLPC. Furthermore, we developed a novel HPLC-fluorescence detection method to accurately determine the flux amount of AC and IS. As expected, the transport characteristics of the three PhGs are consistent with those of PRE, indicating that the present bioassay system is appropriate and reliable for the evaluation of the transport characteristics of active ingredient groups (AIG) in PRE. Moreover, this system may also be suitable for other plant extracts given appropriate bioactivity.	[Gao, Yuan; Liu, Fen; Fang, Lei; Cai, Runlan; Shi, Yue; Chen, Xi; Qi, Yun] Chinese Acad Med Sci, Inst Med Plant Dev, Dept Res Ctr Pharmacol & Toxicol, Beijing 100730, Peoples R China; [Gao, Yuan; Liu, Fen; Fang, Lei; Cai, Runlan; Shi, Yue; Chen, Xi; Qi, Yun] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zong, Chuanjie] Heilongjiang Univ Chinese Med, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Heilongjiang University of Chinese Medicine	Chen, X (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Dept Res Ctr Pharmacol & Toxicol, Beijing 100730, Peoples R China.	chenxi@implad.ac.cn; yqi@implad.ac.cn	Fang, Lei/HHN-8887-2022	Fang, Lei/0000-0001-9980-8285	National Natural Science Foundation of China [81173645, 81274163]; Ministry of Science and Technology of the People's Republic of China [2012ZX09301-002-001, 2014ZX09201022-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (Nos. 81173645 and 81274163) and National S&T Major Project and Scientific Researchers Aiding Enterprise Item (Nos. 2012ZX09301-002-001 and 2014ZX09201022-006) from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Artursson P, 2001, ADV DRUG DELIVER REV, V46, P27, DOI 10.1016/S0169-409X(00)00128-9; Cai RL, 2010, PHYTOTHER RES, V24, P313, DOI 10.1002/ptr.2927; [蔡润兰 CAI Run-lan], 2008, [中国药学杂志, Chinese Pharmaceutical Journal], V43, P1871; Center for Drug Evaluation and Research, 2004, GUID IND BOT DRUG PR, P5; Center for Drug Evaluation and Research, 2012, GUID IND DRUG INT ST, P64, DOI [10.1177/0091270007312153, DOI 10.1177/0091270007312153]; Dong Q, 2007, CARBOHYD RES, V342, P1343, DOI 10.1016/j.carres.2007.03.017; Eguchi A, 2005, FREE RADICAL RES, V39, P1367, DOI 10.1080/10715760500045624; Fu G, 2008, CURR MED CHEM, V15, P2592, DOI 10.2174/092986708785908996; Jiang Y, 2009, J CHROMATOGR A, V1216, P1970, DOI 10.1016/j.chroma.2008.07.031; Jung SJ, 2006, J PHARMACEUT BIOMED, V41, P469, DOI 10.1016/j.jpba.2005.12.020; Li N, 2012, PLANTA MED, V78, P692, DOI 10.1055/s-0031-1298368; MURAI M, 1995, PLANTA MED, V61, P479, DOI 10.1055/s-2006-958143; RANALDI G, 1992, ANTIMICROB AGENTS CH, V36, P1374, DOI 10.1128/AAC.36.7.1374; Sandri G, 2007, EUR J PHARM BIOPHARM, V65, P68, DOI 10.1016/j.ejpb.2006.07.016; The State Commission of Chinese Pharmacopoeia, 2010, PHARM PEOPL 2 REP 1, P126, DOI [10.1016/j.ijpddr.2014.09.001, DOI 10.1016/J.IJPDDR.2014.09.001]; Wang LN, 2008, XI BEI YAO XUE ZA ZH, V23, P67; Wang M, 2008, AM J CHINESE MED, V36, P1199, DOI 10.1142/S0192415X08006521; Wang T, 2012, AM J CHINESE MED, V40, P1123, DOI 10.1142/S0192415X12500838; Xiong Q, 2000, EUR J PHARMACOL, V400, P137, DOI 10.1016/S0014-2999(00)00354-X; Xiong QB, 1996, BIOL PHARM BULL, V19, P1580, DOI 10.1248/bpb.19.1580; Xiong QB, 1998, PLANTA MED, V64, P120, DOI 10.1055/s-2006-957387; Yamashita S, 2000, EUR J PHARM SCI, V10, P195, DOI 10.1016/S0928-0987(00)00076-2; Yang DZ, 2013, J CHROMATOGR SCI, V51, P716, DOI 10.1093/chromsci/bmt057; Yang XW, 2010, PLANTA MED, V76, P1587, DOI 10.1055/s-0030-1249810; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Zhao B, 2011, PLANTA MED, V77, P1531, DOI 10.1055/s-0030-1270741	27	17	19	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116490	10.1371/journal.pone.0116490	http://dx.doi.org/10.1371/journal.pone.0116490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646971	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600026
J	Jiang, XX; Dang, HY; Jiao, NZ				Jiang, Xuexia; Dang, Hongyue; Jiao, Nianzhi			Ubiquity and Diversity of Heterotrophic Bacterial nasA Genes in Diverse Marine Environments	PLOS ONE			English	Article							NITRATE ASSIMILATION GENES; HARMFUL ALGAL BLOOMS; DISSOLVED ORGANIC-MATTER; ALTEROMONAS-MACLEODII; COMPARATIVE GENOMICS; INTERACTIVE TREE; NITROGEN UPTAKE; BARENTS SEA; PHYTOPLANKTON; BACTERIOPLANKTON	Nitrate uptake by heterotrophic bacteria plays an important role in marine N cycling. However, few studies have investigated the diversity of environmental nitrate assimilating bacteria (NAB). In this study, the diversity and biogeographical distribution of NAB in several global oceans and particularly in the western Pacific marginal seas were investigated using both cultivation and culture-independent molecular approaches. Phylogenetic analyses based on 16S rRNA and nasA (encoding the large subunit of the assimilatory nitrate reductase) gene sequences indicated that the cultivable NAB in South China Sea belonged to the alpha-Proteobacteria, gamma-Proteobacteria and CFB (Cytophaga-Flavobacteria-Bacteroides) bacterial groups. In all the environmental samples of the present study, alpha-Proteobacteria, gamma-Proteobacteria and Bacteroidetes were found to be the dominant nasA-harboring bacteria. Almost all of the alpha-Proteobacteria OTUs were classified into three Roseobacter-like groups (I to III). Clone library analysis revealed previously underestimated nasA diversity; e.g. the nasA gene sequences affiliated with beta-Proteobacteria, epsilon-Proteobacteria and Lentisphaerae were observed in the field investigation for the first time, to the best of our knowledge. The geographical and vertical distributions of seawater nasA-harboring bacteria indicated that NAB were highly diverse and ubiquitously distributed in the studied marginal seas and world oceans. Niche adaptation and separation and/or limited dispersal might mediate the NAB composition and community structure in different water bodies. In the shallow-water Kueishantao hydrothermal vent environment, chemolithoautotrophic sulfur-oxidizing bacteria were the primary NAB, indicating a unique nitrate-assimilating community in this extreme environment. In the coastal water of the East China Sea, the relative abundance of Alteromonas and Roseobacter-like nasA gene sequences responded closely to algal blooms, indicating that NAB may be active participants contributing to the bloom dynamics. Our statistical results suggested that salinity, temperature and nitrate may be some of the key environmental factors controlling the composition and dynamics of the marine NAB communities.	[Jiang, Xuexia; Dang, Hongyue; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361102, Peoples R China; [Jiang, Xuexia; Dang, Hongyue; Jiao, Nianzhi] Xiamen Univ, Inst Marine Microbes & Ecospheres, Xiamen 361102, Peoples R China	Xiamen University; Xiamen University	Dang, HY (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361102, Peoples R China.	DangHY@xmu.edu.cn	Dang, Hongyue/H-6577-2019		China MOST 973 grant [2013CB955700]; NSFC [91028001, 91328209, 91428308]; SOA grant [201105021]	China MOST 973 grant; NSFC(National Natural Science Foundation of China (NSFC)); SOA grant	This work was supported by China MOST 973 grant 2013CB955700 (http://www.973.gov.cn/English/Index.aspx), NSFC grants 91028001, 91328209, and 91428308 (http://www.nsfc.gov.cn/publish/portal1), and SOA grant 201105021 (http://www.soa.gov.cn/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhitya A, 2007, MICROB ECOL, V54, P587, DOI 10.1007/s00248-006-9175-0; Allen AE, 2005, AQUAT MICROB ECOL, V39, P247, DOI 10.3354/ame039247; Allen AE, 2002, J MARINE SYST, V38, P93, DOI 10.1016/S0924-7963(02)00171-9; Allen AE, 2001, APPL ENVIRON MICROB, V67, P5343, DOI 10.1128/AEM.67.11.5343-5348.2001; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Bano N, 2002, APPL ENVIRON MICROB, V68, P505, DOI 10.1128/AEM.68.2.505-518.2002; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453; Brinkhoff T, 1999, APPL ENVIRON MICROB, V65, P3843; Burger M, 2003, SOIL BIOL BIOCHEM, V35, P29, DOI 10.1016/S0038-0717(02)00233-X; Burland T G, 2000, Methods Mol Biol, V132, P71; Cai HY, 2008, MICROB ECOL, V56, P751, DOI 10.1007/s00248-008-9394-7; Chen CTA, 2005, CHEM GEOL, V224, P69, DOI 10.1016/j.chemgeo.2005.07.022; Chen YC, 2011, BREAKING FEM WAVES, P1, DOI 10.1057/9780230119185; Church MJ, 2000, APPL ENVIRON MICROB, V66, P455, DOI 10.1128/AEM.66.2.455-466.2000; DANDONNEAU Y, 1992, J GEOPHYS RES-OCEANS, V97, P3581, DOI 10.1029/91JC02848; Dang HY, 2008, MICROBIOL-SGM, V154, P2084, DOI 10.1099/mic.0.2007/013581-0; Davidson K, 2007, LIMNOL OCEANOGR, V52, P2147, DOI 10.4319/lo.2007.52.5.2147; Fernandez-Gomez B, 2013, ISME J, V7, P1026, DOI 10.1038/ismej.2012.169; Fouilland E, 2007, J PLANKTON RES, V29, P369, DOI 10.1093/plankt/fbm022; Gorfer M, 2011, ISME J, V5, P1771, DOI 10.1038/ismej.2011.53; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; HJ Qu, 2011, REG ENV CHANG J, V6, P1; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; Hu AY, 2010, FRESHWATER BIOL, V55, P2375, DOI 10.1111/j.1365-2427.2010.02454.x; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Jacquet S, 2002, MAR ECOL PROG SER, V228, P3, DOI 10.3354/meps228003; Jiao NZ, 2011, NAT REV MICROBIOL, V9, DOI 10.1038/nrmicro2386-c2; Joint I, 2002, AQUAT MICROB ECOL, V29, P145, DOI 10.3354/ame029145; Kirchman DL, 2013, ENV MICROBIOL REP, V5, P188, DOI 10.1111/j.1758-2229.2012.00367.x; KIRCHMAN DL, 2000, UPTAKE REGENERATION; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Kudela RM, 2010, PROG OCEANOGR, V85, P122, DOI 10.1016/j.pocean.2010.02.008; Lee K, 2007, INT J SYST EVOL MICR, V57, P1653, DOI 10.1099/ijs.0.64960-0; Leps J, 2003, MULTIVARIATE ANAL EC; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu KK, 2002, DEEP-SEA RES PT I, V49, P1387, DOI 10.1016/S0967-0637(02)00035-3; Lopez-Lopez A, 2005, ENVIRON MICROBIOL, V7, P649, DOI 10.1111/j.1462-2920.2005.00733.x; Luque-Almagro VM, 2011, BIOCHEM SOC T, V39, P1838, DOI 10.1042/BST20110688; Mann AJ, 2013, APPL ENVIRON MICROB, V79, P6813, DOI 10.1128/AEM.01937-13; McBride MJ, 2009, APPL ENVIRON MICROB, V75, P6864, DOI 10.1128/AEM.01495-09; Middelburg JJ, 2000, MAR ECOL PROG SER, V203, P13, DOI 10.3354/meps203013; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Pedler BE, 2014, P NATL ACAD SCI USA, V111, P7202, DOI 10.1073/pnas.1401887111; Rodrigues RMNV, 2002, LIMNOL OCEANOGR, V47, P1608, DOI 10.4319/lo.2002.47.6.1608; Romera-Castillo C, 2011, APPL ENVIRON MICROB, V77, P7490, DOI 10.1128/AEM.00200-11; Rowe JM, 2012, FEMS MICROBIOL ECOL, V79, P359, DOI 10.1111/j.1574-6941.2011.01223.x; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041204; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thrash JC, 2010, J BACTERIOL, V192, P5552, DOI 10.1128/JB.00873-10; TIBBLES BJ, 1994, MICROBIAL ECOL, V27, P65, DOI 10.1007/BF00170115; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wawrik B, 2012, FEMS MICROBIOL ECOL, V79, P400, DOI 10.1111/j.1574-6941.2011.01226.x; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Yan WJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003575; Yang TF, 2005, GEOCHEM J, V39, P469, DOI 10.2343/geochemj.39.469; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819	65	16	18	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117473	10.1371/journal.pone.0117473	http://dx.doi.org/10.1371/journal.pone.0117473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647610	gold, Green Published, Green Submitted			2022-12-26	WOS:000348822600070
J	Zhang, YS; Li, YQ; Deng, JH; Ji, ZG; Yu, HY; Li, HZ				Zhang, Yushi; Li, Yongqiang; Deng, Jianhua; Ji, Zhigang; Yu, Hongyan; Li, Hanzhong			Sorafenib Neoadjuvant Therapy in the Treatment of High Risk Renal Cell Carcinoma	PLOS ONE			English	Article							GUIDELINES; EFFICACY; ADJUVANT	Objective To evaluate the clinical efficacy of sorafenib as preoperative neoadjuvant therapy in patients with high risk renal cell carcinoma (RCC). Materials and Methods Clinical data of 18 patients with high risk RCC who received surgery done successfully after preoperative neoadjuvant therapy with sorafenib in Peking Union Medical College Hospital (PUMCH) from April 2007 to October 2013 have been reviewed and analyzed in this study. Results Among the 18 patients there were 13 male and 5 female, with a median age of 54.6 years. The objective response rate (ORR) of the operation on the selected patients is very high (94.4%), including 4 cases (22.2%) of partial response (PR) and 13 cases (72.2%) of stable disease (SD). After preoperative sorafenib treatment, the average tumor size of the 18 patients decreased from 7.8 cm (ranging from 3.6 to 19.2 cm) to 6.2 cm (ranging from 2.4 to 16.8 cm), and the median value of average tumor CT value decreased from 61HU to 52 HU. Among the 5 patients who had IVC tumor thrombi, the grades of tumor thrombi in 2 patients who were grade II before sorafenib treatment became grade I and grade 0 respectively, 2 patients of grade III both became grade II. Conclusion Preoperative neoadjuvant therapy with sorafenib for high risk RCC patients can significantly decrease primary tumor volume as well as tumor thrombus, which could help the nephron-sparing surgery (NSS) or radical nephrectomy to be done successfully.	[Zhang, Yushi; Li, Yongqiang; Deng, Jianhua; Ji, Zhigang; Yu, Hongyan; Li, Hanzhong] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Urol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Li, HZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Urol, Beijing 100730, Peoples R China.	lihanzhongpro@126.com	Yu, Houyong/R-1592-2016	Yu, Houyong/0000-0002-6543-5924				Baccala A, 2007, INT J UROL, V14, P1095, DOI 10.1111/j.1442-2042.2007.01902.x; Choueiri M, 2011, CURR CLIN PHARMACOL, V6, P144, DOI 10.2174/157488411797189415; Chow WH, 2013, CANCER-AM CANCER SOC, V119, P388, DOI 10.1002/cncr.27690; Di Silverio F, 2008, UROL INT, V80, P451, DOI 10.1159/000132708; Dutcher JP, 2013, THER ADV UROL, V5, P338, DOI 10.1177/1756287213505672; Escudier B, 2012, ANN ONCOL, V23, P65, DOI 10.1093/annonc/mds227; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; King SC, 2014, J UROLOGY, V191, P1665, DOI 10.1016/j.juro.2013.12.046; LAW TM, 1995, CANCER-AM CANCER SOC, V76, P824, DOI 10.1002/1097-0142(19950901)76:5<824::AID-CNCR2820760517>3.0.CO;2-N; Miles KA, 2012, EUR RADIOL, V22, P1430, DOI 10.1007/s00330-012-2379-4; Porta C, 2009, ANTI-CANCER DRUG, V20, P409, DOI 10.1097/CAD.0b013e32831fb500; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Schrader AJ, 2012, INT J UROL, V19, P903, DOI 10.1111/j.1442-2042.2012.03065.x; Strumberg D, 2012, EXPERT OPIN PHARMACO, V13, P407, DOI 10.1517/14656566.2012.654776; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tobert CM, 2013, UROL ONCOL-SEMIN ORI, V31, P1316, DOI 10.1016/j.urolonc.2011.12.014; Weikert S, 2010, WORLD J UROL, V28, P247, DOI 10.1007/s00345-010-0555-1; Yang L, 2012, ONCOL LETT, V3, P935, DOI 10.3892/ol.2012.585; Ye DW, 2014, ONCOTARGETS THER, V7, P925, DOI 10.2147/OTT.S41828; Zhang HL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-249	20	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115896	10.1371/journal.pone.0115896	http://dx.doi.org/10.1371/journal.pone.0115896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647522	gold, Green Published, Green Submitted			2022-12-26	WOS:000348822600016
J	Trend, S; Strunk, T; Hibbert, J; Kok, CH; Zhang, GC; Doherty, DA; Richmond, P; Burgner, D; Simmer, K; Davidson, DJ; Currie, AJ				Trend, Stephanie; Strunk, Tobias; Hibbert, Julie; Kok, Chooi Heen; Zhang, Guicheng; Doherty, Dorota A.; Richmond, Peter; Burgner, David; Simmer, Karen; Davidson, Donald J.; Currie, Andrew J.			Antimicrobial Protein and Peptide Concentrations and Activity in Human Breast Milk Consumed by Preterm Infants at Risk of Late-Onset Neonatal Sepsis	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; GASTROINTESTINAL-TRACT; BACTERICIDAL ACTIVITY; HUMAN LACTOFERRIN; LYSOZYME; TERM; GUT; IDENTIFICATION; TRANSLOCATION; DEFENSINS	Objective We investigated the levels and antimicrobial activity of antimicrobial proteins and peptides (AMPs) in breast milk consumed by preterm infants, and whether deficiencies of these factors were associated with late-onset neonatal sepsis (LOS), a bacterial infection that frequently occurs in preterm infants in the neonatal period. Study design Breast milk from mothers of preterm infants (<= 32 weeks gestation) was collected on days 7 (n = 88) and 21 (n = 77) postpartum. Concentrations of lactoferrin, LL-37, beta-defensins 1 and 2, and alpha-defensin 5 were measured by enzyme-linked immunosorbent assay. The antimicrobial activity of breast milk samples against Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, and Streptococcus agalactiae was compared to the activity of infant formula, alone or supplemented with physiological levels of AMPs. Samples of breast milk fed to infants with and without subsequent LOS were compared for levels of AMPs and inhibition of bacterial growth. Results Levels of most AMPs and antibacterial activity in preterm breast milk were higher at day 7 than at day 21. Lactoferrin was the only AMP that limited pathogen growth >50% when added to formula at a concentration equivalent to that present in breast milk. Levels of AMPs were similar in the breast milk fed to infants with and without LOS, however, infants who developed LOS consumed significantly less breast milk and lower doses of milk AMPs than those who were free from LOS. Conclusions The concentrations of lactoferrin and defensins in preterm breast milk have antimicrobial activity against common neonatal pathogens.	[Trend, Stephanie; Strunk, Tobias; Kok, Chooi Heen; Simmer, Karen; Currie, Andrew J.] Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA 6009, Australia; [Trend, Stephanie; Strunk, Tobias; Hibbert, Julie; Richmond, Peter; Simmer, Karen; Currie, Andrew J.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Strunk, Tobias; Kok, Chooi Heen; Simmer, Karen] King Edward Mem Hosp Women, Neonatal Clin Care Unit, Perth, WA, Australia; [Zhang, Guicheng] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Doherty, Dorota A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Burgner, David] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Burgner, David] Univ Melbourne, Melbourne, Vic, Australia; [Davidson, Donald J.] Univ Edinburgh, MRC Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Currie, Andrew J.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia	University of Western Australia; University of Western Australia; King Edward Memorial Hospital; University of Western Australia; Curtin University; University of Western Australia; Murdoch Children's Research Institute; University of Melbourne; University of Edinburgh; Murdoch University	Currie, AJ (corresponding author), Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA 6009, Australia.	a.currie@murdoch.edu.au	Strunk, Tobias/AIE-3407-2022; Zhang, Brad/AAF-8719-2021; Richmond, Peter C/G-3379-2012; Currie, Andrew/C-2778-2015	Strunk, Tobias/0000-0001-7079-2339; Richmond, Peter C/0000-0001-7562-7228; Simmer, Karen/0000-0003-4777-9069; Trend, Stephanie/0000-0003-0210-3452; Burgner, David/0000-0002-8304-4302; Currie, Andrew/0000-0002-5193-3404; Zhang, Guicheng/0000-0001-9888-5385; Hibbert, Julie/0000-0002-8839-3966	National Health and Medical Research Council [572548, APP1064629]; Princess Margaret Hospital Foundation; Telethon New Childrens Hospital Research Fund; Clive and Vera Ramaciotti Foundation; Medical Research Council [G1002046]; Murdoch University; Honorary National Heart Foundation Australia Future Leader Fellowship [100026]; Victorian Government's Operational Infrastructure Support Program; Brightspark Foundation Fellowship; Women and Infants Research Foundation; MRC [G1002046] Funding Source: UKRI	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Princess Margaret Hospital Foundation; Telethon New Childrens Hospital Research Fund; Clive and Vera Ramaciotti Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Murdoch University; Honorary National Heart Foundation Australia Future Leader Fellowship; Victorian Government's Operational Infrastructure Support Program; Brightspark Foundation Fellowship; Women and Infants Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was awarded to AC, TS, KS, PR, DAD and DB by the National Health and Medical Research Council (572548; www.nhmrc.gov.au), to AC, TS, KS and DB from the Princess Margaret Hospital Foundation (www.pmhfoundation.com), to AC, DJD, TS, and DB from the Telethon New Childrens Hospital Research Fund (http://www.health.wa.gov.au), and to TS from the Clive and Vera Ramaciotti Foundation (www.perpetual.com.au/ramaciotti). DJD is supported by a Medical Research Council Senior Non-clinical Fellowship (G1002046; http://www.mrc.ac.uk) and a Distinguished Collaborator Award from Murdoch University (www.murdoch.edu.au). DB is supported by a National Health and Medical Research Council Senior Research Fellowship (APP1064629; www.nhmrc.gov.au) and an Honorary National Heart Foundation Australia Future Leader Fellowship (100026; www.heartfoundation.org.au). Research at the Murdoch Childrens Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program (www.vic.gov.au). GZ is supported by a Brightspark Foundation Fellowship (www.brightsparkfoundation.com.au). ST is supported by an Australian postgraduate award (www.education.gov.au), and postgraduate scholarships from the Women and Infants Research Foundation (www.wirf.com.au) and the Princess Margaret Hospital Foundation (www.pmhfoundation.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila A, 2001, FEMS IMMUNOL MED MIC, V31, P145, DOI 10.1111/j.1574-695X.2001.tb00511.x; AKIN IM, 2014, AM J PERINATOL, P13897; Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297; ARNOLD RR, 1980, INFECT IMMUN, V28, P893; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Beaumont PE, 2013, ANTIMICROBIAL PEPTID, P97; Bera A, 2006, INFECT IMMUN, V74, P4598, DOI 10.1128/IAI.00301-06; Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; Campos LF, 2013, J PEDIAT-BRAZIL, V89, P394, DOI 10.1016/j.jped.2012.12.003; Carl MA, 2014, CLIN INFECT DIS, V58, P1211, DOI 10.1093/cid/ciu084; Castellote C, 2011, J NUTR, V141, P1181, DOI 10.3945/jn.110.133652; Chan Gary M, 2003, J Perinatol, V23, P620, DOI 10.1038/sj.jp.7211003; Chantry CJ, 2011, BREASTFEED MED, V6, P111, DOI 10.1089/bfm.2010.0078; Chen XJ, 2005, J DERMATOL SCI, V40, P123, DOI 10.1016/j.jdermsci.2005.03.014; DAWARKADAS AM, 1991, J TROP PEDIATRICS, V37, P214, DOI 10.1093/tropej/37.5.214; de Ferrer PAR, 2000, J AM COLL NUTR, V19, P370; Edde L, 2001, AM J PHYSIOL-GASTR L, V281, pG1140, DOI 10.1152/ajpgi.2001.281.5.G1140; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Findlay EG, 2013, BIODRUGS, V27, P479, DOI 10.1007/s40259-013-0039-0; Guerrero A, 2014, MOL CELL PROTEOMICS, V13, P3343, DOI 10.1074/mcp.M113.036194; HUTCHENS TW, 1991, PEDIATR RES, V29, P243, DOI 10.1203/00006450-199103000-00005; Isaacs D, 2003, ARCH DIS CHILD-FETAL, V88, pF89, DOI 10.1136/fn.88.2.F89; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; KOO WWK, 1982, ARCH DIS CHILD, V57, P500, DOI 10.1136/adc.57.7.500; Lavoie PM, 2009, J PERINATOL, V29, P448, DOI 10.1038/jp.2009.8; Legrand D, 2012, BIOCHEM CELL BIOL, V90, P252, DOI [10.1139/O11-056, 10.1139/o11-056]; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Leitch EC, 1999, J MED MICROBIOL, V48, P867, DOI 10.1099/00222615-48-9-867; Leitch EC, 1999, CURR EYE RES, V19, P12, DOI 10.1076/ceyr.19.1.12.5342; Manzoni P, 2009, JAMA-J AM MED ASSOC, V302, P1421, DOI 10.1001/jama.2009.1403; Mehta R, 2011, BREASTFEED MED, V6, P21, DOI 10.1089/bfm.2010.0024; Mitoulas LR, 2002, BRIT J NUTR, V88, P29, DOI [10.1079/BJN2002579, 10.1079/BJNBJN2002579]; Montagne P, 2001, ADV EXP MED BIOL, V501, P241; NGUYEN DN, 2013, BR J NUTR, P1; Pammi M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007137.pub3; Patel AL, 2013, J PERINATOL, V33, P514, DOI 10.1038/jp.2013.2; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005; Ronnestad A, 2005, PEDIATRICS, V115, pE269, DOI 10.1542/peds.2004-1833; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Silvestre D, 2006, BRIT J BIOMED SCI, V63, P59, DOI 10.1080/09674845.2006.11732721; Sinha Mau, 2013, Int J Pept, V2013, P390230, DOI 10.1155/2013/390230; Soeorg H, 2013, PEDIATR INFECT DIS J, V32, P389, DOI 10.1097/INF.0b013e3182791abd; Steinwender G, 1996, PEDIATR RES, V39, P415, DOI 10.1203/00006450-199603000-00007; Van Gysel M, 2012, EUR J PEDIATR, V171, P1231, DOI 10.1007/s00431-012-1750-4; Velona T, 1999, PEDIATR RES, V45, P658, DOI 10.1203/00006450-199905010-00008; Venkatesh MP, 2008, J MED MICROBIOL, V57, P1113, DOI 10.1099/jmm.0.2008/001263-0; Wagner CL, 2008, CLIN REV ALLERG IMMU, V34, P191, DOI 10.1007/s12016-007-8032-3; Wang XF, 2014, BRIT J NUTR, V111, P867, DOI 10.1017/S0007114513003292; Yen CC, 2009, J INFECT DIS, V199, P590, DOI 10.1086/596212	53	48	50	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117038	10.1371/journal.pone.0117038	http://dx.doi.org/10.1371/journal.pone.0117038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643281	Green Published, gold			2022-12-26	WOS:000348821200031
J	Chen, L; Chu, C; Kong, XY; Huang, T; Cai, YD				Chen, Lei; Chu, Chen; Kong, Xiangyin; Huang, Tao; Cai, Yu-Dong			Discovery of New Candidate Genes Related to Brain Development Using Protein Interaction Information	PLOS ONE			English	Article							NEURAL DEVELOPMENT; MESSENGER-RNA; HORMONE GHRH; EXPRESSION; PREDICTION; SECRETIN; CASPASE; PATHWAY; COMPLEX; ROLES	Human brain development is a dramatic process composed of a series of complex and fine-tuned spatiotemporal gene expressions. A good comprehension of this process can assist us in developing the potential of our brain. However, we have only limited knowledge about the genes and gene functions that are involved in this biological process. Therefore, a substantial demand remains to discover new brain development-related genes and identify their biological functions. In this study, we aimed to discover new brain-development related genes by building a computational method. We referred to a series of computational methods used to discover new disease-related genes and developed a similar method. In this method, the shortest path algorithm was executed on a weighted graph that was constructed using protein-protein interactions. New candidate genes fell on at least one of the shortest paths connecting two known genes that are related to brain development. A randomization test was then adopted to filter positive discoveries. Of the final identified genes, several have been reported to be associated with brain development, indicating the effectiveness of the method, whereas several of the others may have potential roles in brain development.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai 200444, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China; [Chu, Chen] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Kong, Xiangyin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Chu, Chen/J-6527-2019; Chen, Lei/A-2275-2011	Chu, Chen/0000-0001-8084-0867; Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [31371335, 61202021, 61373028, 61303099]; Innovation Program of the Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; Shanghai Educational Development Foundation [12CG55]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Educational Development Foundation	This work was supported by the National Basic Research Program of China (2011CB510101, 2011CB510102), the National Natural Science Foundation of China (31371335, 61202021, 61373028, 61303099), the Innovation Program of the Shanghai Municipal Education Commission (12YZ120, 12ZZ087), and the Shanghai Educational Development Foundation (12CG55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1989, MOLECULAR BIOLOGY OF; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Brouwers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022187; Chang LR, 2011, MICROSC RES TECHNIQ, V74, P153, DOI 10.1002/jemt.20886; CHANG TM, 1985, PEPTIDES, V6, P193, DOI 10.1016/0196-9781(85)90039-7; Chen C, 2011, BIOCHEM BIOPH RES CO, V411, P360, DOI 10.1016/j.bbrc.2011.06.148; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107767; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen Ming, 2005, In Silico Biology, V5, P111; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Deng M, 2014, GENE EXPR PATTERNS, V15, P31, DOI 10.1016/j.gep.2014.03.001; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Doerfler P, 2000, J IMMUNOL, V164, P4071, DOI 10.4049/jimmunol.164.8.4071; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; Gao P, 2012, PROTEIN PEPTIDE LETT, V19, P910, DOI 10.2174/092986612802084528; Gao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045944; Gautam V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-4; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gormen T. H., 1990, INTRO ALGORITHMS; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Hayashi M, 2002, NEPHROL DIAL TRANSPL, V17, P8, DOI 10.1093/ndt/17.suppl_9.8; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inestrosa NC, 2012, J NEUROIMMUNE PHARM, V7, P788, DOI 10.1007/s11481-012-9417-5; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang M, 2013, MOL BIOSYST, V9, P2720, DOI 10.1039/c3mb70089e; Kuranaga E, 2011, DEV GROWTH DIFFER, V53, P137, DOI 10.1111/j.1440-169X.2010.01237.x; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lako M, 1998, HUM MOL GENET, V7, P813, DOI 10.1093/hmg/7.5.813; Laviolette SR, 2006, CELL MOL LIFE SCI, V63, P1597, DOI 10.1007/s00018-006-6027-5; Li BQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/267375; Li XW, 2014, STEM CELL TRANSL MED, V3, P662, DOI 10.5966/sctm.2013-0015; Liao WT, 2014, J PATHOL, V232, P415, DOI 10.1002/path.4309; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Lossi L, 2004, EUR J NEUROSCI, V20, P3259, DOI 10.1111/j.1460-9568.2004.03816.x; Maki RA, 2009, J BIOL CHEM, V284, P3158, DOI 10.1074/jbc.M807731200; Malaterre J, 2007, FRONT BIOSCI-LANDMRK, V12, P492, DOI 10.2741/2077; Matalova E, 2012, ARCH ORAL BIOL, V57, P1474, DOI 10.1016/j.archoralbio.2012.06.009; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Miranda LA, 2002, INT J DEV NEUROSCI, V20, P503, DOI 10.1016/S0736-5748(02)00057-6; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; ODONOHUE TL, 1981, P NATL ACAD SCI-BIOL, V78, P5221, DOI 10.1073/pnas.78.8.5221; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Piper M, 2014, J NEUROSCI, V34, P2921, DOI 10.1523/JNEUROSCI.2319-13.2014; Plaimas K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-67; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sheikh AM, 2010, J NEUROSCI RES, V88, P2641, DOI 10.1002/jnr.22416; Siu FKY, 2005, GENE EXPR PATTERNS, V5, P445, DOI 10.1016/j.modgep.2004.09.001; TAKAHASHI T, 1995, ENDOCRINOLOGY, V136, P4721, DOI 10.1210/en.136.10.4721; Temme C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00143; Waters EM, 2009, J NEUROSCI, V29, P9714, DOI 10.1523/JNEUROSCI.0135-09.2009; Waters M J, 2011, Pediatr Endocrinol Rev, V9, P549; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Xu K, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00137; Yakovlev A, 2010, GENE, V450, P103, DOI 10.1016/j.gene.2009.10.008; Yamagata T, 2008, NEUROSCIENCE, V154, P1417, DOI 10.1016/j.neuroscience.2008.04.037; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Zou M, 2012, DEV BIOL, V364, P114, DOI 10.1016/j.ydbio.2012.01.021	69	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0118003	10.1371/journal.pone.0118003	http://dx.doi.org/10.1371/journal.pone.0118003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635857	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700111
J	Xu, J; Huang, HM; Huang, G; Mo, S				Xu Jing; Huang Haiming; Huang Guo; Mo Song			Numerical Simulation of Supersonic Gap Flow	PLOS ONE			English	Article							CAVITY	Various gaps in the surface of the supersonic aircraft have a significant effect on airflows. In order to predict the effects of attack angle, Mach number and width-to-depth ratio of gap on the local aerodynamic heating environment of supersonic flow, two-dimensional compressible Navier-Stokes equations are solved by the finite volume method, where convective flux of space term adopts the Roe format, and discretization of time term is achieved by 5-step Runge-Kutta algorithm. The numerical results reveal that the heat flux ratio is U-shaped distribution on the gap wall and maximum at the windward corner of the gap. The heat flux ratio decreases as the gap depth and Mach number increase, however, it increases as the attack angle increases. In addition, it is important to find that chamfer in the windward corner can effectively reduce gap effect coefficient. The study will be helpful for the design of the thermal protection system in reentry vehicles.	[Xu Jing; Huang Haiming; Huang Guo; Mo Song] Beijing Jiaotong Univ, Inst Engn Mech, Beijing 100044, Peoples R China	Beijing Jiaotong University	Huang, HM (corresponding author), Beijing Jiaotong Univ, Inst Engn Mech, Beijing 100044, Peoples R China.	hmhuang@bjtu.edu.cn			National Natural Sciences Foundation of China [11272042, 11472037]; Project of Education Ministry of China [62501036026]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Education Ministry of China	This work is supported by the National Natural Sciences Foundation of China (No: 11272042, 11472037) and the Project of Education Ministry of China (No: 62501036026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Huang HM, 2014, THERM SCI, V18, P1591, DOI 10.2298/TSCI1405591H; Huang HM, 2014, INT J NUMER METHOD H, V24, P1290, DOI 10.1108/HFF-03-2013-0095; inderks M, 2006, 44 AIAA AER SCI M EX; Jackson AP, 2001, J FLUID MECH, V427, P329, DOI 10.1017/S0022112000002433; Jiang GQ, 1999, J PROPULSION TECHNOL, V20, P50; Larcheveque L, 2004, J FLUID MECH, V516, P265, DOI 10.1017/S0022112004000709; Mori K, 2012, 43 AIAA THERM C NEW; Paolicchi L, 2010, NAT C MECH ENG CAMP; [沈淳 Shen Chun], 2012, [航空学报, Acta Aeronautica et Astronautica Sinica], V33, P34; Spalar PR, 1992, 30 AIAA AER SCI M EX; Tang GM, 2000, EXPT MEASUREMENTS FL, V14, P1; Yang K, 2012, THEOR APPL MECH LETT, V2, DOI 10.1063/2.1201203	12	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117012	10.1371/journal.pone.0117012	http://dx.doi.org/10.1371/journal.pone.0117012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635395	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700066
J	Gao, Y; Xie, YP; Xiong, Q; Liu, WM; Xue, JL				Gao, Ying; Xie, Ying Ping; Xiong, Qi; Liu, Wei Min; Xue, Jiao Liang			Ultrastructural Exploration on the Histopathological Change in Phenacoccus fraxinus Infected with Lecanicillium lecanii	PLOS ONE			English	Article							VERTICILLIUM-LECANII; INVASION; CUTICLE	The histopathological changes of the second instar nymph of the mealybug Phenacoccus fraxinus infected with Lecanicillium lecanii strain 3.4505 were investigated using light, scanning and transmission electron microscopy. The results demonstrated that L. lecanii 3.4505 could infect P. fraxinus in a short period. At 24 h post-inoculation, the conidia of L. lecanii 3.4505 adhered to the indented gloves or intersegmental folds of the insect body surface. Subsequently, the germinated conidia produced germ-tubes, appressoria and extended hyphae, which tightly adhered to the cuticle. Penetration of cuticle could be achieved either by peg form appressoria or directly by hyphae. Also, the conidia and hyphae could secrete massive mucilages causing visible damage to the host cuticle. After 48 h, the body wall, tissues and organs, including cuticle, trachea, fat body, muscle, Malpighian tubules and nerve ganglion, were destroyed by ramification of hyphae as a result of infection. The endoplasmic reticulum hypertrophied and formed obvious fingerprint agglomerates, and the mitochondria swelled and deformed in the haemocytes. Finally, the mycelium fully occupied the entire haemocoel. The entire bodies were wrapped in a white mycelium, with the mycelium extending radically outward.	[Gao, Ying; Xie, Ying Ping; Xiong, Qi; Xue, Jiao Liang] Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China; [Liu, Wei Min] Shanxi Univ, Inst Appl Biol, Taiyuan 030006, Peoples R China	Shanxi University; Shanxi University	Xie, YP (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China.	xieyingping@eyou.com			National Natural Science Foundation of China [30671693, 31070584]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20101401110008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by the National Natural Science Foundation of China (30671693 and 31070584), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20101401110008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askary H, 1999, J INVERTEBR PATHOL, V74, P1, DOI 10.1006/jipa.1999.4857; Feng Mingguang, 1998, Weishengwu Xuebao, V38, P461; Han Zhenzhen, 2010, Weishengwu Xuebao, V50, P211; Liu WM, 2009, J INVERTEBR PATHOL, V101, P96, DOI 10.1016/j.jip.2009.03.002; Peng Guoliang, 2009, Chinese Journal of Applied and Environmental Biology, V15, P220, DOI 10.3724/SP.J.1145.2009.00220; StLeger RJ, 1996, APPL ENVIRON MICROB, V62, P907, DOI 10.1128/AEM.62.3.907-912.1996; XIE Y. P., 2006, WAX SECRETIONS SOFT; Xie Y. P., 1998, SCALE INSECTS FOREST; Zare R, 2001, NOVA HEDWIGIA, V73, P1; Zhang YF, 2009, J ENTOMOL SCI, V44, P59, DOI 10.18474/0749-8004-44.1.59	10	6	6	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117428	10.1371/journal.pone.0117428	http://dx.doi.org/10.1371/journal.pone.0117428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629309	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100082
J	Henry, M; Bobay, LM; Chevallereau, A; Saussereau, E; Ceyssens, PJ; Debarbieux, L				Henry, Marine; Bobay, Louis-Marie; Chevallereau, Anne; Saussereau, Emilie; Ceyssens, Pieter-Jan; Debarbieux, Laurent			The Search for Therapeutic Bacteriophages Uncovers One New Subfamily and Two New Genera of Pseudomonas-Infecting Myoviridae	PLOS ONE			English	Article							HOST-RANGE; PHAGE THERAPY; AERUGINOSA; PROTEIN; CLASSIFICATION; GENOMICS; SERVER; TREAT	In a previous study, six virulent bacteriophages PAK_P1, PAK_P2, PAK_P3, PAK_P4, PAK_P5 and CHA_P1 were evaluated for their in vivo efficacy in treating Pseudomonas aeruginosa infections using a mouse model of lung infection. Here, we show that their genomes are closely related to five other Pseudomonas phages and allow a subdivision into two clades, PAK_P1-like and KPP10-like viruses, based on differences in genome size, % GC and genomic contents, as well as number of tRNAs. These two clades are well delineated, with a mean of 86% and 92% of proteins considered homologous within individual clades, and 25% proteins considered homologous between the two clades. By ESI-MS/ MS analysis we determined that their virions are composed of at least 25 different proteins and electron microscopy revealed a morphology identical to the hallmark Salmonella phage Felix O1. A search for additional bacteriophage homologs, using profiles of protein families defined from the analysis of the 11 genomes, identified 10 additional candidates infecting hosts from different species. By carrying out a phylogenetic analysis using these 21 genomes we were able to define a new subfamily of viruses, the Felixounavirinae within the Myoviridae family. The new Felixounavirinae subfamily includes three genera: Felixounalikevirus, PAK_P1likevirus and KPP10likevirus. Sequencing genomes of bacteriophages with therapeutic potential increases the quantity of genomic data on closely related bacteriophages, leading to establishment of new taxonomic clades and the development of strategies for analyzing viral genomes as presented in this article.	[Henry, Marine; Chevallereau, Anne; Saussereau, Emilie; Debarbieux, Laurent] Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France; [Bobay, Louis-Marie] Inst Pasteur, Dept Genomes & Genet, Microbial Evolutionary Genom Unit, Paris, France; [Bobay, Louis-Marie] CNRS, UMR3525, Paris, France; [Bobay, Louis-Marie; Saussereau, Emilie] Univ Paris 06, Paris, France; [Chevallereau, Anne] Univ Paris 07, Sorbonne Paris Cite, Paris, France; [Ceyssens, Pieter-Jan] Katholieke Univ Leuven, Div Gene Technol, Lab Gene Technol, B-3001 Heverlee, Belgium; [Ceyssens, Pieter-Jan] Sci Inst Publ Hlth WIV ISP, Unit Bacterial Dis, Brussels, Belgium	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; KU Leuven	Debarbieux, L (corresponding author), Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France.	laurent.debarbieux@pasteur.fr	Chevallereau, Anne/H-9675-2019	Chevallereau, Anne/0000-0003-3369-7468; Ceyssens, Pieter-Jan/0000-0001-7735-8316; Debarbieux, Laurent/0000-0001-6875-5758	Vaincre la Mucoviscidose [IC1011]; Ministere de l'enseignement superieur et de la recherche	Vaincre la Mucoviscidose; Ministere de l'enseignement superieur et de la recherche	Funding: This work was supported by a grant from Vaincre la Mucoviscidose (IC1011) to MH and a grant from the Ministere de l'enseignement superieur et de la recherche to LMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048053; Bailly-Bechet M, 2007, GENOME RES, V17, P1486, DOI 10.1101/gr.6649807; Bobay LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003825; Brussow H, 2012, VIROLOGY, V434, P138, DOI 10.1016/j.virol.2012.09.015; Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]; Ceyssens PJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-134; Ceyssens PJ, 2009, ENVIRON MICROBIOL, V11, P1303, DOI 10.1111/j.1462-2920.2008.01862.x; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Comeau AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040102; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; De Paepe M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004181; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frampton RA, 2014, APPL ENVIRON MICROB, V80, P2216, DOI 10.1128/AEM.00062-14; Garbe J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-102; Gill JJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-542; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Henry M, 2013, ANTIMICROB AGENTS CH, V57, P5961, DOI 10.1128/AAC.01596-13; Huys I, 2013, EMBO REP, V14, P951, DOI 10.1038/embor.2013.163; Jiang XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-194; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Kropinski AM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-76; Krupovic M, 2011, CURR OPIN VIROL, V1, P118, DOI 10.1016/j.coviro.2011.06.001; Lavigne R, 2006, MICROBIOL-SGM, V152, P529, DOI 10.1099/mic.0.28431-0; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Lopes A, 2010, NUCLEIC ACIDS RES, V38, P3952, DOI 10.1093/nar/gkq096; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062933; Mahadevan Padmanabhan, 2009, BMC Res Notes, V2, P168, DOI 10.1186/1756-0500-2-168; Martinsohn JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000065; McCallin S, 2013, VIROLOGY, V443, P187, DOI 10.1016/j.virol.2013.05.022; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Pier GB, 2009, MANDELL DOUGLAS BENN, P2835, DOI 10.1056/NEJMoa1304839.Two; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Santos SB, 2011, J VIROL, V85, P11265, DOI 10.1128/JVI.01769-10; Saussereau E, 2014, CLIN MICROBIOL INFEC; Saussereau E, 2012, ADV VIRUS RES, V83, P123, DOI 10.1016/B978-0-12-394438-2.00004-9; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; TOUSSAINT B, 1993, BIOCHEM BIOPH RES CO, V196, P416, DOI 10.1006/bbrc.1993.2265; Truncaite L, 2012, ARCH VIROL, V157, P2431, DOI 10.1007/s00705-012-1449-x; Tummler B, 2006, PSEUDOMONAS; Uchiyama J, 2012, ARCH VIROL, V157, P733, DOI 10.1007/s00705-011-1210-x; Verbeken G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/621316; Verbeken G, 2014, ARCH IMMUNOL THER EX, V62, P117, DOI 10.1007/s00005-014-0269-y; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Zilberberg MD, 2013, J HOSP MED, V8, P559, DOI 10.1002/jhm.2080; Zuber S, 2007, J BACTERIOL, V189, P8206, DOI 10.1128/JB.00838-07	58	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117163	10.1371/journal.pone.0117163	http://dx.doi.org/10.1371/journal.pone.0117163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629728	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100070
J	Kitajima, K; Tanaka, U; Ueno, Y; Maeda, T; Suenaga, Y; Takahashi, S; Deguchi, M; Miyahara, Y; Ebina, Y; Yamada, H; Tsurusaki, M; Tamaki, Y; Sugimura, K				Kitajima, Kazuhiro; Tanaka, Utaru; Ueno, Yoshiko; Maeda, Tetsuo; Suenaga, Yuko; Takahashi, Satoru; Deguchi, Masashi; Miyahara, Yoshiya; Ebina, Yasuhiko; Yamada, Hideto; Tsurusaki, Masakatsu; Tamaki, Yukihisa; Sugimura, Kazuro			Role of Diffusion Weighted Imaging and Contrast-Enhanced MRI in the Evaluation of Intrapelvic Recurrence of Gynecological Malignant Tumor	PLOS ONE			English	Article							OVARIAN-CANCER; PERITONEAL DISSEMINATION; CARCINOMA; DIAGNOSIS; FUSION; PET/CT	Background and Purpose To investigate the diagnostic performance of diffusion-weighted imaging (DWI) and contrast-enhanced imaging in combination with T2-weighted imaging (T2WI) for magnetic resonance imaging (MRI) evaluation of intrapelvic recurrence of gynecological malignancies. Materials and Methods Sixty-two patients with suspected intrapelvic recurrence of gynecological malignancies underwent pelvic MRI including T2WI DWI, and contrast-enhanced imaging. Diagnostic performance for detection of local recurrence, pelvic lymph node and bone metastases, and peritoneal lesions was evaluated by consensus reading of two experienced radiologists using a 5-point scoring system, and compared among T2WI with unenhanced T1-weighted imaging (T1WI) (protocol A), a combination of protocol A and DWI (protocol B), and a combination of protocol B and contrast-enhanced imaging (protocol C). Final diagnoses were obtained by histopathological examinations, radiological imaging and clinical follow-up for at least 6 months. Receiver operating characteristic (ROC) analysis and McNemar test were employed for statistical analysis. Results Locally recurrent disease, lymph node recurrence, peritoneal dissemination and bone metastases were present in 48.4%, 29.0%, 16.1%, and 6.5% of the patients, respectively. The patient-based sensitivity, specificity, accuracy, and area under the ROC curve (AUC) for detection of intrapelvic recurrence were 55.0, 81.8, 64.5% and 0.753 for protocol A, 80.0, 77.3,79.0% and 0.838 for protocol B, and 80.0, 90.9, 83.9% and 0.862 for protocol C, respectively. The sensitivity, accuracy, and AUC were significantly better for protocols B and C than for protocol A (p<0.001). There was no significant difference between protocols B and C. Conclusion MRI using a combination of DWI and T2WI gives comparatively acceptable results for assessment of intrapelvic recurrence of gynecological malignancies.	[Kitajima, Kazuhiro; Tanaka, Utaru; Ueno, Yoshiko; Maeda, Tetsuo; Suenaga, Yuko; Takahashi, Satoru; Sugimura, Kazuro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan; [Deguchi, Masashi; Miyahara, Yoshiya; Ebina, Yasuhiko; Yamada, Hideto] Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Kobe, Hyogo 657, Japan; [Tsurusaki, Masakatsu] Kinki Univ, Sch Med, Dept Diagnost Radiol, Osaka 589, Japan; [Tamaki, Yukihisa] Shimane Univ, Sch Med, Dept Radiat Oncol, Matsue, Shimane, Japan	Kobe University; Kobe University; Kindai University (Kinki University); Shimane University	Kitajima, K (corresponding author), Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 657, Japan.	kitajima@med.kobe-u.ac.jp	Ebina, Yasuhiko/AAD-8137-2022					Blecharz P, 2011, EUR J GYNAECOL ONCOL, V32, P403; Donati OF, 2013, EUR RADIOL, V23, P2906, DOI 10.1007/s00330-013-2875-1; Fujii S, 2008, EUR RADIOL, V18, P18, DOI 10.1007/s00330-007-0732-9; Kido A, 2013, J MAGN RESON IMAGING, V37, P249, DOI 10.1002/jmri.23716; Kinkel K, 1997, RADIOLOGY, V204, P55, DOI 10.1148/radiology.204.1.9205223; Kitajima K, 2014, ANN NUCL MED, V28, P25, DOI 10.1007/s12149-013-0777-6; Kyriazi S, 2010, RADIOGRAPHICS, V30, P1269, DOI 10.1148/rg.305105073; Low RN, 2005, RADIOLOGY, V235, P918, DOI 10.1148/radiol.2353040447; Namimoto T, 2009, EUR RADIOL, V19, P745, DOI 10.1007/s00330-008-1185-5; Nishie A, 2008, J MAGN RESON IMAGING, V28, P705, DOI 10.1002/jmri.21486; Nougaret S, 2013, AM J ROENTGENOL, V200, P261, DOI 10.2214/AJR.12.9713; Ricke J, 2003, EUR RADIOL, V13, P943, DOI 10.1007/s00330-002-1712-8; Salaa E, 2010, EUR J RADIOL, V76, P367, DOI 10.1016/j.ejrad.2010.01.026; Satoh Y, 2011, AM J ROENTGENOL, V196, P447, DOI 10.2214/AJR.10.4687; Yamashita Y, 1996, JMRI-J MAGN RESON IM, V6, P167, DOI 10.1002/jmri.1880060130	15	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117411	10.1371/journal.pone.0117411	http://dx.doi.org/10.1371/journal.pone.0117411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629156	gold, Green Published, Green Submitted			2022-12-26	WOS:000348732100081
J	Valenti, D; Denaro, G; Spagnolo, B; Conversano, F; Brunet, C				Valenti, Davide; Denaro, Giovanni; Spagnolo, Bernardo; Conversano, Fabio; Brunet, Christophe			How Diffusivity, Thermocline and Incident Light Intensity Modulate the Dynamics of Deep Chlorophyll Maximum in Tyrrhenian Sea	PLOS ONE			English	Article							MEDITERRANEAN SEA; VERTICAL-DISTRIBUTION; PHYTOPLANKTON COMPETITION; NUTRIENT AVAILABILITY; OPTICAL-PROPERTIES; NORTH PACIFIC; NOISE; PICOPHYTOPLANKTON; PROCHLOROCOCCUS; GROWTH	During the last few years theoretical works have shed new light and proposed new hypotheses on the mechanisms which regulate the spatio-temporal behaviour of phytoplankton communities in marine pelagic ecosystems. Despite this, relevant physical and biological issues, such as effects of the time-dependent mixing in the upper layer, competition between groups, and dynamics of non-stationary deep chlorophyll maxima, are still open questions. In this work, we analyze the spatio-temporal behaviour of five phytoplankton populations in a real marine ecosystem by using a one-dimensional reaction-diffusion-taxis model. The study is performed, taking into account the seasonal variations of environmental variables, such as light intensity, thickness of upper mixed layer and profiles of vertical turbulent diffusivity, obtained starting from experimental findings. Theoretical distributions of phytoplankton cell concentration was converted in chlorophyll concentration, and compared with the experimental profiles measured in a site of the Tyrrhenian Sea at four different times (seasons) of the year, during four different oceanographic cruises. As a result we find a good agreement between theoretical and experimental distributions of chlorophyll concentration. In particular, theoretical results reveal that the seasonal changes of environmental variables play a key role in the phytoplankton distribution and determine the properties of the deep chlorophyll maximum. This study could be extended to other marine ecosystems to predict future changes in the phytoplankton biomass due to global warming, in view of devising strategies to prevent the decline of the primary production and the consequent decrease of fish species.	[Valenti, Davide; Denaro, Giovanni; Spagnolo, Bernardo] Univ Palermo, Dipartimento Chim Fis, Grp Interdisciplinary Theoret Phys & Consorzio Na, Unit Palermo, Palermo, Italy; [Spagnolo, Bernardo] Ist Nazl Fis Nucleare, Sez Catania, Catania, Italy; [Spagnolo, Bernardo] Lobachevsky State Univ, Radiophys Dept, Nizhnii Novgorod, Russia; [Conversano, Fabio; Brunet, Christophe] Staz Zoolog Anton Dohrn, Naples, Italy	University of Palermo; Lobachevsky State University of Nizhni Novgorod; Stazione Zoologica Anton Dohrn di Napoli	Valenti, D (corresponding author), Univ Palermo, Dipartimento Chim Fis, Grp Interdisciplinary Theoret Phys & Consorzio Na, Unit Palermo, Palermo, Italy.	davide.valenti@unipa.it	Conversano, Fabio/AAW-9219-2021; brunet, christophe/AAD-7817-2021; Spagnolo, Bernardo/F-6973-2014; Valenti, Davide/K-9228-2015	Spagnolo, Bernardo/0000-0002-6625-3989; Valenti, Davide/0000-0001-5496-1518	Project "PESCA-TEC - Sviluppo di una Pesca Siciliana Sostenibile e Competitiva attraverso l'Innovazione Tecnologica" [PON02_00451_3362121]; Project "SHELF-LIFE-Utilizzo integrato di approcci tecnologici innovativi per migliorare la shelf-life e preservare le proprieta nutrizionali di prodotti agroalimentari" [PON02_00451_3361909]; Ministry of University, Research and Education of Italian Government	Project "PESCA-TEC - Sviluppo di una Pesca Siciliana Sostenibile e Competitiva attraverso l'Innovazione Tecnologica"; Project "SHELF-LIFE-Utilizzo integrato di approcci tecnologici innovativi per migliorare la shelf-life e preservare le proprieta nutrizionali di prodotti agroalimentari"; Ministry of University, Research and Education of Italian Government	The authors acknowledge the financial support by Project PON02_00451_3362121 "PESCA-TEC - Sviluppo di una Pesca Siciliana Sostenibile e Competitiva attraverso l'Innovazione Tecnologica", Project PON02_00451_3361909 "SHELF-LIFE-Utilizzo integrato di approcci tecnologici innovativi per migliorare la shelf-life e preservare le proprieta nutrizionali di prodotti agroalimentari", and partially by Ministry of University, Research and Education of Italian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barale V, 2008, REMOTE SENS ENVIRON, V112, P3300, DOI 10.1016/j.rse.2007.10.014; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Beversdorf LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056103; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Bonanno G, 2006, EUR PHYS J B, V53, P405, DOI 10.1140/epjb/e2006-00388-l; Bonanno G, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016106; Bopp L, 2001, GLOBAL BIOGEOCHEM CY, V15, P81, DOI 10.1029/1999GB001256; Bougaran G, 2010, J THEOR BIOL, V265, P443, DOI 10.1016/j.jtbi.2010.04.018; Brunet C, 2003, J PLANKTON RES, V25, P1413, DOI 10.1093/plankt/fbg091; Brunet C, 2006, AQUAT MICROB ECOL, V44, P127, DOI 10.3354/ame044127; Brunet C, 2008, J PLANKTON RES, V30, P645, DOI 10.1093/plankt/fbn028; Brunet C, 2007, MAR ECOL PROG SER, V346, P15, DOI 10.3354/meps07017; Caruso A, 2005, FLUCT NOISE LETT, V5, pL349, DOI 10.1142/S0219477505002768; Casotti R, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001541; Casotti R, 2000, MAR ECOL PROG SER, V195, P15, DOI 10.3354/meps195015; Chichigina O, 2005, FLUCT NOISE LETT, V5, pL243, DOI 10.1142/S0219477505002616; Chichigina OA, 2008, EUR PHYS J B, V65, P347, DOI 10.1140/epjb/e2008-00226-6; Chichigina OA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021134; CULLEN JJ, 1982, CAN J FISH AQUAT SCI, V39, P791, DOI 10.1139/f82-108; Cuttitta A, 2003, HYDROBIOLOGIA, V503, P117, DOI 10.1023/B:HYDR.0000008473.96144.d3; d'Alcala MR, 2009, DEEP-SEA RES PT II, V56, P676, DOI 10.1016/j.dsr2.2008.07.028; d'Alcala MR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001650; D'Ortenzio F, 2003, THESIS OPEN U LONDON; Denaro G, 2013, ACTA PHYS POL B, V44, P977, DOI 10.5506/APhysPolB.44.977; Denaro G, 2013, ECOL COMPLEX, V13, P21, DOI 10.1016/j.ecocom.2012.10.002; Denaro G, 2014, THESIS U PALERMO ITA; Denaro G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066765; Denis M, 2010, BIOGEOSCIENCES, V7, P2227, DOI 10.5194/bg-7-2227-2010; DENMAN KL, 1983, LIMNOL OCEANOGR, V28, P801, DOI 10.4319/lo.1983.28.5.0801; Dimier C, 2009, LIMNOL OCEANOGR, V54, P823, DOI 10.4319/lo.2009.54.3.0823; Dubkov AA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041104; Fiasconaro A, 2006, EUR PHYS J B, V50, P189, DOI 10.1140/epjb/e2006-00058-4; Garczarek L, 2007, FEMS MICROBIOL ECOL, V60, P189, DOI 10.1111/j.1574-6941.2007.00297.x; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Haefner J.W, 2005, MODELING BIOL SYSTEM; Hickman AE, 2010, MAR ECOL PROG SER, V406, P1, DOI 10.3354/meps08588; Holm-Hansen O, 2004, POLAR BIOL, V27, P699, DOI 10.1007/s00300-004-0641-1; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; Huisman J, 2006, NATURE, V439, P322, DOI 10.1038/nature04245; Hundsdorfer WH., 2003, NUMERICAL SOLUTION T, V33; Jennings S, 2001, MARINE FISHERIES ECO, DOI [10.1002/9781119968535.ch21, DOI 10.1002/9781119968535.CH21]; Justic D, 2002, ECOL MODEL, V152, P33, DOI 10.1016/S0304-3800(01)00472-0; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Ki&DEG;rboe T., 2008, MECHANISTIC APPROACH; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Klausmeier CA, 2007, J THEOR BIOL, V246, P278, DOI 10.1016/j.jtbi.2006.12.032; Klausmeier CA, 2001, LIMNOL OCEANOGR, V46, P1998, DOI 10.4319/lo.2001.46.8.1998; Koroleff F., 1976, METHODS SEAWATER ANA, P117; La Barbera A, 2002, PHYSICA A, V314, P120, DOI 10.1016/S0378-4371(02)01173-1; La Cognata A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011121; La Ferla R, 2012, HELGOLAND MAR RES, V66, P635, DOI 10.1007/s10152-012-0297-0; Lemesle V, 2008, ACTA BIOTHEOR, V56, P87, DOI 10.1007/s10441-008-9031-3; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; LI WKW, 1995, MAR ECOL PROG SER, V122, P1, DOI 10.3354/meps122001; Liu QX, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/05/P05011; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Mann KH, 1996, DYNAMICS MARINE ECOS, P480, DOI 10.2307/2960585; Massel S. R., 1999, FLUID MECH MARINE EC; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; Mei ZP, 2009, J THEOR BIOL, V259, P582, DOI 10.1016/j.jtbi.2009.04.018; Melbourne-Thomas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055093; Mella-Flores D, 2011, BIOGEOSCIENCES, V8, P2785, DOI 10.5194/bg-8-2785-2011; Monin A.S., 1971, STAT FLUID MECH MECH, V2; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Morel A, 1997, LIMNOL OCEANOGR, V42, P1746, DOI 10.4319/lo.1997.42.8.1746; Nakamura Y., 1991, IAHS PUBL INT ASS HY, P227; NISHIMURA H, 1987, CONT SHELF RES, V7, P1245, DOI 10.1016/0278-4343(87)90087-2; Norberg J, 2004, LIMNOL OCEANOGR, V49, P1269, DOI 10.4319/lo.2004.49.4_part_2.1269; OAKEY NS, 1982, J PHYS OCEANOGR, V12, P171, DOI 10.1175/1520-0485(1982)012<0171:DWTSML>2.0.CO;2; Olson R.J., 2018, HDB METHODS AQUATIC, P175, DOI DOI 10.1201/9780203752746; Pankratov EL, 2005, EUR PHYS J B, V46, P15, DOI 10.1140/epjb/e2005-00233-1; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Patti B, 2010, SCI MAR, V74, P577, DOI 10.3989/scimar.2010.74n3577; PETERS H, 1988, J GEOPHYS RES-OCEANS, V93, P1199, DOI 10.1029/JC093iC02p01199; Quevedo M, 2001, MAR ECOL PROG SER, V221, P29, DOI 10.3354/meps221029; Raven JA, 2005, VIE MILIEU, V55, P209; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Roache P. J., 1998, FUNDAMENTALS COMPUTA; Roache P.J., 1976, COMPUTATIONAL FLUID; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; Ryabov AB, 2008, MATH MODEL NAT PHENO, V3, P42, DOI 10.1051/mmnp:2008064; Ryabov AB, 2012, THEOR ECOL-NETH, V5, P373, DOI 10.1007/s12080-012-0158-0; Ryabov AB, 2011, ECOL LETT, V14, P220, DOI 10.1111/j.1461-0248.2010.01574.x; Ryabov AB, 2010, J THEOR BIOL, V263, P120, DOI 10.1016/j.jtbi.2009.10.034; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; Schmittner A, 2005, NATURE, V434, P628, DOI 10.1038/nature03476; SHIGESADA N, 1981, J MATH BIOL, V12, P311, DOI 10.1007/BF00276919; Spagnolo B, 2005, PROG THEOR PHYS SUPP, P312, DOI 10.1143/PTPS.157.312; Spagnolo B, 2004, MATH BIOSCI ENG, V1, P185; Spagnolo B, 2003, FLUCT NOISE LETT, V3, pL177, DOI 10.1142/S0219477503001245; Spagnolo B, 2002, J PHYS-CONDENS MAT, V14, P2247, DOI 10.1088/0953-8984/14/9/313; Spagnolo B, 2002, PHYSICA A, V315, P114, DOI 10.1016/S0378-4371(02)01245-1; Thi NNP, 2005, J COMPUT APPL MATH, V174, P57, DOI 10.1016/j.cam.2004.03.023; THINGSTAD TF, 1995, MAR ECOL PROG SER, V117, P299, DOI 10.3354/meps117299; THINGSTAD TF, 1990, MAR ECOL PROG SER, V63, P261, DOI 10.3354/meps063261; Timmermans KR, 2005, J SEA RES, V53, P109, DOI 10.1016/j.seares.2004.05.003; Turner J. S., 1973, BUOYANCY EFFECTS FLU; Turpin D.H., 1988, P316; Tveito A., 1998, INTRO PARTIAL DIFFER; Valenti D, 2008, EUR PHYS J B, V65, P443, DOI 10.1140/epjb/e2008-00315-6; Valenti D, 2008, ECOL MODEL, V213, P449, DOI 10.1016/j.ecolmodel.2008.01.023; Valenti D, 2006, EUR PHYS J B, V50, P199, DOI 10.1140/epjb/e2006-00102-5; Valenti D, 2004, ACTA PHYS POL B, V35, P1481; Valenti D, 2012, ACTA PHYS POL B, V43, P1227, DOI 10.5506/APhysPolB.43.1227; Valenti D, 2004, PHYSICA A, V331, P477, DOI 10.1016/j.physa.2003.09.036; Veldhuis MJW, 2005, J SEA RES, V53, P7, DOI 10.1016/j.seares.2004.01.006; Veldman AEP, 2001, LECT NOTES; VENRICK EL, 1993, LIMNOL OCEANOGR, V38, P1135, DOI 10.4319/lo.1993.38.6.1135; VENRICK EL, 1973, FISH B-NOAA, V71, P41; Vidussi F, 2001, J GEOPHYS RES-OCEANS, V106, P19939, DOI 10.1029/1999JC000308; Weston K, 2005, J PLANKTON RES, V27, P909, DOI 10.1093/plankt/fbi064; Yeo SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056207; Yoshiyama K, 2009, AM NAT, V174, P190, DOI 10.1086/600113; Zimmer C, 1999, SCIENCE, V284, P83, DOI 10.1126/science.284.5411.83	117	23	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0115468	10.1371/journal.pone.0115468	http://dx.doi.org/10.1371/journal.pone.0115468			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629963	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100017
J	van Munster, JM; Nitsche, BM; Akeroyd, M; Dijkhuizen, L; van der Maarel, MJEC; Ram, AFJ				van Munster, Jolanda M.; Nitsche, Benjamin M.; Akeroyd, Michiel; Dijkhuizen, Lubbert; van der Maarel, Marc J. E. C.; Ram, Arthur F. J.			Systems Approaches to Predict the Functions of Glycoside Hydrolases during the Life Cycle of Aspergillus niger Using Developmental Mutants Delta brlA and Delta flbA	PLOS ONE			English	Article							CHITIN SYNTHASE GENES; CELL-WALL; ASEXUAL SPORULATION; CARBON STARVATION; SACCHAROMYCES-CEREVISIAE; EXPRESSION; AUTOLYSIS; NIDULANS; PROTEIN; GROWTH	Background The filamentous fungus Aspergillus niger encounters carbon starvation in nature as well as during industrial fermentations. In response, regulatory networks initiate and control autolysis and sporulation. Carbohydrate-active enzymes play an important role in these processes, for example by modifying cell walls during spore cell wall biogenesis or in cell wall degradation connected to autolysis. Results In this study, we used developmental mutants (Delta flbA and Delta brlA) which are characterized by an aconidial phenotype when grown on a plate, but also in bioreactor-controlled submerged cultivations during carbon starvation. By comparing the transcriptomes, proteomes, enzyme activities and the fungal cell wall compositions of a wild type A. niger strain and these developmental mutants during carbon starvation, a global overview of the function of carbohydrate- active enzymes is provided. Seven genes encoding carbohydrate-active enzymes, including cfcA, were expressed during starvation in all strains; they may encode enzymes involved in cell wall recycling. Genes expressed in the wild-type during starvation, but not in the developmental mutants are likely involved in conidiogenesis. Eighteen of such genes were identified, including characterized sporulation-specific chitinases and An15g02350, member of the recently identified carbohydrate-active enzyme family AA11. Eight of the eighteen genes were also expressed, independent of FlbA or BrlA, in vegetative mycelium, indicating that they also have a role during vegetative growth. The Delta flbA strain had a reduced specific growth rate, an increased chitin content of the cell wall and specific expression of genes that are induced in response to cell wall stress, indicating that integrity of the cell wall of strain Delta flbA is reduced. Conclusion The combination of the developmental mutants Delta flbA and Delta brlA resulted in the identification of enzymes involved in cell wall recycling and sporulation-specific cell wall modification, which contributes to understanding cell wall remodeling mechanisms during development.	[van Munster, Jolanda M.; Dijkhuizen, Lubbert; van der Maarel, Marc J. E. C.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst GBB, Microbial Physiol Res Grp, Groningen, Netherlands; [Nitsche, Benjamin M.; Ram, Arthur F. J.] Leiden Univ, Kluyver Ctr Genom Ind Fermentat, Inst Biol Leiden, Leiden, Netherlands; [Akeroyd, Michiel] DSM Biotechnol Ctr, Beijerinck Lab, Delft, Netherlands; [van der Maarel, Marc J. E. C.] Univ Groningen, Inst Technol & Management, Aquat Biotechnol & Bioprod Engn Dept, Groningen, Netherlands	University of Groningen; Leiden University; Leiden University - Excl LUMC; DSM NV; University of Groningen	van Munster, JM (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England.	Jolanda.van_Munster@nottingham.ac.uk	Dijkhuizen, Lubbert/K-3539-2019; Dijkhuizen, Lubbert/E-9454-2014; Ram, Arthur FJ/S-4648-2017	Dijkhuizen, Lubbert/0000-0003-2312-7162; Ram, Arthur FJ/0000-0002-2487-8016; Akeroyd, Michiel/0000-0002-3526-5821; van Munster, Jolanda/0000-0003-0412-7001	SenterNovem as IOP Genomics project [IGE07008]	SenterNovem as IOP Genomics project	This work was supported by SenterNovem as IOP Genomics project IGE07008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bennett JW, 2009, MED MYCOL, V47, pS5, DOI 10.1080/13693780802712515; Bennett JW, 1991, MORE GENE MANIPULATI; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; BOS CJ, 1988, CURR GENET, V14, P437, DOI 10.1007/BF00521266; BRODERICK AJ, 1981, J GEN MICROBIOL, V126, P193; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Coyle CM, 2007, MYCOLOGIA, V99, P804, DOI 10.3852/mycologia.99.6.804; Cupertino FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044258; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; Delmas S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002875; Emri T, 2005, MYCOL RES, V109, P757, DOI 10.1017/S0953756205003023; Emri T, 2008, APPL BIOCHEM BIOTECH, V151, P211, DOI 10.1007/s12010-008-8174-7; Erdei E, 2008, ACTA MICROBIOL IMM H, V55, P351, DOI 10.1556/AMicr.55.2008.3.6; Fontaine T, 1997, EUR J BIOCHEM, V243, P315, DOI 10.1111/j.1432-1033.1997.0315a.x; Fontaine T, 2000, J BIOL CHEM, V275, P27594; Freitas FZ, 2010, FUNGAL GENET BIOL, V47, P43, DOI 10.1016/j.fgb.2009.10.011; Fujiwara M, 2000, J BIOCHEM-TOKYO, V127, P359, DOI 10.1093/oxfordjournals.jbchem.a022616; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Garcia-Rivera J, 2004, EUKARYOT CELL, V3, P385, DOI 10.1128/EC.3.2.385-392.2004; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaques AK, 2003, MICROBIOL-SGM, V149, P2931, DOI 10.1099/mic.0.26476-0; JOHNSTON IR, 1965, BIOCHEM J, V96, P651, DOI 10.1042/bj0960651; Jorgensen TR, 2011, APPL ENVIRON MICROB, V77, P5270, DOI 10.1128/AEM.00118-11; Jorgensen TR, 2011, FUNGAL GENET BIOL, V48, P544, DOI 10.1016/j.fgb.2011.01.005; Jorgensen TR, 2010, APPL ENVIRON MICROB, V76, P5344, DOI 10.1128/AEM.00450-10; Kitagaki H, 2002, MOL MICROBIOL, V46, P1011, DOI 10.1046/j.1365-2958.2002.03244.x; Krijgsheld P, 2013, STUD MYCOL, P1, DOI 10.3114/sim0006; Krijgsheld P, 2013, J PROTEOME RES, V12, P1808, DOI 10.1021/pr301154w; Latge JP, 2005, MED MYCOL, V43, pS15, DOI 10.1080/13693780400029155; LEE BN, 1994, GENE DEV, V8, P641, DOI 10.1101/gad.8.6.641; LEE BN, 1994, MOL MICROBIOL, V14, P323, DOI 10.1111/j.1365-2958.1994.tb01293.x; Lee JI, 2004, FUNGAL GENET BIOL, V41, P635, DOI 10.1016/j.fgb.2004.01.009; MacDonald J. W., 2022, AFFYCORETOOLS FUNCTI; Maddi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038872; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; Martens-Uzunova ES, 2009, FUNGAL GENET BIOL, V46, pS170, DOI 10.1016/j.fgb.2008.07.021; MARUYAMA Y, 1994, CARBOHYD RES, V251, P89, DOI 10.1016/0008-6215(94)84278-7; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Nitsche BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-380; PARTA M, 1994, INFECT IMMUN, V62, P4389, DOI 10.1128/IAI.62.10.4389-4395.1994; Peterson SW, 2008, MYCOLOGIA, V100, P205, DOI 10.3852/mycologia.100.2.205; Pocsi I, 2009, J APPL MICROBIOL, V107, P514, DOI 10.1111/j.1365-2672.2009.04237.x; Ram AFJ, 2004, MICROBIOL-SGM, V150, P3315, DOI 10.1099/mic.0.27249-0; Rocklin RD, 1998, ANAL CHEM, V70, P1496, DOI 10.1021/ac970906w; Shimizu K, 2001, GENETICS, V157, P591; Shin KS, 2009, EUKARYOT CELL, V8, P738, DOI 10.1128/EC.00368-08; Sigl C, 2011, APPL ENVIRON MICROB, V77, P972, DOI 10.1128/AEM.01557-10; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sommer U, 2003, J BIOL CHEM, V278, P47724, DOI 10.1074/jbc.M307223200; Szilagyi M, 2010, J APPL MICROBIOL, V109, P1498, DOI 10.1111/j.1365-2672.2010.04782.x; Szilagyi M, 2013, MICROBIOL-SGM, V159, P176, DOI 10.1099/mic.0.062935-0; Tiels P, 2012, NAT BIOTECHNOL, V30, P1225, DOI 10.1038/nbt.2427; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; van Munster JM, 2014, APPL MICROBIOL BIOTE; van Munster JM, 2014, FUNGAL GENET BIOL, V72, P34, DOI 10.1016/j.fgb.2014.04.006; van Munster JM, 2013, MICROBIOL-SGM, V159, P1853, DOI 10.1099/mic.0.067967-0; van Munster JM, 2012, MICROBIOL-SGM, V158, P2168, DOI 10.1099/mic.0.054650-0; Wang J, 2009, CANCER INFORM, V7, P199; Ward OP, 2006, ADV APPL MICROBIOL, V58, P1, DOI 10.1016/S0065-2164(06)58001-8; White S, 2002, CRIT REV BIOTECHNOL, V22, P1, DOI 10.1080/07388550490465817; WIESER J, 1994, CURR GENET, V27, P62, DOI 10.1007/BF00326580; Wu X, 2001, MOL GENET GENOMICS, V265, P622, DOI 10.1007/s004380100455; Yamazaki H, 2008, FUNGAL GENET BIOL, V45, P963, DOI 10.1016/j.fgb.2008.02.008; Yamazaki H, 2007, CURR GENET, V51, P89, DOI 10.1007/s00294-006-0109-7; Yu JH, 1996, EMBO J, V15, P5184, DOI 10.1002/j.1460-2075.1996.tb00903.x; Yu JH, 1999, GENETICS, V151, P97; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	75	19	20	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116269	10.1371/journal.pone.0116269	http://dx.doi.org/10.1371/journal.pone.0116269			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629352	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100034
J	Wu, B; Cao, XM; Liang, XZ; Zhang, XH; Zhang, W; Sun, G; Wang, DW				Wu, Bo; Cao, Xiaoming; Liang, Xuezhi; Zhang, Xuhui; Zhang, Wei; Sun, Guang; Wang, Dongwen			Epigenetic Regulation of Elf5 Is Associated with Epithelial-Mesenchymal Transition in Urothelial Cancer	PLOS ONE			English	Article							BREAST-CANCER; METHYLATION; PROMOTER; CELLS; PLASTICITY; STATES; FATE	E74-like factor 5 (Elf5) has been associated with tumor suppression in breast cancer. However, its role in urothelial cancer (UC) is completely unknown. Immunohistochemistry (IHC) and methylation specific PCR (MSP) were done to detect Elf5 expression level and its promoter methylation. Results revealed that low expression of Elf5 on protein and mRNA levels were associated with tumor progression, early relapse and poor survival. In vitro, downregulation of Elf5 can increase epithelial-mesenchymal transition (EMT). Aberrant Elf5 methylation was identified as major mechanism for Elf5 gene silence. Accordingly, restoration of Elf5 by infection or demethylating treatment effectively reversed EMT processes. In conclusion, we identified Elf5 as a novel biomarker of UC on several biological levels and established a causative link between Elf5 and EMT in UC.	[Wu, Bo; Cao, Xiaoming; Liang, Xuezhi; Zhang, Wei; Wang, Dongwen] Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan, Peoples R China; [Zhang, Xuhui; Wang, Dongwen] Shanxi Med Univ, Clin Med Coll 1, Taiyuan, Peoples R China; [Sun, Guang] Tianjin Med Univ, Hosp 2, Dept Urol, Tianjin, Peoples R China	Shanxi Medical University; Shanxi Medical University; Tianjin Medical University	Wang, DW (corresponding author), Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan, Peoples R China.	dongwen_shanyi@126.com						Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Chakrabarti R, 2012, STEM CELLS, V30, P1496, DOI 10.1002/stem.1112; Donat SM, 2003, UROL CLIN N AM, V30, P765, DOI 10.1016/S0094-0143(03)00060-0; Escamilla-Hernandez R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-68; Hemberger M, 2010, HUM MOL GENET, V19, P2456, DOI 10.1093/hmg/ddq128; Hilton HN, 2010, MOL ENDOCRINOL, V24, P1380, DOI 10.1210/me.2009-0516; Kalyuga M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001461; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Lee HJ, 2011, STEM CELLS, V29, P1611, DOI 10.1002/stem.706; Li H, 2014, J UROLOGY, V191, P493, DOI 10.1016/j.juro.2013.08.087; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Menzies KK, 2010, FUNCT INTEGR GENOMIC, V10, P87, DOI 10.1007/s10142-009-0140-0; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; RUBBEN H, 1988, J UROLOGY, V139, P283, DOI 10.1016/S0022-5347(17)42387-1; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Taddei ML, 2013, CANCER LETT, V341, P80, DOI 10.1016/j.canlet.2013.01.042; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian J, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.395574; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Villicana P, 2009, BIOMARK MED, V3, P265, DOI 10.2217/BMM.09.23; Wang Y, 2013, EXP CELL RES, V319, P160, DOI 10.1016/j.yexcr.2012.07.019; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhou ZJ, 2014, CANCER RES, DOI [10.1158/0008-5472.CAN-74-24-Reviewers, DOI 10.1158/0008-5472.CAN-74-24-REVIEWERS]	29	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117510	10.1371/journal.pone.0117510	http://dx.doi.org/10.1371/journal.pone.0117510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629735	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000348732100086
J	Carels, N; Tilli, T; Tuszynski, JA				Carels, Nicolas; Tilli, Tatiana; Tuszynski, Jack A.			A Computational Strategy to Select Optimized Protein Targets for Drug Development toward the Control of Cancer Diseases	PLOS ONE			English	Article							INVASIVE BREAST-CANCER; GROWTH-FACTOR; DOWN-REGULATION; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; PANCREATIC-CANCER; INHIBITION; KINASE; NUCLEOPHOSMIN; COMPLEXITY	In this report, we describe a strategy for the optimized selection of protein targets suitable for drug development against neoplastic diseases taking the particular case of breast cancer as an example. We combined human interactome and transcriptome data from malignant and control cell lines because highly connected proteins that are up-regulated in malignant cell lines are expected to be suitable protein targets for chemotherapy with a lower rate of undesirable side effects. We normalized transcriptome data and applied a statistic treatment to objectively extract the sub-networks of down-and up-regulated genes whose proteins effectively interact. We chose the most connected ones that act as protein hubs, most being in the signaling network. We show that the protein targets effectively identified by the combination of protein connectivity and differential expression are known as suitable targets for the successful chemotherapy of breast cancer. Interestingly, we found additional proteins, not generally targeted by drug treatments, which might justify the extension of existing formulation by addition of inhibitors designed against these proteins with the consequence of improving therapeutic outcomes. The molecular alterations observed in breast cancer cell lines represent either driver events and/or driver pathways that are necessary for breast cancer development or progression. However, it is clear that signaling mechanisms of the luminal A, B and triple negative subtypes are different. Furthermore, the up- and down-regulated networks predicted subtype-specific drug targets and possible compensation circuits between up-and down-regulated genes. We believe these results may have significant clinical implications in the personalized treatment of cancer patients allowing an objective approach to the recycling of the arsenal of available drugs to the specific case of each breast cancer given their distinct qualitative and quantitative molecular traits.	[Carels, Nicolas; Tilli, Tatiana] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, CNPq,Lab Modelagem Sistemas Biol, INCT IDN,Natl Inst Sci & Technol Innovat Neglecte, Rio De Janeiro, Brazil; [Tuszynski, Jack A.] Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Tuszynski, Jack A.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada	Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; University of Alberta; University of Alberta	Tuszynski, JA (corresponding author), Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB T6G 1Z2, Canada.	jack.tuszynski@gmail.com	Tuszynski, Jack/AAA-2073-2020; Carels, Nicolas/L-4687-2016; Tilli, T M/L-3057-2016; Tilli, Tatiana M/F-8166-2012	Tuszynski, Jack/0000-0001-9976-0429; Carels, Nicolas/0000-0003-4547-7155; Tilli, T M/0000-0003-3699-1494; Tilli, Tatiana M/0000-0002-1111-018X				Alegre MM, 2012, J ONCOL, V2012, DOI 10.1155/2012/575647; Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Atkinson DM, 2008, HEAD NECK-J SCI SPEC, V30, P790, DOI 10.1002/hed.20770; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Bockmayr M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-78; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyer-Guittaut M, 2014, AUTOPHAGY, V10, P986, DOI 10.4161/auto.28390; Braun Michael, 2009, Cancer Genomics & Proteomics, V6, P31; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Breitkreutz D, 2014, BIOMAT INT S MATH CO, P250; Breitkreutz D, 2012, P NATL ACAD SCI USA, V109, P9209, DOI 10.1073/pnas.1201416109; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Cao WD, 2010, APOPTOSIS, V15, P230, DOI 10.1007/s10495-009-0437-4; Carels N, 2013, BIOINFORM BIOL INSIG, V7, P35, DOI 10.4137/BBI.S10053; Chong R, 2009, CELL HOST MICROBE, V6, P268, DOI 10.1016/j.chom.2009.08.006; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672; Costanzo A, 2014, FEBS LETT, V588, P2590, DOI 10.1016/j.febslet.2014.06.047; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Magalhaes JP, 2013, NAT REV CANCER, V13, P357, DOI 10.1038/nrc3497; Deshiere A, 2011, MOL CELL BIOCHEM, V356, P11, DOI 10.1007/s11010-011-0942-y; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Dong S, 2008, LEUKEMIA, V22, P572, DOI 10.1038/sj.leu.2405064; Faust K, 2010, BIOINFORMATICS, V26, P1211, DOI 10.1093/bioinformatics/btq105; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Garlaschelli D, 2010, SYMMETRY-BASEL, V2, P1683, DOI 10.3390/sym2031683; Gay B, 1999, INT J CANCER, V83, P235, DOI 10.1002/(SICI)1097-0215(19991008)83:2<235::AID-IJC15>3.0.CO;2-B; Ghosh A, 2013, ONCOL REP, V29, P1161, DOI 10.3892/or.2012.2186; Giubellino A, 2007, CANCER RES, V67, P6012, DOI 10.1158/0008-5472.CAN-07-0022; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guo CM, 2013, FUTURE ONCOL, V9, P1773, DOI [10.2217/FON.13.114, 10.2217/fon.13.114]; Haines E, 2014, J BIOL CHEM, V289, P5687, DOI 10.1074/jbc.M113.516047; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handa Y, 2010, J MOL BIOL, V404, P260, DOI 10.1016/j.jmb.2010.09.033; HE T, 2013, PLOS ONE, V8, P59345, DOI DOI 10.1371/JOURNAL.PONE.0059345; HINOW P, 2014, ALGEBRAIC TOPOLOGICA, P42331; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Huang L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.256; Huang TH, 2013, CANCER CELL, V23, P796, DOI 10.1016/j.ccr.2013.04.027; Ishigaki Y, 2013, EXP BIOL MED, V238, P889, DOI 10.1177/1535370213494646; Jiang N, 2012, CHEMOTHER RES PRACT, V2012, DOI DOI 10.1155/2012/817304; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Klebig C, 2005, CANCER RES, V65, P394; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Krynetskaia NF, 2009, MOL CANCER THER, V8, P864, DOI 10.1158/1535-7163.MCT-08-0695; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Li B, 2013, CLIN CANCER RES, V19, P5835, DOI 10.1158/1078-0432.CCR-12-3629; Li ZW, 2012, BBA-REV CANCER, V1826, P13, DOI 10.1016/j.bbcan.2012.02.001; Lim DHK, 2010, OBSTET GYNAECOL, V12, P37, DOI 10.1576/toag.12.1.037.27556; Ling SHM, 2009, BIOSCIENCE REP, V29, P339, DOI 10.1042/BSR20090034; Lo SJ, 2013, HEPATOLOGY, V57, P1893, DOI 10.1002/hep.26209; Luo Y, 2014, MOL MED REP, V9, P387, DOI 10.3892/mmr.2013.1831; MacArthur BD, 2008, DISCRETE APPL MATH, V156, P3525, DOI 10.1016/j.dam.2008.04.008; Marquardt JU, 2012, BBA-MOL BASIS DIS, V1822, P942, DOI 10.1016/j.bbadis.2012.02.012; Mathur S, 1998, CANCER, V82, P816, DOI 10.1002/(SICI)1097-0142(19980301)82:5<816::AID-CNCR3>3.0.CO;2-H; Mendelsohn J, 2002, J CLIN ONCOL, V20, p1S, DOI 10.1200/JCO.2002.07.121; Miwa D, 2013, ANGIOGENESIS, V16, P675, DOI 10.1007/s10456-013-9345-x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nihira K, 2014, J PATHOL, V234, P277, DOI 10.1002/path.4354; Oltean S, 2012, BIOCHEM SOC T, V40, P831, DOI 10.1042/BST20120051; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Pallares J, 2009, AM J PATHOL, V174, P287, DOI 10.2353/ajpath.2009.080552; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perez-Nadales E, 2004, BREAST CANCER RES, V6, P137, DOI 10.1186/bcr792; Qi W, 2008, ONCOGENE, V27, P4210, DOI 10.1038/onc.2008.54; Rachidi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057911; Ren HN, 2009, MOL CANCER THER, V8, P1106, DOI 10.1158/1535-7163.MCT-08-0779; Rickelt S, 2012, CELL TISSUE RES, V348, P281, DOI 10.1007/s00441-011-1314-3; Roma-Rodrigues C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179486; Sagot Y, 2000, BRIT J PHARMACOL, V131, P721, DOI 10.1038/sj.bjp.0703633; Schneble EJ, 2014, IMMUNOTHERAPY-UK, V6, P519, DOI [10.2217/IMT.14.22, 10.2217/imt.14.22]; Shepelev V, 2006, BRIEF BIOINFORM, V7, P178, DOI 10.1093/bib/bbl003; Shi YK, 2010, CANCER GENE THER, V17, P694, DOI 10.1038/cgt.2010.25; Sillibourne JE, 2007, MOL BIOL CELL, V18, P3667, DOI 10.1091/mbc.E06-07-0604; Taniuchi K, 2005, CANCER RES, V65, P3092, DOI 10.1158/0008.5472.CAN-04-3646; Usuki F, 2013, P NATL ACAD SCI USA, V110, P15037, DOI 10.1073/pnas.1300654110; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wang J, 2009, J CELL MOL MED, V13, P3888, DOI 10.1111/j.1582-4934.2009.00873.x; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; Warren K, 2012, P NATL ACAD SCI USA, V109, P9587, DOI 10.1073/pnas.1204673109; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wu YH, 2012, DERMATOL SIN, V30, P1, DOI 10.1016/j.dsi.2012.02.004; Ye Diana Zi, 2012, Cell Logist, V2, P105; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zaman N, 2013, CELL REP, V5, P216, DOI 10.1016/j.celrep.2013.08.028; Zeng Q, 2000, J CELL SCI, V113, P471; Zhang Y, 2008, CANCER LETT, V265, P298, DOI 10.1016/j.canlet.2008.02.024; Zheng L, 2004, CELL RES, V14, P497, DOI 10.1038/sj.cr.7290253	92	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115054	10.1371/journal.pone.0115054	http://dx.doi.org/10.1371/journal.pone.0115054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625699	Green Published, gold			2022-12-26	WOS:000348821400005
J	Rider, CF; Shah, S; Miller-Larsson, A; Giembycz, MA; Newton, R				Rider, Christopher F.; Shah, Suharsh; Miller-Larsson, Anna; Giembycz, Mark A.; Newton, Robert			Cytokine-Induced Loss of Glucocorticoid Function: Effect of Kinase Inhibitors, Long-Acting beta 2-Adrenoceptor Agonist and Glucocorticoid Receptor Ligands	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; N-TERMINAL KINASE; INFLAMMATORY GENE-EXPRESSION; PULMONARY EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; BETA(2)-ADRENOCEPTOR AGONISTS; AIRWAY INFLAMMATION; SELECTIVE INHIBITOR; STEROID RESISTANCE	Acting on the glucocorticoid receptor (NR3C1), glucocorticoids are widely used to treat inflammatory diseases. However, glucocorticoid resistance often leads to suboptimal asthma control. Since glucocorticoid-induced gene expression contributes to glucocorticoid activity, the aim of this study was to use a 2xglucocorticoid response element (GRE) reporter and glucocorticoid-induced gene expression to investigate approaches to combat cytokine-induced glucocorticoid resistance. Pre-treatment with tumor necrosis factor-alpha (TNF) or interleukin- 1 beta inhibited dexamethasone-induced mRNA expression of the putative anti-inflammatory genes RGS2 and TSC22D3, or just TSC22D3, in primary human airway epithelial and smooth muscle cells, respectively. Dexamethasone-induced DUSP1 mRNA was unaffected. In human bronchial epithelial BEAS-2B cells, dexamethasone-induced TSC22D3 and CDKN1C expression (at 6 h) was reduced by TNF pre-treatment, whereas DUSP1 and RGS2 mRNAs were unaffected. TNF pre-treatment also reduced dexamethasone-dependent 2xGRE reporter activation. This was partially reversed by PS-1145 and c-jun N-terminal kinase (JNK) inhibitor VIII, inhibitors of IKK2 and JNK, respectively. However, neither inhibitor affected TNF-dependent loss of dexamethasone-induced CDKN1C or TSC22D3 mRNA. Similarly, inhibitors of the extracellular signalregulated kinase, p38, phosphoinositide 3-kinase or protein kinase C pathways failed to attenuate TNF-dependent repression of the 2xGRE reporter. Fluticasone furoate, fluticasone propionate and budesonide were full agonists relative to dexamethasone, while GSK9027, RU24858, des-ciclesonide and GW870086X were partial agonists on the 2xGRE reporter. TNF reduced reporter activity in proportion with agonist efficacy. Full and partial agonists showed various degrees of agonism on RGS2 and TSC22D3 expression, but were equally effective at inducing CDKN1C and DUSP1, and did not affect the repression of CDKN1C or TSC22D3 expression by TNF. Finally, formoterol-enhanced 2xGRE reporter activity was also proportional to agonist efficacy and functionally reversed repression by TNF. As similar effects were apparent on glucocorticoid-induced gene expression, the most effective strategy to overcome glucocorticoid resistance in this model was addition of formoterol to high efficacy NR3C1 agonists.	[Rider, Christopher F.; Shah, Suharsh; Giembycz, Mark A.; Newton, Robert] Univ Calgary, Fac Med, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada; [Miller-Larsson, Anna] AstraZeneca R&D, Molndal, Sweden	University of Calgary; AstraZeneca	Newton, R (corresponding author), Univ Calgary, Fac Med, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB, Canada.	rnewton@ucalgary.ca	Rider, Christopher F/H-7073-2019; Newton, Robert/C-6814-2012	Rider, Christopher F/0000-0003-0399-5931; Newton, Robert/0000-0002-4919-8498	AstraZeneca; GlaxoSmithKline; Canadian Institutes of Health Research [68828]; Lung Association of Alberta; NWT; Alberta Innovates-Health Solutions; Gilead Sciences; Alberta Science and Research Authority; Canadian Fund for Innovation (CFI)	AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Lung Association of Alberta; NWT; Alberta Innovates-Health Solutions; Gilead Sciences(Gilead Sciences); Alberta Science and Research Authority; Canadian Fund for Innovation (CFI)(Canada Foundation for Innovation)	This research was supported by grants from AstraZeneca and GlaxoSmithKline (RN, MAG); an operating grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) [68828] (RN) and studentships from the Lung Association of Alberta and NWT (http://www.ab.lung.ca/)(SS) and Alberta Innovates-Health Solutions (http://www.aihealthsolutions.ca) (CFR). RN is an AI-HS Senior Scholar. MAG holds a Tier 1 Canada Research Chair in Pulmonary Pharmacology. RN and MAG were also supported by grants from Gilead Sciences. Funding from the Alberta Science and Research Authority and the Canadian Fund for Innovation (CFI) provided real time-PCR infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Antonicelli L, 2004, EUR RESPIR J, V23, P723, DOI 10.1183/09031936.04.00004904; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bareille P, 2013, J ASTHMA, V50, P1077, DOI 10.3109/02770903.2013.837480; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Belvisi MG, 2001, J IMMUNOL, V166, P1975, DOI 10.4049/jimmunol.166.3.1975; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Biggadike Keith, 2004, Proc Am Thorac Soc, V1, P352, DOI 10.1513/pats.200409-048TA; Bouazza B, 2012, AM J RESP CELL MOL, V47, P464, DOI 10.1165/rcmb.2011-0364OC; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Cerasoli F, 2006, CHEST, V130, p54S, DOI 10.1378/chest.130.1_suppl.54S; Chang TS, 2003, J BIOL CHEM, V278, P48092, DOI 10.1074/jbc.M309421200; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; DAVIS PD, 1992, J MED CHEM, V35, P177, DOI 10.1021/jm00079a024; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Giembycz MA, 2008, BRIT J PHARMACOL, V153, P1090, DOI 10.1038/sj.bjp.0707627; Goekjian PG, 1999, CURR MED CHEM, V6, P877; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Heffler E, 2007, BIODRUGS, V21, P345, DOI 10.2165/00063030-200721060-00002; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Holden NS, 2014, J PHARMACOL EXP THER, V348, P12, DOI 10.1124/jpet.113.204586; Holden NS, 2011, P NATL ACAD SCI USA, V108, P19713, DOI 10.1073/pnas.1110226108; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Irusen E, 2002, J ALLERGY CLIN IMMUN, V109, P649, DOI 10.1067/mai.2002.122465; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; KAM JC, 1993, J IMMUNOL, V151, P3460; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Keenan CR, 2012, DRUG DISCOV TODAY, V17, P1031, DOI 10.1016/j.drudis.2012.05.011; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; KLEINSCHROTH J, 1993, BIOORG MED CHEM LETT, V3, P1959, DOI 10.1016/S0960-894X(01)80995-1; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Marwick JA, 2010, J ALLERGY CLIN IMMUN, V125, P1146, DOI 10.1016/j.jaci.2010.02.003; Marwick JA, 2009, AM J RESP CRIT CARE, V179, P542, DOI 10.1164/rccm.200810-1570OC; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; Oakley RH, 2011, J BIOL CHEM, V286, P3177, DOI 10.1074/jbc.R110.179325; Onda K, 2006, BIOCHEM BIOPH RES CO, V351, P266, DOI 10.1016/j.bbrc.2006.10.032; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; POWIS G, 1994, CANCER RES, V54, P2419; REDDEL RR, 1988, CANCER RES, V48, P1904; Rider CF, 2013, AM THOR SOC INT C AM, pA4820; Rider CF, 2013, EUR J PHARMACOL, V708, P60, DOI 10.1016/j.ejphar.2013.02.056; Rider CF, 2011, J PHARMACOL EXP THER, V338, P860, DOI 10.1124/jpet.111.181016; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Salem S, 2012, BRIT J PHARMACOL, V166, P2036, DOI 10.1111/j.1476-5381.2012.01885.x; Schacke H, 2008, EXPERT OPIN THER PAT, V18, P339, DOI 10.1517/13543776.18.3.339; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Thomas MJ, 2005, EUR J IMMUNOL, V35, P1283, DOI 10.1002/eji.200425634; Thomas PS, 2002, THORAX, V57, P774, DOI 10.1136/thorax.57.9.774; THOMAS PS, 1995, AM J RESP CRIT CARE, V152, P76, DOI 10.1164/ajrccm.152.1.7599866; Tliba O, 2006, MOL PHARMACOL, V69, P588, DOI 10.1124/mol.105.019679; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Uings IJ, 2013, BRIT J PHARMACOL, V169, P1389, DOI 10.1111/bph.12232; Vayssiere BM, 1997, MOL ENDOCRINOL, V11, P1245, DOI 10.1210/me.11.9.1245; Vazquez-Tello A, 2013, J CLIN IMMUNOL, V33, P466, DOI 10.1007/s10875-012-9828-3; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Xie Y, 2012, J ALLERGY CLIN IMMUN, V130, P968, DOI 10.1016/j.jaci.2012.05.004; Yates CM, 2010, J MED CHEM, V53, P4531, DOI 10.1021/jm100447c; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	71	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116773	10.1371/journal.pone.0116773	http://dx.doi.org/10.1371/journal.pone.0116773			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625944	Green Submitted, gold, Green Published			2022-12-26	WOS:000348821400017
J	Seviourig, EG; Sehgal, V; Lu, Y; Luo, Z; Moss, T; Zhang, F; Hill, SM; Liu, W; Maiti, SN; Cooper, L; Azencot, R; Lopez-Berestein, G; Rodriguez-Aguayo, C; Roopaimoole, R; Pecot, CV; Sood, AK; Mukherjee, S; Gray, JW; Mills, G; Ram, P				Seviourig, E. G.; Sehgal, V.; Lu, Y.; Luo, Z.; Moss, T.; Zhang, F.; Hill, S. M.; Liu, W.; Maiti, S. N.; Cooper, L.; Azencot, R.; Lopez-Berestein, G.; Rodriguez-Aguayo, C.; Roopaimoole, R.; Pecot, C. V.; Sood, A. K.; Mukherjee, S.; Gray, J. W.; Mills, G. B.; Ram, P. T.			Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer	ONCOGENE			English	Article							DEPENDENT KINASE INHIBITOR; C-MYC; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; MICRO RNAS; MIR-124; EXPRESSION; GENE; ACTIVATION; P27(KIP1)	The myc oncogene is overexpressed in almost half of all breast and ovarian cancers, but attempts at therapeutic interventions against myc have proven to be challenging. Myc regulates multiple biological processes, including the cell cycle, and as such is associated with cell proliferation and tumor progression. We identified a protein signature of high myc, low p27 and high phospho-Rb significantly correlated with poor patient survival in breast and ovarian cancers. Screening of a miRNA library by functional proteomics in multiple cell lines and integration of data from patient tumors revealed a panel of five microRNAs (miRNAs) (miR-124, miR-365, miR-34b*, miR-18a and miR-506) as potential tumor suppressors capable of reversing the p27/myc/phospho-Rb protein signature. Mechanistic studies revealed an RNA-activation function of miR-124 resulting in direct induction of p27 protein levels by binding to and inducing transcription on the p27 promoter region leading to a subsequent G1 arrest. Additionally, in vivo studies utilizing a xenograft model demonstrated that nanoparticle-mediated delivery of miR-124 could reduce tumor growth and sensitize cells to etoposide, suggesting a clinical application of miRNAs as therapeutics to target the functional effect of myc on tumor growth.	[Seviourig, E. G.; Sehgal, V.; Lu, Y.; Luo, Z.; Moss, T.; Zhang, F.; Mills, G. B.; Ram, P. T.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Hill, S. M.] Cambridge Inst Publ Hlth, MRC Biostat Unit, Cambridge, England; [Liu, W.] UTMDACC, Dept Bioinformat & Computat Biol, Houston, TX USA; [Maiti, S. N.] UTMDACC, Dept Pediat, Houston, TX USA; [Azencot, R.] Univ Houston, Dept Math, Houston, TX 77204 USA; [Lopez-Berestein, G.; Rodriguez-Aguayo, C.; Roopaimoole, R.] UTMDACC, Dept Expt Therapeut, Houston, TX USA; [Lopez-Berestein, G.] UTMDACC, Ctr RNA Interference & Noncoding RNA, Houston, TX USA; [Pecot, C. V.] UTMDACC, Div Canc Med, Houston, TX USA; [Sood, A. K.] UTMDACC, Dept Gynecol Oncol, Houston, TX USA; [Gray, J. W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR USA	University of Texas System; UTMD Anderson Cancer Center; MRC Biostatistics Unit; University of Cambridge; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University	Ram, P (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	pram@mdandcrson.org	Sood, Anoop Kumar/A-7344-2013; rupaimoole, rajesha/K-3272-2016	Sood, Anoop Kumar/0000-0001-5702-4108; rupaimoole, rajesha/0000-0002-4795-7921; Ram, Prahlad/0000-0003-4739-3166; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723; Seviour, Elena/0000-0003-2885-4246	NIH/NCI ICBP grant [U54-CA112970]; Blanton Davis Foundation; Odessy Fellowship (MDACC); CCBTP training grant from the CPRIT; NATIONAL CANCER INSTITUTE [P50CA083639, U54CA112970, P30CA016672] Funding Source: NIH RePORTER	NIH/NCI ICBP grant; Blanton Davis Foundation; Odessy Fellowship (MDACC); CCBTP training grant from the CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All the data reported are presented and available in the Supplementary Materials. The work presented here was funded by an NIH/NCI ICBP grant U54-CA112970 to JWG (Project 1 Co-PI SM, Project 2 PI-JWG, Project 4 Co-PI's PTR and GBM) and the Blanton Davis Foundation. TM is partly funded by the Odessy Fellowship (MDACC) and ZL and VS are funded by the CCBTP training grant from the CPRIT.	Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chandramohan V, 2008, J CELL BIOCHEM, V104, P2091, DOI 10.1002/jcb.21765; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; DeGregori J, 2004, J CELL SCI, V117, P3411, DOI 10.1242/jcs.01189; Evan G, 2012, SCIENCE, V335, P293, DOI 10.1126/science.1217819; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hazlehurst LA, 2001, BLOOD, V98, P1897, DOI 10.1182/blood.V98.6.1897; Hodkinson PS, 2006, CELL DEATH DIFFER, V13, P1776, DOI 10.1038/sj.cdd.4401849; Hoyt DG, 1996, CANCER RES, V56, P4146; Hunt S, 2011, FEBS LETT, V585, P187, DOI 10.1016/j.febslet.2010.11.038; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kang SS, 2014, PROSTATE, V74, P1095, DOI 10.1002/pros.22822; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lang QB, 2012, BIOCHEM BIOPH RES CO, V426, P247, DOI 10.1016/j.bbrc.2012.08.075; Li CX, 2006, CELL CYCLE, V5, P2103, DOI 10.4161/cc.5.18.3192; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Li YF, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00058; Liang YJ, 2013, CARCINOGENESIS, V34, P713, DOI 10.1093/carcin/bgs383; Lu Y, 2011, ONCOGENE, V30, P4567, DOI 10.1038/onc.2011.164; Lu YX, 2013, BIOCHEM BIOPH RES CO, V441, P873, DOI 10.1016/j.bbrc.2013.10.157; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Mouw JK, 2014, NAT MED, V20, P360, DOI 10.1038/nm.3497; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Shi XB, 2013, ONCOGENE, V32, P4130, DOI 10.1038/onc.2012.425; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Szymaski M, 2003, INT REV CYTOL, V231, P197, DOI 10.1016/S0074-7696(03)31005-8; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Wei J, 2013, CANCER RES, V73, P3913, DOI 10.1158/0008-5472.CAN-12-4318; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; Xia JT, 2012, J PATHOL, V227, P470, DOI 10.1002/path.4030; Xu XL, 2014, ANN THORAC SURG, V97, P1037, DOI 10.1016/j.athoracsur.2013.10.042; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang H, 2002, CANCER, V95, P896, DOI 10.1002/cncr.10751; Zhang JH, 2013, INT J BUS SOC RES, V3, P124; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	51	31	33	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2016	35	6					691	701		10.1038/onc.2014.469	http://dx.doi.org/10.1038/onc.2014.469			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RF	25639871	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000370331300003
J	Zimberlin, CD; Lancini, C; Sno, R; Rosekrans, SL; McLean, CM; Vlaming, H; van den Brink, GR; Bots, M; Medema, JP; Dannenberg, JH				Zimberlin, Cheryl D.; Lancini, Cesare; Sno, Rachel; Rosekrans, Sanne L.; McLean, Chelsea M.; Vlaming, Hanneke; van den Brink, Gijs R.; Bots, Michael; Medema, Jan Paul; Dannenberg, Jan-Hermen			HDAC1 and HDAC2 collectively regulate intestinal stem cell homeostasis	FASEB JOURNAL			English	Article						organoids; histone deacetylase inhibitor; histone deacetylase; MS-275	HISTONE DEACETYLASES; SELF-RENEWAL; CANCER; EXPRESSION; WNT; TUMORIGENESIS; COLON; PROLIFERATION; EPITHELIUM; INDUCTION	Histone deacetylases (HDACs) are posttranslational modifiers that deacetylate proteins. Despite their crucial role in numerous biological processes, the use of broad-range HDAC inhibitors (HDACi), has shown clinical efficacy. However, undesired side effects highlight the necessity to better understand the biology of different HDACs and target the relevant HDACs. Using a novel mouse model, in which HDAC1 and HDAC2 can be simultaneously deleted in the intestine of adult mice, we show that the simultaneous deletion of HDAC1 and HDAC2 leads to a rapid loss of intestinal homeostasis. Importantly, this deletion cannot be sustained, and 8 days after initial ablation, stem cells that have escaped HDAC1 or HDAC2 deletion swiftly repopulate the intestinal lining. In vitro ablation of HDAC1 and HDAC2 using intestinal organoid cultures resulted in a down-regulation of multiple intestinal stem cell markers and functional loss of clonogenic capacity. Importantly, treatment of wild-type organoids with class I-specific HDACi MS-275 also induced a similar loss of stemness, providing a possible rationale for the gastrointestinal side effects often observed in HDACi-treated patients. In conclusion, these data show that HDAC1 and HDAC2 have a redundant function and are essential to maintain intestinal homeostasis.	[Zimberlin, Cheryl D.; Bots, Michael; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands; [Lancini, Cesare; Sno, Rachel; McLean, Chelsea M.; Vlaming, Hanneke; Dannenberg, Jan-Hermen] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Rosekrans, Sanne L.; van den Brink, Gijs R.] Univ Amsterdam, Acad Med Ctr, Tygat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Medema, Jan Paul] Canc Genom Ctr, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University	Dannenberg, JH (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.dannenberg@nki.nl		Medema, Jan Paul/0000-0003-3045-2924; McLean, Chelsea/0000-0002-3548-3482; Vlaming, Hanneke/0000-0003-1743-6428	Dutch Cancer Society [KWF-2007-3978, KWF NKI 2009-4511, UvA2009-4416, UvA2012-5735]; Netherlands Organization for Scientific Research [NWO-VIDI 864.07.008]; Netherlands Organization for Scientific Research (Gravitation; Zwaartekracht); Maag, Lever en Darm Stichting (MLDS) [FP13-07]; Alpe d'Huzes/Dutch Cancer Society (CONNECTION)	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (Gravitation; Zwaartekracht); Maag, Lever en Darm Stichting (MLDS); Alpe d'Huzes/Dutch Cancer Society (CONNECTION)	The authors thank Martijn Koppens for providing the in vitro beta-NF protocol. The authors thank Ton Schrauwers, Corine van Langen, Auke Zwerver, Cor Spaan, and Dienke Jonkers for excellent animal care. J.P.M. and J.-H.D. share senior authorship. This work was supported by grants from the Dutch Cancer Society (KWF-2007-3978) and Netherlands Organization for Scientific Research (NWO-VIDI 864.07.008) (to J.H.D.). H.V. and C.M.M. are supported by a grant from the Dutch Cancer Society (KWF NKI 2009-4511). J.P.M. is supported by the Dutch Cancer Society (UvA2009-4416 and UvA2012-5735), the Netherlands Organization for Scientific Research (Gravitation; Zwaartekracht), Maag, Lever en Darm Stichting (MLDS) (FP13-07), and Alpe d'Huzes/Dutch Cancer Society (CONNECTION).	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Clevers H, 2013, NATURE, V495, P53, DOI 10.1038/nature11958; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Heideman MR, 2013, BLOOD, V121, P2038, DOI 10.1182/blood-2012-08-450916; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Prasetyanti PR, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-126; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Santoro F, 2013, BLOOD, V121, P3459, DOI 10.1182/blood-2012-10-461988; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Turgeon N, 2014, AM J PHYSIOL-GASTR L, V306, pG594, DOI 10.1152/ajpgi.00393.2013; Turgeon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073785; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Winter M, 2013, EMBO J, V32, P3176, DOI 10.1038/emboj.2013.243; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; Zimmermann S, 2007, CANCER RES, V67, P9047, DOI 10.1158/0008-5472.CAN-07-0312	35	29	31	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					2070	2080		10.1096/fj.14-257931	http://dx.doi.org/10.1096/fj.14-257931			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25648995				2022-12-26	WOS:000354114600039
J	Golan, Y; Berman, B; Assaraf, YG				Golan, Yarden; Berman, Bluma; Assaraf, Yehuda G.			Heterodimerization, Altered Subcellular Localization, and Function of Multiple Zinc Transporters in Viable Cells Using Bimolecular Fluorescence Complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELLS; INTRACELLULAR ZINC; ALZHEIMERS-DISEASE; SLC30A2 ZNT-2; DEFICIENCY; EXPRESSION; FAMILY; VISUALIZATION; TOXICITY; MUTATION	Zinc plays a crucial role in numerous key physiological functions. Zinc transporters (ZnTs) mediate zinc efflux and compartmentalization in intracellular organelles; thus, ZnTs play a central role in zinc homeostasis. We have recently shown the in situ dimerization and function of multiple normal and mutant ZnTs using bimolecular fluorescence complementation (BiFC). Prompted by these findings, we here uncovered the heterodimerization, altered subcellular localization, and function of multiple ZnTs in live cells using this sensitive BiFC technique. We show that ZnT1, -2, -3, and -4 form stable heterodimers at distinct intracellular compartments, some of which are completely different from their homodimer localization. Specifically, unlike the plasma membrane (PM) localization of ZnT1 homodimers, ZnT1-ZnT3 heterodimers localized at intracellular vesicles. Furthermore, upon heterodimerization with ZnT1, the zinc transporters ZnT2 and ZnT4 surprisingly localized at the PM, as opposed to their vesicular homodimer localization. We further demonstrate the deleterious effect that the G87R-ZnT2 mutation, associated with transient neonatal zinc deficiency, has on ZnT1, ZnT3, and ZnT4 upon heterodimerization. The functionality of the various ZnTs was assessed by the dual BiFC-Zinquin assay. We also undertook a novel transfection competition assay with ZnT cDNAs to confirm that the driving force for heterodimer formation is the core structure of ZnTs and not the BiFC tags. These findings uncover a novel network of homo-and heterodimers of ZnTs with distinct subcellular localizations and function, hence highlighting their possible role in zinc homeostasis under physiological and pathological conditions.	[Golan, Yarden; Berman, Bluma; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il		Golan, Yarden/0000-0002-3043-3638; Assaraf, Yehuda G./0000-0001-6692-8221				Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Beyer N, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-53; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Gohlke Henning, 2008, Rev Diabet Stud, V5, P25, DOI 10.1900/RDS.2008.5.25; Haider AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025818; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kilpatrick Laura E, 2012, Methods Mol Biol, V897, P109, DOI 10.1007/978-1-61779-909-9_6; KRIEGER I, 1986, AM J CLIN NUTR, V43, P955, DOI 10.1093/ajcn/43.6.955; Kukic I, 2014, J CELL SCI, V127, P3094, DOI 10.1242/jcs.145318; Lasry I, 2014, J BIOL CHEM, V289, P7275, DOI 10.1074/jbc.M113.533786; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Lazarczyk M, 2009, MICROBIOL MOL BIOL R, V73, P348, DOI 10.1128/MMBR.00033-08; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee J, 2011, BRAIN RES BULL, V86, P314, DOI 10.1016/j.brainresbull.2011.08.011; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; Navarro ML, 2014, PEDIATR DERMATOL, V31, P251, DOI 10.1111/pde.12257; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; Miletta MC, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/259189; Nolte C, 2004, GLIA, V48, P145, DOI 10.1002/glia.20065; Overbeck S, 2008, J LEUKOCYTE BIOL, V83, P368, DOI 10.1189/jlb.0307148; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Prasad AS, 2012, J TRACE ELEM MED BIO, V26, P66, DOI 10.1016/j.jtemb.2012.04.004; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; Seo YA, 2011, AM J PHYSIOL-CELL PH, V300, pC1479, DOI 10.1152/ajpcell.00420.2010; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Susperreguy S, 2011, EXP CELL RES, V317, P706, DOI 10.1016/j.yexcr.2010.11.008; Vaniotis G, 2011, AM J PHYSIOL-HEART C, V301, pH1754, DOI 10.1152/ajpheart.00657.2011; Weijers RNM, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-33; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568	42	33	33	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9050	9063		10.1074/jbc.M114.617332	http://dx.doi.org/10.1074/jbc.M114.617332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25657003	Green Published, hybrid			2022-12-26	WOS:000352207100029
J	Thaysen-Andersen, M; Venkatakrishnan, V; Loke, I; Laurini, C; Diestel, S; Parker, BL; Packer, NH				Thaysen-Andersen, Morten; Venkatakrishnan, Vignesh; Loke, Ian; Laurini, Christine; Diestel, Simone; Parker, Benjamin L.; Packer, Nicolle H.			Human Neutrophils Secrete Bioactive Paucimannosidic Proteins from Azurophilic Granules into Pathogen-Infected Sputum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HEXOSAMINIDASE-B; N-GLYCANS; CAENORHABDITIS-ELEGANS; STRUCTURAL-ANALYSIS; INSECT CELLS; GLYCOSYLATION; CANCER; EXPRESSION; MODEL; LIFE	Unlike plants and invertebrates, mammals reportedly lack proteins displaying asparagine (N)-linked paucimannosylation (mannose(1-3)fucose(0-1)N-acetylglucosamine(2)Asn). Enabled by technology advancements in system-wide biomolecular characterization, we document that protein paucimannosylation is a significant host-derived molecular signature of neutrophil-rich sputum from pathogen-infected human lungs and is negligible in pathogen-free sputum. Five types of paucimannosidic N-glycans were carried by compartment-specific and inflammation-associated proteins of the azurophilic granules of human neutrophils including myeloperoxidase (MPO), azurocidin, and neutrophil elastase. The timely expressed human azurophilic granule-resident beta-hexosaminidase A displayed the capacity to generate paucimannosidic N-glycans by trimming hybrid/complex type N-glycan intermediates with relative broad substrate specificity. Paucimannosidic N-glycoepitopes showed significant co-localization with beta-hexosaminidase A and the azurophilic marker MPO in human neutrophils using immunocytochemistry. Furthermore, promyelocyte stage-specific expression of genes coding for paucimannosidic proteins and biosynthetic enzymes indicated a novel spatio-temporal biosynthetic route in early neutrophil maturation. The absence of bacterial exoglycosidase activities and paucimannosidic N-glycans excluded exogenous origins of paucimannosylation. Paucimannosidic proteins from isolated and sputum neutrophils were preferentially secreted upon inoculation with virulent Pseudomonas aeruginosa. Finally, paucimannosidic proteins displayed affinities to mannose-binding lectin, suggesting immune-related functions of paucimannosylation in activated human neutrophils. In conclusion, we are the first to document that human neutrophils produce, store and, upon activation, selectively secrete bioactive paucimannosidic proteins into sputum of lungs undergoing pathogen-based inflammation.	[Thaysen-Andersen, Morten; Venkatakrishnan, Vignesh; Loke, Ian; Packer, Nicolle H.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Laurini, Christine; Diestel, Simone] Univ Bonn, Inst Nutr & Food Sci, D-53113 Bonn, Germany; [Parker, Benjamin L.] Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW 2010, Australia	Macquarie University; University of Bonn; Garvan Institute of Medical Research	Thaysen-Andersen, M (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	morten.andersen@mq.edu.au	Loke, Ian/H-7377-2013; Packer, Nicolle/Q-8929-2019	Loke, Ian/0000-0002-2558-0975; Thaysen-Andersen, Morten/0000-0001-8327-6843; Packer, Nicolle/0000-0002-7532-4021	Australian Research Council Super Science Program [FS110200026]; Early Career Fellowship, Cancer Institute NSW	Australian Research Council Super Science Program(Australian Research Council); Early Career Fellowship, Cancer Institute NSW	This work was supported by the Australian Research Council Super Science Program (FS110200026).; Funded by an Early Career Fellowship, Cancer Institute NSW.	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Altmann F, 2001, BIOCHIMIE, V83, P703, DOI 10.1016/S0300-9084(01)01297-4; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Balog CIA, 2012, MOL CELL PROTEOMICS, V11, P571, DOI 10.1074/mcp.M111.011601; Bilyy RO, 2012, J BIOL CHEM, V287, P496, DOI 10.1074/jbc.M111.273144; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cipollo JF, 2002, J BIOL CHEM, V277, P49143, DOI 10.1074/jbc.M208020200; Dam S, 2013, J PROTEOME RES, V12, P3383, DOI 10.1021/pr400224s; Everest-Dass AV, 2012, GLYCOBIOLOGY, V22, P1465, DOI 10.1093/glycob/cws112; Faid V, 2006, GLYCOBIOLOGY, V16, P440, DOI 10.1093/glycob/cwj081; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Hashii N, 2009, IMMUNOLOGY, V126, P336, DOI 10.1111/j.1365-2567.2008.02898.x; HASLAM SM, 2002, BIOCH SOC S, V69, P117; Hepbildikler ST, 2002, J BIOL CHEM, V277, P2562, DOI 10.1074/jbc.M105457200; Jayaram L, 2007, CAN RESPIR J, V14, P99, DOI 10.1155/2007/679742; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Jin CS, 2012, J BIOL CHEM, V287, P35922, DOI 10.1074/jbc.M112.363119; Joosten CE, 2004, BIOTECHNOL PROGR, V20, P1273, DOI 10.1021/bp034378n; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Kaprio T, 2015, MOL CELL PROTEOMICS, V14, P277, DOI 10.1074/mcp.M114.041632; Kjeldsen L, 1998, J LEUKOCYTE BIOL, V64, P72, DOI 10.1002/jlb.64.1.72; Lacy Paige, 2006, Allergy Asthma Clin Immunol, V2, P98, DOI 10.1186/1710-1492-2-3-98; Lee LY, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00404; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Leymarie N, 2013, MOL CELL PROTEOMICS, V12, P2935, DOI 10.1074/mcp.M113.030643; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Martinelli S, 2004, J BIOL CHEM, V279, P44123, DOI 10.1074/jbc.M405883200; MEIER EM, 1991, J BIOL CHEM, V266, P1879; MIYASAKI KT, 1991, INFECT IMMUN, V59, P3760, DOI 10.1128/IAI.59.10.3760-3767.1991; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Mysling S, 2010, ANAL CHEM, V82, P5598, DOI 10.1021/ac100530w; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Olczak M, 2002, BIOCHEM BIOPH RES CO, V293, P213, DOI 10.1016/S0006-291X(02)00201-2; Parker BL, 2013, J PROTEOME RES, V12, P5791, DOI 10.1021/pr400783j; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ravnsborg T, 2010, BBA-PROTEINS PROTEOM, V1804, P2046, DOI 10.1016/j.bbapap.2010.07.001; Rorvig S, 2013, J LEUKOCYTE BIOL, V94, P711, DOI 10.1189/jlb.1212619; Sarkar M, 2006, J BIOL CHEM, V281, P12776, DOI 10.1074/jbc.M512769200; Schachter H, 2011, FLY, V5, P18, DOI 10.4161/fly.5.1.13920; Schachter H, 2009, CARBOHYD RES, V344, P1391, DOI 10.1016/j.carres.2009.04.028; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Schuette CG, 2001, GLYCOBIOLOGY, V11, P549, DOI 10.1093/glycob/11.7.549; Sethi MK, 2014, J PROTEOME RES, V13, P277, DOI 10.1021/pr400861m; Shi H, 2006, METHOD ENZYMOL, V417, P359, DOI 10.1016/S0076-6879(06)17022-6; Taganna J, 2011, BIOCHEM SOC T, V39, P349, DOI 10.1042/BST0390349; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Timar CI, 2013, BLOOD, V121, P510, DOI 10.1182/blood-2012-05-431114; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; van Remoortere A, 2003, GLYCOBIOLOGY, V13, P217, DOI 10.1093/glycob/cwg025; Venkatakrishnan V, 2015, GLYCOBIOLOGY, V25, P88, DOI 10.1093/glycob/cwu092; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Zhang WL, 2003, BIOCHEM J, V372, P53, DOI 10.1042/BJ20021931; Zinchuk V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01365; Zipser B, 2012, J CARBOHYD CHEM, V31, P504, DOI 10.1080/07328303.2012.661112; Zoega M, 2012, J PROTEOMICS, V75, P1472, DOI 10.1016/j.jprot.2011.11.019	73	67	71	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8789	8802		10.1074/jbc.M114.631622	http://dx.doi.org/10.1074/jbc.M114.631622			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25645918	hybrid, Green Published			2022-12-26	WOS:000352207100010
J	Heissler, SM; Chinthalapudi, K; Sellers, JR				Heissler, Sarah M.; Chinthalapudi, Krishna; Sellers, James R.			Kinetic characterization of the sole nonmuscle myosin-2 from the model organism Drosophila melanogaster	FASEB JOURNAL			English	Article						actin; blebbistatin; cytoskeleton; transient kinetics; rotamer	BLEBBISTATIN INHIBITION; CYTOPLASMIC MYOSIN; MOTOR DOMAIN; DICTYOSTELIUM-DISCOIDEUM; MUSCLE MYOSIN; ACTIN; MORPHOGENESIS; PROTEIN; OOGENESIS; MECHANISM	Nonmuscle myosin-2 is the primary enzyme complex powering contractility of the F-actin cytoskeleton in the model organism Drosophila. Despite myosin's essential function in fly development and homeostasis, its kinetic features remain elusive. The purpose of this in vitro study is a detailed steady-state and presteady-state kinetic characterization of the Drosophila nonmuscle myosin-2 motor domain. Kinetic features are a slow steady-state ATPase activity, high affinities for F-actin and ADP, and a low duty ratio. Comparative analysis of the overall enzymatic signatures across the nonmuscle myosin-2 complement from model organisms indicates that the Drosophila protein resembles nonmuscle myosin-2s from metazoa rather than protozoa, though modulatory aspects of myosin motor function are distinct. Drosophila nonmuscle myosin-2 is uniquely insensitive toward blebbistatin, a commonly used myosin-2 inhibitor. An in silico modeling approach together with kinetic studies indicate that the nonconsensus amino acid Met466 in the Drosophila nonmuscle myosin-2 active-site loop switch-2 acts as blebbistatin desensitizer. Introduction of the M466I mutation sensitized the protein for blebbistatin, resulting in a half-maximal inhibitory concentration of 36.3 +/- 4.1 mu M. Together, these data show that Drosophila nonmuscle myosin-2 is a bona fide molecular motor and establish an important link between switch-2 and blebbistatin sensitivity.	[Heissler, Sarah M.; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Chinthalapudi, Krishna] Scripps Res Inst, Dept Canc Biol, Cell Adhes Lab, Jupiter, FL USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Scripps Research Institute	Sellers, JR (corresponding author), NHLBI, Lab Mol Physiol, NIH, 50 South Dr,B50-3523, Bethesda, MD 20892 USA.	sellersj@nhlbi.nih.gov	Chinthalapudi, Krishna/B-4550-2018	Chinthalapudi, Krishna/0000-0003-3669-561X	U.S. National Institutes of Health National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001786] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Adam C. Martin (Massachusetts Institute of Technology, Cambridge, MA, USA) for the Drosophila nonmuscle myosin-2 cDNA and the polycistronic expression vector encoding for Sqh and Mlc-c. They also thank Fang Zhang for the preparation of F-actin. J.R.S. was funded by the Intramural Research Program of the U.S. National Institutes of Health National Heart, Lung, and Blood Institute.	Aldaz S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2763; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Bloor JW, 2001, DEV BIOL, V239, P215, DOI 10.1006/dbio.2001.0452; Cao Y, 2014, BIOCHEMISTRY-US, V53, P350, DOI 10.1021/bi401236c; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Ferreira T, 2014, DEV BIOL, V394, P277, DOI 10.1016/j.ydbio.2014.08.008; Franke JD, 2007, HUM MOL GENET, V16, P3160, DOI 10.1093/hmg/ddm279; Franke JD, 2010, DEV BIOL, V345, P117, DOI 10.1016/j.ydbio.2010.06.028; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; Heissler SM, 2013, J BIOL CHEM, V288, P26709, DOI 10.1074/jbc.M113.485946; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Heissler SM, 2011, J BIOL CHEM, V286, P21191, DOI 10.1074/jbc.M110.212290; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kuhlman PA, 1998, J MUSCLE RES CELL M, V19, P491, DOI 10.1023/A:1005304408812; Lauzon AM, 1998, J MUSCLE RES CELL M, V19, P825, DOI 10.1023/A:1005489501357; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Ma Xuefei, 2014, Bioarchitecture, V4, P88, DOI 10.4161/bioa.29766; MAHAJANMIKLOS S, 1994, DEV BIOL, V165, P336, DOI 10.1006/dbio.1994.1257; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; Murphy CT, 2001, NAT CELL BIOL, V3, P311, DOI 10.1038/35060110; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Okumura T, 2010, DEV BIOL, V344, P693, DOI 10.1016/j.ydbio.2010.05.501; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; RITCHIE MD, 1993, P NATL ACAD SCI USA, V90, P8619, DOI 10.1073/pnas.90.18.8619; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasaki N, 1998, J BIOL CHEM, V273, P20334, DOI 10.1074/jbc.273.32.20334; Seabrooke S, 2011, J NEUROPHYSIOL, V105, P1966, DOI 10.1152/jn.00718.2010; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Shu S, 2005, P NATL ACAD SCI USA, V102, P1472, DOI 10.1073/pnas.0409528102; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Vasquez CG, 2014, J CELL BIOL, V206, P435, DOI 10.1083/jcb.201402004; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; WHEATLEY S, 1995, DEVELOPMENT, V121, P1937; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; Zhao FQ, 2008, BIOPHYS J, V95, P3322, DOI 10.1529/biophysj.108.137067	48	18	18	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1456	1466		10.1096/fj.14-266742	http://dx.doi.org/10.1096/fj.14-266742			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25636739	Green Published			2022-12-26	WOS:000354115000031
J	Ngu, M; Hirata, E; Suzuki, K				Ngu, Meipin; Hirata, Eri; Suzuki, Kuninori			Visualization of Atg3 during Autophagosome Formation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASM; PROTEINS; YEAST; DELIVERY; MUTANTS; COMPLEX; SYSTEM; ENZYME	Macroautophagy (autophagy) is a highly conserved cellular recycling process involved in degradation of eukaryotic cellular components. During autophagy, macromolecules and organelles are sequestered into the double-membrane autophagosome and degraded in the vacuole/lysosome. Autophagy-related 8 (Atg8), a core Atg protein essential for autophagosome formation, is a marker of several autophagic structures: the pre-autophagosomal structure (PAS), isolation membrane (IM), and autophagosome. Atg8 is conjugated to phosphatidylethanolamine (PE) through a ubiquitin-like conjugation system to yield Atg8-PE; this reaction is called Atg8 lipidation. Although the mechanisms of Atg8 lipidation have been well studied in vitro, the cellular locale of Atg8 lipidation remains enigmatic. Atg3 is an E2-like enzyme that catalyzes the conjugation reaction between Atg8 and PE. Therefore, we hypothesized that the localization of Atg3 would provide insights about the site of the lipidation reaction. To explore this idea, we constructed functional GFP-tagged Atg3 (Atg3-GFP) by inserting the GFP portion immediately after the handle region of Atg3. During autophagy, Atg3-GFP transiently formed a single dot per cell on the vacuolar membrane. This Atg3-GFP dot colocalized with 2 x mCherry-tagged Atg8, demonstrating that Atg3 is localized to autophagic structures. Furthermore, we found that Atg3-GFP is localized to theIMby fine-localization analysis. The localization of Atg3 suggests that Atg3 plays an important role in autophagosome formation at the IM.	[Ngu, Meipin; Hirata, Eri; Suzuki, Kuninori] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Suzuki, Kuninori] Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba 2778562, Japan	University of Tokyo; University of Tokyo	Suzuki, K (corresponding author), Univ Tokyo, FSB 101,5-1-5 Kashiwanoha, Kashiwa, Chiba 2778562, Japan.	kuninori@k.u-tokyo.ac.jp			International Kyowa Scholarship Foundation; Hamaguchi Foundation for the Advancement of Biochemistry; Mishima Kaiun Memorial Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Takeda Science Foundation; Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [24121707, 24657083, 25291040]; Grants-in-Aid for Scientific Research [26111505] Funding Source: KAKEN	International Kyowa Scholarship Foundation; Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the International Kyowa Scholarship Foundation (to M. N.), the Hamaguchi Foundation for the Advancement of Biochemistry (to K. S.), the Mishima Kaiun Memorial Foundation (to K. S.), the NOVARTIS Foundation (Japan) for the Promotion of Science (to K. S.), the Takeda Science Foundation (to K. S.), the Yamada Science Foundation (to K. S.), and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24121707, 24657083, and 25291040) (to K. S.).	Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hanada T, 2009, FEBS LETT, V583, P1078, DOI 10.1016/j.febslet.2009.03.009; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kaiser SE, 2012, NAT STRUCT MOL BIOL, V19, P1242, DOI 10.1038/nsmb.2415; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091651; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Suzuki K, 2011, DEV CELL, V21, P358, DOI 10.1016/j.devcel.2011.06.023; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670	34	20	21	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8146	8153		10.1074/jbc.M114.626952	http://dx.doi.org/10.1074/jbc.M114.626952			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645919	Green Published, hybrid			2022-12-26	WOS:000351662600012
J	Capurro, M; Shi, W; Izumikawa, T; Kitagawa, H; Filmus, J				Capurro, Mariana; Shi, Wen; Izumikawa, Tomomi; Kitagawa, Hiroshi; Filmus, Jorge			Processing by Convertases Is Required for Glypican-3-induced Inhibition of Hedgehog Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Convertase; Glycosaminoglycan; Hedgehog Signaling Pathway; Heparan Sulfate; Proteoglycan; Glypican-3	GOLABI-BEHMEL-SYNDROME; HEPATOCELLULAR-CARCINOMA; CORE PROTEIN; CELL-SURFACE; DALLY-LIKE; GLYPICANS; OVERGROWTH; MORPHOGEN; GROWTH; STIMULATION	Background: Glypican-3 (GPC3) is a proteoglycan that is cleaved by convertases and that inhibits Hedgehog signaling. Results: Convertase-resistant GPC3 stimulates Hedgehog signaling, and unlike wild-type GPC3, binds to Patched through its heparan sulfate chains. Conclusion: Convertase cleavage is required for GPC3-induced inhibition of Hedgehog signaling. Significance: The structure of the GPC3 core-protein determines the binding properties of heparan sulfate chains. Glypican-3 (GPC3) is one of the six members of the mammalian glypican family. We have previously reported that GPC3 inhibits Hedgehog (Hh) signaling by competing with Patched (Ptc) for Hh binding. We also showed that GPC3 binds with high affinity to Hh through its core protein, but that it does not interact with Ptc. Several members of the glypican family, including GPC3, are subjected to an endoproteolytic cleavage by the furin-like convertase family of endoproteases. Surprisingly, however, we have found that a mutant GPC3 that cannot be processed by convertases is as potent as wild-type GPC3 in stimulating Wnt activity in hepatocellular carcinoma cell lines and 293T cells and in promoting hepatocellular carcinoma growth. In this study, we show that processing by convertases is essential for GPC3-induced inhibition of Hh signaling. Moreover, we show that a convertase-resistant GPC3 stimulates Hh signaling by increasing the binding of this growth factor to Ptc. Consistent with this, we show that the convertase-resistant mutant binds to both Hh and Ptc through its heparan sulfate (HS) chains. Unexpectedly, we found that the mutant core protein does not bind to Hh. We also report that the convertase-resistant mutant GPC3 carries HS chains with a significantly higher degree of sulfation than those of wild-type GPC3. We propose that the structural changes generated by the lack of cleavage determine a change in the sulfation of the HS chains and that these hypersulfated chains mediate the interaction of the mutant GPC3 with Ptc.	[Capurro, Mariana; Shi, Wen; Izumikawa, Tomomi; Filmus, Jorge] Univ Toronto, Sunnybrook Res Inst, Biol Sci, Toronto, ON M4N 3M5, Canada; [Capurro, Mariana; Shi, Wen; Izumikawa, Tomomi; Filmus, Jorge] Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; [Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Kobe Pharmaceutical University	Filmus, J (corresponding author), Sunnybrook Res Inst, Rm S218,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	jorge.filmus@sri.utoronto.ca	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079; Capurro, Mariana/0000-0002-4560-7186	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research.	Akiyama T, 2008, DEV BIOL, V313, P408, DOI 10.1016/j.ydbio.2007.10.035; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Capurro M, 2014, J CELL SCI, V127, P1565, DOI 10.1242/jcs.140871; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2012, J CELL SCI, V125, P3380, DOI 10.1242/jcs.098889; Capurro MI, 2009, EMBO REP, V10, P901, DOI 10.1038/embor.2009.98; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Capurro MI, 2005, J BIOL CHEM, V280, P41201, DOI 10.1074/jbc.M507004200; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Dejima K, 2011, J BIOL CHEM, V286, P17103, DOI 10.1074/jbc.M110.208082; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Filmus J, 2014, MATRIX BIOL, V35, P248, DOI 10.1016/j.matbio.2013.12.007; Filmus J, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P209; Gao W, 2014, HEPATOLOGY, V60, P576, DOI 10.1002/hep.26996; Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09; Jackson SM, 1997, DEVELOPMENT, V124, P4113; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; Song HH, 2005, J BIOL CHEM, V280, P2116, DOI 10.1074/jbc.M410090200; Victor XV, 2009, J BIOL CHEM, V284, P25842, DOI 10.1074/jbc.M109.043208; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001	29	17	18	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7576	7585		10.1074/jbc.M114.612705	http://dx.doi.org/10.1074/jbc.M114.612705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25653284	Green Published, hybrid			2022-12-26	WOS:000351613600022
J	Chavan, H; Li, F; Tessman, R; Mickey, K; Dorko, K; Schmitt, T; Kumer, S; Gunewardena, S; Gaikwad, N; Krishnamurthy, P				Chavan, Hemantkumar; Li, Feng; Tessman, Robert; Mickey, Kristen; Dorko, Kenneth; Schmitt, Timothy; Kumer, Sean; Gunewardena, Sumedha; Gaikwad, Nilesh; Krishnamurthy, Partha			Functional Coupling of ATP-binding Cassette Transporter Abcb6 to Cytochrome P450 Expression and Activity in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Cytochrome P450; Gene Regulation; Membrane Transport; Metabolic Regulation	TRANSCRIPTIONAL SUPPRESSION; DRUG-METABOLISM; GENE-EXPRESSION; EVOLUTION; HEME; P450; ACTIVATION; MUTATIONS; ENZYMES; MICE	Background: Physiological signals that negatively regulate CYP450s are not well understood. Results: Loss of Abcb6 in mice results in suppression of CYP450 activity. Conclusion: Suppression of P450 activity in Abcb6 deficiency may result from altered endogenous metabolites involved in maintaining homeostasis. Significance: Understanding metabolite alterations in Abcb6 deficiency should help understand the physiological signals and the mechanisms involved in negative regulation of P450s. Although endogenous mechanisms that negatively regulate cytochrome P450 (P450) monooxygenases in response to physiological and pathophysiological signals are not well understood, they are thought to result from alterations in the level of endogenous metabolites, involved in maintaining homeostasis. Here we show that homeostatic changes in hepatic metabolite profile in Abcb6 (mitochondrial ATP-binding cassette transporter B6) deficiency results in suppression of a specific subset of hepatic P450 activity. Abcb6 null mice are more susceptible to pentobarbital-induced sleep and zoxazolamine-induced paralysis, secondary to decreased expression and activity of Cyp3a11 and Cyp2b10. The knock-out mice also show decrease in both basal and xeno-inducible expression and activity of a subset of hepatic P450s that appear to be related to changes in hepatic metabolite profile. These data, together with the observation that liver extracts from Abcb6-deficient mice suppress P450 expression in human primary hepatocytes, suggest that this mouse model may provide an opportunity to understand the physiological signals and the mechanisms involved in negative regulation of P450s.	[Chavan, Hemantkumar; Li, Feng; Tessman, Robert; Mickey, Kristen; Dorko, Kenneth; Krishnamurthy, Partha] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Schmitt, Timothy; Kumer, Sean] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66160 USA; [Gunewardena, Sumedha] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Gunewardena, Sumedha] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66160 USA; [Dorko, Kenneth] Univ Kansas, Med Ctr, Cell Isolat Core, Kansas City, KS 66160 USA; [Gaikwad, Nilesh] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Gaikwad, Nilesh] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Gaikwad, Nilesh] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Krishnamurthy, P (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	pkasturi@kumc.edu	Chavan, Hemant/ABA-4925-2021; Chavan, Hemantkumar/AAN-6756-2020; Li, Feng/M-5334-2016	Chavan, Hemantkumar/0000-0002-9963-6230; Li, Feng/0000-0002-9680-4614	National Institutes of Health [U01HG004085, U01HG004080]; Children's Hospital Oakland Research Institute [U42RR024244]; National Center for Research Resources [5P20RR021940-07]; National Institute of General Medical Sciences [8P20GM103549-07]; Biomedical Research Training Grant for the University of Kansas Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244, P20RR021940] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004085, U01HG004080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Oakland Research Institute; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biomedical Research Training Grant for the University of Kansas Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U01HG004085 (to Velocigene at Regeneron Inc.) and U01HG004080 (to the CSD Consortium). This work was also supported by Grant U42RR024244 from Children's Hospital Oakland Research Institute, Grant 5P20RR021940-07 from the National Center for Research Resources, Grant 8P20GM103549-07 from the National Institute of General Medical Sciences, and the Biomedical Research Training Grant for the University of Kansas Medical Center (to H. C.).	Abraham A, 2014, ANN HEMATOL, V93, P509, DOI 10.1007/s00277-013-1821-2; Alsaad AMS, 2013, DRUG METAB REV, V45, P173, DOI 10.3109/03602532.2012.754460; Andolfo I, 2013, AM J HEMATOL, V88, P66, DOI 10.1002/ajh.23357; Chavan H, 2013, J BIOL CHEM, V288, P22658, DOI 10.1074/jbc.M113.485284; Chavan H, 2012, J BIOL CHEM, V287, P32054, DOI 10.1074/jbc.M112.371476; Cheng PY, 2003, J PHARMACOL EXP THER, V307, P1205, DOI 10.1124/jpet.103.057174; Cui YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079808; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Easterbrook J, 2001, CHEM-BIOL INTERACT, V134, P243, DOI 10.1016/S0009-2797(01)00159-4; Facciola G, 2001, EUR J CLIN PHARMACOL, V56, P881, DOI 10.1007/s002280000245; Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222; Gaikwad NW, 2013, ANAL CHEM, V85, P4951, DOI 10.1021/ac400016e; Gonzalez FJ, 1996, FASEB J, V10, P1112, DOI 10.1096/fasebj.10.10.8751713; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; Hartter S, 2001, CLIN PHARMACOL THER, V70, P10, DOI 10.1067/mcp.2001.116512; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Huls M, 2009, J PHARMACOL EXP THER, V328, P3, DOI 10.1124/jpet.107.132225; Jover R, 1996, MOL PHARMACOL, V50, P474; Jover R, 2000, EUR J BIOCHEM, V267, P7128, DOI 10.1046/j.1432-1327.2000.01815.x; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Li F, 2011, CHEM RES TOXICOL, V24, P744, DOI 10.1021/tx200033v; Lin WW, 2008, J BIOL CHEM, V283, P30650, DOI 10.1074/jbc.M806132200; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; Manzardo AM, 2014, ALCOHOL CLIN EXP RES, V38, P1594, DOI 10.1111/acer.12429; Miller MS, 1996, FUND APPL TOXICOL, V34, P165, DOI 10.1006/faat.1996.0187; Moitra K, 2011, BIOL CHEM, V392, P29, DOI 10.1515/BC.2011.006; Mookherjee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045077; Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246; Nebert D W, 1994, Prog Liver Dis, V12, P63; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Polireddy K, 2011, MOL ONCOL, V5, P410, DOI 10.1016/j.molonc.2011.07.005; Prough RA, 1996, FASEB J, V10, P1369, DOI 10.1096/fasebj.10.12.8903507; Ramana Kota V., 1998, Indian Journal of Experimental Biology, V36, P437; Riddick DS, 2004, DRUG METAB DISPOS, V32, P367, DOI 10.1124/dmd.32.4.367; ROTH LJ, 1949, J BIOL CHEM, V178, P963; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; SRIVASTAVA G, 1989, EUR J BIOCHEM, V178, P689, DOI 10.1111/j.1432-1033.1989.tb14499.x; Tralau T, 2013, EXPERT OPIN DRUG MET, V9, P1541, DOI 10.1517/17425255.2013.828692; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Wang LJ, 2012, AM J HUM GENET, V90, P40, DOI 10.1016/j.ajhg.2011.11.026; Watanabe M, 1998, LIFE SCI, V63, P1685, DOI 10.1016/S0024-3205(98)00440-8; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; WRIGHTON SA, 1992, CRIT REV TOXICOL, V22, P1, DOI 10.3109/10408449209145319; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Xie YC, 2014, TOXICOL APPL PHARM, V279, P266, DOI 10.1016/j.taap.2014.05.010; Xu MJ, 2013, DRUG METAB REV, V45, P311, DOI 10.3109/03602532.2013.806537; Yang X, 2010, GENOME RES, V20, P1020, DOI 10.1101/gr.103341.109; Zhang CE, 2013, J INVEST DERMATOL, V133, P2221, DOI 10.1038/jid.2013.145	53	8	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7871	7886		10.1074/jbc.M114.605386	http://dx.doi.org/10.1074/jbc.M114.605386			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25623066	Green Published, hybrid			2022-12-26	WOS:000351613600045
J	Hundt, J; Li, ZB; Liu, Q				Hundt, Jana; Li, Zhubing; Liu, Qiang			The Inhibitory Effects of Anacardic Acid on Hepatitis C Virus Life Cycle	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE; CORE PROTEIN; SUMOYLATION; SUMO; APOPTOSIS; PRODUCTS; NUCLEAR; PATHWAY; ALPHA; ASSAY	Hepatitis C virus (HCV) is a small positive-sense single-stranded RNA virus that causes severe liver diseases. Current anti-HCV therapies involving direct-acting antivirals have significantly enhanced efficacy in comparison to traditional interferon and ribavirin combination. However, further improvement is needed to eradicate HCV. Anacardic acid (AnA) is a phytochemical compound that can inhibit the activity of various cellular enzymes including histone acetyltransferases (HATs). In this study, we investigated the effects of AnA on different phases of HCV life cycle. Our data showed that AnA can inhibit HCV entry, replication, translation, and virion secretion in a dose-dependent manner with no measurable effects on cell viability. In addition, we showed that two HAT inhibitors and knocking down HAT (PCAF) by RNAi can reduce HCV replication, suggesting a mechanism of AnA's inhibitory effects on HCV. Elucidation of the AnA-mediated inhibitory mechanism should facilitate the development of new drug candidates for HCV infection.	[Hundt, Jana] Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada; [Li, Zhubing; Liu, Qiang] Univ Saskatchewan, Vaccinol & Immunotherapeut Program, VIDO InterVac, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Liu, Q (corresponding author), Univ Saskatchewan, Vaccinol & Immunotherapeut Program, VIDO InterVac, Saskatoon, SK, Canada.	qiang.liu@usask.ca			Science and Technology Department of Jiangsu Province [BL2014025]; Jiangsu Province Department of Health [F201305]; Wuxi Municipal Hospital Management Center in China [YGZZ1107, YGZXL1317]	Science and Technology Department of Jiangsu Province; Jiangsu Province Department of Health; Wuxi Municipal Hospital Management Center in China	The present study was supported by grants: BL2014025 from Science and Technology Department of Jiangsu Province, F201305 from Jiangsu Province Department of Health, YGZZ1107 and YGZXL1317 from Wuxi Municipal Hospital Management Center in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argentini C, 2009, FUTURE MICROBIOL, V4, P359, DOI [10.2217/fmb.09.8, 10.2217/FMB.09.8]; Ashfaq UA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-161; Assis DN, 2012, CLIN PHARMACOL THER, V92, P294, DOI 10.1038/clpt.2012.103; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Baugh JM, 2013, ANTIVIR RES, V100, P555, DOI 10.1016/j.antiviral.2013.09.020; Bose SK, 2014, J VIROL, V88, P4195, DOI 10.1128/JVI.03327-13; Bradrick SS, 2006, NUCLEIC ACIDS RES, V34, P1293, DOI 10.1093/nar/gkl019; Costi R, 2007, J MED CHEM, V50, P1973, DOI 10.1021/jm060943s; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Gomez-Gonzalo M, 2004, VIROLOGY, V328, P120, DOI 10.1016/j.virol.2004.06.044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hemshekhar M, 2012, BASIC CLIN PHARMACOL, V110, P122, DOI 10.1111/j.1742-7843.2011.00833.x; Hussar DA, 2014, J AM PHARM ASSOC, V54, P202, DOI 10.1331/JAPhA.2014.14513; ITOKAWA H, 1987, CHEM PHARM BULL, V35, P3016; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jothimani D, 2013, INDIAN J GASTROENTER, V32, P71, DOI 10.1007/s12664-012-0254-5; KUBO I, 1994, J NAT PROD, V57, P545, DOI 10.1021/np50106a021; Kusio-Kobialka M, 2013, ANTI-CANCER AGENT ME, V13, P762; Lee HS, 2014, J VIRAL HEPATITIS, V21, pE108, DOI 10.1111/jvh.12241; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Lindenbach BD, 2013, CURR TOP MICROBIOL, V369, P199, DOI 10.1007/978-3-642-27340-7_8; Maasoumy B, 2012, BEST PRACT RES CL GA, V26, P401, DOI 10.1016/j.bpg.2012.09.009; Mamidyala SK, 2013, BIOORG MED CHEM LETT, V23, P1667, DOI 10.1016/j.bmcl.2013.01.074; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Muroi H, 1996, J APPL BACTERIOL, V80, P387, DOI 10.1111/j.1365-2672.1996.tb03233.x; Olmstead AD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002468; Ortega AGO, 1999, J ETHNOPHARMACOL, V68, P109, DOI 10.1016/S0378-8741(99)00047-1; Park WJ, 2012, MOLECULES, V17, P13116, DOI 10.3390/molecules171113116; Pawlotsky JM, 2013, CURR TOP MICROBIOL, V369, P321, DOI 10.1007/978-3-642-27340-7_13; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Qiao L, 2013, BIOCHEM BIOPH RES CO, V432, P643, DOI 10.1016/j.bbrc.2013.02.030; Rea AI, 2003, FITOTERAPIA, V74, P732, DOI 10.1016/j.fitote.2003.08.007; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shukla P, 2010, J MED VIROL, V82, P783, DOI 10.1002/jmv.21660; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Trevisan MTS, 2006, FOOD CHEM TOXICOL, V44, P188, DOI 10.1016/j.fct.2005.06.012; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; Winder T, 2010, GASTROENTEROLOGY, V138, P2163, DOI 10.1053/j.gastro.2010.02.005; Wisastra R, 2012, BIOORGAN MED CHEM, V20, P5027, DOI 10.1016/j.bmc.2012.06.019; Wu YY, 2011, J PHARMACOL EXP THER, V339, P403, DOI 10.1124/jpet.111.181891	45	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0117514	10.1371/journal.pone.0117514	http://dx.doi.org/10.1371/journal.pone.0117514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658101	Green Published, gold, Green Submitted			2022-12-26	WOS:000349444900169
J	Bajic, D; Soiza-Reilly, M; Spalding, AL; Berde, CB; Commons, KG				Bajic, Dusica; Soiza-Reilly, Mariano; Spalding, Allegra L.; Berde, Charles B.; Commons, Kathryn G.			Endogenous Cholinergic Neurotransmission Contributes to Behavioral Sensitization to Morphine	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NICOTINIC ACETYLCHOLINE-RECEPTORS; PERIAQUEDUCTAL GRAY; ANTINOCICEPTIVE TOLERANCE; NUCLEUS-ACCUMBENS; DOPAMINE EFFLUX; LATERODORSAL TEGMENTUM; SYNAPTIC MECHANISMS; EXCITOTOXIC LESIONS; PHYSICAL-DEPENDENCE	Neuroplasticity in the mesolimbic dopaminergic system is critical for behavioral adaptations associated with opioid reward and addiction. These processes may be influenced by cholinergic transmission arising from the laterodorsal tegmental nucleus (LDTg), a main source of acetylcholine to mesolimbic dopaminergic neurons. To examine this possibility we asked if chronic systemic morphine administration affects expression of genes in ventral and ventrolateral periaqueductal gray at the level of the LDTg using rtPCR. Specifically, we examined gene expression changes in the area of interest using Neurotransmitters and Receptors PCR array between chronic morphine and saline control groups. Analysis suggested that chronic morphine administration led to changes in expression of genes associated, in part, with cholinergic neurotransmission. Furthermore, using a quantitative immunofluorescent technique, we found that chronic morphine treatment produced a significant increase in immunolabeling of the cholinergic marker (vesicular acetylcholine transporter) in neurons of the LDTg. Finally, systemic administration of the nonselective and noncompetitive neuronal nicotinic antagonist mecamylamine (0.5 or 2 mg/kg) dose-dependently blocked the expression, and to a lesser extent the development, of locomotor sensitization. The same treatment had no effect on acute morphine antinociception, antinociceptive tolerance or dependence to chronic morphine. Taken together, the results suggest that endogenous nicotinic cholinergic neurotransmission selectively contributes to behavioral sensitization to morphine and this process may, in part, involve cholinergic neurons within the LDTg.	[Bajic, Dusica; Soiza-Reilly, Mariano; Spalding, Allegra L.; Berde, Charles B.; Commons, Kathryn G.] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Bajic, Dusica; Soiza-Reilly, Mariano; Berde, Charles B.; Commons, Kathryn G.] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bajic, D (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA.	dusica.bajic@childrens.harvard.edu	Bajic, Dusica/GPF-9150-2022; Soiza-Reilly, Mariano/AAV-4369-2021; Soiza-Reilly, Mariano/AAO-3973-2020	Soiza-Reilly, Mariano/0000-0002-5800-865X; Bajic, Dusica/0000-0002-3943-2105; Commons, Kathryn/0000-0002-9217-5857	Foundation for Anesthesia Education and Research; Endo Pharmaceuticals; NIH [R03 DA030874, R01 DA021801]; Mayo Family Research Endowment Fund; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021801, R03DA030874] Funding Source: NIH RePORTER	Foundation for Anesthesia Education and Research; Endo Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Family Research Endowment Fund; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Presented work was supported by Foundation for Anesthesia Education and Research, Endo Pharmaceuticals, and NIH R03 DA030874 (DB), Mayo Family Research Endowment Fund (CBB), and NIH R01 DA021801 (KGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014; Azam L, 2003, NEUROSCIENCE, V119, P965, DOI 10.1016/S0306-4522(03)00220-3; Bagley EE, 2011, NAT NEUROSCI, V14, P1548, DOI 10.1038/nn.2940; Bajic D, 2012, NEUROSCIENCE, V226, P165, DOI 10.1016/j.neuroscience.2012.09.028; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BHARGAVA HN, 1976, EUR J PHARMACOL, V36, P79, DOI 10.1016/0014-2999(76)90259-4; Bhargava V. K., 2001, Indian Journal of Pharmacology, V33, P212; Blaha CD, 1996, J NEUROSCI, V16, P714; Buccafusco JJ, 2000, BRAIN RES, V852, P76, DOI 10.1016/S0006-8993(99)02197-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cicero TJ, 2005, J PAIN, V6, P662, DOI 10.1016/j.jpain.2005.05.004; CORNWALL J, 1990, BRAIN RES BULL, V25, P271, DOI 10.1016/0361-9230(90)90072-8; CROSSLAND J, 1984, NEUROCHEM RES, V9, P351, DOI 10.1007/BF00963983; ESPEJO EF, 1995, PSYCHOPHARMACOLOGY, V122, P122, DOI 10.1007/BF02246086; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; Forster GL, 2002, NEUROSCIENCE, V114, P817, DOI 10.1016/S0306-4522(02)00365-2; FREDERICKSON RCA, 1975, J PHARMACOL EXP THER, V193, P44; GELLERT VF, 1978, J PHARMACOL EXP THER, V205, P536; Gilmor ML, 1996, J NEUROSCI, V16, P2179; GODFREY DA, 1977, J HISTOCHEM CYTOCHEM, V25, P397, DOI 10.1177/25.6.69653; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; HARRIS LS, 1964, J PHARMACOL EXP THER, V143, P141; HARTVIG P, 1989, TRENDS PHARMACOL SCI, P75; HAYES RL, 1978, SCIENCE, V200, P343, DOI 10.1126/science.635595; HEDREEN JC, 1985, J HISTOCHEM CYTOCHEM, V33, P134, DOI 10.1177/33.2.2578498; Hikida T, 2003, P NATL ACAD SCI USA, V100, P6169, DOI 10.1073/pnas.0631749100; Hikida T, 2001, P NATL ACAD SCI USA, V98, P13351, DOI 10.1073/pnas.231488998; Holmstrand EC, 2011, BRAIN STRUCT FUNCT, V216, P331, DOI 10.1007/s00429-011-0320-2; JACQUET YF, 1976, BRAIN RES, V103, P501, DOI 10.1016/0006-8993(76)90448-0; JENSEN TS, 1986, BRAIN RES, V363, P99, DOI 10.1016/0006-8993(86)90662-1; JOHANNESSON T, 1973, ACTA PHARMACOL TOX, V33, P429; Jones SL, 1992, INITIAL PROCESSING P, P203; JOYCE EM, 1979, NEUROSCI LETT, V14, P207, DOI 10.1016/0304-3940(79)96149-4; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; KIMES AS, 1990, NEUROSCIENCE, V34, P633, DOI 10.1016/0306-4522(90)90170-9; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; KOELLE GB, 1963, SCIENCE, V141, P63, DOI 10.1126/science.141.3575.63; Lane DA, 2005, NEUROSCIENCE, V135, P227, DOI 10.1016/j.neuroscience.2005.06.014; Lane DA, 2005, BRAIN RES, V1047, P65, DOI 10.1016/j.brainres.2005.04.001; Lane DA, 2004, NEUROSCIENCE, V125, P63, DOI 10.1016/j.neuroscience.2004.01.023; Lester DB, 2010, CNS NEUROSCI THER, V16, P137, DOI 10.1111/j.1755-5949.2010.00142.x; LICHTENSTEIGER W, 1982, NEUROPHARMACOLOGY, V21, P963, DOI 10.1016/0028-3908(82)90107-1; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mandl P, 2003, NEUROCHEM RES, V28, P407, DOI 10.1023/A:1022884231313; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Mark GP, 2011, PHYSIOL BEHAV, V104, P76, DOI 10.1016/j.physbeh.2011.04.052; MASTERS DB, 1993, ANESTHESIOLOGY, V79, P340, DOI 10.1097/00000542-199308000-00020; MCHAFFIE JG, 1991, J COMP NEUROL, V313, P113, DOI 10.1002/cne.903130109; Mena-Segovia J, 2008, BRAIN RES REV, V58, P265, DOI 10.1016/j.brainresrev.2008.02.003; Miller AD, 2002, NEUROSCIENCE, V111, P351, DOI 10.1016/S0306-4522(01)00595-4; Morgan MM, 2006, PHARMACOL BIOCHEM BE, V85, P214, DOI 10.1016/j.pbb.2006.08.003; Morgan MM, 1998, BRAIN RES, V804, P159, DOI 10.1016/S0006-8993(98)00669-6; Neugebauer NM, 2013, PHARMACOL BIOCHEM BE, V109, P77, DOI 10.1016/j.pbb.2013.04.015; Norwood AP, 2014, PSYCHOPHARMACOLOGY B; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; Omelchenko N, 2006, J COMP NEUROL, V494, P863, DOI 10.1002/cne.20852; Omelchenko N, 2005, J COMP NEUROL, V483, P217, DOI 10.1002/cne.20417; Papke RL, 2001, J PHARMACOL EXP THER, V297, P646; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pidoplichko VI, 1997, NATURE, V390, P401, DOI 10.1038/37120; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Plone MA, 1996, PAIN, V66, P265, DOI 10.1016/0304-3959(96)03048-5; Rezayof A, 2007, EUR J PHARMACOL, V562, P92, DOI 10.1016/j.ejphar.2007.01.081; Rho B, 1998, NEUROREPORT, V9, P1283, DOI 10.1097/00001756-199805110-00004; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; RONKEN E, 1993, J NEUROCHEM, V61, P1634, DOI 10.1111/j.1471-4159.1993.tb09797.x; Rothman RB, 2008, EXP CLIN PSYCHOPHARM, V16, P458, DOI 10.1037/a0014103; Schmidt BL, 2001, NEUROSCIENCE, V106, P129, DOI 10.1016/S0306-4522(01)00264-0; Schmidt HD, 2005, EUR J PHARMACOL, V526, P65, DOI 10.1016/j.ejphar.2005.09.068; SCHOFFELMEER ANM, 1993, J PHARMACOL EXP THER, V267, P205; Shytle RD, 2002, J HUM HYPERTENS, V16, P453, DOI 10.1038/sj.jhh.1001416; Silver A, 1967, Int Rev Neurobiol, V10, P57, DOI 10.1016/S0074-7742(08)60151-8; SIUCIAK JA, 1987, BRAIN RES, V424, P311, DOI 10.1016/0006-8993(87)91476-4; SPANAGEL R, 1993, NEUROSCI LETT, V153, P232, DOI 10.1016/0304-3940(93)90329-J; Stein C, 2013, EUR J PHARMACOL, DOI [10.1016/j.ejphar.2013.10.023, DOI 10.1016/J.EJPHAR.2013.10.023]; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; STOOF JC, 1992, NEUROSCIENCE, V47, P755, DOI 10.1016/0306-4522(92)90027-Y; Tapocik JD, 2009, J NEUROSCI, V29, P5295, DOI 10.1523/JNEUROSCI.4020-08.2009; Taraschenko OD, 2005, EUR J PHARMACOL, V513, P207, DOI 10.1016/j.ejphar.2005.03.005; TAYLOR JR, 1988, PSYCHOPHARMACOLOGY, V96, P121, DOI 10.1007/BF02431544; TJON GHK, 1995, EUR J PHARMACOL, V283, P169, DOI 10.1016/0014-2999(95)00319-G; Tortorici V, 1999, BEHAV NEUROSCI, V113, P833, DOI 10.1037/0735-7044.113.4.833; Tortorici V, 2001, PAIN, V89, P237, DOI 10.1016/S0304-3959(00)00367-5; Umberg EN, 2011, PHYSIOL BEHAV, V104, P69, DOI 10.1016/j.physbeh.2011.04.045; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; VEZINA P, 1984, PHARMACOL BIOCHEM BE, V20, P925, DOI 10.1016/0091-3057(84)90018-2; VEZINA P, 1989, PHARMACOL BIOCHEM BE, V32, P581, DOI 10.1016/0091-3057(89)90201-3; Vezina P, 2009, NEUROPHARMACOLOGY, V56, P160, DOI 10.1016/j.neuropharm.2008.06.070; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zhou XP, 2002, J PHARMACOL EXP THER, V302, P889, DOI 10.1124/jpet.102.033548; Zhu HB, 2003, PAIN, V104, P437, DOI 10.1016/S0304-3959(03)00051-4; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	98	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117601	10.1371/journal.pone.0117601	http://dx.doi.org/10.1371/journal.pone.0117601			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647082	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600078
J	Fields, AT; Abercrombie, DL; Eng, R; Feldheim, K; Chapman, DD				Fields, Andrew T.; Abercrombie, Debra L.; Eng, Rowena; Feldheim, Kevin; Chapman, Demian D.			A Novel Mini-DNA Barcoding Assay to Identify Processed Fins from Internationally Protected Shark Species	PLOS ONE			English	Article							GENETIC IDENTIFICATION; TRADE; CONSERVATION; RECORDS; RATES	There is a growing need to identify shark products in trade, in part due to the recent listing of five commercially important species on the Appendices of the Convention on International Trade in Endangered Species (CITES; porbeagle, Lamna nasus, oceanic whitetip, Carcharhinus longimanus scalloped hammerhead, Sphyrna lewini, smooth hammerhead, S. zygaena and great hammerhead S. mokarran) in addition to three species listed in the early part of this century (whale, Rhincodon typus, basking, Cetorhinus maximus, and white, Carcharodon carcharias). Shark fins are traded internationally to supply the Asian dried seafood market, in which they are used to make the luxury dish shark fin soup. Shark fins usually enter international trade with their skin still intact and can be identified using morphological characters or standard DNA-barcoding approaches. Once they reach Asia and are traded in this region the skin is removed and they are treated with chemicals that eliminate many key diagnostic characters and degrade their DNA ("processed fins"). Here, we present a validated mini-barcode assay based on partial sequences of the cytochrome oxidase I gene that can reliably identify the processed fins of seven of the eight CITES listed shark species. We also demonstrate that the assay can even frequently identify the species or genus of origin of shark fin soup (31 out of 50 samples).	[Fields, Andrew T.; Eng, Rowena; Chapman, Demian D.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Abercrombie, Debra L.] Abercrombie & Fish, Miller Pl, NY 11764 USA; [Feldheim, Kevin] Field Museum Nat Hist, Pritzker Lab Mol Systemat & Evolut, Chicago, IL 60605 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Field Museum of Natural History (Chicago)	Chapman, DD (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	demian.chapman@stonybrook.edu		Abercrombie, Debra/0000-0002-2572-1862	Pew Charitable Trusts; Pew Fellowship Program; Roe Foundation; Pritzker Foundation	Pew Charitable Trusts; Pew Fellowship Program; Roe Foundation; Pritzker Foundation	This research was funded by The Pew Charitable Trusts (Global Shark Campaign and Ocean Science Division), the Pew Fellowship Program and the Roe Foundation (to DDC). Genetic data were collected in the Field Museum's Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie D.L., 2013, VISUAL IDENTIFICATIO; Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; Chapman DD, 2003, CONSERV GENET, V4, P415, DOI 10.1023/A:1024771215616; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Naylor GJP, 2012, CRC MAR BIOL SER, P31; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Shivji M, 2002, CONSERV BIOL, V16, P1036, DOI 10.1046/j.1523-1739.2002.01188.x; Vannuccini S., 1999, SHARK UTILIZATION MA; Vilgalys R, 2003, NEW PHYTOL, V160, P4, DOI 10.1046/j.1469-8137.2003.00894.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wesche PL, 2004, DNA SEQUENCE, V15, P362, DOI 10.1080/10425170400008972; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	19	58	63	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0114844	10.1371/journal.pone.0114844	http://dx.doi.org/10.1371/journal.pone.0114844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646789	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600008
J	Michelutti, N; Wolfe, AP; Cooke, CA; Hobbs, WO; Vuille, M; Smol, JP				Michelutti, Neal; Wolfe, Alexander P.; Cooke, Colin A.; Hobbs, William O.; Vuille, Mathias; Smol, John P.			Climate Change Forces New Ecological States in Tropical Andean Lakes	PLOS ONE			English	Article							ARCTIC LAKES; HISTORY; RECORD; COMMUNITIES; CORDILLERA; VEGETATION; AMERICAN; GLACIERS; TRENDS; SHIFTS	Air temperatures in the tropical Andes have risen at an accelerated rate relative to the global average over recent decades. However, the effects of climate change on Andean lakes, which are vital to sustaining regional biodiversity and serve as an important water resource to local populations, remain largely unknown. Here, we show that recent climate changes have forced alpine lakes of the equatorial Andes towards new ecological and physical states, in close synchrony to the rapid shrinkage of glaciers regionally. Using dated sediment cores from three lakes in the southern Sierra of Ecuador, we record abrupt increases in the planktonic thalassiosiroid diatom Discostella stelligera from trace abundances to dominance within the phytoplankton. This unprecedented shift occurs against the backdrop of rising temperatures, changing atmospheric pressure fields, and declining wind speeds. Ecological restructuring in these lakes is linked to warming and/or enhanced water column stratification. In contrast to seasonally ice-covered Arctic and temperate alpine counterparts, aquatic production has not increased universally with warming, and has even declined in some lakes, possibly because enhanced thermal stability impedes the recirculation of hypolimnetic nutrients to surface waters. Our results demonstrate that these lakes have already passed important ecological thresholds, with potentially far-reaching consequences for Andean water resources.	[Michelutti, Neal; Smol, John P.] Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; [Wolfe, Alexander P.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Cooke, Colin A.] Govt Alberta, Dept Environm & Sustainable Resource Dev, Edmonton, AB T5K 2M4, Canada; [Hobbs, William O.] Washington State Dept Ecol, Olympia, WA 98504 USA; [Vuille, Mathias] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA	Queens University - Canada; University of Alberta; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Smol, JP (corresponding author), Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada.	smolj@queensu.ca	Vuille, Mathias/S-3906-2019; Vuille, Mathias/O-8128-2019; Hobbs, William/P-1110-2016	Vuille, Mathias/0000-0002-9736-4518; Hobbs, William/0000-0001-7321-0779; Cooke, Colin/0000-0002-7417-5263; Smol, John/0000-0002-2499-6696	Natural Sciences and Engineering Research Council of Canada, (NSERC) Discovery awards; National Geographic Society award	Natural Sciences and Engineering Research Council of Canada, (NSERC) Discovery awards(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Geographic Society award(National Geographic Society)	This work was supported by Natural Sciences and Engineering Research Council of Canada, (NSERC) Discovery awards to JPS and APW, and National Geographic Society award to CAC.	Abbott MB, 2003, PALAEOGEOGR PALAEOCL, V194, P123, DOI 10.1016/S0031-0182(03)00274-8; Baraer M, 2012, J GLACIOL, V58, P134, DOI 10.3189/2012JoG11J186; Battarbee R.W., 2001, TRACKING ENV CHANGE; Bird BW, 2011, P NATL ACAD SCI USA, V108, P8583, DOI 10.1073/pnas.1003719108; Bradley RS, 2006, SCIENCE, V312, P1755, DOI 10.1126/science.1128087; Bush MB, 2005, J QUATERNARY SCI, V20, P703, DOI 10.1002/jqs.983; Cremer H, 2004, CAN J BOT, V82, P1744, DOI [10.1139/b04-127, 10.1139/B04-127]; Cremer H, 2001, J PALEOLIMNOL, V26, P67, DOI 10.1023/A:1011179321529; *ENV CAN, 1994, MAN AN METH MAJ IONS, V1; *ENV CAN, 1994, TRAC MET, V2; Glew J.R., 1988, J PALEOLIMNOL, V1, P235, DOI DOI 10.1007/BF00177769; Gunkel G, 2002, LIMNOLOGICA, V32, P33, DOI 10.1016/S0075-9511(02)80015-9; Hansen BCS, 2003, PALAEOGEOGR PALAEOCL, V194, P79, DOI 10.1016/S0031-0182(03)00272-4; Herzog S.K., 2011, CLIMATE CHANGE BIODI; Jacobsen D, 2012, NAT CLIM CHANGE, V2, P361, DOI [10.1038/nclimate1435, 10.1038/NCLIMATE1435]; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kelly M. G, 2005, COMMON FRESHWATER DI; LEAVITT PR, 2001, TRACKING ENV CHANGE, V3; Maldonado M., 2011, CLIMATE CHANGE BIODI; Michelutti N, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023693; Michelutti N, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000396; Michelutti N, 2010, J PALEOLIMNOL, V43, P205, DOI 10.1007/s10933-009-9325-8; Niemann H, 2008, J QUATERNARY SCI, V23, P203, DOI 10.1002/jqs.1134; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Polissar PJ, 2013, P NATL ACAD SCI USA, V110, P14551, DOI 10.1073/pnas.1219681110; Rabatel A, 2013, CRYOSPHERE, V7, P81, DOI 10.5194/tc-7-81-2013; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Ruhland KM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1887; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; Schelske C.L., 1994, J PALEOLIMNOL, V10, P115, DOI [10.1007/BF00682508, DOI 10.1007/BF00682508]; Smol J.P., 2010, DIATOMS APPL ENV EAR; Smol JP, 2007, FRONT ECOL ENVIRON, V5, P466, DOI 10.1890/060162; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Tierney JE, 2010, NAT GEOSCI, V3, P422, DOI [10.1038/ngeo865, 10.1038/NGEO865]; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Vuille M, 2003, CLIMATIC CHANGE, V59, P75, DOI 10.1023/A:1024406427519; Vuille M, 2008, EARTH-SCI REV, V89, P79, DOI 10.1016/j.earscirev.2008.04.002; Wolfe AP, 2013, EARTH-SCI REV, V116, P17, DOI 10.1016/j.earscirev.2012.11.001	39	68	69	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115338	10.1371/journal.pone.0115338	http://dx.doi.org/10.1371/journal.pone.0115338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647018	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600012
J	Zhang, XT; Wang, XM				Zhang, Xiaotao; Wang, Ximing			Adsorption and Desorption of Nickel(II) Ions from Aqueous Solution by a Lignocellulose/Montmorillonite Nanocomposite	PLOS ONE			English	Article							WASTE-WATER; METAL-IONS; II IONS; NI II; REMOVAL; BIOSORPTION; NI(II); EQUILIBRIUM; BIOSORBENT; ADSORBENT	A new and inexpensive lignocellulose/montmorillonite (LNC/MMT) nanocomposite was prepared by a chemical intercalation of LNC into MMT and was subsequently investigated as an adsorbent in batch systems for the adsorption-desorption of Ni(II) ions in an aqueous solution. The optimum conditions for the Ni(II) ion adsorption capacity of the LNC/MMT nanocomposite were studied in detail by varying parameters such as the initial Ni(II) concentration, the solution pH value, the adsorption temperature and time. The results indicated that the maximum adsorption capacity of Ni(II) reached 94.86 mg/g at an initial Ni(II) concentration of 0.0032 mol/L, a solution pH of 6.8, an adsorption temperature of 70 degrees C, and adsorption time of 40 min. The represented adsorption kinetics model exhibited good agreement between the experimental data and the pseudo-second-order kinetic model. The Langmuir isotherm equation best fit the experimental data. The structure of the LNC/MMT nanocomposite was characterized by X-ray diffraction (XRD) and transmission electron microscopy (TEM), whereas the adsorption mechanism was discussed in combination with the results obtained from scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), and Fourier-transform infrared spectroscopy analyses (FTIR). The desorption capacity of the LNC/MMT nanocomposite depended on parameters such as HNO3 concentration, desorption temperature, and desorption time. The satisfactory desorption capacity of 81.34 mg/g was obtained at a HNO3 concentration, desorption temperature, and desorption time of 0.2 mol/L, 60 degrees C, and 30 min, respectively. The regeneration studies showed that the adsorption capacity of the LNC/MMT nanocomposite was consistent for five cycles without any appreciable loss in the batch process and confirmed that the LNC/MMT nanocomposite was reusable. The overall study revealed that the LNC/MMT nanocomposite functioned as an effective adsorbent in the detoxification of Ni(II)-contaminated wastewater.	[Zhang, Xiaotao] Inner Mongolia Agr Univ, Coll Sci, Hohhot, Peoples R China; [Wang, Ximing] Inner Mongolia Agr Univ, Coll Mat Sci & Art Design, Hohhot, Peoples R China	Inner Mongolia Agricultural University; Inner Mongolia Agricultural University	Wang, XM (corresponding author), Inner Mongolia Agr Univ, Coll Mat Sci & Art Design, Hohhot, Peoples R China.	w_ximing@263.net	xiaotao, zhang/HGC-2346-2022	xiaotao, zhang/0000-0001-9492-1123	Special Funds for Forestry Research and Public Service Industry of China [201104004]; Science Foundation for College of the Inner Mongolia Autonomous Region [JC2012004]	Special Funds for Forestry Research and Public Service Industry of China; Science Foundation for College of the Inner Mongolia Autonomous Region	This work was supported by Special Funds for Forestry Research and Public Service Industry of China (No. 201104004) and Science Foundation for College of the Inner Mongolia Autonomous Region (No. JC2012004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MA, 2010, J BASIC APPL SCI RES, V4, P3591; Akbal F, 2011, DESALINATION, V269, P214, DOI 10.1016/j.desal.2010.11.001; Barati A, 2013, ENVIRON SCI POLLUT R, V20, P6242, DOI 10.1007/s11356-013-1672-3; Basso MC, 2002, IND ENG CHEM RES, V41, P3580, DOI 10.1021/ie020023h; Betancur M, 2009, BIORESOURCE TECHNOL, V100, P1130, DOI 10.1016/j.biortech.2008.08.023; Bhatnagar A, 2010, COLLOID SURFACE B, V76, P544, DOI 10.1016/j.colsurfb.2009.12.016; Cukierman AL, 2007, ADSORPT SCI TECHNOL, V25, P227, DOI 10.1260/026361707782398182; Elshazly AH, 2003, DESALINATION, V158, P189, DOI 10.1016/S0011-9164(03)00450-8; Ewecharoen A, 2008, CHEM ENG J, V137, P181, DOI 10.1016/j.cej.2007.04.007; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; Gill R, 2013, J MATER CYCLES WASTE, V15, P115, DOI 10.1007/s10163-012-0079-4; Flores-Garnica JG, 2013, BIORESOURCE TECHNOL, V136, P635, DOI 10.1016/j.biortech.2013.02.059; Gupta Vinod K, 2010, J Colloid Interface Sci, V342, P533, DOI 10.1016/j.jcis.2009.10.074; Hanif MA, 2007, J HAZARD MATER, V139, P345, DOI 10.1016/j.jhazmat.2006.06.040; Ho YS, 2000, ADSORPT SCI TECHNOL, V18, P639, DOI 10.1260/0263617001493693; Ijagbemi CO, 2010, J HAZARD MATER, V174, P746, DOI 10.1016/j.jhazmat.2009.09.115; Katal R, 2012, J CHEM ENG DATA, V57, P374, DOI 10.1021/je200953h; Khan MA, 2012, BIORESOURCE TECHNOL, V103, P35, DOI 10.1016/j.biortech.2011.09.065; Lalhruaitluanga H, 2010, J HAZARD MATER, V175, P311, DOI 10.1016/j.jhazmat.2009.10.005; Li JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090440; Malkoc E, 2006, J HAZARD MATER, V137, P899, DOI 10.1016/j.jhazmat.2006.03.004; Pahlavanzadeh H, 2010, J HAZARD MATER, V175, P304, DOI 10.1016/j.jhazmat.2009.10.004; Pandey Piyush Kant, 2007, Int J Environ Res Public Health, V4, P332, DOI 10.3390/ijerph200704040009; Parab H, 2010, WATER RES, V44, P854, DOI 10.1016/j.watres.2009.09.038; Plazinski W, 2009, ADV COLLOID INTERFAC, V152, P2, DOI 10.1016/j.cis.2009.07.009; Ramana DKV, 2012, CAN J CHEM ENG, V90, P111, DOI 10.1002/cjce.20565; Sharma YC, 2009, CAN J CHEM ENG, V87, P921, DOI 10.1002/cjce.20230; Shinde NR, 2012, J ENVIRON MANAGE, V102, P115, DOI 10.1016/j.jenvman.2012.02.026; Shroff KA, 2011, ENG LIFE SCI, V11, P588, DOI 10.1002/elsc.201000205; Subbaiah MV, 2009, COLLOID SURFACE B, V74, P260, DOI 10.1016/j.colsurfb.2009.07.028; Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064; Turp SM, 2011, FRESEN ENVIRON BULL, V20, P3158; Weng CH, 2002, J ENVIRON ENG-ASCE, V128, P716, DOI 10.1061/(ASCE)0733-9372(2002)128:8(716); Yadav S, 2013, ENVIRON SCI POLLUT R, V20, P558, DOI 10.1007/s11356-012-0892-2; Zhang H, 2010, J RADIOANAL NUCL CH, V286, P249, DOI 10.1007/s10967-010-0656-8; Zhang JP, 2010, J CHEM ENG DATA, V55, P2379, DOI 10.1021/je900813z; Zhou YF, 2011, WATER AIR SOIL POLL, V218, P457, DOI 10.1007/s11270-010-0659-7	37	65	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117077	10.1371/journal.pone.0117077	http://dx.doi.org/10.1371/journal.pone.0117077			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647398	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600053
J	Hayakawa, T; Iwai, M; Aoki, S; Takimoto, K; Maruyama, M; Maruyama, W; Motoyama, N				Hayakawa, Tomohisa; Iwai, Mika; Aoki, Satoshi; Takimoto, Koichi; Maruyama, Mitsuo; Maruyama, Wakako; Motoyama, Noboru			SIRT1 Suppresses the Senescence-Associated Secretory Phenotype through Epigenetic Gene Regulation	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; HEMATOPOIETIC STEM-CELLS; NF-KAPPA-B; INDUCED PREMATURE SENESCENCE; EXTENDS LIFE-SPAN; CELLULAR SENESCENCE; TRANSCRIPTION FACTORS; HUMAN FIBROBLASTS; DAMAGE; STRESS	Senescent cells develop a pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). As many SASP components affect surrounding cells and alter their microenvironment, SASP may be a key phenomenon in linking cellular senesence with individual aging and age-related diseases. We herein demonstrated that the expression of Sirtuin1 (SIRT1) was decreased and the expression of SASP components was reciprocally increased during cellular senescence. The mRNAs and proteins of SASP components, such as IL-6 and IL-8, quickly accumulated in SIRT1-depleted cells, and the levels of these factors were also higher than those in control cells, indicating that SIRT1 negatively regulated the expression of SASP factors at the transcriptional level. SIRT1 bound to the promoter regions of IL-8 and IL-6, but dissociated from them during cellular senescence. The acetylation of Histone H3 (K9) and H4 (K16) of the IL-8 and IL-6 promoter regions gradually increased during cellular senescence. In SIRT1-depleted cells, the acetylation levels of these regions were already higher than those in control cells in the pre-senescent stage. Moreover, these acetylation levels in SIRT1-depleted cells were significantly higher than those in control cells during cellular senescence. These results suggest that SIRT1 repressed the expression of SASP factors through the deacetylation of histones in their promoter regions.	[Hayakawa, Tomohisa; Iwai, Mika; Aoki, Satoshi; Maruyama, Wakako; Motoyama, Noboru] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Cognit Brain Sci, Obu, Aichi, Japan; [Hayakawa, Tomohisa; Maruyama, Mitsuo; Motoyama, Noboru] Nagoya Univ, Grad Sch Med, Dept Aging Res, Nagoya, Aichi 4648601, Japan; [Aoki, Satoshi; Takimoto, Koichi] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 94021, Japan; [Maruyama, Mitsuo] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Mech Aging, Obu, Aichi, Japan	National Center for Geriatrics & Gerontology; Nagoya University; Nagaoka University of Technology; National Center for Geriatrics & Gerontology	Motoyama, N (corresponding author), Natl Ctr Geriatr & Gerontol, Res Inst, Dept Cognit Brain Sci, Obu, Aichi, Japan.	motoyama@ncgg.go.jp			Japan Society for the Promotion of Science [KAKENHI 24590369]; Research Founding for Longevity Sciences from National Center for Geriatrics and Gerontology [23-1, 26-25]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Founding for Longevity Sciences from National Center for Geriatrics and Gerontology	This work was supported by the Japan Society for the Promotion of Science, KAKENHI 24590369 (to NM) and the Research Founding for Longevity Sciences 23-1 and 26-25 (to NM) from National Center for Geriatrics and Gerontology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Cao L, 2006, EMBO J, V25, P2167, DOI 10.1038/sj.emboj.7601115; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; de Magalhaes JP, 2002, FEBS LETT, V523, P157, DOI 10.1016/S0014-5793(02)02973-3; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Naka K, 2004, J BIOL CHEM, V279, P2030, DOI 10.1074/jbc.M309457200; Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Sona Hubackova KK, 2014, AGING, V4, P932; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Takahashi A, 2012, MOL CELL, V45, P123, DOI 10.1016/j.molcel.2011.10.018; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	55	88	92	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116480	10.1371/journal.pone.0116480	http://dx.doi.org/10.1371/journal.pone.0116480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635860	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700039
J	Lau, KHW; Baylink, DJ; Sheng, MHC				Lau, Kin-Hing William; Baylink, David J.; Sheng, Matilda H. -C.			Osteocyte-Derived Insulin-Like Growth Factor I Is Not Essential for the Bone Repletion Response in Mice	PLOS ONE			English	Article							CALCIUM-DEFICIENT RATS; PARATHYROID-HORMONE PTH; DOWN-REGULATION; IGF-I; RECEPTOR; MINERALIZATION; OSTEOBLASTS; EXPRESSION; RESORPTION; DEPLETION	The present study sought to evaluate the functional role of osteocyte-derived IGF-I in the bone repletion process by determining whether deficient expression of Igf1 in osteocytes would impair the bone repletion response to one week of dietary calcium repletion after two weeks of dietary calcium deprivation. As expected, the two-week dietary calcium depletion led to hypocalcemia, secondary hyperparathyroidism, and increases in bone resorption and bone loss in both Igf1 osteocyte conditional knockout (cKO) mutants and WT control mice. Thus, conditional disruption of Igf1 in osteocytes did not impair the calcium depletion-induced bone resorption. After one week of calcium repletion, both cKO mutants and WT littermates showed an increase in endosteal bone formation attended by the reduction in osteoclast number, indicating that deficient Igf1 expression in osteocytes also did not have deleterious effects on the bone repletion response. The lack of an effect of deficient osteocyte- derived IGF-I expression on bone repletion is unexpected since previous studies show that these Igf1 osteocyte cKO mice exhibited impaired developmental growth and displayed complete resistance to bone anabolic effects of loading. These studies suggest that there is a dichotomy between the mechanisms necessary for anabolic responses to mechanical loading and the regulatory hormonal and anabolic skeletal repletion following low dietary calcium challenge. In conclusion, to our knowledge this study has demonstrated for the first time that osteocyte-derived IGF-I, which is essential for anabolic bone response to mechanical loading, is not a key regulatory factor for bone repletion after a low calcium challenge.	[Lau, Kin-Hing William; Baylink, David J.; Sheng, Matilda H. -C.] Loma Linda Univ, Sch Med, Dept Med, Div Regenerat Med, Loma Linda, CA 92354 USA; [Lau, Kin-Hing William] Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA 92354 USA	Loma Linda University	Sheng, MHC (corresponding author), Loma Linda Univ, Sch Med, Dept Med, Div Regenerat Med, Loma Linda, CA 92354 USA.	MSheng@llu.edu		Lau, Kin-Hing/0000-0003-1109-5052	Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-08-1-0697]	Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The work is supported by the Telemedicine and Advanced Technology Research Center (TATRC) at the US Army Medical Research and Materiel Command (USAMRMC) under Grant No. W81XWH-08-1-0697. The views, opinions and/or findings contained in this report are those of the authors and should not be construed as an official Department of the Army position, policy or decision, unless so designated by other documentation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson K, 1998, J CLIN ENDOCR METAB, V83, P1921, DOI 10.1210/jc.83.6.1921; Atkins GJ, 2012, OSTEOPOROSIS INT, V23, P2067, DOI 10.1007/s00198-012-1915-z; BEHRINGER RR, 1990, ENDOCRINOLOGY, V127, P1033, DOI 10.1210/endo-127-3-1033; Bellido T., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P358; Ben-Awadh AN, 2014, ENDOCRINOLOGY, V155, P2797, DOI 10.1210/en.2014-1046; Bikle Daniel D, 2012, Curr Mol Pharmacol, V5, P135; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; DRIVDAHL RH, 1984, AM J PHYSIOL, V246, pR190, DOI 10.1152/ajpregu.1984.246.2.R190; Feng JQ, 2013, BONE, V54, P213, DOI 10.1016/j.bone.2013.01.046; GRINSPOON SK, 1995, J CLIN INVEST, V96, P900, DOI 10.1172/JCI118137; HAMALAINEN MM, 1994, J NUTR, V124, P874; Jongen JWJM, 1996, J BONE MINER RES, V11, P1218; Kasukawa Y, 2003, ENDOCRINOLOGY, V144, P4682, DOI 10.1210/en.2003-0745; Lau KHW, 2013, AM J PHYSIOL-ENDOC M, V305, pE271, DOI 10.1152/ajpendo.00092.2013; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; Liu C C, 1982, Prog Clin Biol Res, V101, P93; LIU CC, 1982, METAB BONE DIS RELAT, V4, P201, DOI 10.1016/0221-8747(82)90019-4; Lloyd SA, 2013, BONE, V57, P76, DOI 10.1016/j.bone.2013.07.022; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mohan S, 2003, ENDOCRINOLOGY, V144, P929, DOI 10.1210/en.2002-220948; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; POLIG E, 1990, CALCIFIED TISSUE INT, V47, P261, DOI 10.1007/BF02555907; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Ravn P, 1997, CALCIFIED TISSUE INT, V60, P255, DOI 10.1007/s002239900225; Rhee Y, 2013, J BIOL CHEM, V288, P29809, DOI 10.1074/jbc.M113.485938; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Ryan JW, 2013, CURR DRUG TARGETS, V14, P1683, DOI 10.2174/138945011131400212; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Sheng MHC, 2013, BONE, V52, P133, DOI 10.1016/j.bone.2012.09.027; Sheng MHC, 2002, BONE, V30, P486, DOI 10.1016/S8756-3282(01)00693-7; STAUFFER M, 1972, CALC TISS RES, V9, P163, DOI 10.1007/BF02061954; STAUFFER M, 1973, AM J PHYSIOL, V225, P269, DOI 10.1152/ajplegacy.1973.225.2.269; TANIMOTO H, 1991, CALCIFIED TISSUE INT, V48, P101, DOI 10.1007/BF02555874; THOMPSON ER, 1975, ENDOCRINOLOGY, V97, P283, DOI 10.1210/endo-97-2-283; Wang YM, 2006, J BONE MINER RES, V21, P1350, DOI 10.1359/JBMR.060610; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yoo A, 1998, BONE, V22, P225, DOI 10.1016/S8756-3282(97)00277-9; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115897	10.1371/journal.pone.0115897	http://dx.doi.org/10.1371/journal.pone.0115897			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635763	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700020
J	Boehm, JT; Waldman, J; Robinson, JD; Hickerson, MJ				Boehm, J. T.; Waldman, John; Robinson, John D.; Hickerson, Michael J.			Population Genomics Reveals Seahorses (Hippocampus erectus) of the Western Mid-Atlantic Coast to Be Residents Rather than Vagrants	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC DIVERSITY; FISHES; PHYLOGEOGRAPHY; SYNGNATHIDAE; INFERENCE; HISTORY; SCALE; DIFFERENTIATION; COLONIZATION	Understanding population structure and areas of demographic persistence and transients is critical for effective species management. However, direct observational evidence to address the geographic scale and delineation of ephemeral or persistent populations for many marine fishes is limited. The Lined seahorse (Hippocampus erectus) can be commonly found in three western Atlantic zoogeographic provinces, though inhabitants of the temperate northern Virginia Province are often considered tropical vagrants that only arrive during warm seasons from the southern provinces and perish as temperatures decline. Although genetics can locate regions of historical population persistence and isolation, previous evidence of Virginia Province persistence is only provisional due to limited genetic sampling (i.e., mitochondrial DNA and five nuclear loci). To test alternative hypotheses of historical persistence versus the ephemerality of a northern Virginia Province population we used a RADseq generated dataset consisting of 11,708 single nucleotide polymorphisms (SNP) sampled from individuals collected from the eastern Gulf of Mexico to Long Island, NY. Concordant results from genomic analyses all infer three genetically divergent subpopulations, and strongly support Virginia Province inhabitants as a genetically diverged and a historically persistent ancestral gene pool. These results suggest that individuals that emerge in coastal areas during the warm season can be considered "local" and supports offshore migration during the colder months. This research demonstrates how a large number of genes sampled across a geographical range can capture the diversity of coalescent histories (across loci) while inferring population history. Moreover, these results clearly demonstrate the utility of population genomic data to infer peripheral subpopulation persistence in difficult-to-observe species.	[Boehm, J. T.; Hickerson, Michael J.] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Waldman, John] CUNY Queens Coll, Dept Biol, Queens, NY 11367 USA; [Boehm, J. T.; Waldman, John; Hickerson, Michael J.] CUNY, Grad Ctr, Subprogram Ecol Evolut & Behav, New York, NY 10016 USA; [Robinson, John D.] Marine Resources Res Inst, South Carolina Dept Nat Resources, Charleston, SC 29412 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Boehm, JT (corresponding author), CUNY City Coll, Dept Biol, 160 Convent Ave, New York, NY 10031 USA.	jtboehmjr@gmail.com		Robinson, John/0000-0002-9782-1598	National Science Foundation [40C3300-01]	National Science Foundation(National Science Foundation (NSF))	The National Science Foundation (40C3300-01) supported the dissertational research of J. T. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able K, 1998, ECOLOGY ESTUARINE FI; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Boehm JT, 2013, J BIOGEOGR, V40, P1839, DOI 10.1111/jbi.12127; Bratton JF, 2003, GEO-MAR LETT, V22, P188, DOI 10.1007/s00367-002-0112-z; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Briggs PT, 2002, NORTHEAST NAT, V9, P47; Casazza TL, 2008, FISH B-NOAA, V106, P348; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Corander J, 2013, MOL ECOL, V22, P2931, DOI 10.1111/mec.12174; CRONIN TM, 1981, SCIENCE, V211, P233, DOI 10.1126/science.211.4479.233; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Curran M, 1989, OCCURRENCE TROPICAL, P71; Deagle BE, 2013, MOL ECOL, V22, P1917, DOI 10.1111/mec.12215; Dias TL, 2002, ENVIRON BIOL FISH, V65, P326, DOI 10.1023/A:1020539222587; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; FELSENSTEIN J, 1981, EVOLUTION, V35, P1229, DOI 10.1111/j.1558-5646.1981.tb04991.x; Fish M. P., 1970, SOUNDS W N ATLANTIC; Foster SJ, 2004, J FISH BIOL, V65, P1, DOI 10.1111/j.0022-1112.2004.00429.x; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Gazave E, 2013, GENETICS, V195, P969, DOI 10.1534/genetics.113.153973; Gompert Z, 2014, MOL ECOL, V23, P4555, DOI 10.1111/mec.12811; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Grosberg R, 2001, MARINE COMMUNITY ECOLOGY, P61; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Harris SE, 2015, MOL ECOL RESOUR, V15, P382, DOI 10.1111/1755-0998.12301; Hearn J, 2014, MOL ECOL, V23, P198, DOI 10.1111/mec.12578; Hice LA, 2012, ECOL LETT, V15, P568, DOI 10.1111/j.1461-0248.2012.01769.x; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Howell P, 2012, MAR COAST FISH, V4, P481, DOI 10.1080/19425120.2012.685144; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LAZZARI MA, 1990, ENVIRON BIOL FISH, V27, P177, DOI 10.1007/BF00001671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-22; Lohse K, 2011, GENETICS, V189, P977, DOI 10.1534/genetics.111.129569; Lourie S.A., 2004, GUIDE IDENTIFICATION; Lourie SA, 2005, MOL ECOL, V14, P1073, DOI 10.1111/j.1365-294X.2005.02464.x; Lourie SA, 2004, J BIOGEOGR, V31, P1975, DOI 10.1111/j.1365-2699.2004.01153.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lozier JD, 2014, MOL ECOL, V23, P788, DOI 10.1111/mec.12636; Martinez-Solano I, 2008, BIOL J LINN SOC, V95, P824, DOI 10.1111/j.1095-8312.2008.01098.x; McBride RS, 2014, N AM J FISH MANAGE, V34, P710, DOI 10.1080/02755947.2014.902408; McCartney MA, 2013, J BIOGEOGR, V40, P1386, DOI 10.1111/jbi.12103; MILSTEIN C B, 1976, Chesapeake Science, V17, P198, DOI 10.2307/1351198; Mobley KB, 2011, J FISH BIOL, V78, P1624, DOI 10.1111/j.1095-8649.2011.02967.x; Mobley KB, 2010, J BIOGEOGR, V37, P1363, DOI 10.1111/j.1365-2699.2010.02288.x; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pringle JM, 2007, MAR ECOL PROG SER, V335, P69, DOI 10.3354/meps335069; Pritchard JK, 2000, GENETICS, V155, P945; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Robinson JD, 2014, MOL ECOL, V23, P4458, DOI 10.1111/mec.12881; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Sousa V, 2013, NAT REV GENET, V14, P404, DOI 10.1038/nrg3446; Teixeira R. L., 2001, Brazilian Journal of Biology, V61, P79, DOI 10.1590/S0034-71082001000100011; Teske PR, 2005, MAR ECOL PROG SER, V286, P249, DOI 10.3354/meps286249; Teske PR, 2003, MOL ECOL, V12, P1703, DOI 10.1046/j.1365-294X.2003.01852.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; ULTSCH GR, 1989, BIOL REV, V64, P435, DOI 10.1111/j.1469-185X.1989.tb00683.x; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wenner CA, 1989, NOAA TECHNICAL REPOR, V79, P1; WICKLUND R I, 1968, Underwater Naturalist, V5, P26; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649	67	38	39	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116219	10.1371/journal.pone.0116219	http://dx.doi.org/10.1371/journal.pone.0116219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629166	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100033
J	Carpenter, KLH; Angold, A; Chen, NK; Copeland, WE; Gaur, P; Pelphrey, K; Song, AW; Egger, HL				Carpenter, Kimberly L. H.; Angold, Adrian; Chen, Nan-Kuei; Copeland, William E.; Gaur, Pooja; Pelphrey, Kevin; Song, Allen W.; Egger, Helen L.			Preschool Anxiety Disorders Predict Different Patterns of Amygdala-Prefrontal Connectivity at School-Age	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; PSYCHIATRIC-DISORDERS; CHILDHOOD ANXIETY; SOCIAL PHOBIA; FACIAL EXPRESSIONS; EMOTION REGULATION; CORTEX ACTIVATION; BRAIN ACTIVATION; FEARFUL FACES; ANGRY FACES	Objective In this prospective, longitudinal study of young children, we examined whether a history of preschool generalized anxiety, separation anxiety, and/or social phobia is associated with amygdala-prefrontal dysregulation at school-age. As an exploratory analysis, we investigated whether distinct anxiety disorders differ in the patterns of this amygdala-prefrontal dysregulation. Methods Participants were children taking part in a 5-year study of early childhood brain development and anxiety disorders. Preschool symptoms of generalized anxiety, separation anxiety, and social phobia were assessed with the Preschool Age Psychiatric Assessment (PAPA) in the first wave of the study when the children were between 2 and 5 years old. The PAPA was repeated at age 6. We conducted functional MRIs when the children were 5.5 to 9.5 year old to assess neural responses to viewing of angry and fearful faces. Results A history of preschool social phobia predicted less school-age functional connectivity between the amygdala and the ventral prefrontal cortices to angry faces. Preschool generalized anxiety predicted less functional connectivity between the amygdala and dorsal prefrontal cortices in response to fearful faces. Finally, a history of preschool separation anxiety predicted less school-age functional connectivity between the amygdala and the ventral prefrontal cortices to angry faces and greater school-age functional connectivity between the amygdala and dorsal prefrontal cortices to angry faces. Conclusions Our results suggest that there are enduring neurobiological effects associated with a history of preschool anxiety, which occur over-and-above the effect of subsequent emotional symptoms. Our results also provide preliminary evidence for the neurobiological differentiation of specific preschool anxiety disorders.	[Carpenter, Kimberly L. H.; Angold, Adrian; Copeland, William E.; Egger, Helen L.] Duke Univ, Med Ctr, Ctr Dev Epidemiol, Dept Psychiat & Behav Sci, Durham, NC 27708 USA; [Chen, Nan-Kuei; Song, Allen W.] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC USA; [Gaur, Pooja] Vanderbilt Univ, Sch Med Chem & Phys Biol, Nashville, TN 37235 USA; [Pelphrey, Kevin] Yale Univ, Yale Child Study Ctr, New Haven, CT USA	Duke University; Duke University; Vanderbilt University; Yale University	Carpenter, KLH (corresponding author), Duke Univ, Med Ctr, Ctr Dev Epidemiol, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.	Kimberly.carpenter@dm.duke.edu	Copeland, William E/N-5413-2014; Chen, Nan-Kuei/E-7791-2016	Copeland, William E/0000-0002-1348-7781; Chen, Nan-Kuei/0000-0001-6564-4219; Egger, Helen/0000-0001-8447-5350; Gaur, Pooja/0000-0003-0433-975X; Carpenter, Kimberly/0000-0002-3838-798X	National Institutes of Mental Health [R01-MH-081025]; National Institute of Mental Health [R01-MH-075766]; National Institute for Neurological Disorders and Stroke [R01-NS074045]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075766, R01MH081025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074045] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Mental Health (http://www.nimh.nih.gov/) grant R01-MH-081025 and a National Alliance for Research in Schizophrenia and Affective Disorders Young Investigator Award (http://bbrfoundation.org/) awarded to HLE, National Institute of Mental Health (http://www.nimh.nih.gov/) grant R01-MH-075766 awarded to AA, and National Institute for Neurological Disorders and Stroke (http://www.ninds.nih.gov/) grant R01-NS074045 awarded to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jawadi AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-274; Angold A, 1996, J CHILD PSYCHOL PSYC, V37, P657, DOI 10.1111/j.1469-7610.1996.tb01457.x; ANGOLD A, 1995, PSYCHOL MED, V25, P739, DOI 10.1017/S003329170003498X; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Barbas H, 2007, J ANAT, V211, P237, DOI 10.1111/j.1469-7580.2007.00777.x; Barch DM, 2012, BIOL PSYCHIAT, V72, P1035, DOI 10.1016/j.biopsych.2012.06.009; Bittner A, 2007, J CHILD PSYCHOL PSYC, V48, P1174, DOI 10.1111/j.1469-7610.2007.01812.x; Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060; Blair KS, 2012, EMOT REV, V4, P133, DOI 10.1177/1754073911430251; Brand S, 2011, J PSYCHIATR RES, V45, P452, DOI 10.1016/j.jpsychires.2010.08.014; Bufferd SJ, 2012, AM J PSYCHIAT, V169, P1157, DOI 10.1176/appi.ajp.2012.12020268; Bufferd SJ, 2011, COMPR PSYCHIAT, V52, P359, DOI 10.1016/j.comppsych.2010.08.006; Campbell-Sills L, 2011, NEUROIMAGE, V54, P689, DOI 10.1016/j.neuroimage.2010.07.041; Canino G, 2004, ARCH GEN PSYCHIAT, V61, P85, DOI 10.1001/archpsyc.61.1.85; Carballo JJ, 2010, EUR CHILD ADOLES PSY, V19, P395, DOI 10.1007/s00787-009-0064-1; Cooney RE, 2006, PSYCHIAT RES-NEUROIM, V148, P55, DOI 10.1016/j.pscychresns.2006.05.003; Copeland WE, 2009, ARCH GEN PSYCHIAT, V66, P764, DOI 10.1001/archgenpsychiatry.2009.85; Costello EJ, 2005, CHILD ADOL PSYCH CL, V14, P631, DOI 10.1016/j.chc.2005.06.003; Danti S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00152; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Dougherty LR, 2013, J CLIN CHILD ADOLESC, V42, P577, DOI 10.1080/15374416.2012.759225; Edwards SL, 2010, J CHILD PSYCHOL PSYC, V51, P313, DOI 10.1111/j.1469-7610.2009.02160.x; Egger H.L., 2006, HDB PRESCHOOL MENTAL, P137; Egger HL, 2006, J AM ACAD CHILD PSY, V45, P538, DOI 10.1097/01.chi.0000205705.71194.b8; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Ehrenrelch JT, 2008, BEHAV PSYCHOL, V16, P389; Esbjorn BH, 2010, J ANXIETY DISORD, V24, P866, DOI 10.1016/j.janxdis.2010.06.009; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2012, DEPRESS ANXIETY, V29, P355, DOI 10.1002/da.21957; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Franz L, 2013, J AM ACAD CHILD PSY, V52, P1294, DOI 10.1016/j.jaac.2013.09.008; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Freitas-Ferrari MC, 2010, PROG NEURO-PSYCHOPH, V34, P565, DOI 10.1016/j.pnpbp.2010.02.028; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Gillath O, 2005, NEUROIMAGE, V28, P835, DOI 10.1016/j.neuroimage.2005.06.048; Gleason MM, 2011, EUR CHILD ADOLES PSY, V20, P527, DOI 10.1007/s00787-011-0214-0; Goldin PR, 2009, BIOL PSYCHIAT, V66, P1091, DOI 10.1016/j.biopsych.2009.07.014; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Grolnick WS, 1996, CHILD DEV, V67, P928, DOI 10.1111/j.1467-8624.1996.tb01774.x; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hitchcock CA, 2009, ISR J PSYCHIATR REL, V46, P34; Hoehn-Saric R, 2005, PSYCHIAT RES-NEUROIM, V140, P259, DOI 10.1016/j.pscychresns.2005.05.013; Hoehn-Saric R, 2004, PSYCHIAT RES-NEUROIM, V131, P11, DOI 10.1016/j.pscychresns.2004.02.003; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kern S, 2008, PSYCHONEUROENDOCRINO, V33, P517, DOI 10.1016/j.psyneuen.2008.01.010; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kossowsky J, 2012, J CHILD PSYCHOL PSYC, V53, P178, DOI 10.1111/j.1469-7610.2011.02465.x; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lavigne J, 2009, J CLIN CHILD ADOLESC, V38, P315, DOI 10.1080/15374410902851382; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97; Mian ND, 2012, J ANXIETY DISORD, V26, P102, DOI 10.1016/j.janxdis.2011.09.006; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Monk CS, 2006, AM J PSYCHIAT, V163, P1091, DOI 10.1176/appi.ajp.163.6.1091; Nitschke JB, 2009, AM J PSYCHIAT, V166, P302, DOI 10.1176/appi.ajp.2008.07101682; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Paulesu E, 2010, PSYCHOL MED, V40, P117, DOI 10.1017/S0033291709005649; Perlman SB, 2011, J EXP CHILD PSYCHOL, V108, P607, DOI 10.1016/j.jecp.2010.08.006; Perlman SB, 2010, SOC NEUROSCI-UK, V5, P533, DOI 10.1080/17470911003683219; Pine DS, 1999, J CHILD ADOL PSYCHOP, V9, P1, DOI 10.1089/cap.1999.9.1; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prater KE, 2013, DEPRESS ANXIETY, V30, P234, DOI 10.1002/da.22014; Rilling JK, 2001, BIOL PSYCHIAT, V49, P146, DOI 10.1016/S0006-3223(00)00977-X; ROTHBART MK, 1994, J ABNORM PSYCHOL, V103, P55, DOI 10.1037/0021-843X.103.1.55; Roy AK, 2013, J AM ACAD CHILD PSY, V52, P290, DOI 10.1016/j.jaac.2012.12.010; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stein MB, 2006, J CLIN PSYCHIAT, V67, P3; Sterba S, 2007, J CHILD PSYCHOL PSYC, V48, P1005, DOI 10.1111/j.1469-7610.2007.01770.x; Strickland J, 2011, J ABNORM CHILD PSYCH, V39, P601, DOI 10.1007/s10802-011-9487-5; Talairach J., 1988, COPLANAR STEREOTAXIC; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thomas KM, 2001, ARCH GEN PSYCHIAT, V58, P1057, DOI 10.1001/archpsyc.58.11.1057; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Voyvodic JT, 1999, NEUROIMAGE, V10, P91, DOI 10.1006/nimg.1999.0457; Vrticka P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002868; Whalen PJ, 2008, BIOL PSYCHIAT, V63, P858, DOI 10.1016/j.biopsych.2007.08.019; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; WICHSTROM L, 2013, EUR CHILD ADOLESC PS, P42331; Wichstrom L, 2013, J CHILD PSYCHOL PSYC, V54, P1327, DOI 10.1111/jcpp.12116; Wichstrom L, 2012, J CHILD PSYCHOL PSYC, V53, P695, DOI 10.1111/j.1469-7610.2011.02514.x; World Health Organisation (WHO), 2001, INT CLASS FUNCT DIS; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; 2005, DIAGN CLASS 0 3R DIA, P42331	93	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116854	10.1371/journal.pone.0116854	http://dx.doi.org/10.1371/journal.pone.0116854			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625285	Green Submitted, gold, Green Published			2022-12-26	WOS:000348821400019
J	Rivero, S; Ceballos-Chavez, M; Bhattacharya, SS; Reyes, JC				Rivero, S.; Ceballos-Chavez, M.; Bhattacharya, S. S.; Reyes, J. C.			HMG20A is required for SNAI1-mediated epithelial to mesenchymal transition	ONCOGENE			English	Article							E-CADHERIN REPRESSION; CELL-MIGRATION; EXPRESSION; COMPLEX; LSD1; SNAIL; TRANSCRIPTION; MELANOMA; COREST; GENES	HMG20A is a high mobility group (HMG) domain containing protein homologous to HMG20B, a core subunit of the Lys-specific demethylase 1/REST co-repressor 1 (LSD1-CoREST) histone demethylase complex. Here, we show that HMG20A can replace HMG20B and, therefore, they are mutually exclusive subunits of the complex. Both proteins interact through a coiled-coil domain with BHC80, another subunit of the LSD1-CoREST complex. To investigate the functional differences between the two proteins, we performed transcriptomic analysis of HMG20A-and HMG20B-depleted cells. Analysis of the misregulated genes in HMG20A-knockdown cells evidenced a high proportion of genes related to the epithelial-to-mesenchymal transition (EMT) process. EMT occurs during embryonic development or during the course of malignant cancer progression and consists in the dynamic and reversible transitions between epithelial and mesenchymal phenotypes. We show that HMG20A together with LSD1 are required for SNAI1-dependent repression of epithelial genes and for (transforming growth factor beta) TGF-beta-triggered EMT. Importantly, HMG20A-depleted cells displayed reduced binding of LSD1 to epithelial gene promoters and increased methylation of lysine 4 of histone H3, suggesting a role of HMG20A in recruiting or in stabilizing the complex at the chromatin. SNAI1 and the TGF-beta-related transcription factor SMAD4 were found to be associated with the LSD1-CoREST complex containing HMG20A. Furthermore, we show that HMG20A-depleted cells displayed reduced motility and invasion activity. Finally, we show that expression of HMG20A correlates positively with mesenchymal markers and negatively with epithelial markers in human tumor samples. Taken together, our data demonstrate that HMG20A is essential for the mesenchymal phenotype.	[Rivero, S.; Ceballos-Chavez, M.; Reyes, J. C.] CSIC, Dept Mol Biol, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41092, Spain; [Bhattacharya, S. S.] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Cell Therapy & Regenerat Med Dept, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Reyes, JC (corresponding author), CSIC, Dept Mol Biol, CABIMER, Ave Americo Vespucio, Seville 41092, Spain.	jose.reyes@cabimer.es	Reyes, Jose C/K-3699-2014	Reyes, Jose C/0000-0002-8042-5142; Rivero, Sabrina/0000-0001-6359-1432	Spanish Ministry of Economy and Competitiveness [BFU-2011-23442]; Juan de la Cierva; Junta de Andalucia [P09-CTS-04967]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Juan de la Cierva(Instituto de Salud Carlos III); Junta de Andalucia(Junta de Andalucia)	We thank L Sumoy, T Baba, A Garcia de Herreros and J Lu for reagents and plasmids. We thank Dr M Garcia-Dominguez and Dr JA Pintor-Toro for critical reading of the manuscript. We thank E Andujar and M Perez from the CABIMER Genomic Unit for microarray expression analysis. The results published here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/. This work was funded by the Spanish Ministry of Economy and Competitiveness [BFU-2011-23442 to JCR] and a Juan de la Cierva grant to SR and by Junta de Andalucia (P09-CTS-04967 to SSB).	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Barbera MJ, 2004, ONCOGENE, V23, P7345, DOI 10.1038/sj.onc.1207990; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Ceballos-Chavez M, 2012, P NATL ACAD SCI US; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Ferrari-Amorotti G, 2013, CANCER RES, V73, P235, DOI 10.1158/0008-5472.CAN-12-1739; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Iwase S, 2004, BIOCHEM BIOPH RES CO, V322, P601, DOI 10.1016/j.bbrc.2004.07.163; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; McKay BS, 1997, EXP EYE RES, V65, P661, DOI 10.1006/exer.1997.0374; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Millanes-Romero A, 2013, MOL CELL, V52, P746, DOI 10.1016/j.molcel.2013.10.015; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Peng HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014750; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subtil-Rodriguez A, 2010, EMBO REP, V11, P751, DOI 10.1038/embor.2010.131; Sumoy L, 2000, CYTOGENET CELL GENET, V88, P62, DOI 10.1159/000015486; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu CY, 2012, TRENDS GENET, V28, P454, DOI 10.1016/j.tig.2012.05.005; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454	59	31	32	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 8	2015	34	41					5264	5276		10.1038/onc.2014.446	http://dx.doi.org/10.1038/onc.2014.446			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CT1QL	25639869				2022-12-26	WOS:000362575400006
J	Marudamuthu, AS; Shetty, SK; Bhandary, YP; Karandashova, S; Thompson, M; Sathish, V; Florova, G; Hogan, TB; Pabelick, CM; Prakash, YS; Tsukasaki, Y; Fu, J; Ikebe, M; Idell, S; Shetty, S				Marudamuthu, Amarnath S.; Shetty, Shwetha K.; Bhandary, Yashodhar P.; Karandashova, Sophia; Thompson, Michael; Sathish, Venkatachalenn; Florova, Galina; Hogan, Taryn B.; Pabelick, Christina M.; Prakash, Y. S.; Tsukasaki, Yoshikazu; Fu, Jian; Ikebe, Mitsuo; Idell, Steven; Shetty, Sreerama			Plasminogen Activator Inhibitor-1 Suppresses Profibrotic Responses in Fibroblasts from Fibrotic Lungs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; EPITHELIAL-CELL APOPTOSIS; UROKINASE RECEPTOR; FIBRINOLYTIC SYSTEM; TYPE-1 EXPRESSION; TGF-BETA; IN-VITRO; MICE; PROLIFERATION; DEFICIENCY	Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease characterized by progressive interstitial scarification. A hallmark morphological lesion is the accumulation of myofibroblasts or fibrotic lung fibroblasts (FL-fibroblasts) in areas called fibroblastic foci. We previously demonstrated that the expression of both urokinase-type plasminogen activator (uPA) and the uPA receptor are elevated in FL-fibroblasts from the lungs of patients with IPF. FL-fibroblasts isolated from human IPF lungs and from mice with bleomycin-induced pulmonary fibrosis showed an increased rate of proliferation compared with normal lung fibroblasts (NL-fibroblasts) derived from histologically "normal" lung. Basal expression of plasminogen activator inhibitor-1 (PAI-1) in human and murine FL-fibroblasts was reduced, whereas collagen-I and alpha-smooth muscle actin were markedly elevated. Conversely, alveolar type II epithelial cells surrounding the fibrotic foci in situ, as well as those isolated from IPF lungs, showed increased activation of caspase-3 and PAI-1 with a parallel reduction in uPA expression. Transduction of an adenovirus PAI-1 cDNA construct (Ad-PAI-1) suppressed expression of uPA and collagen-I and attenuated proliferation in FL-fibroblasts. On the contrary, inhibition of basal PAL-1 in NL-fibroblasts increased collagen-I and alpha-smooth muscle actin. Fibroblasts isolated from PAI-1-deficient mice without lung injury also showed increased collagen-I and uPA. These changes were associated with increased Akt/phosphatase and tensin homolog proliferation/survival signals in FL-fibroblasts, which were reversed by transduction with Ad-PAI-i. This study defines a new role of PAL-1 in the control of fibroblast activation and expansion and its role in the pathogenesis of fibrosing lung disease and, in particular, IPF	[Marudamuthu, Amarnath S.; Shetty, Shwetha K.; Bhandary, Yashodhar P.; Karandashova, Sophia; Florova, Galina; Hogan, Taryn B.; Tsukasaki, Yoshikazu; Ikebe, Mitsuo; Idell, Steven; Shetty, Sreerama] Univ Texas Hlth Ctr Tyler, Dept Med, Texas Lung Injury Inst, 11937 US Highway 271, Tyler, TX 75708 USA; [Thompson, Michael; Sathish, Venkatachalenn; Pabelick, Christina M.; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Fu, Jian] Univ Kentucky, Coll Med, Ctr Res Environm Dis & Toxicol, Lexington, KY 40536 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Mayo Clinic; University of Kentucky	Shetty, S (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Med, Texas Lung Injury Inst, 11937 US Highway 271, Tyler, TX 75708 USA.	sreerama.shetty@uthct.edu	Bhandary, Yashodhar P/J-9078-2017	Shetty, Shwetha Kumari/0000-0003-1762-8040; Prakash, Y S/0000-0002-2968-224X; venkatachalem, sathish/0000-0001-9770-8299	Flight Attendant Medical Research Institute [FAMRI-ID-123010]; American Heart Association [19020001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111696, R01HL073050] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Flight Attendant Medical Research Institute Clinical Innovator Award FAMRI-ID-123010 and American Heart Association Grant 19020001.	Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Balsara RD, 2007, CURR DRUG TARGETS, V8, P982, DOI 10.2174/138945007781662382; Balsara RD, 2006, J BIOL CHEM, V281, P22527, DOI 10.1074/jbc.M512819200; Bhandary YP, 2013, AM J PATHOL, V183, P131, DOI 10.1016/j.ajpath.2013.03.022; Bhandary YP, 2012, AM J PHYSIOL-LUNG C, V302, pL463, DOI 10.1152/ajplung.00099.2011; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Chuang-Tsai S, 2003, AM J PATHOL, V163, P445, DOI 10.1016/S0002-9440(10)63674-7; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Datta A, 2011, BRIT J PHARMACOL, V163, P141, DOI 10.1111/j.1476-5381.2011.01247.x; De Almeida CJG, 2013, CELL CYCLE, V12, P2248, DOI 10.4161/cc.25335; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109; Gharaee-Kermani M, 2008, EXPERT OPIN INV DRUG, V17, P905, DOI 10.1517/13543784.17.6.905 ; Ghosh AK, 2010, CIRCULATION, V122, P1200, DOI 10.1161/CIRCULATIONAHA.110.955245; Henke C, 1996, AM J PATHOL, V149, P1639; Hertig A, 2003, FASEB J, V17, P1904, DOI 10.1096/fj.03-0084fje; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; IDELL S, 1992, AM J PHYSIOL, V263, pL487, DOI 10.1152/ajplung.1992.263.4.L487; Ji Y, 2011, ARTERIOSCL THROM VAS, V31, P1781, DOI 10.1161/ATVBAHA.111.228767; Kaikita K, 2001, CIRCULATION, V104, P839, DOI 10.1161/hc3301.092803; Kasper M, 2009, CURR CANCER DRUG TAR, V9, P341, DOI 10.2174/156800909788166501; Kouri FM, 2008, INT J BIOCHEM CELL B, V40, P1872, DOI 10.1016/j.biocel.2008.01.028; Larsson O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003220; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Martens JWM, 2003, THROMB HAEMOSTASIS, V89, P393; Marudamuthu AS, 2015, AM J PATHOL, V185, P55, DOI 10.1016/j.ajpath.2014.08.027; Mason Robert J., 1999, American Journal of Respiratory and Critical Care Medicine, V160, P1771; Mayoral R, 2010, J BIOL CHEM, V285, P3633, DOI 10.1074/jbc.M109.072900; McDougall S, 2006, PHILOS T R SOC A, V364, P1385, DOI [10.1098/rsta.2006.1773, 10.1098/rsta.2000.1773]; Mehta R, 2008, HAEMOPHILIA, V14, P1255, DOI 10.1111/j.1365-2516.2008.01834.x; MU XC, 1995, J CELL PHYSIOL, V165, P647, DOI 10.1002/jcp.1041650324; Mukai Y, 2007, AM J PHYSIOL-HEART C, V292, pH1937, DOI 10.1152/ajpheart.00868.2006; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Osterholzer JJ, 2012, J PATHOL, V228, P170, DOI 10.1002/path.3992; Pechkovsky DV, 2012, AM J PATHOL, V180, P1398, DOI 10.1016/j.ajpath.2011.12.022; Ploplis VA, 2004, J BIOL CHEM, V279, P6143, DOI 10.1074/jbc.M307297200; RAGHU G, 1988, AM REV RESPIR DIS, V138, P703, DOI 10.1164/ajrccm/138.3.703; Samarakoon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022896; Schneider DJ, 2008, THROMB HAEMOSTASIS, V100, P1037, DOI 10.1160/TH08-04-0234; Selman M, 2011, EXPERT OPIN EMERG DR, V16, P341, DOI 10.1517/14728214.2011.565049; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Serrano-Mollar A, 2007, AM J RESP CRIT CARE, V176, P1261, DOI 10.1164/rccm.200610-1491OC; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225; Shetty S, 2002, AM J PHYSIOL-LUNG C, V283, pL319, DOI 10.1152/ajplung.00395.2001; Shetty S, 2001, J BIOL CHEM, V276, P24549, DOI 10.1074/jbc.M101605200; Shetty SK, 2012, AM J RESP CELL MOL, V47, P474, DOI 10.1165/rcmb.2011-0390OC; Shetty S, 2007, MOL CELL BIOL, V27, P5607, DOI 10.1128/MCB.00080-07; Shetty S, 2008, J BIOL CHEM, V283, P19570, DOI 10.1074/jbc.M710268200; Shetty S, 2008, AM J PHYSIOL-LUNG C, V295, pL967, DOI 10.1152/ajplung.90349.2008; Sisson TH, 2002, AM J PHYSIOL-LUNG C, V283, pL1023, DOI 10.1152/ajplung.00049.2002; Sisson TH, 1999, HUM GENE THER, V10, P2315, DOI 10.1089/10430349950016960; Spitalieri P, 2012, EUR RESPIR J, V39, P446, DOI 10.1183/09031936.00005511; Suelves M, 2005, FRONT BIOSCI-LANDMRK, V10, P2978, DOI 10.2741/1754; SUGANUMA H, 1995, THORAX, V50, P984, DOI 10.1136/thx.50.9.984; Tanaka T, 2002, EUR RESPIR J, V20, P359, DOI 10.1183/09031936.02.00252602; Thannickal VJ, 2014, AM J PATHOL, V184, P1643, DOI 10.1016/j.ajpath.2014.02.003; Tourkina Elena, 2012, Open Rheumatol J, V6, P116, DOI 10.2174/1874312901206010116; Tucker TA, 2014, AM J RESP CELL MOL, V50, P316, DOI 10.1165/rcmb.2013-0300OC; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xu Z, 2010, BLOOD, V115, P2038, DOI 10.1182/blood-2009-09-244962; Zhang YP, 2013, THROMB RES, V131, P64, DOI 10.1016/j.thromres.2012.09.003; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; Zhao WL, 2001, CANCER RES, V61, P5537; Zhu S, 2009, AM J PHYSIOL-LUNG C, V297, pL97, DOI 10.1152/ajplung.90283.2008	72	37	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9428	9441		10.1074/jbc.M114.601815	http://dx.doi.org/10.1074/jbc.M114.601815			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25648892	Green Published, hybrid			2022-12-26	WOS:000352729400011
J	Li, QL; Deng, S; Ibarra, RA; Anderson, VE; Brunengraber, H; Zhang, GF				Li, Qingling; Deng, Shuang; Ibarra, Rafael A.; Anderson, Vernon E.; Brunengraber, Henri; Zhang, Guo-Fang			Multiple Mass Isotopomer Tracing of Acetyl-CoA Metabolism in Langendorff-perfused Rat Hearts CHANNELING OF ACETYL-CoA FROM PYRUVATE DEHYDROGENASE TO CARNITINE ACETYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; FRUCTOSE 6-PHOSPHATE; SKELETAL-MUSCLE; MALONYL-COA; ACETATE; OXIDATION; ENRICHMENT; COENZYME; ENZYME; ASSAY	We developed an isotopic technique to assess mitochondrial acetyl-CoA turnover (approximate to citric acid flux) in perfused rat hearts. Hearts are perfused with buffer containing tracer [C-13(2),H-2(3)]acetate, which forms M5 + M4 + M3 acetyl-CoA. The buffer may also contain one or two labeled substrates, which generate M2 acetyl-CoA ( e. g. [C-13(6)] glucose or [1,2-C-13(2)] palmitate) or/and M1 acetyl-CoA ( e. g. [1-13C] octanoate). The total acetylCoA turnover and the contributions of fuels to acetyl-CoA are calculated from the uptake of the acetate tracer and the mass isotopomer distribution of acetyl-CoA. The method was applied to measurements of acetyl-CoA turnover under different conditions ( glucose +/- palmitate +/- insulin +/- dichloroacetate). The data revealed ( i) substrate cycling between glycogen and glucose- 6-P and between glucose-6-P and triose phosphates, ( ii) the release of small excess acetyl groups as acetylcarnitine and ketone bodies, and ( iii) the channeling of mitochondrial acetylCoA from pyruvate dehydrogenase to carnitine acetyltransferase. Because of this channeling, the labeling of acetylcarnitine and ketone bodies released by the heart are not proxies of the labeling of mitochondrial acetyl-CoA.	[Li, Qingling; Deng, Shuang; Ibarra, Rafael A.; Brunengraber, Henri; Zhang, Guo-Fang] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Anderson, Vernon E.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Zhang, GF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, 10900 Euclid Ave W-G48, Cleveland, OH 44106 USA.	gxz35@case.edu		Anderson, Vernon Emmett/0000-0002-1699-7621	National Institutes of Health [R33DK070291]; Case Mouse Metabolic and Phenotyping Center (MMPC) Grant [U24DK76174]; American Heart Association [12GRNT12050453]; Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070291, U24DK076174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Mouse Metabolic and Phenotyping Center (MMPC) Grant; American Heart Association(American Heart Association); Cleveland Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Roadmap Grant R33DK070291 and Case Mouse Metabolic and Phenotyping Center (MMPC) Grant U24DK76174 (to H. B.). This work was also supported by American Heart Association Grant 12GRNT12050453 (to G.-F. Z.) and by funds from the Cleveland Mt. Sinai Health Care Foundation.	Abbas AS, 1998, J MOL CELL CARDIOL, V30, P1305, DOI 10.1006/jmcc.1998.0693; BALLARD FJ, 1972, AM J CLIN NUTR, V25, P773; BEIS A, 1980, EUR J BIOCHEM, V104, P209, DOI 10.1111/j.1432-1033.1980.tb04417.x; Bian F, 2005, J BIOL CHEM, V280, P9265, DOI 10.1074/jbc.M412850200; Bian F, 2006, J MOL CELL CARDIOL, V41, P868, DOI 10.1016/j.yjmcc.2006.08.011; BRODERICK TL, 1992, J BIOL CHEM, V267, P3758; Burgess SC, 2001, ANAL BIOCHEM, V289, P187, DOI 10.1006/abio.2000.4930; CHALLISS RAJ, 1984, BIOCHEM J, V223, P849, DOI 10.1042/bj2230849; CHALLISS RAJ, 1984, BIOCHEM J, V221, P153, DOI 10.1042/bj2210153; CHANCE EM, 1983, J BIOL CHEM, V258, P3785; CHATHAM JC, 1995, J BIOL CHEM, V270, P7999, DOI 10.1074/jbc.270.14.7999; Comte B, 1997, J BIOL CHEM, V272, P26117, DOI 10.1074/jbc.272.42.26117; CRABTREE B, 1990, BIOCHEM J, V270, P219, DOI 10.1042/bj2700219; DAVID F, 1994, ANAL BIOCHEM, V218, P143, DOI 10.1006/abio.1994.1153; DESROSIERS C, 1990, AM J PHYSIOL, V258, pE519, DOI 10.1152/ajpendo.1990.258.3.E519; EGGERER H, 1965, BIOCHEM Z, V343, P111; FINK G, 1988, J BIOL CHEM, V263, P18036; FRITZ IB, 1963, J BIOL CHEM, V238, P2509; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Gu L, 2010, AM J PHYSIOL-ENDOC M, V298, pE362, DOI 10.1152/ajpendo.00384.2009; HACHEY DL, 1991, ANAL CHEM, V63, P919, DOI 10.1021/ac00009a017; Hazey JW, 1997, ANAL BIOCHEM, V248, P158, DOI 10.1006/abio.1997.2068; Henning SL, 1996, CIRCULATION, V93, P1549, DOI 10.1161/01.CIR.93.8.1549; HERSH LB, 1967, J BIOL CHEM, V242, P3468; HUTH W, 1973, H-S Z PHYSIOL CHEM, V354, P635, DOI 10.1515/bchm2.1973.354.1.635; LANDAU BR, 1986, METABOLISM, V35, P94, DOI 10.1016/0026-0495(86)90102-2; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Li Q., 2013, FASEB J, V27; LINN TC, 1979, J BIOL CHEM, V254, P1691; Mitchell GA, 2008, MOL GENET METAB, V94, P4, DOI 10.1016/j.ymgme.2007.12.005; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Ovadi J, 1996, CELL BIOCHEM FUNCT, V14, P249; Panchal AR, 2000, AM J PHYSIOL-HEART C, V279, pH2390, DOI 10.1152/ajpheart.2000.279.5.H2390; POWERS L, 1995, J MASS SPECTROM, V30, P747, DOI 10.1002/jms.1190300514; RANDLE PJ, 1970, BIOCHEM J, V117, P677, DOI 10.1042/bj1170677; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; Schroeder MA, 2012, CIRC-CARDIOVASC IMAG, V5, P201, DOI 10.1161/CIRCIMAGING.111.969451; Seiler SE, 2014, J LIPID RES, V55, P635, DOI 10.1194/jlr.M043448; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Tomcik K, 2011, ANAL BIOCHEM, V410, P110, DOI 10.1016/j.ab.2010.11.030; UZIEL G, 1988, MUSCLE NERVE, V11, P720, DOI 10.1002/mus.880110708; Yang WC, 2008, ANAL CHEM, V80, P9508, DOI 10.1021/ac801693c; Zhang GF, 2009, J BIOL CHEM, V284, P33521, DOI 10.1074/jbc.M109.055665	43	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8121	8132		10.1074/jbc.M114.631549	http://dx.doi.org/10.1074/jbc.M114.631549			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25645937	Green Published, hybrid			2022-12-26	WOS:000351662600010
J	Kobayashi, Y; Tamiya, N; Moriyama, Y; Nishi, A				Kobayashi, Yoko; Tamiya, Nanako; Moriyama, Yoko; Nishi, Akihiro			Triple Difficulties in Japanese Women with Hearing Loss: Marriage, Smoking, and Mental Health Issues	PLOS ONE			English	Article							HARD-OF-HEARING; ADULTS; DEAF; AGE; RELIABILITY; POPULATION; PREVALENCE; DISTRESS; VALIDITY; INCOME	Objective To examine the consequences of early-onset hearing loss on several social and health measures and any related gender differences in Japanese populations. Methods Data from a 2007 nationally representative cross-sectional household survey of 136,849 men and women aged 20 to 39 years were obtained (prevalence of self-reported hearing loss: 0.74%). We focused particularly on four social and health measures: employment status (employed/unemployed), marital status (married/unmarried), smoking behavior (yes/no), and psychological distress (K6 instrument: >= 5 or not). We examined the association of hearing loss for each measure using generalized estimating equations to account for correlated individuals within households. Findings There was no significant association with employment status (p = 0.447). Men with hearing loss were more likely to be married, whereas women with hearing loss were less likely to be married (p < 0.001 for interaction). Although hearing loss was not associated with a current smoking status in men, women with hearing loss were more likely to be current smokers (p < 0.001 for interaction). Moreover, hearing loss was associated with psychological distress in men and women (both p < 0.001). Conclusion These findings suggest that hearing loss is related to social and health issues in daily life, including a lower likelihood of marriage, more frequent smoking, and poorer mental health, especially in women. These issues may reflect a gap between the actual needs of women with hearing loss and the formal support received as a result of existing public health policies in Japan.	[Kobayashi, Yoko; Tamiya, Nanako; Moriyama, Yoko] Univ Tsukuba, Dept Hlth Serv Res, Fac Med, Tsukuba, Ibaraki, Japan; [Kobayashi, Yoko] Tsukuba Univ Technol, Tsukuba, Ibaraki, Japan; [Nishi, Akihiro] Yale Univ, Yale Inst Network Sci, New Haven, CT 06520 USA; [Nishi, Akihiro] Yale Univ, Dept Sociol, New Haven, CT 06520 USA	University of Tsukuba; Tsukuba University of Technology; Yale University; Yale University	Tamiya, N (corresponding author), Univ Tsukuba, Dept Hlth Serv Res, Fac Med, Tsukuba, Ibaraki, Japan.	ntamiya@md.tsukuba.ac.jp		Nishi, Akihiro/0000-0003-1629-5985	JSPS KAKENHI [24249031, 26245086, 26893030]; Japanese Ministry of Health, Labour and Welfare [H22 Seisaku Shitei 033]; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [26245086] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI No. 24249031 (Grant-in-Aid for Scientific Research A); the Japanese Ministry of Health, Labour and Welfare (H22 Seisaku Shitei 033); the JSPS KAKENHI No. 26245086 (Grant-in-Aid for Scientific Research A), and JSPS KAKENHI No. 26893030 (Grant-in-Aid for Research Activity start-up). AN is awarded by the Japan Society for the Promotion of Science (JSPS) for his research at Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2012, LANCET, V379, P979, DOI 10.1016/S0140-6736(11)61670-X; Arlinger S, 2003, INT J AUDIOL, V42, pS17; Barnett S, 1999, AM ANN DEAF, V144, P44, DOI 10.1353/aad.2012.0120; Barnett S, 2011, PREV CHRONIC DIS, V8; BELL AG, 1883, NAT ACAD SCI MEM, V2, P177; BERGMAN I, 1985, J PEDIATR-US, V106, P95, DOI 10.1016/S0022-3476(85)80476-5; Berman BA, 2007, AM ANN DEAF, V152, P344, DOI 10.1353/aad.2007.0024; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Cabral L, 2013, COMMUNITY MENT HLT J, V49, P649, DOI 10.1007/s10597-012-9569-z; Center for Japanese Sign Language Interpreters Problems, 2007, REP SING LANG INT EM; Daniel E, 2007, J SCHOOL HEALTH, V77, P225, DOI 10.1111/j.1746-1561.2007.00197.x; de Graaf R, 2002, PSYCHOSOM MED, V64, P61, DOI 10.1097/00006842-200201000-00009; Deepthi R, 2012, ARCH GERONTOL GERIAT, V55, P762, DOI 10.1016/j.archger.2012.07.006; Donahue A, 2010, EAR HEARING, V31, P2, DOI 10.1097/AUD.0b013e3181cbc783; Elliott D. B., 2011, ACS13 US CENS BUR; Fellinger J, 2005, SOC PSYCH PSYCH EPID, V40, P737, DOI 10.1007/s00127-005-0936-8; Fukuda Y, 2005, ANN EPIDEMIOL, V15, P365, DOI 10.1016/j.annepidem.2004.09.003; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Gussenhoven AHM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-151; HATZIANDREU EJ, 1989, AM J PUBLIC HEALTH, V79, P1020, DOI 10.2105/AJPH.79.8.1020; Hayashi R, 2001, DISABIL SOC, V16, P855, DOI 10.1080/09687590120083994; He Y, 1999, THESIS U TORONTO OTT; HOLM JE, 1992, BEHAV ASSESS, V14, P465; Hong OS, 2011, NURS RES, V60, P326, DOI 10.1097/NNR.0b013e3182281ca0; Ikeda N, 2009, AM J EPIDEMIOL, V170, P80, DOI 10.1093/aje/kwp097; Iwayama M, 2013, SCI RES REGIONAL POL, V10, P1; Japan Ministry of Health Labour and Welfare, 2008, SURV DIS PEOP 2006; Japan Ministry of Health Labour and Welfare, 2013, EMPL TREND FIELD SOC; Japanese Federation of the Deaf, 2005, STUD PROJ REC UND CU; Jung D, 2012, ANN OTO RHINOL LARYN, V121, P771, DOI 10.1177/000348941212101201; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Kiely KM, 2012, J AGING HEALTH, V24, P439, DOI 10.1177/0898264311425088; Kochkin S., 2007, IMPACT UNTREATED HEA; Kvam MH, 2007, J DEAF STUD DEAF EDU, V12, P1, DOI 10.1093/deafed/enl015; Lane H, 2005, J DEAF STUD DEAF EDU, V10, P291, DOI 10.1093/deafed/eni030; Lee DJ, 1996, EPIDEMIOLOGY, V7, P443, DOI 10.1097/00001648-199607000-00019; Lin FR, 2012, MEDICINE, V91, P229, DOI 10.1097/MD.0b013e31826b145a; Margolis S, 1999, J HOPKINS SYMPTOMS R; Mathers C, 2000, GLOB BURD HEAR LOSS; Ministry of Foreign Affairs of Japan, 2014, PERS DIS VOIC COM EF, DOI [10.1038/mp.2014.179, DOI 10.1038/MP.2014.179]; Ministry of International Affairs and Communications, 2012, LAW WELF PEOPL PHYS; Mitchell RE, 2006, J DEAF STUD DEAF EDU, V11, P112, DOI 10.1093/deafed/enj004; Monzani D, 2008, ACTA OTORHINOLARYNGO, V28, P61; Nishi A, 2011, ENV HLTH PREV MED, V17, P252; Nishi A, 2012, B WORLD HEALTH ORGAN, V90, P426, DOI 10.2471/BLT.11.095380; Oikawa R, 1998, NATL U CORPORATION T, V5, P53; Organization for Economic Cooperation and Development, 2014, LIST OECD MEMB COUNT; Organization WH, 2014, DEAFN HEAR LOSS; Osamu N, 2012, RIGHTS PERSONS DISAB, DOI [10.3233/WOR-131592, DOI 10.3233/WOR-131592]; Osamu N, 2013, J POLICY PRACT INTEL, V10, P93, DOI 10.1111/jppi.12030; Oshio T, 2013, PUBLIC HEALTH, V127, P754, DOI 10.1016/j.puhe.2013.05.005; Preston Paul, 1995, MOTHER FATHER DEAF L; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Schley S, 2011, J DEAF STUD DEAF EDU, V16, P524, DOI 10.1093/deafed/enq060; Seyama N, 2009, ASIA JAPAN WOMENS RE, V23, P28; Steinberg AG, 2006, J GEN INTERN MED, V21, P260, DOI 10.1111/j.1525-1497.2006.00340.x; Takamiya A, 2005, SPECIAL ED STUDY J, V43, P279; The Census Bureau, 2014, CENS BUR INF QUAL GU; Timmer B, 2014, HEARING REV, V21, P30; United Nations, 2008, CONV PROT PROM RIGHT; United Nations, 2014, CONV OPT PROT SIGN R; WHO, 2011, WORLD REPORT ON DISABILITY, P1; *WHO CIBA, 1996, PREV HEAR IMP CHRON; Yatougo T, 2005, B FACULTY ED BUNKYO, V39, P79	64	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116648	10.1371/journal.pone.0116648	http://dx.doi.org/10.1371/journal.pone.0116648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA9NG	25651532	Green Published, Green Submitted, gold			2022-12-26	WOS:000349250700003
J	Baklouti, H; Aloui, A; Chtourou, H; Briki, W; Chaouachi, A; Souissi, N				Baklouti, Hana; Aloui, Asma; Chtourou, Hamdi; Briki, Walid; Chaouachi, Anis; Souissi, Nizar			Does Increasing Active Warm-Up Duration Affect Afternoon Short-Term Maximal Performance during Ramadan?	PLOS ONE			English	Article							TIME-OF-DAY; PHYSICAL PERFORMANCE; MUSCULAR PERFORMANCE; DIURNAL-VARIATION; POWER; TEMPERATURE; STRENGTH; DEHYDRATION; HYDRATION; FLUID	Aim The purpose of this study was to examine the effect of active warm-up duration on short-term maximal performance assessed during Ramadan in the afternoon. Methods Twelve healthy active men took part in the study. The experimental design consisted of four test sessions conducted at 5 p. m., before and during Ramadan, either with a 5-minute or a 15-minute warm-up. The warm-up consisted in pedaling at 50% of the power output obtained at the last stage of a submaximal multistage cycling test. During each session, the subjects performed two vertical jump tests (squat jump and counter movement jump) for measurement of vertical jump height followed by a 30-second Wingate test for measurement of peak and mean power. Oral temperature was recorded at rest and after warming-up. Moreover, ratings of perceived exertion were obtained immediately after the Wingate test. Results Oral temperature was higher before Ramadan than during Ramadan at rest, and was higher after the 15-minute warm-up than the 5-minute warm-up both before and during Ramadan. In addition, vertical jump heights were not significantly different between the two warm-up conditions before and during Ramadan, and were lower during Ramadan than before Ramadan after both warm-up conditions. Peak and mean power were not significantly different between the two warm-up durations before Ramadan, but were significantly higher after the 5-minute warm-up than the 15-minute warm-up during Ramadan. Moreover, peak and mean power were lower during Ramadan than before Ramadan after both warm-up conditions. Furthermore, ratings of perceived exertion were higher after the 15-minute warm-up than the 5-minute warm-up only during Ramadan. Conclusion The prolonged active warm-up has no effect on vertical jump height but impairs anaerobic power assessed during Ramadan in the afternoon.	[Baklouti, Hana; Aloui, Asma; Chtourou, Hamdi; Chaouachi, Anis; Souissi, Nizar] Natl Ctr Med & Sci Sport, Res Lab Sport Performance Optimizat, Tunis, Tunisia; [Aloui, Asma] Univ Gafsa, High Inst Sport & Phys Educ Gafsa, Gafsa, Tunisia; [Chtourou, Hamdi] Univ Sfax, High Inst Sport & Phys Educ Sfax, Sfax, Tunisia; Univ French West Indies & Guyana, ACTES Lab, Pointe A Pitre, Guadeloupe, France	Centre National de la Medecine Sciences des Sports; Universite de Gafsa; Universite de Sfax	Chtourou, H (corresponding author), Natl Ctr Med & Sci Sport, Res Lab Sport Performance Optimizat, Tunis, Tunisia.	h_chtourou@yahoo.fr	Aloui, Asma/J-1300-2019; Nizar, Souissi/AAF-4490-2019; Chtourou, Hamdi/GVU-1967-2022	Aloui, Asma/0000-0001-5054-1540; Nizar, Souissi/0000-0003-1227-8221; Chtourou, Hamdi/0000-0002-5482-9151; Briki, Walid/0000-0002-6298-811X	Ministry of Higher Education and Scientific Research of Tunisia; Ministry of Higher Education and Scientific Research of Tunisia	Ministry of Higher Education and Scientific Research of Tunisia; Ministry of Higher Education and Scientific Research of Tunisia	The study was financially supported by the Ministry of Higher Education and Scientific Research of Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloui A, 2013, INT J SPORT PHYSIOL, V8, P254, DOI 10.1123/ijspp.8.3.254; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Barr SI, 1999, CAN J APPL PHYSIOL, V24, P164, DOI 10.1139/h99-014; Bishop D, 2003, SPORTS MED, V33, P483, DOI 10.2165/00007256-200333070-00002; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bosco J S, 1968, J Sports Med Phys Fitness, V8, P81; Bouhlel H, 2013, CLIN J SPORT MED, V23, P222, DOI 10.1097/JSM.0b013e318275d213; Chaouachi A, 2012, J SPORT SCI, V30, pS53, DOI 10.1080/02640414.2012.698297; Chaouachi A, 2009, J STRENGTH COND RES, V23, P2702, DOI 10.1519/JSC.0b013e3181bc17fc; Chennaoui M, 2009, APPL PHYSIOL NUTR ME, V34, P587, DOI 10.1139/H09-014; Chourou H., 2014, SPORT SCI HLTH, V10, P143, DOI [10.1007/s11332-014-0185-x, DOI 10.1007/S11332-014-0185-X]; Chtourou H, 2012, INT J SPORTS MED, V33, P142, DOI 10.1055/s-0031-1286251; Chtourou H., 2012, SCI SPORT, V27, pe85, DOI [10.1016/j.scispo.2012.02.006, DOI 10.1016/J.SCISPO.2012.02.006, 10.1016/j.meatsci.2014.12.009, DOI 10.1016/J.SCISP0.2012.02.006]; Chtourou Hamdi, 2011, Asian J Sports Med, V2, P177; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; Edwards AM, 2007, BRIT J SPORT MED, V41, P385, DOI 10.1136/bjsm.2006.033860; FELLAH, 2010, ASIAN J SPORTS MED, V1, P130; Girard O, 2012, SCI SPORT, V27, P237, DOI 10.1016/j.scispo.2011.09.006; Hamouda O, 2012, BIOL RHYTHM RES, V43, P177, DOI 10.1080/09291016.2011.560050; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Judelson DA, 2007, MED SCI SPORT EXER, V39, P1817, DOI 10.1249/mss.0b013e3180de5f22; Kirkendall DT, 2008, J SPORT SCI, V26, P15, DOI 10.1080/02640410802422199; Maughan RJ, 2010, BRIT J SPORT MED, V44, P473, DOI 10.1136/bjsm.2010.072157; Maughan RJ, 2004, INT J SPORT NUTR EXE, V14, P333, DOI 10.1123/ijsnem.14.3.333; Meckel Y, 2008, EUR J APPL PHYSIOL, V102, P651, DOI 10.1007/s00421-007-0633-2; Racinais S, 2005, MED SCI SPORT EXER, V37, P2134, DOI 10.1249/01.mss.0000179099.81706.11; Racinais S, 2005, MED SCI SPORT EXER, V37, P256, DOI 10.1249/01.MSS.0000149885.82163.9F; Racinais S, 2004, CHRONOBIOL INT, V21, P485, DOI 10.1081/CBI-120038632; Rebai H, 2014, INT J SPORTS MED, V35, P432, DOI 10.1055/s-0033-1353216; Roky R, 2000, ANN NUTR METAB, V44, P101, DOI 10.1159/000012830; Roky R, 2004, ANN NUTR METAB, V48, P296, DOI 10.1159/000081076; Rothenberg JA, 2008, CURR REV MUSCULOSKE, V1, P131, DOI 10.1007/s12178-008-9020-9; Souissi N, 2007, CHRONOBIOL INT, V24, P991, DOI 10.1080/07420520701661914; Souissi N, 2010, CHRONOBIOL INT, V27, P640, DOI 10.3109/07420528.2010.483157; Taylor K, 2011, INT J SPORTS MED, V32, P185, DOI 10.1055/s-0030-1268437; Tian Ho-Heng, 2011, Asian J Sports Med, V2, P145; WALSH RM, 1994, INT J SPORTS MED, V15, P392, DOI 10.1055/s-2007-1021076; Waterhouse J, 2010, BRIT J SPORT MED, V44, P509, DOI 10.1136/bjsm.2007.071712; WIEGNER AW, 1987, J APPL PHYSIOL, V62, P1615, DOI 10.1152/jappl.1987.62.4.1615; Zerguini Y, 2007, BRIT J SPORT MED, V41, P398, DOI 10.1136/bjsm.2006.032037	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116809	10.1371/journal.pone.0116809	http://dx.doi.org/10.1371/journal.pone.0116809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646955	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600038
J	Kabir, AUI; Bin Samad, M; Ahmed, A; Jahan, MR; Akhter, F; Tasnim, J; Hasan, SMN; Sayfe, SS; Hannan, JMA				Kabir, Ashraf U. I.; Bin Samad, Mehdi; Ahmed, Arif; Jahan, Mohammad Rajib; Akhter, Farjana; Tasnim, Jinat; Hasan, S. M. Nageeb; Sayfe, Sania Sarker; Hannan, J. M. A.			Aqueous Fraction of Beta vulgaris Ameliorates Hyperglycemia in Diabetic Mice due to Enhanced Glucose Stimulated Insulin Secretion, Mediated by Acetylcholine and GLP-1, and Elevated Glucose Uptake via Increased Membrane Bound GLUT4 Transporters	PLOS ONE			English	Article							MEDICAL NUTRITION THERAPY; VAR. CICLA EXTRACT; SKELETAL-MUSCLE; GLYCEMIC CONTROL; IN-VIVO; B-CELLS; GLUCAGON; RESISTANCE; RELEASE; PATHOGENESIS	Background The study was designed to investigate the probable mechanisms of anti-hyperglycemic activity of B. Vulgaris. Methodology/Principal Findings Aqueous fraction of B. Vulgaris extract was the only active fraction (50mg/kg). Plasma insulin level was found to be the highest at 30 mins after B. Vulgaris administration at a dose of 200mg/kg.B. Vulgaris treated mice were also assayed for plasma Acetylcholine, Glucagon Like Peptide-1 (GLP-1), Gastric Inhibitory Peptide (GIP), Vasoactive Intestinal Peptide, Pituitary Adenylate Cyclase-Activating Peptide (PACAP), Insulin Like Growth Factor-1 (IGF-1), Pancreatic Polypeptides (PP), and Somatostatin, along with the corresponding insulin levels. Plasma Acetylcholine and GLP-1 significantly increased in B. Vulgaris treated animals and were further studied. Pharmacological enhancers, inhibitors, and antagonists of Acetylcholine and GLP-1 were also administered to the test animals, and corresponding insulin levels were measured. These studies confirmed the role of acetylcholine and GLP-1 in enhanced insulin secretion (p<0.05). Principal signaling molecules were quantified in isolated mice islets for the respective pathways to elucidate their activities. Elevated concentrations of Acetylcholine and GLP-1 in B. Vulgaris treated mice were found to be sufficient to activate the respective pathways for insulin secretion (p<0.05). The amount of membrane bound GLUT1 and GLUT4 transporters were quantified and the subsequent glucose uptake and glycogen synthesis were assayed. We showed that levels of membrane bound GLUT4 transporters, glucose-6-phosphate in skeletal myocytes, activity of glycogen synthase, and level of glycogen deposited in the skeletal muscles all increased (p<0.05). Conclusion Findings of the present study clearly prove the role of Acetylcholine and GLP-1 in the Insulin secreting activity of B. Vulgaris. Increased glucose uptake in the skeletal muscles and subsequent glycogen synthesis may also play a part in the anti-hyperglycemic activity of B. Vulgaris.	[Kabir, Ashraf U. I.; Bin Samad, Mehdi; Ahmed, Arif; Jahan, Mohammad Rajib; Akhter, Farjana; Tasnim, Jinat; Hasan, S. M. Nageeb; Hannan, J. M. A.] North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh; [Sayfe, Sania Sarker] Khulna Univ, Sch Life Sci, Pharm Discipline, Khulna, Bangladesh	North South University (NSU); Khulna University	Kabir, AUI (corresponding author), North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh.	ashraful_kabir@ymail.com	KABIR, ASHRAF UL/AAR-9200-2020	KABIR, ASHRAF UL/0000-0002-9449-8238; Jahan, Mohammad Rajib/0000-0002-1289-2435; Samad, Mehdi Bin/0000-0002-1774-7069; Akhter, Farjana/0000-0003-3258-6854				Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; [Anonymous], 1996, PHYSIOLOGIST; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Baron AD, 1995, J CLIN INVEST, V96, P2792, DOI 10.1172/JCI118349; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Bolkent S, 2000, J ETHNOPHARMACOL, V73, P251, DOI 10.1016/S0378-8741(00)00328-7; Boulton AJM, 1998, MED CLIN N AM, V82, P909, DOI 10.1016/S0025-7125(05)70029-8; DANFORTH WH, 1965, J BIOL CHEM, V240, P588; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Duttaroy A, 2004, DIABETES, V53, P1714, DOI 10.2337/diabetes.53.7.1714; Escribano J, 1998, PHYTOCHEM ANALYSIS, V9, P124, DOI 10.1002/(SICI)1099-1565(199805/06)9:3&lt;124::AID-PCA401&gt;3.0.CO;2-0; EVANS DJ, 1984, J CLIN INVEST, V74, P1515, DOI 10.1172/JCI111565; FEHMANN HC, 1989, SIGNAL TRANSMISSION, P28669; FRANZ MJ, 1995, J AM DIET ASSOC, V95, P1009, DOI 10.1016/S0002-8223(95)00276-6; Gerich JE, 2003, ARCH INTERN MED, V163, P1306, DOI 10.1001/archinte.163.11.1306; Hannan JMA, 2012, BRIT J NUTR, V107, P1316, DOI 10.1017/S0007114511004284; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HONEY RN, 1980, ENDOCRINOLOGY, V107, P1065, DOI 10.1210/endo-107-4-1065; Ilkova H, 1997, DIABETES CARE, V20, P1353, DOI 10.2337/diacare.20.9.1353; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; KLEIN R, 1994, ARCH INTERN MED, V154, P2169, DOI 10.1001/archinte.154.19.2169; KLIP A, 1987, FEBS LETT, V224, P224, DOI 10.1016/0014-5793(87)80452-0; KORANYI LI, 1991, DIABETOLOGIA, V34, P763, DOI 10.1007/BF00401526; KRAEGEN EW, 1993, BIOCHEM J, V295, P287, DOI 10.1042/bj2950287; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; LOUBATIE.MM, 1973, DIABETOLOGIA, V9, P439, DOI 10.1007/BF00461685; MALAISSE WJ, 1979, METABOLISM, V28, P373, DOI 10.1016/0026-0495(79)90111-2; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; MORGAN HE, 1961, J BIOL CHEM, V236, P253; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Parks M, 2010, NEW ENGL J MED, V362, P774, DOI 10.1056/NEJMp1001578; Pastors JG, 2002, DIABETES CARE, V25, P608, DOI 10.2337/diacare.25.3.608; PORTE D, 1967, J CLIN INVEST, V46, P86, DOI 10.1172/JCI105514; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; RASMUSSEN H, 1990, DIABETES CARE, V13, P655, DOI 10.2337/diacare.13.6.655; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; RUBIN RJ, 1994, J CLIN ENDOCR METAB, V78, pA809, DOI 10.1210/jcem.78.4.8157701; Sener G., 2002, Journal of Medicinal Food, V5, P37, DOI 10.1089/109662002753723205; SOWERS JR, 1993, AM J HYPERTENS, V6, pS260, DOI 10.1093/ajh/6.7.260S; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Trinder P., 1969, ANN CLIN BIOCHEM, V6, p24?27, DOI DOI 10.1177/000456326900600108; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Vilsboll T, 2007, DIABETES CARE, V30, P1608, DOI 10.2337/dc06-2593; Wang Q, 2004, DIABETOLOGIA, V47, P478, DOI 10.1007/s00125-004-1327-5; YANARDA GR, 1998, PHARM PHARM COMMUNIC, V4, P309; Yanardag R, 2002, PHYTOTHER RES, V16, P758, DOI 10.1002/ptr.1041; Yarat Aysen, 1998, Pharmacy and Pharmacology Communications, V4, P271; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	54	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116546	10.1371/journal.pone.0116546	http://dx.doi.org/10.1371/journal.pone.0116546			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647228	Green Submitted, Green Published, gold			2022-12-26	WOS:000348822600028
J	Tan, CM; Li, MY; Yang, PY; Chang, SH; Ho, YP; Lin, H; Deng, WL; Yang, JY				Tan, Choon Meng; Li, Meng-Ying; Yang, Pei-Yun; Chang, Shu Heng; Ho, Yi-Ping; Lin, Hong; Deng, Wen-Ling; Yang, Jun-Yi			Arabidopsis HFR1 Is a Potential Nuclear Substrate Regulated by the Xanthomonas Type III Effector XopD(Xcc8004)	PLOS ONE			English	Article							SUMO MODIFICATION; SALICYLIC ACID; TRANSCRIPTIONAL REPRESSION; XOPD TARGETS; PROTEINS; PATHOGEN; DEFENSE; LIGHT; DEGRADATION; SUMOYLATION	XopD(Xcc8004), a type III effector of Xanthomonas campestris pv. campestris (Xcc) 8004, is considered a shorter version of the XopD, which lacks the N-terminal domain. To understand the functions of XopD(Xcc8004), in planta, a transgenic approach combined with inducible promoter to analyze the effects of XopD(Xcc8004) in Arabidopsis was done. Here, the expression of XopD(Xcc8004), in Arabidopsis elicited the accumulation of host defense-response genes. These molecular changes were dependent on salicylic acid and correlated with lesion-mimic phenotypes observed in XVE::XopD(Xcc8004) transgenic plants. Moreover, XopD(Xcc8004) was able to desumoylate HFR1, a basic helix-loop-helix transcription factor involved in photomorphogenesis, through SUMO protease activity. Interestingly, the hfr1-201 mutant increased the expression of host defense-response genes and displayed a resistance phenotype to Xcc8004. These data suggest that HFR1 is involved in plant innate immunity and is potentially regulated by XopD(Xcc8004).	[Tan, Choon Meng; Li, Meng-Ying; Yang, Pei-Yun; Chang, Shu Heng; Ho, Yi-Ping; Lin, Hong; Yang, Jun-Yi] Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan; [Tan, Choon Meng; Yang, Jun-Yi] Natl Chung Hsing Univ, Program Microbial Genom, Taipei, Taiwan; [Tan, Choon Meng; Yang, Jun-Yi] Acad Sinica, Taipei 115, Taiwan; [Deng, Wen-Ling] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Yang, Jun-Yi] Natl Chung Hsing Univ, Inst Biotechnol, Taichung 40227, Taiwan; [Yang, Jun-Yi] Natl Chung Hsing Univ, NCHU UCD Plant & Food Biotechnol Ctr, Taichung 40227, Taiwan; [Yang, Jun-Yi] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Yang, JY (corresponding author), Natl Chung Hsing Univ, Inst Biochem, Taichung 40227, Taiwan.	jyang@nchu.edu.tw	Yang, Jun-Yi/ABA-2044-2021	Yang, Jun-Yi/0000-0002-6332-6265; Chang, Shu-Heng/0000-0002-0584-4152	Ministry of Science and Technology [NSC 100-2321-B-005-007-MY3, NSC 103-2911-I-005-301, MOST 103-2321-B-005-020]; Ministry of Education (ATU plan), Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education (ATU plan), Taiwan	This work was supported by the Ministry of Science and Technology (NSC 100-2321-B-005-007-MY3, NSC 103-2911-I-005-301, MOST 103-2321-B-005-020) and Ministry of Education (ATU plan), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ballare CL, 2012, PLANT PHYSIOL, V160, P145, DOI 10.1104/pp.112.200733; Canonne J, 2011, PLANT CELL, V23, P3498, DOI 10.1105/tpc.111.088815; Canonne J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015773; Cheong MS, 2009, PLANT PHYSIOL, V151, P1930, DOI 10.1104/pp.109.143719; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colby T, 2006, PLANT PHYSIOL, V142, P318, DOI 10.1104/pp.106.085415; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Desveaux D, 2006, CURR OPIN PLANT BIOL, V9, P376, DOI 10.1016/j.pbi.2006.05.005; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; Faigon-Soverna A, 2006, PLANT CELL, V18, P2919, DOI 10.1105/tpc.105.038810; Genoud T, 2002, PLANT J, V31, P87, DOI 10.1046/j.1365-313X.2002.01338.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Ho YP, 2013, MOL PLANT MICROBE IN, V26, P419, DOI 10.1094/MPMI-06-12-0164-R; Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003; Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x; Jang IC, 2005, GENE DEV, V19, P593, DOI 10.1101/gad.1247205; Jang IC, 2012, PLANT J, V72, P345, DOI 10.1111/j.1365-313X.2012.05060.x; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Kim JG, 2013, CELL HOST MICROBE, V13, P143, DOI 10.1016/j.chom.2013.01.006; Kim JG, 2011, MOL PLANT PATHOL, V12, P715, DOI 10.1111/J.1364-3703.2011.00706.X; Kim M, 2013, MOL CELLS, V35, P70, DOI 10.1007/s10059-013-2281-1; Kim YM, 2002, PLANT J, V30, P711, DOI 10.1046/j.1365-313X.2002.01326.x; Lee AHY, 2013, MICROB BIOTECHNOL, V6, P230, DOI 10.1111/1751-7915.12042; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lu H, 2009, PLANT SIGNAL BEHAV, V4, P713, DOI 10.4161/psb.4.8.9173; Moreno JE, 2009, P NATL ACAD SCI USA, V106, P4935, DOI 10.1073/pnas.0900701106; NISHINO H, 1994, BIOCHEM MOL BIOL INT, V34, P409; Okada S, 2009, PLANT CELL PHYSIOL, V50, P1049, DOI 10.1093/pcp/pcp056; Park BS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1408; Park HC, 2011, MOL CELLS, V32, P143, DOI 10.1007/s10059-011-2297-3; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Ribet D, 2010, FEBS LETT, V584, P2748, DOI 10.1016/j.febslet.2010.05.012; Rohira AD, 2013, J BIOL CHEM, V288, P19288, DOI 10.1074/jbc.M113.473744; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Stulemeijer IJE, 2008, MOL PLANT PATHOL, V9, P545, DOI 10.1111/J.1364-3703.2008.00468.X; Tan LT, 2014, NEW PHYTOL, V204, P595, DOI 10.1111/nph.12918; Vaghchhipawala Z, 2011, METHODS MOL BIOL, V678, P65, DOI 10.1007/978-1-60761-682-5_6; van den Burg HA, 2010, PLANT SIGNAL BEHAV, V5, P1597, DOI 10.4161/psb.5.12.13913; van den Burg HA, 2010, PLANT CELL, V22, P1998, DOI 10.1105/tpc.109.070961; Wang YX, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003039; Wise AA, 2006, METH MOL B, V343, P43; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	49	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117067	10.1371/journal.pone.0117067	http://dx.doi.org/10.1371/journal.pone.0117067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647296	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600052
J	Hung, PY; Ho, BC; Lee, SY; Chang, SY; Kao, CL; Lee, SS; Lee, CN				Hung, Pei-Yun; Ho, Bing-Ching; Lee, Szu-Yuan; Chang, Sui-Yuan; Kao, Chuan-Liang; Lee, Shoei-Sheng; Lee, Chun-Nan			Houttuynia cordata Targets the Beginning Stage of Herpes Simplex Virus Infection	PLOS ONE			English	Article							NF-KAPPA-B; ANTI-HSV ACTIVITY; INFLUENZA-VIRUS; GLYCOPROTEIN-D; TYPE-1; CELLS; PROTEIN; ENTRY; TRANSCRIPTION; RESISTANCE	Herpes simplex virus (HSV), a common latent virus in humans, causes certain severe diseases. Extensive use of acyclovir (ACV) results in the development of drug-resistant HSV strains, hence, there is an urgent need to develop new drugs to treat HSV infection. Houttuynia cordata (H. cordata), a natural herbal medicine, has been reported to exhibit anti-HSV effects which is partly NF-kappa B-dependent. However, the molecular mechanisms by which H. cordata inhibits HSV infection are not elucidated thoroughly. Here, we report that H. cordata water extracts (HCWEs) inhibit the infection of HSV-1, HSV-2, and acyclovir-resistant HSV-1 mainly via blocking viral binding and penetration in the beginning of infection. HCWEs also suppress HSV replication. Furthermore, HCWEs attenuate the first-wave of NF-kappa B activation, which is essential for viral gene expressions. Further analysis of six compounds in HCWEs revealed that quercetin and isoquercitrin inhibit NF-kappa B activation and additionally, quercetin also has an inhibitory effect on viral entry. These results indicate that HCWEs can inhibit HSV infection through multiple mechanisms and could be a potential lead for development of new drugs for treating HSV.	[Hung, Pei-Yun; Ho, Bing-Ching; Lee, Szu-Yuan; Chang, Sui-Yuan; Kao, Chuan-Liang; Lee, Chun-Nan] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 100, Taiwan; [Ho, Bing-Ching] Natl Taiwan Univ, Coll Med, Ctr Genom Med, Taipei 100, Taiwan; [Chang, Sui-Yuan; Kao, Chuan-Liang; Lee, Chun-Nan] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan; [Lee, Shoei-Sheng] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lee, CN (corresponding author), Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 100, Taiwan.	cnalee@ntu.edu.tw		KAO, CHUAN-LIANG/0000-0002-1020-2605; HO, BING-CHING/0000-0003-4356-3279; LEE, SHOEI-SHENG/0000-0002-6628-2448; CHANG, SUI-YUAN/0000-0002-6009-6724	National Research Program for Genomic Medicine of Taiwan [CCMP97-RD-208]	National Research Program for Genomic Medicine of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Research Program for Genomic Medicine of Taiwan (CCMP97-RD-208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUKARAM M, 1992, J NAT PROD, V55, P1525, DOI 10.1021/np50088a022; Amici C, 2006, J BIOL CHEM, V281, P7110, DOI 10.1074/jbc.M512366200; BALFOUR HH, 1983, ANN INTERN MED, V98, P404, DOI 10.7326/0003-4819-98-3-404; BARINGER JR, 1974, NEW ENGL J MED, V291, P828, DOI 10.1056/NEJM197410172911606; BEVILACQUA F, 1991, J ACQ IMMUN DEF SYND, V4, P967; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Chen SH, 2008, J CLIN INVEST, V118, P3470, DOI 10.1172/JCI35114; Chen XQ, 2011, ANTIVIR RES, V92, P341, DOI 10.1016/j.antiviral.2011.09.005; Chen YY, 2003, J NUTR SCI VITAMINOL, V49, P327, DOI 10.3177/jnsv.49.327; Chiang LC, 2003, AM J CHINESE MED, V31, P355, DOI 10.1142/S0192415X03001090; Choi HJ, 2009, EUR J PHARM SCI, V37, P329, DOI 10.1016/j.ejps.2009.03.002; EPSTEIN JB, 1991, ORAL SURG ORAL MED O, V72, P47, DOI 10.1016/0030-4220(91)90188-I; ERLICH KS, 1989, NEW ENGL J MED, V320, P293, DOI 10.1056/NEJM198902023200506; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; Faith SA, 2006, ANTIVIR RES, V72, P242, DOI 10.1016/j.antiviral.2006.06.011; Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554; Farooq AV, 2012, SURV OPHTHALMOL, V57, P448, DOI 10.1016/j.survophthal.2012.01.005; FULLER AO, 1992, J VIROL, V66, P5002, DOI 10.1128/JVI.66.8.5002-5012.1992; GELMAN IH, 1985, P NATL ACAD SCI USA, V82, P5265, DOI 10.1073/pnas.82.16.5265; HAYASHI K, 1995, PLANTA MED, V61, P237, DOI 10.1055/s-2006-958063; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Jo HY, 2008, J VET SCI, V9, P267, DOI 10.4142/jvs.2008.9.3.267; JOHNSON DC, 1988, J VIROL, V62, P4605, DOI 10.1128/JVI.62.12.4605-4612.1988; JOHNSON DC, 1990, J VIROL, V64, P2569, DOI 10.1128/JVI.64.6.2569-2576.1990; JONES KA, 1985, NATURE, V317, P179, DOI 10.1038/317179a0; Kavouras JH, 2007, J NEUROVIROL, V13, P416, DOI 10.1080/13550280701460573; Kim JC, 2008, MOL BIOL+, V42, P413, DOI 10.1134/S0026893308030096; Knopf CW, 2000, ACTA VIROL, V44, P289; Kupila L, 2006, NEUROLOGY, V66, P75, DOI 10.1212/01.wnl.0000191407.81333.00; Lau KM, 2008, J ETHNOPHARMACOL, V118, P79, DOI 10.1016/j.jep.2008.03.018; LEE WC, 1993, J VIROL, V67, P5088, DOI 10.1128/JVI.67.9.5088-5097.1993; Liu Zhao-Mei, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1753; Lu HM, 2006, J ETHNOPHARMACOL, V104, P245, DOI 10.1016/j.jep.2005.09.012; Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215; Marcelletti JF, 2002, ANTIVIR RES, V56, P153, DOI 10.1016/S0166-3542(02)00105-5; MCLAREN C, 1985, ANTIMICROB AGENTS CH, V28, P740, DOI 10.1128/AAC.28.6.740; Melancon JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-120; Meng J, 2005, CHEM PHARM BULL, V53, P1604, DOI 10.1248/cpb.53.1604; Meng Jiang, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1335; Moerdyk-Schauwecker M, 2009, ANTIVIR RES, V84, P131, DOI 10.1016/j.antiviral.2009.07.020; Mommeja-Marin H, 2003, CLIN INFECT DIS, V37, P1527, DOI 10.1086/379520; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Ng LT, 2007, AM J CHINESE MED, V35, P465, DOI 10.1142/S0192415X07004989; Ottosen S, 2006, VIROLOGY, V345, P468, DOI 10.1016/j.virol.2005.10.011; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; SACKS WR, 1987, J VIROL, V61, P829, DOI 10.1128/JVI.61.3.829-839.1987; Sato M, 1997, J RHEUMATOL, V24, P1680; Savov VM, 2006, EXP TOXICOL PATHOL, V58, P59, DOI 10.1016/j.etp.2006.05.002; Shih CM, 2004, EUR J PHARMACOL, V496, P41, DOI 10.1016/j.ejphar.2004.06.016; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Su CT, 2008, ANTIVIR RES, V79, P62, DOI 10.1016/j.antiviral.2008.01.156; Taddeo B, 2003, P NATL ACAD SCI USA, V100, P12408, DOI 10.1073/pnas.2034952100; Tao J, 2007, ANTIVIR RES, V75, P227, DOI 10.1016/j.antiviral.2007.03.008; Tatti S, 2010, BRIT J DERMATOL, V162, P176, DOI 10.1111/j.1365-2133.2009.09375.x; Thi THN, 2012, BIOTECHNOL LETT, V34, P831, DOI 10.1007/s10529-011-0845-8; TUTUPALLI LV, 1975, LLOYDIA, V38, P92; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Wutzler P, 1997, INTERVIROLOGY, V40, P343, DOI 10.1159/000150567; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Xu GH, 2009, ARCH PHARM RES, V32, P275, DOI 10.1007/s12272-009-1233-y; Yasin B, 2004, J VIROL, V78, P5147, DOI 10.1128/JVI.78.10.5147-5156.2004	63	46	52	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0115475	10.1371/journal.pone.0115475	http://dx.doi.org/10.1371/journal.pone.0115475			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643242	Green Published, gold, Green Submitted			2022-12-26	WOS:000348821200010
J	Arshad, A; Deutsch, E; Vozenin, MC				Arshad, Adnan; Deutsch, Eric; Vozenin, Marie-Catherine			Simultaneous Irradiation of Fibroblasts and Carcinoma Cells Repress the Secretion of Soluble Factors Able to Stimulate Carcinoma Cell Migration	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MAMMARY-GLAND; FARNESYLTRANSFERASE INHIBITORS; LUNG-CANCER; RHOB; RADIATION; STROMA; INVASION; RAS; EXPRESSION	Stroma mediated wound healing signals may share similarities with the ones produced by tumor's microenvironment and their modulation may impact tumor response to the various anti-cancer treatments including radiation therapy. Therefore we conducted this study, to assess the crosstalk between stromal and carcinoma cells in response to radiotherapy by genetic modulation of the stroma and irradiation. We found that fibroblasts irrespective of their RhoB status do not modulate intrinsic radiosensitivity of TC-1 but produce diffusible factors able to modify tumor cell fate. Then we found that Wt and RhoB deficient fibroblasts stimulated TC-1 migration through distinct mechanisms which are TGF-beta 1 and MMP-mediated respectively. Lastly, we found that simultaneous irradiation of fibroblasts and TC-1 abrogated the pro-migratory phenotype by repression of TGF-beta and MMP secretion. This last result is highly relevant to the clinical situation and suggests that conversely to, the current view; irradiated stroma would not enhance carcinoma migration and could be manipulated to promote anti-tumor immune response.	[Arshad, Adnan; Deutsch, Eric; Vozenin, Marie-Catherine] INSERM, LabEx LERMIT, U1030, Villejuif, France; [Arshad, Adnan; Deutsch, Eric; Vozenin, Marie-Catherine] Univ Paris 11, Le Kremlin Bicetre, France; [Arshad, Adnan; Deutsch, Eric; Vozenin, Marie-Catherine] Inst Gustave Roussy, Villejuif, France; [Vozenin, Marie-Catherine] CHU Vaudois, Dept Oncol, Serv Radio Oncol, Lab Rech Radio Oncol, Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Vozenin, MC (corresponding author), INSERM, LabEx LERMIT, U1030, Villejuif, France.	marie-catherine.vozenin@chuv.ch	Vozenin, Marie-Catherine/AAR-2268-2021	Vozenin, Marie-Catherine/0000-0002-2109-8073; deutsch, eric/0000-0002-8223-3697	Higher Education Commission of Pakistan; Fondation Gustave Roussy; Fondation Gustave Roussy Grant; ANR [ANR-10-LABX-33]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Fondation Gustave Roussy; Fondation Gustave Roussy Grant; ANR(French National Research Agency (ANR))	AA was supported by a Scholarship Grant from Higher Education Commission of Pakistan and Fondation Gustave Roussy. The work was supported by Fondation Gustave Roussy Grant. Inserm U1030 is a member of the Laboratory of Excellence LERMIT supported by a grant from ANR (ANR-10-LABX-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Barcellos-Hoff MH, 2000, BREAST CANCER RES, V2, P92, DOI 10.1186/bcr40; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; BARCELLOSHOFF MH, 1993, CANCER RES, V53, P3880; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Dowlati A, 2008, CLIN CANCER RES, V14, P1407, DOI 10.1158/1078-0432.CCR-07-1154; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hu X, 2010, JOVE-J VIS EXP, V24, P2445, DOI DOI 10.3791/2445; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Lewis MP, 2004, BRIT J CANCER, V90, P822, DOI 10.1038/sj.bjc.6601611; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; Moustakas A, 1999, J CELL SCI, V112, P1169; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; PRENDERGAST GC, 1995, ONCOGENE, V10, P2289; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Rodriguez PL, 2007, CELL SIGNAL, V19, P2361, DOI 10.1016/j.cellsig.2007.07.021; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002	27	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115447	10.1371/journal.pone.0115447	http://dx.doi.org/10.1371/journal.pone.0115447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635683	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700011
J	Ma, M; Chen, S; Zhu, BY; Zhao, BW; Wang, HS; Xiang, J; Wu, XB; Lin, YJ; Zhou, ZW; Peng, JS; Chen, YB				Ma, Min; Chen, Shi; Zhu, Bao-yan; Zhao, Bai-Wei; Wang, Hua-She; Xiang, Jun; Wu, Xiao-Bin; Lin, Yi-Jia; Zhou, Zhi-Wei; Peng, Jun-Sheng; Chen, Ying-Bo			The Clinical Significance and Risk Factors of Solitary Lymph Node Metastasis in Gastric Cancer	PLOS ONE			English	Article							FEASIBILITY; NAVIGATION; RESECTION; SURGERY	Aims To assess the clinical significance and risk factors of solitary lymph node metastasis (SLM) in gastric carcinoma and establish a more accurate method to evaluate the possibility of lymph node metastasis (LM). Methods A total of 385 patients with gastric carcinoma who underwent D2 lymphadenectomy at the Cancer Center of Sun Yat-Sen University were included in this research. Then we used a group of data from Sun Yat-sen University Gastrointestinal Hospital (SYSUGIH) to validate the accuracy of our developed method. The x(2) test, Kaplan-Meier analysis, log-rank test, COX model, and discriminate analysis were used to analyze the data with SPSS 13.0. Results We found that the LM number and pathological T staging were independent prognostic risk factors. CEA grading, LN status by CT, and T staging by CT were independent risk factors for LM in gastric carcinoma. In addition, we developed the equation Y = -5.0 + X-1 + 1.8X(3) + 0.7X4 (X-1 = CEA grading, X-3 = LN status by CT, X-4 = T staging by CT) to evaluate the situation of LM. The data from SYSUGIH shows this equation has a better accuracy compared with CT. Conclusions SLM is an independent risk factor in gastric cancer. And there was no survival difference between the skip metastasis group and the other SLM group (P = 0.659). It is inappropriate for the patient with SLM doing a standard D2 lymphadenectomy, due to the fact that LM rarely occurs in the splenic artery, splenic hilum. The risk factors for LM include CEA grading, LN status by CT, and T staging by CT. And we can use Y = -5.0 + X-1 + 1.8X(3) + 0.7X(4) (X-1, CEA grading, X-3 = LN status by CT, X-4 = T staging by CT, the critical value is 0.3) to estimate the possibility of LM, which has a better accuracy compared with CT.	[Ma, Min; Chen, Shi; Zhu, Bao-yan; Zhao, Bai-Wei; Zhou, Zhi-Wei; Chen, Ying-Bo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Min; Zhu, Bao-yan; Zhao, Bai-Wei; Zhou, Zhi-Wei; Chen, Ying-Bo] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Shi; Wang, Hua-She; Xiang, Jun; Wu, Xiao-Bin; Lin, Yi-Jia; Peng, Jun-Sheng] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Surg Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Peng, JS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Surg Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	pengjunsheng@tom.com; chenyb@sysucc.org.cn			Guang-dong Province Fund Committee [2012B0617000879]	Guang-dong Province Fund Committee	This study was supported by the Guang-dong Province Fund Committee (No2012B0617000879).	Ahn HS, 2009, J SURG ONCOL, V99, P20, DOI 10.1002/jso.21170; Aikou T, 2006, CANCER METAST REV, V25, P269, DOI 10.1007/s10555-006-8507-3; Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Cozzaglio L, 2011, EJSO-EUR J SURG ONC, V37, P55, DOI 10.1016/j.ejso.2010.10.012; Feng XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078846; Gretschel S, 2005, EJSO-EUR J SURG ONC, V31, P393, DOI 10.1016/j.ejso.2004.11.014; Griniatsos J, 2011, SCAND J SURG, V100, P174, DOI 10.1177/145749691110000307; Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Huang BJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-18; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kitagawa Y, 2005, J SURG ONCOL, V90, P147, DOI 10.1002/jso.20220; Kitagawa Y, 2002, J SURG ONCOL, V79, P188, DOI 10.1002/jso.10065; Kitagawa Y, 2013, J CLIN ONCOL, V31, P3704, DOI 10.1200/JCO.2013.50.3789; Lee SE, 2009, ANN SURG ONCOL, V16, P603, DOI 10.1245/s10434-008-0283-6; Li XP, 2013, CHIN J CANCER, V32, P512, DOI 10.5732/cjc.012.10200; Liu CG, 2007, WORLD J GASTROENTERO, V13, P4776, DOI 10.3748/wjg.v13.i35.4776; Matsumoto M, 2003, BRIT J SURG, V90, P563, DOI 10.1002/bjs.4083; Moenig SP, 2005, ANTICANCER RES, V25, P1349; Ohgami M, 1999, WORLD J SURG, V23, P187, DOI 10.1007/PL00013167; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Park SS, 2005, ANZ J SURG, V75, P645, DOI 10.1111/j.1445-2197.2005.03485.x; Roukos DH, 2000, CANCER TREAT REV, V26, P243, DOI 10.1053/ctrv.2000.0164; Tokunaga M, 2009, WORLD J SURG, V33, P1235, DOI 10.1007/s00268-009-9985-6; Tsujitani S, 1999, SURGERY, V125, P148, DOI 10.1016/S0039-6060(99)70258-8	24	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0114939	10.1371/journal.pone.0114939	http://dx.doi.org/10.1371/journal.pone.0114939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633364	Green Submitted, gold, Green Published			2022-12-26	WOS:000348609800003
J	Hagedorn, M; Carter, V; Zuchowicz, N; Phillips, M; Penfield, C; Shamenek, B; Vallen, EA; Kleinhans, FW; Peterson, K; White, M; Yancey, PH				Hagedorn, Mary; Carter, Virginia; Zuchowicz, Nikolas; Phillips, Micaiah; Penfield, Chelsea; Shamenek, Brittany; Vallen, Elizabeth A.; Kleinhans, Frederick W.; Peterson, Kelly; White, Meghan; Yancey, Paul H.			Trehalose Is a Chemical Attractant in the Establishment of Coral Symbiosis	PLOS ONE			English	Article							LARVAL SETTLEMENT; ALGAL SYMBIONTS; SYMBIODINIUM; RECOGNITION; BEHAVIOR; LIGHT; ACQUISITION; DIVERSITY; INFECTION; SEDIMENT	Coral reefs have evolved with a crucial symbiosis between photosynthetic dinoflagellates (genus Symbiodinium) and their cnidarian hosts (Scleractinians). Most coral larvae take up Symbiodinium from their environment; however, the earliest steps in this process have been elusive. Here we demonstrate that the disaccharide trehalose may be an important signal from the symbiont to potential larval hosts. Symbiodinium freshly isolated from Fungia scutaria corals constantly released trehalose (but not sucrose, maltose or glucose) into seawater, and released glycerol only in the presence of coral tissue. Spawning Fungia adults increased symbiont number in their immediate area by excreting pellets of Symbiodinium, and when these naturally discharged Symbiodinium were cultured, they also released trehalose. In Y-maze experiments, coral larvae demonstrated chemoattractant and feeding behaviors only towards a chamber with trehalose or glycerol. Concomitantly, coral larvae and adult tissue, but not symbionts, had significant trehalase enzymatic activities, suggesting the capacity to utilize trehalose. Trehalase activity was developmentally regulated in F. scutaria larvae, rising as the time for symbiont uptake occurs. Consistent with the enzymatic assays, gene finding demonstrated the presence of a trehalase enzyme in the genome of a related coral, Acropora digitifera, and a likely trehalase in the transcriptome of F. scutaria. Taken together, these data suggest that adult F. scutaria seed the reef with Symbiodinium during spawning and the exuded Symbiodinium release trehalose into the environment, which acts as a chemoattractant for F. scutaria larvae and as an initiator of feeding behavior-the first stages toward establishing the coral-Symbiodinium relationship. Because trehalose is a fixed carbon compound, this cue would accurately demonstrate to the cnidarian larvae the photosynthetic ability of the potential symbiont in the ambient environment. To our knowledge, this is the first report of a chemical cue attracting the motile coral larvae to the symbiont.	[Hagedorn, Mary; Carter, Virginia; Zuchowicz, Nikolas; Phillips, Micaiah; Penfield, Chelsea; Shamenek, Brittany] Smithsonian Conservat Biol Inst, Dept Reprod Sci, Front Royal, VA 22630 USA; [Hagedorn, Mary; Carter, Virginia; Zuchowicz, Nikolas; Phillips, Micaiah; Penfield, Chelsea; Shamenek, Brittany] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Vallen, Elizabeth A.] Swarthmore Coll, Dept Biol, Swarthmore, PA USA; [Kleinhans, Frederick W.] Indiana Univ Purdue Univ Indianapolis, Dept Phys, Indianapolis, IN USA; [Peterson, Kelly; White, Meghan; Yancey, Paul H.] Dept Biol, Whitman Coll, Walla Walla, WA USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Hawaii System; Swarthmore College; Indiana University System; Indiana University-Purdue University Indianapolis; Whitman College	Hagedorn, M (corresponding author), Smithsonian Conservat Biol Inst, Dept Reprod Sci, Front Royal, VA 22630 USA.	hagedomm@si.edu		Zuchowicz, Nikolas/0000-0002-3577-0190	Roddenberry Foundation; Anela Kolohe Foundation; Taronga Conservation Society Australia; Whitman College Perry Grant; NIH [1F33GM096488-01]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F33GM096488] Funding Source: NIH RePORTER	Roddenberry Foundation; Anela Kolohe Foundation; Taronga Conservation Society Australia; Whitman College Perry Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These experiments were funded through funds from the Roddenberry Foundation (MH), the Anela Kolohe Foundation (MH), the Taronga Conservation Society Australia (MH), Whitman College Perry Grant (PY) and NIH 1F33GM096488-01 (EAV) and NSF (EAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LM, 2009, MAR ECOL PROG SER, V377, P149, DOI 10.3354/meps07834; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; BENSON AA, 1950, J AM CHEM SOC, V72, P1710, DOI 10.1021/ja01160a080; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Chadwick-Furman NE, 2000, J EXP MAR BIOL ECOL, V249, P199, DOI 10.1016/S0022-0981(00)00204-5; DAVIES PS, 1984, CORAL REEFS, V2, P181; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Douglas AE, 1994, SYMBIOTIC INTERACTIO; Elbein A D, 1974, Adv Carbohydr Chem Biochem, V30, P227, DOI 10.1016/S0065-2318(08)60266-8; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; FITT WK, 1984, MAR BIOL, V81, P9, DOI 10.1007/BF00397620; FUZESSERY ZM, 1978, BIOL BULL, V154, P226, DOI 10.2307/1541124; Hagedorn M, 2006, CRYOBIOLOGY, V52, P33, DOI 10.1016/j.cryobiol.2005.09.008; Hagedorn M, 2010, CRYOBIOLOGY, V60, P147, DOI 10.1016/j.cryobiol.2009.10.005; Hagedorn M, 2010, PHYSIOL BIOCHEM ZOOL, V83, P157, DOI 10.1086/648484; Harii S, 2009, MAR BIOL, V156, P1203, DOI 10.1007/s00227-009-1162-9; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hirose M, 2008, CORAL REEFS, V27, P247, DOI 10.1007/s00338-007-0330-y; Hoegh-Guldberg O, 2007, CORAL REEFS, V26, P731, DOI 10.1007/s00338-007-0320-0; Hoeksema B, 2014, MONTIPORA BLAINVILLE, V1830; Hoeksema BW, 1988, P 6 INT COR REEF S T, V2, P715; Hollingsworth LL, 2005, CORAL REEFS, V24, P523, DOI 10.1007/s00338-005-0063-8; Horiguchi Takeo, 1999, Phycological Research, V47, P101, DOI 10.1111/j.1440-1835.1999.tb00290.x; Koehl MAR, 2007, EXP FLUIDS, V43, P755, DOI 10.1007/S00348-007-0371-6; Koehl MAR, 2010, INTEGR COMP BIOL, V50, P539, DOI 10.1093/icb/icq101; KOPP M, 1993, J BIOL CHEM, V268, P4766; Krupp D.A., 1983, Coral Reefs, V2, P159, DOI 10.1007/BF00336722; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; Lecchini D, 2014, MAR BIOL, V161, P1677, DOI 10.1007/s00227-014-2451-5; LEE KH, 1994, J BACTERIOL, V176, P1985, DOI 10.1128/jb.176.7.1985-1991.1994; Lehnert EM, 2014, G3-GENES GENOM GENET, V4, P277, DOI 10.1534/g3.113.009084; Lin KL, 2000, ZOOL STUD, V39, P172; Lowe RJ, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005081; MCAULEY PJ, 1982, PROC R SOC SER B-BIO, V216, P7, DOI 10.1098/rspb.1982.0058; MUSCATIN.L, 1967, SCIENCE, V156, P516, DOI 10.1126/science.156.3774.516; MUSCATINE L, 1965, COMP BIOCHEM PHYSIOL, V16, P77, DOI 10.1016/0010-406X(65)90165-9; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; OLIVER MJ, 1978, BIOCHEM GENET, V16, P927, DOI 10.1007/BF00483744; Pasternak Z, 2006, CORAL REEFS, V25, P201, DOI 10.1007/s00338-005-0085-2; PORTER JW, 1984, PROC R SOC SER B-BIO, V222, P161, DOI 10.1098/rspb.1984.0057; Relman DA, 2008, NAT REV MICROBIOL, V6, P721, DOI 10.1038/nrmicro1990; REUSER AJJ, 1995, MUSCLE NERVE, pS61; Richmond Robert H., 1997, P175; Rodriguez-Lanetty M, 2006, MAR BIOL, V149, P713, DOI 10.1007/s00227-006-0272-x; Schnitzler CE, 2010, MAR GENOM, V3, P107, DOI 10.1016/j.margen.2010.08.002; Schwarz JA, 1999, BIOL BULL-US, V196, P70, DOI 10.2307/1543169; Schwarz JA, 2003, BIOL BULL-US, V205, P339, DOI 10.2307/1543297; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Takabayashi M, 2012, CORAL REEFS, V31, P157, DOI 10.1007/s00338-011-0832-5; Teramoto N, 2008, MOLECULES, V13, P1773, DOI 10.3390/molecules13081773; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; WOOMER PL, 1988, APPL ENVIRON MICROB, V54, P1494, DOI 10.1128/AEM.54.6.1494-1497.1988; Yancey PH, 2010, PHYSIOL BIOCHEM ZOOL, V83, P167, DOI 10.1086/644625; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	57	18	18	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117087	10.1371/journal.pone.0117087	http://dx.doi.org/10.1371/journal.pone.0117087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629699	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100062
J	Mbefo, MK; Fares, MB; Paleologou, K; Oueslati, A; Yin, GW; Tenreiro, S; Pinto, M; Outeiro, T; Zweckstetter, M; Masliah, E; Lashuel, HA				Mbefo, Martial Kamdem; Fares, Mohamed-Bilal; Paleologou, Katerina; Oueslati, Abid; Yin, Guowei; Tenreiro, Sandra; Pinto, Madalena; Outeiro, Tiago; Zweckstetter, Markus; Masliah, Eliezer; Lashuel, Hilal A.			Parkinson Disease Mutant E46K Enhances alpha-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR KINASES; CENTRAL-NERVOUS-SYSTEM; NUCLEAR TRANSLOCATION; MEMBRANE INTERACTIONS; PHOSPHOLIPID-BINDING; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TRANSGENIC MICE; MUTATION; AGGREGATION	Although alpha-synuclein (alpha-syn) phosphorylation has been considered as a hallmark of sporadic and familial Parkinson disease (PD), little is known about the effect of PD-linked mutations on alpha-syn phosphorylation. In this study, we investigated the effects of the A30P, E46K, and A53T PD-linked mutations on alpha-syn phosphorylation at residues Ser-87 and Ser-129. Although the A30P and A53T mutants slightly affected Ser(P)-129 levels compared with WT alpha-syn, the E46K mutation significantly enhanced Ser-129 phosphorylation in yeast and mammalian cell lines. This effect was not due to the E46K mutant being a better kinase substrate nor due to alterations in endogenous kinase levels, but was mostly linked with enhanced nuclear and endoplasmic reticulum accumulation. Importantly, lentivirus-mediated overexpression in mice also showed enhanced Ser-129 phosphorylation of the E46K mutant compared to WT alpha-syn, thus providing in vivo validation of our findings. Altogether, our findings suggest that the different PD-linked mutations may contribute to PD pathogenesis via different mechanisms.	[Mbefo, Martial Kamdem; Fares, Mohamed-Bilal; Paleologou, Katerina; Oueslati, Abid; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Chem Biol Neurodegenerat, Stn 15, CH-1015 Lausanne, Switzerland; [Yin, Guowei; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Tenreiro, Sandra; Pinto, Madalena; Outeiro, Tiago] Univ Lisbon, Inst Med Mol, Cell & Mol Neurosci Unit, P-1649028 Lisbon, Portugal; [Outeiro, Tiago] Univ Lisbon, Fac Med, Inst Fisiol, P-1649028 Lisbon, Portugal; [Outeiro, Tiago] Univ Med Ctr Goettingen, Dept NeuroDegenerat & Restorat Res, D-37077 Gottingen, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis, D-37077 Gottingen, Germany; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA 92103 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, San Diego, CA 92103 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society; Universidade de Lisboa; Universidade de Lisboa; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of California System; University of California San Diego; University of California System; University of California San Diego	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Chem Biol Neurodegenerat, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Outeiro, Tiago F/C-1067-2008; Oueslati, Abid/ABG-8116-2020; Lashuel, Hilal/M-3500-2017; Outeiro, Tiago/L-7351-2019; Outeiro, Tiago/M-8106-2019; Tenreiro, Sandra/A-9289-2013; Pinto, Madalena/L-1835-2014	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; Tenreiro, Sandra/0000-0001-7272-5842; Zweckstetter, Markus/0000-0002-2536-6581; Oueslati, Abid/0000-0003-1122-7086; Pinto, Madalena/0000-0002-4676-1409	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation [31003A_120653]; Michael J. Fox Foundation; Merck Serono; Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center "Nanoscale Microscopy and Molecular Physiology of the Brain"; Fundacao pare a Ciencia e Tecnologia [PTDC/SAU-NEU/105215/2008, PTDC/BIA-BCM/117975/2010]; EMBO;  [SFRH/BPD/35767/2007];  [IMM/BTI/1-2012]; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Michael J. Fox Foundation; Merck Serono(Merck & Company); Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center "Nanoscale Microscopy and Molecular Physiology of the Brain"; Fundacao pare a Ciencia e Tecnologia; EMBO(European Molecular Biology Organization (EMBO)); ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Ecole Polytechnique Federale de Lausanne, Swiss National Science Foundation Grant 31003A_120653, the Michael J. Fox Foundation, Merck Serono, a Marie Curie post-doctoral fellowship (to A. O.), the Cluster of Excellence and Deutsche Forschungsgemeinschaft Research Center "Nanoscale Microscopy and Molecular Physiology of the Brain" (to M. Z.), Fundacao pare a Ciencia e Tecnologia Projects PTDC/SAU-NEU/105215/2008 and PTDC/BIA-BCM/117975/2010, and Post-doctoral Fellowships SFRH/BPD/35767/2007 (to S. T.) and IMM/BTI/1-2012 (to M. R. P.).r Supported by an EMBO Installation Grant.	Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Boone AN, 2002, AM J PHYSIOL-REG I, V283, pR680, DOI 10.1152/ajpregu.00125.2002; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Chau KY, 2009, J NEUROCHEM, V110, P1005, DOI 10.1111/j.1471-4159.2009.06191.x; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dotan I, 2001, BIOCHEM BIOPH RES CO, V288, P603, DOI 10.1006/bbrc.2001.5804; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Emmer KL, 2011, J BIOL CHEM, V286, P35104, DOI 10.1074/jbc.M111.247965; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Ghosh D, 2014, BIOCHEMISTRY-US, V53, P6419, DOI 10.1021/bi5010365; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; GOLBE LI, 1990, ANN NEUROL, V27, P276, DOI 10.1002/ana.410270309; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Huang Z, 2011, NEUROSCIENCE, V199, P318, DOI 10.1016/j.neuroscience.2011.10.016; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jiang ML, 2010, J NEUROCHEM, V114, P419, DOI 10.1111/j.1471-4159.2010.06752.x; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kim YS, 2006, J MOL BIOL, V360, P386, DOI 10.1016/j.jmb.2006.05.004; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Machiya Y, 2010, J BIOL CHEM, V285, P40732, DOI 10.1074/jbc.M110.141952; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Neznanov N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001887; Nonaka T, 2009, BIOCHEMISTRY-US, V48, P8014, DOI 10.1021/bi900619j; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Perlmutter JD, 2009, J BIOL CHEM, V284, P7177, DOI 10.1074/jbc.M808895200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PREMONT RT, 1994, METHOD ENZYMOL, V238, P116; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Puschmann A, 2009, PARKINSONISM RELAT D, V15, P627, DOI 10.1016/j.parkreldis.2009.06.007; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Salvi M, 2012, BIOCHEM BIOPH RES CO, V418, P156, DOI 10.1016/j.bbrc.2011.12.152; Schell H, 2009, NEUROSCIENCE, V160, P796, DOI 10.1016/j.neuroscience.2009.03.002; Schmid AW, 2009, J BIOL CHEM, V284, P13128, DOI 10.1074/jbc.M809067200; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Wakamatsu M, 2007, J NEUROSCI RES, V85, P1819, DOI 10.1002/jnr.21310; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Xu SL, 2006, BIOCHEM BIOPH RES CO, V342, P330, DOI 10.1016/j.bbrc.2006.01.148; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou M, 2013, BRAIN RES, V1500, P19, DOI 10.1016/j.brainres.2013.01.024	78	41	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2015	290	15					9412	9427		10.1074/jbc.M114.610774	http://dx.doi.org/10.1074/jbc.M114.610774			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF7IJ	25657004	Green Published, hybrid			2022-12-26	WOS:000352729400010
J	Saidak, Z; Henaff, C; Azzi, S; Marty, C; Da Nascimento, S; Sonnet, P; Marie, PJ				Saidak, Zuzana; Le Henaff, Carole; Azzi, Sofia; Marty, Caroline; Da Nascimento, Sophie; Sonnet, Pascal; Marie, Pierre J.			Wnt/beta-Catenin Signaling Mediates Osteoblast Differentiation Triggered by Peptide-induced alpha 5 beta 1 Integrin Priming in Mesenchymal Skeletal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED KINASE ILK; BETA-CATENIN; BONE-FORMATION; TRANSCRIPTION FACTORS; LIGAND-BINDING; WNT; EXPRESSION; PROMOTES; ADHESION; ACTIVATION	The alpha 5 beta 1 integrin is a key fibronectin (EN) receptor that binds to RGD-containing peptides to mediate cell adhesion. We previously reported that alpha 5 beta 1 integrin promotes osteogenic differentiation in mesenchymal skeletal cells (MSCs), but the underlying mechanisms are not fully understood. In this study, we determined the signaling mechanisms induced by alpha 5 beta 1 integrin interaction with its high-affinity ligand CRRETAWAC in murine and human MSCs and in vivo. We show that cyclized CRRETAWAC fully displaced MSC adhesion to FN, whereas related peptides lacking the full RRET sequence produced a partial displacement, indicating that RRET acts as an RGD-like sequence that is required to antagonize EN-mediated cell adhesion. However, all peptides increased focal adhesion kinase phosphorylation, OSE2 transcriptional activity, osteoblast gene expression, and matrix mineralization in MSCs, indicating that peptide-induced alpha 5 beta 1 integrin priming can promote osteogenic differentiation independently of the RRET sequence. Biochemical analyses showed that peptide-induced alpha 5 beta 1 integrin priming transiently increased PI3K/Akt phosphorylation and promoted Wnt/beta-catenin transcriptional activity independently of RRET. Consistently, pharmacological inhibition of PI3K activity reduced osteoblast differentiation and abolished Wnt regulatory gene expression induced by alpha 5 beta 1 integrin priming. In vivo, systemic delivery of cyclized GACRETAWACGA linked to (DSS)(6) to allow delivery to bone-forming sites for 6 weeks increased serum osteocalcin levels and improved long bone mass and microarchitecture in SAMP-6 senescent osteopenic mice. The results support a mechanism whereby alpha 5 beta 1 integrin priming by high-affinity ligands integrates Wnt/beta-catenin signaling to promote osteoblast differentiation independently of cell adhesion, which could be used to improve bone mass and microarchitecture in the aging skeleton.	[Saidak, Zuzana; Le Henaff, Carole; Azzi, Sofia; Marty, Caroline; Marie, Pierre J.] INSERM, UMR 1132, F-75475 Paris 10, France; [Saidak, Zuzana; Le Henaff, Carole; Azzi, Sofia; Marty, Caroline; Marie, Pierre J.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Da Nascimento, Sophie; Sonnet, Pascal] Univ Picardie Jules Verne, UFR Pharm, Equipe Thera,FRE,CNRS 3517, Lab Glycochim Antimicrobiens & Agroressources LG2, F-80037 Amiens 1, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, UMR 1132, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr	sonnet, pascal/AAM-3308-2021	sonnet, pascal/0000-0003-0118-9151	Agence Nationale de la Recherche (Integros) [ANR-2010-BLAN-1505-01]; Association Prevention et Traitement des Decalcifications (Paris, France)	Agence Nationale de la Recherche (Integros)(French National Research Agency (ANR)); Association Prevention et Traitement des Decalcifications (Paris, France)	This work was supported by grants from the Agence Nationale de la Recherche (Integros, ANR-2010-BLAN-1505-01) and the Association Prevention et Traitement des Decalcifications (Paris, France) (to P.J. M.).	Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Brunner M, 2013, INT REV CEL MOL BIO, V305, P1, DOI 10.1016/B978-0-12-407695-2.00001-9; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Damsky CH, 2002, CURR OPIN CELL BIOL, V14, P594, DOI 10.1016/S0955-0674(02)00368-X; Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4; Dedhar S, 1999, TRENDS CELL BIOL, V9, P319, DOI 10.1016/S0962-8924(99)01612-8; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Dufour C, 2007, EXP CELL RES, V313, P394, DOI 10.1016/j.yexcr.2006.10.021; El-Hoss J, 2014, GENE, V533, P246, DOI 10.1016/j.gene.2013.09.074; Fonar Y, 2011, ANTI-CANCER AGENT ME, V11, P600, DOI 10.2174/187152011796817673; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Fromigue O, 2012, J CELL BIOCHEM, V113, P3029, DOI 10.1002/jcb.24181; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hamidouche Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-44; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hay E, 2014, J CELL PHYSIOL, V229, P1765, DOI 10.1002/jcp.24629; Hay E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008284; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Khosla S, 2011, J BONE MINER RES, V26, P2565, DOI 10.1002/jbmr.488; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Liao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042709; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Marie PJ, 2014, J BONE MINER RES, V29, P1311, DOI 10.1002/jbmr.2190; Marie PJ, 2013, NAT REV ENDOCRINOL, V9, P288, DOI 10.1038/nrendo.2013.4; Marie PJ, 2011, EUR J ENDOCRINOL, V165, P1, DOI 10.1530/EJE-11-0132; Maydan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012356; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Mould AP, 2009, BIOCHEM J, V424, P179, DOI 10.1042/BJ20090992; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; Mould AP, 1998, J BIOL CHEM, V273, P25664, DOI 10.1074/jbc.273.40.25664; Moursi AM, 1997, J CELL SCI, V110, P2187; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Saidak Z, 2012, AGING CELL, V11, P467, DOI 10.1111/j.1474-9726.2012.00804.x; Srouji S, 2012, HUM GENE THER, V23, P167, DOI 10.1089/hum.2011.059; Tan C, 2001, ONCOGENE, V20, P133, DOI 10.1038/sj.onc.1204052; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xu JK, 2012, J BIOL CHEM, V287, P26200, DOI 10.1074/jbc.M112.349811; Yao GQ, 2011, J BONE MINER METAB, V29, P141, DOI 10.1007/s00774-010-0202-3; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617	64	77	84	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6903	6912		10.1074/jbc.M114.621219	http://dx.doi.org/10.1074/jbc.M114.621219			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631051	Green Published, hybrid			2022-12-26	WOS:000350991500025
J	Ido, Y; Duranton, A; Lan, F; Weikel, KA; Breton, L; Ruderman, NB				Ido, Yasuo; Duranton, Albert; Lan, Fan; Weikel, Karen A.; Breton, Lionel; Ruderman, Neil B.			Resveratrol Prevents Oxidative Stress-Induced Senescence and Proliferative Dysfunction by Activating the AMPK-FOXO3 Cascade in Cultured Primary Human Keratinocytes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PROTEIN-KINASE; LIFE-SPAN; HUMAN LONGEVITY; HUMAN SKIN; OSTEOBLASTIC DIFFERENTIATION; CELLULAR SENESCENCE; INSULIN-RESISTANCE; FOXO3A GENE; IN-VIVO	The aging process is perceived as resulting from a combination of intrinsic factors such as changes in intracellular signaling and extrinsic factors, most notably environmental stressors. In skin, the relationship between intrinsic changes and keratinocyte function is not clearly understood. Previously, we found that increasing the activity of AMP-activated protein kinase (AMPK) suppressed senescence in hydrogen peroxide (H2O2)-treated human primary keratinocytes, a model of oxidative stress-induced cellular aging. Using this model in the present study, we observed that resveratrol, an agent that increases the activities of both AMPK and sirtuins, ameliorated two age-associated phenotypes: cellular senescence and proliferative dysfunction. In addition, we found that treatment of keratinocytes with Ex527, a specific inhibitor of sirtuin 1 (SIRT1), attenuated the ability of resveratrol to suppress senescence. In keeping with the latter observation, we noted that compared to non-senescent keratinocytes, senescent cells lacked SIRT1. In addition to these effects on H2O2-induced senescence, resveratrol also prevented the H2O2-induced decrease in proliferation (as indicated by H-3-thymidine incorporation) in the presence of insulin. This effect was abrogated by inhibition of AMPK but not SIRT1. Compared to endothelium, we found that human keratinocytes expressed relatively high levels of Forkhead box O-3 (FOXO3), a downstream target of both AMPK and SIRT1. Treatment of keratinocytes with resveratrol transactivated FOXO3 and increased the expression of its target genes including catalase. Resveratrol's effects on both senescence and proliferation disappeared when FOXO3 was knocked down. Finally, we performed an exploratory study which showed that skin from humans over 50 years old had lower AMPK activity than skin from individuals under age 20. Collectively, these findings suggest that the effects of resveratrol on keratinocyte senescence and proliferation are regulated by the AMPK-FOXO3 pathway and in some situations, but not all, by SIRT1.	[Ido, Yasuo; Weikel, Karen A.; Ruderman, Neil B.] Boston Univ, Med Ctr, Sch Med, Diabet & Metab Unit, Boston, MA 02118 USA; [Duranton, Albert; Breton, Lionel] LOREAL Res & Innovat, Aulnay Sous Bois, France; [Lan, Fan] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China	Boston University; L'Oreal Group; Chongqing Medical University	Ido, Y (corresponding author), Boston Univ, Med Ctr, Sch Med, Diabet & Metab Unit, Boston, MA 02118 USA.	yido@bu.edu		Weikel, Karen/0000-0003-0317-7891; Duranton, Albert/0000-0002-4057-7176	L'Oreal [C140305]; NIH [PO1-HL 08758-01]	L'Oreal(L'Oreal Group); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	N.R. received funding from L'Oreal (L'Oreal reference C140305). The funder provided support in the form of salaries for authors (A.D. and L.B) and had roles in the decision to publish and preparation of the manuscript. The specific roles of A.D. and L.B. are articulated in the "author contributions" section. N.R. received funding from the NIH (PO1-HL 08758-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Boric M, 2013, J CHEM NEUROANAT, V53, P33, DOI 10.1016/j.jchemneu.2013.10.001; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bulow MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04048; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Castino R, 2011, J AGR FOOD CHEM, V59, P4264, DOI 10.1021/jf104917q; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Christensen K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5262; Coffer PJ, 1997, ONCOGENE, V15, P2529, DOI 10.1038/sj.onc.1201429; Corbi G, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00324; Cordisco S, 2010, J INVEST DERMATOL, V130, P1048, DOI 10.1038/jid.2009.355; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Franco SS, 2014, HAEMATOLOGICA, V99, P267, DOI 10.3324/haematol.2013.090076; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Garg D, 2014, AGEING RES REV; Giacomoni PU, 2004, MICRON, V35, P179, DOI 10.1016/j.micron.2003.11.004; Gilhar A, 2004, J GERONTOL A-BIOL, V59, P411; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Gunschmann C, 2013, DEV CELL, V26, P176, DOI 10.1016/j.devcel.2013.05.017; Gunn DA, 2013, J GERONTOL A-BIOL, V68, P145, DOI 10.1093/gerona/gls154; Gunn DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008021; Hibino T, 1999, J INVEST DERMATOL, V112, P85, DOI 10.1046/j.1523-1747.1999.00466.x; Hori YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073875; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ido Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035092; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Jiang H, 2010, NEUROCHEM RES, V35, P152, DOI 10.1007/s11064-009-0040-7; Kadic AJ, 2014, J TISSUE VIABILITY, V23, P7, DOI 10.1016/j.jtv.2013.11.002; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kola B, 2008, J CLIN ENDOCR METAB, V93, P4969, DOI 10.1210/jc.2008-1297; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Mandinova A, 2008, EMBO J, V27, P1243, DOI 10.1038/emboj.2008.45; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Nelson LE, 2012, AM J PHYSIOL-CELL PH, V303, pC4, DOI 10.1152/ajpcell.00296.2011; Paris M, 2012, CELL DEATH DIFFER, V19, P186, DOI 10.1038/cdd.2011.181; Peltz L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037162; Peserico A, 2013, CELL MOL LIFE SCI, V70, P2015, DOI 10.1007/s00018-012-1244-6; Pirinen E, 2012, BEST PRACT RES CL EN, V26, P759, DOI 10.1016/j.beem.2012.05.001; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Reznikova TV, 2010, MOL CARCINOGEN, V49, P398, DOI 10.1002/mc.20612; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Saha AK, 2011, CELL CYCLE, V10, P3447, DOI 10.4161/cc.10.20.17886; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Senoo M, 2013, ADV WOUND CARE, V2, P273, DOI 10.1089/wound.2012.0372; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shen S, 2001, DIABETES, V50, P255, DOI 10.2337/diabetes.50.2.255; Soerensen M, 2010, AGING CELL, V9, P1010, DOI 10.1111/j.1474-9726.2010.00627.x; Song LH, 2006, TOXICOL IN VITRO, V20, P915, DOI 10.1016/j.tiv.2006.01.016; Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tullet JMA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004109; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Velarde MC, 2012, AGING-US, V4, P3, DOI 10.18632/aging.100423; Vierkotter A, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.19858; Waaijer MEC, 2012, AGING CELL, V11, P722, DOI 10.1111/j.1474-9726.2012.00837.x; Wallace DC, 2010, DEV DISABIL RES REV, V16, P114, DOI 10.1002/ddrr.113; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; WARREN R, 1991, J AM ACAD DERMATOL, V25, P751, DOI 10.1016/S0190-9622(08)80964-4; Webb AE, 2013, NAT CELL BIOL, V15, P444, DOI 10.1038/ncb2749; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Winter MC, 2009, J INVEST DERMATOL, V129, P2541, DOI 10.1038/jid.2009.236; Xu XJ, 2012, J LIPID RES, V53, P792, DOI 10.1194/jlr.P022905; YU CCW, 1992, HISTOCHEM J, V24, P121, DOI 10.1007/BF01047461; Zobiri O, 2012, STEM CELLS CLONING, V5, P1, DOI 10.2147/SCCAA.S28355	77	88	91	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115341	10.1371/journal.pone.0115341	http://dx.doi.org/10.1371/journal.pone.0115341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647160	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600013
J	Liu, T; Green, AR; Rodriguez, LF; Ramirez, BC; Shike, DW				Liu, Tong; Green, Angela R.; Rodriguez, Luis F.; Ramirez, Brett C.; Shike, Daniel W.			Effects of Number of Animals Monitored on Representations of Cattle Group Movement Characteristics and Spatial Occupancy	PLOS ONE			English	Article							GPS MEASUREMENT ERROR; COLLAR DATA; BEHAVIOR; HERD; MODEL; LIVESTOCK; TRACKING; DISTANCE; PIGEONS; PATTERN	The number of animals required to represent the collective characteristics of a group remains a concern in animal movement monitoring with GPS. Monitoring a subset of animals from a group instead of all animals can reduce costs and labor; however, incomplete data may cause information losses and inaccuracy in subsequent data analyses. In cattle studies, little work has been conducted to determine the number of cattle within a group needed to be instrumented considering subsequent analyses. Two different groups of cattle (a mixed group of 24 beef cows and heifers, and another group of 8 beef cows) were monitored with GPS collars at 4 min intervals on intensively managed pastures and corn residue fields in 2011. The effects of subset group size on cattle movement characterization and spatial occupancy analysis were evaluated by comparing the results between subset groups and the entire group for a variety of summarization parameters. As expected, more animals yield better results for all parameters. Results show the average group travel speed and daily travel distances are overestimated as subset group size decreases, while the average group radius is underestimated. Accuracy of group centroid locations and group radii are improved linearly as subset group size increases. A kernel density estimation was performed to quantify the spatial occupancy by cattle via GPS location data. Results show animals among the group had high similarity of spatial occupancy. Decisions regarding choosing an appropriate subset group size for monitoring depend on the specific use of data for subsequent analysis: a small subset group may be adequate for identifying areas visited by cattle; larger subset group size (e.g. subset group containing more than 75% of animals) is recommended to achieve better accuracy of group movement characteristics and spatial occupancy for the use of correlating cattle locations with other environmental factors.	[Liu, Tong; Green, Angela R.; Rodriguez, Luis F.; Ramirez, Brett C.] Univ Illinois, Dept Agr & Biol Engn, Urbana, IL 61820 USA; [Shike, Daniel W.] Univ Illinois, Dept Anim Sci, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Liu, T (corresponding author), Univ Illinois, Dept Agr & Biol Engn, Urbana, IL 61820 USA.	tongliu3@illinois.edu	Ramirez, Brett/A-8646-2018	Ramirez, Brett/0000-0002-3205-9723; Green-Miller, Angela/0000-0003-3404-4995				Agouridis CT, 2004, T ASAE, V47, P1321, DOI 10.13031/2013.16566; Akasbi Z, 2012, RANGELAND J, V34, P415, DOI 10.1071/RJ12036; Anderson D. M., 2013, POSITIONING, V4, P115, DOI [10.4236/pos.2013.41012, DOI 10.4236/POS.2013.41012]; Anderson DM, 2012, RANGELAND J, V34, P149, DOI 10.1071/RJ11062; Brooks C, 2008, J WILDLIFE MANAGE, V72, P527, DOI 10.2193/2007-061; Davis JD, 2011, APPL ENG AGRIC, V27, P143; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; Della-Rossa L, 2013, BEHAVIOUR, V150, P153, DOI 10.1163/1568539X-00003043; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; Ganskopp DC, 2007, RANGELAND ECOL MANAG, V60, P350, DOI 10.2111/1551-5028(2007)60[350:GEISAA]2.0.CO;2; Gudbjornsson S, 2004, SEA TECHNOL, V45, P23; Guo Y, 2009, ECOL MODEL, V220, P2068, DOI 10.1016/j.ecolmodel.2009.04.047; Hurford A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005632; ION, 1997, 101 ION STD; Jerde CL, 2005, ECOL APPL, V15, P806, DOI 10.1890/04-0895; Johnson DD, 2008, RANGELAND ECOL MANAG, V61, P226, DOI 10.2111/07-044.1; LIU T, 2012, AM SOC AGR BIOL ENG, V7004, P3514; Mech LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025328; Morales JM, 2005, LANDSCAPE ECOL, V20, P301, DOI 10.1007/s10980-005-0061-9; Moritz M, 2012, HUM ECOL, V40, P623, DOI 10.1007/s10745-012-9483-6; Pandey V., 2013, Biological Engineering Transactions, V6, P59; Pepin D, 2004, J MAMMAL, V85, P774, DOI 10.1644/BER-022; Perotto-Baldivieso HL, 2012, APPL ANIM BEHAV SCI, V136, P117, DOI 10.1016/j.applanim.2011.11.009; Rands SA, 2014, PEERJ, V2, DOI 10.7717/peerj.344; Rodgers AR, 1996, WILDLIFE SOC B, V24, P559; Sarova R, 2007, APPL ANIM BEHAV SCI, V108, P327, DOI 10.1016/j.applanim.2007.01.009; Sarova R, 2010, ANIM BEHAV, V79, P1037, DOI 10.1016/j.anbehav.2010.01.019; Shiyomi M, 1999, ECOL MODEL, V119, P231, DOI 10.1016/S0304-3800(99)00059-9; Silverman B.W., 1986, DENSITY ESTIMATION S, DOI [10.1007/978-1-4899-3324-9, DOI 10.1007/978-1-4899-3324-9]; Swain DL, 2011, ANIM PROD SCI, V51, P167, DOI 10.1071/AN10255; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; Turner LW, 2000, CAN J ANIM SCI, V80, P405, DOI 10.4141/A99-093; Ungar ED, 2005, RANGELAND ECOL MANAG, V58, P256, DOI 10.2111/1551-5028(2005)58[256:IOAAFG]2.0.CO;2; Vyssotski AL, 2006, J NEUROPHYSIOL, V95, P1263, DOI 10.1152/jn.00879.2005; Yasuda T, 2005, ZOOL SCI, V22, P547, DOI 10.2108/zsj.22.547	35	9	11	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0113117	10.1371/journal.pone.0113117	http://dx.doi.org/10.1371/journal.pone.0113117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647571	gold, Green Published, Green Submitted			2022-12-26	WOS:000348822600004
J	Peng, Y; Gao, XL; Yang, J; Shekhar, S; Wang, SH; Fan, YJ; Yang, X				Peng, Ying; Gao, Xiaoling; Yang, Jie; Shekhar, Sudhanshu; Wang, Shuhe; Fan, Yijun; Yang, Xi			Chlamydial Lung Infection Induces Transient IL-9 Production Which Is Redundant for Host Defense against Primary Infection	PLOS ONE			English	Article							DENDRITIC CELLS; IFN-GAMMA; T-CELLS; T(H)17; IMMUNITY; ROLES; MICE; INTERFERON; PATHWAYS; ALPHA	IL-9/Th9 responses are recently found to be important for innate and adaptive immunity particularly in parasitic infections. To date, the study on the role of IL-9 in bacterial infections is limited and the reported data are contradictory. One reported function of IL-9/Th9 is to modulate Th1/Th17 responses. Since our and others' previous work has shown a critical role of Th1 and Th17 cells in host defense against chlamydial lung infection, we here examined the role of IL-9 responses in Chlamydia muridarum (Cm) lung infection, particularly its effect on Th1 and Th17 responses and outcome infection. Our data showed quick but transient IL-9 production in the lung following infection, peaking at day 3 and back to baseline around day 7. CD4+ T cell was the major source of IL-9 production in the lung infection. Blockade of endogenous IL-9 using neutralizing antibody failed to change Interferon-Upsilon (IFN-Upsilon) and IL-17 production by cultured spleen mononuclear cells isolated from Cm infected mice. Similarly, in vivo neutralization of IL-9 failed to show significant effect on T cell (Th1 and Th17) and antibody responses (IgA, IgG1 and IgG2a). Consistently, the neutralization of IL-9 had no significant effect on disease process, including body weight change, bacterial burden and histopathological score. The data suggest that IL-9 production following chlamydial lung infection is redundant for host defense against the intracellular bacteria.	[Yang, Xi] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Yang, X (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	yangxi@cc.umanitoba.ca	Gao, xiao ling/GQI-2790-2022	Yang, Xi/0000-0002-8831-7488	Canadian Institutes of Health Research (CIHR); Manitoba Health Research Council (MHRC); Manitoba Institutes of Child Health (MICH)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council (MHRC); Manitoba Institutes of Child Health (MICH)	This work was supported by grants to XY from Canadian Institutes of Health Research (CIHR), Manitoba Health Research Council (MHRC) and Manitoba Institutes of Child Health (MICH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bilenki L, 2006, J IMMUNOL, V177, P7067, DOI 10.4049/jimmunol.177.10.7067; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Demoulin J B, 1998, Int Rev Immunol, V16, P345, DOI 10.3109/08830189809043001; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Finiasz MR, 2007, CLIN EXP IMMUNOL, V147, P139, DOI 10.1111/j.1365-2249.2006.03241.x; Gao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052657; Geng YM, 2000, INFECT IMMUN, V68, P2245, DOI 10.1128/IAI.68.4.2245-2253.2000; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Grohmann U, 2000, J IMMUNOL, V164, P4197, DOI 10.4049/jimmunol.164.8.4197; Han XB, 2006, J IMMUNOL, V176, P5232, DOI 10.4049/jimmunol.176.9.5232; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Jabeen R, 2012, CURR OPIN IMMUNOL, V24, P303, DOI 10.1016/j.coi.2012.02.001; Joyee AG, 2008, AM J RESP CRIT CARE, V178, P745, DOI 10.1164/rccm.200804-517OC; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Nowak EC, 2010, IMMUNOLOGY, V131, P169, DOI 10.1111/j.1365-2567.2010.03332.x; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; SCHACHTER J, 1978, NEW ENGL J MED, V298, P428, DOI 10.1056/NEJM197802232980805; Schmitt E, 2014, TRENDS IMMUNOL, V35, P61, DOI 10.1016/j.it.2013.10.004; Tan CY, 2010, J IMMUNOL, V185, P6795, DOI 10.4049/jimmunol.1001676; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Wu B, 2008, CLIN IMMUNOL, V126, P202, DOI 10.1016/j.clim.2007.09.009; Yang X, 1998, IMMUNOLOGY, V94, P469; Yang X, 1996, J IMMUNOL, V156, P4338; YIN TG, 1994, J BIOL CHEM, V269, P26614; Zhao L, 2011, IMMUNOLOGY, V134, P172, DOI 10.1111/j.1365-2567.2011.03477.x; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0115195	10.1371/journal.pone.0115195	http://dx.doi.org/10.1371/journal.pone.0115195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646821	Green Submitted, Green Published, gold			2022-12-26	WOS:000348822600010
J	Tarasenko, TN; Rosas, OR; Singh, LN; Kristaponis, K; Vernon, H; McGuire, PJ				Tarasenko, Tatyana N.; Rosas, Odrick R.; Singh, Larry N.; Kristaponis, Kara; Vernon, Hilary; McGuire, Peter J.			A New Mouse Model of Mild Ornithine Transcarbamylase Deficiency (spf-j) Displays Cerebral Amino Acid Perturbations at Baseline and upon Systemic Immune Activation	PLOS ONE			English	Article							UREA CYCLE DISORDERS; AMMONIA METABOLISM; HYPERAMMONEMIA; MANAGEMENT; MUTANT; EXPRESSION; ADULT	Ornithine transcarbamylase deficiency (OTCD, OMIM# 311250) is an inherited X-linked urea cycle disorder that is characterized by hyperammonemia and orotic aciduria. In this report, we describe a new animal model of OTCD caused by a spontaneous mutation in the mouse Otc gene (c.240T>A, p.K80N). This transversion in exon 3 of ornithine transcarbamylase leads to normal levels of mRNA with low levels of mature protein and is homologous to a mutation that has also been described in a single patient affected with late-onset OTCD. With higher residual enzyme activity, spf-J were found to have normal plasma ammonia and orotate. Baseline plasma amino acid profiles were consistent with mild OTCD: elevated glutamine, and lower citrulline and arginine. In contrast to WT, spf-J displayed baseline elevations in cerebral amino acids with depletion following immune challenge with polyinosinic: polycytidylic acid. Our results indicate that the mild spf-J mutation constitutes a new mouse model that is suitable for mechanistic studies of mild OTCD and the exploration of cerebral pathophysiology during acute decompensation that characterizes proximal urea cycle dysfunction in humans.	[Tarasenko, Tatyana N.; Singh, Larry N.; McGuire, Peter J.] NHGRI, NIH, Bethesda, MD 20892 USA; Univ Cent Caribe, Bayamon, PR USA; [Kristaponis, Kara] Johns Hopkins Univ, Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA; [Vernon, Hilary] Johns Hopkins Univ, Kennedy Krieger Inst, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Kennedy Krieger Institute	McGuire, PJ (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	peter.mcguire@nih.gov	Singh, Larry N./AAG-6880-2021	Singh, Larry N./0000-0002-2478-5864; Vernon, Hilary/0000-0001-9940-9866	intramural research program of the National Institutes of Health; Kennedy Kreiger Institute at Johns Hopkins University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200381] Funding Source: NIH RePORTER	intramural research program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kennedy Kreiger Institute at Johns Hopkins University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Work performed by T.N.T., L.N.S., O.R.R., and P.J.M. was supported by the intramural research program of the National Institutes of Health. Work performed by H.V. and K.K. was supported by institutional funding from the Kennedy Kreiger Institute at Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann C, 2003, EUR J PEDIATR, V162, pS29, DOI 10.1007/s00431-003-1347-z; BATSHAW ML, 1980, NEW ENGL J MED, V302, P482, DOI 10.1056/NEJM198002283020902; Ben-Ari Z, 2010, J HEPATOL, V52, P292, DOI 10.1016/j.jhep.2009.11.014; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; D'Apolito O, 2010, J SEP SCI, V33, P966, DOI 10.1002/jssc.200900758; Dong ZJ, 2004, J HEPATOL, V41, P966, DOI 10.1016/j.jhep.2004.08.021; Fernandes J, 2006, INBORN METABOLIC DIS, P263; Galloway PJ, 2000, ANN CLIN BIOCHEM, V37, P727, DOI 10.1258/0004563001899807; Gropman A, 2010, MOL GENET METAB, V100, pS20, DOI 10.1016/j.ymgme.2010.01.017; Gropman AL, 2013, METAB BRAIN DIS, V28, P269, DOI 10.1007/s11011-012-9348-0; Holecek M, 2013, NUTRITION, V29, P1186, DOI 10.1016/j.nut.2013.01.022; KREBS HA, 1978, BIOCHEM J, V176, P733, DOI 10.1042/bj1760733; Krivitzky L, 2009, PEDIAT RES; MAESTRI NE, 1992, J PEDIATR-US, V121, P259, DOI 10.1016/S0022-3476(05)81200-4; Marcaggi P, 2004, GLIA, V47, P217, DOI 10.1002/glia.20027; Matsuda I, 1996, J MED GENET, V33, P645, DOI 10.1136/jmg.33.8.645; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; McGuire PJ, 2013, J PEDIATR-US, V163, P1705, DOI 10.1016/j.jpeds.2013.08.029; Meijer AJ, 2004, BIOCHEM BIOPH RES CO, V313, P397, DOI 10.1016/j.bbrc.2003.07.012; Morizono H, 1997, HUM MOL GENET, V6, P963, DOI 10.1093/hmg/6.6.963; Morizono H, 1997, BIOCHEM J, V322, P625, DOI 10.1042/bj3220625; Moscioni D, 2006, MOL THER, V14, P25, DOI 10.1016/j.ymthe.2006.03.009; MSALL M, 1984, NEW ENGL J MED, V310, P1500, DOI 10.1056/NEJM198406073102304; Pacheco-Colon I, 2014, ADV UREA CYCLE NEURO; PASTRALANDIS SC, 1981, ANAL BIOCHEM, V118, P358, DOI 10.1016/0003-2697(81)90594-7; Singh LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002345; Singh RH, 2007, J INHERIT METAB DIS, V30, P880, DOI 10.1007/s10545-007-0718-4; Snodgrass PJ, 2004, ANIMAL MODELS OTC DE, P94; Sprouse C, 2014, MOL GENET METAB, V113, P136, DOI 10.1016/j.ymgme.2014.05.007; Summar M, 2001, J PEDIATR-US, V138, pS6, DOI 10.1067/mpd.2001.111831; USA Jackson Laboratory, 1995, Mouse Genome, V93, P1030	31	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116594	10.1371/journal.pone.0116594	http://dx.doi.org/10.1371/journal.pone.0116594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647322	gold, Green Submitted, Green Published			2022-12-26	WOS:000348822600029
J	Peretz, Y; Wu, H; Patel, S; Bellacosa, A; Katz, RA				Peretz, Yuval; Wu, Hong; Patel, Shayan; Bellacosa, Alfonso; Katz, Richard A.			Inhibitor of DNA Binding 4 (ID4) Is Highly Expressed in Human Melanoma Tissues and May Function to Restrict Normal Differentiation of Melanoma Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; HUMAN-MALIGNANT-MELANOMA; NEURAL CREST; SELF-RENEWAL; GROWTH; HETEROGENEITY; GLIOBLASTOMA; PROTEINS; PHENOTYPE; THERAPY	Melanoma tissues and cell lines are heterogeneous, and include cells with invasive, proliferative, stem cell-like, and differentiated properties. Such heterogeneity likely contributes to the aggressiveness of the disease and resistance to therapy. One model suggests that heterogeneity arises from rare cancer stem cells (CSCs) that produce distinct cancer cell lineages. Another model suggests that heterogeneity arises through reversible cellular plasticity, or phenotype-switching. Recent work indicates that phenotype-switching may include the ability of cancer cells to dedifferentiate to a stem cell-like state. We set out to investigate the phenotype-switching capabilities of melanoma cells, and used unbiased methods to identify genes that may control such switching. We developed a system to reversibly synchronize melanoma cells between 2D-monolayer and 3D-stem cell-like growth states. Melanoma cells maintained in the stem cell-like state showed a striking upregulation of a gene set related to development and neural stem cell biology, which included SRY-box 2 (SOX2) and Inhibitor of DNA Binding 4 (ID4). A gene set related to cancer cell motility and invasiveness was concomitantly downregulated. Intense and pervasive ID4 protein expression was detected in human melanoma tissue samples, suggesting disease relevance for this protein. SiRNA knockdown of ID4 inhibited switching from monolayer to 3D-stem cell-like growth, and instead promoted switching to a highly differentiated, neuronal-like morphology. We suggest that ID4 is upregulated in melanoma as part of a stem cell-like program that facilitates further adaptive plasticity. ID4 may contribute to disease by preventing stem cell-like melanoma cells from progressing to a normal differentiated state. This interpretation is guided by the known role of ID4 as a differentiation inhibitor during normal development. The melanoma stem cell-like state may be protected by factors such as ID4, thereby potentially identifying a new therapeutic vulnerability to drive differentiation to the normal cell phenotype.	[Peretz, Yuval; Wu, Hong; Patel, Shayan; Bellacosa, Alfonso; Katz, Richard A.] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA 19140 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Katz, RA (corresponding author), Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA 19140 USA.	Richard.Katz@fccc.edu			National Institutes of Health [DK082498, CA071515, CA006927]; NATIONAL CANCER INSTITUTE [R01CA071515, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health Grants DK082498 (RAK), CA071515, and CA006927. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2013, J INVEST DERMATOL, V133, P1384, DOI 10.1038/jid.2012.508; Bailey CM, 2012, PIGM CELL MELANOMA R, V25, P573, DOI 10.1111/j.1755-148X.2012.01025.x; Bedford L, 2005, DEV BIOL, V280, P386, DOI 10.1016/j.ydbio.2005.02.001; Bellido M, 2003, HAEMATOLOGICA, V88, P994; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Carey JPW, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-173; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Cartier L, 2006, J NEUROBIOL, V66, P421, DOI 10.1002/neu.20225; Chen SS, 2011, BLOOD, V117, P862, DOI 10.1182/blood-2010-05-284638; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Coradini D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/254085; Dell'Orso S, 2010, ONCOTARGET, V1, P48, DOI 10.18632/oncotarget.108; DiVito KA, 2014, CARCINOGENESIS, V35, P951, DOI 10.1093/carcin/bgt479; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Feder-Mengus C, 2007, BRIT J CANCER, V96, P1072, DOI 10.1038/sj.bjc.6603664; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Ghislin S, 2012, MELANOMA RES, V22, P184, DOI 10.1097/CMR.0b013e328351e7c4; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; Gilbertson RJ, 2012, NATURE, V488, P462, DOI 10.1038/nature11480; Girouard SD, 2011, LAB INVEST, V91, P647, DOI 10.1038/labinvest.2011.50; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Guo SJ, 2011, MOL BIOL REP, V38, P4637, DOI 10.1007/s11033-010-0597-x; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hamid O, 2013, N ENGL J MED; HERLYN D, 1990, CANCER RES, V50, P2296; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Iyengar B, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-87; Jeon HM, 2008, GENE DEV, V22, P2028, DOI 10.1101/gad.1668708; Jeon HM, 2011, CANCER RES, V71, P3410, DOI 10.1158/0008-5472.CAN-10-3340; JUHASZ I, 1993, AM J PATHOL, V143, P528; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Koledova Z, 2010, STEM CELLS DEV, V19, P1663, DOI 10.1089/scd.2010.0136; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kulesa PM, 2013, CELLS TISSUES ORGANS, V198, P12, DOI 10.1159/000348418; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Kuzontkoski PM, 2010, ONCOGENE, V29, P3793, DOI 10.1038/onc.2010.147; La Porta CAM, 2013, CANCER LETT, V338, P69, DOI 10.1016/j.canlet.2012.03.017; Laga AC, 2011, EXP DERMATOL, V20, P339, DOI 10.1111/j.1600-0625.2011.01247.x; Laga AC, 2010, ARCH PATHOL LAB MED, V134, P1750, DOI 10.1043/2009-0394-RAR.1; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Lee N, 2014, LAB INVEST, V94, P13, DOI 10.1038/labinvest.2013.116; Li YQ, 2012, CANCER RES, V72, P576, DOI 10.1158/0008-5472.CAN-11-3070; Liang Y, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-6; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Martini M, 2013, CANCER-AM CANCER SOC, V119, P1004, DOI 10.1002/cncr.27821; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Mothe AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027079; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Ramgolam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018784; Ren Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003778; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Schatton T, 2010, J INVEST DERMATOL, V130, P1769, DOI 10.1038/jid.2010.135; Seftor EA, 2014, SEMIN ONCOL, V41, P259, DOI 10.1053/j.seminoncol.2014.02.001; Shakhova O, 2013, CANCER LETT, V338, P74, DOI 10.1016/j.canlet.2012.10.009; Shan L, 2003, AM J PATHOL, V163, P2495, DOI 10.1016/S0002-9440(10)63604-8; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Sztiller-Sikorska M, 2012, MELANOMA RES, V22, P215, DOI 10.1097/CMR.0b013e3283531317; Thurber AE, 2011, ONCOGENE, V30, P3036, DOI 10.1038/onc.2011.33; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Wen YH, 2012, BREAST CANCER RES TR, V135, P93, DOI 10.1007/s10549-012-2070-0; Woolard K, 2009, CELL STEM CELL, V4, P466, DOI 10.1016/j.stem.2009.05.013; Yuen HF, 2006, MODERN PATHOL, V19, P931, DOI 10.1038/modpathol.3800602; Yun K, 2004, DEVELOPMENT, V131, P5441, DOI 10.1242/dev.01430; Zeng WF, 2010, J CANCER, V1, P1	82	7	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116839	10.1371/journal.pone.0116839	http://dx.doi.org/10.1371/journal.pone.0116839			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642713	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821200027
J	Hetterich, H; Jaber, A; Gehring, M; Curta, A; Bamberg, F; Filipovic, N; Rieber, J				Hetterich, Holger; Jaber, Ahmad; Gehring, Moritz; Curta, Adrian; Bamberg, Fabian; Filipovic, Nenad; Rieber, Johannes			Coronary Computed Tomography Angiography Based Assessment of Endothelial Shear Stress and Its Association with Atherosclerotic Plaque Distribution In-Vivo	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; APPROPRIATE USE CRITERIA; HISTOLOGICAL CLASSIFICATION; CARDIOVASCULAR ANGIOGRAPHY; INTRAVASCULAR ULTRASOUND; NUCLEAR CARDIOLOGY; VASCULAR-LESIONS; NATURAL-HISTORY; BLOOD-FLOW; TASK-FORCE	Purpose The relationship between low endothelial shear stress (ESS) and coronary atherosclerosis is well established. ESS assessment so far depended on invasive procedures. The aim of this study was to demonstrate the relationship between ESS and coronary atherosclerosis by using non-invasive coronary computed tomography angiography (CTA) for computational fluid dynamics (CFD) simulations. Methods A total number of 7 consecutive patients with suspected coronary artery disease who received CTA and invasive angiography with IVUS analysis were included in this study. CTA examinations were performed using a dual-source scanner. These datasets were used to build a 3D mesh model. CFD calculations were performed using a validated CFD solver. The presence of plaque was assumed if the thickness of the intima-media complex exceeded 0.3 mm in IVUS. Plaque composition was derived by IVUS radiofrequency data analysis. Results Plaque was present in 32.1% of all analyzed cross-sections. Plaque prevalence was highest in areas of low ESS (49.6%) and high ESS (34.8%). In parts exposed to intermediate-low and intermediate-high ESS few plaques were found (20.0% and 24.0%) (p<0.001). Wall thickness was closely associated with local ESS. Intima-media thickness was 0.43 +/- 0.34mm in low and 0.38 +/- 0.32mm in high ESS segments. It was significantly lower when the arterial wall was exposed to intermediate ESS (0.25 +/- 0.18mm and 0.28 +/- 0.20mm) (p<0.001). Fibrofatty tissue was predominately found in areas exposed to low ESS (p <= 0.023). Conclusions In this study a close association of atherosclerotic plaque distribution and ESS pattern could be demonstrated in-vivo. Adding CFD analysis to coronary CTA offers the possibility to gather morphologic and physiologic data within one non-invasive examination.	[Hetterich, Holger; Bamberg, Fabian] Univ Munich, Inst Clin Radiol, Munich, Germany; [Jaber, Ahmad; Gehring, Moritz; Curta, Adrian] Univ Munich, Dept Cardiol, Munich, Germany; [Filipovic, Nenad] Univ Kragujevac, Fac Mech Engn, Kragujevac, Serbia; [Rieber, Johannes] Heart Ctr Munich Bogenhausen, Dept Cardiol & Intens Care Med, Munich, Germany	University of Munich; University of Munich; University of Kragujevac; German Heart Centre Munich	Hetterich, H (corresponding author), Univ Munich, Inst Clin Radiol, Munich, Germany.	Holger.Hetterich@med.uni-muenchen.de	Filipovic, Nenad/GSN-0499-2022		Siemens AG, Healthcare Sector; Friedrich Baur Foundation	Siemens AG, Healthcare Sector; Friedrich Baur Foundation	The study was supported by the Siemens AG, Healthcare Sector and the Friedrich Baur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caro CG, 2009, ARTERIOSCL THROM VAS, V29, P158, DOI 10.1161/ATVBAHA.108.166736; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Chatzizisis YS, 2007, CURR OPIN CARDIOL, V22, P552, DOI 10.1097/HCO.0b013e3282f07548; Cheng C, 2005, BLOOD, V106, P3691, DOI 10.1182/blood-2005-06-2326; Cheng C, 2007, J CLIN INVEST, V117, P616, DOI 10.1172/JCI28180; Frangos SG, 1999, ARCH SURG-CHICAGO, V134, P1142, DOI 10.1001/archsurg.134.10.1142; Frauenfelder T, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-35; Frauenfelder T, 2007, EUR RADIOL, V17, P1291, DOI 10.1007/s00330-006-0465-1; Gambillara V, 2006, AM J PHYSIOL-HEART C, V290, pH2320, DOI 10.1152/ajpheart.00486.2005; Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29; Gimbrone MA, 1999, THROMB HAEMOSTASIS, V82, P722; Goubergrits L, 2008, INT J CARDIOVAS IMAG, V24, P411, DOI 10.1007/s10554-007-9275-z; Goubergrits L, 2009, ANN BIOMED ENG, V37, P682, DOI 10.1007/s10439-009-9656-7; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Katranas SA, 2014, ANGIOLOGY, V65, P413, DOI 10.1177/0003319713483543; Krams R, 1997, ARTERIOSCL THROM VAS, V17, P2061, DOI 10.1161/01.ATV.17.10.2061; Leber AW, 2006, J AM COLL CARDIOL, V47, P672, DOI 10.1016/j.jacc.2005.10.058; Liu Y, 2002, ARTERIOSCL THROM VAS, V22, P76, DOI 10.1161/hq0102.101822; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; NISSEN SE, 1991, CIRCULATION, V84, P1087, DOI 10.1161/01.CIR.84.3.1087; Politis AK, 2007, J BIOMECH, V40, P1125, DOI 10.1016/j.jbiomech.2006.05.008; Santamarina A, 1998, ANN BIOMED ENG, V26, P944, DOI 10.1114/1.113; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Stone PH, 2007, EUR HEART J, V28, P705, DOI 10.1093/eurheartj/ehl575; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD; Taylor AJ, 2010, CIRCULATION, V122, pE525, DOI 10.1161/CIR.0b013e3181fcae66; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; Wellnhofer E, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-39; Wentzel JJ, 2003, CIRCULATION, V108, P17, DOI 10.1161/01.CIR.0000078637.21322.D3; Ziegler T, 1998, ARTERIOSCL THROM VAS, V18, P686, DOI 10.1161/01.ATV.18.5.686	35	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115408	10.1371/journal.pone.0115408	http://dx.doi.org/10.1371/journal.pone.0115408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635397	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700010
J	Xiao, LQ; Moller, M				Xiao, Long-Qian; Moeller, Michael			Nuclear Ribosomal ITS Functional Paralogs Resolve the Phylogenetic Relationships of a Late-Miocene Radiation Cycad Cycas (Cycadaceae)	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; SPECIES TREE; EVOLUTION; GENE; INFERENCE; DNA; PSEUDOGENES; SYSTEMATICS; LIKELIHOOD; MORPHOLOGY	Cycas is the most widespread and diverse genus among the ancient cycads, but the extant species could be the product of late Miocene rapid radiations. Taxonomic treatments to date for this genus are quite controversial, which makes it difficult to elucidate its evolutionary history. We cloned 161 genomic ITS sequences from 31 species representing all sections of Cycas. The divergent ITS paralogs were examined within each species and identified as putative pseudogenes, recombinants and functional paralogs. Functional paralogs were used to reconstruct phylogenetic relationships with pseudogene sequences as molecular outgroups, since an unambiguous ITS sequence alignment with their closest relatives, the Zamiaceae, is unachievable. A fully resolved and highly supported tree topology was obtained at the section level, with two major clades including six minor clades. The results fully supported the classification scheme proposed by Hill (2004) at the section level, with the minor clades representing his six sections. The two major clades could be recognised as two subgenera. The obtained pattern of phylogenetic relationships, combined with the different seed dispersal capabilities and paleogeography, allowed us to propose a late Miocene rapid radiation of Cycas that might have been promoted by vicariant events associated with the complex topography and orogeny of South China and adjacent regions. In contrast, transoceanic dispersals might have played an important role in the rapid diversification of sect. Cycas, whose members have evolved a spongy layer in their seeds aiding water dispersals.	[Xiao, Long-Qian] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Moeller, Michael] Royal Bot Garden Edinburgh, Div Sci, Edinburgh, Scotland	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Xiao, LQ (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	xlq@xtbg.ac.cn	Moeller, Michael/O-9748-2015	Moeller, Michael/0000-0002-2819-0323	National Natural Science Foundation of China [31070209]; Yunnan Province Natural Science Foundation [0755051K01]; Rural and Environment Science and Analytical Services division in the Scottish Government	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province Natural Science Foundation(Natural Science Foundation of Yunnan Province); Rural and Environment Science and Analytical Services division in the Scottish Government	This work was supported by National Natural Science Foundation of China [grant number 31070209], the Yunnan Province Natural Science Foundation [grant number 0755051K01], and the Rural and Environment Science and Analytical Services division in the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Amaral AR, 2012, MOL PHYLOGENET EVOL, V64, P243, DOI 10.1016/j.ympev.2012.04.004; [Anonymous], 1943, INTRO HIST PLANT GEO; [Anonymous], [No title captured]; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bogler DJ, 2004, BOT REV, V70, P260, DOI 10.1663/0006-8101(2004)070[0260:MSSICE]2.0.CO;2; Brenner ED, 2003, TRENDS PLANT SCI, V8, P446, DOI 10.1016/S1360-1385(03)00190-0; Buckler ES, 1997, GENETICS, V145, P821; Buckler ES, 1996, MOL BIOL EVOL, V13, P612, DOI 10.1093/oxfordjournals.molbev.a025621; Chamberlain C.J, 1919, THE LIVING CYCADS; Chaw SM, 2005, MOL PHYLOGENET EVOL, V37, P214, DOI 10.1016/j.ympev.2005.01.006; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Chiang TY, 2006, TAXON, V55, P31, DOI 10.2307/25065526; COLLINSON ME, 1981, NATURE, V291, P315, DOI 10.1038/291315a0; Crisp MD, 2011, NEW PHYTOL, V192, P997, DOI 10.1111/j.1469-8137.2011.03862.x; De Laubenfels DJ, 1998, BLUMEA, V43, P351; DEHGAN B, 1983, BOT GAZ, V144, P412, DOI 10.1086/337391; Doyle J., 1991, MOL TECHNIQUES TAXON; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Golonka J, 2006, GEOLINES, V20, P40; Graham SW, 2002, MOL BIOL EVOL, V19, P1769, DOI 10.1093/oxfordjournals.molbev.a003999; Griffith MP, 2014, INT J PLANT SCI, V175, P241, DOI 10.1086/673884; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Harris DJ, 2003, NORD J BOT, V23, P725, DOI 10.1111/j.1756-1051.2003.tb00451.x; He X.-J., 2014, RASP RECONSTRUCT ANC; Hermsen EJ, 2009, REV PALAEOBOT PALYNO, V153, P108, DOI 10.1016/j.revpalbo.2008.07.005; Hill K. D., 1996, Telopea, V7, P1; Hill K. D., 1996, P267; Hill KD, 2004, CYCAD CLASSIFICATION: CONCEPTS AND RECOMMENDATIONS, P23, DOI 10.1079/9780851997414.0023; Hill KD, 1995, P 3 INT C CYC BIOL, P139; HOLLOWAY NH, 1982, AAPG BULL, V66, P1355; Jobes DV, 1997, PLANT MOL BIOL REP, V15, P326, DOI 10.1023/A:1007462330699; Jones D.L., 1993, CYCADS OF THE WORLD; Keppel G, 2008, J BIOGEOGR, V35, P1004, DOI 10.1111/j.1365-2699.2007.01869.x; Leloup PH, 1995, TECTONOPHYSICS, V251, P3, DOI 10.1016/0040-1951(95)00070-4; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Li XW, 1997, ANN MO BOT GARD, V84, P888, DOI 10.2307/2992033; Liu YS, 1991, CHINESE SCI BULL, V22, P1758; LOCONTE H, 1990, BRITTONIA, V42, P197, DOI 10.2307/2807216; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; MCDADE LA, 1992, EVOLUTION, V46, P1329, DOI 10.1111/j.1558-5646.1992.tb01127.x; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Nagalingum NS, 2011, SCIENCE, V334, P796, DOI 10.1126/science.1209926; NORSTOG K, 1997, BIOL CYCADS; Nylander JAA., 2004, MRMODELTEST 2 2; Ochieng JW, 2007, MOL PHYLOGENET EVOL, V44, P752, DOI 10.1016/j.ympev.2007.04.017; OSBORNE R, 1995, BIOL CONSERV, V71, P1, DOI 10.1016/0006-3207(95)91086-D; Osborne R., 2012, Proceedings of Cycad 2008. The 8th International Conference on Cycad Biology, Panama City, Panama, 13-15 January 2008, P480; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Petrov DA, 2000, J HERED, V91, P221, DOI 10.1093/jhered/91.3.221; Rai HS, 2003, MOL PHYLOGENET EVOL, V29, P350, DOI 10.1016/S1055-7903(03)00131-3; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salas-Leiva DE, 2013, ANN BOT-LONDON, V112, P1263, DOI 10.1093/aob/mct192; Sangin P., 2010, Kasetsart Journal, Natural Sciences, V44, P544; Schiele J. H., 2003, RECONCILIATION VIOLE, piii; Schneider D, 2002, NATURWISSENSCHAFTEN, V89, P281, DOI 10.1007/s00114-002-0330-2; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Smitinand T, 1971, NATURAL HIST B SIAM, V24, P163; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEVENSON DW, 1990, MEMOIRS NEW YORK BOT, V57, P8, DOI DOI 10.21135/893273507.003; Tanaka, 1954, SPECIES PROBLEM CITR; Treutlein J, 2002, NATURWISSENSCHAFTEN, V89, P221, DOI 10.1007/s00114-002-0308-0; Wang DY, 2000, THESIS NANJING FORES; Wang WK, 2007, MOL PHYLOGENET EVOL, V44, P503, DOI 10.1016/j.ympev.2007.05.006; Wei XX, 2004, MOL ECOL, V13, P3115, DOI 10.1111/j.1365-294X.2004.02299.x; Wolfe J. A., 1997, EVOLUTION DIVERSIFIC, P269, DOI [10.1007/978-4-431-65918-1_13, DOI 10.1007/978-4-431-65918-1_13]; Xiao LQ, 2010, MOL PHYLOGENET EVOL, V55, P168, DOI 10.1016/j.ympev.2009.11.020; Yang SL, 1996, INT J PLANT SCI, V157, P468, DOI 10.1086/297364; Zheng XY, 2008, MOL PHYLOGENET EVOL, V48, P892, DOI 10.1016/j.ympev.2008.05.039	70	24	26	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117971	10.1371/journal.pone.0117971	http://dx.doi.org/10.1371/journal.pone.0117971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635842	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700110
J	Celin, AR; Rapacioli, M; Gonzalez, MA; Ballarin, VL; de Plazas, SF; Lopez-Costa, JJ; Flores, V				Rodriguez Celin, Alejandra; Rapacioli, Melina; Azul Gonzalez, Mariela; Laura Ballarin, Virginia; Fiszer de Plazas, Sara; Jose Lopez-Costa, Juan; Flores, Vladimir			Temporal-Spatial Correlation between Angiogenesis and Corticogenesis in the Developing Chick Optic Tectum	PLOS ONE			English	Article							SPATIOTEMPORAL GRADIENT; DIFFERENTIATION; BRAIN; MICROVESSELS; EXPRESSION; INTEGRITY; ORIGINS; PATTERN	The developing chick optic tectum is a widely used model of corticogenesis and angiogenesis. Cell behaviors involved in corticogenesis and angiogenesis share several regulatory mechanisms. In this way the 3D organizations of both systems adapt to each other. The consensus about the temporally and spatially organized progression of the optic tectum corticogenesis contrasts with the discrepancies about the spatial organization of its vascular bed as a function of the time. In order to find out spatial and temporal correlations between corticogenesis and angiogenesis, several methodological approaches were applied to analyze the dynamic of angiogenesis in the developing chick optic tectum. The present paper shows that a typical sequence of developmental events characterizes the optic tectum angiogenesis. The first phase, formation of the primitive vascular bed, takes place during the early stages of the tectal corticogenesis along which the large efferent neurons appear and begin their early differentiation. The second phase, remodeling and elaboration of the definitive vascular bed, occurs during the increase in complexity associated to the elaboration of the local circuit networks. The present results show that, apart from the well-known influence of the dorsal-ventral and radial axes as reference systems for the spatial organization of optic tectum angiogenesis, the cephalic-caudal axis also exerts a significant asymmetric influence. The term cortico-angiogenesis to describe the entire process is justified by the fact that tight correlations are found between specific corticogenic and angiogenic events and they take place simultaneously at the same position along the cephalic-caudal and radial axes.	[Rodriguez Celin, Alejandra; Rapacioli, Melina; Flores, Vladimir] Favaloro Univ, Interdisciplinary Grp Theoret Biol, Dept Biostruct Sci, Buenos Aires, DF, Argentina; [Fiszer de Plazas, Sara; Jose Lopez-Costa, Juan; Flores, Vladimir] Buenos Aires Univ CONICET, Inst Cell Biol & Neurosci Prof E De Robertis, Buenos Aires, DF, Argentina; [Azul Gonzalez, Mariela; Laura Ballarin, Virginia] Natl Univ Mar del Plata, Sch Engn, Digital Image Proc Grp, Mar Del Plata, Buenos Aires, Argentina	National University of Mar del Plata	Flores, V (corresponding author), Favaloro Univ, Interdisciplinary Grp Theoret Biol, Dept Biostruct Sci, Buenos Aires, DF, Argentina.	vflores@favaloro.edu.ar	Laura, Virginia/AAC-7511-2019	Laura, Virginia/0000-0002-5648-6463	National Council of Research CONICET [PIP0412]	National Council of Research CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding for the study was provided by National Council of Research CONICET PIP0412. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautch VL, 2009, CELL ADHES MIGR, V3, P199, DOI 10.4161/cam.3.2.8397; Bertossi M, 2002, ANAT EMBRYOL, V205, P229, DOI 10.1007/s00429-002-0245-x; Bertossi M., 1992, Biological Structures and Morphogenesis, V4, P144; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433, DOI DOI 10.1201/9781482277234-12; Eichmann A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006551; FEENEY JF, 1946, J MORPHOL, V78, P231, DOI 10.1002/jmor.1050780205; Firka D., 2004, WSEAS Transactions on Biology and Biomedicine, V1, P24; Galileo DS, 2003, GLIA, V41, P25, DOI 10.1002/glia.10163; Gonzalez MA, 2011, J PHYS CONF SER, V332, DOI 10.1088/1742-6596/332/1/012031; Gonzalez MA, 2007, J COMPUT SCI TECHNOL, V7, P243; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Han HS, 2005, CURR NEUROVASC RES, V2, P409, DOI 10.2174/156720205774962647; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; ITASAKI N, 1991, DEVELOPMENT, V113, P1133; Kim DW, 2006, BRAIN RES, V1076, P16, DOI 10.1016/j.brainres.2006.01.010; LAVAIL JH, 1971, BRAIN RES, V28, P421; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; Lever M, 2014, BRAIN STRUCT FUNCT, V219, P1009, DOI 10.1007/s00429-013-0550-6; Lindhorst T, 2012, HISTOCHEM CELL BIOL, V137, P629, DOI 10.1007/s00418-012-0912-9; Luksch H, 2003, REV NEUROSCIENCE, V14, P85; Mancuso Michael R., 2008, Lymphatic Research and Biology, V6, P173, DOI 10.1089/lrb.2008.1014; MATSUNO T, 1991, DEV BRAIN RES, V58, P265, DOI 10.1016/0165-3806(91)90014-A; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; Mey J, 2000, BRAIN RES REV, V32, P343, DOI 10.1016/S0165-0173(99)00022-3; Rapacioli M, 2011, J MORPHOL, V272, P675, DOI 10.1002/jmor.10943; RONCALI L, 1985, ACTA ANAT, V122, P229; RONCALI L, 1983, Bollettino Societa Italiana Biologia Sperimentale, V59, P765; RONCALI L, 1985, J SUBMICR CYTOL PATH, V17, P83; Ruhrberg C, 2013, CELL MOL LIFE SCI, V70, P1675, DOI 10.1007/s00018-013-1277-5; Scicolone G, 2006, J COMP NEUROL, V494, P1007, DOI 10.1002/cne.20878; Scicolone G, 1995, INT J DEV NEUROSCI, V13, P845, DOI 10.1016/0736-5748(95)00069-0; Seo JH, 2008, NEUROCHEM RES, V33, P1346, DOI 10.1007/s11064-008-9590-3; Stubbs D, 2009, CEREB CORTEX, V19, pI32, DOI 10.1093/cercor/bhp040; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Vates GE, 2005, J NEUROSURG, V103, P136, DOI 10.3171/jns.2005.103.1.0136; Yasuda Y, 2003, CELL TISSUE RES, V314, P315, DOI 10.1007/s00441-003-0796-z	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116343	10.1371/journal.pone.0116343	http://dx.doi.org/10.1371/journal.pone.0116343			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633659	gold, Green Submitted, Green Published			2022-12-26	WOS:000348609800008
J	Mang, GM; Pradervand, S; Du, NH; Arpat, AB; Preitner, F; Wigger, L; Gatfield, D; Franken, P				Mang, Geraldine M.; Pradervand, Sylvain; Ngoc-Hien Du; Arpat, Alaaddin Bulak; Preitner, Frederic; Wigger, Leonore; Gatfield, David; Franken, Paul			A Neuron-Specific Deletion of the MicroRNA-Processing Enzyme DICER Induces Severe but Transient Obesity in Mice	PLOS ONE			English	Article							OVER-EXPRESSION; LEPTIN; MORPHOGENESIS; DEFICIENCY; METABOLISM; ACTIVATION; DISRUPTS; CORTEX	MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression post-transcriptionally. MiRNAs are implicated in various biological processes associated with obesity, including adipocyte differentiation and lipid metabolism. We used a neuronal-specific inhibition of miRNA maturation in adult mice to study the consequences of miRNA loss on obesity development. Camk2a-CreERT2 (Cre(+)) and floxed Dicer (Dicer(lox/lox)) mice were crossed to generate tamoxifen-inducible conditional Dicer knockouts (cKO). Vehicle- and/or tamoxifen-injected Cre(+); Dicer(lox/lox) and Cre(+); Dicer(+/+) served as controls. Four cohorts were used to a) measure body composition, b) follow food intake and body weight dynamics, c) evaluate basal metabolism and effects of food deprivation, and d) assess the brain transcriptome consequences of miRNA loss. cKO mice developed severe obesity and gained 18 g extra weight over the 5 weeks following tamoxifen injection, mainly due to increased fat mass. This phenotype was highly reproducible and observed in all 38 cKO mice recorded and in none of the controls, excluding possible effects of tamoxifen or the non-induced transgene. Development of obesity was concomitant with hyperphagia, increased food efficiency, and decreased activity. Surprisingly, after reaching maximum body weight, obese cKO mice spontaneously started losing weight as rapidly as it was gained. Weight loss was accompanied by lowered O-2-consumption and respiratory-exchange ratio. Brain transcriptome analyses in obese mice identified several obesity-related pathways (e.g. leptin, somatostatin, and nemo-like kinase signaling), as well as genes involved in feeding and appetite (e.g. Pmch, Neurotensin) and in metabolism (e.g. Bmp4, Bmp7, Ptger1, Cox7a1). A gene cluster with anti-correlated expression in the cerebral cortex of post-obese compared to obese mice was enriched for synaptic plasticity pathways. While other studies have identified a role for miRNAs in obesity, we here present a unique model that allows for the study of processes involved in reversing obesity. Moreover, our study identified the cortex as a brain area important for body weight homeostasis.	[Mang, Geraldine M.; Ngoc-Hien Du; Arpat, Alaaddin Bulak; Gatfield, David; Franken, Paul] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Preitner, Frederic] Univ Lausanne, Ctr Integrat Genom, Mouse Metab Evaluat Facil, Lausanne, Switzerland; [Pradervand, Sylvain; Wigger, Leonore] Univ Lausanne, Ctr Integrat Genom, Genom Technol Facil, Lausanne, Switzerland; [Pradervand, Sylvain; Arpat, Alaaddin Bulak; Wigger, Leonore] SIB Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne; Swiss Institute of Bioinformatics	Franken, P (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	paul.franken@unil.ch	Gatfield, David/C-2354-2011; Du, Ngoc-Hien/AAX-5215-2020; Franken, Paul/A-9633-2018; Arpat, Alaaddin Bulak/C-1336-2008	Gatfield, David/0000-0001-5114-2824; Franken, Paul/0000-0002-2500-2921; Arpat, Alaaddin Bulak/0000-0002-7749-3793	Swiss National Science Foundation (SNF) [130825, 136201, PP00P3 128399]; state of Vaud; Fondation Leenaards; Fondation Pierre Mercier; UNIL International PhD Program	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); state of Vaud; Fondation Leenaards; Fondation Pierre Mercier; UNIL International PhD Program	This study was supported by the Swiss National Science Foundation (SNF no 130825 and 136201 to PF; SNF professorship grant PP00P3 128399 to DG), the state of Vaud supporting GMM and PF, the Fondation Leenaards (DG) and the Fondation Pierre Mercier (DG). NHD received a fellowship from the UNIL International PhD Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2013, TRENDS CELL BIOL, V23, P30, DOI 10.1016/j.tcb.2012.08.013; BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breslow MJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE443, DOI 10.1152/ajpendo.1999.276.3.E443; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Crepin D, 2014, MOL CELL ENDOCRINOL, V384, P1, DOI 10.1016/j.mce.2013.12.016; Davidson TL, 2009, HIPPOCAMPUS, V19, P235, DOI 10.1002/hipo.20499; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dhar M, 2014, MOL ENDOCRINOL, V28, P1073, DOI 10.1210/me.2013-1332; Dorval V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044060; Elsen M, 2014, AM J PHYSIOL-CELL PH, V306, pC431, DOI 10.1152/ajpcell.00290.2013; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Greenman Y, 2013, MOL ENDOCRINOL, V27, P1091, DOI 10.1210/me.2012-1344; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Krill KT, 2013, MOL ENDOCRINOL, V27, P754, DOI 10.1210/me.2012-1331; Land BB, 2014, NAT NEUROSCI, V17, P248, DOI 10.1038/nn.3625; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu J, 2013, J MOL ENDOCRINOL, V50, P103, DOI 10.1530/JME-12-0099; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Ma XQ, 2014, MOL CELL BIOL, V34, P3607, DOI 10.1128/MCB.00583-14; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Metzger Daniel, 2011, Curr Protoc Mouse Biol, V1, P55, DOI 10.1002/9780470942390.mo100128; Mul JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019600; Du NH, 2014, ELIFE, V3, DOI 10.7554/eLife.02510; O'Carroll D, 2013, NEUROPSYCHOPHARMACOL, V38, P39, DOI 10.1038/npp.2012.87; Ohira K, 2013, NEUROPSYCHOPHARMACOL, V38, P909, DOI 10.1038/npp.2013.2; Opland D, 2013, MOL METAB, V2, P423, DOI 10.1016/j.molmet.2013.07.008; Parker JA, 2012, NEUROPHARMACOLOGY, V63, P18, DOI 10.1016/j.neuropharm.2012.02.004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pei YF, 2014, HUM MOL GENET, V23, P820, DOI 10.1093/hmg/ddt464; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Quennell JH, 2011, ENDOCRINOLOGY, V152, P1541, DOI 10.1210/en.2010-1100; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schneeberger M, 2013, MOL METAB, V2, P74, DOI 10.1016/j.molmet.2012.10.001; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sousa-Ferreira L, 2014, TRENDS ENDOCRIN MET, V25, P80, DOI 10.1016/j.tem.2013.10.005; Stengel Andreas, 2012, Front Endocrinol (Lausanne), V3, P178, DOI 10.3389/fendo.2012.00178; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Vinnikov IA, 2014, J NEUROSCI, V34, P10659, DOI 10.1523/JNEUROSCI.4251-13.2014; Williams MD, 2012, EXP DIABETES RES, DOI 10.1155/2012/484696; Yang ZG, 2007, ANN NEUROL, V61, P199, DOI 10.1002/ana.21068	49	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0116760	10.1371/journal.pone.0116760	http://dx.doi.org/10.1371/journal.pone.0116760			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629159	Green Published, gold, Green Submitted			2022-12-26	WOS:000348732100049
J	Chen, J; Lan, T; Zhang, W; Dong, L; Kang, N; Zhang, S; Fu, M; Liu, B; Liu, K; Zhang, C; Hou, J; Zhan, Q				Chen, J.; Lan, T.; Zhang, W.; Dong, L.; Kang, N.; Zhang, S.; Fu, M.; Liu, B.; Liu, K.; Zhang, C.; Hou, J.; Zhan, Q.			Platelet-activating factor receptor-mediated PI3K/AKT activation contributes to the malignant development of esophageal squamous cell carcinoma	ONCOGENE			English	Article							FOCAL ADHESION KINASE; GROWTH-FACTOR-RECEPTOR; PROTEIN-COUPLED RECEPTORS; BREAST-CANCER CELLS; VEIN ENDOTHELIAL-CELLS; FACTOR PAF; PHOSPHATIDYLINOSITOL 3-KINASE; SPHINGOSINE 1-PHOSPHATE; LYSOPHOSPHATIDIC ACID; OPIOID RECEPTORS	Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies worldwide and occurs at a relatively high frequency in China, yet the mechanisms underlying its devastating outcome remain unclear. Here we report that platelet-activating factor receptor (PAFR), a type of G-protein-coupled receptor, was upregulated in ESCC tumors and cell lines, compared with controls; PAFR levels were positively correlated with ESCC clinical stages and survival time. Overexpression of PAFR promoted the malignant development of ESCC in vitro and in vivo, whereas depletion of PAFR suppressed these effects. Interestingly, PAFR was observed to activate PI3K/AKT (phosphatidylinositol 3-kinase/AKT) through the upregulation of FAK kinase activity. AKT-triggered nuclear factor-kappa B transcriptionally activated PAFR expression. This mutual positive regulation between PAFR and AKT was required for the aggressiveness of ESCC cells both in vitro and in vivo. Furthermore, treating mice bearing ESCC tumors with cholesterolconjugated PAFR small interfering RNA effectively inhibited tumor progression and the expression of AKT-mediated oncogenic proteins. Taken together, we made the first demonstration that dysregulation of PAFR and the positive regulatory loop between PAFR and pAKT contribute to malignant progression of ESCC.	[Chen, J.; Lan, T.; Zhang, W.; Dong, L.; Kang, N.; Zhang, S.; Fu, M.; Zhan, Q.] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China; [Chen, J.; Lan, T.; Zhang, W.; Dong, L.; Kang, N.; Zhang, S.; Fu, M.; Zhan, Q.] Peking Union Med Coll, Beijing 100021, Peoples R China; [Lan, T.] Capital Med Univ, Dept Neurosurg, Beijing Sanbo Brain Hosp, Beijing, Peoples R China; [Liu, B.] Guangdong Pharmaceut Univ, Dept Pharmacol, Sch Pharm, Guangzhou, Guangdong, Peoples R China; [Liu, K.] Tsinghua Univ, Natl Key Lab Med Mol Biol, Inst Basic Med Sci, Peking Union Med Coll, Beijing 100084, Peoples R China; [Liu, K.] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Zhang, C.; Hou, J.] China Acad Chinese Med Sci, Xiyuan Hosp, Inst Basic Med Sci, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Guangdong Pharmaceutical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS	Zhan, Q (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China.	zhanqimin@pumc.edu.cn	Lan, Ting/GWV-2392-2022		National 973 Program [2015CB553904]; National Natural Fund of China [81021061, 81230047]; China Postdoctoral Science Foundation [2013M530555]	National 973 Program(National Basic Research Program of China); National Natural Fund of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The ESCC cell lines (KYSE180, KYSE140, KYSE150, KYSE30, KYSE410, KYSE450 and KYSE510) were generously provided by Dr Shemada of Kyoto University. This work is supported by the National 973 Program (2015CB553904), National Natural Fund of China (81021061 and 81230047) and China Postdoctoral Science Foundation (2013M530555).	Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; Asanuma H, 2005, CANCER RES, V65, P11018, DOI 10.1158/0008-5472.CAN-05-0491; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Cellai C, 2006, BRIT J CANCER, V94, P1637, DOI 10.1038/sj.bjc.6603156; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Chen J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.312; Chen ML, 2012, CANCER EPIDEM BIOMAR, V21, P1126, DOI 10.1158/1055-9965.EPI-12-0020; Denizot Y, 2001, LUNG CANCER-J IASLC, V33, P195, DOI 10.1016/S0169-5002(01)00197-0; Deo DD, 2004, J BIOL CHEM, V279, P3497, DOI 10.1074/jbc.M304497200; Deo DD, 2002, J BIOL CHEM, V277, P21237, DOI 10.1074/jbc.M110955200; Ding YZ, 2003, CLIN CANCER RES, V9, P3406; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dulinska-Litewka J, 2013, CURR MED CHEM, V20, P144; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Feng GJ, 2003, J BIOL CHEM, V278, P33400, DOI 10.1074/jbc.M305866200; Gibbs TC, 2009, PROSTATE, V69, P1493, DOI 10.1002/pros.20994; Haribabu B, 1999, J BIOL CHEM, V274, P37087, DOI 10.1074/jbc.274.52.37087; HEON SK, 2006, CANCER RES, V66, P4681; Hu H, 2013, CANCER CELL, V22, P781; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kato M, 2002, J IMMUNOL, V169, P5252, DOI 10.4049/jimmunol.169.9.5252; Keane MP, 2004, J IMMUNOL, V172, P2853, DOI 10.4049/jimmunol.172.5.2853; Kim Won Ho, 1993, Yonsei Medical Journal, V34, P45; Lango MN, 2002, J NATL CANCER I, V94, P375; Lee Z, 2006, CANCER RES, V66, P2740, DOI 10.1158/0008-5472.CAN-05-2947; Li JX, 2004, CANCER RES, V64, P94, DOI 10.1158/0008-5472.CAN-03-0737; Li Y, 2009, DIS ESOPHAGUS, V22, P664, DOI 10.1111/j.1442-2050.2008.00928.x; Liu X, 2008, J PHARMACOL EXP THER, V326, P69, DOI 10.1124/jpet.107.134528; Marques SA, 2002, J PHARMACOL EXP THER, V300, P1026, DOI 10.1124/jpet.300.3.1026; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MUTOH H, 1994, BIOCHEM BIOPH RES CO, V205, P1137, DOI 10.1006/bbrc.1994.2784; Quint P, 2013, J BIOL CHEM, V288, P5398, DOI 10.1074/jbc.M112.413583; Rosato A, 2006, INT J CANCER, V119, P1717, DOI 10.1002/ijc.21923; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sahu RP, 2012, CARCINOGENESIS, V33, P694, DOI 10.1093/carcin/bgr322; Senga T, 2003, BLOOD, V101, P1185, DOI 10.1182/blood-2002-06-1881; SHINOZAKI K, 1994, LIFE SCI, V54, P429, DOI 10.1016/0024-3205(94)00701-2; Soldi R, 1996, ONCOGENE, V13, P515; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Sud N, 2006, CANCER LETT, V233, P265, DOI 10.1016/j.canlet.2005.03.018; Suzuki A, 2004, MOL CELL BIOL, V24, P3526, DOI 10.1128/MCB.24.8.3526-3535.2004; Tanigawa N, 1997, CANCER, V79, P220; vanBiesen T, 1996, J BIOL CHEM, V271, P1266, DOI 10.1074/jbc.271.3.1266; VENABLE ME, 1993, J LIPID RES, V34, P691; Walsh CT, 2008, MOL INTERV, V8, P165, DOI 10.1124/mi.8.4.8; Wang DX, 1999, J BIOL CHEM, V274, P22081, DOI 10.1074/jbc.274.31.22081; Zhou WL, 2007, AM J PHYSIOL-HEART C, V292, pH2773, DOI 10.1152/ajpheart.01018.2006	48	31	35	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 1	2015	34	40					5114	5127		10.1038/onc.2014.434	http://dx.doi.org/10.1038/onc.2014.434			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CS6ZP	25639872				2022-12-26	WOS:000362233400002
J	Vidal-Melgosa, S; Pedersen, HL; Schuckel, J; Arnal, G; Dumon, C; Amby, DB; Monrad, RN; Westereng, B; Willats, WGT				Vidal-Melgosa, Silvia; Pedersen, Henriette L.; Schuckel, Julia; Arnal, Gregory; Dumon, Claire; Amby, Daniel B.; Monrad, Rune Nygaard; Westereng, Bjorge; Willats, William G. T.			A New Versatile Microarray-based Method for High Throughput Screening of Carbohydrate-active Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; BINDING MODULES; CELL-WALLS; XYLOGLUCAN; EXPRESSION; HOMOGALACTURONAN; BIOSYNTHESIS; PROTEINS; LOCATION; EPITOPES	Carbohydrate-active enzymes have multiple biological roles and industrial applications. Advances in genome and transcriptome sequencing together with associated bioinformatics tools have identified vast numbers of putative carbohydrate-degrading and -modifying enzymes including glycoside hydrolases and lytic polysaccharide monooxygenases. However, there is a paucity of methods for rapidly screening the activities of these enzymes. By combining the multiplexing capacity of carbohydrate microarrays with the specificity of molecular probes, we have developed a sensitive, high throughput, and versatile semiquantitative enzyme screening technique that requires low amounts of enzyme and substrate. The method can be used to assess the activities of single enzymes, enzyme mixtures, and crude culture broths against single substrates, substrate mixtures, and biomass samples. Moreover, we show that the technique can be used to analyze both endo-acting and exo-acting glycoside hydrolases, polysaccharide lyases, carbohydrate esterases, and lytic polysaccharide monooxygenases. We demonstrate the potential of the technique by identifying the substrate specificities of purified uncharacterized enzymes and by screening enzyme activities from fungal culture broths.	[Vidal-Melgosa, Silvia; Pedersen, Henriette L.; Schuckel, Julia; Amby, Daniel B.; Westereng, Bjorge; Willats, William G. T.] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-1871 Frederiksberg, Denmark; [Arnal, Gregory; Dumon, Claire] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Arnal, Gregory; Dumon, Claire] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Arnal, Gregory; Dumon, Claire] CNRS, UMR5504, F-31400 Toulouse, France; [Monrad, Rune Nygaard] Novozymes AS, DK-2880 Bagsvaerd, Denmark; [Westereng, Bjorge] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	University of Copenhagen; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Novozymes; Norwegian University of Life Sciences	Willats, WGT (corresponding author), Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-1871 Frederiksberg, Denmark.	willats@plen.ku.dk	Westereng, Bjørge/A-1688-2013; amby, daniel/GQI-1580-2022; Schückel, Julia/AAH-3948-2019; Claire, Dumon/AAI-2553-2021; Schückel, Julia/F-7450-2014	Westereng, Bjørge/0000-0002-5141-7231; Claire, Dumon/0000-0003-4925-7336; Schückel, Julia/0000-0001-7402-8768; buchvaldt amby, daniel/0000-0003-1362-9193	European Community [238084]; WallTraC project [263916]; Novo Nordisk Fonden [NNF12OC0000771] Funding Source: researchfish	European Community(European Commission); WallTraC project; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by the European Community's Seventh Framework Program (FP7/2007-2013) under the LEANGREENFOOD project (Grant Agreement No. 238084).; Supported by the WallTraC project (Grant Agreement No. 263916).	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Albersheim P., 2011, PLANT CELL WALLS CHE, P37; Bastien G, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-78; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Biely P, 2013, BBA-GEN SUBJECTS, V1830, P5075, DOI 10.1016/j.bbagen.2013.07.018; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Coenen GJ, 2007, CARBOHYD POLYM, V70, P224, DOI 10.1016/j.carbpol.2007.04.007; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Frankova L, 2013, J EXP BOT, V64, P3519, DOI 10.1093/jxb/ert201; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Honda Y, 2004, J BIOL CHEM, V279, P55097, DOI 10.1074/jbc.M409832200; Irbe I, 2014, INT BIODETER BIODEGR, V86, P71, DOI 10.1016/j.ibiod.2013.06.027; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Jorgensen H, 2007, BIOFUEL BIOPROD BIOR, V1, P119, DOI 10.1002/bbb.4; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; KNOX JP, 1991, PLANT J, V1, P317, DOI 10.1046/j.1365-313X.1991.t01-9-00999.x; Lagaert S, 2007, APPL ENVIRON MICROB, V73, P5374, DOI 10.1128/AEM.00722-07; Lagaert S, 2011, APPL MICROBIOL BIOT, V92, P1179, DOI 10.1007/s00253-011-3396-y; LEVER M, 1973, BIOCHEM MED METAB B, V7, P274, DOI 10.1016/0006-2944(73)90083-5; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; MEIKLE PJ, 1994, PLANT J, V5, P1, DOI 10.1046/j.1365-313X.1994.5010001.x; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Pena MJ, 2012, METHOD ENZYMOL, V510, P121, DOI 10.1016/B978-0-12-415931-0.00007-0; PENNELL RI, 1991, PLANT CELL, V3, P1317, DOI 10.1105/tpc.3.12.1317; Peres NA, 2005, PLANT DIS, V89, P784, DOI 10.1094/PD-89-0784; Pettolino FA, 2001, PLANTA, V214, P235, DOI 10.1007/s004250100606; Prusky D, 2004, PHYTOPATHOLOGY, V94, P44, DOI 10.1094/PHYTO.2004.94.1.44; Ralet MC, 2010, PLANTA, V231, P1373, DOI 10.1007/s00425-010-1116-y; Ribeiro T, 2010, BBA-PROTEINS PROTEOM, V1804, P2054, DOI 10.1016/j.bbapap.2010.07.006; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Sorensen I, 2008, PLANT J, V54, P510, DOI 10.1111/j.1365-313X.2008.03453.x; Steele HL, 2009, J MOL MICROB BIOTECH, V16, P25, DOI 10.1159/000142892; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Vincentelli R, 2011, METHODS, V55, P65, DOI 10.1016/j.ymeth.2011.08.010; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Wan YF, 2014, PLANTA, V239, P1041, DOI 10.1007/s00425-014-2034-1; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2009, MOL NUTR FOOD RES, V53, P780, DOI 10.1002/mnfr.200800199; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066	59	39	39	2	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					9020	9036		10.1074/jbc.M114.630673	http://dx.doi.org/10.1074/jbc.M114.630673			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25657012	Green Published, hybrid			2022-12-26	WOS:000352207100027
J	Li, K; Zhang, J; Yu, JJ; Liu, B; Guo, YJ; Deng, JL; Chen, SH; Wang, CX; Guo, FF				Li, Kai; Zhang, Jin; Yu, Junjie; Liu, Bin; Guo, Yajie; Deng, Jiali; Chen, Shanghai; Wang, Chunxia; Guo, Feifan			MicroRNA-214 Suppresses Gluconeogenesis by Targeting Activating Transcriptional Factor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-FAT DIET; REGULATES GLUCOSE-METABOLISM; INDUCED HEPATIC STEATOSIS; PERFUSED-RAT-LIVER; PHOSPHOENOLPYRUVATE CARBOXYKINASE; DIABETES-MELLITUS; COACTIVATOR PGC-1; LIPID-METABOLISM; ACUTE EXERCISE; EXPRESSION	Although the gluconeogenesis pathway is already a target for the treatment of type 2 diabetes, the potential role of microRNAs (miRNAs) in gluconeogenesis remains unclear. Here, we investigated the physiological functions of miR-214 in gluconeogenesis. The expression of miR-214 was suppressed by glucagon via protein kinase A signaling in primary hepatocytes, and miR-214 was down-regulated in the livers of fasted, high fat diet-induced diabetic and leptin receptor-mutated (db/db) mice. The overexpression of miR-214 in primary hepatocytes suppressed glucose production, and silencing miR-214 reversed this effect. Gluconeogenesis was suppressed in the livers of mice injected with an adenovirus expressing miR-214 (Ad-miR-214). Additionally, Ad-miR-214 alleviated high fat diet-induced elevation of gluconeogenesis and hyperglycemia. Furthermore, we found that activating transcription factor 4 (ATF4), a reported target of miR-214, can reverse the suppressive effect of miR-214 on gluconeogenesis in primary hepatocytes, and this suppressive effect was blocked in liver-specific ATF4 knock-out mice. ATF4 regulated gluconeogenesis via affecting forkhead box protein O1(FOXO1) transcriptional activity. Finally, liver-specific miR214 transgenic mice exhibited suppressed gluconeogenesis and reduced expression of ATF4, phosphoenolpyruvate carboxykinase, and glucose-6-phosphatase in liver. Taken together, our results suggest that the miR-214-ATF4 axis is a novel pathway for the regulation of hepatic gluconeogenesis.	[Li, Kai; Yu, Junjie; Liu, Bin; Guo, Yajie; Deng, Jiali; Chen, Shanghai; Wang, Chunxia; Guo, Feifan] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai 200031, Peoples R China; [Zhang, Jin] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ,Inst Med Sci, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Fudan University	Guo, FF (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	ffguo@sibs.ac.cn		Li, Kai/0000-0002-4040-8604	National Natural Science Foundation [81130076, 81325005, 31271269, 81100615, 81390350]; Ministry of Science and Technology of China 973 Program [2010CB912502]; Basic Research Project of Shanghai Science and Technology Commission [13JC1409000]; International S&T Cooperation Program of China Grant Singapore [2014DFG32470]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2011KIP307]; SA-SIBS Scholarship Program; One Hundred Talents Program of the Chinese Academy of Sciences	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Basic Research Project of Shanghai Science and Technology Commission; International S&T Cooperation Program of China Grant Singapore; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences); SA-SIBS Scholarship Program; One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by National Natural Science Foundation Grants 81130076, 81325005, 31271269, 81100615, and 81390350, Ministry of Science and Technology of China 973 Program 2010CB912502, Basic Research Project of Shanghai Science and Technology Commission Grant 13JC1409000, and International S&T Cooperation Program of China Grant Singapore 2014DFG32470.; Supported by the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant 2011KIP307, and the SA-SIBS Scholarship Program. To whom correspondence may be addressed. E-mail: wangcx@sibs.ac.cn.; Supported by the One Hundred Talents Program of the Chinese Academy of Sciences. To whom correspondence may be addressed. E-mail: ffguo@sibs.ac.cn.	ALFORD FP, 1974, LANCET, V2, P974; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; Borba-Murad GR, 2005, CELL BIOCHEM FUNCT, V23, P405, DOI 10.1002/cbf.1163; Brown JL, 2002, ENDOCRINE, V19, P327, DOI 10.1385/ENDO:19:3:327; Charbonneau A, 2005, AM J PHYSIOL-ENDOC M, V289, pE8, DOI 10.1152/ajpendo.00570.2004; Charbonneau A, 2007, J PHYSIOL-LONDON, V579, P255, DOI 10.1113/jphysiol.2006.121954; Chen DL, 2014, HEPATOLOGY, V60, P598, DOI 10.1002/hep.27118; Cheng Y, 2011, MOL ENDOCRINOL, V25, P1624, DOI 10.1210/me.2011-0028; D'souza AM, 2012, AM J PHYSIOL-GASTR L, V302, pG850, DOI 10.1152/ajpgi.00378.2011; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Exton J H, 1979, Monogr Endocrinol, V12, P535; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kamo N, 2013, HEPATOLOGY, V57, P289, DOI 10.1002/hep.25958; Kode A, 2012, J BIOL CHEM, V287, P8757, DOI 10.1074/jbc.M111.282897; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Li HK, 2011, BIOCHEM J, V438, P283, DOI 10.1042/BJ20110263; Li K, 2012, MOL CELL ENDOCRINOL, V348, P21, DOI 10.1016/j.mce.2011.07.026; Li XL, 2014, GENE, V533, P1, DOI 10.1016/j.gene.2013.09.105; Liang JC, 2013, J HEPATOL, V58, P535, DOI 10.1016/j.jhep.2012.10.024; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mendez-Lucas A, 2014, J BIOL CHEM, V289, P22090, DOI 10.1074/jbc.M114.566927; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; Nemecz M, 1999, HEPATOLOGY, V29, P166, DOI 10.1002/hep.510290110; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Oh KJ, 2013, ARCH PHARM RES, V36, P189, DOI 10.1007/s12272-013-0018-5; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Perriello G, 1997, DIABETES, V46, P1010, DOI 10.2337/diabetes.46.6.1010; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Ramirez CM, 2013, MOL CELL BIOL, V33, P2891, DOI 10.1128/MCB.00016-13; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Schwarzenbach H, 2012, BREAST CANCER RES TR, V134, P933, DOI 10.1007/s10549-012-1988-6; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Wang CX, 2014, J CELL MOL MED, V18, P80, DOI 10.1111/jcmm.12166; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang F, 2013, FEBS LETT, V587, P488, DOI 10.1016/j.febslet.2013.01.016; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xu CX, 2012, J BIOL CHEM, V287, P34970, DOI 10.1074/jbc.M112.374611; Yan HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055276; Yang TS, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-68; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang Q, 2013, DIABETES, V62, P2230, DOI 10.2337/db12-1050	57	57	61	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8185	8195		10.1074/jbc.M114.633990	http://dx.doi.org/10.1074/jbc.M114.633990			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25657009	Green Published, hybrid			2022-12-26	WOS:000351662600016
J	Walker, RG; Angerman, EB; Kattamuri, C; Lee, YS; Lee, SJ; Thompson, TB				Walker, Ryan G.; Angerman, Elizabeth B.; Kattamuri, Chandramohan; Lee, Yun-Sil; Lee, Se-Jin; Thompson, Thomas B.			Alternative Binding Modes Identified for Growth and Differentiation Factor-associated Serum Protein (GASP) Family Antagonism of Myostatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Myostatin; Small Angle X-ray Scattering (SAXS); Structural Biology; Transforming Growth Factor Beta (TGF-B); Growth and Differentiation-associated Serum Protein; Growth and Differentiation factor-8 (GDF-8); WFIKKN	BONE-MORPHOGENETIC PROTEIN; SKELETAL-MUSCLE MASS; RECEPTOR-BINDING; BIOLOGICAL-ACTIVITY; INHIBITORY MODULES; SURFACE BINDING; MULTIPLE TYPES; ACTIVIN-A; FOLLISTATIN; DOMAINS	Background: GASP-1 and GASP-2 are highly specific antagonists for the TGF- ligand myostatin, a negative regulator of muscle growth. Results: GASP-1 and GASP-2 form asymmetric and symmetric complexes with myostatin, respectively. Conclusion: Despite the different binding modes, the GASP proteins retain a high specificity for myostatin. Significance: Inhibition of myostatin can be achieved using different binding modes and may facilitate future development of novel anti-myostatin therapeutics. Myostatin, a member of the TGF- family of ligands, is a strong negative regulator of muscle growth. As such, it is a prime therapeutic target for muscle wasting disorders. Similar to other TGF- family ligands, myostatin is neutralized by binding one of a number of structurally diverse antagonists. Included are the antagonists GASP-1 and GASP-2, which are unique in that they specifically antagonize myostatin. However, little is known from a structural standpoint describing the interactions of GASP antagonists with myostatin. Here, we present the First low resolution solution structure of myostatin-free and myostatin-bound states of GASP-1 and GASP-2. Our studies have revealed GASP-1, which is 100 times more potent than GASP-2, preferentially binds myostatin in an asymmetrical 1:1 complex, whereas GASP-2 binds in a symmetrical 2:1 complex. Additionally, C-terminal truncations of GASP-1 result in less potent myostatin inhibitors that form a 2:1 complex, suggesting that the C-terminal domains of GASP-1 are the primary mediators for asymmetric complex formation. Overall, this study provides a new perspective on TGF- antagonism, where closely related antagonists can utilize different ligand-binding strategies.	[Walker, Ryan G.; Angerman, Elizabeth B.; Kattamuri, Chandramohan; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Coll Med, Cincinnati, OH 45267 USA; [Lee, Yun-Sil; Lee, Se-Jin] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University System of Ohio; University of Cincinnati; Johns Hopkins University	Thompson, TB (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Med Sci Bldg,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	tom.thompson@uc.edu		Walker, Ryan/0000-0001-6160-8026; Thompson, Thomas/0000-0002-7041-5047	National Institutes of Health [R01AR060636, R01GM105404]; Integrated Diffraction Analysis Technologies Program of the Department of Energy Office of Basic Energy Sciences; American Heart Association [12PRE11790027]; Muscular Dystrophy Association [240087]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrated Diffraction Analysis Technologies Program of the Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR060636 (to S.-J. L.) and R01GM105404 (to Project MINOS). This work was also supported by the Integrated Diffraction Analysis Technologies Program of the Department of Energy Office of Basic Energy Sciences (to Advanced Light Source at Lawrence Berkeley National Laboratory), American Heart Association Grant 12PRE11790027 (to R. G. W.), and Muscular Dystrophy Association Grant 240087 (to T. B. T.).	Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Brun C, 2012, CELL PHYSIOL BIOCHEM, V30, P791, DOI 10.1159/000341458; Cash JN, 2013, J BIOMOL SCREEN, V18, P837, DOI 10.1177/1087057113482585; Cash JN, 2012, MOL ENDOCRINOL, V26, P1167, DOI 10.1210/me.2012-1061; Cash JN, 2012, J BIOL CHEM, V287, P1043, DOI 10.1074/jbc.M111.270801; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Lee Se-Jin, 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P183; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lee YS, 2013, P NATL ACAD SCI USA, V110, pE3713, DOI 10.1073/pnas.1309907110; McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Monestier O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043710; Nakatani M, 2008, FASEB J, V22, P477, DOI 10.1096/fj.07-8673com; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Stamler R, 2008, J BIOL CHEM, V283, P32831, DOI 10.1074/jbc.M801266200; Svitel J, 2003, BIOPHYS J, V84, P4062, DOI 10.1016/S0006-3495(03)75132-7; Szlama G, 2013, FEBS J, V280, P3822, DOI 10.1111/febs.12377; Szlama G, 2010, FEBS J, V277, P5040, DOI 10.1111/j.1742-4658.2010.07909.x; Thies RS, 2001, GROWTH FACTORS, V18, P251; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Trexler M, 2002, BIOL CHEM, V383, P223, DOI 10.1515/BC.2002.023; Trexler M, 2001, P NATL ACAD SCI USA, V98, P3705, DOI 10.1073/pnas.061028398; Troilo H, 2014, P NATL ACAD SCI USA, V111, P13063, DOI 10.1073/pnas.1404166111; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	39	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7506	7516		10.1074/jbc.M114.624130	http://dx.doi.org/10.1074/jbc.M114.624130			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25657005	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000351613600018
J	Goetze, JP; Johnsen, AH; Kistorp, C; Gustafsson, F; Johnbeck, CB; Rehfeld, JF				Goetze, Jens P.; Johnsen, Anders H.; Kistorp, Caroline; Gustafsson, Finn; Johnbeck, Camilla B.; Rehfeld, Jens F.			Cardiomyocyte Expression and Cell-specific Processing of Procholecystokinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATRIURETIC PEPTIDE; CHOLECYSTOKININ; PLASMA; GENE; ACCUMULATION; PRECURSORS; HYPOXIA; PROTEIN; GASTRIN	Heart muscle cells produce peptide hormones such as natriuretic peptides. Developing hearts also express the gene for the classic intestinal hormone cholecystokinin (CCK) in amounts similar to those in the intestine and brain. However, cardiac expression of peptides other than natriuretic peptides has only been suggested using transcriptional measures or methods, with the post-translational phase of gene expression unaddressed. In this study, we examined the cardiac expression of the CCK gene in adult mammals and its expression at the protein level. Using quantitative PCR, a library of sequence-specific pro-CCK assays, peptide purification, and mass spectrometry, we demonstrate that the mammalian heart expresses pro-CCK in amounts comparable to natriuretic prohormones and processes it to a unique, triple-sulfated, and N-terminally truncated product distinct from intestinal and cerebral CCK peptides. Isoprenaline rapidly stimulated cardiac CCK gene expression in vitro and in vivo, which suggests that the cardiac-specific truncated pro-CCK may have pathophysiological relevance as a new marker of heart failure. The suggestion is confirmed by measurement of plasma from heart failure patients.	[Goetze, Jens P.; Johnsen, Anders H.; Kistorp, Caroline; Gustafsson, Finn; Johnbeck, Camilla B.; Rehfeld, Jens F.] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Goetze, Jens P.; Johnsen, Anders H.; Kistorp, Caroline; Gustafsson, Finn; Johnbeck, Camilla B.; Rehfeld, Jens F.] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Goetze, Jens P.; Johnsen, Anders H.; Kistorp, Caroline; Gustafsson, Finn; Johnbeck, Camilla B.; Rehfeld, Jens F.] Univ Copenhagen, Herlev Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark; [Goetze, Jens P.] Aarhus Univ, Dept Clin Med, DK-8000 Aarhus C, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University	Goetze, JP (corresponding author), Rigshosp, Dept Clin Biochem KB3014, 9 Blegdamsvej, DK-2100 Copenhagen, Denmark.	jpg@dadlnet.dk; jens.f.rehfeld@regionh.dk		Kistorp, Caroline/0000-0002-3019-6775; Gustafsson, Finn/0000-0003-2144-341X	Novo Nordisk Foundation; Lundbeck Foundation; Danish Biotechnology Center for Cellular Communication; Novo Nordisk Fonden [NNF12OC1016060] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Biotechnology Center for Cellular Communication; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Novo Nordisk Foundation, the Lundbeck Foundation, and The Danish Biotechnology Center for Cellular Communication.	BARDRAM L, 1989, ACTA ENDOCRINOL-COP, V120, P479, DOI 10.1530/acta.0.1200479; CANTOR P, 1989, AM J PHYSIOL, V256, pG53, DOI 10.1152/ajpgi.1989.256.1.G53; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Christoffersen C, 2002, HYPERTENSION, V40, P54, DOI 10.1161/01.HYP.0000021780.21830.DD; DEFTOS LJ, 1993, J CLIN INVEST, V92, P727, DOI 10.1172/JCI116643; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; GEIJER T, 1990, FEBS LETT, V270, P30, DOI 10.1016/0014-5793(90)81227-F; Goetze JP, 2012, CLIN CHEM, V58, P83, DOI 10.1373/clinchem.2011.165696; Goetze JP, 2004, FASEB J, V18, P1928, DOI 10.1096/fj.03-1336fje; HILSTED L, 1986, ANAL BIOCHEM, V152, P119, DOI 10.1016/0003-2697(86)90129-6; ITO H, 1993, J CLIN INVEST, V92, P398, DOI 10.1172/JCI116579; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; LARSSON LI, 1979, BRAIN RES, V165, P201, DOI 10.1016/0006-8993(79)90554-7; Lay JM, 1999, DEV DYNAM, V216, P190, DOI 10.1002/(SICI)1097-0177(199910)216:2<190::AID-DVDY9>3.3.CO;2-B; Rehfeld JF, 2007, CURR TOP MED CHEM, V7, P1154; REHFELD JF, 1978, J BIOL CHEM, V253, P4016; REHFELD JF, 1987, P NATL ACAD SCI USA, V84, P3019, DOI 10.1073/pnas.84.9.3019; Rehfeld JF, 1998, CLIN CHEM, V44, P991; REHFELD JF, 1986, J BIOL CHEM, V261, P5841; Rehfeld JF, 2001, J CLIN ENDOCR METAB, V86, P251, DOI 10.1210/jc.86.1.251; Smith J, 2013, ENDOCRINOLOGY, V154, P1864, DOI 10.1210/en.2012-2186; Weidemann A, 2008, BIOCHEM J, V409, P233, DOI 10.1042/BJ20070629; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Yasuoka C, 2004, J BIOL CHEM, V279, P51182, DOI 10.1074/jbc.M407225200; Zimmer HG, 1997, J MOL MED-JMM, V75, P849, DOI 10.1007/s001090050176	25	22	22	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					6837	6843		10.1074/jbc.M114.622670	http://dx.doi.org/10.1074/jbc.M114.622670			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25627687	Green Published, hybrid			2022-12-26	WOS:000350991500019
J	Zou, J; Li, WJ; Misra, A; Yue, F; Song, K; Chen, Q; Guo, GH; Yi, JL; Kimata, JT; Liu, LY				Zou, Jing; Li, Wenjiao; Misra, Anisha; Yue, Fei; Song, Kun; Chen, Qi; Guo, Guanghua; Yi, Jinglin; Kimata, Jason T.; Liu, Leyuan			The Viral Restriction Factor Tetherin Prevents Leucine-rich Pentatricopeptide Repeat-containing Protein (LRPPRC) from Association with Beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and Enhances Autophagy and Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; HIV-1 RELEASE; BETA-TRCP; T-CELLS; IN-VIVO; MITOCHONDRIA; INSTABILITY; SUPPRESSES; P62/SQSTM1; INFECTION	Tetherin has been characterized as a key factor that restricts viral particles such as HIV and hepatitis C virus on plasma membranes, acts as a ligand of the immunoglobulin-like transcript 7 (ILT7) receptor in tumor cells, and suppresses antiviral innate immune responses mediated by human plasmacytoid dendritic cells. However, the normal cellular function of Tetherin without viral infection is unknown. Here we show that Tetherin not only serves as a substrate of autophagy but itself regulates the initiation of autophagy. Tetherin interacts with the autophagy/mitophagy suppressor LRPPRC and prevents LRPPRC from forming a ternary complex with Beclin 1 and Bcl-2 so that Beclin 1 is released to bind with PI3KCIII (class III PI3K) to activate the initiation of autophagy. Suppression of Tetherin leads to impairment of autophagy, whereas overexpression of Tetherin causes activation of autophagy. Under mitophagic stress, Tetherin is concentrated on mitochondria engulfed in autophagosomes. Tetherin plays a general role in the degradation of autophagosomes containing not only the symbiotic mitochondria but also, possibly, the infected virus. Therefore, Tetherin may enhance autophagy and mitophagy to suppress tumorigenesis, enhance innate immune responses, or prevent T cell apoptosis or pyroptosis,	[Zou, Jing; Li, Wenjiao; Yue, Fei; Song, Kun; Chen, Qi; Liu, Leyuan] Texas A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX 77030 USA; [Zou, Jing; Guo, Guanghua; Yi, Jinglin] Nanchang Univ, Jiangxi Res Inst Ophthalmol & Visual Sci, Affiliated Eye Hosp, Nanchang 330006, Peoples R China; [Misra, Anisha; Kimata, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Liu, Leyuan] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Nanchang University; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Liu, LY (corresponding author), Texas A&M Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	lliu@ibt.tamhsc.edu	Li, Wenjiao/J-2198-2019; Yue, Fei/N-1891-2018	Li, Wenjiao/0000-0003-1308-8489; Song, Kun/0000-0003-3822-2891; Zou, Jing/0000-0002-0976-7078; Kimata, Jason/0000-0002-0504-0090	NCI/National Institutes of Health [CA142862]; NIAID/National Institutes of Health [AI099007]; Department of Defense [W81XWH]; Baylor College of Medicine-University of Texas Houston Medical School Center for AIDS Research [AI036211]; NATIONAL CANCER INSTITUTE [R01CA142862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, R21AI099007] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense(United States Department of Defense); Baylor College of Medicine-University of Texas Houston Medical School Center for AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NCI/National Institutes of Health Grant CA142862 (to L. L.) and NIAID/National Institutes of Health Grant AI099007 (to J. T. K.) This work was also supported by Department of Defense New Investigator Award W81XWH (to L. L.) and by Baylor College of Medicine-University of Texas Houston Medical School Center for AIDS Research Grant AI036211 (to J. T. K.).	Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Blanchet FP, 2012, CURR HIV RES, V10, P307, DOI 10.2174/157016212800792441; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boya P, 2004, BBA-BIOENERGETICS, V1659, P178, DOI 10.1016/j.bbabio.2004.08.007; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; D'Angiolella V, 2007, CELL CYCLE, V6, P576, DOI 10.4161/cc.6.5.3934; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; Fogel AI, 2013, MOL CELL BIOL, V33, P3675, DOI 10.1128/MCB.00079-13; GOTO T, 1994, BLOOD, V84, P1922; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Janvier K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001265; Jiang XH, 2015, MOL CARCINOGEN, V54, P1194, DOI 10.1002/mc.22193; Jiang XH, 2014, CANCER-AM CANCER SOC, V120, P1228, DOI 10.1002/cncr.28551; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Killian MS, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-16; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liberatore RA, 2011, P NATL ACAD SCI USA, V108, P18097, DOI 10.1073/pnas.1113694108; Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x; Liu LY, 2012, AUTOPHAGY, V8, P278, DOI 10.4161/auto.8.2.18939; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Margulis L., 1975, S SOC EXP BIOL, V1975, P21; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; Mishra PK, 2009, FREE RADICAL RES, V43, P718, DOI 10.1080/10715760903037699; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Ryter Stefan W, 2014, Int J Cell Biol, V2014, P502676, DOI 10.1155/2014/502676; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Schweitzer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040537; Suen YK, 2000, APOPTOSIS, V5, P369, DOI 10.1023/A:1009691727077; Tervo HM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-9; Thippeshappa R, 2013, J VIROL, V87, P6678, DOI 10.1128/JVI.00338-13; Thomas WD, 2000, J IMMUNOL, V165, P5612, DOI 10.4049/jimmunol.165.10.5612; Xie R, 2011, CANCER RES, V71, P7537, DOI 10.1158/0008-5472.CAN-11-2170; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Zhang G, 2008, J BIOL CHEM, V283, P24343, DOI 10.1074/jbc.M803444200; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094903; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306	54	17	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7269	7279		10.1074/jbc.M114.627679	http://dx.doi.org/10.1074/jbc.M114.627679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25631043	Green Published, hybrid			2022-12-26	WOS:000350991500055
J	Grabowski, K; Riemenschneider, M; Schulte, L; Witten, A; Schulz, A; Stoll, M; Kreutz, R				Grabowski, Katja; Riemenschneider, Mona; Schulte, Leonard; Witten, Anika; Schulz, Angela; Stoll, Monika; Kreutz, Reinhold			Fetal-Adult Cardiac Transcriptome Analysis in Rats with Contrasting Left Ventricular Mass Reveals New Candidates for Cardiac Hypertrophy	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; HYPERTENSIVE HEART-DISEASE; GENE-EXPRESSION PROFILES; FAILURE; MECHANISMS; MICROARRAY; PROGRAM; PROGRESSION; FIBROBLASTS; INHIBITORS	Reactivation of fetal gene expression patterns has been implicated in common cardiac diseases in adult life including left ventricular (LV) hypertrophy (LVH) in arterial hypertension. Thus, increased wall stress and neurohumoral activation are discussed to induce the return to expression of fetal genes after birth in LVH. We therefore aimed to identify novel potential candidates for LVH by analyzing fetal-adult cardiac gene expression in a genetic rat model of hypertension, i.e. the stroke-prone spontaneously hypertensive rat (SHRSP). To this end we performed genome-wide transcriptome analysis in SHRSP to identify differences in expression patterns between day 20 of fetal development (E20) and adult animals in week 14 in comparison to a normotensive rat strain with contrasting low LV mass, i. e. Fischer (F344). 15232 probes were detected as expressed in LV tissue obtained from rats at E20 and week 14 (p < 0.05) and subsequently screened for differential expression. We identified 24 genes with SHRSP specific up-regulation and 21 genes with down-regulation as compared to F344. Further bioinformatic analysis presented Efcab6 as a new candidate for LVH that showed only in the hypertensive SHRSP rat differential expression during development (logFC = 2.41, p < 0.001) and was significantly higher expressed in adult SHRSP rats compared with adult F344 (+ 76%) and adult normotensive Wistar-Kyoto rats (+ 82%). Thus, it represents an interesting new target for further functional analyses and the elucidation of mechanisms leading to LVH. Here we report a new approach to identify candidate genes for cardiac hypertrophy by combining the analysis of gene expression differences between strains with a contrasting cardiac phenotype with a comparison of fetal-adult cardiac expression patterns.	[Grabowski, Katja; Schulte, Leonard; Schulz, Angela; Kreutz, Reinhold] Charite, Charite Ctr Therapieforsch, Dept Clin Pharmacol & Toxicol, D-13353 Berlin, Germany; [Riemenschneider, Mona; Witten, Anika; Stoll, Monika] Univ Munster, D-48149 Munster, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster	Grabowski, K (corresponding author), Charite, Charite Ctr Therapieforsch, Dept Clin Pharmacol & Toxicol, D-13353 Berlin, Germany.	katja.grabowski@charite.de	Witten, Anika/C-5297-2019; Kreutz, Reinhold/AEV-0507-2022	Kreutz, Reinhold/0000-0002-4818-211X; Schulz, Angela/0000-0002-4576-8035	Deutsche Forschungsgemeinschaft [KR1152/3-1]; Bundesministerium fur Bildung und Forschung; Nationales Genomforschungsnetzwerk (NGFN); Herzkreislaufnetz in NGFNplus in Germany [01GS0839]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Nationales Genomforschungsnetzwerk (NGFN); Herzkreislaufnetz in NGFNplus in Germany	This study was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/) grant KR1152/3-1 and Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/), Nationales Genomforschungsnetzwerk (NGFN), Herzkreislaufnetz in NGFNplus (http://www.ngfn.de/de/ngfn_plus.html) Grant 01GS0839 in Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai D, 2009, P NATL ACAD SCI USA, V106, P564, DOI 10.1073/pnas.0811022106; Andersson KB, 2006, ACTA PHYSIOL, V186, P17, DOI 10.1111/j.1748-1716.2005.01503.x; Arnett DK, 2004, CURR HYPERTENS REP, V6, P36, DOI 10.1007/s11906-004-0009-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asp J, 2012, PHYSIOL GENOMICS, V44, P89, DOI 10.1152/physiolgenomics.00137.2011; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bella JN, 2012, AM J CARDIOVASC DIS, V2, P267; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Boerma M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-6; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Fujiu K, 2014, J MOL CELL CARDIOL, V70, P64, DOI 10.1016/j.yjmcc.2014.01.013; Grabowski K, 2013, PHYSIOL GENOMICS, V45, P827, DOI 10.1152/physiolgenomics.00067.2013; Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Houweling AC, 2005, CARDIOVASC RES, V67, P583, DOI 10.1016/j.cardiores.2005.06.013; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; Marques FZ, 2010, HYPERTENSION, V56, P319, DOI 10.1161/HYPERTENSIONAHA.110.155366; Monti J, 2008, NAT GENET, V40, P529, DOI 10.1038/ng.129; Niki T, 2003, MOL CANCER RES, V1, P247; Pu Q, 2001, AM J HYPERTENS, V14, P1067, DOI 10.1016/S0895-7061(01)02157-4; Qiu H, 2011, CARDIOVASC THER, V29, P99, DOI 10.1111/j.1755-5922.2010.00150.x; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Rebelo RMD, 2012, J PHYSIOL-LONDON, V590, P5389, DOI 10.1113/jphysiol.2012.241141; Rothermund L, 2000, BRIT J PHARMACOL, V130, P205, DOI 10.1038/sj.bjp.0703320; Rothermund L, 2001, HYPERTENSION, V37, P275, DOI 10.1161/01.HYP.37.2.275; Ruilope LM, 2008, AM J HYPERTENS, V21, P500, DOI 10.1038/ajh.2008.16; Rysa J, 2005, HYPERTENSION, V45, P927, DOI 10.1161/01.HYP.0000161873.27088.4c; Schulz A, 2002, J AM SOC NEPHROL, V13, P2706, DOI 10.1097/01.ASN.0000031803.55613.86; Sebkhi A, 1999, HYPERTENSION, V33, P949, DOI 10.1161/01.HYP.33.4.949; Siegel AK, 2003, ARTERIOSCL THROM VAS, V23, P1211, DOI 10.1161/01.ATV.0000079509.20542.C9; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Susic D, 2000, Curr Hypertens Rep, V2, P565, DOI 10.1007/s11906-996-0042-7; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; TANASE H, 1982, HYPERTENSION, V4, P864, DOI 10.1161/01.HYP.4.6.864; van den Hoff MJB, 2006, J HYPERTENS, V24, P273, DOI 10.1097/01.hjh.0000200520.93190.7d; Wadley GD, 2013, PHYSIOL GENOMICS, V45, P99, DOI 10.1152/physiolgenomics.00095.2012; Wang W, 2013, NAT MED, V19, P305, DOI 10.1038/nm.3079; Zhang P, 2012, AM J PHYSIOL-HEART C, V303, pH1385, DOI 10.1152/ajpheart.01167.2011; Zhao TT, 2012, INT J CARDIOL, V155, P181, DOI 10.1016/j.ijcard.2011.05.067; Zhao XS, 2002, PHYSIOL GENOMICS, V12, P53, DOI 10.1152/physiolgenomics.00086.2002	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116807	10.1371/journal.pone.0116807	http://dx.doi.org/10.1371/journal.pone.0116807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646840	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600037
J	Liu, BL; Zhu, YC; Zhang, TZ				Liu, Bingliang; Zhu, Yichao; Zhang, Tianzhen			The R3-MYB Gene GhCPC Negatively Regulates Cotton Fiber Elongation	PLOS ONE			English	Article							EPIDERMAL-CELL DIFFERENTIATION; MYB TRANSCRIPTION FACTORS; TRICHOME DEVELOPMENT; ARABIDOPSIS; CAPRICE; INITIATION; PROTEINS; TRIPTYCHON; ENCODES; BINDING	Cotton (Gossypium spp.) fibers are single-cell trichomes that arise from the outer epidermal layer of seed coat. Here, we isolated a R3-MYB gene GhCPC, identified by cDNA microarray analysis. The only conserved R3 motif and different expression between TM-1 and fuzzless-lintless mutants suggested that it might be a negative regulator in fiber development. Transgenic evidence showed that GhCPC overexpression not only delayed fiber initiation but also led to significant decreases in fiber length. Interestingly, Yeast two-hybrid analysis revealed an interaction complex, in which GhCPC and GhTTG1/4 separately interacted with GhMYC1. In transgenic plants, Q-PCR analysis showed that GhHOX3 (GL2) and GhRDL1 were significantly down regulated in -1-5 DPA ovules and fibers. In addition, Yeast one-hybrid analysis demonstrated that GhMYC1 could bind to the E-box cis-elements and the promoter of GhHOX3. These results suggested that GhHOX3 (GL2) might be downstream gene of the regulatory complex. Also, overexpression of GhCPC in tobacco led to differential loss of pigmentation. Taken together, the results suggested that GhCPC might negatively regulate cotton fiber initiation and early elongation by a potential CPC-MYC1-TTG1/4 complex. Although the fibers were shorter in transgenic cotton lines than in the wild type, no significant difference was detected in stem or leaf trichomes, even in cotton mutants (five naked seed or fuzzless), suggesting that fiber and trichome development might be regulated by two sets of genes sharing a similar model.	[Liu, Bingliang; Zhu, Yichao; Zhang, Tianzhen] Nanjing Agr Univ, Cotton Hybrid R&D Engn Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, TZ (corresponding author), Nanjing Agr Univ, Cotton Hybrid R&D Engn Ctr, Natl Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Nanjing, Jiangsu, Peoples R China.	cotton@njau.edu.cn			National Science Foundation of China [31330058]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was financially supported in part by grants from the National Science Foundation of China (31330058) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt C, 2003, DEVELOPMENT, V130, P6431, DOI 10.1242/dev.00880; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Chaudhary J, 1999, MOL ENDOCRINOL, V13, P774, DOI 10.1210/me.13.5.774; Deng FL, 2012, PLANT PHYSIOL, V158, P890, DOI 10.1104/pp.111.186742; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Esch JJ, 2003, DEVELOPMENT, V130, P5885, DOI 10.1242/dev.00812; Hong GJ, 2012, PLANT CELL, V24, P2635, DOI 10.1105/tpc.112.098749; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Ishida T, 2007, PLANT CELL, V19, P2531, DOI 10.1105/tpc.107.052274; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Jiang YJ, 2012, PLANT BIOTECHNOL J, V10, P301, DOI 10.1111/j.1467-7652.2011.00662.x; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Kirik V, 2004, DEV BIOL, V268, P506, DOI 10.1016/j.ydbio.2003.12.037; Koshino-Kimura Y, 2005, PLANT CELL PHYSIOL, V46, P817, DOI 10.1093/pcp/pci096; Li FF, 2009, PLANT CELL TISS ORG, V97, P225, DOI 10.1007/s11240-009-9521-2; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Machado A, 2009, PLANT J, V59, P52, DOI 10.1111/j.1365-313X.2009.03847.x; Morohashi K, 2007, PLANT PHYSIOL, V145, P736, DOI 10.1104/pp.107.104521; OGATA K, 1992, P NATL ACAD SCI USA, V89, P6428, DOI 10.1073/pnas.89.14.6428; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Payne CT, 2000, GENETICS, V156, P1349; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; Schnittger A, 1999, PLANT CELL, V11, P1105, DOI 10.1105/tpc.11.6.1105; Serna L, 2006, TRENDS PLANT SCI, V11, P274, DOI 10.1016/j.tplants.2006.04.008; Shan CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6519; Szymanski DB, 2000, TRENDS PLANT SCI, V5, P214, DOI 10.1016/S1360-1385(00)01597-1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tominaga R, 2007, PLANT CELL, V19, P2264, DOI 10.1105/tpc.106.045732; Uhrig JF, 2006, PLANTA, V224, P771, DOI 10.1007/s00425-006-0260-x; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111; Walford SA, 2012, PLANT J, V71, P464, DOI 10.1111/j.1365-313X.2012.05003.x; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Wang SC, 2007, DEVELOPMENT, V134, P3873, DOI 10.1242/dev.009597; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang F, 2010, J EXP BOT, V61, P3599, DOI 10.1093/jxb/erq173; Zhang W, 2009, BIOCHEM BIOPH RES CO, V388, P742, DOI 10.1016/j.bbrc.2009.08.092; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873; Zimmermann IM, 2004, PLANT J, V40, P22, DOI 10.1111/j.1365-313X.2004.02183.x	46	30	31	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116272	10.1371/journal.pone.0116272	http://dx.doi.org/10.1371/journal.pone.0116272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646816	gold, Green Submitted, Green Published			2022-12-26	WOS:000348822600024
J	Aguiar, RWS; dos Santos, SF; Morgado, FD; Ascencio, SD; Lopes, MD; Viana, KF; Didonet, J; Ribeiro, BM				Souza Aguiar, Raimundo Wagner; dos Santos, Suetonio Fernandes; Morgado, Fabricio da Silva; Ascencio, Sergio Donizeti; Lopes, Magnolia de Mendonca; Viana, Kelvinson Fernandes; Didonet, Julcemar; Ribeiro, Bergmann Morais			Insecticidal and Repellent Activity of Siparuna guianensis Aubl. (Negramina) against Aedes aegypti and Culex quinquefasciatus	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; LARVICIDAL ACTIVITY; L. DIPTERA; TOXICITY; EXTRACT; LEAVES; ADULTS	This study investigated the toxic effects of essential oils isolated from Siparuna guianensis against Aedes aegypti, Culex quinquefasciatus (eggs, larvae, pupae, and adult) and Aedes albopictus (C6/36) cells. The oviposition-deterring activity, egg viability, and repellence activity in the presence of different essential oils concentrations were determined. The essential oils showed high toxicity to all developmental stages of A. aegypti and C. quinquefasciatus. Furthermore, the oils also showed high repellent activity towards the adult stage of mosquitoes (0.025 to 0.550 mu g/cm2 skin conferred 100% repellence up to 120 min) and in contact with cultured insect cells (C6/36) induced death possibly by necrosis. The results presented in this work show the potential of S. guianensis essential oils for the development of an alternative and effective method for the natural control of mosquitoes in homes and urban areas.	[Souza Aguiar, Raimundo Wagner; dos Santos, Suetonio Fernandes; Lopes, Magnolia de Mendonca; Viana, Kelvinson Fernandes; Didonet, Julcemar] Univ Fed Tocantins, Dept Biotecnol, Gurupi, Tocantins, Brazil; [Ascencio, Sergio Donizeti] Univ Fed Tocantins, Gurupi, Tocantins, Brazil; [Morgado, Fabricio da Silva; Ribeiro, Bergmann Morais] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil	Universidade Federal do Tocantins (UFT); Universidade Federal do Tocantins (UFT); Universidade de Brasilia	Aguiar, RWS (corresponding author), Univ Fed Tocantins, Dept Biotecnol, Campus Univ Gurupi, Gurupi, Tocantins, Brazil.	rwsa@uft.edu.br	Viana, Kelvinson/Y-4325-2019; Ribeiro, Bergmann Morais/C-7114-2015; Aguiar, Raimundo Wagner/ABC-9785-2021	Ribeiro, Bergmann Morais/0000-0002-1061-196X; da Silva Morgado, Fabricio/0000-0002-4612-5613	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); SECT (Secretaria de Ciencia Tecnologia do estado do Tocantins); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); SECT (Secretaria de Ciencia Tecnologia do estado do Tocantins); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), www.cnpq.br, SECT (Secretaria de Ciencia Tecnologia do estado do Tocantins), http://www.sedecti.to.gov.br/sedecti/, and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Aguiar RWD, 2014, SCI WORLD J, DOI 10.1155/2014/492138; Amorim LB, 2013, PEST MANAG SCI, V69, P1307, DOI 10.1002/ps.3502; Andrade MA, 2013, ANTIOXIDANTS-BASEL, V2, P384, DOI 10.3390/antiox2040384; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P377; Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055; Bianco EM, 2013, IND CROP PROD, V43, P270, DOI 10.1016/j.indcrop.2012.07.032; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7; Conti B, 2012, PARASITOL RES, V110, P2013, DOI 10.1007/s00436-011-2730-8; Coria C, 2008, BIORESOURCE TECHNOL, V99, P3066, DOI 10.1016/j.biortech.2007.06.012; Macoris MDD, 2007, MEM I OSWALDO CRUZ, V102, P895, DOI 10.1590/S0074-02762007000800001; Diniz JA, 2014, THESIS U FEDERAL VIC; Ferrari James A., 1996, P512; Ferreira DF, 2001, SISTEMA ANALISES VAR; Finney D.L., 1971, PROBIT ANAL; Fischer DCH, 2005, J ESSENT OIL RES, V17, P101, DOI 10.1080/10412905.2005.9698844; Govindarajan M, 2011, PARASITOL RES, V109, P93, DOI 10.1007/s00436-010-2224-0; Grenand P., 2004, PHARMACOPEES TRADITI, P816; Kabir KE, 2013, ECOTOX ENVIRON SAFE, V90, P52, DOI 10.1016/j.ecoenv.2012.12.028; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003; Leyva Maureen, 2009, Rev Cubana Med Trop, V61, P239; Lucia A, 2009, BIORESOURCE TECHNOL, V100, P6083, DOI 10.1016/j.biortech.2009.02.075; MULLA MS, 1974, J ECON ENTOMOL, V67, P165, DOI 10.1093/jee/67.2.165; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; Rajkumar S., 2008, Canadian Journal of Pure & Applied Sciences, V2, P129; Renner SS, 2005, MONOGRAPH SIPARUNACE, V95, P256, DOI [10.1016/j.talanta.2005.07.013, DOI 10.1016/J.TALANTA.2005.07.013]; Roe RM, 2004, METHOD REPELLING INS, Patent No. 20040242703; Senthilkumar A, 2013, PARASITOL RES, V112, P1337, DOI 10.1007/s00436-012-3188-z; Senthilkumar A., 2012, Asian Pacific Journal of Tropical Disease, V2, P324; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; Valentini C.M.A, 2010, Rev. bras. plantas med., V12, P96, DOI 10.1590/S1516-05722010000100014; Venkatachalam MR, 2001, BIORESOURCE TECHNOL, V76, P287, DOI 10.1016/S0960-8524(00)00096-1; World Health Organization, 2009, REP WHO INF CONS EV, P69, DOI [DOI 10.1016/J.JACL.2009.12.003, 10.1016/j.jacl.2009.12.003]; Yeom HJ, 2013, PESTIC BIOCHEM PHYS, V107, P200, DOI 10.1016/j.pestbp.2013.07.003; Zoghbi M. das G. B., 1998, Journal of Essential Oil Research, V10, P543	38	46	51	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116765	10.1371/journal.pone.0116765	http://dx.doi.org/10.1371/journal.pone.0116765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646797	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600035
J	Furukawa, M; Wheeler, S; Clark, AM; Wells, A				Furukawa, Masashi; Wheeler, Sarah; Clark, Amanda M.; Wells, Alan			Lung Epithelial Cells Induce Both Phenotype Alteration and Senescence in Breast Cancer Cells	PLOS ONE			English	Article							E-CADHERIN; MESENCHYMAL TRANSITION; CARCINOMA-CELLS; TUMOR-CELLS; METASTASIS; MICROMETASTASES; PROGRESSION; EXPRESSION; SURVIVAL; CULTURE	Purpose The lung is one of the most common sites of breast cancer metastasis. While metastatic seeding is often accompanied by a dormancy-promoting mesenchymal to epithelial reverting transitions (MErT), we aimed to determine whether lung epithelial cells can impart this phenotype on aggressive breast cancer cells. Methods Co-culture experiments of normal lung epithelial cell lines (SAEC, NHBE or BEAS-2B) and breast cancer cell lines (MCF-7 or MDA-MB-231) were conducted. Flow cytometry analysis, immunofluorescence staining for E-cadherin or Ki-67 and senescence associated betagalactosidase assays assessed breast cancer cell outgrowth and phenotype. Results Co-culture of the breast cancer cells with the normal lung cells had different effects on the epithelial and mesenchymal carcinoma cells. The epithelialMCF-7 cells were increased in number but still clustered even if in a slightlymore mesenchymal-spindle morphology. On the other hand, the mesenchymal MDA-MB-231 cells survived but did not progressively grow out in co-culture. These aggressive carcinoma cells underwent an epithelial shift as indicated by cuboidal morphology and increased E-cadherin. Disruption of E-cadherin expressed in MDAMB- 231 using shRNA prevented this phenotypic reversion in co-culture. Lung cells limited cancer cell growth kinetics as noted by both (1) some of the cells becoming larger and positive for senescencemarkers/negative for proliferation marker Ki-67, and (2) Ki-67 positive cells significantly decreasing in MDA-MB-231 and MCF-7 cells after co-culture. Conclusions Our data indicate that normal lung epithelial cells can drive an epithelial phenotype and suppress the growth kinetics of breast cancer cells coincident with changing their phenotypes.	[Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; Pittsburgh VA Hlth Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	wellsa@upmc.edu	Clark, Amanda/X-2325-2019; Furukawa, Masashi/ABG-5947-2021	Clark, Amanda/0000-0003-1590-2560; Furukawa, Masashi/0000-0001-8102-9072; Wells, Alan/0000-0002-1637-8150; Wheeler, Sarah/0000-0002-7851-9836	National Institutes of Health [NCATS UH2TR000496]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000496, UH3TR000496] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	VA Merit award and a grant from National Institutes of Health (NCATS UH2TR000496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukholm IK, 2000, J PATHOL, V190, P15; Bussard KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049221; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Chao Y, 2012, CANCER MICROENVIRON, V5, P19, DOI 10.1007/s12307-011-0085-4; Chao Y, 2012, CLIN EXP METASTAS, V29, P39, DOI 10.1007/s10585-011-9427-3; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Clark AM, 2014, EXP BIOL MED, V239, P1170, DOI 10.1177/1535370214532596; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kowalski PJ, 2003, BREAST CANCER RES, V5, pR217, DOI 10.1186/bcr651; Li M, 2010, J BIOL CHEM, V285, P6285, DOI 10.1074/jbc.M109.057943; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001; Rosenfield Sonia M, 2013, Cells, V2, P43, DOI 10.3390/cells2010043; Ruan JW, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3226; Taylor DP, 2014, BREAST CANCER RES TR, V144, P551, DOI 10.1007/s10549-014-2875-0; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Venturelli S, 2013, MOL CANCER THER, V12, P2226, DOI 10.1158/1535-7163.MCT-13-0137; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wheeler SE, 2014, BRIT J CANC IN PRESS; Yates CC, 2007, BRIT J CANCER, V96, P1246, DOI 10.1038/sj.bjc.6603700; Yates C, 2007, ADV CANCER RES, V97, P225, DOI 10.1016/S0065-230X(06)97010-9	27	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0118060	10.1371/journal.pone.0118060	http://dx.doi.org/10.1371/journal.pone.0118060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635394	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000350680700114
J	Hussain, MI; Reigosa, MJ				Hussain, M. Iftikhar; Reigosa, Manuel J.			Characterization of Xanthophyll Pigments, Photosynthetic Performance, Photon Energy Dissipation, Reactive Oxygen Species Generation and Carbon Isotope Discrimination during Artemisinin-Induced Stress in Arabidopsis thaliana	PLOS ONE			English	Article							LEAF WATER RELATIONS; SESQUITERPENE LACTONES; NATURAL-PRODUCTS; ANNUA L.; GROWTH; LEAVES; ACID; BIOSYNTHESIS; LOCALIZATION; ALLELOPATHY	Artemisinin, a potent antimalarial drug, is phytotoxic to many crops and weeds. The effects of artemisinin on stress markers, including fluorescence parameters, photosystem II photochemistry, photon energy dissipation, lipid peroxidation, reactive oxygen species generation and carbon isotope discrimination in Arabidopsis thaliana were studied. Arabidopsis ecotype Columbia (Col-0) seedlings were grown in perlite and watered with 50% Hoagland nutrient solution. Adult plants of Arabidopsis were treated with artemisinin at 0, 40, 80, 160 mu M for one week. Artemisinin, in the range 40-160 mu M, decreased the fresh biomass, chl a, b and leaf mineral contents. Photosynthetic efficiency, yield and electron transport rate in Arabidopsis were also reduced following exposure to 80 and 160 mu M artemisinin. The phi(NPQ) and NPQ were less than control. Artemisinin treatment caused an increase in root oxidizability and lipid peroxidation (MDA contents) of Arabidopsis. Calcium and nitrogen contents decreased after 80 and 160 mu M artemisinin treatment compared to control. delta C-13 values were less negative following treatment with artemisinin as compared to the control. Artemisinin also decreased leaf protein contents in Arabidopsis. Taken together, these data suggest that artemisinin inhibits many physiological and biochemical processes in Arabidopsis.	[Hussain, M. Iftikhar; Reigosa, Manuel J.] Univ Vigo, Dept Plant Biol & Soil Sci, Vigo 36310, Spain; [Hussain, M. Iftikhar] Int Ctr Biosaline Agr, Dubai, U Arab Emirates	Universidade de Vigo	Hussain, MI (corresponding author), Univ Vigo, Dept Plant Biol & Soil Sci, Campus Lagoas Marcosende, Vigo 36310, Spain.	mih76@uvigo.es	Hussain, M. Iftikhar/Y-3575-2018; Roger, Manuel Joaquín Reigosa/O-4438-2019; Reigosa, Manuel J/K-3551-2013; Hussain, M. Iftikhar/AGQ-4987-2022	Hussain, M. Iftikhar/0000-0002-9710-3801; Roger, Manuel Joaquín Reigosa/0000-0003-0527-1849; Reigosa, Manuel J/0000-0003-0527-1849; Hussain, M. Iftikhar/0000-0002-9710-3801	Galician Government [10PXIB310261PR]; project (subprograma AGR) "Estudio del modo de accion del citral en la respuesta temprana de plantas superiors" - Ministerio de Ciencia e Innovacion [AGL2010-17885]	Galician Government; project (subprograma AGR) "Estudio del modo de accion del citral en la respuesta temprana de plantas superiors" - Ministerio de Ciencia e Innovacion	The research was supported by project 10PXIB310261PR from the Galician Government and project AGL2010-17885 (subprograma AGR) "Estudio del modo de accion del citral en la respuesta temprana de plantas superiors" funded by Ministerio de Ciencia e Innovacion. Subdireccion General de Proyectos de Investigacion Proyectos de Investigacion Fundamental no orientada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenavoli MR, 2001, NEW PHYTOL, V150, P619, DOI 10.1046/j.1469-8137.2001.00119.x; Bagchi G. D., 1998, Journal of Medicinal and Aromatic Plant Sciences, V20, P5; Bagchi GD, 1997, PHYTOCHEMISTRY, V45, P1131, DOI 10.1016/S0031-9422(97)00126-X; Barbagallo RP, 2003, PLANT PHYSIOL, V132, P485, DOI 10.1104/pp.102.018093; Barkosky RR, 2000, J CHEM ECOL, V26, P2095, DOI 10.1023/A:1005564315131; Bathellier C, 2008, NEW PHYTOL, V177, P406, DOI 10.1111/j.1469-8137.2007.02246.x; Bharati A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038942; Bohnert HJ, 1998, CURR OPIN PLANT BIOL, V1, P267, DOI 10.1016/S1369-5266(98)80115-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cernusak LA, 2013, NEW PHYTOL, V200, P950, DOI 10.1111/nph.12423; CHEN PK, 1991, J AGR FOOD CHEM, V39, P991, DOI 10.1021/jf00005a038; CHEN PK, 1990, J CHEM ECOL, V16, P1867, DOI 10.1007/BF01020500; Davies MJ, 2009, ANN BOT-LONDON, V104, P315, DOI 10.1093/aob/mcp126; Dayan FE, 2000, J CHEM ECOL, V26, P2079, DOI 10.1023/A:1005512331061; Dayan FE, 1999, PHYTOCHEMISTRY, V50, P607, DOI 10.1016/S0031-9422(98)00568-8; Dayan FE, 2012, PEST MANAG SCI, V68, P519, DOI 10.1002/ps.2332; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; Delabays N, 2001, CURR MED CHEM, V8, P1795, DOI 10.2174/0929867013371635; DITOMASO JM, 1991, PESTIC BIOCHEM PHYS, V39, P158, DOI 10.1016/0048-3575(91)90136-A; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; DUKE SO, 1987, WEED SCI, V35, P499, DOI 10.1017/S0043174500060458; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hussain MI, 2014, PAK J BOT, V46, P995; Hussain MI, 2012, AUST J BOT, V60, P676, DOI 10.1071/BT12072; Hussain MI, 2011, J EXP BOT, V62, P4533, DOI 10.1093/jxb/err161; Hussain MI, 2011, PLANT PHYSIOL BIOCH, V49, P825, DOI 10.1016/j.plaphy.2011.05.003; Imai K, 2008, ANN BOT-LONDON, V101, P135, DOI 10.1093/aob/mcm270; Inderjit, 2003, PLANTA, V217, P529, DOI 10.1007/s00425-003-1054-z; Inderjit, 2007, J PLANT INTERACT, V1, P69; Jessing KK, 2014, J CHEM ECOL, V40, P100, DOI 10.1007/s10886-014-0384-6; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Liu J, 2008, J PLANT BIOL, V51, P11, DOI 10.1007/BF03030735; Lommen WJM, 2007, PLANTA MED, V73, P1133, DOI 10.1055/s-2007-981567; Lydon J, 1997, WEED SCI, V45, P807, DOI 10.1017/S0043174500089001; Macias FA, 2000, J AGR FOOD CHEM, V48, P5288, DOI 10.1021/jf0005364; Macias FA, 2007, PEST MANAG SCI, V63, P327, DOI 10.1002/ps.1342; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; Narwal SS, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P537, DOI 10.1007/1-4020-4280-9_24; Olsson ME, 2009, PHYTOCHEMISTRY, V70, P1123, DOI 10.1016/j.phytochem.2009.07.009; Robertson A, 2001, J GEOPHYS RES-ATMOS, V106, P14783, DOI 10.1029/2000JD900469; SALSAC L, 1987, PLANT PHYSIOL BIOCH, V25, P805; Sanchez-Moreiras AM, 2008, PHYTOCHEMISTRY, V69, P2172, DOI 10.1016/j.phytochem.2008.05.014; Sanchez-Moreiras AM, 2011, J PLANT PHYSIOL, V168, P863, DOI 10.1016/j.jplph.2010.11.011; Shen HC, 1991, J ZHEJIANG AGR U, V17, P423; Spundova M, 2003, J PLANT PHYSIOL, V160, P1051, DOI 10.1078/0176-1617-00902; STILES LH, 1994, J CHEM ECOL, V20, P969, DOI 10.1007/BF02059591; Weathers PJ, 2006, IN VITRO CELL DEV-PL, V42, P309, DOI 10.1079/IVP2006782; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Weston LA, 1996, AGRON J, V88, P860, DOI 10.2134/agronj1996.00021962003600060004x; Xu Q, 1995, ENVIRON EXP BOT, V35, P441, DOI 10.1016/0098-8472(95)00040-2; Yang RY, 2010, PLANTA MED, V76, P734, DOI 10.1055/s-0029-1240620	57	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0114826	10.1371/journal.pone.0114826	http://dx.doi.org/10.1371/journal.pone.0114826			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635811	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700005
J	Jashashvili, T; Dowdeswell, MR; Lebrun, R; Carlson, KJ				Jashashvili, Tea; Dowdeswell, Mark R.; Lebrun, Renaud; Carlson, Kristian J.			Cortical Structure of Hallucal Metatarsals and Locomotor Adaptations in Hominoids	PLOS ONE			English	Article							CROSS-SECTIONAL GEOMETRY; BONE FUNCTIONAL ADAPTATION; IN-VIVO; FOOT BONES; AUSTRALOPITHECUS-AFARENSIS; DIAPHYSEAL STRUCTURE; ANATOMICAL EVIDENCE; MORPHOMETRIC MAPS; MIDTARSAL BREAK; HUMAN SKELETONS	Diaphyseal morphology of long bones, in part, reflects in vivo loads experienced during the lifetime of an individual. The first metatarsal, as a cornerstone structure of the foot, presumably expresses diaphyseal morphology that reflects loading history of the foot during stance phase of gait. Human feet differ substantially from those of other apes in terms of loading histories when comparing the path of the center of pressure during stance phase, which reflects different weight transfer mechanisms. Here we use a novel approach for quantifying continuous thickness and cross-sectional geometric properties of long bones in order to test explicit hypotheses about loading histories and diaphyseal structure of adult chimpanzee, gorilla, and human first metatarsals. For each hallucal metatarsal, 17 cross sections were extracted at regularly-spaced intervals (2.5% length) between 25% and 65% length. Cortical thickness in cross sections was measured in one degree radially-arranged increments, while second moments of area were measured about neutral axes also in one degree radially-arranged increments. Standardized thicknesses and second moments of area were visualized using false color maps, while penalized discriminant analyses were used to evaluate quantitative species differences. Humans systematically exhibit the thinnest diaphyseal cortices, yet the greatest diaphyseal rigidities, particularly in dorsoplantar regions. Shifts in orientation of maximum second moments of area along the diaphysis also distinguish human hallucal metatarsals from those of chimpanzees and gorillas. Diaphyseal structure reflects different loading regimes, often in predictable ways, with human versus non-human differences probably resulting both from the use of arboreal substrates by non-human apes and by differing spatial relationships between hallux position and orientation of the substrate reaction resultant during stance. The novel morphological approach employed in this study offers the potential for transformative insights into form-function relationships in additional long bones, including those of extinct organisms (e.g., fossils).	[Jashashvili, Tea; Carlson, Kristian J.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Jashashvili, Tea] Georgian Natl Museum, Dept Geol & Palaeontol, Tbilisi, Georgia; [Dowdeswell, Mark R.] Univ Witwatersrand, Sch Stat & Actuarial Sci, ZA-2050 Johannesburg, South Africa; [Lebrun, Renaud] Inst Sci Evolut Montpellier, UMR 5554, Montpellier, France; [Carlson, Kristian J.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA	University of Witwatersrand; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Indiana University System; Indiana University Bloomington	Jashashvili, T (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa.	tjashashvili@yahoo.fr		Lebrun, Renaud/0000-0002-5819-2653; Dowdeswell, Mark/0000-0003-0200-653X	post-doctoral fellowship from the Claude Leon Foundation; Strategic Planning and Allocation of Resources Committee at the University of the Witwatersrand; South African Department of Science and Technology; National Research Foundation; Centre of Excellence in Palaeosciences; Evolutionary Studies Institute at the University of the Witwatersrand	post-doctoral fellowship from the Claude Leon Foundation; Strategic Planning and Allocation of Resources Committee at the University of the Witwatersrand; South African Department of Science and Technology; National Research Foundation; Centre of Excellence in Palaeosciences; Evolutionary Studies Institute at the University of the Witwatersrand	TJ was funded by a post-doctoral fellowship from the Claude Leon Foundation and the Strategic Planning and Allocation of Resources Committee at the University of the Witwatersrand. The South African Department of Science and Technology and the National Research Foundation, as well as the Centre of Excellence in Palaeosciences and the Evolutionary Studies Institute at the University of the Witwatersrand provided funding in support of the Virtual Imaging in Palaeosciences laboratory. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; ARCHIBALD JD, 1972, AM J PHYS ANTHROPOL, V37, P93, DOI 10.1002/ajpa.1330370112; Arndt A, 2002, J BIOMECH, V35, P621, DOI 10.1016/S0021-9290(01)00241-X; BOJSENMOLLER F, 1979, J ANAT, V129, P165; Bondioli L, 2010, AM J PHYS ANTHROPOL, V142, P328, DOI 10.1002/ajpa.21271; Caravaggi P, 2009, J EXP BIOL, V212, P2491, DOI 10.1242/jeb.025767; Carlson K, 2008, INT J PRIMATOL, V29, P1401, DOI 10.1007/s10764-008-9297-y; Carlson KJ, 2006, J HUM EVOL, V50, P394, DOI 10.1016/j.jhevol.2005.10.004; Carlson KJ, 2005, AM J PHYS ANTHROPOL, V127, P312, DOI 10.1002/ajpa.20124; Carlson KJ, 2014, RECONSTRUCTING MOBIL, DOI [10.1002/ajpa.22673, DOI 10.1002/AJPA.22673]; Carlson KJ, 2007, J EXP BIOL, V210, P3117, DOI 10.1242/jeb.006544; Cartmill M., 1974, P45; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; DAout K., 2008, ADV PLANTAR PRESSURE, P44; Davies T.G., 2014, RECONSTRUCTING MOBIL, P67, DOI [DOI 10.1007/978-1-4899-7460-0, 10.1007/978-1-4899-7460-0_5]; DAY MH, 1964, NATURE, V201, P969, DOI 10.1038/201969a0; Dayal MR, 2009, AM J PHYS ANTHROPOL, V140, P324, DOI 10.1002/ajpa.21072; DEMES B, 1991, AM J PHYS ANTHROPOL, V86, P537, DOI 10.1002/ajpa.1330860409; Demes B, 2007, AM J PHYS ANTHROPOL, V133, P717, DOI 10.1002/ajpa.20584; DeSilva JM, 2010, AM J PHYS ANTHROPOL, V141, P245, DOI 10.1002/ajpa.21140; Donahue SW, 1999, J BONE JOINT SURG AM, V81A, P1236, DOI 10.2106/00004623-199909000-00005; Doran Diane M., 1996, P213, DOI 10.1017/CBO9780511752414.018; Elftman H, 1935, J ANAT, V70, P56; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; Gebo Daniel L., 1993, P175; Gebol DL, 2006, AM J PHYS ANTHROPOL, V129, P499, DOI 10.1002/ajpa.20320; GOMBERG DN, 1985, J HUM EVOL, V14, P553, DOI 10.1016/S0047-2484(85)80080-4; Griffin NL, 2008, HOMO, V59, P27, DOI 10.1016/j.jchb.2006.08.008; Griffin NL, 2010, J HUM EVOL, V59, P608, DOI 10.1016/j.jhevol.2010.07.017; Griffin NL, 2005, BONE, V37, P253, DOI 10.1016/j.bone.2005.04.019; HASTIE T, 1995, ANN STAT, V23, P73, DOI 10.1214/aos/1176324456; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; HICKS JH, 1954, J ANAT, V88, P25; Johnstone IM, 2009, PHILOS T R SOC A, V367, P4237, DOI 10.1098/rsta.2009.0159; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Kidd RS, 1998, FOOT, V8, P75; Kraft TS, 2014, J HUM EVOL, V71, P105, DOI 10.1016/j.jhevol.2014.02.002; LATIMER B, 1990, AM J PHYS ANTHROPOL, V82, P125, DOI 10.1002/ajpa.1330820202; Lazenby RA, 1998, AM J PHYS ANTHROPOL, V106, P157; Lewis O.J., 1989, FUNCTIONAL MORPHOLOG; LEWIS OJ, 1980, J ANAT, V131, P275; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; LOVEJOY CO, 1976, AM J PHYS ANTHROPOL, V44, P489, DOI 10.1002/ajpa.1330440312; Lundgren P, 2008, GAIT POSTURE, V28, P93, DOI 10.1016/j.gaitpost.2007.10.009; Marchi D, 2005, J HUM EVOL, V49, P743, DOI 10.1016/j.jhevol.2005.08.002; Martin RB, 1998, SKELETAL TISSUE MECH; Mays SA, 2002, J ARCHAEOL SCI, V29, P435, DOI 10.1006/jasc.2002.0729; Morimoto N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102074; Morimoto N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041980; Morimoto N, 2011, ANAT REC, V294, P1433, DOI 10.1002/ar.21424; Morimoto N, 2011, ANAT REC, V294, P589, DOI 10.1002/ar.21346; Morton D.J., 1935, HUMAN FOOT ITS EVOLU; MOTT RL, 1996, APPL STRENGTH MAT; Nowak MG, 2010, AM J PHYS ANTHROPOL, V142, P180, DOI 10.1002/ajpa.21210; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; Preuschoft H., 1970, THE CHIMPANZEE, V3, P221; Puymerail L, 2012, J HUM EVOL, V63, P741, DOI 10.1016/j.jhevol.2012.08.003; Richmond BG, 2007, J HUM EVOL, V53, P678, DOI 10.1016/j.jhevol.2007.05.011; RIESENFELD A, 1974, Primates, V15, P1, DOI 10.1007/BF01749589; RODGERS MM, 1995, J ORTHOP SPORT PHYS, V21, P306, DOI 10.2519/jospt.1995.21.6.306; Rolian C, 2009, J EXP BIOL, V212, P713, DOI 10.1242/jeb.019885; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ruff C.B., 1999, PREHISTORIC LIFEWAYS, P290; RUFF CB, 1992, ANNU REV ANTHROPOL, V21, P407; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; Ruff CB, 2002, AM J PHYS ANTHROPOL, V119, P305, DOI 10.1002/ajpa.10117; RUFF CB, 1991, AM J PHYS ANTHROPOL, V86, P397, DOI 10.1002/ajpa.1330860306; SCHAFFLER MB, 1985, FOLIA PRIMATOL, V45, P61, DOI 10.1159/000156218; Sharkey N. A., 1995, Journal of Bone and Joint Surgery American Volume, V77, P1050; Shaw CN, 2009, AM J PHYS ANTHROPOL, V140, P160, DOI 10.1002/ajpa.21063; Shaw CN, 2009, AM J PHYS ANTHROPOL, V140, P149, DOI 10.1002/ajpa.21064; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUMNER DR, 1989, AM J PHYS ANTHROPOL, V79, P225, DOI 10.1002/ajpa.1330790210; SUSMAN RL, 1983, FOOT ANKLE, V3, P365, DOI 10.1177/107110078300300605; Trinkaus E, 2005, J ARCHAEOL SCI, V32, P1515, DOI 10.1016/j.jas.2005.04.006; Trinkaus E, 2008, J ARCHAEOL SCI, V35, P1928, DOI 10.1016/j.jas.2007.12.002; Tuttle R. H., 1970, THE CHIMPANZEE, V2, P167; Venkataraman VV, 2013, HUM BIOL, V85, P309; Venkataraman VV, 2013, P NATL ACAD SCI USA, V110, P1237, DOI 10.1073/pnas.1208717110; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Vereecke EE, 2005, J ANAT, V206, P453, DOI 10.1111/j.1469-7580.2005.00412.x; Wunderlich R.E., 1999, PEDAL FORM PLANTAR P; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703; Zollikofer CPE, 2001, HOM EVOLUT CLIMAT CH, V2, P50	88	32	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117905	10.1371/journal.pone.0117905	http://dx.doi.org/10.1371/journal.pone.0117905			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635768	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700108
J	O'Mullan, G; Dueker, ME; Clauson, K; Yang, Q; Umemoto, K; Zakharova, N; Matter, J; Stute, M; Takahashi, T; Goldberg, D				O'Mullan, Gregory; Dueker, M. Elias; Clauson, Kale; Yang, Qiang; Umemoto, Kelsey; Zakharova, Natalia; Matter, Juerg; Stute, Martin; Takahashi, Taro; Goldberg, David			Microbial Stimulation and Succession following a Test Well Injection Simulating CO2 Leakage into a Shallow Newark Basin Aquifer	PLOS ONE			English	Article							BACTERIAL DIVERSITY; SALINE AQUIFERS; COMMUNITY COMPOSITION; GEOLOGICAL STORAGE; CARBON-DIOXIDE; RIFT BASIN; WATER; GROUNDWATER; REDUCTION; HYDROGENOPHAGA	In addition to efforts aimed at reducing anthropogenic production of greenhouse gases, geological storage of CO2 is being explored as a strategy to reduce atmospheric greenhouse gas emission and mitigate climate change. Previous studies of the deep subsurface in North America have not fully considered the potential negative effects of CO2 leakage into shallow drinking water aquifers, especially from a microbiological perspective. A test well in the Newark Rift Basin was utilized in two field experiments to investigate patterns of microbial succession following injection of CO2-saturated water into an isolated aquifer interval, simulating a CO2 leakage scenario. A decrease in pH following injection of CO2 saturated aquifer water was accompanied by mobilization of trace elements (e.g. Fe and Mn), and increased bacterial cell concentrations in the recovered water. 16S ribosomal RNA gene sequence libraries from samples collected before and after the test well injection were compared to link variability in geochemistry to changes in aquifer microbiology. Significant changes in microbial composition, compared to background conditions, were found following the test well injections, including a decrease in Proteobacteria, and an increased presence of Firmicutes, Verrucomicrobia and microbial taxa often noted to be associated with iron and sulfate reduction. The concurrence of increased microbial cell concentrations and rapid microbial community succession indicate significant changes in aquifer microbial communities immediately following the experimental CO2 leakage event. Samples collected one year post-injection were similar in cell number to the original background condition and community composition, although not identical, began to revert toward the pre-injection condition, indicating microbial resilience following a leakage disturbance. This study provides a first glimpse into the in situ successional response of microbial communities to CO2 leakage after subsurface injection in the Newark Basin and the potential microbiological impact of CO2 leakage on drinking water resources.	[O'Mullan, Gregory; Dueker, M. Elias; Clauson, Kale] CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA; [O'Mullan, Gregory; Dueker, M. Elias; Yang, Qiang; Zakharova, Natalia; Matter, Juerg; Stute, Martin; Takahashi, Taro; Goldberg, David] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Umemoto, Kelsey; Stute, Martin] Barnard Coll, Dept Environm Sci, New York, NY USA; [Matter, Juerg] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	City University of New York (CUNY) System; Queens College NY (CUNY); Columbia University; NERC National Oceanography Centre; University of Southampton	O'Mullan, G (corresponding author), CUNY Queens Coll, Sch Earth & Environm Sci, Flushing, NY 11367 USA.	gomullan@qc.cuny.edu	Yang, Qiang/N-8198-2013	Yang, Qiang/0000-0002-6788-8775; Zakharova, Natalia V/0000-0002-7677-258X; O'Mullan, Gregory/0000-0003-0590-7704	United States Environmental Protection Agency Grant [R834503]	United States Environmental Protection Agency Grant(United States Environmental Protection Agency)	This research was funded by a United States Environmental Protection Agency Grant (#R834503) to Columbia University (GO, TT, MS, JM, DG), entitled: "Diagnostic monitoring of biogeochemical interactions of a shallow aquifer in response to a CO<INF>2</INF> leak". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouas A, 2000, SCI TOTAL ENVIRON, V250, P21, DOI 10.1016/S0048-9697(99)00549-5; Assayag N, 2009, CHEM GEOL, V265, P227, DOI 10.1016/j.chemgeo.2009.02.007; BACHU S, 1994, ENERG CONVERS MANAGE, V35, P269, DOI 10.1016/0196-8904(94)90060-4; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; BERGMAN PD, 1995, ENERG CONVERS MANAGE, V36, P523, DOI 10.1016/0196-8904(95)00058-L; Booth IR, 2002, ANTON LEEUW INT J G, V81, P33, DOI 10.1023/A:1020565206835; Burgdorff K., 2001, VIS GEOSCI, V6, P1; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; Chaban B, 2006, CAN J MICROBIOL, V52, P73, DOI [10.1139/WDS-147, 10.1139/w05-147]; CHRISTENSEN H, 1995, MICROBIAL ECOL, V29, P49, DOI 10.1007/BF00217422; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Flynn TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-146; Giese R, 2009, ENRGY PROCED, V1, P2251, DOI 10.1016/j.egypro.2009.01.293; Gonzalez-Toril E, 2003, APPL ENVIRON MICROB, V69, P4853, DOI 10.1128/AEM.69.8.4853-4865.2003; Gunter W.D., 2004, GEOLOGICAL SOC SPECI, V233, P129, DOI [DOI 10.1144/GSL.SP.2004.233.01.09, 10.1144/GSL.SP.2004.233.01.09]; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Hitchon B, 1996, AQUIFER DISPOSAL OF; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Holloway S, 2001, ANNU REV ENERG ENV, V26, P145, DOI 10.1146/annurev.energy.26.1.145; Intergovernmental Panel on Climate Change, 2005, IPCC SPECIAL REPORT; Kharaka YK, 2009, APPL GEOCHEM, V24, P1106, DOI 10.1016/j.apgeochem.2009.02.010; Kim J, 2004, SCIENCE, V303, P830, DOI 10.1126/science.1093245; Kwon MJ, 2008, GROUND WATER, V46, P286, DOI 10.1111/j.1745-6584.2007.00401.x; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Lall U, 2011, J CONTEMP WATER RESE, V123, P4; Lavalleur HJ, 2013, FEMS MICROBIOL ECOL, V85, P62, DOI 10.1111/1574-6941.12098; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; Little MG, 2010, ENVIRON SCI TECHNOL, V44, P9225, DOI 10.1021/es102235w; Lovely DR, 1995, MICROBIOL REV, V55, P259; Lu JM, 2010, ENVIRON EARTH SCI, V60, P335, DOI 10.1007/s12665-009-0382-0; Macalady JL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0383; Matter JM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001427; Matter JM, 2006, HYDROGEOL J, V14, P689, DOI 10.1007/s10040-005-0456-3; McCune B, 2002, ANALYSIS OF ECOLOGIC; McCune B., 2011, PC ORD MULTIVARIATE; McMahon S, 2014, FEMS MICROBIOL ECOL, V87, P113, DOI 10.1111/1574-6941.12196; Morozova D, 2011, ENRGY PROCED, V4, P4362, DOI 10.1016/j.egypro.2011.02.388; Morozova D, 2010, INT J GREENH GAS CON, V4, P981, DOI 10.1016/j.ijggc.2009.11.014; Navarro-Noya YE, 2013, MICROB ECOL, V66, P19, DOI 10.1007/s00248-013-0222-3; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; O'Flaherty V, 1998, PROCESS BIOCHEM, V33, P555, DOI 10.1016/S0032-9592(98)00018-1; Olsen PE, 1996, GEOL SOC AM BULL, V108, P40, DOI 10.1130/0016-7606(1996)108<0040:HRSOTN>2.3.CO;2; Onstott TC, 2005, CARBON DIOXIDE CAPTURE FOR STORAGE IN DEEP GEOLOGIC FORMATIONS - RESULTS FROM THE CO2 CAPTURE PROJECT, VOLS 1 AND 2, P1217; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Pedersen K, 1997, GEOLOGY, V25, P827, DOI 10.1130/0091-7613(1997)025<0827:EOALAM>2.3.CO;2; Petsch ST, 2005, PALAEOGEOGR PALAEOCL, V219, P157, DOI 10.1016/j.palaeo.2004.10.019; Pokrovsky OS, 2005, CHEM GEOL, V217, P239, DOI 10.1016/j.chemgeo.2004.12.012; Purkamo L, 2013, FEMS MICROBIOL ECOL, V85, P324, DOI 10.1111/1574-6941.12126; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Rhine ED, 2008, ENVIRON SCI TECHNOL, V42, P1423, DOI 10.1021/es071859k; Rochelle C.A., 2004, GEOL SOC LOND SPEC P, V233, P87, DOI [10.1144/GSL.SP.2004.233.01.07, DOI 10.1144/GSL.SP.2004.233.01.07]; Roden EE, 1996, ENVIRON SCI TECHNOL, V30, P1618, DOI 10.1021/es9506216; Routh J, 2005, ACS SYM SER, V915, P132, DOI 10.1021/bk-2005-0915.ch010; Sahl JW, 2008, APPL ENVIRON MICROB, V74, P143, DOI 10.1128/AEM.01133-07; Santillan EU, 2013, GEOMICROBIOL J, V30, P578, DOI 10.1080/01490451.2013.767396; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Senko JM, 2009, GEOMICROBIOL J, V26, P71, DOI 10.1080/01490450802660193; Shani N, 2013, GROUND WATER MONIT R, V33, P31, DOI 10.1111/j.1745-6592.2012.01420.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sorensen JPR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070264; Srinivasan V, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011087; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Szulczewski ML, 2012, P NATL ACAD SCI USA, V109, P5185, DOI 10.1073/pnas.1115347109; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Tischer K, 2013, ENVIRON MICROBIOL, V15, P2603, DOI 10.1111/1462-2920.12168; Trautz RC, 2013, ENVIRON SCI TECHNOL, V47, P298, DOI 10.1021/es301280t; Vaz-Moreira I, 2011, APPL ENVIRON MICROB, V77, P5697, DOI 10.1128/AEM.00579-11; Visser A, 1996, WATER SCI TECHNOL, V33, P99, DOI 10.1016/0273-1223(96)00324-1; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wall JD, 2007, SULPHATE-REDUCING BACTERIA: ENVIRONMENTAL AND ENGINEERED SYSTEMS, P141, DOI 10.1017/CBO9780511541490.005; Wandrey M, 2011, ENRGY PROCED, V4, P3651, DOI 10.1016/j.egypro.2011.02.296; Weber KA, 2011, APPL ENVIRON MICROB, V77, P4693, DOI 10.1128/AEM.02539-10; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; WILLEMS A, 1989, INT J SYST BACTERIOL, V39, P319, DOI 10.1099/00207713-39-3-319; Williams KH, 2010, ENVIRON SCI TECHNOL, V44, P47, DOI 10.1021/es9017464; Williams WL, 2010, J DAIRY SCI, V93, P4735, DOI 10.3168/jds.2009-2920; Yang CB, 2013, INT J GREENH GAS CON, V18, P375, DOI 10.1016/j.ijggc.2012.12.030; Yang Q, 2014, INT J GREENH GAS CON, V26, P193, DOI 10.1016/j.ijggc.2014.04.025; Yoon JH, 2008, INT J SYST EVOL MICR, V58, P393, DOI 10.1099/ijs.0.65271-0; Zheng LG, 2012, INT J GREENH GAS CON, V7, P202, DOI 10.1016/j.ijggc.2011.10.003; Zhu WY, 2008, GEOCHIM COSMOCHIM AC, V72, P5243, DOI 10.1016/j.gca.2008.08.006; Zhu WY, 2012, GEOMICROBIOL J, V29, P186, DOI 10.1080/01490451.2010.539663	86	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117812	10.1371/journal.pone.0117812	http://dx.doi.org/10.1371/journal.pone.0117812			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635675	Green Accepted, Green Published, gold			2022-12-26	WOS:000350680700099
J	Peng, XJ; Li, WP; Johnson, WD; Torres, KEO; McCormick, DL				Peng, Xinjian; Li, Wenping; Johnson, William D.; Torres, Karen E. O.; McCormick, David L.			Overexpression of Lipocalins and Pro-Inflammatory Chemokines and Altered Methylation of PTGS2 and APC2 in Oral Squamous Cell Carcinomas Induced in Rats by 4-Nitroquinoline-1-Oxide	PLOS ONE			English	Article							BOWMAN-BIRK INHIBITOR; GELATINASE-ASSOCIATED LIPOCALIN; UP-REGULATION; HUMAN-PAPILLOMAVIRUS; OVARIAN-CANCER; KALLIKREIN 6; LIGAND 2; EXPRESSION; CYCLOOXYGENASE-2; CARCINOGENESIS	Oral squamous cell carcinomas (OSCC) induced in F344 rats by 4-nitroquinoline-1-oxide (4-NQO) demonstrate considerable phenotypic similarity to human oral cancers. Gene expression studies (microarray and PCR) were coupled with methylation analysis of selected genes to identify molecular markers of carcinogenesis in this model and potential biochemical and molecular targets for oral cancer chemoprevention. Microarray analysis of 11 pairs of OSCC and site-matched phenotypically normal oral tissues from 4-NQO-treated rats identified more than 3500 differentially expressed genes; 1735 genes were up-regulated in rat OSCC versus non-malignant tissues, while 1803 genes were down-regulated. In addition to several genes involved in normal digestion, genes demonstrating the largest fold increases in expression in 4-NQO-induced OSCC include three lipocalins (VEGP1, VEGP2, LCN2) and three chemokines (CCL, CXCL2, CXCL3); both classes are potentially druggable targets for oral cancer chemoprevention and/or therapy. Down-regulated genes in 4-NQO-induced OSCC include numerous keratins and keratin-associated proteins, suggesting that alterations in keratin expression profiles may provide a useful biomarker of oral cancer in F344 rats treated with 4-NQO. Confirming and extending our previous results, PTGS2 (cyclooxygenase-2) and several cyclooxygenase-related genes were significantly up-regulated in 4-NQO-induced oral cancers; up-regulation of PTGS2 was associated with promoter hypomethylation. Rat OSCC also demonstrated increased methylation of the first exon of APC2; the increased methylation was correlated with down-regulation of this tumor suppressor gene. Overexpression of pro-inflammatory chemokines, hypomethylation of PTGS2, and hypermethylation of APC2 may be causally linked to the etiology of oral cancer in this model.	[Peng, Xinjian; Li, Wenping; Johnson, William D.; McCormick, David L.] IIT Res Inst, Life Sci Grp, Chicago, IL 60616 USA; [Torres, Karen E. O.] GenUs Biosyst, Northbrook, IL 60062 USA	Illinois Institute of Technology	Peng, XJ (corresponding author), IIT Res Inst, Life Sci Grp, Chicago, IL 60616 USA.	xpeng@iitri.org		Torres, Keila E/0000-0002-1855-0989; Li, Wenping/0000-0001-5917-5380	IIT Research Institute	IIT Research Institute	This work was supported by internal research and development funds from IIT Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul B, 2011, J GEN VIROL, V92, P395, DOI 10.1099/vir.0.025064-0; Ambatipudi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070688; Armstrong WB, 2003, LARYNGOSCOPE, V113, P1687, DOI 10.1097/00005537-200310000-00007; Armstrong WB, 2000, CLIN CANCER RES, V6, P4684; Armstrong WB, 2013, CANCER PREV RES, V6, P410, DOI 10.1158/1940-6207.CAPR-13-0004; Baba T, 2013, J EXP MED, V210, P2661, DOI 10.1084/jem.20130112; BLOT WJ, 1988, CANCER RES, V48, P3282; Bremmer JF, 2009, CANCER PREV RES, V2, P128, DOI 10.1158/1940-6207.CAPR-08-0128; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Christodoulou S, 2014, TUMOR BIOL, V35, P4673, DOI 10.1007/s13277-014-1612-y; Ding L, 2014, TUMOR BIOL, V35, P10539, DOI 10.1007/s13277-014-2306-1; Domingo-Gonzalez R, 2012, J IMMUNOL, V189, P4528, DOI 10.4049/jimmunol.1201116; Fernandez-Alvarez A, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.23; Ferreira JG, 2013, J BIOL CHEM, V288, P13641, DOI 10.1074/jbc.M112.404053; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Graveland AP, 2013, ORAL ONCOL, V49, P1129, DOI 10.1016/j.oraloncology.2013.09.005; Hiromoto T, 2011, ONCOL REP, V26, P1415, DOI 10.3892/or.2011.1429; Hu CJ, 2013, WSPOLCZESNA ONKOL, V17, P64, DOI 10.5114/wo.2013.33776; Ida-Yonemochi H, 2012, MODERN PATHOL, V25, P784, DOI 10.1038/modpathol.2011.218; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; Kanojia Deepak, 2012, J Carcinog, V11, P14, DOI 10.4103/1477-3163.100861; Kaur S, 2014, CLIN CANCER RES, V20, P688, DOI 10.1158/1078-0432.CCR-13-2174; Kennedy AR, 1998, AM J CLIN NUTR, V68, p1406S, DOI 10.1093/ajcn/68.6.1406S; KENNEDY AR, 1993, NUTR CANCER, V19, P191, DOI 10.1080/01635589309514249; Kim JT, 2011, CANCER-AM CANCER SOC, V117, P2608, DOI 10.1002/cncr.25841; KITANO M, 1992, JPN J CANCER RES, V83, P843, DOI 10.1111/j.1349-7006.1992.tb01989.x; Leng XH, 2011, J CELL PHYSIOL, V226, P309, DOI 10.1002/jcp.22403; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li X, 2014, CARCINOGENESIS, V35, P1362, DOI 10.1093/carcin/bgu046; McCormick DL, 2010, CANCER PREV RES, V3, P73, DOI 10.1158/1940-6207.CAPR-09-0151; Meng XY, 2012, J DIGEST DIS, V13, P208, DOI 10.1111/j.1751-2980.2012.00578.x; Mighty KK, 2014, RECENT RESULTS CANC, V193, P135, DOI 10.1007/978-3-642-38965-8_8; Nakahata AM, 2013, PLANTA MED, V79, P227, DOI 10.1055/s-0032-1328156; National Institute of Dental and Craniofacial Research, ORAL CANCER 5 YEAR S; Oue E, 2012, BIOCHEM BIOPH RES CO, V424, P456, DOI 10.1016/j.bbrc.2012.06.132; Peng XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070442; Pytynia KB, 2014, ORAL ONCOL, V50, P380, DOI 10.1016/j.oraloncology.2013.12.019; Rezze GG, 2011, HUM PATHOL, V42, P409, DOI 10.1016/j.humpath.2010.09.004; ROTHMAN K, 1972, J CHRON DIS, V25, P711, DOI 10.1016/0021-9681(72)90006-9; Sandhu SK, 2013, CANCER CHEMOTH PHARM, V71, P1041, DOI 10.1007/s00280-013-2099-8; Seiz L, 2012, BIOL CHEM, V393, P391, DOI 10.1515/hsz-2011-0264; Shan SJC, 2007, BRIT J CANCER, V96, P362, DOI 10.1038/sj.bjc.6603556; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silva TA, 2007, ONCOL REP, V18, P1107; Tanaka Takuji, 2011, Patholog Res Int, V2011, P431246, DOI 10.4061/2011/431246; Tsimplaki E, 2014, ANTICANCER RES, V34, P1021; Tung MC, 2013, PROSTATE, V73, P1281, DOI 10.1002/pros.22670; Vallet S, 2011, EXPERT OPIN THER TAR, V15, P1037, DOI 10.1517/14728222.2011.586634; Wyss A, 2013, AM J EPIDEMIOL, V178, P679, DOI 10.1093/aje/kwt029; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yoshida K, 2003, CANCER SCI, V94, P365, DOI 10.1111/j.1349-7006.2003.tb01448.x; Zhang J, 2010, PROG MOL BIOL TRANSL, V95, P31, DOI 10.1016/B978-0-12-385071-3.00003-4	53	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116285	10.1371/journal.pone.0116285	http://dx.doi.org/10.1371/journal.pone.0116285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635769	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700028
J	Miyake, T; Shimizu, K; Kamiya, K				Miyake, Toshiyuki; Shimizu, Kimiya; Kamiya, Kazutaka			Distribution of Posterior Corneal Astigmatism According to Axis Orientation of Anterior Corneal Astigmatism	PLOS ONE			English	Article							SCHEIMPFLUG PHOTOGRAPHY; SURFACE TORICITY; REPEATABILITY; PENTACAM; AGREEMENT; THICKNESS; SYSTEM; POWER	Purpose To investigate the distribution of posterior corneal astigmatism in eyes with with-the-rule (WTR) and against-the-rule (ATR) anterior corneal astigmatism. Methods We retrospectively examined six hundred eight eyes of 608 healthy subjects (275 men and 333 women; mean age +/- standard deviation, 55.3 +/- 20.2 years). The magnitude and axis orientation of anterior and posterior corneal astigmatism were determined with a rotating Scheimpflug system (Pentacam HR, Oculus) when we divided the subjects into WTR and ATR anterior corneal astigmatism groups. Results The mean magnitudes of anterior and posterior corneal astigmatism were 1.14 +/- 0.76 diopters (D), and 0.37 +/- 0.19 D, respectively. We found a significant correlation between the magnitudes of anterior and posterior corneal astigmatism (Pearson correlation coefficient r = 0.4739, P<0.001). In the WTR anterior astigmatism group, we found ATR astigmatism of the posterior corneal surface in 402 eyes (96.6%). In the ATR anterior astigmatism group, we found ATR posterior corneal astigmatism in 82 eyes (73.9%). Especially in eyes with ATR anterior corneal astigmatism of 1 D or more and 1.5 D or more, ATR posterior corneal astigmatism was found in 28 eyes (59.6%) and 9 eyes (42.9%), respectively. Conclusions WTR anterior astigmatism and ATR posterior astigmatism were found in approximately 68% and 91% of eyes, respectively. The magnitude and the axis orientation of posterior corneal astigmatism were not constant, especially in eyes having high ATR anterior corneal astigmatism, as is often the case in patients who have undergone toric IOL implantation.	[Miyake, Toshiyuki; Shimizu, Kimiya; Kamiya, Kazutaka] Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa, Japan	Kitasato University	Miyake, T (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Sagamihara, Kanagawa, Japan.	ys01.w.mmipfirdf@gmail.com						Barkana Y, 2005, J CATARACT REFR SURG, V31, P1729, DOI 10.1016/j.jcrs.2005.03.058; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Buehl W, 2006, AM J OPHTHALMOL, V141, P7, DOI 10.1016/j.ajo.2005.08.048; Cheng LS, 2011, ACTA OPHTHALMOL, V89, P417, DOI 10.1111/j.1755-3768.2009.01732.x; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Dubbelman M, 2002, ACTA OPHTHALMOL SCAN, V80, P379, DOI 10.1034/j.1600-0420.2002.800406.x; DUNNE MCM, 1991, OPTOMETRY VISION SCI, V68, P708, DOI 10.1097/00006324-199109000-00006; Ho JD, 2008, J CATARACT REFR SURG, V34, P137, DOI 10.1016/j.jcrs.2007.09.033; Ho JD, 2010, CORNEA, V29, P632, DOI 10.1097/ICO.0b013e3181c2965f; Ho JD, 2009, AM J OPHTHALMOL, V147, P788, DOI 10.1016/j.ajo.2008.12.020; Kawamorita T, 2009, J CATARACT REFR SURG, V35, P127, DOI 10.1016/j.jcrs.2008.10.019; Koch DD, 2013, J CATARACT REFR SURG, V39, P1803, DOI 10.1016/j.jcrs.2013.06.027; Koch DD, 2012, J CATARACT REFR SURG, V38, P2080, DOI 10.1016/j.jcrs.2012.08.036; Lackner B, 2005, OPTOMETRY VISION SCI, V82, P858, DOI 10.1097/01.opx.0000177804.53192.15; Modis L, 2004, CORNEA, V23, P689; Pinero DP, 2009, J CATARACT REFR SURG, V35, P113, DOI 10.1016/j.jcrs.2008.10.010; Prisant O, 2002, J CATARACT REFR SURG, V28, P1636, DOI 10.1016/S0886-3350(01)01258-5; ROYSTON JM, 1990, OPTOMETRY VISION SCI, V67, P757, DOI 10.1097/00006324-199010000-00002; Shankar H, 2008, J CATARACT REFR SURG, V34, P103, DOI 10.1016/j.jcrs.2007.09.013; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P1716, DOI 10.1167/iovs.09-4982; Wang L, 2010, J CATARACT REFR SURG, V36, P425, DOI 10.1016/j.jcrs.2009.09.034	21	44	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117194	10.1371/journal.pone.0117194	http://dx.doi.org/10.1371/journal.pone.0117194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625283	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821400029
J	Guo, YR; Scheuermann, TH; Partch, CL; Tomchick, DR; Gardner, KH				Guo, Yirui; Scheuermann, Thomas H.; Partch, Carrie L.; Tomchick, Diana R.; Gardner, Kevin H.			Coiled-coil Coactivators Play a Structural Role Mediating Interactions in Hypoxia-inducible Factor Heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Hypoxia-inducible Factor (HIF); Nuclear Magnetic Resonance (NMR); Transcription Coactivator; Transcription Regulation; ARNT; TACC3; Coiled-coil Coactivator Recruitment	RECEPTOR NUCLEAR TRANSLOCATOR; PAS-B DOMAIN; TRANSCRIPTION FACTOR; SMALL MOLECULES; X-RAY; RECRUITMENT; ARNT; SOFTWARE; BINDING; FAMILY	Background: Coiled-coil coactivators can enhance HIF-dependent gene transcription via direct interaction with the HIF/ARNT heterodimer. Results: ARNT uses the -sheet of the PAS-B domain to recruit coiled-coil coactivators. Conclusion: Coiled-coil coactivators bridge HIF and ARNT via the PAS-B domain -sheet contacts to both proteins to form a ternary structure. Significance: This work reveals the mechanism for assembling a coiled-coil coactivator complex with the HIF-2 transcription factor heterodimer. The hypoxia-inducible factor complex (HIF-alpha.aryl hydrocarbon receptor nuclear translocator (ARNT)) requires association with several transcription coactivators for a successful cellular response to hypoxic stress. In addition to the conventional global transcription coactivator CREB-binding protein/p300 (CBP/p300) that binds to the HIF-alpha transactivation domain, a new group of transcription coactivators called the coiled-coil coactivators (CCCs) interact directly with the second PER-ARNT-SIM (PAS) domain of ARNT (ARNT PAS-B). These less studied transcription coactivators play essential roles in the HIF-dependent hypoxia response, and CCC misregulation is associated with several forms of cancer. To better understand CCC protein recruitment by the heterodimeric HIF transcription factor, we used x-ray crystallography, NMR spectroscopy, and biochemical methods to investigate the structure of the ARNT PAS-B domain in complex with the C-terminal fragment of a coiled-coil coactivator protein, transforming acidic coiled-coil coactivator 3 (TACC3). We found that the HIF-2 alpha PAS-B domain also directly interacts with TACC3, motivating an NMR data-derived model suggesting a means by which TACC3 could form a ternary complex with HIF-2 alpha PAS-B and ARNT PAS-B via beta-sheet/coiled-coil interactions. These findings suggest that TACC3 could be recruited as a bridge to cooperatively mediate between the HIF-2 PAS-B.ARNT PAS-B complex, thereby participating more directly in HIF-dependent gene transcription than previously anticipated.	[Guo, Yirui; Scheuermann, Thomas H.; Partch, Carrie L.; Tomchick, Diana R.; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Guo, Yirui; Scheuermann, Thomas H.; Partch, Carrie L.; Tomchick, Diana R.; Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Gardner, Kevin H.] CUNY, Struct Biol Initiat, Adv Sci Res Ctr, New York, NY 10031 USA; [Gardner, Kevin H.] CUNY City Coll, Dept Chem, New York, NY 10031 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; City University of New York (CUNY) System; City University of New York (CUNY) System; City College of New York (CUNY)	Gardner, KH (corresponding author), CUNY, Struct Biol Initiat, Adv Sci Res Ctr, 85 St Nicholas Terrace, New York, NY 10031 USA.	Kevin.Gardner@asrc.cuny.edu	Gardner, Kevin H./K-7802-2012; Tomchick, Diana/HGV-2018-2022; Gardner, Kevin/K-5493-2019	Gardner, Kevin H./0000-0002-8671-2556; Partch, Carrie/0000-0002-4677-2861; Tomchick, Diana/0000-0002-7529-4643	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [F32CA130441, P01CA095471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081875] Funding Source: NIH RePORTER	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Richard Bruick for discussions about this work and HIF signaling in general, Drs. Arati Ramesh and Dominika Borek for their kind help with x-ray crystallography data analysis, Dr. Fernando Correa for assistance with PRE data analysis, and Dr. Chad Brautigam for assistance with MST assay. Portions of this work were performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. The Argonne National Laboratory is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Greenfield NJ, 1998, BIOCHEMISTRY-US, V37, P7834, DOI 10.1021/bi973167m; Guo YR, 2013, ACS CHEM BIOL, V8, P626, DOI 10.1021/cb300604u; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Huang NA, 2012, SCIENCE, V337, P189, DOI 10.1126/science.1222804; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JH, 2004, J BIOL CHEM, V279, P49842, DOI 10.1074/jbc.M408535200; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Partch CL, 2010, J CELL PHYSIOL, V223, P553, DOI 10.1002/jcp.22067; Partch CL, 2009, J BIOL CHEM, V284, P15184, DOI 10.1074/jbc.M808479200; Rogers JL, 2013, J MED CHEM, V56, P1739, DOI 10.1021/jm301847z; Sadek CM, 2000, MECH DEVELOP, V97, P13, DOI 10.1016/S0925-4773(00)00415-9; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/nchembio.1185, 10.1038/NCHEMBIO.1185]; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834	35	19	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7707	7721		10.1074/jbc.M114.632786	http://dx.doi.org/10.1074/jbc.M114.632786			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25627682	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000351613600032
J	Rodionova, IA; Zuccola, HJ; Sorci, L; Aleshin, AE; Kazanov, MD; Ma, CT; Sergienko, E; Rubin, EJ; Locher, CP; Osterman, AL				Rodionova, Irina A.; Zuccola, Harmon J.; Sorci, Leonardo; Aleshin, Alexander E.; Kazanov, Marat D.; Ma, Chen-Ting; Sergienko, Eduard; Rubin, Eric J.; Locher, Christopher P.; Osterman, Andrei L.			Mycobacterial Nicotinate Mononucleotide Adenylyltransferase STRUCTURE, MECHANISM, AND IMPLICATIONS FOR DRUG DISCOVERY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitor; Enzyme Structure; NAD Biosynthesis; Protein Engineering; Protein Targeting	TARGETING NAD BIOSYNTHESIS; CRYSTAL-STRUCTURE; TUBERCULOSIS; IDENTIFICATION; INHIBITORS; SUBSTRATE; RECONSTRUCTION; DEAMIDASE; INSIGHTS; REVEALS	Background: NAD biosynthesis was implicated as an antibacterial target pathway. Results: Structure-functional analysis of Mycobacterium tuberculosis NadD revealed an over-closed conformation and a sequential kinetic mechanism. Conclusion:M. tuberculosis NadD is a potentially druggable target suitable for the development of selective inhibitors. Significance: This study describes a novel regulatory mechanism and points to a specific strategy for targeting mycobacterial NadD. Nicotinate mononucleotide adenylyltransferase NadD is an essential enzyme in the biosynthesis of the NAD cofactor, which has been implicated as a target for developing new antimycobacterial therapies. Here we report the crystal structure of Mycobacterium tuberculosis NadD (MtNadD) at a resolution of 2.4 angstrom. A remarkable new feature of the MtNadD structure, compared with other members of this enzyme family, is a 3(10) helix that locks the active site in an over-closed conformation. As a result, MtNadD is rendered inactive as it is topologically incompatible with substrate binding and catalysis. Directed mutagenesis was also used to further dissect the structural elements that contribute to the interactions of the two MtNadD substrates, i.e. ATP and nicotinic acid mononucleotide (NaMN). For inhibitory profiling of partially active mutants and wild type MtNadD, we used a small molecule inhibitor of MtNadD with moderate affinity (K-i approximate to 25 m) and antimycobacterial activity (MIC80) approximate to 40-80 m). This analysis revealed interferences with some of the residues in the NaMN binding subsite consistent with the competitive inhibition observed for the NaMN substrate (but not ATP). A detailed steady-state kinetic analysis of MtNadD suggests that ATP must first bind to allow efficient NaMN binding and catalysis. This sequential mechanism is consistent with the requirement of transition to catalytically competent (open) conformation hypothesized from structural modeling. A possible physiological significance of this mechanism is to enable the down-regulation of NAD synthesis under ATP-limiting dormancy conditions. These findings point to a possible new strategy for designing inhibitors that lock the enzyme in the inactive over-closed conformation.	[Rodionova, Irina A.; Aleshin, Alexander E.; Ma, Chen-Ting; Sergienko, Eduard; Osterman, Andrei L.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Zuccola, Harmon J.; Locher, Christopher P.] Vertex Pharmaceut Inc, Boston, MA 02210 USA; [Sorci, Leonardo] Polytech Univ Marche, Biochem Sect, Dept Clin Sci, I-60131 Ancona, Italy; [Kazanov, Marat D.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow 127051, Russia; [Rubin, Eric J.] Harvard Univ, Dept Immunol & Infect Dis, Sch Publ Hlth, Boston, MA 02115 USA	Sanford Burnham Prebys Medical Discovery Institute; Vertex Pharmaceuticals; Marche Polytechnic University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Osterman, AL (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	osterman@sanfordburnham.org	Kazanov, Marat D/D-6381-2013; SORCI, LEONARDO/AAD-7395-2019	Kazanov, Marat D/0000-0002-2314-5507; SORCI, LEONARDO/0000-0002-4356-8873; Zuccola, Harmon/0000-0002-2454-784X	NIH [R03 MH095597-02]; NIGMS, National Institutes of Health; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH095597] Funding Source: NIH RePORTER; Russian Science Foundation [14-24-00155] Funding Source: Russian Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Russian Science Foundation(Russian Science Foundation (RSF))	Identification of S. aureus NadD inhibitors from National Institutes of Health (NIH) Molecular Libraries Screening Centers Network (MLSCN) collection used in this study was supported by NIH Grant R03 MH095597-02 (to A. O.). We are grateful to Dr. A. Pinkerton and other colleagues at Conrad Prebys Center for Chemical Genomics (Sanford-Burnham Medical Research Institute (SBMRI)) for invaluable contributions to this effort. We thank Dr. Dongyang Li, Yuzhou Xu, and Yannan Wang of Shanghai ChemPartner for protein expression, protein purification, and crystallography support and Dr. John A. Thomson of Vertex Pharmaceuticals for support of the project. We thank Brian Schuster for help on mycobacterial genetics and physiology during his graduate work at Harvard Medical School. The Berkeley Center for Structural Biology is supported in part by the NIGMS, National Institutes of Health and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fattorini L, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.072; Galeazzi L, 2011, J BIOL CHEM, V286, P40365, DOI 10.1074/jbc.M111.275818; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Haagsma AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023575; Han S, 2006, J MOL BIOL, V360, P814, DOI 10.1016/j.jmb.2006.05.055; Hegymegi-Barakonyi B, 2008, CURR MED CHEM, V15, P2760, DOI 10.2174/092986708786242886; Huang NA, 2010, J MED CHEM, V53, P5229, DOI 10.1021/jm100377f; Kim JH, 2013, P NATL ACAD SCI USA, V110, P19095, DOI 10.1073/pnas.1315860110; Koul A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4369; LaRonde-LeBlanc N, 2009, NAT STRUCT MOL BIOL, V16, P421, DOI 10.1038/nsmb.1567; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olland AM, 2002, J BIOL CHEM, V277, P3698, DOI 10.1074/jbc.M109670200; Organization W. H., 2014, GLOB TUB REP 2014, P1; OSTERMAN AL, 1995, BIOCHEMISTRY-US, V34, P13431, DOI 10.1021/bi00041a021; Rodionova IA, 2014, MBIO, V5, DOI 10.1128/mBio.00747-13; Segel I. H., 1975, ENZYME KINETICS, P819; Sershon VC, 2009, J MOL BIOL, V385, P867, DOI 10.1016/j.jmb.2008.10.037; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Sorci L, 2014, FEBS LETT, V588, P1016, DOI 10.1016/j.febslet.2014.01.063; Sorci L, 2013, J BACTERIOL, V195, P726, DOI 10.1128/JB.02002-12; Sorci L, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P213; Sorci L, 2010, J BIOL CHEM, V285, P39490, DOI 10.1074/jbc.M110.185629; Sorci L, 2009, CHEM BIOL, V16, P849, DOI 10.1016/j.chembiol.2009.07.006; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Syhre M, 2009, TUBERCULOSIS, V89, P263, DOI 10.1016/j.tube.2009.04.003; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang C, 2008, J BACTERIOL, V190, P1773, DOI 10.1128/JB.01469-07; Yoon HJ, 2005, J MOL BIOL, V351, P258, DOI 10.1016/j.jmb.2005.06.001; Zhang H, 2002, STRUCTURE, V10, P69, DOI 10.1016/S0969-2126(01)00693-1; Zumla A, 2013, LANCET, V382, P1765, DOI 10.1016/S0140-6736(13)62078-4; Zumla AI, 2014, LANCET INFECT DIS, V14, P327, DOI 10.1016/S1473-3099(13)70328-1	41	17	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7693	7706		10.1074/jbc.M114.628016	http://dx.doi.org/10.1074/jbc.M114.628016			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25631047	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000351613600031
J	Sanders, YY; Cui, ZB; Le Saux, CJ; Horowitz, JC; Rangarajan, S; Kurundkar, A; Antony, VB; Thannickal, VJ				Sanders, Yan Y.; Cui, Zongbin; Le Saux, Claude Jourdan; Horowitz, Jeffrey C.; Rangarajan, Sunad; Kurundkar, Ashish; Antony, Veena B.; Thannickal, Victor J.			SMAD-Independent Down-Regulation of Caveolin-1 by TGF-beta: Effects on Proliferation and Survival of Myofibroblasts	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; HUMAN LUNG FIBROBLASTS; GENE-EXPRESSION; MAP KINASE; CELL-PROLIFERATION; P38 MAPK; GROWTH-FACTOR-BETA-1; ACTIVATION; INDUCTION	Transforming growth factor-beta (TGF-beta) mediates growth-inhibitory effects on most target cells via activation of the canonical SMAD signaling pathway. This growth-inhibitory activity may be coupled with cellular differentiation. Our studies demonstrate that TGF-beta 1 inhibits proliferation of primary, non-transformed human lung fibroblasts in association with the induction of myofibroblast differentiation. Differentiated myofibroblasts maintain the capacity to proliferate in response to exogenous mitogenic stimuli and are resistant to serum deprivation-induced apoptosis. These proliferative and anti-apoptotic properties of myofibroblasts are related, in part, to the down-regulation of caveolin-1 (Cav-1) by TGF-beta 1. Cav-1 down-regulation is mediated by early activation of p38 MAPK and does not require SMAD signaling. In contrast, myofibroblast differentiation is dependent on activation of the SMAD pathway, but not on p38 MAPK. Thus, combinatorial signaling by TGF-beta 1 of myofibroblast differentiation and down-regulation of Cav-1 by SMAD and p38 MAPK pathways, respectively, confer proliferative and apoptosis-resistant properties to myofibroblasts. Selective targeting of this SMAD-independent, p38-MAPK/Cav-1-dependent pathway is likely to be effective in the treatment of pathological conditions characterized by TGF-beta signaling and myofibroblast activation.	[Sanders, Yan Y.; Rangarajan, Sunad; Kurundkar, Ashish; Antony, Veena B.; Thannickal, Victor J.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care, Birmingham, AL 35294 USA; [Cui, Zongbin; Horowitz, Jeffrey C.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Sch Med, Ann Arbor, MI 48109 USA; [Le Saux, Claude Jourdan] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Cardiol, San Antonio, TX 78229 USA	University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health San Antonio	Thannickal, VJ (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care, Birmingham, AL 35294 USA.	vjthan@uab.edu	Rangarajan, Sunad/AAQ-5285-2021; Le Saux, Claude/AGF-7659-2022; Horowitz, Jeffrey/AAY-7238-2021; Sanders, Yan/AAJ-3413-2020	Rangarajan, Sunad/0000-0001-5313-4828; Le Saux, Claude/0000-0002-6041-2870; Horowitz, Jeffrey/0000-0002-1505-2837	National Institutes of Health [P01 HL114470, R01 AG046210]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105489, P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by a National Institutes of Health grant P01 HL114470 and R01 AG046210 (VJT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boopathi E, 2011, AM J PATHOL, V178, P2236, DOI 10.1016/j.ajpath.2011.01.038; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Chen ST, 2004, INT J MOL MED, V14, P577; Dai CS, 2003, J BIOL CHEM, V278, P12537, DOI 10.1074/jbc.M300777200; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Engelman JA, 1999, J BIOL CHEM, V274, P32333, DOI 10.1074/jbc.274.45.32333; Finlay GA, 2000, J BIOL CHEM, V275, P27650; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Fujimoto T, 2000, J CELL SCI, V113, P3509; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Jin Y, 2011, AM J PHYSIOL-LUNG C, V300, pL151, DOI 10.1152/ajplung.00170.2010; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Khalil N, 2005, J BIOL CHEM, V280, P43000, DOI 10.1074/jbc.M510441200; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; Liu J, 2001, AM J PHYSIOL-CELL PH, V280, pC823, DOI 10.1152/ajpcell.2001.280.4.C823; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; MULLER G, 1987, P NATL ACAD SCI USA, V84, P5600, DOI 10.1073/pnas.84.16.5600; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; Nho RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061017; Oeztuerk-Winder F, 2012, EMBO J, V31, P3431, DOI 10.1038/emboj.2012.192; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; Qiu P, 2003, J MOL CELL CARDIOL, V35, P1407, DOI 10.1016/j.yjmcc.2003.09.002; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; ROSENBAUM J, 1995, GASTROENTEROLOGY, V109, P1986, DOI 10.1016/0016-5085(95)90767-X; Sanders YY, 2014, EUR RESPIR J, V43, P1448, DOI 10.1183/09031936.00095113; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; TAKEHARA K, 1987, CELL, V49, P415, DOI 10.1016/0092-8674(87)90294-7; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Thannickal VJ, 1998, BIOCHEM BIOPH RES CO, V251, P437, DOI 10.1006/bbrc.1998.9443; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254; Walker GA, 2001, CURR TOP DEV BIOL, V51, P91, DOI 10.1016/S0070-2153(01)51003-0; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Williams TM, 2004, J BIOL CHEM, V279, P24745, DOI 10.1074/jbc.M402064200; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Yang G, 1998, CLIN CANCER RES, V4, P1873; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366	57	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2015	10	2							e0116995	10.1371/journal.pone.0116995	http://dx.doi.org/10.1371/journal.pone.0116995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CB2GK	25658089	gold, Green Published, Green Submitted			2022-12-26	WOS:000349444900088
J	Nakatochi, M; Ushida, Y; Yasuda, Y; Yoshida, Y; Kawai, S; Kato, R; Nakashima, T; Iwata, M; Kuwatsuka, Y; Ando, M; Hamajima, N; Kondo, T; Oda, H; Hayashi, M; Kato, S; Yamaguchi, M; Maruyama, S; Matsuo, S; Honda, H				Nakatochi, Masahiro; Ushida, Yasunori; Yasuda, Yoshinari; Yoshida, Yasuko; Kawai, Shun; Kato, Ryuji; Nakashima, Toru; Iwata, Masamitsu; Kuwatsuka, Yachiyo; Ando, Masahiko; Hamajima, Nobuyuki; Kondo, Takaaki; Oda, Hiroaki; Hayashi, Mutsuharu; Kato, Sawako; Yamaguchi, Makoto; Maruyama, Shoichi; Matsuo, Seiichi; Honda, Hiroyuki			Identification of an Interaction between VWF rs7965413 and Platelet Count as a Novel Risk Marker for Metabolic Syndrome: An Extensive Search of Candidate Polymorphisms in a Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VON-WILLEBRAND-FACTOR; CORONARY-HEART-DISEASE; INSULIN-RESISTANCE; GENETIC-VARIANTS; DIABETIC-NEPHROPATHY; SUSCEPTIBILITY; OBESITY; LOCI; METAANALYSIS	Although many single nucleotide polymorphisms (SNPs) have been identified to be associated with metabolic syndrome (MetS), there was only a slight improvement in the ability to predict future MetS by the simply addition of SNPs to clinical risk markers. To improve the ability to predict future MetS, combinational effects, such as SNP-SNP interaction, SNP-environment interaction, and SNP-clinical parameter (SNP x CP) interaction should be also considered. We performed a case-control study to explore novel SNP x CP interactions as risk markers for MetS based on health check-up data of Japanese male employees. We selected 99 SNPs that were previously reported to be associated with MetS and components of MetS; subsequently, we genotyped these SNPs from 360 cases and 1983 control subjects. First, we performed logistic regression analyses to assess the association of each SNP with MetS. Of these SNPs, five SNPs were significantly associated with MetS (P < 0.05): LRP2 rs2544390, rs1800592 between UCP1 and TBC1D9, APOA5 rs662799, VWF rs7965413, and rs1411766 between MYO16 and IRS2. Furthermore, we performed multiple logistic regression analyses, including an SNP term, a CP term, and an SNP x CP interaction term for each CP and SNP that was significantly associated with MetS. We identified a novel SNP x CP interaction between rs7965413 and platelet count that was significantly associated with MetS [SNP term: odds ratio ( OR) = 0.78, P = 0.004; SNP x CP interaction term: OR = 1.33, P = 0.001]. This association of the SNP x CP interaction with MetS remained nominally significant in multiple logistic regression analysis after adjustment for either the number of MetS components or MetS components excluding obesity. Our results reveal new insight into platelet count as a risk marker for MetS.	[Nakatochi, Masahiro; Kuwatsuka, Yachiyo; Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Ushida, Yasunori; Honda, Hiroyuki] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan; [Yasuda, Yoshinari; Kato, Sawako; Yamaguchi, Makoto; Maruyama, Shoichi; Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Yasuda, Yoshinari] Nagoya Univ, Grad Sch Med, Dept CKD Initiat, Nagoya, Aichi 4648601, Japan; [Yoshida, Yasuko; Honda, Hiroyuki] Nagoya Univ, Innovat Res Ctr Prevent Med Engn, Nagoya, Aichi 4648601, Japan; [Kawai, Shun; Kato, Ryuji] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan; [Nakashima, Toru; Iwata, Masamitsu] Toyota Motor Co Ltd, Safety & Hlth Promot Div, Toyota, Japan; [Hamajima, Nobuyuki] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Kondo, Takaaki] Nagoya Univ, Grad Sch Med, Program Radiol & Med Lab Sci, Nagoya, Aichi 4648601, Japan; [Oda, Hiroaki] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; [Hayashi, Mutsuharu] Fujita Hlth Univ, Hosp 2, Dept Cardiol, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University; Toyota Motor Corporation; Nagoya University; Nagoya University; Nagoya University; Fujita Health University	Honda, H (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan.	honda@nubio.nagoya-u.ac.jp	Nakatochi, Masahiro/Q-1247-2015; Hamajima, Nobuyuki/I-7237-2014; Kato, Sawako/T-2422-2019; ANDO, Masahiko/F-7035-2015; Kato, Ryuji/I-6952-2014	Nakatochi, Masahiro/0000-0002-1838-4837; Kato, Sawako/0000-0001-7210-1888; 	Toyota Motor Co., Ltd; Grants-in-Aid for Scientific Research [15H04792] Funding Source: KAKEN	Toyota Motor Co., Ltd; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support for this work was provided by Toyota Motor Co., Ltd which employs two authors (TN MI). Toyota Motor contributed to study design and decision to publish.	Aiken L. S., 1991, MULTIPLE REGRESSION, V11; Dalgaard LT, 2001, DIABETOLOGIA, V44, P946, DOI 10.1007/s001250100596; Defago MD, 2013, AM J HYPERTENS, V26, P643, DOI 10.1093/ajh/hps099; Di Bitondo R, 2001, BRIT J HAEMATOL, V115, P701, DOI 10.1046/j.1365-2141.2001.03176.x; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Grallert H, 2007, J LIPID RES, V48, P2614, DOI 10.1194/jlr.M700011-JLR200; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jia JJ, 2010, MOL BIOL REP, V37, P1513, DOI 10.1007/s11033-009-9550-2; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Keightley AM, 1999, BLOOD, V93, P4277, DOI 10.1182/blood.V93.12.4277.412k03_4277_4283; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Maeda S, 2010, DIABETES, V59, P2075, DOI 10.2337/db10-0067; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Maric C, 2011, CONTRIB NEPHROL, V170, P28, DOI 10.1159/000324941; McCurry J, 2004, LANCET, V363, P1126, DOI 10.1016/S0140-6736(04)15942-4; Meigs JB, 2000, JAMA-J AM MED ASSOC, V283, P221, DOI 10.1001/jama.283.2.221; Metabolic Syndrome Diagnostic Criteria Review Committee, 2005, J JPN SOC INT MED, V94, P188; *MIN HLTH LAB WELF, 2007, THE WHITE PAPER OF T, P97; *MIN HLTH LAB WELF, 2007, OUTLINE FOR THE RESU, P28669, DOI DOI 10.1093/JXB/ERM028; Nakatochi M, 2011, DIABETES RES CLIN PR, V92, pE61, DOI 10.1016/j.diabres.2011.02.029; Nebeck K, 2012, DIABETES METAB SYND, V6, P22, DOI 10.1016/j.dsx.2012.05.009; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Paulik MA, 1998, PHARM RES-DORDR, V15, P944, DOI 10.1023/A:1011993019385; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Povel CM, 2011, OBES REV, V12, P952, DOI 10.1111/j.1467-789X.2011.00907.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ragab Amany, 2008, Lab Hematol, V14, P1, DOI 10.1532/LH96.07017; RUGGERI ZM, 1993, FASEB J, V7, P308, DOI 10.1096/fasebj.7.2.8440408; Taniguchi A, 2003, METABOLISM, V52, P1246, DOI 10.1016/S0026-0495(03)00099-4; TAO LX, 2013, ENDOCRINE, P28669, DOI DOI 10.1007/S12020-013-0144-3; Ushida Y, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-80; van der Meer IM, 2004, BRIT J HAEMATOL, V124, P343, DOI 10.1046/j.1365-2141.2003.04776.x; Vischer UM, 2006, J THROMB HAEMOST, V4, P1186, DOI 10.1111/j.1538-7836.2006.01949.x; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Whincup RH, 2002, EUR HEART J, V23, P1764, DOI 10.1053/euhj.2001.3237; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-989; Xu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056216; Yamada Y, 2007, ATHEROSCLEROSIS, V191, P298, DOI 10.1016/j.atherosclerosis.2006.05.035; Yin RX, 2008, AM J MED, V121, P811, DOI 10.1016/j.amjmed.2008.04.026; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961	44	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0117591	10.1371/journal.pone.0117591	http://dx.doi.org/10.1371/journal.pone.0117591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646961	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600077
J	White, MJ; Eren, F; Agirbasli, D; Williams, SM; Agirbasli, M				White, Marquitta J.; Eren, Fatih; Agirbasli, Deniz; Williams, Scott M.; Agirbasli, Mehmet			SHBG Gene Polymorphism (rs1799941) Associates with Metabolic Syndrome in Children and Adolescents	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; BODY-MASS INDEX; CHOLESTEROL LEVELS; SEX-HORMONES; DISEASE RISK; LIPID-LEVELS; INSULIN; TURKISH; OBESITY; POPULATION	Background Metabolic syndrome (MetS) is a complex disorder characterized by coexistence of several cardiometabolic (CM) factors, i.e. hyperlipidemia, obesity, high blood pressure and insulin resistance. The presence of MetS is strongly associated with increased risk of cardiovascular disease (CVD). The syndrome was originally defined as an adult disorder, but MetS has become increasingly recognized in children and adolescents. Methods Genetic variants influence biological components common to the CM factors that comprise MetS. We investigated single locus associations between six single nucleotide polymorphisms (SNPs), previously shown to modulate lipid or sex hormone binding globulin (SHBG) levels, with MetS in a Turkish pediatric cohort (37 cases, 323 controls). Results Logistic regression analysis revealed a significant association between rs1799941, located in SHBG, and MetS (OR = 3.09, p-value = 0.006). The association with MetS remained after sequential adjustment for each CM factor included in the syndrome definition, indicating that the identified association is not being driven by any single trait. A relationship between rs1799941 and SHBG levels, was also discovered, but it was dependent on MetS status. In control subjects, the A allele of rs1799941 associated with a significant increase in SHBG levels (p = 0.012), while in cases there was no association between rs1799941 and SHBG levels (p = 0.963). Conclusions The significant association between rs1799941 and MetS in children is not contingent on any single CM trait. Additionally, the presence of MetS may abrogate effect of rs1799941 polymorphism on SHBG levels in children.	[White, Marquitta J.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [White, Marquitta J.; Williams, Scott M.] Dartmouth Coll, Inst Quantitat Biomed Sci, Dept Genet, Hanover, NH 03755 USA; [Eren, Fatih] Marmara Univ, Sch Med, Dept Med Biol, Istanbul, Turkey; [Agirbasli, Deniz] Acibadem Univ, Sch Med, Dept Med Biol, Istanbul, Turkey; [Agirbasli, Mehmet] Marmara Univ, Sch Med, Dept Cardiol, Istanbul, Turkey	Vanderbilt University; Dartmouth College; Marmara University; Acibadem University; Marmara University	Agirbasli, M (corresponding author), Marmara Univ, Sch Med, Dept Cardiol, Istanbul, Turkey.	magirbasli@gmail.com	Williams, Scott/Q-4812-2019; Ağırbaşlı, Deniz/ABG-4903-2021; Agirbasli, Deniz/D-2525-2015; eren, fatih/AAS-6286-2020; Ağırbaşlı, Deniz/AAY-6306-2020	Williams, Scott/0000-0002-4835-9544; Ağırbaşlı, Deniz/0000-0003-2584-451X; eren, fatih/0000-0001-8126-2413; 	Scientific Research Council of Turkey (TUBITAK) [109S282]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	Scientific Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the Scientific Research Council of Turkey (TUBITAK) Project Number: 109S282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahaman A, 2005, METABOLISM, V54, P91, DOI 10.1016/j.metabol.2004.07.018; Agirbasli M, 2005, PREV MED, V41, P843, DOI 10.1016/j.ypmed.2005.08.001; Agirbasli M, 2013, OMICS, V17, P636, DOI 10.1089/omi.2013.0066; Agirbasli M, 2010, HORM RES PAEDIAT, V73, P166, DOI 10.1159/000284357; Agirbasli M, 2009, METABOLISM, V58, P1256, DOI 10.1016/j.metabol.2009.03.024; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Asselbergs FW, 2013, CURR OPIN LIPIDOL, V24, P123, DOI 10.1097/MOL.0b013e32835df2d6; Balkau B, 1999, DIABETIC MED, V16, P442; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Oya I, 2010, PEDIATR DIABETES, V11, P188, DOI 10.1111/j.1399-5448.2009.00559.x; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Genuth S, 2003, DIABETES CARE, V26, P3160; Gungor N, 2004, J PEDIATR-US, V144, P47, DOI 10.1016/j.jpeds.2003.09.045; Haiman CA, 2005, J CLIN ENDOCR METAB, V90, P2198, DOI 10.1210/jc.2004-1417; Hammond GL, 2012, CURR OPIN ENDOCRINOL, V19, P183, DOI 10.1097/MED.0b013e328353732f; Hatipoglu N, 2008, EUR J PEDIATR, V167, P383, DOI 10.1007/s00431-007-0502-3; Hergenc G, 1999, ATHEROSCLEROSIS, V145, P147, DOI 10.1016/S0021-9150(99)00027-1; Hodoglugil U, 1999, J LIPID RES, V40, P432; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jago R, 2006, PEDIATRICS, V117, P2065, DOI 10.1542/peds.2005-1716; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; Keskin M, 2005, PEDIATRICS, V115, pE500, DOI 10.1542/peds.2004-1921; Koyama S, 2014, PEDIATRICS, V133, pE114, DOI 10.1542/peds.2013-0966; Krishnasamy SS, 2012, ENDOCR PRACT, V18, P668, DOI 10.4158/EP12026.OR; LAAKSO M, 1993, AM J EPIDEMIOL, V137, P959, DOI 10.1093/oxfordjournals.aje.a116768; Messiah SE, 2013, OBESITY, V21, P424, DOI 10.1002/oby.20343; Neyzi O., 1993, PEDIATRI, P69, DOI [10.1007/BF00235292, DOI 10.1007/BF00235292]; NGHS Coordinating Center, 1998 NHLBI GROWTH HL; Onat A, 2008, METABOLISM, V57, P207, DOI 10.1016/j.metabol.2007.09.002; Ordovas JM, 2000, ARTERIOSCL THROM VAS, V20, P1323, DOI 10.1161/01.ATV.20.5.1323; Ozanne SE, 2002, TRENDS ENDOCRIN MET, V13, P368, DOI 10.1016/S1043-2760(02)00666-5; Pirruccello J, 2010, CURR OPIN CARDIOL, V25, P238, DOI 10.1097/HCO.0b013e328338574d; Prodam F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-44; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riancho JA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-112; ROSNER B, 1993, J PEDIATR-US, V123, P871, DOI 10.1016/S0022-3476(05)80382-8; Skilton MR, 2013, PEDIATRICS, V131, pE1821, DOI 10.1542/peds.2012-2789; StataCorp, 2021, STATA STAT SOFTWARE; Sunbul M, 2013, CARDIOL J, V20, P287, DOI 10.5603/CJ.2013.0074; Svartberg J, 2014, ANDROLOGY-US, V2, P212, DOI 10.1111/j.2047-2927.2013.00174.x; Team R Core, 2013, R LANG ENV STAT COMP; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	47	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116915	10.1371/journal.pone.0116915	http://dx.doi.org/10.1371/journal.pone.0116915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647406	gold, Green Submitted, Green Published			2022-12-26	WOS:000348822600042
J	Matthijsse, SM; van Rosmalen, J; Hontelez, JAC; Bakker, R; de Kok, IMCM; van Ballegooijen, M; de Vlas, SJ				Matthijsse, Suzette M.; van Rosmalen, Joost; Hontelez, Jan A. C.; Bakker, Roel; de Kok, Inge M. C. M.; van Ballegooijen, Marjolein; de Vlas, Sake J.			The Role of Acquired Immunity in the Spread of Human Papillomavirus (HPV): Explorations with a Microsimulation Model	PLOS ONE			English	Article							AGE-DEPENDENT PREVALENCE; NATURAL-HISTORY; CERVICAL-CANCER; CONTROLLED-TRIAL; SEXUAL-BEHAVIOR; NORMAL CYTOLOGY; INFECTION; WOMEN; RISK; EPIDEMIOLOGY	Background: Knowledge of the natural history of human papillomavirus (HPV), in particular the role of immunity, is crucial in estimating the (cost-) effectiveness of HPV vaccination and cervical cancer screening strategies, because naturally acquired immunity after clearing an infection may already protect part of the risk population against new HPV infections. Methods: We used STDSIM, an established stochastic microsimulation model, quantified to the Netherlands. We explored different assumptions regarding the natural history of HPV-16 and HPV-18, and estimated the transmission probabilities and durations of acquired immunity necessary to reproduce age-specific prevalence. Results: A model without acquired immunity cannot reproduce the age-specific patterns of HPV. Also, it is necessary to assume a high degree of individual variation in the duration of infection and acquired immunity. According to the model estimates, on average 20% of women are immune for HPV-16 and 15% for HPV-18. After an HPV-16 infection, 50% are immune for less than 1 year, whereas 20% exceed 30 years. For HPV-18, up to 12% of the individuals are immune for less than 1 year, and about 50% over 30 years. Almost half of all women will never acquire HPV-16 or HPV-18. Conclusions: Acquired immunity likely plays a major role in HPV epidemiology, but its duration shows substantial variation. Combined with the lifetime risk, this explains to a large extent why many women will never develop cervical cancer.	[Matthijsse, Suzette M.; Hontelez, Jan A. C.; Bakker, Roel; de Kok, Inge M. C. M.; van Ballegooijen, Marjolein; de Vlas, Sake J.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [van Rosmalen, Joost] Erasmus MC, Univ Med Ctr Rotterdam, Dept Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Matthijsse, SM (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	s.matthijsse@erasmusmc.nl		de Vlas, Sake J./0000-0002-1830-5668; van Rosmalen, Joost/0000-0002-9187-244X				Alexander MG, 2003, J SEX RES, V40, P27, DOI 10.1080/00224490309552164; Antonsson A, 2010, VIROLOGY, V407, P26, DOI 10.1016/j.virol.2010.07.046; BAKKER F, 2009, SEXUAL HEALTH IN THE; BAKKER F, 2006, SEXUAL HEALTH IN THE; Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baussano I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081171; Baussano I, 2010, EPIDEMICS-NETH, V2, P21, DOI 10.1016/j.epidem.2010.02.002; Berkhof J, 2010, INT J CANCER, V127, P2147, DOI 10.1002/ijc.25211; Bogaards JA, 2011, EPIDEMIOLOGY, V22, P505, DOI 10.1097/EDE.0b013e31821d107b; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Bulkmans NWJ, 2004, INT J CANCER, V110, P94, DOI 10.1002/ijc.20076; Burchell AN, 2006, AM J EPIDEMIOL, V163, P534, DOI 10.1093/aje/kwj077; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Carter JJ, 2000, J INFECT DIS, V181, P1911, DOI 10.1086/315498; Coupe VMH, 2008, BRIT J CANCER, V98, P646, DOI 10.1038/sj.bjc.6604162; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; DEGRAAF H, 2006, RUTGERS NISSO GROUP, V7; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fischer E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014061; Franceschi S, 2014, J INFECT DIS, V210, P507, DOI 10.1093/infdis/jiu143; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Goodman MT, 2008, CANCER RES, V68, P8813, DOI 10.1158/0008-5472.CAN-08-1380; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Johnson HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049614; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; Korenromp EL, 2000, MATH POPUL STUD, V8, P135, DOI DOI 10.1080/08898480009525479; LAW A, 2000, SIMULATION MODELING, P622; Lenselink CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003743; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Manhart LE, 2002, SEX TRANSM DIS, V29, P725, DOI 10.1097/00007435-200211000-00018; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; McCallum EB, 2012, J SEX RES, V49, P212, DOI 10.1080/00224499.2012.658923; Mikolajczyk RT, 2012, J NATL CANCER I, V104, P163, DOI 10.1093/jnci/djr517; Molano M, 2003, AM J EPIDEMIOL, V158, P486, DOI 10.1093/aje/kwg171; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; *SIG INF CTR HLTH, 1985, HOSPITAL DIAGNOSIS S; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; *US DEP EC SOC AFF, 2011, WORLD POPULATION PRO; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; van den Broek IVF, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4316; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; VOLKSGEZONDHEID NA, 2013, VACCINE COVERAGE LOW; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 2013, OBSTET GYN CLIN N AM, V40, P165, DOI 10.1016/j.ogc.2013.02.004; *WHO ICO HPV INF C, 2010, SUMMARY REPORT UPDAT; Wilson L, 2014, J INFECT DIS, V210, P448, DOI 10.1093/infdis/jiu104	49	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116618	10.1371/journal.pone.0116618	http://dx.doi.org/10.1371/journal.pone.0116618			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642941	gold, Green Published, Green Submitted			2022-12-26	WOS:000348821200021
J	Okada, K; Abe, H; Ike, F; Ogura, Y; Hayashi, T; Fukui-Miyazaki, A; Nakamura, K; Shinzawa, N; Horiguchi, Y				Okada, Keisuke; Abe, Hiroyuki; Ike, Fumio; Ogura, Yoshitoshi; Hayashi, Tetsuya; Fukui-Miyazaki, Aya; Nakamura, Keiji; Shinzawa, Naoaki; Horiguchi, Yasuhiko			Polymorphisms Influencing Expression of Dermonecrotic Toxin in Bordetella bronchiseptica	PLOS ONE			English	Article							III SECRETION SYSTEM; ACTIN STRESS FIBERS; GENE-EXPRESSION; BINDING; PERTUSSIS; BVGA; PROMOTER; IDENTIFICATION; PATHOGENESIS; ACTIVATION	Bordetella bronchiseptica is a pathogenic bacterium causing respiratory infections in a broad range of mammals. Recently, we determined the whole genome sequence of B. bronchiseptica S798 strain isolated from a pig infected with atrophic rhinitis and found four single-nucleotide polymorphisms (SNPs) at positions -129, -72, + 22, and + 38 in the region upstream of dnt encoding dermonecrotic toxin (DNT), when compared with a rabbit isolate, RB50. DNT is known to be involved in turbinate atrophy observed in atrophic rhinitis. Immunoblotting, quantitative real-time PCR, and beta-galactosidase reporter assay revealed that these SNPs resulted in the increased promoter activity of dnt and conferred the increased ability to produce DNT on the bacteria. Similar or identical SNPs were also found in other pig isolates kept in our laboratory, all of which produce a larger amount of DNT than RB50. Our analysis revealed that substitution of at least two of the four bases, at positions -72 and +22, influenced the promoter activity for dnt. These results imply that these SNPs are involved in the pathogenicity of bordetellae specific to pig diseases.	[Okada, Keisuke; Abe, Hiroyuki; Fukui-Miyazaki, Aya; Nakamura, Keiji; Shinzawa, Naoaki; Horiguchi, Yasuhiko] Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, Osaka, Japan; [Ike, Fumio] RIKEN BioResource Ctr, Expt Anim Div, Ibaraki, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Frontier Sci Res Ctr, Dept Genom & Bioenvironm Sci, Div Microbial Genom, Miyazaki, Japan; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Miyazaki Univ, Fac Med, Dept Infect Dis, Div Microbiol, Miyazaki, Japan	Osaka University; RIKEN; University of Miyazaki; University of Miyazaki	Abe, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Bacteriol, Osaka, Japan.	hirop@biken.osaka-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020	jia si, zhong cun/0000-0002-8500-9359	Japan Society for the Promotion of Science [26293096, 26460525];  [25670212]; Grants-in-Aid for Scientific Research [25670212] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (26293096) (http://www.jsps.go.jp/j-grantsinaid/index.html), Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (26460525) (http://www.jsps.go.jp/j-grantsinaid/index.html), Grants-in-Aid for Scientific Research for Challenging Exploratory Research (25670212) (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUCHER PE, 1995, J BACTERIOL, V177, P6486, DOI 10.1128/jb.177.22.6486-6491.1995; Boucher PE, 2001, MOL MICROBIOL, V40, P991, DOI 10.1046/j.1365-2958.2001.02442.x; Brockmeier SL, 2002, INFECT IMMUN, V70, P481, DOI 10.1128/IAI.70.2.481-490.2002; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; COWELL JL, 1979, INFECT IMMUN, V25, P896, DOI 10.1128/IAI.25.3.896-901.1979; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; HORIGUCHI Y, 1991, INFECT IMMUN, V59, P1112, DOI 10.1128/IAI.59.3.1112-1116.1991; HORIGUCHI Y, 1990, FEMS MICROBIOL LETT, V66, P39, DOI 10.1111/j.1574-6968.1990.tb03969.x; Horiguchi Y, 1997, P NATL ACAD SCI USA, V94, P11623, DOI 10.1073/pnas.94.21.11623; HORIGUCHI Y, 1993, INFECT IMMUN, V61, P3611, DOI 10.1128/IAI.61.9.3611-3615.1993; HORIGUCHI Y, 1995, J CELL SCI, V108, P3243; HORIGUCHI Y, 1995, FEMS IMMUNOL MED MIC, V12, P29, DOI 10.1111/j.1574-695X.1995.tb00170.x; Horiguchi Y, 2012, CURR TOP MICROBIOL, V361, P113, DOI 10.1007/82_2012_206; Karimova G, 1996, MOL MICROBIOL, V20, P489, DOI 10.1046/j.1365-2958.1996.5231057.x; Kurushima J, 2012, MICROBIOL IMMUNOL, V56, P356, DOI 10.1111/j.1348-0421.2012.00442.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda M, 2000, EMBO J, V19, P521, DOI 10.1093/emboj/19.4.521; Matsuzawa T, 2002, INFECT IMMUN, V70, P3427, DOI 10.1128/IAI.70.7.3427-3432.2002; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Merkel TJ, 2003, J BACTERIOL, V185, P6902, DOI 10.1128/JB.185.23.6902-6912.2003; Miller JH., 1972, EXPT MOL GENETICS; Nagamatsu K, 2009, J EXP MED, V206, P3073, DOI 10.1084/jem.20090494; NAKAI T, 1985, AM J VET RES, V46, P870; Okada K, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00436-14; Park J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-545; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pullinger GD, 1996, INFECT IMMUN, V64, P4163, DOI 10.1128/IAI.64.10.4163-4171.1996; ROY CR, 1991, J BACTERIOL, V173, P2385, DOI 10.1128/JB.173.7.2385-2392.1991; Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Zu T, 1996, MOL MICROBIOL, V21, P557, DOI 10.1111/j.1365-2958.1996.tb02564.x	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116604	10.1371/journal.pone.0116604	http://dx.doi.org/10.1371/journal.pone.0116604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642712	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821200020
J	Yamane, C; Yamazaki, T; Nakamura, S; Matsuo, J; Ishida, K; Yamazaki, S; Oguri, S; Shouji, N; Hayashi, Y; Yoshida, M; Yimin; Yamaguchi, H				Yamane, Chikayo; Yamazaki, Tomohiro; Nakamura, Shinji; Matsuo, Junji; Ishida, Kasumi; Yamazaki, Sumire; Oguri, Satoshi; Shouji, Natsumi; Hayashi, Yasuhiro; Yoshida, Mitsutaka; Yimin; Yamaguchi, Hiroyuki			Amoebal Endosymbiont Parachlamydia acanthamoebae Bn-9 Can Grow in Immortal Human Epithelial HEp-2 Cells at Low Temperature; An In Vitro Model System to Study Chlamydial Evolution	PLOS ONE			English	Article							CHLAMYDOPHILA-PNEUMONIAE; III SECRETION; FACTOR CPAF; HOST-RANGE; INFECTION; EPIDEMIOLOGY; PROTEINS; PATHOGEN; HISTORY; GENOME	Ancient chlamydiae diverged into pathogenic and environmental chlamydiae 0.7-1.4 billion years ago. However, how pathogenic chlamydiae adapted to mammalian cells that provide a stable niche at approximately 37 degrees C, remains unknown, although environmental chlamydiae have evolved as endosymbionts of lower eukaryotes in harsh niches of relatively low temperatures. Hence, we assessed whether an environmental chlamydia, Parachlamydia Bn-9, could grow in human HEp-2 cells at a low culture temperature of 30 degrees C. The assessment of inclusion formation by quantitative RT-PCR revealed that the numbers of bacterial inclusion bodies and the transcription level of 16SrRNA significantly increased after culture at 30 degrees C compared to at 37 degrees C. Confocal microscopy showed that the bacteria were located close to HEp-2 nuclei and were actively replicative. Transmission electron microscopy also revealed replicating bacteria consisting of reticular bodies, but with a few elementary bodies. Cytochalasin D and rifampicin inhibited inclusion formation. Lactacystin slightly inhibited bacterial inclusion formation. KEGG analysis using a draft genome sequence of the bacteria revealed that it possesses metabolic pathways almost identical to those of pathogenic chlamydia. Interestingly, comparative genomic analysis with pathogenic chlamydia revealed that the Parachlamydia similarly possess the genes encoding Type III secretion system, but lacking genes encoding inclusion membrane proteins (IncA to G) required for inclusion maturation. Taken together, we conclude that ancient chlamydiae had the potential to grow in human cells, but overcoming the thermal gap was a critical event for chlamydial adaptation to human cells.	[Yamane, Chikayo; Yamazaki, Tomohiro; Matsuo, Junji; Ishida, Kasumi; Yamazaki, Sumire; Oguri, Satoshi; Shouji, Natsumi; Hayashi, Yasuhiro; Yamaguchi, Hiroyuki] Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Kita Ku, Sapporo, Hokkaido, Japan; [Yamazaki, Tomohiro] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Nakamura, Shinji] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Bunkyo Ku, Tokyo, Japan; [Oguri, Satoshi; Hayashi, Yasuhiro] Hokkaido Univ Hosp, Kita Ku, Sapporo, Hokkaido 060, Japan; [Yoshida, Mitsutaka] Juntendo Univ, Grad Sch Med, Div Ultrastruct Res, Bunkyo Ku, Tokyo, Japan; [Yimin] Hokkaido Univ, Grad Sch Med, Dept Adv Med, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Japan Society for the Promotion of Science; Juntendo University; Hokkaido University; Juntendo University; Hokkaido University	Yamaguchi, H (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Kita Ku, North 12,West 5, Sapporo, Hokkaido, Japan.	hiroyuki@med.hokudai.ac.jp			KAKENHI, "Innovation Areas (Matryoshka-type evolution)" [21590474, 24659194, 24117501];  [13J04219]	KAKENHI, "Innovation Areas (Matryoshka-type evolution)"; 	This study was supported by grants-in-aid for Japan Society for the Promotion Science (JSPS) fellows (13J04219) and scientific research from KAKENHI, grant numbers 21590474, 24659194, and 24117501, "Innovation Areas (Matryoshka-type evolution)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Amann R, 1997, APPL ENVIRON MICROB, V63, P115, DOI 10.1128/AEM.63.1.115-121.1997; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bednar MM, 2011, BIOCHEMISTRY-US, V50, P7441, DOI 10.1021/bi201098r; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Boleti H, 1999, J CELL SCI, V112, P1487; Burillo A, 2010, INFECT DIS CLIN N AM, V24, P61, DOI 10.1016/j.idc.2009.10.002; Collingro A, 2005, MICROBIOL-SGM, V151, P301, DOI 10.1099/mic.0.27406-0; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Cooksey CMJL, 2010, OBSTET GYNECOL SURV, V65, P729, DOI 10.1097/OGX.0b013e3182110204; Corsaro D, 2002, RES MICROBIOL, V153, P563, DOI 10.1016/S0923-2508(02)01369-4; Coulon C, 2012, FEMS IMMUNOL MED MIC, V64, P364, DOI 10.1111/j.1574-695X.2011.00919.x; Da Ros CT, 2008, ASIAN J ANDROL, V10, P110, DOI 10.1111/j.1745-7262.2008.00367.x; Fischer H, 1995, J PHYSIOL-LONDON, V489, P745, DOI 10.1113/jphysiol.1995.sp021088; Gimenez G, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-542; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Hayashi Y, 2010, MICROBIOL IMMUNOL, V54, P707, DOI 10.1111/j.1348-0421.2010.00265.x; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Hu VH, 2010, TROP MED INT HEALTH, V15, P673, DOI 10.1111/j.1365-3156.2010.02521.x; Ishida K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095166; Jorgensen I, 2011, CELL HOST MICROBE, V10, P21, DOI 10.1016/j.chom.2011.06.008; Kobayashi M, 2011, MICROB PATHOGENESIS, V51, P209, DOI 10.1016/j.micpath.2011.03.010; Madej T, 2012, NUCLEIC ACIDS RES, V40, pD461, DOI 10.1093/nar/gkr1162; Matsuo J, 2008, APPL ENVIRON MICROB, V74, P6397, DOI 10.1128/AEM.00841-08; Matsuo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056005; Matsuo J, 2010, RES MICROBIOL, V161, P711, DOI [10.1016/J.resmic.2010.07.004, 10.1016/j.resmic.2010.07.004]; Matsuo J, 2010, MICROBIOL IMMUNOL, V54, P63, DOI 10.1111/j.1348-0421.2009.00182.x; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Mylonas I, 2012, ARCH GYNECOL OBSTET, V285, P1271, DOI 10.1007/s00404-012-2240-7; Paschen SA, 2008, J CELL BIOL, V182, P117, DOI 10.1083/jcb.200804023; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pirbhai M, 2006, J BIOL CHEM, V281, P31495, DOI 10.1074/jbc.M602796200; Sampo A, 2014, ENVIRON MICROBIOL, V16, P486, DOI 10.1111/1462-2920.12266; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Watson C, 2008, CLIN SCI, V114, P509, DOI 10.1042/CS20070298	38	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116486	10.1371/journal.pone.0116486	http://dx.doi.org/10.1371/journal.pone.0116486			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643359	gold, Green Published, Green Submitted			2022-12-26	WOS:000348821200019
J	Cao, Z; Xu, JW; Huang, H; Shen, P; You, L; Zhou, L; Zheng, LF; Zhang, TP; Zhao, YP				Cao, Zhe; Xu, Jianwei; Huang, Hua; Shen, Peng; You, Lei; Zhou, Li; Zheng, Lianfang; Zhang, Taiping; Zhao, Yupei			MiR-1178 Promotes the Proliferation, G1/S Transition, Migration and Invasion of Pancreatic Cancer Cells by Targeting CHIP	PLOS ONE			English	Article							HSC70-INTERACTING PROTEIN; INDUCED DEGRADATION; TUMOR-SUPPRESSOR; C-TERMINUS; MUTANT P53; CARCINOMA; CHAPERONE; GROWTH; ADENOCARCINOMA; INACTIVATION	CHIP, a co-chaperone protein that interacts with Hsc/Hsp70, has been shown to be underexpressed in pancreatic cancer cells and has demonstrated a potential tumor suppressor property. Nevertheless, the underlying mechanisms of CHIP regulation in pancreatic cancer cells remain unknown. In this study, we found that miR-1178 decreased the translation of the CHIP protein by targeting the 30-UTR region. We observed that over-expression of miR-1178 facilitated the proliferation, G1/S transition, migration and invasion of pancreatic cancer cells. Conversely, the inhibition of miR-1178 expression significantly suppressed these phenotypes. Furthermore, CHIP over-expression abrogated miR-1178-induced cell proliferation and invasion. Our data suggest that miR-1178 acts as an oncomiR in pancreatic cancer cells by inhibiting CHIP expression.	[Cao, Zhe; Xu, Jianwei; Huang, Hua; Shen, Peng; You, Lei; Zhou, Li; Zhang, Taiping; Zhao, Yupei] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China; [Cao, Zhe; Xu, Jianwei; Huang, Hua; Shen, Peng; You, Lei; Zhou, Li; Zheng, Lianfang; Zhang, Taiping; Zhao, Yupei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zheng, Lianfang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhang, TP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China.	tpingzhang@yahoo.com; zhao8028@263.net			National Natural Science Foundation of China [81272484]; Beijing Natural Science Foundation [7132179]; Major State Basic Research Development Program of China (973 Program) [2014CB542300]; Research Special Fund for Public Welfare Industry of Health [201202007]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2014BAI09B11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Research Special Fund for Public Welfare Industry of Health; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	This study was supported by grants from the National Natural Science Foundation of China (No. 81272484), Beijing Natural Science Foundation (No. 7132179), Major State Basic Research Development Program of China (973 Program, No. 2014CB542300), the Research Special Fund for Public Welfare Industry of Health (No. 201202007), and National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (No. 2014BAI09B11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Choi YN, 2014, BIOCHEM BIOPH RES CO, V446, P1060, DOI 10.1016/j.bbrc.2014.03.061; Chuong MD, 2014, J GASTROINTEST ONCOL, V5, P166, DOI 10.3978/j.issn.2078-6891.2014.025; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; DRUCKER BJ, 1988, IN VITRO CELL DEV B, V24, P1179, DOI 10.1007/BF02624187; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Funamizu N, 2014, INT J ONCOL, V44, P725, DOI 10.3892/ijo.2014.2243; Guo JW, 2012, J BONE MINER RES, V27, P1607, DOI 10.1002/jbmr.1597; Jang KW, 2011, J CELL BIOCHEM, V112, P3612, DOI 10.1002/jcb.23292; Jang KW, 2011, J THORAC ONCOL, V6, P679, DOI 10.1097/JTO.0b013e31820d9c7e; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Lee JH, 2010, J BIOL CHEM, V285, P42033, DOI 10.1074/jbc.M110.149831; Lennon AM, 2014, CANCER RES, V74, P3381, DOI 10.1158/0008-5472.CAN-14-0734; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Li Y., 2010, CANCER RES, V70, P5703, DOI [10.1158/1538-7445.AM10-5703, DOI 10.1158/1538-7445.AM10-5703]; Li YY, 2013, CANCER LETT, V339, P260, DOI 10.1016/j.canlet.2013.06.018; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu C, 2013, CURR MOL MED, V13, P467; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Maftouh M, 2014, NUCLEOS NUCLEOT NUCL, V33, P384, DOI 10.1080/15257770.2014.891741; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Naito AT, 2010, CIRC RES, V106, P1692, DOI 10.1161/CIRCRESAHA.109.214346; Ruckova E, 2012, CELL MOL BIOL LETT, V17, P446, DOI 10.2478/s11658-012-0021-8; Shimamoto S, 2013, J BIOL CHEM, V288, P7158, DOI 10.1074/jbc.M112.436758; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sisoula C, 2011, FREE RADICAL BIO MED, V50, P157, DOI 10.1016/j.freeradbiomed.2010.10.701; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Villanueva M Teresa, 2013, Nat Rev Clin Oncol, V10, P665, DOI 10.1038/nrclinonc.2013.209; Wang J, 2011, J CELL BIOCHEM, V112, P509, DOI 10.1002/jcb.22941; Wang TX, 2014, ONCOTARGET, V5, P1969, DOI 10.18632/oncotarget.1890; Wang YM, 2014, CARCINOGENESIS, V35, P983, DOI 10.1093/carcin/bgt393; Wolin EM, 2013, CANCER LETT, V335, P1, DOI 10.1016/j.canlet.2013.02.016; Yao Z, 2002, PANCREAS, V24, P42, DOI 10.1097/00006676-200201000-00006; Zhang J, 2014, ONCOL REP, V31, P1157, DOI 10.3892/or.2013.2960; Zhao G, 2013, MOL CANCER THER, V12, P2569, DOI 10.1158/1535-7163.MCT-13-0296	39	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116934	10.1371/journal.pone.0116934	http://dx.doi.org/10.1371/journal.pone.0116934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635996	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700065
J	Han, XJ; Li, X; Rigon, R; Jin, R; Endrizzi, S				Han, Xujun; Li, Xin; Rigon, Riccardo; Jin, Rui; Endrizzi, Stefano			Soil Moisture Estimation by Assimilating L-Band Microwave Brightness Temperature with Geostatistics and Observation Localization	PLOS ONE			English	Article							LAND DATA ASSIMILATION; MODEL; WATER; RESOLUTION; SYSTEM; VALIDATION; EMISSION; IMPACT	The observation could be used to reduce the model uncertainties with data assimilation. If the observation cannot cover the whole model area due to spatial availability or instrument ability, how to do data assimilation at locations not covered by observation? Two commonly used strategies were firstly described: One is covariance localization (CL); the other is observation localization (OL). Compared with CL, OL is easy to parallelize and more efficient for large-scale analysis. This paper evaluated OL in soil moisture profile characterizations, in which the geostatistical semivariogram was used to fit the spatial correlated characteristics of synthetic L-Band microwave brightness temperature measurement. The fitted semivariogram model and the local ensemble transform Kalman filter algorithm are combined together to weight and assimilate the observations within a local region surrounding the grid cell of land surface model to be analyzed. Six scenarios were compared: 1_Obs with one nearest observation assimilated, 5_Obs with no more than five nearest local observations assimilated, and 9_Obs with no more than nine nearest local observations assimilated. The scenarios with no more than 16, 25, and 36 local observations were also compared. From the results we can conclude that more local observations involved in assimilation will improve estimations with an upper bound of 9 observations in this case. This study demonstrates the potentials of geostatistical correlation representation in OL to improve data assimilation of catchment scale soil moisture using synthetic L-band microwave brightness temperature, which cannot cover the study area fully in space due to vegetation effects.	[Han, Xujun; Li, Xin; Jin, Rui] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Li, Xin; Jin, Rui] Chinese Acad Sci, CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing, Peoples R China; [Rigon, Riccardo] Univ Trento, Dept Civil & Environm Engn, Trento, Italy; [Endrizzi, Stefano] Univ Zurich, Dept Geog, Zurich, Switzerland	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; University of Trento; University of Zurich	Han, XJ (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China.	hanxj@lzb.ac.cn	Li, Xin/F-7473-2011; li, xin/HHS-9461-2022; Rigon, Riccardo/B-5395-2008	Li, Xin/0000-0003-2999-9818; Rigon, Riccardo/0000-0002-7668-5806	Chinese Academy of Sciences Action Plan for West Development Program Project [KZCX2-XB3-15]; National Science Foundation of China (NSFC) project [41271357, 91125001]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-312]; Italian Space Agency Project MORFEO	Chinese Academy of Sciences Action Plan for West Development Program Project; National Science Foundation of China (NSFC) project(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Italian Space Agency Project MORFEO	This work was supported by the Chinese Academy of Sciences Action Plan for West Development Program Project (KZCX2-XB3-15), the National Science Foundation of China (NSFC) project (grant number: 41271357, 91125001), the Knowledge Innovation Program of the Chinese Academy of Sciences (grant number: KZCX2-EW-312), and the Italian Space Agency Project MORFEO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogena HR, 2010, VADOSE ZONE J, V9, P1002, DOI 10.2136/vzj2009.0173; Brocca L, 2007, J HYDROL, V333, P356, DOI 10.1016/j.jhydrol.2006.09.004; Buttafuoco G, 2005, J HYDROL, V311, P202, DOI 10.1016/j.jhydrol.2005.01.018; Calvet JC, 2011, IEEE T GEOSCI REMOTE, V49, P1190, DOI 10.1109/TGRS.2010.2050488; Crow WT, 2014, WATER RESOUR RES, V50, P371, DOI 10.1002/2013WR014550; Crow WT, 2003, ADV WATER RESOUR, V26, P137, DOI 10.1016/S0309-1708(02)00088-X; De Lannoy GJM, 2010, J HYDROMETEOROL, V11, P352, DOI 10.1175/2009JHM1192.1; De Lannoy GJM, 2006, J HYDROL, V331, P719, DOI 10.1016/j.jhydrol.2006.06.016; De Lannoy GJM, 2009, J HYDROMETEOROL, V10, P766, DOI 10.1175/2008JHM1037.1; de Rosnay P, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010724; Drusch M, 2009, J HYDROMETEOROL, V10, P213, DOI 10.1175/2008JHM964.1; Entekhabi D, 2010, P IEEE, V98, P704, DOI 10.1109/JPROC.2010.2043918; Evensen G., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; FAO/IIASA/ISRIC/ISS-CAS/JRC, 2010, HARM WORLD SOIL DAT; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Greybush SJ, 2011, MON WEATHER REV, V139, P511, DOI 10.1175/2010MWR3328.1; Han X, 2012, HYDROL EARTH SYST SC, V16, P1349, DOI 10.5194/hess-16-1349-2012; Han XJ, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0072; Houtekamer PL, 2014, MON WEATHER REV, V142, P1163, DOI 10.1175/MWR-D-13-00011.1; Houtekamer PL, 1998, MON WEATHER REV, V126, P796, DOI 10.1175/1520-0493(1998)126<0796:DAUAEK>2.0.CO;2; Hunt BR, 2007, PHYSICA D, V230, P112, DOI 10.1016/j.physd.2006.11.008; Janjic T, 2011, MON WEATHER REV, V139, P2046, DOI 10.1175/2011MWR3552.1; Kerr YH, 2010, P IEEE, V98, P666, DOI 10.1109/JPROC.2010.2043032; Kumar SV, 2012, GEOSCI MODEL DEV, V5, P869, DOI 10.5194/gmd-5-869-2012; Kumar SV, 2008, ENVIRON MODELL SOFTW, V23, P169, DOI 10.1016/j.envsoft.2007.05.012; Kumar SV, 2012, WATER RESOUR RES, V48, DOI 10.1029/2010WR010261; Kumar SV, 2009, J HYDROMETEOROL, V10, P1534, DOI 10.1175/2009JHM1134.1; Lewis P, 2012, REMOTE SENS ENVIRON, V120, P219, DOI 10.1016/j.rse.2011.12.027; Li X, 2007, PROG NAT SCI-MATER, V17, P881; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Lien GY, 2013, TELLUS A, V65, DOI 10.3402/tellusa.v65i0.19915; Liston GE, 2006, J HYDROMETEOROL, V7, P217, DOI 10.1175/JHM486.1; Mascaro G, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008855; McLaughlin D, 2006, J HYDROMETEOROL, V7, P494, DOI 10.1175/JHM493.1; Merlin O, 2013, REMOTE SENS ENVIRON, V130, P25, DOI 10.1016/j.rse.2012.11.008; Merlin O, 2010, REMOTE SENS ENVIRON, V114, P2305, DOI 10.1016/j.rse.2010.05.007; Minasny B, 2005, GEODERMA, V128, P192, DOI 10.1016/j.geoderma.2005.04.003; Miyoshi T, 2007, MON WEATHER REV, V135, P3841, DOI 10.1175/2007MWR1873.1; Miyoshi T, 2014, GEOPHYS RES LETT, V41, P5264, DOI 10.1002/2014GL060863; Montzka C, 2008, J HYDROL, V353, P322, DOI 10.1016/j.jhydrol.2008.02.018; Montzka C, 2013, IEEE T GEOSCI REMOTE, V51, P1728, DOI 10.1109/TGRS.2012.2206031; Nerger L, 2011, Q J ROY METEOR SOC; Niu GY, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015139; Njoku EG, 2006, REMOTE SENS ENVIRON, V100, P190, DOI 10.1016/j.rse.2005.10.017; Oleson KW, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042194; Oleson K. W., 2013, TECHNICAL DESCRIPTIO, DOI [10.5065/D6RR1W7M, DOI 10.5065/D6RR1W7M]; Oliphant T. E., 2006, BAYESIAN PERSPECTIVE; Park S.K., 2009, DATA ASSIMILATION AT; Piles M, 2011, IEEE T GEOSCI REMOTE, V49, P3156, DOI 10.1109/TGRS.2011.2120615; Reichle RH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031986; Reichle RH, 2003, J HYDROMETEOROL, V4, P1229, DOI 10.1175/1525-7541(2003)004<1229:ATIOHE>2.0.CO;2; Reichle RH, 2010, J HYDROMETEOROL, V11, P1103, DOI 10.1175/2010JHM1262.1; Reichle RH, 2008, ADV WATER RESOUR, V31, P1411, DOI 10.1016/j.advwatres.2008.01.001; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Rigon R, 2006, J HYDROMETEOROL, V7, P371, DOI 10.1175/JHM497.1; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Ryu D, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025831; Sahoo AK, 2013, ADV WATER RESOUR, V52, P19, DOI 10.1016/j.advwatres.2012.08.007; Sakov P, 2011, COMPUTAT GEOSCI, V15, P225, DOI 10.1007/s10596-010-9202-6; Song CY, 2014, IEEE J-STARS, V7, P935, DOI 10.1109/JSTARS.2013.2272053; Sun WX, 2008, REMOTE SENS ENVIRON, V112, P1010, DOI 10.1016/j.rse.2007.07.022; TOWNSHEND JRG, 1992, IEEE T GEOSCI REMOTE, V30, P1054, DOI 10.1109/36.175340; Wan Z, 2008, INT J REMOTE SENS, V29, P5373, DOI 10.1080/01431160802036565; Wigneron JP, 2007, REMOTE SENS ENVIRON, V107, P639, DOI 10.1016/j.rse.2006.10.014; WILHEIT TT, 1978, IEEE T GEOSCI REMOTE, V16, P138, DOI 10.1109/TGE.1978.294577; Wood EF, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010090; Zacharias S, 2011, VADOSE ZONE J, V10, P955, DOI 10.2136/vzj2010.0139; Zreda M, 2012, HYDROL EARTH SYST SC, V16, P4079, DOI 10.5194/hess-16-4079-2012	69	6	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116435	10.1371/journal.pone.0116435	http://dx.doi.org/10.1371/journal.pone.0116435			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635771	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700036
J	Hollister, JR; Lee, KS; Dorward, DW; Baron, GS				Hollister, Jason R.; Lee, Kil Sun; Dorward, David W.; Baron, Gerald S.			Efficient Uptake and Dissemination of Scrapie Prion Protein by Astrocytes and Fibroblasts from Adult Hamster Brain	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; DENSITY-LIPOPROTEIN RECEPTOR; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; RAT HIPPOCAMPAL-NEURONS; SMOOTH-MUSCLE-CELLS; IN-VITRO; PRP; INFECTION; TISSUE; SHEEP	Prion infections target neurons and lead to neuronal loss. However, the role of non-neuronal cells in the initiation and spread of infection throughout the brain remains unclear despite the fact these cells can also propagate prion infectivity. To evaluate how different brain cells process scrapie prion protein (PrPres) during acute infection, we exposed neuron-enriched and non-neuronal cell cultures from adult hamster brain to fluorescently-labeled purified PrPres and followed the cultures by live cell confocal imaging over time. Non-neuronal cells present in both types of cultures, specifically astrocytes and fibroblasts, internalized PrPres more efficiently than neurons. PrPres was trafficked to late endosomal/lysosomal compartments and rapidly transported throughout the cell bodies and processes of all cell types, including contacts between astrocytes and neurons. These observations suggest that astrocytes and meningeal fibroblasts play an as yet unappreciated role in prion infections via efficient uptake and dissemination of PrPres.	[Hollister, Jason R.; Lee, Kil Sun; Baron, Gerald S.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Dorward, David W.] NIAID, Microscopy Unit, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Baron, GS (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	gbaron@niaid.nih.gov	Lee, Kil S/D-3678-2012; Lee, Kil Sun/AAL-8564-2020	Lee, Kil S/0000-0002-2390-2774; 	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000982, ZICAI001052] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; Blanpied TA, 2003, NEUROBIOL AGING, V24, P1095, DOI 10.1016/j.neurobiolaging.2003.04.004; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Brewer GJ, 2005, EXP GERONTOL, V40, P426, DOI 10.1016/j.exger.2005.03.007; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cady C, 2001, BRAIN RES, V921, P1, DOI 10.1016/S0006-8993(01)03063-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CLARKE MC, 1976, NATURE, V261, P144, DOI 10.1038/261144a0; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cronier S, 2012, FASEB J, V26, P3854, DOI 10.1096/fj.11-201772; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, pE1938, DOI 10.1073/pnas.1206999109; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; DIEDRICH JF, 1991, P NATL ACAD SCI USA, V88, P375, DOI 10.1073/pnas.88.2.375; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Ersdal C, 2009, NEUROPATH APPL NEURO, V35, P259, DOI 10.1111/j.1365-2990.2008.00988.x; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Hirsch S, 1999, GLIA, V26, P36, DOI 10.1002/(SICI)1098-1136(199903)26:1<36::AID-GLIA4>3.0.CO;2-C; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; JEFFREY M, 1994, BRAIN RES, V656, P329, DOI 10.1016/0006-8993(94)91477-X; Jen A, 2010, J CELL SCI, V123, P246, DOI 10.1242/jcs.058099; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kobayashi A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-32; Luhr KM, 2002, J VIROL, V76, P12259, DOI 10.1128/JVI.76.23.12259-12264.2002; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Makarava N, 2012, J NEUROSCI, V32, P7345, DOI 10.1523/JNEUROSCI.6351-11.2012; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Patel JR, 2003, J NEUROSCI RES, V72, P527, DOI 10.1002/jnr.10602; Pihlaja R, 2008, GLIA, V56, P154, DOI 10.1002/glia.20599; PITAS RE, 1992, ARTERIOSCLER THROMB, V12, P1235, DOI 10.1161/01.ATV.12.11.1235; PITAS RE, 1990, J BIOL CHEM, V265, P12722; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; Raeber AJ, 1997, EMBO J, V16, P6057, DOI 10.1093/emboj/16.20.6057; Raymond GJ, 2012, J VIROL, V86, P11763, DOI 10.1128/JVI.01353-12; Ritchie DL, 2004, NEUROPATH APPL NEURO, V30, P360, DOI 10.1111/j.1365-2990.2003.00544.x; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sarasa R, 2012, CELL TISSUE RES, V350, P127, DOI 10.1007/s00441-012-1461-1; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Speare JO, 2010, EMBO J, V29, P782, DOI 10.1038/emboj.2009.392; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; THADANI V, 1988, J NEUROSURG, V69, P766, DOI 10.3171/jns.1988.69.5.0766; VANKEULEN LJM, 1995, VET PATHOL, V32, P299, DOI 10.1177/030098589503200312; Vidal E, 2006, J VIROL METHODS, V134, P15, DOI 10.1016/j.jviromet.2005.11.010; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamasaki T, 2014, VIROLOGY, V450, P324, DOI 10.1016/j.virol.2013.11.007; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0; Yang P, 2003, BRAIN RES PROTOC, V12, P67, DOI 10.1016/S1385-299X(03)00073-4; Ye XM, 1998, BRAIN RES, V809, P277, DOI 10.1016/S0006-8993(98)00833-6	75	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115351	10.1371/journal.pone.0115351	http://dx.doi.org/10.1371/journal.pone.0115351			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635871	Green Submitted, gold, Green Published			2022-12-26	WOS:000350680700008
J	Mistry, V; Bockett, NA; Levine, AP; Mirza, MM; Hunt, KA; Ciclitira, PJ; Hummerich, H; Neuhausen, SL; Simpson, MA; Plagnol, V; van Heel, DA				Mistry, Vanisha; Bockett, Nicholas A.; Levine, Adam P.; Mirza, Muddassar M.; Hunt, Karen A.; Ciclitira, Paul J.; Hummerich, Holger; Neuhausen, Susan L.; Simpson, Michael A.; Plagnol, Vincent; van Heel, David A.			Exome Sequencing of 75 Individuals from Multiply Affected Coeliac Families and Large Scale Resequencing Follow Up	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SMALL-INTESTINAL MUCOSA; T-CELLS; COMMON VARIANTS; CROHNS-DISEASE; RARE VARIANTS; MUTATIONS; GLIADIN; ASSOCIATION; RECEPTOR	Coeliac disease (CeD) is a highly heritable common autoimmune disease involving chronic small intestinal inflammation in response to dietary wheat. The human leukocyte antigen (HLA) region, and 40 newer regions identified by genome wide association studies (GWAS) and dense fine mapping, account for similar to 40% of the disease heritability. We hypothesized that in pedigrees with multiple individuals with CeD rare [minor allele frequency (MAF) <0.5%] mutations of larger effect size (odds ratios of similar to 2-5) might exist. We sequenced the exomes of 75 coeliac individuals of European ancestry from 55 multiply affected families. We selected interesting variants and genes for further follow up using a combination of: an assessment of shared variants between related subjects, a model-free linkage test, and gene burden tests for multiple, potentially causal, variants. We next performed highly multiplexed amplicon resequencing of all RefSeq exons from 24 candidate genes selected on the basis of the exome sequencing data in 2,248 unrelated coeliac cases and 2,230 controls. 1,335 variants with a 99.9% genotyping call rate were observed in 4,478 samples, of which 939 were present in coding regions of 24 genes (Ti/Tv 2.99). 91.7% of coding variants were rare (MAF < 0.5%) and 60% were novel. Gene burden tests performed on rare functional variants identified no significant associations (p<1x10(-3)) in the resequenced candidate genes. Our strategy of sequencing multiply affected families with deep follow up of candidate genes has not identified any new CeD risk mutations.	[Mistry, Vanisha; Bockett, Nicholas A.; Hunt, Karen A.; van Heel, David A.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, London E1 2AT, England; [Levine, Adam P.] UCL, Div Med, London WC1E 6JF, England; [Mirza, Muddassar M.] UCL Adv Diagnost, Mol Profiling Lab, Sarah Cannon UCL Labs, London WC1E 6JA, England; [Ciclitira, Paul J.] Kings Coll London, Div Diabet & Nutr Sci, St Thomas Hosp, Gastroenterol,Rayne Inst, London SE1 7EH, England; [Hummerich, Holger] UCL, Inst Neurol, MRC, Prion Unit,Dept Neurodegenerat Dis, London WC1N 3BG, England; [Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Simpson, Michael A.] Kings Coll London, Sch Med, Guys Hosp, Div Genet & Mol Med, London SE1 9RY, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; City of Hope; Beckman Research Institute of City of Hope; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London	Mistry, V (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst, 4 Newark St, London E1 2AT, England.	vmm28@medschl.cam.ac.uk	; Simpson, Michael/F-4737-2011	Plagnol, Vincent/0000-0002-5597-9215; Bockett, Nicholas/0000-0002-7630-7637; Simpson, Michael/0000-0002-8539-8753; Levine, Adam/0000-0003-1333-9938; van Heel, David/0000-0002-0637-2265	Medical Research Council [MRC G1001158]; Coeliac UK; National Institutes of Health (NIH) [R01 DK081645]; UK MRC [G0000934]; Wellcome Trust [068545/Z/02]; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; MRC [G1001158, G0000934] Funding Source: UKRI; Medical Research Council [G1001158, G0000934] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081645] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Coeliac UK; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was primarily funded by the Medical Research Council (MRC G1001158 to DAVH), with further funding from Coeliac UK (to DAVH). Families provided by SLN were collected under funding by the National Institutes of Health (NIH R01 DK081645). DNA from the British 1958 Birth Control collection was funded by the UK MRC grant G0000934 and the Wellcome Trust grant 068545/Z/02. The BRC Genomics sequencing facility is funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bensellam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029807; Blaydon DC, 2013, AM SOC HUMAN GENETIC, V93, P1; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; CEPEK KL, 1993, J IMMUNOL, V150, P3459; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Eller E, 2006, HUM IMMUNOL, V67, P940, DOI 10.1016/j.humimm.2006.08.293; FAIS S, 1992, GUT, V33, P472, DOI 10.1136/gut.33.4.472; Fearnhead NS, 2004, P NATL ACAD SCI USA, V101, P15992, DOI 10.1073/pnas.0407187101; Fodinger M, 2001, KIDNEY INT, V59, pS238; Hunt KA, 2013, NATURE, V498, P232, DOI 10.1038/nature12170; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Jostins L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076328; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; King AL, 2000, ANN HUM GENET, V64, P479, DOI 10.1046/j.1469-1809.2000.6460479.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Liu JQ, 2001, IMMUNITY, V15, P23, DOI 10.1016/S1074-7613(01)00162-5; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P285, DOI 10.1016/0198-8859(94)90047-7; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Morrison AC, 2013, NAT GENET, V45, P899, DOI 10.1038/ng.2671; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Tang H, 2013, NAT GENET, DOI [10.1038/ng/2827, DOI 10.1038/NG/2827]; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Heel DA, 2005, LANCET, V365, P1794, DOI 10.1016/S0140-6736(05)66582-8; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhao HR, 2001, J EXP MED, V194, P1441, DOI 10.1084/jem.194.10.1441	47	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116845	10.1371/journal.pone.0116845	http://dx.doi.org/10.1371/journal.pone.0116845			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635822	Green Submitted, gold, Green Published			2022-12-26	WOS:000350680700061
J	Sit, RWS; Yip, BHK; Chan, DCC; Wong, SYS				Sit, Regina W. S.; Yip, Benjamin H. K.; Chan, Dicken C. C.; Wong, Samuel Y. S.			Primary Care Physicians' Attitudes and Beliefs towards Chronic Low Back Pain: An Asian Study	PLOS ONE			English	Article							PRACTITIONERS ATTITUDES; GENERAL-PRACTITIONERS; CLINICAL MANAGEMENT; PROVIDERS; RECOMMENDATIONS; GUIDELINES; THERAPISTS; ILLNESS; COST	Background Chronic low back pain is a serious global health problem. There is substantial evidence that physicians' attitudes towards and beliefs about chronic low back pain can influence their subsequent management of the condition. Objectives (1) to evaluate the attitudes and beliefs towards chronic low back pain among primary care physicians in Asia; (2) to study the cultural differences and other factors that are associated with these attitudes and beliefs. Method A cross sectional online survey was sent to primary care physicians who are members of the Hong Kong College of Family Physician (HKCFP). The Pain Attitudes and Beliefs Scale for Physiotherapist (PABS-PT) was used as the questionnaire to determine the biomedical and biopsychosocial orientation of the participants. Results The mean Biomedical (BM) score was 34.8+/-6.1; the mean biopsychosocial (BPS) score was 35.6 (+/-4.8). Both scores were higher than those of European doctors. Family medicine specialists had a lower biomedical score than General practitioners. Physicians working in the public sector tended to have low BM and low BPS scores; whereas physicians working in private practice tended to have high BM and high BPS scores. Conclusion The lack of concordance in the pain explanatory models used by private and public sector may have a detrimental effect on patients who are under the care of both parties. The uncertain treatment orientation may have a negative influence on patients' attitudes and beliefs, thus contributing to the tension and, perhaps, even ailing mental state of a person with chronic LBP.	[Sit, Regina W. S.; Yip, Benjamin H. K.; Chan, Dicken C. C.; Wong, Samuel Y. S.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Sit, RWS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	reginasit@cuhk.edu.hk	Sit, Regina Wing Shan/V-9982-2017; Yip, Benjamin/AAC-7845-2019; WONG, Samuel Yeung Shan/D-7311-2013	Sit, Regina Wing Shan/0000-0002-4717-7773; Yip, Benjamin/0000-0002-4749-7611; WONG, Samuel Yeung Shan/0000-0003-0934-6385				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Bishop A, 2008, PAIN, V135, P187, DOI 10.1016/j.pain.2007.11.010; Bishop A, 2007, PAIN, V132, P91, DOI 10.1016/j.pain.2007.01.028; Crawford Cameron, 2007, N Z Med J, V120, pU2536; Dagenais S, 2008, SPINE J, V8, P8, DOI 10.1016/j.spinee.2007.10.005; Darlow B, 2012, EUR J PAIN, V16, P3, DOI 10.1016/j.ejpain.2011.06.006; Domenech J, 2011, PAIN, V152, P2557, DOI 10.1016/j.pain.2011.07.023; Fabb W. E., 1995, Hong Kong Medical Journal, V1, P230; Foster NE, 2003, ORTHOP CLIN N AM, V34, P239, DOI 10.1016/S0030-5898(03)00011-7; Fullen BM, 2011, CLIN J PAIN, V27, P542, DOI 10.1097/AJP.0b013e31821771e2; Gorey TM, 2004, ANN FAM MED, V2, pS3, DOI 10.1370/afm.130; Hoffman BM, 2007, HEALTH PSYCHOL, V26, P1, DOI 10.1037/0278-6133.26.1.1; Holden MA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1511, DOI 10.1002/art.24829; Houben RMA, 2005, EUR J PAIN, V9, P173, DOI 10.1016/j.ejpain.2004.05.002; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Magalhaes MO, 2012, REV BRAS FISIOTER, V16, P248, DOI 10.1590/S1413-35552012005000014; Medalie JH, 1993, FAMILY SYSTEMS MED, V11, P15; Nicholas MK, 2008, BEST PRACT RES CL RH, V22, P451, DOI 10.1016/j.berh.2007.11.008; Ostelo RWJG, 2003, MANUAL THER, V8, P214, DOI 10.1016/S1356-689X(03)00013-4; Parsons S, 2007, CLIN J PAIN, V23, P91, DOI 10.1097/01.ajp.0000210947.34676.34; Pool JJM, 2010, SPINE, V35, P1017, DOI 10.1097/BRS.0b013e3181c212ee; RASKER JJ, 1995, BRIT J RHEUMATOL, V34, P494; Savigny P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1805; Skelton AM, 1996, BRIT J GEN PRACT, V46, P153; Toye Francine, 2012, Prim Health Care Res Dev, V13, P72, DOI 10.1017/S1463423611000387; VANTULDER MW, 1995, PAIN, V62, P233, DOI 10.1016/0304-3959(94)00272-G; Wieser S, 2005, EUR J HEALTH ECON, V12, P455, DOI DOI 10.1007/S10198-010-0258-Y	28	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117521	10.1371/journal.pone.0117521	http://dx.doi.org/10.1371/journal.pone.0117521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635919	Green Published, gold, Green Submitted			2022-12-26	WOS:000350680700088
J	Pal, R; Yang, JP; Ortiz, D; Qiu, SM; Resto, V; McCammon, S; Vargas, G				Pal, Rahul; Yang, Jinping; Ortiz, Daniel; Qiu, Suimin; Resto, Vicente; McCammon, Susan; Vargas, Gracie			In-Vivo Nonlinear Optical Microscopy (NLOM) of Epithelial-Connective Tissue Interface (ECTI) Reveals Quantitative Measures of Neoplasia in Hamster Oral Mucosa	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; COHERENCE TOMOGRAPHY; MULTIPHOTON MICROSCOPY; STEM-CELLS; CANCER; MATRIX; DIAGNOSIS; METASTASIS; EXPRESSION; INVASION	The epithelial-connective tissue interface (ECTI) plays an integral role in epithelial neoplasia, including oral squamous cell carcinoma (OSCC). This interface undergoes significant alterations due to hyperproliferating epithelium that supports the transformation of normal epithelium to precancers and cancer. We present a method based on nonlinear optical microscopy to directly assess the ECTI and quantify dysplastic alterations using a hamster model for oral carcinogenesis. Neoplastic and non-neoplastic normal mucosa were imaged in-vivo by both multiphoton autofluorescence microscopy (MPAM) and second harmonic generation microscopy (SHGM) to obtain cross-sectional reconstructions of the oral epithelium and lamina propria. Imaged sites were biopsied and processed for histopathological grading and measurement of ECTI parameters. An ECTI shape parameter was calculated based on deviation from the linear geometry (Delta Linearity) seen in normal mucosa was measured using MPAM-SHGM and histology. The ECTI was readily visible in MPAM-SHGM and quantitative shape analysis showed ECTI deformation in dysplasia but not in normal mucosa..Linearity was significantly (p < 0.01) higher in dysplasia (0.41 +/- 0.24) than normal (0.11 +/- 0.04) as measured in MPAM-SHGM and results were confirmed in histology which showed similar trends in Delta Linearity-Increase in Delta Linearity was also statistically significant for different grades of dysplasia. In-vivo Delta Linearity measurement alone from microscopy discriminated dysplasia from normal tissue with 87.9% sensitivity and 97.6% specificity, while calculations from histology provided 96.4% sensitivity and 85.7% specificity. Among other quantifiable architectural changes, a progressive statistically significant increase in epithelial thickness was seen with increasing grade of dysplasia. MPAM-SHGM provides new noninvasive ways for direct characterization of ECTI which may be used in preclinical studies to investigate the role of this interface in early transformation. Further development of the method may also lead to new diagnostic approaches to differentiate non-neoplastic tissue from precancers and neoplasia, possibly with other cellular and layer based indicators of abnormality.	[Pal, Rahul; Yang, Jinping; Vargas, Gracie] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Ortiz, Daniel] Eastern Virginia Med Sch, Dept Radiol, Norfolk, VA 23507 USA; [Resto, Vicente; McCammon, Susan] Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; [Qiu, Suimin] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Vargas, Gracie] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Pal, Rahul; Resto, Vicente] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Qiu, Suimin; Resto, Vicente; McCammon, Susan; Vargas, Gracie] Univ Texas Med Branch, Ctr Canc Head & Neck, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Eastern Virginia Medical School; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Pal, R (corresponding author), Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA.	rapal@utmb.edu	Vargas, Gracie/ABH-3648-2020; Pal, Rahul/AAT-6342-2020		National Institutes of Health [RO1CA127429, RO1CA127429S1]; NATIONAL CANCER INSTITUTE [R01CA127429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health (www.nih.gov; National Cancer Institute). The grant numbers are: RO1CA127429 and RO1CA127429S1. The funding was received by GV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter M, 2011, J Oral Maxillofac Pathol, V15, P168, DOI 10.4103/0973-029X.84485; Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Bouquot JE, 2006, CURR DIAGN PATHOL, V12, P11, DOI DOI 10.1016/J.CDIP.2005.10.008; BOYSEN M, 1983, VIRCHOWS ARCH B, V42, P173, DOI 10.1007/BF02890380; Calenic B, 2010, ROM J MORPHOL EMBRYO, V51, P641; DALE B A, 1990, Critical Reviews in Oral Biology and Medicine, V1, P167; Derka S, 2006, ORAL ONCOL, V42, P540, DOI 10.1016/j.oraloncology.2005.10.008; DESOUZA FL, 2014, ISRN OTOLARYNGOL, V2014; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Durr NJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548646; Edward K, 2012, BIOMED OPT EXPRESS, V3, P1579, DOI 10.1364/BOE.3.001579; Fedele S, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-5; Gimenez-Conti I, 1993, Acta Odontol Latinoam, V7, P3; Hamdoon Z, 2013, PHOTODIAGN PHOTODYN, V10, P17, DOI 10.1016/j.pdpdt.2012.07.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; JOHNSON NW, 1976, P ROY SOC MED, V69, P740, DOI 10.1177/003591577606901006; Jones KB, 2013, INT J ORAL SCI, V5, P121, DOI 10.1038/ijos.2013.46; Jung WG, 2005, IEEE J SEL TOP QUANT, V11, P811, DOI 10.1109/JSTQE.2005.857678; Keith RL, 2013, NAT REV CLIN ONCOL, V10, P334, DOI 10.1038/nrclinonc.2013.64; Kirkpatrick ND, 2007, AM J PHYSIOL-HEART C, V292, pH3198, DOI 10.1152/ajpheart.01234.2006; KOBAT D, 2011, 2011 C LAS EL CLEO; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; LANDINI G, 1993, ANAL QUANT CYTOL, V15, P144; Landini G, 2000, PATHOL RES PRACT, V196, P251, DOI 10.1016/S0344-0338(00)80074-6; Lee CK, 2012, BIOMED OPT EXPRESS, V3, P1632, DOI 10.1364/BOE.3.001632; LIOTTA LA, 1991, CANCER RES, V51, pS5054; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Matheny ES, 2004, J BIOMED OPT, V9, P978, DOI 10.1117/1.1783897; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Oliver RJ, 2000, J ORAL PATHOL MED, V29, P49, DOI 10.1034/j.1600-0714.2000.290201.x; Pande P, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086022; Papakosta V, 2006, ANTICANCER RES, V26, P2957; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paulsen F, 1998, J ANAT, V193, P457, DOI 10.1046/j.1469-7580.1998.19330457.x; Pena AM, 2005, OPT EXPRESS, V13, P6667, DOI 10.1364/OPEX.13.006667; Poh CF, 2008, J CAN DENT ASSOC, V74, P283; POTTEN CS, 1988, J CELL SCI, P45; Psilodimitrakopoulos S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3059627; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; RICH AM, 1991, BRIT J CANCER, V64, P96, DOI 10.1038/bjc.1991.248; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SAMI MM, 2010, ORAL MED PATHOL, V14, P89, DOI DOI 10.1016/J; Sen S, 2011, INVEST OPHTH VIS SCI, V52, P9548, DOI 10.1167/iovs.11-7946; Skala MC, 2005, CANCER RES, V65, P1180, DOI 10.1158/0008-5472.CAN-04-3031; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Sun J, 2004, OPT EXPRESS, V12, P2478, DOI 10.1364/OPEX.12.002478; Sutinen M, 1998, BRIT J CANCER, V77, P2239, DOI 10.1038/bjc.1998.372; Teh SK, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.036001; Tsai MT, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2960632; Valraktaris E, 2008, ORAL ONCOL, V44, P315, DOI 10.1016/j.oraloncology.2007.08.015; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Vargas G, 2009, IEEE ENG MED BIO, P6311, DOI 10.1109/IEMBS.2009.5332783; Volgger V, 2013, HEAD NECK-J SCI SPEC, V35, P1558, DOI 10.1002/hed.23189; WANG K, 2013, OPTICS PHOTONICS NEW; Wenig BM, 2002, MODERN PATHOL, V15, P229, DOI 10.1038/modpathol.3880520; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; WHITE FH, 1981, DIAGN HISTOPATHOL, V4, P307; Wilder-Smith P, 2004, LASER SURG MED, V35, P269, DOI 10.1002/lsm.20098; Wilder-Smith P, 2004, LASER SURG MED, V35, P96, DOI 10.1002/lsm.20079; Wilson DF, 1999, AUST DENT J, V44, P93, DOI 10.1111/j.1834-7819.1999.tb00207.x; Winning TA, 2000, CLIN DERMATOL, V18, P499, DOI 10.1016/S0738-081X(00)00140-1; Zhang Y, 2006, J EXP CLIN CANC RES, V25, P417; Zheng W, 2011, OPT LETT, V36, P3620, DOI 10.1364/OL.36.003620; Zhuo SM, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3505762; Zhuo SM, 2007, PHYS MED BIOL, V52, P4967, DOI 10.1088/0031-9155/52/16/017	67	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116754	10.1371/journal.pone.0116754	http://dx.doi.org/10.1371/journal.pone.0116754			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633927	Green Published, Green Submitted, gold			2022-12-26	WOS:000348609800010
J	Lim, MSC; Zhang, XD; Kennedy, E; Li, Y; Yang, Y; Li, L; Li, YX; Temmerman, M; Luchters, S				Lim, Megan S. C.; Zhang, Xu-Dong; Kennedy, Elissa; Li, Yan; Yang, Yin; Li, Lin; Li, Yun-Xia; Temmerman, Marleen; Luchters, Stanley			Sexual and Reproductive Health Knowledge, Contraception Uptake, and Factors Associated with Unmet Need for Modern Contraception among Adolescent Female Sex Workers in China	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; BEHAVIOR; VIOLENCE; WOMEN; HIV; DRINKING; ALCOHOL; RISK	Objective In China, policy and social taboo prevent unmarried adolescents from accessing sexual and reproductive health (SRH) services. Research is needed to determine the SRH needs of highly disadvantaged groups, such as adolescent female sex workers (FSWs). This study describes SRH knowledge, contraception use, pregnancy, and factors associated with unmet need for modern contraception among adolescent FSWs in Kunming, China. Methods A cross-sectional study using a one-stage cluster sampling method was employed to recruit adolescents aged 15 to 20 years, and who self-reported having received money or gifts in exchange for sex in the past 6 months. A semi-structured questionnaire was administered by trained peer educators or health workers. Multivariable logistic regression was conducted to determine correlates of low knowledge and unmet need for modern contraception. Results SRH knowledge was poor among the 310 adolescents surveyed; only 39% had heard of any long-acting reversible contraception (implant, injection or IUD). Despite 98% reporting not wanting to get pregnant, just 43% reported consistent condom use and 28% currently used another form of modern contraception. Unmet need for modern contraception was found in 35% of adolescents, and was associated with having a current non-paying partner, regular alcohol use, and having poorer SRH knowledge. Past abortion was common (136, 44%). In the past year, 76% had reported a contraception consultation but only 27% reported ever receiving SRH information from a health service. Conclusions This study demonstrated a low level of SRH knowledge, a high unmet need for modern contraception and a high prevalence of unintended pregnancy among adolescent FSWs in Kunming. Most girls relied on condoms, emergency contraception, or traditional methods, putting them at risk of unwanted pregnancy. This study identifies an urgent need for Chinese adolescent FSWs to be able to access quality SRH information and effective modern contraception.	[Lim, Megan S. C.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Zhang, Xu-Dong; Temmerman, Marleen; Luchters, Stanley] Univ Ghent, Int Ctr Reprod Hlth, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium; [Kennedy, Elissa; Luchters, Stanley] Burnet Inst, Ctr Int Hlth, Melbourne, Vic, Australia; [Lim, Megan S. C.; Kennedy, Elissa; Luchters, Stanley] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Li, Yan] Kunming Med Univ, Sch Publ Hlth, Kunming, Peoples R China; [Yang, Yin] Kunming Third Peoples Hosp, Dept AIDS Management, Kunming, Peoples R China; [Li, Lin] Kunming Maternal & Child Hlth Care Ctr, Dept Primary Hlth Care, Kunming, Peoples R China; [Li, Yun-Xia] Kunming Maternal & Child Hlth Care Ctr, Dept AIDS Prevent, Kunming, Peoples R China	Burnet Institute; Ghent University; Burnet Institute; Monash University; Kunming Medical University	Zhang, XD (corresponding author), Univ Ghent, Int Ctr Reprod Hlth, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium.	Xudong.Zhang@UGent.be		Luchters, Stanley/0000-0001-5235-5629	FSW research from the AIDS department of Kunming Public Health Bureau [KM2012AIDS]; Kunming Xishan District Center for Disease Prevention and Control [XSCDC-FSW-2012-06]	FSW research from the AIDS department of Kunming Public Health Bureau; Kunming Xishan District Center for Disease Prevention and Control	This study was supported by grants on FSW research from the AIDS department of Kunming Public Health Bureau (KM2012AIDS), the Kunming Xishan District Center for Disease Prevention and Control (XSCDC-FSW-2012-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AS PAC NETW SEX W, 2012, HIV SEX WORK COLL IN, P42331; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Bruce J, 2007, GIRLS LEFT REDIRECTI; Bruce J., 2006, NOTE SOCIAL EC DEV R; Chandra-Mouli V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-1; Cheng Y, 2004, INT J GYNECOL OBSTET, V87, P199, DOI 10.1016/j.ijgo.2004.06.010; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, 2012, OBSTET GYNECOL, V120, P983, DOI DOI 10.1097/AOG.0B013E3182723B7D; *DEP MAT NEWB CHIL, 2011, GUID PREV EARL PREGN, P42331; Ditmore MH., 2013, SEX WORK DRUG USE OV; Fang Xiaoyi, 2007, World Health Popul, V9, P46; Hong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062290; Hu Y., 2010, J INT REPROD HLTH FA, V29.6, P392; *INT WOM HLTH COAL, 2008, TRIPL JEOP FEM AD SE, P42331; Kavanaugh ML, 2011, OBSTET GYNECOL, V117, P1349, DOI 10.1097/AOG.0b013e31821c47c9; KENDAL M, 2010, SEX WORK HIV, P42331; Li JK, 2013, EUR J CONTRACEP REPR, V18, P148, DOI 10.3109/13625187.2013.776673; Li L, 2009, DERMATOL VENEREOL, V31, P1; Luchters S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068855; Luchters S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-384; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Mao Z-Y, 2011, NW POPUL, V32, P95, DOI DOI 10.15884/J.CNKI.ISSN.1007-0672.2011.05.016; MIDDLETONLEE S, 2011, HIV SRHR INTEGRATION, P42331; Moraros J, 2012, J HIV-AIDS SOC SERV, V11, P125, DOI 10.1080/15381501.2012.678117; *NAT BUR STAT CHIN, 2011, NAT POP CENS 2010, P42331; Neal S, 2012, ACTA OBSTET GYN SCAN, V91, P1114, DOI 10.1111/j.1600-0412.2012.01467.x; Okal J, 2011, AIDS CARE, V23, P612, DOI 10.1080/09540121.2010.525605; *PATH, 2013, PHIL INT FAM PLANN H, P42331; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; *POP COUNC, 2001, REPR TRACT INF INTR, P42331; QIAN X, 2004, BMC HEALTH SERV RES, V4, pE1; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Silverman JG, 2011, ARCH DIS CHILD, V96, P478, DOI 10.1136/adc.2009.178715; Tang J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-917; TAYLOR C, 2007, SERVICES YOUNG PEOPL, P42331; TEAL SB, 2013, J ADOLESCENT HEALTH, V52, P35, DOI DOI 10.1016/J.JADOHEALTH.2012.07.016; Tu XW, 2004, B WORLD HEALTH ORGAN, V82, P274; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; *UNFPA, 2013, STAT WORLD POP MOTH, P42331; United Nations Population Fund (UNFPA), 2013, AD PREGN REV EV; Wechsberg WM, 2006, AIDS BEHAV, V10, P131, DOI 10.1007/s10461-005-9036-8; WHO, 2014, HLTH WORLDS AD 2 CHA; WHO, 2011, SEX REPR HLTH YOUNG; *WHO DEP REPR HLTH, 2004, SEL PRACT REC CONTR, P42331; Williamson Lisa M, 2009, Reprod Health, V6, P3, DOI 10.1186/1742-4755-6-3; World Health Organization, 2013, IMPL COMPR HIV STI P; ZHANG C, 2014, JOURNAL, P42331; Zhang C, 2013, PSYCHOL HEALTH MED, V18, P330, DOI 10.1080/13548506.2012.712705; Zhang XD, 2014, EUR J CONTRACEP REPR, V19, P368, DOI 10.3109/13625187.2014.927421; Zhang XD, 2013, SEX TRANSM INFECT, V89, P237, DOI 10.1136/sextrans-2012-050690; Zheng X., 2010, POPUL DEV, V16, P2; Zhou YY, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-13	52	21	21	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0115435	10.1371/journal.pone.0115435	http://dx.doi.org/10.1371/journal.pone.0115435			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA3QM	25625194	Green Published, gold			2022-12-26	WOS:000348821400008
J	Aguilar, A; Wagstaff, KM; Suarez-Sanchez, R; Zinker, S; Jans, DA; Cisneros, B				Aguilar, Areli; Wagstaff, Kylie M.; Suarez-Sanchez, Rocio; Zinker, Samuel; Jans, David A.; Cisneros, Bulmaro			Nuclear localization of the dystrophin-associated protein alpha-dystrobrevin through importin alpha 2/beta 1 is critical for interaction with the nuclear lamina/maintenance of nuclear integrity	FASEB JOURNAL			English	Article						nuclear import; lamin B1; nuclear envelope; nuclear morphology	ZINC-FINGER DOMAIN; MUSCULAR-DYSTROPHIES; BETA-DYSTROGLYCAN; IN-VITRO; SIGNAL; CELLS; ENVELOPE; COMPLEX; MUSCLE; IDENTIFICATION	Although alpha-dystrobrevin (DB) is assembled into the dystrophin-associated protein complex, which is central to cytoskeletal organization, it has also been found in the nucleus. Here we delineate the nuclear import pathway responsible for nuclear targeting of alpha-DB for the first time, together with the importance of nuclear alpha-DB in determining nuclear morphology. We map key residues of the nuclear localization signal of alpha-DB within the zinc finger domain (ZZ) using various truncated versions of the protein, and site-directed mutagenesis. Pulldown, immunoprecipitation, and AlphaScreen assays showed that the importin (IMP) alpha 2/beta 1 heterodimer interacts with high affinity with the ZZ domain of alpha-DB. In vitro nuclear import assays using antibodies to specific importins, as well as in vivo studies using siRNA or a dominant negative importin construct, confirmed the key role of IMP alpha 2/beta 1 in alpha-DB nuclear translocation. Knockdown of alpha-DB expression perturbed cell cycle progression in C2C12 myoblasts, with decreased accumulation of cells in S phase and, significantly, altered localization of lamins A/C, B1, and B2 with accompanying gross nuclear morphology defects. Because alpha-DB interacts specifically with lamin B1 in vivo and in vitro, nuclear alpha-DB would appear to play a key role in nuclear shape maintenance through association with the nuclear lamina.	[Aguilar, Areli; Zinker, Samuel; Cisneros, Bulmaro] Dept Genet Biol Mol, Centro Investigac Estudios Avanzados Inst Politec, Mexico City, DF, Mexico; [Aguilar, Areli; Zinker, Samuel; Cisneros, Bulmaro] Inst Politecn Nacl, Ctr Invest Estudios Avanzados, Dept Genet & Biol Mol, Mexico City, DF, Mexico; [Wagstaff, Kylie M.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Clayton, Vic, Australia; [Suarez-Sanchez, Rocio] Inst Nacl Rehabil, Dept Genet, Lab Med Genom, Mexico City 07360, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Monash University	Cisneros, B (corresponding author), Av IPN 2508,Col San Pedro Zacatenco, Mexico City 07360, DF, Mexico.	david.jans@monash.edu; bcisnero@cinvestav.mx		Wagstaff, Kylie/0000-0003-4791-1410; Jans, David/0000-0001-5115-4745	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [54858]; National Health and Medical Research Council, Australia [APP1002486]	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico (Grant 54858 to B.C.), and the National Health and Medical Research Council, Australia (Grant APP1002486 to D.A.J.). The authors thank Juan de Dios Gomez-Lopez for performing the pulldown assays.	Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Beetz C, 2004, BIOCHEM BIOPH RES CO, V318, P1079, DOI 10.1016/j.bbrc.2004.03.195; Blake DJ, 1996, J BIOL CHEM, V271, P7802, DOI 10.1074/jbc.271.13.7802; Borutinskaite VV, 2011, MOL BIOL REP, V38, P3001, DOI 10.1007/s11033-010-9965-9; Bruening W, 1996, FEBS LETT, V393, P41, DOI 10.1016/0014-5793(96)00853-8; Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; Cerna J, 2006, J MOL BIOL, V362, P954, DOI 10.1016/j.jmb.2006.07.075; Crisp M, 2008, FEBS LETT, V582, P2023, DOI 10.1016/j.febslet.2008.05.001; De Castro SCP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003059; Efthymiadis A, 1997, J BIOL CHEM, V272, P22134, DOI 10.1074/jbc.272.35.22134; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Forwood JK, 2001, J BIOL CHEM, V276, P46575, DOI 10.1074/jbc.M101668200; Fuentes-Mera L, 2006, EXP CELL RES, V312, P3023, DOI 10.1016/j.yexcr.2006.06.002; Funkhouser CM, 2013, P NATL ACAD SCI USA, V110, P3248, DOI 10.1073/pnas.1300215110; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Gonzalez-Ramirez R, 2008, J CELL BIOCHEM, V105, P735, DOI 10.1002/jcb.21870; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Hatayama M, 2008, HUM MOL GENET, V17, P3459, DOI 10.1093/hmg/ddn239; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Jans DA, 1996, J BIOL CHEM, V271, P30781, DOI 10.1074/jbc.271.48.30781; Lara-Chacon B, 2010, J CELL BIOCHEM, V110, P706, DOI 10.1002/jcb.22581; Martin C, 2010, CHROMOSOME RES, V18, P525, DOI 10.1007/s10577-010-9137-8; Martinez-Vieyra IA, 2013, BBA-MOL CELL RES, V1833, P698, DOI 10.1016/j.bbamcr.2012.11.019; MATHENY C, 1994, J BIOL CHEM, V269, P8176; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Metzinger L, 1997, HUM MOL GENET, V6, P1185, DOI 10.1093/hmg/6.7.1185; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Nakamori M, 2011, INT J MOL SCI, V12, P1660, DOI 10.3390/ijms12031660; Navakauskiene R, 2012, J PROTEOMICS, V75, P3291, DOI 10.1016/j.jprot.2012.03.041; Newey SE, 2001, J BIOL CHEM, V276, P6645, DOI 10.1074/jbc.M008305200; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Peters MF, 1997, J BIOL CHEM, V272, P31561, DOI 10.1074/jbc.272.50.31561; Rothballer A, 2013, CHROMOSOMA, V122, P415, DOI 10.1007/s00412-013-0417-x; Rothballer A, 2013, NUCLEUS-PHILA, V4, P29, DOI 10.4161/nucl.23387; SadouletPuccio HM, 1997, P NATL ACAD SCI USA, V94, P12413, DOI 10.1073/pnas.94.23.12413; SadouletPuccio HM, 1996, HUM MOL GENET, V5, P489, DOI 10.1093/hmg/5.4.489; Villarreal-Silva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023504; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Young JC, 2011, FASEB J, V25, P3958, DOI 10.1096/fj.10-176941; Yu Z, 1998, J ENDOCRINOL, V159, P53, DOI 10.1677/joe.0.1590053	43	10	10	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1842	1858		10.1096/fj.14-257147	http://dx.doi.org/10.1096/fj.14-257147			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25636738				2022-12-26	WOS:000354114600020
J	Pol, JG; Lekbaby, B; Redelsperger, F; Klamer, S; Mandouri, Y; Ahodantin, J; Bieche, I; Lefevre, M; Souque, P; Charneau, P; Gadessaud, N; Kremsdorf, D; Soussan, P				Pol, Jonathan G.; Lekbaby, Bouchra; Redelsperger, Francois; Klamer, Sofieke; Mandouri, Yassmina; Ahodantin, James; Bieche, Ivan; Lefevre, Marine; Souque, Philippe; Charneau, Pierre; Gadessaud, Noemie; Kremsdorf, Dina; Soussan, Patrick			Alternative splicing-regulated protein of hepatitis B virus hacks the TNF-alpha-stimulated signaling pathways and limits the extent of liver inflammation	FASEB JOURNAL			English	Article						TAK1; HBSP; hepadnavirus; liver injury	NF-KAPPA-B; ACTIVATED KINASE 1; GENE-EXPRESSION; TRANSGENIC MICE; JNK ACTIVATION; HEPG2 CELLS; MOUSE-LIVER; IN-VIVO; TAK1; RNA	Hepatitis B splicing-regulated protein (HBSP) of the hepatitis B virus (HBV) was uncovered a few years ago but its function remains unknown. HBSP expression occurs from a spliced viral transcript that increases during the course of liver disease. This study aimed at characterizing the impact of HBSP on cellular signaling pathways in vitro and on liver pathogenesis in transgenic (Tg) mice. By RT-qPCR array, NF-kappa B-inducible genes appeared modulated in HepG2 cells transduced with a HBSP-encoding lentivirus. Using luciferase and Western blot assays, we observed a decreased activation of the NF-kappa B pathway in HBSP-expressing cells following TNF-alpha treatment, as illustrated by lower levels of phosphorylated I kappa B-alpha. Meanwhile, the level of phosphorylated JNK increased together with the sensitivity to apoptosis. The contrasting effects on JNK and I kappa B-alpha activation upon TNF-alpha stimulation matched with a modulated maturation of TGF-beta-activated kinase 1 (TAK1) kinase, assessed by 2-dimensional SDS-PAGE. Inhibition of the NF-kappa B pathway by HBSP was confirmed in the liver of HBSP Tg mice and associated with a significant decrease of chemically induced chronic liver inflammation, as assessed by immunohistochemistry. In conclusion, HBSP contributes to limit hepatic inflammation during chronic liver disease and may favor HBV persistence by evading immune response.	[Pol, Jonathan G.; Lekbaby, Bouchra; Redelsperger, Francois; Klamer, Sofieke; Mandouri, Yassmina; Ahodantin, James; Kremsdorf, Dina; Soussan, Patrick] INSERM, Pathogenese Hepatites Virales B & Immunotherapie, U845, Paris, France; [Pol, Jonathan G.; Lekbaby, Bouchra; Redelsperger, Francois; Klamer, Sofieke; Mandouri, Yassmina; Ahodantin, James; Kremsdorf, Dina; Soussan, Patrick] Inst Pasteur, Dept Virol, Paris, France; [Pol, Jonathan G.; Lekbaby, Bouchra; Redelsperger, Francois; Klamer, Sofieke; Mandouri, Yassmina; Ahodantin, James; Kremsdorf, Dina; Soussan, Patrick] Univ Necker, Univ Paris Descartes, Ctr Hosp, Paris, France; [Bieche, Ivan] Fac Pharmaceut Sci, Genet Mol Lab, Paris, France; [Lefevre, Marine] Hop Tenon, Serv Anatomopathol, F-75970 Paris, France; [Souque, Philippe; Charneau, Pierre] Inst Pasteur, CNRS, Virol Mol & Vectorol, Unite Rech Associee 3015, Paris, France; [Gadessaud, Noemie] Lab L RB126, Paris, France; [Soussan, Patrick] Hop Tenon, Virol Lab, F-75970 Paris, France; [Soussan, Patrick] Univ Paris 06, Ctr Hosp Univ Tenon, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Soussan, P (corresponding author), CHU Broussais, INSERM, U845, 96 Rue Didot, F-75014 Paris, France.	patrick.soussan@inserm.fr	Ahodantin, James/AAB-7216-2022; CHARNEAU, Pierre/M-1565-2017; Pol, Jonathan/R-6507-2016; Bièche, Ivan/O-7399-2017; soussan, patrick/O-9801-2017; Ahodantin, James/AAK-3326-2020; Kremsdorf, Dina/O-9797-2017	Ahodantin, James/0000-0003-4405-2593; CHARNEAU, Pierre/0000-0003-1184-5773; Pol, Jonathan/0000-0002-8355-7562; Bièche, Ivan/0000-0002-2430-5429; soussan, patrick/0000-0003-2706-7371; Ahodantin, James/0000-0003-4405-2593; 	French Ministry of Research; INSERM; Agence Nationale de la Recherche sur le SIDA-VIH et les Hepatites Virales [12229]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche sur le SIDA-VIH et les Hepatites Virales(French National Research Agency (ANR))	The authors thank Raphaelle Desvaux and Nicolas Goudin (Microscopy and Histology core facilities, INSERM U845), Hualin Wang (INSERM U1135) for helpful technical assistance, Prof.Sallenave (Pasteur Institute, Paris, France) and Dr. Le Goffic (French National Institute for Agricultural Research;INRA, Jouy en Josas) for helpful discussion and providing viral vectors. J.G.P. and F.R. received support from the French Ministry of Research. This work was supported by grants from INSERM and the Agence Nationale de la Recherche sur le SIDA-VIH et les Hepatites Virales (Grant number 12229).	Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; Bayliss J, 2013, J HEPATOL, V59, P1022, DOI 10.1016/j.jhep.2013.06.018; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Broglie P, 2010, J BIOL CHEM, V285, P2333, DOI 10.1074/jbc.M109.090522; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen JY, 2010, J MED VIROL, V82, P2019, DOI 10.1002/jmv.21918; Chen WN, 2012, J VIROL, V86, P13533, DOI 10.1128/JVI.02095-12; Cho G, 2000, BIOCHEM BIOPH RES CO, V269, P191, DOI 10.1006/bbrc.2000.2240; Giannini C, 2003, HEPATOLOGY, V38, P114, DOI 10.1053/jhep.2003.50265; Golan-Gerstl R, 2011, CANCER RES, V71, P4464, DOI 10.1158/0008-5472.CAN-10-4410; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Gunther S, 1997, VIROLOGY, V238, P363, DOI 10.1006/viro.1997.8863; Hamidi A, 2012, J BIOL CHEM, V287, P123, DOI 10.1074/jbc.M111.285122; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Inokuchi-Shimizu S, 2014, J CLIN INVEST, V124, P3566, DOI 10.1172/JCI74068; Kim YS, 2002, HEPATOLOGY, V36, P1498, DOI 10.1053/jhep.2002.36942; Liu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091658; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Lu YW, 2008, IUBMB LIFE, V60, P700, DOI 10.1002/iub.108; Mancini-Bourgine M, 2007, J VIROL, V81, P4963, DOI 10.1128/JVI.02619-06; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Quetier I, 2013, J HEPATOL, V59, P285, DOI 10.1016/j.jhep.2013.03.021; Redelsperger F, 2012, VIROLOGY, V431, P21, DOI 10.1016/j.virol.2012.05.008; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Scott MJ, 2010, J HEPATOL, V53, P693, DOI 10.1016/j.jhep.2010.04.026; Scott MJ, 2009, HEPATOLOGY, V49, P1695, DOI 10.1002/hep.22839; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Sene D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001184; Soussan P, 2000, J CLIN INVEST, V105, P55, DOI 10.1172/JCI8098; Soussan P, 2003, J HEPATOL, V38, P343, DOI 10.1016/S0168-8278(02)00422-1; Soussan P, 2008, J INFECT DIS, V198, P218, DOI 10.1086/589623; Suzuki S, 2007, J BIOL CHEM, V282, P25177, DOI 10.1074/jbc.C700065200; TERRE S, 1991, J VIROL, V65, P5539; Wang YJ, 2006, J BIOL CHEM, V281, P15258, DOI 10.1074/jbc.M512953200; Wang YJ, 2010, HEPATOLOGY, V52, P2118, DOI 10.1002/hep.23929; WU HL, 1991, J VIROL, V65, P1680, DOI 10.1128/JVI.65.4.1680-1686.1991; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367	44	14	17	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2015	29	5					1879	1889		10.1096/fj.14-258715	http://dx.doi.org/10.1096/fj.14-258715			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZJ	25630972				2022-12-26	WOS:000354114600023
J	Radhakrishnan, VM; Kojs, P; Ramalingam, R; Midura-Kiela, MT; Angeli, P; Kiela, PR; Ghishan, FK				Radhakrishnan, Vijayababu M.; Kojs, Pawel; Ramalingam, Rajalakshmy; Midura-Kiela, Monica T.; Angeli, Peter; Kiela, Pawel R.; Ghishan, Fayez K.			Experimental Colitis Is Associated with Transcriptional Inhibition of Na+/Ca2+ Exchanger Isoform 1 (NCX1) Expression by Interferon gamma in the Renal Distal Convoluted Tubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CARDIAC-SPECIFIC EXPRESSION; KNOCKOUT MICE; CROHNS-DISEASE; UP-REGULATION; IFN-GAMMA; VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; CALCIUM TRANSPORTER; NA+-CA2+ EXCHANGER	NCX1 is a Na+/Ca2+ exchanger, which is believed to provide a key route for basolateral Ca2+ efflux in the renal epithelia, thus contributing to renal Ca2+ reabsorption. Altered mineral homeostasis, including intestinal and renal Ca2+ transport may represent a significant component of the pathophysiology of the bone mineral density loss associated with Inflammatory Bowel Diseases (IBD). The objective of our research was to investigate the effects of TNBS and DSS colitis and related inflammatory mediators on renal Ncx1 expression. Colitis was associated with decreased renal Ncx1 expression, as examined by real-time RTPCR, Western blotting, and immunofluorescence. In mIMCD3 cells, IFN gamma significantly reduced Ncx1 mRNA and protein expression. Similar effects were observed in cells transiently transfected with a reporter construct bearing the promoter region of the kidney-specific Ncx1 gene. This inhibitory effect of IFN gamma is mediated by STAT1 recruitment to the proximal promoter region of Ncx1. Further in vivo study with Stat1(-/-) mice confirmed that STAT1 is indeed required for the IFN gamma mediated Ncx1 gene regulation. These results strongly support the hypothesis that impaired renal Ca2+ handling occurs in experimental colitis. Negative regulation of NCX1-mediated renal Ca2+ absorption by IFN gamma may significantly contribute to the altered Ca2+ homeostasis in IBD patients and to IBD-associated loss of bone mineral density.	[Radhakrishnan, Vijayababu M.; Kojs, Pawel; Ramalingam, Rajalakshmy; Midura-Kiela, Monica T.; Kiela, Pawel R.; Ghishan, Fayez K.] Univ Arizona, Hlth Sci Ctr, Steele Childrens Res Ctr, Dept Pediat, Tucson, AZ 85724 USA; [Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Dept Immunobiol, Tucson, AZ 85724 USA; [Angeli, Peter] Johns Hopkins Univ, Zanvyl Krieger Sch Arts & Sci, Baltimore, MD 21218 USA	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; Johns Hopkins University	Ghishan, FK (corresponding author), Univ Arizona, Hlth Sci Ctr, Steele Childrens Res Ctr, Dept Pediat, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	fghishan@peds.arizona.edu	Kiela, Pawel/AAF-5320-2020	Angeli, Peter/0000-0002-0208-5808; Kiela, Pawel/0000-0002-0014-3517	National Institutes of Health [R37DK033209]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R37DK033209 (to F. K. G.).	ABITBOL V, 1995, GASTROENTEROLOGY, V108, P417, DOI 10.1016/0016-5085(95)90068-3; Ali T, 2009, AM J MED, V122, P599, DOI 10.1016/j.amjmed.2009.01.022; Barnes KV, 1997, J BIOL CHEM, V272, P11510, DOI 10.1074/jbc.272.17.11550; Billerey-Larmonier C, 2008, INFLAMM BOWEL DIS, V14, P780, DOI 10.1002/ibd.20348; Bisping G, 2001, CLIN EXP IMMUNOL, V123, P15, DOI 10.1046/j.1365-2249.2001.01443.x; Bjarnason I, 1997, GUT, V40, P228, DOI 10.1136/gut.40.2.228; BREUER RI, 1970, GUT, V11, P314, DOI 10.1136/gut.11.4.314; Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Di Stefano M, 2002, GASTROENTEROLOGY, V122, P1793, DOI 10.1053/gast.2002.33600; FAIS S, 1994, J INTERFERON RES, V14, P235, DOI 10.1089/jir.1994.14.235; Ghishan FK, 2011, AM J PHYSIOL-GASTR L, V300, pG191, DOI 10.1152/ajpgi.00496.2010; Gobbi P, 2007, PHARMACOL RES, V56, P556, DOI 10.1016/j.phrs.2007.10.005; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Hoenderop JGJ, 2002, ANNU REV PHYSIOL, V64, P529, DOI 10.1146/annurev.physiol.64.081501.155921; Hoenderop JGJ, 1999, BIOCHEM BIOPH RES CO, V261, P488, DOI 10.1006/bbrc.1999.1059; Hofmeister MV, 2011, ADV EXP MED BIOL, V704, P277, DOI 10.1007/978-94-007-0265-3_15; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Huybers S, 2008, INFLAMM BOWEL DIS, V14, P803, DOI 10.1002/ibd.20385; Kiela PR, 2009, GASTROENTEROLOGY, V137, P965, DOI 10.1053/j.gastro.2009.05.043; Ko SH, 2009, J REPROD DEVELOP, V55, P137, DOI 10.1262/jrd.20139; KOFUJI P, 1994, J BIOL CHEM, V269, P5145; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Lortat-Jacob H, 1996, J BIOL CHEM, V271, P16139, DOI 10.1074/jbc.271.27.16139; Majewski PM, 2010, J BIOL CHEM, V285, P34828, DOI 10.1074/jbc.M110.152868; Muller JG, 2002, CIRC RES, V90, P158, DOI 10.1161/hh0202.103231; Nagano T, 2004, J NEUROCHEM, V90, P784, DOI 10.1111/j.1471-4159.2004.02511.x; Navath S, 2012, ACS MED CHEM LETT, V3, P710, DOI 10.1021/ml300086c; Nicholas SB, 1998, AM J PHYSIOL-HEART C, V274, pH217, DOI 10.1152/ajpheart.1998.274.1.H217; NOGUCHI M, 1995, J GASTROENTEROL, V30, P52; Peng JB, 2000, J BIOL CHEM, V275, P28186; Pollak RD, 1998, AM J GASTROENTEROL, V93, P1483; Qiu ZY, 2001, J BIOL CHEM, V276, P194, DOI 10.1074/jbc.M005571200; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Radhakrishnan VM, 2013, GASTROENTEROLOGY, V145, P613, DOI 10.1053/j.gastro.2013.06.002; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Samanta K, 2010, J BIOCHEM, V147, P225, DOI 10.1093/jb/mvp176; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; Targownik LE, 2014, CURR OPIN GASTROEN, V30, P168, DOI 10.1097/MOG.0000000000000037; Thurston RD, 2010, GASTROENTEROLOGY, V138, P1384, DOI 10.1053/j.gastro.2009.12.002; Tilg H, 2008, GUT, V57, P684, DOI 10.1136/gut.2006.117382; Uno JK, 2006, GASTROENTEROLOGY, V131, P497, DOI 10.1053/j.gastro.2006.05.020; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; VanBaal J, 1996, AM J PHYSIOL-RENAL, V271, pF985, DOI 10.1152/ajprenal.1996.271.5.F985; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu GS, 2009, P NATL ACAD SCI USA, V106, P10829, DOI 10.1073/pnas.0903408106; Xu L, 2006, J BIOL CHEM, V281, P34430, DOI 10.1074/jbc.M607446200	49	4	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2015	290	14					8964	8974		10.1074/jbc.M114.616516	http://dx.doi.org/10.1074/jbc.M114.616516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CF0BI	25648899	hybrid, Green Published			2022-12-26	WOS:000352207100023
J	Almeida, MT; Mesquita, FS; Cruz, R; Osorio, H; Custodio, R; Brito, C; Vingadassalom, D; Martins, M; Leong, JM; Holden, DW; Cabanes, D; Sousa, S				Almeida, Maria Teresa; Mesquita, Francisco S.; Cruz, Rui; Osorio, Hugo; Custodio, Rafael; Brito, Claudia; Vingadassalom, Didier; Martins, Mariana; Leong, John M.; Holden, David W.; Cabanes, Didier; Sousa, Sandra			Src-dependent Tyrosine Phosphorylation of Non-muscle Myosin Heavy Chain-IIA Restricts Listeria monocytogenes Cellular Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; PHOSPHOINOSITIDE 3-KINASE; MEDIATED INTERNALIZATION; MAMMALIAN-CELLS; MET RECEPTOR; C-SRC; ACTIN; ADHESION; KINASE; VIRULENCE	Bacterial pathogens often interfere with host tyrosine phosphorylation cascades to control host responses and cause infection. Given the role of tyrosine phosphorylation events in different human infections and our previous results showing the activation of the tyrosine kinase Src upon incubation of cells with Listeria monocytogenes, we searched for novel host proteins undergoing tyrosine phosphorylation upon L. monocytogenes infection. We identify the heavy chain of the non-muscle myosin IIA (NMHC-IIA) as being phosphorylated in a specific tyrosine residue in response to L. monocytogenes infection. We characterize this novel post-translational modification event and show that, upon L. monocytogenes infection, Src phosphor-ylates NMHC-IIA in a previously uncharacterized tyrosine residue (Tyr-158) located in its motor domain near the ATP-binding site. In addition, we found that other intracellular and extracellular bacterial pathogens trigger NMHC-IIA tyrosine phosphorylation. Wedemonstrate that NMHC-IIA limits intracellular levels of L. monocytogenes, and this is dependent on the phosphorylation of Tyr-158. Our data suggest a novel mechanism of regulation of NMHC-IIA activity relying on the phosphorylation of Tyr-158 by Src.	[Almeida, Maria Teresa; Mesquita, Francisco S.; Cruz, Rui; Osorio, Hugo; Custodio, Rafael; Brito, Claudia; Martins, Mariana; Cabanes, Didier; Sousa, Sandra] Univ Porto, Inst Invest & Inovacao Saude, P-4200 Oporto, Portugal; [Almeida, Maria Teresa; Mesquita, Francisco S.; Cruz, Rui; Custodio, Rafael; Brito, Claudia; Martins, Mariana; Cabanes, Didier; Sousa, Sandra] Univ Porto, Inst Biol Mol & Celular, Grp Mol Microbiol, P-4150180 Oporto, Portugal; [Almeida, Maria Teresa; Cruz, Rui; Brito, Claudia] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4050313 Oporto, Portugal; [Mesquita, Francisco S.; Holden, David W.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Bacteriol & Infect, MRC, London SW7 2AZ, England; [Osorio, Hugo] Univ Porto, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal; [Vingadassalom, Didier; Leong, John M.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Imperial College London; Universidade do Porto; University of Massachusetts System; University of Massachusetts Worcester	Cabanes, D (corresponding author), Inst Biol Mol & Celular, Grp Mol Microbiol, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	didier@ibmc.up.pt; srsousa@ibmc.up.pt	Brito, Cláudia/Y-3145-2019; Mesquita, Francisco/AAF-7557-2019; Sousa, Sandra/K-3934-2013; Sousa, Sandra/P-2133-2019; Cabanes, Didier/P-3052-2019; da Silva e Cruz, Rui Filipe/W-1359-2017; Brito, Cláudia/A-3347-2016; Osorio, Hugo/A-7847-2012; Cabanes, Didier/K-3917-2013; Martins, M. Cristina/J-8284-2013	Brito, Cláudia/0000-0002-2320-7747; Mesquita, Francisco/0000-0002-3777-825X; Sousa, Sandra/0000-0001-8578-0461; Sousa, Sandra/0000-0001-8578-0461; Cabanes, Didier/0000-0002-4001-1332; da Silva e Cruz, Rui Filipe/0000-0001-7453-3756; Brito, Cláudia/0000-0002-2320-7747; Osorio, Hugo/0000-0002-6362-8255; Cabanes, Didier/0000-0002-4001-1332; Martins, M. Cristina/0000-0002-6574-4794; Holden, David/0000-0002-8369-5105; Martins, Mariana/0000-0002-5677-7068	Fundo Europeu de Desenvolvimento Regional (FEDER) through the Operational Competitiveness Programme (COMPETE); National Funds through Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-BCM/100088/2008FCOMP-01-0124-FEDER-008860, ERANet-Pathogenomics LISTRESS ERA-PTG/0003/2010, NORTE-07-0124-FEDER-000002-Host-Pathogen Interactions]; Programa Operacional Regional do Norte (ON.2-O Novo Norte) under the Quadro de Referencia Estrategico Nacional, through FEDER; FCT; European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Boehringer Ingelheim Fonds; Fundacao para a Ciencia e Tecnologia [BD/43352/2008, BD/90607/2012]; EMBO Long Term Post-doctoral Fellowship [EMBO ALTF 864-2012]; Ciencia; MRC [MR/J006874/1] Funding Source: UKRI; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/100088/2008, ERA-PTG/0003/2010] Funding Source: FCT	Fundo Europeu de Desenvolvimento Regional (FEDER) through the Operational Competitiveness Programme (COMPETE); National Funds through Fundacao para a Ciencia e Tecnologia (FCT); Programa Operacional Regional do Norte (ON.2-O Novo Norte) under the Quadro de Referencia Estrategico Nacional, through FEDER; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Society of Clinical Microbiology and Infectious Diseases (ESCMID); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); EMBO Long Term Post-doctoral Fellowship(European Molecular Biology Organization (EMBO)); Ciencia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundação para a Ciência e a Tecnologia	This work was supported by the Fundo Europeu de Desenvolvimento Regional (FEDER) through the Operational Competitiveness Programme (COMPETE), by National Funds through Fundacao para a Ciencia e Tecnologia (FCT) under Project PTDC/BIA-BCM/100088/2008FCOMP-01-0124-FEDER-008860 and ERANet-Pathogenomics LISTRESS ERA-PTG/0003/2010, Project NORTE-07-0124-FEDER-000002-Host-Pathogen Interactions, co-funded by Programa Operacional Regional do Norte (ON.2-O Novo Norte), under the Quadro de Referencia Estrategico Nacional, through FEDER, by FCT, and by a Research Grant 2014 by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (to S. S.). M. T. A. received a Travel Grant from Boehringer Ingelheim Fonds.; Recipients of Fundacao para a Ciencia e Tecnologia Doctoral Fellowships BD/43352/2008 and BD/90607/2012.; Recipient of EMBO Long Term Post-doctoral Fellowship EMBO ALTF 864-2012.; Supported by Ciencia 2008 and FCT Investigator Programs COMPETE, POPH, and FCT. To whom correspondence may be addressed: Group of Molecular Microbiology, Instituto de Biologia Molecular e Celular, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. Tel.: 351226074907; Fax: 351226099157; E-mail: srsousa@ibmc.up.pt.	Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Barfod ET, 2011, MOL BIOL CELL, V22, P634, DOI 10.1091/mbc.E10-06-0514; Barfod ET, 2005, J BIOL CHEM, V280, P25548, DOI 10.1074/jbc.M411717200; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Bonazzi M, 2008, CELL MICROBIOL, V10, P2208, DOI 10.1111/j.1462-5822.2008.01200.x; Bonazzi M, 2011, J CELL BIOL, V195, P525, DOI 10.1083/jcb.201105152; Bruce-Staskal PJ, 2002, J CELL SCI, V115, P2689; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Cai YF, 2009, CURR OPIN CELL BIOL, V21, P47, DOI 10.1016/j.ceb.2009.01.020; Camejo A, 2011, VIRULENCE, V2, P379, DOI 10.4161/viru.2.5.17703; Campellone KG, 2007, MOL MICROBIOL, V63, P1468, DOI 10.1111/j.1365-2958.2007.05602.x; Chakraborty S, 2012, P NATL ACAD SCI USA, V109, pE1163, DOI 10.1073/pnas.1119592109; Chandran B, 2010, J VIROL, V84, P2188, DOI 10.1128/JVI.01334-09; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Destaing O, 2011, CURR OPIN CELL BIOL, V23, P597, DOI 10.1016/j.ceb.2011.04.002; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hanisch J, 2011, CELL HOST MICROBE, V9, P273, DOI 10.1016/j.chom.2011.03.009; Harney DF, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-12; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0; Kirchner M, 2008, MOL MICROBIOL, V68, P749, DOI 10.1111/j.1365-2958.2008.06188.x; Kuhbacher A, 2012, J BIOL CHEM, V287, P13128, DOI 10.1074/jbc.M111.315788; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Odendall C, 2012, CELL HOST MICROBE, V12, P657, DOI 10.1016/j.chom.2012.09.011; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Osorio Hugo, 2013, Methods Mol Biol, V1007, P301, DOI 10.1007/978-1-62703-392-3_13; Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009; Rajabian T, 2009, NAT CELL BIOL, V11, P1212, DOI 10.1038/ncb1964; Reis O, 2010, J INFECT DIS, V202, P551, DOI 10.1086/654880; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rosado LAR, 2011, J CELL SCI, V124, P483, DOI 10.1242/jcs.074211; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Sousa S, 2007, CELL MICROBIOL, V9, P2629, DOI 10.1111/j.1462-5822.2007.00984.x; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Veettil MV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001238; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Veiga E, 2006, TRENDS CELL BIOL, V16, P499, DOI 10.1016/j.tcb.2006.08.005; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wasylnka JA, 2008, INFECT IMMUN, V76, P2722, DOI 10.1128/IAI.00152-08; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; WILSON LK, 1989, MOL CELL BIOL, V9, P1536, DOI 10.1128/MCB.9.4.1536	56	10	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2015	290	13					8383	8395		10.1074/jbc.M114.591313	http://dx.doi.org/10.1074/jbc.M114.591313			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2RE	25635050	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000351662600032
J	Matsuoka, T; Kaneto, H; Kawashima, S; Miyatsuka, T; Tochino, Y; Yoshikawa, A; Imagawa, A; Miyazaki, J; Gannon, M; Stein, R; Shimomura, I				Matsuoka, Taka-aki; Kaneto, Hideaki; Kawashima, Satoshi; Miyatsuka, Takeshi; Tochino, Yoshihiro; Yoshikawa, Atsushi; Imagawa, Akihisa; Miyazaki, Jun-ichi; Gannon, Maureen; Stein, Roland; Shimomura, Iichiro			Preserving Mafa Expression in Diabetic Islet beta-Cells Improves Glycemic Control in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Glucose Metabolism; Insulin Synthesis; Islet; Oxidative Stress; Mafa; Insulin Transcription Factor	ENZYME GENE-EXPRESSION; PANCREATIC-ISLETS; REGULATORY PROTEIN; INSULIN-SECRETION; GLUCOSE TOXICITY; CRE-RECOMBINASE; MOUSE MODEL; TRANSCRIPTION; GLUCOKINASE; FAMILY	Background: MAFA expression is markedly decreased in islet -cells of type 2 diabetes mellitus. Results: Mis-expression of Mafa in mouse diabetic db/db -cells ameliorated glucose-stimulated insulin secretion and -cell mass. Conclusion: Mafa alone is sufficient to improve -cell function and mass under diabetic conditions. Significance: These results establish how consequential this transcription factor is to islet -cells under pathological conditions. The murine Mafa transcription factor is a key regulator of postnatal islet -cell activity, affecting insulin transcription, insulin secretion, and -cell mass. Human MAFA expression is also markedly decreased in islet -cells of type 2 diabetes mellitus (T2DM) patients. Moreover, levels are profoundly reduced in db/db islet -cells, a mouse model of T2DM. To examine the significance of this key islet -cell-enriched protein to glycemic control under diabetic conditions, we generated transgenic mice that conditionally and specifically produced Mafa in db/db islet -cells. Sustained expression of Mafa resulted in significantly lower plasma glucose levels, higher plasma insulin, and augmented islet -cell mass. In addition, there was increased expression of insulin, Slc2a2, and newly identified Mafa-regulated genes involved in reducing -cell stress, like Gsta1 and Gckr. Importantly, the levels of human GSTA1 were also compromised in T2DM islets. Collectively, these results illustrate how consequential the reduction in Mafa activity is to islet -cell function under pathophysiological conditions.	[Matsuoka, Taka-aki; Kaneto, Hideaki; Kawashima, Satoshi; Miyatsuka, Takeshi; Tochino, Yoshihiro; Yoshikawa, Atsushi; Imagawa, Akihisa; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan; [Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka 5650871, Japan; [Gannon, Maureen] Vanderbilt Univ, Med Ctr, Div Diabet Endocrinol & Metab, Dept Med, Nashville, TN 37232 USA; [Stein, Roland] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Osaka University; Osaka University; Vanderbilt University; Vanderbilt University	Matsuoka, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	matsuoka@endmet.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X	National Institutes of Health [DK090570]; Juvenile Diabetes Research Foundation Career Development Award [2-2005-946]; JSPS KAKENHI [10379258]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090570] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24591328] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Career Development Award(Juvenile Diabetes Research Foundation); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant DK090570 (to R. S.), Juvenile Diabetes Research Foundation Career Development Award 2-2005-946 (to T. Matsuoka), and JSPS KAKENHI Grant 10379258 (to T. Matsuoka).	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Butler AE, 2012, DIABETOLOGIA, V55, P2985, DOI 10.1007/s00125-012-2666-2; D'Aleo V, 2009, MOL CELL ENDOCRINOL, V309, P63, DOI 10.1016/j.mce.2009.05.010; de la Iglesia N, 2000, J BIOL CHEM, V275, P10597, DOI 10.1074/jbc.275.14.10597; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Hang Y, 2014, DIABETES, V63, P1994, DOI 10.2337/db13-1001; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HUMMEL KP, 1972, BIOCHEM GENET, V7, P1, DOI 10.1007/BF00487005; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kawashima S, 2011, BIOCHEM BIOPH RES CO, V404, P534, DOI 10.1016/j.bbrc.2010.12.021; Kjorholt C, 2005, DIABETES, V54, P2755, DOI 10.2337/diabetes.54.9.2755; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lupi R, 2007, DIABETES METAB, V33, P340, DOI 10.1016/j.diabet.2007.03.005; Mahadevan J, 2013, DIABETES, V62, P3582, DOI 10.2337/db13-0357; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Nebert Daniel W., 2004, Human Genomics, V1, P460; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Steck AK, 2011, CURR OPIN ENDOCRINOL, V18, P252, DOI 10.1097/MED.0b013e3283488275; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Waguri M, 1997, DIABETES, V46, P1281, DOI 10.2337/diabetes.46.8.1281; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhang HJ, 2005, GENESIS, V42, P210, DOI 10.1002/gene.20137	38	46	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2015	290	12					7647	7657		10.1074/jbc.M114.595579	http://dx.doi.org/10.1074/jbc.M114.595579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CE2AC	25645923	Green Published, hybrid			2022-12-26	WOS:000351613600027
J	Li, J; Yuan, W; Jiang, S; Ye, W; Yang, H; Shapiro, IM; Risbud, MV				Li, Jun; Yuan, Wen; Jiang, Shuai; Ye, Wei; Yang, Hao; Shapiro, Irving M.; Risbud, Makarand V.			Prolyl-4-hydroxylase Domain Protein 2 Controls NF-kappa B/p65 Transactivation and Enhances the Catabolic Effects of Inflammatory Cytokines on Cells of the Nucleus Pulposus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INTERVERTEBRAL DISC; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; HYPOXIA-INDUCIBLE FACTOR; PROLYL HYDROXYLASE INHIBITION; TNF-ALPHA; EXPRESSION; DEGENERATION; OXYGEN; DEGRADATION	Prolyl-4-hydroxylase (PHD) proteins are key in sensing tissue hypoxia. In nucleus pulposus (NP) cells, our previous work demonstrated that PHD isoforms have a differential contribution in controlling hypoxia-inducible factor (HIF)-alpha degradation and activity. Recently we have shown that a regulatory relationship exists between PHD3 and inflammatory cytokines in NP cells. With respect to PHD2, the most abundant PHD isoform in NP cells, very little is known concerning its function and regulation under inflammatory conditions that characterize intervertebral disc degeneration. Here, we show that PHD2 is a potent regulator of the catabolic activities of TNF-alpha; silencing of PHD2 significantly decreased TNF-alpha-induced expression of catabolic markers including SDC4, MMP-3, MMP-13, and ADAMTS5, as well as several inflammatory cytokines and chemokines, while partially restoring aggrecan and collagen II expression. Use of NF-kappa B reporters with ShPHD2, SiHIF-1 alpha, as well as p65(-/-), PHD2(-/-), and PHD3(-/-) cells, shows that PHD2 serves as a co-activator of NF-kappa B/p65 signaling in HIF-1-independent fashion. Immunoprecipitation of endogenous and exogenously expressed tagged proteins, as well as fluorescence microscopy, indicates that following TNF-alpha treatment, PHD2 interacts and co-localizes with p65. Conversely, loss of function experiments using lentivirally delivered Sh-p65, Sh-IKK beta, and NF-kappa B inhibitor confirmed that cytokine-dependent PHD2 expression in NP cells requires NF-kappa B signaling. These findings clearly demonstrate that PHD2 forms a regulatory circuit with TNF-alpha via NF-kappa B and thereby plays an important role in enhancing activity of this cytokine. We pro-pose that during disc degeneration PHD2 may offer a therapeutic target to mitigate the deleterious actions of TNF-alpha, a key proinflammatory cytokine.	[Li, Jun; Ye, Wei; Yang, Hao; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Li, Jun; Yuan, Wen; Jiang, Shuai] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai 200003, Peoples R China; [Ye, Wei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthopaed Surg, Guangzhou 510120, Guangdong, Peoples R China; [Yang, Hao] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed, Guangzhou 510080, Guangdong, Peoples R China	Jefferson University; Jefferson University; Naval Medical University; Sun Yat Sen University; Sun Yat Sen University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Suite 511,Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			National Institutes of Health [AR055655, AR064733, AR050087]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055655, R01AR064733, R01AR050087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR055655, AR064733, and AR050087.	Abe Y, 2007, SPINE, V32, P635, DOI 10.1097/01.brs.0000257556.90850.53; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hams E, 2011, SHOCK, V36, P295, DOI 10.1097/SHK.0b013e318225ad7e; Haro H, 1997, J ORTHOPAED RES, V15, P734, DOI 10.1002/jor.1100150516; Hertlein E, 2005, MOL CELL BIOL, V25, P4956, DOI 10.1128/MCB.25.12.4956-4968.2005; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keely S, 2014, MUCOSAL IMMUNOL, V7, P114, DOI 10.1038/mi.2013.29; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Mern DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096870; Mern DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081467; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Natarajan R, 2007, AM J PHYSIOL-HEART C, V293, pH1571, DOI 10.1152/ajpheart.00291.2007; Pientka FK, 2012, J CELL SCI, V125, P5168, DOI 10.1242/jcs.109041; Podichetty VK, 2007, CELL MOL BIOL, V53, P4, DOI 10.1170/T814; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Smith MF, 2006, GLYCOBIOLOGY, V16, P221, DOI 10.1093/glycob/cwj061; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Takeda K, 2009, ARTERIOSCL THROM VAS, V29, P2132, DOI 10.1161/ATVBAHA.109.196071; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wang X, 2014, AM J PATHOL, V184, P2560, DOI 10.1016/j.ajpath.2014.06.006; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Yeramian A, 2011, LAB INVEST, V91, P859, DOI 10.1038/labinvest.2011.58; Yoshida M, 2005, SPINE, V30, P55, DOI 10.1097/01.brs.0000149194.17891.bf; Yu ZG, 2009, CHINESE MED J-PEKING, V122, P2483, DOI 10.3760/cma.j.issn.0366-6999.2009.20.016; Zhao CQ, 2011, J ORTHOP RES, V29, P718, DOI 10.1002/jor.21285	45	43	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2015	290	11					7195	7207		10.1074/jbc.M114.611483	http://dx.doi.org/10.1074/jbc.M114.611483			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CD3PP	25635047	Green Published, hybrid			2022-12-26	WOS:000350991500049
J	Gizzo, S; Andrisani, A; Noventa, M; Di Gangi, S; Quaranta, M; Cosmi, E; D'Antona, D; Nardelli, GB; Ambrosini, G				Gizzo, Salvatore; Andrisani, Alessandra; Noventa, Marco; Di Gangi, Stefania; Quaranta, Michela; Cosmi, Erich; D'Antona, Donato; Nardelli, Giovanni Battista; Ambrosini, Guido			Caesarean Section: Could Different Transverse Abdominal Incision Techniques Influence Postpartum Pain and Subsequent Quality of Life? A Systematic Review	PLOS ONE			English	Article							MISGAV-LADACH METHOD; JOEL-COHEN INCISION; LONG-TERM OUTCOMES; PFANNENSTIEL INCISION; NON-CLOSURE; DELIVERY; WOMEN; ANATOMY; NERVES; RISK	The choice of the type of abdominal incision performed in caesarean delivery is made chiefly on the basis of the individual surgeon's experience and preference. A general consensus on the most appropriate surgical technique has not yet been reached. The aim of this systematic review of the literature is to compare the two most commonly used transverse abdominal incisions for caesarean delivery, the Pfannenstiel incision and the modified Joel-Cohen incision, in terms of acute and chronic post-surgical pain and their subsequent influence in terms of quality of life. Electronic database searches formed the basis of the literature search and the following databases were searched in the time frame between January 1997 and December 2013: MEDLINE, EMBASE Sciencedirect and the Cochrane Library. Key search terms included: "acute pain", "chronic pain", "Pfannenstiel incision", "MisgavLadach", "Joel Cohen incision", in combination with "Caesarean Section", "abdominal incision", "numbness", "neuropathic pain"and "nerve entrapment". Data on 4771 patients who underwent caesarean section (CS) was collected with regards to the relation between surgical techniques and postoperative outcomes defined as acute or chronic pain and future pregnancy desire. The Misgav-Ladach incision was associated with a significant advantage in terms of reduction of post-surgical acute and chronic pain. It was indicated as the optimal technique in view of its characteristic of reducing lower pelvic discomfort and pain, thus improving quality of life and future fertility desire. Further studies which are not subject to important bias like pre-existing chronic pain, non-standardized analgesia administration, variable length of skin incision and previous abdominal surgery are required.	[Gizzo, Salvatore; Andrisani, Alessandra; Noventa, Marco; Di Gangi, Stefania; Cosmi, Erich; D'Antona, Donato; Nardelli, Giovanni Battista; Ambrosini, Guido] Univ Padua, Dept Womens & Childrens Health, Padua, Italy; [Quaranta, Michela] Univ Verona, Dept Obstet & Gynecol, I-37100 Verona, Italy	University of Padua; University of Verona	Noventa, M (corresponding author), Univ Padua, Dept Womens & Childrens Health, Padua, Italy.	marco.noventa@gmail.com	Noventa, Marco/ABB-4669-2020	Noventa, Marco/0000-0002-7809-6001				*AG HEALTHC RES QU, 2010, AHRQ PUBLICATION, pE3; Almeida ECS, 2002, INT J GYNECOL OBSTET, V79, P101, DOI 10.1016/S0020-7292(02)00227-8; Altinbas SK, 2013, J MATERN-FETAL NEO M, V26, P1128, DOI 10.3109/14767058.2013.770458; Ansaloni L, 2001, WORLD J SURG, V25, P1164, DOI 10.1007/BF03215866; Berretta R, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/686027; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Darj E, 1999, ACTA OBSTET GYN SCAN, V78, P37, DOI 10.1034/j.1600-0412.1999.780109.x; Eisenach JC, 2008, PAIN, V140, P87, DOI 10.1016/j.pain.2008.07.011; Eisenach JC, 2013, ANESTHESIOLOGY, V118, P143, DOI 10.1097/ALN.0b013e318278ccfd; Fatusic Z, 2011, J MATERN-FETAL NEO M, V24, P1138, DOI 10.3109/14767058.2010.545919; Ferrari AG, 2001, INT J GYNECOL OBSTET, V72, P135, DOI 10.1016/S0020-7292(00)00315-5; Franchi M, 2002, ACTA OBSTET GYN SCAN, V81, P1040, DOI 10.1034/j.1600-0412.2002.811108.x; Gedikbasi A, 2011, ARCH GYNECOL OBSTET, V283, P711, DOI 10.1007/s00404-010-1428-y; Ghahiry A, 2012, J OBSTET GYNAECOL RE, V38, P1235, DOI 10.1111/j.1447-0756.2011.01777.x; Gizzo S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/638093; Gizzo S, 2014, ARCH GYNECOL OBSTET, V290, P21, DOI 10.1007/s00404-014-3212-x; Gizzo S, 2014, J PERINAT MED, V42, P339, DOI 10.1515/jpm-2013-0160; Gizzo S, 2013, SCI WORLD J, DOI 10.1155/2013/254901; Gizzo S, 2013, FERTIL STERIL, V99, P496, DOI 10.1016/j.fertnstert.2012.10.019; Gizzo S, 2012, BREASTFEED MED, V7, P262, DOI 10.1089/bfm.2011.0099; Hofmeyr GJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004662.pub2; Hofmeyr JG, 2009, AM J OBSTET GYNECOL, V201, P431, DOI 10.1016/j.ajog.2009.03.018; Hojberg KE, 1998, ACTA OBSTET GYN SCAN, V77, P741, DOI 10.1034/j.1600-0412.1998.770708.x; Holmgren G, 1996, TROP DOCT, V26, P150, DOI 10.1177/004947559602600404; *IT NAT I STAT, BRIEF STAT, P28669; Jansen AJG, 2007, J PSYCHOSOM RES, V63, P275, DOI 10.1016/j.jpsychores.2007.06.003; Jansen AJG, 2007, ACTA OBSTET GYN SCAN, V86, P579, DOI 10.1080/00016340701275424; Kainu JP, 2010, INT J OBSTET ANESTH, V19, P4, DOI 10.1016/j.ijoa.2009.03.013; Klaassen Z, 2011, CLIN ANAT, V24, P454, DOI 10.1002/ca.21098; Loos MJ, 2008, OBSTET GYNECOL, V111, P839, DOI 10.1097/AOG.0b013e31816a4efa; Loos MJA, 2008, ANN SURG, V248, P880, DOI 10.1097/SLA.0b013e318185da2e; Luijendijk RW, 1997, ANN SURG, V225, P365, DOI 10.1097/00000658-199704000-00004; Lurie S, 2003, AM J OBSTET GYNECOL, V189, P1803, DOI 10.1016/S0002-9378(03)00856-1; Malvasi A, 2007, J MATERN-FETAL NEO M, V20, P757, DOI 10.1080/14767050701580531; Mathai M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004453.pub3; Nabhan AF, 2008, INT J GYNECOL OBSTET, V100, P69, DOI 10.1016/j.ijgo.2007.07.011; Naki MM, 2011, J MATERN-FETAL NEO M, V24, P239, DOI 10.3109/14767058.2010.482612; Nikolajsen L, 2004, ACTA ANAESTH SCAND, V48, P111, DOI 10.1111/j.1399-6576.2004.00271.x; Shahin AY, 2009, INT J GYNECOL OBSTET, V104, P135, DOI 10.1016/j.ijgo.2008.09.012; SIPPO WC, 1987, AM J OBSTET GYNECOL, V157, P420, DOI 10.1016/S0002-9378(87)80184-9; Torkan B, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-4; Tosun K, 2006, UROLOGY, V67, DOI 10.1016/j.urology.2005.09.053; Walsh CA, 2010, CURR OPIN OBSTET GYN, V22, P110, DOI 10.1097/GCO.0b013e3283372327; Whiteside JL, 2003, AM J OBSTET GYNECOL, V189, P1574, DOI 10.1016/S0002-9378(03)00934-7; Xavier P, 2005, ACTA OBSTET GYN SCAN, V84, P878, DOI 10.1111/j.0001-6349.2005.00631.x	45	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0114190	10.1371/journal.pone.0114190	http://dx.doi.org/10.1371/journal.pone.0114190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646621	gold, Green Submitted, Green Published			2022-12-26	WOS:000348822600006
J	Jansen, C; Reiberger, T; Huang, J; Eischeid, H; Schierwagen, R; Mandorfer, M; Anadol, E; Schwabl, P; Schwarze-Zander, C; Warnecke-Eberz, U; Strassburg, CP; Rockstroh, JK; Peck-Radosavljevic, M; Odenthal, M; Trebicka, J				Jansen, Christian; Reiberger, Thomas; Huang, Jia; Eischeid, Hannah; Schierwagen, Robert; Mandorfer, Mattias; Anadol, Evrim; Schwabl, Philipp; Schwarze-Zander, Carolynne; Warnecke-Eberz, Ute; Strassburg, Christian P.; Rockstroh, Juergen K.; Peck-Radosavljevic, Markus; Odenthal, Margarete; Trebicka, Jonel			Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; CO-INFECTED PATIENTS; HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; VIRUS; HIV; CIRRHOSIS; FIBROSIS; THERAPY; DECOMPENSATION	Background Introduction of combined antiretroviral therapy (cART) has improved survival of HIV infected individuals, while the relative contribution of liver-related mortality increased. Especially in HIV/HCV-coinfected patients hepatic fibrosis and portal hypertension represent the main causes of liver-related morbidity and mortality. Circulating miRNA-122 levels are elevated in HIV patients and have been shown to correlate with severity of liver injury. However, the association of miRNA-122 levels and hepatic fibrosis and portal hypertension remains to be explored in HIV/HCV coinfection. Methods From a total of 74 (31% female) patients with HIV/HCV coinfection were included. Serum levels of miRNA-122 were analyzed by quantitative polymerase chain reaction (PCR) and normalized to SV-40 spike-in RNA. Hepatic venous pressure gradient (HVPG) was measured in 52 (70%) patients and the fibrosis stage was determined in 63 (85%) patients using transient elastography. Results The levels of circulating miRNA-122 were increased in HIV/HCV coinfected patients and significantly correlated with the alanine aminotransferase (ALT) (r(s) = 0.438; p<0.001) and aspartate transaminase AST values (r(s) = 0.336; p = 0.003), but not with fibrosis stage (p = n.s.). Interestingly, miRNA-122 levels showed an inverse correlation with hepatic venous pressure gradient (HVPG) (r(s) = -0.302; p = 0.03). Conclusion Elevated miRNA-122 levels are associated with liver injury, and with low HVPG. Though, miRNA-122 levels are not suitable to predict the degree of fibrosis, they might function as indicators for portal hypertension in HIV/HCV coinfected patients.	[Jansen, Christian; Schierwagen, Robert; Anadol, Evrim; Schwarze-Zander, Carolynne; Strassburg, Christian P.; Rockstroh, Juergen K.; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Reiberger, Thomas; Schwabl, Philipp; Peck-Radosavljevic, Markus] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria; [Huang, Jia; Eischeid, Hannah; Odenthal, Margarete] Univ Cologne, Dept Pathol, D-50931 Cologne, Germany; [Warnecke-Eberz, Ute] Univ Cologne, Dept Gen Visceral & Canc Surg, D-50931 Cologne, Germany; [Rockstroh, Juergen K.] Partner Site Bonn Cologne, German Ctr Infect Res DZIF, Bonn, Germany	University of Bonn; Medical University of Vienna; University of Cologne; University of Cologne; German Center for Infection Research	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	jonel.trebicka@ukb.uni-bonn.de	Reiberger, Thomas/H-7613-2019; Schierwagen, Robert/AAE-6305-2019; Mandorfer, Mattias/H-7603-2019	Reiberger, Thomas/0000-0002-4590-3583; Schierwagen, Robert/0000-0002-2195-3666; Mandorfer, Mattias/0000-0003-2330-0017; Trebicka, Jonel/0000-0002-7028-3881; Schwabl, Philipp/0000-0002-7183-8076; Warnecke-Eberz, Ute/0000-0002-2833-5633	Deutsche Forschungsgemeinschaft [SFB TRR57 P18]; J. & W. Hector-Foundation [M60.2]; Roche Austria; MSD Austria; DZIF TTU HIV Project [05.803]; German Center for Infection Research (DZIF); Research and Education program of the Medical Faculty of the University of Cologne; German Competence Network for Viral Hepatitis (Hepnet); German Ministry of Education and Research (BMBF) [01KI0601]; German Liver Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); J. & W. Hector-Foundation; Roche Austria(Roche Holding); MSD Austria; DZIF TTU HIV Project; German Center for Infection Research (DZIF); Research and Education program of the Medical Faculty of the University of Cologne; German Competence Network for Viral Hepatitis (Hepnet); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Liver Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (SFB TRR57 P18 to J.T.), J. & W. Hector-Foundation (M60.2 to J.T.), unrestricted research grants from Roche Austria (to M.P.R.), MSD Austria (to M.P.R.), DZIF TTU HIV Project 05.803, and the German Center for Infection Research (DZIF), Research and Education program of the Medical Faculty of the University of Cologne, German Competence Network for Viral Hepatitis (Hepnet), German Ministry of Education and Research (BMBF), Grant No 01KI0601 (to M.O.), and German Liver Foundation (to M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anadol E, 2014, HEPATOLOGY; Aranzabal L, 2005, CLIN INFECT DIS, V40, P588, DOI 10.1086/427216; Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Brau N, 2005, SEMIN LIVER DIS, V25, P33, DOI 10.1055/s-2005-864780; Castiella A, 2010, WORLD J HEPATOL, V2, P251, DOI 10.4254/wjh.v2.i7.251; Casu S, 2014, LIVER INT; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Dimitroulis D, 2013, WORLD J HEPATOL, V5, P323, DOI 10.4254/wjh.v5.i6.323; Ferlitsch M, 2012, HEPATOLOGY, V56, P1439, DOI 10.1002/hep.25806; Fernandes FF, 2014, J CLIN GASTROENTEROL; Frulio N, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-405; Gelley F, 2014, J GASTROEN HEPATOL, V29, P121, DOI 10.1111/jgh.12362; Jansen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108544; Jansen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103779; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Klein MB, 2014, AIDS, V28, P1957, DOI 10.1097/QAD.0000000000000377; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Lee CH, 2014, J MICROBIOL, V52, P445, DOI 10.1007/s12275-014-4267-x; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Mandorfer M, 2014, AIDS PATIENT CARE ST, V28, P221, DOI 10.1089/apc.2013.0359; Marcellin F, 2014, SEX TRANSM INFECT; Merchante N, 2014, AIDS, V28, P41, DOI 10.1097/QAD.0000000000000005; Mocroft A, 2005, AIDS, V19, P2117, DOI 10.1097/01.aids.0000194799.43799.ea; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Nunnari G, 2012, EUR REV MED PHARMACO, V16, P1257; Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626; Reiberger T, 2010, J VIRAL HEPATITIS, V17, P400, DOI 10.1111/j.1365-2893.2009.01197.x; Reiberger T, 2013, GUT, V62, P1634, DOI 10.1136/gutjnl-2012-304038; Reiberger T, 2011, ANTIVIR THER, V16, P815, DOI 10.3851/IMP1831; Reiberger T, 2011, CLIN GASTROENTEROL H, V9, P602, DOI 10.1016/j.cgh.2011.03.002; Roderburg C, 2014, LIVER INT; Rosenthal E, 2007, J VIRAL HEPATITIS, V14, P183, DOI 10.1111/j.1365-2893.2006.00791.x; Rotman Y, 2009, J VIROL, V83, P7366, DOI 10.1128/JVI.00191-09; Takaki Y, 2014, CANC SCI; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Uchino K, 2013, J CLIN VIROL, V57, P173, DOI 10.1016/j.jcv.2013.01.012; UNAIDS, 2013, GLOB REP 2013; van Beek JHDA, 2013, BEHAV GENET, V43, P329, DOI 10.1007/s10519-013-9593-y; Yoshioka K, 2014, HEPATOL RES	41	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0116768	10.1371/journal.pone.0116768	http://dx.doi.org/10.1371/journal.pone.0116768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25646812	Green Published, Green Submitted, gold			2022-12-26	WOS:000348822600036
J	Li, YJ; Jiang, YR; Li, SH; Shen, XM; Liu, JF; Jiang, F				Li, Youjin; Jiang, Yanrui; Li, Shenghui; Shen, Xiaoming; Liu, Jinfen; Jiang, Fan			Pre- and Postnatal Risk Factors in Relation to Allergic Rhinitis in School-Aged Children in China	PLOS ONE			English	Article							CESAREAN-SECTION; PREVALENCE; ASTHMA; DELIVERY; CHILDHOOD; SCHOOLCHILDREN; DISEASES; IMPACT; ECZEMA; MICROFLORA	Objective The objective of this study was to investigate the relationship between prenatal and postnatal risk factors and the prevalence of allergic rhinitis (AR) in Chinese children of specific ages. Study Design This study was a cross-sectional survey. Students from 8 metropolitan cities in China were studied in November and December, 2005. There were 20,803 elementary-school Chinese children (49.6% boys, mean age, 9.19 years) enrolled. Questions from the standard questionnaire of the International Study of Asthma and Allergies in Children were completed to enable us to examine the pattern of current AR. The potential confounders and pre-and postnatal risk factors were analyzed using logistic regression. Results The overall prevalence of AR was found in this study to be 9.8%. After adjusting for several likely confounders, there was a higher likelihood of AR in school-aged children who were not exclusively breastfed in the first 4 months of their lives (odds ratio [OR]: 1.28; 95% confidence interval [CI]: 1.16-1.41), children who were born post-term (OR: 1.34; 95% CI: 1.12-1.60), children delivered by cesarean section (OR: 1.07; 95% CI: 1.00-1.19), or children born to mothers who experienced depressive symptoms during the pre-and postnatal periods (OR: 1.28; 95% CI: 1.15-1.42). Conclusions AR in school-aged children was found to be associated with pre- and postnatal events. These findings indicate that strategies to reduce exposure to risk factors during pre- and postnatal periods for childhood allergies might be warranted.	[Li, Youjin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Li, Youjin; Jiang, Yanrui; Li, Shenghui; Shen, Xiaoming; Jiang, Fan] MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai, Peoples R China; [Jiang, Yanrui; Jiang, Fan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Dev & Behav Pediat, Shanghai 200030, Peoples R China; [Liu, Jinfen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat, Shanghai 200030, Peoples R China; [Liu, Jinfen] Shanghai Jiao Tong Univ, Inst Pediat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, JF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat, Shanghai 200030, Peoples R China.	liujinfen2002@126.com; fanjiang@shsmu.edu.cn	Jiang, Fan/AHA-6297-2022; Jiang, Fan/AGX-9052-2022	Jiang, Fan/0000-0003-0634-101X	Chinese National Natural Science Foundation [81172685]; Ministry of Science and Technology [2010CB535000]; Ministry of Health [201002006]; Shanghai Science and Technology Commission [12411950405, 13QH1401800]; Shanghai Municipal Committee of Education [11SG19, HJTY-2010-A09]; Shanghai Key Discipline of Public Health, AFINS research project [AFINS-HOPE-2011025]; Shengyuan Research Project	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Committee of Education; Shanghai Key Discipline of Public Health, AFINS research project; Shengyuan Research Project	The study was supported by Chinese National Natural Science Foundation (81172685); Ministry of Science and Technology (2010CB535000); Ministry of Health (201002006), Shanghai Science and Technology Commission (12411950405, 13QH1401800); and Shanghai Municipal Committee of Education (11SG19, HJTY-2010-A09), Shanghai Key Discipline of Public Health, AFINS research project (AFINS-HOPE-2011025), Shengyuan Research Project.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Bloch AM, 2002, ACTA PAEDIATR, V91, P275, DOI 10.1080/08035250252833914; Bolte G, 2004, CLIN EXP ALLERGY, V34, P381, DOI 10.1111/j.1365-2222.2004.01890.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Braback L, 1998, CLIN EXP ALLERGY, V28, P936; Chen Yuzhi, 1998, CHIN J PEDIAT, V36, P352; Chiang LC, 2007, ASIAN PAC J ALLERGY, V25, P1; Department of urban social and economic survey, 2006, NAT BUR STAT CHIN CH; Eggesbo M, 2003, J ALLERGY CLIN IMMUN, V112, P420, DOI 10.1067/mai.2003.1610; Elliott L, 2008, J ALLERGY CLIN IMMUN, V122, P49, DOI 10.1016/j.jaci.2008.04.001; Futamura Masaki, 2011, Allergology International, V60, P509, DOI 10.2332/allergolint.10-OA-0293; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Hanson LA, 2007, P NUTR SOC, V66, P384, DOI 10.1017/S0029665107005654; Katz KA, 2003, CLIN EXP ALLERGY, V33, P737, DOI 10.1046/j.1365-2222.2003.01670.x; Kneepkens CMF, 2010, EUR J PEDIATR, V169, P911, DOI 10.1007/s00431-010-1141-7; Kolokotroni O, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-179; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Li F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-437; Li SH, 2008, SLEEP MED, V9, P555, DOI 10.1016/j.sleep.2007.07.008; Li SH, 2007, SLEEP, V30, P361, DOI 10.1093/sleep/30.3.361; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Ma Y, 2009, PEDIATR PULM, V44, P793, DOI 10.1002/ppul.21061; Madar J, 1999, ACTA PAEDIATR, V88, P1244, DOI 10.1080/080352599750030365; Mallen CD, 2008, J ASTHMA, V45, P309, DOI 10.1080/02770900801911194; MURPHY BEP, 1983, ENDOCR REV, V4, P150; Pekkanen J, 2001, CLIN EXP ALLERGY, V31, P95, DOI 10.1046/j.1365-2222.2001.00930.x; Penaranda A, 2012, RHINOLOGY, V50, P122, DOI [10.4193/Rhin11.175, 10.4193/Rhino11.175]; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Renz-Polster H, 2005, CLIN EXP ALLERGY, V35, P1466, DOI 10.1111/j.1365-2222.2005.02356.x; Spiekermann GM, 2001, J PEDIATR GASTR NUTR, V32, P237, DOI 10.1097/00005176-200103000-00003; Tamay Z, 2007, INT J PEDIATR OTORHI, V71, P463, DOI 10.1016/j.ijporl.2006.11.013; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; von Hertzen LC, 2002, J ALLERGY CLIN IMMUN, V109, P923, DOI 10.1067/mai.2002.124776; Wang L, 1999, J PERINAT MED, V27, P195; Xu B, 1999, ALLERGY, V54, P829, DOI 10.1034/j.1398-9995.1999.00117.x; Zhang YM, 2013, LARYNGOSCOPE, V123, P28, DOI 10.1002/lary.23573; Zhao J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-551	39	14	18	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2015	10	2							e0114022	10.1371/journal.pone.0114022	http://dx.doi.org/10.1371/journal.pone.0114022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QZ	25647669	Green Published, gold, Green Submitted			2022-12-26	WOS:000348822600005
J	Ai, M; Cui, Y; Sy, MS; Lee, DM; Zhang, LX; Larson, KM; Kurek, KC; Jay, GD; Warman, ML				Ai, Minrong; Cui, Yajun; Sy, Man-Sun; Lee, David M.; Zhang, Ling Xiu; Larson, Katherine M.; Kurek, Kyle C.; Jay, Gregory D.; Warman, Matthew L.			Anti-Lubricin Monoclonal Antibodies Created Using Lubricin-Knockout Mice Immunodetect Lubricin in Several Species and in Patients with Healthy and Diseased Joints	PLOS ONE			English	Article							SUPERFICIAL ZONE PROTEIN; CRUCIATE LIGAMENT TRANSECTION; HUMAN SYNOVIAL FIBROBLASTS; ARTICULAR-CARTILAGE; BOUNDARY LUBRICATION; PROTEOGLYCAN-4 PRG4; GENE-EXPRESSION; PREVENTION; FRICTION; FLUID	Lubricin, encoded by the gene PRG4, is the principal lubricant in articulating joints. We immunized mice genetically deficient for lubricin (Prg4-/-) with purified human lubricin, and generated several mAbs. We determined each mAb's binding epitope, sensitivity, and specificity using biologic samples and recombinant lubricin sub-domains, and we also developed a competition ELISA assay to measure lubricin in synovial fluid and blood. We found the mAbs all recognized epitopes containing O-linked oligosaccharides conjugated to the peptide motif KEPAPTTT. By western blot, the mAbs detected lubricin in 1 mu l of synovial fluid from several animal species, including human. The mAbs were specific for lubricin since they did not cross-react with other synovial fluid constituents from patients with camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP), who genetically lack this protein. The competition ELISA detected lubricin in blood samples from healthy individuals but not from patients with CACP, indicating blood can be used in a diagnostic test for patients suspected of having CACP. Lubricin epitopes in blood do not represent degradation fragments from synovial fluid. Therefore, although blood lubricin levels did not differentiate patients with inflammatory joint disease from healthy controls, epitope-specific anti-lubricin mAbs could be useful for monitoring disease activity in synovial fluid.	[Ai, Minrong; Cui, Yajun; Warman, Matthew L.] Case Western Reserve Univ, Sch Med, Howard Hughes Med Inst, Cleveland, OH 44106 USA; [Ai, Minrong; Cui, Yajun; Warman, Matthew L.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Sy, Man-Sun] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Lee, David M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Zhang, Ling Xiu; Larson, Katherine M.; Jay, Gregory D.] Rhode Isl Hosp, Dept Emergency Med, Providence, RI USA; [Larson, Katherine M.; Jay, Gregory D.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Kurek, Kyle C.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Boston Childrens Hosp, Orthopaed Res Labs, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Warman, Matthew L.] Harvard Univ, Dept Orthopaed Surg, Sch Med, Boston, MA USA	Case Western Reserve University; Howard Hughes Medical Institute; Case Western Reserve University; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Warman, ML (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.	matthew.warman@childrens.harvard.edu		Jay, Gregory/0000-0003-1517-8488	NIH [AR050180]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant AR050180 to GDJ and MLW. MLW is an employee of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazami AM, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9399; Coles JM, 2010, ARTHRITIS RHEUM-US, V62, P1666, DOI 10.1002/art.27436; Drewniak EI, 2012, ARTHRITIS RHEUM-US, V64, P465, DOI 10.1002/art.33337; Elsaid KA, 2008, ARTHRITIS RHEUM-US, V58, P1707, DOI 10.1002/art.23495; Elsaid KA, 2012, OSTEOARTHR CARTILAGE, V20, P940, DOI 10.1016/j.joca.2012.04.021; Elsaid KA, 2005, ARTHRITIS RHEUM-US, V52, P1746, DOI 10.1002/art.21038; Elsaid KA, 2007, ARTHRITIS RHEUM, V56, P108, DOI 10.1002/art.22321; Estrella RP, 2010, BIOCHEM J, V429, P359, DOI 10.1042/BJ20100360; Flannery CR, 1999, BIOCHEM BIOPH RES CO, V254, P535, DOI 10.1006/bbrc.1998.0104; Gleghorn JP, 2009, J ORTHOP RES, V27, P771, DOI 10.1002/jor.20798; Jay GD, 2001, GLYCOCONJUGATE J, V18, P807, DOI 10.1023/A:1021159619373; Jay GD, 2001, J ORTHOPAED RES, V19, P677, DOI 10.1016/S0736-0266(00)00040-1; Jay GD, 2000, J RHEUMATOL, V27, P594; Jay GD, 2007, ARTHRITIS RHEUM-US, V56, P3662, DOI 10.1002/art.22974; Jay GD, 2012, ARTHRITIS RHEUM-US, V64, P1162, DOI 10.1002/art.33461; Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550; Jones ARC, 2007, J ORTHOP RES, V25, P283, DOI 10.1002/jor.20325; Liu YJ, 2004, BLOOD, V103, P4449, DOI 10.1182/blood-2003-06-1825; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Nugent GE, 2006, BIORHEOLOGY, V43, P191; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Rees SG, 2002, MATRIX BIOL, V21, P593, DOI 10.1016/S0945-053X(02)00056-2; Rhee DK, 2005, J BIOL CHEM, V280, P31325, DOI 10.1074/jbc.M505401200; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Schmidt TA, 2007, OSTEOARTHR CARTILAGE, V15, P35, DOI 10.1016/j.joca.2006.06.005; Schmidt TA, 2009, BBA-GEN SUBJECTS, V1790, P375, DOI 10.1016/j.bbagen.2009.03.016; Schumacher BL, 2005, J ORTHOP RES, V23, P562, DOI 10.1016/j.orthres.2004.11.011; Schumacher BL, 1999, J ORTHOP RES, V17, P110, DOI 10.1002/jor.1100170117; Steele BL, 2013, OSTEOARTHR CARTILAGE, V21, P498, DOI 10.1016/j.joca.2012.12.002; Su JL, 2001, HYBRIDOMA, V20, P149, DOI 10.1089/027245701750293475; Sun YL, 2013, J BONE JOINT SURG AM, V95A, P273, DOI 10.2106/JBJS.K.01522; Sun YL, 2006, J ORTHOP RES, V24, P1861, DOI 10.1002/jor.20239; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; Waller KA, 2013, P NATL ACAD SCI USA, V110, P5852, DOI 10.1073/pnas.1219289110; Young AA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1898	35	28	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116237	10.1371/journal.pone.0116237	http://dx.doi.org/10.1371/journal.pone.0116237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642942	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821200014
J	Lin, JX; Huang, CM; Zheng, CH; Li, P; Xie, JW; Wang, JB; Lu, J; Chen, QY; Cao, LL; Lin, M				Lin, Jian-Xian; Huang, Chang-Ming; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun; Chen, Qi-Yue; Cao, Long-Long; Lin, Mi			Surgical Outcomes of 2041 Consecutive Laparoscopic Gastrectomy Procedures for Gastric Cancer: A Large-Scale Case Control Study	PLOS ONE			English	Article							ASSISTED DISTAL GASTRECTOMY; LYMPH-NODE DISSECTION; MULTICENTER; EXPERIENCE	Background Laparoscopic gastrectomy (LG) for gastric cancer has increased in popularity due to advances in surgical techniques. The aim of this study is to validate the efficacy and safety of laparoscopic gastrectomy for gastric cancer compared with open gastrectomy (OG). Methods The study comprised 3,580 patients who were treated with curative intent either by laparoscopic gastrectomy (2,041 patients) or open gastrectomy (1,539 patents) between January 2005 and October 2013. The surgical outcomes were compared between the two groups. Results Laparoscopic gastrectomy was associated with significantly less blood loss, transfused patient number, time to ground activities, and post-operative hospital stay, but with similar operation time, time to first flatus, and time to resumption of diet, compared with the open gastrectomy. No significant difference in the number of lymph nodes dissected was observed between these two groups. The morbidity and mortality rates of the LG group were comparable to those of the OG group (13.6% vs. 14.4%, P = 0.526, and 0.3% vs. 0.2%, P = 0.740). The 3-year disease-free and overall survival rates between the two groups were statistically significant (P < 0.05). According to the UICC TNM classification of gastric cancer, the 3-year disease-free and overall survival rates were not statistically different at each stage. Conclusions Our single-center study of a large patient series revealed that LG for gastric cancer yields comparable surgical outcomes. This result was also true of local advanced gastric cancer (AGC). A well-designed randomized controlled trial comparing surgical outcomes between LG and OG in a larger number of patients for AGC can be carried out.	[Lin, Jian-Xian; Huang, Chang-Ming; Zheng, Chao-Hui; Li, Ping; Xie, Jian-Wei; Wang, Jia-Bin; Lu, Jun; Chen, Qi-Yue; Cao, Long-Long; Lin, Mi] Fujian Med Univ, Union Hosp, Dept Gastr Surg, Fuzhou 350001, Fujian, Peoples R China	Fujian Medical University	Huang, CM (corresponding author), Fujian Med Univ, Union Hosp, Dept Gastr Surg, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China.	hcmlr2002@163.com	Li, Ping/GYV-4914-2022; Zheng, Chao-hui/HGE-3348-2022	Zheng, Chao-hui/0000-0001-8680-3127	National Key Clinical Specialty Discipline Construction Program of China [[2012]649]; Key Project of Science and Technology Plan of Fujian Province, China [2014Y0025]	National Key Clinical Specialty Discipline Construction Program of China; Key Project of Science and Technology Plan of Fujian Province, China	Our funding was provided by National Key Clinical Specialty Discipline Construction Program of China (No. [2012] 649) and The Key Project of Science and Technology Plan of Fujian Province, China (Grant No. 2014Y0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bo T, 2013, J GASTROINTEST SURG, V17, P1202, DOI 10.1007/s11605-013-2218-1; Han HS, 2003, SURG LAPARO ENDO PER, V13, P361, DOI 10.1097/00129689-200312000-00002; Hu Yan-feng, 2010, Zhonghua Wei Chang Wai Ke Za Zhi, V13, P510; Huang Chang-ming, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P1265; Hur H, 2008, J SURG ONCOL, V98, P515, DOI 10.1002/jso.21155; Hwang SI, 2009, SURG ENDOSC, V23, P1252, DOI 10.1007/s00464-008-0140-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong O, 2012, SURG ENDOSC, V26, P3418, DOI 10.1007/s00464-012-2356-7; Kawamura H, 2008, WORLD J SURG, V32, P2366, DOI 10.1007/s00268-008-9697-3; Kim HH, 2010, ANN SURG, V251, P417, DOI 10.1097/SLA.0b013e3181cc8f6b; Kim JP, 2002, J SURG ONCOL, V79, P79, DOI 10.1002/jso.10050.abs; Kim KH, 2012, J GASTRIC CANCER, V12, P18, DOI 10.5230/jgc.2012.12.1.18; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Kitano S, 2007, ANN SURG, V245, P68, DOI 10.1097/01.sla.0000225364.03133.f8; Kunisaki C, 2008, SURG LAPARO ENDO PER, V18, P236, DOI 10.1097/SLE.0b013e31816aa13f; Lee JH, 2005, SURG ENDOSC, V19, P168, DOI 10.1007/s00464-004-8808-y; Lee JH, 2009, SURG ENDOSC, V23, P1759, DOI 10.1007/s00464-008-0198-0; Lee SI, 2006, J AM COLL SURGEONS, V202, P874, DOI 10.1016/j.jamcollsurg.2006.02.028; Lin JX, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-4; Miura S, 2004, J AM COLL SURGEONS, V198, P933, DOI 10.1016/j.jamcollsurg.2004.01.021; Nam BH, 2013, J GASTRIC CANCER, V13, P164, DOI 10.5230/jgc.2013.13.3.164; Pak KH, 2012, SURG ENDOSC, V26, P130, DOI 10.1007/s00464-011-1838-3; PARKDO J, 2012, SURG ENDOSC, V26, P1548, DOI DOI 10.1007/S00464-011-2065-7; Shuang JB, 2011, J GASTROINTEST SURG, V15, P57, DOI 10.1007/s11605-010-1361-1; SOBIN LH, 2010, TNM CLASSIFICATION O; Song KY, 2008, SURG ENDOSC, V22, P655, DOI 10.1007/s00464-007-9431-5; Sugimoto M, 2013, SURG ENDOSC, V27, P4291, DOI 10.1007/s00464-013-3045-x; Tanimura S, 2008, SURG ENDOSC, V22, P1161, DOI 10.1007/s00464-008-9786-2; Wang Jia-bin, 2010, Zhonghua Wai Ke Za Zhi, V48, P502	31	45	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0114948	10.1371/journal.pone.0114948	http://dx.doi.org/10.1371/journal.pone.0114948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25642698	Green Submitted, Green Published			2022-12-26	WOS:000348821200006
J	Morgan, WH; Abdul-Rahman, A; Yu, DY; Hazelton, ML; Betz-Stablein, B; Lind, CRP				Morgan, William H.; Abdul-Rahman, Anmar; Yu, Dao-Yi; Hazelton, Martin L.; Betz-Stablein, Brigid; Lind, Christopher R. P.			Objective Detection of Retinal Vessel Pulsation	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; VENOUS PULSATION; VEIN; FREQUENCY; GLAUCOMA	Purpose Retinal venous pulsation detection is a subjective sign, which varies in elevated intracranial pressure, venous obstruction and glaucoma. To date no method can objectively measure and identify pulsating regions. Method Using high resolution video-recordings of the optic disk and retina we measured fluctuating light absorption by haemoglobin during pulsation. Pulsation amplitude was calculated from all regions of the retinal image video-frames in a raster pattern. Segmented retinal images were formed by objectively selecting regions with amplitudes above a range of threshold values. These were compared to two observers manually drawing an outline of the pulsating areas while viewing video-clips in order to generate receiver operator characteristics. Results 216,515 image segments were analysed from 26 eyes in 18 research participants. Using data from each eye, the median area under the receiver operator curve (AU-ROC) was 0.95. With all data analysed together the AU-ROC was 0.89. We defined the ideal threshold amplitude for detection of any pulsating segment being that with maximal sensitivity and specificity. This was 5 units (95% confidence interval 4.3 to 6.0) compared to 12 units before any regions were missed. A multivariate model demonstrated that ideal threshold amplitude increased with increased variation in video-sequence illumination (p = 0.0119), but between the two observers (p = 0.0919) or other variables. Conclusion This technique demonstrates accurate identification of retinal vessel pulsating regions with no areas identified manually being missed with the objective technique. The amplitude values are derived objectively and may be a significant advance upon subjective ophthalmodynamometric threshold techniques.	[Morgan, William H.; Yu, Dao-Yi] Univ Western Australia, Lions Eye Inst, Nedlands, WA 6009, Australia; [Hazelton, Martin L.; Betz-Stablein, Brigid] Massey Univ, Inst Fundamental Sci, Stat & Bioinformat Grp, Palmerston North, New Zealand; [Lind, Christopher R. P.] Univ Western Australia, Sch Surg, Nedlands, WA 6009, Australia; [Abdul-Rahman, Anmar] Manukau Hlth, Dept Ophthalmol, Auckland, New Zealand	Lions Eye Institute; University of Western Australia; Massey University; University of Western Australia	Morgan, WH (corresponding author), Univ Western Australia, Lions Eye Inst, Nedlands, WA 6009, Australia.	BillMorgan@lei.org.au	Hazelton, Martin/AAB-9373-2019; Abdul-Rahman, Anmar/ABA-5090-2021; Betz-Stablein, Brigid/S-6925-2018; Lind, Christopher/K-3629-2012	Hazelton, Martin/0000-0001-7831-725X; Abdul-Rahman, Anmar/0000-0002-0812-8944; Betz-Stablein, Brigid/0000-0003-3876-501X; Lind, Christopher/0000-0001-9991-1725; Yu, Dao-Yi/0000-0002-9490-534X	National Health and Medical Research Council NHMRC [APP1020367, 102367, 107310]	National Health and Medical Research Council NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council NHMRC (https://www.nhmrc.gov.au), NHMRC Grant Reference Number APP1020367 WHM, NHMRC Project Grant 102367 WHM, and NHMRC Development Grant 107310 WHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaratnasingam C, 2007, BRIT J OPHTHALMOL, V91, P441, DOI 10.1136/bjo.2006.105338; BEAUMONT PE, 1994, AUST NZ J OPHTHALMOL, V22, P271, DOI 10.1111/j.1442-9071.1994.tb00796.x; Coccius E.A., 1853, UEBER ANWENDUNG AUGE; Firsching R, 1998, LANCET, V351, P523, DOI 10.1016/S0140-6736(05)78717-1; Foo JYA, 2005, PHYSIOL MEAS, V26, P531, DOI 10.1088/0967-3334/26/4/017; Gibbs FA, 1936, ARCH NEURO PSYCHIATR, V35, P292, DOI 10.1001/archneurpsyc.1936.02260020086006; Golzan SM, 2011, CURR EYE RES, V36, P53, DOI 10.3109/02713683.2010.530731; Jonas JB, 2007, AM J OPHTHALMOL, V143, P112, DOI 10.1016/j.ajo.2006.09.019; Kain S, 2010, BRIT J OPHTHALMOL, V94, P854, DOI 10.1136/bjo.2009.169813; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097943; Legler U, 2009, J GLAUCOMA, V18, P210, DOI 10.1097/IJG.0b013e318182edd2; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Morgan WH, 2014, INVEST OPHTHALMOL VI; Morgan WH, 2014, INVEST OPHTH VIS SCI, V55, P5998, DOI 10.1167/iovs.14-15104; Morgan WH, 2010, GRAEF ARCH CLIN EXP, V248, P401, DOI 10.1007/s00417-009-1288-y; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Popovic Djordje, 2009, Recent Patents on Biomedical Engineering, V2, P165, DOI 10.2174/1874764710902030165; R Core Development Team, 2013, R LANG ENV STAT COMP; Seo JH, 2012, OPHTHALMOLOGY, V119, P2254, DOI 10.1016/j.ophtha.2012.06.007; Stodtmeister R, 2008, KLIN MONATSBL AUGENH, V225, P632, DOI 10.1055/s-2008-1027233; WALSH TJ, 1969, AM J OPHTHALMOL, V67, P954, DOI 10.1016/0002-9394(69)90094-4; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929; Zou KH, 2004, STAT MED, V23, P1259, DOI 10.1002/sim.1723	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116475	10.1371/journal.pone.0116475	http://dx.doi.org/10.1371/journal.pone.0116475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643350	Green Submitted, gold, Green Published			2022-12-26	WOS:000348821200018
J	O'Brien, KM; Lindsay, EL; Starai, VJ				O'Brien, Kevin M.; Lindsay, Elizabeth L.; Starai, Vincent J.			The Legionella pneumophila Effector Protein, LegC7, Alters Yeast Endosomal Trafficking	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; PLASMA-MEMBRANE; ENDOCYTOSIS; IDENTIFICATION; BACTERIUM; COMPLEX; DOMAIN; HRS; UBIQUITINATION; PHAGOSOME	The intracellular pathogen, Legionella pneumophila, relies on numerous secreted effector proteins to manipulate host endomembrane trafficking events during pathogenesis, thereby preventing fusion of the bacteria-laden phagosome with host endolysosomal compartments, and thus escaping degradation. Upon expression in the surrogate eukaryotic model Saccharomyces cerevisiae, we find that the L. pneumophila LegC7/YlfA effector protein disrupts the delivery of both biosynthetic and endocytic cargo to the yeast vacuole. We demonstrate that the effects of LegC7 are specific to the endosome: vacuole delivery pathways; LegC7 expression does not disrupt other known vacuole-directed pathways. Deletions of the ESCRT-0 complex member, VPS27, provide resistance to the LegC7 toxicity, providing a possible target for LegC7 function in vivo. Furthermore, a single amino acid substitution in LegC7 abrogates both its toxicity and ability to alter endosomal traffic in vivo, thereby identifying a critical functional domain. LegC7 likely inhibits endosomal trafficking during L. pneumophila pathogenesis to prevent entry of the phagosome into the endosomal maturation pathway and eventual fusion with the lysosome.	[O'Brien, Kevin M.; Lindsay, Elizabeth L.; Starai, Vincent J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Starai, Vincent J.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Starai, VJ (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	vjstarai@uga.edu		Tinder, Elizabeth/0000-0002-0262-5253	National Institute of Allergy and Infectious Diseases award [R01-AI100913]; National Science Foundation's Research Experience for Undergraduates Site Award to The University of Georgia [DBI-1062589]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100913] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1062589] Funding Source: National Science Foundation	National Institute of Allergy and Infectious Diseases award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation's Research Experience for Undergraduates Site Award to The University of Georgia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	VJS is supported by National Institute of Allergy and Infectious Diseases award R01-AI100913. ELL was supported by the National Science Foundation's Research Experience for Undergraduates Site Award to The University of Georgia (DBI-1062589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bennett TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056798; Brachmann CB, 1998, YEAST, V14, P115; BURNSTEIN D, 2009, PLOS PATHOG, V5, DOI DOI 10.1371/JOURNAL.PPAT.1000508; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769; Darsow T, 1998, J CELL BIOL, V142, P913, DOI 10.1083/jcb.142.4.913; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; FIELDS BS, 1986, INFECT IMMUN, V53, P553, DOI 10.1128/IAI.53.3.553-559.1986; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Gaspar AH, 2014, P NATL ACAD SCI USA, V111, P4560, DOI 10.1073/pnas.1316376111; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KAUFMANN AF, 1981, AM J EPIDEMIOL, V114, P337, DOI 10.1093/oxfordjournals.aje.a113200; KLIONSKY DJ, 1992, JOURNAL OF CELL BIOL, V119, DOI DOI 10.1083/JCB.119.2.287; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Ku B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003082; Leber R, 2001, J BIOL CHEM, V276, P29210, DOI 10.1074/jbc.M101438200; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; MacDonald C, 2012, TRAFFIC, V13, P586, DOI 10.1111/j.1600-0854.2011.01326.x; Maldonado-Baez L, 2008, MOL BIOL CELL, V19, P2936, DOI 10.1091/mbc.E07-10-1019; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Neunuebel MR, 2012, J BACTERIOL, V194, P1389, DOI 10.1128/JB.06306-11; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013; Progida C, 2007, J CELL SCI, V120, P3729, DOI 10.1242/jcs.017301; Prosser DC, 2010, TRAFFIC, V11, P1141, DOI 10.1111/j.1600-0854.2010.01088.x; Raiborg C, 2001, J CELL SCI, V114, P2255; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; ROBINSON JS, 1988, MOLECULAR AND CELLUL, V8, P13; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; SCHUH AL, 2014, CRITICAL REVIEWS IN, P1549; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; SOLINGER JA, 2012, THE FEBS JOURNAL, V280, P2743, DOI DOI 10.1111/FEBS.12151; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tilney LG, 2001, J CELL SCI, V114, P4637; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Yao DQ, 2014, ACTA CRYSTALLOGR D, V70, P436, DOI 10.1107/S139900471302991X	60	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0116824	10.1371/journal.pone.0116824	http://dx.doi.org/10.1371/journal.pone.0116824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	25643265	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821200024
J	Correia, M; Snabe, T; Thiagarajan, V; Petersen, SB; Campos, SRR; Baptista, AM; Neves-Petersen, MT				Correia, Manuel; Snabe, Torben; Thiagarajan, Viruthachalam; Petersen, Steffen Bjorn; Campos, Sara R. R.; Baptista, Antonio M.; Neves-Petersen, Maria Teresa			Photonic Activation of Plasminogen Induced by Low Dose UVB	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; EXCITED-STATE CHEMISTRY; AROMATIC-AMINO-ACIDS; CRYSTAL-STRUCTURE; DECAY KINETICS; FLUORESCENCE CHARACTERISTICS; N-FORMYLKYNURENINE; SULFHYDRYL-GROUPS; DISULFIDE BONDS	Activation of plasminogen to its active form plasmin is essential for several key mechanisms, including the dissolution of blood clots. Activation occurs naturally via enzymatic proteolysis. We report that activation can be achieved with 280 nm light. A 2.6 fold increase in proteolytic activity was observed after 10 min illumination of human plasminogen. Irradiance levels used are in the same order of magnitude of the UVB solar irradiance. Activation is correlated with light induced disruption of disulphide bridges upon UVB excitation of the aromatic residues and with the formation of photochemical products, e.g. dityrosine and N-formylkynurenine. Most of the protein fold is maintained after 10 min illumination since no major changes are observed in the near-UV CD spectrum. Far-UV CD shows loss of secondary structure after illumination (33.4% signal loss at 206 nm). Thermal unfolding CD studies show that plasminogen retains a native like cooperative transition at similar to 70 degrees C after UV-illumination. We propose that UVB activation of plasminogen occurs upon photocleavage of a functional allosteric disulphide bond, Cys737-Cys765, located in the catalytic domain and in van der Waals contact with Trp761 (4.3 angstrom). Such proximity makes its disruption very likely, which may occur upon electron transfer from excited Trp761. Reduction of Cys737-Cys765 will result in likely conformational changes in the catalytic site. Molecular dynamics simulations reveal that reduction of Cys737-Cys765 in plasminogen leads to an increase of the fluctuations of loop 760-765, the S1-entrance frame located close to the active site. These fluctuations affect the range of solvent exposure of the catalytic triad, particularly of Asp646 and Ser74, which acquire an exposure profile similar to the values in plasmin. The presented photonic mechanism of plasminogen activation has the potential to be used in clinical applications, possibly together with other enzymatic treatments for the elimination of blood clots.	[Correia, Manuel; Snabe, Torben] Aalborg Univ, Dept Phys & Nanotechnol, Aalborg, Denmark; [Thiagarajan, Viruthachalam; Petersen, Steffen Bjorn; Neves-Petersen, Maria Teresa] Int Iberian Nanotechnol Lab INL, Dept Nanomed, BioPhoton Grp, Braga, Portugal; [Thiagarajan, Viruthachalam] Bharathidasan Univ, Sch Chem, Tiruchirappalli, Tamil Nadu, India; [Petersen, Steffen Bjorn] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Petersen, Steffen Bjorn] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA; [Campos, Sara R. R.; Baptista, Antonio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal	Aalborg University; International Iberian Nanotechnology Laboratory; Bharathidasan University; Aalborg University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Universidade Nova de Lisboa	Neves-Petersen, MT (corresponding author), Int Iberian Nanotechnol Lab INL, Dept Nanomed, BioPhoton Grp, Braga, Portugal.	nevespetersen@gmail.com	Viruthachalam, Thiagarajan/I-2503-2013; Campos, Sara R. R./C-7550-2012; Petersen, Steffen b/E-8727-2015; INL, Citations/K-3436-2015; Baptista, Antonio M./C-7246-2012	Campos, Sara R. R./0000-0003-1020-6830; Petersen, Steffen b/0000-0002-0739-2751; INL, Citations/0000-0002-3745-5100; Baptista, Antonio M./0000-0002-7044-1210; Thiagarajan, Viruthachalam/0000-0003-4197-2255; Neves-Petersen, Maria Teresa/0000-0003-3178-3709; Correia, Manuel/0000-0001-7619-2780	"Fundacao para a Ciencia e Tecnologia" (FCT) [SFRH/BD/61012/2009]; "Programa Operacional Potencial Humano" (POPH); European Social Fund ("Fundo Social Europeu", FSE)	"Fundacao para a Ciencia e Tecnologia" (FCT)(Portuguese Foundation for Science and Technology); "Programa Operacional Potencial Humano" (POPH); European Social Fund ("Fundo Social Europeu", FSE)(European Social Fund (ESF))	MC acknowledges the support from "Fundacao para a Ciencia e Tecnologia" (FCT) for the PhD grant (SFRH/BD/61012/2009) supported by "Programa Operacional Potencial Humano" (POPH) in the framework of "Quadro de Referencia Estrategico Nacional" (QREN) and co-financed by the European Social Fund ("Fundo Social Europeu", FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESCHBACH R, 1976, BIOCHIM BIOPHYS ACTA, V439, P292, DOI 10.1016/0005-2795(76)90064-7; BENT DV, 1975, J AM CHEM SOC, V97, P2599, DOI 10.1021/ja00843a002; BENT DV, 1975, J AM CHEM SOC, V97, P2612, DOI 10.1021/ja00843a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bhushan B., 2007, SPRINGER HDB NANOTEC; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Chen VM, 2006, J THROMB HAEMOST, V4, P2533, DOI 10.1111/j.1538-7836.2006.02236.x; Chen VM, 2006, BIOCHEMISTRY-US, V45, P12020, DOI 10.1021/bi061271a; Christ G, 1999, J THROMB THROMBOLYS, V7, P277, DOI 10.1023/A:1008983110941; Collen D, 2001, Hematology Am Soc Hematol Educ Program, P1; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Correia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050733; Correia M, 2012, J FLUORESC, V22, P323, DOI 10.1007/s10895-011-0963-7; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P563; D'Costa SS, 1998, MICROB PATHOGENESIS, V24, P341, DOI 10.1006/mpat.1998.0207; Duroux M, 2007, PROTEOMICS, V7, P3491, DOI 10.1002/pmic.200700472; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fasman G.D., 1976, HDB BIOCH MOL BIOL P, V1; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P129, DOI 10.1093/oxfordjournals.jbchem.a133909; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HAN MK, 1990, J BIOL CHEM, V265, P1985; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOFFMAN MZ, 1972, J AM CHEM SOC, V94, P7950, DOI 10.1021/ja00778a002; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Homchaudhuri L, 2001, CHEM LETT, P844; Jacob JS, 1996, J BIOL CHEM, V271, P19950, DOI 10.1074/jbc.271.33.19950; Janes RW, 2009, MODERN TECHNIQUES CI; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Klitgaard S, 2006, J FLUORESC, V16, P595, DOI 10.1007/s10895-006-0081-0; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; LEHRER SS, 1967, BIOCHEMISTRY-US, V6, P757, DOI 10.1021/bi00855a017; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; Linde V, 1998, EUR J BIOCHEM, V251, P472, DOI 10.1046/j.1432-1327.1998.2510472.x; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lousa D, 2013, PHYS CHEM CHEM PHYS, V15, P13723, DOI 10.1039/c3cp51761f; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; MALENCIK DA, 1991, BIOCHEM BIOPH RES CO, V178, P60, DOI 10.1016/0006-291X(91)91779-C; MALENCIK DA, 1987, BIOCHEMISTRY-US, V26, P695, DOI 10.1021/bi00377a006; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; McCormick ML, 1998, J BIOL CHEM, V273, P32030, DOI 10.1074/jbc.273.48.32030; MILES LA, 1988, J BIOL CHEM, V263, P11928; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Moan J., 2001, RAD HOME OUTDOORS WO, P69; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Neves-Petersen MT, 2006, PROTEIN SCI, V15, P343, DOI 10.1110/ps.051885306; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Novokhatny V, 2008, THROMB RES, V122, pS3, DOI 10.1016/j.thromres.2008.06.018; Parracino A, 2011, BIOTECHNOL BIOENG, V108, P999, DOI 10.1002/bit.23015; Parracino A, 2010, PROTEIN SCI, V19, P1751, DOI 10.1002/pro.461; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; Peisach E, 1999, BIOCHEMISTRY-US, V38, P11180, DOI 10.1021/bi991130r; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; PIRIE A, 1971, BIOCHEM J, V125, P203, DOI 10.1042/bj1250203; PIRIE A, 1972, BIOCHEM J, V128, P1365, DOI 10.1042/bj1281365; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Schaller J, 2011, CELL MOL LIFE SCI, V68, P785, DOI 10.1007/s00018-010-0566-5; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sionkowska A, 2006, J PHOTOCH PHOTOBIO B, V85, P79, DOI 10.1016/j.jphotobiol.2006.05.005; Skovsen E, 2009, PROTEOMICS, V9, P3945, DOI 10.1002/pmic.200800960; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SUENSON E, 1981, BIOCHEM J, V197, P619, DOI 10.1042/bj1970619; TEW D, 1988, J BIOL CHEM, V263, P17880; URANO T, 1987, J BIOL CHEM, V262, P15959; URANO T, 1987, P NATL ACAD SCI USA, V84, P4031, DOI 10.1073/pnas.84.12.4031; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Webb AR, 2006, PHOTOCHEM PHOTOBIOL, V82, P1697, DOI 10.1562/2006-09-01-RA-670; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WILLIS KJ, 1991, J PHYS CHEM-US, V95, P1585, DOI 10.1021/j100157a015; WILSON JM, 1980, J AM CHEM SOC, V102, P359, DOI 10.1021/ja00521a058; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; Wong J.W.H., 2010, J THROMB HAEMOSTASIS, V8, P2345, DOI [10.1111/j.1538-7836.2010.03894.x, DOI 10.1111/J.1538-7836.2010.03894.X]; World Health Organization, KNOWL HLTH EFF UV; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x	83	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116737	10.1371/journal.pone.0116737	http://dx.doi.org/10.1371/journal.pone.0116737			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635856	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700055
J	Gossner, MM; Brandle, M; Brandl, R; Bail, J; Muller, J; Opgenoorth, L				Gossner, Martin M.; Braendle, Martin; Brandl, Roland; Bail, Johannes; Mueller, Joerg; Opgenoorth, Lars			Where Is the Extended Phenotype in the Wild? The Community Composition of Arthropods on Mature Oak Trees Does Not Depend on the Oak Genotype	PLOS ONE			English	Article							GENETIC-VARIATION; PLANT HYBRIDIZATION; ECOSYSTEM GENETICS; BETA-DIVERSITY; CONSEQUENCES; DETERMINANTS; CONSERVATISM; LINEAGES; INSECTS	Through a series of common garden experiments, it has been shown that heritable phenotypic differences between individual trees can affect arthropod communities. However, field studies under heterogeneous environmental conditions remain rare. In the present study, we investigated the genetic constitution of 121 mature oak host trees at different trophic levels from 10 sites across Bavaria, southern Germany and their associated insect communities. A total of 23,576 individuals representing 395 species of beetles and true bugs were evaluated. In particular, we determined whether the composition of arthropod communities is related to the oak genotype and whether the strength of the relationships decreases from lower to higher trophic levels, such as for phytophagous, xylophagous, zoophagous, and mycetophagous species. The genetic differentiation of oaks was assessed using eight microsatellite markers. We found no significant influence of the oak genotype on neither the full beetle and true bug community nor on any of the analyzed trophic guilds. In contrast, the community composition of the insects was highly related to the space and climate, such that the community similarity decreased with increases in spatial distance and climatic differences. The relationship with space and climate was much stronger in beetles than in true bugs, particularly in mycetophagous species. Our results suggest that spatial processes override the genetic effects of the host plant in structuring arthropod communities on oak trees. Because we used neutral markers, we cannot exclude the possibility that trait-specific markers may reveal a genetic imprint of the foundation tree species on the composition of the arthropod community. However, based on the strength of the spatial patterns in our data set, we assume that genetic differences among oaks are less important in the structuring of arthropod communities. Future whole-genome studies are required to draw a final conclusion.	[Gossner, Martin M.; Mueller, Joerg] Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, D-85354 Freising Weihenstephan, Germany; [Braendle, Martin; Brandl, Roland; Opgenoorth, Lars] Univ Marburg, Dept Ecol, D-35043 Marburg, Germany; [Bail, Johannes] Univ Erlangen Nurnberg, D-91058 Erlangen, Germany; [Mueller, Joerg] Bavarian Forest Natl Pk, D-94481 Grafenau, Germany	Technical University of Munich; Philipps University Marburg; University of Erlangen Nuremberg	Gossner, MM (corresponding author), Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Hans Carl Von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany.	martin.gossner@tum.de; opgenoorth@uni-marburg.de	Opgenoorth, Lars/C-9624-2018; Gossner, Martin M./J-2730-2015	Gossner, Martin M./0000-0003-1516-6364; Opgenoorth, Lars/0000-0003-0737-047X; Muller, Jorg/0000-0002-1409-1586	Federal Ministry of Education, Science, Research and Technology, Germany [0339735/8]; Bavarian Forest Service [L49, L51]; German Research Foundation DFG (Biodiversity Exploratories) [WE 3081/21-1]	Federal Ministry of Education, Science, Research and Technology, Germany; Bavarian Forest Service; German Research Foundation DFG (Biodiversity Exploratories)(German Research Foundation (DFG))	The field experimental work was financed by grants of the Federal Ministry of Education, Science, Research and Technology, Germany ('Zukunftsorientierte Waldwirtschaft', project-no. 0339735/8) and the 'Bavarian Forest Service' (project no. L49 and L51). The genetic analysis was paid for by internal university funds of RB and LO. MG is supported by the German Research Foundation DFG (Biodiversity Exploratories, WE 3081/21-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacilieri R, 1996, EVOLUTION, V50, P900, DOI 10.1111/j.1558-5646.1996.tb03898.x; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bailey R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000179; Bangert RK, 2008, HEREDITY, V100, P121, DOI 10.1038/sj.hdy.6800914; Bangert RK, 2006, MOL ECOL, V15, P4215, DOI 10.1111/j.1365-294X.2006.03092.x; Bernhardsson C, 2013, ECOL LETT, V16, P791, DOI 10.1111/ele.12114; Bohme J, 2005, DIE KAFER MITTELEURO; Brandle M, 2006, OIKOS, V113, P296, DOI 10.1111/j.2006.0030-1299.14418.x; Brandle M, 2001, J ANIM ECOL, V70, P491, DOI 10.1046/j.1365-2656.2001.00506.x; Castagneyrol B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044247; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Crutsinger GM, 2008, OECOLOGIA, V158, P65, DOI 10.1007/s00442-008-1130-y; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Crutsinger GM, 2010, ECOLOGY, V91, P1237, DOI 10.1890/09-0613.1; Crutsinger GM, 2009, BASIC APPL ECOL, V10, P535, DOI 10.1016/j.baae.2008.10.011; Crutsinger GM, 2009, ECOL LETT, V12, P285, DOI 10.1111/j.1461-0248.2009.01288.x; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Double MC, 2001, EVOLUTION INT J ORG, V59; Eisenbach J, 1996, OECOLOGIA, V105, P258, DOI 10.1007/BF00328555; FRITZ RS, 1995, ECOL ENTOMOL, V20, P18, DOI 10.1111/j.1365-2311.1995.tb00424.x; FRITZ RS, 1988, ECOLOGY, V69, P845, DOI 10.2307/1941034; Gossner M., 2004, NEOBIOTA, V5, P1; Gossner MM, 2013, BIOL CONSERV, V166, P212, DOI 10.1016/j.biocon.2013.06.033; Gossner MM, 2009, AM NAT, V173, P599, DOI 10.1086/597603; GREENSTONE MH, 1984, OECOLOGIA, V62, P299, DOI 10.1007/BF00384260; Guichoux E, 2011, MOL ECOL RESOUR, V11, P578, DOI 10.1111/j.1755-0998.2011.02983.x; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Haloin JR, 2008, ANN NY ACAD SCI, V1133, P87, DOI 10.1196/annals.1438.003; Hochwender CG, 2004, OECOLOGIA, V138, P547, DOI 10.1007/s00442-003-1472-4; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Koch K, 1989, DIE KAFER MITTELEURO; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Mattila Anu, 1994, Silva Fennica, V28, P251; Nekola JC, 2001, J BIOGEOGRAPHY, V26; Peakall R, 2001, EVOLUTION INT J ORG, V57; PIMENTEL D, 1961, AM NAT, V95, P65, DOI 10.1086/282160; PRESZLER RW, 1994, OECOLOGIA, V100, P66, DOI 10.1007/BF00317131; Pritchard JK, 2001, GENETICS, V155; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037679; Simpson GG, 1943, AM J SCI, V241, P1, DOI 10.2475/ajs.241.1.1; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Southwood TRE, THE COMPOSITION OF T; Southwood TRE, 1961, JOURNAL OF ANIMAL EC, V30; Stone GN, 2009, EVOLUTION, V63, P854, DOI 10.1111/j.1558-5646.2008.00604.x; Tack AJM, 2012, ECOLOGY LETTERS; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tack AJM, 2011, ECOLOGY, V92, P1594, DOI 10.1890/10-2006.1; Tack AJM, 2010, ECOLOGY, V91, P2660, DOI 10.1890/09-1027.1; Vakkari P, 2006, GENETICA, V127, P231, DOI 10.1007/s10709-005-4014-7; Wachmann E., 2004, WANZEN; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitham TG, 2012, TRENDS PLANT SCI, V17, P271, DOI 10.1016/j.tplants.2012.01.005; Wimp GM, 2005, EVOLUTION, V59, P61, DOI 10.1111/j.0014-3820.2005.tb00894.x; Wimp GM, 2001, ECOLOGY, V82, P440, DOI 10.1890/0012-9658(2001)082[0440:BCOPAH]2.0.CO;2; Zytynska SE, 2011, PHILOS T R SOC B, V366, P1329, DOI 10.1098/rstb.2010.0183	62	8	8	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0115733	10.1371/journal.pone.0115733	http://dx.doi.org/10.1371/journal.pone.0115733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635387	gold, Green Published, Green Submitted			2022-12-26	WOS:000350680700018
J	Holtappels, M; Noss, C; Hancke, K; Cathalot, C; McGinnis, DF; Lorke, A; Glud, RN				Holtappels, Moritz; Noss, Christian; Hancke, Kasper; Cathalot, Cecile; McGinnis, Daniel F.; Lorke, Andreas; Glud, Ronnie N.			Aquatic Eddy Correlation: Quantifying the Artificial Flux Caused by Stirring-Sensitive O-2 Sensors	PLOS ONE			English	Article							OXYGEN FLUXES; BENTHIC EXCHANGE; BOUNDARY-LAYER; SEDIMENTS; HETEROGENEITY; RATES; FLOW		[Holtappels, Moritz] Max Planck Inst Marine Microbiol, Biogeochem Grp, Bremen, Germany; [Holtappels, Moritz] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Noss, Christian; Lorke, Andreas] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Hancke, Kasper; Glud, Ronnie N.] Univ Southern Denmark, Inst Biol, Odense, Denmark; [Hancke, Kasper; Glud, Ronnie N.] Univ Southern Denmark, Nord Ctr Earth Evolut NordCEE, Odense, Denmark; [Cathalot, Cecile] Royal Netherland Inst Sea Res NIOZ, Yerseke, Netherlands; [McGinnis, Daniel F.] IGB Leibniz Inst Freshwater Ecol & Inland Fisheri, Expt Limnol, Berlin, Germany; [McGinnis, Daniel F.] Univ Geneva, Fac Sci, Inst FA Forel, Geneva, Switzerland; [Glud, Ronnie N.] Aarhus Univ, Arctic Res Ctr, Aarhus, Denmark; [Glud, Ronnie N.] Scottish Assoc Marine, Scottish Marine Inst, Oban, Argyll, Scotland; [Glud, Ronnie N.] Greenland Climate Res Ctr, Greenland Inst Nat Resources, Nuuk, Greenland	Max Planck Society; University of Bremen; University of Koblenz & Landau; University of Southern Denmark; University of Southern Denmark; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Geneva; Aarhus University; Greenland Institute of Natural Resources	Holtappels, M (corresponding author), Max Planck Inst Marine Microbiol, Biogeochem Grp, Bremen, Germany.	mholtapp@mpi-bremen.de	McGinnis, Daniel/G-1389-2011; Holtappels, Moritz/ABC-7901-2020; Lorke, Andreas/B-9195-2008	McGinnis, Daniel/0000-0002-6163-4299; Lorke, Andreas/0000-0001-5533-1817; Cathalot, Cecile/0000-0002-0868-7201; Holtappels, Moritz/0000-0003-3682-1903; Glud, Ronnie N./0000-0002-7069-893X	Max-Planck-Gesellschaft; DFG-Research Center/Cluster of Excellence "The Ocean in the Earth System" at the University of Bremen; European Union project; EC grant [226213]; Faculty of Science at the University of Southern Denmark; Danish Council for Independent Research [FNU-12-125843, DNRF53]; ERC Advanced Grants [ERC-2010-AdG-20100224]; Commission for Scientific Research in Greenland [GCRC6507]; Natural Environment Research Council [NE/F012691/1] Funding Source: researchfish; NERC [NE/F012691/1] Funding Source: UKRI	Max-Planck-Gesellschaft(Max Planck Society); DFG-Research Center/Cluster of Excellence "The Ocean in the Earth System" at the University of Bremen(German Research Foundation (DFG)); European Union project(European Commission); EC grant; Faculty of Science at the University of Southern Denmark; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); ERC Advanced Grants; Commission for Scientific Research in Greenland; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was funded by the Max-Planck-Gesellschaft (www.mpg.de), the DFG-Research Center/Cluster of Excellence "The Ocean in the Earth System" at the University of Bremen (http://www.marum.de), the European Union project "HYPOX - In situ monitoring of oxygen depletion in hypoxic ecosystems of coastal and open seas and land-locked water bodies," EC grant 226213 (http://ec.europa.eu/research/fp7). RNG, DFM and KH received financial support from the Faculty of Science at the University of Southern Denmark, the Danish Council for Independent Research (FNU-12-125843), The Danish Council for Independent Research (DNRF53), ERC Advanced Grants (ERC-2010-AdG-20100224), and The Commission for Scientific Research in Greenland (GCRC6507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Attard KM, 2014, LIMNOL OCEANOGR, V59, P1555, DOI 10.4319/lo.2014.59.5.1555; Berg P, 2003, MAR ECOL PROG SER, V261, P75, DOI 10.3354/meps261075; Berg P, 2013, LIMNOL OCEANOGR, V58, P1329, DOI 10.4319/lo.2013.58.4.1329; Berg P, 2009, LIMNOL OCEANOGR-METH, V7, P576, DOI 10.4319/lom.2009.7.576; Buffin-Belanger T, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004070; Chipman L, 2012, LIMNOL OCEANOGR-METH, V10, P304, DOI 10.4319/lom.2012.10.304; Donis D, 2014, J ATMOSPHERIC OCEANI, DOI [10.1175/JTECH-D-14-00089.1, DOI 10.1175/JTECH-D-14-000891]; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; Glud R.N., 2000, SITU MONITORING AQUA SITU MONITORING AQUA, P19; GLUD RN, 1995, DEEP-SEA RES PT I, V42, P1029; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Glud RN, 2007, LIMNOL OCEANOGR, V52, P547, DOI 10.4319/lo.2007.52.2.0547; Glud RN, 2010, MAR ECOL PROG SER, V417, P1, DOI 10.3354/meps08795; Gundersen JK, 1998, LIMNOL OCEANOGR, V43, P1932; GUST G, 1987, NETH J SEA RES, V21, P255, DOI 10.1016/0077-7579(87)90001-9; Holtappels M, 2013, J GEOPHYS RES-OCEANS, V118, P1157, DOI 10.1002/jgrc.20112; Holtappels M, 2011, LIMNOL OCEANOGR-METH, V9, P1, DOI 10.4319/lom.2011.9.1; Holtappels M, 2011, LIMNOL OCEANOGR-METH, V9, P29, DOI 10.4319/lom.2011.9.29; Huettel M, 2014, ANNU REV MAR SCI, V6, P23, DOI 10.1146/annurev-marine-051413-012706; Hume AC, 2011, LIMNOL OCEANOGR, V56, P86, DOI 10.4319/lo.2011.56.1.0086; Kiorboe T, 2001, MAR ECOL PROG SER, V211, P1, DOI 10.3354/meps211001; Kreling J, 2014, LIMNOL OCEANOGR, V59, P1637, DOI 10.4319/lo.2014.59.5.1637; Li MZ, 1996, MAR GEOL, V130, P139, DOI 10.1016/0025-3227(95)00132-8; Long MH, 2012, BIOGEOSCIENCES, V9, P1957, DOI 10.5194/bg-9-1957-2012; Long MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058581; Lorke A, 2013, LIMNOL OCEANOGR-METH, V11, P425, DOI 10.4319/lom.2013.11.425; Lorke A, 2003, LIMNOL OCEANOGR, V48, P2077, DOI 10.4319/lo.2003.48.6.2077; Lorrai C, 2010, J ATMOS OCEAN TECH, V27, P1533, DOI 10.1175/2010JTECHO723.1; McGinnis DF, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032747; Murniati E, 2015, AQUAT SCI, V77, P183, DOI 10.1007/s00027-014-0362-7; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; Reidenbach M.A., 2013, LIMNOL OCEANOGR FLUI, V3, P225, DOI 10.1215/21573689-2395266; REIMERS CE, 1986, NATURE, V320, P741, DOI 10.1038/320741a0; Reimers CE, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007564; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Rheuban JE, 2013, LIMNOL OCEANOGR-METH, V11, P351, DOI 10.4319/lom.2013.11.351; Rosman JH, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006892; Tennekes H., 1972, 1 COURSE TURBULENCE; Voulgaris G, 1998, J ATMOS OCEAN TECH, V15, P272, DOI 10.1175/1520-0426(1998)015<0272:EOTADV>2.0.CO;2	40	31	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116564	10.1371/journal.pone.0116564	http://dx.doi.org/10.1371/journal.pone.0116564			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635679	Green Published, gold			2022-12-26	WOS:000350680700043
J	Prasad, R; Hochmuth, GJ; Boote, KJ				Prasad, Rishi; Hochmuth, George J.; Boote, Kenneth J.			Estimation of Nitrogen Pools in Irrigated Potato Production on Sandy Soil Using the Model SUBSTOR	PLOS ONE			English	Article							NUTRIENT MANAGEMENT; CROPPING SYSTEM; NITRATE; FERTILIZER; YIELD; GROUNDWATER; BALANCE; CROPS; PREDICTION; IMPACTS	Recent increases in nitrate concentrations in the Suwannee River and associated springs in northern Florida have raised concerns over the contributions of non-point sources. The Middle Suwannee River Basin (MSRB) is of special concern because of prevalent karst topography, unconfined aquifers and sandy soils which increase vulnerability of the ground water contamination from agricultural operations-a billion dollar industry in this region. Potato (Solanum tuberosum L.) production poses a challenge in the area due to the shallow root system of potato plants, and low water and nutrient holding capacity of the sandy soils. A four-year monitoring study for potato production on sandy soil was conducted on a commercial farm located in the MSRB to identify major nitrogen (N) loss pathways and determine their contribution to the total environmental N load, using a partial N budget approach and the potato model SUBSTOR. Model simulated environmental N loading rates were found to lie within one standard deviation of the observed values and identified leaching loss of N as the major sink representing 25 to 38% (or 85 to 138 kg ha(-1) N) of the total input N (310 to 349 kg ha(-1) N). The crop residues left in the field after tuber harvest represented a significant amount of N (64 to 110 kg ha(-1) N) and posed potential for indirect leaching loss of N upon their mineralization and the absence of subsequent cover crops. Typically, two months of fallow period exits between harvest of tubers and planting of the fall row crop (silage corn). The fallow period is characterized by summer rains which pose a threat to N released from rapidly mineralizing potato vines. Strategies to reduce N loading into the groundwater from potato production must focus on development and adoption of best management practices aimed on reducing direct as well as indirect N leaching losses.	[Prasad, Rishi; Hochmuth, George J.] Univ Florida, Inst Food & Agr Sci, Dept Soil & Water Sci, Gainesville, FL 32611 USA; [Boote, Kenneth J.] Univ Florida, Inst Food & Agr Sci, Dept Agron, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Prasad, R (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Soil & Water Sci, Gainesville, FL 32611 USA.	rprasad3@ufl.edu		Boote, Kenneth/0000-0002-1358-5496	Florida Department of Agriculture and Consumer Services; Florida Department of Environmental Protection; Suwannee River Water Management District;  [015765]	Florida Department of Agriculture and Consumer Services; Florida Department of Environmental Protection; Suwannee River Water Management District; 	Funding was provided by Grant no: 015765. Funding agencies: Florida Department of Agriculture and Consumer Services, Florida Department of Environmental Protection, Suwannee River Water Management District. GH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdrabbo M.A.A., 2010, J APPL SCI RES, V6, P751; Albert MA, 2002, THESIS U FLORIDA GAI; [Anonymous], 2000, EOS, DOI [DOI 10.1029/00E000244, DOI 10.1029/00EO00244]; Basso B, 2011, SOIL SCI SOC AM J, V75, P69, DOI 10.2136/sssaj2010.0115; Bowen W., 1999, Impact on a changing world. International Potato Center Program Report 1997-1998., P381; Bundy LG, 2005, SOIL SCI SOC AM J, V69, P640, DOI 10.2136/sssaj2004.0216; Cheryl H., 2010, OPER RES INT J, V10, P247, DOI [DOI 10.1007/S12351-009-0059-1, 10.1007/s12351-009-0059-1]; Chintala R, 2014, ENV SCI POLLUT R; Chintala R, 2013, MICROPOR MESOPOR MAT, V179, P250, DOI 10.1016/j.micromeso.2013.05.023; Daccache A, 2011, AGR FOREST METEOROL, V151, P1641, DOI 10.1016/j.agrformet.2011.06.018; Errebhi M, 1998, AGRON J, V90, P10, DOI 10.2134/agronj1998.00021962009000010003x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Giletto CM, 2013, NUTR CYCL AGROECOSYS, V95, P73, DOI 10.1007/s10705-012-9549-2; HALL DW, 1993, WATER RESOUR BULL, V29, P55; Ham LK, 1996, 964037 US GEOL SURV; Hicks R., 2010, FLORIDA SPRINGS INIT; Hochmuth G J, 2000, IFAS STANDARDIZED FE; Hoogenboom G., 2012, DECISION SUPPORT SYS; Hornsby D, 2007, THESIS U FLORIDA GAI; Hutson JL, 1998, J PROD AGRIC, V11, P233, DOI 10.2134/jpa1998.0233; Hyatt CR, 2010, SOIL SCI SOC AM J, V74, P419, DOI 10.2136/sssaj2009.0126; Jamaati-E-Somarin S., 2010, American-Eurasian Journal of Agricultural and Environmental Science, V9, P16; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Katz B.G., 2000, MONTHLY VARIABILITY; Kidder G, 1992, HORTICULTURALLY ENV; Kraft GJ, 2003, AGR ECOSYST ENVIRON, V100, P63, DOI 10.1016/S0167-8809(03)00172-5; Lara MAS, 2012, AGRON J, V104, P600, DOI 10.2134/agronj2011.0272; LESCZYNSKI DB, 1976, AM POTATO J, V53, P69, DOI 10.1007/BF02852656; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; MAHDIAN MH, 1995, T ASAE, V38, P513, DOI 10.13031/2013.27860; Meisinger J.J., 1991, MANAGING NITROGEN GR, P85, DOI DOI 10.2136/1991.MANAGINGNITROGEN.C5; Monteith JL, 1996, AGRON J, V88, P695, DOI 10.2134/agronj1996.00021962008800050003x; Mylavarapu RS, 2009, IFAS EXTENSION SOIL; Naab JB, 2004, AGRON J, V96, P1231, DOI 10.2134/agronj2004.1231; Natural Resources Conservation Service (NRCS), 2006, SOIL SURV SUW COUNT; NEETESON JJ, 1990, FERT RES, V26, P291, DOI 10.1007/BF01048767; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; *NRC, 1993, SOIL WAT QUAL AG AGR; Obreza Tom, 2006, CHARACTERIZING AGR F; Oenema O, 2003, EUR J AGRON, V20, P3, DOI 10.1016/S1161-0301(03)00067-4; Pack JE, 2004, THESIS U FLORIDA GAI; Pittman JR, 1997, 974152 US GEOL SURV; Postma R., 2000, MANAGEMENT NITROGEN, P136; Powell JM, 2007, AGRON J, V99, P211, DOI 10.2134/agronj2006.0116; Prasad R, 2014, CALCULATE PARTIAL NI; Randall G. W., 2008, AGRON MONOGR, P911; Randazzo AF, 1997, GEOLOGY FLORIDA; Ritchie J. T., 1995, P401; Ritchie JT, 1998, SYST APPR S, V7, P41; Ritchie JT, 1985, NATO ASI SERIES A, P293, DOI DOI 10.1007/978-1-4899-3665-3/PAGE/2; Rotz CA, 2005, CROP SCI, V45, P2139, DOI 10.2135/cropsci2004.0523; SAFFIGNA PG, 1976, AGRON J, V68, P337, DOI 10.2134/agronj1976.00021962006800020033x; Sebilo M, 2013, P NATL ACAD SCI USA, V110, P18185, DOI 10.1073/pnas.1305372110; Shrestha RK, 2010, AM J POTATO RES, V87, P229, DOI 10.1007/s12230-010-9131-x; SPALDING RF, 1993, J ENVIRON QUAL, V22, P392, DOI 10.2134/jeq1993.00472425002200030002x; St'astna M, 2010, AGR WATER MANAGE, V97, P286, DOI 10.1016/j.agwat.2009.09.015; Suwannee River Water Management District (SRWMD), 2005, MFL EST LOW SUW RIV; TANNER CB, 1982, AM POTATO J, V59, P107, DOI 10.1007/BF02866365; Travasso MI, 1996, POTATO RES, V39, P305, DOI 10.1007/BF02360922; U.S. Environmental Protection Agency, 2005, PROT WAT QUAL AGR RU; United States Department of Agriculture/Natural Resources Conservation Service (USDA/NRCS), 2013, FLOR SOILS INF ONL S; Unlu K, 1999, EUR J SOIL SCI, V50, P609, DOI 10.1046/j.1365-2389.1999.00260.x; Upchurch SB, 2007, TRENDS NITRATE CONCE; USDA, 2011, US STAND GRAD POT; Verhagen J, 1997, AGR ECOSYST ENVIRON, V66, P165, DOI 10.1016/S0167-8809(97)00086-8; Vos J, 1997, POTATO RES, V40, P237, DOI 10.1007/BF02358249; WALLACH D, 1987, BIOMETRICS, V43, P561, DOI 10.2307/2531995; WILLMOTT CJ, 1982, B AM METEOROL SOC, V63, P1309, DOI 10.1175/1520-0477(1982)063<1309:SCOTEO>2.0.CO;2	68	23	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0117891	10.1371/journal.pone.0117891	http://dx.doi.org/10.1371/journal.pone.0117891			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25635904	Green Published, Green Submitted, gold			2022-12-26	WOS:000350680700105
J	Watson, DM; Anderson, SE; Olson, V				Watson, David M.; Anderson, Susan E.; Olson, Valerie		Inst Land Water & Soc	Reassessing Breeding Investment in Birds: Class-Wide Analysis of Clutch Volume Reveals a Single Outlying Family	PLOS ONE			English	Article							OPTIMAL EGG SIZE; LIFE-HISTORY; GEOGRAPHIC-VARIATION; BODY SIZE; DIVERSIFICATION; EVOLUTION; WEIGHT; MASS; ENVIRONMENT; PHYLOGENY	Reproductive investment is typically considered in terms of size and number of propagules produced. Compared with a thorough understanding of the overall patterns and ecological correlates of avian clutch size, egg size has received less attention and the total effort invested in laying a clutch of eggs is rarely considered. We used clutch volume as an alternative estimate of reproductive investment and present the first class-level analysis of clutch volume in birds using 1,364 randomly-selected species in 204 families. The relationship between body mass and egg volume was very strong (r(2) = 0.946), validating previous studies identifying four families (Apterygidae, Pelecanoidiididae, Sternidae and Dromadidiae) with disproportionately large eggs. Clutch volume was also closely related to body mass (r(2) = 0.909) and all but one of the taxa with disproportionately large eggs conformed to the overall relationship, their greater egg dimensions compensated by diminished clutch size. The only family which departed significantly from the relationship between body mass and clutch volume was the mound builders (Megapodiidae)-the only group of birds that do not rely on body heat for incubation. Although previously known for laying large clutches of large eggs containing disproportionately large yolks, the remarkable investment of megapodes in reproduction (more than seven times greater than other birds of comparable mass) has been hitherto overlooked. We consider the evolutionary basis and ecological implications of this finding, suggesting that energetic costs associated with incubation act as an upper limit on reproductive output of other birds. We recommend clutch volume as a sensitive, fine-grained measure of reproductive effort for research at a wide range of scales and advocate further analysis of ecological correlates of clutch volume in birds and amniotes generally.	[Watson, David M.; Anderson, Susan E.] Charles Sturt Univ, Albury, NSW, Australia; [Olson, Valerie] Zool Soc London, London, England	Charles Sturt University; Zoological Society of London	Watson, DM (corresponding author), Charles Sturt Univ, Albury, NSW, Australia.	dwatson@csu.edu.au		David, Watson/0000-0003-1821-4632	Australian Research Council; NERC	Australian Research Council(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	DMW acknowledges the support of the Australian Research Council, and VO was supported by a NERC research grant awarded to Dr Tamas Szekely. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 2002, THESIS C STURT U; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; BENNETT PM, 2002, EVOLUTIONARY ECOLOGY; Bernardo J, 1996, AM ZOOL, V36, P216; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Booth DT, 1988, MEGAPODE NEWSLETTER, V2, P13; Brooke MD, 1999, P ROY SOC B-BIOL SCI, V266, P405, DOI 10.1098/rspb.1999.0652; CALDER WA, 1979, BIOSCIENCE, V29, P461, DOI 10.2307/1307538; Christensen VL, 1996, POULTRY SCI, V75, P1404, DOI 10.3382/ps.0751404; CRACRAFT J, 1974, IBIS, V116, P494, DOI 10.1111/j.1474-919X.1974.tb07648.x; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; D'Alba L, 2014, J EXP BIOL, V217, P1116, DOI 10.1242/jeb.098343; Dickinson EC., 2003, HOWARD MOORE COMPLET; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; FORD NB, 1989, HERPETOLOGICA, V45, P75; Heinroth O., 1922, Journal fuer Ornithologie Leipzig, V70, P172, DOI 10.1007/BF02537515; HOYT DF, 1976, CONDOR, V78, P343, DOI 10.2307/1367694; HOYT DF, 1979, AUK, V96, P73; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; JOHNSGARD P. A., 1997, AVIAN BROOD PARASITE; Jones D. N., 1995, THE MEGAPODES; KLOMP H, 1970, ARDEA, V58, P1; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; LACK D, 1948, IBIS, V90, P25, DOI 10.1111/j.1474-919X.1948.tb01399.x; Ligon JD, 1999, EVOLUTION AVIAN BREE; Lovich JE, 2012, AMPHIBIA-REPTILIA, V33, P161, DOI 10.1163/156853812X634035; Martin TE, 2006, EVOLUTION, V60, P390; Martin TE, 2004, AUK, V121, P289, DOI 10.1642/0004-8038(2004)121[0289:ALEHAE]2.0.CO;2; MOREAU R. E., 1944, IBIS, V86, P286, DOI 10.1111/j.1474-919X.1944.tb04093.x; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Nealen PM, 2001, J ZOOL, V253, P391, DOI 10.1017/S095283690100036X; OLSEN PD, 1994, AUST J ZOOL, V42, P307, DOI 10.1071/ZO9940307; OLSEN PD, 1994, AUST J ZOOL, V42, P323, DOI 10.1071/ZO9940323; OWENS IPF, 1995, P ROY SOC B-BIOL SCI, V261, P227, DOI 10.1098/rspb.1995.0141; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Potti J, 1999, EVOLUTION, V53, P279, DOI 10.1111/j.1558-5646.1999.tb05353.x; PRESTON FW, 1974, AUK, V91, P132, DOI 10.2307/4084667; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; RAHN H, 1975, AUK, V92, P750, DOI 10.2307/4084786; Ramos JA, 2001, IBIS, V143, P83, DOI 10.1111/j.1474-919X.2001.tb04172.x; RAYNER JMV, 1985, J ZOOL, V206, P415; SAETHER BE, 1987, OIKOS, V48, P79, DOI 10.2307/3565691; Schonwetter M, 1960, HDB OOLOGIE HERAU SG; SEIM E, 1983, J THEOR BIOL, V104, P161, DOI 10.1016/0022-5193(83)90408-3; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Spencer RJ, 2001, OIKOS, V93, P401, DOI 10.1034/j.1600-0706.2001.930305.x; Wang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064312; Wojczulanis-Jakubas K, 2014, AUK, V131, P743, DOI 10.1642/AUK-14-62.1; [No title captured]; [No title captured]	52	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0117678	10.1371/journal.pone.0117678	http://dx.doi.org/10.1371/journal.pone.0117678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	25633998	Green Submitted, Green Published, gold			2022-12-26	WOS:000348609800013
J	Mokhtari, M; Abd Ghaffar, M; Usup, G; Cob, ZC				Mokhtari, Mohammad; Abd Ghaffar, Mazlan; Usup, Gires; Cob, Zaidi Che			Determination of Key Environmental Factors Responsible for Distribution Patterns of Fiddler Crabs in a Tropical Mangrove Ecosystem	PLOS ONE			English	Article							UCA-PUGNAX SMITH; TRACE-METALS; GENUS UCA; SPATIAL-DISTRIBUTION; HUMIC SUBSTANCES; SEDIMENTS; SULFIDES	In tropical regions, different species of fiddler crabs coexist on the mangrove floor, which sometimes makes it difficult to define species-specific habitat by visual inspection. The aim of this study is to find key environmental parameters which affect the distribution of fiddler crabs and to determine the habitats in which each species was most abundant. Crabs were collected from 19 sites within the mudflats of Sepang-Lukut mangrove forest. Temperature, porewater salinity, organic matter, water content, carbon and nitrogen content, porosity, chlorophyll content, pH, redox potential, sediment texture and heavy metals were determined in each 1 m(2) quadrate. Pearson correlation indicated that all sediment properties except pH and redox potential were correlated with sediment grain size. Canonical correspondence analysis (CCA) indicated that Uca paradussumieri was negatively correlated with salinity and redox potential. Sand dwelling species, Uca perplexa and Uca annulipes, were highly dependent on the abundance of 250 mu m and 150 mu m grain size particles in the sediment. Canonical Discriminative Analysis (CDA) indicated that variation in sediment grain size best explained where each crab species was most abundant. Moreover, U. paradussumieri commonly occupies muddy substrates of low shore, while U. forcipata lives under the shade of mangrove trees. U. annulipes and U. perplexa with the high number of spoon tipped setae on their second maxiliped are specialized to feed on the sandy sediments. U. rosea and U. triangularis are more common on muddy sediment with high sediment density. In conclusion, sediment grain size that influences most sediment properties acts as a main factor responsible for sediment heterogeneity. In this paper, the correlation between fiddler crab species and environmental parameters, as well as the interaction between sediment characteristics, was explained in order to define the important environmental factors in fiddler crab distributions.	[Mokhtari, Mohammad] Natl Univ Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Ukm Bangi 43600, Selangor, Malaysia; [Abd Ghaffar, Mazlan; Usup, Gires; Cob, Zaidi Che] Natl Univ Malaysia, Fac Sci & Technol, Marine Ecosyst Res Ctr, Ukm Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Cob, ZC (corresponding author), Natl Univ Malaysia, Fac Sci & Technol, Marine Ecosyst Res Ctr, Ukm Bangi 43600, Selangor, Malaysia.	zaidicob@gmail.com	GHAFFAR, MAZLAN ABD/O-3604-2016; Cob, Zaidi Che/E-9498-2016	GHAFFAR, MAZLAN ABD/0000-0001-9248-5284; 	National University of Malaysia [UKM-GUP-2011-200]	National University of Malaysia	This research was financially supported by National University of Malaysia (grant no: UKM-GUP-2011-200 to ZCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Bezerra LEA, 2006, SCI MAR, V70, P759, DOI 10.3989/scimar.2006.70n4759; Backwell PRY, 1998, ANIM BEHAV, V55, P1659, DOI 10.1006/anbe.1997.0713; Bale A.J., 2005, METHODS STUDY MARINE, V3, P43, DOI DOI 10.1002/9780470995129.CH2; BERTNESS MD, 1984, J EXP MAR BIOL ECOL, V83, P211, DOI 10.1016/S0022-0981(84)80002-7; CALMANO W, 1993, WATER SCI TECHNOL, V28, P223, DOI 10.2166/wst.1993.0622; Clark MW, 1998, CHEM GEOL, V149, P147, DOI 10.1016/S0009-2541(98)00034-5; Clark MW, 1997, J COASTAL RES, V13, P1050; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cooper DC, 1999, AQUAT GEOCHEM, V5, P87, DOI 10.1023/A:1009672022351; Costa TM., 2001, NAUPLIUS, V9, P123; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; DYE AH, 1986, MAR ECOL PROG SER, V32, P259, DOI 10.3354/meps032259; EDNEY EB, 1962, BIOMETEOROLOGY, P79; Edney EB., 1961, T ROY SOC S AFR, V36, P71, DOI [10.1080/00359196109519035, DOI 10.1080/00359196109519035]; HARBISON P, 1986, MAR POLLUT BULL, V17, P246, DOI 10.1016/0025-326X(86)90057-3; Hogarth, 2008, BIOL MANGROVES SEAGR; Horowitz A.J., 1987, APPL GEOCHEM, V2, P437, DOI 10.1016/0883-2927(87)90027-8; HUERTADIAZ MA, 1992, GEOCHIM COSMOCHIM AC, V56, P2681, DOI 10.1016/0016-7037(92)90353-K; ICELY JD, 1978, ESTUAR COAST MAR SCI, V6, P315, DOI 10.1016/0302-3524(78)90019-1; JORGENSEN BB, 1979, APPL ENVIRON MICROB, V38, P46; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; LU JCS, 1977, ENVIRON SCI TECHNOL, V11, P174, DOI 10.1021/es60125a004; Machado W, 2008, J COASTAL RES, V24, P25, DOI 10.2112/06-0736.1; Macintosh D.J., 1982, P243; Macintosh D. J., 1977, PHYSL BEHAV MARINE O, P49; MACINTOSH DJ, 1988, S ZOOL SOC LOND, V59, P315; Macintosh DJ, 1979, THESIS U MALAYA; Marchand C, 2011, GEODERMA, V160, P444, DOI 10.1016/j.geoderma.2010.10.015; MOORE JN, 1989, ENVIRON GEOL WATER S, V14, P107, DOI 10.1007/BF01728502; NISSENBAUM A, 1976, GEOCHIM COSMOCHIM AC, V40, P809, DOI 10.1016/0016-7037(76)90033-8; NISSENBAUM A, 1972, LIMNOL OCEANOGR, V17, P570, DOI 10.4319/lo.1972.17.4.0570; OCONNOR NJ, 1990, J CRUSTACEAN BIOL, V10, P608, DOI 10.2307/1548404; Passino, 1987, METALS SPECIATION SE, P27; Ray AK, 2006, ENVIRON INT, V32, P219, DOI 10.1016/j.envint.2005.08.014; Ribeiro PD, 2005, J EXP MAR BIOL ECOL, V314, P99, DOI 10.1016/j.jembe.2004.09.014; Rosenberg MS, 2001, J CRUSTACEAN BIOL, V21, P839, DOI 10.1651/0278-0372(2001)021[0839:TSATOF]2.0.CO;2; StatSoft, 2011, EL STAT TXB, DOI [10.1080/17437199.2011.587961, DOI 10.1080/17437199.2011.587961]; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Stevenson F J., 1985, MICRONUTRIENTS AGR, P145; TAN CGS, 1994, HYDROBIOLOGIA, V285, P75, DOI 10.1007/BF00005655; TEAL JM, 1958, ECOLOGY, V39, P185, DOI 10.2307/1931862; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; WEISSBURG M, 1992, J EXP MAR BIOL ECOL, V156, P105, DOI 10.1016/0022-0981(92)90019-7	46	24	26	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117467	10.1371/journal.pone.0117467	http://dx.doi.org/10.1371/journal.pone.0117467			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629519	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100084
J	Sroga, GE; Wu, PC; Vashishth, D				Sroga, Grazyna E.; Wu, Ping-Cheng; Vashishth, Deepak			Insulin-Like Growth Factor 1, Glycation and Bone Fragility: Implications for Fracture Resistance of Bone	PLOS ONE			English	Article							FACTOR-I; CROSS-LINKING; LYSYL OXIDASE; BIOMECHANICAL PROPERTIES; NONENZYMATIC GLYCATION; EXTRACELLULAR-MATRIX; MAILLARD PROCESSES; LEUCINE KINETICS; GLUCOSE LEVELS; CORTICAL BONE	Despite our extensive knowledge of insulin-like growth factor 1 (IGF1) action on the growing skeleton, its role in skeletal homeostasis during aging and age-related development of certain diseases is still unclear. Advanced glycation end products (AGEs) derived from glucose are implicated in osteoporosis and a number of diabetic complications. We hypothesized that because in humans and rodents IGF1 stimulates uptake of glucose (a glycation substrate) from the bloodstream in a dose-dependent manner, the decline of IGF1 could be associated with the accumulation of glycation products and the decreasing resistance of bone to fracture. To test the aforementioned hypotheses, we used human tibial posterior cortex bone samples to perform biochemical (measurement of IGF1, fluorescent AGEs and pentosidine (PEN) contents) and mechanical tests (crack initiation and propagation using compact tension specimens). Our results for the first time show a significant, age-independent association between the levels of IGF1 and AGEs. Furthermore, AGEs (fAGEs, PEN) predict propensity of bone to fracture (initiation and propagation) independently of age in human cortical bone. Based on these results we propose a model of IGF1-based regulation of bone fracture. Because IGF1 level increases postnatally up to the juvenile developmental phase and decreases thereafter with aging, we propose that IGF1 may play a protective role in young skeleton and its age-related decline leads to bone fragility and an increased fracture risk. Our results may also have important implications for current understanding of osteoporosis-and diabetes-related bone fragility as well as in the development of new diagnostic tools to screen for fragile bones.	[Vashishth, Deepak] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Vashishth, D (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.	vashid@rpi.edu		Vashishth, Deepak/0000-0001-5712-0167	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH) [AG20618]; NIH [5 U42 RR006042]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG020618, R01AG020618] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health (NIH), under award number AG20618. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors acknowledge use of human bone tissues provided by the National Disease Research Interchange (NDRI) with support from NIH grant 5 U42 RR006042 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery NC, 2005, SCAND J MED SCI SPOR, V15, P231, DOI 10.1111/j.1600-0838.2005.00464.x; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; BAUTISTA CM, 1990, METABOLISM, V39, P96, DOI 10.1016/0026-0495(90)90154-5; Biemel KM, 2001, J BIOL CHEM, V276, P23405, DOI 10.1074/jbc.M102035200; Booth SL, 2013, NAT REV ENDOCRINOL, V9, P43, DOI 10.1038/nrendo.2012.201; BOULWARE SD, 1994, J CLIN INVEST, V93, P1131, DOI 10.1172/JCI117065; Chronopoulos A, 2010, DIABETES, V59, P3159, DOI 10.2337/db10-0365; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; ELAHI D, 1993, AM J PHYSIOL, V265, pE831, DOI 10.1152/ajpendo.1993.265.6.E831; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Frystyk J, 2010, GROWTH HORM IGF RES, V20, P8, DOI 10.1016/j.ghir.2009.09.004; Fulzele K, 2012, BONE, V50, P452, DOI 10.1016/j.bone.2011.06.018; Garnero P, 2000, LANCET, V355, P898, DOI 10.1016/S0140-6736(99)05463-X; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; GULER HP, 1987, NEW ENGL J MED, V317, P137, DOI 10.1056/NEJM198707163170303; Hernandez CJ, 2005, BONE, V37, P825, DOI 10.1016/j.bone.2005.07.019; HOCK JM, 1988, ENDOCRINOLOGY, V122, P254, DOI 10.1210/endo-122-1-254; JACOB R, 1989, J CLIN INVEST, V83, P1717, DOI 10.1172/JCI114072; Karim L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035047; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Ko GTC, 2006, CROAT MED J, V47, P709; LAAGER R, 1993, J CLIN INVEST, V92, P1903, DOI 10.1172/JCI116783; Langlois JA, 1998, J CLIN ENDOCR METAB, V83, P4257, DOI 10.1210/jc.83.12.4257; Lederer MO, 1999, BIOORGAN MED CHEM, V7, P1081, DOI 10.1016/S0968-0896(99)00040-1; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leslie WD, 2012, J BONE MINER RES, V27, P2231, DOI 10.1002/jbmr.1759; Moxley RT, AM J PHYSL, V259, pE561; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Nakamura K, 1997, BIOCHEM BIOPH RES CO, V232, P227, DOI 10.1006/bbrc.1997.6262; NICOLAS V, 1994, J CLIN ENDOCR METAB, V78, P1011, DOI 10.1210/jc.78.5.1011; Ohlsson C, 2011, J BONE MINER RES, V26, P865, DOI 10.1002/jbmr.281; OSULLIVAN JB, 1974, DIABETES, V23, P713, DOI 10.2337/diab.23.8.713; Poundarik AA, 2012, P NATL ACAD SCI USA, V109, P19178, DOI 10.1073/pnas.1201513109; Reiser K, 1996, AM J PHYSIOL-REG I, V271, pR696, DOI 10.1152/ajpregu.1996.271.3.R696; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; Schwartz AV, 2009, J CLIN ENDOCR METAB, V94, P2380, DOI 10.1210/jc.2008-2498; Seck T, 1998, J CLIN ENDOCR METAB, V83, P2331, DOI 10.1210/jc.83.7.2331; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; SRAWLEY JE, 1976, INT J FRACTURE, V12, P475; Sroga GE, 2012, CURR OSTEOPOROS REP, V10, P141, DOI 10.1007/s11914-012-0103-6; Sroga GE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006718; Sroga GE, 2011, J CHROMATOGR B, V879, P379, DOI 10.1016/j.jchromb.2010.12.024; Trackman PC, 1998, HISTOCHEM CELL BIOL, V110, P9, DOI 10.1007/s004180050259; TURKALJ I, 1992, J CLIN ENDOCR METAB, V75, P1186, DOI 10.1210/jc.75.5.1186; Vandenput L, 2012, FRONTIERS ENDOCRINOL, V3, P1, DOI [10.3389/fendo.2012.00001, DOI 10.3389/FENDO.2012.00001]; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Vashishth D, 2004, J BIOMECH, V37, P943, DOI 10.1016/j.jbiomech.2003.11.003; Viguet-Carrin S, 2009, J CHROMATOGR B, V877, P1, DOI 10.1016/j.jchromb.2008.10.043; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Viguet-Carrin S, 2006, BONE, V39, P1073, DOI 10.1016/j.bone.2006.05.013; Yashin AI, 2009, MECH AGEING DEV, V130, P611, DOI 10.1016/j.mad.2009.07.004; ZAPF J, 1986, J CLIN INVEST, V77, P1768, DOI 10.1172/JCI112500; Zimmermann EA, 2010, BIOMATERIALS, V31, P5297, DOI 10.1016/j.biomaterials.2010.03.056	56	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2015	10	1							e0117046	10.1371/journal.pone.0117046	http://dx.doi.org/10.1371/journal.pone.0117046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA2IM	25629402	Green Published, Green Submitted, gold			2022-12-26	WOS:000348732100059
J	Bonanomi, G; Incerti, G; Cesarano, G; Gaglione, SA; Lanzotti, V				Bonanomi, Giuliano; Incerti, Guido; Cesarano, Gaspare; Gaglione, Salvatore A.; Lanzotti, Virginia			Cigarette Butt Decomposition and Associated Chemical Changes Assessed by C-13 CPMAS NMR	PLOS ONE			English	Article							PLANT LITTER DECOMPOSITION; TEMPERATURE SENSITIVITY; DIVERSITY; NITROGEN; SOIL; DEGRADATION; ECOSYSTEMS; TOXICITY; CLIMATE; LIGNIN	Cigarette butts (CBs) are the most common type of litter on earth, with an estimated 4.5 trillion discarded annually. Apart from being unsightly, CBs pose a serious threat to living organisms and ecosystem health when discarded in the environment because they are toxic to microbes, insects, fish and mammals. In spite of the CB toxic hazard, no studies have addressed the effects of environmental conditions on CB decomposition rate. In this study we investigate the interactive effects of substrate fertility and N transfer dynamics on CB decomposition rate and carbon quality changes. We carried out an experiment using smoked CBs and wood sticks, used as a slow decomposing standard organic substrate, incubated in both laboratory and field conditions for two years. CB carbon quality changes during decomposition was assessed by C-13 CPMAS NMR. Our experiment confirmed the low degradation rate of CBs which, on average, lost only 37.8% of their initial mass after two years of decomposition. Although a net N transfer occurred from soil to CBs, contrary to our hypothesis, mass loss in the medium-term (two years) was unaffected by N availability in the surrounding substrate. The opposite held for wood sticks, in agreement with the model that N-rich substrates promote the decomposition of other N-poor natural organic materials with a high C/N ratio. As regards CB chemical quality, after two years of decomposition C-13 NMR spectroscopy highlighted very small changes in C quality that are likely to reflect a limited microbial attack.	[Bonanomi, Giuliano; Incerti, Guido; Cesarano, Gaspare; Gaglione, Salvatore A.; Lanzotti, Virginia] Univ Naples Federico II, Dipartimento Agr, Portici, NA, Italy	University of Naples Federico II	Bonanomi, G (corresponding author), Univ Naples Federico II, Dipartimento Agr, Via Univ 100, Portici, NA, Italy.	giuliano.bonanomi@unina.it	Incerti, Guido/O-5870-2019; Incerti, Guido/B-5106-2017	Incerti, Guido/0000-0003-1288-8708; Incerti, Guido/0000-0003-1288-8708; BONANOMI, Giuliano/0000-0002-1831-4361				Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Almendros G, 2000, SOIL BIOL BIOCHEM, V32, P793, DOI 10.1016/S0038-0717(99)00202-3; Altaner C, 2003, CELLULOSE, V10, P85, DOI 10.1023/A:1023010330865; Ariza E, 2008, WASTE MANAGE, V28, P2604, DOI 10.1016/j.wasman.2007.11.012; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Berglund SL, 2012, OIKOS, V121, P1112, DOI 10.1111/j.1600-0706.2011.19787.x; Bonanomi G, 2014, PLANT SOIL, V381, P307, DOI 10.1007/s11104-014-2119-4; Bonanomi G, 2013, SOIL BIOL BIOCHEM, V56, P40, DOI 10.1016/j.soilbio.2012.03.003; Bonanomi G, 2011, NEW PHYTOL, V191, P1018, DOI 10.1111/j.1469-8137.2011.03765.x; Breitmaier E., 1987, CARBON 13 NMR SPECTR; *CIG LITT ORG, 2001, THE AWFUL TRUTH ABOU; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dieng H, 2013, ACTA TROP, V128, P584, DOI 10.1016/j.actatropica.2013.08.013; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gillon D, 1999, ECOLOGY, V80, P175, DOI 10.1890/0012-9658(1999)080[0175:CLDBPB]2.0.CO;2; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; HAYNES SK, 1991, EASTMAN CHEMICAL CUS; Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3; Hoffmann D, 1997, J TOXICOL ENV HEALTH, V50, P307, DOI 10.1080/009841097160393; Huang Y, 1998, SOIL BIOL BIOCHEM, V30, P1517, DOI 10.1016/S0038-0717(97)00234-4; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Incerti G, 2011, APPL SOIL ECOL, V49, P148, DOI 10.1016/j.apsoil.2011.06.004; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; LUKE JA, 1991, DEGRADABILITY OF FIL; Micevska T, 2006, ARCH ENVIRON CON TOX, V50, P205, DOI 10.1007/s00244-004-0132-y; Novotny TE, 2011, TOB CONTROL, V20, pI17, DOI 10.1136/tc.2011.043489; Novotny TE, 2009, INT J ENV RES PUB HE, V6, P1691, DOI 10.3390/ijerph6051691; *OC CONS, 2007, INTERNATIONAL COASTA; Pane C, 2011, BIOL CONTROL, V56, P115, DOI 10.1016/j.biocontrol.2010.10.002; Preston CM, 2009, ECOSYSTEMS, V12, P1078, DOI 10.1007/s10021-009-9267-z; Puls J, 2011, J POLYM ENVIRON, V19, P152, DOI 10.1007/s10924-010-0258-0; Robertson RM, 2012, GREEN CHEM, V14, P2266, DOI 10.1039/c2gc16635f; Rustemeyer P, 2004, MACROMOL SYMP, V208, P267, DOI 10.1002/masy.200450411; Slaughter E, 2011, TOB CONTROL, V20, pI25, DOI 10.1136/tc.2010.040170; Suarez-Rodriguez M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0931; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wardle DA, 2006, SOIL BIOL BIOCHEM, V38, P1052, DOI 10.1016/j.soilbio.2005.09.003; Wilson M., 2005, MICROBIAL INHABITANT	43	43	44	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0117393	10.1371/journal.pone.0117393	http://dx.doi.org/10.1371/journal.pone.0117393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625643	Green Submitted, Green Published, gold			2022-12-26	WOS:000348821400033
J	Kesters, D; Brams, M; Nys, M; Wijckmans, E; Spurny, R; Voets, T; Tytgat, J; Kusch, J; Ulens, C				Kesters, Divya; Brams, Marijke; Nys, Mieke; Wijckmans, Eveline; Spurny, Radovan; Voets, Thomas; Tytgat, Jan; Kusch, Jana; Ulens, Chris			Structure of the SthK Carboxy-Terminal Region Reveals a Gating Mechanism for Cyclic Nucleotide-Modulated Ion Channels	PLOS ONE			English	Article							MOLECULAR-MECHANISM; BINDING DOMAIN; REARRANGEMENTS; TRANSITION; DYNAMICS; FAMILY	Cyclic nucleotide-sensitive ion channels are molecular pores that open in response to cAMP or cGMP, which are universal second messengers. Binding of a cyclic nucleotide to the carboxyterminal cyclic nucleotide binding domain (CNBD) of these channels is thought to cause a conformational change that promotes channel opening. The C-linker domain, which connects the channel pore to this CNBD, plays an important role in coupling ligand binding to channel opening. Current structural insight into this mechanism mainly derives from X-ray crystal structures of the C-linker/CNBD from hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels. However, these structures reveal little to no conformational changes upon comparison of the ligand-bound and unbound form. In this study, we take advantage of a recently identified prokaryote ion channel, SthK, which has functional properties that strongly resemble cyclic nucleotide-gated (CNG) channels and is activated by cAMP, but not by cGMP. We determined X-ray crystal structures of the C-linker/CNBD of SthK in the presence of cAMP or cGMP. We observe that the structure in complex with cGMP, which is an antagonist, is similar to previously determined HCN channel structures. In contrast, the structure in complex with cAMP, which is an agonist, is in a more open conformation. We observe that the CNBD makes an outward swinging movement, which is accompanied by an opening of the C-linker. This conformation mirrors the open gate structures of the K(v)1.2 channel or MthK channel, which suggests that the cAMP-bound C-linker/CNBD from SthK represents an activated conformation. These results provide a structural framework for better understanding cyclic nucleotide modulation of ion channels, including HCN and CNG channels.	[Kesters, Divya; Brams, Marijke; Nys, Mieke; Wijckmans, Eveline; Spurny, Radovan; Ulens, Chris] Katholieke Univ Leuven, Lab Struct Neurobiol, B-3000 Leuven, Belgium; [Voets, Thomas] Katholieke Univ Leuven, Lab Ion Channel Res, B-3000 Leuven, Belgium; [Tytgat, Jan] Katholieke Univ Leuven, Lab Toxicol & Pharmacol, B-3000 Leuven, Belgium; [Kusch, Jana] Univ Hosp Jena, Inst Physiol 2, D-07743 Jena, Germany	KU Leuven; KU Leuven; KU Leuven; Friedrich Schiller University of Jena	Ulens, C (corresponding author), Katholieke Univ Leuven, Lab Struct Neurobiol, Herestraat 49,PB601, B-3000 Leuven, Belgium.	chris.ulens@med.kuleuven.be	Nys, Mieke/AAC-2859-2019; Voets, Thomas/E-2466-2012; Voets, Thomas/AAD-4389-2019; Kusch, Jana/ABC-9738-2020	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Kusch, Jana/0000-0001-7206-8133; Tytgat, Jan/0000-0003-1778-6022; Nys, Mieke/0000-0003-3976-8538	FWO-Vlaanderen [G.0743.10, G.0939.11, G.0762.13, OT/13/095]	FWO-Vlaanderen(FWO)	Financial support was from FWO-Vlaanderen G.0743.10, G.0939.11, G.0762.13 and Onderzoekstoelage OT/13/095 to CU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altieri SL, 2008, J MOL BIOL, V381, P655, DOI 10.1016/j.jmb.2008.06.011; Baruscotti M, 2004, ANN NY ACAD SCI, V1015, P111, DOI 10.1196/annals.1302.009; Brams M, 2014, P NATL ACAD SCI USA, V111, P7855, DOI 10.1073/pnas.1401917111; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; PULJUNG MC, 2014, P NATL ACAD SCI, P42331; Puljung MC, 2013, J BIOL CHEM, V288, P12944, DOI 10.1074/jbc.M113.464123; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Schunke S, 2009, EMBO REP, V10, P729, DOI 10.1038/embor.2009.68; SCHUNKE S, 2011, P NATL ACAD SCI US, P42331; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Taraska JW, 2007, NAT STRUCT MOL BIOL, V14, P854, DOI 10.1038/nsmb1281; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	33	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2015	10	1							e0116369	10.1371/journal.pone.0116369	http://dx.doi.org/10.1371/journal.pone.0116369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QM	25625648	Green Published, Green Submitted, gold			2022-12-26	WOS:000348821400014
J	Hasebe, Y; Yamamoto, H; Fukuda, K; Nishimiya, K; Hanawa, K; Shindo, T; Kondo, M; Nakano, M; Wakayama, Y; Takayama, K; Shimokawa, H				Hasebe, Yuhi; Yamamoto, Hiroaki; Fukuda, Koji; Nishimiya, Kensuke; Hanawa, Kenichiro; Shindo, Tomohiko; Kondo, Masateru; Nakano, Makoto; Wakayama, Yuji; Takayama, Kazuyoshi; Shimokawa, Hiroaki			Development of a Novel Shock Wave Catheter Ablation System - The First Feasibility Study in Pigs	PLOS ONE			English	Article							RECURRENT VENTRICULAR-TACHYCARDIA; RADIOFREQUENCY ABLATION; ATRIAL-FIBRILLATION; NONISCHEMIC CARDIOMYOPATHY; LESION FORMATION; THERAPY; RISK; DEFIBRILLATOR; COMPLICATIONS; TEMPERATURE	Introduction Radio-frequency catheter ablation (RFCA) using Joule heat has two fundamental weaknesses: the limited depth of treatment and the risk of thrombus formation. In contrast, focused shock wave (SW) therapy could damage tissues at arbitrary depths without heat generation. Thus, we aimed to develop a SWcatheter ablation (SWCA) system that could compensate for the weaknesses of RFCA therapy. Methods and Results We developed a SWCA system where the SW generated by a Q-switched Holmium: yttrium aluminum garnet (YAG) laser beam was reflected by a reflector attached to 14-Fr catheter tip and then was converged onto the focus. We examined the feasibility of our system on pigs in vivo. When applied using the epicardial approach, the SWCA caused persistent spheroidal lesions with mild superficial injury than the RFCA. The lesions were created to a depth based on the focal length (2.0 mm) [2.36 +/- 0.45 (SD) mm immediately after procedure, n = 16]. When applied to the atrioventricular (AV) node using the endocardial approach, the SWCA caused junctional escape rhythms in 2 pigs and AV block in 12 pigs (complete AV block in 9) in acute phase (n = 14). Nine of the 14 pigs survived with pacemakers for the long-term study, and the AV block persisted for 12.6 +/- 3.9 (SD) days in all surviving pigs. Histological examination showed AV nodal cell body atrophy in the acute phase and fibrotic lesions in the chronic phase. Importantly, no acute or chronic fatal complications were noted. Conclusions Our novel SWCA system could be a promising modality as a non-thermal ablation method to compensate for the weaknesses of RFCA therapy. However, further research and development will be necessary as the current prototype still exhibited the presence of micro-thrombus formation in the animal studies.	[Hasebe, Yuhi; Fukuda, Koji; Nishimiya, Kensuke; Hanawa, Kenichiro; Shindo, Tomohiko; Kondo, Masateru; Nakano, Makoto; Wakayama, Yuji; Takayama, Kazuyoshi; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Yamamoto, Hiroaki; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Adv Cardiovasc Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Shimokawa, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan.	shimo@cardio.med.tohoku.ac.jp	Santos-Gomes, G/J-2367-2019; Lago, Joao/W-5238-2019; Fukuda, Koji/AAP-5927-2021; Passero, Luiz Felipe D/B-9549-2012; Laurenti, Marcia Dalastra/C-4734-2012; Santos-Gomes, Gabriela/I-2391-2012; Levy, Debora/G-8208-2014	Lago, Joao/0000-0002-1193-8374; Passero, Luiz Felipe D/0000-0002-5986-6381; FUKUDA, KOJI/0000-0001-7209-8420; Levy, Debora/0000-0001-7492-997X; Santos-Gomes, Gabriela/0000-0001-9264-3887; Yamamoto, Eduardo/0000-0003-2375-6081; Kallas, Esper/0000-0003-2026-6925; Shimokawa, Hiroaki/0000-0001-7534-4826; Rafael-Fernandes, Mariana/0000-0002-5214-7667; Silva, Marcelo/0000-0002-1000-0149; Laurenti, Marcia Dalastra/0000-0002-1080-2440	Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan; Japan Science and Technology Agency, Tokyo, Japan [AS2313010F]	Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency, Tokyo, Japan(Japan Science & Technology Agency (JST))	The authors had no disclosure for this work. This work was supported in part by the grants-in- aid for Medical Equipment Development and Promotion Research Project (H20-Activity-General-002) from the Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan and the grants- in- aid for Adaptable and Seamless Technology transfer Program (A- STEP) through target-driven R& D (AS2313010F) from Japan Science and Technology Agency, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; DELIUS M, 1987, ULTRASOUND MED BIOL, V13, P61, DOI 10.1016/0301-5629(87)90075-5; Dukkipati SR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P185, DOI 10.1161/CIRCEP.110.957290; EVAN AP, 1991, AM J KIDNEY DIS, V17, P445, DOI 10.1016/S0272-6386(12)80639-1; Evan AP, 1998, NEPHRON, V78, P1, DOI 10.1159/000044874; Fenelon G, 2006, J INTERV CARD ELECTR, V15, P57, DOI 10.1007/s10840-006-7620-0; Gaita F, 2010, CIRCULATION, V122, P1667, DOI 10.1161/CIRCULATIONAHA.110.937953; Haqqani HM, 2011, HEART RHYTHM, V8, P1169, DOI 10.1016/j.hrthm.2011.03.008; Hohnloser SH, 2006, EUR HEART J, V27, P3027, DOI 10.1093/eurheartj/ehl276; Hsia HH, 2003, CIRCULATION, V108, P704, DOI 10.1161/01.CIR.0000083725.72693.EA; JACKMAN WM, 1992, NEW ENGL J MED, V327, P313, DOI 10.1056/NEJM199207303270504; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Keane D, 2005, J CARDIOVASC ELECTR, V16, P1025, DOI 10.1111/j.1540-8167.2005.00270.x; Khairy P, 2003, CIRCULATION, V107, P2045, DOI 10.1161/01.CIR.0000058706.82623.A1; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; Koruth JS, 2012, HEART RHYTHM, V9, P1932, DOI 10.1016/j.hrthm.2012.08.001; KUWAHARA MA, 1987, J UROLOGY, V137, P837, DOI 10.1016/S0022-5347(17)44268-6; Matlaga BR, 2008, J ENDOUROL, V22, P121, DOI 10.1089/end.2007.9852; MAYER R, 1990, J UROLOGY, V144, P1505, DOI 10.1016/S0022-5347(17)39787-2; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; NAKAGAWA H, 1995, CIRCULATION, V91, P2264, DOI 10.1161/01.CIR.91.8.2264; Nakahara S, 2010, J AM COLL CARDIOL, V55, P2355, DOI 10.1016/j.jacc.2010.01.041; NATH S, 1995, PROG CARDIOVASC DIS, V37, P185, DOI 10.1016/S0033-0620(05)80006-4; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Rassweiler JJ, 2011, EUR UROL, V59, P784, DOI 10.1016/j.eururo.2011.02.033; Raum K, 1997, IEEE T ULTRASON FERR, V44, P810, DOI 10.1109/58.655196; Sacher F, 2010, J AM COLL CARDIOL, V55, P2366, DOI 10.1016/j.jacc.2009.10.084; Sinelnikov YD, 2009, ACOUST PHYS+, V55, P647, DOI 10.1134/S1063771009040216; Soejima K, 2001, CIRCULATION, V103, P1858; Sosa E, 2000, J AM COLL CARDIOL, V35, P1442, DOI 10.1016/S0735-1097(00)00606-9; STRICKBERGER SA, 1995, AM HEART J, V130, P1026, DOI 10.1016/0002-8703(95)90204-X; TAKAYAMA K, 1989, P INT WORKSH SHOCK W, P217; TANNO K, 1994, JPN CIRC J, V58, P123, DOI 10.1253/jcj.58.123; Tokuda M, 2011, CIRC-ARRHYTHMIA ELEC, V4, P889, DOI 10.1161/CIRCEP.111.966283; Zhou L, 1999, J CARDIOVASC ELECTR, V10, P611, DOI 10.1111/j.1540-8167.1999.tb00719.x	35	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116017	10.1371/journal.pone.0116017	http://dx.doi.org/10.1371/journal.pone.0116017			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	26674781	Green Published, Green Submitted, gold			2022-12-26	WOS:000348609800005
J	Borner, J; Kis-Katos, K; Hargrave, J; Konig, K				Boerner, Jan; Kis-Katos, Krisztina; Hargrave, Jorge; Koenig, Konstantin			Post-Crackdown Effectiveness of Field-Based Forest Law Enforcement in the Brazilian Amazon	PLOS ONE			English	Article							PROPENSITY SCORE; PROTECTED AREAS; DEFORESTATION; POLICY; ISSUES; FIRE; BEEF	Regulatory enforcement of forest conservation laws is often dismissed as an ineffective approach to reducing tropical forest loss. Yet, effective enforcement is often a precondition for alternative conservation measures, such as payments for environmental services, to achieve desired outcomes. Fair and efficient policies to reducing emissions from deforestation and forest degradation (REDD) will thus crucially depend on understanding the determinants and requirements of enforcement effectiveness. Among potential REDD candidate countries, Brazil is considered to possess the most advanced deforestation monitoring and enforcement infrastructure. This study explores a unique dataset of over 15 thousand point coordinates of enforcement missions in the Brazilian Amazon during 2009 and 2010, after major reductions of deforestation in the region. We study whether local deforestation patterns have been affected by field-based enforcement and to what extent these effects vary across administrative boundaries. Spatial matching and regression techniques are applied at different spatial resolutions. We find that field-based enforcement operations have not been universally effective in deterring deforestation during our observation period. Inspections have been most effective in reducing large-scale deforestation in the states of Mato Grosso and Para, where average conservation effects were 4.0 and 9.9 hectares per inspection, respectively. Despite regional and actor-specific heterogeneity in inspection effectiveness, field-based law enforcement is highly cost-effective on average and might be enhanced by closer collaboration between national and state-level authorities.	[Boerner, Jan] Univ Bonn, Res Dev Ctr, Bonn, Germany; [Boerner, Jan] Ctr Int Forestry Res, Bogor, Indonesia; [Kis-Katos, Krisztina] Univ Freiburg, Inst Econ Res, D-79106 Freiburg, Germany; [Hargrave, Jorge] Boston Consulting Grp Inc, Sao Paulo, Brazil; [Koenig, Konstantin] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, D-10099 Berlin, Germany	University of Bonn; CGIAR; Center for International Forestry Research (CIFOR); University of Freiburg; Boston Consulting Group (BCG); Humboldt University of Berlin	Borner, J (corresponding author), Univ Bonn, Res Dev Ctr, Bonn, Germany.	jborner@uni-bonn.de	Wunder, Sven/ABE-7773-2020; Börner, Jan JB/I-2139-2015; Kis-Katos, Krisztina/ABC-3624-2021; Börner, Jan/ABF-8775-2021	Wunder, Sven/0000-0002-9422-0260; Börner, Jan/0000-0003-3034-5360	Robert Bosch Foundation [32.5.8043.0012.0]; European Commission [DCI-ENV/2011/269520]	Robert Bosch Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Robert Bosch Foundation (Grant: 32.5.8043.0012.0; www.bosch-stiftung.de) and the European Commission (Grant: DCI-ENV/2011/269520; http://ec.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HJ, 2010, RESOUR ENERGY ECON, V32, P165, DOI 10.1016/j.reseneeco.2009.11.011; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Anselin L, 2002, AGR ECON-BLACKWELL, V27, P247, DOI 10.1111/j.1574-0862.2002.tb00120.x; Arima EY, 2007, J REGIONAL SCI, V47, P541, DOI 10.1111/j.1467-9787.2007.00519.x; Arima EY, 2014, LAND USE POLICY, V41, P465, DOI 10.1016/j.landusepol.2014.06.026; Assunu║ao JJ., 2013, DETERRING DEFORESTAT; Barretto AGOP, 2013, GLOBAL CHANGE BIOL, V19, P1804, DOI 10.1111/gcb.12174; Bartolini F, 2012, J AGR ECON, V63, P310, DOI 10.1111/j.1477-9552.2012.00339.x; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Borner J, 2014, GLOBAL ENVIRON CHANG, V29, P294, DOI 10.1016/j.gloenvcha.2014.04.021; Borner J., 2011, REDD STICKS CARROTS; Bowman MS, 2012, LAND USE POLICY, V29, P558, DOI 10.1016/j.landusepol.2011.09.009; CEPAL-IPEA-GIZ, 2011, AVALIACAO PLANO ACAO, DOI [10.1016/j.rpsm.2014.10.004, DOI 10.1016/J.RPSM.2014.10.004]; CLARKE HR, 1993, RESOUR ENERGY ECON, V15, P271, DOI 10.1016/0928-7655(93)90009-J; Dalla-Nora EL, 2014, LAND USE POLICY, V39, P403, DOI 10.1016/j.landusepol.2014.02.004; Aguiar APD, 2007, ECOL MODEL, V209, P169, DOI 10.1016/j.ecolmodel.2007.06.019; Ezzine-de-Blas D, 2011, ENVIRON SCI POLICY, V14, P188, DOI 10.1016/j.envsci.2010.11.009; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; Garoupa Nuno, 1997, J ECON SURV, V11, P267, DOI DOI 10.1111/1467-6419.00034; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Godar J, 2014, P NATL ACAD SCI USA; Godar J, 2012, FOREST ECOL MANAG, V267, P58, DOI 10.1016/j.foreco.2011.11.046; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hargrave J, 2013, ENVIRON RESOUR ECON, V54, P471, DOI 10.1007/s10640-012-9610-2; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Mitchell Polinsky A., 2000, AM LAW ECON REV, V2, P223, DOI [10.1093/aler/2.2.223, DOI 10.1093/ALER/2.2.223]; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Pacheco P, 2012, GEOFORUM, V43, P864, DOI 10.1016/j.geoforum.2012.02.003; Piquero AR, 2011, ANNU REV LAW SOC SCI, V7, P335, DOI 10.1146/annurev-lawsocsci-102510-105404; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Robinson EJZ., 2010, J NAT RES POLICY RES, V2, P25, DOI 10.1080/19390450903350820; Rosa IMD, 2012, CONSERV BIOL, V26, P932, DOI 10.1111/j.1523-1739.2012.01901.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; STIGLER GJ, 1970, J POLIT ECON, V78, P526, DOI 10.1086/259646; Weber JG, 2011, LAND ECON, V87, P661, DOI 10.3368/le.87.4.661; Wooldridge JM, 2003, AM ECON REV, V93, P133, DOI 10.1257/000282803321946930	46	86	87	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121544	10.1371/journal.pone.0121544	http://dx.doi.org/10.1371/journal.pone.0121544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875656	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800022
J	Wang, Y; Chen, ZH; Yin, C; Ma, JH; Li, DJ; Zhao, F; Sun, YL; Hu, LF; Shang, P; Qian, AR				Wang, Yang; Chen, Zhi-Hao; Yin, Chun; Ma, Jian-Hua; Li, Di-Jie; Zhao, Fan; Sun, Yu-Long; Hu, Li-Fang; Shang, Peng; Qian, Ai-Rong			GeneChip Expression Profiling Reveals the Alterations of Energy Metabolism Related Genes in Osteocytes under Large Gradient High Magnetic Fields	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; GRAVITY; LEVITATION; OSTEOBLAST; MICROGRAVITY; INDUCTION; MUSCLE; CELLS; MICE	The diamagnetic levitation as a novel ground-based model for simulating a reduced gravity environment has recently been applied in life science research. In this study a specially designed superconducting magnet with a large gradient high magnetic field (LG-HMF), which can provide three apparent gravity levels (mu-g, 1-g, and 2-g), was used to simulate a space-like gravity environment. Osteocyte, as the most important mechanosensor in bone, takes a pivotal position in mediating the mechano-induced bone remodeling. In this study, the effects of LG-HMF on gene expression profiling of osteocyte-like cell line MLO-Y4 were investigated by Affymetrix DNA microarray. LG-HMF affected osteocyte gene expression profiling. Differentially expressed genes (DEGs) and data mining were further analyzed by using bioinfomatic tools, such as DAVID, iReport. 12 energy metabolism related genes (PFKL, AK4, ALDOC, COX7A1, STC1, ADM, CA9, CA12, P4HA1, APLN, GPR35 and GPR84) were further confirmed by real-time PCR. An integrated gene interaction network of 12 DEGs was constructed. Bio-data mining showed that genes involved in glucose metabolic process and apoptosis changed notablly. Our results demostrated that LG-HMF affected the expression of energy metabolism related genes in osteocyte. The identification of sensitive genes to special environments may provide some potential targets for preventing and treating bone loss or osteoporosis.	[Wang, Yang; Chen, Zhi-Hao; Yin, Chun; Ma, Jian-Hua; Li, Di-Jie; Zhao, Fan; Sun, Yu-Long; Hu, Li-Fang; Shang, Peng; Qian, Ai-Rong] Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China	Northwestern Polytechnical University	Shang, P (corresponding author), Northwestern Polytech Univ, Sch Life Sci, Inst Special Environm Biophys, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China.	shangpeng@nwpu.edu.cn; qianair@nwpu.edu.cn	chen, zhihao/GXM-3816-2022; Hu, Lifang/W-8020-2019	Chen, Zhihao/0000-0003-0128-1409	Natural Science Foundation of China [31370845]; National Basic Research Program of China [2011CB710903]; New Century Excellent Talents in University [NCET-12-0469]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the Natural Science Foundation of China (No. 31370845), the National Basic Research Program of China (2011CB710903), and the New Century Excellent Talents in University (NCET-12-0469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Andreis PG, 2004, INT J MOL MED, V13, P551; Babbick M, 2007, ADV SPACE RES, V39, P1182, DOI 10.1016/j.asr.2007.01.001; BEAUGNON E, 1991, NATURE, V349, P470, DOI 10.1038/349470a0; Bonewald LF, 1999, J BONE MINER METAB, V17, P61, DOI 10.1007/s007740050066; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Brooks JS, 2000, J APPL PHYS, V87, P6194, DOI 10.1063/1.372653; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Burger EH, 2003, J BIOMECH, V36, P1453, DOI 10.1016/S0021-9290(03)00126-X; Cao HL, 2013, ACTA CRYSTALLOGR D, V69, P1901, DOI 10.1107/S0907444913016296; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Davet J, 1998, J APPL PHYSIOL, V84, P19, DOI 10.1152/jappl.1998.84.1.19; Di SM, 2012, INT J RADIAT BIOL, V88, P806, DOI 10.3109/09553002.2012.698365; Filvaroff EH, 2002, ENDOCRINOLOGY, V143, P3681, DOI 10.1210/en.2001-211424; Graham JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063884; Guevorkian K, 2006, P NATL ACAD SCI USA, V103, P13051, DOI 10.1073/pnas.0601839103; Hammer BE, 2009, MICROGRAVITY SCI TEC, V21, P311, DOI 10.1007/s12217-008-9092-6; Iolascon G, 2013, AGING CLIN EXP RES, V25, pS3, DOI 10.1007/s40520-013-0101-2; Kawakami S, 2006, JPN J APPL PHYS 1, V45, P6055, DOI 10.1143/JJAP.45.6055; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kondrachuk AV, 2001, ADV SPACE RES, V27, P1001, DOI 10.1016/S0273-1177(01)00167-3; Kuznetsov OA, 1997, J EXP BOT, V48, P1951, DOI 10.1093/jexbot/48.316.1951; Kuznetsov OA, 1996, PLANTA, V198, P87; Lee EG, 2011, INFLAMMATION, V34, P335, DOI 10.1007/s10753-010-9239-7; Liu YM, 2010, ADV SPACE RES, V45, P208, DOI 10.1016/j.asr.2009.08.033; MANCHESTER JK, 1990, FASEB J, V4, P55, DOI 10.1096/fasebj.4.1.1967237; Masakazu TE, 2013, B TOKYO DENT COLL, V53, P203, DOI [10.2209/tdcpublication.53.203, DOI 10.2209/TDCPUBLICATION.53.203]; Meng R, 2011, ACTA BIOCH BIOPH SIN, V43, P133, DOI 10.1093/abbs/gmq121; National Research Council Committee on Opportunities in High Magnetic Field Science Solid State Sciences Committee, 2005, OPP HIGH MAGN FIELD; Qian AR, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2232919; Qian AR, 2012, IEEE T BIO-MED ENG, V59, P68, DOI 10.1109/TBME.2010.2103377; Qian AR, 2010, ADV SPACE RES, V46, P687, DOI 10.1016/j.asr.2010.04.012; Qian AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051036; Qian AR, 2009, BIOELECTROMAGNETICS, V30, P545, DOI 10.1002/bem.20511; Qian AR, 2008, ACTA ASTRONAUT, V63, P929, DOI 10.1016/j.actaastro.2008.03.005; Qian AR, 2009, ACTA BIOCH BIOPH SIN, V41, P561, DOI 10.1093/abbs/gmp041; Qian AR, 2009, IEEE T APPL SUPERCON, V19, P42, DOI 10.1109/TASC.2009.2012422; Ramirez J, 2014, MICROGRAVITY SCI TEC, V25, P303, DOI 10.1007/s12217-013-9356-7; Riihonen R, 2007, BONE, V40, P1021, DOI 10.1016/j.bone.2006.11.028; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; Saier MH, 1988, ENZYMES METABOLIC PA, V16, P110; Santos A, 2009, OSTEOPOROSIS INT, V20, P1027, DOI 10.1007/s00198-009-0858-5; Shi DY, 2010, STEM CELL REV REP, V6, P567, DOI 10.1007/s12015-010-9182-x; Simon MD, 2000, J APPL PHYS, V87, P6200, DOI 10.1063/1.372654; Tan SD, 2007, BONE, V41, P745, DOI 10.1016/j.bone.2007.07.019; Tian ZC, 2010, MICROGRAVITY SCI TEC, V22, P163, DOI 10.1007/s12217-009-9170-4; Valiron O, 2005, J MAGN RESON IMAGING, V22, P334, DOI 10.1002/jmri.20398; Valles JM, 2005, ADV SPACE RES, V36, P114, DOI 10.1016/j.asr.2005.01.081; Valles JM, 2002, BIOPHYS J, V82, P1260, DOI 10.1016/S0006-3495(02)75482-9; Valles JM, 1997, BIOPHYS J, V73, P1130, DOI 10.1016/S0006-3495(97)78145-1; Venkataraman C, 2005, IMMUNOL LETT, V101, P144, DOI 10.1016/j.imlet.2005.05.010; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wattanachanya L, 2013, ENDOCRINOLOGY, V154, P2069, DOI 10.1210/en.2012-2034; Wykoff CC, 2000, CANCER RES, V60, P7075; Xie H, 2006, REGUL PEPTIDES, V134, P118, DOI 10.1016/j.regpep.2006.02.004; Yamaguchi M, 2006, SPRINGER SER MATER S, V89, P41	57	60	74	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2015	10	1							e0116359	10.1371/journal.pone.0116359	http://dx.doi.org/10.1371/journal.pone.0116359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC9HX	25962184	Green Submitted, Green Published, gold			2022-12-26	WOS:000350680700030
J	Yamamoto, ES; Campos, BLS; Jesus, JA; Laurenti, MD; Ribeiro, SP; Kallas, EG; Rafael-Fernandes, M; Santos-Gomes, G; Silva, MS; Sessa, DP; Lago, JHG; Levy, D; Passero, LFD				Yamamoto, Eduardo S.; Campos, Bruno L. S.; Jesus, Jessica A.; Laurenti, Marcia D.; Ribeiro, Susan P.; Kallas, Esper G.; Rafael-Fernandes, Mariana; Santos-Gomes, Gabriela; Silva, Marcelo S.; Sessa, Deborah P.; Lago, Joao H. G.; Levy, Debora; Passero, Luiz F. D.			The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis	PLOS ONE			English	Article							OLEANOLIC ACID; AMPHOTERICIN-B; IN-VITRO; ANTILEISHMANIAL ACTIVITY; VISCERAL LEISHMANIASIS; SECONDARY METABOLITES; TRADITIONAL MEDICINE; APOPTOSIS; DONOVANI; MECHANISM	Among neglected tropical diseases, leishmaniasis is one of the most important ones, affecting more than 12 million people worldwide. The available treatments are not well tolerated, and present diverse side effects, justifying the search for new therapeutic compounds. In the present study, the activity of ursolic acid (UA) and oleanolic acid (OA) were assayed in experimental cutaneous leishmaniasis (in vitro and in vivo). Promastigote forms of L. amazonensis were incubated with OA and UA for 24h, and effective concentration 50% (EC50) was estimated. Ultraestructural alterations in Leishmania amazonensis promastigotes after UA treatment were evaluated by transmission electron microscopy, and the possible mode of action was assayed through Annexin V and propidium iodide staining, caspase 3/7 activity, DNA fragmentation and transmembrane mitochondrial potential. The UA potential was evaluated in intracellular amastigotes, and its therapeutic potential was evaluated in L. amazonensis infected BALB/c mice. UA eliminated L. amazonensis promastigotes with an EC50 of 6.4 mu g/mL, comparable with miltefosine, while OA presented only a marginal effect on promastigote forms at 100 mu g/mL. The possible mechanism by which promastigotes were eliminated by UA was programmed cell death, independent of caspase 3/7, but it was highly dependent on mitochondria activity. UA was not toxic for peritoneal macrophages from BALB/c mice, and it was able to eliminate intracellular amastigotes, associated with nitric oxide (NO) production. OA did not eliminate amastigotes nor trigger NO. L. amazonensis infected BALB/c mice submitted to UA treatment presented lesser lesion size and parasitism compared to control. This study showed, for the first time, that UA eliminate promastigote forms through a mechanism associated with programed cell death, and importantly, was effective in vivo. Therefore, UA can be considered an interesting candidate for future tests as a prototype drug for the treatment of cutaneous leishmaniasis.	[Yamamoto, Eduardo S.; Campos, Bruno L. S.; Jesus, Jessica A.; Laurenti, Marcia D.; Passero, Luiz F. D.] Univ Sao Paulo, Lab Pathol Infect Dis LIM50, Dept Pathol, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Ribeiro, Susan P.; Kallas, Esper G.] Univ Sao Paulo, Lab Clin Immunol & Allergy LIM60, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Rafael-Fernandes, Mariana; Santos-Gomes, Gabriela; Silva, Marcelo S.] Univ Nova Lisboa, Global Hlth & Trop Med, IHMT, P-1349008 Lisbon, Portugal; [Sessa, Deborah P.; Lago, Joao H. G.] Univ Fed Sao Paulo, Inst Environm Chem & Pharmaceut Sci, BR-09920000 Diadema, SP, Brazil; [Levy, Debora] Univ Sao Paulo, Lab Genet & Mol Hematol LIM31, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Ribeiro, Susan P.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Case Western Reserve University	Passero, LFD (corresponding author), Univ Sao Paulo, Lab Pathol Infect Dis LIM50, Dept Pathol, Sch Med, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.	felipepassero@yahoo.com.br	Santos-Gomes, G/J-2367-2019; Lago, Joao/W-5238-2019; Fukuda, Koji/AAP-5927-2021; Passero, Luiz Felipe D/B-9549-2012; Laurenti, Marcia Dalastra/C-4734-2012; Santos-Gomes, Gabriela/I-2391-2012; Levy, Debora/G-8208-2014	Lago, Joao/0000-0002-1193-8374; Passero, Luiz Felipe D/0000-0002-5986-6381; FUKUDA, KOJI/0000-0001-7209-8420; Levy, Debora/0000-0001-7492-997X; Santos-Gomes, Gabriela/0000-0001-9264-3887; Yamamoto, Eduardo/0000-0003-2375-6081; Kallas, Esper/0000-0003-2026-6925; Shimokawa, Hiroaki/0000-0001-7534-4826; Rafael-Fernandes, Mariana/0000-0002-5214-7667; Silva, Marcelo/0000-0002-1000-0149; Laurenti, Marcia Dalastra/0000-0002-1080-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/03903-9, 2013/16297-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants: 2012/03903-9 and 2013/16297-2. URL: http://fapesp.br/en/.	Alvarado HL, 2015, COLLOID SURFACE B, V130, P40, DOI 10.1016/j.colsurfb.2015.03.062; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Begum S, 2014, CHEM BIODIVERS, V11, P709, DOI 10.1002/cbdv.201300151; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bero J, 2011, J ETHNOPHARMACOL, V137, P998, DOI 10.1016/j.jep.2011.07.022; Both DM, 2002, ARCH DERMATOL RES, V293, P569, DOI 10.1007/s00403-001-0272-0; Camargos HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104429; Campos BLS, 2015, PARASITE IMMUNOL, V37, P407, DOI 10.1111/pim.12206; Carneiro MB, 2015, IFN GAMMA DEPENDENT; Chattopadhyay A, 2011, BIOCHEM BIOPH RES CO, V416, P7, DOI 10.1016/j.bbrc.2011.11.023; da Luz RAI, 2011, J ANTIMICROB CHEMOTH, V66, P350, DOI 10.1093/jac/dkq444; da Silva AA, 2009, FITOTERAPIA, V80, P478, DOI 10.1016/j.fitote.2009.06.007; Das M, 2001, J CELL SCI, V114, P2461; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Demicheli C, 2008, CHEM COMMUN, P4828, DOI 10.1039/b809186b; Passero LFD, 2014, CURR CLIN PHARMACOL, V9, P187, DOI 10.2174/1574884709999140606161413; Passero LFD, 2010, APMIS, V118, P973, DOI 10.1111/j.1600-0463.2010.02679.x; Dutta A, 2007, J MED MICROBIOL, V56, P1196, DOI 10.1099/jmm.0.47114-0; Serna ME, 2015, PARASITOL INT, V64, P295, DOI 10.1016/j.parint.2015.03.005; Franca F, 1996, Rev Soc Bras Med Trop, V29, P229, DOI 10.1590/S0037-86821996000300002; Freitas-Junior LH, 2012, INT J PARASITOL-DRUG, V2, P11, DOI 10.1016/j.ijpddr.2012.01.003; Gachet MS, 2010, J ETHNOPHARMACOL, V128, P184, DOI 10.1016/j.jep.2010.01.007; Germonprez N, 2005, J MED CHEM, V48, P32, DOI 10.1021/jm031150y; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; Gnoatto SCB, 2008, J ENZYM INHIB MED CH, V23, P604, DOI [10.1080/14756360802204870, 10.1080/14756360802204870 ]; Hill RA, 2012, NAT PROD REP, V29, P780, DOI 10.1039/c2np20027a; Jesus JA, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/620472; Johann S, 2012, MED MYCOL, V50, P843, DOI 10.3109/13693786.2012.678903; Kontogianni VG, 2009, ANAL CHIM ACTA, V635, P188, DOI 10.1016/j.aca.2009.01.021; Laniado-Laborin R, 2009, REV IBEROAM MICOL, V26, P223, DOI 10.1016/j.riam.2009.06.003; Laurenti MD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/134236; Lin XR, 2014, FOOD FUNCT, V5, P1175, DOI 10.1039/c3fo60720h; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Machado M, 2012, EXP PARASITOL, V130, P223, DOI 10.1016/j.exppara.2011.12.012; Maes L, 2004, ANTIMICROB AGENTS CH, V48, P2056, DOI 10.1128/AAC.48.6.2056-2060.2004; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Neto RLM, 2011, EXP PARASITOL, V127, P215, DOI 10.1016/j.exppara.2010.07.020; Nam H, 2013, FOOD CHEM TOXICOL, V62, P579, DOI 10.1016/j.fct.2013.09.024; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Ovesna Z, 2006, MUTAT RES-FUND MOL M, V600, P131, DOI 10.1016/j.mrfmmm.2006.03.008; Passero LFD, 2015, PARASITOL INT, V64, P32, DOI 10.1016/j.parint.2015.01.006; Passero LFD, 2011, PARASITOL RES, V108, P529, DOI 10.1007/s00436-010-2091-8; Rath S, 2003, QUIM NOVA, V26, P550, DOI 10.1590/S0100-40422003000400018; Rego FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122038; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Santos DO, 2008, PARASITOL RES, V103, P1, DOI 10.1007/s00436-008-0943-2; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Seebacher W, 2003, MAGN RESON CHEM, V41, P636, DOI 10.1002/mrc.1214; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Tan N, 2002, PHYTOCHEMISTRY, V61, P881, DOI 10.1016/S0031-9422(02)00361-8; Thakur CP, 1999, T ROY SOC TROP MED H, V93, P319, DOI 10.1016/S0035-9203(99)90037-8; Torrado JJ, 2008, J PHARM SCI-US, V97, P2405, DOI 10.1002/jps.21179; Torres-Santos EC, 2004, PHYTOMEDICINE, V11, P114, DOI 10.1078/0944-7113-00381; Wang X, 2013, CARCINOGENESIS, V34, P1323, DOI 10.1093/carcin/bgt058; Yamamoto ES, 2014, PARASITOL RES, V113, P333, DOI 10.1007/s00436-013-3659-x; Yang L, 2010, CANCER LETT, V298, P128, DOI 10.1016/j.canlet.2010.06.010; You HJ, 2001, FEBS LETT, V509, P156, DOI 10.1016/S0014-5793(01)03161-1; Zeng JW, 2015, MOL MED REP, V12, P1997, DOI 10.3892/mmr.2015.3666	62	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144946	10.1371/journal.pone.0144946	http://dx.doi.org/10.1371/journal.pone.0144946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674781	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700076
J	Borner, J; Marinho, E; Wunder, S				Boerner, Jan; Marinho, Eduardo; Wunder, Sven			Mixing Carrots and Sticks to Conserve Forests in the Brazilian Amazon: A Spatial Probabilistic Modeling Approach	PLOS ONE			English	Article							ENVIRONMENTAL SERVICES; POLICY MIX; DEFORESTATION; PAYMENTS	Annual forest loss in the Brazilian Amazon had in 2012 declined to less than 5,000 sqkm, from over 27,000 in 2004. Mounting empirical evidence suggests that changes in Brazilian law enforcement strategy and the related governance system may account for a large share of the overall success in curbing deforestation rates. At the same time, Brazil is experimenting with alternative approaches to compensate farmers for conservation actions through economic incentives, such as payments for environmental services, at various administrative levels. We develop a spatially explicit simulation model for deforestation decisions in response to policy incentives and disincentives. The model builds on elements of optimal enforcement theory and introduces the notion of imperfect payment contract enforcement in the context of avoided deforestation. We implement the simulations using official deforestation statistics and data collected from field-based forest law enforcement operations in the Amazon region. We show that a large-scale integration of payments with the existing regulatory enforcement strategy involves a tradeoff between the cost-effectiveness of forest conservation and landholder incomes. Introducing payments as a complementary policy measure increases policy implementation cost, reduces income losses for those hit hardest by law enforcement, and can provide additional income to some land users. The magnitude of the tradeoff varies in space, depending on deforestation patterns, conservation opportunity and enforcement costs. Enforcement effectiveness becomes a key determinant of efficiency in the overall policy mix.	[Boerner, Jan] Univ Bonn, Ctr Dev Res ZEF, D-53113 Bonn, Germany; [Boerner, Jan; Marinho, Eduardo; Wunder, Sven] Ctr Int Forestry Res CIFOR, Rio De Janeiro, Brazil	University of Bonn; CGIAR; Center for International Forestry Research (CIFOR)	Borner, J (corresponding author), Univ Bonn, Ctr Dev Res ZEF, Walter Flex Str 3, D-53113 Bonn, Germany.	jborner@uni-bonn.de	Wunder, Sven/ABE-7773-2020; Börner, Jan JB/I-2139-2015; Kis-Katos, Krisztina/ABC-3624-2021; Börner, Jan/ABF-8775-2021	Wunder, Sven/0000-0002-9422-0260; Börner, Jan/0000-0003-3034-5360	Robert Bosch Foundation; European Commission [DCI-ENV/2011/269520]; Forest, Trees, and Agroforestry Program	Robert Bosch Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Forest, Trees, and Agroforestry Program	This work was funded by the Robert Bosch Foundation (www.bosch-stiftung.de), European Commission (http://ec.europa.eu/index_en.htm; Grant number: DCI-ENV/2011/269520), and Forest, Trees, and Agroforestry Program (http://foreststreesagroforestry.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers HJ, 2010, RESOUR ENERGY ECON, V32, P165, DOI 10.1016/j.reseneeco.2009.11.011; Angelsen A, 2010, P NATL ACAD SCI USA, V107, P19639, DOI 10.1073/pnas.0912014107; Armsworth PR, 2012, ECOL LETT, V15, P406, DOI 10.1111/j.1461-0248.2012.01747.x; Assuncao J., 2013, DOES CREDIT AFFECT D; Assuncao Juliano., 2012, DEFORESTATION SLOWDO; Barton DN, 2013, SOC NATUR RESOUR, V26, P1185, DOI 10.1080/08941920.2013.799727; Barton DN, 2014, TECHINCAL BRIEF; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Borner J, 2014, GLOBAL ENVIRON CHANG, V29, P294, DOI 10.1016/j.gloenvcha.2014.04.021; Borner J, 2010, ECOL ECON, V69, P1272, DOI 10.1016/j.ecolecon.2009.11.003; Borner J., 2013, GOVERNING PROVISION, P21, DOI [10.1007/978-94-007-5176-7_2, DOI 10.1007/978-94-007-5176-7]; Borner J, 2013, COMPENSACAO PORSERVI; Borner J, 2014, GLOBAL ENV IN PRESS; Cattaneo A., 2002, RES REPORT; Ezzine-de-Blas D, 2011, ENVIRON SCI POLICY, V14, P188, DOI 10.1016/j.envsci.2010.11.009; Garoupa Nuno, 1997, J ECON SURV, V11, P267, DOI DOI 10.1111/1467-6419.00034; Godar J, 2014, P NATL ACAD SCI USA; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hargrave J, 2013, ENVIRON RESOUR ECON, V54, P471, DOI 10.1007/s10640-012-9610-2; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Lehmann P, 2012, J ECON SURV, V26, P71, DOI 10.1111/j.1467-6419.2010.00628.x; Merger Eduard, 2012, Carbon Balance Manag, V7, P9, DOI 10.1186/1750-0680-7-9; MMA, 2009, BRAZ REDD STRAT DOC; Moxey A, 2014, LAND USE POLICY, V39, P397, DOI 10.1016/j.landusepol.2014.04.008; Nepstad D, 2014, SCIENCE, V344, P1118, DOI 10.1126/science.1248525; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Persson UM, 2013, WORLD DEV, V43, P124, DOI 10.1016/j.worlddev.2012.10.006; Prager K, 2011, LAND DEGRAD DEV, V22, P111, DOI 10.1002/ldr.1038; Sandmo A, 2002, ENVIRON RESOUR ECON, V23, P85, DOI 10.1023/A:1020236324130; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Sohngen B, 2004, CAN J FOREST RES, V34, P829, DOI [10.1139/x03-249, 10.1139/X03-249]; Sparovek G, 2012, ENVIRON SCI POLICY, V16, P65, DOI 10.1016/j.envsci.2011.10.008; Tinbergen Jan, 1952, THEORY EC POLICY; Wunscher T, 2008, ECOL ECON, V65, P822, DOI 10.1016/j.ecolecon.2007.11.014; Wunder S, 2014, EARTHSCAN FOR LIBR, P202; Wunder S, 2013, CONSERV LETT, V6, P230, DOI 10.1111/conl.12034	37	86	87	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2015	10	2							e0116846	10.1371/journal.pone.0116846	http://dx.doi.org/10.1371/journal.pone.0116846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA9NG	25875656	Green Published, Green Submitted, gold			2022-12-26	WOS:000349250700007
